PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Altare, C; Guha-Sapir, D				Altare, Chiara; Guha-Sapir, Debarati			The Complex Emergency Database: A Global Repository of Small-Scale Surveys on Nutrition, Health and Mortality	PLOS ONE			English	Article							CONFLICT	Evidence has become central for humanitarian decision making, as it is now commonly agreed that aid must be provided solely in proportion to the needs and on the basis of needs assessments. Still, reliable epidemiological data from conflict-affected communities are difficult to acquire in time for effective decisions, as existing health information systems progressively lose functionality with the onset of conflicts. In the last decade, health and nutrition humanitarian agencies have made substantial progress in collecting quality data using small-scale surveys. In 2002, a group of academics, non-governmental organizations, and UN agencies launched the Standardized Monitoring and Assessment of Relief and Transitions (SMART) methodology. Since then, field agencies have conducted thousands of surveys. Although the contribution of each survey by itself is limited by its small sample and the impossibility to extrapolate results to national level, their aggregation can provide a more stable view of both trends and distributions in a larger region. The Complex Emergency Database (CEDAT) was set up in order to make best use of the collective force of these surveys. Functioning as a central repository, it can provide valuable information on trends and patterns of mortality and nutrition indicators from conflict-affected communities. Given their high spatial resolution and their high frequency, CEDAT data can complement official statistics in between nationwide surveys. They also provide information of the displacement status of the measured population, pointing out vulnerabilities. CEDAT is hosted at the Centre for Research on the Epidemiology of Disasters, University of Louvain. It runs on voluntary agreements between the survey implementer and the CEDAT team. To date, it contains 3309 surveys from 51 countries, and is a unique repository of such data.	[Altare, Chiara; Guha-Sapir, Debarati] Catholic Univ Louvain, Inst Hlth & Soc, Ctr Res Epidemiol Disaster, B-1200 Brussels, Belgium	Universite Catholique Louvain	Altare, C (corresponding author), Catholic Univ Louvain, Inst Hlth & Soc, Ctr Res Epidemiol Disaster, B-1200 Brussels, Belgium.	chiara.altare@uclouvain.be		Altare, Chiara/0000-0002-3410-0427	Universite catholique de Louvain; European Commission	Universite catholique de Louvain; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors are supported by following sources: Universite catholique de Louvain and European Commission. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; Centre for Research on the Epidemiology of Disasters, 2012, CEDAT SPOTL DEM REP; Centre for Research on the Epidemiology of Disasters, 2012, CEDAT SPOTL ETH; CRED, 2007, CEDAT EXP GROUP M P; Degomme O, 2010, LANCET, V375, P294, DOI 10.1016/S0140-6736(09)61967-X; Degomme O, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-11; DFID, 2012, PROM INN EV BAS APPR; Good Humanitarian Donorship, 2003, GHD PRINC GOOD PRACT; Grijalva-Eternod CS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001320; Guha-Sapir D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000108; Leaning J, 2013, NEW ENGL J MED, V369, P1836, DOI 10.1056/NEJMra1109877; Linard C, 2013, INT C NUTR FOOD PROD; Mason JB, 2012, INT J ENV RES PUB HE, V9, P791, DOI 10.3390/ijerph9030791; Olives C, 2010, EMERG THEMES EPIDEMI, V7, DOI 10.1186/1742-7622-7-3; Prudhon C, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-10; The SMART Project, 2006, MEAS MORT NUTR FOOD; Union E, 2008, AID, V179, P1; United Nations Office for Coordination of Humanitarian Affairs (OCHA), 2001, GUID PRINC INT DISPL; Vogt F, 2011, HLTH DATA CIVIL CONF	19	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109022	10.1371/journal.pone.0109022	http://dx.doi.org/10.1371/journal.pone.0109022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333954	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200009
J	Chollett, I; Enriquez, S; Mumby, PJ				Chollett, Iliana; Enriquez, Susana; Mumby, Peter J.			Redefining Thermal Regimes to Design Reserves for Coral Reefs in the Face of Climate Change	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; OCEAN ACIDIFICATION; BLEACHING EVENT; BUILDING CORALS; STRESS; CONSERVATION; FUTURE; PHOTOSYNTHESIS; ABSORPTION; MANAGEMENT	Reef managers cannot fight global warming through mitigation at local scale, but they can use information on thermal patterns to plan for reserve networks that maximize the probability of persistence of their reef system. Here we assess previous methods for the design of reserves for climate change and present a new approach to prioritize areas for conservation that leverages the most desirable properties of previous approaches. The new method moves the science of reserve design for climate change a step forwards by: (1) recognizing the role of seasonal acclimation in increasing the limits of environmental tolerance of corals and ameliorating the bleaching response; (2) using the best proxy for acclimatization currently available; (3) including information from several bleaching events, which frequency is likely to increase in the future; (4) assessing relevant variability at country scales, where most management plans are carried out. We demonstrate the method in Honduras, where a reassessment of the marine spatial plan is in progress.	[Chollett, Iliana; Mumby, Peter J.] Univ Exeter, Coll Life & Environm Sci, Marine Spatial Ecol Lab, Exeter, Devon, England; [Chollett, Iliana; Mumby, Peter J.] Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, Brisbane, Qld, Australia; [Enriquez, Susana] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Puerto Morelos, Mexico	University of Exeter; University of Queensland; Universidad Nacional Autonoma de Mexico	Chollett, I (corresponding author), Univ Exeter, Coll Life & Environm Sci, Marine Spatial Ecol Lab, Exeter, Devon, England.	iliana.chollett@gmail.com	Mumby, Peter/F-9914-2010	Mumby, Peter/0000-0002-6297-9053; Chollett, Iliana/0000-0003-0536-499X; Enriquez, Susana/0000-0001-5776-902X	European Union [244161]; Pew [2008-000330-010]; ARC [FL0992179]	European Union(European Commission); Pew; ARC(Australian Research Council)	The research leading to these results has received funding from the European Union 7th Framework programme (P7/2007-2013) under grant agreement no. 244161, Pew (grant 2008-000330-010) and ARC Laureate Fellowships (FL0992179) to PJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AJ, 2013, ANNU REV MAR SCI, V5, P321, DOI 10.1146/annurev-marine-121211-172241; Andrufouut S., 2006, P 10 INT COR REEF S, P1732; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Ban NC, 2012, CONSERV BIOL, V26, P799, DOI 10.1111/j.1523-1739.2012.01894.x; Bellantuono AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050685; Bellantuono AJ, 2012, P ROY SOC B-BIOL SCI, V279, P1100, DOI 10.1098/rspb.2011.1780; Burke L., 2011, REEFS RISK REVISITED; CARICOMP, 1997, P 8 INT COR REEF S P, P673; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; Castillo KD, 2005, MAR BIOL, V148, P261, DOI 10.1007/s00227-005-0046-x; Chollett I, 2013, BIOL CONSERV, V167, P179, DOI 10.1016/j.biocon.2013.08.010; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Eakin CM, 2010, OCEANOGRAPHY, V23, P118, DOI 10.5670/oceanog.2010.10; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Game ET, 2008, ECOL APPL, V18, P670, DOI 10.1890/07-1027.1; Gledhill DK, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004629; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Groves CR, 2012, BIODIVERS CONSERV, V21, P1651, DOI 10.1007/s10531-012-0269-3; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Kintisch Eli, 2010, SCIENCE; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kwiatkowski L, 2013, CLIM DYNAM, P1; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Levy JS, 2013, MAR POLICY, V38, P16, DOI 10.1016/j.marpol.2012.05.015; Liu G, 2006, P 10 INT COR REEF S; Liu G., 2003, EOS, V84, P137, DOI [10.1029/2003EO150001, DOI 10.1029/2003E0150001]; Liu G, 2012, P 12 INT COR REEF S, P5; Magris RA, 2014, BIOL CONSERV, V170, P207, DOI 10.1016/j.biocon.2013.12.032; Marcelino LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061492; Maynard JA, 2008, MAR BIOL, V155, P173, DOI 10.1007/s00227-008-1015-y; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; Mcleod E, 2013, FRONT ECOL ENVIRON, V11, P20, DOI 10.1890/110240; McLeod E, 2010, COAST MANAGE, V38, P518, DOI 10.1080/08920753.2010.509466; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Mumby PJ, 2011, ECOL LETT, V14, P132, DOI 10.1111/j.1461-0248.2010.01562.x; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Pielke Sr R. A., 2012, T AM GEOPHYS UNION, V93, P52; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Smale DA, 2009, MAR ECOL PROG SER, V387, P27, DOI 10.3354/meps08132; Strong AE, 2000, GEOPHYS RES LETT, V27, P1667, DOI 10.1029/1999GL002392; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Teran E, 2010, APPL OPTICS, V49, P5032, DOI 10.1364/AO.49.005032; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; West J, 2003, COMMENTARY, V115, P17; Zanakis SH, 1998, EUR J OPER RES, V107, P507, DOI 10.1016/S0377-2217(97)00147-1	57	21	21	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110634	10.1371/journal.pone.0110634	http://dx.doi.org/10.1371/journal.pone.0110634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333380	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200062
J	Ilin, V; Stevenson, IH; Volgushev, M				Ilin, Vladimir; Stevenson, Ian H.; Volgushev, Maxim			Injection of Fully-Defined Signal Mixtures: A Novel High-Throughput Tool to Study Neuronal Encoding and Computations	PLOS ONE			English	Article							IN-VIVO; COINCIDENCE DETECTION; NEOCORTICAL NEURONS; SPIKE GENERATION; OPTICAL CONTROL; ENSEMBLES; PROPAGATION; INTEGRATION; SYNCHRONY; NETWORKS	Understanding of how neurons transform fluctuations of membrane potential, reflecting input activity, into spike responses, which communicate the ultimate results of single-neuron computation, is one of the central challenges for cellular and computational neuroscience. To study this transformation under controlled conditions, previous work has used a signal immersed in noise paradigm where neurons are injected with a current consisting of fluctuating noise that mimics on-going synaptic activity and a systematic signal whose transmission is studied. One limitation of this established paradigm is that it is designed to examine the encoding of only one signal under a specific, repeated condition. As a result, characterizing how encoding depends on neuronal properties, signal parameters, and the interaction of multiple inputs is cumbersome. Here we introduce a novel fully-defined signal mixture paradigm, which allows us to overcome these problems. In this paradigm, current for injection is synthetized as a sum of artificial postsynaptic currents (PSCs) resulting from the activity of a large population of model presynaptic neurons. PSCs from any presynaptic neuron(s) can be now considered as "signal", while the sum of all other inputs is considered as "noise". This allows us to study the encoding of a large number of different signals in a single experiment, thus dramatically increasing the throughput of data acquisition. Using this novel paradigm, we characterize the detection of excitatory and inhibitory PSCs from neuronal spike responses over a wide range of amplitudes and firing-rates. We show, that for moderately-sized neuronal populations the detectability of individual inputs is higher for excitatory than for inhibitory inputs during the 2-5 ms following PSC onset, but becomes comparable after 78 ms. This transient imbalance of sensitivity in favor of excitation may enhance propagation of balanced signals through neuronal networks. Finally, we discuss several open questions that this novel high-throughput paradigm may address.	[Ilin, Vladimir; Stevenson, Ian H.; Volgushev, Maxim] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA	University of Connecticut	Volgushev, M (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA.	maxim.volgushev@uconn.edu	Ilin, Vladimir/F-9494-2015; Volgushev, Maxim/AAO-6793-2020	Ilin, Vladimir/0000-0003-3934-249X; Volgushev, Maxim/0000-0002-8080-1136; Ilin, Vladimir/0000-0003-0067-9749; Stevenson, Ian/0000-0002-1428-5946	National Institutes of Health [R01 MH087631]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health, R01 MH087631 http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Baranauskas G, 2010, NEUROSCIENCE, V167, P1070, DOI 10.1016/j.neuroscience.2010.02.072; Battaglia D, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00013; Boucsein C, 2009, J NEUROSCI, V29, P1006, DOI 10.1523/JNEUROSCI.3424-08.2009; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Brunel N, 2001, PHYS REV LETT, V86, P2186, DOI 10.1103/PhysRevLett.86.2186; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Chen Z, 2011, IEEE T NEUR SYS REH, V19, P121, DOI 10.1109/TNSRE.2010.2086079; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Druckmann S, 2013, CEREB CORTEX, V23, P2994, DOI 10.1093/cercor/bhs290; Estebanez L, 2012, NAT NEUROSCI, V15, P1691, DOI 10.1038/nn.3258; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Herrmann A, 2001, J COMPUT NEUROSCI, V11, P135, DOI 10.1023/A:1012841516004; Higgs MH, 2011, J PHYSIOL-LONDON, V589, P5125, DOI 10.1113/jphysiol.2011.216721; Higgs MH, 2009, J NEUROSCI, V29, P1285, DOI 10.1523/JNEUROSCI.3728-08.2009; Ilin V, 2013, J NEUROSCI, V33, P2281, DOI 10.1523/JNEUROSCI.0771-12.2013; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kondgen H, 2008, CEREB CORTEX, V18, P2086, DOI 10.1093/cercor/bhm235; Kremkow J, 2010, J NEUROSCI, V30, P15760, DOI 10.1523/JNEUROSCI.3874-10.2010; Linaro D, 2014, J NEUROSCI METH, V230, P5, DOI 10.1016/j.jneumeth.2014.04.003; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Malyshev A, 2013, EUR J NEUROSCI, V38, P3181, DOI 10.1111/ejn.12338; Margulis M, 1998, J NEUROPHYSIOL, V79, P2809, DOI 10.1152/jn.1998.79.5.2809; Naundorf B, 2005, J COMPUT NEUROSCI, V18, P297, DOI 10.1007/s10827-005-0329-8; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Ostojic S, 2009, J NEUROSCI, V29, P10234, DOI 10.1523/JNEUROSCI.1275-09.2009; Paninski L, 2010, J COMPUT NEUROSCI, V29, P107, DOI 10.1007/s10827-009-0179-x; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Shea-Brown E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108102; Silberberg G, 2004, J NEUROPHYSIOL, V91, P704, DOI 10.1152/jn.00415.2003; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Stevenson IH, 2008, CURR OPIN NEUROBIOL, V18, P582, DOI 10.1016/j.conb.2008.11.005; Tchumatchenko T, 2011, J NEUROSCI, V31, P12171, DOI 10.1523/JNEUROSCI.2182-11.2011; Tchumatchenko T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058102; Trousdale J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002408; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Urban N, 2012, NATURE, V488, P289, DOI 10.1038/488289a; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Volgushev M, 2003, EUR J NEUROSCI, V17, P1768, DOI 10.1046/j.1460-9568.2003.02609.x; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Volgushev M, IDENTIFYING TR UNPUB; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Wolfe J, 2010, CURR OPIN NEUROBIOL, V20, P306, DOI 10.1016/j.conb.2010.03.006; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	59	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109928	10.1371/journal.pone.0109928	http://dx.doi.org/10.1371/journal.pone.0109928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25335081	Green Published, gold			2022-12-27	WOS:000343731200021
J	Nayak, SN; Song, J; Villa, A; Pathak, B; Ayala-Silva, T; Yang, XP; Todd, J; Glynn, NC; Kuhn, DN; Glaz, B; Gilbert, RA; Comstock, JC; Wang, JP				Nayak, Spurthi N.; Song, Jian; Villa, Andrea; Pathak, Bhuvan; Ayala-Silva, Tomas; Yang, Xiping; Todd, James; Glynn, Neil C.; Kuhn, David N.; Glaz, Barry; Gilbert, Robert A.; Comstock, Jack C.; Wang, Jianping			Promoting Utilization of Saccharum spp. Genetic Resources through Genetic Diversity Analysis and Core Collection Construction	PLOS ONE			English	Article							MARKER-TRAIT ASSOCIATIONS; MICROSATELLITE MARKERS; POPULATION-STRUCTURE; DNA MARKERS; LINKAGE DISEQUILIBRIUM; AFLP ANALYSIS; SNP MARKERS; SUGARCANE; GERMPLASM; SORGHUM	Sugarcane (Saccharum spp.) and other members of Saccharum spp. are attractive biofuel feedstocks. One of the two World Collections of Sugarcane and Related Grasses (WCSRG) is in Miami, FL. This WCSRG has 1002 accessions, presumably with valuable alleles for biomass, other important agronomic traits, and stress resistance. However, the WCSRG has not been fully exploited by breeders due to its lack of characterization and unmanageable population. In order to optimize the use of this genetic resource, we aim to 1) genotypically evaluate all the 1002 accessions to understand its genetic diversity and population structure and 2) form a core collection, which captures most of the genetic diversity in the WCSRG. We screened 36 microsatellite markers on 1002 genotypes and recorded 209 alleles. Genetic diversity of the WCSRG ranged from 0 to 0.5 with an average of 0.304. The population structure analysis and principal coordinate analysis revealed three clusters with all S. spontaneum in one cluster, S. officinarum and S. hybrids in the second cluster and mostly non-Saccharum spp. in the third cluster. A core collection of 300 accessions was identified which captured the maximum genetic diversity of the entire WCSRG which can be further exploited for sugarcane and energy cane breeding. Sugarcane and energy cane breeders can effectively utilize this core collection for cultivar improvement. Further, the core collection can provide resources for forming an association panel to evaluate the traits of agronomic and commercial importance.	[Nayak, Spurthi N.; Song, Jian; Villa, Andrea; Pathak, Bhuvan; Yang, Xiping; Gilbert, Robert A.; Wang, Jianping] Univ Florida, Dept Agron, Gainesville, FL 32611 USA; [Song, Jian] Dezhou Univ, Coll Life Sci, Dezhou, Shandong, Peoples R China; [Ayala-Silva, Tomas; Kuhn, David N.] USDA ARS, Subtrop Hort Res Stn, Miami, FL 33158 USA; [Todd, James] Univ Florida, Everglades Res & Educ Ctr, Belle Glade, FL 33430 USA; [Glynn, Neil C.; Glaz, Barry; Comstock, Jack C.] USDA ARS, Sugarcane Field Stn, Canal Point, FL USA; [Wang, Jianping] Univ Florida, Genet Inst, Plant Mol & Biol Program, Gainesville, FL 32611 USA; [Wang, Jianping] Fujian Agr & Forestry Univ, FAFU, Fuzhou, Fujian, Peoples R China; [Wang, Jianping] Fujian Agr & Forestry Univ, UIUC SIB Joint Ctr Genom & Biotechnol, Fuzhou, Fujian, Peoples R China	State University System of Florida; University of Florida; Dezhou University; United States Department of Agriculture (USDA); State University System of Florida; University of Florida; United States Department of Agriculture (USDA); State University System of Florida; University of Florida; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Wang, JP (corresponding author), Univ Florida, Dept Agron, Gainesville, FL 32611 USA.	wangjp@ufl.edu	Pathak, Bhuvan/L-3442-2019; Glaz, Barry/I-6231-2019	Pathak, Bhuvan/0000-0002-9313-6817; 	Office of Science (BER), U.S. Department of Energy; ARS [ARS-0425148] Funding Source: Federal RePORTER	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the Office of Science (BER), U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken KS, 2006, AUST J AGR RES, V57, P1167, DOI 10.1071/AR05391; Alexander K, 1995, ACIAR P, P19; Ali ML, 2008, MOL BREEDING, V21, P497, DOI 10.1007/s11032-007-9149-z; ALJANABI SM, 1993, GENETICS, V134, P1249; Andru S, 2011, THEOR APPL GENET, V123, P77, DOI 10.1007/s00122-011-1568-x; Aragon C., 2009, Tropical Plant Biology, V2, P38, DOI 10.1007/s12042-008-9026-x; Arruda P., 2011, Tropical Plant Biology, V4, P3, DOI 10.1007/s12042-011-9074-5; Arumugasundaram S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028252; Balakrishnan R., 2000, UNIVERSITEX, DOI 10.1007/978-1-4419-8505-7; Banumathi G., 2010, Electronic Journal of Plant Breeding, V1, P517; Berding N, 1987, SUGARCANE IMPROVEMEN, P143, DOI DOI 10.1016/B978-0-444-42769-4.50009-6; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Brown JS, 2007, GENET RESOUR CROP EV, V54, P627, DOI 10.1007/s10722-006-0035-z; BULL TA, 1963, AUST J BIOL SCI, V16, P737, DOI 10.1071/BI9630737; Burner DM, 2009, BIOMASS BIOENERG, V33, P610, DOI 10.1016/j.biombioe.2008.10.002; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Cai Q, 2005, PLANT SCI, V169, P976, DOI 10.1016/j.plantsci.2005.07.002; Chandra Amaresh, 2013, BMC Res Notes, V6, P47, DOI 10.1186/1756-0500-6-47; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044510; Coimbra RR, 2009, GENET MOL BIOL, V32, P538, DOI 10.1590/S1415-47572009005000059; Comstock J., 1995, ACIAR P, P17; Cooper H, 2001, BROADENING GENETIC B, P1, DOI DOI 10.1079/9780851994116.0001; Cordeiro GM, 2003, PLANT SCI, V165, P181, DOI 10.1016/S0168-9452(03)00157-2; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; Cordeiro GM, 2000, PLANT SCI, V155, P161, DOI 10.1016/S0168-9452(00)00208-9; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; D'Hont A, 1998, GENOME, V41, P221, DOI 10.1139/gen-41-2-221; Dahlberg JA, 2004, ECON BOT, V58, P556, DOI 10.1663/0013-0001(2004)058[0556:DOASCC]2.0.CO;2; Daniels SJ, 1987, SUGARCANE IMPROVEMEN, V11, P7, DOI DOI 10.1016/B978-0-444-42769-4.50007-2; DASILVA JAG, 1993, GENOME, V36, P782, DOI 10.1139/g93-103; Borba TCD, 2010, GENET MOL BIOL, V33, P515, DOI 10.1590/S1415-47572010005000065; DHONT A, 1995, THEOR APPL GENET, V91, P320, DOI 10.1007/BF00220894; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Glynn N. C., 2009, Journal - American Society of Sugar Cane Technologists, V29, P36; Henry R, 2010, GENETICS GENOMICS BR; Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3; Irvine JE, 1999, THEOR APPL GENET, V98, P186, DOI 10.1007/s001220051057; JACKSON P, 2011, WILD CROP RELATIVES, P97, DOI DOI 10.1007/978-3-642-21102-7_5; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; Li Y, 2004, GENET RESOUR CROP EV, V51, P845, DOI 10.1007/s10722-005-8313-8; Lima MLA, 2002, THEOR APPL GENET, V104, P30, DOI 10.1007/s001220200003; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu PW, 2011, SUGAR TECH, V13, P129, DOI 10.1007/s12355-011-0077-1; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; Mazzucato A, 2008, THEOR APPL GENET, V116, P657, DOI 10.1007/s00122-007-0699-6; Ming R, 2006, PL BRED RE, V27, P15; Mukherjee S. K, 1957, BOT GAZ, V119, P55, DOI DOI 10.1086/335962; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pan YB, 2003, MAYDICA, V48, P319; PANJE R. R., 1960, CYTOLOGIA, V25, P152, DOI 10.1508/cytologia.25.152; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2003, GENETIC DIVERSITY CU, P47; Pritchard JK, 2000, GENETICS, V155, P945; Rae A. L., 2009, Tropical Plant Biology, V2, P13, DOI 10.1007/s12042-008-9019-9; Selvi A, 2006, GENET RESOUR CROP EV, V53, P831, DOI 10.1007/s10722-004-6376-6; Selvi A, 2003, GENOME, V46, P394, DOI 10.1139/G03-018; Singh RK, 2010, AUST J CROP SCI, V4, P116; SLADDEN SE, 1991, BIOMASS BIOENERG, V1, P119, DOI 10.1016/0961-9534(91)90034-A; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Stich B, 2005, THEOR APPL GENET, V111, P723, DOI 10.1007/s00122-005-2057-x; Tai PYP, 2002, CROP SCI, V42, P958, DOI 10.2135/cropsci2002.0958; Tai PYP, 2001, CROP SCI, V41, P879, DOI 10.2135/cropsci2001.413879x; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Tew Thomas L., 2008, P249, DOI 10.1007/978-0-387-70805-8_9; Todd J, 2014, GENETIC RES IN PRESS; Upadhyaya HD, 2013, THEOR APPL GENET, V126, P2003, DOI 10.1007/s00122-013-2113-x; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wei XM, 2006, THEOR APPL GENET, V114, P155, DOI 10.1007/s00122-006-0418-8; Wei XM, 2010, GENOME, V53, P973, DOI 10.1139/G10-050; Weir BS, 1996, GENETIC DATA ANAL, P209; Zhang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027565	74	50	51	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110856	10.1371/journal.pone.0110856	http://dx.doi.org/10.1371/journal.pone.0110856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333358	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000343731200081
J	Kong, LC; Holmes, BA; Cotillard, A; Habi-Rachedi, F; Brazeilles, R; Gougis, S; Gausseres, N; Cani, PD; Fellahi, S; Bastard, JP; Kennedy, SP; Dore, J; Ehrlich, SD; Zucker, JD; Rizkalla, SW; Clement, K				Kong, Ling Chun; Holmes, Bridget A.; Cotillard, Aurelie; Habi-Rachedi, Fatiha; Brazeilles, Remi; Gougis, Sophie; Gausseres, Nicolas; Cani, Patrice D.; Fellahi, Soraya; Bastard, Jean-Philippe; Kennedy, Sean P.; Dore, Joel; Ehrlich, Stanislav Dusko; Zucker, Jean-Daniel; Rizkalla, Salwa W.; Clement, Karine			Dietary Patterns Differently Associate with Inflammation and Gut Microbiota in Overweight and Obese Subjects	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DAIRY PRODUCT INTAKE; BODY-MASS INDEX; MEDITERRANEAN DIET; WEIGHT; RISK; FOOD; NUTRITION; MARKERS; COMPONENTS	Background: Associations between dietary patterns, metabolic and inflammatory markers and gut microbiota are yet to be elucidated. Objectives: We aimed to characterize dietary patterns in overweight and obese subjects and evaluate the different dietary patterns in relation to metabolic and inflammatory variables as well as gut microbiota. Design: Dietary patterns, plasma and adipose tissue markers, and gut microbiota were evaluated in a group of 45 overweight and obese subjects (6 men and 39 women). A group of 14 lean subjects were also evaluated as a reference group. Results: Three clusters of dietary patterns were identified in overweight/obese subjects. Cluster 1 had the least healthy eating behavior (highest consumption of potatoes, confectionary and sugary drinks, and the lowest consumption of fruits that was associated also with low consumption of yogurt, and water). This dietary pattern was associated with the highest LDL cholesterol, plasma soluble CD14 (p = 0.01) a marker of systemic inflammation but the lowest accumulation of CD163+ macrophages with anti-inflammatory profile in adipose tissue (p = 0.05). Cluster 3 had the healthiest eating behavior (lower consumption of confectionary and sugary drinks, and highest consumption of fruits but also yogurts and soups). Subjects in this Cluster had the lowest inflammatory markers (sCD14) and the highest anti-inflammatory adipose tissue CD163+ macrophages. Dietary intakes, insulin sensitivity and some inflammatory markers (plasma IL6) in Cluster 3 were close to those of lean subjects. Cluster 2 was in-between clusters 1 and 3 in terms of healthfulness. The 7 gut microbiota groups measured by qPCR were similar across the clusters. However, the healthiest dietary cluster had the highest microbial gene richness, as evaluated by quantitative metagenomics. Conclusion: A healthier dietary pattern was associated with lower inflammatory markers as well as greater gut microbiota richness in overweight and obese subjects.	[Kong, Ling Chun; Cotillard, Aurelie; Zucker, Jean-Daniel; Rizkalla, Salwa W.; Clement, Karine] INSERM, UMR S U1166, Paris, France; [Kong, Ling Chun; Cotillard, Aurelie; Zucker, Jean-Daniel; Rizkalla, Salwa W.; Clement, Karine] Univ Paris 06, Sorbonne Univ, Paris, France; [Kong, Ling Chun; Cotillard, Aurelie; Gougis, Sophie; Fellahi, Soraya; Bastard, Jean-Philippe; Zucker, Jean-Daniel; Rizkalla, Salwa W.; Clement, Karine] Hop La Pitie Salpetriere, AP HP, ICAN, Heart & Nutr Dept, Paris, France; [Kong, Ling Chun; Cotillard, Aurelie; Gougis, Sophie; Fellahi, Soraya; Bastard, Jean-Philippe; Zucker, Jean-Daniel; Rizkalla, Salwa W.; Clement, Karine] Hop La Pitie Salpetriere, Human Nutr Res Ctr Ile France, Paris, France; [Holmes, Bridget A.; Habi-Rachedi, Fatiha; Brazeilles, Remi; Gausseres, Nicolas] Danone Res, RD 128, Palaiseau, France; [Brazeilles, Remi] IT&M STATS, Paris, France; [Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, WELBIO Walloon Excellence Life Sci & BIOTechnol, Metab & Nutr Res Grp, B-1200 Brussels, Belgium; [Fellahi, Soraya; Bastard, Jean-Philippe] Hop Tenon, AP HP, Serv Biochim & Hormonol, F-75970 Paris, France; [Kennedy, Sean P.; Dore, Joel; Ehrlich, Stanislav Dusko] INRA, MICALIS, UMR 1319, Jouy En Josas, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Danone Nutricia; Universite Catholique Louvain; WELBIO; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Rizkalla, SW (corresponding author), INSERM, UMR S U1166, Paris, France.	salwa.rizkalla@psl.aphp.fr	Clément, karine/R-1120-2017; Dore, Joel/ABA-8921-2020; ZUCKER, Jean-Daniel/K-3008-2016; D., Cani Patrice/M-8055-2016; Ehrlich, S./Y-2423-2019	ZUCKER, Jean-Daniel/0000-0002-5597-7922; D., Cani Patrice/0000-0003-2040-2448; Ehrlich, S./0000-0002-7563-4046; Kennedy, Sean/0000-0002-3932-8922	National Research Agency (Investissements d'avenir) [ANR-10-IAHU-05]; National Research Agency (ANR MICRO-Obes); National Research Agency (ANR Nutra2sense); KOT-Ceprodi Laboratory (Florence Massiera and Reginald Alouche); association "Fondation Coeur et Arteres" Danone Research PhD grant; European Commission FP7 grant [HEALTH-F4-2007-201052, HEALTH-F4-2012-305312]	National Research Agency (Investissements d'avenir)(French National Research Agency (ANR)); National Research Agency (ANR MICRO-Obes)(French National Research Agency (ANR)); National Research Agency (ANR Nutra2sense)(French National Research Agency (ANR)); KOT-Ceprodi Laboratory (Florence Massiera and Reginald Alouche); association "Fondation Coeur et Arteres" Danone Research PhD grant; European Commission FP7 grant	This work was supported by the National Research Agency (Investissements d'avenir ANR-10-IAHU-05, ANR MICRO-Obes, and ANR Nutra2sense), KOT-Ceprodi Laboratory (Florence Massiera and Reginald Alouche) and the association "Fondation Coeur et Arteres" Danone Research PhD grant. Other funding came from the European Commission FP7 grant HEALTH-F4-2007-201052 and HEALTH-F4-2012-305312 (MetaCardis project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia N, 2013, DIABETES METAB, V39, P99, DOI 10.1016/j.diabet.2012.08.007; Anderson AL, 2012, EUR J CLIN NUTR, V66, P18, DOI 10.1038/ejcn.2011.162; [Anonymous], 2007, UN SURV EP NUTR US E, V13; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Bouche C, 2002, DIABETES CARE, V25, P822, DOI 10.2337/diacare.25.5.822; Buijsse B, 2009, AM J CLIN NUTR, V90, P202, DOI 10.3945/ajcn.2008.27394; Cani PD, 2010, ACTA GASTRO-ENT BELG, V73, P267; Castetbon K, 2014, J ACAD NUTR DIET, V114, P918, DOI 10.1016/j.jand.2013.08.002; Costacou T, 2003, EUR J CLIN NUTR, V57, P1378, DOI 10.1038/sj.ejcn.1601699; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Esmaillzadeh A, 2007, J NUTR, V137, P992, DOI 10.1093/jn/137.4.992; Estaquio C, 2008, J NUTR, V138, P946, DOI 10.1093/jn/138.5.946; Fujisaka S, 2011, ENDOCRINOLOGY, V152, P1789, DOI 10.1210/en.2010-1312; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Habi-Rachedi F, 2012, 12 EUR S STAT METH F; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Kesse-Guyot E, 2013, NUTR METAB CARDIOVAS, V23, P677, DOI 10.1016/j.numecd.2012.02.005; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Liu RH, 2013, ADV NUTR, V4, p384S, DOI 10.3945/an.112.003517; Liu SM, 2003, AM J CLIN NUTR, V78, P920, DOI 10.1093/ajcn/78.5.920; Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; McNaughton SA, 2007, J NUTR, V137, P99, DOI 10.1093/jn/137.1.99; Newby PK, 2006, J NUTR, V136, P2580, DOI 10.1093/jn/136.10.2580; O'Connor LM, 2014, DIABETOLOGIA, V57, P909, DOI 10.1007/s00125-014-3176-1; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oude Griep Linda M, 2013, Curr Nutr Rep, V2, P97; Pons N, 2010, JOBIM, P127; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rizkalla SW, 2012, AM J CLIN NUTR, V95, P49, DOI 10.3945/ajcn.111.017277; Rosner B., 2006, FUNDAMENTALS BIOSTAT, P385; Schulz M, 2002, J NUTR, V132, P1335, DOI 10.1093/jn/132.6.1335; Schulze MB, 2006, OBESITY, V14, P1444, DOI 10.1038/oby.2006.164; Schulze MB, 2001, BRIT J NUTR, V85, P363, DOI 10.1079/BJN2000254; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sluijs I, 2012, AM J CLIN NUTR, V96, P382, DOI 10.3945/ajcn.111.021907; Tam CS, 2010, DIABETES, V59, P2164, DOI 10.2337/db10-0162; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vergnaud AC, 2012, AM J CLIN NUTR, V95, P184, DOI 10.3945/ajcn.111.019968; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	42	93	95	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109434	10.1371/journal.pone.0109434	http://dx.doi.org/10.1371/journal.pone.0109434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330000	Green Submitted, gold, Green Published			2022-12-27	WOS:000343942100026
J	Wada, H; Masumoto-Kubo, C; Gholipour, Y; Nonami, H; Tanaka, F; Erra-Balsells, R; Tsutsumi, K; Hiraoka, K; Morita, S				Wada, Hiroshi; Masumoto-Kubo, Chisato; Gholipour, Yousef; Nonami, Hiroshi; Tanaka, Fukuyo; Erra-Balsells, Rosa; Tsutsumi, Koichi; Hiraoka, Kenzo; Morita, Satoshi			Rice Chalky Ring Formation Caused by Temporal Reduction in Starch Biosynthesis during Osmotic Adjustment under Foehn-Induced Dry Wind	PLOS ONE			English	Article							HIGH-TEMPERATURE; MASS-SPECTROMETRY; GENE-EXPRESSION; WATER RELATIONS; STRESS; GROWTH; ACCUMULATION; SYNTHASE; PLANTS; STAGE	Foehn-like extreme hot and dry wind conditions (34 degrees C >2.5 kPa vapor pressure deficit, and 7 m s(-1)) strongly affect grain quality in rice (Oryza sativa L.). This is a current concern because of the increasing frequency and intensity of combined heat and water-deficit stress under climate change. Foehn-induced dry wind conditions during the grain-filling stage increase ring-shaped chalkiness as a result of spatiotemporal reduction in starch accumulation in the endosperm, but kernel growth is sometimes maintained by osmotic adjustment. Here, we assess the effects of dry wind on chalky ring formation in environmentally controlled growth chambers. Our results showed that hot and dry wind conditions that lasted for >24 h dramatically increased chalky ring formation. Hot and dry wind conditions temporarily reduced panicle water potential to -0.65 MPa; however, kernel growth was maintained by osmotic adjustment at control levels with increased transport of assimilate to the growing kernels. Dynamic tracer analysis with a nano-electrospray-ionization Orbitrap mass spectrometer and quantitative polymerase chain reaction analysis revealed that starch degradation was negligible in the short-term treatment. Overall expression of starch synthesis-related genes was found to be down-regulated at moderately low water potential. Because the events observed at low water potential preceded the packing of starch granules in cells, we concluded that reduced rates of starch biosynthesis play a central role in the events of cellular metabolism that are altered at osmotic adjustment, which leads to chalky ring formation under short-term hot and dry wind conditions.	[Wada, Hiroshi; Masumoto-Kubo, Chisato; Tsutsumi, Koichi; Morita, Satoshi] Kyushu Okinawa Agr Res Ctr, Natl Agr & Food Res Org, Chikugo, Fukuoka, Japan; [Gholipour, Yousef; Nonami, Hiroshi] Ehime Univ, Fac Agr, Dept Biomech Syst, Matsuyama, Ehime 790, Japan; [Tanaka, Fukuyo] Agr Res Ctr, Natl Agr & Food Res Org, Tsukuba, Ibaraki, Japan; [Erra-Balsells, Rosa] Univ Buenos Aires, Fac Exact & Nat Sci, CIHIDECAR, Dept Organ Chem, Buenos Aires, DF, Argentina; [Hiraoka, Kenzo] Univ Yamanashi, Clean Energy Res Ctr, Kofu, Yamanashi, Japan	National Agriculture & Food Research Organization - Japan; Ehime University; National Agriculture & Food Research Organization - Japan; University of Buenos Aires; University of Yamanashi	Wada, H (corresponding author), Kyushu Okinawa Agr Res Ctr, Natl Agr & Food Res Org, Chikugo, Fukuoka, Japan.	hwada@affrc.go.jp	TANAKA, Fukuyo/L-3978-2019	TANAKA, Fukuyo/0000-0002-0904-3248	JSPS KAKENHI [24380013, 24228004];  [24248005]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported by JSPS KAKENHI Grant Number 24380013 (Grant-in-Aid Scientific Research (B)) and in part by JSPS KAKENHI Grant Number 24228004 (Grant-in-Aid Scientific Research (S)) and Grant Number 24248005 (Grant-in-Aid Scientific Research (A)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Boyer JS., 1995, MEASURING WATER STAT; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; CHAVES MM, 1991, J EXP BOT, V42, P1, DOI 10.1093/jxb/42.1.1; DELROSARIO AR, 1968, CEREAL CHEM, V45, P225; EBATA M, 1989, JPN J CROP SCI, V58, P555, DOI 10.1626/jcs.58.555; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; GARRITY DP, 1986, CROP SCI, V26, P789, DOI 10.2135/cropsci1986.0011183X002600040034x; Gholipour Y, 2008, ANAL BIOCHEM, V383, P159, DOI 10.1016/j.ab.2008.08.034; Gholipour Y, 2013, ANAL BIOCHEM, V433, P70, DOI 10.1016/j.ab.2012.10.001; Gross J.H., 2004, MASS SPECTROMETRY TX, DOI 10.1007/978-3-319-54398-7; Hakata M, 2012, PLANT BIOTECHNOL J, V10, P1110, DOI 10.1111/j.1467-7652.2012.00741.x; Hoshikawa K., 1989, GROWING RICE PLANT A; Hoshikawa K, 1967, P CROP SCI SOC JPN, V36, P151; Hu QZ, 2005, J MASS SPECTROM, V40, P430, DOI 10.1002/jms.856; HUSKEN D, 1978, PLANT PHYSIOL, V61, P158, DOI 10.1104/pp.61.2.158; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Ishihara K, 2005, P CROP SCI SOC JPN, V74, P122; Ishimaru T, 2009, J CEREAL SCI, V50, P166, DOI 10.1016/j.jcs.2009.04.011; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Juliano BO., 1985, RICE CHEM TECHNOLOGY; Kang HG, 2005, PLANT J, V42, P901, DOI 10.1111/j.1365-313X.2005.02423.x; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Liao JL, 2014, J EXP BOT, V65, P655, DOI 10.1093/jxb/ert435; Liu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-730; Matsuba K., 1991, Bulletin of the Chugoku National Agricultural Experiment Station, P11; MCCAIN DC, 1995, BIOPHYS J, V69, P1105, DOI 10.1016/S0006-3495(95)79984-2; MEYER RF, 1981, PLANTA, V151, P482, DOI 10.1007/BF00386543; Mohapatra PK, 2004, FUNCT PLANT BIOL, V31, P131, DOI 10.1071/FP03177; MORGAN JM, 1977, NATURE, V270, P234, DOI 10.1038/270234a0; Morita S, 2011, CROP SCI, V51, P818, DOI 10.2135/cropsci2010.06.0373; Morita S, 2000, JPN J CROP SCI, V69, P391, DOI 10.1626/jcs.69.391; NAGATO K, 1970, Proceedings of the Crop Science Society of Japan, V39, P204; Nagato K, 1959, JAPANESE J CROP SCI, V27, P204, DOI [10.1626/jcs.27.204, DOI 10.1626/JCS.27.204]; Nobel PS, 2009, PHYSICOCHEMICAL AND ENVIRONMENTAL PLANT PHYSIOLOGY, 4TH EDITION, P1; Nonami H, 1997, PLANT PHYSIOL, V114, P501, DOI 10.1104/pp.114.2.501; NONAMI H, 1993, PLANT PHYSIOL, V102, P13, DOI 10.1104/pp.102.1.13; Nonami Hiroshi, 2010, Environmental Control in Biology, V48, P117; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; OTOOLE JC, 1984, PLANT SCI LETT, V33, P137, DOI 10.1016/0304-4211(84)90003-8; Pyke KA, 1999, PLANT CELL, V11, P549, DOI 10.1105/tpc.11.4.549; Saika H, 2007, PLANT CELL PHYSIOL, V48, P287, DOI 10.1093/pcp/pcm003; Sarkar NK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-393; Sato Y, 2011, NUCLEIC ACIDS RES, V39, pD1141, DOI 10.1093/nar/gkq1085; TASHIRO T, 1991, AUST J AGR RES, V42, P485, DOI 10.1071/AR9910485; Tsukaguchi T, 2008, PLANT PROD SCI, V11, P203, DOI 10.1626/pps.11.203; TURNER NC, 1988, IRRIGATION SCI, V9, P289, DOI 10.1007/BF00296704; Umemoto T, 2002, FUNCT PLANT BIOL, V29, P1121, DOI 10.1071/PP01145; VASSEY TL, 1989, PLANT PHYSIOL, V89, P1066, DOI 10.1104/pp.89.4.1066; Veley KM, 2012, CURR BIOL, V22, P408, DOI 10.1016/j.cub.2012.01.027; Wada Hiroshi, 2011, Environmental Control in Biology, V49, P61; Wada H, 2011, CROP SCI, V51, P1703, DOI 10.2135/cropsci2010.08.0503; Yakushiji H, 1998, J AM SOC HORTIC SCI, V123, P719, DOI 10.21273/JASHS.123.4.719; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; Yamakawa H, 2010, PLANT CELL PHYSIOL, V51, P795, DOI 10.1093/pcp/pcq034; Zakaria S, 2002, PLANT PROD SCI, V5, P160, DOI 10.1626/pps.5.160; Zhang GY, 2011, GENOME, V54, P448, DOI [10.1139/G11-010, 10.1139/g11-010]; Zubarev RA, 2013, ANAL CHEM, V85, P5288, DOI 10.1021/ac4001223	58	27	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110374	10.1371/journal.pone.0110374	http://dx.doi.org/10.1371/journal.pone.0110374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330305	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100058
J	Wu, Y; Fan, HZ; Wang, YH; Zhang, LP; Gao, X; Chen, Y; Li, JY; Ren, HY; Gao, HJ				Wu, Yang; Fan, Huizhong; Wang, Yanhui; Zhang, Lupei; Gao, Xue; Chen, Yan; Li, Junya; Ren, HongYan; Gao, Huijiang			Genome-Wide Association Studies Using Haplotypes and Individual SNPs in Simmental Cattle	PLOS ONE			English	Article							QUANTITATIVE TRAIT; CARCASS; QTL; SUSCEPTIBILITY; ACCURACY; PROGRESS; MARKERS; SCAN	Recent advances in high-throughput genotyping technologies have provided the opportunity to map genes using associations between complex traits and markers. Genome-wide association studies (GWAS) based on either a single marker or haplotype have identified genetic variants and underlying genetic mechanisms of quantitative traits. Prompted by the achievements of studies examining economic traits in cattle and to verify the consistency of these two methods using real data, the current study was conducted to construct the haplotype structure in the bovine genome and to detect relevant genes genuinely affecting a carcass trait and a meat quality trait. Using the Illumina BovineHD BeadChip, 942 young bulls with genotyping data were introduced as a reference population to identify the genes in the beef cattle genome significantly associated with foreshank weight and triglyceride levels. In total, 92,553 haplotype blocks were detected in the genome. The regions of high linkage disequilibrium extended up to approximately 200 kb, and the size of haplotype blocks ranged from 22 bp to 199,266 bp. Additionally, the individual SNP analysis and the haplotype-based analysis detected similar regions and common SNPs for these two representative traits. A total of 12 and 7 SNPs in the bovine genome were significantly associated with foreshank weight and triglyceride levels, respectively. By comparison, 4 and 5 haplotype blocks containing the majority of significant SNPs were strongly associated with foreshank weight and triglyceride levels, respectively. In addition, 36 SNPs with high linkage disequilibrium were detected in the GNAQ gene, a potential hotspot that may play a crucial role for regulating carcass trait components.	[Wu, Yang; Fan, Huizhong; Wang, Yanhui; Zhang, Lupei; Gao, Xue; Chen, Yan; Li, Junya; Gao, Huijiang] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Ren, HongYan] Natl Nat Sci Fdn China, Dept Life Sci, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; National Natural Science Foundation of China (NSFC)	Ren, HY (corresponding author), Natl Nat Sci Fdn China, Dept Life Sci, Beijing, Peoples R China.	renhy@nsfc.gov.cn; gaohj111@sina.com	Wu, Yang/D-6754-2017	Wu, Yang/0000-0002-0128-7280	Cattle Breeding Innovative Research Team [cxgc-ias-03]; 12th "Five-Year'' National Science and Technology Support Project basic research fund program [2011BAD28B04]; Chinese Academy of Agricultural Sciences Fundamental Research Budget Increment Project [2013ZL031]; National High Technology Research and Development Program of China (863 Program) [2013AA102505-4]; National Natural Science Foundations of China [31372294]	Cattle Breeding Innovative Research Team; 12th "Five-Year'' National Science and Technology Support Project basic research fund program; Chinese Academy of Agricultural Sciences Fundamental Research Budget Increment Project; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Cattle Breeding Innovative Research Team (cxgc-ias-03), the 12th "Five-Year'' National Science and Technology Support Project (2011BAD28B04) basic research fund program, Chinese Academy of Agricultural Sciences Fundamental Research Budget Increment Project (2013ZL031), National High Technology Research and Development Program of China (863 Program 2013AA102505-4) and National Natural Science Foundations of China (31372294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Barsh GS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002812; Beuten J, 2006, NEUROPSYCHOPHARMACOL, V31, P675, DOI 10.1038/sj.npp.1300997; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Bray NJ, 2003, AM J HUM GENET, V73, P152, DOI 10.1086/376578; Calus MPL, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-11; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Dupuis MC, 2011, MAMM GENOME, V22, P613, DOI 10.1007/s00335-011-9337-3; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gill JL, 2010, MEAT SCI, V86, P985, DOI 10.1016/j.meatsci.2010.08.005; Grapes L, 2004, GENETICS, V166, P1561, DOI 10.1534/genetics.166.3.1561; Gutierrez-Gil B, 2010, MEAT SCI, V85, P721, DOI 10.1016/j.meatsci.2010.03.031; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hayes BJ, 2007, GENET RES, V89, P215, DOI 10.1017/S0016672307008865; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041336; Huang JA, 2003, AM J HUM GENET, V72, P949, DOI 10.1086/374568; Jiang HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005280; Kim Y, 2011, ANIM GENET, V42, P361, DOI 10.1111/j.1365-2052.2010.02156.x; Lange C, 2001, GENETICS, V159, P1325; Lee YM, 2010, ASIAN AUSTRAL J ANIM, V23, P417, DOI 10.5713/ajas.2010.10019; McClure MC, 2010, ANIM GENET, V41, P597, DOI 10.1111/j.1365-2052.2010.02063.x; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Nalaila SM, 2012, J ANIM BREED GENET, V129, P107, DOI 10.1111/j.1439-0388.2011.00954.x; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; Niu TH, 2004, GENET EPIDEMIOL, V27, P334, DOI 10.1002/gepi.20024; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rolf MM, 2012, ANIM GENET, V43, P367, DOI 10.1111/j.1365-2052.2011.02273.x; Shim Heejung, 2009, BMC Proc, V3 Suppl 7, pS35; Shriner Daniel, 2012, Frontiers in Genetics, V3, P1, DOI 10.3389/fgene.2012.00001; Szczerbal I, 2007, J APPL GENETICS, V48, P73, DOI 10.1007/BF03194660; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang H, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-26; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao HY, 2003, PHARMACOGENOMICS, V4, P171, DOI 10.1517/phgs.4.2.171.22636; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219	40	27	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109330	10.1371/journal.pone.0109330	http://dx.doi.org/10.1371/journal.pone.0109330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330174	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100022
J	Yuan, YM; Zhan, Q; Huang, H				Yuan, Yumin; Zhan, Qian; Huang, Hua			Efficient Unrestricted Identity-Based Aggregate Signature Scheme	PLOS ONE			English	Article							AUTHENTICATION	An aggregate signature scheme allows anyone to compress multiple individual signatures from various users into a single compact signature. The main objective of such a scheme is to reduce the costs on storage, communication and computation. However, among existing aggregate signature schemes in the identity-based setting, some of them fail to achieve constant-length aggregate signature or require a large amount of pairing operations which grows linearly with the number of signers, while others have some limitations on the aggregated signatures. The main challenge in building efficient aggregate signature scheme is to compress signatures into a compact, constant-length signature without any restriction. To address the above drawbacks, by using the bilinear pairings, we propose an efficient unrestricted identity-based aggregate signature. Our scheme achieves both full aggregation and constant pairing computation. We prove that our scheme has existential unforgeability under the computational Diffie-Hellman assumption.	[Yuan, Yumin] Xiamen Univ Technol, Sch Appl Math, Xiamen, Peoples R China; [Zhan, Qian] Univ Sci & Technol Beijing, Beijing 100083, Peoples R China; [Huang, Hua] Xiamen Univ, Xiamen, Peoples R China	Xiamen University of Technology; University of Science & Technology Beijing; Xiamen University	Yuan, YM (corresponding author), Xiamen Univ Technol, Sch Appl Math, Xiamen, Peoples R China.	yuanymp@163.com						Bagherzandi A, 2010, LECT NOTES COMPUT SC, V6056, P480; Bellare M., 2006, P 13 ACM C COMP COMM, P390, DOI DOI 10.1145/1180405.1180453; Bellare M, 2007, LECT NOTES COMPUT SC, V4596, P411; Boneh D, 2003, LECT NOTES COMPUT SC, V2656, P416; Cha JC, 2003, LECT NOTES COMPUT SC, V2567, P18; Cheon JH, 2004, CRYPTOLOGY EPRINT AR; Dou BN, 2012, INT J INNOV COMPUT I, V8, P6401; Gentry C, 2006, LECT NOTES COMPUT SC, V3958, P257; GOLDWASSER S, 1988, SIAM J COMPUT, V17, P281, DOI 10.1137/0217017; He DB, 2013, MATH COMPUT MODEL, V57, P2510, DOI 10.1016/j.mcm.2012.12.037; He DB, 2011, ANN TELECOMMUN, V66, P657, DOI 10.1007/s12243-011-0244-0; Herranz J, 2006, COMPUT J, V49, P322, DOI 10.1093/comjnl/bxh153; Hohenberger S, 2013, LECT NOTES COMPUT SC, V8042, P494, DOI 10.1007/978-3-642-40041-4_27; Kang BY, 2012, J APPL MATH, DOI 10.1155/2012/416137; Kar J., 2012, 2012 International Conference on Cyber-Enabled Distributed Computing and Knowledge Discovery (CyberC 2012), P137, DOI 10.1109/CyberC.2012.30; Liu JK, 2014, EXPERT SYST APPL, V41, P2559, DOI 10.1016/j.eswa.2013.10.003; Niu SF, 2013, COMPUT ELECTR ENG, V39, P1726, DOI 10.1016/j.compeleceng.2012.11.022; Selvi SSD, 2010, CRYPTOLOGY EPRINT AR; Shamir A., 1984, LECT NOTES COMPUTER, P47, DOI [DOI 10.1007/3-540-39568-7, 10.1007/3-540-39568-7_5]; Shao ZH, 2008, COMPUT COMMUN, V31, P1961, DOI 10.1016/j.comcom.2007.12.030; Shim KA, 2010, J SYST SOFTWARE, V83, P1873, DOI 10.1016/j.jss.2010.05.071; Tian HB, 2013, MATH COMPUT MODEL, V58, P1289, DOI 10.1016/j.mcm.2013.01.010; TSAI JL, 2013, P 2013 INT S BIOM SE, P136; Tu H, 2014, SCI WORLD J, DOI 10.1155/2014/343715; Wei LF, 2014, INFORM SCIENCES, V258, P371, DOI 10.1016/j.ins.2013.04.028; Xiong H, 2013, INFORM SCIENCES, V219, P225, DOI 10.1016/j.ins.2012.07.004; Xu J, 2005, LECT NOTES COMPUT SC, V3810, P110; Zhang L, 2010, COMPUT NETW, V54, P2482, DOI 10.1016/j.comnet.2010.04.008	28	5	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110100	10.1371/journal.pone.0110100	http://dx.doi.org/10.1371/journal.pone.0110100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329777	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100037
J	Tallon, BJM; Bruneau, J; Tsoukas, CM; Routy, JP; Kiani, Z; Tan, XM; Bernard, NF				Tallon, Benjamin J. M.; Bruneau, Julie; Tsoukas, Christos M.; Routy, Jean-Pierre; Kiani, Zahra; Tan, Xianming; Bernard, Nicole F.			Time to Seroconversion in HIV-Exposed Subjects Carrying Protective versus Non Protective KIR3DS1/L1 and HLA-B Genotypes	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; CELL-INHIBITORY RECEPTOR; INJECTION-DRUG USERS; UNINFECTED INDIVIDUALS; CUTTING EDGE; NK CELLS; RECOGNITION; INFECTION; KIR3DL1; POLYMORPHISM	Natural killer (NK) cells play a role in the clearance of viral infections. Combinations of alleles at the polymorphic HLA-B locus and the NK cell surface killer immunoglobulin-like receptor locus KIR3DL1/S1 have been shown to influence time to AIDS in HIV-infected individuals and risk of seroconversion in HIV exposed seronegative (HESN) subjects. Here, we assessed time to seroconversion or duration of seronegative status in a group of 168 HIV exposed individuals, including 74 seroconverters and 94 HESN based on carriage or not of KIR3DL1/S1/HLA-B genotypes previously shown to be associated with protection from infection and/or slow time to AIDS. KIR3DL1/S1 genotyping was performed by sequence-specific primer polymerase chain reaction using two pairs of specific primers for each locus. The MHC class IB locus was typed to four-position resolution to resolve Bw4 and Bw6 alleles and the amino acid present at position 80. KIR3DL1/S1 heterozygotes became HIV infected significantly faster than KIR3DS1 homozygotes. Individuals who carried both KIR3DS1 and Bw4*80I did not remain HIV seronegative longer than those from a control group who were homozygous for HLA-Bw6 and carried no HLA-A locus Bw4 alleles Subjects who were *h/*y+B*57 showed a trend towards slower time to serconversion than those with other KIR3DL1 homozygous and KIR3DL1/S1 heterozygous genotypes. Thus, KIR3DS1 homozygosity is associated with protection from HIV infection while co-carriage of KIR3DS1 and Bw4*80I is not. The requirements for protection from HIV infection can differ from those that influence time to AIDS in HIV infected individuals.	[Tallon, Benjamin J. M.; Tsoukas, Christos M.; Routy, Jean-Pierre; Kiani, Zahra; Bernard, Nicole F.] RI MUHC, Montreal, PQ, Canada; [Tallon, Benjamin J. M.; Tsoukas, Christos M.; Kiani, Zahra; Bernard, Nicole F.] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Bruneau, Julie] CRCHUM, Montreal, PQ, Canada; [Bruneau, Julie] Univ Montreal, Dept Family Med, Montreal, PQ, Canada; [Tsoukas, Christos M.; Bernard, Nicole F.] McGill Univ, Ctr Hlth, Div Clin Immunol & Allergy, Montreal, PQ, Canada; [Routy, Jean-Pierre] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Immunodeficiency Serv, Montreal, PQ, Canada; [Routy, Jean-Pierre] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Hematol, Montreal, PQ, Canada; [Tan, Xianming] McGill Univ, Ctr Hlth, Res Inst, Biostat Core Facil, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University	Bernard, NF (corresponding author), RI MUHC, Montreal, PQ, Canada.	nicole.bernard@mcgill.ca			Canadian Institutes for Health Research (CIHR) [HVI-79515, HOP-123800, 103230]; CIHR/Canadian HIV Trials Network [254]; Fonds de la Recherche du Quebec-Sante (FRQ-S) AIDS; Infectious Diseases Network; CIHR; FRQ-S; Alberta Innovates [201201140] Funding Source: researchfish	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR/Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche du Quebec-Sante (FRQ-S) AIDS; Infectious Diseases Network; CIHR(Canadian Institutes of Health Research (CIHR)); FRQ-S; Alberta Innovates	This study received support from the Canadian Institutes for Health Research (CIHR) HVI-79515, HOP-123800, 103230, the CIHR/Canadian HIV Trials Network grant #254 and the Fonds de la Recherche du Quebec-Sante (FRQ-S) AIDS and Infectious Diseases Network. BT was the recipient of an M.Sc. scholarship from CIHR. JB holds a senior clinical research career award from FRQ-S. J-RP holds the Louis Lowenstein Chair in Hematology & Oncology, McGill University. NB, CMT and J-PR are members of the Research Institute of the McGill University Health Centre, an institution funded in part by the FRQ-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2003, J IMMUNOL, V171, P477, DOI 10.4049/jimmunol.171.1.477; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; [Anonymous], AIDS RES HUM RETROVI, V23, P451; Bernard NF, 1999, J INFECT DIS, V179, P538, DOI 10.1086/314621; Biassoni R, 1997, EUR J IMMUNOL, V27, P3095, DOI 10.1002/eji.1830271203; Boulet S, 2008, AIDS, V22, P1487, DOI 10.1097/QAD.0b013e3282ffde7e; Boulet S, 2008, AIDS, V22, P595, DOI 10.1097/QAD.0b013e3282f56b23; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; BROOKMEYER R, 1987, AM J EPIDEMIOL, V126, P14, DOI 10.1093/oxfordjournals.aje.a114646; BROOKMEYER R, 1987, BIOMETRICS, V43, P739, DOI 10.2307/2531529; Bruneau J, 2001, CAN MED ASSOC J, V164, P767; Bruneau J, 2011, AM J EPIDEMIOL, V173, P1049, DOI 10.1093/aje/kwq479; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Fauriat C, 2010, BLOOD, V115, P1166, DOI 10.1182/blood-2009-09-245746; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; Gillespie G. E., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2707, P1; Gillespie GMA, 2007, AIDS RES HUM RETROV, V23, P451, DOI 10.1089/aid.2006.0165; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; Guerini FR, 2011, J INFECT DIS, V203, P1235, DOI 10.1093/infdis/jir020; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Gumperz JE, 1997, J IMMUNOL, V158, P5237; Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998; Horton RE, 2010, J INFECT DIS, V202, pS377, DOI 10.1086/655971; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Katz G, 2004, J IMMUNOL, V173, P1819, DOI 10.4049/jimmunol.173.3.1819; Katz G, 2001, J IMMUNOL, V166, P7260, DOI 10.4049/jimmunol.166.12.7260; Koehler RN, 2013, J INFECT DIS, V208, P1250, DOI 10.1093/infdis/jit349; Kulkarni S, 2010, METHODS MOL BIOL, V612, P365, DOI 10.1007/978-1-60761-362-6_25; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martro E, 2005, J CLIN MICROBIOL, V43, P6197, DOI 10.1128/JCM.43.12.6197-6199.2005; O'Connor GM, 2007, J IMMUNOL, V178, P235, DOI 10.4049/jimmunol.178.1.235; Pelak K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001208; Ravet S, 2007, BLOOD, V109, P4296, DOI 10.1182/blood-2006-08-040238; Robinson J, 2010, NUCLEIC ACIDS RES, V38, pD863, DOI 10.1093/nar/gkp879; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Song RJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003867; Stern M, 2008, BLOOD, V112, P708, DOI 10.1182/blood-2008-02-137521; Stewart CA, 2005, P NATL ACAD SCI USA, V102, P13224, DOI 10.1073/pnas.0503594102; Tomescu C, 2010, AIDS, V24, P2151, DOI 10.1097/QAD.0b013e32833dfc20; Traherne JA, 2010, HUM MOL GENET, V19, P737, DOI 10.1093/hmg/ddp538; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; WAN AM, 1986, J IMMUNOL, V137, P3671	48	23	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110480	10.1371/journal.pone.0110480	http://dx.doi.org/10.1371/journal.pone.0110480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330014	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100080
J	Webb, LMC; Pascall, JC; Hepburn, L; Carter, C; Turner, M; Butcher, GW				Webb, Louise M. C.; Pascall, John C.; Hepburn, Lucy; Carter, Christine; Turner, Martin; Butcher, Geoffrey W.			Generation and Characterisation of Mice Deficient in the Multi-GTPase Domain Containing Protein, GIMAP8	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-CELL; BB RAT; IAN FAMILY; NUCLEOTIDE-BINDING; HUMAN ORTHOLOG; MATURE B; GENE; SURVIVAL; APOPTOSIS	Background: GTPases of the immunity-associated protein family (GIMAPs) are predominantly expressed in mature lymphocytes. Studies of rodents deficient in GIMAP1, GIMAP4, or GIMAP5 have demonstrated that these GTPases regulate lymphocyte survival. In contrast to the other family members, GIMAP8 contains three potential GTP-binding domains (G-domains), a highly unusual feature suggesting a novel function for this protein. To examine a role for GIMAP8 in lymphocyte biology we examined GIMAP8 expression during lymphocyte development. We also generated a mouse deficient in GIMAP8 and examined lymphocyte development and function. Principal Findings: We show that GIMAP8 is expressed in the very early and late stages of T cell development in the thymus, at late stages during B cell development, and peripheral T and B cells. We find no defects in T or B lymphocyte development in the absence of GIMAP8. A marginal decrease in the number of recirculating bone marrow B cells suggests that GIMAP8 is important for the survival of mature B cells within the bone marrow niche. We also show that deletion of GIMAP8 results in a delay in apoptotic death of mature T cell in vitro in response to dexamethasone or c-irradiation. However, despite these findings we find that GIMAP8-deficient mice mount normal primary and secondary responses to a T cell dependent antigen. Conclusions: Despite its unique structure, GIMAP8 is not required for lymphocyte development but appears to have a minor role in maintaining recirculating B cells in the bone marrow niche and a role in regulating apoptosis of mature T cells.	[Webb, Louise M. C.; Pascall, John C.; Hepburn, Lucy; Carter, Christine; Turner, Martin; Butcher, Geoffrey W.] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Webb, LMC (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England.	louise.webb@babraham.ac.uk	Webb, Louise/V-3121-2019; Turner, Martin/N-9976-2014	Turner, Martin/0000-0002-3801-9896; Webb, Louise/0000-0003-3417-1484	UK BBSRC [BBS/E/B/0000C0409]; UK Medical Research Council [MR/J001856/1]; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0409, BBS/E/B/0000C042, BBS/E/B/000C0407] Funding Source: researchfish; Medical Research Council [MR/J001856/1] Funding Source: researchfish; BBSRC [BBS/E/B/000C0409, BBS/E/B/000C0407] Funding Source: UKRI; MRC [MR/J001856/1] Funding Source: UKRI	UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Core Strategic Grant and Institute Strategic Grant (grant number BBS/E/B/0000C0409 funding by the UK BBSRC (http://www.bbsrc.ac.uk). Research Grant (grant number MR/J001856/1) by the UK Medical Research Council (http://gtr.rcuk.ac.uk/project/07D060DF-61B4-49D5-9A8F-51E845F54F88). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2010, J EXP MED, V207, P1113, DOI 10.1084/jem.20092210; Aravind L, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00089; Baldwin TA, 2007, J IMMUNOL, V179, P837, DOI 10.4049/jimmunol.179.2.837; Barnes MJ, 2010, J IMMUNOL, V184, P3743, DOI 10.4049/jimmunol.0903164; Biller L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-63; Cambot M, 2002, BLOOD, V99, P3293, DOI 10.1182/blood.V99.9.3293; Carter C, 2007, J IMMUNOL, V179, P1784, DOI 10.4049/jimmunol.179.3.1784; Chen XL, 2013, BIOCHEM J, V449, P353, DOI 10.1042/BJ20120516; Chen YH, 2011, J EXP MED, V208, P923, DOI 10.1084/jem.20101192; Dalberg U, 2007, INT IMMUNOL, V19, P447, DOI 10.1093/intimm/dxm009; Dion C, 2005, INT IMMUNOL, V17, P1257, DOI 10.1093/intimm/dxh302; ELDER ME, 1983, J IMMUNOL, V130, P1723; Hellquist A, 2007, J MED GENET, V44, P314, DOI 10.1136/jmg.2006.046185; Hernandez-Hoyos G, 1999, EUR J IMMUNOL, V29, P1832, DOI 10.1002/(SICI)1521-4141(199906)29:06&lt;1832::AID-IMMU1832&gt;3.0.CO;2-F; Hinman RM, 2009, INT IMMUNOL, V21, P831, DOI 10.1093/intimm/dxp049; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Hwang J, 2001, J BIOL CHEM, V276, P31415, DOI 10.1074/jbc.M104455200; JACKSON R, 1981, DIABETES, V30, P887, DOI 10.2337/diabetes.30.10.887; Jokinen R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001161; Krucken J, 2005, J CELL BIOCHEM, V96, P339, DOI 10.1002/jcb.20552; Krucken J, 2004, GENE, V341, P291, DOI 10.1016/j.gene.2004.07.005; Lee YJ, 2013, ANN RHEUM DIS, V72, P1510, DOI 10.1136/annrheumdis-2011-200288; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lim MK, 2009, LUPUS, V18, P1045, DOI 10.1177/0961203309106830; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Mehr IJ, 2000, GENETICS, V154, P523; Muench SP, 2006, P NATL ACAD SCI USA, V103, P12359, DOI 10.1073/pnas.0602585103; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; Pandarpurkar M, 2003, P NATL ACAD SCI USA, V100, P10382, DOI 10.1073/pnas.1832170100; Pascall JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077782; Poirier GMC, 1999, J IMMUNOL, V163, P4960; Reuber TL, 1996, PLANT CELL, V8, P241, DOI 10.1105/tpc.8.2.241; Robinson VL, 2002, STRUCTURE, V10, P1649, DOI 10.1016/S0969-2126(02)00905-X; Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436; Sandal T, 2003, MOL BIOL CELL, V14, P3292, DOI 10.1091/mbc.e02-10-0700; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; Saunders A, 2010, BLOOD, V115, P3249, DOI 10.1182/blood-2009-08-237586; Schnell S, 2006, BLOOD, V108, P591, DOI 10.1182/blood-2005-11-4616; Schulteis RD, 2008, BLOOD, V112, P4905, DOI 10.1182/blood-2008-03-146555; Schwefel David, 2011, Small GTPases, V2, P27; Schwefel D, 2013, STRUCTURE, V21, P550, DOI 10.1016/j.str.2013.01.014; Schwefel D, 2010, P NATL ACAD SCI USA, V107, P20299, DOI 10.1073/pnas.1010322107; Schwefel D, 2010, ACTA CRYSTALLOGR F, V66, P725, DOI 10.1107/S174430911001537X; Shin JH, 2007, GENES IMMUN, V8, P503, DOI 10.1038/sj.gene.6364413; Stamm O, 2002, GENE, V282, P159, DOI 10.1016/S0378-1119(01)00837-X; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wong Vivian Wy, 2010, Self Nonself, V1, P259, DOI 10.4161/self.1.3.12819; Zenz T, 2004, GENES IMMUN, V5, P109, DOI 10.1038/sj.gene.6364044	51	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110294	10.1371/journal.pone.0110294	http://dx.doi.org/10.1371/journal.pone.0110294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329815	Green Published, gold			2022-12-27	WOS:000345204100059
J	Shen, YM; Zhou, JS; Li, Y; Ye, F; Wan, XY; Lu, WG; Xie, X; Cheng, XD				Shen, Yuanming; Zhou, Jiansong; Li, Yang; Ye, Feng; Wan, Xiaoyun; Lu, Weiguo; Xie, Xing; Cheng, Xiaodong			miR-375 Mediated Acquired Chemo-Resistance in Cervical Cancer by Facilitating EMT	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; DRUG-RESISTANCE; CARCINOMA-CELLS; E-CADHERIN; MICRORNA; METASTASIS; PROFILES; DORMANCY; PROTEIN; ALPHA	Acquired chemo-resistance is one of the key causal factors in cancer death. Emerging evidences suggest that miRNA and epithelial-mesenchymal transition play critical roles in the chemo-resistance in cancers. Here, we showed the association of paclitaxel-resistance with miR-375 over-expression and epithelial-mesenchymal transition inducement in cervical cancer. Using different cervical cancer cell models, we found that paclitaxel transiently induced up-regulation of miR-375 expression, proliferation inhibition, transition from epithelial to mesenchymal phenotype, and consequently impaired paclitaxel sensitivity. Forced over-expression of miR-375 may suppress Ecadherin expression by a directly targeting pathway, which led to paclitaxel resistance. Contrarily, re-expression of Ecadherin partly reversed epithelial-mesenchymal transition phenotype and miR-375 induced paclitaxel-resistance. Our findings suggest that paclitaxel-induced miR-375 overexpression facilitates epithelial-mesenchymal transition process via directly targeting Ecadherin, proliferation inhibition, and consequently results in chemo-resistance in cervical cancer cells. A reversion of miR-375 or Ecadherin expression may be a novel therapeutic approach for overcoming chemo-resistance in cervical cancer.	[Shen, Yuanming; Zhou, Jiansong; Li, Yang; Ye, Feng; Wan, Xiaoyun; Lu, Weiguo; Xie, Xing; Cheng, Xiaodong] Zhejiang Univ, Sch Med, Womens Hosp, Dept Gynecol Oncol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Cheng, XD (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Dept Gynecol Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	chengxd@zju.edu.cn	Lu, Wei/AAE-2921-2022	Lu, Wei/0000-0002-4150-8674	National Natural Science Foundation of China [81172475, 81172474]; Natural Science Foundation of Zhejiang Province of China [Z2110056, LQ13H160005, Y2110206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province)	The authors would like to acknowledge the continuous financial support from the National Natural Science Foundation of China (grant No. 81172475 and 81172474), the Natural Science Foundation of Zhejiang Province of China (grant No. Z2110056, LQ13H160005 and Y2110206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Doerner AM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-100; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Kajiyama H, 2007, INT J ONCOL, V31, P277; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li Y, 2011, J PATHOL, V224, P484, DOI 10.1002/path.2873; Li YW, 2010, PHARM RES-DORDR, V27, P1027, DOI 10.1007/s11095-010-0105-y; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Moes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035440; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Rho JK, 2009, LUNG CANCER, V63, P219, DOI 10.1016/j.lungcan.2008.05.017; Rosano L, 2011, CLIN CANCER RES, V17, P2350, DOI 10.1158/1078-0432.CCR-10-2325; Shen Y., 2013, BR J CANC; Shinto O, 2010, BRIT J CANCER, V102, P844, DOI 10.1038/sj.bjc.6605561; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Szczyrba J, 2011, MOL CANCER RES, V9, P791, DOI 10.1158/1541-7786.MCR-10-0573; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wang FF, 2011, AM J PATHOL, V179, P2580, DOI 10.1016/j.ajpath.2011.07.037; Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001; Ward A, 2013, ONCOGENE, V32, P1173, DOI 10.1038/onc.2012.128; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yu L, 2010, INT J CANCER, V127, P2870, DOI 10.1002/ijc.25289; Yu YY, 2013, ANTI-CANCER AGENT ME, V13, P199, DOI 10.2174/1871520611313020003	33	41	41	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109299	10.1371/journal.pone.0109299	http://dx.doi.org/10.1371/journal.pone.0109299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330011	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800019
J	Wang, W; Zhang, XL				Wang, Wei; Zhang, Xiulan			Systemic Adverse Events after Intravitreal Bevacizumab versus Ranibizumab for Age-Related Macular Degeneration: A Meta-Analysis	PLOS ONE			English	Article							GROWTH-FACTOR INHIBITORS; RANDOMIZED CLINICAL-TRIAL; SAFETY; OUTCOMES; PREVALENCE; THERAPIES; INJECTION; MORTALITY; LUCENTIS; EFFICACY	Objective: To assess whether the incidence of systemic adverse events differs between those who used bevacizumab and those who used ranibizumab in the treatment of age-related macular degeneration (AMD). Methods: A systematic literature search was conducted to identify randomised controlled trials (RCTs) comparing the use of intravitreal bevacizumab with the use of ranibizumab in AMD patients. Results were expressed as risk ratios (RRs) with accompanying 95% confidence intervals (CIs). The data were pooled using the fixed-effect or random-effect model according to the heterogeneity present. Results: Four RCTs were included in the final meta-analysis. Overall, the quality of the evidence was high. There were 2,613 treated patients: 1,291 treated with bevacizumab and 1,322 treated with ranibicizumab. No significant differences between bevacizumab use and ranizumab use were found in terms of the incidence of death from all causes, arteriothrombotic events, stroke, nonfatal myocardial infarction, vascular death, venous thrombotic events, and hypertension, with the pooled RRs being 1.11 (0.77, 1.61), 1.03 (0.69,1.55), 0.84 (0.39,1.80), 0.97 (0.48, 1.96), 1.24 (0.63, 2.44), 2.38 (0.94, 6.04), and 1.02 (0.29, 3.62), respectively. Conclusions: The meta-analysis shows that both treatments are comparably safe. However, the findings from our study must be confirmed in future research via well-designed cohort or intervention studies because of the limited number of studies.	[Wang, Wei; Zhang, Xiulan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, XL (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhangxl2@mail.sysu.edu.cn			National Natural Science Foundation of China [81371008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81371008). No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouammoh MA, 2013, CAN J OPHTHALMOL, V48, P317, DOI 10.1016/j.jcjo.2013.03.004; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Aujla JS, 2012, CLIN EXP OPTOM, V95, P538, DOI 10.1111/j.1444-0938.2012.00735.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Biswas P, 2011, INDIAN J OPHTHALMOL, V59, P191, DOI 10.4103/0301-4738.81023; Brown MM, 2006, CURR OPIN OPHTHALMOL, V17, P257; Campbell RJ, 2013, CURR OPIN OPHTHALMOL, V24, P197, DOI 10.1097/ICU.0b013e32835f8bbe; Campbell RJ, 2012, OPHTHALMOLOGY, V119, P1604, DOI 10.1016/j.ophtha.2012.05.028; Campbell RJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4203; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015; Cheung CMG, 2013, LANCET, V382, P1230, DOI 10.1016/S0140-6736(13)61580-9; Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; DeCroos FC, 2012, OPHTHALMOLOGY, V119, P2549, DOI 10.1016/j.ophtha.2012.06.040; Donahue SP, 2010, AM J OPHTHALMOL, V150, P287, DOI 10.1016/j.ajo.2010.04.006; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Frampton JE, 2013, DRUG AGING, V30, P331, DOI 10.1007/s40266-013-0077-9; French DD, 2011, RETINA-J RET VIT DIS, V31, P1036, DOI 10.1097/IAE.0b013e31821dc66f; Grunwald JE, 2012, OPHTHALMOLOGY, V119, P1634, DOI 10.1016/j.ophtha.2012.02.013; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hurwitz HI, 2013, ONCOLOGIST, V18, P1004, DOI 10.1634/theoncologist.2013-0107; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jaffe GJ, 2013, OPHTHALMOLOGY, V120, P1860, DOI 10.1016/j.ophtha.2013.01.073; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Kodjikian L, 2013, OPHTHALMOLOGY; Krebs I, 2013, BRIT J OPHTHALMOL, V97, P266, DOI 10.1136/bjophthalmol-2012-302391; Lally DR, 2012, CURR OPIN OPHTHALMOL, V23, P182, DOI 10.1097/ICU.0b013e328352411c; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mitchell P, 2011, CURR MED RES OPIN, V27, P1465, DOI 10.1185/03007995.2011.585394; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Owen CG, 2012, BRIT J OPHTHALMOL, V96, P752, DOI 10.1136/bjophthalmol-2011-301109; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Schmier JK, 2006, PHARMACOECONOMICS, V24, P319, DOI 10.2165/00019053-200624040-00003; Schmucker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042701; Schmucker C, 2010, CURR OPIN OPHTHALMOL, V21, P218, DOI 10.1097/ICU.0b013e3283386783; Subramanian ML, 2010, EYE, V24, P1708, DOI 10.1038/eye.2010.147; Subramanian ML, 2009, AM J OPHTHALMOL, V148, P875, DOI 10.1016/j.ajo.2009.07.009; Torjesen I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4678; Ying GS, 2013, OPHTHALMOLOGY, V120, P122, DOI 10.1016/j.ophtha.2012.07.042	41	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109744	10.1371/journal.pone.0109744	http://dx.doi.org/10.1371/journal.pone.0109744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330364	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210800037
J	Herrera-May, AL; Tapia, JA; Dominguez-Nicolas, SM; Juarez-Aguirre, R; Gutierrez, EA; Flores, A; Figueras, E; Manjarrez, E				Herrera-May, Agustin L.; Tapia, Jesus A.; Dominguez-Nicolas, Saul M.; Juarez-Aguirre, Raul; Gutierrez-D, Edmundo A.; Flores, Amira; Figueras, Eduard; Manjarrez, Elias			Improved Detection of Magnetic Signals by a MEMS Sensor Using Stochastic Resonance	PLOS ONE			English	Article							FIELD SENSOR; MAGNETOSTOCHASTIC RESONANCE; TACTILE STIMULI; NOISE; SYSTEM; MECHANORECEPTORS; ENHANCEMENT; PERCEPTION; TUTORIAL; CRAYFISH	We introduce the behavior of the electrical output response of a magnetic field sensor based on microelectromechanical systems (MEMS) technology under different levels of controlled magnetic noise. We explored whether a particular level of magnetic noise applied on the vicinity of the MEMS sensor can improve the detection of subthreshold magnetic fields. We examined the increase in the signal-to-noise ratio (SNR) of such detected magnetic fields as a function of the magnetic noise intensity. The data disclosed an inverted U-like graph between the SNR and the applied magnetic noise. This finding shows that the application of an intermediate level of noise in the environment of a MEMS magnetic field sensor improves its detection capability of subthreshold signals via the stochastic resonance phenomenon.	[Herrera-May, Agustin L.; Dominguez-Nicolas, Saul M.; Juarez-Aguirre, Raul] Univ Veracruzana, Micro & Nanotechnol Res Ctr, Boca Del Rio, Veracruz, Mexico; [Flores, Amira; Manjarrez, Elias] Benemerita Univ Autonoma Puebla, Inst Physiol, Puebla, Mexico; [Gutierrez-D, Edmundo A.] INAOE, Dept Elect, Puebla, Mexico; [Dominguez-Nicolas, Saul M.] IPN, CINVESTAV, Dept Automat Control, Mexico City 07738, DF, Mexico; [Figueras, Eduard] CSIC, CNM, IMB, Barcelona, Spain	Universidad Veracruzana; Benemerita Universidad Autonoma de Puebla; Instituto Nacional de Astrofisica, Optica y Electronica; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Microelectronica (CNM); CSIC - Instituto de Microelectronica de Barcelona (IMB-CNM)	Manjarrez, E (corresponding author), Benemerita Univ Autonoma Puebla, Inst Physiol, Puebla, Mexico.	eliasmanjarrez@gmail.com	Figueras, Eduardo/O-6492-2016; Manjarrez, Elias/B-8492-2012; Herrera-May, Agustín L./M-3501-2014	Figueras, Eduardo/0000-0002-4229-3214; Manjarrez, Elias/0000-0002-3277-0101; Herrera-May, Agustín L./0000-0002-7373-9258; Dominguez-Nicolas, Saul Manuel/0000-0001-6086-0684; Gutierrez D, Edmundo A/0000-0002-3015-8736; Tapia-Lopez, Jesus Angel/0000-0001-6686-1282	grant PIFI-VIEP-CONACYT [153583]; grant Catedra Marcos Moshinsky; grant Cuerpos Academicos PROMEP BUAP; grant Vicerrectoria de Docencia BUAP; grant Vicerrectoria de Investigacion y de Estudios de Posgrado VIEP BUAP; grant PROMEP [4543 EXB 468]; grant PROMEP-Red: "Instrumentacion-de-Sensores-para-Aplicaciones-de-Fisiologia-y-Biomedicina", Mexico	grant PIFI-VIEP-CONACYT; grant Catedra Marcos Moshinsky; grant Cuerpos Academicos PROMEP BUAP; grant Vicerrectoria de Docencia BUAP; grant Vicerrectoria de Investigacion y de Estudios de Posgrado VIEP BUAP; grant PROMEP; grant PROMEP-Red: "Instrumentacion-de-Sensores-para-Aplicaciones-de-Fisiologia-y-Biomedicina", Mexico	This work was supported by the grants PIFI-VIEP-CONACYT 153583 (EM), Catedra Marcos Moshinsky (EM), Cuerpos Academicos PROMEP BUAP (AF, EM), Vicerrectoria de Docencia BUAP (AF, EM), Vicerrectoria de Investigacion y de Estudios de Posgrado VIEP BUAP (AF, EM), PROMEP 4543 EXB 468 (AHM) and PROMEP-Red: "Instrumentacion-de-Sensores-para-Aplicaciones-de-Fisiologia-y-Biomedicina" (AHM, EAGD, AF, EM) Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger S, 2009, J MICROELECTROMECH S, V18, P1432, DOI 10.1109/JMEMS.2009.2031675; Chapeau-Blondeau F, 2005, INT J BIFURCAT CHAOS, V15, P2985, DOI 10.1142/S0218127405013824; Choi S, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/4/045004; Collins JJ, 1996, J NEUROPHYSIOL, V76, P642, DOI 10.1152/jn.1996.76.1.642; Cordo P, 1996, NATURE, V383, P769, DOI 10.1038/383769a0; Dominguez-Nicolas SM, 2013, INT J MED SCI, V10, P1445, DOI 10.7150/ijms.4732; Dominguez-Nicolas SM, 2012, IEEE SENS J, V12, P935, DOI 10.1109/JSEN.2011.2167012; Emmerich H, 2000, IEEE T ELECTRON DEV, V47, P972, DOI 10.1109/16.841228; Gammaitoni L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.230601; Grigorenko AN, 1997, SENSOR ACTUAT A-PHYS, V59, P277, DOI 10.1016/S0924-4247(97)80189-6; GRIGORENKO AN, 1990, JETP LETT+, V52, P593; Harmer GP, 2001, MICROELECTRON J, V32, P959, DOI 10.1016/S0026-2692(01)00094-5; Herrera-May AL, 2011, SENSOR ACTUAT A-PHYS, V165, P399, DOI 10.1016/j.sna.2010.07.005; Herrera-May AL, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/1/015016; Herrera-May AL, 2009, SENSORS-BASEL, V9, P7785, DOI 10.3390/s91007785; HIBBS AD, 1995, NUOVO CIMENTO D, V17, P811, DOI 10.1007/BF02451838; Ivey C, 1998, J NEUROPHYSIOL, V79, P1879, DOI 10.1152/jn.1998.79.4.1879; Jaramillo F, 1998, NAT NEUROSCI, V1, P384, DOI 10.1038/1597; Krijnen GJM, 2006, NANOTECHNOLOGY, V17, pS84, DOI 10.1088/0957-4484/17/4/013; Langfelder G, 2013, IEEE T IND ELECTRON, V60, P3983, DOI 10.1109/TIE.2012.2210958; Leng JC, 2013, NDT&E INT, V55, P42, DOI 10.1016/j.ndteint.2013.01.005; Li M, 2012, J MICROELECTROMECH S, V21, P1002, DOI 10.1109/JMEMS.2012.2196493; Magalhaes FH, 2011, EXP BRAIN RES, V209, P139, DOI 10.1007/s00221-010-2529-3; Manjarrez E, 2003, J NEUROSCI, V23, P1997; Manjarrez E, 2002, NEUROSCI LETT, V324, P213, DOI 10.1016/S0304-3940(02)00212-4; Manjarrez E, 2002, NEUROSCI LETT, V326, P93, DOI 10.1016/S0304-3940(02)00318-X; Manjarrez E, 2007, NEUROSCI LETT, V415, P231, DOI 10.1016/j.neulet.2007.01.030; Mendez-Balbuena I, 2012, J NEUROSCI, V32, P12612, DOI 10.1523/JNEUROSCI.0680-12.2012; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; MOSS F, 1994, INT J BIFURCAT CHAOS, V4, P1383, DOI 10.1142/S0218127494001118; Mulavara AP, 2011, EXP BRAIN RES, V210, P303, DOI 10.1007/s00221-011-2633-z; Ripka P, 2010, IEEE SENS J, V10, P1108, DOI 10.1109/JSEN.2010.2043429; Rousseau D, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021102; Rousseau D, 2005, SIGNAL PROCESS, V85, P571, DOI 10.1016/j.sigpro.2004.11.002; Sejdic E, 2013, COMPUT METH PROG BIO, V111, P459, DOI 10.1016/j.cmpb.2013.03.014; Simonotto E, 1997, PHYS REV LETT, V78, P1186, DOI 10.1103/PhysRevLett.78.1186; Stoop R, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061918; Sunier R, 2006, J MICROELECTROMECH S, V15, P1098, DOI 10.1109/JMEMS.2006.880212; Tapia JA, 2011, BIOMED MICRODEVICES, V13, P303, DOI 10.1007/s10544-010-9494-2; Thompson MJ, 2011, J MICROELECTROMECH S, V20, P702, DOI 10.1109/JMEMS.2011.2140355; Than TD, 2012, IEEE T BIO-MED ENG, V59, P2387, DOI 10.1109/TBME.2012.2201715; Volgushev M, 2000, SCIENCE, V290, P1908, DOI 10.1126/science.290.5498.1908; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Wilson JW, 2007, SENSOR ACTUAT A-PHYS, V135, P381, DOI 10.1016/j.sna.2006.08.010; Wu GQ, 2013, IEEE ELECTR DEVICE L, V34, P459, DOI 10.1109/LED.2013.2241727; Yang T, 1998, PHYS LETT A, V245, P79, DOI 10.1016/S0375-9601(98)00351-X	49	5	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109534	10.1371/journal.pone.0109534	http://dx.doi.org/10.1371/journal.pone.0109534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329563	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200035
J	Lee, KH; Lee, R; Lee, WY; Kim, DH; Chung, HJ; Kim, JH; Kim, NH; Choi, SH; Kim, JH; Song, H				Lee, Kyung Hoon; Lee, Ran; Lee, Won Young; Kim, Dong Hoon; Chung, Hak Jae; Kim, Jin Hoi; Kim, Nam Hyung; Choi, Suk Hwa; Kim, Jae Hwan; Song, Hyuk			Identification and In Vitro Derivation of Spermatogonia in Beagle Testis	PLOS ONE			English	Article							GERMLINE STEM-CELLS; NEONATAL PIG TESTIS; SELF-RENEWAL; SEMINIFEROUS EPITHELIUM; GROWTH-FACTORS; CULTURE; SPERMATOGENESIS; SPERM; DOG; TRANSPLANTATION	Background: In vitro culture of spermatogonial stem cells (SSCs) is important for exploration of SSCs self-renewal, differentiation, and manipulation. There are several reports on rodent SSC cultures; however, data on SSC cultures in domestic animals are limited. To provide basic scientific information on canine SSC cultures, we report canine testes development, and the development of spermatogonia-derived colonies (SDCs) for in vitro cultures. Methodology/Principal Findings: Testes from 2-, 3-, and 12-month-old beagles were used for histology, immunohistochemistry, in vitro culture, immunocytochemistry, and PCR. Protein gene product 9.5 (PGP9.5)-positive spermatogonia, both single and paired, were found to be abundant in the testes of 2-month-old beagles. stempro-34 and Dulbecco's modified Eagle medium with 5% fetal bovine serum provided as useful substrates for culture of SDCs, and fibroblast growth factor (FGF) played a key role in colony formation. Colonies were positive for alkaline phosphatase and anti-PGP9.5 staining. The early spermatogonia and stem cell markers such as octamer binding protein 4 (Oct4), Nanog homeobox (Nanog), promyelocytic leukemia zinc finger (PLZF), PGP9.5, and GDNF family receptor alpha-1 (GFR alpha-1) were expressed in the colonies at higher levels than in the testis tissue. Conclusions: Testes of the 2-month-old beagles had abundant single and paired spermatogonia, which can be used for derivation of SDCs, and FGF was important for colony formation.	[Lee, Kyung Hoon; Lee, Ran; Lee, Won Young; Song, Hyuk] Konkuk Univ, RIBH, Dept Anim & Food Biosci, Chungju, South Korea; [Kim, Dong Hoon; Chung, Hak Jae] Natl Inst Anim Sci, Anim Biotechnol Div, Suwon, South Korea; [Kim, Jin Hoi] Konkuk Univ, Dept Anim Biotechnol, Seoul, South Korea; [Kim, Nam Hyung] Chungbuk Natl Univ, Dept Anim Sci, Choung Ju, South Korea; [Choi, Suk Hwa] Chungbuk Natl Univ, Dept Vet Sci, Choung Ju, South Korea; [Kim, Jae Hwan] CHA Univ, Dept Biomed Sci, Songnam, South Korea	Konkuk University; National Institute of Animal Science, Republic of Korea; Konkuk University; Chungbuk National University; Chungbuk National University; Pochon Cha University	Song, H (corresponding author), Konkuk Univ, RIBH, Dept Anim & Food Biosci, Chungju, South Korea.	lovelyhusband@kku.ac.kr		Lee, Kyung Hoon/0000-0002-3909-4222; kim, jin-hoi/0000-0003-1232-5307	Rural Development Administration, Republic of Korea [PJ009846]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ009846)'' Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Elhija M, 2012, ASIAN J ANDROL, V14, P285, DOI 10.1038/aja.2011.112; Aponte PM, 2006, THERIOGENOLOGY, V65, P1828, DOI 10.1016/j.theriogenology.2005.10.020; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; DYM M, 1994, P NATL ACAD SCI USA, V91, P11287, DOI 10.1073/pnas.91.24.11287; FOOTE RH, 1972, ANAT RECORD, V173, P341, DOI 10.1002/ar.1091730309; Goel S, 2008, REPRODUCTION, V135, P785, DOI 10.1530/REP-07-0476; Goel S, 2007, BIOL REPROD, V77, P127, DOI 10.1095/biolreprod.106.056879; Montoto LG, 2012, REPRODUCTION, V143, P333, DOI 10.1530/REP-11-0245; Grieco V, 2010, J COMP PATHOL, V142, P213, DOI 10.1016/j.jcpa.2009.07.002; Heidari B, 2012, J ASSIST REPROD GEN, V29, P1029, DOI 10.1007/s10815-012-9828-5; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Ishii K, 2012, DEVELOPMENT, V139, P1734, DOI 10.1242/dev.076539; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kanatsu-Shinohara M, 2011, BIOL REPROD, V84, P97, DOI 10.1095/biolreprod.110.086462; Kim Y, 2008, REPRODUCTION, V136, P823, DOI 10.1530/REP-08-0226; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kuijk EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010987; Kuijk EW, 2009, REPRODUCTION, V138, P721, DOI 10.1530/REP-09-0138; Lee KH, 2013, REPROD DOMEST ANIM, V48, P954, DOI 10.1111/rda.12193; Lee KH, 2009, SEX DEV, V3, P225, DOI 10.1159/000228723; Lee WY, 2013, STEM CELL RES, V11, P1234, DOI 10.1016/j.scr.2013.08.008; Martins DS, 2011, REPROD DOMEST ANIM, V46, pe62, DOI 10.1111/j.1439-0531.2010.01631.x; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Sato T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1478; Soares JM, 2009, J ANAT, V215, P462, DOI 10.1111/j.1469-7580.2009.01122.x; Zheng Y, 2014, REPRODUCTION, V147, pR65, DOI 10.1530/REP-13-0466	29	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109963	10.1371/journal.pone.0109963	http://dx.doi.org/10.1371/journal.pone.0109963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333749	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200069
J	Li, Y; Li, N; Han, QY; He, SX; Bae, RS; Liu, ZW; Lv, Y; Shi, BY				Li, Yan; Li, Na; Han, Qunying; He, Shuixiang; Bae, Ricard S.; Liu, Zhengwen; Lv, Yi; Shi, Bingyin			Performance of Physical Examination Skills in Medical Students during Diagnostic Medicine Course in a University Hospital of Northwest China	PLOS ONE			English	Article							COGNITIVE-ABILITIES TEST; SEX-DIFFERENCES; CLERKSHIP; GENDER; SCORES	This study was conducted to evaluate the performance of physical examination (PE) skills during our diagnostic medicine course and analyze the characteristics of the data collected to provide information for practical guidance to improve the quality of teaching. Seventy-two fourth-year medical students were enrolled in the study. All received an assessment of PE skills after receiving a 17-week formal training course and systematic teaching. Their performance was evaluated and recorded in detail using a checklist, which included 5 aspects of PE skills: examination techniques, communication and care skills, content items, appropriateness of examination sequence, and time taken. Error frequency and type were designated as the assessment parameters in the survey. The results showed that the distribution and the percentage in examination errors between male and female students and among the different body parts examined were significantly different (p<0.001). The average error frequency per student in females (0.875) was lower than in males (1.375) although the difference was not statistically significant (p = 0.167). The average error frequency per student in cardiac (1.267) and pulmonary (1.389) examinations was higher than in abdominal (0.867) and head, neck and nervous system examinations (0.917). Female students had a lower average error frequency than males in cardiac examinations (p = 0.041). Additionally, error in examination techniques was the highest type of error among the 5 aspects of PE skills irrespective of participant gender and assessment content (p<0.001). These data suggest that PE skills in cardiac and pulmonary examinations and examination techniques may be included in the main focus of improving the teaching of diagnostics in these medical students.	[Li, Yan; Li, Na; Han, Qunying; He, Shuixiang; Bae, Ricard S.; Liu, Zhengwen; Lv, Yi; Shi, Bingyin] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Liu, ZW (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Xian 710049, Shaanxi, Peoples R China.	liuzhengwen@medmail.com.cn	Li, Yuan/GXV-1310-2022; Li, Yang/GWM-7879-2022; li, yong/HDN-3885-2022		First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University; 10000 Women: The Yale-Tsinghua Certificate Program in International Healthcare Management	First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University; 10000 Women: The Yale-Tsinghua Certificate Program in International Healthcare Management	Yan Li was supported by the First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University and 10000 Women: The Yale-Tsinghua Certificate Program in International Healthcare Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2001, AM J MED, V110, P419, DOI 10.1016/S0002-9343(01)00621-0; Azer SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2728; Clauser BE, 2009, ACAD MED, V84, pS86, DOI 10.1097/ACM.0b013e3181b36fda; Cleland J, 2013, CLIN TEACH, V10, P84, DOI 10.1111/j.1743-498X.2012.00620.x; Colbert-Getz JM, 2013, ACAD MED, V88, P44, DOI 10.1097/ACM.0b013e318276bcc4; Dilaveri CA, 2013, BJOG-INT J OBSTET GY, V120, P1171, DOI 10.1111/1471-0528.12289; Duvivier RJ, 2012, ADV HEALTH SCI EDUC, V17, P339, DOI 10.1007/s10459-011-9312-5; Easton G, 2012, EDUC PRIM CARE, V23, P246, DOI 10.1080/14739879.2012.11494117; Flatters I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088692; Haring CM, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-73; Heller MA, 2010, J GEN PSYCHOL, V137, P49; Janjigian MP, 2012, J HOSP MED, V7, P640, DOI 10.1002/jhm.1954; Lee CA, 2011, J GEN INTERN MED, V26, P1374, DOI 10.1007/s11606-011-1809-3; LI JTC, 1994, ACAD MED, V69, P296, DOI 10.1097/00001888-199404000-00013; Lohman DF, 2009, BRIT J EDUC PSYCHOL, V79, P389, DOI 10.1348/000709908X354609; Louis DZ, 1996, ACAD MED, V71, pS19, DOI 10.1097/00001888-199610000-00032; Martineau B, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-55; McElhinney E, 2010, J CLIN NURS, V19, P3177, DOI 10.1111/j.1365-2702.2010.03304.x; Meller Stephanie M., 2013, Yale Journal of Biology and Medicine, V86, P583; Nakatani M, 2011, INT J COSMETIC SCI, V33, P346, DOI 10.1111/j.1468-2494.2010.00634.x; Oliver CM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002257; Rutherford HJV, 2012, PERSONAL DISORD, V3, P393, DOI 10.1037/a0028938; St-Onge C, 2013, TEACH LEARN MED, V25, P195, DOI 10.1080/10401334.2013.797342; Strand S, 2006, BRIT J EDUC PSYCHOL, V76, P463, DOI 10.1348/000709905X50906; Wilkerson L, 2003, ACAD MED, V78, pS30, DOI 10.1097/00001888-200310001-00010; Williams RG, 2007, ACAD MED, V82, pS22, DOI 10.1097/ACM.0b013e318141f5ca; York NL, 1999, AM J SURG, V177, P240, DOI 10.1016/S0002-9610(99)00005-7; Zhang N, 2012, J CHIPROPR EDUC, V26, P40, DOI 10.7899/1042-5055-26.1.40	28	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109294	10.1371/journal.pone.0109294	http://dx.doi.org/10.1371/journal.pone.0109294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329685	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200023
J	Liu, W; Yin, DX; Liu, JJ; Li, N				Liu, Wei; Yin, Dongxue; Liu, Jianjun; Li, Na			Genetic Diversity and Structure of Sinopodophyllum hexandrum (Royle) Ying in the Qinling Mountains, China	PLOS ONE			English	Article							PODOPHYLLUM-HEXANDRUM; POPULATION-STRUCTURE; SICHUAN PROVINCE; ISSR MARKERS; CONSERVATION; RAPD; DIFFERENTIATION; BERBERIDACEAE; DISCOVERY; ETOPOSIDE	Sinopodophyllum hexandrum is an important medicinal plant whose genetic diversity must be conserved because it is endangered. The Qinling Mts. are a S. hexandrum distribution area that has unique environmental features that highly affect the evolution of the species. To provide the reference data for evolutionary and conservation studies, the genetic diversity and population structure of S. hexandrum in its overall natural distribution areas in the Qinling Mts. were investigated through inter-simple sequence repeats analysis of 32 natural populations. The 11 selected primers generated a total of 135 polymorphic bands. S. hexandrum genetic diversity was low within populations (average H-e = 0.0621), but higher at the species level (H-e = 0.1434). Clear structure and high genetic differentiation among populations were detected by using the unweighted pair group method for arithmetic averages, principle coordinate analysis and Bayesian clustering. The clustering approaches supported a division of the 32 populations into three major groups, for which analysis of molecular variance confirmed significant variation (63.27%) among populations. The genetic differentiation may have been attributed to the limited gene flow (N-m = 0.3587) in the species. Isolation by distance among populations was determined by comparing genetic distance versus geographic distance by using the Mantel test. Result was insignificant (r = 0.212, P = 0.287) at 0.05, showing that their spatial pattern and geographic locations are not correlated. Given the low within-population genetic diversity, high differentiation among populations and the increasing anthropogenic pressure on the species, in situ conservation measures were recommended to preserve S. hexandrum in Qinling Mts., and other populations must be sampled to retain as much genetic diversity of the species to achieve ex situ preservation as a supplement to in situ conservation.	[Liu, Wei; Yin, Dongxue; Liu, Jianjun; Li, Na] Northwest A & F Univ, Coll Forestry, Yangling, Peoples R China	Northwest A&F University - China	Liu, JJ (corresponding author), Northwest A & F Univ, Coll Forestry, Yangling, Peoples R China.	ljj@nwsuaf.edu.cn			Forestry Research Foundation for the Public Service Industry of China [200904004]	Forestry Research Foundation for the Public Service Industry of China	This work was supported by the program from the Forestry Research Foundation for the Public Service Industry of China (200904004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2008, AFR J BIOTECHNOL, V7, P1028; Alam MA, 2009, INDIAN J BIOTECHNOL, V8, P391; [Anonymous], 1997, TFPGA TOOLS POPULATI; [Anonymous], 1997, MOL BIOL BIOTECHNOLO; [Anonymous], 1997, ACTA BOT BOREALI-OCC; Bornet B, 2001, PLANT MOL BIOL REP, V19, P209, DOI 10.1007/BF02772892; Bunn E, 2005, PLANT CELL TISS ORG, V83, P97, DOI 10.1007/s11240-005-3275-2; Chang CS, 2004, BIOL CONSERV, V119, P387, DOI 10.1016/j.biocon.2003.12.003; CHATTERJEE RAMGOPAL, 1952, ECON BOT, V6, P342, DOI 10.1007/BF02984882; Chattopadhyay S, 2004, NAT PROD RES, V18, P51, DOI 10.1080/1057563031000122095; Cochrane JA, 2007, AUST J BOT, V55, P356, DOI 10.1071/BT06173; Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893; Dong JE, 2011, IND CROP PROD, V34, P1607, DOI 10.1016/j.indcrop.2011.06.007; Editorial committee Chinese Academy of Sciences, 2010, FLORA CHINA, V29, P249; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Esselman EJ, 1999, MOL ECOL, V8, P443, DOI 10.1046/j.1365-294X.1999.00585.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; FAY DA, 1985, J LIQ CHROMATOGR, V8, P1501, DOI 10.1080/01483918508067160; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Francisco-Ortega J, 2000, AM J BOT, V87, P909, DOI 10.2307/2656988; Fu LK, 1992, PLANT RED BOOK CHINA; Ge XJ, 1999, MOL ECOL, V8, P2061, DOI 10.1046/j.1365-294x.1999.00821.x; Giri A, 2000, CYTOTECHNOLOGY, V34, P17, DOI 10.1023/A:1008138230896; Goel H. C., 1998, Indian Journal of Experimental Biology, V36, P583; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J.L., 1983, GENETICS CONSERVATIO, P335, DOI DOI 10.1111/J.1471-8286.2004.00845.X; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; HOLTHUIS JJM, 1988, PHARM WEEKBLAD, V10, P101, DOI 10.1007/BF01959294; Huang Kun, 2012, Zhongguo Zhong Yao Za Zhi, V37, P1360; Imbert TF, 1998, BIOCHIMIE, V80, P207, DOI 10.1016/S0300-9084(98)80004-7; INAMORI Y, 1986, CHEM PHARM BULL, V34, P3928; JENSEN RJ, 1989, Q REV BIOL, V64, P250, DOI 10.1086/416356; Jin Y, 2003, ACTA BOT SIN, V45, P995; Kalisz S, 1999, ECOLOGY, V80, P2620, DOI 10.1890/0012-9658(1999)080[2620:AMSDAP]2.0.CO;2; KAMIL WM, 1986, PHYTOCHEMISTRY, V25, P2093, DOI 10.1016/0031-9422(86)80072-3; KARRON JD, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P87; Kong Y, 2010, FITOTERAPIA, V81, P367, DOI 10.1016/j.fitote.2009.11.003; Larson SR, 2003, CROP SCI, V43, P394, DOI 10.2135/cropsci2003.0394; Lata H, 2010, IN VITRO CELL DEV-PL, V46, P22, DOI 10.1007/s11627-009-9243-5; Lee T.B., 1980, ILLUSTRATED FLORA KO; Li GM, 1975, J BOT, V2, P28; Li GY, 2005, CHINESE J NEW DRUGS, V26, P2185; Li HS, 2004, ACTA BOT SIN, V46, P515; LI J, 1989, CANADIAN MEDICAL AND BIOLOGICAL ENGINEERING SOCIETY CONFERENCE : PROCEEDINGS - 1989, P1; Li QM, 2002, BIOL CONSERV, V106, P151, DOI 10.1016/S0006-3207(01)00240-3; Li Y, 2011, MOL PHYLOGENET EVOL, V59, P412, DOI 10.1016/j.ympev.2011.01.009; Liao Wen-Fang, 2004, Acta Botanica Yunnanica, V26, P58; Lin MC, 2008, J FOOD DRUG ANAL, V16, P29; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Luijten SH, 2000, CONSERV BIOL, V14, P1776, DOI 10.1111/j.1523-1739.2000.99345.x; Malone CL, 2003, CONSERV GENET, V4, P1, DOI 10.1023/A:1021885323539; Moraes RM, 2002, TRENDS NEW CROPS NEW, P527; Nadeem M, 2000, BIOL CONSERV, V92, P121, DOI 10.1016/S0006-3207(99)00059-2; Nagaoka T, 1997, THEOR APPL GENET, V94, P597, DOI 10.1007/s001220050456; Naik Pradeep Kumar, 2010, Physiology and Molecular Biology of Plants, V16, P135, DOI 10.1007/s12298-010-0015-9; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Ohsawa T, 2008, FLORA, V203, P187, DOI 10.1016/j.flora.2007.02.007; Oostermeijer JGB, 1995, J EVOLUTION BIOL, V8, P739, DOI 10.1046/j.1420-9101.1995.8060739.x; Pritchard JK, 2000, GENETICS, V155, P945; Purohit MC, 1999, CURR SCI INDIA, V77, P1078; [秦杨 QIN Yang], 2009, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V29, P1490; Qiu YX, 2006, BIOCHEM SYST ECOL, V34, P745, DOI 10.1016/j.bse.2006.06.001; Reddy PB, 2008, ARCH PHARM, V341, P126, DOI 10.1002/ardp.200700116; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; STAHELIN HF, 1991, CANCER RES, V51, P5; Sun YJ, 2011, BIOORG MED CHEM LETT, V21, P3794, DOI 10.1016/j.bmcl.2011.04.036; Tang N, 2014, PLANT SYST EVOL, V300, P1453, DOI 10.1007/s00606-013-0973-9; Thriveni HN, 2014, PLANT SYST EVOL, V300, P403, DOI 10.1007/s00606-013-0890-y; Totland O, 1999, OECOLOGIA, V120, P242, DOI 10.1007/s004420050854; Wang DW, 1997, CHINESE MED MATRIA, V20, P571; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wu CJ, 2004, PLANT SCI, V167, P35, DOI 10.1016/j.plantsci.2004.02.022; Xiao M, 2006, J INTEGR PLANT BIOL, V48, P1140, DOI 10.1111/j.1744-7909.2006.00304.x; Xiao M, 2006, BIOCHEM GENET, V44, P44, DOI 10.1007/s10528-006-9006-5; Ying TS, 1979, ACTA PHYTOTAX SINICA, V17, P17; Yousefzadi M, 2010, ENG LIFE SCI, V10, P281, DOI 10.1002/elsc.201000027; Zhang Zhi-Yong, 2003, Acta Botanica Yunnanica, V25, P544; Zhao CQ, 2011, CHINESE CHEM LETT, V22, P181, DOI 10.1016/j.cclet.2010.10.013; Zhao CQ, 2001, CHEM PHARM BULL, V49, P1474, DOI 10.1248/cpb.49.1474; Zhou TH, 2010, POPUL ECOL, V52, P223, DOI 10.1007/s10144-009-0139-3; Zhou Y, 2008, CHROMATOGRAPHIA, V68, P781, DOI 10.1365/s10337-008-0786-0; Zhu CG, 2004, DRUG EVAL, V1, P306; Zong M, 2008, BIOCHEM GENET, V46, P180, DOI 10.1007/s10528-007-9141-7	85	15	18	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110500	10.1371/journal.pone.0110500	http://dx.doi.org/10.1371/journal.pone.0110500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333788	Green Submitted, gold, Green Published			2022-12-27	WOS:000346766200123
J	Losch, S; Moghaddam, N; Grossschmidt, K; Risser, DU; Kanz, F				Loesch, Sandra; Moghaddam, Negahnaz; Grossschmidt, Karl; Risser, Daniele U.; Kanz, Fabian			Stable Isotope and Trace Element Studies on Gladiators and Contemporary Romans from Ephesus (Turkey, 2nd and 3rd Ct. AD) - Implications for Differences in Diet	PLOS ONE			English	Article							STRONTIUM RANELATE TREATMENT; BONE-COLLAGEN; IRON-AGE; SKELETAL MATERIAL; CARBON ISOTOPES; TROPHIC LEVEL; ISOLA-SACRA; SULFUR; IMPERIAL; CALCIUM	The gladiator cemetery discovered in Ephesus (Turkey) in 1993 dates to the 2nd and 3rd century AD. The aim of this study is to reconstruct diverse diet, social stratification, and migration of the inhabitants of Roman Ephesus and the distinct group of gladiators. Stable carbon, nitrogen, and sulphur isotope analysis were applied, and inorganic bone elements (strontium, calcium) were determined. In total, 53 individuals, including 22 gladiators, were analysed. All individuals consumed C-3 plants like wheat and barley as staple food. A few individuals show indication of consumption of C-4 plants. The delta C-13 values of one female from the gladiator cemetery and one gladiator differ from all other individuals. Their delta S-34 values indicate that they probably migrated from another geographical region or consumed different foods. The delta N-15 values are relatively low in comparison to other sites from Roman times. A probable cause for the depletion of N-15 in Ephesus could be the frequent consumption of legumes. The Sr/Ca-ratios of the gladiators were significantly higher than the values of the contemporary Roman inhabitants. Since the Sr/Ca-ratio reflects the main Ca-supplier in the diet, the elevated values of the gladiators might suggest a frequent use of a plant ash beverage, as mentioned in ancient texts.	[Loesch, Sandra; Moghaddam, Negahnaz] Univ Bern, Dept Phys Anthropol, Inst Forens Med, Bern, Switzerland; [Grossschmidt, Karl] Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria; [Risser, Daniele U.; Kanz, Fabian] Med Univ Vienna, Dept Forens Med, Vienna, Austria	University of Bern; Medical University of Vienna; Medical University of Vienna	Kanz, F (corresponding author), Med Univ Vienna, Dept Forens Med, Vienna, Austria.	Fabian.Kanz@meduniwien.ac.at	Lösch, Sandra/AAA-9806-2021; Lösch, Sandra/H-3230-2013	Lösch, Sandra/0000-0003-3442-9764; Lösch, Sandra/0000-0003-3442-9764; Kanz, Fabian/0000-0001-6720-6781; Moghaddam, Negahnaz/0000-0002-0615-0451	Department of Forensic Medicine at University of Medicine Vienna	Department of Forensic Medicine at University of Medicine Vienna	The study was funded internally by the Department of Forensic Medicine at University of Medicine Vienna. There were no other individuals employed or contracted by the funder than the named authors. Therefore no one other than the authors played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsadi G., 1970, HIST HUMAN LIFESPAN; ALEXANDER GV, 1956, J BIOL CHEM, V218, P911; Ambrose S.H., 1993, INVESTIGATIONS ANCIE, P59; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; [Anonymous], GALENUS ALIMENTORUM, VVI, P529; Beaudoin C, 2003, PHOENIX, V57, P139; Bocherens H, 2006, J ARCHAEOL SCI, V33, P253, DOI 10.1016/j.jas.2005.07.010; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Boivin G, 1996, J BONE MINER RES, V11, P1302; BROWN A B, 1974, Contributions to Geology University of Wyoming, V13, P47; Burton J., 2008, BIOL ANTHR HUMAN SKE, P443, DOI DOI 10.1002/9780470245842.CH14; BURTON JD, 1962, NATURE, V193, P846, DOI 10.1038/193846a0; Burton JH, 1999, J ARCHAEOL SCI, V26, P609, DOI 10.1006/jasc.1998.0378; BURTON JH, 1995, AM J PHYS ANTHROPOL, V96, P273, DOI 10.1002/ajpa.1330960305; Carter M, 2004, GREEK ROMAN BYZANTIN, V44, P41; Carter MJ, 2009, INT J HIST SPORT, V26, P298, DOI 10.1080/09523360802531621; Coleman K. M., 2006, MARTIALIS LIBER SPEC; COMAR CL, 1957, SCIENCE, V126, P485, DOI 10.1126/science.126.3272.485; Craig OE, 2006, J ARCHAEOL SCI, V33, P1642, DOI 10.1016/j.jas.2006.05.006; Craig OE, 2009, AM J PHYS ANTHROPOL, V139, P572, DOI 10.1002/ajpa.21021; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Dupras TL, 2001, J ARCHAEOL SCI, V28, P1199, DOI 10.1006/jasc.2001.0640; Dupras TL, 2001, AM J PHYS ANTHROPOL, V115, P204, DOI 10.1002/ajpa.1075; Dupras TL, 2007, AM J PHYS ANTHROPOL, V134, P63, DOI 10.1002/ajpa.20639; ECKELMANN WR, 1958, SCIENCE, V127, P266, DOI 10.1126/science.127.3293.266; ELIAS RW, 1982, GEOCHIM COSMOCHIM AC, V46, P2561, DOI 10.1016/0016-7037(82)90378-7; Elloumi M, 2009, J BONE MINER METAB, V27, P713, DOI 10.1007/s00774-009-0086-2; Fabrizii-Reuer S, 1995, VIA SACRA EPHESIACA; FEREMBACH D, 1979, B MEM SOC ANTHRO PAR, V6, P7, DOI 10.3406/bmsap.1979.1945; Fornander E, 2008, J ANTHROPOL ARCHAEOL, V27, P281, DOI 10.1016/j.jaa.2008.03.004; Friedlander L, 1995, SITTENGESCHICHTE ROM; Friendship-Taylor R, 2001, ANTIQUITY, V75, P27, DOI 10.1017/S0003598X00052625; Fuller BT, 2012, AM J PHYS ANTHROPOL, V149, P157, DOI 10.1002/ajpa.22100; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P45, DOI 10.1002/ajpa.20244; GAWLIK D, 1982, J CLIN CHEM CLIN BIO, V20, P499; Grupe G, 1999, APPL GEOCHEM, V14, P271; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; HASSAN AA, 1977, ARCHAEOMETRY, V19, P131, DOI 10.1111/j.1475-4754.1977.tb00190.x; Hedges REM, 2007, J ARCHAEOL SCI, V34, P1240, DOI 10.1016/j.jas.2006.10.015; Henneberg RJ, 2006, HOMO, V57, P230; Herrmann B, 1990, PRAHISTORISCHE ANTHR; HODGES RM, 1950, J BIOL CHEM, V185, P519; Honch NV, 2006, J ARCHAEOL SCI, V33, P1493, DOI 10.1016/j.jas.2006.02.002; Hu YW, 2009, P NATL ACAD SCI USA, V106, P10971, DOI 10.1073/pnas.0904826106; Jorkov MLS, 2010, AM J PHYS ANTHROPOL, V143, P523, DOI 10.1002/ajpa.21346; Junkelmann M, 2000, SPIEL TOD SO KAMPFTE; Junkelmann M, 2008, GLADIATOREN SPIEL TO; Kanz F, 2005, JAHRESHEFTE OSTERREI, V74, P103; Kanz F, 2005, THESIS U WIEN; Kanz F, 2009, BRIT ARCHAELOGICAL R, V1946, P211; Kanz F, 2006, FORENSIC SCI INT, V160, P207, DOI 10.1016/j.forsciint.2005.10.010; Katzenberg M. A., 2008, BIOL ANTHR HUMAN SKE, V2, P413; Kavanaugh M, 1979, THESIS U WISCONSIN M; Keenleyside A, 2009, J ARCHAEOL SCI, V36, P51, DOI 10.1016/j.jas.2008.07.008; KLEPINGER LL, 1984, ANNU REV ANTHROPOL, V13, P75; Kuhnen HP, 2000, MORITURI MENSCHENOPF, V17, P105; KULP JL, 1957, SCIENCE, V125, P219, DOI 10.1126/science.125.3241.219; LAMBERT JB, 1984, ACCOUNTS CHEM RES, V17, P298, DOI 10.1021/ar00105a001; Le Huray JD, 2005, J ANTHROPOL ARCHAEOL, V24, P135, DOI 10.1016/j.jaa.2004.09.002; Lee-Thorp JA, 2008, ARCHAEOMETRY, V50, P925, DOI 10.1111/j.1475-4754.2008.00441.x; LEETHORP JA, 1989, J ARCHAEOL SCI, V16, P585, DOI 10.1016/0305-4403(89)90024-1; Li CH, 2010, J BONE MINER RES, V25, P968, DOI 10.1359/jbmr.091038; Lightfoot E, 2012, AM J PHYS ANTHROPOL, V148, P543, DOI 10.1002/ajpa.22070; Losch S, 2006, AM J PHYS ANTHROPOL, V131, P181, DOI 10.1002/ajpa.20395; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Losch S, 2009, THESIS LUDWIG MAXIMI; Maimoun L, 2004, J SPORT SCI, V22, P875, DOI 10.1080/02640410410001716698; Manas A, 2011, INT J HIST SPORT, V28, P2726, DOI 10.1080/09523367.2011.618267; Mann C, 2009, INT J HIST SPORT, V26, P272, DOI 10.1080/09523360802513322; Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055; Mayhoff K, 1906, NATURALIS HIST; Meijer F, 2005, GLADIATORS HIST MOST; Muldner G, 2011, J ARCHAEOL SCI, V38, P280, DOI 10.1016/j.jas.2010.09.003; Nehlich O, 2012, AM J PHYS ANTHROPOL, V149, P115, DOI 10.1002/ajpa.22104; Nehlich O, 2011, GEOCHIM COSMOCHIM AC, V75, P4963, DOI 10.1016/j.gca.2011.06.009; Nehlich O, 2009, ARCHAEOL ANTHROP SCI, V1, P59, DOI 10.1007/s12520-009-0003-6; Oelze VM, 2012, AM J PHYS ANTHROPOL, V148, P406, DOI 10.1002/ajpa.22063; Pagano AR, 2007, J NUTR, V137, P1795, DOI 10.1093/jn/137.7.1795; PAPAPOSTOLOU IA, 1989, B CORRESP HELLENIQUE, V113, P351; Pearson JA, 2007, J ARCHAEOL SCI, V34, P2170, DOI 10.1016/j.jas.2007.09.001; Pearson JA, 2010, AM J PHYS ANTHROPOL, V143, P448, DOI 10.1002/ajpa.21335; Pemmer B, 2013, BONE, V57, P184, DOI 10.1016/j.bone.2013.07.038; PETERSON BJ, 1986, ECOLOGY, V67, P865, DOI 10.2307/1939809; Pietsch W, 1995, GRABUNGSBERICHT KAMP; Pietsch W, 1995, 100 JAHRE OSTERREICH; Pietsch W, 1999, STEINE WEGE FESTSCHR, P373; Pietsch W, 1995, BERICHT MAT OSTERREI, V6, P19; Plinus SC, NATURALIS HIST, V14, P72; PRICE TD, 1985, J HUM EVOL, V14, P419, DOI 10.1016/S0047-2484(85)80022-1; PRICE TD, 1986, AM J PHYS ANTHROPOL, V70, P365, DOI 10.1002/ajpa.1330700311; Privat KL, 2007, J ARCHAEOL SCI, V34, P1197, DOI 10.1016/j.jas.2006.10.008; Prowse T, 2004, J ARCHAEOL SCI, V31, P259, DOI 10.1016/j.jas.2003.08.008; Prowse TL, 2005, AM J PHYS ANTHROPOL, V128, P2, DOI 10.1002/ajpa.20094; Prowse TL, 2008, AM J PHYS ANTHROPOL, V137, P294, DOI 10.1002/ajpa.20870; Prowse TL, 2007, AM J PHYS ANTHROPOL, V132, P510, DOI 10.1002/ajpa.20541; Radosevich SC, 1993, INVESTIGATIONS ANCIE; Redfern RC, 2010, J ARCHAEOL SCI, V37, P1149, DOI 10.1016/j.jas.2009.10.022; Reuer E, 1995, VIA SACRA EPHESIACA; Reuer E, 1996, SKELETTFUNDE GRABBAU; Richards MP, 2003, J ARCHAEOL SCI, V30, P67, DOI 10.1006/jasc.2001.0825; Richards MP, 2003, INT J OSTEOARCHAEOL, V13, P37, DOI 10.1002/oa.654; Rosing FW, 2007, HOMO, V58, P75, DOI 10.1016/j.jchb.2005.07.002; Roschger P, 2010, J BONE MINER RES, V25, P891, DOI 10.1359/jbmr.091028; Sanford MK, 1993, INVESTIGATIONS ANCIE; Schlange-Schoningen H, 2003, UNTERSUCHUNGEN ANTIK, V65, P1; SCHOENINGER MJ, 1982, AM J PHYS ANTHROPOL, V58, P37, DOI 10.1002/ajpa.1330580105; SCHROEDER HA, 1972, J CHRON DIS, V25, P491, DOI 10.1016/0021-9681(72)90150-6; Schutkowski H, 1996, J ARCHAEOL SCI, V23, P823, DOI 10.1006/jasc.1996.0077; Schutkowski H, 1999, J ARCHAEOL SCI, V26, P675, DOI 10.1006/jasc.1998.0384; Schutkowski H, 1994, ARCHAOMETRIE NATURWI; Schweissing MM, 2003, J ARCHAEOL SCI, V30, P1373, DOI 10.1016/S0305-4403(03)00025-6; SILLEN A, 1986, PALEOBIOLOGY, V12, P311, DOI 10.1017/S0094837300013816; SILLEN A, 1982, Yearbook of Physical Anthropology, V25, P67; SILLEN A, 1981, AM J PHYS ANTHROPOL, V56, P131, DOI 10.1002/ajpa.1330560204; Sillen A, 1989, CHEM PREHISTORIC HUM, P211; Sjovold T., 1988, HDB VERGLEICHENDEN B, VI, P444; Smiciklas I, 2010, J NUCL MATER, V400, P15, DOI 10.1016/j.jnucmat.2010.02.004; SUHR NH, 1966, ANAL CHEM, V38, P730, DOI 10.1021/ac60238a015; Szilv?ssy Johann., 1988, ANTHR HDB VERGLEICHE, P421; Tafuri MA, 2009, AM J PHYS ANTHROPOL, V139, P146, DOI 10.1002/ajpa.20955; THURBER DL, 1958, SCIENCE, V128, P256, DOI 10.1126/science.128.3318.256; TOOTS H, 1965, SCIENCE, V149, P854, DOI 10.1126/science.149.3686.854; TUREKIAN KK, 1956, SCIENCE, V124, P405, DOI 10.1126/science.124.3218.405-a; Vika E, 2009, J ARCHAEOL SCI, V36, P2024, DOI 10.1016/j.jas.2009.05.022; Ville G., 1981, GLADIATURE OCCIDENT; White CD, 1997, AM J PHYS ANTHROPOL, V103, P185, DOI 10.1002/1096-8644(199706)103:2<185::AID-AJPA11>3.0.CO;2-#; White T.D., 1992, PREHISTORIC CANNIBAL; White T.D., 2000, HUMAN OSTEOLOGY; Wiedemann T., 1992, EMPERORS GLADIATORS	130	31	32	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110489	10.1371/journal.pone.0110489	http://dx.doi.org/10.1371/journal.pone.0110489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AX2IH	25333366	Green Published, gold			2022-12-27	WOS:000346766200121
J	Robinson, KA; Hegyi, K; Hannun, YA; Buse, MG; Sethi, JK				Robinson, Katherine A.; Hegyi, Krisztina; Hannun, Yusuf A.; Buse, Maria G.; Sethi, Jaswinder K.			Go-6976 Reverses Hyperglycemia-Induced Insulin Resistance Independently of cPKC Inhibition in Adipocytes	PLOS ONE			English	Article							PROTEIN-KINASE-C; STIMULATED GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; AKT ACTIVATION; MECHANISMS	Chronic hyperglycemia induces insulin resistance by mechanisms that are incompletely understood. One model of hyperglycemia-induced insulin resistance involves chronic preincubation of adipocytes in the presence of high glucose and low insulin concentrations. We have previously shown that the mTOR complex 1 (mTORC1) plays a partial role in the development of insulin resistance in this model. Here, we demonstrate that treatment with Go-6976, a widely used "specific" inhibitor of cPKCs, alleviates hyperglycemia-induced insulin resistance. However, the effects of mTOR inhibitor, rapamycin and Go-6976 were not additive and only rapamycin restored impaired insulin-stimulated AKT activation. Although, PKC alpha, (but not -beta) was abundantly expressed in these adipocytes, our studies indicate cPKCs do not play a major role in causing insulin-resistance in this model. There was no evidence of changes in the expression or phosphorylation of PKCa, and PKCa knock-down did not prevent the reduction of insulin-stimulated glucose transport. This was also consistent with lack of IRS-1 phosphorylation on Ser-24 in hyperglycemia-induced insulin-resistant adipocytes. Treatment with Go-6976 did inhibit a component of the mTORC1 pathway, as evidenced by decreased phosphorylation of S6 ribosomal protein. Raptor knock-down enhanced the effect of insulin on glucose transport in insulin resistant adipocytes. Go-6976 had the same effect in control cells, but was ineffective in cells with Raptor knock-down. Taken together these findings suggest that Go-6976 exerts its effect in alleviating hyperglycemia-induced insulin-resistance independently of cPKC inhibition and may target components of the mTORC1 signaling pathway.	[Hegyi, Krisztina; Sethi, Jaswinder K.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Metab Res Labs,Inst Metab Sci, Cambridge CB2 2QQ, England; [Robinson, Katherine A.; Buse, Maria G.] Med Univ S Carolina, Dept Biochem & Mol Biol, Div Diabet Endocrinol & Med Genet, Charleston, SC 29425 USA; [Robinson, Katherine A.; Buse, Maria G.] Med Univ S Carolina, Dept Med, Div Diabet Endocrinol & Med Genet, Charleston, SC 29425 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Medical University of South Carolina; Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sethi, JK (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Metab Res Labs,Inst Metab Sci, Cambridge CB2 2QQ, England.	j.sethi@oxon.org	Sethi, Jaswinder K./B-1413-2008	Sethi, Jaswinder K./0000-0003-4157-0475	Biotechnology and Biological Sciences Research Council (David Phillips Fellowship) [JF16994]; Diabetes UK [BDA:RD06/0003237]; British Heart Foundation [PG/10/38/28359]; National Institute of Diabetes and Digestive and Kidney Diseases [DK-02001]; Biotechnology and Biological Sciences Research Council [JF16994] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK002001, R01DK002001] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (David Phillips Fellowship)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diabetes UK(Diabetes UK); British Heart Foundation(British Heart Foundation); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (David Phillips Fellowship, JF16994), Diabetes UK (BDA:RD06/0003237) and British Heart Foundation (PG/10/38/28359) to J.K. Sethi and also from National Institute of Diabetes and Digestive and Kidney Diseases (DK-02001) to M.G. Buse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deshayes S, 2004, BBA-BIOMEMBRANES, V1667, P141, DOI 10.1016/j.bbamem.2004.09.010; Haxhinasto SA, 2003, J IMMUNOL, V171, P4655, DOI 10.4049/jimmunol.171.9.4655; Idris I, 2001, DIABETOLOGIA, V44, P659, DOI 10.1007/s001250051675; Mehta NN, 2009, CARDIOVASC DRUG THER, V23, P17, DOI 10.1007/s10557-008-6144-5; Mitra P, 2004, J BIOL CHEM, V279, P37431, DOI 10.1074/jbc.C400180200; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Nawaratne R, 2006, MOL ENDOCRINOL, V20, P1838, DOI 10.1210/me.2005-0536; Nelson BA, 2002, J BIOL CHEM, V277, P3809, DOI 10.1074/jbc.C100645200; Nelson BA, 2002, AM J PHYSIOL-ENDOC M, V282, pE497, DOI 10.1152/ajpendo.00438.2001; Nelson BA, 2000, DIABETES, V49, P981, DOI 10.2337/diabetes.49.6.981; Robinson KA, 2008, AM J PHYSIOL-ENDOC M, V294, pE870, DOI 10.1152/ajpendo.00644.2007; Robinson KA, 2007, AM J PHYSIOL-ENDOC M, V292, pE884, DOI 10.1152/ajpendo.00569.2006; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; YKIJARVINEN H, 1987, DIABETES, V36, P892, DOI 10.2337/diabetes.36.8.892	18	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e108963	10.1371/journal.pone.0108963	http://dx.doi.org/10.1371/journal.pone.0108963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25330241	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200013
J	Bradshaw, NJ; Bader, V; Prikulis, I; Lueking, A; Mullner, S; Korth, C				Bradshaw, Nicholas J.; Bader, Verian; Prikulis, Ingrid; Lueking, Angelika; Muellner, Stefan; Korth, Carsten			Aggregation of the Protein TRIOBP-1 and Its Potential Relevance to Schizophrenia	PLOS ONE			English	Article							ACTIN BINDING-PROTEIN; F-ACTIN; PREDICTION; RISK; HEARING; PATHWAY; IDENTIFICATION; EXPRESSION; MUTATIONS; DISORDER	We have previously proposed that specific proteins may form insoluble aggregates as a response to an illness-specific proteostatic dysbalance in a subset of brains from individuals with mental illness, as is the case for other chronic brain conditions. So far, established risk factors DISC1 and dysbindin were seen to specifically aggregate in a subset of such patients, as was a novel schizophrenia-related protein, CRMP1, identified through a condition-specific epitope discovery approach. In this process, antibodies are raised against the pooled insoluble protein fractions (aggregomes) of post mortem brain samples from schizophrenia patients, followed by epitope identification and confirmation using additional techniques. Pursuing this epitope discovery paradigm further, we reveal TRIO binding protein (TRIOBP) to be a major substrate of a monoclonal antibody with a high specificity to brain aggregomes from patients with chronic mental illness. TRIOBP is a gene previously associated with deafness which encodes for several distinct protein species, each involved in actin cytoskeletal dynamics. The 39 splice variant TRIOBP-1 is found to be the antibody substrate and has a high aggregation propensity when over-expressed in neuroblastoma cells, while the major 59 splice variant, TRIOBP-4, does not. Endogenous TRIOBP-1 can also spontaneously aggregate, doing so to a greater extent in cell cultures which are post-mitotic, consistent with aggregated TRIOBP-1 being able to accumulate in the differentiated neurons of the brain. Finally, upon expression in Neuroscreen-1 cells, aggregated TRIOBP-1 affects cell morphology, indicating that TRIOBP-1 aggregates may directly affect cell development, as opposed to simply being a by-product of other processes involved in major mental illness. While further experiments in clinical samples are required to clarify their relevance to chronic mental illness in the general population, TRIOBP-1 aggregates are thus implicated for the first time as a biological element of the neuropathology of a subset of chronic mental illness.	[Bradshaw, Nicholas J.; Bader, Verian; Prikulis, Ingrid; Korth, Carsten] Univ Dusseldorf, Dept Neuropathol, Dusseldorf, Germany; [Lueking, Angelika; Muellner, Stefan] Protagen AG, Dortmund, Germany	Heinrich Heine University Dusseldorf; Protagen Protein Services (PPS)	Bradshaw, NJ (corresponding author), Univ Dusseldorf, Dept Neuropathol, Dusseldorf, Germany.	nicholas.bradshaw@hhu.de; ckorth@hhu.de	Bradshaw, Nicholas J./A-5625-2009	Bradshaw, Nicholas J./0000-0001-5581-8828; Bader, Verian/0000-0001-5260-4728	Alexander von Humboldt Foundation; Fritz Thyssen Foundation; Forschungskommission of the Medical Faculty of the Heinrich Heine University; EU-FP6 ("cNEUPRO''); Stanley Medical Research Institute (Baltimore, Maryland, United States of America) [02R-186]; Brain Behavior and Research Foundation (NARSAD Independent Investigator Award) [20350]; NEURON-ERANET ("DISCover'') [BMBF 01EW1003]; U-FP7 (MC-ITN "IN-SENS'') [607616]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Fritz Thyssen Foundation; Forschungskommission of the Medical Faculty of the Heinrich Heine University; EU-FP6 ("cNEUPRO''); Stanley Medical Research Institute (Baltimore, Maryland, United States of America); Brain Behavior and Research Foundation (NARSAD Independent Investigator Award); NEURON-ERANET ("DISCover''); U-FP7 (MC-ITN "IN-SENS'')	This work was supported by the Alexander von Humboldt Foundation (www.humboldt-foundation.de), the Fritz Thyssen Foundation (www.fritz-thyssen-stiftung.de) and the Forschungskommission of the Medical Faculty of the Heinrich Heine University (www.medizin.hhu.de/dekanat/gremien-und-kommissionen/kommissionen/forschungskommission.html) to NJB. EU-FP6 ("cNEUPRO'', ec.europa.eu/research/fp6) to CK and SM, and the Stanley Medical Research Institute (02R-186, Baltimore, Maryland, United States of America, www.stanleyresearch.org), the Brain Behavior and Research Foundation (NARSAD Independent Investigator Award #20350, bbrfoundation.org/II), NEURON-ERANET ("DISCover'', BMBF 01EW1003, www.neuron-eranet.eu/en/196.php) and EU-FP7 (MC-ITN "IN-SENS'' #607616, ec.europa.eu/research/mariecurieactions/about-mca/actions/itn/index_en.htm) to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als TD, 2004, MOL PSYCHIATR, V9, P93, DOI 10.1038/sj.mp.4001393; ARD MD, 1985, BIOCHEM BIOPH RES CO, V133, P60, DOI 10.1016/0006-291X(85)91841-8; Atkin TA, 2012, HUM MOL GENET, V21, P2017, DOI 10.1093/hmg/dds018; Bader V, 2012, HUM MOL GENET, V21, P4406, DOI 10.1093/hmg/dds273; Bao JJ, 2013, BIOCHEMISTRY-US, V52, P5256, DOI 10.1021/bi400585h; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bradshaw Nicholas J, 2013, Biomol Concepts, V4, P447, DOI 10.1515/bmc-2013-0023; Bradshaw NJ, 2011, J NEUROSCI, V31, P9043, DOI 10.1523/JNEUROSCI.5410-10.2011; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cavallucci V, 2012, MOL NEUROBIOL, V45, P366, DOI 10.1007/s12035-012-8251-3; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; DAVID A, 1995, SCHIZOPHR RES, V14, P247, DOI 10.1016/0920-9964(94)00068-J; Diaz-Horta O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050628; Fang YP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-314; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fors A, 2013, PSYCHOL MED, V43, P2067, DOI 10.1017/S0033291712002644; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Gu X, 2015, CLIN GENET, V87, P588, DOI 10.1111/cge.12431; Hennah W, 2007, HUM MOL GENET, V16, P453, DOI 10.1093/hmg/ddl462; Hennah W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004906; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Itokawa M, 2004, PSYCHIAT CLIN NEUROS, V58, P333, DOI 10.1111/j.1440-1819.2004.01241.x; Kendler KS, 2013, MOL PSYCHIATR, V18, P1058, DOI 10.1038/mp.2013.50; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Knight HM, 2008, EUR J HUM GENET, V16, P750, DOI 10.1038/ejhg.2008.11; Korth C, 2012, PRION, V6, P134, DOI 10.4161/pri.18989; Lee YJ, 2012, BBA-MOL CELL RES, V1823, P971, DOI 10.1016/j.bbamcr.2011.12.011; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Leliveld SR, 2009, BIOCHEMISTRY-US, V48, P7746, DOI 10.1021/bi900901e; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Lueking A, 2008, BIOTECHNIQUES, V45, pPi; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moreno C, 2013, WORLD PSYCHIATRY, V12, P251, DOI 10.1002/wps.20070; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ottis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075112; Ottis P, 2011, BIOL PSYCHIAT, V70, P604, DOI 10.1016/j.biopsych.2011.03.027; Porat S, 1999, ANN NY ACAD SCI, V893, P372, DOI 10.1111/j.1749-6632.1999.tb07858.x; Presgraves SP, 2004, NEUROTOX RES, V5, P579, DOI 10.1007/bf03033178; Riazuddin S, 2006, AM J HUM GENET, V78, P137, DOI 10.1086/499164; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Seipel K, 2001, J CELL SCI, V114, P389; Shahin H, 2006, AM J HUM GENET, V78, P144, DOI 10.1086/499495; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Truyers C, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-132; Yano T, 2011, J CELL BIOL, V193, P319, DOI 10.1083/jcb.201009100; Yerabham ASK, 2013, BIOL CHEM, V394, P1425, DOI 10.1515/hsz-2013-0178; Yun SP, 2011, J CELL PHYSIOL, V226, P559, DOI 10.1002/jcp.22366; Zheng LL, 2010, J NEUROSCI, V30, P7187, DOI 10.1523/JNEUROSCI.0852-10.2010	51	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111196	10.1371/journal.pone.0111196	http://dx.doi.org/10.1371/journal.pone.0111196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333879	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200107
J	Gordy, C; Liang, J; Pua, H; He, YW				Gordy, Claire; Liang, Jie; Pua, Heather; He, You-Wen			c-FLIP Protects Eosinophils from TNF-alpha-Mediated Cell Death In Vivo	PLOS ONE			English	Article							NF-KAPPA-B; GLUCOCORTICOID-RECEPTOR; ACTIVATION; APOPTOSIS; INDUCE; NEUTROPHILS; MECHANISMS; EXPRESSION; PATHWAY; DISEASE	Understanding the signals that regulate eosinophil survival and death is critical to developing new treatments for asthma, atopy, and gastrointestinal disease. Previous studies suggest that TNF-alpha stimulation protects eosinophils from apoptosis, and this TNF-alpha-mediated protection is mediated by the upregulation of an unknown protein by NF-kappa B. Here, we show for the first time that eosinophils express the caspase 8-inhibitory protein c-FLIP, and c-FLIP expression is upregulated upon TNF-alpha stimulation. Considering that c-FLIP expression is regulated by NF-kappa B, we hypothesized that c-FLIP might serve as the "molecular switch'' that converts TNFRI activation to a pro-survival signal in eosinophils. Indeed, we found that one c-FLIP isoform, c-FLIPL, is required for mouse eosinophil survival in the presence of TNF-alpha both in vitro and in vivo. Importantly, our results suggest c-FLIP as a potential therapeutic target for the treatment of eosinophil-mediated disease.	[Gordy, Claire; Liang, Jie; Pua, Heather; He, You-Wen] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27706 USA	Duke University	Gordy, C (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27706 USA.	claire.gordy@alumni.duke.edu		Gordy, Claire/0000-0002-7379-4417	National Institutes of Health [AI073947]; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073947, T32AI052077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (http://www.nih.gov/) grant AI073947 to You-Wen He and a National Science Foundation Graduate Research Fellowship (http://www.nsfgrfp.org/) to Claire Gordy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardite E, 1998, BRIT J PHARMACOL, V124, P431, DOI 10.1038/sj.bjp.0701887; Benayoun B, 2008, FASEB J, V22, P1521, DOI 10.1096/fj.07-8701com; Bickham UR, 2013, APOPTOTIC SURVIVAL S, Vxxiii; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Dewson G, 2001, BLOOD, V98, P2239, DOI 10.1182/blood.V98.7.2239; Dohrman A, 2005, J IMMUNOL, V174, P5270, DOI 10.4049/jimmunol.174.9.5270; Fabre V, 2009, J IMMUNOL, V182, P1577, DOI 10.4049/jimmunol.182.3.1577; Fujihara S, 2002, EUR J IMMUNOL, V32, P457, DOI 10.1002/1521-4141(200202)32:2<457::AID-IMMU457>3.0.CO;2-1; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Gebreselassie NG, 2012, J IMMUNOL, V188, P417, DOI 10.4049/jimmunol.1101980; Gordy C, 2011, BLOOD, V117, P618, DOI 10.1182/blood-2010-01-265959; Ilmarinen Pinja, 2014, J Cell Death, V7, P1, DOI 10.4137/JCD.S13588; Kanetaka Y, 2008, EXP CELL RES, V314, P246, DOI 10.1016/j.yexcr.2007.10.001; Kankaanranta H, 2006, MOL PHARMACOL, V69, P1861, DOI 10.1124/mol.105.021170; Kankaanranta H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090298; Kankaanranta H, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-9; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Koenig A, 2013, J BIOL CHEM; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Meagher LC, 1996, J IMMUNOL, V156, P4422; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; Niazi S, 2003, CHEST, V123, p345S, DOI 10.1378/chest.123.3_suppl.345S; Nittoh T, 1998, EUR J PHARMACOL, V354, P73, DOI 10.1016/S0014-2999(98)00426-9; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Segal M, 2007, IMMUNOL CELL BIOL, V85, P518, DOI 10.1038/sj.icb.7100075; Shen HHH, 2003, J IMMUNOL, V170, P3296, DOI 10.4049/jimmunol.170.6.3296; VANDESTOLPE A, 1994, J BIOL CHEM, V269, P6185; Wilson SJ, 2001, AM J RESP CRIT CARE, V164, P1047, DOI 10.1164/ajrccm.164.6.2010045; Zhang N, 2008, J IMMUNOL, V180, P5506, DOI 10.4049/jimmunol.180.8.5506; Zhang XZ, 2002, LIFE SCI, V71, P1523, DOI 10.1016/S0024-3205(02)01921-5	36	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e107724	10.1371/journal.pone.0107724	http://dx.doi.org/10.1371/journal.pone.0107724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333625	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200004
J	Poinhos, R; van der Lans, IA; Rankin, A; Fischer, ARH; Bunting, B; Kuznesof, S; Stewart-Knox, B; Frewer, LJ				Poinhos, Rui; van der Lans, Ivo A.; Rankin, Audrey; Fischer, Arnout R. H.; Bunting, Brendan; Kuznesof, Sharron; Stewart-Knox, Barbara; Frewer, Lynn J.			Psychological Determinants of Consumer Acceptance of Personalised Nutrition in 9 European Countries	PLOS ONE			English	Article							SELF-EFFICACY; PROTECTION MOTIVATION; HEALTH BEHAVIOR; CARDIOVASCULAR-DISEASE; PREDICTIVE-VALIDITY; PLANNED BEHAVIOR; FEAR APPEALS; FOOD CHOICE; RISK; TRUST	Objective: To develop a model of the psychological factors which predict people's intention to adopt personalised nutrition. Potential determinants of adoption included perceived risk and benefit, perceived self-efficacy, internal locus of control and health commitment. Methods: A questionnaire, developed from exploratory study data and the existing theoretical literature, and including validated psychological scales was administered to N = 9381 participants from 9 European countries (Germany, Greece, Ireland, Poland, Portugal, Spain, the Netherlands, the UK, and Norway). Results: Structural equation modelling indicated that the greater participants' perceived benefits to be associated with personalised nutrition, the more positive their attitudes were towards personalised nutrition, and the greater their intention to adopt it. Higher levels of nutrition self-efficacy were related to more positive attitudes towards, and a greater expressed intention to adopt, personalised nutrition. Other constructs positively impacting attitudes towards personalised nutrition included more positive perceptions of the efficacy of regulatory control to protect consumers (e.g. in relation to personal data protection), higher self-reported internal health locus of control, and health commitment. Although higher perceived risk had a negative relationship with attitude and an inverse relationship with perceived benefit, its effects on attitude and intention to adopt personalised nutrition was less influential than perceived benefit. The model was stable across the different European countries, suggesting that psychological factors determining adoption of personalised nutrition have generic applicability across different European countries. Conclusion: The results suggest that transparent provision of information about potential benefits, and protection of consumers' personal data is important for adoption, delivery of public health benefits, and commercialisation of personalised nutrition.	[Poinhos, Rui] Univ Porto, Fac Nutr & Food Sci, P-4100 Oporto, Portugal; [van der Lans, Ivo A.; Fischer, Arnout R. H.] Wageningen Univ, Mkt & Consumer Behav Grp, NL-6700 AP Wageningen, Netherlands; [Rankin, Audrey] Univ Ulster, Northern Ireland Ctr Food & Hlth, Coleraine BT52 1SA, Londonderry, North Ireland; [Bunting, Brendan] Univ Ulster, Sch Psychol, Coleraine BT52 1SA, Londonderry, North Ireland; [Kuznesof, Sharron; Frewer, Lynn J.] Newcastle Univ, SAFRD, Food & Soc Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Stewart-Knox, Barbara] Univ Bradford, Div Psychol, Bradford BD7 1DP, W Yorkshire, England	Universidade do Porto; Wageningen University & Research; Ulster University; Ulster University; Newcastle University - UK; University of Bradford	Frewer, LJ (corresponding author), Newcastle Univ, SAFRD, Food & Soc Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Lynn.Frewer@newcastle.ac.uk	van der Lans, Ivo A/G-5800-2011; Fischer, Arnout R.H/B-9589-2009; RANKIN, AUDREY/E-5875-2018	van der Lans, Ivo A/0000-0003-3351-1379; Fischer, Arnout R.H/0000-0003-0474-5336; RANKIN, AUDREY/0000-0002-3241-0536; Stewart-Knox, Barbara/0000-0002-6741-3657; Poinhos, Rui/0000-0002-9177-6423	European Union's Seventh Framework Programme [265494]; MRC [MR/K023241/1] Funding Source: UKRI; Medical Research Council [MR/K023241/1] Funding Source: researchfish	European Union's Seventh Framework Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 265494 (http://cordis.europa.eu/fp7/home_en.html). Food4Me is the acronym of the project "Personalised nutrition: an integrated analysis of opportunities and challenges" (http://www.food4me.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2014, OBES REV, V15, P49, DOI 10.1111/obr.12123; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; ALHAKAMI AS, 1994, RISK ANAL, V14, P1085, DOI 10.1111/j.1539-6924.1994.tb00080.x; Anderson ES, 2000, HEALTH PSYCHOL, V19, P479, DOI 10.1037/0278-6133.19.5.479; Martinez-Gonzalez MA, 2014, CURR OPIN LIPIDOL, V25, P20, DOI 10.1097/MOL.0000000000000044; Armitage CJ, 1999, BRIT J SOC PSYCHOL, V38, P35, DOI 10.1348/014466699164022; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bentler PM, 2009, PSYCHOMETRIKA, V74, P137, DOI 10.1007/s11336-008-9100-1; Boland M, 2008, INNOV-MANAG POLICY P, V10, P53, DOI 10.5172/impp.453.10.1.53; Carter P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4229; Cohen M, 2007, ETHNIC DIS, V17, P636; Conner M, 2006, FRONT NUTR SCI, P41, DOI 10.1079/9780851990323.0041; Costa-Font M, 2009, FOOD QUAL PREFER, V20, P399, DOI 10.1016/j.foodqual.2009.02.011; CRITES SL, 1994, PERS SOC PSYCHOL B, V20, P619, DOI 10.1177/0146167294206001; de Almeida MDV, 2006, NUTR BULL, V31, P239, DOI 10.1111/j.1467-3010.2006.00576.x; de Jonge J, 2007, RISK ANAL, V27, P729, DOI 10.1111/j.1539-6924.2007.00917.x; Dunn KI, 2011, APPETITE, V57, P349, DOI 10.1016/j.appet.2011.06.004; Eagly A. H., 1993, PSYCHOL ATTITUDES; Fischer ARH, 2009, FOOD QUAL PREFER, V20, P576, DOI 10.1016/j.foodqual.2009.06.008; Flavian C, 2006, IND MANAGE DATA SYST, V106, P601, DOI 10.1108/02635570610666403; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; Freedman MR, 2011, J AM COLL HEALTH, V59, P205, DOI 10.1080/07448481.2010.502203; Frewer LJ, 2011, TRENDS FOOD SCI TECH, V22, P442, DOI 10.1016/j.tifs.2011.05.005; Frewer LJ, 2003, RISK ANAL, V23, P1117, DOI 10.1111/j.0272-4332.2003.00385.x; Frewer LJ, 1996, RISK ANAL, V16, P473, DOI 10.1111/j.1539-6924.1996.tb01094.x; Frewer LJ, 1998, RISK ANAL, V18, P95, DOI 10.1111/j.1539-6924.1998.tb00919.x; FREWER LJ, 1994, J FOOD SAFETY, V14, P19, DOI 10.1111/j.1745-4565.1994.tb00581.x; Friese M, 2008, BRIT J SOC PSYCHOL, V47, P397, DOI 10.1348/014466607X241540; Gebhardt WA, 2001, HEALTH EDUC RES, V16, P579, DOI 10.1093/her/16.5.579; Gibney MJ, 1997, EUR J CLIN NUTR, V51, pS57; Gittelsohn J, 2006, J NUTR EDUC BEHAV, V38, P163, DOI 10.1016/j.jneb.2005.12.004; Grunert K. G., 2004, Agribusiness (New York), V20, P95, DOI 10.1002/agr.10086; Grunert K. G., 2003, Innovative Food Science & Emerging Technologies, V4, P435, DOI 10.1016/S1466-8564(03)00035-3; Grunert KG, 2002, TRENDS FOOD SCI TECH, V13, P275, DOI 10.1016/S0924-2244(02)00137-1; Hair J., 2010, MULTIVARIATE DATA AN, V7; Horst M, 2007, COMPUT HUM BEHAV, V23, P1838, DOI 10.1016/j.chb.2005.11.003; Hurlimann T, 2014, GENES NUTR, V9, DOI 10.1007/s12263-013-0370-6; Madden J, 2011, ANNU REV NUTR, V31, P203, DOI 10.1146/annurev-nutr-010411-095239; MADDUX JE, 1983, J EXP SOC PSYCHOL, V19, P469, DOI 10.1016/0022-1031(83)90023-9; Marshall S, 2014, J HUM NUTR IN PRESS; Mead E, 2010, J HUM NUTR DIET, V23, P92, DOI 10.1111/j.1365-277X.2010.01095.x; Melnyk V, 2011, PSYCHOL MARKET, V28, P709, DOI 10.1002/mar.20408; Miles S, 2003, NUTR RES REV, V16, P3, DOI 10.1079/NRR200249; Nordstrom K, 2013, ETHICS CONSUMPTION C, P321; Norman P., 1996, PREDICTING HLTH BEHA, P62; Oliver RL, 1997, J RETAILING, V73, P311, DOI 10.1016/S0022-4359(97)90021-X; Organization WH, 2016, GLOBAL STATUS REPORT; Ouhtit A, 2014, SULTAN QABOOS U MED, V14, pe1; Petrovici D, 2012, BRIT FOOD J, V114, P768, DOI 10.1108/00070701211234318; Pin RR, 2009, THESIS TWENTE U NETH; Poortinga W, 2003, RISK ANAL, V23, P961, DOI 10.1111/1539-6924.00373; Popa ME, 2012, NOVEL TECHNOLOGIES F, P137, DOI [10.1007/978-1-4419-7880-6_6, DOI 10.1007/978-1-4419-7880-6_6]; Povey R, 2000, BRIT J HEALTH PSYCH, V5, P121, DOI 10.1348/135910700168810; Reedy J, 2014, J NUTR, V144, P881, DOI 10.3945/jn.113.189407; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Ronteltap A, 2007, APPETITE, V49, P1, DOI 10.1016/j.appet.2007.02.002; Ronteltap A, 2013, GENES NUTR, V8, P153, DOI 10.1007/s12263-012-0308-4; Ronteltap A, 2011, J NANOPART RES, V13, P4399, DOI 10.1007/s11051-011-0473-1; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Satorra A., 1988, AM STAT ASS 1988 P B, P308; Satorra A., 1994, LATENT VARIABLES ANA, P399, DOI DOI 10.2307/2291370; Schwarzer R, 2000, HEALTH PSYCHOL, V19, P487, DOI 10.1037/0278-6133.19.5.487; Shepherd R, 1999, P NUTR SOC, V58, P807, DOI 10.1017/S0029665199001093; Siegrist M, 2000, RISK ANAL, V20, P353, DOI 10.1111/0272-4332.203034; Siegrist M, 2000, RISK ANAL, V20, P195, DOI 10.1111/0272-4332.202020; Steenkamp JBEM, 1998, J CONSUM RES, V25, P78, DOI 10.1086/209528; Steenkamp JBEM, 2002, INT J RES MARK, V19, P185, DOI 10.1016/S0167-8116(02)00076-9; Stewart-Knox B, 2013, APPETITE, V66, P67, DOI 10.1016/j.appet.2013.03.001; Stewart-Knox BJ, 2009, BRIT J NUTR, V101, P982, DOI 10.1017/S0007114508055657; STRECHER VJ, 1986, HEALTH EDUC QUART, V13, P73, DOI 10.1177/109019818601300108; Tarkiainen A, 2005, BRIT FOOD J, V107, P808, DOI 10.1108/00070700510629760; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; van Dijk H, 2011, RISK ANAL, V31, P429, DOI 10.1111/j.1539-6924.2010.01505.x; Verbeke W, 2005, PUBLIC HEALTH NUTR, V8, P422, DOI 10.1079/PHN2004697; Vergeres G, 2013, TRENDS FOOD SCI TECH, V31, P6, DOI 10.1016/j.tifs.2013.02.002; Walker SN, 2006, WESTERN J NURS RES, V28, P449, DOI 10.1177/0193945906286613; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; Williams LK, 2012, APPETITE, V59, P41, DOI 10.1016/j.appet.2012.03.014; Yang YY, 2011, J PSYCHOEDUC ASSESS, V29, P377, DOI 10.1177/0734282911406668	83	37	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110614	10.1371/journal.pone.0110614	http://dx.doi.org/10.1371/journal.pone.0110614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR7AB	25334009	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200060
J	Shin, J; Bataille, A; Kosch, TA; Waldman, B				Shin, Jaehyub; Bataille, Arnaud; Kosch, Tiffany A.; Waldman, Bruce			Swabbing Often Fails to Detect Amphibian Chytridiomycosis under Conditions of Low Infection Load	PLOS ONE			English	Article							FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; CHYTRID FUNGUS; EXTINCTION; MADAGASCAR; EMERGENCE; PATHOGEN; DECLINES; ASSAY; DNA	The pathogenic chytrid fungus, Batrachochytrium dendrobatidis (denoted Bd), causes large-scale epizootics in naive amphibian populations. Intervention strategies to rapidly respond to Bd incursions require sensitive and accurate diagnostic methods. Chytridiomycosis usually is assessed by quantitative polymerase chain reaction (qPCR) amplification of amphibian skin swabs. Results based on this method, however, sometimes yield inconsistent results on infection status and inaccurate scores of infection intensity. In Asia and other regions where amphibians typically bear low Bd loads, swab results are least reliable. We developed a Bd-sampling method that collects zoospores released by infected subjects into an aquatic medium. Bd DNA is extracted by filters and amplified by nested PCR. Using laboratory colonies and field populations of Bombina orientalis, we compare results with those obtained on the same subjects by qPCR of DNA extracted from swabs. Many subjects, despite being diagnosed as Bd-negative by conventional methods, released Bd zoospores into collection containers and thus must be considered infected. Infection loads determined from filtered water were at least 1000 times higher than those estimated from swabs. Subjects significantly varied in infection load, as they intermittently released zoospores, over a 5-day period. Thus, the method might be used to compare the infectivity of individuals and study the periodicity of zoospore release. Sampling methods based on water filtration can dramatically increase the capacity to accurately diagnose chytridiomycosis and contribute to a better understanding of the interactions between Bd and its hosts.	[Shin, Jaehyub; Bataille, Arnaud; Kosch, Tiffany A.; Waldman, Bruce] Seoul Natl Univ, Sch Biol Sci, Lab Behav & Populat Ecol, Seoul, South Korea	Seoul National University (SNU)	Waldman, B (corresponding author), Seoul Natl Univ, Sch Biol Sci, Lab Behav & Populat Ecol, Seoul, South Korea.	waldman@snu.ac.kr	Kosch, Tiffany A/A-3110-2017; Waldman, Bruce/A-1269-2009	Kosch, Tiffany A/0000-0001-5158-5748; Waldman, Bruce/0000-0003-0006-5333; Bataille, Arnaud/0000-0002-3508-2144	National Research Foundation of Korea (NRF) - government of the Republic of Korea (MSIP) [2010-0002767, 2012R1A1A2044449, 2012K1A2B1A03000496]; Seoul National University (Brain Fusion Program); Seoul National University (Brain Korea 21 Program); Seoul National University (New Faculty Resettlement Fund)	National Research Foundation of Korea (NRF) - government of the Republic of Korea (MSIP); Seoul National University (Brain Fusion Program); Seoul National University (Brain Korea 21 Program); Seoul National University (New Faculty Resettlement Fund)	The research was supported by the National Research Foundation of Korea (NRF), funded by the government of the Republic of Korea (MSIP) (grants 2010-0002767, 2012R1A1A2044449, and 2012K1A2B1A03000496 to BW), and by Seoul National University (Brain Fusion Program, Brain Korea 21 Program, and New Faculty Resettlement Fund grants to BW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Bai CM, 2012, DIVERS DISTRIB, V18, P307, DOI 10.1111/j.1472-4642.2011.00878.x; Balaz V, 2014, CONSERV BIOL, V28, P213, DOI 10.1111/cobi.12128; Bataille A, 2013, MOL ECOL, V22, P4196, DOI 10.1111/mec.12385; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2002, DIS AQUAT ORGAN, V48, P213, DOI 10.3354/dao048213; Berger L., 1999, ZOOS PRINT J, V15, P184, DOI DOI 10.11609/JOTT.ZPJ.15.1.184-90; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carver S, 2010, COPEIA, P487, DOI 10.1643/CH-09-128; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Cunningham AA, 2003, J PARASITOL, V89, P78; Dahanukar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077528; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Gandola R, 2013, HERPETOL J, V23, P233; Gilbert M, 2012, ECOHEALTH, V9, P386, DOI 10.1007/s10393-013-0817-7; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Hyman OJ, 2012, DIS AQUAT ORGAN, V97, P185, DOI 10.3354/dao02423; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Kirshtein JD, 2007, DIS AQUAT ORGAN, V77, P11, DOI 10.3354/dao01831; Kolby JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089660; Kolby JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090750; Kosch TA, 2013, MOL ECOL RESOUR, V13, P230, DOI 10.1111/1755-0998.12041; Kriger KM, 2007, DIS AQUAT ORGAN, V73, P257, DOI 10.3354/dao073257; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P149, DOI 10.3354/dao071149; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P141, DOI 10.3354/dao071141; Lehtinen Richard M., 2008, Herpetological Review, V39, P317; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059499; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Pessier A. P., 2010, MANUAL CONTROL INFEC; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Roberts SH, 2014, SALAMANDRA, V50, P18; Rowley JJL, 2007, DIS AQUAT ORGAN, V78, P87, DOI 10.3354/dao01861; Rowley Jodi J. L., 2013, Herpetological Review, V44, P466; Savage AE, 2011, ECOHEALTH, V8, P121, DOI 10.1007/s10393-011-0685-y; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Smith KG, 2007, DIS AQUAT ORGAN, V73, P253, DOI 10.3354/dao073253; Swei A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023179; Van Rooij P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041481; Venesky MD, 2014, BIOL REV, V89, P477, DOI 10.1111/brv.12064; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Voros J, 2012, HERPETOL NOTES, V5, P519; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Waldman B, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P394; Weldon C, 2013, ECOHEALTH, V10, P234, DOI 10.1007/s10393-013-0869-8; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	53	28	28	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111091	10.1371/journal.pone.0111091	http://dx.doi.org/10.1371/journal.pone.0111091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333363	Green Published, Green Accepted, gold			2022-12-27	WOS:000343731200102
J	Siddiqui, S; Chattopadhyay, S; Akhtar, MS; Najm, MZ; Deo, SVS; Shukla, NK; Husain, SA				Siddiqui, Sarah; Chattopadhyay, Shilpi; Akhtar, Md. Salman; Najm, Mohammad Zeeshan; Deo, S. V. S.; Shukla, N. K.; Husain, Syed Akhtar			A Study on Genetic Variants of Fibroblast Growth Factor Receptor 2 (FGFR2) and the Risk of Breast Cancer from North India	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AFRICAN-AMERICAN; REPRODUCTIVE FACTORS; SUSCEPTIBILITY LOCI; POLYGENIC SUSCEPTIBILITY; FEMALE BREAST; POLYMORPHISMS; ESTROGEN; WOMEN; POPULATION	Genome-Wide Association Studies (GWAS) have identified Fibroblast growth factor receptor 2 (FGFR2) as a candidate gene for breast cancer with single nucleotide polymorphisms (SNPs) located in intron 2 region as the susceptibility loci strongly associated with the risk. However, replicate studies have often failed to extrapolate the association to diverse ethnic regions. This hints towards the existing heterogeneity among different populations, arising due to differential linkage disequilibrium (LD) structures and frequencies of SNPs within the associated regions of the genome. It is therefore important to revisit the previously linked candidates in varied population groups to unravel the extent of heterogeneity. In an attempt to investigate the role of FGFR2 polymorphisms in susceptibility to the risk of breast cancer among North Indian women, we genotyped rs2981582, rs1219648, rs2981578 and rs7895676 polymorphisms in 368 breast cancer patients and 484 healthy controls by Polymerase chain reaction-Restriction fragment length polymorphism (PCR-RFLP) assay. We observed a statistically significant association with breast cancer risk for all the four genetic variants (P < 0.05). In per-allele model for rs2981582, rs1219648, rs7895676 and in dominant model for rs2981578, association remained significant after bonferroni correction (P < 0.0125). On performing stratified analysis, significant correlations with various clinicopathological as well as environmental and lifestyle characteristics were observed. It was evident that rs1219648 and rs2981578 interacted with exogenous hormone use and advanced clinical stage III (after Bonferroni correction, P < 0.000694), respectively. Furthermore, combined analysis on these four loci revealed that compared to women with 0-1 risk loci, those with 2-4 risk loci had increased risk (OR = 1.645, 95% CI = 1.152-2.347, P = 0.006). In haplotype analysis, for rs2981578, rs2981582 and rs1219648, risk haplotype (GTG) was associated with a significantly increased risk compared to the common (ACA) haplotype (OR = 1.365, 95% CI = 1.086-1.717, P = 0.008). Our results suggest that intron 2 SNPs of FGFR2 may contribute to genetic susceptibility of breast cancer in North India population.	[Siddiqui, Sarah; Chattopadhyay, Shilpi; Akhtar, Md. Salman; Najm, Mohammad Zeeshan; Husain, Syed Akhtar] Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India; [Deo, S. V. S.; Shukla, N. K.] All India Inst Med Sci, Dept Surg Oncol, New Delhi, India	Jamia Millia Islamia; All India Institute of Medical Sciences (AIIMS) New Delhi	Husain, SA (corresponding author), Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India.	akhtarhusain2000@yahoo.com			University Grants Commission (UGC); Council of Scientific and Industrial Research (CSIR) [09/466(0127)/2010-EMR-I]	University Grants Commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Financial support for the production of the manuscript was provided by University Grants Commission (UGC) to Department of Biotechnology, Jamia Millia Islamia and Council of Scientific and Industrial Research (CSIR) to S. Siddiqui as scholarship under Grant No. File No. 09/466(0127)/2010-EMR-I. UGC (http://www.ugc.ac.in/) CSIR (http://csirhrdg.res.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADNANE J, 1991, ONCOGENE, V6, P659; Agarwal G, 2007, WORLD J SURG, V31, P1031, DOI 10.1007/s00268-005-0585-9; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Anderson BO, 2008, WORLD J SURG, V32, P2578, DOI 10.1007/s00268-007-9454-z; [Anonymous], 2009, LANCET, V374, P1567, DOI 10.1016/S0140-6736(09)61930-9; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Bai AL, 2010, CANCER RES, V70, P7630, DOI 10.1158/0008-5472.CAN-10-1489; Barnholtz-Sloan JS, 2010, CARCINOGENESIS, V31, P1417, DOI 10.1093/carcin/bgq128; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Boyarskikh UA, 2009, EUR J HUM GENET, V17, P1688, DOI 10.1038/ejhg.2009.98; Bray F, 2004, BREAST CANCER RES, V6, P229, DOI 10.1186/bcr932; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cha JY, 2008, MOL CANCER RES, V6, P435, DOI 10.1158/1541-7786.MCR-07-0187; Chakravarti A, 1998, NAT GENET, V19, P216, DOI 10.1038/885; Chan M, 2012, BREAST CANCER RES TR, V136, P209, DOI 10.1007/s10549-012-2234-y; Chen F, 2012, IMMUNOGENETICS, V64, P71, DOI 10.1007/s00251-011-0564-2; Chen XH, 2011, BREAST CANCER RES TR, V125, P575, DOI 10.1007/s10549-010-1032-7; Chen YC, 2005, CA-CANCER J CLIN, V55, P45, DOI 10.3322/canjclin.55.1.45; Clavel-Chapelon F, 2002, BRIT J CANCER, V86, P723, DOI 10.1038/sj.bjc.6600124; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Dillon C, 2004, J MAMMARY GLAND BIOL, V9, P207, DOI 10.1023/B:JOMG.0000037163.56461.1e; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fu FM, 2012, TOHOKU J EXP MED, V226, P221, DOI 10.1620/tjem.226.221; Gajalakshmi V, 2009, INT J CANCER, V125, P662, DOI 10.1002/ijc.24429; Gao YT, 2000, INT J CANCER, V87, P295, DOI 10.1002/1097-0215(20000715)87:2<295::AID-IJC23>3.0.CO;2-7; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Ghoussaini M, 2009, FUTURE ONCOL, V5, P689, DOI [10.2217/fon.09.29, 10.2217/FON.09.29]; Green M, 2008, ASIA-PAC J CLIN ONCO, V4, pS5, DOI 10.1111/j.1743-7563.2008.00191.x; Haugsten EM, 2010, MOL CANCER RES, V8, P1439, DOI 10.1158/1541-7786.MCR-10-0168; Hemminki K, 2010, INT J CANCER, V126, P2858, DOI 10.1002/ijc.24986; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Huijts PEA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1793; Huijts PEA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2917; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Huo DZ, 2012, CARCINOGENESIS, V33, P835, DOI 10.1093/carcin/bgs093; Hynes NE, 2010, CANCER RES, V70, P5199, DOI 10.1158/0008-5472.CAN-10-0918; Ingersoll RG, 2001, CYTOGENET CELL GENET, V94, P121, DOI 10.1159/000048802; Jang JH, 2001, CANCER RES, V61, P3541; Jara L, 2013, BREAST CANCER RES TR, V137, P559, DOI 10.1007/s10549-012-2359-z; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katoh M, 2008, INT J ONCOL, V33, P233, DOI 10.3892/ijo_00000001; Kawase T, 2009, INT J CANCER, V125, P1946, DOI 10.1002/ijc.24505; Key T, 2002, JNCI-J NATL CANCER I, V94, P606, DOI DOI 10.1093/JNCI/94.8.606; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Leong SPL, 2010, WORLD J SURG, V34, P2308, DOI 10.1007/s00268-010-0683-1; Liang J, 2008, CARCINOGENESIS, V29, P2341, DOI 10.1093/carcin/bgn235; Long JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058350; LUQMANI YA, 1992, BRIT J CANCER, V66, P273, DOI 10.1038/bjc.1992.256; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; Mehrian-Shai R, 2004, MOL GENET METAB, V83, P47, DOI 10.1016/j.ymgme.2004.07.014; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Moffa AB, 2004, MOL CANCER RES, V2, P643; Moffa AB, 2007, J CELL PHYSIOL, V210, P720, DOI 10.1002/jcp.20880; Murthy NS, 2007, EUR J CANCER CARE, V16, P185, DOI 10.1111/j.1365-2354.2006.00761.x; Nandakumar A, 2010, INDIA J SURG ONCOL, V1, P8, DOI 10.1007/s13193-010-0004-z; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; RAO DN, 1994, BRIT J CANCER, V70, P129, DOI 10.1038/bjc.1994.261; Raskin L, 2008, CANCER EPIDEM BIOMAR, V17, P1060, DOI 10.1158/1055-9965.EPI-08-0018; Rebbeck TR, 2009, CARCINOGENESIS, V30, P269, DOI 10.1093/carcin/bgn247; Sambrook J., 2001, MOL CLONING LAB MANU; Samson M, 2009, ASIAN PAC J CANCER P, V10, P111; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Takiar R, 2008, ASIAN PAC J CANCER P, V9, P777; Tannheimer SL, 2000, BREAST CANCER RES, V2, P311, DOI 10.1186/bcr73; Tavani A, 1999, EUR J CANCER, V35, P1361, DOI 10.1016/S0959-8049(99)00139-2; Taylor JG, 2001, TRENDS MOL MED, V7, P507, DOI 10.1016/S1471-4914(01)02183-9; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Tozlu S, 2006, ENDOCR-RELAT CANCER, V13, P1109, DOI 10.1677/erc.1.01120; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Wang H, 2013, BREAST CANCER RES TR, V137, P511, DOI 10.1007/s10549-012-2343-7; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Yeole BB, 2008, ASIAN PAC J CANCER P, V9, P119; Zang XP, 2001, CLIN EXP METASTAS, V18, P573; Zhao WM, 2010, CLIN CANCER RES, V16, P5750, DOI 10.1158/1078-0432.CCR-10-0531; Zheng W, 2009, CANCER EPIDEM BIOMAR, V18, P2761, DOI 10.1158/1055-9965.EPI-09-0624	87	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110426	10.1371/journal.pone.0110426	http://dx.doi.org/10.1371/journal.pone.0110426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333473	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200039
J	Chen, DY; Jiao, Y; Torquato, S				Chen, Duyu; Jiao, Yang; Torquato, Salvatore			A Cellular Automaton Model for Tumor Dormancy: Emergence of a Proliferative Switch	PLOS ONE			English	Article							SOLID TUMOR; MATHEMATICAL-MODEL; IMMUNE COMPETITION; MAMMARY-CARCINOMA; ANGIOGENIC SWITCH; CANCER DORMANCY; PROSTATE-CANCER; LEUKEMIC-CELLS; GROWTH; MECHANISMS	Malignant cancers that lead to fatal outcomes for patients may remain dormant for very long periods of time. Although individual mechanisms such as cellular dormancy, angiogenic dormancy and immunosurveillance have been proposed, a comprehensive understanding of cancer dormancy and the "switch'' from a dormant to a proliferative state still needs to be strengthened from both a basic and clinical point of view. Computational modeling enables one to explore a variety of scenarios for possible but realistic microscopic dormancy mechanisms and their predicted outcomes. The aim of this paper is to devise such a predictive computational model of dormancy with an emergent "switch'' behavior. Specifically, we generalize a previous cellular automaton (CA) model for proliferative growth of solid tumor that now incorporates a variety of cell-level tumor-host interactions and different mechanisms for tumor dormancy, for example the effects of the immune system. Our new CA rules induce a natural "competition'' between the tumor and tumor suppression factors in the microenvironment. This competition either results in a "stalemate'' for a period of time in which the tumor either eventually wins (spontaneously emerges) or is eradicated; or it leads to a situation in which the tumor is eradicated before such a "stalemate'' could ever develop. We also predict that if the number of actively dividing cells within the proliferative rim of the tumor reaches a critical, yet low level, the dormant tumor has a high probability to resume rapid growth. Our findings may shed light on the fundamental understanding of cancer dormancy.	[Chen, Duyu; Torquato, Salvatore] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Chen, Duyu; Jiao, Yang; Torquato, Salvatore] Princeton Univ, Phys Sci Oncol Ctr, Princeton, NJ 08544 USA; [Jiao, Yang] Arizona State Univ, Tempe, AZ USA; [Torquato, Salvatore] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Torquato, Salvatore] Princeton Univ, Program Appl & Computat Math, Princeton, NJ 08544 USA; [Torquato, Salvatore] Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton, NJ 08544 USA	Princeton University; Princeton University; Arizona State University; Arizona State University-Tempe; Princeton University; Princeton University; Princeton University	Torquato, S (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	torquato@electron.princeton.edu	Chen, Duyu/S-6953-2019	Chen, Duyu/0000-0002-4962-8013	National Cancer Institute [U54CA143803]; NATIONAL CANCER INSTITUTE [U54CA143803] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research described was supported by the National Cancer Institute under Award NO. U54CA143803 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Barkan D, 2011, JOVE-J VIS EXP, DOI 10.3791/2914; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Bellomo N, 2008, PHYS LIFE REV, V5, P183, DOI 10.1016/j.plrev.2008.07.001; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Bos PD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005283; Brazzoli I, 2010, MATH METHOD APPL SCI, V33, P733, DOI 10.1002/mma.1190; BURTON AC, 1966, GROWTH, V30, P157; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; Chaterjee M, 2011, BONE MARROW RES, DOI 10.1155/2011/362938; De Angelis E, 2008, MATH COMPUT MODEL, V47, P196, DOI 10.1016/j.mcm.2007.02.016; ENGLAND DM, 1989, AM J SURG PATHOL, V13, P640, DOI 10.1097/00000478-198908000-00003; Finn OJ, 2006, IMMUNOL RES, V36, P73, DOI 10.1385/IR:36:1:73; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; GREENSPAN HP, 1972, STUD APPL MATH, V51, P317; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HOFFMAN HJ, 1980, NEUROSURGERY, V7, P243, DOI 10.1227/00006123-198009000-00007; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Jiao Y, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052707; Jiao Y, 2012, AIP ADV, V2, DOI 10.1063/1.3697959; Jiao Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002314; Kansal AR, 2000, BIOSYSTEMS, V55, P119, DOI 10.1016/S0303-2647(99)00089-1; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kim Y, 2007, MATH MOD METH APPL S, V17, P1773, DOI 10.1142/S0218202507002479; Kleffel S, 2013, ADV EXP MED BIOL, V734, P145, DOI 10.1007/978-1-4614-1445-2_8; Klein CA, 2013, NATURE, V501, P365, DOI 10.1038/nature12628; Kloxin AM, 2010, ADV MATER, V22, P61, DOI 10.1002/adma.200900917; KRAHENBUHL JL, 1976, CELL IMMUNOL, V25, P279, DOI 10.1016/0008-8749(76)90118-0; Kusumbe AP, 2009, CANCER RES, V69, P9245, DOI 10.1158/0008-5472.CAN-09-2802; Kuznetsov VA, 2001, MATH COMPUT MODEL, V33, P1275, DOI 10.1016/S0895-7177(00)00314-9; LEFEVER R, 1979, B MATH BIOL, V41, P469, DOI 10.1016/S0092-8240(79)80003-8; MAHALEY MS, 1989, J NEUROSURG, V71, P826, DOI 10.3171/jns.1989.71.6.0826; Marches R, 2006, CELL CYCLE, V5, P1772, DOI 10.4161/cc.5.16.2995; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; MATSUZAWA A, 1991, INT J CANCER, V49, P303, DOI 10.1002/ijc.2910490227; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c; Owen MR, 2004, J THEOR BIOL, V226, P377, DOI 10.1016/j.jtbi.2003.09.004; Page KM, 2005, LEUKEMIA LYMPHOMA, V46, P313, DOI 10.1080/10428190400011625; Pfitzenmaier J, 2006, BJU INT, V97, P1309, DOI 10.1111/j.1464-410X.2006.06194.x; Quaranta V, 2008, SEMIN CANCER BIOL, V18, P338, DOI 10.1016/j.semcancer.2008.03.018; Quesnel B, 2008, CANCER LETT, V267, P10, DOI 10.1016/j.canlet.2008.02.055; Saudemont A, 2004, BLOOD, V104, P2124, DOI 10.1182/blood-2004-01-0064; Schmitz JE, 2002, COMPUT MATH METHOD M, V4, P223, DOI [DOI 10.1080/1027366031000086674, 10.1080/1027366031000086674]; Seewaldt V, 2014, NAT MED, V20, P332, DOI 10.1038/nm.3523; Smallbone K, 2005, J THEOR BIOL, V235, P476, DOI 10.1016/j.jtbi.2005.02.001; Takayanagi T, 2006, INF MEDIA TECHNOL, V1, P780; Torquato S., 2002, APPL MECH REV, V55, pB62, DOI [10.1115/1.1483342, DOI 10.1115/1.1483342]; Torquato S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015017; Uhr JW, 1997, NAT MED, V3, P505, DOI 10.1038/nm0597-505; Weckermann D, 2001, J UROLOGY, V166, P699, DOI 10.1016/S0022-5347(05)66046-6; WEINHOLD KJ, 1979, J EXP MED, V149, P732, DOI 10.1084/jem.149.3.732; Wells A, 2013, CANCER RES, V73, P1; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wu A, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0028; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	61	16	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109934	10.1371/journal.pone.0109934	http://dx.doi.org/10.1371/journal.pone.0109934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329892	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800048
J	Lieb, K; Scheurich, A				Lieb, Klaus; Scheurich, Armin			Contact between Doctors and the Pharmaceutical Industry, Their Perceptions, and the Effects on Prescribing Habits	PLOS ONE			English	Article							SALES REPRESENTATIVES; PHYSICIANS; BEHAVIOR; INFORMATION; HOUSESTAFF; ATTITUDES	Background: The prescribing behaviour of doctors is influenced by the pharmaceutical industry. This study investigated the extent to which contacts with pharmaceutical sales representatives (PSR) and the perception of these contacts influence prescribing habits. Method: An online questionnaire regarding contact with PSRs and perceptions of this contact was sent to 1,388 doctors, 11.5% (n = 160) of whom completed the survey. Individual prescribing data over a year (number of prescriptions, expenditure, and daily doses) for all on-patent branded, off-patent branded, and generic drugs were obtained from the Bavarian Association of Statutory Health Insurance Physicians. Results: 84% of the doctors saw PSR at least once a week, and 14% daily. 69% accepted drug samples, 39% accepted stationery and 37% took part in sponsored continuing medical education (CME) frequently. 5 physicians (3%) accepted no benefits at all. 43% of doctors believed that they received adequate and accurate information from PSRs frequently or always and 42% believed that their prescribing habits were influenced by PSR visits occasionally or frequently. Practices that saw PSRs frequently had significantly higher total prescriptions and total daily doses (but not expenditure) than practices that were less frequently visited. Doctors who believed that they received accurate information from PSRs showed higher expenditures on off-patent branded drugs (thus available as generics) and a lower proportion of generics. The eschewal of sponsored CME was associated with a lower proportion of on patent-branded drug prescriptions, lower expenditure on off-patent branded drug prescriptions and a higher proportion of generics. Acceptance of office stationery was associated with higher daily doses. Conclusions: Avoidance of industry-sponsored CME is associated with more rational prescribing habits. Furthermore, gift acceptance and the belief that one is receiving adequate information from a PSR are associated with changed prescribing habits. Further studies with larger sample sizes are needed.	[Lieb, Klaus; Scheurich, Armin] Univ Med Ctr Mainz, Dept Psychiat & Psychotherapy, Mainz, Germany	Johannes Gutenberg University of Mainz	Lieb, K (corresponding author), Univ Med Ctr Mainz, Dept Psychiat & Psychotherapy, Mainz, Germany.	klaus.lieb@unimedizin-mainz.de						AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; BECKER MH, 1972, MOL CRYST LIQ CRYST, V16, P118; Bowman M A, 1988, J Contin Educ Health Prof, V8, P13, DOI 10.1002/chp.4750080104; Caamano F, 2002, EUR J PUBLIC HEALTH, V12, P187, DOI 10.1093/eurpub/12.3.187; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Campbell EG, 2010, ARCH INTERN MED, V170, P1820, DOI 10.1001/archinternmed.2010.383; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Darlington RB, 1990, REGRESSION LINEAR MO, P249; Korzilius H, 2007, DTSCH ARZTEBLATT, V104, P143; Lexchin Joel, 2012, Mens Sana Monogr, V10, P143, DOI 10.4103/0973-1229.91294; Lieb K, 2010, DTSCH ARZTEBL INT, V107, P392, DOI 10.3238/arztebl.2010.0392; LURIE N, 1990, J GEN INTERN MED, V5, P240, DOI 10.1007/BF02600542; Mintzes B, 2013, J GEN INTERN MED, V28, P1368, DOI 10.1007/s11606-013-2411-7; ORLOWSKI JP, 1992, CHEST, V102, P270, DOI 10.1378/chest.102.1.270; Pronin E, 2004, PSYCHOL REV, V111, P781, DOI 10.1037/0033-295X.111.3.781; Rodwin MA, 2010, J LAW MED ETHICS, V38, P807, DOI 10.1111/j.1748-720X.2010.00534.x; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; Watkins C, 2003, QUAL SAF HEALTH CARE, V12, P29, DOI 10.1136/qhc.12.1.29	19	78	79	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110130	10.1371/journal.pone.0110130	http://dx.doi.org/10.1371/journal.pone.0110130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9XC	25330392	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800059
J	Lee, MF; Lin, TM; Liu, SW; Chen, YH				Lee, Mey-Fann; Lin, Tzu-Mei; Liu, Szu-Wei; Chen, Yi-Hsing			A Rapid Method of Detecting Autoantibody against Fc epsilon RI alpha for Chronic Spontaneous Urticaria	PLOS ONE			English	Article							CHRONIC IDIOPATHIC URTICARIA; SERUM SKIN-TEST; QUALITY-OF-LIFE; CHRONIC AUTOIMMUNE URTICARIA; BASOPHIL CD63 EXPRESSION; ANTI-IGE AUTOANTIBODIES; HISTAMINE-RELEASE; THYROID AUTOIMMUNITY; RESPIRATORY ALLERGY; CLASSIFICATION	Background: Chronic spontaneous urticaria (CU) is a common skin disorder, with an estimated prevalence of 0.5-1.8% in most populations. Around 30-50% of CU patients have an autoimmune etiology, with autoantibodies (autoAbs) against IgE, Fc epsilon RI alpha, and Fc epsilon RII/CD23. Although the in vivo autologous serum skin test (ASST) and in vitro histamine release/activation assay are the most frequently used screening methods, these two have many limitations and do not directly measure susceptible autoAbs. This study aimed to establish an in vitro rapid screening test using recombinant autoantigen Fc epsilon RI alpha(rFc epsilon RI alpha) to improve the diagnosis of autoimmune urticaria. Methods: Forty patients with CU and 20 healthy individuals were enrolled. After PCR-based cloning and the production of extracellular fragments of the Fc epsilon RI alpha protein using the E. coli expression system, serum autoAb to rFc epsilon RI alpha was evaluated using in-house ELISA and rapid immunodot test. Results: In ELISA-based detection, 14 out of 20 CU-ASST(+) patients exhibited anti-Fc epsilon RI alpha responses, whereas five of the 20 CU-ASST(-) and two of the 20 non-CU patients showed autoantibody background in the assay. For the immunodot test, 55% (11/20) of the CU-ASST(+) sera exhibited anti-Fc epsilon RI alpha reactivity. There was no false positive among the CU-ASST(-) and non-CU groups. Using clinical urticaria plus ASST(+) as the gold standard, in-house ELISA had 70% sensitivity, 82.5% specificity, and positive likelihood ratio of 4, while immunodot had 55% sensitivity, 100% specificity, and positive likelihood ratio >55. Conclusions: This study has developed a rapid immunodot method with high specificity for detecting autoAb to Fc epsilon RI alpha in patients with CU. Preliminary data indicates that this immunodot technique has the potential to be a routine diagnostic assay for autoimmune CU.	[Lee, Mey-Fann] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Tzu-Mei; Liu, Szu-Wei; Chen, Yi-Hsing] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Yi-Hsing] Natl Yang Ming Univ, Fac Med, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, YH (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.	ysanne@vghtc.gov.tw			Taichung Veterans General Hospital [TCVGH-1027311C]	Taichung Veterans General Hospital	This study was supported by grant from Taichung Veterans General Hospital (TCVGH-1027311C). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrichter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014794; Baiardini I, 2003, ALLERGY, V58, P621, DOI 10.1034/j.1398-9995.2003.00091.x; De Swerdt A, 2005, J ALLERGY CLIN IMMUN, V116, P662, DOI 10.1016/j.jaci.2005.04.042; DeLong LK, 2008, ARCH DERMATOL, V144, P35, DOI 10.1001/archdermatol.2007.5; Fiebiger E, 1995, J CLIN INVEST, V96, P2606, DOI 10.1172/JCI118325; Fiebiger E, 1998, J CLIN INVEST, V101, P243, DOI 10.1172/JCI511; Frezzolini A, 2006, ALLERGY, V61, P1071, DOI 10.1111/j.1398-9995.2006.01033.x; FUREDER W, 1995, J IMMUNOL, V155, P3152; GRATTAN CEH, 1991, CLIN EXP ALLERGY, V21, P695, DOI 10.1111/j.1365-2222.1991.tb03198.x; Guttman-Yassky E, 2007, J EUR ACAD DERMATOL, V21, P35, DOI 10.1111/j.1468-3083.2006.01852.x; Gyimesi E, 2004, BRIT J DERMATOL, V151, P388, DOI 10.1111/j.1365-2133.2004.06042.x; HIDE M, 1993, NEW ENGL J MED, V328, P1599, DOI 10.1056/NEJM199306033282204; Hide M, 2014, IMMUNOL ALLERGY CLIN, V34, P53, DOI 10.1016/j.iac.2013.09.009; Horn MP, 1999, EUR J IMMUNOL, V29, P1139, DOI 10.1002/(SICI)1521-4141(199904)29:04<1139::AID-IMMU1139>3.0.CO;2-J; Iqbal Kamran, 2012, Clin Transl Allergy, V2, P19, DOI 10.1186/2045-7022-2-19; Kaplan AP, 2009, CLIN EXP ALLERGY, V39, P777, DOI 10.1111/j.1365-2222.2009.03256.x; Kaplan A, 2013, J ALLERGY CLIN IMMUN, V132, P101, DOI 10.1016/j.jaci.2013.05.013; Kikuchi Y, 2002, J ALLERGY CLIN IMMUN, V109, P114, DOI 10.1067/mai.2002.120954; Konstantinou GN, 2013, ALLERGY, V68, P27, DOI 10.1111/all.12056; LEZNOFF A, 1983, ARCH DERMATOL, V119, P636, DOI 10.1001/archderm.119.8.636; Mari A, 2004, INT ARCH ALLERGY IMM, V133, P29, DOI 10.1159/000075251; Najib U, 2009, ANN ALLERG ASTHMA IM, V103, P496, DOI 10.1016/S1081-1206(10)60266-9; ODonnell BF, 1997, BRIT J DERMATOL, V136, P197; Ozkan M, 2007, ANN ALLERG ASTHMA IM, V99, P29; Platzer MH, 2005, ALLERGY, V60, P1152, DOI 10.1111/j.1398-9995.2005.00841.x; Puccetti A, 2005, CLIN EXP ALLERGY, V35, P1599, DOI 10.1111/j.1365-2222.2005.02380.x; Sabroe RA, 2002, J ALLERGY CLIN IMMUN, V110, P492, DOI 10.1067/mai.2002.126782; Sabroe RA, 1999, BRIT J DERMATOL, V140, P446; Sabroe RA, 1999, J AM ACAD DERMATOL, V40, P443, DOI 10.1016/S0190-9622(99)70495-0; Saini SS, 2014, IMMUNOL ALLERGY CLIN, V34, P33, DOI 10.1016/j.iac.2013.09.012; Song ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064142; Soundararajan S, 2005, J ALLERGY CLIN IMMUN, V115, P815, DOI 10.1016/j.jaci.2004.12.1120; Szegedi A, 2006, BRIT J DERMATOL, V155, P67, DOI 10.1111/j.1365-2133.2006.07205.x; Taskapan O, 2008, CLIN EXP DERMATOL, V33, P754, DOI 10.1111/j.1365-2230.2008.02819.x; Wedi B, 2000, J ALLERGY CLIN IMMUN, V105, P552, DOI 10.1067/mai.2000.104939; Zhong H, 2014, ALLERGY, V69, P359, DOI 10.1111/all.12338; Zuberbier T, 2014, ALLERGY, V69, P868, DOI 10.1111/all.12313; Zuberbier T, 2010, CLIN EXP DERMATOL, V35, P869, DOI 10.1111/j.1365-2230.2010.03840.x; Zuberbier T, 2009, ALLERGY, V64, P1417, DOI 10.1111/j.1398-9995.2009.02179.x	39	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109565	10.1371/journal.pone.0109565	http://dx.doi.org/10.1371/journal.pone.0109565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333273	gold, Green Submitted, Green Published			2022-12-27	WOS:000346766200040
J	Aziz, MA; Periyasamy, S; Al Yousef, Z; AlAbdulkarim, I; Al Otaibi, M; Alfahed, A; Alasiri, G				Aziz, Mohammad Azhar; Periyasamy, Sathish; Al Yousef, Zeyad; AlAbdulkarim, Ibrahim; Al Otaibi, Majed; Alfahed, Abdulaziz; Alasiri, Glowi			Integrated Exon Level Expression Analysis of Driver Genes Explain Their Role in Colorectal Cancer	PLOS ONE			English	Article							COPY-NUMBER; COLON-CANCER; ABERRATIONS; CENSUS; ARRAY; NABC1; RNA; DNA	Integrated analysis of genomic and transcriptomic level changes holds promise for a better understanding of colorectal cancer (CRC) biology. There is a pertinent need to explain the functional effect of genome level changes by integrating the information at the transcript level. Using high resolution cytogenetics array, we had earlier identified driver genes by 'Genomic Identification of Significant Targets In Cancer (GISTIC)' analysis of paired tumour-normal samples from colorectal cancer patients. In this study, we analyze these driver genes at three levels using exon array data - gene, exon and network. Gene level analysis revealed a small subset to experience differential expression. These results were reinforced by carrying out separate differential expression analyses (SAM and LIMMA). ATP8B1 was found to be the novel gene associated with CRC that shows changes at cytogenetic, gene and exon levels. Splice index of 29 exons corresponding to 13 genes was found to be significantly altered in tumour samples. Driver genes were used to construct regulatory networks for tumour and normal groups. There were rearrangements in transcription factor genes suggesting the presence of regulatory switching. The regulatory pattern of AHR gene was found to have the most significant alteration. Our results integrate data with focus on driver genes resulting in highly enriched novel molecules that need further studies to establish their role in CRC.	[Aziz, Mohammad Azhar; Periyasamy, Sathish; AlAbdulkarim, Ibrahim; Al Otaibi, Majed; Alfahed, Abdulaziz; Alasiri, Glowi] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Al Yousef, Zeyad] Natl Guard Hlth Affairs, Riyadh, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia	Aziz, MA (corresponding author), King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.	azharbiotech@yahoo.com	Periyasamy, Sathish/AHD-9115-2022; Aziz, Mohammad Azhar/F-7486-2013	Periyasamy, Sathish/0000-0002-8132-5717; Aziz, Mohammad Azhar/0000-0002-0798-5063; AlOtaibi, Majed/0000-0002-3721-7110	King Abdullah International Medical Research Center [RC10/083]	King Abdullah International Medical Research Center	This study was funded by King Abdullah International Medical Research Center through research grant RC10/083 awarded to MAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bemmo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-529; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bisognin A, 2013, MOL ONCOL; Camps J, 2009, GENE CHROMOSOME CANC, V48, P1002, DOI 10.1002/gcc.20699; Chen WX, 2013, GENOMICS, V102, P27, DOI 10.1016/j.ygeno.2013.02.003; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Consiglio A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S21; Correa RG, 2000, GENOMICS, V65, P299, DOI 10.1006/geno.2000.6172; Eldai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076251; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Fan BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029824; Furuta K, 2012, CANCER SCI, V103, P221, DOI 10.1111/j.1349-7006.2011.02132.x; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Hornberg JJ, 2006, BIOSYSTEMS, V83, P81, DOI 10.1016/j.biosystems.2005.05.014; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Kim YA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001095; Lahti L, 2013, BRIEF BIOINFORM, V14, P27, DOI 10.1093/bib/bbs005; Louhimo R, 2012, NAT METHODS, V9, P351, DOI [10.1038/NMETH.1893, 10.1038/nmeth.1893]; Lu TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024829; Madhamshettiwar PB, 2012, GENOME MED, V4, DOI 10.1186/gm340; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Mathieson W, 2013, ANAL BIOCHEM, V433, P10, DOI 10.1016/j.ab.2012.10.006; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mojica W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-5; Nakagawa H, 2004, ONCOGENE, V23, P7366, DOI 10.1038/sj.onc.1208013; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Piepoli A, 2012, EXP BIOL MED, V237, P1123, DOI 10.1258/ebm.2012.012042; Platzer P, 2002, CANCER RES, V62, P1134; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Srinivasan K, 2005, METHODS, V37, P345, DOI 10.1016/j.ymeth.2005.09.007; Thorsen K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002998; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wen ZS, 2013, J AM MED INFORM ASSN, V20, P659, DOI 10.1136/amiajnl-2012-001168; Xi LQ, 2008, NUCLEIC ACIDS RES, V36, P6535, DOI 10.1093/nar/gkn697; Yoshida T, 2010, CANCER INFORM, V9, P147; Zimmerman MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058300; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	40	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110134	10.1371/journal.pone.0110134	http://dx.doi.org/10.1371/journal.pone.0110134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25335079	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200026
J	Rosenberg, A; Fan, HT; Chiu, YG; Bolce, R; Tabechian, D; Barrett, R; Moorehead, S; Baribaud, F; Liu, H; Peffer, N; Shealy, D; Schwarz, EM; Ritchlin, CT				Rosenberg, Alexander; Fan, Hongtao; Chiu, Yahui G.; Bolce, Rebecca; Tabechian, Darren; Barrett, Rick; Moorehead, Sharon; Baribaud, Frederic; Liu, Hao; Peffer, Nancy; Shealy, David; Schwarz, Edward M.; Ritchlin, Christopher T.			Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy	PLOS ONE			English	Article							TERMINAL DIFFERENTIATION; CELL-PROLIFERATION; EXPRESSION PROFILE; DISEASE; CRITERIA; CLASSIFICATION; TRANSCRIPTION; APOPTOSIS; LEUKEMIA; EFFICACY	Objective: The immune inflammatory disorders rheumatoid arthritis (RA), psoriatic arthritis (PsA) and psoriasis (Ps) share common pathologic features and show responsiveness to anti-tumor necrosis factor (TNF) agents yet they are phenotypically distinct. The aim of this study was to examine if anti-TNF therapy is associated with divergent gene expression profiles in circulating cells and target tissues of patients with these diseases. Methods: Peripheral blood CD14(+) and CD14(-) cells were isolated from 9 RA, 12 PsA and 10 Ps patients before and after infliximab (IFX) treatment. Paired synovial (n = 3, RA, PsA) and skin biopsies (n = 5, Ps) were also collected. Gene expression was analyzed by microarrays. Results: 26 out of 31 subjects responded to IFX. The transcriptional response of CD14(+) cells to IFX was unique for the three diseases, with little overlap (<25%) in significantly changed gene lists (with PsA having the largest number of changed genes). In Ps, altered gene expression was more pronounced in lesional skin (relative to paired, healthy skin) compared to blood (relative to healthy controls). Marked suppression of up-regulated genes in affected skin was noted 2 weeks after therapy but the expression patterns differed from uninvolved skin. Divergent patterns of expression were noted between the blood cells and skin or synovial tissues in individual patients. Functions that promote cell differentiation, proliferation and apoptosis in all three diseases were enriched. RA was enriched in functions in CD14(-) cells, PsA in CD14(+) cells and Ps in both CD14(+) and CD14(-) cells, however, the specific functions showed little overlap in the 3 disorders. Conclusion: Divergent patterns of altered gene expression are observed in RA, PsA and Ps patients in blood cells and target organs in IFX responders. Differential gene expression profiles in the blood do not correlate with those in target organs.	[Rosenberg, Alexander; Chiu, Yahui G.; Tabechian, Darren; Barrett, Rick; Moorehead, Sharon; Ritchlin, Christopher T.] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Schwarz, Edward M.; Ritchlin, Christopher T.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Fan, Hongtao; Chiu, Yahui G.; Baribaud, Frederic; Liu, Hao; Peffer, Nancy; Shealy, David] Janssen Res & Dev LLC, Spring House, PA USA	University of Rochester; University of Rochester; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Ritchlin, CT (corresponding author), Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA.	Christopher_Ritchlin@urmc.rochester.edu		ritchlin, christopher/0000-0002-2602-1219	Janssen RD, LLC	Janssen RD, LLC	This work was funded by Janssen R&D, LLC. Authors who were employed by Janssen R&D, LLC generated the microarray data and contributed to study design, data analysis and manuscript preparation.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; Barnes MG, 2009, ARTHRITIS RHEUM-US, V60, P2102, DOI 10.1002/art.24601; Batliwalla FM, 2005, MOL MED, V11, P21, DOI 10.2119/2006-00003.Gulko; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; Dey BK, 2008, MOL CELL BIOL, V28, P5312, DOI 10.1128/MCB.00128-08; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Firestein GS, 2005, J RHEUMATOL, V32, P8; Genovese MC, 2012, ANN RHEUM DIS; Gudjonsson JE, 2007, J AM ACAD DERMATOL, V57, P365, DOI 10.1016/j.jaad.2007.02.015; Haupl T, 2010, ANN RHEUM DIS, V69, P37, DOI 10.1136/ard.2009.119487; Huffmeier U, 2010, J INVEST DERMATOL, V130, P979, DOI 10.1038/jid.2009.385; Ito M, 2004, J DERMATOL SCI, V36, P157, DOI 10.1016/j.jdermsci.2004.08.012; Jackson-Boeters L, 2009, J CELL COMMUN SIGNAL, V3, P125, DOI 10.1007/s12079-009-0057-3; Julia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007556; Kingsley GH, 2012, RHEUMATOLOGY, V51, P1368, DOI 10.1093/rheumatology/kes001; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lindberg J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1903; Lindberg J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011310; Manenschijn L, 2009, ANN NY ACAD SCI, V1179, P179, DOI 10.1111/j.1749-6632.2009.05013.x; MARKS R, 1989, ARCH DERMATOL, V125, P235, DOI 10.1001/archderm.125.2.235; McGonagle D, 2011, ANN RHEUM DIS, V70, pI71, DOI 10.1136/ard.2010.144097; McInnes IB, 2013, LANCET, V382, P780, DOI 10.1016/S0140-6736(13)60594-2; Mease P, 2011, ARTHRITIS RHEUM-US, V63, P939, DOI 10.1002/art.30176; Mease PJ, 2012, J RHEUMATOL, V39, P2235, DOI 10.3899/jrheum.121149; Meugnier E, 2011, PHYSIOL GENOMICS, V43, P365, DOI 10.1152/physiolgenomics.00127.2010; Moots RJ, 2012, RHEUMATOLOGY, V51, P2252, DOI 10.1093/rheumatology/kes217; Nakajima H, 2006, J BIOL CHEM, V281, P14494, DOI 10.1074/jbc.M600575200; Nograles KE, 2009, NAT CLIN PRACT RHEUM, V5, P83, DOI 10.1038/ncprheum0987; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Robb L, 1998, MECH DEVELOP, V76, P197, DOI 10.1016/S0925-4773(98)00122-1; Sakamaki J, 2009, BIOCHEM BIOPH RES CO, V382, P497, DOI 10.1016/j.bbrc.2009.03.022; Stoeckman AK, 2006, GENES IMMUN, V7, P583, DOI 10.1038/sj.gene.6364334; Suarez-Farinas M, 2011, J INVEST DERMATOL, V131, P391, DOI 10.1038/jid.2010.280; Systems I, 2013, ING UPSTR REG AN WHI; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Toonen EJM, 2008, ANN RHEUM DIS, V67, P1663, DOI 10.1136/ard.2007.076588; Tuller T, 2012, GENES IMMUN; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Walsh DS, 2005, J DERMATOL SCI, V37, P61, DOI 10.1016/j.jdermsci.2004.10.003; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhao J, 2011, HEMATOLOGY, V16, P232, DOI 10.1179/102453311X13025568941925	50	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110657	10.1371/journal.pone.0110657	http://dx.doi.org/10.1371/journal.pone.0110657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333715	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200065
J	Garcia-Gil, M; Elorza, JM; Banque, M; Comas-Cufi, M; Blanch, J; Ramos, R; Mendez-Boo, L; Hermosilla, E; Bolibar, B; Prieto-Alhambra, D				Garcia-Gil, Maria; Elorza, Josep-Maria; Banque, Marta; Comas-Cufi, Marc; Blanch, Jordi; Ramos, Rafel; Mendez-Boo, Leonardo; Hermosilla, Eduardo; Bolibar, Bonaventura; Prieto-Alhambra, Daniel			Linking of Primary Care Records to Census Data to Study the Association between Socioeconomic Status and Cancer Incidence in Southern Europe: A Nation-Wide Ecological Study	PLOS ONE			English	Article							COLORECTAL-CANCER; RISK-FACTORS; DEPRIVATION INDEXES; SOCIAL DEPRIVATION; PROSTATE-CANCER; CERVICAL-CANCER; HEALTH-CARE; BREAST; LUNG; INEQUALITIES	Background: Area-based measures of economic deprivation are seldom applied to large medical records databases to establish population-scale associations between deprivation and disease. Objective: To study the association between deprivation and incidence of common cancer types in a Southern European region. Methods: Retrospective ecological study using the SIDIAP (Information System for the Development of Research in Primary Care) database of longitudinal electronic medical records for a representative population of Catalonia (Spain) and the MEDEA index based on urban socioeconomic indicators in the Spanish census. Study outcomes were incident cervical, breast, colorectal, prostate, and lung cancer in 2009-2012. The completeness of SIDIAP cancer recording was evaluated through linkage of a geographic data subset to a hospital cancer registry. Associations between MEDEA quintiles and cancer incidence was evaluated using zero-inflated Poisson regression adjusted for sex, age, smoking, alcoholism, obesity, hypertension, and diabetes. Results: SIDIAP sensitivity was 63% to 92% for the five cancers studied. There was direct association between deprivation and lung, colorectal, and cervical cancer: incidence rate ratios (IRR) 1.82 [1.64-2.01], IRR 1.60 [1.34-1.90], IRR 1.22 [1.07-1.38], respectively, comparing the most deprived to most affluent areas. In wealthy areas, prostate and breast cancers were more common: IRR 0.92 [0.80-1.00], IRR 0.91 [0.78-1.06]. Adjustment for confounders attenuated the association with lung cancer risk (fully adjusted IRR 1.16 [1.08-1.25]), reversed the direction of the association with colorectal cancer (IRR 0.90 [0.84-0.95]), and did not modify the associations with cervical (IRR 1.27 [1.11-1.45]), prostate (0.74 [0.69-0.80]), and breast (0.76 [0.71-0.81]) cancer. Conclusions: Deprivation is associated differently with the occurrence of various cancer types. These results provide evidence that MEDEA is a useful, area-based deprivation index for analyses of the SIDIAP database. This information will be useful to improve screening programs, cancer prevention and management strategies, to reach patients more effectively, particularly in deprived urban areas.	[Garcia-Gil, Maria; Comas-Cufi, Marc; Blanch, Jordi] Res Unit, Girona, Spain; [Garcia-Gil, Maria; Elorza, Josep-Maria; Comas-Cufi, Marc; Blanch, Jordi; Hermosilla, Eduardo; Bolibar, Bonaventura; Prieto-Alhambra, Daniel] IDIAP Jordi Gol, Jordi Gol Inst Primary Care Res, Catalunya, Spain; [Garcia-Gil, Maria] Univ Girona, Sch Med, Dept Med Sci, Translab Res Grp, Catalunya, Spain; [Banque, Marta] Hosp Mar, Dept Epidemiol & Evaluat, Canc Prevent Unit, Barcelona, Catalunya, Spain; [Banque, Marta] Hosp Mar, Dept Epidemiol & Evaluat, Canc Registry, Barcelona, Catalunya, Spain; [Ramos, Rafel] Primary Care Serv, Girona, Spain; [Ramos, Rafel] Catalan Inst Hlth ICS, Catalunya, Spain; [Mendez-Boo, Leonardo] Catalan Inst Hlth ICS, Primary Care Informat Syst, Catalunya, Spain; [Prieto-Alhambra, Daniel] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England	Universitat de Girona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Oxford	Garcia-Gil, M (corresponding author), Res Unit, Girona, Spain.	mgarcia@idiapjgol.info	Méndez-Boo, Leonardo/AAW-3237-2021; Blanch, Jordi/U-1407-2019; Comas-Cufí, Marc/V-5842-2019; Ramos, Rafel/P-2083-2019; García-Gil, M/E-5093-2016; Ramos, Rafel/D-9627-2016; Blanch, Jordi/K-1685-2017; Hermosilla Pérez, Eduardo/AAC-4585-2022; Comas-Cufí, Marc/A-4935-2015	Méndez-Boo, Leonardo/0000-0002-9215-4378; Blanch, Jordi/0000-0001-8211-3292; Comas-Cufí, Marc/0000-0001-9759-0622; Ramos, Rafel/0000-0001-7970-5537; García-Gil, M/0000-0001-8146-5288; Ramos, Rafel/0000-0001-7970-5537; Blanch, Jordi/0000-0001-8211-3292; Hermosilla Pérez, Eduardo/0000-0002-3031-0304; Comas-Cufí, Marc/0000-0001-9759-0622; Prieto-Alhambra, Daniel/0000-0002-3950-6346; Bolibar, Bonaventura/0000-0003-4653-9805				Barcelo MA, 2009, SCI TOTAL ENVIRON, V407, P5501, DOI 10.1016/j.scitotenv.2009.07.028; BOFFETTA P, 1997, IARC SCI PUBL, V138, P331; Bolibar B, 2012, MED CLIN-BARCELONA, V138, P617, DOI 10.1016/j.medcli.2012.01.020; Borrell C, 2010, HEALTH PLACE, V16, P703, DOI 10.1016/j.healthplace.2010.03.002; Brown SBF, 2007, BREAST CANCER RES TR, V103, P233, DOI 10.1007/s10549-006-9361-2; Bryere J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-87; Butler DC, 2013, HEALTH SERV RES, V48, P539, DOI 10.1111/j.1475-6773.2012.01449.x; Carstairs V, 1995, J EPIDEMIOL COMMUN H, V49, pS3, DOI 10.1136/jech.49.Suppl_2.S3; Cleries R, 2013, CLIN TRANSL ONCOL; Damiani G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-99; Dominguez-Berjon F, 2006, EUR J PUBLIC HEALTH, V16, P54, DOI 10.1093/eurpub/cki069; Dominguez-Berjon MF, 2008, GAC SANIT, V22, P179, DOI 10.1157/13123961; Dominguez-Berjon MF, 2005, J URBAN HEALTH, V82, P225, DOI 10.1093/jurban/jti047; Doubeni CA, 2012, JNCI-J NATL CANCER I, V104, P1353, DOI 10.1093/jnci/djs346; Doubeni CA, 2012, CANCER-AM CANCER SOC, V118, P3636, DOI 10.1002/cncr.26677; Eachus J, 1996, BMJ-BRIT MED J, V312, P287; Exeter DJ, 2011, SOC SCI MED, V72, P389, DOI 10.1016/j.socscimed.2010.10.009; Faggiano F, 1997, IARC Sci Publ, P65; Garcia-Gil MM, 2011, INFORM PRIM CARE, V19, P135; Gordon D, 1995, J EPIDEMIOL COMMUN H, V49, pS39, DOI 10.1136/jech.49.Suppl_2.S39; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Krieger N, 1999, CANCER CAUSE CONTROL, V10, P525, DOI 10.1023/A:1008950210967; Kuznetsov L, 2012, INT J PUBLIC HEALTH, V57, P827, DOI 10.1007/s00038-012-0342-4; Lambert D, 2008, TECHNOMETRICS, V34; Lyratzopoulos G, 2013, ANN ONCOL, V24, P843, DOI 10.1093/annonc/mds526; Lyratzopoulos G, 2011, ANN ONCOL, V22, P1661, DOI 10.1093/annonc/mdq647; Pampalon R, 2014, CHRON DIS INJ CAN, V34, P12; Pollock AM, 1997, J PUBLIC HEALTH MED, V19, P288, DOI 10.1093/oxfordjournals.pubmed.a024632; Prieto-Alhambra D, 2014, ANN RHEUM DIS, V73, P1659, DOI 10.1136/annrheumdis-2013-203355; Probst C, 2014, INT J EPIDEMIOL, V43, P1314, DOI 10.1093/ije/dyu043; Puigpinos-Riera R, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-6; Ramos R, 2012, REV ESP CARDIOL, V65, P29, DOI [10.1016/j.rec.2011.07.016, 10.1016/j.recesp.2011.07.017]; Salcedo N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-574; Sanchez-Santos MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072656; Santelli JS, 2000, AM J PUBLIC HEALTH, V90, P1582, DOI 10.2105/AJPH.90.10.1582; SCHRIJVERS CTM, 1994, J EPIDEMIOL COMMUN H, V48, P441, DOI 10.1136/jech.48.5.441; Shack L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-271; Shafique K, 2012, BRIT J CANCER, V107, P575, DOI 10.1038/bjc.2012.289; Sidorchuk A, 2009, CANCER CAUSE CONTROL, V20, P459, DOI 10.1007/s10552-009-9300-8; Simo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079968; StataCorp, 2011, STAT STAT SOFTW REL; Vaucher P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000692; Vinagre I, 2012, DIABETES CARE, V35, P774, DOI 10.2337/dc11-1679; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; Yin DX, 2010, CANCER CAUSE CONTROL, V21, P1721, DOI 10.1007/s10552-010-9601-y	45	35	36	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109706	10.1371/journal.pone.0109706	http://dx.doi.org/10.1371/journal.pone.0109706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25329578	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100034
J	Gaig, C; Vilas, D; Infante, J; Sierra, M; Garcia-Gorostiaga, I; Buongiorno, M; Ezquerra, M; Marti, MJ; Valldeoriola, F; Aguilar, M; Calopa, M; Hernandez-Vara, J; Tolosa, E				Gaig, Carles; Vilas, Dolores; Infante, Jon; Sierra, Maria; Garcia-Gorostiaga, Ines; Buongiorno, Mariateresa; Ezquerra, Mario; Jose Marti, Maria; Valldeoriola, Francesc; Aguilar, Miquel; Calopa, Matilde; Hernandez-Vara, Jorge; Tolosa, Eduardo			Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson's Disease	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; MUTATION CARRIERS; SCALE; INSTRUMENT; PENETRANCE; PSYCHOSIS; PHENOTYPE; SLEEP	Background: Idiopathic Parkinson's disease (IPD) and LRRK2-associated PD (LRRK2-PD) might be expected to differ clinically since the neuropathological substrate of LRRK2-PD is heterogeneous. The range and severity of extra-nigral nonmotor features associated with LRRK2 mutations is also not well-defined. Objective: To evaluate the prevalence and time of onset of nonmotor symptoms (NMS) in LRRK2-PD patients. Methods: The presence of hyposmia and of neuropsychiatric, dysautonomic and sleep disturbances was assessed in 33 LRRK2-G2019S-PD patients by standardized questionnaires and validated scales. Thirty-three IPD patients, matched for age, gender, duration of parkinsonism and disease severity and 33 healthy subjects were also evaluated. Results: University of Pennsylvania Smell Identification Test (UPSIT) scores in LRRK2-G2019S-PD were higher than those in IPD (23.5 +/- 6.8 vs 18.4 +/- 6.0; p = 0.002), and hyposmia was less frequent in G2019S carriers than in IPD (39.4% vs 75.8%; p = 0.01). UPSIT scores were significantly higher in females than in males in LRRK2-PD patients (26.9 +/- 4.7 vs 19.4 +/- 6.8; p < 0.01). The frequency of sleep and neuropsychiatric disturbances and of dysautonomic symptoms in LRRK2-G2019S-PD was not significantly different from that in IPD. Hyposmia, depression, constipation and excessive daytime sleepiness, were reported to occur before the onset of classical motor symptoms in more than 40% of LRRK2-PD patients in whom these symptoms were present at the time of examination. Conclusion: Neuropsychiatric, dysautonomic and sleep disturbances occur as frequently in patients with LRRK2-G2019S-PD as in IPD but smell loss was less frequent in LRRK2-PD. Like in IPD, disturbances such as hyposmia, depression, constipation and excessive daytime sleepiness may antedate the onset of classical motor symptoms in LRRK2-G2019S-PD.	[Gaig, Carles; Vilas, Dolores; Buongiorno, Mariateresa; Ezquerra, Mario; Jose Marti, Maria; Valldeoriola, Francesc; Tolosa, Eduardo] Univ Barcelona, Inst Neurociencies Hosp Clin, Neurol Serv, Parkinsons Dis & Movement Disorders Unit, Barcelona, Spain; [Gaig, Carles; Buongiorno, Mariateresa; Ezquerra, Mario; Jose Marti, Maria; Valldeoriola, Francesc; Tolosa, Eduardo] Inst Invest Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain; [Gaig, Carles; Infante, Jon; Sierra, Maria; Ezquerra, Mario; Jose Marti, Maria; Valldeoriola, Francesc; Tolosa, Eduardo] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Infante, Jon; Sierra, Maria] Univ Cantabria, Hosp Univ Marques Valdecilla, Neurol Serv, E-39005 Santander, Spain; [Garcia-Gorostiaga, Ines] Hosp Galdakao, Neurol Serv, Usansolo, Vizcaya, Spain; [Aguilar, Miquel] Hosp Univ Mutua Terrasa, Neurol Serv, Barcelona, Spain; [Calopa, Matilde] Hosp Univ Bellvitge, Neurol Serv, Barcelona, Spain; [Hernandez-Vara, Jorge] Hosp Univ Vall DHebron, Neurol Serv, Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Galdakao Hospital; Hospital Universitario Mutua Terrassa; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Universitari Vall d'Hebron	Tolosa, E (corresponding author), Univ Barcelona, Inst Neurociencies Hosp Clin, Neurol Serv, Parkinsons Dis & Movement Disorders Unit, Barcelona, Spain.	etolosa@clinic.ub.es	Vilas, Dolores/AAB-7244-2019; HERNANDEZ-VARA, JORGE/R-2748-2018; Ezquerra, Mario/I-1233-2014; Trabalon, Mario Ezquerra/E-3723-2019; Sierra, Maria/GYU-1134-2022	HERNANDEZ-VARA, JORGE/0000-0002-9129-5224; Ezquerra, Mario/0000-0003-3246-6641; Trabalon, Mario Ezquerra/0000-0003-3246-6641; Calopa, Matilde/0000-0002-6943-3707; Infante, Jon/0000-0003-4025-4606; Buongiorno, Mariateresa/0000-0002-1745-5744	Spaniard Network for Research on neurodegenerative Disorders (CIBERNED)- instituto Carlos III (ISCIII); Michael J. Fox Foundation for Parkinson's Research (MJFF); Fondo de Investigaciones Sanitarias de la Seguridad Social (FISS); Fondo de Investigacion Sanitaria-ISCIII [PI11/00228]; "Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas" (CIBERNED) [CB06/05/0037]; Institute for Formation and Research from the Marques de Valdecilla Foundation-IFIMAV [WLA 04/11]; "Centro de Investigacion Biomedicaen Red de Enfermedades Neurodegenerativas'' (CIBERNED) [CB06/05/0037]; Instituto de Salud Carlos III (ISCIII)	Spaniard Network for Research on neurodegenerative Disorders (CIBERNED)- instituto Carlos III (ISCIII); Michael J. Fox Foundation for Parkinson's Research (MJFF); Fondo de Investigaciones Sanitarias de la Seguridad Social (FISS)(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria-ISCIII(Instituto de Salud Carlos III); "Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas" (CIBERNED); Institute for Formation and Research from the Marques de Valdecilla Foundation-IFIMAV; "Centro de Investigacion Biomedicaen Red de Enfermedades Neurodegenerativas'' (CIBERNED); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission)	Dr. Tolosa received honoraria for consultancy from Novartis, TEVA, Boehringer Ingelheim, UCB, Solvay, Lundbeck, and TEVA. He also received funding for research from Spaniard Network for Research on neurodegenerative Disorders (CIBERNED)- instituto Carlos III (ISCIII), The Michael J. Fox Foundation for Parkinson's Research (MJFF), and Fondo de Investigaciones Sanitarias de la Seguridad Social (FISS). Dr. Infante receives research support from the Fondo de Investigacion Sanitaria-ISCIII (PI11/00228) and from "Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas" (CIBERNED) (CB06/05/0037). Dr. Sierra receives research support from the Institute for Formation and Research from the Marques de Valdecilla Foundation-IFIMAV (WLA 04/11) and from "Centro de Investigacion Biomedicaen Red de Enfermedades Neurodegenerativas'' (CIBERNED) (CB06/05/0037). Dr. Ezquerra was supported by a Miguel Servet contract of the Instituto de Salud Carlos III (ISCIII). Dr. Gaig, Dr. Vilas, Dr. Buongiorno, and Dr. Marti report no disclosures. Dr. Valldeoriola has received honoraria from Medtronic Iberica, Boston Scientific, Abbvie Pharmaceutiocals and UCB pharma for lectures and courses. Dr. Garcia-Gorostiaga, Dr. Aguilar, Dr. Calopa, and Dr. Hernandez-Vara report no disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brockmann K, 2011, MOVEMENT DISORD, V26, P2335, DOI 10.1002/mds.23991; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chaudhuri KR, 2002, J NEUROL NEUROSUR PS, V73, P629, DOI 10.1136/jnnp.73.6.629; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; DOTY RL, 1995, NEURODEGENERATION, V4, P93, DOI 10.1006/neur.1995.0011; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Friedberg G, 1998, CLIN NEUROPHARMACOL, V21, P280; Gaig C, 2006, ARCH NEUROL-CHICAGO, V63, P377, DOI 10.1001/archneur.63.3.377; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Gjerstad MD, 2002, NEUROLOGY, V58, P1544, DOI 10.1212/WNL.58.10.1544; Goldwurm S, 2006, PARKINSONISM RELAT D, V12, P410, DOI 10.1016/j.parkreldis.2006.04.001; Hayashi S, 2000, MOVEMENT DISORD, V15, P884, DOI 10.1002/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Iranzo A, 2009, SLEEP MED REV, V13, P385, DOI 10.1016/j.smrv.2008.11.003; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kasten M, 2010, ARCH NEUROL-CHICAGO, V67, P670, DOI 10.1001/archneurol.67.6.670; Khan NL, 2004, NEUROLOGY, V62, P1224, DOI 10.1212/01.WNL.0000118281.66802.81; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Marras C, 2011, NEUROLOGY, V77, P325, DOI 10.1212/WNL.0b013e318227042d; Medicine AASM, 2005, INT CLASS SLEEP DIS; Moller JC, 2005, J NEUROL, V252, P926, DOI 10.1007/s00415-005-0784-1; Orr-Urtreger A, 2007, NEUROLOGY, V69, P1595, DOI 10.1212/01.wnl.0000277637.33328.d8; Paisan Ruiz C, 2004, NEURON, V44, P595; Poulopoulos M, 2012, MOVEMENT DISORD, V27, P831, DOI 10.1002/mds.24962; Ravina B, 2007, MOVEMENT DISORD, V22, P1061, DOI 10.1002/mds.21382; Riegler G, 2001, Tech Coloproctol, V5, P163, DOI 10.1007/s101510100019; Ruiz Martinez J, 2011, MOVEMENT DISORD, V26, P2026; Saunders Pullman R, 2011, NEUROLOGY, V77, P319; Silveira Moriyama L, 2008, NEUROLOGY, V71, P1021; Simuni T, 2008, ANN NEUROL, V64, pS65, DOI 10.1002/ana.21472; Visser M, 2004, MOVEMENT DISORD, V19, P1306, DOI 10.1002/mds.20153; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	56	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e108982	10.1371/journal.pone.0108982	http://dx.doi.org/10.1371/journal.pone.0108982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330404	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100006
J	Vallely, LM; Homiehombo, P; Kelly-Hanku, A; Kumbia, A; Mola, GDL; Whittaker, A				Vallely, Lisa M.; Homiehombo, Primrose; Kelly-Hanku, Angela; Kumbia, Antonia; Mola, Glen D. L.; Whittaker, Andrea			Hospital Admission following Induced Abortion in Eastern Highlands Province, Papua New Guinea - A Descriptive Study	PLOS ONE			English	Article							MANUAL VACUUM ASPIRATION; MISOPROSTOL; PREGNANCY; WORLDWIDE; TRENDS; SAFE	Background: In Papua New Guinea abortion is restricted under the Criminal Code Act. While safe abortions should available in certain situations, frequently they are not available to the majority of women. Sepsis from unsafe abortion is a leading cause of maternal mortality. Our findings form part of a wider, mixed methods study designed to identify complications requiring hospital treatment for post abortion care and to explore the circumstances surrounding unsafe abortion. Methods: Through a six month prospective study we identified all women presenting to the Eastern Highlands Provincial Hospital following spontaneous and induced abortions. We undertook semi-structured interviews with women and reviewed individual case notes, extracting demographic and clinical information. Findings: Case notes were reviewed for 56% (67/119) of women presenting for post abortion care. At least 24% (28/119) of these admissions were due to induced abortion. Women presenting following induced abortions were significantly more likely to be younger, single, in education at the time of the abortion and report that the baby was unplanned and unwanted, compared to those reporting spontaneous abortion. Obtained illegally, misoprostol was the method most frequently used to end the pregnancy. Physical and mechanical means and traditional herbs were also widely reported. Conclusion: In a country with a low contraceptive prevalence rate and high unmet need for family planning, all reproductive age women need access to contraceptive information and services to avoid, postpone or space pregnancies. In the absence of this, women are resorting to unsafe means to end an unwanted pregnancy, putting their lives at risk and putting an increased strain on an already struggling health system. Women in this setting need access to safe, effective means of abortion.	[Vallely, Lisa M.] Papua New Guinea Inst Med Res, Sexual & Reprod Hlth Unit, Alotau, Milne Bay Provi, Papua N Guinea; [Homiehombo, Primrose; Kelly-Hanku, Angela] Papua New Guinea Inst Med Res, Sexual & Reprod Hlth Unit, Goroka, Eastern Highlan, Papua N Guinea; [Kelly-Hanku, Angela] Univ New S Wales, Sch Publ Hlth & Community Med, Int HIV Res Grp, Sydney, NSW, Australia; [Kumbia, Antonia] Eastern Highlands Prov Hosp, Div Obstet & Gynaecol, Goroka, Eastern Highlan, Papua N Guinea; [Mola, Glen D. L.] Univ Papua New Guinea, Sch Med & Hlth Sci, Port Moresby, Papua N Guinea; [Whittaker, Andrea] Monash Univ, Sch Social Sci, Clayton, Vic 3800, Australia	PNG Institute Of Medical Research; PNG Institute Of Medical Research; University of New South Wales Sydney; University of Papua New Guinea; Monash University	Vallely, LM (corresponding author), Papua New Guinea Inst Med Res, Sexual & Reprod Hlth Unit, Alotau, Milne Bay Provi, Papua N Guinea.	lmvallely@yahoo.com	Vallely, Lisa Michelle/H-8698-2019	Vallely, Lisa Michelle/0000-0002-8247-7683; Kelly-Hanku, Angela/0000-0003-0152-2954; Whittaker, Andrea/0000-0002-2616-9651	AusAID PNG; Marie Stopes PNG	AusAID PNG; Marie Stopes PNG	This study was supported by through AusAID PNG funding for sexual and reproductive health research at the PNGIMR and Marie Stopes PNG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asa I, 2012, AUST NZ J OBSTET GYN, V52, P491, DOI 10.1111/j.1479-828X.2012.01452.x; Basu JK, 2009, CONTRACEPTION, V80, P170, DOI 10.1016/j.contraception.2009.01.015; Belton S, 2007, SOC SCI MED, V65, P1512, DOI 10.1016/j.socscimed.2007.05.046; Bique C, 2007, INT J GYNECOL OBSTET, V98, P222, DOI 10.1016/j.ijgo.2007.05.003; Culwell KR, 2013, INT J GYNECOL OBSTET, V121, pS16, DOI 10.1016/j.ijgo.2013.02.003; Dao B, 2007, BJOG-INT J OBSTET GY, V114, P1368, DOI 10.1111/j.1471-0528.2007.01468.x; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Guttmacher Institute, 2012, FACTS IND AB WORLDW; Harper CC, 2007, INT J GYNECOL OBSTET, V98, P66, DOI 10.1016/j.ijgo.2007.03.009; Harris LH, 2011, INT J GYNECOL OBSTET, V115, P77, DOI 10.1016/j.ijgo.2011.05.018; Jejeebhoy SJ, 2011, CONTRACEPTION, V84, P615, DOI 10.1016/j.contraception.2011.08.010; Jenkins C., 1994, KNOWLEDGE EVENTS BEF, P24; Kassebaum N.J, 2014, LANCET; Kawonga M, 2008, J FAM PLAN REPROD H, V34, P159, DOI 10.1783/147118908784734846; Kulczycki A, 2009, MATERNAL AND CHILD HEALTH: GLOBAL CHALLENGES, PROGRAMS AND POLICIES, P191, DOI 10.1007/b106524_11; Leyandowski BA, 2012, INT J GYNECOL OBSTET, V118, pS167, DOI 10.1016/S0020-7292(12)60017-4; Mola GDL, 2010, MANUAL STANDARD MANA; Moore AM, 2011, J BIOSOC SCI, V43, P31, DOI 10.1017/S0021932010000507; Murray SF, 2001, HEALTH POLICY PLANN, V16, P353, DOI 10.1093/heapol/16.4.353; NDoH-NHIS, 2009, NAT HLTH INF SYST NA; NDoH-NHIS, 2009, NAT HLTH INF SYST; PNG-DHS, 2009, DEM HLTH SURV PAP NE; Sanga K, 2010, AUST NZ J OBSTET GYN, V50, P21, DOI 10.1111/j.1479-828X.2009.01116.x; Say L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003037.pub2; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; Sherris J, 2005, INT J GYNECOL OBSTET, V88, P76, DOI 10.1016/j.ijgo.2004.09.006; Singh S, 2006, LANCET, V368, P1887, DOI 10.1016/S0140-6736(06)69778-X; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; SINGH Susheela, 2009, ABORTION WORLDWIDE D; UnitedNations, 2013, PAP NEW GUIN IND; USAID NAC-PNG, 2011, BEH KNOWL EXP INT RE; Vallely L, 2014, BMC RH UNPUB     MAR; Vallely LM, 2013, PREGNANCY LOSS MIXED; Winikoff B, 2012, LANCET, V379, P594, DOI 10.1016/S0140-6736(12)60038-5; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, 2013, UNS AB GLOB REG EST	36	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110791	10.1371/journal.pone.0110791	http://dx.doi.org/10.1371/journal.pone.0110791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TF	25329982	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100107
J	Zhao, QL; Yang, L; Zhang, X; Zhu, XM; Zuo, QQ; Wu, YN; Yang, L; Gao, W; Li, MH; Cheng, SS				Zhao, Qiuli; Yang, Li; Zhang, Xiao; Zhu, Xuemei; Zuo, Qingqing; Wu, Yanni; Yang, Liu; Gao, Wei; Li, Minghui; Cheng, Shanshan			Development and Validation of the Pre-Hospital Stroke Symptoms Coping Test	PLOS ONE			English	Article							ISCHEMIC-STROKE; SECONDARY PREVENTION; RISK-FACTORS; KNOWLEDGE; AWARENESS; DELAY; CARE; COMMUNICATION; GUIDELINES; COMMUNITY	Background and Purpose: Measures of specific knowledge of coping with pre-hospital stroke symptoms can help educate high-risk patients and family caregivers. This study aimed to develop and validate the Pre-hospital Stroke Symptoms Coping Test (PSSCT). Materials and Methods: Reliability and validity were analyzed using multiple data sources. The Delphi expert consultation method was applied to assess the test's surface validity and content validity index. The final edition of the 19-item PSSCT contained 3 sections assessing coping with typical symptoms and symptoms associated with vomiting and twitching. Its psychometric properties were investigated in a community sample of 300 high-risk patients and family members. Results: The PSSCT was readily accepted by participants. It demonstrated adequate surface validity and content validity, and good internal consistency (KR20 = 0.822) and test-retest reliability (0.769), with difficulty (P) and degree of differentiation (D) ranges of 0.28-0.83 and 0.15-0.66, respectively. It was also able to distinguish between individuals who had/had not experienced a stroke. Experienced individuals scored significantly higher overall and on coping with typical symptoms and twitching (P<0.01). Conclusions: The PSSCT can practically and directly assess critical knowledge regarding coping with pre-hospital stroke symptoms and has good reliability and validity.	[Zhao, Qiuli; Yang, Li; Zhang, Xiao; Zhu, Xuemei; Zuo, Qingqing; Yang, Liu; Gao, Wei; Li, Minghui; Cheng, Shanshan] Harbin Med Univ, Affiliated Hosp 2nd, Sch Nursing, Harbin, Peoples R China; [Wu, Yanni] Harbin Med Univ, Affiliated Hosp 2nd, Dept Nursing Dept, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Zhao, QL (corresponding author), Harbin Med Univ, Affiliated Hosp 2nd, Sch Nursing, Harbin, Peoples R China.	zhaoqiuli1957@163.com	Yang, Li/K-2466-2019		China National Natural Science Foundation [81273194]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The development and evaluation of the PSSCT was supported by a grant from the China National Natural Science Foundation (Grant No: 81273194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe IM, 2011, INT J STROKE, V6, P33, DOI 10.1111/j.1747-4949.2010.00538.x; Baldereschi M, 2012, CEREBROVASC DIS, V34, P182, DOI 10.1159/000341856; Billings-Gagliardi S, 2005, STROKE, V36, P1035, DOI 10.1161/01.STR.0000162716.82295.ac; Bouckaert M, 2009, NAT REV NEUROL, V5, P477, DOI 10.1038/nrneurol.2009.116; Braig S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-104; Cowman S, 2010, BMC GERIATR, V10, DOI [10.1186/1471-2318-10-4, 10.1186/1471-2318-9-35]; Donnan GA, 2011, INT J STROKE, V6, P97, DOI 10.1111/j.1747-4949.2011.00581.x; Dubois S, 2009, J EVAL CLIN PRACT, V15, P346, DOI 10.1111/j.1365-2753.2008.01013.x; Ebinger M, 2012, INT J STROKE, V7, P348, DOI 10.1111/j.1747-4949.2011.00756.x; Exall K, 1999, Nurs Times, V95, P50; Ferris A, 2005, CIRCULATION, V111, P1321, DOI 10.1161/01.CIR.0000157745.46344.A1; Fogle Crystelle C, 2008, J Public Health Manag Pract, V14, pe17, DOI 10.1097/01.PHH.0000316496.78282.47; Gongora-Rivera F, 2009, J STROKE CEREBROVASC, V18, P208, DOI 10.1016/j.jstrokecerebrovasdis.2008.10.002; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Haladyna T., 1999, DEV VALIDATING MULTI; Hickey A, 2012, INT J STROKE, V7, P298, DOI 10.1111/j.1747-4949.2011.00698.x; Kaste M, 2010, INT J STROKE, V5, P342, DOI 10.1111/j.1747-4949.2010.00475.x; Kim YS, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-2; Labeau SO, 2010, WORLDV EVID-BASED NU, V7, P16, DOI 10.1111/j.1741-6787.2009.00177.x; Lecouturier J, 2010, SYSTEMATIC REV MASS; Long A, 2009, CLIN REHABIL, V23, P846, DOI 10.1177/0269215509336055; Ministry of Health of the People's Republic of China, 2008, CHIN J CLIN ONCOL, V17, P344; Neau JP, 2009, CLIN NEUROL NEUROSUR, V111, P659, DOI 10.1016/j.clineuro.2009.05.015; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Robinson-Smith G, 1995, J Neurosci Nurs, V27, P83; Teuschl Y, 2010, INT J STROKE, V5, P187, DOI 10.1111/j.1747-4949.2010.00428.x; UMBERSON D, 1987, J HEALTH SOC BEHAV, V28, P306, DOI 10.2307/2136848; van der Meulen I, 2010, INT J LANG COMM DIS, V45, P424, DOI 10.3109/13682820903111952; Wang YJ, 2012, CNS NEUROSCI THER, V18, P93, DOI 10.1111/j.1755-5949.2011.00290.x; Weltermann BM, 2000, STROKE, V31, P1230, DOI 10.1161/01.STR.31.6.1230; Weltermann BM, 1999, AKTUELLE NEUROL, V26, pV87; White JH, 2013, DISABIL REHABIL, V35, P931, DOI 10.3109/09638288.2012.717578; Yoon SS, 2001, STROKE, V32, P1926, DOI 10.1161/01.STR.32.8.1926; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	35	0	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110022	10.1371/journal.pone.0110022	http://dx.doi.org/10.1371/journal.pone.0110022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330453	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100040
J	Zhou, L; Yoon, SJ; Jang, KY; Moon, YJ; Wagle, S; Lee, KB; Park, BH; Kim, JR				Zhou, Lu; Yoon, Sun Jung; Jang, Kyu Yun; Moon, Young Jae; Wagle, Sajeev; Lee, Kwang Bok; Park, Byung-Hyun; Kim, Jung Ryul			COMP-Angiopoietin1 Potentiates the Effects of Bone Morphogenic Protein-2 on Ischemic Necrosis of the Femoral Head in Rats	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; LONG-TERM; IN-VITRO; ANGIOGENESIS; COMP-ANG1; BMP-2; ANGIOPOIETIN-1; OSTEONECROSIS; REGENERATION	Angiogenesis is considered essential for proper bone regeneration. The purpose of this investigation was to determine if a combined therapy of bone morphogenetic protein-2 (BMP-2) and cartilage oligomeric matrix protein angiopoietin-1 (COMP-Ang1) can potentiate the therapeutic effect of BMP-2 in a rat model of ischemic necrosis of the femoral head (INFH). INFH was surgically induced in the femoral head of rats, and the animals were divided into the following groups: 1) a sham-operated group (sham group), 2) a bovine serum albumin-injected group (BSA group), 3) a BMP-2-injected group (BMP-2 group), and 4) a COMP-Ang1 and BMP-2-injected group (COMP-Ang1 + BMP-2 group) (n = 20/group). Radiologic, histologic, and histomorphometric assessments were performed to assess femoral head morphology, vascular density, and bone resorption activity. Western blots and immunohistochemical staining were performed to evaluate production of BMP-related signaling proteins in C3H10T1/2 cells and tissues. Real-time RT-PCR was performed to investigate expression of the target integrin gene, and the effect of integrin on C3H10T1/2 cells was determined using a cell adhesion assay. Radiographs obtained six weeks after injection revealed better preservation of the architecture of the femoral head in the COMP-Ang1 + BMP-2 group compared with the BSA and BMP-2 groups. Histological findings indicated increased trabecular bone and vascularity and decreased osteoclast bone resorption activity in the COMP-Ang1 + BMP-2 group compared with those in the BSA and BMP-2 groups. The combination of COMP-Ang1 and BMP-2 increased phosphorylation of Smad1/3/5, p38, and Akt. Increased integrin alpha 3 and beta 1 mRNA expression in the COMP-Ang1 + BMP-2 group promoted cell adhesion. These results suggest that COMP-Ang1 preserved the necrotic femoral head through the potentiation of BMP-2 signaling pathways and angiogenesis. Combination treatment with COMP-Ang1 and BMP-2 may be a clinically useful therapeutic application in INFH.	[Zhou, Lu; Yoon, Sun Jung; Wagle, Sajeev; Lee, Kwang Bok; Kim, Jung Ryul] Chonbuk Natl Univ, Dept Orthoped Surg, Sch Med, Res Inst Endocrine Sci, Jeonju, South Korea; [Zhou, Lu; Yoon, Sun Jung; Jang, Kyu Yun; Wagle, Sajeev; Lee, Kwang Bok; Kim, Jung Ryul] Res Inst Clin Med, Jeonju, South Korea; [Jang, Kyu Yun] Chonbuk Natl Univ, Dept Pathol, Sch Med, Res Inst Endocrine Sci, Jeonju, South Korea; [Moon, Young Jae; Park, Byung-Hyun] Chonbuk Natl Univ, Dept Biochem, Sch Med, Res Inst Endocrine Sci, Jeonju, South Korea; [Zhou, Lu] Taishan Med Univ, Dept Sports Med, Tai An, Shandong, Peoples R China	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Shandong First Medical University & Shandong Academy of Medical Sciences	Kim, JR (corresponding author), Chonbuk Natl Univ, Dept Orthoped Surg, Sch Med, Res Inst Endocrine Sci, Jeonju, South Korea.	jrkeem@jbnu.ac.kr	Wagle, Sajeev/N-1524-2013	Wagle, Sajeev/0000-0001-9762-0262; Yoon, Sun-Jung/0000-0003-3487-6863; zhou, lu/0000-0001-9014-6350	National Research Foundation of Korea (NRF) - Korea government [2011-0028928]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (No. 2011-0028928). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aya-Ay J, 2007, J BONE MINER RES, V22, P93, DOI 10.1359/JBMR.060817; Bejar J, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-24; Bostrom MPG, 1998, CLIN ORTHOP RELAT R, pS116, DOI 10.1097/00003086-199810001-00013; Cho CH, 2005, CIRC RES, V97, P86, DOI 10.1161/01.RES.0000174093.64855.a6; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Dallabrida SM, 2005, CIRC RES, V96, DOI 10.1161/01.RES.0000158285.57191.60; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Duggirala S S, 1996, Pharm Dev Technol, V1, P165, DOI 10.3109/10837459609029891; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Galeano M, 2003, DIABETOLOGIA, V46, P546, DOI 10.1007/s00125-003-1064-1; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010; Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656; Jeong BC, 2010, BONE, V46, P479, DOI 10.1016/j.bone.2009.09.019; Kakudo N, 2006, LIFE SCI, V79, P1847, DOI 10.1016/j.lfs.2006.06.033; Kamiya N, 2008, J BONE MINER RES, V23, P2007, DOI 10.1359/JBMR.080809; Kamoshida G, 2012, FEBS J, V279, P4535, DOI 10.1111/febs.12040; Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031; Kerachian MA, 2006, ENDOTHELIUM-J ENDOTH, V13, P237, DOI 10.1080/10623320600904211; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Koppel H, 2011, NEPHROL DIAL TRANSPL, V26, P3852, DOI 10.1093/ndt/gfr324; Koh GY, 2013, TRENDS MOL MED, V19, P31, DOI 10.1016/j.molmed.2012.10.010; Lee KB, 2012, J ORTHOP RES, V30, P1985, DOI 10.1002/jor.22160; Lee KB, 2011, SPINE J, V11, P568, DOI 10.1016/j.spinee.2011.02.001; MCANDREW MP, 1984, J BONE JOINT SURG AM, V66A, P860, DOI 10.2106/00004623-198466060-00006; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Murakami N, 2003, BIOMATERIALS, V24, P2153, DOI 10.1016/S0142-9612(03)00041-3; Park BH, 2009, BONE, V44, P886, DOI 10.1016/j.bone.2009.01.366; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Patel ZS, 2008, PHARM RES-DORDR, V25, P2370, DOI 10.1007/s11095-008-9685-1; Puleo DA, 1998, J BIOMED MATER RES, V41, P104, DOI 10.1002/(SICI)1097-4636(199807)41:1<104::AID-JBM13>3.0.CO;2-N; Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P244, DOI 10.1034/j.1600-0501.1997.080311.x; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Valentin-Opran A, 2002, CLIN ORTHOP RELAT R, P110; Vandermeer JS, 2011, J BONE JOINT SURG AM, V93A, P905, DOI 10.2106/JBJS.J.00716; Winet H, 1996, BONE, V19, pS39, DOI 10.1016/S8756-3282(96)00133-0; Woo EJ, 2012, SPINE J, V12, P894, DOI 10.1016/j.spinee.2012.09.052; Youn SW, 2011, BLOOD, V117, P4376, DOI 10.1182/blood-2010-07-295964; Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633	43	3	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110593	10.1371/journal.pone.0110593	http://dx.doi.org/10.1371/journal.pone.0110593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329960	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100093
J	Caban-Martinez, AJ; Courtney, TK; Chang, WR; Lombardi, DA; Huang, YH; Brennan, MJ; Perry, MJ; Katz, JN; Verma, SK				Caban-Martinez, Alberto J.; Courtney, Theodore K.; Chang, Wen-Ruey; Lombardi, David A.; Huang, Yueng-Hsiang; Brennan, Melanye J.; Perry, Melissa J.; Katz, Jeffrey N.; Verma, Santosh K.			Preventing Slips and Falls through Leisure-Time Physical Activity: Findings from a Study of Limited-Service Restaurants	PLOS ONE			English	Article							RISK-FACTORS; OLDER-ADULTS; EXERCISE; INJURY	Background/Objective: Physical activity has been shown to be beneficial at improving health in some medical conditions and in preventing injury. Epidemiologic studies suggest that physical activity is one factor associated with a decreased risk for slips and falls in the older (>= 65 years) adult population. While the risk of slips and falls is generally lower in younger than in older adults; little is known of the relative contribution of physical activity in preventing slips and falls in younger adults. We examined whether engagement in leisure-time physical activity (LTPA) was protective of slips and falls among a younger/middle-aged (<= 50 years old) working population. Methods: 475 workers from 36 limited-service restaurants in six states in the U.S. were recruited to participate in a prospective cohort study of workplace slipping. Information on LTPA was collected at the time of enrollment. Participants reported their slip experience and work hours weekly for up to 12 weeks. We investigated the association between the rate of slipping and the rate of major slipping (i.e., slips that resulted in a fall and/or injury) and LTPA for workers 50 years of age and younger (n = 433, range 18-50 years old) using a multivariable negative binomial generalized estimating equation model. Results: The rate of major slips among workers who engaged in moderate (Adjusted Rate Ratio (RR) = 0.65; 95% Confidence Interval (CI) = [0.18-2.44]) and vigorous (RR = 0.64; 95% CI = [0.18-2.26]) LTPA, while non-significant, were approximately one-third lower than the rate of major slips among less active workers. Conclusion: While not statistically significant, the results suggest a potential association between engagement in moderate and vigorous LTPA and the rate of major slips in younger adults. Additional studies that examine the role of occupational and non-occupational physical activity on the risk of slips, trips and falls among younger and middle aged adults appear warranted.	[Caban-Martinez, Alberto J.; Courtney, Theodore K.; Lombardi, David A.; Brennan, Melanye J.; Verma, Santosh K.] Liberty Mutual Res Inst Safety, Ctr Injury Epidemiol, Hopkinton, MA 01748 USA; [Caban-Martinez, Alberto J.; Courtney, Theodore K.; Lombardi, David A.; Katz, Jeffrey N.; Verma, Santosh K.] Harvard Univ, Dept Environm Hlth, Environm & Occupat Med & Epidemiol Program, Sch Publ Hlth, Boston, MA 02115 USA; [Caban-Martinez, Alberto J.; Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Orthoped Surg, Orthopaed & Arthrit Ctr Outcomes Res, Boston, MA 02115 USA; [Caban-Martinez, Alberto J.; Katz, Jeffrey N.] Harvard Univ, Sch Med, Boston, MA USA; [Chang, Wen-Ruey] Liberty Mutual Res Inst Safety, Ctr Phys Ergon, Hopkinton, MA USA; [Huang, Yueng-Hsiang] Liberty Mutual Res Inst Safety, Ctr Behav Sci, Hopkinton, MA USA; [Perry, Melissa J.] George Washington Univ, Dept Environm & Occupat Hlth, Washington, DC USA; [Verma, Santosh K.] Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA USA	Liberty Mutual Research Institute for Safety; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Liberty Mutual Research Institute for Safety; Liberty Mutual Research Institute for Safety; George Washington University; University of Massachusetts System; University of Massachusetts Worcester	Verma, SK (corresponding author), Liberty Mutual Res Inst Safety, Ctr Injury Epidemiol, Hopkinton, MA 01748 USA.	Santosh.Verma@LibertyMutual.com	Courtney, Theodore K./P-4829-2019; Courtney, Theodore/J-8902-2013; Caban-Martinez, Alberto/AAG-1499-2019	Courtney, Theodore K./0000-0001-8139-1565; Courtney, Theodore/0000-0001-8139-1565; Caban-Martinez, Alberto/0000-0002-5960-1308; Lombardi, David/0000-0001-6151-2024; Verma, Santosh/0000-0001-9285-0325; Chang, Wen-Ruey/0000-0003-0116-1386	Liberty Mutual Research Institute for Safety; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [T32 AR055885]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR055885] Funding Source: NIH RePORTER	Liberty Mutual Research Institute for Safety; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding support to accomplish the research was largely supported by the Liberty Mutual Research Institute for Safety and from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant T32 AR055885 (PI: Katz) to the Clinical Orthopedic and Musculoskeletal Education and Training (COMET) Program at Brigham and Women's Hospital, Harvard Medical School and Harvard School of Public Health (Trainee: Caban-Martinez). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boaro Nancy, 2009, Evid Based Nurs, V12, P86, DOI 10.1136/ebn.12.3.86; Demura S, 2012, ARCH GERONTOL GERIAT, V55, P186, DOI 10.1016/j.archger.2011.06.033; Gauchard GC, 2003, OCCUP ENVIRON MED, V60, P330, DOI 10.1136/oem.60.5.330; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hoidrup S, 2001, AM J EPIDEMIOL, V154, P60, DOI 10.1093/aje/154.1.60; Holroyd-Leduc Jayna M, 2009, Evid Based Med, V14, P176, DOI 10.1136/ebm.14.6.176; Moayyeri A, 2008, ANN EPIDEMIOL, V18, P827, DOI 10.1016/j.annepidem.2008.08.007; NORTHRIDGE ME, 1995, AM J PUBLIC HEALTH, V85, P509, DOI 10.2105/AJPH.85.4.509; PROVINCE MA, 1995, JAMA-J AM MED ASSOC, V273, P1341, DOI 10.1001/jama.273.17.1341; Schiller Jeannine S, 2007, Adv Data, P1; Suzuki T, 2004, J BONE MINER METAB, V22, P602, DOI 10.1007/s00774-004-0530-2; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; Tideiksaar R, 1996, GERIATRICS, V51, P43; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; Unsworth John, 2003, Br J Community Nurs, V8, P214; Verma SK, 2011, OCCUP ENVIRON MED, V68, P279, DOI 10.1136/oem.2010.056218; Verma SK, 2010, J OCCUP ENVIRON HYG, V7, P491, DOI 10.1080/15459624.2010.486693; Yamashita T, 2012, GERONTOLOGIST, V52, P822, DOI 10.1093/geront/gns043	19	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110248	10.1371/journal.pone.0110248	http://dx.doi.org/10.1371/journal.pone.0110248			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9XC	25329816	Green Published, gold			2022-12-27	WOS:000343210800072
J	Wang, Q; Zhang, SY; Pang, SC; Zhang, MH; Wang, B; Liu, Q; Li, J				Wang, Qing; Zhang, Siyi; Pang, Shichao; Zhang, Menghuan; Wang, Bo; Liu, Qi; Li, Jing			GroupRank: Rank Candidate Genes in PPI Network by Differentially Expressed Gene Groups	PLOS ONE			English	Article							PRIORITIZATION; INTERACTOME; RESOURCE; DATABASE; CANCER	Many cell activities are organized as a network, and genes are clustered into co-expressed groups if they have the same or closely related biological function or they are co-regulated. In this study, based on an assumption that a strong candidate disease gene is more likely close to gene groups in which all members coordinately differentially express than individual genes with differential expression, we developed a novel disease gene prioritization method GroupRank by integrating gene co-expression and differential expression information generated from microarray data as well as PPI network. A candidate gene is ranked high using GroupRank if it is differentially expressed in disease and control or is close to differentially co-expressed groups in PPI network. We tested our method on data sets of lung, kidney, leukemia and breast cancer. The results revealed GroupRank could efficiently prioritize disease genes with significantly improved AUC value in comparison to the previous method with no consideration of co-exprssed gene groups in PPI network. Moreover, the functional analyses of the major contributing gene group in gene prioritization of kidney cancer verified that our algorithm GroupRank not only ranks disease genes efficiently but also could help us identify and understand possible mechanisms in important physiological and pathological processes of disease.	[Wang, Qing; Zhang, Siyi; Pang, Shichao; Zhang, Menghuan; Wang, Bo; Liu, Qi; Li, Jing] Shanghai Jiao Tong Univ, Dept Bioinformat & Biostat, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Liu, Qi] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Liu, Qi] Vanderbilt Univ, Sch Med, Ctr Quantitat Sci, Nashville, TN 37212 USA; [Li, Jing] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Vanderbilt University; Vanderbilt University; Chinese Academy of Sciences	Liu, Q (corresponding author), Shanghai Jiao Tong Univ, Dept Bioinformat & Biostat, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	qi.liu@vanderbilt.edu; jing.li@sjtu.edu.cn		Pang, Shichao/0000-0002-4111-2864	National Natural Science Foundation of China [31271416, 31000582, J1210047]; National Key Basic Research Program [2011CB910204]; Pujiang Talent Program [12PJ1406600]; Program for "Chen Xing'' Young Scholars, Shanghai Jiao Tong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); Pujiang Talent Program; Program for "Chen Xing'' Young Scholars, Shanghai Jiao Tong University	The authors acknowledge the support by National Natural Science Foundation of China (31271416, 31000582, J1210047), National Key Basic Research Program (2011CB910204). Additional support from Pujiang Talent Program (12PJ1406600) and Program for "Chen Xing'' Young Scholars, Shanghai Jiao Tong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Chen YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021137; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gaire RK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S7; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Haixuan Yang, 2007, 30th Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P431, DOI 10.1145/1277741.1277815; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Ma XT, 2007, BIOINFORMATICS, V23, P215, DOI 10.1093/bioinformatics/btl569; Nitsch D, 2011, NUCLEIC ACIDS RES, V39, pW334, DOI 10.1093/nar/gkr289; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; SHORT BG, 1993, ENVIRON HEALTH PERSP, V101, P115, DOI 10.2307/3431853; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024306	26	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110406	10.1371/journal.pone.0110406	http://dx.doi.org/10.1371/journal.pone.0110406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330105	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800083
J	Ashor, AW; Lara, J; Siervo, M; Celis-Morales, C; Mathers, JC				Ashor, Ammar W.; Lara, Jose; Siervo, Mario; Celis-Morales, Carlos; Mathers, John C.			Effects of Exercise Modalities on Arterial Stiffness and Wave Reflection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							ALL-CAUSE MORTALITY; INTENSITY INTERMITTENT EXERCISE; AEROBIC EXERCISE; BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; PHYSICAL-ACTIVITY; VASCULAR FUNCTION; OXIDATIVE STRESS; OLDER-ADULTS; NITRIC-OXIDE	Background and Objectives: Physical activity is associated with lower cardiovascular and all-cause mortality. However, the effects of different exercise modalities on arterial stiffness are currently unclear. Our objectives were to investigate the effects of exercise modalities (aerobic, resistance or combined) on pulse wave velocity (PWV) and augmentation index (AIx), and to determine whether the effects on these indices differed according to the participants' or exercise characteristics. Methods: We searched the Medline, Embase and Cochrane Library databases from inception until April 2014 for randomized controlled trials lasting >= 4 weeks investigating the effects of exercise modalities on PWV and AIx in adults aged >= 18 years. Results: Forty-two studies (1627 participants) were included in this analysis. Aerobic exercise improved both PWV (WMD: -0.63 m/s, 95% CI: -0.90, -0.35) and AIx (WMD: -2.63%, 95% CI: -5.25 to -0.02) significantly. Aerobic exercise training showed significantly greater reduction in brachial-ankle (WMD: -1.01 m/s, 95% CI: -1.57, -0.44) than in carotid-femoral (WMD: -0.39 m/s, 95% CI: -0.52, -0.27) PWV. Higher aerobic exercise intensity was associated with larger reductions in AIx (beta: -1.55%, CI -3.09, 0.0001). In addition, aerobic exercise had a significantly larger effect in reducing PWV (WMD: -1.0 m/s, 95% CI: -1.43, -0.57) in participants with stiffer arteries (PWV >= 8 m/s). Resistance exercise had no effect on PWV and AIx. There was no significant effect of combined exercise on PWV and AIx. Conclusions: We conclude that aerobic exercise improved arterial stiffness significantly and that the effect was enhanced with higher aerobic exercise intensity and in participants with greater arterial stiffness at baseline.	[Ashor, Ammar W.; Lara, Jose; Siervo, Mario; Celis-Morales, Carlos; Mathers, John C.] Newcastle Univ, Inst Cellular Med, Human Nutr Res Ctr, Newcastle Upon Tyne, England; [Ashor, Ammar W.] Univ Al Mustansiriyah, Coll Med, Baghdad, Iraq	Newcastle University - UK; Mustansiriya University	Ashor, AW (corresponding author), Newcastle Univ, Inst Cellular Med, Human Nutr Res Ctr, Campus Ageing & Vital, Newcastle Upon Tyne, England.	a.w.ashor@ncl.ac.uk	Ashor, Ammar Waham/A-9094-2013; Celis-Morales, Carlos/AAJ-5103-2020; Stefanadis, Christodoulos/ABH-2232-2020; Siervo, Mario/AAB-9302-2019	Ashor, Ammar Waham/0000-0002-0826-5471; Stefanadis, Christodoulos/0000-0001-5974-6454; Siervo, Mario/0000-0001-5515-0944; Lara, Jose/0000-0002-4449-9304; Celis-Morales, Carlos/0000-0003-2612-3917; Mathers, John/0000-0003-3406-3002	Lifelong Health and Wellbeing (LLHW) initiative, [G0900686]; MRC [G0700718, MR/K006312/1, G0900686] Funding Source: UKRI; Medical Research Council [G0700718, MR/K006312/1, G0900686] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH111030] Funding Source: researchfish	Lifelong Health and Wellbeing (LLHW) initiative,; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NIHR Newcastle Biomedical Research Centre	AA is funded by the Ministry of Higher Education and Scientific Research of Iraq. JL and JCM acknowledge support from the LiveWell Programme a research project funded through a collaborative grant from the Lifelong Health and Wellbeing (LLHW) initiative, managed by the Medical Research Council (MRC) (grant number G0900686). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck DT, 2013, AM J HYPERTENS, V26, P1093, DOI 10.1093/ajh/hpt080; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Choi KM, 2012, J CLIN ENDOCR METAB, V97, P3751, DOI 10.1210/jc.2012-1951; Ciolac EG, 2010, HYPERTENS RES, V33, P836, DOI 10.1038/hr.2010.72; Correia Marcelo L G, 2007, Curr Diab Rep, V7, P269, DOI 10.1007/s11892-007-0043-1; Cortez-Cooper MY, 2008, EUR J CARDIOV PREV R, V15, P149, DOI 10.1097/HJR.0b013e3282f02fe2; Crowther M, 2010, BLOOD, V116, P3140, DOI 10.1182/blood-2010-05-280883; Croymans DM, 2014, J HUM HYPERTENS, V28, P157, DOI 10.1038/jhh.2013.81; Cummings P, 2011, ARCH PEDIAT ADOL MED, V165, P592, DOI 10.1001/archpediatrics.2011.97; DeLoach SS, 2008, CLIN J AM SOC NEPHRO, V3, P184, DOI 10.2215/CJN.03340807; Dobrosielski DA, 2012, J GEN INTERN MED, V27, P1453, DOI 10.1007/s11606-012-2103-8; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Ferrier KE, 2001, HYPERTENSION, V38, P222, DOI 10.1161/01.HYP.38.2.222; Figueroa A, 2011, MENOPAUSE, V18, P980, DOI 10.1097/gme.0b013e3182135442; Gielen S, 2010, CIRCULATION, V122, P1221, DOI 10.1161/CIRCULATIONAHA.110.939959; Goldberg MJ, 2012, J HUM HYPERTENS, V26, P644, DOI 10.1038/jhh.2011.95; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Guimaraes GV, 2010, HYPERTENS RES, V33, P627, DOI 10.1038/hr.2010.42; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Heffernan KS, 2013, HYPERTENS RES, V36, P422, DOI 10.1038/hr.2012.198; Heydari M, 2013, INT J PSYCHOPHYSIOL, V87, P141, DOI 10.1016/j.ijpsycho.2012.11.013; Heydari M, 2013, CLIN AUTON RES, V23, P57, DOI 10.1007/s10286-012-0179-1; Higashi Y, 2004, PHARMACOL THERAPEUT, V102, P87, DOI 10.1016/j.pharmthera.2004.02.003; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho SS, 2012, J CLIN HYPERTENS, V14, P848, DOI 10.1111/j.1751-7176.2012.00700.x; Howley ET, 2001, MED SCI SPORT EXER, V33, pS364, DOI 10.1097/00005768-200106001-00005; Kawasaki T, 2011, HYPERTENS RES, V34, P1059, DOI 10.1038/hr.2011.81; Kearney TM, 2014, J AM SOC HYPERTENS, V8, P117, DOI 10.1016/j.jash.2013.10.001; Koh KP, 2010, AM J KIDNEY DIS, V55, P88, DOI 10.1053/j.ajkd.2009.09.025; Kojda G, 2005, CARDIOVASC RES, V67, P187, DOI 10.1016/j.cardiores.2005.04.032; Krustrup P, 2010, SCAND J MED SCI SPOR, V20, P40, DOI 10.1111/j.1600-0838.2010.01110.x; Krustrup P, 2013, MED SCI SPORT EXER, V45, P553, DOI 10.1249/MSS.0b013e3182777051; Laurent S, 2007, J NEPHROL, V20, pS45; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Loimaala A, 2009, AM J CARDIOL, V103, P972, DOI 10.1016/j.amjcard.2008.12.026; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Madden KM, 2013, J HUM HYPERTENS, V27, P335, DOI 10.1038/jhh.2012.38; Madden KM, 2009, DIABETES CARE, V32, P1531, DOI 10.2337/dc09-0149; Marzolini S, 2012, EUR J PREV CARDIOL, V19, P81, DOI 10.1177/1741826710393197; Miura H, 2008, EUR J APPL PHYSIOL, V104, P1039, DOI 10.1007/s00421-008-0860-1; Miyachi M, 2004, CIRCULATION, V110, P2858, DOI 10.1161/01.CIR.0000146380.08401.99; Miyachi M, 2013, BRIT J SPORT MED, V47, P393, DOI 10.1136/bjsports-2012-090488; Montero D, 2014, SPORTS MED, V44, P833, DOI 10.1007/s40279-014-0165-y; Montero D, 2014, INT J CARDIOL, V173, P361, DOI 10.1016/j.ijcard.2014.03.072; Mora S, 2007, CIRCULATION, V116, P2110, DOI 10.1161/CIRCULATIONAHA.107.729939; Munk PS, 2009, AM HEART J, V158, P734, DOI 10.1016/j.ahj.2009.08.021; Mustata S, 2011, INT UROL NEPHROL, V43, P1133, DOI 10.1007/s11255-010-9823-7; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Nualnim N, 2012, AM J CARDIOL, V109, P1005, DOI 10.1016/j.amjcard.2011.11.029; Ohta M, 2012, GROWTH HORM IGF RES, V22, P36, DOI 10.1016/j.ghir.2011.12.004; Okamoto T, 2008, J HUM HYPERTENS, V22, P509, DOI 10.1038/jhh.2008.12; Okamoto T, 2006, J HUM HYPERTENS, V20, P348, DOI 10.1038/sj.jhh.1001979; Okamoto T, 2013, INT J SPORTS MED, V34, P385, DOI 10.1055/s-0032-1312604; Okamoto T, 2009, J HUM HYPERTENS, V23, P470, DOI 10.1038/jhh.2008.152; Okamoto T, 2007, J APPL PHYSIOL, V103, P1655, DOI 10.1152/japplphysiol.00327.2007; Okamoto T, 2011, EUR J APPL PHYSIOL, V111, P743, DOI 10.1007/s00421-010-1702-5; Okamoto T, 2009, EUR J APPL PHYSIOL, V107, P127, DOI 10.1007/s00421-009-1110-x; Olson TP, 2006, MED SCI SPORT EXER, V38, P1558, DOI 10.1249/01.mss.0000227540.58916.0e; Oudegeest-Sander MH, 2013, EXP GERONTOL, V48, P1509, DOI 10.1016/j.exger.2013.10.009; Padilla J, 2008, VASC MED, V13, P105, DOI 10.1177/1358863x07086671; Park S, 2012, YONSEI MED J, V53, P258, DOI 10.3349/ymj.2012.53.2.258; Parnell MM, 2002, CLIN SCI, V102, P1, DOI 10.1042/CS20010107; Patel RS, 2011, ATHEROSCLEROSIS, V218, P90, DOI 10.1016/j.atherosclerosis.2011.04.033; Rakobowchuk M, 2009, EUR J APPL PHYSIOL, V105, P787, DOI 10.1007/s00421-008-0964-7; Roque FR, 2013, BRIT J PHARMACOL, V168, P686, DOI 10.1111/j.1476-5381.2012.02224.x; Sakuragi S, 2010, INT J CARDIOL, V138, P112, DOI 10.1016/j.ijcard.2009.04.027; Schuler G, 2013, EUR HEART J, V34, P1790, DOI 10.1093/eurheartj/eht111; Seals DR, 2008, J APPL PHYSIOL, V105, P1323, DOI 10.1152/japplphysiol.90553.2008; Shirwany NA, 2010, ACTA PHARMACOL SIN, V31, P1267, DOI 10.1038/aps.2010.123; Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317; Stewart KJ, 2005, ARCH INTERN MED, V165, P756, DOI 10.1001/archinte.165.7.756; Sugawara J, 2012, AM J HYPERTENS, V25, P651, DOI 10.1038/ajh.2012.24; Teixeira-Lemos E, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-12; Toussaint ND, 2008, HEMODIAL INT, V12, P254, DOI 10.1111/j.1542-4758.2008.00262.x; Vlachopoulos C, 2012, HYPERTENSION, V60, P556, DOI 10.1161/HYPERTENSIONAHA.112.194779; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Vona M, 2009, CIRCULATION, V119, P1601, DOI 10.1161/CIRCULATIONAHA.108.821736; Westhoff TH, 2008, J HYPERTENS, V26, P1336, DOI 10.1097/HJH.0b013e3282ffac13; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002; Wong A, 2014, J HUM HYPERTENS, V28, P246, DOI 10.1038/jhh.2013.98; Yasmin, 1999, QJM-INT J MED, V92, P595, DOI 10.1093/qjmed/92.10.595; Yoshizawa M, 2009, BRIT J SPORT MED, V43, P615, DOI 10.1136/bjsm.2008.052126; Zoungas S, 2007, CLIN EXP PHARMACOL P, V34, P647, DOI 10.1111/j.1440-1681.2007.04654.x	85	266	268	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110034	10.1371/journal.pone.0110034	http://dx.doi.org/10.1371/journal.pone.0110034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333969	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000346766200082
J	Nuytens, K; Tuand, K; Fu, QL; Stijnen, P; Pruniau, V; Meulemans, S; Vankelecom, H; Creemers, JWM				Nuytens, Kim; Tuand, Krizia; Fu, Quili; Stijnen, Pieter; Pruniau, Vincent; Meulemans, Sandra; Vankelecom, Hugo; Creemers, John W. M.			The Dwarf Phenotype in GH240B Mice, Haploinsufficient for the Autism Candidate Gene Neurobeachin, Is Caused by Ectopic Expression of Recombinant Human Growth Hormone	PLOS ONE			English	Article							LOCUS-CONTROL REGION; COPY NUMBER VARIANTS; SPECTRUM DISORDER; SOMATOSTATIN; SECRETION; HYPOTHALAMUS; ACTIVATION; RECEPTORS; DELETION; PATIENT	Two knockout mouse models for the autism candidate gene Neurobeachin (Nbea) have been generated independently. Although both models have similar phenotypes, one striking difference is the dwarf phenotype observed in the heterozygous configuration of the GH240B model that is generated by the serendipitous insertion of a promoterless human growth hormone (hGH) genomic fragment in the Nbea gene. In order to elucidate this discrepancy, the dwarfism present in this Nbea mouse model was investigated in detail. The growth deficiency in Nbea(+/-) mice coincided with an increased percentage of fat mass and a decrease in bone mineral density. Low but detectable levels of hGH were detected in the pituitary and hypothalamus of Nbea(+/-) mice but not in liver, hippocampus nor in serum. As a consequence, several members of the mouse growth hormone (mGH) signaling cascade showed altered mRNA levels, including a reduction in growth hormone-releasing hormone mRNA in the hypothalamus. Moreover, somatotrope cells were less numerous in the pituitary of Nbea(+/-) mice and both contained and secreted significantly less mGH resulting in reduced levels of circulating insulin-like growth factor 1. These findings demonstrate that the random integration of the hGH transgene in this mouse model has not only inactivated Nbea but has also resulted in the tissue-specific expression of hGH causing a negative feedback loop, mGH hyposecretion and dwarfism.	[Nuytens, Kim; Tuand, Krizia; Stijnen, Pieter; Pruniau, Vincent; Meulemans, Sandra; Creemers, John W. M.] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium; [Nuytens, Kim; Tuand, Krizia; Creemers, John W. M.] Katholieke Univ Leuven, Leuven Autism Res Consortium LAuRes, Leuven, Belgium; [Fu, Quili; Vankelecom, Hugo] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Creemers, JWM (corresponding author), Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium.	john.creemers@med.kuleuven.be	Tuand, Krizia/AAF-7888-2019; Tuand, Krizia/E-1657-2015	Tuand, Krizia/0000-0003-2670-5415; Tuand, Krizia/0000-0003-2670-5415; stijnen, pieter/0000-0002-3047-6902; Vankelecom, Hugo/0000-0002-2251-7284	Fonds wetenschappelijk onderzoek [G1187213N]; het agentschap voor innovatie, wetenschap en techniek [083312]; stichting Marguerite-Marie Delacroix [PC-301]; KU Leuven interdisciplinary research applications [IDO/08/13]	Fonds wetenschappelijk onderzoek(FWO); het agentschap voor innovatie, wetenschap en techniek; stichting Marguerite-Marie Delacroix; KU Leuven interdisciplinary research applications	KT received funding from Fonds wetenschappelijk onderzoek (G1187213N; www.fwo.be). KN received funding from het agentschap voor innovatie, wetenschap en techniek (083312; www.iwt.be). JWMC received funding from stichting Marguerite-Marie Delacroix (PC-301; www.stichtingdelacroix.be) and from KU Leuven interdisciplinary research applications (IDO/08/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anlar B, 2007, NEUROPEDIATRICS, V38, P151, DOI 10.1055/s-2007-990282; Brinkmeier ML, 2001, MOL ENDOCRINOL, V15, P2129, DOI 10.1210/me.15.12.2129; Castermans D, 2003, J MED GENET, V40, P352, DOI 10.1136/jmg.40.5.352; Castermans D, 2010, HUM MOL GENET, V19, P1368, DOI 10.1093/hmg/ddq013; Celestino-Soper PBS, 2011, HUM MOL GENET, V20, P4360, DOI 10.1093/hmg/ddr363; Flavell DM, 1996, EMBO J, V15, P3871, DOI 10.1002/j.1460-2075.1996.tb00761.x; Fleetwood MR, 2012, J BIOL CHEM, V287, P25454, DOI 10.1074/jbc.M112.365825; FRAWLEY LS, 1991, ENDOCR REV, V12, P337, DOI 10.1210/edrv-12-4-337; Fu QL, 2012, ENDOCRINOLOGY, V153, P3224, DOI 10.1210/en.2012-1152; Goffin V, 1996, ENDOCR REV, V17, P385, DOI 10.1210/er.17.4.385; Ho YG, 2002, MOL CELL, V9, P291, DOI 10.1016/S1097-2765(02)00447-1; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Kineman RD, 1996, ENDOCRINOLOGY, V137, P4630, DOI 10.1210/endo.137.11.8895326; Kumar U, 1997, ENDOCRINOLOGY, V138, P4473, DOI 10.1210/en.138.10.4473; Kumar U, 2010, RESULTS PROBL CELL D, V50, P137, DOI 10.1007/400_2009_29; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACLEOD JN, 1991, J ENDOCRINOL, V131, P395, DOI 10.1677/joe.0.1310395; Mayo KE, 1996, ANN NY ACAD SCI, V805, P184, DOI 10.1111/j.1749-6632.1996.tb17483.x; Medrihan L., 2009, J PHYSL; Mills JL, 2007, CLIN ENDOCRINOL, V67, P230, DOI 10.1111/j.1365-2265.2007.02868.x; Minami S, 1998, ENDOCR J, V45, pS19, DOI 10.1507/endocrj.45.Suppl_S19; Nair R, 2013, J CELL BIOL, V200, P61, DOI 10.1083/jcb.201207113; Niesmann K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1565; Nuytens K, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-43; Nuytens K, 2013, NEUROBIOL DIS, V51, P144, DOI 10.1016/j.nbd.2012.11.004; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Olszewski PK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002568; Prasad A, 2012, G3-GENES GENOM GENET, V2, P1665, DOI 10.1534/g3.112.004689; Pruniau VP, 2013, HEPATOLOGY; Reddy Kavita S, 2005, BMC Med Genet, V6, P3, DOI 10.1186/1471-2350-6-3; Rhodin JAG, 1974, HISTOLOGY TEXT ATLAS, P427; Riikonen R, 2006, DEV MED CHILD NEUROL, V48, P751, DOI 10.1017/S0012162206001605; RITVO ER, 1988, ARCH GEN PSYCHIAT, V45, P600; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Smith M, 2002, CYTOGENET GENOME RES, V98, P233, DOI 10.1159/000071040; Su YH, 2004, J NEUROSCI, V24, P3627, DOI 10.1523/JNEUROSCI.4644-03.2004; SZABO M, 1995, ENDOCRINOLOGY, V136, P4044, DOI 10.1210/en.136.9.4044; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	41	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109598	10.1371/journal.pone.0109598	http://dx.doi.org/10.1371/journal.pone.0109598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333629	gold, Green Submitted, Green Published			2022-12-27	WOS:000346766200043
J	Sossauer, G; Zbinden, M; Tebeu, PM; Fosso, GK; Untiet, S; Vassilakos, P; Petignat, P				Sossauer, Gaetan; Zbinden, Michel; Tebeu, Pierre-Marie; Fosso, Gisele K.; Untiet, Sarah; Vassilakos, Pierre; Petignat, Patrick			Impact of an Educational Intervention on Women's Knowledge and Acceptability of Human Papillomavirus Self-Sampling: A Randomized Controlled Trial in Cameroon	PLOS ONE			English	Article							CERVICAL-CANCER; COLLECTED SAMPLES; PREVENTION	Objective: Human papillomavirus (HPV) self-sampling (Self-HPV) may be used as a primary cervical cancer screening method in a low resource setting. Our aim was to evaluate whether an educational intervention would improve women's knowledge and confidence in the Self-HPV method. Method: Women aged between 25 and 65 years old, eligible for cervical cancer screening, were randomly chosen to receive standard information (control group) or standard information followed by educational intervention (interventional group). Standard information included explanations about what the test detects (HPV), the link between HPV and cervical cancer and how to perform HPV self-sampling. The educational intervention consisted of a culturally tailored video about HPV, cervical cancer, Self-HPV and its relevancy as a screening test. All participants completed a questionnaire that assessed sociodemographic data, women's knowledge about cervical cancer and acceptability of Self-HPV. Results: A total of 302 women were enrolled in 4 health care centers in Yaounde and the surrounding countryside. 301 women (149 in the "control group'' and 152 in the "intervention group'') completed the full process and were included into the analysis. Participants who received the educational intervention had a significantly higher knowledge about HPV and cervical cancer than the control group (p < 0.05), but no significant difference on Self-HPV acceptability and confidence in the method was noticed between the two groups. Conclusion: Educational intervention promotes an increase in knowledge about HPV and cervical cancer. Further investigation should be conducted to determine if this intervention can be sustained beyond the short term and influences screening behavior. Trials Registration: International Standard Randomised Controlled Trial Number (ISRCTN) Register ISRCTN78123709	[Sossauer, Gaetan; Zbinden, Michel] Univ Geneva, Fac Med, Geneva, Switzerland; [Tebeu, Pierre-Marie; Fosso, Gisele K.] Univ Ctr Hosp, Dept Gynecol & Obstet, Yaounde, Cameroon; [Untiet, Sarah; Petignat, Patrick] Univ Hosp Geneva, Dept Gynecol & Obstet, Gynecol Div, Geneva, Switzerland; [Vassilakos, Pierre] Geneva Fdn Med Educ & Res, Geneva, Switzerland	University of Geneva; University of Geneva	Sossauer, G (corresponding author), Univ Geneva, Fac Med, Geneva, Switzerland.	gaetan.sossauer@gmail.com; zbindem6@etu.unige.ch		Petignat, Patrick/0000-0002-6835-533X	"Solidarite Internationale Geneve", University Hospitals of Geneva, Switzerland; UBS Geneve	"Solidarite Internationale Geneve", University Hospitals of Geneva, Switzerland; UBS Geneve	This study was supported by a grant from "Solidarite Internationale Geneve", the University Hospitals of Geneva, Switzerland, and UBS Geneve. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berner A, 2013, J LOW GENIT TRACT DI; Bosch FX, 2002, CAUSAL RELATION HUMA; Chirwa Susan, 2010, Glob Health Promot, V17, P47, DOI 10.1177/1757975910363938; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Dzuba IG, 2002, J WOMEN HEALTH GEN-B, V11, P265, DOI 10.1089/152460902753668466; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; Franco E, 1996, CANCER EPIDEM BIOMAR, V5, P853; FREE K, 1991, GYNECOL ONCOL, V43, P129, DOI 10.1016/0090-8258(91)90058-D; Gaffikin L, 2003, LANCET, V361, P814, DOI 10.1016/S0140-6736(03)12707-9; Gichangi P, 2003, INT J GYNECOL CANCER, V13, P827, DOI 10.1111/j.1525-1438.2003.13612.x; Gimeno-Garcia AZ, 2009, CANCER EPIDEMIOL, V33, P216, DOI 10.1016/j.canep.2009.08.003; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Love GD, 2012, J CANCER EDUC, P1; Miller Anthony B., 2000, International Journal of Cancer, V86, P440, DOI 10.1002/(SICI)1097-0215(20000501)86:3<440::AID-IJC22>3.3.CO;2-1; Mitchell S, 2011, INT J GYNECOL OBSTET, V114, P111, DOI 10.1016/j.ijgo.2011.01.028; Nene B, 2007, DETERMINANTS WOMENS; Nzarubara RG, 1999, E AFR MED J, V76, P661; Papa D, 2009, J LOW GENIT TRACT DI, V13, P66, DOI 10.1097/LGT.0b013e31818a53f0; Petignat P, 2007, GYNECOL ONCOL, V105, P530, DOI 10.1016/j.ygyno.2007.01.023; Rositch AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040766; Rwamugira J, 2012, EUR J CANCER CARE, V21, P266, DOI 10.1111/j.1365-2354.2011.01310.x; Sankaranarayanan R, 2005, INT J GYNECOL OBSTET, V89, pS4, DOI 10.1016/j.ijgo.2005.01.009; Tebeu PM, 2008, INT J GYNECOL CANCER, V18, P761, DOI 10.1111/j.1525-1438.2007.01066.x; Waller J, 2006, J MED SCREEN, V13, P208, DOI 10.1177/096914130601300409; Wang JHY, 2012, CANCER EPIDEM BIOMAR, V21, P1923, DOI 10.1158/1055-9965.EPI-12-0821; Wright KO, 2010, ASIAN PAC J CANCER P, V11, P137	26	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109788	10.1371/journal.pone.0109788	http://dx.doi.org/10.1371/journal.pone.0109788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333793	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200052
J	Zhao, QC; Liu, MH; Tan, MM; Gao, JH; Shen, ZC				Zhao, Qichao; Liu, Minghong; Tan, Miaomiao; Gao, Jianhua; Shen, Zhicheng			Expression of Cry1Ab and Cry2Ab by a Polycistronic Transgene with a Self-Cleavage Peptide in Rice	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXINS; INSECT RESISTANCE; FIELD-EVALUATION; INDICA RICE; BT CROPS; PLANTS; GENE; PROTEIN; 2A	Insect resistance to Bacillus thuringiensis (Bt) crystal protein is a major threat to the long-term use of transgenic Bt crops. Gene stacking is a readily deployable strategy to delay the development of insect resistance while it may also broaden insecticidal spectrum. Here, we report the creation of transgenic rice expressing discrete Cry1Ab and Cry2Ab simultaneously from a single expression cassette using 2A self-cleaving peptides, which are autonomous elements from virus guiding the polycistronic viral gene expression in eukaryotes. The synthetic coding sequences of Cry1Ab and Cry2Ab, linked by the coding sequence of a 2A peptide from either foot and mouth disease virus or porcine teschovirus-1, regardless of order, were all expressed as discrete Cry1Ab and Cry2Ab at high levels in the transgenic rice. Insect bioassays demonstrated that the transgenic plants were highly resistant to lepidopteran pests. This study suggested that 2A peptide can be utilized to express multiple Bt genes at high levels in transgenic crops.	[Zhao, Qichao; Liu, Minghong; Tan, Miaomiao; Shen, Zhicheng] Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Gao, Jianhua] Shanxi Agr Univ, Coll Life Sci, Taigu, Peoples R China	Zhejiang University; Shanxi Agricultural University	Shen, ZC (corresponding author), Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	zcshen@zju.edu.cn			The National Natural Science Foundation of China [31021003]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by The National Natural Science Foundation of China (31021003, http://www.nsfc.gov.cn/) received by Zc Shen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir K, 2004, MOL BREEDING, V13, P301, DOI 10.1023/B:MOLB.0000034078.54872.25; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Brown JD, 2010, NUCLEIC ACIDS MOL BI, V24, P101, DOI 10.1007/978-0-387-89382-2_5; Cao J, 2002, THEOR APPL GENET, V105, P258, DOI 10.1007/s00122-002-0942-0; Chen H, 2005, THEOR APPL GENET, V111, P1330, DOI 10.1007/s00122-005-0062-8; Chen Y, 2010, J ECON ENTOMOL, V103, P1444, DOI 10.1603/EC10014; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Ha SH, 2010, PLANT BIOTECHNOL J, V8, P928, DOI 10.1111/j.1467-7652.2010.00543.x; Halpin C, 1999, PLANT J, V17, P453, DOI 10.1046/j.1365-313X.1999.00394.x; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Heiberger R. M., 2009, ONE WAY ANOVA R EXCE, P165; Hiei Y, 1997, PLANT MOL BIOL, V35, P205, DOI 10.1023/A:1005847615493; Luke GA, 2010, BIOTECHNOL GENET ENG, V26, P223; Perlak FJ, 2001, PLANT J, V27, P489, DOI 10.1046/j.1365-313X.2001.01120.x; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Ryan M, 2014, 2A 2A SEQUENCES; Sainsbury F, 2012, TOXINS, V4, P455, DOI 10.3390/toxins4060455; Hernandez-Rodriguez CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068164; Shelton AM, 2000, NAT BIOTECHNOL, V18, P339, DOI 10.1038/73804; Shu QY, 2000, MOL BREEDING, V6, P433, DOI 10.1023/A:1009658024114; Szymczak-Workman AL, 2012, COLD SPRING HARBOR P, V2012; Szymczak-Workman AL., 2012, COLD SPRING HARBOR P, V2012; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tang W, 2006, MOL BREEDING, V18, P1, DOI 10.1007/s11032-006-9002-9; Tian JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035164; Wang P, 2006, APPL ENVIRON MICROB; Ye GY, 2001, J ECON ENTOMOL, V94, P271, DOI 10.1603/0022-0493-94.1.271; Zhao JZ, 2003, NAT BIOTECHNOL, V21, P1493, DOI 10.1038/nbt907	29	15	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110006	10.1371/journal.pone.0110006	http://dx.doi.org/10.1371/journal.pone.0110006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333312	Green Submitted, gold, Green Published			2022-12-27	WOS:000346766200074
J	Ao, M; Miyauchi, M; Inubushi, T; Kitagawa, M; Furusho, H; Ando, T; Ayuningtyas, NF; Nagasaki, A; Ishihara, K; Tahara, H; Kozai, K; Takata, T				Ao, Min; Miyauchi, Mutsumi; Inubushi, Toshihiro; Kitagawa, Masae; Furusho, Hisako; Ando, Toshinori; Ayuningtyas, Nurina Febriyanti; Nagasaki, Atsuhiro; Ishihara, Kazuyuki; Tahara, Hidetoshi; Kozai, Katsuyuki; Takata, Takashi			Infection with Porphyromonas gingivalis Exacerbates Endothelial Injury in Obese Mice	PLOS ONE			English	Article							NF-KAPPA-B; POLYMERASE-CHAIN-REACTION; FREE FATTY-ACIDS; CELLS; ATHEROSCLEROSIS; INFLAMMATION; ACTIVATION; PALMITATE; BACTERIA; DISEASE	Background: A number of studies have revealed a link between chronic periodontitis and cardiovascular disease in obese patients. However, there is little information about the influence of periodontitis-associated bacteria, Porphyromonas gingivalis (Pg), on pathogenesis of atherosclerosis in obesity. Methods: In vivo experiment: C57BL/6J mice were fed with a high-fat diet (HFD) or normal chow diet (CD), as a control. Pg was infected from the pulp chamber. At 6 weeks post-infection, histological and immunohistochemical analysis of aortal tissues was performed. In vitro experiment: hTERT-immortalized human umbilical vein endothelial cells (HuhT1) were used to assess the effect of Pg/Pg-LPS on free fatty acid (FFA) induced endothelial cells apoptosis and regulation of cytokine gene expression. Results: Weaker staining of CD31 and increased numbers of TUNEL positive cells in aortal tissue of HFD mice indicated endothelial injury. Pg infection exacerbated the endothelial injury. Immunohistochemically, Pg was detected deep in the smooth muscle of the aorta, and the number of Pg cells in the aortal wall was higher in HFD mice than in CD mice. Moreover, in vitro, FFA treatment induced apoptosis in HuhT1 cells and exposure to Pg-LPS increased this effect. In addition, Pg and Pg-LPS both attenuated cytokine production in HuhT1 cells stimulated by palmitate. Conclusions: Dental infection of Pg may contribute to pathogenesis of atherosclerosis by accelerating FFA-induced endothelial injury.	[Ao, Min; Miyauchi, Mutsumi; Inubushi, Toshihiro; Furusho, Hisako; Ando, Toshinori; Ayuningtyas, Nurina Febriyanti; Nagasaki, Atsuhiro; Takata, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan; [Ao, Min; Kozai, Katsuyuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Pediat Dent, Hiroshima, Japan; [Kitagawa, Masae] Hiroshima Univ, Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima, Japan; [Ishihara, Kazuyuki] Tokyo Dent Coll, Dept Microbiol, Tokyo, Japan; [Tahara, Hidetoshi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cellular & Mol Biol, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Tokyo Dental College; Hiroshima University	Takata, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan.	ttakata@hiroshima-u.ac.jp	Ando, Toshinori/AAA-6401-2021; Furusho, Hisako/H-2351-2019; Ando, Toshinori/AAG-4033-2021; Tahara, Hidetoshi/G-7697-2019	Ando, Toshinori/0000-0002-3141-8173; Ando, Toshinori/0000-0002-3141-8173; Ayuningtyas, Nurina Febriyanti/0000-0003-4403-6542; Ishihara, Kazuyuki/0000-0002-6567-807X	 [25462855]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by Grants-in-Aid for Scientific Research Scientific Research (C). Research Project Number: 25462855. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Anno K, 2007, BIOCHEM BIOPH RES CO, V353, P926, DOI 10.1016/j.bbrc.2006.12.112; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Cai Y, 2012, FEMS IMMUNOL MED MIC, V11, DOI [10.1111/1574-695x.12001, DOI 10.1111/1574-695X.12001]; Carrithers M, 2005, AM J PATHOL, V166, P185, DOI 10.1016/S0002-9440(10)62243-2; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Fernandez AZ, 2010, INT J VASC MED, V2010, DOI 10.1155/2010/437809; Figuero E, 2011, J PERIODONTOL, V82, P1469, DOI 10.1902/jop.2011.100719; Filippatos G, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-6; Furusho H, 2013, J GASTROENTEROL, V48, P1259, DOI 10.1007/s00535-012-0738-1; Fuster, 2010, PROMOTING CARDIOVASC; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Inubushi T, 2012, J BIOL CHEM, V287, P23527, DOI 10.1074/jbc.M111.324673; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kuvin JT, 1999, AM HEART J, V137, P216, DOI 10.1053/hj.1999.v137.92261; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Libby P, 1997, CIRCULATION, V96, P4095; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; Pereira CV, 2011, J PERIODONTOL, V82, P1767, DOI 10.1902/jop.2011.110063; Piro S, 2008, NUTR METAB CARDIOVAS, V18, P96, DOI 10.1016/j.numecd.2007.01.009; ROSS R, 1976, SCIENCE, V193, P1094, DOI 10.1126/science.822515; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Saito D, 2009, J ENDODONT, V35, P1518, DOI 10.1016/j.joen.2009.08.005; Shah Prediman K., 1999, Cardiology Clinics, V17, P271, DOI 10.1016/S0733-8651(05)70074-6; Tritto I, 2004, CARDIOVASC RES, V63, P1, DOI 10.1016/j.cardiores.2004.04.028; Wang Zhou, 2012, Hua Xi Kou Qiang Yi Xue Za Zhi, V30, P308; Wobser H, 2009, CELL RES, V19, P996, DOI 10.1038/cr.2009.73; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang HW, 2004, J PERIODONTOL, V75, P1077, DOI 10.1902/jop.2004.75.8.1077; Yoshimura M, 2000, INFECT IMMUN, V68, P6912, DOI 10.1128/IAI.68.12.6912-6916.2000; Yu Q, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/506159; Yun PLW, 2005, INFECT IMMUN, V73, P1386, DOI 10.1128/IAI.73.3.1386-1398.2005	36	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110519	10.1371/journal.pone.0110519	http://dx.doi.org/10.1371/journal.pone.0110519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25334003	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200051
J	Chinnici, JL; Fu, C; Caccamise, LM; Arnold, JW; Free, SJ				Chinnici, Jennifer L.; Fu, Ci; Caccamise, Lauren M.; Arnold, Jason W.; Free, Stephen J.			Neurospora crassa Female Development Requires the PACC and Other Signal Transduction Pathways, Transcription Factors, Chromatin Remodeling, Cell-To-Cell Fusion, and Autophagy	PLOS ONE			English	Article							FRUITING-BODY DEVELOPMENT; PROTEIN-KINASE PATHWAY; GIBBERELLA-ZEAE ANAMORPH; SEXUAL DEVELOPMENT; VEGETATIVE GROWTH; GENE-EXPRESSION; HYPHAL FUSION; ASCOSPORE GERMINATION; SORDARIA-MACROSPORA; NADPH OXIDASES	Using a screening protocol we have identified 68 genes that are required for female development in the filamentous fungus Neurospora crassa. We find that we can divide these genes into five general groups: 1) Genes encoding components of the PACC signal transduction pathway, 2) Other signal transduction pathway genes, including genes from the three N. crassa MAP kinase pathways, 3) Transcriptional factor genes, 4) Autophagy genes, and 5) Other miscellaneous genes. Complementation and RIP studies verified that these genes are needed for the formation of the female mating structure, the protoperithecium, and for the maturation of a fertilized protoperithecium into a perithecium. Perithecia grafting experiments demonstrate that the autophagy genes and the cell-to-cell fusion genes (the MAK-1 and MAK-2 pathway genes) are needed for the mobilization and movement of nutrients from an established vegetative hyphal network into the developing protoperithecium. Deletion mutants for the PACC pathway genes palA, palB, palC, palF, palH, and pacC were found to be defective in two aspects of female development. First, they were unable to initiate female development on synthetic crossing medium. However, they could form protoperithecia when grown on cellophane, on corn meal agar, or in response to the presence of nearby perithecia. Second, fertilized perithecia from PACC pathway mutants were unable to produce asci and complete female development. Protein localization experiments with a GFP-tagged PALA construct showed that PALA was localized in a peripheral punctate pattern, consistent with a signaling center associated with the ESCRT complex. The N. crassa PACC signal transduction pathway appears to be similar to the PacC/Rim101 pathway previously characterized in Aspergillus nidulans and Saccharomyces cerevisiae. In N. crassa the pathway plays a key role in regulating female development.	[Chinnici, Jennifer L.; Fu, Ci; Caccamise, Lauren M.; Arnold, Jason W.; Free, Stephen J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Free, SJ (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	free@buffalo.edu		Arnold, Jason W./0000-0002-6363-6140	National Institutes of Health [R01 GM078589, P01 GM068087]; University at Buffalo Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078589, P01GM068087] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University at Buffalo Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this study was provided by National Institutes of Health Grant R01 GM078589 and by the University at Buffalo Foundation. The authors acknowledge the Neurospora Genome Project for the creation of the deletion mutants and the Fungal Genetics Stock Center for providing the mutants for their research efforts. Funding for the Neurospora Genome Project was provided by Grant #P01 GM068087 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhvaryu KK, 2005, EUKARYOT CELL, V4, P1455, DOI 10.1128/EC.4.8.1455-1464.2005; Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Aldabbous MS, 2010, MICROBIOL-SGM, V156, P2621, DOI 10.1099/mic.0.040147-0; Aramayo R, 1996, GENETICS, V144, P991; Araujo-Palomares CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027148; Arst HN, 2003, TRENDS GENET, V19, P224, DOI 10.1016/S0168-9525(03)00052-0; Benkhali JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003642; Bistis GN., 2003, FUNGAL GENET NEWSL, V50, P17, DOI [10.4148/1941-4765.1154, DOI 10.4148/1941-4765.1154]; Bloemendal S, 2012, MOL MICROBIOL, V84, P310, DOI 10.1111/j.1365-2958.2012.08024.x; Bloemendal S, 2010, EUKARYOT CELL, V9, P1856, DOI 10.1128/EC.00186-10; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Bowman BJ, 2009, EUKARYOT CELL, V8, P1845, DOI 10.1128/EC.00174-09; Brenna A, 2012, MOL BIOL CELL, V23, P3863, DOI 10.1091/mbc.E12-02-0142; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Collopy PD, 2010, METHODS MOL BIOL, V638, P33, DOI 10.1007/978-1-60761-611-5_3; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Coppin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037488; Cupertino FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044258; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; Dettmann A, 2013, MOL MICROBIOL, V90, P796, DOI 10.1111/mmi.12399; Dettmann A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002950; Diez E, 2002, EMBO J, V21, P1350, DOI 10.1093/emboj/21.6.1350; Dirschnabel DE, 2014, GENETICS, V196, P729, DOI 10.1534/genetics.113.159368; Engh I, 2007, EUKARYOT CELL, V6, P831, DOI 10.1128/EC.00269-06; Engh I, 2010, EUR J CELL BIOL, V89, P864, DOI 10.1016/j.ejcb.2010.07.002; Fleissner A, 2005, EUKARYOT CELL, V4, P920, DOI 10.1128/EC.4.5.920-930.2005; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; Fu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107773; Fu C, 2011, EUKARYOT CELL, V10, P1100, DOI 10.1128/EC.05003-11; Fuentes AM, 1994, FUNGAL GENET NEWSL, V41, P38, DOI DOI 10.4148/1941-4765.1371; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Gesing S, 2012, MOL MICROBIOL, V84, P748, DOI 10.1111/j.1365-2958.2012.08058.x; Guenther JC, 2005, MYCOLOGIA, V97, P229, DOI 10.3852/mycologia.97.1.229; Hallen HE, 2007, FUNGAL GENET BIOL, V44, P1146, DOI 10.1016/j.fgb.2007.04.007; HARRIS JL, 1975, J BACTERIOL, V122, P1239, DOI 10.1128/JB.122.3.1239-1246.1975; Heilig Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004306; Heilig Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079464; HOROWITZ NH, 1961, GENETICS, V46, P1015; HOWE HB, 1974, MOL GEN GENET, V131, P79, DOI 10.1007/BF00269389; Hutchison EA, 2010, GENETICS, V185, P1271, DOI 10.1534/genetics.110.117184; Ivey FD, 2002, EUKARYOT CELL, V1, P634, DOI 10.1128/EC.1.4.634-642.2002; Iyer SV, 2009, J GENET, V88, P33, DOI 10.1007/s12041-009-0005-2; JOHNSON TE, 1978, GENETICS, V88, P27; Jones CA, 2007, MOL BIOL CELL, V18, P2123, DOI 10.1091/mbc.E06-03-0226; Justa-Schuch D, 2010, MOL MICROBIOL, V76, P220, DOI 10.1111/j.1365-2958.2010.07093.x; Kaida D, 2002, GENES CELLS, V7, P543, DOI 10.1046/j.1365-2443.2002.00538.x; Kamerewerd J, 2008, GENETICS, V180, P191, DOI 10.1534/genetics.108.091603; Kikuma T, 2011, FEMS MICROBIOL LETT, V316, P61, DOI 10.1111/j.1574-6968.2010.02192.x; Kim H, 2006, EUKARYOT CELL, V5, P544, DOI 10.1128/EC.5.3.544-554.2006; Kim H, 2004, MOL MICROBIOL, V52, P1781, DOI 10.1111/j.1365-2958.2004.04096.x; Kim H, 2002, EUKARYOT CELL, V1, P987, DOI 10.1128/EC.1.6.987-999.2002; Kim H, 2012, GENETICS, V190, P1389, DOI 10.1534/genetics.111.136358; Kim SR., 2005, KOREAN J MICROBIOL, V41, P246; Kothe GO, 1998, GENETICS, V149, P117; Kothe GO, 1998, FUNGAL GENET BIOL, V23, P248, DOI 10.1006/fgbi.1998.1037; Krystofova S, 2005, EUKARYOT CELL, V4, P365, DOI 10.1128/EC.4.2.365-378.2005; Lamb TM, 2001, J BIOL CHEM, V276, P1850, DOI 10.1074/jbc.M008381200; Leadsham JE, 2009, J CELL SCI, V122, P706, DOI 10.1242/jcs.042424; Leeder AC, 2013, GENETICS, V195, P883, DOI 10.1534/genetics.113.156984; Lewis ZA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001196; Li D, 2005, GENETICS, V170, P1091, DOI 10.1534/genetics.104.036772; Li MC, 2004, EUKARYOT CELL, V3, P741, DOI 10.1128/EC.3.3.741-751.2004; Li WS, 1997, GENETICS, V145, P63; Lichius A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030372, 10.1371/journal.pone.0042565]; Lin FC, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P33, DOI 10.1007/978-1-4020-9500-9_4; Liu TB, 2010, AUTOPHAGY, V6, P74, DOI 10.4161/auto.6.1.10438; Lord KM, 2011, FUNGAL GENET BIOL, V48, P388, DOI 10.1016/j.fgb.2010.11.009; Maddi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042374; Maerz S, 2008, GENETICS, V179, P1313, DOI 10.1534/genetics.108.089425; Maerz S, 2009, MOL MICROBIOL, V74, P707, DOI 10.1111/j.1365-2958.2009.06896.x; MAI SH, 1976, AM J BOT, V63, P821, DOI 10.2307/2442040; Malagnac F, 2004, FUNGAL GENET BIOL, V41, P982, DOI 10.1016/j.fgb.2004.07.008; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Masloff S, 1999, GENETICS, V152, P191; Masloff S, 2002, FUNGAL GENET BIOL, V36, P107, DOI 10.1016/S1087-1845(02)00010-5; Mayrhofer S, 2006, GENETICS, V172, P1521, DOI 10.1534/genetics.105.047381; McCluskey K, 2011, G3-GENES GENOM GENET, V1, P303, DOI 10.1534/g3.111.000307; Mendl N, 2011, J CELL SCI, V124, P1339, DOI 10.1242/jcs.076406; Mitchell AP, 2008, P NATL ACAD SCI USA, V105, P7111, DOI 10.1073/pnas.0803384105; Muller M, 2011, BIOCHEM SOC T, V39, P1514, DOI 10.1042/BST0391514; MULLER F, 1995, MOL GEN GENET, V248, P162, DOI 10.1007/BF02190797; MYLYK OM, 1974, GENET RES, V24, P91, DOI 10.1017/S001667230001510X; Nolting N, 2006, MOL MICROBIOL, V62, P853, DOI 10.1111/j.1365-2958.2006.05415.x; Nolting N, 2006, EUKARYOT CELL, V5, P1043, DOI 10.1128/EC.00086-06; Nolting N, 2009, FUNGAL GENET BIOL, V46, P531, DOI 10.1016/j.fgb.2009.03.008; Nowrousian M, 2005, MOL GENET GENOMICS, V273, P137, DOI 10.1007/s00438-005-1118-9; Nowrousian M, 2007, MOL MICROBIOL, V64, P923, DOI 10.1111/j.1365-2958.2007.05694.x; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Nowrousian M, 2009, CURR GENET, V55, P185, DOI 10.1007/s00294-009-0236-z; Pandey A, 2004, EUKARYOT CELL, V3, P348, DOI 10.1128/EC.3.2.348-358.2004; Park G, 2011, EUKARYOT CELL, V10, P1553, DOI 10.1128/EC.05140-11; Park G, 2008, EUKARYOT CELL, V7, P2113, DOI 10.1128/EC.00466-07; Penalva MA, 2002, MICROBIOL MOL BIOL R, V66, P426, DOI 10.1128/MMBR.66.3.426-446.2002; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Poggeler S, 2000, CURR GENET, V37, P403, DOI 10.1007/s002940000120; Poggeler S., 2006, FRUITING BODY DEV AS; RAJU NB, 1992, MYCOL RES, V96, P241, DOI 10.1016/S0953-7562(09)80934-9; Ramon AM, 1999, J BACTERIOL, V181, P7524, DOI 10.1128/JB.181.24.7524-7530.1999; Rasmussen CG, 2005, EUKARYOT CELL, V4, P1913, DOI 10.1128/EC.4.11.1913-1925.2005; READ ND, 1983, CAN J BOT, V61, P3217, DOI 10.1139/b83-359; Richthammer C, 2012, MOL MICROBIOL, V85, P716, DOI 10.1111/j.1365-2958.2012.08133.x; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Rollins JA, 2003, MOL PLANT MICROBE IN, V16, P785, DOI 10.1094/MPMI.2003.16.9.785; Schindler D, 2014, FUNGAL GENET BIOL, V68, P48, DOI 10.1016/j.fgb.2014.04.008; SEALE T, 1973, J BACTERIOL, V113, P1015, DOI 10.1128/JB.113.2.1015-1025.1973; Selker EU, 1999, CELL, V97, P157, DOI 10.1016/S0092-8674(00)80725-4; Silar P, 2014, OPEN MYCOL J, V8, P148, DOI DOI 10.2174/1874437001408010148; Silar P, 2011, FUNGAL BIOL-UK, V115, P793, DOI 10.1016/j.funbio.2011.06.005; Simonin AR, 2010, FUNGAL GENET BIOL, V47, P855, DOI 10.1016/j.fgb.2010.06.010; SU SSY, 1993, GENETICS, V133, P67; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; TEE T S, 1970, Molecular and General Genetics, V107, P158, DOI 10.1007/BF00333631; Teichert I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-511; Trail F, 2000, MYCOLOGIA, V92, P130, DOI 10.2307/3761457; VIGFUSSON NV, 1972, GENET RES, V19, P205, DOI 10.1017/S0016672300014476; Vogt N, 2008, MOL BIOL CELL, V19, P4554, DOI 10.1091/mbc.E07-12-1266; Voigt O, 2014, MICROBIOL RES, V169, P128, DOI 10.1016/j.micres.2013.07.012; Voigt O, 2013, FUNGAL GENET BIOL, V61, P50, DOI 10.1016/j.fgb.2013.09.006; Voigt O, 2013, AUTOPHAGY, V9, P33, DOI 10.4161/auto.22398; Wang Z, 2014, EUKARYOT CELL, V13, P154, DOI 10.1128/EC.00248-13; Xiang QJ, 2002, GENETICS, V160, P169; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666; Yamashiro CT, 1996, MOL CELL BIOL, V16, P6218; Yang Q, 2002, EUKARYOT CELL, V1, P378, DOI 10.1128/EC.1.3.378-390.2002	127	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110603	10.1371/journal.pone.0110603	http://dx.doi.org/10.1371/journal.pone.0110603			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333968	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200059
J	Vaughn, JN; Chaluvadi, SR; Tushar; Rangan, L; Bennetzen, JL				Vaughn, Justin N.; Chaluvadi, Srinivasa R.; Tushar; Rangan, Latha; Bennetzen, Jeffrey L.			Whole Plastome Sequences from Five Ginger Species Facilitate Marker Development and Define Limits to Barcode Methodology	PLOS ONE			English	Article							CHLOROPLAST GENOME; DNA BARCODES; IDENTIFICATION; ZINGIBERACEAE; ANNOTATION; PHYLOGENY; PLANTS; GENUS	Plants from the Zingiberaceae family are a key source of spices and herbal medicines. Species identification within this group is critical in the search for known and possibly novel bioactive compounds. To facilitate precise characterization of this group, we have sequenced chloroplast genomes from species representing five major groups within Zingiberaceae. Generally, the structure of these genomes is similar to the basal angiosperm excepting an expansion of 3 kb associated with the inverted repeat A region. Portions of this expansion appear to be shared across the entire Zingiberales order, which includes gingers and bananas. We used whole plastome alignment information to develop DNA barcodes that would maximize the ability to differentiate species within the Zingiberaceae. Our computation pipeline identified regions of high variability that were flanked by highly conserved regions used for primer design. This approach yielded hitherto unexploited regions of variability. These theoretically optimal barcodes were tested on a range of species throughout the family and were found to amplify and differentiate genera and, in some cases, species. Still, though these barcodes were specifically optimized for the Zingiberaceae, our data support the emerging consensus that whole plastome sequences are needed for robust species identification and phylogenetics within this family.	[Vaughn, Justin N.; Chaluvadi, Srinivasa R.; Bennetzen, Jeffrey L.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Tushar; Rangan, Latha] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India	University System of Georgia; University of Georgia; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Bennetzen, JL (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	maize@uga.edu	chaluvadi, srinivasa/AAC-5258-2020; Chaluvadi, Srinivasa Rao/C-7163-2011	Chaluvadi, Srinivasa/0000-0003-2865-4156; Vaughn, Justin/0000-0002-5261-5096	University of Georgia Giles Professorship; Georgia Research Alliance and Department of Information Technology; Ministry of Information Technology, Government of India (DIT) [0526/T/IITG/014/0809/38]; Direct For Biological Sciences [1127079] Funding Source: National Science Foundation	University of Georgia Giles Professorship; Georgia Research Alliance and Department of Information Technology; Ministry of Information Technology, Government of India (DIT); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by endowment funds from the University of Georgia Giles Professorship, the Georgia Research Alliance and Department of Information Technology, and Ministry of Information Technology, Government of India (DIT Grant No. DIT No: 0526/T/IITG/014/0809/38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Barrett CF, 2013, CLADISTICS, V29, P65, DOI 10.1111/j.1096-0031.2012.00418.x; BIRKY CW, 1992, GENETICS, V130, P677; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Fang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037164; Garcia-Robledo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052967; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Kress WJ, 2002, AM J BOT, V89, P1682, DOI 10.3732/ajb.89.10.1682; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kress WJ, 2005, AM J BOT, V92, P167, DOI 10.3732/ajb.92.1.167; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Martin G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067350; Minami M, 2009, J NAT MED-TOKYO, V63, P75, DOI 10.1007/s11418-008-0283-7; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Ran JH, 2010, J INTEGR PLANT BIOL, V52, P1109, DOI 10.1111/j.1744-7909.2010.00995.x; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Shi LC, 2011, J SYST EVOL, V49, P261, DOI 10.1111/j.1759-6831.2011.00133.x; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tushar, 2010, J ETHNOPHARMACOL, V132, P286, DOI 10.1016/j.jep.2010.08.032; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vinitha MR, 2014, J INTEGRATIVE PLANT; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Xiao WL, 2011, J AGR FOOD CHEM, V59, P1548, DOI 10.1021/jf1028174; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]	29	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e108581	10.1371/journal.pone.0108581	http://dx.doi.org/10.1371/journal.pone.0108581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333869	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200007
J	Yazar, Y; Bergstrom, ZM; Simons, JS				Yazar, Yasemin; Bergstroem, Zara M.; Simons, Jon S.			Continuous Theta Burst Stimulation of Angular Gyrus Reduces Subjective Recollection	PLOS ONE			English	Article							EPISODIC MEMORY RETRIEVAL; POSTERIOR PARIETAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; LOBE; LESIONS; SYSTEM; DAMAGE; BRAIN; INTERFERENCE; RECOGNITION	The contribution of lateral parietal regions such as the angular gyrus to human episodic memory has been the subject of much debate following widespread observations of left parietal activity in healthy volunteers during functional neuroimaging studies of memory retrieval. Patients with lateral parietal lesions are not amnesic, but recent evidence indicates that their memory abilities may not be entirely preserved. Whereas recollection appears intact when objective measures such as source accuracy are used, patients often exhibit reduced subjective confidence in their accurate recollections. When asked to recall autobiographical memories, they may produce spontaneous narratives that lack richness and specificity, but can remember specific details when prompted. Two distinct theoretical accounts have been proposed to explain these results: that the patients have a deficit in the bottom-up capturing of attention by retrieval output, or that they have an impairment in the subjective experience of recollection. The present study aimed to differentiate between these accounts using continuous theta burst stimulation (cTBS) in healthy participants to disrupt function of specific left parietal subregions, including angular gyrus. Inconsistent with predictions of the attentional theory, angular gyrus cTBS did not result in greater impairment of free recall than cued recall. Supporting predictions of the subjective recollection account, temporary disruption of angular gyrus was associated with highly accurate source recollection accuracy but a selective reduction in participants' rated source confidence. The findings are consistent with a role for angular gyrus in the integration of memory features into a conscious representation that enables the subjective experience of remembering.	[Yazar, Yasemin; Simons, Jon S.] Univ Cambridge, Dept Psychol, Cambridge, England; [Yazar, Yasemin; Bergstroem, Zara M.; Simons, Jon S.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Bergstroem, Zara M.] Univ Kent, Dept Psychol, Canterbury CT2 7NZ, Kent, England	University of Cambridge; University of Cambridge; University of Kent	Simons, JS (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.	jss30@cam.ac.uk	Simons, Jon/AAG-7104-2020	Simons, Jon/0000-0002-7508-9084; Bergstrom, Zara/0000-0001-8794-0182	James S. McDonnell Foundation; German Academic Exchange Service; Medical Research Council [G0001354B, G0001354, G1000183B] Funding Source: researchfish	James S. McDonnell Foundation; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a James S. McDonnell Foundation Scholar Award to JSS. YY was supported by a scholarship from the German Academic Exchange Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ally BA, 2008, NEUROPSYCHOLOGIA, V46, P1800, DOI 10.1016/j.neuropsychologia.2008.02.026; [Anonymous], 1983, CANADIAN PSYCHOL; Berryhill ME, 2007, J NEUROSCI, V27, P14415, DOI 10.1523/JNEUROSCI.4163-07.2007; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Ciaramelli E, 2010, J EXP PSYCHOL LEARN, V36, P619, DOI 10.1037/a0019181; Ciaramelli E, 2010, J NEUROSCI, V30, P4943, DOI 10.1523/JNEUROSCI.1209-09.2010; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Davidson PSR, 2008, NEUROPSYCHOLOGIA, V46, P1743, DOI 10.1016/j.neuropsychologia.2008.01.011; Dobbins IG, 2012, NEUROPSYCHOLOGIA, V50, P2992, DOI 10.1016/j.neuropsychologia.2012.07.037; Duarte A, 2008, CEREB CORTEX, V18, P2169, DOI 10.1093/cercor/bhm243; Flegal KE, 2014, J COGNITIVE NEUROSCI, V26, P1694, DOI 10.1162/jocn_a_00587; Holdstock JS, 2000, NEUROPSYCHOLOGIA, V38, P410, DOI 10.1016/S0028-3932(99)00099-8; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; Nelson SM, 2010, NEURON, V67, P156, DOI 10.1016/j.neuron.2010.05.025; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Rossi S, 2006, EUR J NEUROSCI, V23, P793, DOI 10.1111/j.1460-9568.2006.04600.x; Schmitz TW, 2013, 2013 NEUR M PLANN; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Sestieri C, 2013, NEUROPSYCHOLOGIA, V51, P900, DOI 10.1016/j.neuropsychologia.2013.01.023; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Shimamura AP, 2011, COGN AFFECT BEHAV NE, V11, P277, DOI 10.3758/s13415-011-0031-4; Simons JS, 2008, NEUROPSYCHOLOGIA, V46, P1185, DOI 10.1016/j.neuropsychologia.2007.07.024; Simons JS, 2010, CEREB CORTEX, V20, P479, DOI 10.1093/cercor/bhp116; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Yazar Y, 2012, CORTEX, V48, P1381, DOI 10.1016/j.cortex.2012.05.011; Zaehle T, 2007, BRAIN RES, V1137, P92, DOI 10.1016/j.brainres.2006.12.044	35	51	51	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110414	10.1371/journal.pone.0110414	http://dx.doi.org/10.1371/journal.pone.0110414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333985	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000343731200035
J	Anderson, GS; Bell, LS				Anderson, Gail S.; Bell, Lynne S.			Deep Coastal Marine Taphonomy: Investigation into Carcass Decomposition in the Saanich Inlet, British Columbia Using a Baited Camera	PLOS ONE			English	Article							BEHAVIORAL-RESPONSES; CANCER-MAGISTER; WHALE FALL; FOOD FALL; SEA-FLOOR; SALINITY; CONSUMPTION; ATLANTIC; BODIES; RATES	Decomposition and faunal colonization of a carcass in the terrestrial environment has been well studied, but knowledge of decomposition in the marine environment is based almost entirely on anecdotal reports. Three pig carcasses were deployed in Saanich Inlet, BC, over 3 years utilizing Ocean Network Canada's VENUS observatory. Each carcass was deployed in late summer/early fall at 99 m under a remotely controlled camera and observed several times a day. Dissolved oxygen, temperature, salinity, density and pressure were continuously measured. Carcass 1 was immediately colonized by Munida quadrispina, Pandalus platyceros and Metacarcinus magister, rapidly scavenged then dragged from view by Day 22. Artifacts specific to each of the crustaceans' feeding patterns were observed. Carcass 2 was scavenged in a similar fashion. Exposed tissue became covered by Orchomenella obtusa (Family Lysianassidae) which removed all the internal tissues rapidly. Carcass 3 attracted only a few M. quadrispina, remaining intact, developing a thick filamentous sulphur bacterial mat, until Day 92, when it was skeletonized by crustacea. The major difference between the deployments was dissolved oxygen levels. The first two carcasses were placed when oxygen levels were tolerable, becoming more anoxic. This allowed larger crustacea to feed. However, Carcass 3 was deployed when the water was already extremely anoxic, which prevented larger crustacea from accessing the carcass. The smaller M. quadrispina were unable to break the skin alone. The larger crustacea returned when the Inlet was re-oxygenated in spring. Oxygen levels, therefore, drive the biota in this area, although most crustacea endured stressful levels of oxygen to access the carcasses for much of the time. These data will be valuable in forensic investigations involving submerged bodies, indicating types of water conditions to which the body has been exposed, identifying post-mortem artifacts and providing realistic expectations for recovery divers and families of the deceased.	[Anderson, Gail S.; Bell, Lynne S.] Simon Fraser Univ, Ctr Forens Res, Sch Criminol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Anderson, GS (corresponding author), Simon Fraser Univ, Ctr Forens Res, Sch Criminol, Burnaby, BC V5A 1S6, Canada.	ganderso@sfu.ca			Canadian Police Research Centre [NRC 615341]	Canadian Police Research Centre(Natural Resources Canada)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by funding from the Canadian Police Research Centre to Anderson - NRC 615341.	AIRRIESS CN, 1994, J EXP BIOL, V190, P23; Anderson G., 2002, TR092002 CAN POL RES; Anderson G.S., 2009, FORENSIC SCI INTRO S, P137; Anderson GS, 2010, CURRENT CONCEPTS IN FORENSIC ENTOMOLOGY, P223, DOI 10.1007/978-1-4020-9684-6_12; Anderson GS, 2004, INT J LEGAL MED, V118, P206, DOI 10.1007/s00414-004-0447-2; ANDERSON J J, 1973, Estuarine and Coastal Marine Science, V1, P1, DOI 10.1016/0302-3524(73)90052-2; [Anonymous], 2010, COMMUNICATION; ASCENZI A, 1984, J HUM EVOL, V13, P531, DOI 10.1016/S0047-2484(84)80006-8; Baco AR, 2003, MAR ECOL PROG SER, V260, P109, DOI 10.3354/meps260109; Barbero AM, 2009, TOXICOL IN VITRO, V23, P1, DOI 10.1016/j.tiv.2008.10.008; Bell LS, 2008, INT J OSTEOARCHAEOL, V18, P523, DOI 10.1002/oa.952; Bell LS, 1996, FORENSIC SCI INT, V82, P129, DOI 10.1016/0379-0738(96)01984-6; Benbow ME, CARRION ECO IN PRESS; BENECKE M, 2008, ACTA BIOL BENRODIS, V14, P15; Bergstrom BI, 2000, ADV MAR BIOL, V38, P55, DOI 10.1016/S0065-2881(00)38003-8; Bernatis JL, 2007, MAR BIOL, V150, P941, DOI 10.1007/s00227-006-0392-3; Burd B.J., 1985, P435; BURD BJ, 1984, J EXP MAR BIOL ECOL, V81, P1, DOI 10.1016/0022-0981(84)90221-1; Byrd J.H., 2009, FORENSIC ENTOMOLOGY, VSecond; CATTS EP, 1992, ANNU REV ENTOMOL, V37, P253, DOI 10.1146/annurev.en.37.010192.001345; DEARBORN J.H., 1967, NZ DEP SCI IND RES B, V176, P31; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dumser TK, 2008, J FORENSIC SCI, V53, P1049, DOI 10.1111/j.1556-4029.2008.00816.x; Ebbesmeyer C.C., 2002, ADV FORENSIC TAPHONO, P219; EBERT DA, 1986, COPEIA, P131; GIERTSEN JC, 1989, AM J FOREN MED PATH, V10, P25, DOI 10.1097/00000433-198903000-00007; Glover AG, 2005, P ROY SOC B-BIOL SCI, V272, P2587, DOI 10.1098/rspb.2005.3275; Goffredi SK, 2004, DEEP-SEA RES PT I, V51, P1295, DOI 10.1016/j.dsr.2004.05.009; Golubic S., 1975, STUDY TRACE FOSSILS, P229; Haglund W. D., 2002, ADV FORENSIC TAPHONO; Hall D.W., 2012, FORENSIC BOT PRACTIC; HERLINVEAUX RH, 1962, J FISH RES BOARD CAN, V19, P1, DOI 10.1139/f62-001; Hobischak NR, 2002, J FORENSIC SCI, V47, P142; Hobischak NR, 1999, CAN SOC FORENSIC SCI, p[32, 97], DOI DOI 10.1080/00085030.1999.10757492; HOBISCHAK NR, 1998, TR1098 CAN POL RES C; Ismael D, 1997, COMP BIOCHEM PHYS A, V118, P871, DOI 10.1016/S0300-9629(97)00016-9; JAMIESON GS, 1988, FISH B-NOAA, V86, P601; Jones EG, 1998, P ROY SOC B-BIOL SCI, V265, P1119, DOI 10.1098/rspb.1998.0407; Juniper K, 2009, COMMUNICATION; Kahana T, 1999, J FORENSIC SCI, V44, P897; Kemp KM, 2006, MAR ECOL PROG SER, V310, P65, DOI 10.3354/meps310065; Klages M, 2002, DEEP-SEA RES PT I, V49, P143, DOI 10.1016/S0967-0637(01)00047-4; Koseki T, 1963, JPN J LEGAL MED, V18, P12; Levings CD, 1980, CANAD TECH REP FISH, V951, P1; Matabos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045626; McMahon BR, 2001, J EXP BIOL, V204, P923; MOREIRA GS, 1982, AQUACULTURE, V29, P95, DOI 10.1016/0044-8486(82)90036-9; Mottonen M, 1977, FORENSIC MED STUDY T; NELSON SG, 1977, COMP BIOCHEM PHYS A, V56, P533, DOI 10.1016/0300-9629(77)90281-X; Peters KL, 2007, DISTRIBUTION DENSITY; Petrik MS, 2004, CAN SOC FORENSIC SCI, V37, P9, DOI DOI 10.1080/00085030.2004.10757565; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Sorg Marcella H., 1997, P567; Sotkowy C, 2008, THESIS W MICHIGAN U; Stubblefield PR, 1999, J FORENSIC SCI, V44, P716; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Teather RB, 1994, ENCY UNDERWATER INVE; Treude T, 2009, MAR ECOL PROG SER, V382, P1, DOI 10.3354/meps07972; Tunnicliffe V, 2006, COMMUNICATION; Tunnicliffe V, 1981, NATURE, V294, P354, DOI 10.1038/294354a0; Whiteley NM, 2001, J EXP BIOL, V204, P1003; Williams GD, 2010, T AM FISH SOC, V139, P108, DOI 10.1577/T09-045.1; Wisshak M, 2005, FACIES, V51, P93, DOI 10.1007/s10347-005-0009-1; Witte U, 1999, MAR ECOL PROG SER, V183, P139, DOI 10.3354/meps183139	64	27	27	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110710	10.1371/journal.pone.0110710	http://dx.doi.org/10.1371/journal.pone.0110710			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329759	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100087
J	Ogawa, DMO; Moriya, S; Tsuboi, Y; Date, Y; Prieto-da-Silva, ARB; Radis-Baptista, G; Yamane, T; Kikuchi, J				Ogawa, Diogo M. O.; Moriya, Shigeharu; Tsuboi, Yuuri; Date, Yasuhiro; Prieto-da-Silva, Alvaro R. B.; Radis-Baptista, Gandhi; Yamane, Tetsuo; Kikuchi, Jun			Biogeochemical Typing of Paddy Field by a Data-Driven Approach Revealing Sub-Systems within a Complex Environment - A Pipeline to Filtrate, Organize and Frame Massive Dataset from Multi-Omics Analyses	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; DIVERSITY; METABOLOMICS; RHIZOSPHERE; SEQUENCES; ARCHAEAL; BACTERIA; GENES; PLANT; KEGG	We propose the technique of biogeochemical typing (BGC typing) as a novel methodology to set forth the sub-systems of organismal communities associated to the correlated chemical profiles working within a larger complex environment. Given the intricate characteristic of both organismal and chemical consortia inherent to the nature, many environmental studies employ the holistic approach of multi-omics analyses undermining as much information as possible. Due to the massive amount of data produced applying multi-omics analyses, the results are hard to visualize and to process. The BGC typing analysis is a pipeline built using integrative statistical analysis that can treat such huge datasets filtering, organizing and framing the information based on the strength of the various mutual trends of the organismal and chemical fluctuations occurring simultaneously in the environment. To test our technique of BGC typing, we choose a rich environment abounding in chemical nutrients and organismal diversity: the surficial freshwater from Japanese paddy fields and surrounding waters. To identify the community consortia profile we employed metagenomics as high throughput sequencing (HTS) for the fragments amplified from Archaea rRNA, universal 16S rRNA and 18S rRNA; to assess the elemental content we employed ionomics by inductively coupled plasma optical emission spectroscopy (ICP-OES); and for the organic chemical profile, metabolomics employing both Fourier transformed infrared (FT-IR) spectroscopy and proton nuclear magnetic resonance (1 H-NMR) all these analyses comprised our multi-omics dataset. The similar trends between the community consortia against the chemical profiles were connected through correlation. The result was then filtered, organized and framed according to correlation strengths and peculiarities. The output gave us four BGC types displaying uniqueness in community and chemical distribution, diversity and richness. We conclude therefore that the BGC typing is a successful technique for elucidating the sub-systems of organismal communities with associated chemical profiles in complex ecosystems.	[Ogawa, Diogo M. O.; Prieto-da-Silva, Alvaro R. B.; Radis-Baptista, Gandhi; Yamane, Tetsuo] Univ State Amazonas, Biotechnol & Nat Resources Program, Manaus, AM, Brazil; [Ogawa, Diogo M. O.; Radis-Baptista, Gandhi] Univ Fed Ceara, Inst Marine Sci, Lab Biochem Biotechnol, Fortaleza, CE, Brazil; [Ogawa, Diogo M. O.; Prieto-da-Silva, Alvaro R. B.; Radis-Baptista, Gandhi; Yamane, Tetsuo] Univ State Amazonas, Ctr Environm & Biodivers Studies, Manaus, AM, Brazil; [Ogawa, Diogo M. O.; Moriya, Shigeharu; Tsuboi, Yuuri; Date, Yasuhiro; Kikuchi, Jun] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Ogawa, Diogo M. O.; Moriya, Shigeharu; Tsuboi, Yuuri; Date, Yasuhiro; Kikuchi, Jun] Biomass Engn Corp Div, Yokohama, Kanagawa, Japan; [Moriya, Shigeharu] RIKEN, Antibiot Lab, Yokohama, Kanagawa, Japan; [Moriya, Shigeharu; Date, Yasuhiro; Kikuchi, Jun] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 232, Japan; [Prieto-da-Silva, Alvaro R. B.] Butantan Inst, Genet Lab, Sao Paulo, Brazil; [Yamane, Tetsuo] Ctr Biotechnol Amazon, Manaus, AM, Brazil; [Kikuchi, Jun] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Universidade do Estado do Amazonas; Universidade Federal do Ceara; Universidade do Estado do Amazonas; RIKEN; RIKEN; Yokohama City University; Instituto Butantan; Nagoya University	Kikuchi, J (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan.	jun.kikuchi@riken.jp	DATE, Yasuhiro/V-3630-2018; RADIS-BAPTISTA, GANDHI/J-4991-2019; RADIS-BAPTISTA, GANDHI/H-9574-2016; Prieto, Alvaro/G-8505-2017; Moriya, Shigeharu/AGY-8351-2022; Kikuchi, Jun/M-5512-2015; Moriya, Shigeharu/F-4604-2014; Kikuchi, Jun/O-4725-2019	DATE, Yasuhiro/0000-0001-9645-4370; RADIS-BAPTISTA, GANDHI/0000-0001-9210-092X; RADIS-BAPTISTA, GANDHI/0000-0001-9210-092X; Prieto, Alvaro/0000-0003-0289-9809; Moriya, Shigeharu/0000-0002-2519-5874; Kikuchi, Jun/0000-0002-6809-394X; Moriya, Shigeharu/0000-0002-2519-5874; Kikuchi, Jun/0000-0002-6809-394X	Ministry of Education, Culture, Sports, Science, and Technology, Japan [25513012, 21247010]; RIKEN Yokohama Institute under the International Program Associate (IPA) program	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Yokohama Institute under the International Program Associate (IPA) program	This research was supported in part by Grants-in-Aid for Scientific Research (C) (No. 25513012 to J.K.), Grants-in-Aid for Scientific Research (A) (No. 21247010 to S. M. and J.K.) and Advanced Low Carbon Technology Research and Developmental Program (ALCA to J.K.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This study was also financially supported by RIKEN Yokohama Institute under the International Program Associate (IPA) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Kenji, 2008, In Silico Biology, V8, P339; [Anonymous], [No title captured]; Asakura T, 2014, ANAL CHEM, V86, P5425, DOI 10.1021/ac5005037; BALL AS, 1990, APPL ENVIRON MICROB, V56, P3017, DOI 10.1128/AEM.56.10.3017-3022.1990; Bonder MJ, 2012, BIOINFORMATICS, V28, P2891, DOI 10.1093/bioinformatics/bts552; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braeckman U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059289; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Brownlee C., 2002, ALGAL CALCIFICATION; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castell WZ, 2012, TREES-STRUCT FUNCT, V26, P1723, DOI 10.1007/s00468-012-0777-5; Chikayama E, 2010, ANAL CHEM, V82, P1653, DOI 10.1021/ac9022023; Chikayama E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003805; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; CRAWFORD DL, 1978, APPL ENVIRON MICROB, V35, P1041, DOI 10.1128/AEM.35.6.1041-1045.1978; Date Y, 2012, J PROTEOME RES, V11, P5602, DOI 10.1021/pr3008682; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edoardo G, 2012, MUMA METABOLISMICS U; Enjalbert B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021318; Everroad RC, 2012, JOVE-J VIS EXP, DOI 10.3791/3163; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Grossart HP, 2011, P NATL ACAD SCI USA, V108, P19657, DOI 10.1073/pnas.1110716108; Herrmann M, 2008, APPL ENVIRON MICROB, V74, P3279, DOI 10.1128/AEM.02802-07; Hirschi KD, 2003, TRENDS BIOTECHNOL, V21, P520, DOI 10.1016/j.tibtech.2003.09.013; Izquierdo-Carrasco F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-470; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; JURGENS K, 1994, MAR ECOL PROG SER, V112, P169, DOI 10.3354/meps112169; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kikuchi J, 1999, BIOPOLYMERS, V49, P361, DOI 10.1002/(SICI)1097-0282(19990415)49:5<361::AID-BIP3>3.0.CO;2-4; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; Kiorboe T, 2003, APPL ENVIRON MICROB, V69, P3036, DOI 10.1128/AEM.69.6.3036-3047.2003; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kolde R., 2013, PHEATMAP PRETTY HEAT; Kraft BJ, 2003, BIOCHEMISTRY-US, V42, P6726, DOI 10.1021/bi030055o; Kudo Y, 1997, FEMS MICROBIOL ECOL, V22, P39, DOI 10.1111/j.1574-6941.1997.tb00354.x; Ludwig C, 2012, METABOLOMICS, V8, P8, DOI 10.1007/s11306-011-0347-7; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mirkin B, 1998, COMPUT J, V41, P518, DOI 10.1093/comjnl/41.8.518; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakanishi Y, 2011, J PROTEOME RES, V10, P824, DOI 10.1021/pr100989c; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Ogata Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030263; Ogura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066919; PAERL HW, 1988, SCIENCE, V241, P442, DOI 10.1126/science.241.4864.442; Peeples M. A, 2011, R SCRIPT K MEANS CLU; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Ploug H, 1997, AQUAT MICROB ECOL, V13, P285, DOI 10.3354/ame013285; POLLARD D, 1982, ANN PROBAB, V10, P919, DOI 10.1214/aop/1176993713; Poulsen M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2432; Pratscher J, 2011, P NATL ACAD SCI USA, V108, P4170, DOI 10.1073/pnas.1010981108; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Sakai S, 2008, INT J SYST EVOL MICR, V58, P929, DOI 10.1099/ijs.0.65571-0; Sanchez-Moral S, 2004, ANN MICROBIOL, V54, P1; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sitole L, 2014, OMICS, V18, P513, DOI 10.1089/omi.2013.0157; Team RDC, 2019, R LANG ENV STAT COMP; Unal B, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00175; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang SY, 2011, APPL MICROBIOL BIOT, V90, P779, DOI 10.1007/s00253-011-3090-0; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Whitford MF, 2001, BMC MICROBIOLOGY; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500; Xie J, 2011, P NATL ACAD SCI USA, V108, pE1381, DOI 10.1073/pnas.1111043108	68	19	20	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110723	10.1371/journal.pone.0110723	http://dx.doi.org/10.1371/journal.pone.0110723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330259	gold, Green Submitted, Green Published			2022-12-27	WOS:000343942100090
J	Ruiz-Cooley, RI; Koch, PL; Fiedler, PC; McCarthy, MD				Ruiz-Cooley, Rocio I.; Koch, Paul L.; Fiedler, Paul C.; McCarthy, Matthew D.			Carbon and Nitrogen Isotopes from Top Predator Amino Acids Reveal Rapidly Shifting Ocean Biochemistry in the Outer California Current	PLOS ONE			English	Article							TROPHIC RELATIONSHIPS; PLANKTON DELTA-C-13; STABLE-ISOTOPES; LONG-TERM; FRACTIONATION; PRODUCTIVITY; VARIABILITY; DELTA-N-15; PATTERNS; LATITUDE	Climatic variation alters biochemical and ecological processes, but it is difficult both to quantify the magnitude of such changes, and to differentiate long-term shifts from inter-annual variability. Here, we simultaneously quantify decade-scale isotopic variability at the lowest and highest trophic positions in the offshore California Current System (CCS) by measuring delta N-15 and delta C-13 values of amino acids in a top predator, the sperm whale (Physeter macrocephalus). Using a time series of skin tissue samples as a biological archive, isotopic records from individual amino acids (AAs) can reveal the proximate factors driving a temporal decline we observed in bulk isotope values (a decline of >= 1 %) by decoupling changes in primary producer isotope values from those linked to the trophic position of this toothed whale. A continuous decline in baseline (i. e., primary producer) delta N-15 and delta C-13 values was observed from 1993 to 2005 (a decrease of similar to 4% for delta N-15 source-AAs and 3% for delta C-13 essential-AAs), while the trophic position of whales was variable over time and it did not exhibit directional trends. The baseline delta N-15 and delta C-13 shifts suggest rapid ongoing changes in the carbon and nitrogen biogeochemical cycling in the offshore CCS, potentially occurring at faster rates than long-term shifts observed elsewhere in the Pacific. While the mechanisms forcing these biogeochemical shifts remain to be determined, our data suggest possible links to natural climate variability, and also corresponding shifts in surface nutrient availability. Our study demonstrates that isotopic analysis of individual amino acids from a top marine mammal predator can be a powerful new approach to reconstructing temporal variation in both biochemical cycling and trophic structure.	[Ruiz-Cooley, Rocio I.; McCarthy, Matthew D.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Koch, Paul L.] Univ Calif Santa Cruz, Earth & Planetary Sci Dept, Santa Cruz, CA 95064 USA; [Fiedler, Paul C.] Natl Marine Fisheries Serv, Southwest Fisheries Sci Ctr, Natl Ocean & Atmospher Adm, La Jolla, CA 92038 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA	Ruiz-Cooley, RI (corresponding author), Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA.	rcooley@ucsc.edu			Marine Mammal and Turtle Division, Southwest Fisheries Science Center-National Oceanographic Atmospheric Administration; National Science Foundation(Division of Ocean Sciences) [(OCE)-1155728, OCE-0623622]; University of California, Santa Cruz; Division Of Ocean Sciences [1155728] Funding Source: National Science Foundation	Marine Mammal and Turtle Division, Southwest Fisheries Science Center-National Oceanographic Atmospheric Administration; National Science Foundation(Division of Ocean Sciences)(National Science Foundation (NSF)); University of California, Santa Cruz(University of California System); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by Marine Mammal and Turtle Division, Southwest Fisheries Science Center-National Oceanographic Atmospheric Administration for data collection and isotope analysis and National Science Foundation(Division of Ocean Sciences(OCE)-1155728, and OCE-0623622) for analysis of amino acids and data. Funding for Open Access provided by the University of California, Santa Cruz, Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes DL, 2009, LIMNOL OCEANOGR, V54, P1272, DOI 10.4319/lo.2009.54.4.1272; Bograd SJ, 2014, DEEP SEA R 2; Bograd Steven J., 2010, P106; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Brinton E, 2003, DEEP-SEA RES PT II, V50, P2449, DOI 10.1016/S0967-0645(03)00126-7; Carretta JV, 2010, US PACIFIC MARINE MA; Casciotti KL, 2001, ENCY OCEAN SCI, P1884, DOI [10.1006/rwos.2001.0172, DOI 10.1006/RWOS.2001.0172]; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Dave AC, 2013, J GEOPHYS RES-OCEANS, V118, P3114, DOI 10.1002/jgrc.20224; Dufault S., 1999, Journal of Cetacean Research and Management, V1, P1; Emslie SD, 2007, P NATL ACAD SCI USA, V104, P11666, DOI 10.1073/pnas.0608477104; FARRELL JW, 1995, NATURE, V377, P514, DOI 10.1038/377514a0; Fiedler PC, 2013, J CLIMATE, V26, P583, DOI 10.1175/JCLI-D-11-00728.1; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Garcia-Reyes M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005576; Germain LR, 2013, MAR ECOL PROG SER, V482, P265, DOI 10.3354/meps10257; GOERICKE R, 1994, GLOBAL BIOGEOCHEM CY, V8, P85, DOI 10.1029/93GB03272; Guilderson TP, 2013, BIOGEOSCIENCES, V10, P6019, DOI 10.5194/bg-10-6019-2013; Jacox MG, 2014, GEOPHYS RES LETT, V41, P3189, DOI 10.1002/2014GL059589; Kahru M, 2012, DEEP-SEA RES PT II, V77-80, P89, DOI 10.1016/j.dsr2.2012.04.007; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Marcoux M, 2007, MAR ECOL PROG SER, V333, P309, DOI 10.3354/meps333309; McCarthy MD, 2007, GEOCHIM COSMOCHIM AC, V71, P4727, DOI 10.1016/j.gca.2007.06.061; McClatchie S, 2013, REGIONAL FISHERIES O; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; McGowan JA, 2003, DEEP-SEA RES PT II, V50, P2567, DOI 10.1016/S0967-0645(03)00135-8; Mesnick SL, 2011, MOL ECOL RESOUR, V11, P278, DOI 10.1111/j.1755-0998.2010.02973.x; Morin PA, 2005, MOL ECOL, V14, P3275, DOI 10.1111/j.1365-294X.2005.02651.x; O'Brien DM, 2002, P NATL ACAD SCI USA, V99, P4413, DOI 10.1073/pnas.072346699; Ohman MD, 2012, DEEP-SEA RES PT I, V60, P46, DOI 10.1016/j.dsr.2011.11.003; Palacios DM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002380; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Polovina JJ, 2011, ICES J MAR SCI, V68, P986, DOI 10.1093/icesjms/fsq198; Popp BN, 2007, TERR ECOL SER, V1, P173; RAU GH, 1982, DEEP-SEA RES, V29, P1035, DOI 10.1016/0198-0149(82)90026-7; Rau GH, 2003, DEEP-SEA RES PT II, V50, P2431, DOI 10.1016/S0967-0645(03)00128-0; RAU GH, 1989, NATURE, V341, P516, DOI 10.1038/341516a0; Ruiz-Cooley R, 2012, MAR BIOL, P1; Ruiz-Cooley RI, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00094.1; Ruiz-Cooley RI, 2004, MAR ECOL PROG SER, V277, P275, DOI 10.3354/meps277275; Ruiz-Cooley RI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059651; Rykaczewski RR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045019; Schell DM, 2001, LIMNOL OCEANOGR, V46, P999; Sherwood OA, 2011, P NATL ACAD SCI US; Sherwood OA, 2014, NATURE, V505, P78, DOI 10.1038/nature12784; Somes CJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003767; Sonnerup RE, 1999, GLOBAL BIOGEOCHEM CY, V13, P857, DOI 10.1029/1999GB900027; WADA E., 1990, NITROGEN SEA FORMS A; Wiley AE, 2013, P NATL ACAD SCI USA, V110, P8972, DOI 10.1073/pnas.1300213110	54	27	28	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110355	10.1371/journal.pone.0110355	http://dx.doi.org/10.1371/journal.pone.0110355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329915	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100066
J	Huberman, LB; Murray, AW				Huberman, Lori B.; Murray, Andrew W.			A Model for Cell Wall Dissolution in Mating Yeast Cells: Polarized Secretion and Restricted Diffusion of Cell Wall Remodeling Enzymes Induces Local Dissolution	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; A-AGGLUTININ; ACTIN CYTOSKELETON; SIGNALING PATHWAYS; ALPHA-AGGLUTININ; MYOBLAST FUSION; PHEROMONE; PROTEIN; FUS2P	Mating of the budding yeast, Saccharomyces cerevisiae, occurs when two haploid cells of opposite mating types signal using reciprocal pheromones and receptors, grow towards each other, and fuse to form a single diploid cell. To fuse, both cells dissolve their cell walls at the point of contact. This event must be carefully controlled because the osmotic pressure differential between the cytoplasm and extracellular environment causes cells with unprotected plasma membranes to lyse. If the cell wall-degrading enzymes diffuse through the cell wall, their concentration would rise when two cells touched each other, such as when two pheromone-stimulated cells adhere to each other via mating agglutinins. At the surfaces that touch, the enzymes must diffuse laterally through the wall before they can escape into the medium, increasing the time the enzymes spend in the cell wall, and thus raising their concentration at the point of attachment and restricting cell wall dissolution to points where cells touch each other. We tested this hypothesis by studying pheromone treated cells confined between two solid, impermeable surfaces. This confinement increases the frequency of pheromone-induced cell death, and this effect is diminished by reducing the osmotic pressure difference across the cell wall or by deleting putative cell wall glucanases and other genes necessary for efficient cell wall fusion. Our results support the model that pheromone-induced cell death is the result of a contact-driven increase in the local concentration of cell wall remodeling enzymes and suggest that this process plays an important role in regulating cell wall dissolution and fusion in mating cells.	[Huberman, Lori B.; Murray, Andrew W.] Harvard Univ, Cambridge, MA 02138 USA; [Huberman, Lori B.; Murray, Andrew W.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Murray, AW (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	amurray@mcb.harvard.edu		Huberman, Lori/0000-0003-2638-8528	National Institute of General Medical Sciences [P50GM068763]; National Centers for Systems Biology Program; National Science Foundation; Graduate Research Fellowship; Ashford Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Centers for Systems Biology Program; National Science Foundation(National Science Foundation (NSF)); Graduate Research Fellowship; Ashford Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences (http://www.nigms.nih.gov/) Grant P50GM068763 of the National Centers for Systems Biology Program and a National Science Foundation (http://www.nsf.gov/) Graduate Research Fellowship and Ashford Fellowship (http://www.gsas.harvard.edu/fellowships.php) to L.B.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr Susan A., 2008, V475, P75, DOI 10.1007/978-1-59745-250-2_5; Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Alper Scott, 2008, V475, P53, DOI 10.1007/978-1-59745-250-2_4; Ayscough KR, 1998, CURR BIOL, V8, P927, DOI 10.1016/S0960-9822(07)00374-0; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Barkai N, 1998, NATURE, V396, P422, DOI 10.1038/24760; BIELY P, 1976, EUR J BIOCHEM, V70, P75, DOI 10.1111/j.1432-1033.1976.tb10957.x; BLOMBERG A, 1992, ADV MICROB PHYSIOL, V33, P145, DOI 10.1016/S0065-2911(08)60217-9; Bon E, 2000, YEAST, V16, P1229, DOI 10.1002/1097-0061(20000930)16:13<1229::AID-YEA618>3.0.CO;2-Q; Brizzio V, 1996, J CELL BIOL, V135, P1727, DOI 10.1083/jcb.135.6.1727; Brizzio V, 1998, J CELL BIOL, V141, P567, DOI 10.1083/jcb.141.3.567; Brown A D, 1978, Adv Microb Physiol, V17, P181, DOI 10.1016/S0065-2911(08)60058-2; CAPPELLARO C, 1994, EMBO J, V13, P4737, DOI 10.1002/j.1460-2075.1994.tb06799.x; Cappellaro C, 1998, J BACTERIOL, V180, P5030, DOI 10.1128/JB.180.19.5030-5037.1998; CHAN RK, 1982, MOL CELL BIOL, V2, P21, DOI 10.1128/MCB.2.1.21; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; CHEN EH, 2008, CELL FUSION OVERVIEW; CHENEVERT J, 1994, GENETICS, V136, P1287; CID VJ, 1995, MICROBIOL REV, V59, P345, DOI 10.1128/MMBR.59.3.345-386.1995; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; DOLAN JW, 1989, P NATL ACAD SCI USA, V86, P5703, DOI 10.1073/pnas.86.15.5703; Dupres V, 2010, ACS NANO, V4, P5498, DOI 10.1021/nn101598v; Friesen H, 2006, MOL BIOL CELL, V17, P1306, DOI 10.1091/mbc.e05-06-0476; GALINDO B, 1974, INFECT IMMUN, V9, P212, DOI 10.1128/IAI.9.2.212-216.1974; Gammie AE, 1998, MOL BIOL CELL, V9, P1395, DOI 10.1091/mbc.9.6.1395; HERSKOWITZ I, 1988, MICROBIOL REV, V52, P536, DOI 10.1128/MMBR.52.4.536-553.1988; HIRAYAMA T, 1995, MOL GEN GENET, V249, P127, DOI 10.1007/BF00290358; Huppertz Berthold, 2008, V475, P135, DOI 10.1007/978-1-59745-250-2_8; HUTCHISON HT, 1967, J BACTERIOL, V94, P1697, DOI 10.1128/JB.94.5.1697-1705.1967; Ishii M, 2008, MOD RHEUMATOL, V18, P220, DOI 10.1007/s10165-008-0051-2; JACKSON CL, 1990, CELL, V63, P1039, DOI 10.1016/0092-8674(90)90507-B; Joglekar AP, 2008, METHOD CELL BIOL, V85, P127, DOI 10.1016/S0091-679X(08)85007-8; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; KLIS FM, 1994, YEAST, V10, P851, DOI 10.1002/yea.320100702; KURIHARA LJ, 1994, J CELL BIOL, V126, P911, DOI 10.1083/jcb.126.4.911; Lee PJ, 2008, BIOTECHNIQUES, V44, P91, DOI 10.2144/000112673; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; MARSH L, 1997, MOL CELLULAR BIOL YE, V3, P827; Nelson B, 2004, GENETICS, V166, P67, DOI 10.1534/genetics.166.1.67; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Paterson JM, 2008, J CELL BIOL, V181, P697, DOI 10.1083/jcb.200801101; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Philips J, 1997, J CELL BIOL, V138, P961, DOI 10.1083/jcb.138.5.961; ROY A, 1991, MOL CELL BIOL, V11, P4196, DOI 10.1128/MCB.11.8.4196; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Sheltzer JM, 2009, MOL BIOL CELL, V20, P2909, DOI 10.1091/mbc.E08-09-0923; Sherman F., 1974, METHODS YEAST GENETI; Sheu YJ, 2000, MOL CELL BIOL, V20, P5235, DOI 10.1128/MCB.20.14.5235-5247.2000; SPRAGUE GF, 1981, J MOL BIOL, V153, P305, DOI 10.1016/0022-2836(81)90280-1; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; TRUEHEART J, 1987, MOL CELL BIOL, V7, P2316, DOI 10.1128/MCB.7.7.2316; TRUEHEART J, 1989, P NATL ACAD SCI USA, V86, P9916, DOI 10.1073/pnas.86.24.9916; Ydenberg CA, 2012, MOL BIOL CELL, V23, P1208, DOI 10.1091/mbc.E11-08-0723; Ydenberg Casey A., 2008, V475, P3, DOI 10.1007/978-1-59745-250-2_1; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5; Zhang NN, 2006, MOL BIOL CELL, V17, P3409, DOI 10.1091/mbc.E06-03-0177; Zhao H, 2001, J BACTERIOL, V183, P2874, DOI 10.1128/JB.183.9.2874-2880.2001	61	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109780	10.1371/journal.pone.0109780	http://dx.doi.org/10.1371/journal.pone.0109780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329559	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800040
J	Dewar, M; Alber, J; Cowan, N; Della Sala, S				Dewar, Michaela; Alber, Jessica; Cowan, Nelson; Della Sala, Sergio			Boosting Long-Term Memory via Wakeful Rest: Intentional Rehearsal Is Not Necessary, Consolidation Is Sufficient	PLOS ONE			English	Article							RETROACTIVE INTERFERENCE; REMEMBER/KNOW JUDGMENTS; ANTEROGRADE AMNESIA; RECOGNITION MEMORY; RETRIEVAL PRACTICE; FALSE RECOGNITION; AWAKE STATE; RECALL; RECOLLECTION; RETENTION	People perform better on tests of delayed free recall if learning is followed immediately by a short wakeful rest than by a short period of sensory stimulation. Animal and human work suggests that wakeful resting provides optimal conditions for the consolidation of recently acquired memories. However, an alternative account cannot be ruled out, namely that wakeful resting provides optimal conditions for intentional rehearsal of recently acquired memories, thus driving superior memory. Here we utilised non-recallable words to examine whether wakeful rest boosts long-term memory, even when new memories could not be rehearsed intentionally during the wakeful rest delay. The probing of non-recallable words requires a recognition paradigm. Therefore, we first established, via Experiment 1, that the rest-induced boost in memory observed via free recall can be replicated in a recognition paradigm, using concrete nouns. In Experiment 2, participants heard 30 non-recallable non-words, presented as 'foreign names in a bridge club abroad' and then either rested wakefully or played a visual spot-the-difference game for 10 minutes. Retention was probed via recognition at two time points, 15 minutes and 7 days after presentation. As in Experiment 1, wakeful rest boosted recognition significantly, and this boost was maintained for at least 7 days. Our results indicate that the enhancement of memory via wakeful rest is not dependent upon intentional rehearsal of learned material during the rest period. We thus conclude that consolidation is sufficient for this rest-induced memory boost to emerge. We propose that wakeful resting allows for superior memory consolidation, resulting in stronger and/or more veridical representations of experienced events which can be detected via tests of free recall and recognition.	[Dewar, Michaela] Heriot Watt Univ, Sch Life Sci, Dept Psychol, Edinburgh, Midlothian, Scotland; [Dewar, Michaela; Alber, Jessica; Cowan, Nelson; Della Sala, Sergio] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Dewar, Michaela; Della Sala, Sergio] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Cowan, Nelson] Univ Missouri, Dept Psychol, Columbia, MO USA	Heriot Watt University; University of Edinburgh; University of Edinburgh; University of Missouri System; University of Missouri Columbia	Dewar, M (corresponding author), Heriot Watt Univ, Sch Life Sci, Dept Psychol, Edinburgh, Midlothian, Scotland.	m.dewar@hw.ac.uk		Alber, Jessica/0000-0002-5090-4206; Dewar, Michaela/0000-0002-7841-2975	Age UK [355]; Personal Research Fellowship - Royal Society of Edinburgh and Lloyds/TSB Foundation for Scotland [29400 R41255]; Medical Research Council [MR/K026992/1] Funding Source: researchfish	Age UK; Personal Research Fellowship - Royal Society of Edinburgh and Lloyds/TSB Foundation for Scotland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Age UK (Grant 355; url: www.ageuk.org.uk/) as part of a Ph.D. studentship awarded to MD and SDS and held by JA, and by a Personal Research Fellowship (Grant number: 29400 R41255; url: www.ltsbfoundationforscotland.org.uk) awarded to MD by the Royal Society of Edinburgh and Lloyds/TSB Foundation for Scotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRANOFF BERNARD W., 1966, BRAIN RES, V1, P303, DOI 10.1016/0006-8993(66)90095-3; Borota D, 2014, NAT NEUROSCI, V17, P201, DOI 10.1038/nn.3623; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cowan N, 2004, BRAIN, V127, P825, DOI 10.1093/brain/awh107; Craig M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093915; CRAIK FIM, 1973, J VERB LEARN VERB BE, V12, P599, DOI 10.1016/S0022-5371(73)80039-8; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Della Sala S, 2005, MEMORY, V13, P435, DOI 10.1080/09658210344000387; Deuker L, 2013, J NEUROSCI, V33, P19373, DOI 10.1523/JNEUROSCI.0414-13.2013; Dewar M, 2012, PSYCHOL SCI, V23, P955, DOI 10.1177/0956797612441220; Dewar M, 2010, NEUROPSYCHOLOGY, V24, P357, DOI 10.1037/a0018207; Dewar M, 2009, NEUROPSYCHOLOGY, V23, P627, DOI 10.1037/a0015568; Dewar MT, 2007, CORTEX, V43, P616, DOI 10.1016/S0010-9452(08)70492-1; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Drosopoulos S, 2005, LEARN MEMORY, V12, P44, DOI 10.1101/lm.83805; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dunn JC, 2004, PSYCHOL REV, V111, P524, DOI 10.1037/0033-295X.111.2.524; Dunn JC, 2008, PSYCHOL REV, V115, P426, DOI 10.1037/0033-295X.115.2.426; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Fenn KM, 2009, LEARN MEMORY, V16, P509, DOI 10.1101/lm.1500808; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Gallo DA, 2004, J EXP PSYCHOL LEARN, V30, P120, DOI 10.1037/0278-7393.30.1.120; GARDINER JM, 1994, PSYCHON B REV, V1, P107, DOI 10.3758/BF03200764; GARDINER JM, 1988, MEM COGNITION, V16, P309, DOI 10.3758/BF03197041; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; McTighe SM, 2010, SCIENCE, V330, P1408, DOI 10.1126/science.1194780; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Molitor RJ, 2014, HIPPOCAMPUS, P1; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Nelson HE., 1982, NATL ADULT READING T; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; Roediger HL, 2011, TRENDS COGN SCI, V15, P20, DOI 10.1016/j.tics.2010.09.003; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; Romberg C, 2012, BRAIN, V135, P2103, DOI 10.1093/brain/aws074; Smith MA, 2013, J EXP PSYCHOL LEARN, V39, P1712, DOI 10.1037/a0033569; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Wixted JT, 2007, PSYCHOL REV, V114, P152, DOI 10.1037/0033-295X.114.1.152; Wixted JT, 2010, PSYCHOL REV, V117, P1025, DOI 10.1037/a0020874; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Wixted JT, 2004, PSYCHON B REV, V11, P616, DOI 10.3758/BF03196616; WOODWARD AE, 1973, J VERB LEARN VERB BE, V12, P608, DOI 10.1016/S0022-5371(73)80040-4; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864	45	49	49	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109542	10.1371/journal.pone.0109542	http://dx.doi.org/10.1371/journal.pone.0109542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25333957	Green Published, gold			2022-12-27	WOS:000346766200037
J	Janis, CM; Buttrill, K; Figueirido, B				Janis, Christine M.; Buttrill, Karalyn; Figueirido, Borja			Locomotion in Extinct Giant Kangaroos: Were Sthenurines Hop-Less Monsters?	PLOS ONE			English	Article							FUNCTIONAL-ANATOMY; TREE-KANGAROOS; RAT-KANGAROO; MARSUPIALIA; EVOLUTION; ADAPTATIONS; LIMB; MACROPODOIDEA; MORPHOLOGY; PHYLOGENY	Sthenurine kangaroos (Marsupialia, Diprotodontia, Macropodoidea) were an extinct subfamily within the family Macropodidae (kangaroos and rat-kangaroos). These "short-faced browsers'' first appeared in the middle Miocene, and radiated in the Plio-Pleistocene into a diversity of mostly large-bodied forms, more robust than extant forms in their build. The largest (Procoptodon goliah) had an estimated body mass of 240 kg, almost three times the size of the largest living kangaroos, and there is speculation whether a kangaroo of this size would be biomechanically capable of hopping locomotion. Previously described aspects of sthenurine anatomy (specialized forelimbs, rigid lumbar spine) would limit their ability to perform the characteristic kangaroo pentapedal walking (using the tail as a fifth limb), an essential gait at slower speeds as slow hopping is energetically unfeasible. Analysis of limb bone measurements of sthenurines in comparison with extant macropodoids shows a number of anatomical differences, especially in the large species. The scaling of long bone robusticity indicates that sthenurines are following the "normal'' allometric trend for macropodoids, while the large extant kangaroos are relatively gracile. Other morphological differences are indicative of adaptations for a novel type of locomotor behavior in sthenurines: they lacked many specialized features for rapid hopping, and they also had anatomy indicative of supporting their body with an upright trunk (e.g., dorsally tipped ischiae), and of supporting their weight on one leg at a time (e.g., larger hips and knees, stabilized ankle joint). We propose that sthenurines adopted a bipedal striding gait (a gait occasionally observed in extant tree-kangaroos): in the smaller and earlier forms, this gait may have been employed as an alternative to pentapedal locomotion at slower speeds, while in the larger Pleistocene forms this gait may have enabled them to evolve to body sizes where hopping was no longer a feasible form of more rapid locomotion.	[Janis, Christine M.; Buttrill, Karalyn] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Figueirido, Borja] Univ Malaga, Fac Ciencias, Dept Ecol & Geol, E-29071 Malaga, Spain	Brown University; Universidad de Malaga	Janis, CM (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	Christine_Janis@Brown.edu	Janis, Christine/GPT-3398-2022; Figueirido, Borja/AAV-7882-2020; Figueirido, Borja/G-9665-2015	Figueirido, Borja/0000-0003-2542-3977; Figueirido, Borja/0000-0003-2542-3977	The Bushnell Research and Teaching Grant	The Bushnell Research and Teaching Grant	CJ was supported by The Bushnell Research and Teaching Grant (private foundation grant to Brown University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello L., 1990, P1; ALEXANDER RM, 1975, J ZOOL, V177, P265, DOI 10.1111/j.1469-7998.1975.tb05983.x; Arena DA, 2014, SEDIMENT GEOL, V304, P28, DOI 10.1016/j.sedgeo.2014.01.005; BADOUX DM, 1965, ACTA ANAT, V62, P418; Bassarova M, 2009, J MAMM EVOL, V16, P1, DOI 10.1007/s10914-008-9093-7; BAUDINETTE RV, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P245; BAUDINETTE RV, 1993, J EXP BIOL, V174, P81; Bennett MB, 2000, PHYSIOL BIOCHEM ZOOL, V73, P726, DOI 10.1086/318110; BENNETT MB, 1995, NATURE, V378, P56, DOI 10.1038/378056a0; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Bishop Nicolas, 1997, Proceedings of the Linnean Society of New South Wales, V117, P17; Burk A, 1998, SYST BIOL, V47, P457, DOI 10.1080/106351598260824; Chen XM, 2005, J MORPHOL, V266, P167, DOI 10.1002/jmor.10370; Clauss M, 2003, OIKOS, V102, P253, DOI 10.1034/j.1600-0706.2003.12406.x; Clifford AB, 2010, J VERTEBR PALEONTOL, V30, P1827, DOI 10.1080/02724634.2010.521216; Cooke Bernard N., 1999, Records of the Western Australian Museum Supplement, V57, P239; Cronin L., 2008, AUSTR MAMMALS; Davis JR., 2002, SYS CON FDN, P1; Dawson TJ, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P99; Dawson T.J., 1995, KANGAROOS BIOL LARGE; Dawson TJ, 1983, MONOTREMES MARSUPIAL; Elftman HO, 1929, B AM MUS NAT HIST, V58, P189; Figueirido B, 2010, J VERTEBR PALEONTOL, V30, P262, DOI 10.1080/02724630903416027; Flannery T., 2008, CHASING KANGAROOS CO; FLEAGLE JG, 1992, J HUM EVOL, V22, P285, DOI 10.1016/0047-2484(92)90060-M; Helgen KM, 2006, AUST J ZOOL, V54, P293, DOI 10.1071/ZO05077; Hooker JJ, 2007, ZOOL J LINN SOC-LOND, V151, P609, DOI 10.1111/j.1096-3642.2007.00352.x; HOPWOOD PR, 1990, AUST J ZOOL, V38, P397, DOI 10.1071/ZO9900397; HOPWOOD PR, 1976, J ANAT, V121, P259; Hudson PE, 2011, J ANAT, V218, P363, DOI 10.1111/j.1469-7580.2010.01310.x; Janis CM, 2002, J VERTEBR PALEONTOL, V22, P110, DOI 10.1671/0272-4634(2002)022[0110:LEICRA]2.0.CO;2; KAPPELMAN J, 1988, J MORPHOL, V198, P119, DOI 10.1002/jmor.1051980111; Kear B.P., 2001, Memoir of the Association of Australasian Palaeontologists, V25, P103; Kear B.P., 2001, Memoir of the Association of Australasian Palaeontologists, V25, P83; Kear BP, 2007, J PALEONTOL, V81, P1147, DOI 10.1666/04-218.1; Kear Benjamin P., 2008, P25, DOI 10.1007/978-1-4020-6997-0_2; Kear BP, 2002, ALCHERINGA, V26, P299, DOI 10.1080/03115510208619259; Martin R, 2005, AUSTRAL NAT HIST SER, P1; McGowan CP, 2008, J ANAT, V212, P153, DOI 10.1111/j.1469-7580.2007.00841.x; Mcgowan CP, 2009, INTEGR COMP BIOL, V49, pE112; Mendoza M, 2002, J ZOOL, V258, P223, DOI 10.1017/S0952836902001346; Meredith RW, 2008, AUST J ZOOL, V56, P395, DOI 10.1071/ZO08044; Munn AJ, 2008, COMP BIOCHEM PHYS A, V151, P78, DOI 10.1016/j.cbpa.2008.06.001; MURRAY PF, 1995, ALCHERINGA, V19, P119, DOI 10.1080/03115519508619271; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; O'Connor SM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0381; O'Sullivan Jay A., 2008, P159, DOI 10.1007/978-1-4020-6997-0_8; Prideaux GJ, 2007, NATURE, V445, P422, DOI 10.1038/nature05471; Prideaux GJ, 2010, ZOOL J LINN SOC-LOND, V159, P954, DOI 10.1111/j.1096-3642.2009.00607.x; Prideaux GJ, 2004, U CALIF PUBL GEOL SC, V146, P1; Reilly SM, 2003, SCIENCE, V299, P400, DOI 10.1126/science.1074905; Samuels JX, 2013, J MORPHOL, V274, P121, DOI 10.1002/jmor.20077; Sanchez-Villagra MR, 2005, ZOOLOGY, V108, P3, DOI 10.1016/j.zool.2004.07.006; Sears KE, 2011, EVOL DEV, V13, P533, DOI 10.1111/j.1525-142X.2011.00509.x; TEDFORD RICHARD H., 1966, UNIV CALIF PUBL GEOL SCI, V57, P1; Travouillon KJ, 2009, PALAEOGEOGR PALAEOCL, V276, P24, DOI 10.1016/j.palaeo.2009.02.025; Warburton NM, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P137; Warburton NM, 2012, AUST J ZOOL, V60, P246, DOI 10.1071/ZO12059; Warburton NM, 2011, J MORPHOL, V272, P1230, DOI 10.1002/jmor.10979; Webster KN, 2003, J COMP PHYSIOL B, V173, P549, DOI 10.1007/s00360-003-0364-6; Webster Koa N., 2004, Australian Mammalogy, V26, P153; WELLS RT, 1995, B AM MUS NAT HIST, P1; WINDSOR DE, 1971, J ZOOL, V163, P165, DOI 10.1111/j.1469-7998.1971.tb04530.x; Woodburne M.O., 1967, BUREAU MINERAL RESOU, V87, P1	64	27	28	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109888	10.1371/journal.pone.0109888	http://dx.doi.org/10.1371/journal.pone.0109888			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333823	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200062
J	Vanco, J; Galikova, J; Hosek, J; Dvorak, Z; Parakova, L; Travnicek, Z				Vanco, Jan; Galikova, Jana; Hosek, Jan; Dvorak, Zdenek; Parakova, Lenka; Travnicek, Zdenek			Gold(I) Complexes of 9-Deazahypoxanthine as Selective Antitumor and Anti-Inflammatory Agents	PLOS ONE			English	Article							IN-VITRO; RHEUMATOID-ARTHRITIS; BIOLOGICAL-ACTIVITY; AURANOFIN; DERIVATIVES; CYTOTOXICITY; INHIBITOR; COMPOUND; BINDING; DESIGN	The gold(I) mixed-ligand complexes involving O-substituted derivatives of 9-deazahypoxanthine (HLn) and triphenylphosphine (PPh3) with the general formula [Au(L-n)(PPh3)] (1-5) were prepared and thoroughly characterized by elemental analysis, FT-IR and multinuclear NMR spectroscopy, ESI+ mass spectrometry, single crystal X-ray (HL5 and complex 2) and TG/DTA analyses. Complexes 1-5 were evaluated for their in vitro antitumor activity against nine human cancer lines, i.e. MCF7 (breast carcinoma), HOS (osteosarcoma), A549 (adenocarcinoma), G361 (melanoma), HeLa (cervical cancer), A2780 (ovarian carcinoma), A2780R (ovarian carcinoma resistant to cisplatin), 22Rv1 (prostate cancer) and THP-1 (monocytic leukaemia), for their in vitro anti-inflammatory activity using a model of LPS-activated macrophages, and for their in vivo antiedematous activity by lambda-carrageenan-induced hind paw edema model on rats. The results showed that the complexes 1-5 exhibit selective in vitro cytotoxicity against MCF7, HOS, 22Rv1, A2780 and A2780R, with submicromolar IC50 values for 2 against the MCF7 (0.6 mu M) and HOS (0.9 mu M). The results of in vitro cytotoxicity screening on primary culture of human hepatocytes (HEP220) revealed up to 30-times lower toxicity of compounds against healthy cells as compared with cancer cells. Additionally, the complexes 1-5 significantly influence the secretion and expression of pro-inflammatory cytokines TNF-alpha and IL-1 beta by a similar manner as a commercially used anti-arthritic drug Auranofin. The tested complexes also significantly influence the rate and overall volume of the edema, caused by the intraplantar application of lambda-carrageenan polysaccharide to rats. Based on these promising results, the presented compounds could qualify to become feasible candidates for advanced testing as potential antitumor and anti-inflammatory drug-like compounds.	[Vanco, Jan; Galikova, Jana; Hosek, Jan; Dvorak, Zdenek; Travnicek, Zdenek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic; [Vanco, Jan; Galikova, Jana; Hosek, Jan; Travnicek, Zdenek] Palacky Univ, Fac Sci, Dept Inorgan Chem, CR-77147 Olomouc, Czech Republic; [Dvorak, Zdenek] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic; [Parakova, Lenka] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Human Pharmacol & Toxicol, Brno, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc; University of Veterinary Sciences Brno	Travnicek, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic.	zdenek.travnicek@upol.cz	Parakova, Lenka/AGZ-4403-2022; Vanco, Jan/H-2705-2013; Hosek, Jan/B-6274-2009	Vanco, Jan/0000-0003-3351-1192; Hosek, Jan/0000-0003-0975-1671; Dvorak, Zdenek/0000-0002-3938-3585; Travnicek, Zdenek/0000-0002-5890-7874	Operational Program Research and Development for Innovations - European Regional Development Fund [CZ.1.05/2.1.00/03.0058]; Ministry of Education, Youth and Sports of the Czech Republic [LO1305]	Operational Program Research and Development for Innovations - European Regional Development Fund; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	The authors gratefully thank the Operational Program Research and Development for Innovations - European Regional Development Fund (CZ.1.05/2.1.00/03.0058), the National Program of Sustainability I (LO1305) of the Ministry of Education, Youth and Sports of the Czech Republic and Palacky University in Olomouc (IGA_PrF_2014009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbehausen C, 2013, INORG CHEM, V52, P11280, DOI 10.1021/ic401535s; Abdel-Salam OME, 2003, PHARMACOL RES, V47, P331, DOI 10.1016/S1043-6618(03)00002-1; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Balakrishnan K, 2010, BLOOD, V116, P886, DOI 10.1182/blood-2010-02-272039; Bantia S, 2001, INT IMMUNOPHARMACOL, V1, P1199, DOI 10.1016/S1567-5769(01)00056-X; Barreiro E, 2008, J INORG BIOCHEM, V102, P184, DOI 10.1016/j.jinorgbio.2007.07.034; BERNERS-PRICE S., 1988, STRUCT BOND, V70, P27; Berners-Price SJ, 2008, AUST J CHEM, V61, P661, DOI 10.1071/CH08175; BERNERSPRICE SJ, 1987, INORG CHEM, V26, P3074, DOI 10.1021/ic00265a032; BERNERSPRICE SJ, 1990, J MED CHEM, V33, P1386, DOI 10.1021/jm00167a017; BERNERSPRICE SJ, 1986, CANCER RES, V46, P5486; Brandenburg K., 2011, DIAMOND RELEASE 3 2I; BRUCE MI, 1989, INORG SYN, V26, P324, DOI 10.1002/9780470132579.ch59; Bruijnincx PCA, 2008, CURR OPIN CHEM BIOL, V12, P197, DOI 10.1016/j.cbpa.2007.11.013; Bzowska A, 2000, PHARMACOL THERAPEUT, V88, P349, DOI 10.1016/S0163-7258(00)00097-8; Carland M, 2005, METALLOTHERAPEUTIC D, P313, DOI 10.1002/0470864052; Casas JS, 2007, INORG CHEM, V46, P6236, DOI 10.1021/ic700861a; Casas JS, 2006, J INORG BIOCHEM, V100, P1858, DOI 10.1016/j.jinorgbio.2006.07.006; Casini A, 2011, CURR TOP MED CHEM, V11, P2647, DOI 10.2174/156802611798040732; Chang HY, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep027; Che CM, 2011, CHEM COMMUN, V47, P9554, DOI 10.1039/c1cc10860c; Clinch K, 2009, J MED CHEM, V52, P1126, DOI 10.1021/jm801421q; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Eisler R, 2003, INFLAMM RES, V52, P487, DOI 10.1007/s00011-003-1208-2; FAGGIANI R, 1987, CAN J CHEM, V65, P1568, DOI 10.1139/v87-264; Farrer N.J., 2011, BIOINORG MED CHEM, P1; Galassi R, 2012, DALTON T, V41, P5307, DOI 10.1039/c2dt11781a; Galikova J, 2014, POLYHEDRON, V79, P269, DOI 10.1016/j.poly.2014.05.008; Garber JC, 2011, GUIDE CARE USE LAB A; Gibson AE, 2002, J MED CHEM, V45, P3381, DOI 10.1021/jm020056z; Hambley TW, 2007, SCIENCE, V318, P1392, DOI 10.1126/science.1150504; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hickey JL, 2008, J AM CHEM SOC, V130, P12570, DOI 10.1021/ja804027j; Horvath UEI, 2012, J INORG BIOCHEM, V111, P80, DOI 10.1016/j.jinorgbio.2012.02.026; Hosek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082441; Illan-Cabeza NA, 2013, EUR J MED CHEM, V64, P260, DOI 10.1016/j.ejmech.2013.03.067; Iqbal MS, 2009, BIOL TRACE ELEM RES, V130, P204, DOI 10.1007/s12011-009-8330-0; Jeon KI, 2000, J IMMUNOL, V164, P5981, DOI 10.4049/jimmunol.164.11.5981; Kamath VP, 2009, ORG PROCESS RES DEV, V13, P928, DOI 10.1021/op9001142; Kean W. F., 2008, Inflammopharmacology, V16, P112, DOI 10.1007/s10787-007-0021-x; Kean WF, 1997, BRIT J RHEUMATOL, V36, P560; LEWIS D, 1983, ANN RHEUM DIS, V42, P566, DOI 10.1136/ard.42.5.566; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madeira J. M., 2012, Inflammopharmacology, V20, P297, DOI 10.1007/s10787-012-0149-1; Mann FG, 1937, J CHEM SOC, P1828, DOI 10.1039/jr9370001828; Milacic V, 2009, COORDIN CHEM REV, V253, P1649, DOI 10.1016/j.ccr.2009.01.032; MIRABELLI CK, 1986, J MED CHEM, V29, P218, DOI 10.1021/jm00152a009; MIRABELLI CK, 1985, CANCER RES, V45, P32; MIRABELLI CK, 1987, J MED CHEM, V30, P2181, DOI 10.1021/jm00395a004; Nakamoto K., 1997, INFRARED RAMAN SPE B; Nardon C, 2014, ANTICANCER RES, V34, P487; Ott I, 2009, COORDIN CHEM REV, V253, P1670, DOI 10.1016/j.ccr.2009.02.019; Ott I, 2009, J MED CHEM, V52, P763, DOI 10.1021/jm8012135; Oxford Diffraction, CRYSALIS RED CRYSALI; Rode HJ, 2008, APOPTOSIS CYTOTOXICI; Rubbiani R, 2010, J MED CHEM, V53, P8608, DOI 10.1021/jm100801e; Saccoccia F, 2012, J INORG BIOCHEM, V108, P105, DOI 10.1016/j.jinorgbio.2011.11.005; Salemi G, 2009, NEUROL SCI, V30, P361, DOI 10.1007/s10072-009-0090-2; Seitz M, 2003, J CLIN IMMUNOL, V23, P477, DOI 10.1023/B:JOCI.0000010424.41475.17; Serratrice M, 2012, INORG CHEM, V51, P3161, DOI 10.1021/ic202639t; SHAW CF, 1988, J AM CHEM SOC, V110, P729, DOI 10.1021/ja00211a011; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIGLER JW, 1974, ANN INTERN MED, V80, P21, DOI 10.7326/0003-4819-80-1-21; SIMON TM, 1979, CANCER, V44, P1965, DOI 10.1002/1097-0142(197912)44:6<1965::AID-CNCR2820440602>3.0.CO;2-6; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Stallings-Mann M, 2006, CANCER RES, V66, P1767, DOI 10.1158/0008-5472.CAN-05-3405; Starha P, 2012, J INORG BIOCHEM, V115, P57, DOI 10.1016/j.jinorgbio.2012.05.006; Tiekink E. R. T., 2008, Inflammopharmacology, V16, P138, DOI 10.1007/s10787-007-0018-5; Tiekink ERT, 2002, CRIT REV ONCOL HEMAT, V42, P225, DOI 10.1016/S1040-8428(01)00216-5; Travnicek Z, 2012, J MED CHEM, V55, P4568, DOI 10.1021/jm201416p; Vrzal R, 2010, J INORG BIOCHEM, V104, P1130, DOI 10.1016/j.jinorgbio.2010.07.002; WILLIAMS HJ, 1992, ARTHRITIS RHEUM, V35, P259, DOI 10.1002/art.1780350304; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	74	16	17	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109901	10.1371/journal.pone.0109901	http://dx.doi.org/10.1371/journal.pone.0109901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333949	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200064
J	Fields, S; Song, BB; Rasoul, B; Fong, JL; Works, MG; Shew, K; Yiu, Y; Mirsalis, J; D'Andrea, A				Fields, Scott; Song, Benben; Rasoul, Bareza; Fong, Julie; Works, Melissa G.; Shew, Kenneth; Yiu, Ying; Mirsalis, Jon; D'Andrea, Annalisa			New Candidate Biomarkers in the Female Genital Tract to Evaluate Microbicide Toxicity	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEINS; CHEMOKINE RECEPTOR EXPRESSION; VAGINAL MICROBICIDE; PRECLINICAL EVALUATION; MOUSE MODEL; NONOXYNOL 9; IN-VITRO; TRANSMISSION; INFLAMMATION; HIV	Vaginal microbicides hold great promise for the prevention of viral diseases like HIV, but the failure of several microbicide candidates in clinical trials has raised important questions regarding the parameters to be evaluated to determine in vivo efficacy in humans. Clinical trials of the candidate microbicides nonoxynol-9 (N9) and cellulose sulfate revealed an increase in HIV infection, vaginal inflammation, and recruitment of HIV susceptible lymphocytes, highlighting the need to identify biomarkers that can accurately predict microbicide toxicity early in preclinical development and in human trials. We used quantitative proteomics and RT-PCR approaches in mice and rabbits to identify protein changes in vaginal fluid and tissue in response to treatment with N9 or benzalkonium chloride (BZK). We compared changes generated with N9 and BZK treatment to the changes generated in response to tenofovir gel, a candidate microbicide that holds promise as a safe and effective microbicide. Both compounds down regulated mucin 5 subtype B, and peptidoglycan recognition protein 1 in vaginal tissue; however, mucosal brush samples also showed upregulation of plasma proteins fibrinogen, plasminogen, apolipoprotein A-1, and apolipoprotein C-1, which may be a response to the erosive nature of N9 and BZK. Additional proteins down-regulated in vaginal tissue by N9 or BZK treatment include CD166 antigen, olfactomedin-4, and anterior gradient protein 2 homolog. We also observed increases in the expression of C-C chemokines CCL3, CCL5, and CCL7 in response to treatment. There was concordance in expression level changes for several of these proteins using both the mouse and rabbit models. Using a human vaginal epithelial cell line, the expression of mucin 5 subtype B and olfactomedin-4 were down-regulated in response to N9, suggesting these markers could apply to humans. These data identifies new proteins that after further validation could become part of a panel of biomarkers to effectively evaluate microbicide toxicity.	[Fields, Scott; Song, Benben; Rasoul, Bareza; Fong, Julie; Works, Melissa G.; Shew, Kenneth; Yiu, Ying; Mirsalis, Jon; D'Andrea, Annalisa] SRI Int, Biosci Div, Menlo Pk, CA 94025 USA	SRI International	D'Andrea, A (corresponding author), SRI Int, Biosci Div, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	annalisa.dandrea@sri.com			National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200700043C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200700043C. JM and AD received the funding to support the work. The funder approved the manuscript for submission.	Achilles SL, 2002, SEX TRANSM DIS, V29, P655, DOI 10.1097/00007435-200211000-00007; Alt C, 2009, CURR HIV RES, V7, P639, DOI 10.2174/157016209789973682; Anderson RA, 2002, J ANDROL, V23, P426; BARBERINI F, 1991, ARCH HISTOL CYTOL, V54, P365, DOI 10.1679/aohc.54.365; Catalone BJ, 2005, BIOMED PHARMACOTHER, V59, P430, DOI 10.1016/j.biopha.2005.07.008; Catalone BJ, 2005, ANTIMICROB AGENTS CH, V49, P1509, DOI 10.1128/AAC.49.4.1509-1520.2005; Catalone BJ, 2004, ANTIMICROB AGENTS CH, V48, P1837, DOI 10.1128/AAC.48.5.1837-1847.2004; Cohen J, 2008, SCIENCE, V319, P1026, DOI 10.1126/science.319.5866.1026b; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Costin GE, 2011, ATLA-ALTERN LAB ANIM, V39, P317, DOI 10.1177/026119291103900403; Fichorova RN, 2011, MBIO, V2, DOI 10.1128/mBio.00168-11; Fichorova RN, 2004, JAIDS-J ACQ IMM DEF, V37, pS184, DOI 10.1097/00126334-200410013-00010; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; Habte HH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-269; Honey K, 2007, J CLIN INVEST, V117, P1116, DOI 10.1172/JCI32291; KAMINSKY M, 1985, FOOD CHEM TOXICOL, V23, P705, DOI 10.1016/0278-6915(85)90161-9; Kashyap DR, 2011, NAT MED, V17, P676, DOI 10.1038/nm.2357; Kish-Catalone TM, 2006, ANTIMICROB AGENTS CH, V50, P1497, DOI 10.1128/AAC.50.4.1497-1509.2006; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; Kurita T, 2010, DIFFERENTIATION, V80, P99, DOI 10.1016/j.diff.2010.06.007; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Liu W, 2010, OLFACTOMEDIN 4 DOWN; Liu WL, 2013, J CLIN INVEST, V123, P3751, DOI 10.1172/JCI68453; Liu Y, J PROTEOME RES, V12, P1830; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Mayer KH, 2001, CLIN INFECT DIS, V32, P476, DOI 10.1086/318496; Milligan GN, 2002, SEX TRANSM DIS, V29, P597, DOI 10.1097/00007435-200210000-00006; Mulayim N, 2003, BIOL REPROD, V68, P1491, DOI 10.1095/biolreprod.102.009639; Osanai A, 2011, INFECT IMMUN, V79, P858, DOI 10.1128/IAI.00466-10; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Patterson BK, 1998, AM J PATHOL, V153, P481, DOI 10.1016/S0002-9440(10)65591-5; Patton DL, 1999, AM J OBSTET GYNECOL, V180, P1080, DOI 10.1016/S0002-9378(99)70598-3; Ravel J, 2012, MBIO, V3, DOI 10.1128/mBio.00370-12; Redd AD, 2014, J CLIN MICROBIOL, V52, P844, DOI 10.1128/JCM.03143-13; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Roy S, 2001, ANTIMICROB AGENTS CH, V45, P1671, DOI 10.1128/AAC.45.6.1671-1681.2001; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; Van Damme L, 2000, AIDS, V14, P85, DOI 10.1097/00002030-200001070-00010; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Wagner RD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-58; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zalenskaya IA, 2011, AM J REPROD IMMUNOL, V65, P569, DOI 10.1111/j.1600-0897.2010.00964.x; Zeitlin L, 2001, SEX TRANSM DIS, V28, P417, DOI 10.1097/00007435-200107000-00010; Zhou YH, 2002, NOVART FDN SYMP, V248, P150	51	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110980	10.1371/journal.pone.0110980	http://dx.doi.org/10.1371/journal.pone.0110980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333937	gold, Green Submitted, Green Published			2022-12-27	WOS:000343731200097
J	Grases, F; Rodriguez, A; Costa-Bauza, A				Grases, Felix; Rodriguez, Adrian; Costa-Bauza, Antonia			Theobromine Inhibits Uric Acid Crystallization. A Potential Application in the Treatment of Uric Acid Nephrolithiasis	PLOS ONE			English	Article							STATES VETERAN POPULATION; TRACT STONE DISEASE; UPPER URINARY-TRACT; RENAL-CALCULI; UNITED-STATES; LIQUID-CHROMATOGRAPHY; METHYLXANTHINES; UROLITHIASIS; DISPOSITION; PREVALENCE	Purpose: To assess the capacity of methylxanthines (caffeine, theophylline, theobromine and paraxanthine) to inhibit uric acid crystallization, and to evaluate their potential application in the treatment of uric acid nephrolithiasis. Materials and Methods: The ability of methylxathines to inhibit uric acid nucleation was assayed turbidimetrically. Crystal morphology and its modification due to the effect of theobromine were evaluated by scanning electron microscopy (SEM). The ability of theobromine to inhibit uric acid crystal growth on calculi fragments resulting from extracorporeal shock wave lithotripsy (ESWL) was evaluated using a flow system. Results: The turbidimetric assay showed that among the studied methylxanthines, theobromine could markedly inhibit uric acid nucleation. SEM images showed that the presence of theobromine resulted in thinner uric acid crystals. Furthermore, in a flow system theobromine blocked the regrowth of post-ESWL uric acid calculi fragments. Conclusions: Theobromine, a natural dimethylxanthine present in high amounts in cocoa, acts as an inhibitor of nucleation and crystal growth of uric acid. Therefore, theobromine may be clinically useful in the treatment of uric acid nephrolithiasis.	[Grases, Felix] Univ Balearic Isl, Univ Inst Hlth Sci Res IUNICS IdISPa, Lab Renal Lithiasis Res, Palma De Mallorca, Spain; Univ Balearic Isl, Fac Sci, Palma De Mallorca, Spain	Institut Investigacio Sanitaria Illes Balears (IdISBa); Universitat de les Illes Balears; Universitat de les Illes Balears	Grases, F (corresponding author), Univ Balearic Isl, Univ Inst Hlth Sci Res IUNICS IdISPa, Lab Renal Lithiasis Res, Palma De Mallorca, Spain.	fgrases@uib.es	RODRIGUEZ, ADRIAN/D-6606-2019	RODRIGUEZ, ADRIAN/0000-0002-6521-4558; Costa-Bauza, Antonia/0000-0003-0647-4154; Grases, Felix/0000-0001-5636-9139	Ministerio de Ciencia e Innovacion (Gobierno de Espana) [CTQ2010-18271/PPQ, TEC2010-19467]; FEDER funds (European Union); Conselleria d'Educacio, Cultura i Universitat (Govern de les Illes Balears) [9/2011]; European Social Fund; Conselleria d'Educacio, Cultura i Universitats [FPI/1570/2013]	Ministerio de Ciencia e Innovacion (Gobierno de Espana)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER funds (European Union)(European Commission); Conselleria d'Educacio, Cultura i Universitat (Govern de les Illes Balears); European Social Fund(European Social Fund (ESF)); Conselleria d'Educacio, Cultura i Universitats	This work was supported by project grants CTQ2010-18271/PPQ and TEC2010-19467 from the Ministerio de Ciencia e Innovacion (Gobierno de Espana), FEDER funds (European Union) and project grant 9/2011 from the Conselleria d'Educacio, Cultura i Universitat (Govern de les Illes Balears). A.R. is grateful to the European Social Fund and the Conselleria d'Educacio, Cultura i Universitats for the fellowship FPI/1570/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MS, 2005, INT J UROL, V12, P12, DOI 10.1111/j.1442-2042.2004.00990.x; BECKER MA, 1988, RHEUM DIS CLIN N AM, V14, P377; Bell DSH, 2012, DIABETES OBES METAB, V14, P299, DOI 10.1111/j.1463-1326.2011.01519.x; Brikowski TH, 2008, P NATL ACAD SCI USA, V105, P9841, DOI 10.1073/pnas.0709652105; Chow K, 2004, KIDNEY INT, V65, P1724, DOI 10.1111/j.1523-1755.2004.00566.x; Costa-Bauza A, 2006, BMC Urol, V6, P16, DOI 10.1186/1471-2490-6-16; Costa-Bauza A, 2007, WORLD J UROL, V25, P415, DOI 10.1007/s00345-007-0177-4; CRAIG WJ, 1984, J FOOD SCI, V49, P302, DOI 10.1111/j.1365-2621.1984.tb13737.x; de Aragdo NM, 2005, TALANTA, V67, P1007, DOI 10.1016/j.talanta.2005.04.066; Gates S, 1999, BRIT J CLIN PHARMACO, V47, P299, DOI 10.1046/j.1365-2125.1999.00890.x; Gault MH, 2000, J UROLOGY, V164, P302, DOI 10.1016/S0022-5347(05)67345-4; Gentle DL, 1997, J UROLOGY, V158, P2221, DOI 10.1016/S0022-5347(01)68203-X; Grases F, 1999, UROL INT, V62, P201, DOI 10.1159/000030395; Grases F, 2006, INT J UROL, V13, P252, DOI 10.1111/j.1442-2042.2006.01262.x; Grases F., 1994, International Urology and Nephrology, V26, P145, DOI 10.1007/BF02768277; Grases F, 2012, UROL RES, V40, P41, DOI 10.1007/s00240-011-0389-3; Grases F, 2007, SCAND J UROL NEPHROL, V41, P26, DOI 10.1080/00365590600831571; Grases F, 2007, FRONT BIOSCI-LANDMRK, V12, P2580, DOI 10.2741/2256; GRENABO L, 1985, SCAND J UROL NEPHROL, V19, P285, DOI 10.3109/00365598509180271; GUTMAN AB, 1968, AM J MED, V45, P756, DOI 10.1016/0002-9343(68)90209-X; Halfdanarson Thorvardur R, 2007, Support Cancer Ther, V4, P119, DOI 10.3816/SCT.2007.n.006; HESSE A, 1975, INVEST UROL, V12, P405; Karabacak OR, 2013, UROLOGY, V82, P532, DOI 10.1016/j.urology.2013.04.059; Kargul B, 2012, ORAL HLTH PREV DENT, V10, P275; Khan N, 2012, NUTR METAB CARDIOVAS, V22, P1046, DOI 10.1016/j.numecd.2011.02.001; Khan SR, 2004, FRONT BIOSCI-LANDMRK, V9, P1450, DOI 10.2741/1347; LI MK, 1985, J UROLOGY, V133, P123; MANDEL NS, 1989, J UROLOGY, V142, P1513, DOI 10.1016/S0022-5347(17)39144-9; MANDEL NS, 1989, J UROLOGY, V142, P1516, DOI 10.1016/S0022-5347(17)39145-0; Massey L, 2005, MAGNESIUM RES, V18, P123; Neufingerl N, 2013, AM J CLIN NUTR, V97, P1201, DOI 10.3945/ajcn.112.047373; Ngo Tin C, 2007, Rev Urol, V9, P17; PAK CYC, 1991, AM J KIDNEY DIS, V17, P420, DOI 10.1016/S0272-6386(12)80635-4; Ptolemy AS, 2010, J CHROMATOGR B, V878, P409, DOI 10.1016/j.jchromb.2009.12.019; Ramello A, 2000, J NEPHROL, V13, pS45; Rodopoulos N, 1996, SCAND J CLIN LAB INV, V56, P373, DOI 10.3109/00365519609090590; SHIVELY CA, 1985, CLIN PHARMACOL THER, V37, P415, DOI 10.1038/clpt.1985.65; TARKA SM, 1983, CLIN PHARMACOL THER, V34, P546, DOI 10.1038/clpt.1983.212; Wagner CA, 2010, J NEPHROL, V23, pS165; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Zambonin CG, 2004, J PHARMACEUT BIOMED, V36, P621, DOI 10.1016/j.jpba.2004.07.010	41	29	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111184	10.1371/journal.pone.0111184	http://dx.doi.org/10.1371/journal.pone.0111184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333633	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200104
J	Kosuwin, R; Putaporntip, C; Tachibana, H; Jongwutiwes, S				Kosuwin, Rattiporn; Putaporntip, Chaturong; Tachibana, Hiroshi; Jongwutiwes, Somchai			Spatial Variation in Genetic Diversity and Natural Selection on the Thrombospondin-Related Adhesive Protein Locus of Plasmodium vivax (PvTRAP)	PLOS ONE			English	Article							ANONYMOUS PROTEIN; GLIDING MOTILITY; POPULATION-STRUCTURE; SPOROZOITE INVASION; FALCIPARUM ANTIGENS; PROTECTIVE EFFICACY; KNOWLESI MALARIA; CLINICAL MALARIA; TRAP GENE; RECOMBINATION	Thrombospondin-related adhesive protein (TRAP) of malaria parasites is essential for sporozoite motility and invasions into mosquito's salivary gland and vertebrate's hepatocyte; thereby, it is a promising target for pre-erythrocytic vaccine. TRAP of Plasmodium vivax (PvTRAP) exhibits sequence heterogeneity among isolates, an issue relevant to vaccine development. To gain insights into variation in the complete PvTRAP sequences of parasites in Thailand, 114 vivax malaria patients were recruited in 2006-2007 from 4 major endemic provinces bordering Myanmar (Tak in the northwest, n = 30 and Prachuap Khirikhan in the southwest, n = 25), Cambodia (Chanthaburi in the east, n = 29) and Malaysia (Yala and Narathiwat in the south, n = 30). In total, 26 amino acid substitutions were detected and 9 of which were novel, resulting in 44 distinct haplotypes. Haplotype and nucleotide diversities were lowest in southern P. vivax population while higher levels of diversities were observed in other populations. Evidences of positive selection on PvTRAP were demonstrated in domains II and IV and purifying selection in domains I, II and VI. Genetic differentiation was significant between each population except that between populations bordering Myanmar where transmigration was common. Regression analysis of pairwise linearized Fst and geographic distance suggests that P. vivax populations in Thailand have been isolated by distance. Sequence diversity of PvTRAP seems to be temporally stable over one decade in Tak province based on comparison of isolates collected in 1996 (n = 36) and 2006-2007. Besides natural selection, evidences of intragenic recombination have been supported in this study that could maintain and further generate diversity in this locus. It remains to be investigated whether amino acid substitutions in PvTRAP could influence host immune responses although several predicted variant T cell epitopes drastically altered the epitope scores. Knowledge on geographic diversity in PvTRAP constitutes an important basis for vaccine design provided that vaccination largely confers variant-specific immunity.	[Kosuwin, Rattiporn; Putaporntip, Chaturong; Jongwutiwes, Somchai] Chulalongkorn Univ, Fac Med, Dept Parasitol, Mol Biol Malaria & Opportunist Parasites Res Unit, Bangkok 10330, Thailand; [Tachibana, Hiroshi] Tokai Univ, Sch Med, Dept Infect Dis, Kanagawa 2591100, Japan	Chulalongkorn University; Tokai University	Jongwutiwes, S (corresponding author), Chulalongkorn Univ, Fac Med, Dept Parasitol, Mol Biol Malaria & Opportunist Parasites Res Unit, Bangkok 10330, Thailand.	jongwutiwes@gmail.com		Tachibana, Hiroshi/0000-0002-1807-9090	Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University [RA56/059]; Thailand Research Fund through The Royal Golden Jubilee Ph.D. Program [PHD/0278/2552]	Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University(Chulalongkorn University); Thailand Research Fund through The Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University (Grant No. RA56/059) to SJ. Financial support from The Thailand Research Fund through The Royal Golden Jubilee Ph.D. Program (Grant PHD/0278/2552) to RK and SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Castellanos A, 2007, MEM I OSWALDO CRUZ, V102, P411, DOI 10.1590/S0074-02762007005000047; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; EXCOFFIER L, 1992, GENETICS, V131, P479; Flanagan KL, 2006, AM J TROP MED HYG, V74, P367, DOI 10.4269/ajtmh.2006.74.367; FU YX, 1993, GENETICS, V133, P693; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; Hafalla JCR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003303; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HUDSON RR, 1985, GENETICS, V111, P147; John CC, 2003, INFECT IMMUN, V71, P4320, DOI 10.1128/IAI.71.8.4320-4325.2003; John CC, 2008, J INFECT DIS, V197, P519, DOI 10.1086/526787; Jongwutiwes S, 1998, MOL BIOCHEM PARASIT, V92, P349, DOI 10.1016/S0166-6851(98)00004-8; Jongwutiwes S, 2010, VACCINE, V28, P3112, DOI 10.1016/j.vaccine.2010.02.062; Jongwutiwes S, 2011, EMERG INFECT DIS, V17, P1799, DOI 10.3201/eid1710.110349; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kappe SHI, 2004, TRENDS PARASITOL, V20, P13, DOI 10.1016/j.pt.2003.10.011; KHUSMITH S, 1991, SCIENCE, V252, P715, DOI 10.1126/science.1827210; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MARUYAMA T, 1984, GENETICS, V108, P745; Matuschewski K, 2002, EMBO J, V21, P1597, DOI 10.1093/emboj/21.7.1597; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MULLER HM, 1993, EMBO J, V12, P2881, DOI 10.1002/j.1460-2075.1993.tb05950.x; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nam MH, 2011, TROP MED INT HEALTH, V16, P923, DOI 10.1111/j.1365-3156.2011.02784.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; NEIM, 1987, MOL EVOLUTIONARY GEN; Ohashi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090522; Pihlajamaa T, 2013, BIOCHEM J, V450, P469, DOI 10.1042/BJ20121058; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Pritchard JK, 2000, GENETICS, V155, P945; Putaporntip C, 2001, GENE, V268, P97, DOI 10.1016/S0378-1119(01)00425-5; Putaporntip C, 2002, P NATL ACAD SCI USA, V99, P16348, DOI 10.1073/pnas.252348999; Putaporntip C, 2010, GENE, V456, P24, DOI 10.1016/j.gene.2010.02.007; Putaporntip C, 2009, INFECT GENET EVOL, V9, P821, DOI 10.1016/j.meegid.2009.04.017; Putaporntip C, 2009, J INFECT DIS, V199, P1143, DOI 10.1086/597414; ROBSON KJH, 1988, NATURE, V335, P79, DOI 10.1038/335079a0; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; ROGERS WO, 1992, P NATL ACAD SCI USA, V89, P9176, DOI 10.1073/pnas.89.19.9176; SCARSELLI E, 1993, INFECT IMMUN, V61, P3490, DOI 10.1128/IAI.61.8.3490-3495.1993; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Song GJ, 2012, P NATL ACAD SCI USA, V109, P21420, DOI 10.1073/pnas.1218581109; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Templeton TJ, 1997, MOL BIOCHEM PARASIT, V84, P13, DOI 10.1016/S0166-6851(96)02775-2; Thimasarn, 1995, J Travel Med, V2, P59, DOI 10.1111/j.1708-8305.1995.tb00627.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Todryk SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002027; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wengelnik K, 1999, EMBO J, V18, P5195, DOI 10.1093/emboj/18.19.5195	63	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110463	10.1371/journal.pone.0110463	http://dx.doi.org/10.1371/journal.pone.0110463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333779	Green Submitted, gold, Green Published			2022-12-27	WOS:000343731200041
J	Peng, ZY; Green, PG; Arakane, Y; Kanost, MR; Gorman, MJ				Peng, Zeyu; Green, Peter G.; Arakane, Yasuyuki; Kanost, Michael R.; Gorman, Maureen J.			A Multicopper Oxidase-Related Protein Is Essential for Insect Viability, Longevity and Ovary Development	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ELECTRON-TRANSFER; TOBACCO HORNWORM; GENE FAMILY; LACCASE; COPPER; PURIFICATION; EXPRESSION	Typical multicopper oxidases (MCOs) have ten conserved histidines and one conserved cysteine that coordinate four copper atoms. These copper ions are required for oxidase activity. During our studies of insect MCOs, we discovered a gene that we named multicopper oxidase-related protein (MCORP). MCORPs share sequence similarity with MCOs, but lack many of the copper-coordinating residues. We identified MCORP orthologs in many insect species, but not in other invertebrates or vertebrates. We predicted that MCORPs would lack oxidase activity due to the absence of copper-coordinating residues. To test this prediction, we purified recombinant Tribolium castaneum (red flour beetle) MCORP and analyzed its enzymatic activity using a variety of substrates. As expected, no oxidase activity was detected. To study MCORP function in vivo, we analyzed expression profiles of TcMCORP and Anopheles gambiae (African malaria mosquito) MCORP, and assessed RNAi-mediated knockdown phenotypes. We found that both MCORPs are constitutively expressed at a low level in all of the tissues we analyzed. Injection of TcMCORP dsRNA into larvae resulted in 100% mortality prior to adult eclosion, with death occurring mainly during the pharate pupal stage or late pharate adult stage. Injection of TcMCORP dsRNA into pharate pupae resulted in the death of approximately 20% of the treated insects during the pupal to adult transition and a greatly shortened life span for the remaining insects. In addition, knockdown of TcMCORP in females prevented oocyte maturation and, thus, greatly decreased the number of eggs laid. These results indicate that TcMCORP is an essential gene and that its function is required for reproduction. An understanding of the role MCORP plays in insect physiology may help to develop new strategies for controlling insect pests.	[Peng, Zeyu; Arakane, Yasuyuki; Kanost, Michael R.; Gorman, Maureen J.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Green, Peter G.] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA	Kansas State University; University of California System; University of California Davis	Gorman, MJ (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	mgorman@ksu.edu	Green, Peter/AAX-6619-2021	Gorman, Maureen/0000-0003-2005-6223; Kanost, Michael/0000-0002-6827-0061	National Institute of Allergy and Infectious Diseases [R01 AI070864]; National Institute of General Medical Sciences [R37 GM41247]; National Science Foundation [IOS-0726425]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041247] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1257961] Funding Source: National Science Foundation	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institute of Allergy and Infectious Diseases grant R01 AI070864, National Institute of General Medical Sciences grant R37 GM41247, and National Science Foundation grant IOS-0726425 to M. R. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANI D, 1992, PLANT J, V2, P331; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; BEEMAN RW, 1990, J ECON ENTOMOL, V83, P1745, DOI 10.1093/jee/83.5.1745; CLEMENTS AN, 1984, PHYSIOL ENTOMOL, V9, P1, DOI 10.1111/j.1365-3032.1984.tb00675.x; DAYAN J, 1976, BIOCHEM BIOPH RES CO, V73, P451, DOI 10.1016/0006-291X(76)90728-2; Dittmer NT, 2009, INSECT BIOCHEM MOLEC, V39, P596, DOI 10.1016/j.ibmb.2009.06.006; Dittmer NT, 2004, INSECT BIOCHEM MOLEC, V34, P29, DOI 10.1016/j.ibmb.2003.08.003; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Gorman MJ, 2008, INSECT BIOCHEM MOLEC, V38, P817, DOI 10.1016/j.ibmb.2008.07.001; Gorman MJ, 2012, INSECT BIOCHEM MOLEC, V42, P193, DOI 10.1016/j.ibmb.2011.11.010; Horn T, 2010, NUCLEIC ACIDS RES, V38, pW332, DOI 10.1093/nar/gkq317; Kaneko S, 2009, BIOSCI BIOTECH BIOCH, V73, P939, DOI 10.1271/bbb.80740; Kosman DJ, 2010, J BIOL INORG CHEM, V15, P15, DOI 10.1007/s00775-009-0590-9; Lang ML, 2012, P NATL ACAD SCI USA, V109, P13337, DOI 10.1073/pnas.1208703109; Lang ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033985; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Min KL, 2001, ARCH BIOCHEM BIOPHYS, V392, P279, DOI 10.1006/abbi.2001.2459; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nakamura K, 2005, CELL MOL LIFE SCI, V62, P2050, DOI 10.1007/s00018-004-5076-x; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Palmieri G, 1997, J BIOL CHEM, V272, P31301, DOI 10.1074/jbc.272.50.31301; Parthasarathy R, 2011, INSECT BIOCHEM MOLEC, V41, P294, DOI 10.1016/j.ibmb.2011.01.006; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P429, DOI 10.1016/j.ibmb.2010.04.002; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006; Pinto SB, 2009, P NATL ACAD SCI USA, V106, P21270, DOI 10.1073/pnas.0909463106; Prasain K, 2012, BIOORGAN MED CHEM, V20, P1679, DOI 10.1016/j.bmc.2012.01.021; Quintanar L, 2007, ACCOUNTS CHEM RES, V40, P445, DOI 10.1021/ar600051a; SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16; Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y; Sakurai T, 2007, CHEM REC, V7, P220, DOI 10.1002/tcr.20125; Schuckel J, 2011, ENZYME MICROB TECH, V48, P278, DOI 10.1016/j.enzmictec.2010.12.002; Sedbrook JC, 2002, PLANT CELL, V14, P1635, DOI 10.1105/tpc.002360; Shleev S, 2005, BIOSENS BIOELECTRON, V20, P2517, DOI 10.1016/j.bios.2004.10.003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Tufail M, 2009, J INSECT PHYSIOL, V55, P87, DOI 10.1016/j.jinsphys.2008.11.007; Zhang HB, 2009, BIOTECHNOL LETT, V31, P837, DOI 10.1007/s10529-009-9945-0	38	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e111344	10.1371/journal.pone.0111344	http://dx.doi.org/10.1371/journal.pone.0111344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330116	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100117
J	Aadland, E; Terum, T; Mamen, A; Andersen, LB; Resaland, GK				Aadland, Eivind; Terum, Torkil; Mamen, Asgeir; Andersen, Lars Bo; Resaland, Geir Kare			The Andersen Aerobic Fitness Test: Reliability and Validity in 10-Year-Old Children	PLOS ONE			English	Article							SHUTTLE RUN TEST; RANDOMIZED CONTROLLED-TRIAL; STATISTICAL-METHODS; PHYSICAL-ACTIVITY; SPORTS-MEDICINE; OXYGEN-UPTAKE; RISK-FACTORS; SCHOOL; ADOLESCENTS; PREDICTOR	Background: High aerobic fitness is consistently associated with a favorable metabolic risk profile in children. Direct measurement of peak oxygen consumption (VO2peak) is often not feasible, thus indirect tests such as the Andersen test are required in many settings. The present study seeks to determine the reliability and validity of the Andersen test in 10-year-old children. Methods: A total of 118 10-year-old children (67 boys and 51 girls) were recruited from one school and performed four VO2peak tests over three weeks: three Andersen tests (indirect) and one continuous progressive treadmill test (direct). Of these, 104 children provided valid data on all Andersen tests and 103 children also provided valid data on the direct treadmill test. Reliability and validity were assessed using Bland Altman plots and linear regression analysis. Results: Bias (mean change) and random error (limits of agreement) were 26.7 +/- 125.2 m for test 2 vs. test 1 (p<.001 for mean difference) and 3.9 +/- 88.8 m for test 3 vs. test 2 (p = .514 for mean difference). The equation to estimate VO2peak suggested by Andersen et al. (2008) showed a poor fit in the present sample; thus, we suggest a new equation: VO2peak = 23.262+0.050*Andersen distance -3.858*gender -0.376*body weight (R-2 = 0.61, standard error of the estimate = 5.69, p<.001, boys = 0, girls = 1). Conclusions: The Andersen test provided reliable and valid data on a group level. However, a substantial degree of individual variability was found for estimates of VO2peak. Researchers should be aware of the amount of noise in indirect tests that estimate aerobic fitness.	[Aadland, Eivind] Sogn Og Fjordane Univ Coll, Fac Hlth Studies, Forde, Norway; [Terum, Torkil; Mamen, Asgeir; Resaland, Geir Kare] Sogn Og Fjordane Univ Coll, Fac Teacher Educ & Sports, Sogndal, Norway; [Mamen, Asgeir] Univ Coll Hlth Sci, Oslo, Norway; [Andersen, Lars Bo] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway; [Andersen, Lars Bo] Univ Southern Denmark, Dept Sport Sci & Clin Biomech, Odense, Denmark; [Resaland, Geir Kare] Sogn Og Fjordane Ctr Hlth Res, Forde Cent Hosp, Forde, Norway	Western Norway University of Applied Sciences; Western Norway University of Applied Sciences; Norwegian School of Sport Sciences; University of Southern Denmark	Aadland, E (corresponding author), Sogn Og Fjordane Univ Coll, Fac Hlth Studies, Forde, Norway.	eivind.aadland@hisf.no	Mamen, Asgeir/N-9572-2019	Resaland, Geir K./0000-0001-7562-0552				Ahler T, 2012, EUR J APPL PHYSIOL, V112, P871, DOI 10.1007/s00421-011-2039-4; Andersen LB, 2008, J SPORT MED PHYS FIT, V48, P434; Andersen LB, 2008, INT J PEDIATR OBES, V3, P58, DOI 10.1080/17477160801896366; Anderssen SA, 2007, EUR J CARDIOV PREV R, V14, P526, DOI 10.1097/HJR.0b013e328011efc1; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Batista MB, 2013, J STRENGTH COND RES, V27, P2774, DOI 10.1519/JSC.0b013e3182815724; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Damsgaard CT, 2012, SCAND J PUBLIC HEALT, V40, P693, DOI 10.1177/1403494812463173; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hutcheon J.A., 2010, BMJ-BRIT MED J, V340, P1402, DOI DOI 10.1136/BMJ.C2289; Jorgensen T, 2009, EUR J SPORT SCI, V9, P257, DOI 10.1080/17461390902862664; Lamb KL, 2007, EUR J APPL PHYSIOL, V100, P287, DOI 10.1007/s00421-007-0432-9; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; LIU NYS, 1992, RES Q EXERCISE SPORT, V63, P360, DOI 10.1080/02701367.1992.10608757; McVeigh S.K., 1995, PEDIATR EXERC SCI, V7, P69, DOI 10.1123/pes.7.1.69; Medbo JI, 2012, APPL PHYSIOL NUTR ME, V37, P860, DOI [10.1139/H2012-056, 10.1139/h2012-056]; Melo X, 2011, EUR J APPL PHYSIOL, V111, P839, DOI 10.1007/s00421-010-1708-z; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Ortega FB, 2008, INT J OBESITY, V32, pS49, DOI 10.1038/ijo.2008.183; Pitetti KH, 2002, PEDIATR EXERC SCI, V14, P125, DOI 10.1123/pes.14.2.125; Rowland T., 2005, CHILDRENS EXERCISE P, V2nd; Steyerberg E., 2009, CLIN PREDICTION MODE; Toftager M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-777; Wedderkopp N, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-128; Welsman J, 2005, EUR J APPL PHYSIOL, V94, P228, DOI 10.1007/s00421-004-1300-5	28	35	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110492	10.1371/journal.pone.0110492	http://dx.doi.org/10.1371/journal.pone.0110492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330388	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000345204100084
J	Fernandez-Novell, JM; Ramio-Lluch, L; Orozco, A; Gomez-Foix, AM; Guinovart, JJ; Rodriguez-Gil, JE				Fernandez-Novell, Josep M.; Ramio-Lluch, Laura; Orozco, Anna; Gomez-Foix, Anna M.; Guinovart, Joan J.; Rodriguez-Gil, Joan E.			Glucose and Fructose Have Sugar-Specific Effects in Both Liver and Skeletal Muscle In Vivo: A Role for Liver Fructokinase	PLOS ONE			English	Article							ISOLATED RAT HEPATOCYTES; INSULIN-RESISTANCE; METABOLIC SYNDROME; DIETARY FRUCTOSE; PHOSPHORYLATION; STIMULATION; EXPRESSION; CELLS; ATP	We examined glucose and fructose effects on serine phosphorylation levels of a range of proteins in rat liver and muscle cells. For this, healthy adult rats were subjected to either oral glucose or fructose loads. A mini-array system was utilized to determine serine phosphorylation levels of liver and skeletal muscle proteins. A glucose oral load of 125 mg/100 g body weight (G 1/2) did not induce changes in phosphorylated serines of the proteins studied. Loading with 250 mg/100 g body weight of fructose (Fr), which induced similar glycemia levels as G 1/2, significantly increased serine phosphorylation of liver cyclin D3, PI3 kinase/p85, ERK-2, PTP2 and clusterin. The G 1/2 increased serine levels of the skeletal muscle proteins cyclin H, Cdk2, IRAK, total PKC, PTP1B, c-Raf 1, Ras and the b-subunit of the insulin receptor. The Fr induced a significant increase only in muscle serine phosphorylation of PI3 kinase/p85. The incubation of isolated rat hepatocytes with 10 mM glucose for 5 min significantly increased serine phosphorylation of 31 proteins. In contrast, incubation with 10 mM fructose produced less intense effects. Incubation with 10 mM glucose plus 75 mu M fructose counteracted the effects of the incubation with glucose alone, except those on Raf-1 and Ras. Less marked effects were detected in cultured muscle cells incubated with 10 mM glucose or 10 mM glucose plus 75 mu M fructose. Our results suggest that glucose and fructose act as specific functional modulators through a general mechanism that involves liver-generated signals, like micromolar fructosemia, which would inform peripheral tissues of the presence of either glucose-or fructose-derived metabolites.	[Fernandez-Novell, Josep M.; Orozco, Anna; Gomez-Foix, Anna M.] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Ramio-Lluch, Laura; Rodriguez-Gil, Joan E.] Univ Autonoma Barcelona, Dept Anim Med & Surg, Bellaterra, Spain; [Orozco, Anna; Gomez-Foix, Anna M.; Guinovart, Joan J.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Guinovart, Joan J.] Inst Biomed Res, Barcelona, Spain	University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Rodriguez-Gil, JE (corresponding author), Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain.	juanenrique.rodriguez@uab.cat	Fernández-Novell, Josep/ABF-6738-2020; Rodriguez-Gil, Joan E./F-8748-2016	Rodriguez-Gil, Joan E./0000-0002-1112-9884; Ramio-Lluch, Laura/0000-0001-9261-463X	Direccion General de Programas y Transferencia de Conocimiento, Ministerio de Ciencia e Innovacion, Spain [AGL2008-01792GAN]; Spanish Ministerio de Ciencia e Innovacion [SAF2009-07559]; CIBERDEM de Diabetes y Enfermedades Metabolicas Asociadas from the Instituto de Salud Carlos III (Spain)	Direccion General de Programas y Transferencia de Conocimiento, Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CIBERDEM de Diabetes y Enfermedades Metabolicas Asociadas from the Instituto de Salud Carlos III (Spain)	This work has been partially supported by Grants AGL2008-01792GAN (Direccion General de Programas y Transferencia de Conocimiento, Ministerio de Ciencia e Innovacion, Spain) and SAF2009-07559 from the Spanish Ministerio de Ciencia e Innovacion, and CIBERDEM de Diabetes y Enfermedades Metabolicas Asociadas from the Instituto de Salud Carlos III (Spain). All of the funding needed for this study has been provided by the aforementioned institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asipu A, 2003, DIABETES, V52, P2426, DOI 10.2337/diabetes.52.9.2426; BAIS R, 1985, BIOCHEM J, V230, P53, DOI 10.1042/bj2300053; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNI C, 1965, AM J PATHOL, V46, P691; Campbell M, 2003, DIABETES, V52, P519, DOI 10.2337/diabetes.52.2.519; CREIGHTON SR, 1972, COMP BIOCHEM PHYSIOL, V42, P509, DOI 10.1016/0305-0491(72)90312-4; DONNELLY R, 1995, ENDOCRINE, V3, P129, DOI 10.1007/BF02990064; FALCIERI E, 1990, CYTOTECHNOLOGY, V4, P251, DOI 10.1007/BF00563785; Fernandez-Novell JM, 2011, REPROD FERT DEVELOP, V23, P1; FILLAT C, 1993, ARCH BIOCHEM BIOPHYS, V300, P564, DOI 10.1006/abbi.1993.1078; Gaby AR, 2005, ALTERN MED REV, V10, P294; Glushakova O, 2008, J AM SOC NEPHROL, V19, P1712, DOI 10.1681/ASN.2007121304; Hundal HS, 1998, ADV EXP MED BIOL, V441, P35; Kelley GL, 2004, ENDOCRINOLOGY, V145, P548, DOI 10.1210/en.2003-1167; Konrad RJ, 1996, J BIOL CHEM, V271, P24179, DOI 10.1074/jbc.271.39.24179; Lambrecht M, 1984, METHOD ENZYMAT AN, P543; Latta M, 2000, J EXP MED, V191, P1975, DOI 10.1084/jem.191.11.1975; MASSAGUE J, 1977, FEBS LETT, V82, P317, DOI 10.1016/0014-5793(77)80610-8; MAYES PA, 1993, AM J CLIN NUTR, V58, P754; Michal G, 1984, METHOD ENZYMAT AN, P191; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Rutledge AC, 2007, NUTR REV, V65, pS13, DOI [10.1111/j.1753-4887.2007.tb00322.x, 10.1301/nr.2007.jun.S13-S23]; Shapiro A, 2008, AM J PHYSIOL-REG I, V295, pR1370, DOI 10.1152/ajpregu.00195.2008; Tanaka A, 2005, VET RES COMMUN, V29, P477, DOI 10.1007/s11259-005-1868-1; THORBURN AW, 1989, AM J CLIN NUTR, V49, P1155, DOI 10.1093/ajcn/49.6.1155; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P173; Wu DC, 2009, J AM SOC NEPHROL, V20, P554, DOI 10.1681/ASN.2008040445	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109726	10.1371/journal.pone.0109726	http://dx.doi.org/10.1371/journal.pone.0109726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330076	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100023
J	Kumar, D; Thakur, MK				Kumar, Dhiraj; Thakur, Mahendra Kumar			Perinatal Exposure to Bisphenol-A Impairs Spatial Memory through Upregulation of Neurexin1 and Neuroligin3 Expression in Male Mouse Brain	PLOS ONE			English	Article							DEVELOPMENTAL EXPOSURE; ENVIRONMENTAL ESTROGENS; LACTATIONAL EXPOSURE; INHIBITORY SYNAPSES; ADHESION MOLECULES; ENTORHINAL CORTEX; CEREBRAL-CORTEX; MICE; HIPPOCAMPUS; FEMALE	Bisphenol-A (BPA), a well known endocrine disruptor, impairs learning and memory in rodents. However, the underlying molecular mechanism of BPA induced impairment in learning and memory is not well known. As synaptic plasticity is the cellular basis of memory, the present study investigated the effect of perinatal exposure to BPA on the expression of synaptic proteins neurexin1 (Nrxn1) and neuroligin3 (Nlgn3), dendritic spine density and spatial memory in postnatal male mice. The pregnant mice were orally administered BPA (50 mu g/kgbw/d) from gestation day (GD) 7 to postnatal day (PND) 21 and sesame oil was used as a vehicle control. In Morris water maze (MWM) test, BPA extended the escape latency time to locate the hidden platform in 8 weeks male mice. RT-PCR and Immunoblotting results showed significant upregulation of Nrxn1 and Nlgn3 expression in both cerebral cortex and hippocampus of 3 and 8 weeks male mice. This was further substantiated by in-situ hybridization and immunofluorescence techniques. BPA also significantly increased the density of dendritic spines in both regions, as analyzed by rapid Golgi staining. Thus our data suggest that perinatal exposure to BPA impairs spatial memory through upregulation of expression of synaptic proteins Nrxn1 and Nlgn3 and increased dendritic spine density in cerebral cortex and hippocampus of postnatal male mice.	[Kumar, Dhiraj; Thakur, Mahendra Kumar] Banaras Hindu Univ, Brain Res Ctr, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Thakur, MK (corresponding author), Banaras Hindu Univ, Brain Res Ctr, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.	mkt_bhu@yahoo.com			Council of Scientific and Industrial Research (CSIR), India; Department of Biotechnology, Government of India [BT/PR3996/MED/97/57/2011]	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	D. Kumar is a recipient of Senior Research Fellowship from the Council of Scientific and Industrial Research (CSIR), India. The work was supported by grants from the Department of Biotechnology (BT/PR3996/MED/97/57/2011) Government of India to M. K. Thakur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson OS, 2013, FASEB J, V27, P1784, DOI 10.1096/fj.12-223545; Biswas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009133; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Calhoun KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085894; Charles GD, 2007, TOXICOL APPL PHARM, V218, P280, DOI 10.1016/j.taap.2006.11.029; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Cooper JE, 2011, CHEMOSPHERE, V85, P943, DOI 10.1016/j.chemosphere.2011.06.060; de Vries GJ, 2014, CURR TOP BEHAV NEURO, V16, P79, DOI 10.1007/7854_2014_286; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Farabollino F, 2002, ENVIRON HEALTH PERSP, V110, P409, DOI 10.1289/ehp.02110s3409; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; Garner CC, 2006, CELL TISSUE RES, V326, P249, DOI 10.1007/s00441-006-0278-1; Gautam A, 2013, NEUROBIOL LEARN MEM, V106, P177, DOI 10.1016/j.nlm.2013.08.009; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Ghosh S, 2008, NEUROCHEM INT, V52, P363, DOI 10.1016/j.neuint.2007.07.015; Goncalves CR, 2010, ENVIRON TOXICOL PHAR, V30, P195, DOI 10.1016/j.etap.2010.06.003; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Hotchkiss AK, 2005, CONTEMP TOP LAB ANIM, V44, P46; Inagaki T, 2012, ENDOCRINOLOGY, V153, P3357, DOI 10.1210/en.2012-1121; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jasarevic E, 2013, HORM BEHAV, V63, P180, DOI 10.1016/j.yhbeh.2012.09.009; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; Kokaia Z, 2000, CURRENT PROTOCOLS TO, P271; Kolozsi E, 2009, NEUROSCIENCE, V163, P1201, DOI 10.1016/j.neuroscience.2009.07.021; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kumar A, 2012, NEUROCHEM INT, V61, P778, DOI 10.1016/j.neuint.2012.07.001; Le HH, 2008, TOXICOL LETT, V176, P149, DOI 10.1016/j.toxlet.2007.11.001; Li Y, 2011, HIPPOCAMPUS, V21, P265, DOI 10.1002/hipo.20745; MacLusky NJ, 2005, ENVIRON HEALTH PERSP, V113, P675, DOI 10.1289/ehp.7633; Medinilla V, 2013, J PHYSIOL-LONDON, V591, P169, DOI 10.1113/jphysiol.2012.237172; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Nadel L, 2012, NEUROSCI BIOBEHAV R, V36, P1640, DOI 10.1016/j.neubiorev.2012.03.001; Nakamura K, 2012, BRAIN DEV-JPN, V34, P57, DOI 10.1016/j.braindev.2010.12.011; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Prasanth GK, 2010, J APPL TOXICOL, V30, P769, DOI 10.1002/jat.1570; Raju T. R., 2004, BRAIN BEHAV, P108; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783; Ryan BC, 2006, HORM BEHAV, V50, P85, DOI 10.1016/j.yhbeh.2006.01.007; Ryan BC, 2010, TOXICOL SCI, V114, P133, DOI 10.1093/toxsci/kfp266; Sarnat HB, 2013, DEV NEUROSCI-BASEL, V35, P69, DOI 10.1159/000350503; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shikimi H, 2004, NEUROSCI LETT, V364, P114, DOI 10.1016/j.neulet.2004.04.023; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stump DG, 2010, TOXICOL SCI, V115, P167, DOI 10.1093/toxsci/kfq025; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Woolley CS, 1998, HORM BEHAV, V34, P140, DOI 10.1006/hbeh.1998.1466; Xu Xi-Hui, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P1021; Xu XH, 2010, HORM BEHAV, V58, P326, DOI 10.1016/j.yhbeh.2010.02.012; Xu XH, 2010, ENVIRON TOXICOL CHEM, V29, P176, DOI 10.1002/etc.18; Xu XH, 2013, HORM BEHAV, V63, P766, DOI 10.1016/j.yhbeh.2013.03.004; Xu XH, 2013, CHEMOSPHERE, V91, P1073, DOI 10.1016/j.chemosphere.2012.12.065; Xu XH, 2012, HORM BEHAV, V62, P480, DOI 10.1016/j.yhbeh.2012.08.005; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yokosuka M, 2008, TOXICOL IN VITRO, V22, P1, DOI 10.1016/j.tiv.2007.07.003; Zhou W, 2008, MOL CELL ENDOCRINOL, V283, P12, DOI 10.1016/j.mce.2007.10.010	70	28	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110482	10.1371/journal.pone.0110482	http://dx.doi.org/10.1371/journal.pone.0110482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330104	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204100081
J	Szava-Kovats, RC; Partel, M				Szava-Kovats, Robert C.; Paertel, Meelis			Biodiversity Patterns along Ecological Gradients: Unifying beta-Diversity Indices	PLOS ONE			English	Article							QUANTIFYING SPECIES-DIVERSITY; CONSISTENT TERMINOLOGY; GAMMA DIVERSITY; PARTITIONING DIVERSITY; ALPHA; COMMUNITIES; VARIANCE	Ecologists have developed an abundance of conceptions and mathematical expressions to define beta-diversity, the link between local (alpha) and regional-scale (gamma) richness, in order to characterize patterns of biodiversity along ecological (i. e., spatial and environmental) gradients. These patterns are often realized by regression of beta-diversity indices against one or more ecological gradients. This practice, however, is subject to two shortcomings that can undermine the validity of the biodiversity patterns. First, many beta-diversity indices are constrained to range between fixed lower and upper limits. As such, regression analysis of beta-diversity indices against ecological gradients can result in regression curves that extend beyond these mathematical constraints, thus creating an interpretational dilemma. Second, despite being a function of the same measured alpha- and gamma-diversity, the resultant biodiversity pattern depends on the choice of beta-diversity index. We propose a simple logistic transformation that rids beta-diversity indices of their mathematical constraints, thus eliminating the possibility of an uninterpretable regression curve. Moreover, this transformation results in identical biodiversity patterns for three commonly used classical beta-diversity indices. As a result, this transformation eliminates the difficulties of both shortcomings, while allowing the researcher to use whichever beta-diversity index deemed most appropriate. We believe this method can help unify the study of biodiversity patterns along ecological gradients.	[Szava-Kovats, Robert C.; Paertel, Meelis] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Szava-Kovats, RC (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Ulikooli 18, EE-50090 Tartu, Estonia.	robszav@ut.ee	Pärtel, Meelis/D-5493-2012	Pärtel, Meelis/0000-0002-5874-0138; Szava-Kovats, Robert/0000-0001-7966-1327	Estonian Research Council [IUT20-29]; European Union through the European Regional Development Fund (Centre of Excellence FIBIR)	Estonian Research Council(Estonian Research Council); European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission)	This study was supported by Estonian Research Council institutional research funding IUT20-29 and by the European Union through the European Regional Development Fund (Centre of Excellence FIBIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Angeler DG, 2013, OECOLOGIA, V172, P1191, DOI 10.1007/s00442-012-2554-y; Bacon-Shone J, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P3; Bolker B, 2008, ECOLOGICAL MODELS DA; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; HARRISON S, 1992, J ANIM ECOL, V61, P151, DOI 10.2307/5518; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Janisova M, 2014, AGR ECOSYST ENVIRON, V182, P47, DOI 10.1016/j.agee.2013.05.022; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jurasinski G, 2011, OECOLOGIA, V167, P893, DOI 10.1007/s00442-011-2126-6; Jurasinski G, 2009, OECOLOGIA, V159, P15, DOI 10.1007/s00442-008-1190-z; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Lezama F, 2014, J VEG SCI, V25, P8, DOI 10.1111/jvs.12053; MACARTHUR R, 1966, AM NAT, V100, P319, DOI 10.1086/282425; Magurran A.E., 2004, AFR J AQUAT SCI, V29, P256; MILLIGAN GW, 1987, EDUC PSYCHOL MEAS, V47, P563, DOI 10.1177/001316448704700303; Mori AS, 2013, GLOBAL ECOL BIOGEOGR, V22, P878, DOI 10.1111/geb.12058; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P659, DOI 10.1111/geb.12020; Qian H, 2013, J PLANT ECOL, V6, P12, DOI 10.1093/jpe/rts040; Ramalho EA, 2011, J ECON SURV, V25, P19, DOI 10.1111/j.1467-6419.2009.00602.x; Ricotta C, 2010, ECOLOGY, V91, P1981, DOI 10.1890/09-0126.1; Rocha-Ortega M, 2013, J INSECT CONSERV, V17, P1161, DOI 10.1007/s10841-013-9597-1; Scheiner SM, 2012, OIKOS, V121, P1191, DOI 10.1111/j.1600-0706.2012.20607.x; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wilson K, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P48, DOI 10.1017/CBO9780511542053.004	32	3	3	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110485	10.1371/journal.pone.0110485	http://dx.doi.org/10.1371/journal.pone.0110485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330181	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100082
J	Dewey, JA; Knoblich, G				Dewey, John A.; Knoblich, Guenther			Do Implicit and Explicit Measures of the Sense of Agency Measure the Same Thing?	PLOS ONE			English	Article							INTENTIONAL BINDING; TEMPORAL BINDING; MAGICAL IDEATION; ATTENUATION; SELF; PHENOMENOLOGY; CONSEQUENCES; EXPERIENCE; AUTHORSHIP; CAUSATION	The sense of agency (SoA) refers to perceived causality of the self, i.e. the feeling of causing something to happen. The SoA has been probed using a variety of explicit and implicit measures. Explicit measures include rating scales and questionnaires. Implicit measures, which include sensory attenuation and temporal binding, use perceptual differences between self- and externally generated stimuli as measures of the SoA. In the present study, we investigated whether the different measures tap into the same self-attribution processes by determining whether individual differences on implicit and explicit measures of SoA are correlated. Participants performed tasks in which they triggered tones via key presses (operant condition) or passively listened to tones triggered by a computer (observational condition). We replicated previously reported effects of sensory attenuation and temporal binding. Surprisingly the two implicit measures of SoA were not significantly correlated with each other, nor did they correlate with the explicit measures of SoA. Our results suggest that some explicit and implicit measures of the SoA may tap into different processes.	[Dewey, John A.; Knoblich, Guenther] Cent European Univ, Dept Cognit Sci, Budapest, Hungary	Central European University	Dewey, JA (corresponding author), Cent European Univ, Dept Cognit Sci, Budapest, Hungary.	DeweyJ@ceu.h		Knoblich, Gunther/0000-0003-4463-5318				Aarts H, 2005, CONSCIOUS COGN, V14, P439, DOI 10.1016/j.concog.2004.11.001; Aarts H, 2006, BEHAV RES THER, V44, P1621, DOI 10.1016/j.brat.2005.12.004; Aarts H, 2012, SOC NEUROSCI-UK, V7, P105, DOI 10.1080/17470919.2011.590602; Asai T, 2008, CONSCIOUS COGN, V17, P1131, DOI 10.1016/j.concog.2008.04.004; Baess P, 2009, EUR J NEUROSCI, V29, P1514, DOI 10.1111/j.1460-9568.2009.06683.x; Bays PM, 2006, PLOS BIOL, V4, P281, DOI 10.1371/journal.pbio.0040028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buehner MJ, 2012, PSYCHOL SCI, V23, P1490, DOI 10.1177/0956797612444612; Cardoso-Leite P, 2010, PSYCHOL SCI, V21, P1740, DOI 10.1177/0956797610389187; Coyle D., 2012, P SIGCHI C HUM FACT; Desantis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037959; Desantis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029557; Desantis A, 2011, CONSCIOUS COGN, V20, P1211, DOI 10.1016/j.concog.2011.02.012; Dewey JA, 2014, COGNITION, V132, P383, DOI 10.1016/j.cognition.2014.05.002; Dewey JA, 2013, CONSCIOUS COGN, V22, P155, DOI 10.1016/j.concog.2012.12.004; Ebert JP, 2010, CONSCIOUS COGN, V19, P481, DOI 10.1016/j.concog.2009.10.002; ECKBLAD M, 1983, J CONSULT CLIN PSYCH, V51, P215, DOI 10.1037/0022-006X.51.2.215; Engbert K, 2008, COGNITION, V107, P693, DOI 10.1016/j.cognition.2007.07.021; Farrer C, 2008, BEHAV NEUROL, V19, P53, DOI 10.1155/2008/425267; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; GEORGE L, 1987, J CONSULT CLIN PSYCH, V55, P778, DOI 10.1037/0022-006X.55.5.778; Haering C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00393; Haggard P, 2003, CONSCIOUS COGN, V12, P695, DOI 10.1016/S1053-8100(03)00052-7; Haggard P, 2003, NEUROREPORT, V14, P1081, DOI 10.1097/01.wnr.0000073684.00308.c0; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Helmer Stefanie M, 2012, BMC Res Notes, V5, P703, DOI 10.1186/1756-0500-5-703; Hughes G, 2013, EUR J NEUROSCI, V37, P1152, DOI 10.1111/ejn.12120; Humphreys GR, 2010, EXP BRAIN RES, V203, P465, DOI 10.1007/s00221-010-2199-1; Humphreys GR, 2009, J EXP PSYCHOL HUMAN, V35, P1542, DOI 10.1037/a0014492; Kuhn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028657; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Mahajan N, 2012, INT J APPL PSYCHOL, V2, P98; Moore JW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00023; Moore JW, 2012, CONSCIOUS COGN, V21, P546, DOI 10.1016/j.concog.2011.12.002; Moore JW, 2011, CONSCIOUS COGN, V20, P792, DOI 10.1016/j.concog.2011.01.002; Moore JW, 2009, CONSCIOUS COGN, V18, P1056, DOI 10.1016/j.concog.2009.05.004; Obhi S, 2011, EXP BRAIN RES, V211, P663, DOI 10.1007/s00221-011-2662-7; Pacherie E., 2007, PSYCHE INTERDISCIPL, V13, P30, DOI DOI 10.1093/ACPR0F:0S0/9780199988341.003.0020; Pacherie E, 2008, COGNITION, V107, P179, DOI 10.1016/j.cognition.2007.09.003; Poonian SK, 2013, EXP BRAIN RES, V229, P419, DOI 10.1007/s00221-013-3505-5; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; Sato A, 2008, CONSCIOUS COGN, V17, P1219, DOI 10.1016/j.concog.2008.01.003; Stenner MP, 2014, COGNITION, V130, P227, DOI 10.1016/j.cognition.2013.11.008; Strother L, 2010, CONSCIOUS COGN, V19, P12, DOI 10.1016/j.concog.2009.12.007; Takahata K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053421; Voss M, 2010, BRAIN, V133, P3104, DOI 10.1093/brain/awq152; Waszak F, 2012, NEUROSCI BIOBEHAV R, V36, P943, DOI 10.1016/j.neubiorev.2011.11.004; Wegner DM, 1999, AM PSYCHOL, V54, P480, DOI 10.1037/0003-066X.54.7.480; Weiss C, 2012, CONSCIOUS COGN, V21, P1654, DOI 10.1016/j.concog.2012.08.010; Weiss C, 2011, COGNITION, V121, P207, DOI 10.1016/j.cognition.2011.06.011; Wolfensteller U, 2011, Q J EXP PSYCHOL, V64, P1273, DOI 10.1080/17470218.2010.546417	54	130	132	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110118	10.1371/journal.pone.0110118	http://dx.doi.org/10.1371/journal.pone.0110118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9XC	25330184	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800058
J	Erijman, A; Rosenthal, E; Shifman, JM				Erijman, Ariel; Rosenthal, Eran; Shifman, Julia M.			How Structure Defines Affinity in Protein-Protein Interactions	PLOS ONE			English	Article							BINDING-AFFINITY; FREE-ENERGY; SALT BRIDGES; FORCE-FIELD; MEAN FORCE; PREDICTION; RECOGNITION; PRINCIPLES; ASSOCIATION; MUTATIONS	Protein-protein interactions (PPI) in nature are conveyed by a multitude of binding modes involving various surfaces, secondary structure elements and intermolecular interactions. This diversity results in PPI binding affinities that span more than nine orders of magnitude. Several early studies attempted to correlate PPI binding affinities to various structure-derived features with limited success. The growing number of high-resolution structures, the appearance of more precise methods for measuring binding affinities and the development of new computational algorithms enable more thorough investigations in this direction. Here, we use a large dataset of PPI structures with the documented binding affinities to calculate a number of structure-based features that could potentially define binding energetics. We explore how well each calculated biophysical feature alone correlates with binding affinity and determine the features that could be used to distinguish between high-, medium- and low- affinity PPIs. Furthermore, we test how various combinations of features could be applied to predict binding affinity and observe a slow improvement in correlation as more features are incorporated into the equation. In addition, we observe a considerable improvement in predictions if we exclude from our analysis low-resolution and NMR structures, revealing the importance of capturing exact intermolecular interactions in our calculations. Our analysis should facilitate prediction of new interactions on the genome scale, better characterization of signaling networks and design of novel binding partners for various target proteins.	[Erijman, Ariel; Rosenthal, Eran; Shifman, Julia M.] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Shifman, JM (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	jshifman@mail.huji.ac.il	Erijman, Ariel/W-2801-2018	Erijman, Ariel/0000-0001-7567-0955; Rosenthal, Eran/0000-0003-2330-4878	Israel Science Foundation [1372/10]; Abisch-Frenkel foundation	Israel Science Foundation(Israel Science Foundation); Abisch-Frenkel foundation	This work was supported by the Israel Science Foundation (1372/10) http://www.isf.org.il/, and The Abisch-Frenkel foundation, http://ard.huji.ac.il/huard/infoPageViewer.jsp?ardNum=2033&lang=heb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audie J, 2007, BIOPHYS CHEM, V129, P198, DOI 10.1016/j.bpc.2007.05.021; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; CONNOLLY ML, 1986, INT J PEPT PROT RES, V28, P360; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; EASTMAN J, 1995, J BIOL CHEM, V270, P19694, DOI 10.1074/jbc.270.34.19694; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Fischer E, 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Gilbreth RN, 2012, CURR OPIN STRUC BIOL, V22, P413, DOI 10.1016/j.sbi.2012.06.001; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Gordon DB, 1999, CURR OPIN STRUC BIOL, V9, P509, DOI 10.1016/S0959-440X(99)80072-4; HAMMERSLEY JM, 1960, ANN NY ACAD SCI, V86, P844, DOI 10.1111/j.1749-6632.1960.tb42846.x; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; HORTON N, 1992, PROTEIN SCI, V1, P169; HUBBARD SJ, 1994, PROTEIN SCI, V3, P2194, DOI 10.1002/pro.5560031205; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jiang L, 2002, PROTEINS, V46, P190, DOI 10.1002/prot.10031; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KARLSSON E, 1984, J PHYSIOLOGY PARIS, V79, P232; Kastritis PL, 2011, PROTEIN SCI, V20, P482, DOI 10.1002/pro.580; Kastritis PL, 2010, J PROTEOME RES, V9, P2216, DOI 10.1021/pr9009854; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Keskin O, 1998, PROTEIN SCI, V7, P2578, DOI 10.1002/pro.5560071211; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kimura SR, 2001, BIOPHYS J, V80, P635, DOI 10.1016/S0006-3495(01)76044-4; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727; Levy ED, 2010, J MOL BIOL, V403, P660, DOI 10.1016/j.jmb.2010.09.028; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Li W, 1998, BIOCHEMISTRY-US, V37, P11771, DOI 10.1021/bi9808621; Ma XH, 2002, PROTEIN ENG, V15, P677, DOI 10.1093/protein/15.8.677; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Moal IH, 2011, BIOINFORMATICS, V27, P3002, DOI 10.1093/bioinformatics/btr513; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Qin S, 2011, STRUCTURE, V19, P1744, DOI 10.1016/j.str.2011.10.015; RADIC Z, 1994, J BIOL CHEM, V269, P11233; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Sharabi O, 2011, J COMPUT CHEM, V32, P23, DOI 10.1002/jcc.21594; Sonavane S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000188; Su Y, 2009, PROTEIN SCI, V18, P2550, DOI 10.1002/pro.257; Tian FF, 2012, AMINO ACIDS, V43, P531, DOI 10.1007/s00726-011-1101-1; Tsai CJ, 1997, PROTEIN SCI, V6, P1793, DOI 10.1002/pro.5560060901; VICENTINI AM, 1990, BIOCHEMISTRY-US, V29, P8827, DOI 10.1021/bi00489a046; Vreven T, 2012, PROTEIN SCI, V21, P396, DOI 10.1002/pro.2027; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Xu D, 1997, J MOL BIOL, V265, P68, DOI 10.1006/jmbi.1996.0712; Zhang C, 2005, J MED CHEM, V48, P2325, DOI 10.1021/jm049314d	65	52	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110085	10.1371/journal.pone.0110085	http://dx.doi.org/10.1371/journal.pone.0110085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329579	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800054
J	Liu, HY; Cheng, ZL; Song, W; Wu, WY; Zhou, Z				Liu, Haiyan; Cheng, Zhongle; Song, Wen; Wu, Wenyong; Zhou, Zheng			Immunoproteomic to Analysis the Pathogenicity Factors in Leukopenia Caused by Klebsiella Pneumonia Bacteremia	PLOS ONE			English	Article							ELONGATION-FACTOR TU; C-REACTIVE PROTEIN; LENGTH-OF-STAY; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PYRUVATE-DEHYDROGENASE; BACTERIAL PATHOGENS; GLUTATHIONE; METABOLISM; STRESS	Incidences of leukopenia caused by bacteremia have increased significantly and it is associated with prolonged hospital stay and increased cost. Immunoproteomic is a promising method to identify pathogenicity factors of different diseases. In the present study, we used immunoproteomic to analysis the pathogenicity factors in leukopenia caused by Klebsiella Pneumonia bacteremia. Approximately 40 protein spots localized in the 4 to 7 pI range were detected on two-dimensional electrophoresis gels, and 6 differentially expressed protein spots between 10 and 170 kDa were identified. Pathogenicity factors including S-adenosylmethionine synthetase, pyruvate dehydrogenase, glutathione synthetase, UDP-galactose-4-epimerase, acetate kinase A and elongation factor tu (EF-Tu). In validation of the pathogenicity factor, we used western blotting to show that Klebsiella pneumonia had higher (EF-Tu) expression when they accompanied by leukopenia rather than leukocytosis. Thus, we report 6 pathogenicity factors of leukopenia caused by Klebsiella pneumonia bacteremia, including 5 housekeeping enzymes and EF-Tu. We suggest EF-Tu could be a potential pathogenicity factor for leukopenia caused by Klebsiella pneumonia.	[Liu, Haiyan] Anhui Med Univ, Affiliated Hosp 1, Dept Crit Care, Hefei, Anhui, Peoples R China; [Cheng, Zhongle] Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab, Hefei, Anhui, Peoples R China; [Song, Wen] Anhui Med Univ, Affiliated Hosp 1, Dept Radiol, Hefei, Anhui, Peoples R China; [Wu, Wenyong; Zhou, Zheng] Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Zhou, Z (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hefei, Anhui, Peoples R China.	zhougnehz@sina.com		Liu, Haiyan/0000-0002-4244-027X	National Natural Science Foundation of China [81101223]; universitites natural science research foundation of Anhui Province [KJ20122174]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); universitites natural science research foundation of Anhui Province	This work was supported by grants from the National Natural Science Foundation of China (81101223) and universitites natural science research foundation of Anhui Province (KJ20122174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkenstock T, 2012, J BIOL CHEM, V287, P2887, DOI 10.1074/jbc.M111.288894; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Dacheux D, 2002, INFECT IMMUN, V70, P3973, DOI 10.1128/IAI.70.7.3973-3977.2002; DelVecchio VG, 2006, APPL ENVIRON MICROB, V72, P6355, DOI 10.1128/AEM.00455-06; Ferguson GP, 1998, J BACTERIOL, V180, P4314, DOI 10.1128/JB.180.16.4314-4318.1998; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Jungblut PR, 2001, MICROBES INFECT, V3, P831, DOI 10.1016/S1286-4579(01)01441-1; Klade CS, 2002, CURR OPIN MOL THER, V4, P216; Lawrence SH, 2006, J BACTERIOL, V188, P1155, DOI 10.1128/JB.188.3.1155-1158.2006; LEIBOVICI L, 1995, QJM-INT J MED, V88, P181; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nieves W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014361; Njalssson R, 2005, ACTA PAEDIATR, V94, P132, DOI 10.1080/08035250410025285; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; Potter MD, 1996, INFECT IMMUN, V64, P855, DOI 10.1128/IAI.64.3.855-860.1996; Riccillo PM, 2000, J BACTERIOL, V182, P1748, DOI 10.1128/JB.182.6.1748-1753.2000; Saeme A, 2013, J MICROBIOL BIOTECHN, V23, P1544, DOI 10.4014/jmb.1305.05026; Schirmer J, 2002, APPL ENVIRON MICROB, V68, P4894, DOI 10.1128/AEM.68.10.4894-4899.2002; Siegman-Igra Y, 2002, CLIN INFECT DIS, V34, P1431, DOI 10.1086/339809; Sierra R, 2004, INTENS CARE MED, V30, P2038, DOI 10.1007/s00134-004-2434-y; Smirnova GV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P973, DOI 10.1023/A:1012361323992; Sostarich AM, 2008, INFECTION, V36, P31, DOI 10.1007/s15010-007-6316-4; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; von Lilienfeld-Toal M, 2004, EUR J CLIN MICROBIOL, V23, P539, DOI 10.1007/s10096-004-1156-y; Yahr TL, 1996, MOL MICROBIOL, V22, P991, DOI 10.1046/j.1365-2958.1996.01554.x; Zhou Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081662; Zhou Z, 2011, CLIN INVEST MED, V34, pE38	30	3	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110011	10.1371/journal.pone.0110011	http://dx.doi.org/10.1371/journal.pone.0110011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330314	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800052
J	Mazari, AMA; Dahlberg, O; Mannervik, B; Mannervik, M				Mazari, Aslam M. A.; Dahlberg, Olle; Mannervik, Bengt; Mannervik, Mattias			Overexpression of Glutathione Transferase E7 in Drosophila Differentially Impacts Toxicity of Organic Isothiocyanates in Males and Females	PLOS ONE			English	Article								Organic isothiocyanates (ITCs) are allelochemicals produced by plants in order to combat insects and other herbivores. The compounds are toxic electrophiles that can be inactivated and conjugated with intracellular glutathione in reactions catalyzed by glutathione transferases (GSTs). The Drosophila melanogaster GSTE7 was heterologously expressed in Escherichia coli and purified for functional studies. The enzyme showed high catalytic activity with various isothiocyanates including phenethyl isothiocyanate (PEITC) and allyl isothiocyanate (AITC), which in millimolar dietary concentrations conferred toxicity to adult D. melanogaster leading to death or a shortened life-span of the flies. In situ hybridization revealed a maternal contribution of GSTE7 transcripts to embryos, and strongest zygotic expression in the digestive tract. Transgenesis involving the GSTE7 gene controlled by an actin promoter produced viable flies expressing the GSTE7 transcript ubiquitously. Transgenic females show a significantly increased survival when subjected to the same PEITC treatment as the wild-type flies. By contrast, transgenic male flies show a significantly lower survival rate. Oviposition activity was enhanced in transgenic flies. The effect was significant in transgenic females reared in the absence of ITCs as well as in the presence of 0.15 mM PEITC or 1 mM AITC. Thus the GSTE7 transgene elicits responses to exposure to ITC allelochemicals which differentially affect life-span and fecundity of male and female flies.	[Mazari, Aslam M. A.; Mannervik, Bengt] Stockholm Univ, Wenner Gren Inst, Dept Neurochem, S-10691 Stockholm, Sweden; [Dahlberg, Olle; Mannervik, Mattias] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Mannervik, B (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Neurochem, S-10691 Stockholm, Sweden.	bengt.mannervik@neurochem.su.se; mattias.mannervik@su.se		Mannervik, Mattias/0000-0003-4999-9655	Swedish Research Council; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by grants from the Swedish Research Council and the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Elbaz M, 2012, MOL ECOL, V21, P4533, DOI 10.1111/j.1365-294X.2012.05713.x; Gloss AD, 2014, MOL BIOL EVOL, V31, P2441, DOI 10.1093/molbev/msu201; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; Josephy P.D., 2006, MOL TOXICOLOGY, V2nd, P303; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; KOLM RH, 1995, BIOCHEM J, V311, P453, DOI 10.1042/bj3110453; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Orr WC, 2013, ANTIOXID REDOX SIGN, V19, P788, DOI 10.1089/ars.2012.5002; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Schramm K, 2012, INSECT BIOCHEM MOLEC, V42, P174, DOI 10.1016/j.ibmb.2011.12.002; Tu CPD, 2005, METHOD ENZYMOL, V401, P204, DOI 10.1016/S0076-6879(05)01013-X; Whiteman NK, 2011, MOL ECOL, V20, P995, DOI 10.1111/j.1365-294X.2010.04901.x; ZHANG YS, 1995, BIOCHEM BIOPH RES CO, V206, P748, DOI 10.1006/bbrc.1995.1106; Zust T, 2012, SCIENCE, V338, P116, DOI 10.1126/science.1226397	22	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110103	10.1371/journal.pone.0110103	http://dx.doi.org/10.1371/journal.pone.0110103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329882	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210800055
J	Zhou, F; Zhang, YK; Chen, D; Su, ZT; Jin, L; Wang, L; Hu, ZX; Ke, ZS; Song, ZM				Zhou, Fen; Zhang, Yikui; Chen, Ding; Su, Zhitao; Jin, Ling; Wang, Lei; Hu, Zhixiang; Ke, Zhisheng; Song, Zongming			Potential Role of Cyr61 Induced Degeneration of Human Muller Cells in Diabetic Retinopathy	PLOS ONE			English	Article							CYSTEINE-RICH 61; GROWTH-FACTOR; GLIAL REACTIVITY; CCN FAMILY; EXPRESSION; GENE	The degeneration of Muller cells has been recognized to involve in the pathogenesis of diabetic retinopathy. However, the mechanism is not yet clear. This study is to explore the potential role of Cyr61, a secreted signaling protein in extracellular matrix, in inducing human Muller cell degeneration in diabetic retinopathy (DR). Twenty patients with proliferative diabetic retinopathy (PDR) and twelve non-diabetic patients were recruited for this study. Vitreous fluid was collected during vitrectomy surgery for Cyr61 ELISA. Human Muller cell line MIO-M1 were cultured to be subconfluent, and then treated with glucose (0-20 mM) or Cyr61 (0-300 ng/ml). Cyr61 expression induced by increasing concentrations of glucose was evaluated by RT-qPCR and Western blot. Effects of Cyr61 on Muller cells viability, migration and apoptosis were observed by MTT assay, Transwell assay, and TUNEL assay. Vitreous Cyr61 levels were observed to be 8-fold higher in patients with PDR (3576.92 +/- 1574.58 pg/mL), compared with non-diabetic controls (436.14 +/- 130.69 pg/mL). Interestingly, the active PDR group was significantly higher than the quiescent PDR group (P<0.01). In retinal Muller cells culture, high glucose significantly and dose-dependently elevated Cyr61 expression at both mRNA and protein levels. Cyr61 at high concentrations dose-dependently inhibited the viability and migration of Muller cells. TUNEL assay further revealed that high concentration of Cyr61 significantly promoted the cell apoptosis. In conclusion, these findings demonstrated for the first time that the expression of Cyr61 was elevated by high glucose in Muller cells, and Cyr61 inhibited cell viability and migration while induced apoptosis, suggesting the potential role of Cyr61 in Muller cell degeneration. The elevated Cyr61 levels in vitreous fluid of PDR patients further support its role in diabetic retinopathy (DR).	[Zhou, Fen; Zhang, Yikui; Chen, Ding; Jin, Ling; Wang, Lei; Hu, Zhixiang; Ke, Zhisheng; Song, Zongming] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Su, Zhitao] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Ctr Eye, Hangzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Zhejiang University	Song, ZM (corresponding author), Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China.	szmeyes@126.com			Zhejiang Province Nature Science Foundation [Y13H120009]; Clinical Research Foundation of the Eye Hospital of Wenzhou Medical University [YNZQ201101]; Innovation Guiding Program of the Eye Hospital of Wenzhou Medical University [YNCX201008]	Zhejiang Province Nature Science Foundation; Clinical Research Foundation of the Eye Hospital of Wenzhou Medical University; Innovation Guiding Program of the Eye Hospital of Wenzhou Medical University	This work was supported by the Zhejiang Province Nature Science Foundation (No. Y13H120009), the Clinical Research Foundation of the Eye Hospital of Wenzhou Medical University (No. YNZQ201101), and the Innovation Guiding Program of the Eye Hospital of Wenzhou Medical University (No. YNCX201008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2013, MOL MED REP, V7, P16, DOI 10.3892/mmr.2012.1152; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Chaqour Brahim, 2013, J Ophthalmic Vis Res, V8, P77; Cheng LJ, 2013, INVEST OPHTH VIS SCI, V54, P8191, DOI 10.1167/iovs.13-12428; Coorey NJ, 2012, CLIN EXP OPTOM, V95, P266, DOI 10.1111/j.1444-0938.2012.00741.x; Guidry C, 2005, PROG RETIN EYE RES, V24, P75, DOI 10.1016/j.preteyeres.2004.07.001; Guidry C, 2009, INVEST OPHTH VIS SCI, V50, P1929, DOI 10.1167/iovs.08-2475; HAMMES HP, 1995, MOL MED, V1, P527, DOI 10.1007/BF03401589; Harada C, 2003, NEUROSCIENCE, V122, P229, DOI 10.1016/S0306-4522(03)00599-2; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Hasan A, 2011, J BIOL CHEM, V286, P9542, DOI 10.1074/jbc.M110.198689; Hughes JM, 2007, DIABETOLOGIA, V50, P1089, DOI 10.1007/s00125-007-0621-4; Jay P, 1997, ONCOGENE, V14, P1753, DOI 10.1038/sj.onc.1200986; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kolomeyer AM, 2014, SURV OPHTHALMOL, V59, P134, DOI 10.1016/j.survophthal.2013.09.004; Kucharska J, 2014, J NEUROCHEM; Lang GE, 2012, OPHTHALMOLOGICA, V227, P21, DOI 10.1159/000337156; Lenkowski JR, 2014, PROG RETIN IN PRESS; Li Q, 2002, INVEST OPHTH VIS SCI, V43, P3109; Lieth E, 1998, DIABETES, V47, P815, DOI 10.2337/diabetes.47.5.815; Lin MT, 2004, J BIOL CHEM, V279, P24015, DOI 10.1074/jbc.M402305200; Liu HB, 2008, ENDOCRINOLOGY, V149, P1666, DOI 10.1210/en.2007-1415; Ola MS, 2014, BIOCHEM BIOPH RES CO, V444, P264, DOI 10.1016/j.bbrc.2014.01.052; Porta M, 2014, ENDOCRINE, V46, P199, DOI 10.1007/s12020-013-0119-4; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Roque RS, 1996, INVEST OPHTH VIS SCI, V37, P196; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Scholl S, 2011, EUR J OPHTHALMOL, V21, pS10, DOI 10.5301/EJO.2010.6050; Schutze N, 2005, PROTEIN EXPRES PURIF, V42, P219, DOI 10.1016/j.pep.2005.03.031; Schutze N, 2001, J CLIN PATHOL-MOL PA, V54, P170, DOI 10.1136/mp.54.3.170; Shen X, 2009, CURR EYE RES, V34, P727, DOI 10.1080/02713680903030875; Tackenberg MA, 2009, MOL VIS, V15, P1886; Vacca O, 2014, GLIA, V62, P468, DOI 10.1002/glia.22617; Xu C, 2014, INT J MOL MED, V33, P624, DOI 10.3892/ijmm.2013.1597; Xu ZH, 2014, DIABETOLOGIA, V57, P204, DOI 10.1007/s00125-013-3093-8; Yafai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068773; You JJ, 2012, RETINA-J RET VIT DIS, V32, P103, DOI 10.1097/IAE.0b013e318219e4ad; You JJ, 2009, INVEST OPHTH VIS SCI, V50, P3447, DOI 10.1167/iovs.08-2603; Zao ZF, 2013, INT J OPHTHALMOL-CHI, V6, P422, DOI 10.3980/j.issn.2222-3959.2013.04.02; Zhang X, 2012, GRAEF ARCH CLIN EXP, V250, P661, DOI 10.1007/s00417-011-1882-7	42	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109418	10.1371/journal.pone.0109418	http://dx.doi.org/10.1371/journal.pone.0109418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329584	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210800024
J	Aebischer, NJ; Wheatley, CJ; Rose, HR				Aebischer, Nicholas J.; Wheatley, Christopher J.; Rose, Hugh R.			Factors Associated with Shooting Accuracy and Wounding Rate of Four Managed Wild Deer Species in the UK, Based on Anonymous Field Records from Deer Stalkers	PLOS ONE			English	Article							VARIABLE SELECTION; RED DEER	The amount of wounding during routine culling is an important factor in the welfare of wild deer. Little information exists on factors determining shooting accuracy and wounding rates under field conditions in the UK. In this study, 102 anonymous stalkers collected data on the outcomes and circumstances of 2281 shots. Using hot-deck imputation and generalised linear mixed modelling, we related the probability that a shot hit its target, and the probability that the shot killed the deer if it was hit, to 28 variables describing the circumstances of the shot. Overall, 96% of deer were hit, of which 93% were killed outright. A reduced probability of hitting the target was associated with an uncomfortable firing position, too little time available, shooting off elbows or freehand, taking the head or upper neck as point of aim, a heavily obscured target, a distant target, shooting at females, lack of shooting practice and a basic (or no) stalker qualification. An increase in the likelihood of wounding was associated with an uncomfortable firing position, shooting with insufficient time, a distant target (only when time was not sufficient), a bullet weight below 75 grains, a target concealed in thicket or on the move and an area rarely stalked. To maximise stalking success and deer welfare, we recommend that stalkers ensure a comfortable firing position, use a gun rest, aim at the chest, use bullets heavier than 75 grains, avoid taking a rushed shot, shoot a distant animal only if there is plenty of time, fire only when the target is stationary, avoid shooting at an obscured animal, take care when the ground is unfamiliar, and do shooting practice at least once a month. The high miss rate of basic-level stalkers suggests that training should include additional firing practice under realistic shooting conditions.	[Aebischer, Nicholas J.; Wheatley, Christopher J.] Game & Wildlife Conservat Trust, Fordingbridge, Hants, England; [Rose, Hugh R.] British Deer Soc, Fordingbridge, Hants, England		Aebischer, NJ (corresponding author), Game & Wildlife Conservat Trust, Fordingbridge, Hants, England.	naebischer@gwct.org.uk	Wheatley, Christopher/U-7196-2019; Aebischer, Nicholas J/AAU-9285-2021	Wheatley, Christopher/0000-0002-8550-2450	The British Deer Society [1069663, SCO37817, 1112023, SC038868]	The British Deer Society	The project was funded entirely by the British Deer Society (www.bds.org.uk), registered as a charity in England & Wales (1069663) and Scotland (SCO37817). The British Deer Society, through HRR, was responsible for the survey design and data collection. The British Deer Society funded the analysis of the data and manuscript preparation by NJA and CJW of the Game & Wildlife Conservation Trust (www.gwct.org.uk), also registered as a charity in England & Wales (1112023) and Scotland (SC038868). The decision to publish was taken by the British Deer Society.	Aebischer NJ., 2011, NATL GAMEBAG CENSUS; [Anonymous], 2012, CODE PRACTICE DEER S; [Anonymous], 2008, BEST PRACTICE GUIDAN; [Anonymous], 2013, GENSTAT WINDOWS; Armstrong H, 2003, FOREST RES ANN REP, V2001-2002, P28; Bateson P, 1999, DEER, V11, P180; Battersby, 2005, UK MAMMALS SPECIES S; Bode R., 1995, State Veterinary Journal, V5, P13; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bows A. T., 1997, Deer, Journal of the British Deer Society, V10, P226; Bradshaw EL, 2000, ANIM WELFARE, V9, P3; Bruinderink GWTAG, 1996, CONSERV BIOL, V10, P1059, DOI 10.1046/j.1523-1739.1996.10041059.x; Chen QX, 2013, STAT MED, V32, P3646, DOI 10.1002/sim.5783; COOKE AS, 1995, ENACT, V3, P12; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Doney J, 2002, DEER, V12, P98; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Froelich K., 2000, Rangifer, V20, P83; GIBBS EPJ, 1975, VET REC, V96, P558, DOI 10.1136/vr.96.26.558; Harris S., 2008, MAMMALS BRIT ISLES H, V4th; Korn E. L., 1999, ANAL HLTH SURVEYS; Moore NP, 1999, BIOL CONSERV, V87, P255, DOI 10.1016/S0006-3207(98)00055-X; Mouron D, 1998, GIBIER FANE SAUVAGE - GAME AND WILDLIFE, VOL 15 (SPECIAL NUMBER PTS 2 AND 3) 1998, P855; Ogston A, 1898, Br Med J, V2, P813; Putman R.J., 2011, UNGULATE MANAGEMENT; Putman RJ, 1998, MAMMAL REV, V28, P141, DOI 10.1046/j.1365-2907.1998.00031.x; Risely K., 2012, 624 BTO; Scanlon PF, 1998, GIBIER FANE SAUVAGE - GAME AND WILDLIFE, VOL 15 (SPECIAL NUMBER PTS 2 AND 3) 1998, P849; Schelldorfer J, 2011, SCAND J STAT, V38, P197, DOI 10.1111/j.1467-9469.2011.00740.x; Simpson VR, 2002, VET J, V163, P128, DOI 10.1053/tvjl.2001.0662; Smith-Jones C, 2012, DEER, V16, P23; STORMER F A, 1979, Wildlife Society Bulletin, V7, P10; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Urquhart KA, 2003, VET REC, V152, P497, DOI 10.1136/vr.152.16.497; Verbeke G, 2000, LINEAR MIXED MODELS; Wilson CJ, 2003, CURRENT FUTURE MANAG; Wood AM, 2008, STAT MED, V27, P3227, DOI 10.1002/sim.3177; Wooldridge J.M., 2008, INTRO ECONOMETRICS M, VFourth	38	18	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109698	10.1371/journal.pone.0109698	http://dx.doi.org/10.1371/journal.pone.0109698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25334012	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200047
J	Johnson, JB; Macedo, DC; Passow, CN; Rosenthal, GG				Johnson, James B.; Macedo, Danielle C.; Passow, Courtney N.; Rosenthal, Gil G.			Sexual Ornaments, Body Morphology, and Swimming Performance in Naturally Hybridizing Swordtails (Teleostei: Xiphophorus)	PLOS ONE			English	Article							MODEL SELECTION; TRANSGRESSIVE SEGREGATION; LOCOMOTOR PERFORMANCE; GROWTH COMPENSATION; GREEN SWORDTAILS; PREDATION RISK; TRADE-OFF; EVOLUTION; FISH; ADAPTATION	Determining the costs of sexual ornaments is complicated by the fact that ornaments are often integrated with other, nonsexual traits, making it difficult to dissect the effect of ornaments independent of other aspects of the phenotype. Hybridization can produce reduced phenotypic integration, allowing one to evaluate performance across a broad range of multivariate trait values. Here we assess the relationship between morphology and performance in the swordtails Xiphophorus malinche and X. birchmanni, two naturally-hybridizing fish species that differ extensively in non-sexual as well as sexual traits. We took advantage of novel trait variation in hybrids to determine if sexual ornaments incur a cost in terms of locomotor ability. For both fast-start and endurance swimming, hybrids performed at least as well as the two parental species. The sexually-dimorphic sword did not impair swimming performance per se. Rather, the sword negatively affected performance only when paired with a sub-optimal body shape. Studies seeking to quantify the costs of ornaments should consider that covariance with non-sexual traits may create the spurious appearance of costs.	[Johnson, James B.; Macedo, Danielle C.; Passow, Courtney N.; Rosenthal, Gil G.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Johnson, James B.; Rosenthal, Gil G.] Ctr Invest Cient Huastecas, Calnali, Hidalgo, Mexico	Texas A&M University System; Texas A&M University College Station	Johnson, JB (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	jamesbjohnson@tamu.edu	Rosenthal, Gil/E-6924-2015	Rosenthal, Gil/0000-0003-0342-9024	NSF [IOS-0923825]; Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	NSF(National Science Foundation (NSF)); Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	Research support was provided by NSF (IOS-0923825, www.nsf.gov) to GGR. The open access publishing fees for this manuscript have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 1999, EVOL ECOL RES, V1, P959; Andersson Malte, 1994; [Anonymous], 2014, R LANG ENV STAT COMP; Arnold SJ, 2003, INTEGR COMP BIOL, V43, P367, DOI 10.1093/icb/43.3.367; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Ballentine B, 2006, EVOLUTION, V60, P1936; Basolo AL, 2004, BIOL J LINN SOC, V83, P87, DOI 10.1111/j.1095-8312.2004.00369.x; Basolo AL, 2003, P ROY SOC B-BIOL SCI, V270, P1631, DOI 10.1098/rspb.2003.2388; Baumgartner A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015837; Blake RW, 2004, J FISH BIOL, V65, P1193, DOI 10.1111/j.0022-1112.2004.00568.x; Blake RW, 1983, FISH LOCOMOTION, P228; Bonduriansky R, 2007, AM NAT, V169, P9, DOI 10.1086/510214; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calcagno V, 2010, J STAT SOFTW, V34, P1; Collyer ML, 2007, ECOLOGY, V88, P683, DOI 10.1890/06-0727; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Culumber ZW, 2012, J EVOLUTION BIOL, V25, P1800, DOI 10.1111/j.1420-9101.2012.02562.x; Culumber ZW, 2011, MOL ECOL, V20, P342, DOI 10.1111/j.1365-294X.2010.04949.x; Culumber ZW, 2014, AM NAT, V184, P225, DOI 10.1086/677033; DOBZHANSKY T, 1956, AM NAT, V90, P337, DOI 10.1086/281944; Domenici P, 1997, J EXP BIOL, V200, P1165; Domenici P, 2003, EXPTL BIOL REV, P137; Fitzpatrick BM, 2008, J EVOLUTION BIOL, V21, P342, DOI 10.1111/j.1420-9101.2007.01448.x; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Ghalambor CK, 2003, INTEGR COMP BIOL, V43, P431, DOI 10.1093/icb/43.3.431; GRANT PR, 1994, EVOLUTION, V48, P297, DOI 10.1111/j.1558-5646.1994.tb01313.x; Haas TC, 2010, BIOL LETTERS, V6, P803, DOI 10.1098/rsbl.2010.0401; Hawkins DK, 1996, CAN J FISH AQUAT SCI, V53, P1487, DOI 10.1139/cjfas-53-7-1487; Hernandez-Jimenez A, 2012, ANIM BEHAV, V84, P1051, DOI 10.1016/j.anbehav.2012.08.004; HEWITT GM, 1988, TRENDS ECOL EVOL, V3, P158, DOI 10.1016/0169-5347(88)90033-X; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Husak JF, 2011, BEHAVIOUR, V148, P1, DOI 10.1163/000579510X541265; Johnson JR, 2010, FUNCT ECOL, V24, P1073, DOI 10.1111/j.1365-2435.2010.01723.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KATZIR G, 1993, COPEIA, P549; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Kruesi K, 2007, J FISH BIOL, V70, P1161, DOI 10.1111/j.1095-8649.2007.01379.x; Lailvaux SP, 2006, ANIM BEHAV, V72, P263, DOI 10.1016/j.anbehav.2006.02.003; Langerhans RB, 2009, J EVOLUTION BIOL, V22, P1057, DOI 10.1111/j.1420-9101.2009.01716.x; Langerhans R. Brian, 2010, P200, DOI 10.1201/b10190-8; Langerhans RB, 2009, BIOL LETTERS, V5, P488, DOI 10.1098/rsbl.2009.0179; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; Langerhans RB, 2005, P NATL ACAD SCI USA, V102, P7618, DOI 10.1073/pnas.0500935102; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Mead LS, 2004, TRENDS ECOL EVOL, V19, P264, DOI 10.1016/j.tree.2004.03.003; NIIMI AJ, 1974, CAN J ZOOL, V52, P447, DOI 10.1139/z74-056; Nychka D, 2014, FIELDS TOOLS SPATIAL; Ojanguren AF, 2000, J FISH BIOL, V56, P1342, DOI 10.1006/jfbi.2000.1253; Oufiero CE, 2007, FUNCT ECOL, V21, P676, DOI 10.1111/j.1365-2435.2007.01259.x; Oufiero CE, 2014, FUNCT ECOL, V28, P924, DOI 10.1111/1365-2435.12222; Oufiero CE, 2014, EVOLUTION, V68, P1806, DOI 10.1111/evo.12391; Oufiero CE, 2012, PHYSIOL BIOCHEM ZOOL, V85, P684, DOI 10.1086/666089; Parsons KJ, 2011, EVOL BIOL, V38, P306, DOI 10.1007/s11692-011-9126-7; Pavlicev M, 2009, EVOL BIOL, V36, P157, DOI 10.1007/s11692-008-9042-7; Plaut I, 2001, COMP BIOCHEM PHYS A, V131, P41, DOI 10.1016/S1095-6433(01)00462-7; Prum RO, 2012, PHILOS T R SOC B, V367, P2253, DOI 10.1098/rstb.2011.0285; Prum RO, 2010, EVOLUTION, V64, P3085, DOI 10.1111/j.1558-5646.2010.01054.x; RAUCHENBERGER M, 1990, AM MUS NOVIT, P1; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rohlf F.J., 2010, TPSRELW V 1 49; Rohlf F. J., 2010, TPSDIG V 2 16; Rohlf FJ, 1996, SYST BIOL, V45, P344, DOI 10.2307/2413569; ROHLF FJ, 1993, CONTRIBUTIONS MORPHO, P134; Rosenfield JA, 2004, CONSERV BIOL, V18, P1589, DOI 10.1111/j.1523-1739.2004.00356.x; Rosenthal GG, 2001, AM NAT, V158, P146, DOI 10.1086/321309; Rosenthal GG, 2003, COPEIA, P299, DOI 10.1643/0045-8511(2003)003[0299:DOSSCI]2.0.CO;2; Royle NJ, 2006, FUNCT ECOL, V20, P662, DOI 10.1111/j.1365-2435.2006.01147.x; Royle NJ, 2006, BIOL LETT-UK, V2, P39, DOI 10.1098/rsbl.2005.0414; RYAN MJ, 1988, COPEIA, P484; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Semlitsch RD, 1999, CAN J ZOOL, V77, P748, DOI 10.1139/cjz-77-5-748; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Sinervo B., 1996, ADAPTATION; Tytell ED, 2008, J EXP BIOL, V211, P3359, DOI 10.1242/jeb.020917; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; Walker JA, 1998, J EXP BIOL, V201, P981; Ward JL, 2009, BIOL J LINN SOC, V96, P769, DOI 10.1111/j.1095-8312.2008.01180.x; WEBB PW, 1986, CAN J FISH AQUAT SCI, V43, P763, DOI 10.1139/f86-094; Wilson RS, 2010, P ROY SOC B-BIOL SCI, V277, P1923, DOI 10.1098/rspb.2009.2196; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	85	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109025	10.1371/journal.pone.0109025	http://dx.doi.org/10.1371/journal.pone.0109025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329558	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200017
J	Laillou, A; Yakes, E; Le, TH; Wieringa, FT; Le, BM; Moench-Pfanner, R; Berger, J				Laillou, Arnaud; Yakes, Elizabeth; Le, Thi Hop; Wieringa, Frank Tammo; Le, Bach Mai; Moench-Pfanner, Regina; Berger, Jacques			Intra-Individual Double Burden of Overweight and Micronutrient Deficiencies among Vietnamese Women	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; IRON-DEFICIENCY; FERRITIN CONCENTRATIONS; OBESITY; POPULATION; INDICATORS; RETINOL; PREVALENCE; TRANSITION; ADIPOSITY	Background: Vietnamese Living Standard Surveys showed that the rate of overweight and obese in Vietnamese adults doubled between 1992 and 2002, from 2% to 5.5%, respectively with no significant difference in the proportions of overweight/obesity between men and women. Objectives: Considering the increasing public health concern over the double burden of malnutrition in Vietnam, we investigated micronutrient deficiencies among women of reproductive age according to their Body Mass Index. Methods: A transversal study was conducted in 2010 among 1530 women of reproductive age from 19 provinces. Participating women were asked to give a non-fasting blood sample for plasma iron, vitamin A, folate, vitamin B-12 and zinc assessment. Results: Although % body fat was associated with haemoglobin, ferritin, retinol and zinc concentrations, BMI category was only associated with marginal vitamin A status (19% among underweight vs 7% among overweight/obese; p<0.0001) and not with iron deficiency anemia, zinc deficiency, vitamin B-12 deficiency or folate status. The prevalence of iron, and vitamin B-12 deficiencies was respectively 11.4% and 15% among the 20% overweight/obese women; prevalence of zinc deficiency and marginal/deficient folate status was much higher, affecting respectively 61.1% and 25.8%. Intra-individual double burden of malnutrition (overweight/obesity (OW) and micronutrient deficiency) was observed among 2.0% for OW-anemia, 2.3% OW-iron deficient, 3.0% for OW-Vitamin B-12 deficiency, 12.2% for OW-Zinc deficiency and 5.2% for OW-marginal/deficient folate status. Conclusions: This large, cross-sectional survey demonstrated that micronutrient deficiencies are an issue across the weight spectrum among women in Vietnam, with only vitamin A status being better among overweight than underweight women. It is therefore essential for Vietnam to actively prevent women of reproductive age from overweight/obesity and at same time to control micronutrient deficiencies in this population to limit their economic and health consequences.	[Laillou, Arnaud] UNICEF, Maternal Child Hlth & Nutr sect, Phnom Penh, Cambodia; [Yakes, Elizabeth] Univ New Mexico, Dept Individual Family & Community Educ, Albuquerque, NM 87131 USA; [Yakes, Elizabeth] Dept Family & Community Med, Albuquerque, NM USA; [Le, Thi Hop; Le, Bach Mai] Natl Inst Nutr, Nutr sect, Hanoi, Vietnam; [Wieringa, Frank Tammo; Berger, Jacques] Inst Dev Res, Unite Mixte Rech Prevent Malnutr & Pathol Associe, Montpellier, France; [Moench-Pfanner, Regina] GAIN, Singapore Off, Singapore, Singapore	University of New Mexico; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Laillou, A (corresponding author), UNICEF, Maternal Child Hlth & Nutr sect, Phnom Penh, Cambodia.	alaillou@unicef.org.org	Wieringa, Frank Tammo/K-7565-2017	Wieringa, Frank Tammo/0000-0002-6010-355X; Yakes Jimenez, Elizabeth/0000-0003-0315-7022	Global Alliance for Improved Nutrition (GAIN)	Global Alliance for Improved Nutrition (GAIN)	Global Alliance for Improved Nutrition (GAIN) has funded this research as they were interested to understand the micronutrient deficiencies in Vietnam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeberli I, 2009, INT J OBESITY, V33, P1111, DOI 10.1038/ijo.2009.146; Allen L, 2006, GUIDELINES FOOD FORT; Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; AOAC International, 1995, OFF METH AN AOAC INT, P95; Ausk KJ, 2008, OBESITY, V16, P2356, DOI 10.1038/oby.2008.353; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barton-Wright EC, 1952, PRACTICAL METHODS MI; Bui MH, 1999, INT J VITAM NUTR RES, V69, P362, DOI 10.1024/0300-9831.69.5.362; Cepeda-Lopez AC, 2010, INT J VITAM NUTR RES, V80, P263, DOI 10.1024/0300-9831/a000033; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; Dien LN, 2004, ASIA PAC J CLIN NUTR, V13, P40; European Committee for Standardization, 2003, FOODST DET FOL MICR; Garcia OP, 2009, NUTR REV, V67, P559, DOI 10.1111/j.1753-4887.2009.00228.x; Gartner A, 2013, AM J CLIN NUTR, V98, P821, DOI 10.3945/ajcn.112.054551; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Ha DTP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-62; *IVACG, 1982, BIOCH METH ASS VIT A; Jones KM, 2007, J NUTR, V137, P1307, DOI 10.1093/jn/137.5.1307; KANG SS, 1987, METABOLISM, V36, P458, DOI 10.1016/0026-0495(87)90043-6; Khan NC, 2008, EUR J CLIN NUTR, V62, P810, DOI 10.1038/sj.ejcn.1602782; Laillou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034906; Mackay J, 2004, ATLAS HEART DIS STRO; Nguyen MD, 2007, PUBLIC HEALTH NUTR, V10, P115, DOI 10.1017/S1368980007224085; Hieu NT, 2012, BRIT J NUTR, V108, P1419, DOI 10.1017/S0007114511006945; Nyamdorj R, 2008, OBESITY, V16, P1622, DOI 10.1038/oby.2008.73; Garcia OP, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-59; Nguyen PVN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-141; Popkin Barry M Jr, 2002, Malays J Nutr, V8, P109; Reis JP, 2009, PEDIATRICS, V124, pE371, DOI 10.1542/peds.2009-0213; Rutstein S.O., DHS WEALTH INDEX APP; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; STABLER SP, 1995, J AM GERIATR SOC, V43, P1290, DOI 10.1111/j.1532-5415.1995.tb07408.x; SUHARNO D, 1993, LANCET, V342, P1325, DOI 10.1016/0140-6736(93)92246-P; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; Via Michael, 2012, ISRN Endocrinol, V2012, P103472, DOI 10.5402/2012/103472; Wieringa FT, 2002, J NUTR, V132, P3061, DOI 10.1093/jn/131.10.3061; Wiss O, 1950, HYG, P225; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; World Health Organization, 2016, OB OV; Zimmermann MB, 2008, INT J OBESITY, V32, P1098, DOI 10.1038/ijo.2008.43	42	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110499	10.1371/journal.pone.0110499	http://dx.doi.org/10.1371/journal.pone.0110499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333716	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200122
J	Landers, TF; Dent, A				Landers, Timothy F.; Dent, Anthony			Nitrile versus Latex for Glove Juice Sampling	PLOS ONE			English	Article							HAND HYGIENE; HEALTH-CARE; GUIDELINES; ALLERGY	The objective of this study was to explore the utility of nitrile gloves as a replacement for latex surgical gloves in recovering bacteria from the hands. Two types of nitrile gloves were compared to latex gloves using the parallel streak method. Streaks of Klebsiella pneumoniae and Staphylococcus aureus were made on tryptic soy agar plates, and the zones of inhibition were measured around pieces of glove material placed on the plates. Latex gloves produced a mean zone of inhibition of 0.28 mm, compared to 0.002 mm for nitrile gloves (p<.001). While the parallel streak method is not intended as a quantitative estimate of antimicrobial properties, these results suggest that nitrile may be a viable alternative to latex in glove juice sampling methods, since nitrile avoids the risk of latex exposure.	[Landers, Timothy F.; Dent, Anthony] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Landers, TF (corresponding author), Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA.	landers.37@osu.edu	Landers, Timothy F/B-4908-2012	Dent, Anthony/0000-0002-8162-0839; Landers, Timothy/0000-0003-3269-664X	Robert Wood Johnson Foundation [70320]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This study was supported by grant #70320 from Robert Wood Johnson Foundation Nurse Faculty Scholars to TL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of Textile Chemists and Colorists, 2014, AATCC TECHN MAUAL 20; [Anonymous], 2010, STAND TEST METH DET; ASTM International, 2013, STAND TEST METH EV E; ASTM International, 2011, STAND TEST METH EV S; Hamilton RG, 2014, LATEX ALLERGY EPIDEM; Hospodsky D, 2014, MICROBIOL-SGM, V160, P1144, DOI 10.1099/mic.0.075390-0; Istenes N, 2013, AM J INFECT CONTROL, V41, P793, DOI 10.1016/j.ajic.2012.11.012; Lemiere C, 2014, MIDDLETONS ALLERGY P, P970; Pittet D, 2009, INFECT CONT HOSP EP, V30, P611, DOI 10.1086/600379; Raghavendra R., 2011, INT J PHARM PHARM SC, V3, P70; Rosenthal M, 2014, PATHOGENS, V3, P1, DOI 10.3390/pathogens3010001; Rosenthal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088999; Simons FER, 2013, INT ARCH ALLERGY IMM, V162, P193, DOI 10.1159/000354543; Wrangsjo K, 2012, CONTACT DERMATITIS, V66, P165, DOI 10.1111/j.1600-0536.2012.02057.x	14	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110686	10.1371/journal.pone.0110686	http://dx.doi.org/10.1371/journal.pone.0110686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333880	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200129
J	Mouammine, A; Lanois, A; Pages, S; Lafay, B; Molle, V; Canova, M; Girard, PA; Duvic, B; Givaudan, A; Gaudriault, S				Mouammine, Annabelle; Lanois, Anne; Pages, Sylvie; Lafay, Benedicte; Molle, Virginie; Canova, Marc; Girard, Pierre-Alain; Duvic, Bernard; Givaudan, Alain; Gaudriault, Sophie			Ail and PagC-Related Proteins in the Entomopathogenic Bacteria of Photorhabdus Genus	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; OUTER-MEMBRANE PROTEIN; SALMONELLA-TYPHIMURIUM VIRULENCE; ENTERICA SEROVAR TYPHIMURIUM; YERSINIA-PESTIS KIM; ANTIMICROBIAL PEPTIDES; PHOP-PHOQ; INSECTICIDAL ACTIVITY; INVERTEBRATE HOSTS; EPITHELIAL-CELLS	Among pathogenic Enterobacteriaceae, the proteins of the Ail/OmpX/PagC family form a steadily growing family of outer membrane proteins with diverse biological properties, potentially involved in virulence such as human serum resistance, adhesion and entry into eukaryotic culture cells. We studied the proteins Ail/OmpX/PagC in the bacterial Photorhabdus genus. The Photorhabdus bacteria form symbiotic complexes with nematodes of Heterorhabditis species, associations which are pathogenic to insect larvae. Our phylogenetic analysis indicated that in Photorhabdus asymbiotica and Photorhabdus luminescens only Ail and PagC proteins are encoded. The genomic analysis revealed that the Photorhabdus ail and pagC genes were present in a unique copy, except two ail paralogs from P. luminescens. These genes, referred to as ail1(Pl) and ail2(Pl), probably resulted from a recent tandem duplication. Surprisingly, only ail1(Pl) expression was directly controlled by PhoPQ and low external Mg2+ conditions. In P. luminescens, the magnesium-sensing two-component regulatory system PhoPQ regulates the outer membrane barrier and is required for pathogenicity against insects. In order to characterize Ail functions in Photorhabdus, we showed that only ail2(Pl) and pagC(Pl) had the ability, when expressed into Escherichia coli, to confer resistance to complement in human serum. However no effect in resistance to antimicrobial peptides was found. Thus, the role of Ail and PagC proteins in Photorhabdus life cycle is discussed.	[Mouammine, Annabelle; Lanois, Anne; Pages, Sylvie; Girard, Pierre-Alain; Duvic, Bernard; Givaudan, Alain; Gaudriault, Sophie] INRA, UMR Diversite Genomes & Interact Microorganismes, F-34060 Montpellier, France; [Mouammine, Annabelle; Lanois, Anne; Pages, Sylvie; Girard, Pierre-Alain; Duvic, Bernard; Givaudan, Alain; Gaudriault, Sophie] Univ Montpellier 2, UMR Diversite Genomes & Interact Microorganismes, Montpellier, France; [Lafay, Benedicte] Univ Lyon, Ecully, France; [Lafay, Benedicte] Ecole Cent Lyon, CNRS, UMR5005, Lab Ampere, Ecully, France; [Molle, Virginie; Canova, Marc] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, Montpellier, France; [Molle, Virginie; Canova, Marc] Univ Montpellier I, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, Montpellier, France	INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Gaudriault, S (corresponding author), INRA, UMR Diversite Genomes & Interact Microorganismes, F-34060 Montpellier, France.	sgaudriault@univ-montp2.fr	, Gaudriault/AAK-9152-2021; Duvic, Bernard/ABG-5094-2020; Lafay, Bénédicte/D-8359-2011; MOLLE, Virginie/D-4050-2019	, Gaudriault/0000-0003-2789-4959; Lafay, Bénédicte/0000-0001-5783-5269; MOLLE, Virginie/0000-0002-6573-3411; Duvic, Bernard/0000-0002-7618-7719	National Institute of Agronomical Research [2011-1333-03]	National Institute of Agronomical Research	This work was supported by grant no 2011-1333-03 from National Institute of Agronomical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi Khattar Z, 2009, THESIS U MONTPELLIER; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005; Bialas N, 2012, ARCH IMMUNOL THER EX, V60, P199, DOI 10.1007/s00005-012-0168-z; BLISKA JB, 1992, P NATL ACAD SCI USA, V89, P3561, DOI 10.1073/pnas.89.8.3561; Brillard J, 2002, J BACTERIOL, V184, P3871, DOI 10.1128/JB.184.14.3871-3878.2002; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Ciche TA, 2003, APPL ENVIRON MICROB, V69, P1890, DOI 10.1128/AEM.69.4.1890-1897.2003; Ciche TA, 2008, APPL ENVIRON MICROB, V74, P2275, DOI 10.1128/AEM.02646-07; Clarke DJ, 2014, ADV APPL MICROBIOL, V88, P1, DOI 10.1016/B978-0-12-800260-5.00001-2; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Derzelle S, 2004, J BACTERIOL, V186, P1270, DOI 10.1128/JB.186.5.1270-1279.2004; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Dupont M, 2004, FEBS LETT, V569, P27, DOI 10.1016/j.febslet.2004.05.047; FARMER JJ, 1989, J CLIN MICROBIOL, V27, P1594, DOI 10.1128/JCM.27.7.1594-1600.1989; Ferreira T, 2014, INT J SYST EVOL MICR, V64, P1540, DOI 10.1099/ijs.0.059840-0; Fischer-Le Saux M, 1999, INT J SYST BACTERIOL, V49, P1645, DOI 10.1099/00207713-49-4-1645; Galdiero S, 2012, CURR PROTEIN PEPT SC, V13, P843, DOI 10.2174/138920312804871120; Gaudriault S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r117; Gerrard J, 2004, MICROBES INFECT, V6, P229, DOI 10.1016/j.micinf.2003.10.018; Gevers D, 2004, TRENDS MICROBIOL, V12, P148, DOI 10.1016/j.tim.2004.02.007; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Guillier M, 2006, GENE DEV, V20, P2338, DOI 10.1101/gad.1457506; Guina T, 2000, J BACTERIOL, V182, P4077, DOI 10.1128/JB.182.14.4077-4086.2000; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; HEFFERNAN EJ, 1994, INFECT IMMUN, V62, P5183, DOI 10.1128/IAI.62.11.5183-5186.1994; Hirayama Shintaro, 2009, Genomics Proteomics & Bioinformatics, V7, P163, DOI 10.1016/S1672-0229(08)60046-7; Jubelin G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003915; Jubelin G, 2011, ENVIRON MICROBIOL, V13, P1271, DOI 10.1111/j.1462-2920.2011.02427.x; Kato A, 2008, ADV EXP MED BIOL, V631, P7; Khattar ZA, 2009, J BACTERIOL, V191, P7063, DOI 10.1128/JB.00892-09; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Kolodziejek AM, 2007, MICROBIOL-SGM, V153, P2941, DOI 10.1099/mic.0.2006/005694-0; Kolodziejek AM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00103; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; MILLER VL, 1988, INFECT IMMUN, V56, P1242, DOI 10.1128/IAI.56.5.1242-1248.1988; MILLER VL, 1992, INFECT IMMUN, V60, P3763, DOI 10.1128/IAI.60.9.3763-3770.1992; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Nielsen-LeRoux C, 2012, CURR OPIN MICROBIOL, V15, P220, DOI 10.1016/j.mib.2012.04.006; Nishio M, 2005, MICROBIOL-SGM, V151, P863, DOI 10.1099/mic.0.27654-0; Ogier JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-568; Pacheco SV, 1997, FEMS MICROBIOL LETT, V156, P129; Papamichail D, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-12; Papenfort K, 2008, MOL MICROBIOL, V68, P890, DOI 10.1111/j.1365-2958.2008.06189.x; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; Peel MM, 1999, J CLIN MICROBIOL, V37, P3647, DOI 10.1128/JCM.37.11.3647-3653.1999; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PIERSON DE, 1993, INFECT IMMUN, V61, P1846, DOI 10.1128/IAI.61.5.1846-1852.1993; PULKKINEN WS, 1991, J BACTERIOL, V173, P86, DOI 10.1128/jb.173.1.86-93.1991; Sanchez-Perez G, 2008, TRENDS GENET, V24, P154, DOI 10.1016/j.tig.2008.01.002; Silva CP, 2002, CELL MICROBIOL, V4, P329, DOI 10.1046/j.1462-5822.2002.00194.x; Skorek K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079525; Somvanshi VS, 2010, MOL MICROBIOL, V77, P1021, DOI 10.1111/j.1365-2958.2010.07270.x; Stock SP, 2012, J INVERTEBR PATHOL, V110, P135, DOI 10.1016/j.jip.2012.03.018; Strandberg KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049588; Suzuki Fumihiko, 2004, Journal of General Plant Pathology, V70, P97, DOI 10.1007/s10327-003-0096-1; Tang YT, 2012, CHEM BIOL DRUG DES, V79, P1007, DOI 10.1111/j.1747-0285.2012.01362.x; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; Tsang TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083621; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Vigneux F, 2007, J BIOL CHEM, V282, P9571, DOI 10.1074/jbc.M604301200; Vlisidou I, 2010, J INVERTEBR PATHOL, V105, P352, DOI 10.1016/j.jip.2010.09.020; WACHTEL MR, 1995, INFECT IMMUN, V63, P2541, DOI 10.1128/IAI.63.7.2541-2548.1995; Waterfield NR, 2008, P NATL ACAD SCI USA, V105, P15967, DOI 10.1073/pnas.0711114105; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Wilkinson P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-302; Yang G, 2006, J BACTERIOL, V188, P2254, DOI 10.1128/JB.188.6.2254-2261.2006; Yang GW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002692; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; Zhang X, 2014, FEMS MICROBIOL LETT, V350, P48, DOI 10.1111/1574-6968.12321	77	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110060	10.1371/journal.pone.0110060	http://dx.doi.org/10.1371/journal.pone.0110060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333642	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200088
J	Park, SH; Shin, D; Lim, SS; Lee, JY; Kang, YH				Park, Sin-Hye; Shin, Daekeun; Lim, Soon Sung; Lee, Jae-Yong; Kang, Young-Hee			Purple Perilla Extracts Allay ER Stress in Lipid-Laden Macrophages	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; METABOLIC DISEASES; SCAVENGER RECEPTOR; OXIDIZED LDL; CHEMICAL CHAPERONES; INDUCED APOPTOSIS; ATHEROSCLEROSIS; MECHANISMS; INFLAMMATION	There is a growing body of evidence that excess lipids, hypoxic stress and other inflammatory signals can stimulate endoplasmic reticulum (ER) stress in metabolic diseases. However, the pathophysiological importance and the underlying mechanisms of this phenomenon remain unknown. The current study investigated that 50 ng/ml oxidized LDL promoted unfolded protein response (UPR) and ER stress in J774A1 murine macrophages, which was blocked by extracts (PPE) of purple Perilla frutescens, a plant of the mint family Lamiaceae. The ER stressor tunicamycin was employed as a positive control. Treating 1-10 mu g/ml oxidized LDL for 24 h elicited lipotoxic apoptosis in macrophages with obvious nuclear condensation and DNA fragmentation, which was inhibited by PPE. Tunicamycin and oxidized LDL activated and induced the UPR components of activating transcription factor 6 and ER resident chaperone BiP/Grp78 in temporal manners and such effects were blocked by >= 5 mu g/ml PPE. In addition, PPE suppressed the enhanced mRNA transcription and splicing of X-box binding protein 1 (XBP1) by tunicamycin and oxidized LDL. The protein induction and nuclear translocation of XBP1 were deterred in PPE-treated macrophages under ER stress. The induction of ATP-binding cassette transporter A1 (ABCA1), scavenger receptor-B1 (SR-B1) and intracellular adhesion molecule-1 (ICAM-1) was abolished by the ER stressor in activated macrophages. The protein induction of ABCA1 and ICAM1 but not SR-B1 was retrieved by adding 10 mu g/ml PPE to cells. These results demonstrate that PPE inhibited lipotoxic apoptosis and demoted the induction and activation of UPR components in macrophages. PPE restored normal proteostasis in activated macrophages oxidized LDL. Therefore, PPE was a potent agent antagonizing macrophage ER stress due to lipotoxic signals associated with atherosclerosis.	[Park, Sin-Hye; Shin, Daekeun; Lim, Soon Sung; Kang, Young-Hee] Hallym Univ, Dept Food Sci & Nutr, Chunchon, Kangwon Do, South Korea; [Lee, Jae-Yong] Hallym Univ, Dept Biochem, Chunchon, Kangwon Do, South Korea	Hallym University; Hallym University	Kang, YH (corresponding author), Hallym Univ, Dept Food Sci & Nutr, Chunchon, Kangwon Do, South Korea.	yhkang@hallym.ac.kr			High Value-added Food Technology Development Program, Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries [112085-03-1-SB010]; National Research Foundation of Korea through the Human Resource Training Project for Regional Innovation [2012-01-A-05-003-12-010100]	High Value-added Food Technology Development Program, Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries; National Research Foundation of Korea through the Human Resource Training Project for Regional Innovation(National Research Foundation of Korea)	This study was supported by High Value-added Food Technology Development Program, Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (112085-03-1-SB010) and by National Research Foundation of Korea through the Human Resource Training Project for Regional Innovation (2012-01-A-05-003-12-010100). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Bernales S, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00005; Bravo R, 2013, INT REV CEL MOL BIO, V301, P215, DOI 10.1016/B978-0-12-407704-1.00005-1; Cao SS, 2013, EXPERT OPIN THER TAR, V17, P437, DOI 10.1517/14728222.2013.756471; Chuang CC, 2011, ANNU REV NUTR, V31, P155, DOI 10.1146/annurev-nutr-072610-145149; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Ding Y, 2013, MOL NUTR FOOD RES, V57, P365, DOI 10.1002/mnfr.201200463; Endres Kristina, 2013, Am J Neurodegener Dis, V2, P247; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Iwawaki T, 2013, SEMIN IMMUNOPATHOL, V35, P333, DOI 10.1007/s00281-013-0369-5; Jeong YJ, 2005, BRIT J NUTR, V93, P581, DOI 10.1079/BJN20041397; Ji AL, 2011, ATHEROSCLEROSIS, V217, P106, DOI 10.1016/j.atherosclerosis.2011.03.017; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Li DY, 2005, CARDIOVASC RES, V68, P353, DOI 10.1016/j.cardiores.2005.09.009; Liu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077458; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Paek JH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/679463; Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644; Park SH, 2011, J NUTR, V141, P1931, DOI 10.3945/jn.111.144816; Park S, 2010, J AGR FOOD CHEM, V58, P1551, DOI 10.1021/jf903432b; Ryno LM, 2013, CURR OPIN CHEM BIOL, V17, P346, DOI 10.1016/j.cbpa.2013.04.009; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Tabas I, 2009, ANN NY ACAD SCI, V1173, pE40, DOI 10.1111/j.1749-6632.2009.04957.x; Tabata Y, 2007, AM J PHYSIOL-CELL PH, V293, pC411, DOI 10.1152/ajpcell.00095.2007; Valacchi G, 2011, ANN NY ACAD SCI, V1229, pE1, DOI 10.1111/j.1749-6632.2011.06205.x; Vandewynckel YP, 2013, ANTICANCER RES, V33, P4683; Yao ST, 2012, EXP BIOL MED, V237, P822, DOI 10.1258/ebm.2012.012027; Yokoyama S, 2006, J ATHEROSCLER THROMB, V13, P1, DOI 10.5551/jat.13.1; Yoshiuchi K, 2009, ENDOCR J, V56, P1103, DOI 10.1507/endocrj.K09E-140; Zhao H, 2008, HYPERTENS RES, V31, P1977, DOI 10.1291/hypres.31.1977; Zhou AX, 2013, SEMIN IMMUNOPATHOL, V35, P321, DOI 10.1007/s00281-013-0372-x; Zingg JM, 2013, BIOFACTORS, V39, P101, DOI 10.1002/biof.1072	35	10	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110581	10.1371/journal.pone.0110581	http://dx.doi.org/10.1371/journal.pone.0110581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333946	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200126
J	Sanz-Aguilar, A; Anadon, JD; Edelaar, P; Carrete, M; Tella, JL				Sanz-Aguilar, Ana; Anadon, Jose D.; Edelaar, Pim; Carrete, Martina; Luis Tella, Jose			Can Establishment Success Be Determined through Demographic Parameters? A Case Study on Five Introduced Bird Species	PLOS ONE			English	Article							POPULATION-SIZE; SURVIVAL; PATTERNS; CONSEQUENCES; CONSERVATION; MANAGEMENT; EXPANSION; INVASIONS; BIOLOGY; MODELS	The dominant criterion to determine when an introduced species is established relies on the maintenance of a self-sustaining population in the area of introduction, i.e. on the viability of the population from a demographic perspective. There is however a paucity of demographic studies on introduced species, and establishment success is thus generally determined by expert opinion without undertaking population viability analyses (PVAs). By means of an intensive five year capture-recapture monitoring program (involving >12,000 marked individuals) we studied the demography of five introduced passerine bird species in southern Spain which are established and have undergone a fast expansion over the last decades. We obtained useful estimates of demographic parameters (survival and reproduction) for one colonial species (Ploceus melanocephalus), confirming the long-term viability of its local population through PVAs. However, extremely low recapture rates prevented the estimation of survival parameters and population growth rates for widely distributed species with low local densities (Estrilda troglodytes and Amandava amandava) but also for highly abundant yet non-colonial species (Estrilda astrild and Euplectes afer). Therefore, determining the establishment success of introduced passerine species by demographic criteria alone may often be troublesome even when devoting much effort to field-work. Alternative quantitative methodologies such as the analysis of spatio-temporal species distributions complemented with expert opinion deserve thus their role in the assessment of establishment success of introduced species when estimates of demographic parameters are difficult to obtain, as is generally the case for non-colonial, highly mobile passerines.	[Sanz-Aguilar, Ana; Anadon, Jose D.; Edelaar, Pim; Carrete, Martina; Luis Tella, Jose] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Sanz-Aguilar, Ana] UIB, CSIC, Inst Mediterraneo Estudios Avanzados, Esporles, Islas Baleares, Spain; [Anadon, Jose D.] CUNY Queens Coll, Dept Biol, New York, NY USA; [Edelaar, Pim; Carrete, Martina] Univ Pablo de Olavide, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; City University of New York (CUNY) System; Universidad Pablo de Olavide	Sanz-Aguilar, A (corresponding author), CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain.	ana.sanzaguilar@ebd.csic.es	Carrete, Martina/A-6376-2009; Anadon, Jose/H-6482-2015; Edelaar, Pim/P-5650-2014; Carrete, Martina/D-2618-2017; Sanz-Aguilar, Ana/D-3778-2014; Tella, José L/I-3707-2015	Carrete, Martina/0000-0002-0491-2950; Edelaar, Pim/0000-0003-4649-6366; Sanz-Aguilar, Ana/0000-0002-4177-9749; Tella, José L/0000-0002-3038-7424	Fundacion Repsol; Junta de Andalucia [P07RNM 02918, P08-RNM-4014]; Spanish Ministry of Economy and Competitiveness [JCI-2011-09085, RYC-2009-04860, RYC-2011-07889, CGL2012-35232, AIC-A-2011-0706]; project Estacion Biologica de Donana-Severo Ochoa [SEV-2012-0262]	Fundacion Repsol; Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Economy and Competitiveness(Spanish Government); project Estacion Biologica de Donana-Severo Ochoa	Fundacion Repsol, two Projects of Excellence from the Junta de Andalucia (P07RNM 02918 and P08-RNM-4014), and the Spanish Ministry of Economy and Competitiveness (projects JCI-2011-09085, RYC-2009-04860, RYC-2011-07889, CGL2012-35232, AIC-A-2011-0706) funded this research, with the support from the project Estacion Biologica de Donana-Severo Ochoa (SEV-2012-0262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, DIVERS DISTRIB, V20, P547, DOI 10.1111/ddi.12175; Abadi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062636; Allen CR, 2013, GLOBAL ECOL BIOGEOGR, V22, P889, DOI 10.1111/geb.12054; [Anonymous], 1982, ESTIMATION ANIMAL AB; Bauer Hans-Guenther, 2008, Vogelwarte, V46, P157; Blackburn TM, 2009, GLOBAL CHANGE BIOL, V15, P2852, DOI 10.1111/j.1365-2486.2008.01841.x; Blackburn TM, 2013, BIOL INVASIONS, V15, P1459, DOI 10.1007/s10530-013-0451-x; Blackburn TM, 2010, ECOGRAPHY, V33, P168, DOI 10.1111/j.1600-0587.2009.05882.x; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; Blackburn TM, 2001, NATURE, V414, P195, DOI 10.1038/35102557; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cabezas S, 2013, BIOL INVASIONS, P1; Carrete M, 2008, FRONT ECOL ENVIRON, V6, P207, DOI 10.1890/070075; Carrete M, 2012, TRENDS ECOL EVOL, V27, P67, DOI 10.1016/j.tree.2011.11.011; Carrete M, 2009, ECOL APPL, V19, P840, DOI 10.1890/07-2134.1; Cassey P, 2004, P ROY SOC B-BIOL SCI, V271, pS405, DOI 10.1098/rsbl.2004.0199; Caswell, 2000, MATRIX POPULATION MO; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Clement P, 2010, FINCHES SPARROWS; Conroy MJ, 2009, ENVIRON ECOL STAT SE, V3, P491, DOI 10.1007/978-0-387-78151-8_21; Covas R, 2004, AUK, V121, P1199, DOI 10.1642/0004-8038(2004)121[1199:JAASIT]2.0.CO;2; DACAMARASMEETS M, 1982, IBIS, V124, P241; Dudley SP, 2005, IBIS, V147, P803, DOI 10.1111/j.1474-919X.2005.00470.x; DUNNING JB, 1995, ECOL APPL, V5, P3, DOI 10.2307/1942045; Edelaar P, 2012, IBIS, V154, P635, DOI 10.1111/j.1474-919X.2012.01250.x; Ellis MM, 2007, J APPL ECOL, V44, P312, DOI 10.1111/j.1365-2664.2006.01265.x; Ferreira L, 1982, NOVOS DADOS BIOL EST; FLUX JEC, 1981, NEW ZEAL J ECOL, V4, P65; Fry C.H., 2004, BIRDS AFRICA, V7; Johnson CJ, 2004, J APPL ECOL, V41, P1032, DOI 10.1111/j.0021-8901.2004.00975.x; KARR JR, 1990, AM NAT, V136, P277, DOI 10.1086/285098; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; KOWARIK I, 1995, PLANT INVASIONS, P15; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Legendre S, 1995, J APPL STAT, V22, P817, DOI 10.1080/02664769524649; Lever C., 2005, NATURALISED BIRDS WO; Link WA, 2003, BIOMETRICS, V59, P1123, DOI 10.1111/j.0006-341X.2003.00129.x; Lockwood JL, 2007, INVASION ECOLOGY; MACARTHUR RH, 1974, P NATL ACAD SCI USA, V71, P3230, DOI 10.1073/pnas.71.8.3230; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mcgregor R, 2007, IBIS, V149, P615, DOI 10.1111/j.1474-919X.2007.00670.x; Millspaugh JJ., 2001, RADIO TRACKING ANIMA; Morris W. F., 2002, QUANTITATIVE CONSERV; Newton I, 1989, LIFETIME REPROD BIRD; OTIS DL, 1978, WILDLIFE MONOGR, P1; Payevsky VA, 2006, RUSS J ECOL+, V37, P180, DOI 10.1134/S1067413606030064; Peach WJ, 2001, OIKOS, V93, P235, DOI 10.1034/j.1600-0706.2001.930207.x; Ralph CJ, 1998, CONDOR, V100, P468, DOI 10.2307/1369712; Rasmussen PC., 2005, BIRDS S ASIA RIPLEY; Reino L, 2009, ECOGRAPHY, V32, P237, DOI 10.1111/j.1600-0587.2008.05354.x; Rodriguez-Cabal MA, 2013, BIOL INVASIONS, V15, P249, DOI 10.1007/s10530-012-0285-y; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sanz-Aguilar A, 2010, J ORNITHOL, V151, P133, DOI 10.1007/s10336-009-0435-x; Schwarz CJ, 2006, JOLLY SEBER MODELS M, P1; Simberloff D, 2005, FRONT ECOL ENVIRON, V3, P12, DOI 10.2307/3868440; Sol D, 2012, SCIENCE, V337, P580, DOI 10.1126/science.1221523; Tarwater CE, 2010, J AVIAN BIOL, V41, P479, DOI 10.1111/j.1600-048X.2010.05006.x; Tattoni C, 2006, BIOL INVASIONS, V8, P1605, DOI 10.1007/s10530-005-3503-z; Valery L, 2008, BIOL INVASIONS, V10, P1345, DOI 10.1007/s10530-007-9209-7; White GC, 2008, ENVIRON ECOL STAT, V15, P89, DOI 10.1007/s10651-007-0030-3; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM	62	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110019	10.1371/journal.pone.0110019	http://dx.doi.org/10.1371/journal.pone.0110019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333743	gold, Green Published			2022-12-27	WOS:000346766200078
J	Seedat, F; Hargreaves, S; Friedland, JS				Seedat, Farah; Hargreaves, Sally; Friedland, Jonathan S.			Engaging New Migrants in Infectious Disease Screening: A Qualitative Semi-Structured Interview Study of UK Migrant Community Health-Care Leads	PLOS ONE			English	Article							CHRONIC VIRAL-HEPATITIS; TUBERCULOSIS; HIV; IMMIGRANTS; BARRIERS; ENTRANTS; SERVICES; OUTREACH; WOMEN	Migration to Europe - and in particular the UK - has risen dramatically in the past decades, with implications for public health services. Migrants have increased vulnerability to infectious diseases (70% of TB cases and 60% HIV cases are in migrants) and face multiple barriers to healthcare. There is currently considerable debate as to the optimum approach to infectious disease screening in this often hard-to-reach group, and an urgent need for innovative approaches. Little research has focused on the specific experience of new migrants, nor sought their views on ways forward. We undertook a qualitative semi-structured interview study of migrant community health-care leads representing dominant new migrant groups in London, UK, to explore their views around barriers to screening, acceptability of screening, and innovative approaches to screening for four key diseases (HIV, TB, hepatitis B, and hepatitis C). Participants unanimously agreed that current screening models are not perceived to be widely accessible to new migrant communities. Dominant barriers that discourage uptake of screening include disease-related stigma present in their own communities and services being perceived as non-migrant friendly. New migrants are likely to be disproportionately affected by these barriers, with implications for health status. Screening is certainly acceptable to new migrants, however, services need to be developed to become more community-based, proactive, and to work more closely with community organisations; findings that mirror the views of migrants and health-care providers in Europe and internationally. Awareness raising about the benefits of screening within new migrant communities is critical. One innovative approach proposed by participants is a community-based package of health screening combining all key diseases into one general health check-up, to lessen the associated stigma. Further research is needed to develop evidence-based community-focused screening models - drawing on models of best practice from other countries receiving high numbers of migrants.	[Seedat, Farah; Hargreaves, Sally; Friedland, Jonathan S.] Univ London Imperial Coll Sci Technol & Med, Sect Infect Dis & Immun, Int Hlth Unit, London, England	Imperial College London	Hargreaves, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Infect Dis & Immun, Int Hlth Unit, Commonwealth Bldg,Hammersmith Campus, London, England.	s.hargreaves@imperial.ac.uk		Seedat, Farah/0000-0002-3563-7875; Hargreaves, Sally/0000-0003-2974-4348; Friedland, Jonathan S/0000-0001-7789-9649	Imperial College Healthcare Charity; Biomedical Research Centre at Imperial College London	Imperial College Healthcare Charity; Biomedical Research Centre at Imperial College London	The study was funded by the Imperial College Healthcare Charity and the Biomedical Research Centre at Imperial College London. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	ADHIKARI N, 1995, AM J PUBLIC HEALTH, V85, P786, DOI 10.2105/AJPH.85.6.786; Anderson J, 2004, AIDS CARE, V16, P95, DOI 10.1080/09540120310001634001; Arai L, 2002, HLTH SOCIAL CARE SER; Brassard P, 2006, PEDIATRICS, V117, pE148, DOI 10.1542/peds.2005-1534; Brewin P, 2006, J PUBLIC HEALTH-UK, V28, P253, DOI 10.1093/pubmed/fdl031; Clark RC, 2007, J PUBLIC HEALTH-UK, V29, P420, DOI 10.1093/pubmed/fdm063; Coker R, 2006, EUR RESPIR J, V27, P801, DOI 10.1183/09031936.06.00104305; Coker RJ, 2004, INT J TUBERC LUNG D, V8, P1022; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Doyal L, 2005, SOC SCI MED, V60, P1729, DOI 10.1016/j.socscimed.2004.08.041; European Centre for Disease Prevention and Control, 2013, TUB SURV MON EUR; European Centre for Disease Prevention and Control, 2009, MIGR HLTH BACKGR NOT; Gany FM, 2005, AM J PUBLIC HEALTH, V95, P117, DOI 10.2105/AJPH.2003.019620; Gerrish K, 2010, TACKLING TB TOGETHER; Griffiths C, 2007, LANCET, V369, P1528, DOI 10.1016/S0140-6736(07)60707-7; Guirgis M, 2012, INTERN MED J, V42, P491, DOI 10.1111/j.1445-5994.2011.02647.x; Hargreaves S, 2014, SCREENING L IN PRESS; Hargreaves S, 2006, IDENTIFICATION CHARG; Hargreaves S, 2012, MIGRATION HEATH INEQ, P27; Hargreaves S, 2008, J TRAVEL MED, V15, P13, DOI 10.1111/j.1708-8305.2007.00161.x; Hargreaves S, 2009, LANCET INFECT DIS, V9, P139, DOI 10.1016/S1473-3099(09)70026-X; International Organization for Migration, 2010, FUT MIGR BUILD CAP C; Jafferbhoy H, 2012, EPIDEMIOL INFECT, V140, P1048, DOI 10.1017/S095026881100152X; Johnson A, 2006, BELIEFS BARRIERS REL; Jones L, 2011, SYSTEMATIC REV QUALI; Lewis H, 2011, GUT, V60, pA26, DOI 10.1136/gutjnl-2011-300857a.56; Lewis H, 2012, J HEPATOL, V56, pS351, DOI 10.1016/S0168-8278(12)60915-5; Manirankunda L, 2009, AIDS EDUC PREV, V21, P582, DOI 10.1521/aeap.2009.21.6.582; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Migrant Friendly Hospitals, 2004, AMST DECL MIGR FRIEN; Office for National Statistics, 2015, 2011 CENS AGGR DAT E; OMara A, 2010, TUBERCULOSIS EVIDENC; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Public Health England, 2013, TUB UK ANN REP TUB S; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Sadler KE, 2006, AIDS CARE, V18, P398, DOI 10.1080/09540120600634400; Smaje C, 1997, SOC SCI MED, V45, P485, DOI 10.1016/S0277-9536(96)00380-2; Stagg HR, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001453; Thomas F, 2010, AIDS CARE, V22, P526, DOI 10.1080/09540120903499170; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Van den Bosch CA, 2000, J PUBLIC HEALTH MED, V22, P220, DOI 10.1093/pubmed/22.2.220; van der Veen YJJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-328; Wagner K, 2011, MIGRANT HLTH INFECT; Williams R, 2013, LANCET, V381, P2164, DOI 10.1016/S0140-6736(13)61438-5; Wormann T., 2011, Migration and health in the European Union, P121; Yazdanpanah Y, 2010, ANTIVIR THER, V15, P17, DOI 10.3851/IMP1526; Zenner D, 2013, LANCET, V382, P1311, DOI 10.1016/S0140-6736(13)62113-3	47	47	47	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e108261	10.1371/journal.pone.0108261	http://dx.doi.org/10.1371/journal.pone.0108261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25330079	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200010
J	Shibuya, S; Ozawa, Y; Watanabe, K; Izuo, N; Toda, T; Yokote, K; Shimizu, T				Shibuya, Shuichi; Ozawa, Yusuke; Watanabe, Kenji; Izuo, Naotaka; Toda, Toshihiko; Yokote, Koutaro; Shimizu, Takahiko			Palladium and Platinum Nanoparticles Attenuate Aging-Like Skin Atrophy via Antioxidant Activity in Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; LIFE-SPAN; COLLAGEN; AGE; ACCUMULATION; DEGRADATION; DYSFUNCTION; FIBROBLASTS; PROMOTER; MODEL	Cu-Zn superoxide dismutase (Sod1) loss causes a redox imbalance as it leads to excess superoxide generation, which results in the appearance of various aging-related phenotypes, including skin atrophy. Noble metal nanoparticles, such as palladium (Pd) and platinum (Pt) nanoparticles, are considered to function as antioxidants due to their strong catalytic activity. In Japan, a mixture of Pd and Pt nanoparticles called PAPLAL has been used to treat chronic diseases over the past 60 years. In the present study, we investigated the protective effects of PAPLAL against aging-related skin pathologies in mice. Transdermal PAPLAL treatment reversed skin thinning associated with increased lipid peroxidation in Sod1(-/-) mice. Furthermore, PAPLAL normalized the gene expression levels of Col1a1, Mmp2, Has2, Tnf-alpha, Il-6, and p53 in the skin of the Sod1(-/-) mice. Pt nanoparticles exhibited marked SOD and catalase activity, while Pd nanoparticles only displayed weak SOD and catalase activity in vitro. Although the SOD and catalase activity of the Pt nanoparticles significantly declined after they had been oxidized in air, a mixture of Pd and Pt nanoparticles continued to exhibit SOD and catalase activity after oxidation. Importantly, a mixture of Pd and Pt nanoparticles with a molar ratio of 3 or 4 to 1 continued to exhibit SOD and catalase activity after oxidation, indicating that Pd nanoparticles prevent the oxidative deterioration of Pt nanoparticles. These findings indicate that PAPLAL stably suppresses intrinsic superoxide generation both in vivo and in vitro via SOD and catalase activity. PAPLAL is a potentially powerful tool for the treatment of aging-related skin diseases caused by oxidative damage.	[Shibuya, Shuichi; Ozawa, Yusuke; Watanabe, Kenji; Izuo, Naotaka; Toda, Toshihiko; Shimizu, Takahiko] Chiba Univ, Grad Sch Med, Dept Adv Aging Med, Chiba, Japan; [Yokote, Koutaro] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan; [Shimizu, Takahiko] Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo, Japan	Chiba University; Chiba University; Tokyo Metropolitan Institute of Gerontology	Shimizu, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Adv Aging Med, Chiba, Japan.	shimizut@chiba-u.jp	Nanozymes, Nanozymes/D-8197-2019		Musashino Pharmaceutical Co.	Musashino Pharmaceutical Co.	This research was supported by funds from Musashino Pharmaceutical Co. (http://www.musashino-p.co.jp/). The PAPLAL and the Pd and Pt nanoparticles were provided from Musashino Pharmaceutical and Toyo Kosei pharmaceutical (http://toyokosei.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchef G, 2012, J BIOL CHEM, V287, P3462, DOI 10.1074/jbc.M111.286443; Bigot N, 2012, J INVEST DERMATOL, V132, P2360, DOI 10.1038/jid.2012.164; Elhusseiny AF, 2013, SPECTROCHIM ACTA A, V103, P232, DOI 10.1016/j.saa.2012.10.063; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Ibrahim OMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099328; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Ishizuka S, 1956, GENERATION PAPLAL; Iuchi Y, 2007, BIOCHEM J, V402, P219, DOI 10.1042/BJ20061386; Kajita M, 2007, FREE RADICAL RES, V41, P615, DOI 10.1080/10715760601169679; Kim J, 2008, MECH AGEING DEV, V129, P322, DOI 10.1016/j.mad.2008.02.011; Kojima T, 2012, AM J PATHOL, V180, P1879, DOI 10.1016/j.ajpath.2012.01.019; Kondo Y, 2014, FEBS OPEN BIO, V4, P522, DOI 10.1016/j.fob.2014.05.003; Kondo Y, 2008, INVEST OPHTH VIS SCI, V49, P4850, DOI 10.1167/iovs.08-1897; LEWIS LN, 1986, J AM CHEM SOC, V108, P7228, DOI 10.1021/ja00283a016; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Morikawa D, 2014, J SHOULDER ELB SURG, V23, P628, DOI 10.1016/j.jse.2014.01.041; Morikawa D, 2013, J BONE MINER RES, V28, P2368, DOI 10.1002/jbmr.1981; Murakami K, 2011, J BIOL CHEM, V286, P44557, DOI 10.1074/jbc.M111.279208; Murakami K, 2009, BIOCHEM BIOPH RES CO, V382, P457, DOI 10.1016/j.bbrc.2009.03.053; Naylor EC, 2011, MATURITAS, V69, P249, DOI 10.1016/j.maturitas.2011.04.011; Newkirk CE, 2014, J ENVIRON SCI HEAL A, V49, P269, DOI 10.1080/10934529.2014.846589; Noda Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092999; Nojiri H, 2006, J BIOL CHEM, V281, P33789, DOI 10.1074/jbc.M602118200; Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489; Okamoto H, 2012, EXP DERMATOL, V21, P5, DOI 10.1111/j.1600-0625.2012.01494.x; Onizawa S, 2009, PULM PHARMACOL THER, V22, P340, DOI 10.1016/j.pupt.2008.12.015; Poljsak B, 2012, ACTA DERMATOVEN ALP, V21, P33, DOI 10.2478/v10162-012-0009-0; Rehman MU, 2012, INFLAMM RES, V61, P1177, DOI 10.1007/s00011-012-0512-0; Roucoux A, 2002, CHEM REV, V102, P3757, DOI 10.1021/cr010350j; Sakaue Y, 2010, INT J NANOMED, V5, P687; Salem MMAEL, 2009, FASEB J, V23, P3790, DOI 10.1096/fj.09-132621; Schallreuter KU, 2013, FASEB J, V27, P3113, DOI 10.1096/fj.12-226779; Shibuya S, 2012, HUM HEALT HANDB, P351; Shibuya S, 2014, AGING OXIDATIVE STRE, P152; Shibuya S, 2014, BIOSCI BIOTECH BIOCH, V78, P1212, DOI 10.1080/09168451.2014.915728; SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x; Tajima K, 2009, CLIN PHARM THERAPY, V19, P397; Tajima K, 2005, CLIN PHARM THERAPY, V15, P635; Takamiya M, 2012, NEUROSCIENCE, V221, P47, DOI 10.1016/j.neuroscience.2012.06.060; Toshima N, 1998, NEW J CHEM, V22, P1179, DOI 10.1039/a805753b; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Uchiyama S, 2006, J BIOL CHEM, V281, P31713, DOI 10.1074/jbc.M603422200; Verrecchia F, 2004, CELL SIGNAL, V16, P873, DOI 10.1016/j.cellsig.2004.02.007; Watanabe K, 2013, INT J MOL SCI, V14, P10998, DOI 10.3390/ijms140610998; Yoshihisa Y, 2011, FREE RADICAL RES, V45, P326, DOI 10.3109/10715762.2010.532494; Yoshihisa Y, 2010, EXP DERMATOL, V19, P1000, DOI 10.1111/j.1600-0625.2010.01128.x	46	66	68	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109288	10.1371/journal.pone.0109288	http://dx.doi.org/10.1371/journal.pone.0109288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333617	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200022
J	Sieber, CMK; Lee, W; Wong, P; Munsterkotter, M; Mewes, HW; Schmeitzl, C; Varga, E; Berthiller, F; Adam, G; Guldener, U				Sieber, Christian M. K.; Lee, Wanseon; Wong, Philip; Muensterkoetter, Martin; Mewes, Hans-Werner; Schmeitzl, Clemens; Varga, Elisabeth; Berthiller, Franz; Adam, Gerhard; Gueldener, Ulrich			The Fusarium graminearum Genome Reveals More Secondary Metabolite Gene Clusters and Hints of Horizontal Gene Transfer	PLOS ONE			English	Article							POLYKETIDE SYNTHASE GENES; PLANT-PATHOGENIC FUNGUS; GIBBERELLA-ZEAE; ASPERGILLUS-NIDULANS; TRANSCRIPTION FACTOR; TRICHOTHECENE BIOSYNTHESIS; UDP-GLUCOSYLTRANSFERASE; AFFYMETRIX-GENECHIP; TOXIN BIOSYNTHESIS; COREGULATED GENES	Fungal secondary metabolite biosynthesis genes are of major interest due to the pharmacological properties of their products (like mycotoxins and antibiotics). The genome of the plant pathogenic fungus Fusarium graminearum codes for a large number of candidate enzymes involved in secondary metabolite biosynthesis. However, the chemical nature of most enzymatic products of proteins encoded by putative secondary metabolism biosynthetic genes is largely unknown. Based on our analysis we present 67 gene clusters with significant enrichment of predicted secondary metabolism related enzymatic functions. 20 gene clusters with unknown metabolites exhibit strong gene expression correlation in planta and presumably play a role in virulence. Furthermore, the identification of conserved and over-represented putative transcription factor binding sites serves as additional evidence for cluster co-regulation. Orthologous cluster search provided insight into the evolution of secondary metabolism clusters. Some clusters are characteristic for the Fusarium phylum while others show evidence of horizontal gene transfer as orthologs can be found in representatives of the Botrytis or Cochliobolus lineage. The presented candidate clusters provide valuable targets for experimental examination.	[Sieber, Christian M. K.; Lee, Wanseon; Wong, Philip; Muensterkoetter, Martin; Mewes, Hans-Werner; Gueldener, Ulrich] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Lee, Wanseon] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Wong, Philip] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Mewes, Hans-Werner; Gueldener, Ulrich] Tech Univ Munich, Wissensch Zentrum Weihenstephan, Dept Genome Oriented Bioinformat, Freising Weihenstephan, Germany; [Schmeitzl, Clemens; Adam, Gerhard] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Tulln, Austria; [Varga, Elisabeth; Berthiller, Franz] Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Christian Doppler Lab Mycotoxin Metab, Tulln, Austria; [Varga, Elisabeth; Berthiller, Franz] Univ Nat Resources & Life Sci, Ctr Analyt Chem, Tulln, Austria	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Oxford; Wellcome Centre for Human Genetics; University of Toronto; Technical University of Munich; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Guldener, U (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany.	u.gueldener@helmholtz-muenchen.de	Münsterkötter, Martin/C-5288-2017; Münsterkötter, Martin/L-3436-2019; Varga, Elisabeth/V-5936-2019; Lee, Wanseon/H-8735-2019; Güldener, Ulrich/G-5227-2012; Mewes, Hans-Werner/A-8204-2019	Münsterkötter, Martin/0000-0002-0044-2381; Münsterkötter, Martin/0000-0002-0044-2381; Güldener, Ulrich/0000-0001-5052-8610; Varga, Elisabeth/0000-0001-6046-3259; Lee, Wanseon/0000-0002-2881-8184; Adam, Gerhard/0000-0002-3008-3797; Mewes, Hans-Werner/0000-0002-9713-6398; Berthiller, Franz/0000-0001-5883-2879; Sieber, Christian/0000-0002-9560-0281	Austrian Science Fund FWF [F3705, F3702, F3706]; Helmholtz graduate school of environmental health, HELENA	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Helmholtz graduate school of environmental health, HELENA	This work was supported by the Austrian Science Fund FWF (http://www.fwf.ac.at/) (special research project Fusarium, F3705, F3702, F3706) and the Helmholtz graduate school of environmental health, HELENA (http://www.helmholtz-muenchen.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NJ, 2011, FUNGAL GENET BIOL, V48, P485, DOI 10.1016/j.fgb.2011.01.003; Alvarez-Venegas R, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00065; ARST HN, 1975, NATURE, V254, P26, DOI 10.1038/254026a0; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthiller F, 2005, J CHROMATOGR A, V1062, P209, DOI 10.1016/j.chroma.2004.11.011; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Blom J, 2012, J BACTERIOL, V194, P1845, DOI 10.1128/JB.06762-11; Boenisch MJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-110; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; Brown DW, 2012, FUNGAL BIOL-UK, V116, P318, DOI 10.1016/j.funbio.2011.12.005; Brown DW, 2004, FUNGAL GENET BIOL, V41, P454, DOI 10.1016/j.fgb.2003.12.002; Brown DW, 2003, J AGR FOOD CHEM, V51, P7936, DOI 10.1021/jf030607+; Brown DW, 2001, FUNGAL GENET BIOL, V32, P121, DOI 10.1006/fgbi.2001.1256; Campbell MA, 2013, MYCOLOGIA; Campbell MA, 2012, GENOME BIOL EVOL, V4, P289, DOI 10.1093/gbe/evs011; Cary JW, 2006, MYCOPATHOLOGIA, V162, P167, DOI 10.1007/s11046-006-0051-8; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Collemare J, 2008, NEW PHYTOL, V179, P196, DOI 10.1111/j.1469-8137.2008.02459.x; Connolly LR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003916; COULOMBE RA, 1993, J DAIRY SCI, V76, P880, DOI 10.3168/jds.S0022-0302(93)77414-7; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; DESJARDINS AE, 1993, MICROBIOL REV, V57, P595, DOI 10.1128/MMBR.57.3.595-604.1993; DIOLEZ A, 1995, APPL ENVIRON MICROB, V61, P103, DOI 10.1128/AEM.61.1.103-108.1995; Dvorska JE, 2001, BRIT POULTRY SCI, V42, P643, DOI 10.1080/00071660120088470; Ehrlich KC, 1999, GENE, V230, P249, DOI 10.1016/S0378-1119(99)00075-X; EMERY T, 1980, BIOCHIM BIOPHYS ACTA, V629, P382, DOI 10.1016/0304-4165(80)90110-5; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Frandsen RJN, 2006, MOL MICROBIOL, V61, P1069, DOI 10.1111/j.1365-2958.2006.05295.x; Fraser JA, 2004, PLOS BIOL, V2, P2243, DOI 10.1371/journal.pbio.0020384; Gaffoor I, 2006, APPL ENVIRON MICROB, V72, P1793, DOI 10.1128/AEM.72.3.1793-1799.2006; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Gardiner DM, 2005, MICROBIOL-SGM, V151, P1021, DOI 10.1099/mic.0.27847-0; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; Gardiner DM, 2004, MOL MICROBIOL, V53, P1307, DOI 10.1111/j.1365-2958.2004.04215.x; Gardiner DM, 2013, PLANT SCI, V210, P151, DOI 10.1016/j.plantsci.2013.06.002; Gardiner DM, 2009, MOL PLANT MICROBE IN, V22, P1588, DOI 10.1094/MPMI-22-12-1588; Gardiner DM, 2009, MICROBIOL-SGM, V155, P3149, DOI 10.1099/mic.0.029546-0; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Guldener U, 2006, FUNGAL GENET BIOL, V43, P316, DOI 10.1016/j.fgb.2006.01.005; Guenther JC, 2009, MOL PLANT MICROBE IN, V22, P1492, DOI 10.1094/MPMI-22-12-1492; Hansen FT, 2012, INT J FOOD MICROBIOL, V155, P128, DOI 10.1016/j.ijfoodmicro.2012.01.018; Harris LJ, 2007, FUNGAL GENET BIOL, V44, P293, DOI 10.1016/j.fgb.2006.11.001; Hatta R, 2002, GENETICS, V161, P59; Hohn TM, 1999, FUNGAL GENET BIOL, V26, P224, DOI 10.1006/fgbi.1999.1122; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Inglis DO, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-91; Jin JM, 2010, FEMS MICROBIOL LETT, V302, P197, DOI 10.1111/j.1574-6968.2009.01854.x; Jonkers W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002724; Jorgensen SH, 2014, FUNGAL GENET BIOL, V70, P24, DOI 10.1016/j.fgb.2014.06.008; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Khaldi Nora, 2011, Int J Evol Biol, V2011, P423821, DOI 10.4061/2011/423821; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Kim JE, 2006, APPL ENVIRON MICROB, V72, P1645, DOI 10.1128/AEM.72.2.1645-1652.2006; Kim JE, 2005, APPL ENVIRON MICROB, V71, P1701, DOI 10.1128/AEM.71.4.1701-1708.2005; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; Kimura M, 2003, FEBS LETT, V539, P105, DOI 10.1016/S0014-5793(03)00208-4; Kimura M, 1998, J BIOL CHEM, V273, P1654, DOI 10.1074/jbc.273.3.1654; Lawler K, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-52; Lee T, 2002, APPL ENVIRON MICROB, V68, P2148, DOI 10.1128/AEM.68.5.2148-2154.2002; Lysoe E, 2006, APPL ENVIRON MICROB, V72, P3924, DOI 10.1128/AEM.00963-05; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P995, DOI 10.1094/MPMI-02-11-0038; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P54, DOI 10.1094/MPMI-03-10-0075; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Malz S, 2005, FUNGAL GENET BIOL, V42, P420, DOI 10.1016/j.fgb.2005.01.010; Maragos CM, 2008, FOOD ADDIT CONTAM, V25, P105, DOI 10.1080/02652030701518098; MARTIN JF, 1989, ANNU REV MICROBIOL, V43, P173, DOI 10.1146/annurev.micro.43.1.173; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McCormick SP, 2010, APPL ENVIRON MICROB, V76, P136, DOI 10.1128/AEM.02017-09; McCormick SP, 2011, TOXINS, V3, P802, DOI 10.3390/toxins3070802; Meek IB, 2003, APPL ENVIRON MICROB, V69, P1607, DOI 10.1128/AEM.69.3.1607-1613.2003; Mirocha CJ, 1974, OESTROGENIC MYCOTOXI; Nasmith CG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002266; Niehaus EM, 2013, CHEM BIOL, V20, P1055, DOI 10.1016/j.chembiol.2013.07.004; Nielen MWF, 2014, RAPID ENZYMATIC HYDR; Nutzmann HW, 2011, P NATL ACAD SCI USA, V108, P14282, DOI 10.1073/pnas.1103523108; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Pedley KF, 2001, P NATL ACAD SCI USA, V98, P14174, DOI 10.1073/pnas.231491298; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Proctor RH, 2007, FOOD ADDIT CONTAM A, V24, P1076, DOI 10.1080/02652030701546495; Proctor RH, 2009, MOL MICROBIOL, V74, P1128, DOI 10.1111/j.1365-2958.2009.06927.x; Rattei T, 2010, NUCLEIC ACIDS RES, V38, pD223, DOI 10.1093/nar/gkp949; Rees DO, 2007, CHEMBIOCHEM, V8, P46, DOI 10.1002/cbic.200600404; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Schweiger W, 2010, MOL PLANT MICROBE IN, V23, P977, DOI 10.1094/MPMI-23-7-0977; Seong KY, 2008, FUNGAL GENET BIOL, V45, P389, DOI 10.1016/j.fgb.2007.09.002; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Smit A, 1996, REPEATMASKER OPEN 30; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SOPHIANOPOULOU V, 1993, MOL GEN GENET, V236, P209, DOI 10.1007/BF00277114; Sorensen JL, 2012, ENVIRON MICROBIOL, V14, P1159, DOI 10.1111/j.1462-2920.2011.02696.x; Stephens AE, 2008, MOL PLANT MICROBE IN, V21, P1571, DOI 10.1094/MPMI-21-12-1571; Strauss J, 2011, FUNGAL GENET BIOL, V48, P62, DOI 10.1016/j.fgb.2010.07.009; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Tobiasen C, 2007, CURR GENET, V51, P43, DOI 10.1007/s00294-006-0103-0; Tominaga M, 2006, APPL ENVIRON MICROB, V72, P484, DOI 10.1128/AEM.72.1.484-490.2006; Tudzynski B, 2005, APPL MICROBIOL BIOT, V66, P597, DOI 10.1007/s00253-004-1805-1; Walter MC, 2009, NUCLEIC ACIDS RES, V37, pD408, DOI 10.1093/nar/gkn749; Wang T, 2003, BIOINFORMATICS, V19, P2369, DOI 10.1093/bioinformatics/btg329; Wang YM, 2006, TOXICOL LETT, V164, P231, DOI 10.1016/j.toxlet.2006.01.002; Watson AJ, 1999, APPL ENVIRON MICROB, V65, P307; Wiemann P, 2013, P NATL ACAD SCI USA, V110, P17065, DOI 10.1073/pnas.1313258110; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Wong P, 2011, NUCLEIC ACIDS RES, V39, pD637, DOI 10.1093/nar/gkq1016; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang H, 2010, PHYTOPATHOLOGY, V100, P328, DOI 10.1094/PHYTO-100-4-0328; Zhang XW, 2012, PLANT CELL, V24, P5159, DOI 10.1105/tpc.112.105957	117	79	89	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110311	10.1371/journal.pone.0110311	http://dx.doi.org/10.1371/journal.pone.0110311			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333987	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200112
J	Stevens, M; Lown, AE; Denton, AM				Stevens, Martin; Lown, Alice E.; Denton, Alexander M.			Rockpool Gobies Change Colour for Camouflage	PLOS ONE			English	Article							DISRUPTIVE COLORATION; GOBY; PATTERNS; SIZE; CUTTLEFISH; PREDATORS; STIMULI; SNEAKER; CRYPSIS; VISION	Camouflage is found in a wide range of species living in numerous habitat types, offering protection from visually guided predators. This includes many species from the intertidal zone, which must cope with background types diverse in appearance and with multiple predator groups foraging at high and low tide. Many animals are capable of either relatively slow (hours, days, weeks) or rapid (seconds and minutes) colour change in order to better resemble the background against which they are found, but most work has been restricted to a few species or taxa. It is often suggested that many small intertidal fish are capable of colour change for camouflage, yet little experimental work has addressed this. Here, we test rock gobies (Gobius paganellus) for colour change abilities, and whether they can tune their appearance to match the background. In two experiments, we place gobies on backgrounds of different brightness (black or white), and of different colours (red and blue) and use digital image analysis and modelling of predator (avian) vision to quantify colour and luminance (perceived lightness) changes and camouflage. We find that gobies are capable of rapid colour change (occurring within one minute), and that they can change their luminance on lighter or darker backgrounds. When presented on backgrounds of different colours, gobies also change their colour (hue and saturation) while keeping luminance the same. These changes lead to predicted improvements in camouflage match to the background. Our study shows that small rockpool fish are capable of rapid visual change for concealment, and that this may be an important mechanism in many species to avoid predation, especially in complex heterogeneous environments.	[Stevens, Martin; Lown, Alice E.; Denton, Alexander M.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, Cornwall, England	University of Exeter	Stevens, M (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn Campus, Penryn, Cornwall, England.	martin.stevens@exeter.ac.uk		Stevens, Martin/0000-0001-7768-3426	Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Research Fellowship [BB/G022887/1]; BBSRC [BB/G022887/2, BB/G022887/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G022887/2, BB/G022887/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Research Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	M.S. and A.E.L. were supported by a Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Research Fellowship (BB/G022887/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT JC, 1985, BEHAVIOUR, V92, P241; Barbosa A, 2008, VISION RES, V48, P1242, DOI 10.1016/j.visres.2008.02.011; Bond AB, 2002, NATURE, V415, P609, DOI 10.1038/415609a; Cott H.B., 1940, ADAPTIVE COLORATION; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Fries EFB, 1942, BIOL BULL-US, V82, P273, DOI 10.2307/1538077; Hart NS, 2002, J EXP BIOL, V205, P3925; HASTINGS PA, 1991, ETHOL ECOL EVOL, V3, P177, DOI 10.1080/08927014.1991.9525367; Hoglund E, 2002, J EXP BIOL, V205, P2535; Hultgren K, 2011, ANIMAL CAMOUFLAGE ME; Immler S, 2004, J EXP ZOOL PART A, V301A, P177, DOI 10.1002/jez.a.20019; Kelman EJ, 2006, J EXP BIOL, V209, P3288, DOI 10.1242/jeb.02380; Komdeur J, 2005, BEHAV ECOL, V16, P805, DOI 10.1093/beheco/ari059; Lovell PG, 2013, CURR BIOL, V23, P260, DOI 10.1016/j.cub.2012.12.031; MAGNHAGEN C, 1991, MAR ECOL PROG SER, V70, P11, DOI 10.3354/meps070011; Marshall J, 2011, ANIMAL CAMOUFLAGE ME; Merilaita S, 2005, P ROY SOC B-BIOL SCI, V272, P665, DOI 10.1098/rspb.2004.3000; Merilaita Sami, 2011, P17; Odeen A, 2010, BIOL LETTERS, V6, P370, DOI 10.1098/rsbl.2009.0877; PFEIFFER W, 1977, COPEIA, P653, DOI 10.2307/1443164; Pike TW, 2011, BEHAV ECOL SOCIOBIOL, V65, P849, DOI 10.1007/s00265-010-1097-7; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Rowland HM, 2008, P ROY SOC B-BIOL SCI, V275, P2539, DOI 10.1098/rspb.2008.0812; Ruxton G. D., 2004, AVOIDING ATTACK; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Skelhorn J, 2010, SCIENCE, V327, P51, DOI 10.1126/science.1181931; Skold HN, 2013, PIGM CELL MELANOMA R, V26, P29, DOI 10.1111/pcmr.12040; SMITH RJF, 1992, ENVIRON BIOL FISH, V34, P103; Spottiswoode CN, 2011, P ROY SOC B-BIOL SCI, V278, P3566, DOI 10.1098/rspb.2011.0401; Stevens M, 2007, ANIM BEHAV, V74, P1215, DOI 10.1016/j.anbehav.2007.01.031; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2006, P R SOC B, V273, P2141, DOI 10.1098/rspb.2006.3556; Stevens M, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00014; Stevens M, 2013, BIOL J LINN SOC, V109, P257, DOI 10.1111/bij.12039; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Stuart-Fox D, 2008, BIOL LETTERS, V4, P326, DOI 10.1098/rsbl.2008.0173; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; Sumner FB, 1940, BIOL REV CAMB PHILOS, V15, P351, DOI 10.1111/j.1469-185X.1940.tb00763.x; Svensson O, 2007, BEHAV ECOL, V18, P410, DOI 10.1093/beheco/arl098; Todd PA, 2006, MAR BIOL, V148, P1357, DOI 10.1007/s00227-005-0159-2; Utne-Palm AC, 2006, J EXP BIOL, V209, P2034, DOI 10.1242/jeb.02171; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Wallace AR, 1889, DARWINISM; Webster RJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0501; Zylinski S, 2009, PHILOS T R SOC B, V364, P439, DOI 10.1098/rstb.2008.0264	49	24	24	11	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110325	10.1371/journal.pone.0110325	http://dx.doi.org/10.1371/journal.pone.0110325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333382	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200113
J	Fang, C; Ning, B; Waqar, AB; Niimi, M; Li, S; Satoh, K; Shiomi, M; Ye, T; Dong, SJ; Fan, JL				Fang, Chao; Ning, Bo; Waqar, Ahmed Bilal; Niimi, Manabu; Li, Shen; Satoh, Kaneo; Shiomi, Masashi; Ye, Ting; Dong, Sijun; Fan, Jianglin			Bisphenol A Exposure Enhances Atherosclerosis in WHHL Rabbits	PLOS ONE			English	Article							ADIPOSE-TISSUE; WIDESPREAD EXPOSURE; ESTROGEN-RECEPTOR; DISEASE; URINARY; EXPRESSION; DIFFERENTIATION; HYPERLIPIDEMIA; ASSOCIATION; CHEMICALS	Bisphenol A (BPA) is an environmental endocrine disrupter. Excess exposure to BPA may increase susceptibility to many metabolic disorders, but it is unclear whether BPA exposure has any adverse effects on the development of atherosclerosis. To determine whether there are such effects, we investigated the response of Watanabe heritable hyperlipidemic (WHHL) rabbits to 400-mu g/kg BPA per day, administered orally by gavage, over the course of 12 weeks and compared aortic and coronary atherosclerosis in these rabbits to the vehicle group using histological and morphometric methods. In addition, serum BPA, cytokines levels and plasma lipids as well as pathologic changes in liver, adipose and heart were analyzed. Moreover, we treated human umbilical cord vein endothelial cells (HUVECs) and rabbit aortic smooth muscle cells (SMCs) with different doses of BPA to investigate the underlying molecular mechanisms involved in BPA action(s). BPA treatment did not change the plasma lipids and body weights of the WHHL rabbits; however, the gross atherosclerotic lesion area in the aortic arch was increased by 57% compared to the vehicle group. Histological and immunohistochemical analyses revealed marked increases in advanced lesions (37%) accompanied by smooth muscle cells (60%) but no significant changes in the numbers of macrophages. With regard to coronary atherosclerosis, incidents of coronary stenosis increased by 11% and smooth muscle cells increased by 73% compared to the vehicle group. Furthermore, BPA-treated WHHL rabbits showed increased adipose accumulation and hepatic and myocardial injuries accompanied by up-regulation of endoplasmic reticulum (ER) stress and inflammatory and lipid metabolism markers in livers. Treatment with BPA also induced the expression of ER stress and inflammation related genes in cultured HUVECs. These results demonstrate for the first time that BPA exposure may increase susceptibility to atherosclerosis in WHHL rabbits.	[Fang, Chao; Ye, Ting; Dong, Sijun; Fan, Jianglin] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China; [Fang, Chao; Ning, Bo; Waqar, Ahmed Bilal; Niimi, Manabu; Li, Shen; Fan, Jianglin] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Yamanashi, Japan; [Satoh, Kaneo] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Lab Med, Yamanashi, Japan; [Shiomi, Masashi] Kobe Univ, Grad Sch Med, Inst Expt Anim, Kobe, Hyogo, Japan	Chinese Academy of Sciences; Institute of Urban Environment, CAS; University of Yamanashi; University of Yamanashi; Kobe University	Dong, SJ (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China.	sjdong@iue.ac.cn; jianglin@yamanashi.ac.jp	ye, ting/HGC-5924-2022; Niimi, Manabu/AAU-5428-2020; DONG, SIJUN/C-8807-2018; CAS, KLUEH/T-5743-2019; Waqar, Ahmed Bilal/P-2954-2015	Niimi, Manabu/0000-0002-3694-5642; Waqar, Ahmed Bilal/0000-0001-8255-3634; Fan, Jianglin/0000-0002-1737-6130	National Natural Science Foundation of China [21207127, 21277137, 21477124, 41390240]; Ministry of Education, Culture, Sports and Technology, Japan [KAKENHI 22390068]; Grants-in-Aid for Scientific Research [25670190] Funding Source: KAKEN	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Culture, Sports and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The research was supported by (1) National Natural Science Foundation of China (21207127, 21277137, 21477124, and 41390240), (http://www.nsfc.gov.cn/): CF, SD. (2) Grants-in-aid for scientific research from Ministry of Education, Culture, Sports and Technology, Japan (KAKENHI 22390068), (http://www.mext.go.jp/): CF, JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2005, ENVIRON HEALTH PERSP, V113, P969, DOI 10.1289/ehp.8002; Asano S, 2010, BRIT J PHARMACOL, V160, P160, DOI 10.1111/j.1476-5381.2010.00687.x; Brent RL, 2013, PEDIATRICS, V132, pE747, DOI 10.1542/peds.2013-2054; Buttke DE, 2012, ENVIRON HEALTH PERSP, V120, P1613, DOI 10.1289/ehp.1104748; Calafat AM, 2009, ENVIRON HEALTH PERSP, V117, P639, DOI 10.1289/ehp.0800265; Fan JL, 2003, PHARMACOL THERAPEUT, V99, P261, DOI 10.1016/S0163-7258(03)00069-X; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Fernandez MF, 2007, REPROD TOXICOL, V24, P259, DOI 10.1016/j.reprotox.2007.06.007; Guleria Ashwani, 2013, Trop Gastroenterol, V34, P74; Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Howdeshell KL, 2003, ENVIRON HEALTH PERSP, V111, P1180, DOI 10.1289/ehp.5993; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Kim MJ, 2014, CARDIOVASC TOXICOL, V14, P120, DOI 10.1007/s12012-013-9235-x; Kobayashi T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/406473; Koike T, 2005, CARDIOVASC RES, V65, P524, DOI 10.1016/j.cardiores.2004.10.022; Koike T, 2004, J BIOL CHEM, V279, P7521, DOI 10.1074/jbc.M311514200; Koike T, 2009, CIRCULATION, V120, P2088, DOI 10.1161/CIRCULATIONAHA.109.872796; La Merrill M, 2013, ENVIRON HEALTH PERSP, V121, P162, DOI 10.1289/ehp.1205485; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Li S, 2014, J ATHEROSCLER THROMB, V21, P648, DOI 10.5551/jat.21600; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lin Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.206; Lind PM, 2011, ATHEROSCLEROSIS, V218, P207, DOI 10.1016/j.atherosclerosis.2011.05.001; Liu LP, 2014, ANAL BIOANAL CHEM, V406, P5049, DOI 10.1007/s00216-014-7908-3; Lubick N, 2010, ENVIRON HEALTH PERSP, V118, pA116, DOI 10.1289/ehp.118-a116a; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Masuno H, 2005, TOXICOL SCI, V84, P319, DOI 10.1093/toxsci/kfi088; Melzer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043378; Melzer D, 2012, CIRCULATION, V125, P1482, DOI 10.1161/CIRCULATIONAHA.111.069153; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Miyawaki J, 2007, J ATHEROSCLER THROMB, V14, P245, DOI 10.5551/jat.E486; Patel BB, 2013, TOXICOL SCI, V133, P174, DOI 10.1093/toxsci/kft026; Phrakonkham P, 2008, J STEROID BIOCHEM, V110, P95, DOI 10.1016/j.jsbmb.2008.02.006; Posnack NG, 2014, ENVIRON HEALTH PERSP, V122, P384, DOI 10.1289/ehp.1206157; Robbins SL, 2012, BLOOD VESSELS, P338; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Saal FSV, 2012, MOL CELL ENDOCRINOL, V354, P74, DOI 10.1016/j.mce.2012.01.001; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shankar A, 2012, ENVIRON HEALTH PERSP, V120, P1297, DOI 10.1289/ehp.1104114; Shiomi M, 2008, CURR OPIN LIPIDOL, V19, P631, DOI 10.1097/MOL.0b013e3283189c18; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Sui YP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000492; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Taylor JA, 2008, REPROD TOXICOL, V25, P169, DOI 10.1016/j.reprotox.2008.01.001; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1051, DOI 10.1289/ehp.0901717; Walsh DE, 2005, MOL CELL ENDOCRINOL, V230, P23, DOI 10.1016/j.mce.2004.11.006; Waqar AB, 2010, ATHEROSCLEROSIS, V213, P148, DOI 10.1016/j.atherosclerosis.2010.07.051; WATANABE Y, 1980, ATHEROSCLEROSIS, V36, P261, DOI 10.1016/0021-9150(80)90234-8; YAMAMOTO T, 1986, SCIENCE, V232, P1230, DOI 10.1126/science.3010466; Yan SJ, 2013, FOOD CHEM TOXICOL, V56, P75, DOI 10.1016/j.fct.2013.02.011; Yan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025455; Ye XY, 2013, ENVIRON HEALTH PERSP, V121, P283, DOI 10.1289/ehp.1206093	56	37	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110977	10.1371/journal.pone.0110977	http://dx.doi.org/10.1371/journal.pone.0110977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333893	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200096
J	Gallisai, R; Peters, F; Volpe, G; Basart, S; Baldasano, JM				Gallisai, Rachele; Peters, Francesc; Volpe, Gianluca; Basart, Sara; Baldasano, Jose Maria			Saharan Dust Deposition May Affect Phytoplankton Growth in the Mediterranean Sea at Ecological Time Scales	PLOS ONE			English	Article							QUALITY MODELING SYSTEM; ATMOSPHERIC DEPOSITION; CHEMICAL-COMPOSITION; IRON CONCENTRATIONS; PARTICULATE MATTER; LEVANTINE BASIN; SOUTHERN-OCEAN; VARIABILITY; AEROSOLS; PHOSPHORUS	The surface waters of the Mediterranean Sea are extremely poor in the nutrients necessary for plankton growth. At the same time, the Mediterranean Sea borders with the largest and most active desert areas in the world and the atmosphere over the basin is subject to frequent injections of mineral dust particles. We describe statistical correlations between dust deposition over the Mediterranean Sea and surface chlorophyll concentrations at ecological time scales. Aerosol deposition of Saharan origin may explain 1 to 10% (average 5%) of seasonally detrended chlorophyll variability in the low nutrient-low chlorophyll Mediterranean. Most of the statistically significant correlations are positive with main effects in spring over the Eastern and Central Mediterranean, conforming to a view of dust events fueling needed nutrients to the planktonic community. Some areas show negative effects of dust deposition on chlorophyll, coinciding with regions under a large influence of aerosols from European origin. The influence of dust deposition on chlorophyll dynamics may become larger in future scenarios of increased aridity and shallowing of the mixed layer.	[Gallisai, Rachele; Peters, Francesc] CSIC, Inst Ciencias Mar, Dept Biol Marina & Oceanografia, Barcelona, Spain; [Volpe, Gianluca] Ist Sci Atmosfera & Clima, Rome, Italy; [Basart, Sara; Baldasano, Jose Maria] BSC CNS, Ctr Nacl Super, Barcelona Supercomp Ctr, Dept Earth Sci, Barcelona, Spain; [Baldasano, Jose Maria] Tech Univ Catalonia, Environm Modelling Lab, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Universitat Politecnica de Catalunya	Gallisai, R (corresponding author), CSIC, Inst Ciencias Mar, Dept Biol Marina & Oceanografia, Barcelona, Spain.	gallisai@icm.csic.es	Baldasano, Jose M./A-3852-2016; Peters, Francesc/A-6364-2009	Baldasano, Jose M./0000-0002-6191-635X; Peters, Francesc/0000-0001-9405-4306; Basart, Sara/0000-0002-9821-8504; Gallisai, Rachele/0000-0003-4224-3265; VOLPE, GIANLUCA/0000-0002-3916-5393	Spanish Scientific Research Council (CSIC); Spanish Ministry of Science and Innovation project [CTM2011-23458]; Estructura de la materia organica en el oceano costero: implicaciones biogeoquimicas y ecologicas [CTM2009-09352]; Generalitat de Catalunya project; Spanish Ministry of Economy and Competitivity [SEV-2011-00067, CSD2007-0050]	Spanish Scientific Research Council (CSIC); Spanish Ministry of Science and Innovation project(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Estructura de la materia organica en el oceano costero: implicaciones biogeoquimicas y ecologicas; Generalitat de Catalunya project(Generalitat de Catalunya); Spanish Ministry of Economy and Competitivity(Spanish Government)	The work was supported by the following: JAE-Predoc fellowship from the Spanish Scientific Research Council (CSIC), RG; Aerosol deposition and ocean plankton dynamics (CTM2011-23458), Spanish Ministry of Science and Innovation project, http://www.idi.mineco.gob.es/, RG and FP; Estructura de la materia organica en el oceano costero: implicaciones biogeoquimicas y ecologicas (CTM2009-09352), Spanish Ministry of Science and Innovation project, http://www.idi.mineco.gob.es/, FP; Grup d'Oceanografia Mediterra'nia (2009/SGR/588), Generalitat de Catalunya project, http://www10.gencat.cat/agaur_web/AppJava/catala/index.jsp, RG and FP; La ricerca italiana per il mare, Italian Ministry of Education, University and Research, http://www.ritmare.it/, GV; Acoplamiento on-line de un modulo completo de aerosoles multicomponente al modelo atmosferico global regional NMMB (CGL2010-19652), Spanish Ministry of Science and Innovation project, http://www.idi.mineco.gob.es/, SB and JMB; Supercomputacion and e-ciencia project (CSD2007-0050) from the Consolider-Ingenio 2010 program of the Spanish Ministry of Economy and Competitivity, http://www.idi.mineco.gob.es/, SB and JMB; and Severo Ochoa program (SEV-2011-00067) from Spanish Ministry of Economy and Competitivity, http://www.idi.mineco.gob.es/, SB and JMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Perez S, 2011, TELLUS B, V63, P255, DOI 10.1111/j.1600-0889.2010.00524.x; Amiridis V, 2009, ANN GEOPHYS-GERMANY, V27, P3155, DOI 10.5194/angeo-27-3155-2009; Avila A, 1999, SCI TOTAL ENVIRON, V228, P153, DOI 10.1016/S0048-9697(99)00041-8; Baker AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024764; Barnaba F, 2004, ATMOS CHEM PHYS, V4, P2367, DOI 10.5194/acp-4-2367-2004; Basart S, 2012, ATMOS CHEM PHYS, V12, P3363, DOI 10.5194/acp-12-3363-2012; Basart S, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.18539; BERGAMETTI G, 1992, J ATMOS CHEM, V14, P501, DOI 10.1007/BF00115254; Bethoux JP, 2002, DEEP-SEA RES PT II, V49, P2007, DOI 10.1016/S0967-0645(02)00024-3; Bonnet S, 2005, LIMNOL OCEANOGR, V50, P1810, DOI 10.4319/lo.2005.50.6.1810; Bonnet S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003213; Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; Carbo P, 2005, DEEP-SEA RES PT II, V52, P3041, DOI 10.1016/j.dsr2.2005.08.014; Creamean JM, 2013, SCIENCE, V339, P1572, DOI 10.1126/science.1227279; Cropp RA, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002436; D'Ortenzio F, 2009, BIOGEOSCIENCES, V6, P139, DOI 10.5194/bg-6-139-2009; de Madron XD, 2011, PROG OCEANOGR, V91, P97, DOI 10.1016/j.pocean.2011.02.003; Diaz F, 2001, MAR ECOL PROG SER, V211, P51, DOI 10.3354/meps211051; Eker-Develi E, 2006, MAR ECOL PROG SER, V314, P61, DOI 10.3354/meps314061; Estrada M, 1996, SCI MAR, V60, P55; Gabric AJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013545; Gaetani M, 2012, REGIONAL ENV CHANGE, P1; Gallisai R, 2012, BIOGEOSCIENCES DISCU, V9, P28; Ganor E, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012500; Gobbi GP, 2013, ATMOS CHEM PHYS, V13, P7395, DOI 10.5194/acp-13-7395-2013; Goudie AS, 2009, J ENVIRON MANAGE, V90, P89, DOI 10.1016/j.jenvman.2008.07.007; Goudie AS, 2001, EARTH-SCI REV, V56, P179, DOI 10.1016/S0012-8252(01)00067-8; Guerzoni S, 1999, PROG OCEANOGR, V44, P147, DOI 10.1016/S0079-6611(99)00024-5; GUIEU C, 1991, MAR POLLUT BULL, V22, P176, DOI 10.1016/0025-326X(91)90467-7; Guieu C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014454; Guieu C, 2010, BIOGEOSCIENCES, V7, P2765, DOI 10.5194/bg-7-2765-2010; Guieu C, 2010, MAR CHEM, V120, P164, DOI 10.1016/j.marchem.2009.02.004; Haustein K, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036463; Herut B, 2005, DEEP-SEA RES PT II, V52, P3024, DOI 10.1016/j.dsr2.2005.09.003; Herut B, 2002, LIMNOL OCEANOGR, V47, P870, DOI 10.4319/lo.2002.47.3.0870; Herut B, 1999, LIMNOL OCEANOGR, V44, P1683, DOI 10.4319/lo.1999.44.7.1683; Izquierdo R, 2012, ATMOS ENVIRON, V49, P361, DOI 10.1016/j.atmosenv.2011.11.007; Jaccard SL, 2013, SCIENCE, V339, P1419, DOI 10.1126/science.1227545; Jimenez-Guerrero P, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031580; Jordi A, 2012, P NATL ACAD SCI USA, V109, P21246, DOI 10.1073/pnas.1207567110; Kanakidou M, 2011, ATMOS ENVIRON, V45, P1223, DOI 10.1016/j.atmosenv.2010.11.048; Lekunberri I, 2010, J PLANKTON RES, V32, P381, DOI 10.1093/plankt/fbp137; Lelieveld J, 2002, SCIENCE, V298, P794, DOI 10.1126/science.1075457; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Ludwig W, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003594; Mahowald NM, 2010, ATMOS CHEM PHYS, V10, P10875, DOI 10.5194/acp-10-10875-2010; Markaki Z, 2003, LIMNOL OCEANOGR, V48, P1557, DOI 10.4319/lo.2003.48.4.1557; Markaki Z, 2010, MAR CHEM, V120, P187, DOI 10.1016/j.marchem.2008.10.005; Marty JC, 2002, DEEP-SEA RES PT II, V49, P1965, DOI 10.1016/S0967-0645(02)00022-X; Mona L, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006569; Morales-Baquero R, 2006, LIMNOL OCEANOGR, V51, P830, DOI 10.4319/lo.2006.51.2.0830; Papanastasiou DK, 2010, ADV METEOROL, V2010, DOI 10.1155/2010/154368; Papayannis A, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009028; Pay MT, 2012, ATMOS ENVIRON, V46, P376, DOI 10.1016/j.atmosenv.2011.09.049; Pay MT, 2010, ATMOS ENVIRON, V44, P3322, DOI 10.1016/j.atmosenv.2010.05.040; Paytan A, 2009, P NATL ACAD SCI USA, V106, P4601, DOI 10.1073/pnas.0811486106; Perez C, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006579; Perez C, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006717; Pey J, 2013, ATMOS CHEM PHYS, V13, P1395, DOI 10.5194/acp-13-1395-2013; Pujo-Pay M, 2011, BIOGEOSCIENCES, V8, P883, DOI 10.5194/bg-8-883-2011; Pulido-Villena E, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041415; Pulido-Villena E, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003091; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Querol X, 2009, ATMOS CHEM PHYS, V9, P4575, DOI 10.5194/acp-9-4575-2009; Rahav E, 2013, OCEAN SCI, V9, P489, DOI 10.5194/os-9-489-2013; Ridame C, 2011, BIOGEOSCIENCES, V8, P2773, DOI 10.5194/bg-8-2773-2011; Ridame C, 2002, LIMNOL OCEANOGR, V47, P856, DOI 10.4319/lo.2002.47.3.0856; Romero E, 2011, ESTUAR COAST SHELF S, V93, P27, DOI 10.1016/j.ecss.2011.03.019; Sarthou G, 2001, MAR CHEM, V74, P115, DOI 10.1016/S0304-4203(00)00119-5; Struglia MV, 2004, J CLIMATE, V17, P4740, DOI 10.1175/JCLI-3225.1; Ternon E, 2011, BIOGEOSCIENCES, V8, P1067, DOI 10.5194/bg-8-1067-2011; Theodosi C, 2011, ATMOS CHEM PHYS, V11, P11895, DOI 10.5194/acp-11-11895-2011; Volpe G, 2007, REMOTE SENS ENVIRON, V107, P625, DOI 10.1016/j.rse.2006.10.017; Volpe G, 2012, REMOTE SENS ENVIRON, V117, P223, DOI 10.1016/j.rse.2011.09.020; Volpe G, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003216; Wagener T, 2010, BIOGEOSCIENCES, V7, P3769, DOI 10.5194/bg-7-3769-2010	76	55	57	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110762	10.1371/journal.pone.0110762	http://dx.doi.org/10.1371/journal.pone.0110762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333783	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200075
J	Pignatelli, J; Castro, R; Granja, AG; Abos, B; Gonzalez, L; Jensen, LB; Tafalla, C				Pignatelli, Jaime; Castro, Rosario; Granja, Aitor Gonzalez; Abos, Beatriz; Gonzalez, Lucia; Jensen, Linda B.; Tafalla, Carolina			Immunological Characterization of the Teleost Adipose Tissue and Its Modulation in Response to Viral Infection and Fat-Content in the Diet	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; OMENTAL MILKY SPOTS; TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; RAINBOW-TROUT; CC CHEMOKINES; CELLS; LEPTIN; INFLAMMATION; OBESITY; FISH	The immune response of the adipose tissue (AT) has been neglected in most animal models until recently, when the observations made in human and mice linking obesity to chronic inflammation and diabetes highlighted an important immune component of this tissue. In the current study, we have immunologically characterized the AT for the first time in teleosts. We have analyzed the capacity of rainbow trout (Oncorhynchus mykiss) AT to produce different immune mediators and we have identified the presence of local populations of B lymphocytes expressing IgM, IgD or IgT, CD8 alpha(+) cells and cells expressing major histocompatibility complex II (MHC-II). Because trout AT retained antigens from the peritoneal cavity, we analyzed the effects of intraperitoneal infection with viral hemorrhagic septicemia virus (VHSV) on AT functionality. A wide range of secreted immune factors were modulated within the AT in response to VHSV. Furthermore, the viral infection provoked a significant decrease in the number of IgM(+) cells which, along with an increased secretion of IgM in the tissue, suggested a differentiation of B cells into plasmablasts. The virus also increased the number of CD8 alpha(+) cells in the AT. Finally, when a fat-enriched diet was fed to the fish, a significant modulation of immune gene expression in the AT was also observed. Thus, we have demonstrated for the first time in teleost that the AT functions as a relevant immune tissue; responsive to peritoneal viral infections and that this immune response can be modulated by the fat-content in the diet.	[Pignatelli, Jaime; Castro, Rosario; Granja, Aitor Gonzalez; Abos, Beatriz; Gonzalez, Lucia; Tafalla, Carolina] Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain; [Jensen, Linda B.] Skretting Aquaculture Res Ctr, Stavanger, Norway		Tafalla, C (corresponding author), Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain.	tafalla@inia.es	Pignatelli, Jaime/L-3122-2014; Granja, Aitor/K-8102-2014; pignatelli, jaime/AAY-8734-2021; Tafalla, Carolina/J-8074-2014	Pignatelli, Jaime/0000-0002-8431-2241; pignatelli, jaime/0000-0002-8431-2241; Tafalla, Carolina/0000-0002-0860-2976; Jensen, Linda/0000-0003-2786-5920	European Research Council (ERC) [2011 280469]; European Commission under the 7th Framework Programme for Research and Technological Development (FP7) of the European Union [311993]; Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2011-29676]	European Research Council (ERC)(European Research Council (ERC)); European Commission under the 7th Framework Programme for Research and Technological Development (FP7) of the European Union; Spanish Ministry of Economy and Competitiveness (MINECO)	This work was supported by the European Research Council (ERC Starting Grant 2011 280469), by the European Commission under the 7th Framework Programme for Research and Technological Development (FP7) of the European Union (Grant Agreement 311993 TARGETFISH), and by project AGL2011-29676 from the Spanish Ministry of Economy and Competitiveness (MINECO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abos B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082737; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Aquilino C, 2014, DEV COMP IMMUNOL, V44, P12, DOI 10.1016/j.dci.2013.11.006; Ballesteros NA, 2014, DEV COMP IMMUNOL, V44, P195, DOI 10.1016/j.dci.2013.12.009; Ballesteros NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066118; Bedford PA, 2006, J LEUKOCYTE BIOL, V80, P546, DOI 10.1189/jlb.0905501; BEELEN RHJ, 1980, J RETICULOENDOTH SOC, V28, P585; Beetz S, 2007, IMMUNOGENETICS, V59, P735, DOI 10.1007/s00251-007-0241-7; Boardman T, 2012, VET IMMUNOL IMMUNOP, V145, P511, DOI 10.1016/j.vetimm.2011.11.017; Carlow DA, 2009, J IMMUNOL, V183, P1155, DOI 10.4049/jimmunol.0900409; Castro R, 2014, J IMMUNOL, V192, P1257, DOI 10.4049/jimmunol.1302471; Chandra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020446; Cui L, 2002, CELL TISSUE RES, V310, P321, DOI 10.1007/s00441-002-0636-6; DELUCA D, 1983, EUR J IMMUNOL, V13, P546, DOI 10.1002/eji.1830130706; Descatoire M, 2011, J EXP MED, V208, P2563, DOI 10.1084/jem.20112232; Edholm ES, 2010, J IMMUNOL, V185, P4082, DOI 10.4049/jimmunol.1000631; Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; FEDORKO ME, 1971, EXP CELL RES, V69, P313, DOI 10.1016/0014-4827(71)90230-8; Fillatreau S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00028; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Gill MB, 2009, J GEN VIROL, V90, P1461, DOI 10.1099/vir.0.010603-0; Gong NP, 2013, ENDOCRINOLOGY, V154, P2331, DOI 10.1210/en.2012-2082; Gray KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043196; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; Hansen JD, 1997, IMMUNOGENETICS, V46, P367, DOI 10.1007/s002510050290; Hsu MC, 2006, P NATL ACAD SCI USA, V103, P5905, DOI 10.1073/pnas.0601502103; Iikuni Noriko, 2008, Current Immunology Reviews, V4, P70, DOI 10.2174/157339508784325046; John BJ, 2006, ALIMENT PHARM THER, V23, P1511, DOI 10.1111/j.1365-2036.2006.02915.x; Jorgensen LV, 2011, J FISH DIS, V34, P749, DOI 10.1111/j.1365-2761.2011.01291.x; Kaminski DA, 2010, TRENDS IMMUNOL, V31, P384, DOI 10.1016/j.it.2010.08.001; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Koethe JR, 2013, J INFECT DIS, V208, P1194, DOI 10.1093/infdis/jit324; Laing KJ, 2004, MOL IMMUNOL, V41, P793, DOI 10.1016/j.molimm.2004.03.038; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Montero J, 2011, J VIROL, V85, P4046, DOI 10.1128/JVI.02519-10; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Olsen MM, 2011, FISH SHELLFISH IMMUN, V30, P859, DOI 10.1016/j.fsi.2011.01.010; Otero M, 2006, DRUG NEWS PERSPECT, V19, P21, DOI 10.1358/dnp.2006.19.1.966243; Palti Y, 2011, DEV COMP IMMUNOL, V35, P1263, DOI 10.1016/j.dci.2011.03.006; Peatman E, 2007, IMMUNOGENETICS, V59, P613, DOI 10.1007/s00251-007-0228-4; Ramirez-Gomez F, 2012, J IMMUNOL, V188, P1341, DOI 10.4049/jimmunol.1101938; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sauerwein H, 2014, CURR PROTEIN PEPT SC, V15, P146, DOI 10.2174/1389203715666140221123105; SOLVASON N, 1992, J EXP MED, V175, P397, DOI 10.1084/jem.175.2.397; SOLVASON N, 1992, ANN NY ACAD SCI, V651, P10; SZANIAWSKA B, 1975, Archivum Immunologiae et Therapiae Experimentalis, V23, P11; SZANIWSKA B, 1974, Archivum Immunologiae et Therapiae Experimentalis, V22, P585; Tafalla C, 2008, MOL IMMUNOL, V45, P1439, DOI 10.1016/j.molimm.2007.08.015; Takizawa F, 2011, DEV COMP IMMUNOL, V35, P752, DOI 10.1016/j.dci.2011.02.008; vanVugt E, 1996, ANAT REC, V244, P235; Vgontzas AN, 1997, J CLIN ENDOCR METAB, V82, P1313, DOI 10.1210/jc.82.5.1313; WILLIAMS R, 1986, CURR PROB SURG, V23, P795, DOI 10.1016/0011-3840(86)90007-9; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Yang YK, 2008, CELL PHYSIOL BIOCHEM, V22, P531, DOI 10.1159/000185527; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zou J, 2005, J IMMUNOL, V175, P2484, DOI 10.4049/jimmunol.175.4.2484; Zou J, 1999, EUR J BIOCHEM, V259, P901, DOI 10.1046/j.1432-1327.1999.00121.x	61	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110920	10.1371/journal.pone.0110920	http://dx.doi.org/10.1371/journal.pone.0110920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333488	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200093
J	Rosenegger, DG; Tran, CHT; Ledue, J; Zhou, N; Gordon, GR				Rosenegger, David G.; Tran, Cam Ha T.; Ledue, Jeffery; Zhou, Ning; Gordon, Grant R.			A High Performance, Cost-Effective, Open-Source Microscope for Scanning Two-Photon Microscopy that Is Modular and Readily Adaptable	PLOS ONE			English	Article							NEURAL ACTIVITY; CONSTRUCTION; RESOLUTION; SOFTWARE; NEURONS; TISSUE	Two-photon laser scanning microscopy has revolutionized the ability to delineate cellular and physiological function in acutely isolated tissue and in vivo. However, there exist barriers for many laboratories to acquire two-photon microscopes. Additionally, if owned, typical systems are difficult to modify to rapidly evolving methodologies. A potential solution to these problems is to enable scientists to build their own high-performance and adaptable system by overcoming a resource insufficiency. Here we present a detailed hardware resource and protocol for building an upright, highly modular and adaptable two-photon laser scanning fluorescence microscope that can be used for in vitro or in vivo applications. The microscope is comprised of high-end componentry on a skeleton of off-the-shelf compatible opto-mechanical parts. The dedicated design enabled imaging depths close to 1 mm into mouse brain tissue and a signal-to-noise ratio that exceeded all commercial two-photon systems tested. In addition to a detailed parts list, instructions for assembly, testing and troubleshooting, our plan includes complete three dimensional computer models that greatly reduce the knowledge base required for the non-expert user. This open-source resource lowers barriers in order to equip more laboratories with high-performance two-photon imaging and to help progress our understanding of the cellular and physiological function of living systems.	[Rosenegger, David G.; Tran, Cam Ha T.; Gordon, Grant R.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Ledue, Jeffery] Univ British Columbia, Brain Res Ctr, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; [Zhou, Ning] China Med Univ, Translat Med Res Ctr, Grad Inst Clin Med Sci, Taichung, Taiwan	University of Calgary; University of British Columbia; China Medical University Taiwan	Gordon, GR (corresponding author), Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	gordong@ucalgary.ca	LeDue, Jeffrey/C-9230-2012	Zhou, Ning/0000-0003-4693-0679; Tran, Cam Ha/0000-0003-1177-7723	Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research; Canada Research Chairs; Alberta Innovates Health Solutions	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs(Canada Research ChairsCGIAR); Alberta Innovates Health Solutions	Heart and Stroke Foundation of Canada, www.heartandstroke.ca, to GG. Canadian Institutes of Health Research, www.cihr-irsc.gc.ca, to GG. Canada Research Chairs, www.chairs-chaires.gc.ca. Alberta Innovates Health Solutions, www.aihealthsolutions.ca, to DG and CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaurepaire E, 2002, APPL OPTICS, V41, P5376, DOI 10.1364/AO.41.005376; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; Cole RW, 2011, NAT PROTOC, V6, P1929, DOI 10.1038/nprot.2011.407; Coscoy S, 2002, P NATL ACAD SCI USA, V99, P12813, DOI 10.1073/pnas.192084599; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Diaspro A, 1999, MICROSC RES TECHNIQ, V47, P196, DOI 10.1002/(SICI)1097-0029(19991101)47:3<196::AID-JEMT5>3.0.CO;2-V; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Driscoll JD, 2011, J NEUROPHYSIOL, V105, P3106, DOI 10.1152/jn.00649.2010; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Heider B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013829; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Jiang RH, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4705972; Kim KH, 1999, APPL OPTICS, V38, P6004, DOI 10.1364/AO.38.006004; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kobat D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3646209; Konig K, 1996, CELL MOL BIOL, V42, P1181; Langer D, 2013, J NEUROSCI METH, V215, P38, DOI 10.1016/j.jneumeth.2013.02.006; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Nguyen QT, 2001, CELL CALCIUM, V30, P383, DOI 10.1054/ceca.2001.0246; Nguyen QT, 2006, J NEUROSCI METHODS; Nikolenko Volodymyr, 2013, Cold Spring Harb Protoc, V2013, P588, DOI 10.1101/pdb.ip075135; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Pettit DL, 1997, NEURON, V19, P465, DOI 10.1016/S0896-6273(00)80361-X; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Soeller C, 1996, PFLUG ARCH EUR J PHY, V432, P555, DOI 10.1007/s004240050169; Tan YP, 1999, J NEUROSCI METH, V92, P123, DOI 10.1016/S0165-0270(99)00103-X; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsai PS, 2002, METH NE FRO NEUROSCI, P113; Wier WG, 2000, AM J PHYSIOL-HEART C, V278, pH2150, DOI 10.1152/ajpheart.2000.278.6.H2150; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	36	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110475	10.1371/journal.pone.0110475	http://dx.doi.org/10.1371/journal.pone.0110475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333934	gold, Green Submitted, Green Published			2022-12-27	WOS:000343731200042
J	Sadreev, II; Chen, MZQ; Welsh, GI; Umezawa, Y; Kotov, NV; Valeyev, NV				Sadreev, Ildar I.; Chen, Michael Z. Q.; Welsh, Gavin I.; Umezawa, Yoshinori; Kotov, Nikolay V.; Valeyev, Najl V.			A Systems Model of Phosphorylation for Inflammatory Signaling Events	PLOS ONE			English	Article							SITE-SPECIFIC PHOSPHORYLATION; MYELOID-LEUKEMIA CELLS; REGULATORY T-CELLS; MULTISITE PHOSPHORYLATION; DIFFERENTIAL ACTIVATION; SERINE PHOSPHORYLATION; COVALENT MODIFICATION; CONSTITUTIVE STAT3; TH17 CELLS; ULTRASENSITIVITY	Phosphorylation is a fundamental biochemical reaction that modulates protein activity in cells. While a single phosphorylation event is relatively easy to understand, multisite phosphorylation requires systems approaches for deeper elucidation of the underlying molecular mechanisms. In this paper we develop a mechanistic model for single-and multisite phosphorylation. The proposed model is compared with previously reported studies. We compare the predictions of our model with experiments published in the literature in the context of inflammatory signaling events in order to provide a mechanistic description of the multisite phosphorylation-mediated regulation of Signal Transducer and Activator of Transcription 3 (STAT3) and Interferon Regulatory Factor 5 (IRF-5) proteins. The presented model makes crucial predictions for transcription factor phosphorylation events in the immune system. The model proposes potential mechanisms for T cell phenotype switching and production of cytokines. This study also provides a generic framework for the better understanding of a large number of multisite phosphorylation-regulated biochemical circuits.	[Sadreev, Ildar I.] Univ Exeter, Coll Engn Math & Phys Sci, Ctr Syst Dynam & Control, Exeter, Devon, England; [Chen, Michael Z. Q.] Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China; [Welsh, Gavin I.; Valeyev, Najl V.] Univ Bristol, Sch Clin Sci, Acad Renal Unit, Bristol, Avon, England; [Umezawa, Yoshinori] Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo, Japan; [Kotov, Nikolay V.; Valeyev, Najl V.] Kazan Fed Univ, Inst Phys, Biophys & Bion Lab, Kazan, Russia	University of Exeter; University of Hong Kong; University of Bristol; Jikei University; Kazan Federal University	Chen, MZQ (corresponding author), Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China.	mzqchen@hku.hk		Sadreev, Ildar/0000-0003-2628-8287; Welsh, Gavin Iain/0000-0002-2148-6658; Kotov, Nikolay/0000-0003-2084-2988	NSFC [61374053]; Russian Government; SATRE grant; Engineering and Physical Sciences Research Council [EP/K503484/1] Funding Source: researchfish	NSFC(National Natural Science Foundation of China (NSFC)); Russian Government; SATRE grant; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was carried out under SATRE grant (NVV and GIW) and NSFC grant 61374053 (MZQC). This work was funded by the subsidy of the Russian Government to support the Program of Competitive Growth of Kazan Federal University among World's Leading Academic Centers ( NVV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; Balkhi MY, 2010, CELL SIGNAL, V22, P117, DOI 10.1016/j.cellsig.2009.09.021; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Borghans JAM, 1996, B MATH BIOL, V58, P43, DOI 10.1016/0092-8240(95)00306-1; Casanovas G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003421; Chan C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002551; Cheng TF, 2006, J IMMUNOL, V176, P7462, DOI 10.4049/jimmunol.176.12.7462; Cherian TS, 2012, ARTHRITIS RHEUM-US, V64, P3383, DOI 10.1002/art.34571; Ciliberto A, 2007, PLOS COMPUT BIOL, V3, P463, DOI 10.1371/journal.pcbi.0030045; Coskun M, 2013, PHARMACOL RES, V76, P1, DOI 10.1016/j.phrs.2013.06.007; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dushek O, 2011, BIOPHYS J, V100, P1189, DOI 10.1016/j.bpj.2011.01.060; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Floss DM, 2013, J BIOL CHEM, V288, P19386, DOI 10.1074/jbc.M112.432153; Foreman HCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033098; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gong QK, 2009, ISLETS, V1, P34, DOI 10.4161/isl.1.1.8629; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gunawardena J, 2005, P NATL ACAD SCI USA, V102, P14617, DOI 10.1073/pnas.0507322102; Gunawardena J, 2007, BIOPHYS J, V93, P3828, DOI 10.1529/biophysj.107.110866; Hochrainer K, 2013, J BIOL CHEM, V288, P285, DOI 10.1074/jbc.M112.385625; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; Kapuy O, 2009, PROG BIOPHYS MOL BIO, V100, P47, DOI 10.1016/j.pbiomolbio.2009.06.004; Kaymaz BT, 2013, AM J BLOOD RES, V3, P58; Kleinewietfeld M, 2013, SEMIN IMMUNOL, V25, P305, DOI 10.1016/j.smim.2013.10.009; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kusaba H, 2005, J BIOL CHEM, V280, P1037, DOI 10.1074/jbc.M405204200; Lechner MG, 2012, CLIN CANCER RES, V18, P4549, DOI 10.1158/1078-0432.CCR-12-0101; Liu XF, 2010, BIOPHYS J, V98, P1396, DOI 10.1016/j.bpj.2009.12.4307; Liu YP, 2008, INT J MOL MED, V21, P153; Lovato P, 2003, J BIOL CHEM, V278, P16777, DOI 10.1074/jbc.M207999200; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Minton K, 2011, NAT REV IMMUNOL, V11, DOI 10.1038/nri2934; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Mutalik VK, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-19; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Palani S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.13; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Sakaguchi M, 2012, J INVEST DERMATOL, V132, P1877, DOI 10.1038/jid.2012.45; Schuringa JJ, 2000, BLOOD, V95, P3765, DOI 10.1182/blood.V95.12.3765; Selvarajoo K, 2006, FEBS LETT, V580, P1457, DOI 10.1016/j.febslet.2006.01.046; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Szomolay B, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-26; Tai WT, 2012, MOL CANCER THER, V11, P452, DOI 10.1158/1535-7163.MCT-11-0412; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Thingnes J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-11; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; Varedi SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014029; Wang LM, 2010, BIOPHYS J, V99, pL41, DOI 10.1016/j.bpj.2010.07.030; Xing JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002140; Zheng SG, 2013, AM J CLIN EXP IMMUNO, V2, P94; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	62	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110913	10.1371/journal.pone.0110913	http://dx.doi.org/10.1371/journal.pone.0110913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333362	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200092
J	Welinder, C; Jonsson, GB; Ingvar, C; Lundgren, L; Baldetorp, B; Olsson, H; Breslin, T; Rezeli, M; Jansson, B; Fehniger, TE; Laurell, T; Wieslander, E; Pawlowski, K; Marko-Varga, G				Welinder, Charlotte; Jonsson, Goran B.; Ingvar, Christian; Lundgren, Lotta; Baldetorp, Bo; Olsson, Hakan; Breslin, Thomas; Rezeli, Melinda; Jansson, Bo; Fehniger, Thomas E.; Laurell, Thomas; Wieslander, Elisabet; Pawlowski, Krzysztof; Marko-Varga, Gyorgy			Analysis of Alpha-Synuclein in Malignant Melanoma - Development of a SRM Quantification Assay	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; PARKINSON DISEASE; INSIGHTS; BIOMARKERS; OLIGOMERS; RESOURCE; PROTEIN; MITF; RISK; CSF	Globally, malignant melanoma shows a steady increase in the incidence among cancer diseases. Malignant melanoma represents a cancer type where currently no biomarker or diagnostics is available to identify disease stage, progression of disease or personalized medicine treatment. The aim of this study was to assess the tissue expression of alpha-synuclein, a protein implicated in several disease processes, in metastatic tissues from malignant melanoma patients. A targeted Selected Reaction Monitoring (SRM) assay was developed and utilized together with stable isotope labeling for the relative quantification of two target peptides of alpha-synuclein. Analysis of alpha-synuclein protein was then performed in ten metastatic tissue samples from the Lund Melanoma Biobank. The calibration curve using peak area ratio (heavy/light) versus concentration ratios showed linear regression over three orders of magnitude, for both of the selected target peptide sequences. In support of the measurements of specific protein expression levels, we also observed significant correlation between the protein and mRNA levels of alpha-synuclein in these tissues. Investigating levels of tissue alpha-synuclein may add novel aspect to biomarker development in melanoma, help to understand disease mechanisms and ultimately contribute to discriminate melanoma patients with different prognosis.	[Welinder, Charlotte; Jonsson, Goran B.; Lundgren, Lotta; Baldetorp, Bo; Olsson, Hakan; Breslin, Thomas; Jansson, Bo; Fehniger, Thomas E.; Wieslander, Elisabet; Pawlowski, Krzysztof] Lund Univ, Div Oncol & Pathol Clin Sci, Lund, Sweden; [Welinder, Charlotte; Fehniger, Thomas E.; Laurell, Thomas; Marko-Varga, Gyorgy] Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry, Lund, Sweden; [Ingvar, Christian; Lundgren, Lotta; Olsson, Hakan] Skane Univ Hosp, Lund, Sweden; [Ingvar, Christian] Lund Univ, Skane Univ Hosp, Dept Surg,Clin Sci, Lund, Sweden; [Olsson, Hakan] Lund Univ, Dept Canc Epidemiol Clin Sci, Lund, Sweden; [Rezeli, Melinda; Laurell, Thomas; Marko-Varga, Gyorgy] Lund Univ, Biomed Ctr, Lund, Sweden; [Pawlowski, Krzysztof] Warsaw Univ Life Sci, Fac Agr & Biol, Dept Expt Design & Bioinformat, Warsaw, Poland; [Marko-Varga, Gyorgy] Tokyo Med Univ, Dept Surg 1, Tokyo, Japan	Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Lund University; Warsaw University of Life Sciences; Tokyo Medical University	Welinder, C (corresponding author), Lund Univ, Div Oncol & Pathol Clin Sci, Lund, Sweden.	charlotte.welinder@med.lu.se	Pawłowski, Krzysztof/C-2949-2013; Baldetorp, Bo/HDM-9924-2022; Ingvar, Christian/AAE-9841-2019; Laurell, Thomas/B-5524-2013; Welinder, Charlotte/G-1144-2014	Pawłowski, Krzysztof/0000-0002-5367-0935; Laurell, Thomas/0000-0002-2486-3607; Olsson, Hakan/0000-0002-8794-9635; Welinder, Charlotte/0000-0001-9626-0576	Kamprad Foundation	Kamprad Foundation	This work was supported by The Kamprad Foundation (http://familjenkampradsstiftelse.se), ( to CW GBJ CI LL BB HO TB BJ TL EW KP GMV). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Alim MA, 2002, J BIOL CHEM, V277, P2112, DOI 10.1074/jbc.M102981200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bertoni JM, 2010, ARCH NEUROL-CHICAGO, V67, P347, DOI 10.1001/archneurol.2010.1; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Bonini NM, 2005, CELL, V123, P359, DOI 10.1016/j.cell.2005.10.017; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Campbell J, 2011, PROTEOMICS, V11, P1148, DOI 10.1002/pmic.201000511; Chace DH, 2006, MASS SPECTROMETRY CL; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56; Gao X, 2009, NEUROLOGY, V73, P1286, DOI 10.1212/WNL.0b013e3181bd13a1; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; George S, 2013, BRAIN PATHOL, V23, P350, DOI 10.1111/bpa.12046; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Kasuga Kensaku, 2012, Int J Alzheimers Dis, V2012, P437025, DOI 10.1155/2012/437025; Kitchen S, 2006, SEMIN THROMB HEMOST, V32, P492, DOI 10.1055/s-2006-947863; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Matsuo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010481; McGlinchey RP, 2011, PHYS CHEM CHEM PHYS, V13, P20066, DOI 10.1039/c1cp21376h; McInnes J, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-12; McLean JR, 2012, MOL CELL NEUROSCI, V49, P230, DOI 10.1016/j.mcn.2011.11.006; McLean PJ, 2002, NEUROSCI LETT, V323, P219, DOI 10.1016/S0304-3940(02)00154-4; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Olsen JH, 2007, MOVEMENT DISORD, V22, P1252, DOI 10.1002/mds.21397; Olsen JH, 2006, EPIDEMIOLOGY, V17, P582, DOI 10.1097/01.ede.0000229445.90471.5e; Paisan-Ruiz C, 2010, NEUROLOGY, V75, P1653, DOI 10.1212/WNL.0b013e3181fb4466; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Rochet JC, 2012, PROG MOL BIOL TRANSL, V107, P125, DOI 10.1016/B978-0-12-385883-2.00011-4; Schmid AW, 2013, MOL CELL PROTEOMICS, V12, P3543, DOI 10.1074/mcp.R113.032730; Schmid AW, 2013, MOL CELLULAR PROTEOM; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Tabares-Seisdedos R, 2013, NAT REV NEUROSCI, V14, P293, DOI 10.1038/nrn3464; Takahashi T, 2002, BRAIN RES, V938, P73, DOI 10.1016/S0006-8993(02)02498-8; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Welinder C, 2014, J PROTEOME RES, V13, P1315, DOI 10.1021/pr400876p; Wirdefeldt K, 2013, AM J EPIDEMIOLOGY; Yajima I, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/730170	54	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110804	10.1371/journal.pone.0110804	http://dx.doi.org/10.1371/journal.pone.0110804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333933	Green Submitted, gold, Green Published			2022-12-27	WOS:000343731200076
J	Zeitoun, JD; Lefevre, JH; Downing, N; Bergeron, H; Ross, JS				Zeitoun, Jean-David; Lefevre, Jeremie H.; Downing, Nicholas; Bergeron, Henri; Ross, Joseph S.			Inconsistencies among European Union Pharmaceutical Regulator Safety Communications: A Cross-Country Comparison	PLOS ONE			English	Article								Background: The European Medicines Agency (EMA) and national regulators share the responsibility to communicate to healthcare providers postmarketing safety events but little is known about the consistency of this process. We aimed to compare public availability of safety-related communications and drug withdrawals from the EMA and European Union member countries for novel medicines. Methods and Findings: We performed a cross-sectional analysis using public Dear Healthcare Professional Communications (DHPCs) for all novel medicines authorized between 2001 and 2010 by the EMA and available for use in France, Netherlands, Spain, and the United Kingdom. Between 2001 and 2010, the EMA approved 185 novel medicines. DHPCs could not be ascertained for the EMA. Among the 4 national regulators, as of April 30, 2013, at least one safety DHPC or withdrawal occurred for 53 (28.6%) medicines, totaling 90 DHPCs and 5 withdrawals. Among these 53 medicines, all 4 national agencies issued at least one communication for 17 (32.1%), three of the four for 25 (47.2%), two of the four for 6 (11.3%), and one of the four for 5 (9.4%). Five drugs were reported to be withdrawn, three by all four countries, one by three and one by two. Among the 95 DHPCs and withdrawals, 20 (21.1%) were issued by all 4 national regulators, 37 (38.9%) by 3 of the 4, 22 (23.2%) by 2 of the 4, and 16 (16.8%) by one. Consistency of making publicly available all identified safety DHPC or withdrawal across regulator pairs varied from 33% to 73% agreement. Conclusions: Safety communications were not made publicly available by the EMA. Among the 4 European member countries with national regulators that make DHPCs publicly available since at least 2001, there were substantial inconsistencies in safety communications for novel medicines. The impact of those inconsistencies in terms of public health remains to be determined.	[Zeitoun, Jean-David; Bergeron, Henri] Sciences Po, Paris, France; [Zeitoun, Jean-David] St Antoine Hosp, AP HP, Dept Gastroenterol & Nutr, Paris, France; [Zeitoun, Jean-David] Deaconesses Hosp, Dept Proctol, Paris, France; [Lefevre, Jeremie H.] St Antoine Hosp, AP HP, Dept Digest & Gen Surg, Paris, France; [Lefevre, Jeremie H.] Univ Paris 06, F-75252 Paris 05, France; [Downing, Nicholas] Yale Univ, Sch Med, New Haven, CT USA; [Bergeron, Henri] Natl Ctr Sci Res CNRS, Paris, France; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06510 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Yale University; Centre National de la Recherche Scientifique (CNRS); Yale University; Yale University; Yale University	Zeitoun, JD (corresponding author), Sciences Po, Paris, France.	jdzeitoun@yahoo.fr	Lefevre, Jeremie/I-6952-2019	Lefevre, Jeremie/0000-0001-7601-7464; Ross, Joseph/0000-0002-9218-3320	Pew Charitable Trusts; Medtronic, Inc.; Centers of Medicare and Medicaid Services (CMS); Food and Drug Administration (FDA); National Institute on Aging [K08 AG032886]; American Federation for Aging Research; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	Pew Charitable Trusts; Medtronic, Inc.(Medtronic); Centers of Medicare and Medicaid Services (CMS); Food and Drug Administration (FDA)(United States Department of Health & Human Services); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was not supported by any external grants or funds. Mr. Downing and Dr. Ross receive support from The Pew Charitable Trusts to examine FDA regulatory issues. Dr. Ross receives support from Medtronic, Inc. to develop methods of clinical trial data sharing, from the Centers of Medicare and Medicaid Services (CMS) to develop and maintain performance measures that are used for public reporting, and from the Food and Drug Administration (FDA) to develop methods for post-market surveillance of medical devices and is also supported by the National Institute on Aging (K08 AG032886) and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carpenter D, 2010, PRINC STUD AM POLIT, P1; Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; Eichler HG, 2008, NAT REV DRUG DISCOV, V7, P818, DOI 10.1038/nrd2664; Giezen TJ, 2008, JAMA-J AM MED ASSOC, V300, P1887, DOI 10.1001/jama.300.16.1887; Groves T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2961; Mol PGM, 2010, DRUG SAFETY, V33, P463, DOI 10.2165/11532840-000000000-00000; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Psaty BM, 2013, JAMA-J AM MED ASSOC, V309, P2103, DOI 10.1001/jama.2013.4503; Psaty BM, 2012, JAMA-J AM MED ASSOC, V307, P2491, DOI 10.1001/jama.2012.5545; Viera AJ, 2005, FAM MED, V37, P360	10	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109100	10.1371/journal.pone.0109100	http://dx.doi.org/10.1371/journal.pone.0109100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333986	gold, Green Published			2022-12-27	WOS:000343731200010
J	Quinteros, D; Vicario-de-la-Torre, M; Andres-Guerrero, V; Palma, S; Allemandi, D; Herrero-Vanrell, R; Molina-Martinez, IT				Quinteros, Daniela; Vicario-de-la-Torre, Marta; Andres-Guerrero, Vanessa; Palma, Santiago; Allemandi, Daniel; Herrero-Vanrell, Rocio; Molina-Martinez, Irene T.			Hybrid Formulations of Liposomes and Bioadhesive Polymers Improve the Hypotensive Effect of the Melatonin Analogue 5-MCA-NAT in Rabbit Eyes	PLOS ONE			English	Article							OPHTHALMIC DRUG-DELIVERY; IN-VITRO EVALUATION; INTRAOCULAR-PRESSURE; BENZALKONIUM CHLORIDE; CHANG CONJUNCTIVAL; OCULAR EVALUATION; HUMAN TEARS; GLAUCOMA; PRESERVATIVES; SURFACE	For the treatment of chronic ocular diseases such as glaucoma, continuous instillations of eye drops are needed. However, frequent administrations of hypotensive topical formulations can produce adverse ocular surface effects due to the active substance or other components of the formulation, such as preservatives or other excipients. Thus the development of unpreserved formulations that are well tolerated after frequent instillations is an important challenge to improve ophthalmic chronic topical therapies. Furthermore, several components can improve the properties of the formulation in terms of efficacy. In order to achieve the mentioned objectives, we have developed formulations of liposomes (150-200 nm) containing components similar to those in the tear film and loaded with the hypotensive melatonin analog 5-methoxycarbonylamino-N-acetyltryptamine (5-MCA-NAT, 100 mu M). These formulations were combined with mucoadhesive (sodium hyaluronate or carboxymethylcellulose) or amphiphilic block thermosensitive (poloxamer) polymers to prolong the hypotensive efficacy of the drug. In rabbit eyes, the decrease of intraocular pressure with 5-MCA-NAT-loaded liposomes that were dispersed with 0.2% sodium hyaluronate, 39.1 +/- 2.2%, was remarkably higher compared to other liposomes formulated without or with other bioadhesive polymers, and the effect lasted more than 8 hours. According to the results obtained in the present work, these technological strategies could provide an improved modality for delivering therapeutic agents in patients with glaucoma.	[Quinteros, Daniela; Palma, Santiago; Allemandi, Daniel] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Pharm, RA-5000 Cordoba, Argentina; [Quinteros, Daniela; Palma, Santiago; Allemandi, Daniel] Consejo Nacl Invest Cient & Tecn, Ciudad Univ, Cordoba, Argentina; [Vicario-de-la-Torre, Marta; Andres-Guerrero, Vanessa; Herrero-Vanrell, Rocio; Molina-Martinez, Irene T.] Univ Complutense Madrid, Fac Pharm, Dept Pharm & Pharmaceut Technol, Madrid, Spain; [Vicario-de-la-Torre, Marta; Andres-Guerrero, Vanessa; Herrero-Vanrell, Rocio; Molina-Martinez, Irene T.] Inst Hlth Carlos III, Ocular Pathol Natl Net OFTARED, San Carlos Clin Hosp IdISSC, Pharmaceut Innovat Ophthalmol Res Grp,Sanit Res I, Madrid, Spain	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Complutense University of Madrid	Molina-Martinez, IT (corresponding author), Univ Complutense Madrid, Fac Pharm, Dept Pharm & Pharmaceut Technol, Madrid, Spain.	iremm@farm.ucm.es	Martínez, Irene Teresa Molina/G-4970-2017; Andrés-Guerrero, Vanessa/K-8077-2015; Herrero-Vanrell, Rocio/G-6849-2017	Martínez, Irene Teresa Molina/0000-0002-9157-571X; Andrés-Guerrero, Vanessa/0000-0003-0157-1932; Herrero-Vanrell, Rocio/0000-0001-9764-7975; Vicario-de-la-Torre, Marta/0000-0002-0048-1794; Quinteros, Daniela/0000-0001-7459-7442	Research Group UCM [920415]; FIS [PI10/00645, PI10/00993]; Spanish Ministry of Science and Innovation [MAT 2010-18242]; RETICS RD [12/0034/0003]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); FONCyT PICT [2010-0380, 2437/OC-AR]; SECyT-UNC	Research Group UCM; FIS(Instituto de Salud Carlos III); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); RETICS RD; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT PICT(ANPCyTFONCyT); SECyT-UNC(Secretaria de Ciencia y Tecnologia (SECYT))	Research Group UCM 920415, FIS PI10/00645 and FIS PI10/00993, Spanish Ministry of Science and Innovation (MAT 2010-18242), RETICS RD 12/0034/0003. Financial support from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), FONCyT PICT 2010-0380 (Prestamo BID No 2437/OC-AR) and SECyT-UNC is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrés-Guerrero V., 2008, Arch Soc Esp Oftalmol, V83, P683; Andres-Guerrero V, 2011, INVEST OPHTH VIS SCI, V52, P3548, DOI 10.1167/iovs.10-6338; Andres-Guerrero V, 2011, INVEST OPHTH VIS SCI, V52, P1507, DOI 10.1167/iovs.10-6099; Andres-Guerrero V, 2009, EXP EYE RES, V88, P504, DOI 10.1016/j.exer.2008.11.004; Ayaki M, 2008, CLIN EXP OPHTHALMOL, V36, P553, DOI 10.1111/j.1442-9071.2008.01803.x; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Bartlett JD, 2012, OPHTHALMIC DRUG FACT; Baudouin C, 2008, ACTA OPHTHALMOL, V86, P716, DOI 10.1111/j.1755-3768.2008.01250.x; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Bhatia A, 2004, J PHARM PHARM SCI, V7, P252; Brasnu E, 2008, MOL VIS, V14, P394; Burstein N, 1997, CLIN OCULAR PHARM, P21; Burstein N, 1997, CLIN OCULAR PHARM; Camras CB, 1999, DRUG AGING, V15, P377, DOI 10.2165/00002512-199915050-00005; Cao F, 2010, DRUG DELIV, V17, P500, DOI 10.3109/10717544.2010.483255; CHRAI SS, 1974, J PHARM SCI, V63, P1218, DOI 10.1002/jps.2600630810; de Salamanca AE, 2006, INVEST OPHTH VIS SCI, V47, P1416, DOI 10.1167/iovs.05-0495; Debbasch C, 2001, INVEST OPHTH VIS SCI, V42, P642; Dumortier G, 2006, PHARM RES-DORDR, V23, P2709, DOI 10.1007/s11095-006-9104-4; Flanagan JG, 1998, OPHTHAL PHYSL OPT, V18, P126, DOI 10.1016/S0275-5408(97)00108-7; Ishibashi T, 2003, J GLAUCOMA, V12, P486, DOI 10.1097/00061198-200312000-00008; Kaur IP, 2002, DRUG DEV IND PHARM, V28, P353, DOI 10.1081/DDC-120002997; Krause WE, 2001, BIOMACROMOLECULES, V2, P65, DOI 10.1021/bm0055798; Law SL, 2000, J CONTROL RELEASE, V63, P135, DOI 10.1016/S0168-3659(99)00192-3; Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5; Leung EW, 2008, J GLAUCOMA, V17, P350, DOI 10.1097/IJG.0b013e31815c5f4f; Lin HH, 1996, J PHARM PHARMACOL, V48, P801, DOI 10.1111/j.2042-7158.1996.tb03977.x; Ludwig A, 2005, ADV DRUG DELIVER REV, V57, P1595, DOI 10.1016/j.addr.2005.07.005; Lundmark PO, 2007, EXP EYE RES, V84, P1021, DOI 10.1016/j.exer.2006.10.018; Martinez-Aguila A, 2013, EUR J PHARMACOL, V701, P213, DOI 10.1016/j.ejphar.2012.12.009; Moon JW, 2006, INVEST OPHTH VIS SCI, V47, P3968, DOI 10.1167/iovs.05-1345; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264; Nii T, 2005, INT J PHARMACEUT, V298, P198, DOI 10.1016/j.ijpharm.2005.04.029; PATTON TF, 1975, J PHARM SCI, V64, P1312, DOI 10.1002/jps.2600640811; Purslow Christine, 2005, Eye Contact Lens, V31, P117, DOI 10.1097/01.ICL.0000141921.80061.17; Schuman JS, 2000, CLIN THER, V22, P167, DOI 10.1016/S0149-2918(00)88478-7; Serle JB, 2004, J GLAUCOMA, V13, P385, DOI 10.1097/01.ijg.0000133150.44686.0b; SIMMONS ST, 1988, BRIT J OPHTHALMOL, V72, P688, DOI 10.1136/bjo.72.9.688; STEIN PJ, 1994, INVEST OPHTH VIS SCI, V35, P2765; TIFFANY JM, 1994, ADV EXP MED BIOL, V350, P267; TIFFANY JM, 1991, INT OPHTHALMOL, V15, P371, DOI 10.1007/BF00137947; Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027; Vemuri S, 1995, Pharm Acta Helv, V70, P95, DOI 10.1016/0031-6865(95)00010-7; Vicario-de-la-Torre M., 2007, Arch Soc Esp Oftalmol, V82, P395; Vicario-de-la-Torre M, 2010, INVEST OPHTHALMOL VI, V51; Whitson JT, 2006, OPHTHALMOLOGY, V113, P1333, DOI 10.1016/j.ophtha.2006.03.025; Wiechmann AF, 2001, VISUAL NEUROSCI, V18, P695, DOI 10.1017/S0952523801185032; Zhao M, 2008, INVEST OPHTH VIS SCI, V49, P550, DOI 10.1167/iovs.07-1037	48	27	27	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110344	10.1371/journal.pone.0110344	http://dx.doi.org/10.1371/journal.pone.0110344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329636	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100056
J	Zhang, SD; Liu, XM; Zhu, B; Yin, XM; Du, MF; Song, QS; An, SH				Zhang, Songdou; Liu, Xiaoming; Zhu, Bin; Yin, Xinming; Du, Mengfang; Song, Qisheng; An, Shiheng			Identification of Differentially Expressed Genes in the Pheromone Glands of Mated and Virgin Bombyx mori by Digital Gene Expression Profiling	PLOS ONE			English	Article							JUVENILE-HORMONE BIOSYNTHESIS; SEX-PHEROMONE; DROSOPHILA-MELANOGASTER; REPRODUCTIVE-BEHAVIOR; HELICOVERPA-ARMIGERA; PEPTIDE; FEMALES; MOTH; TRANSCRIPTOME; TERMINATION	Background: Mating decreases female receptivity and terminates sex pheromone production in moths. Although significant progress has been made in elucidating the mating-regulated inactivation of pheromone biosynthesis-activating neuropeptide (PBAN) secretion, little is known about the mating induced gene expression profiles in pheromone glands (PGs). In this study, the associated genes involved in Bombyx mori mating were identified through digital gene expression (DGE) profiling and subsequent RNA interference (RNAi) to elucidate the molecular mechanisms underlying the mating-regulated gene expression in PGs. Results: Eight DGE libraries were constructed from the PGs of mated and virgin females: 1 h mating (M1)/virgin (V1) PGs, 3 h mating (M3)/virgin (V3) PGs, 24 h mating (M24)/virgin (V24) PGs and 48 h mating (M48)/virgin (V48) PGs (M48 and V48). These libraries were used to investigate the gene expression profiles affected by mating. DGE profiling revealed a series of genes showing differential expression in each set of mated and virgin female samples, including immune-associated genes, sex pheromone synthesis-associated genes, juvenile hormone (JH) signal-associated genes, etc. Most interestingly, JH signal was found to be activated by mating. Application of the JH mimics, methoprene to the newly-emerged virgin females leaded to the significant reduction of sex pheromone production. RNAi-mediated knockdown of putative JH receptor gene, Methoprene tolerant 1 (Met1), in female pupa resulted in a significant decrease in sex pheromone production in mature females, suggesting the importance of JH in sex pheromone synthesis. Conclusion: A series of differentially expressed genes in PGs in response to mating was identified. This study improves our understanding of the role of JH signaling on the mating-elicited termination of sex pheromone production.	[Zhang, Songdou; Liu, Xiaoming; Zhu, Bin; Yin, Xinming; Du, Mengfang; An, Shiheng] Henan Agr Univ, State Key Lab Wheat & Maize Crop Sci, Coll Plant Protect, Zhengzhou, Henan, Peoples R China; [Song, Qisheng] Univ Missouri, Div Plant Sci, Columbia, MO USA	Henan Agricultural University; University of Missouri System; University of Missouri Columbia	Du, MF (corresponding author), Henan Agr Univ, State Key Lab Wheat & Maize Crop Sci, Coll Plant Protect, Zhengzhou, Henan, Peoples R China.	dumengfang@sohu.com; anshiheng@aliyun.com		Liu, Xiaoming/0000-0003-4466-8961	National Natural Science Foundation of China [31301916, 31472041, 31172156]; Science and Technology talents of Zhengzhou [131PLJRC686]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology talents of Zhengzhou	This study was supported by the National Natural Science Foundation of China (Project 31301916, 31472041, and 31172156) and Science and Technology talents of Zhengzhou (131PLJRC686). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGAKI T, 1991, NEURON, V7, P557, DOI 10.1016/0896-6273(91)90368-A; An SH, 2012, INSECT SCI, V19, P621, DOI 10.1111/j.1744-7917.2011.01469.x; Ando T, 1996, ARCH INSECT BIOCHEM, V31, P207, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;207::AID-ARCH8&gt;3.0.CO;2-W; Apger-McGlaughon J, 2013, J INSECT PHYSIOL, V59, P1024, DOI 10.1016/j.jinsphys.2013.07.001; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Bilen J, 2013, P NATL ACAD SCI USA, V110, P18321, DOI 10.1073/pnas.1318119110; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; Delisle J, 2000, J INSECT PHYSIOL, V46, P913, DOI 10.1016/S0022-1910(99)00198-5; Domanitskaya EV, 2007, FEBS J, V274, P5659, DOI 10.1111/j.1742-4658.2007.06088.x; Du MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031045; Du MF, 2012, J INSECT PHYSIOL, V58, P699, DOI 10.1016/j.jinsphys.2012.02.002; Fedorka KM, 2004, EVOLUTION, V58, P2478; FOSTER SP, 1993, J INSECT PHYSIOL, V39, P267, DOI 10.1016/0022-1910(93)90098-C; GIEBULTOWICZ JM, 1991, ARCH INSECT BIOCHEM, V16, P95, DOI 10.1002/arch.940160203; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Gioti A, 2012, P ROY SOC B-BIOL SCI, V279, P4423, DOI 10.1098/rspb.2012.1634; Karube F, 1999, ARCH INSECT BIOCHEM, V42, P111, DOI 10.1002/(SICI)1520-6327(199910)42:2&lt;111::AID-ARCH1&gt;3.0.CO;2-N; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; KINGAN TG, 1995, P NATL ACAD SCI USA, V92, P5082, DOI 10.1073/pnas.92.11.5082; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; LEOPOLD RA, 1976, ANNU REV ENTOMOL, V21, P199, DOI 10.1146/annurev.en.21.010176.001215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANNING A, 1966, NATURE, V211, P1321, DOI 10.1038/2111321b0; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Moshitzky P, 1996, ARCH INSECT BIOCHEM, V32, P363, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;363::AID-ARCH9&gt;3.0.CO;2-T; Ohnishi A, 2011, J BIOL CHEM, V286, P24101, DOI 10.1074/jbc.M111.250555; Ohnishi A, 2009, J BIOL CHEM, V284, P5128, DOI 10.1074/jbc.M806072200; Peng J, 2005, CURR BIOL, V15, P1690, DOI 10.1016/j.cub.2005.08.048; Rafaeli A, 2005, J INSECT PHYSIOL, V51, P401, DOI 10.1016/j.jinsphys.2005.01.004; Rafaeli A, 2003, INSECT BIOCHEM MOLEC, V33, P371, DOI 10.1016/S0965-1748(02)00264-3; RAFAELI A, 1995, INSECT BIOCHEM MOLEC, V25, P827, DOI 10.1016/0965-1748(95)00019-R; Rafaeli A, 2009, GEN COMP ENDOCR, V162, P69, DOI 10.1016/j.ygcen.2008.04.004; RAINA AK, 1989, J INSECT PHYSIOL, V35, P821, DOI 10.1016/0022-1910(89)90097-8; Rolff J, 2002, P NATL ACAD SCI USA, V99, P9916, DOI 10.1073/pnas.152271999; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Short SM, 2012, J INSECT PHYSIOL, V58, P1192, DOI 10.1016/j.jinsphys.2012.06.002; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Yamamoto R, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-85; Zhang SD, 2014, INSECT SCI, V21, P459, DOI 10.1111/1744-7917.12053	43	6	7	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e111003	10.1371/journal.pone.0111003	http://dx.doi.org/10.1371/journal.pone.0111003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330197	gold, Green Submitted, Green Published			2022-12-27	WOS:000343942100108
J	Huber, RJ; Myre, MA; Cotman, SL				Huber, Robert J.; Myre, Michael A.; Cotman, Susan L.			Loss of Cln3 Function in the Social Amoeba Dictyostelium discoideum Causes Pleiotropic Effects That Are Rescued by Human CLN3	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSES; BATTEN-DISEASE GENE; CONTRACTILE VACUOLE; MATRICELLULAR PROTEIN; CELL-DIFFERENTIATION; BINDING PROTEINS; COUNTING FACTOR; MEMBRANE; CALCIUM; SYSTEM	The neuronal ceroid lipofuscinoses (NCL) are a group of inherited, severe neurodegenerative disorders also known as Batten disease. Juvenile NCL (JNCL) is caused by recessive loss-of-function mutations in CLN3, which encodes a transmembrane protein that regulates endocytic pathway trafficking, though its primary function is not yet known. The social amoeba Dictyostelium discoideum is increasingly utilized for neurological disease research and is particularly suited for investigation of protein function in trafficking. Therefore, here we establish new overexpression and knockout Dictyostelium cell lines for JNCL research. Dictyostelium Cln3 fused to GFP localized to the contractile vacuole system and to compartments of the endocytic pathway. cln3(-) cells displayed increased rates of proliferation and an associated reduction in the extracellular levels and cleavage of the autocrine proliferation repressor, AprA. Mid-and late development of cln3(-) cells was precocious and cln3(-) slugs displayed increased migration. Expression of either Dictyostelium Cln3 or human CLN3 in cln3(-) cells suppressed the precocious development and aberrant slug migration, which were also suppressed by calcium chelation. Taken together, our results show that Cln3 is a pleiotropic protein that negatively regulates proliferation and development in Dictyostelium. This new model system, which allows for the study of Cln3 function in both single cells and a multicellular organism, together with the observation that expression of human CLN3 restores abnormalities in Dictyostelium cln3(-) cells, strongly supports the use of this new model for JNCL research.	[Huber, Robert J.; Myre, Michael A.; Cotman, Susan L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02163 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Huber, RJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02163 USA.	rhuber@mgh.harvard.edu			Canadian Institutes of Health Research [289813]; National Institutes of Health: National Institute of Neurological Disorders Stroke [R01NS073813]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073813] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health: National Institute of Neurological Disorders Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Postdoctoral Fellowship from the Canadian Institutes of Health Research (289813 to R.J.H.) and the National Institutes of Health: National Institute of Neurological Disorders & Stroke (R01NS073813 to S.L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GW, 2013, BBA-MOL BASIS DIS, V1832, P1807, DOI 10.1016/j.bbadis.2012.11.014; Bakthavatsalam D, 2008, J CELL SCI, V121, P2473, DOI 10.1242/jcs.026682; Bakthavatsalam D, 2010, PROTEOMICS, V10, P2556, DOI 10.1002/pmic.200900516; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Bear JE, 1998, J CELL BIOL, V142, P1325, DOI 10.1083/jcb.142.5.1325; Benghezal M, 2001, IMMUNOGENETICS, V52, P284; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; Brock DA, 1999, GENE DEV, V13, P1960, DOI 10.1101/gad.13.15.1960; Brock DA, 2002, DEVELOPMENT, V129, P3657; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017118; Castaneda JA, 2008, NEUROBIOL DIS, V29, P92, DOI 10.1016/j.nbd.2007.08.007; Chang JW, 2007, HUM MOL GENET, V16, P317, DOI 10.1093/hmg/ddl466; Charette SJ, 2006, FEBS LETT, V580, P4923, DOI 10.1016/j.febslet.2006.08.009; Chattopadhyay S, 2002, HUM MOL GENET, V11, P1421, DOI 10.1093/hmg/11.12.1421; Codlin S, 2008, TRAFFIC, V9, P936, DOI 10.1111/j.1600-0854.2008.00735.x; Cotman SL, 2012, CLIN LIPIDOL, V7, P79, DOI 10.2217/CLP.11.70; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; FOK AK, 1993, J CELL SCI, V106, P1103; Fossale E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-57; Fukuzawa M, 2002, FEBS LETT, V527, P37, DOI 10.1016/S0014-5793(02)03150-2; Gabriel D, 1999, J CELL SCI, V112, P3995; Gachet Y, 2005, J CELL SCI, V118, P5525, DOI 10.1242/jcs.02656; Gerisch G, 2002, CELL BIOL INT, V26, P845, DOI 10.1006/cbir.2002.0938; Getty AL, 2011, CELL MOL LIFE SCI, V68, P453, DOI 10.1007/s00018-010-0468-6; Gilsbach BK, 2012, P NATL ACAD SCI USA, V109, P10322, DOI 10.1073/pnas.1203223109; Greene DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010543; Haack KA, 2011, BBA-GEN SUBJECTS, V1810, P186, DOI 10.1016/j.bbagen.2010.09.004; Hacker U, 1997, J CELL SCI, V110, P105; Hadwiger JA, 1996, DEVELOPMENT, V122, P1215; Haltia M, 2013, BBA-MOL BASIS DIS, V1832, P1795, DOI 10.1016/j.bbadis.2012.08.012; Haskell RE, 2000, HUM MOL GENET, V9, P735, DOI 10.1093/hmg/9.5.735; Haskell RE, 1999, MOL GENET METAB, V66, P253, DOI 10.1006/mgme.1999.2802; Hofman I L, 2001, Eur J Paediatr Neurol, V5 Suppl A, P213; Holopainen JM, 2001, EUR J BIOCHEM, V268, P5851, DOI 10.1046/j.0014-2956.2001.02530.x; Huber RJ, 2014, CELL MOL LIFE SCI, V71, P629, DOI 10.1007/s00018-013-1449-3; Huber RJ, 2012, CELL MOL LIFE SCI, V69, P3989, DOI 10.1007/s00018-012-1068-4; Huber RJ, 2012, MATRIX BIOL, V31, P271, DOI 10.1016/j.matbio.2012.02.003; Huber RJ, 2012, J CELL BIOCHEM, V113, P868, DOI 10.1002/jcb.23417; Huber RJ, 2011, HISTOCHEM CELL BIOL, V136, P177, DOI 10.1007/s00418-011-0839-6; Journet A, 2012, PROTEOMICS, V12, P241, DOI 10.1002/pmic.201100313; Kawata T, 2011, DEV GROWTH DIFFER, V53, P897, DOI 10.1111/j.1440-169X.2011.01296.x; Kollmann K, 2013, BBA-MOL BASIS DIS, V1832, P1866, DOI 10.1016/j.bbadis.2013.01.019; Lee CH, 2005, BBA-MOL CELL RES, V1743, P281, DOI 10.1016/j.bbamcr.2005.01.003; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Lo Sardo V, 2012, NAT NEUROSCI, V15, P713, DOI 10.1038/nn.3080; Luiro K, 2004, HUM MOL GENET, V13, P3017, DOI 10.1093/hmg/ddh321; Luiro K, 2001, HUM MOL GENET, V10, P2123, DOI 10.1093/hmg/10.19.2123; Malchow D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-31; Maniak M, 2003, TRAFFIC, V4, P1, DOI 10.1034/j.1600-0854.2003.40101.x; Maniak M, 2011, SEMIN CELL DEV BIOL, V22, P114, DOI 10.1016/j.semcdb.2010.11.001; Vidal-Donet JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055526; McMains VC, 2010, DIS MODEL MECH, V3, P581, DOI 10.1242/dmm.004457; Mercanti V, 2006, J CELL SCI, V119, P4079, DOI 10.1242/jcs.03190; Meyer I, 2011, SEMIN CELL DEV BIOL, V22, P89, DOI 10.1016/j.semcdb.2010.10.007; Mole S, 2012, NCL RESOURCE GATEWAY; Muller-Taubenberger A, 2013, EUR J CELL BIOL, V92, P45, DOI 10.1016/j.ejcb.2012.10.003; Munroe PB, 1997, AM J HUM GENET, V61, P310, DOI 10.1086/514846; Myre MA, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-41; Myre MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002052; Nelson MK, 2000, DEV BIOL, V224, P42, DOI 10.1006/dbio.2000.9793; Ostergaard JR, 2011, NEUROLOGY, V76, P1245, DOI 10.1212/WNL.0b013e31821435bd; Pearce DA, 1999, MOL GENET METAB, V66, P320, DOI 10.1006/mgme.1999.2819; Poloz Y, 2012, DIFFERENTIATION, V84, P163, DOI 10.1016/j.diff.2012.02.009; Poloz Y, 2012, DIFFERENTIATION, V83, P185, DOI 10.1016/j.diff.2011.12.006; Prabhu Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-44; Ravanel K, 2001, EUR J CELL BIOL, V80, P754, DOI 10.1078/0171-9335-00215; Rivero Francisco, 2006, V346, P423; RODRIGUEZPARIS JM, 1993, J BIOL CHEM, V268, P9110; Rot G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-265; Sakamoto H, 2003, DEV GROWTH DIFFER, V45, P507; SANTAVUORI P, 1988, BRAIN DEV-JPN, V10, P80, DOI 10.1016/S0387-7604(88)80075-5; Scherer A, 2010, J CELL SCI, V123, P3756, DOI 10.1242/jcs.068619; Schulz A, 2013, BBA-MOL BASIS DIS, V1832, P1801, DOI 10.1016/j.bbadis.2013.04.008; Singleton CK, 1998, DEV BIOL, V203, P345, DOI 10.1006/dbio.1998.9049; Sriskanthadevan S, 2013, FEBS J, V280, P1795, DOI 10.1111/febs.12203; Sriskanthadevan S, 2009, J BIOL CHEM, V284, P36377, DOI 10.1074/jbc.M109.057257; Suarez A, 2011, CELL SIGNAL, V23, P1197, DOI 10.1016/j.cellsig.2011.03.008; Tecedor L, 2013, J NEUROSCI, V33, P18065, DOI 10.1523/JNEUROSCI.0498-13.2013; TEMESVARI L, 1994, J BIOL CHEM, V269, P25719; Torija P, 2006, J CELL SCI, V119, P1154, DOI 10.1242/jcs.02819; Uusi-Rauva K, 2012, CELL MOL LIFE SCI, V69, P2075, DOI 10.1007/s00018-011-0913-1; van Egmond Wouter N, 2008, J Biol Chem, V283, P30412, DOI 10.1074/jbc.M804265200; Warnock A, 2013, BIOCHEM BIOPH RES CO, V436, P645, DOI 10.1016/j.bbrc.2013.04.113; Warrier V, 2013, BBA-MOL BASIS DIS, V1832, P1827, DOI 10.1016/j.bbadis.2013.03.017; ZHU QL, 1992, J CELL BIOL, V118, P347, DOI 10.1083/jcb.118.2.347	87	40	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110544	10.1371/journal.pone.0110544	http://dx.doi.org/10.1371/journal.pone.0110544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330233	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100091
J	Ma, YY; Ying, XH; Zou, HD; Xu, XC; Liu, HY; Bai, L; Xu, X; Zhang, X				Ma, Yingyan; Ying, Xiaohua; Zou, Haidong; Xu, Xiaocheng; Liu, Haiyun; Bai, Lin; Xu, Xun; Zhang, Xi			Rhegmatogenous Retinal Detachment Surgery in Elderly People over 70 Years Old: Visual Acuity, Quality of Life, and Cost-Utility Values	PLOS ONE			English	Article							PRIMARY VITRECTOMY; RECOVERY; MACULA; ALONGSIDE; OUTCOMES; RATIOS	Background and Purpose: To evaluate the influence of rhegmatogenous retinal detachment (RRD) surgery on elderly patients in terms of visual acuity, vision-related quality of life and its cost-effectiveness. Methods: Elderly patients over 70 years old, who were diagnosed and underwent RRD surgery at Shanghai First People's Hospital, Shanghai Jiao Tong University, China, from January 1, 2009, through January 1, 2013. The participants received scleral buckling surgery and vitreous surgery with or without scleral buckling under retrobulbar anesthesia. We followed the patients for 1 year and collected best-corrected visual acuity (BCVA), vision-related quality of life, and direct medical costs data. Utility values elicited by time-trade-off were analyzed to determine the quality of life. Quality-adjusted life years (QALYs) gained in life expectancy were calculated and discounted at 3% annually. Costs per QALY gained were reported using the bootstrap method. Further analyses were made for two age groups, age 70-79 and age over 80 years. Sensitivity analyses were performed to test stability of the results. Results: 98 patients were included in the study. The BCVA significantly improved by 0.53 +/- 0.44 (Logarithm of the Minimum Angle of Resolution (logMAR)) at the 1-year postoperative time point (p<0.001). Utility values increased from 0.77 to 0.84 (p<0.001), and an average of 0.4 QALYs were gained in the life expectancy. Costs per QALY gained from the RRD surgery were 33,186 Chinese Yuan (CNY) (5,276 US dollars (USD))/QALY; 24,535 CNY (3,901 USD)/QALY for the age group of 70-79 years and 71,240 CNY (11,326 USD)/QALY for the age group over 80 years. Conclusions: RRD surgery improved the visual acuity and quality of life in the elderly patients over 70 years old. According to the World Health Organization's recommendation, at a threshold of willingness to pay of 115,062 CNY (18,293 USD)/QALY, RRD surgery is cost effective in the elderly patients.	[Ma, Yingyan; Zou, Haidong; Liu, Haiyun; Bai, Lin; Xu, Xun; Zhang, Xi] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Ying, Xiaohua; Xu, Xiaocheng] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Zou, Haidong] Shanghai Eye Dis Prevent & Treatment Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Fudan University	Zou, HD (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China.	zouhaidong@hotmail.com		Zou, Haidong/0000-0002-6831-7560	Shanghai Health Bureau [20114007]; Shanghai Leading Talent Reserve Programme [40311]; National Population and Family Planning Commission [SJYF2014XD010B]	Shanghai Health Bureau; Shanghai Leading Talent Reserve Programme; National Population and Family Planning Commission	This study was funded by a key grant from the Shanghai Health Bureau (20114007), a grant from the Shanghai Leading Talent Reserve Programme (40311), and a grand from National Population and Family Planning Commission: Researches on modern hospital management system-costs calculation in hospital (SJYF2014XD010B). ZHD received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadieh H, 2005, OPHTHALMOLOGY, V112, P1421, DOI 10.1016/j.ophtha.2005.02.018; Ahmadieh H, 2000, EUR J OPHTHALMOL, V10, P153, DOI 10.1177/112067210001000211; [Anonymous], 2017, STATE STAT COMMITTEE; Azad RV, 2007, ACTA OPHTHALMOL SCAN, V85, P540, DOI 10.1111/j.1600-0420.2007.00888.x; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; Briggs AH, 1999, HLTH TECHNOLOGY ASSE, V3, P1, DOI DOI 10.3310/hta3020; Brown GC, 2002, AM J OPHTHALMOL, V133, P365, DOI 10.1016/S0002-9394(01)01423-4; Brown MM, 2003, OPHTHALMOLOGY, V110, P1076, DOI 10.1016/S0161-6420(03)00254-9; Chang JS, 2014, OPHTHALMOLOGY, V121, P946, DOI 10.1016/j.ophtha.2013.11.003; Commission on Macroeconomics HealthWorld Health Organization, 2001, MACR HLTH INV HLTH E; Drummond M, 2005, METHODS ECONOMICEVAL, P7; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Heimann H, 2006, GRAEF ARCH CLIN EXP, V244, P69, DOI 10.1007/s00417-005-0026-3; Heimann H, 2007, OPHTHALMOLOGY, V114, P2142, DOI 10.1016/j.ophtha.2007.09.013; Heussen N, 2011, GRAEF ARCH CLIN EXP, V249, P1129, DOI 10.1007/s00417-011-1619-7; Huang Xiao-bo, 2009, Zhonghua Yan Ke Za Zhi, V45, P786; Li XX, 2003, OPHTHALMOLOGY, V110, P2413, DOI 10.1016/S0161-6420(03)00867-4; Liu F, 2006, OPHTHALMOLOGICA, V220, P174, DOI 10.1159/000091761; Ma YY, 2015, OPHTHAL EPIDEMIOL, V22, P13, DOI 10.3109/09286586.2014.884601; Mitry D, 2010, BRIT J OPHTHALMOL, V94, P678, DOI 10.1136/bjo.2009.157727; Mitry D, 2010, INVEST OPHTH VIS SCI, V51, P4963, DOI 10.1167/iovs.10-5400; Mowatt L, 2005, EUR J OPHTHALMOL, V15, P109, DOI 10.1177/112067210501500117; Muennig P, 2008, COST EFFECTIVENESS A, P1; Okamoto F, 2008, AM J OPHTHALMOL, V146, P85, DOI 10.1016/j.ajo.2008.02.011; PARK SJ, 2013, ASIAN WOMEN, V29; Pastor JC, 2008, BRIT J OPHTHALMOL, V92, P378, DOI 10.1136/bjo.2007.129437; Polsky D, 1997, HEALTH ECON, V6, P243, DOI 10.1002/(SICI)1099-1050(199705)6:3<243::AID-HEC269>3.0.CO;2-Z; Ross W H, 2000, Curr Opin Ophthalmol, V11, P191, DOI 10.1097/00055735-200006000-00007; Ross WH, 2002, EYE, V16, P440, DOI 10.1038/sj.eye.6700192; Sach TH, 2010, EYE, V24, P276, DOI 10.1038/eye.2009.112; Salicone A, 2006, OPHTHALMOLOGY, V113, P1734, DOI 10.1016/j.ophtha.2006.03.064; Schneider EW, 2012, RETINA-J RET VIT DIS, V32, P213, DOI 10.1097/IAE.0b013e3182278b29; Seider MI, 2013, AM J OPHTHALMOL, V156, P661, DOI 10.1016/j.ajo.2013.05.019; Shanghai Health Insurance, INF URB BAS HLTH INS; Sharma S, 2002, BRIT J OPHTHALMOL, V86, P493, DOI 10.1136/bjo.86.5.493; Sharma S, 2001, CURR OPIN OPHTHALMOL, V12, P230, DOI 10.1097/00055735-200106000-00016; Sodhi A, 2008, SURV OPHTHALMOL, V53, P50, DOI 10.1016/j.survophthal.2007.10.007; Van de Put MAJ, 2013, OPHTHALMOLOGY, V120, P616, DOI 10.1016/j.ophtha.2012.09.001; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505; World Health Rankings, HLTH PROF CHIN; Yang L, 2012, VALUE HLTH S, V15, P56; Yorston D, 2002, EYE, V16, P353, DOI 10.1038/sj.eye.6700188; Yuan Y, 2008, VALUE HEALTH, V11, pS11, DOI 10.1111/j.1524-4733.2008.00362.x; Zou H, 2011, PLOS ONE; Zou HD, 2008, OPHTHAL EPIDEMIOL, V15, P212, DOI 10.1080/09286580701843804; Zou HD, 2011, OPHTHALMOLOGY, V118, P601, DOI 10.1016/j.ophtha.2010.10.046	46	7	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110256	10.1371/journal.pone.0110256	http://dx.doi.org/10.1371/journal.pone.0110256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TF	25330168	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100052
J	Zhao, RZ; Liang, XR; Zhao, MM; Liu, SL; Huang, Y; Idell, S; Li, XM; Ji, HL				Zhao, Runzhen; Liang, Xinrong; Zhao, Meimi; Liu, Shan-Lu; Huang, Yao; Idell, Steven; Li, Xiumin; Ji, Hong-Long			Correlation of Apical Fluid-Regulating Channel Proteins with Lung Function in Human COPD Lungs	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL SODIUM-CHANNELS; SURFACE LIQUID VOLUME; CHRONIC-BRONCHITIS; CIGARETTE-SMOKE; MUCUS SECRETION; I CELLS; ENAC; AIRWAY; CFTR	Links between epithelial ion channels and chronic obstructive pulmonary diseases (COPD) are emerging through animal model and in vitro studies. However, clinical correlations between fluid-regulating channel proteins and lung function in COPD remain to be elucidated. To quantitatively measure epithelial sodium channels (ENaC), cystic fibrosis transmembrane conductance regulator (CFTR), and aquaporin 5 (AQP5) proteins in human COPD lungs and to analyze the correlation with declining lung function, quantitative western blots were used. Spearman tests were performed to identify correlations between channel proteins and lung function. The expression of alpha and beta ENaC subunits was augmented and inversely associated with lung function. In contrast, both total and alveolar type I (ATI) and II (ATII)-specific CFTR proteins were reduced. The expression level of CFTR proteins was associated with FEV1 positively. Abundance of AQP5 proteins and extracellular superoxide dismutase (SOD3) was decreased and correlated with spirometry test results and gas exchange positively. Furthermore, these channel proteins were significantly associated with severity of disease. Our study demonstrates that expression of ENaC, AQP5, and CFTR proteins in human COPD lungs is quantitatively associated with lung function and severity of COPD. These apically located fluid-regulating channels may thereby serve as biomarkers and potent druggable targets of COPD.	[Zhao, Runzhen; Liang, Xinrong; Zhao, Meimi; Idell, Steven; Ji, Hong-Long] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Idell, Steven] Univ Texas Hlth Sci Ctr Tyler, Tyler, TX USA; [Zhao, Runzhen; Idell, Steven; Ji, Hong-Long] Univ Texas Hlth Sci Ctr Tyler, Texas Lung Injury Inst, Tyler, TX USA; [Liu, Shan-Lu] Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Huang, Yao] St Josephs Hosp, Dept Obstet & Gynecol, Phoenix, AZ USA; [Huang, Yao] Med Ctr, Phoenix, AZ USA; [Li, Xiumin] Xinxiang Med Univ, Xinxiang, Herts, Peoples R China	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Missouri System; University of Missouri Columbia; St. Joseph's Hospital and Medical Center; Xinxiang Medical University	Ji, HL (corresponding author), Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA.	james.hl.ji@gmail.com	Liu, Shan-Lu/L-5923-2016; li, xiu/GXV-1745-2022; JI, HONGLONG/N-7822-2014	Liu, Shan-Lu/0000-0003-1620-3817; JI, HONGLONG/0000-0002-3228-7144	National Institutes of Health [HL87017, HL095435]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087017, R03HL095435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants HL87017 and HL095435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAI S, 1992, AM REV RESPIR DIS, V146, P781, DOI 10.1164/ajrccm/146.3.781; Baker SE, 2011, RESP PHYSIOL NEUROBI, V179, P212, DOI 10.1016/j.resp.2011.08.007; Berdiev BK, 2009, MOL BIOSYST, V5, P123, DOI 10.1039/b810471a; Bodas M, 2011, AM J PHYSIOL-LUNG C, V300, pL811, DOI 10.1152/ajplung.00408.2010; Bodas M, 2011, J IMMUNOL, V186, P602, DOI 10.4049/jimmunol.1002850; Bonora M, 2011, RESP PHYSIOL NEUROBI, V178, P346, DOI 10.1016/j.resp.2011.06.006; Borrill ZL, 2008, EUR RESPIR J, V32, P472, DOI 10.1183/09031936.00116107; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8; BUBIEN JK, 1993, AM J PHYSIOL, V265, pC1175, DOI 10.1152/ajpcell.1993.265.4.C1175; Bubien JK, 2001, J BIOL CHEM, V276, P8557, DOI 10.1074/jbc.M008886200; Coxson HO, 1999, AM J RESP CRIT CARE, V159, P851, DOI 10.1164/ajrccm.159.3.9805067; Dahl M, 2008, AM J RESP CRIT CARE, V178, P906, DOI 10.1164/rccm.200804-549OC; Davis IC, 2007, ADV EXP MED BIOL, V618, P127; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Escoubet B, 1997, AM J PHYSIOL-CELL PH, V272, pC1482, DOI 10.1152/ajpcell.1997.272.5.C1482; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Hassan F, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-69; Hummler E, 2010, CELL PHYSIOL BIOCHEM, V25, P63, DOI 10.1159/000272051; Ianowski JP, 2007, J PHYSIOL-LONDON, V580, P301, DOI 10.1113/jphysiol.2006.123653; Imai K, 2005, EUR RESPIR J, V25, P250, DOI 10.1183/09031936.05.00023704; Ji HL, 2000, J BIOL CHEM, V275, P27947; Jiang QS, 2000, J BIOL CHEM, V275, P13266, DOI 10.1074/jbc.275.18.13266; Johnson MD, 2006, P NATL ACAD SCI USA, V103, P4964, DOI 10.1073/pnas.0600855103; Johnson MD, 2002, P NATL ACAD SCI USA, V99, P1966, DOI 10.1073/pnas.042689399; Johnson M, 2009, AM J PHYSIOL-LUNG C, V297, pL816, DOI 10.1152/ajplung.90466.2008; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Livraghi A, 2009, J IMMUNOL, V182, P4357, DOI 10.4049/jimmunol.0802557; Mahadeva Ravi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P665, DOI 10.2174/156801005774912860; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall MA, 2008, AM J RESP CRIT CARE, V177, P730, DOI 10.1164/rccm.200708-1233OC; Matthay MA, 2002, J APPL PHYSIOL, V93, P1533, DOI 10.1152/japplphysiol.01210.2001; Montano M, 2010, INHAL TOXICOL, V22, P868, DOI 10.3109/08958378.2010.491840; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Park JA, 2005, AM J PATHOL, V167, P651, DOI 10.1016/S0002-9440(10)62040-8; Postma DS, 2011, AM J RESP CRIT CARE, V183, P1588, DOI 10.1164/rccm.201011-1796PP; Rab A, 2013, AM J PHYSIOL-LUNG C, V305, pL530, DOI 10.1152/ajplung.00039.2013; Regan EA, 2011, FREE RADICAL BIO MED, V51, P726, DOI 10.1016/j.freeradbiomed.2011.05.008; Regnier A, 2008, HUM PATHOL, V39, P368, DOI 10.1016/j.humpath.2007.06.020; Reid L, 2005, AM J RESP CRIT CARE, V172, P136, DOI 10.1164/rccm.200502-203WS; ROGERS DF, 1993, EXP LUNG RES, V19, P37, DOI 10.3109/01902149309071079; Sandford AJ, 1997, EUR RESPIR J, V10, P1380, DOI 10.1183/09031936.97.10061380; Siedlinski M, 2009, EUR RESPIR J, V33, P986, DOI 10.1183/09031936.00171507; Smit RNV, 2010, EUR RESPIR J, V35, P27, DOI 10.1183/09031936.00072909; Smolonska J, 2009, AM J RESP CRIT CARE, V180, P618, DOI 10.1164/rccm.200905-0722OC; Song WF, 2007, AM J PHYSIOL-LUNG C, V293, pL855, DOI 10.1152/ajplung.00305.2007; Song YL, 2001, J BIOL CHEM, V276, P41288, DOI 10.1074/jbc.M107257200; Song YL, 2001, J GEN PHYSIOL, V117, P573, DOI 10.1085/jgp.117.6.573; Wang K, 2007, ACTA PHARMACOL SIN, V28, P1166, DOI 10.1111/j.1745-7254.2007.00608.x; Wielputz MO, 2011, EUR RESPIR J, V38, P1060, DOI 10.1183/09031936.00149810; Yan WS, 2004, J BIOL CHEM, V279, P23183, DOI 10.1074/jbc.M402373200; Yao HW, 2010, P NATL ACAD SCI USA, V107, P15571, DOI 10.1073/pnas.1007625107; Zhou Z, 2008, AM J RESP CRIT CARE, V178, P1245, DOI 10.1164/rccm.200803-442OC	53	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109725	10.1371/journal.pone.0109725	http://dx.doi.org/10.1371/journal.pone.0109725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329998	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100022
J	Blakeman, T; Blickem, C; Kennedy, A; Reeves, D; Bower, P; Gaffney, H; Gardner, C; Lee, V; Jariwala, P; Dawson, S; Mossabir, R; Brooks, H; Richardson, G; Spackman, E; Vassilev, I; Chew-Graham, C; Rogers, A				Blakeman, Tom; Blickem, Christian; Kennedy, Anne; Reeves, David; Bower, Peter; Gaffney, Hannah; Gardner, Caroline; Lee, Victoria; Jariwala, Praksha; Dawson, Shoba; Mossabir, Rahena; Brooks, Helen; Richardson, Gerry; Spackman, Eldon; Vassilev, Ivaylo; Chew-Graham, Carolyn; Rogers, Anne			Effect of Information and Telephone-Guided Access to Community Support for People with Chronic Kidney Disease: Randomised Controlled Trial	PLOS ONE			English	Article							SELF-MANAGEMENT SUPPORT; LONG-TERM CONDITIONS; PRIMARY-CARE; COST-EFFECTIVENESS; ULCERATIVE-COLITIS; SOCIAL NETWORK; UNITED-STATES; METAANALYSIS; SCALE; LIFE	Background: Implementation of self-management support in traditional primary care settings has proved difficult, encouraging the development of alternative models which actively link to community resources. Chronic kidney disease (CKD) is a common condition usually diagnosed in the presence of other co-morbidities. This trial aimed to determine the effectiveness of an intervention to provide information and telephone-guided access to community support versus usual care for patients with stage 3 CKD. Methods and Findings: In a pragmatic, two-arm, patient level randomised controlled trial 436 patients with a diagnosis of stage 3 CKD were recruited from 24 general practices in Greater Manchester. Patients were randomised to intervention (215) or usual care (221). Primary outcome measures were health related quality of life (EQ-5D health questionnaire), blood pressure control, and positive and active engagement in life (heiQ) at 6 months. At 6 months, mean health related quality of life was significantly higher for the intervention group (adjusted mean difference = 0.05; 95% CI = 0.01, 0.08) and blood pressure was controlled for a significantly greater proportion of patients in the intervention group (adjusted odds-ratio = 1.85; 95% CI = 1.25, 2.72). Patients did not differ significantly in positive and active engagement in life. The intervention group reported a reduction in costs compared with control. Conclusions: An intervention to provide tailored information and telephone-guided access to community resources was associated with modest but significant improvements in health related quality of life and better maintenance of blood pressure control for patients with stage 3 CKD compared with usual care. However, further research is required to identify the mechanisms of action of the intervention.	[Blakeman, Tom; Blickem, Christian; Reeves, David; Gaffney, Hannah; Jariwala, Praksha; Dawson, Shoba; Mossabir, Rahena; Brooks, Helen] Univ Manchester, Inst Populat Hlth, Ctr Primary Care, NIHR Collaborat Leadership Appl Hlth Res CLAHRC G, Manchester, Lancs, England; [Kennedy, Anne; Vassilev, Ivaylo; Rogers, Anne] Univ Southampton, NIHR CLAHRC Wessex, Southampton, Hants, England; [Bower, Peter; Gardner, Caroline; Lee, Victoria] Univ Manchester, Inst Populat Hlth, Ctr Primary Care, NIHR Sch Primary Care Res, Manchester, Lancs, England; [Richardson, Gerry; Spackman, Eldon] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Chew-Graham, Carolyn] Keele Univ, Primary Care & Hlth Serv, Keele, Staffs, England	University of Manchester; University of Southampton; University of Manchester; University of York - UK; Keele University	Blickem, C (corresponding author), Univ Manchester, Inst Populat Hlth, Ctr Primary Care, NIHR Collaborat Leadership Appl Hlth Res CLAHRC G, Manchester, Lancs, England.	christian.blickem@manchester.ac.uk	Brooks, Helen/N-3849-2018; Bower, Peter/A-1508-2011; Brooks, Helen/O-4307-2014; Reeves, David/H-6203-2014	Brooks, Helen/0000-0002-2157-0200; Bower, Peter/0000-0001-9558-3349; Brooks, Helen/0000-0002-2157-0200; Dawson, Shoba/0000-0002-6700-6445; Vassilev, Ivaylo/0000-0002-2206-8247; Spackman, David Eldon/0000-0001-8558-5973; Gardner, Caroline/0000-0003-0487-3979; Reeves, David/0000-0001-6377-6859; Lee, Victoria/0000-0001-9578-3260; Blakeman, Tom/0000-0003-3298-8423; Gaffney, Hannah/0000-0001-9561-2488	National Institute for Health Research [CL-2009-06-004] Funding Source: researchfish; Department of Health [WMCLAHRC-2014-1] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Abdi Z, 2012, BRIT J GEN PRACT, V62, P172, DOI 10.3399/bjgp12X635958; Bajekal M, 2011, SOCIAL CAPITAL SOCIA; Blakeman T, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636056; Blickem C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-262; Blickem C, 2013, HEALTH EXPECT, V16, pE48, DOI 10.1111/hex.12088; Blickem C, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-28; Bower P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-7; Broadbent E, 2006, J PSYCHOSOM RES, V60; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cornwell B, 2009, J AGING HEALTH, V21, P129, DOI 10.1177/0898264308328649; Crinson I, 2010, BRIT J GEN PRACT, V60, P403, DOI 10.3399/bjgp10X502100; De Lusignan S, 2011, CHRONIC KIDNEY DIS F; Dennis SM, 2008, MED J AUSTRALIA, V188, pS53; Dolan P, 1995, SOCIAL TARIFF EUROQO; Egginton JS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-72; Excellence NIfHaC, 2013, AC KIDN INJ PREV DET; Fraser S. D. S., 2012, LANCET, V380, pS40; Furler J, 2008, CHRONIC ILLN, V4, P157, DOI 10.1177/1742395308090064; Greer RC, 2011, AM J KIDNEY DIS, V57, P583, DOI 10.1053/j.ajkd.2010.08.027; Hossain MP, 2012, QJM-INT J MED, V105, P167, DOI 10.1093/qjmed/hcr153; Humphreys J, 2012, BMJ QUAL SAF, V21, P700, DOI 10.1136/bmjqs-2011-000664; Jha V, 2013, LANCET; Kennedy A, 2003, PATIENT EDUC COUNS, V50, P303, DOI 10.1016/S0738-3991(03)00054-5; Kennedy A D M, 2003, Health Technol Assess, V7, P1; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Kennedy A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2882; Kennedy AP, 1999, HEALTH SOC CARE COMM, V7, P177, DOI 10.1046/j.1365-2524.1999.00174.x; Kennedy AP, 2002, PATIENT EDUC COUNS, V47, P257, DOI 10.1016/S0738-3991(01)00228-2; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kind P, 1996, QUALITY LIFE PHARMAC; Li T, 2011, COCHRANE DATABASE SY, V15; Lorig K., 1996, OUTCOME MEASURES HLT, VVol. 2019; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; Marmot M, 2010, FAIR SOC HLTH LIVES; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; May C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2803; McCall N, 2011, NEW ENGL J MED, V365, P1704, DOI 10.1056/NEJMsa1011785; McIntyre NJ, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636047; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Motheral Brenda R, 2011, Am J Manag Care, V17, pe10; MOYNIHAN R, 2013, BMJ BRIT MED J, V347; National Institute for Health and Care Excellence (NICE), 2008, CHRON KIDN DIS EARL; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; Plantinga LC, 2010, ADV CHRONIC KIDNEY D, V17, P225, DOI 10.1053/j.ackd.2010.03.002; Powell LH, 2010, JAMA-J AM MED ASSOC, V304, P1331, DOI 10.1001/jama.2010.1362; Prescribing and Primary Care team HaSCIC Quality and Outcomes Framework, 2012, HASCIC QUAL OUTC FRA; Remuzzi G, 2013, LANCET, V382, P353, DOI 10.1016/S0140-6736(13)60438-9; Rogers A, 2011, IMPLEMENTATION SCI, V6; Rogers A, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-6; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Small N, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-533; Statistics OfN, 2007, IND MULT DEPR IMD; Stewart S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7156; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Trialists'Collaboration BPLT, 2013, BMJ BRIT MED J, V347; Vassilev I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059723; Wagner E H, 1998, Eff Clin Pract, V1, P2; WANLESS D, 2003, SECURING GOOD HLTH W; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	39	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109135	10.1371/journal.pone.0109135	http://dx.doi.org/10.1371/journal.pone.0109135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9XC	25330169	Green Published, Green Accepted, gold			2022-12-27	WOS:000343210800016
J	Pappalardo, M; Shachaf, N; Basile, L; Milardi, D; Zeidan, M; Raiyn, J; Guccione, S; Rayan, A				Pappalardo, Matteo; Shachaf, Nir; Basile, Livia; Milardi, Danilo; Zeidan, Mouhammed; Raiyn, Jamal; Guccione, Salvatore; Rayan, Anwar			Sequential Application of Ligand and Structure Based Modeling Approaches to Index Chemicals for Their hH(4)R Antagonism	PLOS ONE			English	Article							HISTAMINE H-4 RECEPTOR; PROTEIN-COUPLED RECEPTORS; SUPPORT VECTOR MACHINE; INHIBITORY-ACTIVITY; H4 RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; STOCHASTIC ALGORITHM; EXPLORING QSARS; BINDING MODE; DRUG DESIGN	The human histamine H-4 receptor (hH(4)R), a member of the G-protein coupled receptors (GPCR) family, is an increasingly attractive drug target. It plays a key role in many cell pathways and many hH(4)R ligands are studied for the treatment of several inflammatory, allergic and autoimmune disorders, as well as for analgesic activity. Due to the challenging difficulties in the experimental elucidation of hH(4)R structure, virtual screening campaigns are normally run on homology based models. However, a wealth of information about the chemical properties of GPCR ligands has also accumulated over the last few years and an appropriate combination of these ligand-based knowledge with structure-based molecular modeling studies emerges as a promising strategy for computer-assisted drug design. Here, two chemoinformatics techniques, the Intelligent Learning Engine (ILE) and Iterative Stochastic Elimination (ISE) approach, were used to index chemicals for their hH(4)R bioactivity. An application of the prediction model on external test set composed of more than 160 hH(4)R antagonists picked from the chEMBL database gave enrichment factor of 16.4. A virtual high throughput screening on ZINC database was carried out, picking similar to 4000 chemicals highly indexed as H4R antagonists' candidates. Next, a series of 3D models of hH(4)R were generated by molecular modeling and molecular dynamics simulations performed in fully atomistic lipid membranes. The efficacy of the hH(4)R 3D models in discrimination between actives and non-actives were checked and the 3D model with the best performance was chosen for further docking studies performed on the focused library. The output of these docking studies was a consensus library of 11 highly active scored drug candidates. Our findings suggest that a sequential combination of ligand-based chemoinformatics approaches with structure-based ones has the potential to improve the success rate in discovering new biologically active GPCR drugs and increase the enrichment factors in a synergistic manner.	[Pappalardo, Matteo] Univ Catania, Dept Chem Sci, Catania, Italy; [Shachaf, Nir; Zeidan, Mouhammed; Raiyn, Jamal; Rayan, Anwar] Al Qasemi Acad Coll, QRC Qasemi Res Ctr, Drug Discovery Informat Lab, Baka El Garbiah, Israel; [Basile, Livia; Guccione, Salvatore] Univ Catania, Etnalead Srl, Scuola Super Catania, Catania, Italy; [Milardi, Danilo] CNR, Inst Biostruct & Bioimaging, Catania, Italy; [Guccione, Salvatore] Univ Catania, Dept Pharmaceut Sci, Catania, Italy	University of Catania; University of Catania; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Catania	Guccione, S (corresponding author), Univ Catania, Etnalead Srl, Scuola Super Catania, Catania, Italy.	guccione@unict.it; a_rayan@qsm.ac.il	Basile, Livia/AAR-6833-2021; Milardi, Danilo/K-1194-2013	Basile, Livia/0000-0001-8046-6393; Milardi, Danilo/0000-0003-3940-9439; Guccione, Salvatore/0000-0001-9858-7732	Qasemi Research Foundation; PRACE [Deci Call 09 - GPCR-4D]; Iscra [B05-GPCR4D]; COST Action [BM0806, CM1207]	Qasemi Research Foundation; PRACE; Iscra(CINECA, Italy); COST Action(European Cooperation in Science and Technology (COST))	This research was partially supported by Qasemi Research Foundation, COST Action BM0806 and COST Action CM1207. Calculation has been granted by project: PRACE Deci Call 09 - GPCR-4D and Iscra B05-GPCR4D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenbach RJ, 2008, J MED CHEM, V51, P6571, DOI 10.1021/jm8005959; Arooj M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063030; CALEBIRO D, 2010, TRENDS PHARM SCI; Deeb O, 2013, CURR PHARM DESIGN, V19, P2237, DOI 10.2174/1381612811319120010; Deeb O, 2010, CHEM BIOL DRUG DES, V75, P506, DOI 10.1111/j.1747-0285.2010.00953.x; Deng W, 2008, J CHEM INF MODEL, V48, P2010, DOI 10.1021/ci800154w; Dunford PJ, 2006, J IMMUNOL, V176, P7062, DOI 10.4049/jimmunol.176.11.7062; Efremov RG, 2007, CURR MED CHEM, V14, P393, DOI 10.2174/092986707779941050; Engelhardt H, 2013, J MED CHEM, V56, P4264, DOI 10.1021/jm301886t; Feng ZW, 2013, J MOL GRAPH MODEL, V39, P1, DOI 10.1016/j.jmgm.2012.10.003; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Fung-Leung Wai-Ping, 2004, Curr Opin Investig Drugs, V5, P1174; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Glick M, 2002, P NATL ACAD SCI USA, V99, P703, DOI 10.1073/pnas.022418199; Glick M, 2000, PROTEINS, V38, P273, DOI 10.1002/(SICI)1097-0134(20000215)38:3<273::AID-PROT4>3.3.CO;2-9; Gutzmer R, 2005, J IMMUNOL, V174, P5224, DOI 10.4049/jimmunol.174.9.5224; Hao M, 2012, INT J MOL SCI, V13, P7015, DOI 10.3390/ijms13067015; Heikamp K, 2013, J CHEM INF MODEL, V53, P1595, DOI 10.1021/ci4002712; Hough LB, 2001, MOL PHARMACOL, V59, P415, DOI 10.1124/mol.59.3.415; Jablonowski JA, 2003, J MED CHEM, V46, P3957, DOI 10.1021/jm0341047; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jamalan M, 2013, CHEM BIOL DRUG DES, V81, P455, DOI 10.1111/cbdd.12062; Jiang XH, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-18; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kiss R, 2008, J MED CHEM, V51, P3145, DOI 10.1021/jm7014777; Kiss R, 2008, EUR J MED CHEM, V43, P1059, DOI 10.1016/j.ejmech.2007.07.014; Kooistra AJ, 2013, METHOD ENZYMOL, V522, P279, DOI 10.1016/B978-0-12-407865-9.00015-7; Li H, 2007, J PHARM SCI-US, V96, P2838, DOI 10.1002/jps.20985; Lim HD, 2006, J MED CHEM, V49, P6650, DOI 10.1021/jm060880d; Lim HD, 2010, MOL PHARMACOL, V77, P734, DOI 10.1124/mol.109.063040; Liu CL, 2001, MOL PHARMACOL, V59, P420, DOI 10.1124/mol.59.3.420; Liu H, 2008, J MED CHEM, V51, P7094, DOI 10.1021/jm8007618; Luksch T, 2008, CHEMMEDCHEM, V3, P1323, DOI 10.1002/cmdc.200700270; Lusci A, 2013, J CHEM INF MODEL, V53, P1563, DOI 10.1021/ci400187y; Medek P, 2007, JOURNAL WSCG, V15, P107; Miura T, 2011, BIOORG MED CHEM LETT, V21, P5778, DOI 10.1016/j.bmcl.2011.08.001; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morse KL, 2001, J PHARMACOL EXP THER, V296, P1058; Mussa HY, 2011, J CHEM INF MODEL, V51, P4, DOI 10.1021/ci100022u; Nguyen T, 2001, MOL PHARMACOL, V59, P427, DOI 10.1124/mol.59.3.427; Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; Paoletta S, 2008, BIOORGAN MED CHEM, V16, P8466, DOI 10.1016/j.bmc.2008.08.034; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plewczynski D, 2007, COMB CHEM HIGH T SCR, V10, P189, DOI 10.2174/138620707780126705; Rayan A, 2004, J MOL GRAPH MODEL, V22, P319, DOI 10.1016/j.jmgm.2003.12.012; Rayan A, 2004, CURR MED CHEM, V11, P675, DOI 10.2174/0929867043455701; Rayan A, 2000, RECEPTOR CHANNEL, V7, P121; Rayan A, 2010, P BRIT PHARM SOC, V7, P26; Rayan A., 2005, WIPO Patent, Patent No. 2005022111; RAYAN A, 2009, Patent No. 2009090613; Rayan A, 2013, EUR J MED CHEM, V65, P304, DOI 10.1016/j.ejmech.2013.04.059; Rayan A, 2010, LETT DRUG DES DISCOV, V7, P409, DOI 10.2174/157018010791306515; Rayan A, 2010, J CHEM INF MODEL, V50, P437, DOI 10.1021/ci9004354; Rayan A, 2010, J MOL MODEL, V16, P183, DOI 10.1007/s00894-009-0533-y; Schuller A, 2008, J CHEM INF MODEL, V48, P1473, DOI 10.1021/ci8001205; Schuffenhauer A, 2006, J CHEM INF MODEL, V46, P525, DOI 10.1021/ci0503558; Seifert R, 2011, MOL PHARMACOL, V79, P631, DOI 10.1124/mol.111.071266; Shen M, 2004, J MED CHEM, V47, P2356, DOI 10.1021/jm030584q; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Simmons KJ, 2010, NAT REV MICROBIOL, V8, P501, DOI 10.1038/nrmicro2349; Sirci F, 2012, J CHEM INF MODEL, V52, P3308, DOI 10.1021/ci3004094; Smits RA, 2006, J MED CHEM, V49, P4512, DOI 10.1021/jm051008s; Smits RA, 2009, DRUG DISCOV TODAY, V14, P745, DOI 10.1016/j.drudis.2009.05.007; Srinivasan R, 2002, PROTEINS, V47, P489, DOI 10.1002/prot.10103; Tanrikulu Y, 2009, CHEMMEDCHEM, V4, P820, DOI 10.1002/cmdc.200800443; Thurmond RL, 2004, J PHARMACOL EXP THER, V309, P404, DOI 10.1124/jpet.103.061754; ul-Haq Z, 2008, J CHEM INF MODEL, V48, P1092, DOI 10.1021/ci8000056; Watanabe M, 2006, J MED CHEM, V49, P5587, DOI 10.1021/jm0603318; Zaid H, 2012, FRONT BIOSCI-LANDMRK, V17, P232, DOI 10.2741/3924; Zhang M, 2007, PHARMACOL THERAPEUT, V113, P594, DOI 10.1016/j.pharmthera.2006.11.008; Zhu Y, 2001, MOL PHARMACOL, V59, P434, DOI 10.1124/mol.59.3.434	72	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109340	10.1371/journal.pone.0109340	http://dx.doi.org/10.1371/journal.pone.0109340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330207	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800020
J	Rivaes, RP; Rodriguez-Gonzalez, PM; Ferreira, MT; Pinheiro, AN; Politti, E; Egger, G; Garcia-Arias, A; Frances, F				Rivaes, Rui P.; Rodriguez-Gonzalez, Patricia M.; Teresa Ferreira, Maria; Pinheiro, Antonio N.; Politti, Emilio; Egger, Gregory; Garcia-Arias, Alicia; Frances, Felix			Modeling the Evolution of Riparian Woodlands Facing Climate Change in Three European Rivers with Contrasting Flow Regimes	PLOS ONE			English	Article							GLOBAL WATER-RESOURCES; SAN-PEDRO; FLUVIAL LANDFORMS; AIR-POLLUTION; VEGETATION; DISTURBANCE; IMPACTS; FUTURE; FLOODPLAIN; ECOSYSTEM	Global circulation models forecasts indicate a future temperature and rainfall pattern modification worldwide. Such phenomena will become particularly evident in Europe where climate modifications could be more severe than the average change at the global level. As such, river flow regimes are expected to change, with resultant impacts on aquatic and riparian ecosystems. Riparian woodlands are among the most endangered ecosystems on earth and provide vital services to interconnected ecosystems and human societies. However, they have not been the object of many studies designed to spatially and temporally quantify how these ecosystems will react to climate change-induced flow regimes. Our goal was to assess the effects of climate-changed flow regimes on the existing riparian vegetation of three different European flow regimes. Cases studies were selected in the light of the most common watershed alimentation modes occurring across European regions, with the objective of appraising expected alterations in the riparian elements of fluvial systems due to climate change. Riparian vegetation modeling was performed using the CASiMiR-vegetation model, which bases its computation on the fluvial disturbance of the riparian patch mosaic. Modeling results show that riparian woodlands may undergo not only at least moderate changes for all flow regimes, but also some dramatic adjustments in specific areas of particular vegetation development stages. There are circumstances in which complete annihilation is feasible. Pluvial flow regimes, like the ones in southern European rivers, are those likely to experience more pronounced changes. Furthermore, regardless of the flow regime, younger and more water-dependent individuals are expected to be the most affected by climate change.	[Rivaes, Rui P.; Rodriguez-Gonzalez, Patricia M.; Teresa Ferreira, Maria] Univ Lisbon, Forest Res Ctr, Inst Super Agron, P-1699 Lisbon, Portugal; [Pinheiro, Antonio N.] Univ Lisbon, CEHIDRO, Inst Super Tecn, P-1699 Lisbon, Portugal; [Politti, Emilio; Egger, Gregory] Environm Consulting Klagenfurt, Klagenfurt, Austria; [Garcia-Arias, Alicia; Frances, Felix] Univ Politecn Valencia, Res Inst Water & Environm Engn, E-46071 Valencia, Spain	Universidade de Lisboa; Forest Research Centre; Universidade de Lisboa; Instituto Superior Tecnico; Universitat Politecnica de Valencia	Rivaes, RP (corresponding author), Univ Lisbon, Forest Res Ctr, Inst Super Agron, P-1699 Lisbon, Portugal.	ruirivaes@isa.ulisboa.pt	Ferreira, Teresa/C-9785-2012; García-Arias, Alicia/ABE-5070-2020; Politti, Emilio/F-9490-2018; Rivaes, Rui Pedro/L-1465-2016; Pinheiro, António N./E-2520-2012; Frances, Felix/H-7179-2015; Rodríguez-González, Patricia M/J-3445-2013; Egger, Gregory/AAA-2961-2020	Ferreira, Teresa/0000-0002-3900-1460; García-Arias, Alicia/0000-0001-8676-1326; Politti, Emilio/0000-0003-2981-0325; Rivaes, Rui Pedro/0000-0001-7910-4387; Pinheiro, António N./0000-0002-1423-5391; Frances, Felix/0000-0003-1173-4969; Rodríguez-González, Patricia M/0000-0001-8507-8429; 	IWRM Era-Net Funding Initiative through the RIPFLOW project [ERAC-CT-2005-026025, ERA-IWRM/0001/2008, CGL2008-03076-E/BTE]; UTL - Universidade Tecnica de Lisboa; Patricia Maria Rodriguez-Gonzalez; FCT - Fundacao para a Ciencia e Tecnologia [SFRH/BPD/47140/2008]; Spanish Ministry of the Economy and Competitiveness [Consolider-Ingenio 2010 CSD2009-00065]	IWRM Era-Net Funding Initiative through the RIPFLOW project; UTL - Universidade Tecnica de Lisboa; Patricia Maria Rodriguez-Gonzalez; FCT - Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Spanish Ministry of the Economy and Competitiveness(Spanish Government)	This work was supported by the IWRM Era-Net Funding Initiative through the RIPFLOW project (references ERAC-CT-2005-026025, ERA-IWRM/0001/2008, CGL2008-03076-E/BTE), http://www.old.iwrm-net.eu/spip.php. Rui Rivaes benefited from a PhD grant sponsored by UTL - Universidade Tecnica de Lisboa (www.utl.pt) and Patricia Maria Rodriguez-Gonzalez benefited from a post-doctoral grant sponsored by FCT - Fundacao para a Ciencia e Tecnologia (www.fct.pt) (SFRH/BPD/47140/2008). The Spanish team would like to thank the Spanish Ministry of the Economy and Competitiveness the support provided through the SCARCE project (Consolider-Ingenio 2010 CSD2009-00065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Environmental Consulting Klagenfurt provided support in the form of salaries for authors EP and GE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aguiar FC, 2005, ENVIRON CONSERV, V32, P30, DOI 10.1017/S0376892905001992; Alcamo J, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P541; Alcamo J, 2007, HYDROLOG SCI J, V52, P247, DOI 10.1623/hysj.52.2.247; Auble GT, 2005, WETLANDS, V25, P143, DOI 10.1672/0277-5212(2005)025[0143:UOISRA]2.0.CO;2; Auble GT, 1998, WETLANDS, V18, P546, DOI 10.1007/BF03161671; BACH W, 1976, REV GEOPHYS, V14, P429, DOI 10.1029/RG014i003p00429; Bendix J, 2000, HYDROL PROCESS, V14, P2977, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2977::AID-HYP130&gt;3.0.CO;2-4; Benjankar R, 2009, DEV DYNAMIC FLOODPLA; Benjankar R, 2011, J ENVIRON MANAGE, V92, P3058, DOI 10.1016/j.jenvman.2011.07.017; Benton GS, 1970, CARBON DIOXIDE ITS R, P898; Berges SA, 2009, ECOSYSTEM SERVICES R; Blackwell MSA, 2006, USE FLOODPLANTS FLOO; Broadmeadow S, 2004, HYDROL EARTH SYST SC, V8, P286, DOI 10.5194/hess-8-286-2004; Camporeale C, 2006, WATER RESOUR RES, V42, DOI 10.1029/2006WR004933; Camporeale C, 2013, REV GEOPHYS, V51, P379, DOI 10.1002/rog.20014; Casatti L, 2012, NEOTROP ICHTHYOL, V10, P205, DOI 10.1590/S1679-62252012000100020; Christensen JH, 2007, CLIMATIC CHANGE, V81, P1, DOI 10.1007/s10584-006-9211-6; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Corenblit D, 2007, EARTH-SCI REV, V84, P56, DOI 10.1016/j.earscirev.2007.05.004; Corenblit D, 2011, EARTH-SCI REV, V106, P307, DOI 10.1016/j.earscirev.2011.03.002; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crawford N.H., 1966, DIGITAL SIMULATION H; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Dixon MD, 2006, RIVER RES APPL, V22, P1057, DOI 10.1002/rra.948; Egger G, 2012, J HYDRO-ENVIRON RES, V6, P151, DOI 10.1016/j.jher.2012.01.007; Ferreira MT, 2005, FOREST ECOL MANAG, V212, P145, DOI 10.1016/j.foreco.2005.03.010; Flather CH, 1995, WILDLIFE RECREATIONI, P372; Frederick KD, 1997, CLIMATIC CHANGE, V37, P7, DOI 10.1023/A:1005336924908; Friedman JM, 2002, ECOL MONOGR, V72, P409, DOI 10.1890/0012-9615(2002)072[0409:EFCCAR]2.0.CO;2; Garcia-Arias A, 2013, ECOHYDROLOGY, V6, P635, DOI 10.1002/eco.1331; Garcia-Arias A, 2011, EUROMECH C 15 17 JUN, V523, P153; Gran K, 2001, WATER RESOUR RES, V37, P3275, DOI 10.1029/2000WR000203; Gurnell A, 2014, EARTH SURF PROC LAND, V39, P4, DOI 10.1002/esp.3397; Gurnell AM, 2012, EARTH-SCI REV, V111, P129, DOI 10.1016/j.earscirev.2011.11.005; HANSEN J, 1981, SCIENCE, V213, P957, DOI 10.1126/science.213.4511.957; Hernandez L., 2007, EFECTOS CAMBIO CLIMA; Hoffman MT, 2011, J HIST BIOL, V44, P59, DOI 10.1007/s10739-010-9246-4; Holmes TP, 2004, ECOL ECON, V49, P19, DOI 10.1016/j.ecolecon.2003.10.015; Hultine KR, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010317; HUTCHINSON G. EVELYN, 1953, PROC ACAD NAT SCI PHILADELPHIA, V105, P1; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Johnson SL, 2000, HYDROL PROCESS, V14, P3031, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;3031::AID-HYP133&gt;3.0.CO;2-6; Johnson WC, 2002, FRESHWATER BIOL, V47, P749, DOI 10.1046/j.1365-2427.2002.00910.x; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Karrenberg S, 2002, FRESHWATER BIOL, V47, P733, DOI 10.1046/j.1365-2427.2002.00894.x; Lake PS, 2000, J N AM BENTHOL SOC, V19, P573, DOI 10.2307/1468118; Linsley RK, 1960, INT ASS SCI HYDROLOG, V5, P526; Lloyd N., 2004, 12004 CRC FRESHW EC; Louckova B, 2012, RIVER RES APPL, V28, P1275, DOI 10.1002/rra.1519; LOVELOCK JE, 1971, ATMOS ENVIRON, V5, P403, DOI 10.1016/0004-6981(71)90143-0; Lvovich M.I., 1979, WORLD WATER RESOURCE; Mader H., 1996, ABFLUSSREGIME OSTERR; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; Mearns LO, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P739; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Merritt DM, 2010, FRESHWATER BIOL, V55, P206, DOI 10.1111/j.1365-2427.2009.02206.x; Moreno JM, 2005, PRELIMINARY ASSESSME; Muneepeerakul R, 2007, WATER RESOUR RES, V43, DOI 10.1029/2007WR006100; Murray SJ, 2012, J HYDROL, V448, P14, DOI 10.1016/j.jhydrol.2012.02.044; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Naiman RJ, 2000, BIOSCIENCE, V50, P996, DOI 10.1641/0006-3568(2000)050[0996:REAMIT]2.0.CO;2; Nakicenovik N, 2000, EMISSION SCENARIOS I; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Nijssen B, 2001, CLIMATIC CHANGE, V50, P143, DOI 10.1023/A:1010616428763; NRC NRC, 2002, RIP AR FUNCT STRAT M; Orellana F, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000383; Pachauri R.K., 2008, CLIMATE CHANGE 2007; Parde M, 1955, FLEUVES RIVIERES; Perry LG, 2012, GLOBAL CHANGE BIOL, V18, P821, DOI 10.1111/j.1365-2486.2011.02588.x; Pettit NE, 2001, REGUL RIVER, V17, P201, DOI 10.1002/rrr.624; Poff LN, 2010, FRESHWATER BIOL, V55, P11; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Politti E, 2011, EVALUATING CLIMATE C, P177; Politti E, 2014, HYDROBIOLOGIA, P1; Primack AGB, 2000, WETLANDS, V20, P538, DOI 10.1672/0277-5212(2000)020&lt;0538:SOCEOR&gt;2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RESH VH, 1988, J N AM BENTHOL SOC, V7, P433, DOI 10.2307/1467300; RIPFLOW, 2011, RIP VEG MOD ASS ENV; Rivaes R, 2012, CLIMATE CHANGE IMPAC; Rivaes R, 2013, ECOHYDROLOGY, V6, P413, DOI 10.1002/eco.1287; Rood SB, 2003, TREE PHYSIOL, V23, P1113, DOI 10.1093/treephys/23.16.1113; Santos F.D., 2006, ALTERACOES CLIMATICA, V1st ed.; Santos F. D., 2002, CLIMATE CHANGE PORTU; Schneider C, 2013, HYDROL EARTH SYST SC, V17, P325, DOI 10.5194/hess-17-325-2013; Schneider C, 2011, J WATER CLIM CHANGE, V2, P106, DOI 10.2166/wcc.2011.020; Serrat-Capdevila A, 2007, J HYDROL, V347, P48, DOI 10.1016/j.jhydrol.2007.08.028; Serrat-Capdevila A, 2011, J HYDROL, V399, P1, DOI 10.1016/j.jhydrol.2010.12.021; Shafroth PB, 2002, ECOL APPL, V12, P107, DOI 10.1890/1051-0761(2002)012[0107:RVRTAD]2.0.CO;2; Stanley EH, 2010, J N AM BENTHOL SOC, V29, P67, DOI 10.1899/08-027.1; Stanzel P., 2010, Oesterreichische Wasser- und Abfallwirtschaft, V62, P180, DOI 10.1007/s00506-010-0234-x; Stromberg JC, 2010, RIVER RES APPL, V26, P712, DOI 10.1002/rra.1272; Stromberg JC, 1996, ECOL APPL, V6, P113, DOI 10.2307/2269558; Stromberg JC, 2001, J ARID ENVIRON, V49, P17, DOI 10.1006/jare.2001.0833; Stromberg JC, 2007, GLOBAL ECOL BIOGEOGR, V16, P381, DOI 10.1111/j.1466-8238.2007.00297.x; Stromberg JC, 2010, FOREST ECOL MANAG, V259, P1181, DOI 10.1016/j.foreco.2010.01.005; Tabacchi E, 1998, FRESHWATER BIOL, V40, P497, DOI 10.1046/j.1365-2427.1998.00381.x; Tague C, 2009, CLIMATIC CHANGE, V93, P137, DOI 10.1007/s10584-008-9497-7; Tealdi S, 2013, J THEOR BIOL, V318, P13, DOI 10.1016/j.jtbi.2012.11.006; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Tockner K, 2000, HYDROL PROCESS, V14, P2861, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2861::AID-HYP124&gt;3.0.CO;2-F; Tockner Klement, 2008, P45, DOI 10.1017/CBO9780511751790.006; Verzano K, 2007, IAHS P REPORTS, P147, DOI Perugia, IT; Watson R.T., 1996, CLIMATE CHANGE 1995; WHITE PS, 1979, BOT REV, V45, P229, DOI 10.1007/BF02860857; Whited DC, 2007, ECOLOGY, V88, P940, DOI 10.1890/05-1149; Winemiller KO, 2010, J N AM BENTHOL SOC, V29, P84, DOI 10.1899/08-048.1; Wohl E, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR003985; Wrzesinski D, 2013, QUAEST GEOGR, V32, P43, DOI 10.2478/quageo-2013-0006; [No title captured]	110	27	27	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110200	10.1371/journal.pone.0110200	http://dx.doi.org/10.1371/journal.pone.0110200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330151	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800068
J	Zou, ZH; Jiang, YM; Xiao, MJ; Zhou, RY				Zou, Zhenhong; Jiang, Yuming; Xiao, Mingjia; Zhou, Ruiyao			The Impact of Prophylactic Dexamethasone on Nausea and Vomiting after Thyroidectomy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							POSTOPERATIVE NAUSEA; PAIN; PREVENTION; EFFICACY; SURGERY; STRENGTH; QUALITY	Background: We carried out a systematic review and meta-analysis to evaluate the impact of prophylactic dexamethasone on post-operative nausea and vomiting (PONV), post-operative pain, and complications in patients undergoing thyroidectomy. Methods: We searched Pubmed, Embase, and Cochrane Library databases for randomized controlled trials (RCTs) that evaluated the prophylactic effect of dexamethasone versus placebo with or without other antiemetics for PONV in patients undergoing thyroidectomy. Meta-analyses were performed using RevMan 5.0 software. Results: Thirteen RCTs that considered high quality evidence including 2,180 patients were analyzed. The meta-analysis demonstrated a significant decrease in the incidence of PONV (RR 0.52, 95% CI 0.43 to 0.63, P<0.00001), the need for rescue anti-emetics (RR 0.42, 95% CI 0.30 to 0.57, P<0.00001), post-operative pain scores (WMD -1.17, 95% CI -1.91 to -0.44, P=0.002), and the need for rescue analgesics (RR 0.65, 95% CI 0.50-0.83, P=0.0008) in patients receiving dexamethasone compared to placebo, with or without concomitant antiemetics. Dexamethasone 8-10 mg had a significantly greater effect for reducing the incidence of PONV than dexamethasone 1.25-5 mg. Dexamethasone was as effective as other anti-emetics for reducing PONV (RR 1.25, 95% CI 0.86-1.81, P=0.24). A significantly higher level of blood glucose during the immediate post-operative period in patients receiving dexamethasone compared to controls was the only adverse event. Conclusions: Prophylactic dexamethasone 8-10 mg administered intravenously before induction of anesthesia should be recommended as a safe and effective strategy for reducing the incidence of PONV, the need for rescue anti-emetics, postoperative pain, and the need for rescue analgesia in thyroidectomy patients, except those that are pregnant, have diabetes mellitus, hyperglycemia, or contraindications for dexamethasone. More high quality trials are warranted to define the benefits and risks of prophylactic dexamethasone in potential patients with a high risk for PONV.	[Zou, Zhenhong; Jiang, Yuming] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Xiao, Mingjia] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Hepatobiliary Surg, Wuxi, Jiangsu, Peoples R China; [Zhou, Ruiyao] Wenzhou Med Univ, Affiliated Hosp 3, Dept Gen Surg, Ruian City, Zhejiang, Peoples R China	Southern Medical University - China; Jiangnan University; Nanjing Medical University; Wenzhou Medical University	Zhou, RY (corresponding author), Wenzhou Med Univ, Affiliated Hosp 3, Dept Gen Surg, Ruian City, Zhejiang, Peoples R China.	doctor_zry@126.com	Jiang, Yuming/Z-5132-2019					AAPRO MS, 1984, J CLIN ONCOL, V2, P466, DOI 10.1200/JCO.1984.2.5.466; Barros A, 2013, PHARMACOLOGY, V91, P153, DOI 10.1159/000346612; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bononi M, 2010, HEAD NECK-J SCI SPEC, V32, P1173, DOI 10.1002/hed.21313; Chen CC, 2012, WORLD J SURG, V36, P61, DOI 10.1007/s00268-011-1343-9; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Doksrod S, 2012, ACTA ANAESTH SCAND, V56, P513, DOI 10.1111/j.1399-6576.2012.02654.x; Feroci F, 2011, HEAD NECK-J SCI SPEC, V33, P840, DOI 10.1002/hed.21543; FREDRIKSON M, 1992, BRIT J CANCER, V65, P779, DOI 10.1038/bjc.1992.165; Fujii Y, 2000, ANAESTH INTENS CARE, V28, P266; Fujii Y, 2007, OTOLARYNG HEAD NECK, V136, P274, DOI 10.1016/j.otohns.2006.09.013; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; HARGREAVES KM, 1990, CLIN PHARMACOL THER, V48, P168, DOI 10.1038/clpt.1990.132; Higgins JPT, 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; HONG D, 1993, PAIN, V55, P171, DOI 10.1016/0304-3959(93)90146-G; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Karanicolas PJ, 2008, ANN SURG, V248, P751, DOI 10.1097/SLA.0b013e3181856024; Kovac AL, 2000, DRUGS, V59, P213, DOI 10.2165/00003495-200059020-00005; Kranke P, 2011, EUR J ANAESTH, V28, P758, DOI 10.1097/EJA.0b013e32834a4e1e; Lee Y, 2001, Acta Anaesthesiol Sin, V39, P151; Lefebvre C., 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.CH6; MATORY YL, 1993, J SURG ONCOL, V53, P17, DOI 10.1002/jso.2930530107; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schietroma M, 2013, JAMA OTOLARYNGOL, V139, P471, DOI 10.1001/jamaoto.2013.2821; Schwartz AE, 1998, J CLIN ENDOCR METAB, V83, P1097, DOI 10.1210/jc.83.4.1103; Song YK, 2013, J ANESTH, V27, P29, DOI 10.1007/s00540-012-1473-8; Sonner JM, 1997, J CLIN ANESTH, V9, P398, DOI 10.1016/S0952-8180(97)00069-X; Wang JJ, 2000, ANESTH ANALG, V91, P1404, DOI 10.1097/00000539-200012000-00019; Wang JJ, 2000, ANESTH ANALG, V91, P136, DOI 10.1097/00000539-200007000-00025; Wang JJ, 1999, ANESTH ANALG, V89, P200, DOI 10.1097/00000539-199907000-00036; WATCHA MF, 1992, ANESTHESIOLOGY, V77, P162, DOI 10.1097/00000542-199207000-00023; WHITE PF, 1993, ANESTHESIOLOGY, V78, P2, DOI 10.1097/00000542-199301000-00002; Worni M, 2008, ANN SURG, V248, P1060, DOI 10.1097/SLA.0b013e31818c709a; Zhou HY, 2012, WORLD J SURG, V36, P1217, DOI 10.1007/s00268-011-1363-5	35	22	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109582	10.1371/journal.pone.0109582	http://dx.doi.org/10.1371/journal.pone.0109582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330115	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800029
J	LaBelle, EV; Marshall, CW; Gilbert, JA; May, HD				LaBelle, Edward V.; Marshall, Christopher W.; Gilbert, Jack A.; May, Harold D.			Influence of Acidic pH on Hydrogen and Acetate Production by an Electrosynthetic Microbiome	PLOS ONE			English	Article							CARBON-DIOXIDE; COMMODITY CHEMICALS; CATHODE MATERIALS; ELECTRON-TRANSFER; FORMATE; CYTOCHROMES; METABOLISM; REDUCTION; BACTERIA; METHANE	Production of hydrogen and organic compounds by an electrosynthetic microbiome using electrodes and carbon dioxide as sole electron donor and carbon source, respectively, was examined after exposure to acidic pH (similar to 5). Hydrogen production by biocathodes poised at -600 mV vs. SHE increased > 100-fold and acetate production ceased at acidic pH, but similar to 5-15 mM (catholyte volume)/day acetate and >1,000 mM/day hydrogen were attained at pH similar to 6.5 following repeated exposure to acidic pH. Cyclic voltammetry revealed a 250 mV decrease in hydrogen overpotential and a maximum current density of 12.2 mA/cm(2) at -765 mV (0.065 mA/cm(2) sterile control at -800 mV) by the Acetobacterium-dominated community. Supplying -800 mV to the microbiome after repeated exposure to acidic pH resulted in up to 2.6 kg/m(3)/day hydrogen (approximate to 2.6 gallons gasoline equivalent), 0.7 kg/m(3)/day formate, and 3.1 kg/m(3)/day acetate (= 4.7 kg CO2 captured).	[LaBelle, Edward V.; May, Harold D.] Med Univ S Carolina, Dept Microbiol & Immunol, Marine Biomed & Environm Sci Ctr, Hollings Marine Lab, Charleston, SC 29425 USA; [Marshall, Christopher W.; Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Gilbert, Jack A.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Gilbert, Jack A.] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Medical University of South Carolina; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Marine Biological Laboratory - Woods Hole; Zhejiang University	May, HD (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, Marine Biomed & Environm Sci Ctr, Hollings Marine Lab, Charleston, SC 29425 USA.	mayh@musc.edu	Gilbert, Jack/AAF-3270-2019	Marshall, Christopher/0000-0001-6669-3231	Department of Energy, Advanced Projects Research Agency - Energy [DE-AR0000089]; Argonne National Laboratory	Department of Energy, Advanced Projects Research Agency - Energy(United States Department of Energy (DOE)); Argonne National Laboratory(United States Department of Energy (DOE))	This research was supported by a grant from the Department of Energy, Advanced Projects Research Agency - Energy (DE-AR0000089). CWM was supported with a Director's Postdoctoral Fellowship from Argonne National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agler MT, 2014, WATER SCI TECHNOL, V69, P62, DOI 10.2166/wst.2013.549; Aulenta F, 2012, CHEMSUSCHEM, V5, P1080, DOI 10.1002/cssc.201100720; Baron D, 2009, J BIOL CHEM, V284, P28865, DOI 10.1074/jbc.M109.043455; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Clarke TA, 2011, P NATL ACAD SCI USA, V108, P9384, DOI 10.1073/pnas.1017200108; Conrado R. J., 2013, ADV BIOFUELS BIOPROD, P1037, DOI [DOI 10.1007/978-1-4614-3348-4_38, 10.1007/978-1-4614-3348-4_38]; Croese E, 2011, APPL MICROBIOL BIOT, V92, P1083, DOI 10.1007/s00253-011-3583-x; da Silva SM, 2013, MICROBIOL-SGM, V159, P1760, DOI 10.1099/mic.0.067868-0; da Silva SM, 2012, J BIOL INORG CHEM, V17, P831, DOI 10.1007/s00775-012-0900-5; Demler M, 2011, BIOTECHNOL BIOENG, V108, P470, DOI 10.1002/bit.22935; Desloover J, 2012, BIOCHEM SOC T, V40, P1233, DOI 10.1042/BST20120111; Fast AG, 2012, CURR OPIN CHEM ENG, V1, P380, DOI 10.1016/j.coche.2012.07.005; Hatti-Kaul R, 2007, TRENDS BIOTECHNOL, V25, P119, DOI 10.1016/j.tibtech.2007.01.001; Jeremiasse AW, 2012, BIOTECHNOL BIOENG, V109, P657, DOI 10.1002/bit.24338; Jiang Y, 2013, INT J HYDROGEN ENERG, V38, P3497, DOI 10.1016/j.ijhydene.2012.12.107; Kloeke FV, 1995, ANAEROBE, V1, P351, DOI 10.1006/anae.1995.1038; Kodama Y, 2007, INT J SYST EVOL MICR, V57, P827, DOI 10.1099/ijs.0.64823-0; Kotsyurbenko OR, 2001, FEMS MICROBIOL ECOL, V38, P153, DOI 10.1111/j.1574-6941.2001.tb00893.x; Lee HS, 2009, BIOTECHNOL BIOENG, V102, P749, DOI 10.1002/bit.22107; Liu Y, 2012, CHEMSUSCHEM, V5, P1047, DOI 10.1002/cssc.201100734; Lovley DR, 2013, CURR OPIN BIOTECH, V24, P385, DOI 10.1016/j.copbio.2013.02.012; Marshall CW, 2013, CURR OPIN BIOTECH, V24, P391, DOI 10.1016/j.copbio.2013.03.016; Marshall CW, 2013, ENVIRON SCI TECHNOL, V47, P6023, DOI 10.1021/es400341b; Marshall CW, 2012, APPL ENVIRON MICROB, V78, P8412, DOI 10.1128/AEM.02401-12; MENZEL U, 1985, ARCH MICROBIOL, V143, P47, DOI 10.1007/BF00414767; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nevin KP, 2011, APPL ENVIRON MICROB, V77, P2882, DOI 10.1128/AEM.02642-10; Nevin KP, 2010, MBIO, V1, DOI 10.1128/mBio.00103-10; Ni BJ, 2011, BIOTECHNOL BIOENG, V108, P345, DOI 10.1002/bit.22908; Nie HR, 2013, PHYS CHEM CHEM PHYS, V15, P14290, DOI 10.1039/c3cp52697f; Ozawa K, 1997, ANAEROBE, V3, P339, DOI 10.1006/anae.1997.0114; Rabaey K, 2011, CURR OPIN BIOTECH, V22, P371, DOI 10.1016/j.copbio.2011.01.010; Rabaey K, 2010, NAT REV MICROBIOL, V8, P706, DOI 10.1038/nrmicro2422; Reda T, 2008, P NATL ACAD SCI USA, V105, P10654, DOI 10.1073/pnas.0801290105; Richter H, 2009, ENERG ENVIRON SCI, V2, P506, DOI 10.1039/b816647a; Rozendal RA, 2008, ENVIRON SCI TECHNOL, V42, P629, DOI 10.1021/es071720+; Schuchmann K, 2013, SCIENCE, V342, P1382, DOI 10.1126/science.1244758; Siegert M, 2014, ACS SUSTAIN CHEM ENG, V2, P910, DOI 10.1021/sc400520x; Spirito CM, 2014, CURR OPIN BIOTECH, V27, P115, DOI 10.1016/j.copbio.2014.01.003; Straub M, 2014, J BIOTECHNOL, V178, P67, DOI 10.1016/j.jbiotec.2014.03.005; vanHouten RT, 1995, BIORESOURCE TECHNOL, V54, P73, DOI 10.1016/0960-8524(95)00117-4; Venceslau SS, 2010, J BIOL CHEM, V285, P22772, DOI 10.1074/jbc.M110.124305; Zhang F, 2013, WATER RES, V47, P6122, DOI 10.1016/j.watres.2013.07.033; Zhang T, 2013, ENERG ENVIRON SCI, V6, P217, DOI 10.1039/c2ee23350a	45	100	104	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109935	10.1371/journal.pone.0109935	http://dx.doi.org/10.1371/journal.pone.0109935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333313	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200067
J	Lundgren, P; Kistner, A; Andersson, EM; Pupp, IH; Holmstrom, G; Ley, D; Niklasson, A; Smith, LEH; Wu, C; Hellstrom, A; Lofqvist, C				Lundgren, Pia; Kistner, Anna; Andersson, Eva M.; Pupp, Ingrid Hansen; Holmstrom, Gerd; Ley, David; Niklasson, Aimon; Smith, Lois E. H.; Wu, Carolyn; Hellstrom, Ann; Lofqvist, Chatarina			Low Birth Weight Is a Risk Factor for Severe Retinopathy of Prematurity Depending on Gestational Age	PLOS ONE			English	Article							LONGITUDINAL POSTNATAL WEIGHT; PRETERM INFANTS; THRESHOLD RETINOPATHY; INTRAUTERINE GROWTH; NEONATAL OUTCOMES; GAIN; BORN; PREDICTION; MORBIDITY; MORTALITY	Objective: To evaluate the impact of low birth weight as a risk factor for retinopathy of prematurity (ROP) that will require treatment in correlation with gestational age at birth (GA). Study design: In total, 2941 infants born <32 weeks GA were eligible from five cohorts of preterm infants previously collected for analysis in WINROP (Weight IGF-I Neonatal ROP) from the following locations: Sweden (EXPRESS) (n = 426), North America (n = 1772), Boston (n = 338), Lund (n = 52), and Gothenburg (n = 353). Data regarding GA at birth, birth weight (BW), gender, and need for ROP treatment were retrieved. Birth weight standard deviation scores (BWSDS) were calculated with Swedish as well as Canadian reference models. Small for gestational age (SGA) was defined as BWSDS less than -2.0 SDS using the Swedish reference and as BW below the 10 th percentile using the Canadian reference charts. Results: Univariate analysis showed that low GA (p<0.001), low BW (p<0.001), male gender (p<0.05), low BWSDSCanada (p<0.001), and SGACanada (p<0.01) were risk factors for ROP that will require treatment. In multivariable logistic regression analysis, low GA (p<0.0001), male gender (p<0.01 and p<0.05), and an interaction term of BWSDS*GA group (p<0.001), regardless of reference chart, were risk factors. Low BWSDS was less important as a risk factor in infants born at GA <26 weeks compared with infants born at GA >= 26 weeks calculated with both reference charts (BWSDSSweden, OR = 0.80 vs 0.56; and BWSDSCanada, OR = 0.72 vs 0.41). Conclusions: Low BWSDS as a risk factor for vision-threatening ROP is dependent on the infant's degree of immaturity. In more mature infants (GA >= 26 weeks), low BWSDS becomes a major risk factor for developing ROP that will require treatment. These results persist even when calculating BW deficit with different well-established approaches.	[Lundgren, Pia; Kistner, Anna; Hellstrom, Ann; Lofqvist, Chatarina] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Lundgren, Pia] Karolinska Inst, Inst Mol Med & Surg, Stockholm, Sweden; [Andersson, Eva M.] Univ Gothenburg, Dept Occupat & Environm Med, Sahlgrenska Acad, Gothenburg, Sweden; [Pupp, Ingrid Hansen; Ley, David] Lund Univ, Dept Pediat, Inst Clin Sci, Lund, Sweden; [Pupp, Ingrid Hansen; Ley, David] Skane Univ Hosp, Lund, Sweden; [Holmstrom, Gerd] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Niklasson, Aimon] Univ Gothenburg, Sahlgrenska Acad, Dept Pediat, Inst Clin Sci, Gothenburg, Sweden; [Smith, Lois E. H.; Wu, Carolyn] Harvard Univ, Sch Med, Dept Ophthalmol, Boston Childrens Hosp, Boston, MA USA	University of Gothenburg; Karolinska Institutet; University of Gothenburg; Lund University; Lund University; Skane University Hospital; Uppsala University; University of Gothenburg; Harvard University; Boston Children's Hospital; Harvard Medical School	Lundgren, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden.	pia.lundgren@gu.se	Kistner, Anna/AAG-7740-2022; Kistner, Anna/H-6720-2018; Kistner, Anna/AFL-7807-2022	Kistner, Anna/0000-0002-7942-3211; Kistner, Anna/0000-0002-7942-3211; Kistner, Anna/0000-0002-7942-3211; Hellstrom, Ann/0000-0002-9259-1244; Wu, Carolyn/0000-0003-4324-1472; Lofqvist, Chatarina/0000-0003-4371-5164; , Eva/0000-0003-1466-8987	Swedish Medical Research Council [2011-2432, 2008-2842]; VINNOVA [2009-01152, 2009-00221]; Torsten and Ragnar Soderberg Foundation; Skane Council Foundation for Research and Development; Linnea and Josef Carlsson Foundation; NIH/NEI [EY022275, EY017017, P01 HD18655]; Research to Prevent Blindness Senior Investigator Award; Alcon Research Institute Award; Lowy Medical Foundation; Herman Svensson Foundation; V. Kann Rasmussen Foundation; European Commission FP7 project [305485 PREVENT-ROP];  [ALFGB-137491];  [ALFGB-21611]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017017] Funding Source: NIH RePORTER	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); VINNOVA(Vinnova); Torsten and Ragnar Soderberg Foundation; Skane Council Foundation for Research and Development; Linnea and Josef Carlsson Foundation; NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Senior Investigator Award(Research to Prevent Blindness (RPB)); Alcon Research Institute Award; Lowy Medical Foundation; Herman Svensson Foundation; V. Kann Rasmussen Foundation; European Commission FP7 project; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Swedish Medical Research Council (grant numbers 2011-2432 and 2008-2842), government grants (grant numbers ALFGB-137491 and ALFGB-21611), VINNOVA (grant numbers 2009-01152 and 2009-00221), the Torsten and Ragnar Soderberg Foundation, the Skane Council Foundation for Research and Development, the Linnea and Josef Carlsson Foundation, and, in part, by the NIH/NEI (EY022275, EY017017, P01 HD18655), Research to Prevent Blindness Senior Investigator Award, Alcon Research Institute Award, Lowy Medical Foundation, Herman Svensson Foundation and V. Kann Rasmussen Foundation and European Commission FP7 project 305485 PREVENT-ROP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegaert K, 2004, BRIT J OPHTHALMOL, V88, P239, DOI 10.1136/bjo.2003.027474; Allegaert K, 2003, J AAPOS, V7, P34, DOI 10.1016/S1091-8531(02)42015-0; Austeng D, 2010, ACTA PAEDIATR, V99, P978, DOI 10.1111/j.1651-2227.2010.01846.x; Austeng D, 2009, ARCH OPHTHALMOL-CHIC, V127, P1315, DOI 10.1001/archophthalmol.2009.244; Bardin C, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.2.e4; Binenbaum G, 2012, ARCH OPHTHALMOL-CHIC, V130, P1560, DOI 10.1001/archophthalmol.2012.2524; Binenbaum G, 2011, PEDIATRICS, V127, pE607, DOI 10.1542/peds.2010-2240; Darlow BA, 2005, PEDIATRICS, V115, P990, DOI 10.1542/peds.2004-1309; Fortes JB, 2010, GRAEF ARCH CLIN EXP, V248, P893, DOI 10.1007/s00417-009-1248-6; Fortes JB, 2009, J PEDIAT-BRAZIL, V85, P48, DOI 10.2223/JPED.1870; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Hellstrom A, 2009, PEDIATRICS, V123, pE638, DOI 10.1542/peds.2008-2697; Holmstrom G, 1998, ACTA OPHTHALMOL SCAN, V76, P204, DOI 10.1034/j.1600-0420.1998.760216.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kaempf JW, 2011, J PERINATOL, V31, P251, DOI 10.1038/jp.2010.152; Kamoji VM, 2006, PEDIATRICS, V118, P758, DOI 10.1542/peds.2005-2399; KINSEY VE, 1949, JAMA-J AM MED ASSOC, V139, P572, DOI 10.1001/jama.1949.02900260018005; Klinger G, 2010, PEDIATRICS, V125, pE736, DOI 10.1542/peds.2009-2017; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Loqvist C, 2009, ARCH OPHTHALMOL-CHIC, V127, P622, DOI 10.1001/archophthalmol.2009.69; Lundgren P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073256; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8; Nodgaard H, 1996, ACTA OPHTHALMOL SCAN, V74, P306; Piper JM, 1996, OBSTET GYNECOL, V87, P1064; Qiu XM, 2012, AM J PERINAT, V29, P87, DOI 10.1055/s-0031-1295647; Roberts CL, 1999, MED J AUSTRALIA, V170, P114, DOI 10.5694/j.1326-5377.1999.tb127678.x; Smith PB, 2012, PEDIATRICS, V129, pE1508, DOI 10.1542/peds.2011-2216; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; USHER R, 1969, J PEDIATR-US, V74, P901, DOI 10.1016/S0022-3476(69)80224-6; Wallace DK, 2000, J AAPOS, V4, P343, DOI 10.1067/mpa.2000.110342; Woo SJ, 2011, EYE, V25, P1478, DOI 10.1038/eye.2011.208; Wu C, 2012, ARCH OPHTHALMOL-CHIC, V130, P992, DOI 10.1001/archophthalmol.2012.243; Wu C, 2010, ARCH OPHTHALMOL-CHIC, V128, P443, DOI 10.1001/archophthalmol.2010.31; Zaw W, 2003, PEDIATRICS, V111, P1273, DOI 10.1542/peds.111.6.1273	38	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109460	10.1371/journal.pone.0109460	http://dx.doi.org/10.1371/journal.pone.0109460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25330287	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200032
J	Ilic, M; Ilic, I				Ilic, Milena; Ilic, Irena			Malignant Lymphatic and Hematopoietic Neoplasms Mortality in Serbia, 1991-2010: A Joinpoint Regression Analysis	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; CANCER-MORTALITY; RISK; LEUKEMIA; TRENDS; METAANALYSIS; EUROPE; EPIDEMIOLOGY; COUNTRIES; PATTERNS	Background: Limited data on mortality from malignant lymphatic and hematopoietic neoplasms have been published for Serbia. Methods: The study covered population of Serbia during the 1991-2010 period. Mortality trends were assessed using the joinpoint regression analysis. Results: Trend for overall death rates from malignant lymphoid and haematopoietic neoplasms significantly decreased: by -2.16% per year from 1991 through 1998, and then significantly increased by +2.20% per year for the 1998-2010 period. The growth during the entire period was on average +0.8% per year (95% CI 0.3 to 1.3). Mortality was higher among males than among females in all age groups. According to the comparability test, mortality trends from malignant lymphoid and haematopoietic neoplasms in men and women were parallel (final selected model failed to reject parallelism, P = 0.232). Among younger Serbian population (0-44 years old) in both sexes: trends significantly declined in males for the entire period, while in females 15-44 years of age mortality rates significantly declined only from 2003 onwards. Mortality trend significantly increased in elderly in both genders (by +1.7% in males and +1.5% in females in the 60-69 age group, and +3.8% in males and +3.6% in females in the 70+ age group). According to the comparability test, mortality trend for Hodgkin's lymphoma differed significantly from mortality trends for all other types of malignant lymphoid and haematopoietic neoplasms (P < 0.05). Conclusion: Unfavourable mortality trend in Serbia requires targeted intervention for risk factors control, early diagnosis and modern therapy.	[Ilic, Milena; Ilic, Irena] Univ Kragujevac, Fac Med Sci, Dept Epidemiol, Kragujevac, Serbia	University of Kragujevac	Ilic, M (corresponding author), Univ Kragujevac, Fac Med Sci, Dept Epidemiol, Kragujevac, Serbia.	drmilenailic@yahoo.com	Ilic, Milena/W-1498-2019; Matsuo, Keitaro/H-6758-2019; Ilic, Irena/T-8121-2019	Matsuo, Keitaro/0000-0003-1761-6314; Ilic, Irena/0000-0001-5347-3264; Ilic, Milena/0000-0003-3229-4990	Ministry of Education and Science of Republic of Serbia [175042]	Ministry of Education and Science of Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education and Science of Republic of Serbia, through Contract No. 175042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2008, CANCER EPIDEM BIOMAR, V17, P3069, DOI 10.1158/1055-9965.EPI-08-0408; [Anonymous], 1993, IMPACT UN SECURITY C; Balasubramaniam G, 2013, ASIAN PAC J CANCER P, V14, P5657, DOI 10.7314/APJCP.2013.14.10.5657; Bertuccio P, 2013, INT J CANCER, V132, P427, DOI 10.1002/ijc.27624; Bikit I, 2005, APPL RADIAT ISOTOPES, V63, P261, DOI 10.1016/j.apradiso.2005.03.015; Bosetti C, 2008, ANN ONCOL, V19, P631, DOI 10.1093/annonc/mdm597; Bosetti C, 2009, ANN ONCOL, V20, P767, DOI 10.1093/annonc/mdn673; Bosetti C, 2008, INT J CANCER, V123, P1917, DOI 10.1002/ijc.23722; Castillo JJ, 2012, BLOOD, V119, P4845, DOI 10.1182/blood-2011-06-362830; Center for Prevention and Control of Noncommunicable Diseases (2003-2010), 1999, CANC INC MORT CENTR; Chen GC, 2013, INT J CANCER, V133, P190, DOI 10.1002/ijc.27992; Clarke CA, 2002, CANCER-AM CANCER SOC, V94, P2015, DOI 10.1002/cncr.10403; Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733; Collier AC, 1996, NEW ENGL J MED, V334, P1011, DOI 10.1056/NEJM199604183341602; Coory M, 2008, INTERN MED J, V38, P921, DOI 10.1111/j.1445-5994.2008.01809.x; Dal Maso L, 2006, CANCER EPIDEM BIOMAR, V15, P2078, DOI 10.1158/1055-9965.EPI-06-0308; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferlay J, 2010, GLOBOCAN 2008 CANC I; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gluzman D., 2006, Experimental Oncology, V28, P60; Hajder J, 2012, J BUON, V17, P753; Howlander N, 2013, SEER CANC STAT REV, P1975; Institute of Public Health of the Republic of Serbia Dr Milan Jovanovic Batut', 2008, HLTH POP SERB AB STU; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V83; Jaffe ESHN., 2001, WHO CLASSIFICATION T; Jakovljevic K, 2012, LEUKEMIA LYMPHOMA, V53, P1327, DOI 10.3109/10428194.2011.645210; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen OM, 1991, CANC REGISTRATION PR; Karami S, 2013, OCCUP ENVIRON MED, V70, P591, DOI 10.1136/oemed-2012-101212; Kim HJ, 2004, BIOMETRICS, V60, P1005, DOI 10.1111/j.0006-341X.2004.00256.x; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kovacevic AM, 2014, HOSP PHARM, V1, P93, DOI DOI 10.5937/HPIMJ1402093K; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Kunitz SJ, 2004, AM J PUBLIC HEALTH, V94, P1894, DOI 10.2105/AJPH.94.11.1894; Larsson SC, 2011, EUR J CANCER, V47, P2422, DOI 10.1016/j.ejca.2011.06.029; Levi F, 2000, LEUKEMIA, V14, P1980, DOI 10.1038/sj.leu.2401915; Levi F, 2002, BRIT J CANCER, V87, P291, DOI 10.1038/sj.bjc.6600452; MARKOVICDENIC LJ, 1995, NEOPLASMA, V42, P79; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Medicines and Medical Devices Agency of Serbia, MED PROD; Mihaljevic B, 2010, ACTA CLIN, V10, P33; Ministry of Health, 2006, NAT HLTH SURV SERB 2; Montella M, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.12725; Morton LM, 2007, BLOOD, V110, P695, DOI 10.1182/blood-2006-11-051672; Muller AMS, 2005, ANN HEMATOL, V84, P1, DOI 10.1007/s00277-004-0939-7; Novak I, 2012, CROAT MED J, V53, P115, DOI 10.3325/cmj.2012.53.115; Parkin DM, 2010, INT J CANCER, V126, P1187, DOI 10.1002/ijc.24838; Pastor-Barriuso R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-250; Scudla Vlastimil, 2003, Hematol J, V4, P351, DOI 10.1038/sj.thj.6200309; Sergentanis TN, 2013, EUR J CANCER PREV, V22, P131, DOI 10.1097/CEJ.0b013e328355ed08; Shiels MS, 2013, CANCER EPIDEM BIOMAR, V22, P1069, DOI 10.1158/1055-9965.EPI-13-0040; Statistical Office of the Republic of Serbia, 2011, DEM YB REP SERB 1991; Storm HH, 2010, ACTA ONCOL, V49, P694, DOI 10.3109/02841861003631495; Takkouche B, 2009, INT J EPIDEMIOL, V38, P1512, DOI 10.1093/ije/dyp283; The European Society for Medical Oncology, ESMO CLIN PRACT GUID; Tramacere I, 2012, ANN ONCOL, V23, P2791, DOI 10.1093/annonc/mds013; Verdecchia A, 2009, ANN I SUPER SANITA, V45, P315; Vlajinac HD, 2003, NEOPLASMA, V50, P79	58	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109379	10.1371/journal.pone.0109379	http://dx.doi.org/10.1371/journal.pone.0109379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333862	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200014
J	Koller, D; Hackl, H; Bogner-Strauss, JG; Hermetter, A				Koller, Daniel; Hackl, Hubert; Bogner-Strauss, Juliane Gertrude; Hermetter, Albin			Effects of Oxidized Phospholipids on Gene Expression in RAW 264.7 Macrophages: A Microarray Study	PLOS ONE			English	Article							MINIMALLY MODIFIED LDL; PROGRAMMED CELL-DEATH; C-JUN; CHOLESTEROL EFFLUX; UP-REGULATION; ENDOTHELIAL-CELLS; TNF-ALPHA; PROTEIN; ACTIVATION; ATHEROSCLEROSIS	Oxidized phospholipids (oxPLs) are components of oxidized LDL (oxLDL). It is known that oxLDL activates expression of a series of atherogenic genes and their oxPLs contribute to their biological activities. In this study we present the effects of 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine (PGPC) and 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC) on gene expression in RAW 264.7 macrophages using cDNA microarrays. PGPC affected the regulation of 146 genes, whereas POVPC showed only very minor effects. PGPC preferentially influenced expression of genes related to cell death, angiogenesis, cholesterol efflux, procoagulant mechanisms, atherogenesis, inflammation, and cell cycle. Many of these effects are known from studies with oxLDL or oxidized 1-hexadecanoyl-2-eicosatetra-59,89,119,149-enoyl-sn-glycero-3phosphocholine (oxPAPC), containing PGPC in addition to other oxPL species. It is known that POVPC efficiently reacts with proteins by Schiff base formation, whereas PGPC only physically interacts with its biological targets. POVPC seems to affect cell physiology to a great extent on the protein level, whereas PGPC gives rise to both the modulation of protein function and regulation on the transcriptional level.	[Koller, Daniel; Bogner-Strauss, Juliane Gertrude; Hermetter, Albin] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Hackl, Hubert] Med Univ Innsbruck, Bioctr, Div Bioinformat, A-6020 Innsbruck, Austria	Graz University of Technology; Medical University of Innsbruck	Hermetter, A (corresponding author), Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria.	albin.hermetter@tugraz.at	Hackl, Hubert/B-3168-2018	Hackl, Hubert/0000-0003-4055-3841; Bogner-Strauss, Juliane/0000-0003-2459-0124	Austrian Science Fund (FWF) [I308-B12, P24143]; Austrian Science Fund (FWF) [F 3006, I 308] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (FWF), grant numbers I308-B12 (to AH) and P24143 (to JGBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonyushkin T, 2010, ARTERIOSCL THROM VAS, V30, P1007, DOI 10.1161/ATVBAHA.110.204354; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; BATZRI S, 1973, BIOCHIM BIOPHYS ACTA, V298, P1015, DOI 10.1016/0005-2736(73)90408-2; Ben-Porath I, 1999, MOL CELL BIOL, V19, P3529; Bochkov VN, 2006, CIRC RES, V99, P900, DOI 10.1161/01.RES.0000245485.04489.ee; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Groeneweg M, 2008, BBA-MOL CELL BIOL L, V1781, P336, DOI 10.1016/j.bbalip.2008.04.016; Groeneweg M, 2006, J LIPID RES, V47, P2259, DOI 10.1194/jlr.M600181-JLR200; Hagg D, 2006, ATHEROSCLEROSIS, V185, P282, DOI 10.1016/j.atherosclerosis.2005.06.034; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Herijgers N, 1997, ARTERIOSCL THROM VAS, V17, P1995, DOI 10.1161/01.ATV.17.10.1995; Hermetter A, 2013, BBA-BIOMEMBRANES, V1828, P1700, DOI 10.1016/j.bbamem.2013.03.030; Hirose K, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029092; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Kadl A, 2002, VASC PHARMACOL, V38, P219, DOI 10.1016/S1537-1891(02)00172-6; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Khurana R, 2005, CIRCULATION, V112, P1813, DOI 10.1161/CIRCULATIONAHA.105.535294; KUMAMOTO M, 1995, HUM PATHOL, V26, P450, DOI 10.1016/0046-8177(95)90148-5; Linton MF, 1999, J BIOL CHEM, V274, P19204, DOI 10.1074/jbc.274.27.19204; Loidl A, 2004, BBA-MOL BASIS DIS, V1690, P150, DOI 10.1016/j.bbadis.2004.06.003; Loidl A, 2003, J BIOL CHEM, V278, P32921, DOI 10.1074/jbc.M306088200; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; McCaffrey TA, 2000, J CLIN INVEST, V105, P653, DOI 10.1172/JCI8592; Moulton KS, 2003, P NATL ACAD SCI USA, V100, P4736, DOI 10.1073/pnas.0730843100; Moumtzi A, 2007, J LIPID RES, V48, P565, DOI 10.1194/jlr.M600394-JLR200; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Nawa T, 2002, ATHEROSCLEROSIS, V161, P281, DOI 10.1016/S0021-9150(01)00639-6; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oskolkova OV, 2008, BLOOD, V112, P330, DOI 10.1182/blood-2007-09-112870; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Pinent M, 2005, INT J OBESITY, V29, P934, DOI 10.1038/sj.ijo.0802988; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Reddy ST, 2002, VASC PHARMACOL, V38, P211, DOI 10.1016/S1537-1891(02)00171-4; ROBAYE B, 1991, AM J PATHOL, V138, P447; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Ruiz-Velasco N, 2004, BIOCHEM PHARMACOL, V67, P303, DOI 10.1016/j.bcp.2003.09.006; Shang YY, 2009, FEBS J, V276, P2752, DOI 10.1111/j.1742-4658.2009.06998.x; Shtil AA, 1999, ONCOGENE, V18, P377, DOI 10.1038/sj.onc.1202305; Steinberg D, 2003, LIPOPROTEINS LIPOPRO; Stemmer U, 2012, BBA-MOL CELL BIOL L, V1821, P706, DOI 10.1016/j.bbalip.2012.01.014; Stemmer U, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-110; Stemmer U, 2012, BBA-BIOMEMBRANES, V1818, P2436, DOI 10.1016/j.bbamem.2012.03.006; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; TAKASHIBA S, 1993, GENE, V131, P307, DOI 10.1016/0378-1119(93)90314-S; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang NP, 1999, CIRC RES, V85, P387, DOI 10.1161/01.RES.85.5.387; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yin TG, 1997, J BIOL CHEM, V272, P19943, DOI 10.1074/jbc.272.32.19943; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zettler ME, 2004, ARTERIOSCL THROM VAS, V24, P727, DOI 10.1161/01.ATV.0000120373.95552.aa	67	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110486	10.1371/journal.pone.0110486	http://dx.doi.org/10.1371/journal.pone.0110486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333283	gold, Green Published			2022-12-27	WOS:000343731200046
J	Ajslev, TA; Angquist, L; Silventoinen, K; Baker, JL; Sorensen, TIA				Ajslev, Teresa A.; Aengquist, Lars; Silventoinen, Karri; Baker, Jennifer L.; Sorensen, Thorkild I. A.			Trends in Parent-Child Correlations of Childhood Body Mass Index during the Development of the Obesity Epidemic	PLOS ONE			English	Article							ENVIRONMENTAL-INFLUENCES; COHORT; BIRTH; ASSOCIATIONS; DENMARK; MOTHER; WEIGHT; HEALTH; RISK	Background: The intergenerational resemblance in body mass index may have increased during the development of the obesity epidemic due to changes in environment and/or expression of genetic predisposition. Objectives: This study investigates trends in intergenerational correlations of childhood body mass index (BMI; kg/m(2)) during the emergence of the obesity epidemic. Methods: The study population was derived from the Copenhagen School Health Records Register, which includes height and weight measurements since birth year 1930. Mothers and fathers with BMIs available at ages 7 (n = 25,923 and n = 20,972) or 13 years (n = 26,750 and n = 21,397), respectively, were linked through the civil registration system introduced in 1968 to their children with BMIs available at age 7 years. Age- and sex-specific BMI z-scores were calculated. Correlations were estimated across eight intervals of child birth years (1952-1989) separately by sex. Trends in these correlations were examined. Whereas the mother-child correlations reflected the biological relationship, a likely decline in the assignment of non-biological fathers through the registration system across time must be considered when interpreting the father-child correlations. Results: The BMI correlations between mothers and sons ranged from 0.29-0.36 and they decreased marginally, albeit significantly across time at ages 7-7 years (20.002/year, p = 0.006), whereas those at 13-7 years remained stable (<0.0004/year, p = 0.96). Mother-daughter correlations ranged from 0.30-0.34, and they were stable at ages 7-7 years (0.0001/year, p = 0.84) and at 13-7 years (0.0004/year, p = 0.56). In contrast, father-son correlations increased significantly during this period, both at ages 7-7 (0.002/year, p = 0.007) and at ages 13-7 years (0.003/year, p, 0.001), whereas the increase in father-daughter correlations were insignificant both at ages 7-7 (0.001/year, p = 0.37) and at ages 13-7 years (0.001/year, p = 0.18). Conclusion: During the obesity epidemics development, the intergenerational resemblance with mothers remained stable, whereas the father-child BMI resemblance increased, possibly reflecting changes in family relationships, and unlikely to have influenced the epidemic.	[Ajslev, Teresa A.; Aengquist, Lars; Baker, Jennifer L.; Sorensen, Thorkild I. A.] Frederiksberg & Bispebjerg Hosp, Inst Prevent Med, Frederiksberg, Denmark; [Baker, Jennifer L.; Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Silventoinen, Karri] Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland	Novo Nordisk Foundation; University of Copenhagen; University of Helsinki	Ajslev, TA (corresponding author), Frederiksberg & Bispebjerg Hosp, Inst Prevent Med, Frederiksberg, Denmark.	teresa.ajslev@regionh.dk	Baker, Jennifer/F-1917-2010; Baker, Jennifer L./AAH-4693-2020	Baker, Jennifer/0000-0002-9649-6615; Baker, Jennifer L./0000-0002-9649-6615; Angquist, Lars/0000-0002-9516-4424; Silventoinen, Karri/0000-0003-1759-3079	UNIK Food, Fitness and Pharma program [28]; Danish Ministry of Science, Technology and Innovation; Helsefonden [2008B104]	UNIK Food, Fitness and Pharma program; Danish Ministry of Science, Technology and Innovation; Helsefonden	This study was funded by The UNIK Food, Fitness and Pharma program, grant 28 (www.foodfitnesspharma.ku.dk). The UNIK project is supported by the Danish Ministry of Science, Technology and Innovation. Funding was also received from Helsefonden (grant number 2008B104). We thank the Danish Governmental Archive for their ongoing work in preserving the Copenhagen School Health Records. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajslev I A, 2012, FRONT GENET, V3; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Baker JL, 2009, INT J EPIDEMIOL, V38, P656, DOI 10.1093/ije/dyn164; Bua J, 2007, OBESITY, V15, P977, DOI 10.1038/oby.2007.603; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Classen TJ, 2010, ECON HUM BIOL, V8, P30, DOI 10.1016/j.ehb.2009.11.002; Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Fleten C, 2012, AM J EPIDEMIOL, V176, P83, DOI 10.1093/aje/kws134; Jaaskelainen A, 2011, INT J OBESITY, V35, P1289, DOI 10.1038/ijo.2011.150; Jacobson P, 2007, AM J EPIDEMIOL, V165, P101, DOI 10.1093/aje/kwj342; Johnson PCD, 2012, EUR J EPIDEMIOL, V27, P53, DOI 10.1007/s10654-011-9639-5; Kivimaki M, 2007, AM J CLIN NUTR, V86, P1509, DOI 10.1093/ajcn/86.5.1509; Knudsen Lisbeth B, 1993, STAT UNDERSOGELSER; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Olsen LW, 2006, EPIDEMIOLOGY, V17, P292, DOI 10.1097/01.ede.0000208349.16893.e0; Patel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014607; Patro B, 2013, ANN NUTR METAB, V63, P32, DOI 10.1159/000350313; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Perez-Pastor EM, 2009, INT J OBESITY, V33, P727, DOI 10.1038/ijo.2009.76; Power C, 2011, ANN HUM BIOL, V38, P390, DOI 10.3109/03014460.2011.591827; Rokholm B, 2013, INT J OBESITY, V37, P211, DOI 10.1038/ijo.2012.151; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027135; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020816; Schwenk RW, 2013, MOL METAB, V2, P337, DOI 10.1016/j.molmet.2013.09.002; Silventoinen K, 2007, INT J OBESITY, V31, P615, DOI 10.1038/sj.ijo.0803577; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; Smith GD, 2007, ARCH DIS CHILD, V92, P876, DOI 10.1136/adc.2006.104869; SORENSEN TIA, 1992, INT J OBESITY, V16, P705; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; Thomsen BL, 1999, INT J OBESITY, V23, P693, DOI 10.1038/sj.ijo.0800907; Vatter R H, 1994, Stat Bull Metrop Insur Co, V75, P2; Voracek M, 2008, PSYCHOL REPORTS, V103; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Wolf JB, 2008, EPIGENETICS-US, V3, P295, DOI 10.4161/epi.3.6.7257	37	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109932	10.1371/journal.pone.0109932	http://dx.doi.org/10.1371/journal.pone.0109932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329656	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100036
J	Kumar, S; van Raam, BJ; Salvesen, GS; Cieplak, P				Kumar, Sonu; van Raam, Bram J.; Salvesen, Guy S.; Cieplak, Piotr			Caspase Cleavage Sites in the Human Proteome: CaspDB, a Database of Predicted Substrates	PLOS ONE			English	Article							GRANZYME-B; SEQUENCE; SPECIFICITY; RESOURCE; VARIANT; SIZE	Caspases are enzymes belonging to a conserved family of cysteine-dependent aspartic-specific proteases that are involved in vital cellular processes and play a prominent role in apoptosis and inflammation. Determining all relevant protein substrates of caspases remains a challenging task. Over 1500 caspase substrates have been discovered in the human proteome according to published data and new substrates are discovered on a daily basis. To aid the discovery process we developed a caspase cleavage prediction method using the recently published curated MerCASBA database of experimentally determined caspase substrates and a Random Forest classification method. On both internal and external test sets, the ranking of predicted cleavage positions is superior to all previously developed prediction methods. The in silico predicted caspase cleavage positions in human proteins are available from a relational database: CaspDB. Our database provides information about potential cleavage sites in a verified set of all human proteins collected in Uniprot and their orthologs, allowing for tracing of cleavage motif conservation. It also provides information about the positions of disease-annotated single nucleotide polymorphisms, and posttranslational modifications that may modulate the caspase cleaving efficiency.	[Kumar, Sonu; van Raam, Bram J.; Salvesen, Guy S.; Cieplak, Piotr] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Cieplak, P (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	pcieplak@sanfordburnham.org	Kumar, Sonu/AAH-2962-2019; Kumar, Sonu/AAA-1746-2019; Kumar, Sonu/GZA-9110-2022	Kumar, Sonu/0000-0003-0423-2880; van Raam, Bram/0000-0002-6500-2731	National Institutes of Health (NIH) [R01GM098835, R01GM099040]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098835, R01GM099040] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grants R01GM098835 (PC) and R01GM099040 (GSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053786; Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; Barkan DT, 2010, BIOINFORMATICS, V26, P1714, DOI 10.1093/bioinformatics/btq267; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boutet Emmanuel, 2007, V406, P89; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; Chae JJ, 2008, BLOOD, V112, P1794, DOI 10.1182/blood-2008-01-134932; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Crawford ED, 2012, CELL DEATH DIFFER, V19, P2040, DOI 10.1038/cdd.2012.99; Crawford ED, 2013, MOL CELL PROTEOMICS, V12, P813, DOI 10.1074/mcp.O112.024372; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Fridman A, 2013, APOPTOSIS, V18, P369, DOI 10.1007/s10495-012-0789-z; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Lange PF, 2012, NUCLEIC ACIDS RES, V40, pD351, DOI 10.1093/nar/gkr1025; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Los M, 2001, TRENDS IMMUNOL, V22, P31, DOI 10.1016/S1471-4906(00)01814-7; Lu CT, 2013, NUCLEIC ACIDS RES, V41, pD295, DOI 10.1093/nar/gks1229; Luschen S, 1998, BIOCHEM BIOPH RES CO, V253, P92, DOI 10.1006/bbrc.1998.9754; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mansouri M, 2012, J BIOMECH, V45, P1517, DOI 10.1016/j.jbiomech.2012.03.016; Mark Hall EF, 2009, SIGKDD EXPLORATIONS, P11; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piippo M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-320; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Poreba M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008680; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Taylor RC, 2007, J BIOL CHEM, V282, P15011, DOI 10.1074/jbc.M611051200; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Turowec JP, 2014, MOL CELL PROTEOMICS, V13, P1184, DOI 10.1074/mcp.M113.037374; Wang MJ, 2014, BIOINFORMATICS, V30, P71, DOI 10.1093/bioinformatics/btt603; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; Yip YL, 2004, HUM MUTAT, V23, P464, DOI 10.1002/humu.20021	44	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110539	10.1371/journal.pone.0110539	http://dx.doi.org/10.1371/journal.pone.0110539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330111	gold, Green Published			2022-12-27	WOS:000345204100090
J	Mokry, T; Bellemann, N; Muller, D; Bermejo, JL; Klauss, M; Stampfl, U; Radeleff, B; Schemmer, P; Kauczor, HU; Sommer, CM				Mokry, Theresa; Bellemann, Nadine; Mueller, Dirk; Bermejo, Justo Lorenzo; Klauss, Miriam; Stampfl, Ulrike; Radeleff, Boris; Schemmer, Peter; Kauczor, Hans-Ulrich; Sommer, Christof-Matthias			Accuracy of Estimation of Graft Size for Living-Related Liver Transplantation: First Results of a Semi-Automated Interactive Software for CT-Volumetry	PLOS ONE			English	Article							DONOR; COMPUTER; WEIGHT	Objectives: To evaluate accuracy of estimated graft size for living-related liver transplantation using a semi-automated interactive software for CT-volumetry. Materials and Methods: Sixteen donors for living-related liver transplantation (11 male; mean age: 38.2 +/- 9.6 years) underwent contrast-enhanced CT prior to graft removal. CT-volumetry was performed using a semi-automated interactive software (P), and compared with a manual commercial software (TR). For P, liver volumes were provided either with or without vessels. For TR, liver volumes were provided always with vessels. Intraoperative weight served as reference standard. Major study goals included analyses of volumes using absolute numbers, linear regression analyses and interobserver agreements. Minor study goals included the description of the software workflow: degree of manual correction, speed for completion, and overall intuitiveness using five-point Likert scales: 1-markedly lower/faster/higher for P compared with TR, 2-slightly lower/faster/higher for P compared with TR, 3-identical for P and TR, 4-slightly lower/faster/higher for TR compared with P, and 5-markedly lower/faster/higher for TR compared with P. Results: Liver segments II/III, II-IV and V-VIII served in 6, 3, and 7 donors as transplanted liver segments. Volumes were 642.9 +/- 368.8 ml for TR with vessels, 623.8 +/- 349.1 ml for P with vessels, and 605.2 +/- 345.8 ml for P without vessels (P<0.01). Regression equations between intraoperative weights and volumes were y = 0.94x + 30.1 (R-2 = 0.92; P< 0.001) for TR with vessels, y = 1.00x+12.0 (R-2 = 0.92; P< 0.001) for P with vessels, and y = 1.01x+28.0 (R-2 = 0.92; P< 0.001) for P without vessels. Inter-observer agreement showed a bias of 1.8 ml for TR with vessels, 5.4 ml for P with vessels, and 4.6 ml for P without vessels. For the degree of manual correction, speed for completion and overall intuitiveness, scale values were 2.6 +/- 0.8, 2.4 +/- 0.5 and 2. Conclusions: CT-volumetry performed with P can predict accurately graft size for living-related liver transplantation while improving workflow compared with TR.	[Mokry, Theresa; Bellemann, Nadine; Klauss, Miriam; Stampfl, Ulrike; Radeleff, Boris; Kauczor, Hans-Ulrich; Sommer, Christof-Matthias] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Mueller, Dirk] Philips Healthcare Germany, Hamburg, Germany; [Bermejo, Justo Lorenzo] Univ Heidelberg Hosp, Dept Med Biometry & Informat, Heidelberg, Germany; [Schemmer, Peter] Univ Heidelberg Hosp, Dept Gen & Transplant Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Philips; Philips Healthcare; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Sommer, CM (corresponding author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.	christof.sommer@med.uni-heidelberg.de	Kauczor, Hans-Ulrich/AAU-5955-2021; Kauczor, HU/AAX-6033-2021	Lorenzo Bermejo, Justo/0000-0002-6568-5333				Dello SAWG, 2011, WORLD J SURG, V35, P386, DOI 10.1007/s00268-010-0877-6; Fischer L, 2010, EUR J RADIOL, V74, pE145, DOI 10.1016/j.ejrad.2009.05.033; Fukazawa K, 2013, TRANSPL INT, V26, P724, DOI 10.1111/tri.12111; Grant RC, 2013, CLIN TRANSPLANT, V27, P140, DOI 10.1111/ctr.12031; Hori M, 2011, LIVER TRANSPLANT, V17, P1427, DOI 10.1002/lt.22419; Kamel IR, 2000, AM J ROENTGENOL, V175, P1141, DOI 10.2214/ajr.175.4.1751141; Kim KW, 2010, RADIOLOGY, V256, P433, DOI 10.1148/radiol.10091897; Krawczyk M, 2003, HPB (Oxford), V5, P146, DOI 10.1080/13651820310000938; Lemke AJ, 2006, RADIOLOGY, V240, P736, DOI 10.1148/radiol.2403042062; Li YC, 2011, PEDIATR SURG INT, V27, P445, DOI 10.1007/s00383-010-2830-z; Muller SA, 2007, NEPHROL DIAL TRANSPL, V22, P13, DOI 10.1093/ndt/gfm653; Muller SA, 2011, J SURG RES, V171, P87, DOI 10.1016/j.jss.2010.02.038; Nakayama Y, 2006, RADIOLOGY, V240, P743, DOI 10.1148/radiol.2403050850; Neumann JO, 2006, AM J TRANSPLANT, V6, P1407, DOI 10.1111/j.1600-6143.2006.01315.x; Puesken M, 2011, ROFO-FORTSCHR RONTG, V183, P372, DOI 10.1055/s-0029-1245983; Ringe KI, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-21; Satou S, 2011, J HEPATO-BIL-PAN SCI, V18, P586, DOI 10.1007/s00534-011-0374-9; Sauer P, 2004, NEPHROL DIAL TRANSPL, V19, P11, DOI 10.1093/ndt/gfh1035; Schemmer P, 2005, TRANSPLANTATION, V80, pS138, DOI 10.1097/01.tp.0000187132.49178.ec; Tongyoo A, 2012, AM J TRANSPLANT, V12, P1229, DOI 10.1111/j.1600-6143.2011.03909.x; Yoneyama T, 2011, LIVER TRANSPLANT, V17, P369, DOI 10.1002/lt.22239; Zhou JY, 2010, EUR RADIOL, V20, P1738, DOI 10.1007/s00330-010-1712-z	22	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110201	10.1371/journal.pone.0110201	http://dx.doi.org/10.1371/journal.pone.0110201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330198	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100046
J	Mozo-Villarias, A; Cedano, J; Querol, E				Mozo-Villarias, Angel; Cedano, Juan; Querol, Enrique			A Model of Protein Association Based on Their Hydrophobic and Electric Interactions	PLOS ONE			English	Article							THERMAL-STABILITY; ATOMIC-STRUCTURE; ACTIN; MECHANISMS; SURFACE; MOMENT	The propensity of many proteins to oligomerize and associate to form complex structures from their constituent monomers, is analyzed in terms of their hydrophobic (H), and electric pseudo-dipole (D) moment vectors. In both cases these vectors are defined as the product of the distance between their positive and negative centroids, times the total hydrophobicity or total positive charge of the protein. Changes in the magnitudes and directions of H and D are studied as monomers associate to form larger complexes. We use these descriptors to study similarities and differences in two groups of associations: a) open associations such as polymers with an undefined number of monomers (i. e. actin polymerization, amyloid and HIV capsid assemblies); b) closed symmetrical associations of finite size, like spherical virus capsids and protein cages. The tendency of the hydrophobic moments of the monomers in an association is to align in parallel arrangements following a pattern similar to those of phospholipids in a membrane. Conversely, electric dipole moments of monomers tend to align in antiparallel associations. The final conformation of a given assembly is a fine-tuned combination of these forces, limited by steric constraints. This determines whether the association will be open (indetermined number of monomers) or closed (fixed number of monomers). Any kinetic, binding or molecular peculiarities that characterize a protein assembly, comply with the vector rules laid down in this paper. These findings are also independent of protein size and shape.	[Mozo-Villarias, Angel] Univ Lleida, Inst Recerca Biomed Lleida, Lleida, Spain; [Mozo-Villarias, Angel] Univ Lleida, Dept Med Expt, Lleida, Spain; [Cedano, Juan] Univ Republ Reg Norte Salto, Lab Inmunol, Salto, Uruguay; [Querol, Enrique] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Querol, Enrique] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; Universitat de Lleida; Universidad de la Republica, Uruguay; Autonomous University of Barcelona; Autonomous University of Barcelona	Mozo-Villarias, A (corresponding author), Univ Lleida, Inst Recerca Biomed Lleida, Lleida, Spain.	angel.mozo@mex.udl.cat	Cedano, Juan/HIR-3692-2022	Cedano, Juan/0000-0003-1380-8036	MCYT (Ministerio de Ciencia y Tecnologia, Spain) [BIO2013-48704-R]; Centre de Referencia de R+D de Biotecnologia de la Generalitat de Catalunya; Comision Coordinadora del Interior de Uruguay	MCYT (Ministerio de Ciencia y Tecnologia, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Centre de Referencia de R+D de Biotecnologia de la Generalitat de Catalunya(Generalitat de Catalunya); Comision Coordinadora del Interior de Uruguay	This research was supported by grant BIO2013-48704-R from MCYT (Ministerio de Ciencia y Tecnologia, Spain); from the Centre de Referencia de R+D de Biotecnologia de la Generalitat de Catalunya and from the Comision Coordinadora del Interior de Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Carlsson AE, 2010, ANNU REV BIOPHYS, V39, P91, DOI 10.1146/annurev.biophys.093008.131207; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Eisenberg D, 2012, FARADAY S CHEM SOC, V17, P109; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fan L, 2002, J STRUCT BIOL, V138, P92; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Gomis-Roth FX, 2003, STRUCTURE, V11, P423, DOI 10.1016/S0969-2126(03)00050-9; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107; Hummer G, 1999, J AM CHEM SOC, V121, P6299, DOI 10.1021/ja984414s; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kim W, 2008, J MOL BIOL, V377, P565, DOI 10.1016/j.jmb.2007.12.079; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Levy Y, 2006, ACCOUNTS CHEM RES, V39, P135, DOI 10.1021/ar040204a; Lucas RW, 2002, J MOL BIOL, V317, P95, DOI 10.1006/jmbi.2001.5389; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; Matthews JM, 2012, PROTEIN DIMERIZATION, P170; Mozo-Villarias A, 2003, PROTEIN ENG, V16, P279, DOI 10.1093/proeng/gzg033; Mozo-Villarias A, 2006, PROTEIN J, V25, P529, DOI 10.1007/s10930-006-9039-y; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Querol E, 1996, PROTEIN ENG, V9, P265, DOI 10.1093/protein/9.3.265; Sabate R, 2010, J MOL BIOL, V404, P337, DOI 10.1016/j.jmb.2010.09.052; Sarkar A, 2010, CURR TOP MED CHEM, V10, P67, DOI 10.2174/156802610790232233; Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526; Tsuchiya Y, 2006, PROTEIN ENG DES SEL, V19, P421, DOI 10.1093/protein/gzl026; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	36	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110352	10.1371/journal.pone.0110352	http://dx.doi.org/10.1371/journal.pone.0110352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329830	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100065
J	Shashova, EE; Lyupina, YV; Glushchenko, SA; Slonimskaya, EM; Savenkova, OV; Kulikov, AM; Gornostaev, NG; Kondakova, IV; Sharova, NP				Shashova, Elena E.; Lyupina, Yulia V.; Glushchenko, Svetlana A.; Slonimskaya, Elena M.; Savenkova, Olga V.; Kulikov, Alexey M.; Gornostaev, Nikolay G.; Kondakova, Irina V.; Sharova, Natalia P.			Proteasome Functioning in Breast Cancer: Connection with Clinical-Pathological Factors	PLOS ONE			English	Article							CHYMOTRYPSIN-LIKE ACTIVITY; MHC CLASS-I; 20S PROTEASOME; ESTROGEN-RECEPTOR; EXPRESSION; SUBUNITS; CELLS; CARCINOMA; MICRORNA; GROWTH	Breast cancer is one of four oncology diseases that are most widespread in the world. Moreover, breast cancer is one of leading causes of cancer-related deaths in female population within economically developed regions of the world. So far, detection of new mechanisms of breast cancer development is very important for discovery of novel areas in which therapy approaches may be elaborated. The objective of the present study is to investigate involvement of proteasomes, which cleave up to 90% of cellular proteins and regulate numerous cellular processes, in mechanisms of breast cancer development. Proteasome characteristics in 106 patient breast carcinomas and adjacent tissues, as well as relationships of detected proteasome parameters with clinical-pathological factors, were investigated. Proteasome chymotrypsin-like activity was evaluated by hydrolysis of fluorogenic peptide Suc-LLVY-AMC. The expression of proteasome subunits was studied by Western-blotting and immunohistochemistry. The wide range of chymotrypsin-like activity in tumors was detected. Activity in tumors was higher if compared to adjacent tissues in 76 from 106 patients. Multiple analysis of generalized linear models discovered that in estrogen alpha-receptor absence, tumor growth was connected with the enhanced expression of proteasome immune subunit LMP2 and proteasome activator PA700 in tumor (at 95% confidence interval). Besides, by this analysis we detected some phenomena in adjacent tissue, which are important for tumor growth and progression of lymph node metastasis in estrogen alpha-receptor absence. These phenomena are related to the enhanced expression of activator PA700 and immune subunit LMP7. Thus, breast cancer development is connected with functioning of immune proteasome forms and activator PA700 in patients without estrogen alpha-receptors in tumor cells. These results could indicate a field for search of new therapy approaches for this category of patients, which has the worst prognosis of health recovery.	[Shashova, Elena E.; Kondakova, Irina V.] Russian Acad Med Sci, Dept Expt Oncol, Canc Res Inst, Siberian Branch, Tomsk, Russia; [Lyupina, Yulia V.; Sharova, Natalia P.] Russian Acad Sci, Dept Biochem Ontogenesis Proc, NK Koltsov Inst Dev Biol, Moscow, Russia; [Glushchenko, Svetlana A.; Savenkova, Olga V.] Russian Acad Med Sci, Dept Pathol Anat & Cytol, Canc Res Inst, Siberian Branch, Tomsk, Russia; [Slonimskaya, Elena M.] Russian Acad Med Sci, Dept Gen Oncol, Canc Res Inst, Siberian Branch, Tomsk, Russia; [Slonimskaya, Elena M.] Siberian State Med Univ, Dept Oncol, Tomsk, Russia; [Kulikov, Alexey M.; Gornostaev, Nikolay G.] Russian Acad Sci, Dept Evolutionary & Dev Genet, NK Koltsov Inst Dev Biol, Moscow, Russia	Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Cancer Research Institute of the RAS; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Cancer Research Institute of the RAS; Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Cancer Research Institute of the RAS; Siberian State Medical University; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Sharova, NP (corresponding author), Russian Acad Sci, Dept Biochem Ontogenesis Proc, NK Koltsov Inst Dev Biol, Moscow, Russia.	npsharova@bk.ru	Sharova, Natalia P/B-8361-2014; Kondakova, Irina/C-8658-2012; Gornostaev, Nikolay/E-6135-2014; Lyupina, Yulia V/B-8365-2014; Sereda, Elena/D-1472-2012; Slonimskaya, Elena/C-7405-2012; Kulikov, Alex/E-5495-2014	Kondakova, Irina/0000-0002-0947-8778; Lyupina, Yulia V/0000-0002-9903-3544; Sereda, Elena/0000-0002-7752-9346; Slonimskaya, Elena/0000-0003-4382-5697; Kulikov, Alex/0000-0001-6179-6848	Russian Foundation for Basic Research [12-04-90832, 12-04-00072, 13-04-90701, 13-04-00169]; Ministry of Education and Science of Russian Federation [8236]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported by The Russian Foundation for Basic Research, grant numbers: 12-04-90832 (NS EES), 12-04-00072 (NS), 13-04-90701 (EES), 13-04-00169 (IK), http://www.rfbr.ru/rffi/ru/; and Ministry of Education and Science of Russian Federation, Government Contract number 8236 (AK), The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramova EB, 2004, BIOL BULL+, V31, P115, DOI 10.1023/B:BIBU.0000022464.37305.b4; Abramova EB, 2002, MOL BIOL+, V36, P613, DOI 10.1023/A:1020654926226; Andorfer CA, 2011, TRENDS MOL MED, V17, P313, DOI 10.1016/j.molmed.2011.01.006; Astakhova TM, 2006, BIOL BULL+, V33, P216, DOI 10.1134/S1062359006030022; Astakhova TM, 2010, ACTA NATURAE, V2, P102, DOI 10.32607/20758251-2010-2-1-102-107; Aue G, 2011, BLOOD, V118, P4674, DOI 10.1182/blood-2011-04-351528; Barginear MF, 2008, CRIT REV ONCOL HEMAT, V65, P223, DOI 10.1016/j.critrevonc.2007.11.004; Ben-Shahar S, 1999, J BIOL CHEM, V274, P21963, DOI 10.1074/jbc.274.31.21963; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; Chabottaux V, 2007, CLIN EXP METASTAS, V24, P647, DOI 10.1007/s10585-007-9113-7; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen L, 2005, CANCER RES, V65, P5599, DOI 10.1158/0008-5472.CAN-05-0201; Cruz I, 2005, AM J CLIN PATHOL, V123, P66, DOI 10.1309/WP3QWKVJFYDHHXQD; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Dees E Claire, 2006, Future Oncol, V2, P121, DOI 10.2217/14796694.2.1.121; Deng SS, 2007, BREAST CANCER RES TR, V104, P21, DOI 10.1007/s10549-006-9393-7; Di Leva G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003311; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; FRENTZEL S, 1993, EUR J BIOCHEM, V216, P119, DOI 10.1111/j.1432-1033.1993.tb18123.x; Gobbi G, 2004, INT J ONCOL, V25, P1625; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 1997, P NATL ACAD SCI USA, V94, P8970, DOI 10.1073/pnas.94.17.8970; Guttilla IK, 2012, TRENDS ENDOCRIN MET, V23, P73, DOI 10.1016/j.tem.2011.12.001; Kondakova IV, 2014, MOL BIOL+, V48, P384, DOI 10.1134/S002689331403011X; Kondakova IV, 2012, RUSS J BIOORG CHEM+, V38, P89, DOI 10.1134/S106816201201013X; Kotamraju S, 2006, FREE RADICAL BIO MED, V40, P1034, DOI 10.1016/j.freeradbiomed.2005.10.052; Lee JH, 2012, ARCH PHARM RES, V35, P397, DOI 10.1007/s12272-012-0301-x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marx C, 2007, MOL PHARMACOL, V71, P1525, DOI 10.1124/mol.107.034090; Nagpal N, 2013, CARCINOGENESIS, V34, P1889, DOI 10.1093/carcin/bgt107; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sato K, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S2; Sharova N, 2008, RECENT PATENTS ENDOC, V2, P152, DOI 10.2174/187221408786241847; Sharova NP, 2011, CENT EUR J BIOL, V6, P486, DOI 10.2478/s11535-011-0040-x; Shashova EE, 2013, B EXP BIOL MED+, V156, P242, DOI 10.1007/s10517-013-2321-z; Singh R, 2013, CANCER BIOL THER, V14, P201, DOI 10.4161/cbt.23296; Spirina LV, 2013, J CANCER RES CLIN, V139, P625, DOI 10.1007/s00432-012-1366-0; Spirina LV, 2012, MOL BIOL REP, V39, P8655, DOI 10.1007/s11033-012-1720-y; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Xu J, 2013, CANCER LETT, V335, P380, DOI 10.1016/j.canlet.2013.02.054; Yang Xiaolin, 2013, Evid Based Complement Alternat Med, V2013, P926928, DOI 10.1155/2013/926928; Zaikova Iu Ia, 2011, Tsitologiia, V53, P459; Zakharova LA, 2011, CELL IMMUNOL, V271, P385, DOI 10.1016/j.cellimm.2011.08.005	47	22	27	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109933	10.1371/journal.pone.0109933	http://dx.doi.org/10.1371/journal.pone.0109933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329802	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100037
J	Xiong, HZ; Li, QL; Liu, SY; Wang, F; Xiong, ZT; Chen, J; Chen, H; Yang, YX; Tan, XX; Luo, QP; Peng, J; Xiao, GH; Jiang, QP				Xiong, Hanzhen; Li, Qiulian; Liu, Shaoyan; Wang, Fang; Xiong, Zhongtang; Chen, Juan; Chen, Hui; Yang, Yuexin; Tan, Xuexian; Luo, Qiuping; Peng, Juan; Xiao, Guohong; Jiang, Qingping			Integrated microRNA and mRNA Transcriptome Sequencing Reveals the Potential Roles of miRNAs in Stage I Endometrioid Endometrial Carcinoma	PLOS ONE			English	Article							INCREASED EXPRESSION; CELL-PROLIFERATION; CYCLIN D1; CANCER; ADENOCARCINOMA; TARGETS; SEQ; P16(INK4A); PROTEIN; TUMORS	Endometrioid endometrial carcinoma (EEC) is the most dominant subtype of endometrial cancer. Aberrant transcriptional regulation has been implicated in EEC. Herein, we characterized mRNA and miRNA transcriptomes by RNA sequencing in EEC to investigate potential molecular mechanisms underlying the pathogenesis. Total mRNA and small RNA were simultaneously sequenced by next generation sequencing technology for 3 pairs of stage I EEC and adjacent non-tumorous tissues. On average, 52,716,765 pair-end 100 bp mRNA reads and 1,669,602 single-end 50 bp miRNA reads were generated. Further analysis indicated that 7 miRNAs and 320 corresponding target genes were differentially expressed in the three stage I EEC patients. Six of all the seven differentially expressed miRNAs were targeting on eleven differentially expressed genes in the cell cycle pathway. Real-time quantitative PCR in sequencing samples and other independent 21 pairs of samples validated the miRNA-mRNA differential co-expression, which were involved in cell cycle pathway, in the stage I EEC. Thus, we confirmed the involvement of hsa-let-7c-5p and hsa-miR-99a-3p in EEC and firstly found dysregulation of hsa-miR-196a-5p, hsa-miR-328-3p, hsa-miR-337-3p, and hsa-miR-181c-3p in EEC. Moreover, synergistic regulations among these miRNAs were detected. Transcript sequence variants such as single nucleotide variant (SNV) and short insertions and deletions (Indels) were also characterized. Our results provide insights on dysregulated miRNA-mRNA co-expression and valuable resources on transcript variation in stage I EEC, which implies the new molecular mechanisms that underlying pathogenesis of stage I EEC and supplies opportunity for further in depth investigations.	[Xiong, Hanzhen; Li, Qiulian; Liu, Shaoyan; Xiong, Zhongtang; Chen, Juan; Chen, Hui; Yang, Yuexin; Tan, Xuexian; Luo, Qiuping; Peng, Juan; Jiang, Qingping] Guangzhou Med Univ, Affiliated Hosp 3, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Wang, Fang; Xiao, Guohong; Jiang, Qingping] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Xiao, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	Xiaogh66@163.com; jiangqp2003@126.com			Guangdong Science and Technology Department [2013B021800193]; Third Affiliated Hospital of Guangzhou Medical University [110201704, 11021403]	Guangdong Science and Technology Department; Third Affiliated Hospital of Guangzhou Medical University	This study is supported by the Scientific Research Grant from Guangdong Science and Technology Department (No. 2013B021800193) and the Scientific Research Grant from the Third Affiliated Hospital of Guangzhou Medical University (No. 110201704, 11021403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, BRIT J CANCER, V107, P1354, DOI 10.1038/bjc.2012.383; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Buchynska L. G., 2006, Experimental Oncology, V28, P152; Cai H, 2011, AM J EPIDEMIOL, V173, P1263, DOI 10.1093/aje/kwr002; Chen F, 2013, CELL BIOCHEM BIOPHYS, V66, P747, DOI 10.1007/s12013-013-9519-6; Chung TKH, 2009, INT J CANCER, V124, P1358, DOI 10.1002/ijc.24071; Evans T, 2011, BRIT J CANCER, V104, P1505, DOI 10.1038/bjc.2011.68; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hashimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062589; Kamata Y, 2005, J CANCER RES CLIN, V131, P591, DOI 10.1007/s00432-005-0671-2; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kowalewska M, 2013, TUMOR BIOL, V34, P2153, DOI 10.1007/s13277-013-0748-5; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mueller DW, 2011, INT J CANCER, V129, P1064, DOI 10.1002/ijc.25768; Murphy N, 2005, J CLIN PATHOL, V58, P525, DOI 10.1136/jcp.2004.018895; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Obel Jennifer C, 2006, Clin Adv Hematol Oncol, V4, P459; Polanowska J, 2000, GENE CHROMOSOME CANC, V28, P126, DOI 10.1002/(SICI)1098-2264(200005)28:1<126::AID-GCC15>3.0.CO;2-G; Ramon LA, 2012, HUM REPROD, V27, P3036, DOI 10.1093/humrep/des292; Ray S, 2012, P NATL ACAD SCI USA, V109, pE1334, DOI 10.1073/pnas.1118515109; Rodriguez GC, 2008, CANCER EPIDEM BIOMAR, V17, P578, DOI 10.1158/1055-9965.EPI-07-0551; Saini S, 2009, CANCER RES, V69, P7038, DOI 10.1158/0008-5472.CAN-09-1691; Suzuki A, 2010, J CELL MOL MED, V14, P2305, DOI 10.1111/j.1582-4934.2009.00839.x; Torres A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-369; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Umemura S, 2009, BRIT J CANCER, V100, P764, DOI 10.1038/sj.bjc.6604900; Vale CL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003915.pub4; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang ZS, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-76; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047270; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Xu XT, 2012, BRIT J CANCER, V106, P1320, DOI 10.1038/bjc.2012.88; Xu YY, 2013, FEBS J, V280, P3768, DOI 10.1111/febs.12365; Yan GJ, 2014, CANCER LETT, V345, P39, DOI 10.1016/j.canlet.2013.11.023; Zhao BT, 2014, CANCER LETT, V342, P43, DOI 10.1016/j.canlet.2013.08.030	44	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110163	10.1371/journal.pone.0110163	http://dx.doi.org/10.1371/journal.pone.0110163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329664	Green Published, Green Submitted			2022-12-27	WOS:000345204100045
J	Hadifar, F; Ignjatovic, J; Tarigan, S; Indriani, R; Ebrahimie, E; Hasan, NH; McWhorter, A; Putland, S; Ownagh, A; Hemmatzadeh, F				Hadifar, Farshid; Ignjatovic, Jagoda; Tarigan, Simson; Indriani, Risa; Ebrahimie, Esmaeil; Hasan, Noor Haliza; McWhorter, Andrea; Putland, Sophie; Ownagh, Abdulghaffar; Hemmatzadeh, Farhid			Multimeric Recombinant M2e Protein-Based ELISA: A Significant Improvement in Differentiating Avian Influenza Infected Chickens from Vaccinated Ones	PLOS ONE			English	Article							H5N1 INFLUENZA; INDONESIA; EVOLUTION	Killed avian influenza virus (AIV) vaccines have been used to control H5N1 infections in countries where the virus is endemic. Distinguishing vaccinated from naturally infected birds (DIVA) in such situations however, has become a major challenge. Recently, we introduced the recombinant ectodomain of the M2 protein (M2e) of H5N1 subtype as a novel tool for an ELISA based DIVA test. Despite being antigenic in natural infection the monomer form of the M2e used in ELISA had limited antigenicity and consequently poor diagnostic capability. To address this shortcoming, we evaluated the use of four tandem copies of M2e (tM2e) for increased efficiency of M2e antibody detection. The tM2e gene of H5N1 strain from Indonesia (A/Indonesia/CDC540/2006) was cloned into a pMAL-p4x expression vector and expressed in E. coli as a recombinant tM2e-MBP or M2e-MBP proteins. Both of these, M2e and tM2e antigens reacted with sera obtained from chickens following live H5N1 infection but not with sera from vaccinated birds. A significantly stronger M2e antibody reaction was observed with the tM2e compared to M2e antigen. Western blotting also supported the superiority of tM2e over M2e in detection of specific M2e antibodies against live H5N1 infection. Results from this study demonstrate that M2e tetramer is a better antigen than single M2e and could be more suitable for an ELISA based DIVA test.	[Hadifar, Farshid; Hasan, Noor Haliza; McWhorter, Andrea; Putland, Sophie; Hemmatzadeh, Farhid] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia; [Ignjatovic, Jagoda] Univ Melbourne, Sch Vet Sci, Melbourne, Vic, Australia; [Tarigan, Simson; Indriani, Risa] Indonesian Res Ctr Vet Sci, Bogor, West Java, Indonesia; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Ownagh, Abdulghaffar] Urmia Univ, Fac Vet Med, Orumiyeh, Iran	University of Adelaide; University of Melbourne; University of Adelaide; Urmia University	Hemmatzadeh, F (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia.	farhid.hemmatzadeh@adelaide.edu.au	HASAN, Noor Haliza/I-6963-2016; Ebrahimi, Mansour/AAO-9096-2021; Ebrahimie, Esmaeil/AAN-2611-2020; McWhorter, Andrea/L-8964-2019	HASAN, Noor Haliza/0000-0003-0319-9417; Ebrahimi, Mansour/0000-0001-7011-2567; Ebrahimie, Esmaeil/0000-0002-4431-2861; McWhorter, Andrea/0000-0002-5793-1629; Hemmatzadeh, Farhid/0000-0002-4572-8869	Australian Centre for International Agricultural Research (ACIAR) [AH/2010/039]; University of Adelaide	Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); University of Adelaide	This work was supported by Australian Centre for International Agricultural Research (ACIAR) fund (project number AH/2010/039) and the University of Adelaide post graduate support fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisasmito W, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-571; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Escorcia M, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-15; Feng JQ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-102; Fiebig L, 2011, EURO SURVEILL, V16; Green MR, 2012, MOL CLONING LAB MANU, V1; Greiner M, 1995, J IMMUNOL METHODS, V185, P2; Hemmatzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056801; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jennings LC, 2013, INFLUENZA OTHER RESP, V7, P44, DOI 10.1111/irv.12180; Kelly TR, 2008, J AVIAN MED SURG, V22, P1, DOI 10.1647/2006-036R.1; Kosasih H, 2013, INFLUENZA OTHER RESP, V7, P312, DOI 10.1111/j.1750-2659.2012.00403.x; Lambrecht B, 2007, AVIAN DIS, V51, P221, DOI 10.1637/7589-040206R.1; Lee YN, 2014, VACCINE; Robles F, 2010, ENG TECHNOLOGY, V41, P4; Smith GJD, 2014, INFLUENZA OTHER RESP, V8, P384, DOI 10.1111/irv.12230; Suarez DL, 2005, BIOLOGICALS, V33, P221, DOI 10.1016/j.biologicals.2005.08.003; Swayne DE, 2012, AVIAN DIS, V56, P818, DOI 10.1637/10183-041012-Review.1; Swayne DE, 2006, DEV BIOLOGICALS, V124, P61; Uversky VN, 2012, WILEY SER PROTEIN P, pIX; Watanabe T, 2008, J VIROL, V82, P2486, DOI 10.1128/JVI.01899-07; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Zaman M, 2014, J INFECT DEV COUNTR, V8, P202, DOI 10.3855/jidc.3329	24	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e108420	10.1371/journal.pone.0108420	http://dx.doi.org/10.1371/journal.pone.0108420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330391	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800009
J	Ribeiro-Resende, VT; Gomes, TA; de Lima, S; Nascimento-Lima, M; Bargas-Rega, M; Santiago, MF; Reis, RAD; de Mello, FG				Ribeiro-Resende, Victor Tulio; Gomes, Tiago Araujo; de Lima, Silmara; Nascimento-Lima, Maiara; Bargas-Rega, Michele; Santiago, Marcelo Felipe; de Melo Reis, Ricardo Augusto; de Mello, Fernando Garcia			Mice Lacking GD3 Synthase Display Morphological Abnormalities in the Sciatic Nerve and Neuronal Disturbances during Peripheral Nerve Regeneration	PLOS ONE			English	Article							GANGLIOSIDE 9-O-ACETYL GD3; O-ACETYLATION; GROWTH; EXPRESSION; GENE; LOCALIZATION; NEUREGULIN-1; CHAINS; BRAIN	The ganglioside 9-O-acetyl GD3 is overexpressed in peripheral nerves after lesioning, and its expression is correlated with axonal degeneration and regeneration in adult rodents. However, the biological roles of this ganglioside during the regenerative process are unclear. We used mice lacking GD3 synthase (Siat3a KO), an enzyme that converts GM3 to GD3, which can be further converted to 9-O-acetyl GD3. Morphological analyses of longitudinal and transverse sections of the sciatic nerve revealed significant differences in the transverse area and nerve thickness. The number of axons and the levels of myelin basic protein were significantly reduced in adult KO mice compared to wild-type (WT) mice. The G-ratio was increased in KO mice compared to WT mice based on quantification of thin transverse sections stained with toluidine blue. We found that neurite outgrowth was significantly reduced in the absence of GD3. However, addition of exogenous GD3 led to neurite growth after 3 days, similar to that in WT mice. To evaluate fiber regeneration after nerve lesioning, we compared the regenerated distance from the lesion site and found that this distance was one-fourth the length in KO mice compared to WT mice. KO mice in which GD3 was administered showed markedly improved regeneration compared to the control KO mice. In summary, we suggest that 9-O-acetyl GD3 plays biological roles in neuron-glia interactions, facilitating axonal growth and myelination induced by Schwann cells. Moreover, exogenous GD3 can be converted to 9-O-acetyl GD3 in mice lacking GD3 synthase, improving regeneration.	[Ribeiro-Resende, Victor Tulio; Gomes, Tiago Araujo; de Lima, Silmara; Nascimento-Lima, Maiara; de Melo Reis, Ricardo Augusto; de Mello, Fernando Garcia] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Neuroquim, BR-21941 Rio De Janeiro, Brazil; [Bargas-Rega, Michele; Santiago, Marcelo Felipe] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Neurobiol Celular & Mol, BR-21941 Rio De Janeiro, Brazil; [Ribeiro-Resende, Victor Tulio; Nascimento-Lima, Maiara] Univ Fed Rio de Janeiro, Nucleo Multidisciplinar Pesquisa Biol NUMPEX BIO, Polo Xerem, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Ribeiro-Resende, VT (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Neuroquim, BR-21941 Rio De Janeiro, Brazil.	vtulio@biof.ufrj.br	Santiago, Marcelo Felippe/AAZ-3553-2020; Santiago, Marcelo F/H-3943-2011; de Melo Reis, Ricardo A/E-9962-2011	Santiago, Marcelo Felippe/0000-0003-2428-9606; Santiago, Marcelo F/0000-0003-2428-9606; de Melo Reis, Ricardo A/0000-0001-9689-4085; Lima, Maiara/0000-0002-9532-1936	Fundacao Carlos Chagas Fihlo de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Instituto Nacional de Ciencia e Tecnologia	Fundacao Carlos Chagas Fihlo de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia	Fundacao Carlos Chagas Fihlo de Amparo a Pesquisa do Estado do Rio de Janeiro (VTRR, RAMR, FGM). 2- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (VTRR RAMR FGM). 3- Instituto Nacional de Ciencia e Tecnologia (RAMR FGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo H, 1997, EUR J CELL BIOL, V72, P202; BIXBY JL, 1994, J CELL BIOL, V127, P1461, DOI 10.1083/jcb.127.5.1461; BLUM AS, 1987, P NATL ACAD SCI USA, V84, P8716, DOI 10.1073/pnas.84.23.8716; Bovolenta P, 1997, EUR J NEUROSCI, V9, P977, DOI 10.1111/j.1460-9568.1997.tb01448.x; Brosenitsch TA, 1998, J NEUROSCI, V18, P1047; Chen HY, 2006, J BIOL CHEM, V281, P7825, DOI 10.1074/jbc.M512379200; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Reis RAD, 2011, CELL MOL NEUROBIOL, V31, P835, DOI 10.1007/s10571-011-9673-6; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Furukawa K, 2008, J NEUROCHEM, V105, P1057, DOI 10.1111/j.1471-4159.2008.05232.x; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Mendez-Otero R, 2003, Prog Mol Subcell Biol, V32, P97; MendezOtero R, 1996, EUR J CELL BIOL, V71, P192; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Miyakoshi LM, 2012, MOL CELL NEUROSCI, V49, P240, DOI 10.1016/j.mcn.2011.08.010; Miyakoshi LM, 2001, BRAZ J MED BIOL RES, V34, P669, DOI 10.1590/S0100-879X2001000500016; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Negreiros EMA, 2003, J NEUROBIOL, V57, P31, DOI 10.1002/neu.10248; Okada M, 2002, J BIOL CHEM, V277, P1633, DOI 10.1074/jbc.C100395200; Paratcha G, 2002, CURR OPIN NEUROBIOL, V12, P542, DOI 10.1016/S0959-4388(02)00363-X; Ribeiro-Resende VT, 2007, NEUROSCIENCE, V147, P97, DOI 10.1016/j.neuroscience.2007.03.046; Ribeiro-Resende VT, 2010, J BIOL CHEM, V285, P34086, DOI 10.1074/jbc.M110.147272; Santiago MF, 2004, J NEUROSCI, V24, P474, DOI 10.1523/JNEUROSCI.0116-03.2004; Santiago MF, 2001, MOL CELL NEUROSCI, V17, P488, DOI 10.1006/mcne.2000.0943; Satake H, 2003, J BIOL CHEM, V278, P7942, DOI 10.1074/jbc.M210565200; SCHLOSSHAUER B, 1988, J NEUROSCI, V8, P580; Stassart RM, 2013, NAT NEUROSCI, V16, P48, DOI 10.1038/nn.3281; Suzuki Y, 2011, J NEUROCHEM, V116, P874, DOI 10.1111/j.1471-4159.2010.07042.x; Tapinos N, 2006, NAT MED, V12, P961, DOI 10.1038/nm1433; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Wallquist W, 2002, J COMP NEUROL, V454, P284, DOI 10.1002/cne.10434; Yu RK, 2004, J LIPID RES, V45, P783, DOI 10.1194/jlr.R3000020-JLR200	34	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e108919	10.1371/journal.pone.0108919	http://dx.doi.org/10.1371/journal.pone.0108919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330147	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800012
J	Uchiyama, K; Miyata, H; Yano, M; Yamaguchi, Y; Imamura, M; Muramatsu, N; Das, NR; Chida, J; Hara, H; Sakaguchi, S				Uchiyama, Keiji; Miyata, Hironori; Yano, Masashi; Yamaguchi, Yoshitaka; Imamura, Morikazu; Muramatsu, Naomi; Das, Nandita Rani; Chida, Junji; Hara, Hideyuki; Sakaguchi, Suehiro			Mouse-Hamster Chimeric Prion Protein (PrP) Devoid of N-Terminal Residues 23-88 Restores Susceptibility to 22L Prions, but Not to RML Prions in PrP-Knockout Mice	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; TRANSGENIC MICE; SCRAPIE ISOFORM; GENE; RESISTANT; DOPPEL; CONVERSION; REGION; IDENTIFICATION; EXPRESSION	Prion infection induces conformational conversion of the normal prion protein PrPC, into the pathogenic isoform PrPSc, in prion diseases. It has been shown that PrP-knockout (Prnp(0/0)) mice transgenically reconstituted with a mouse-hamster chimeric PrP lacking N-terminal residues 23-88, or Tg(MHM2 Delta 23-88)/Prnp(0/0) mice, neither developed the disease nor accumulated MHM2(Sc) Delta 23-88 in their brains after inoculation with RML prions. In contrast, RML-inoculated Tg(MHM2 Delta 23-88)/Prnp(0/+) mice developed the disease with abundant accumulation of MHM2(Sc) Delta 23-88 in their brains. These results indicate that MHM2 Delta 23-88 itself might either lose or greatly reduce the converting capacity to MHM2(Sc) Delta 23-88, and that the co-expressing wild-type PrPC can stimulate the conversion of MHM2 Delta 23-88 to MHM2(Sc) Delta 23-88 in trans. In the present study, we confirmed that Tg(MHM2 Delta 23-88)/Prnp(0/0) mice remained resistant to RML prions for up to 730 days after inoculation. However, we found that Tg(MHM2 Delta 23-88)/Prnp(0/0) mice were susceptible to 22L prions, developing the disease with prolonged incubation times and accumulating MHM2(Sc) Delta 23-88 in their brains. We also found accelerated conversion of MHM2 Delta 23-88 into MHM2(Sc) Delta 23-88 in the brains of RML-and 22L-inoculated Tg(MHM2 Delta 23-88)/Prnp(0/+) mice. However, wildtype PrPSc accumulated less in the brains of these inoculated Tg(MHM2 Delta 23-88)/Prnp(0/+) mice, compared with RML-and 22Linoculated Prnp(0/+) mice. These results show that MHM2 Delta 23-88 itself can convert into MHM2(Sc) Delta 23-88 without the help of the trans-acting PrPC, and that, irrespective of prion strains inoculated, the co-expressing wild-type PrPC stimulates the conversion of MHM2 Delta 23-88 into MHM2(Sc) Delta 23-88 , but to the contrary, the co-expressing MHM2 Delta 23-88 disturbs the conversion of wild-type PrPC into PrPSc.	[Uchiyama, Keiji; Yano, Masashi; Yamaguchi, Yoshitaka; Muramatsu, Naomi; Das, Nandita Rani; Chida, Junji; Hara, Hideyuki; Sakaguchi, Suehiro] Univ Tokushima, Div Mol Neurobiol, Inst Enzyme Res KOSOKEN, Tokushima 770, Japan; [Miyata, Hironori] Univ Occupat & Environm Hlth, Sch Med, Anim Res Ctr, Kitakyushu, Fukuoka 807, Japan; [Imamura, Morikazu] Natl Inst Anim Hlth, Influenza & Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan	Tokushima University; University of Occupational & Environmental Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Sakaguchi, S (corresponding author), Univ Tokushima, Div Mol Neurobiol, Inst Enzyme Res KOSOKEN, Tokushima 770, Japan.	sakaguchi@tokushima-u.ac.jp	Yamaguchi, Yoshitaka/ABD-2499-2020	UCHIYAMA, KEIJI/0000-0002-5667-3509	Ministry of Agriculture, Forestry and Fisheries of Japan; Research Committee of Prion Disease and Slow Virus infection, the Ministry of Health, Labour and Welfare of Japan; Institute for Enzyme Research, the University of Tokushima	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Research Committee of Prion Disease and Slow Virus infection, the Ministry of Health, Labour and Welfare of Japan; Institute for Enzyme Research, the University of Tokushima	This work was partly supported by a Grant-in-Aid from the bovine spongiform encephalopathy (BSE) and other Prion Disease Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan, and Grants-in-Aid from the Research Committee of Prion Disease and Slow Virus infection, the Ministry of Health, Labour and Welfare of Japan. HM is partly supported by a Cooperative Research Grant of the Institute for Enzyme Research, the University of Tokushima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2003, J BIOL CHEM, V278, P28944, DOI 10.1074/jbc.M303655200; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Li AM, 2000, CELL MOL NEUROBIOL, V20, P553, DOI 10.1023/A:1007059827541; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Miller MB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002128; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; REED L. J., 1938, AMER JOUR HYG, V27, P493; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Saijo E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003692; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Striebel JF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002275; Supattapone S, 2001, J VIROL, V75, P1408, DOI 10.1128/JVI.75.3.1408-1413.2001; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Turnbaugh JA, 2012, J NEUROSCI, V32, P8817, DOI 10.1523/JNEUROSCI.1103-12.2012; Tuzi NL, 2002, J GEN VIROL, V83, P705, DOI 10.1099/0022-1317-83-3-705; Wadsworth JDF, 2010, NEUROPATH APPL NEURO, V36, P576, DOI 10.1111/j.1365-2990.2010.01129.x; Weissmann C, 2002, ACTA NEUROBIOL EXP, V62, P153; Yam AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009316; Yamaguchi N, 2004, BIOCHEM BIOPH RES CO, V319, P1247, DOI 10.1016/j.bbrc.2004.05.115	40	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109737	10.1371/journal.pone.0109737	http://dx.doi.org/10.1371/journal.pone.0109737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330286	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800036
J	Gronthal, T; Moodley, A; Nykasenoja, S; Junnila, J; Guardabassi, L; Thomson, K; Rantala, M				Gronthal, Thomas; Moodley, Arshnee; Nykasenoja, Suvi; Junnila, Jouni; Guardabassi, Luca; Thomson, Katariina; Rantala, Merja			Large Outbreak Caused by Methicillin Resistant Staphylococcus pseudintermedius ST71 in a Finnish Veterinary Teaching Hospital - From Outbreak Control to Outbreak Prevention	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; AUREUS; DOGS; INFECTION; IDENTIFICATION; CATS; SUSCEPTIBILITY; CONTAMINATION; INTERMEDIUS; CHALLENGE	Introduction: The purpose of this study was to describe a nosocomial outbreak caused by methicillin resistant Staphylococcus pseudintermedius (MRSP) ST71 SCCmec II-III in dogs and cats at the Veterinary Teaching Hospital of the University of Helsinki in November 2010 - January 2012, and to determine the risk factors for acquiring MRSP. In addition, measures to control the outbreak and current policy for MRSP prevention are presented. Methods: Data of patients were collected from the hospital patient record software. MRSP surveillance data were acquired from the laboratory information system. Risk factors for MRSP acquisition were analyzed from 55 cases and 213 controls using multivariable logistic regression in a case-control study design. Forty-seven MRSP isolates were analyzed by pulsed field gel electrophoresis and three were further analyzed with multi-locus sequence and SCCmec typing. Results: Sixty-three MRSP cases were identified, including 27 infections. MRSPs from the cases shared a specific multi-drug resistant antibiogram and PFGE-pattern indicated clonal spread. Four risk factors were identified; skin lesion (OR = 6.2; CI95% 2.3-17.0, P = 0.0003), antimicrobial treatment (OR = 3.8, CI95% 1.0-13.9, P = 0.0442), cumulative number of days in the intensive care unit (OR = 1.3, CI95% 1.1-1.6, P = 0.0007) or in the surgery ward (OR = 1.1, CI95% 1.0-1.3, P = 0.0401). Tracing and screening of contact patients, enhanced hand hygiene, cohorting and barrier nursing, as well as cleaning and disinfection were used to control the outbreak. To avoid future outbreaks and spread of MRSP a search-and-isolate policy was implemented. Currently nearly all new MRSP findings are detected in screening targeted to risk patients on admission. Conclusion: Multidrug resistant MRSP is capable of causing a large outbreak difficult to control. Skin lesions, antimicrobial treatment and prolonged hospital stay increase the probability of acquiring MRSP. Rigorous control measures were needed to control the outbreak. We recommend the implementation of a search-and-isolate policy to reduce the burden of MRSP.	[Gronthal, Thomas; Rantala, Merja] Univ Helsinki, Dept Equine & Small Anim Med, Cent Lab, Helsinki, Finland; [Moodley, Arshnee; Guardabassi, Luca] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark; [Nykasenoja, Suvi] Finnish Food Safety Author Evira, Food & Feed Microbiol Res Unit, Helsinki, Finland; [Junnila, Jouni] Pharma Ltd, Espoo, Finland; [Thomson, Katariina] Univ Helsinki, Vet Teaching Hosp, Helsinki, Finland	University of Helsinki; University of Copenhagen; Finnish Food Authority; University of Helsinki	Gronthal, T (corresponding author), Univ Helsinki, Dept Equine & Small Anim Med, Cent Lab, Helsinki, Finland.	thomas.gronthal@helsinki.fi	Rantala, Merja/AAC-5544-2019	Junnila, Jouni/0000-0003-2703-0798; Moodley, Arshnee/0000-0002-6469-3948; Guardabassi, Luca/0000-0002-2389-5084; Gronthal, Thomas/0000-0001-8339-5818	Finnish Foundation of Veterinary Research;  [3-291-29]	Finnish Foundation of Veterinary Research; 	TG was funded by Finnish Foundation of Veterinary Research; http://www.sels.fi/index_eng.htm, grant number 3-291-29. 4Pharma Ltd., provided support in the form of a salary for author JJ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bemis DA, 2009, J VET DIAGN INVEST, V21, P53, DOI 10.1177/104063870902100108; Borjesson S, 2012, MICROB DRUG RESIST, V18, P597, DOI 10.1089/mdr.2012.0069; Boyce JM, 2007, J HOSP INFECT, V65, P50, DOI 10.1016/S0195-6701(07)60015-2; CLSI, 2020, PERFORMANCE STANDARD, V5th ed.; Gomez-Sanz E, 2011, COMP IMMUNOL MICROB, V34, P447, DOI [10.1016/j.cimid.2011.08.002, 10.1016/j.cimid.2010.06.006]; Holzknecht BJ, 2010, J CLIN MICROBIOL, V48, P4221, DOI 10.1128/JCM.01382-10; Huerta B, 2011, VET MICROBIOL, V150, P302, DOI 10.1016/j.vetmic.2011.02.002; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lederer JW, 2009, JT COMM J QUAL PATIE, V35, P180, DOI 10.1016/S1553-7250(09)35024-2; Lehner G, 2014, VET MICROBIOL, V168, P154, DOI 10.1016/j.vetmic.2013.10.023; Lilenbaum W, 1998, LETT APPL MICROBIOL, V27, P224, DOI 10.1046/j.1472-765X.1998.00406.x; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Nienhoff U, 2011, VET MICROBIOL, V153, P414, DOI 10.1016/j.vetmic.2011.05.045; Nienhoff U, 2011, VET MICROBIOL, V150, P191, DOI 10.1016/j.vetmic.2010.12.018; Osland AM, 2012, J ANTIMICROB CHEMOTH, V67, P841, DOI 10.1093/jac/dkr576; Paul NC, 2011, ZOONOSES PUBLIC HLTH, V58, P533, DOI 10.1111/j.1863-2378.2011.01398.x; Perlin JB, 2013, J HEALTHC QUAL, V35, P57, DOI 10.1111/jhq.12008; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Pletinckx LJ, 2012, VET MICROBIOL, V154, P363, DOI 10.1016/j.vetmic.2011.07.027; Sakamoto F, 2010, AM J INFECT CONTROL, V38, P529, DOI 10.1016/j.ajic.2009.12.014; Sasaki T, 2010, J CLIN MICROBIOL, V48, P765, DOI 10.1128/JCM.01232-09; Simou C, 2005, VET DERMATOL, V16, P385, DOI 10.1111/j.1365-3164.2005.00484.x; Singh A, 2013, VET SURG, V42, P643, DOI 10.1111/j.1532-950X.2013.12024.x; Solyman SM, 2013, J CLIN MICROBIOL, V51, P306, DOI 10.1128/JCM.02421-12; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; van Duijkeren E, 2008, VET MICROBIOL, V128, P213, DOI 10.1016/j.vetmic.2007.11.016; van Duijkeren E, 2011, J ANTIMICROB CHEMOTH, V66, P2705, DOI 10.1093/jac/dkr367; van Trijp MJCA, 2007, INFECT CONT HOSP EP, V28, P970, DOI 10.1086/519210; Veenemans J, 2013, J CLIN MICROBIOL, V51, P1026, DOI 10.1128/JCM.02995-12; Verkade E, 2011, EUR J CLIN MICROBIOL, V30, P109, DOI 10.1007/s10096-010-1035-7; Verkade E, 2011, J MED MICROBIOL, V60, P905, DOI 10.1099/jmm.0.021964-0; Weese JS, 2012, VET DERMATOL, V23, P292, DOI 10.1111/j.1365-3164.2012.01048.x; Weese JS, 2012, JAVMA-J AM VET MED A, V240, P1450, DOI 10.2460/javma.240.12.1450; Weese JS, 2010, ILAR J, V51, P233, DOI 10.1093/ilar.51.3.233; Wilson APR, 2011, CRIT CARE MED, V39, P651, DOI 10.1097/CCM.0b013e318206bc66; Woodford N, 2009, J INFECTION, V59, pS4, DOI 10.1016/S0163-4453(09)60003-7; Zubeir 8. IE, 2007, VET MICROBIOL, V121, P170	39	42	43	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110084	10.1371/journal.pone.0110084	http://dx.doi.org/10.1371/journal.pone.0110084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333798	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200090
J	Le Bailly, M; Landolt, M; Mauchamp, L; Dufour, B				Le Bailly, Matthieu; Landolt, Michael; Mauchamp, Leslie; Dufour, Benjamin			Intestinal Parasites in First World War German Soldiers from "Kilianstollen", Carspach, France	PLOS ONE			English	Article							SYN. CAPILLARIA-HEPATICA; ARCHAEOLOGICAL SITES; PALEOPARASITOLOGY; REMAINS; EGGS; PHILIPPINENSIS; ARCHIPELAGO; HELMINTHS; PATAGONIA; RODENTS	Paleoparasitological investigations revealed the presence of intestinal helminths in samples taken from the abdominal cavities of two German soldiers, recovered in the First World War site named "Kilianstollen" in Carspach, France. Eggs from roundworm, whipworm, tapeworm and capillariids were identified. The morphological and morphometrical comparison, followed by statistical analyses, showed that the Carspach capillariid eggs are similar to rodent parasites. Poor sanitary conditions in the trenches, the lack of knowledge of parasites, and the widespread presence of commensal animals, can explain the occurrence of such parasites in human intestines. This study is the second dealing with 20th century human samples. It confirms the presence of intestinal worms in First World War German soldiers. In this case study, the application of statistics to precise measurements facilitated the diagnosis of ancient helminth eggs and completed the microscopic approach.	[Le Bailly, Matthieu; Mauchamp, Leslie; Dufour, Benjamin] Univ Franche Comte, CNRS UMR Chronoenvironm 6249, F-25030 Besancon, France; [Landolt, Michael] CIRSUD, ZA Sud, CNRS UMR Archimede 7044, PAIR, Selestat, France	Universite de Franche-Comte	Le Bailly, M (corresponding author), Univ Franche Comte, CNRS UMR Chronoenvironm 6249, F-25030 Besancon, France.	matthieu.lebailly@univ-fcomte.fr	Le Bailly, Matthieu/AAA-2977-2019	Dufour, Benjamin/0000-0002-8075-6881; Le Bailly, Matthieu/0000-0001-6320-6741				Ahmed Laila, 1999, Journal of the Egyptian Society of Parasitology, V29, P483; [Anonymous], 1871, CUISINIERE ASSIEGNEE; Araujo A, 2000, MEM I OSWALDO CRUZ, V95, P89, DOI 10.1590/S0074-02762000000700016; Ash LR, 2007, ATLAS HUMAN PARASITO, V5th; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P47, DOI 10.1590/S0074-02762003000900009; Bouchet F., 1997, Bulletin de la Societe Francaise de Parasitologie, V15, P49; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P95, DOI 10.1590/S0074-02762003000900015; Bouchet F, 1997, LANCET, V349, P256, DOI 10.1016/S0140-6736(05)64868-4; Bowman DD, 2002, FELINE CLIN PARASITO; BUTTERWORTH E W, 1980, Systematic Parasitology, V1, P211, DOI 10.1007/BF00009847; Carvalho-Costa FA, 2009, T ROY SOC TROP MED H, V103, P1071, DOI 10.1016/j.trstmh.2009.04.015; Confalonieri U E, 1988, Paleopathol Newsl, P7; CROSS JH, 1992, CLIN MICROBIOL REV, V5, P120, DOI 10.1128/CMR.5.2.120-129.1992; da Rocha GC, 2006, MEM I OSWALDO CRUZ, V101, P43, DOI 10.1590/S0074-02762006001000008; Dittmar K, 2003, MEM I OSWALDO CRUZ, V98, P141, DOI 10.1590/S0074-02762003000900021; Dommelier-Espejo S, 2001, CONTRIBUTION LETUDE; Dufour B, 2013, INT J PALEOPATHOL, V3, P199, DOI 10.1016/j.ijpp.2013.03.008; Fernandes Alexandre, 2005, Cad. Saúde Pública, V21, P329, DOI 10.1590/S0102-311X2005000100037; Fugassa MH, 2006, J PARASITOL, V92, P1110, DOI 10.1645/GE-876R1.1; Fugassa MH, 2008, J ARCHAEOL SCI, V35, P1408, DOI 10.1016/j.jas.2007.10.006; Fugassa MH, 2008, MEM I OSWALDO CRUZ, V103, P104, DOI 10.1590/S0074-02762008000100016; Fugassa MH, 2006, MEM I OSWALDO CRUZ, V101, P29, DOI 10.1590/S0074-02762006001000006; Goncalves MLC, 2003, MEM I OSWALDO CRUZ, V98, P103, DOI 10.1590/S0074-02762003000900016; Harter S., 2003, IMPLICATION PALEOPAR; Fugassa MH, 2010, J ARCHAEOL SCI, V37, P880, DOI 10.1016/j.jas.2009.11.018; JONES AKG, 1982, ENV ARCHAEOLOGY URBA, P66; Junger E., 1920, STAHLGEWITTERN; JUSTINE J-L, 1988, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V10, P693; JUSTINE J-L, 1987, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V9, P579; KAMIYA H, 1972, JPN J VET RES, V20, P117; Labouchere Henry du Pre, 1871, DIARY BESIEGED RESID; Landolt M., 2013, EST NOUVEAU ARCHEOLO, P281; Landolt M, 2012, ARCHEOLOGIA, V499, P30; Landolt M, 2014, ARCHEOTHEMA, V35, P44; Le Bailly M, 2012, J PARASITOL, V98, P1273, DOI 10.1645/GE-3200.1; Le Bailly M., 2011, PARASITES LACS NORD; Magi M, 2012, PARASITE, V19, P433, DOI 10.1051/parasite/2012194433; Moravec F, 2001, J PARASITOL, V87, P161, DOI 10.1645/0022-3395(2001)087[0161:RASSOC]2.0.CO;2; Nicot J, 2003, POILUS ONT PAROLE LE; Pisanu B, 1999, SYST PARASITOL, V43, P17, DOI 10.1023/A:1006119714038; Redrobe SP, 2005, J COMP PATHOL, V133, P73, DOI 10.1016/j.jcpa.2005.01.013; Remarque Erich Maria, 1929, WESTEN NICHTS NEUES; Resendes AR, 2009, VET PARASITOL, V160, P340, DOI 10.1016/j.vetpar.2008.11.001; Richter J, 1934, NACH KRIEGSAKTEN REG; Sianto L, 2009, REV INST MED TROP SP, V51, P119, DOI 10.1590/S0036-46652009000300001; Spratt DM, 2006, ZOOTAXA, P1; Sukontason KL, 2006, MICRON, V37, P87, DOI 10.1016/j.micron.2005.05.006	47	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109543	10.1371/journal.pone.0109543	http://dx.doi.org/10.1371/journal.pone.0109543			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333988	Green Published, gold			2022-12-27	WOS:000346766200038
J	Behbahani, M				Behbahani, Mandana			Anti-HIV-1 Activity of Eight Monofloral Iranian Honey Types	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTI-HIV; INFECTION; METHYLGLYOXAL; ANTIOXIDANT; CAPACITY; AIDS; HSV	Monofloral Iranian honeys from eight floral sources were analyzed to determine their anti-HIV-1 activities as well as their effects on lymphocyte proliferation. The Peripheral Blood Mononuclear Cells (PBMCs) used in this study were prepared from five healthy volunteers who were seronegative for HIV, HCV, HBV and TB. The anti-HIV-1 activity of eight different honeys was performed by quantitative polymerase chain reaction (PCR) assay and high pure viral nucleic acid kit. The results demonstrated that monofloral honeys from Petro selinum sativum, Nigella sativa, Citrus sinensis, Zataria multiflora, Citrus aurantium and Zizyphus mauritiana flowers had potent anti-HIV-1 activity with half maximal effective concentration (EC50) values of 37.5, 88, 70, 88, 105 and 5 mg/ml respectively. However, monofloral Iranian honeys from Astragalus gummifer and Chamaemelum nobile flowers had weak anti-HIV-1 activity. The frequency and intensity of CD4 expression on PBMCs increased in the presence of all honey types. CD19 marker were also increased after the treatment with monofloral honeys from Z. multiflora and N. sativa. The anti-HIV-1 agent in monofloral honeys from P. sativum, N. sativa, Z. multiflora and Z. mauritiana flowers was detected by spectroscopic analysis as methylglyoxal. Time of drug addition studies demonstrated that the inhibitory effect of methylglyoxal is higher on the late stage of HIV-1 infection. The result demonstrated that methylglyoxal isolated from monofloral honey types is a good candidate for preclinical evaluation of anti-HIV-1 therapies.	Univ Isfahan, Fac Adv Sci & Technol, Dept Biotechnol, Esfahan, Iran	University of Isfahan	Behbahani, M (corresponding author), Univ Isfahan, Fac Adv Sci & Technol, Dept Biotechnol, Esfahan, Iran.	Ma_behbahani@yahoo.com			Isfahan University	Isfahan University	This work has been done in Isfahan University and supported by Isfahan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Waili NS, 2006, THESCIENTIFICWORLDJO, V6, P1985, DOI 10.1100/tsw.2006.331; Alvarez-Suarez JM, 2010, FOOD CHEM TOXICOL, V48, P2490, DOI 10.1016/j.fct.2010.06.021; Alvarez-Suarez JM, 2010, MEDITERR J NUTR META, V3, P15, DOI 10.1007/s12349-009-0051-6; Bessong PO, 2006, AFR J BIOTECHNOL, V5, P1693; Donarski JA, 2010, ANAL METHODS-UK, V2, P1479, DOI 10.1039/c0ay00125b; DUKE N C, 1991, Australian Systematic Botany, V4, P299, DOI 10.1071/SB9910299; Gheldof N, 2002, J AGR FOOD CHEM, V50, P3050, DOI 10.1021/jf0114637; Grainger MNC, 2014, FOOD CHEM, V153, P134, DOI 10.1016/j.foodchem.2013.12.017; Hermans N, 2011, NAT PROD, V67, P284; Jayaraman Sudha, 2008, In Silico Biol, V8, P427; Legoff J, 2006, J CLIN MICROBIOL, V44, P423, DOI 10.1128/JCM.44.2.423-432.2006; Li XL, 1999, ADV DRUG DELIVER REV, V39, P81, DOI 10.1016/S0169-409X(99)00021-6; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Lusby PE, 2005, ARCH MED RES, V36, P464, DOI 10.1016/j.arcmed.2005.03.038; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Morgan DM, 1997, POLYAMINE PROTOCOLS, V79, P8; Mulu A, 2010, INT J STD AIDS, V21, P741, DOI 10.1258/ijsa.2010.010140; Nada OH, 2007, J EGYPT SOC PARASITO, V37, P691; Norman AR, 2011, INSECT BIOCHEM MOLEC, V41, P747; Passaes CP, 2014, VIROLOGY, V454, P340, DOI 10.1016/j.virol.2014.02.021; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Singh IP, 2005, CURR SCI INDIA, V89, P269; Tao J, 2007, ANTIVIR RES, V75, P227, DOI 10.1016/j.antiviral.2007.03.008; Terrab A, 2002, FOOD CHEM, V79, P373, DOI 10.1016/S0308-8146(02)00189-9; Yang J, 2012, FITOTERAPIA, V83, P348, DOI 10.1016/j.fitote.2011.11.016	25	16	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e108195	10.1371/journal.pone.0108195	http://dx.doi.org/10.1371/journal.pone.0108195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333699	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200005
J	Isiguzo, C; Anyanti, J; Ujuju, C; Nwokolo, E; De la Cruz, A; Schatzkin, E; Modrek, S; Montagu, D; Liu, J				Isiguzo, Chinwoke; Anyanti, Jennifer; Ujuju, Chinazo; Nwokolo, Ernest; De la Cruz, Anna; Schatzkin, Eric; Modrek, Sepideh; Montagu, Dominic; Liu, Jenny			Presumptive Treatment of Malaria from Formal and Informal Drug Vendors in Nigeria	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; SUB-SAHARAN AFRICA; MEDICINE RETAILERS; HEALTH FACILITIES; FEBRILE ILLNESS; SELLERS; SHOPS; SERVICES; TANZANIA; FEVERS	Background: Despite policies that recommend parasitological testing before treatment for malaria, presumptive treatment remains widespread in Nigeria. The majority of Nigerians obtain antimalarial drugs from two types of for-profit drug vendors-formal and informal medicine shops-but little is known about the quality of malaria care services provided at these shops. Aims: This study seeks to (1) describe the profile of patients who seek treatment at different types of drug outlets, (2) document the types of drugs purchased for treating malaria, (3) assess which patients are purchasing recommended drugs, and (4) estimate the extent of malaria over-treatment. Methods: In urban, peri-urban, and rural areas in Oyo State, customers exiting proprietary and patent medicine vendor (PPMV) shops or pharmacies having purchased anti-malarial drugs were surveyed and tested with malaria rapid diagnostic test. A follow-up phone survey was conducted four days after to assess self-reported drug administration. Bivariate and multivariate regression analysis was conducted to determine the correlates of patronizing a PPMV versus pharmacy, and the likelihood of purchasing an artemisinin-combination therapy (ACT) drug. Results: Of the 457participants who sought malaria treatment in 49 enrolled outlets, nearly 92% had diagnosed their condition by themselves, a family member, or a friend. Nearly 60% pharmacy customers purchased an ACT compared to only 29% of PPMV customers, and pharmacy customers paid significantly more on average. Multivariate regression results show that patrons of PPMVs were younger, less wealthy, waited fewer days before seeking care, and were less likely to be diagnosed at a hospital, clinic, or laboratory. Only 3.9% of participants tested positive with a malaria rapid diagnostic test. Conclusions: Poorer individuals seeking care at PPMVs are more likely to receive inappropriate malaria treatment when compared to those who go to pharmacies. Increasing accessibility to reliable diagnosis should be explored to reduce malaria over-treatment.	[Isiguzo, Chinwoke; Ujuju, Chinazo] Soc Family Hlth, Res & Evaluat Div, Abuja, Nigeria; [Anyanti, Jennifer] Soc Family Hlth, Tech Serv Div, Abuja, Nigeria; [Nwokolo, Ernest] Soc Family Hlth, Global Fund Malaria Div, Abuja, Nigeria; [De la Cruz, Anna; Schatzkin, Eric; Liu, Jenny] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Modrek, Sepideh] Stanford Univ, Sch Med, Gen Med Disciplines, Palo Alto, CA 94304 USA; [Montagu, Dominic] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco	Isiguzo, C (corresponding author), Soc Family Hlth, Res & Evaluat Div, Abuja, Nigeria.	cisiguzo@sfhnigeria.org		Modrek, Sepideh/0000-0003-4557-7156; Ujuju, Chinazo/0000-0002-3946-6364	ExxonMobil; Global Fund	ExxonMobil(Exxon Mobil Corporation); Global Fund	The authors wish to acknowledge ExxonMobil for financial support of this study as well as the Global Fund to Fight AIDS, Tuberculosis and Malaria for provision of RDTs and ACTs for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269; Amin AA, 2003, TROP MED INT HEALTH, V8, P1143, DOI 10.1046/j.1360-2276.2003.01140.x; [Anonymous], 2013, RETAIL PRICES ACTS C; [Anonymous], 2012, IND EV PHAS 1 AFF ME; [Anonymous], 2012, NIG MAL IND SURV 201; Bastiaens GJH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001590; Basu S, 2014, MED DECIS MAKING; Brieger WR, 2000, AFRICAN J MED MED SC, V30, P7; Cohen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048296; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Ezeoke OP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-368; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-157; Liu J, 2012, AM SOC TROP MED HYG, P62; Mangham LJ, 2012, TROP MED INT HEALTH, V17, P330, DOI 10.1111/j.1365-3156.2011.02918.x; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; Masanja MI, 2010, AM J TROP MED HYG, V83, P1238, DOI 10.4269/ajtmh.2010.10-0194; Modrek S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-69; Nshakira N, 2002, TROP MED INT HEALTH, V7, P309, DOI 10.1046/j.1365-3156.2002.00858.x; Okebe JU, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-180; Okeke TA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-97; Oladepo O, 2008, POLICY BRIEF, V2008, P01; Onwujekwe O, 2000, HEALTH POLICY, V54, P143, DOI 10.1016/S0168-8510(00)00105-6; Onwujekwe O, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-162; Oyibo WA, 2013, ISRN INFECT DIS, P2013; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Salako LA, 2001, TROPICAL PEDIAT, V47, P38; SNOW RW, 1992, T ROY SOC TROP MED H, V86, P237, DOI 10.1016/0035-9203(92)90290-S; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; Uzochukwu BSC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014627; VANDERGEEST S, 1987, SOC SCI MED, V25, P293, DOI 10.1016/0277-9536(87)90232-2; Wafula FN, 2010, INT J QUAL HEALTH C, V22, P316, DOI 10.1093/intqhc/mzq022; Yukich J, 2010, AM J TROP MED HYG, V83, P61, DOI 10.4269/ajtmh.2010.09-0632	35	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110361	10.1371/journal.pone.0110361	http://dx.doi.org/10.1371/journal.pone.0110361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR7AB	25333909	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200034
J	Kawada, H; Dida, GO; Ohashi, K; Kawashima, E; Sonye, G; Njenga, SM; Mwandawiro, C; Minakawa, N				Kawada, Hitoshi; Dida, Gabriel O.; Ohashi, Kazunori; Kawashima, Emiko; Sonye, George; Njenga, Sammy M.; Mwandawiro, Charles; Minakawa, Noboru			A Small-Scale Field Trial of Pyriproxyfen-Impregnated Bed Nets against Pyrethroid-Resistant Anopheles gambiae s.s. in Western Kenya	PLOS ONE			English	Article							GROWTH-REGULATOR PYRIPROXYFEN; JUVENILE-HORMONE; AEDES-AEGYPTI; INSECTICIDE RESISTANCE; PLASMODIUM-FALCIPARUM; MALARIA VECTORS; DIPTERA; ARABIENSIS; FUNESTUS; POPULATIONS	Pyrethroid resistance is becoming a major problem for vector control programs, because at present, there are few suitable chemical substitutes for pyrethroids, as when used on bed nets the insecticide must have low mammalian toxicity as well as high activity to mosquitoes. Pyriproxyfen (PPF) is one of the most active chemicals among the juvenile hormone mimic (JHM) group. Sterilizing mosquitoes by using PPF could be a potential control measure for pyrethroid-resistant malaria vectors. We investigated the sterilizing effects of two types of PPF-impregnated bed nets - a 1% PPF-impregnated net and a 1% PPF + 2% permethrin-impregnated net (Olyset Duo) - to pyrethroid-resistant wild population of Anopheles gambiae s.s. in western Kenya. High mortality of blood-fed mosquitos was observed 3 days post-collection, in the houses where PPF-impregnated nets were used, indicating the effect of PPF on the longevity of mosquitos that came in contact with the net. Reduction in the number of ovipositing females, number of eggs, and number of progeny per female were also observed in the houses in which both Olyset Duo and PPF-impregnated nets were used. This is the first field study showing the high sterilizing efficacy of PPF against wild pyrethroid-resistant An. gambiae s.s. population. In addition, we recognized the necessity of combined use of permethrin with PPF, in order to reduce the risk of mosquito bites and provide a level of personal protection. Further studies on wild pyrethroid-resistant mosquito populations such as An. arabiensis and An. funestus s.s. would provide more information on the practical use of the PPF-impregnated bed nets.	[Kawada, Hitoshi; Dida, Gabriel O.; Kawashima, Emiko; Minakawa, Noboru] Nagasaki Univ, Inst Trop Med, Dept Vector Ecol & Environm, Nagasaki 852, Japan; [Dida, Gabriel O.] Maseno Univ, Sch Publ Hlth, Kisumu, Kenya; [Ohashi, Kazunori] Sumitomo Chem Co Ltd, Hlth & Crop Sci Res Lab, Tokyo, Hyogo, Japan; [Sonye, George] Springs Hope, Mbita, Kenya; [Njenga, Sammy M.] Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya; [Mwandawiro, Charles] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Minakawa, Noboru] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan	Nagasaki University; Maseno University; Sumitomo Chem Co Ltd; Kenya Medical Research Institute; Nagasaki University	Kawada, H (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Vector Ecol & Environm, Nagasaki 852, Japan.	vergiss@nagasaki-u.ac.jp		O Dida, Gabriel/0000-0003-2442-0352; Njenga, Sammy/0000-0001-6309-476X; , Noboru/0000-0003-3664-9605	Nagasaki University; Sumitomo Chemical Co. Ltd	Nagasaki University; Sumitomo Chemical Co. Ltd(Sumitomo Chem Co Ltd)	This study was funded as a joint research between Nagasaki University and Sumitomo Chemical Co. Ltd in creating the field and semi-field bioassay system for insecticide delivering technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KO is an employee of funder company, Sumitomo Chemical Co., Ltd. KO gave an advisory opinion at the intervention of the bed nets as one of the developer of Olyset Duo.	Aiku A O, 2006, West Afr J Med, V25, P22; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Ebrahimi B, 2014, J MED ENTOMOL, V51, P580, DOI 10.1603/ME13100; Futami K, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-63; Gillies M. T., 1987, A supplement to the Anophelinae of Africa south of the Sahara (Afrotropical Region).; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Harris C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-144; HENRICK CA, 1973, J AGR FOOD CHEM, V21, P354, DOI 10.1021/jf60187a043; Himeidan YE, 2007, AM J TROP MED HYG, V77, P1066, DOI 10.4269/ajtmh.2007.77.1066; Hirano M., 1998, REV TOXICOL, V2, P357; Hunt RH, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-122; ITOH T, 1994, J AM MOSQUITO CONTR, V10, P344; IWANAGA K, 1988, APPL ENTOMOL ZOOL, V23, P186, DOI 10.1303/aez.23.186; JUDSON CL, 1976, J MED ENTOMOL, V13, P197, DOI 10.1093/jmedent/13.2.197; Kasai S, 2007, J MED ENTOMOL, V44, P822, DOI 10.1603/0022-2585(2007)44[822:IRIPVM]2.0.CO;2; Kawada H., 1993, P 1 INT C INS PESTS, P497; Kawada Hitoshi, 1993, Japanese Journal of Sanitary Zoology, V44, P349; Kawada H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-383; Kawada H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-208; Kawada H, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-230; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024323; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Kawada Hitoshi, 1992, Japanese Journal of Sanitary Zoology, V43, P169; KLOWDEN MJ, 1989, J INSECT PHYSIOL, V35, P513, DOI 10.1016/0022-1910(89)90058-9; Kulkarni MA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-56; Lwetoijera DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-331; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; McCann RS, 2014, AM J TROP MED HYG, V90, P597, DOI 10.4269/ajtmh.13-0614; Meola R, 1996, J MED ENTOMOL, V33, P670, DOI 10.1093/jmedent/33.4.670; MIYAMOTO J, 1993, ACS SYM SER, V524, P144; Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406; Ngufor C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093603; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Ohashi K, 2012, J MED ENTOMOL, V49, P1052, DOI 10.1603/ME12006; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Siegert PY, 2009, J ECON ENTOMOL, V102, P2061, DOI 10.1603/029.102.0607; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Syafruddin, 1990, Japanese Journal of Sanitary Zoology, V41, P15; van den Berg, 2012, ENVIRON HEALTH PERSP; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108	40	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111195	10.1371/journal.pone.0111195	http://dx.doi.org/10.1371/journal.pone.0111195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333785	Green Published, gold			2022-12-27	WOS:000343731200106
J	Mahajan, Y; Davis, C; Kim, J				Mahajan, Yatin; Davis, Chris; Kim, Jeesun			Attentional Modulation of Auditory Steady-State Responses	PLOS ONE			English	Article							SELECTIVE ATTENTION; TEMPORAL ENVELOPE; CORTEX; SOUNDS; REPRESENTATION; FIELDS; EEG	Auditory selective attention enables task-relevant auditory events to be enhanced and irrelevant ones suppressed. In the present study we used a frequency tagging paradigm to investigate the effects of attention on auditory steady state responses (ASSR). The ASSR was elicited by simultaneously presenting two different streams of white noise, amplitude modulated at either 16 and 23.5 Hz or 32.5 and 40 Hz. The two different frequencies were presented to each ear and participants were instructed to selectively attend to one ear or the other (confirmed by behavioral evidence). The results revealed that modulation of ASSR by selective attention depended on the modulation frequencies used and whether the activation was contralateral or ipsilateral. Attention enhanced the ASSR for contralateral activation from either ear for 16 Hz and suppressed the ASSR for ipsilateral activation for 16 Hz and 23.5 Hz. For modulation frequencies of 32.5 or 40 Hz attention did not affect the ASSR. We propose that the pattern of enhancement and inhibition may be due to binaural suppressive effects on ipsilateral stimulation and the dominance of contralateral hemisphere during dichotic listening. In addition to the influence of cortical processing asymmetries, these results may also reflect a bias towards inhibitory ipsilateral and excitatory contralateral activation present at the level of inferior colliculus. That the effect of attention was clearest for the lower modulation frequencies suggests that such effects are likely mediated by cortical brain structures or by those in close proximity to cortex.	[Mahajan, Yatin; Davis, Chris; Kim, Jeesun] Univ Western Sydney, MARCS Inst, Penrith, NSW 1797, Australia	Western Sydney University	Mahajan, Y (corresponding author), Univ Western Sydney, MARCS Inst, Penrith, NSW 1797, Australia.	y.mahajan@uws.edu.au		Mahajan, Yatin/0000-0002-0280-5879; Kim, Jeesun/0000-0003-2651-1020; Davis, Chris/0000-0002-6387-4181	MARCS Institute research fund	MARCS Institute research fund	The study was supported by MARCS Institute research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidet-Caulet A, 2007, J NEUROSCI, V27, P9252, DOI 10.1523/JNEUROSCI.1402-07.2007; Choi I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00115; Choi I, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00988; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; EVANS EF, 1982, SENSES, P239; Fujiki N, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0003.2002; Giard MH, 2000, FRONT BIOSCI-LANDMRK, V5, pD84, DOI 10.2741/Giard; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P11, DOI 10.1111/j.1467-9450.2008.00676.x; John MS, 2003, EAR HEARING, V24, P406, DOI 10.1097/01.AUD.0000090442.37624.BE; Kaneko K, 2003, HEARING RES, V183, P1, DOI 10.1016/S0378-5955(03)00186-2; Kawase T, 2012, NEUROIMAGE, V59, P1037, DOI 10.1016/j.neuroimage.2011.08.108; Lazzouni L, 2010, CLIN NEUROPHYSIOL, V121, P200, DOI 10.1016/j.clinph.2009.11.004; Liegeois-Chauvel C, 2004, CEREB CORTEX, V14, P731, DOI 10.1093/cercor/bhh033; LINDEN RD, 1987, ELECTROEN CLIN NEURO, V66, P145, DOI 10.1016/0013-4694(87)90184-2; Mahajan Y, 2010, J NEUROSCI METH, V188, P287, DOI 10.1016/j.jneumeth.2010.02.024; MICHIE PT, 1993, PSYCHOPHYSIOLOGY, V30, P205, DOI 10.1111/j.1469-8986.1993.tb01733.x; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Muller N, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.001.2009; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Reagan D, 1989, HUMAN BRAIN ELECTROP; Rinne T, 2008, J NEUROPHYSIOL, V100, P3323, DOI 10.1152/jn.90607.2008; Ross B, 2004, Neurol Clin Neurophysiol, V2004, P22; Ross B, 2014, HDB CLIN NEUROPHYSIO, V10, P137; Sanes DH, 1998, J NEUROSCI, V18, P794; Sininger YS, 2012, LATERALITY, V17, P129, DOI 10.1080/1357650X.2010.541464; Skosnik PD, 2007, NEUROSCI LETT, V420, P223, DOI 10.1016/j.neulet.2007.04.072; Staines WR, 2002, NEUROIMAGE, V15, P190, DOI 10.1006/nimg.2001.0953; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Xiong XRR, 2013, NEURON, V79, P738, DOI 10.1016/j.neuron.2013.06.012	33	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110902	10.1371/journal.pone.0110902	http://dx.doi.org/10.1371/journal.pone.0110902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25334021	gold, Green Submitted, Green Published			2022-12-27	WOS:000343731200089
J	Okabe, T; Kumagai, M; Nakajima, Y; Shirotake, S; Kodaira, K; Oyama, M; Ueno, M; Ikeda, M				Okabe, Takashi; Kumagai, Megumi; Nakajima, Yoshihiro; Shirotake, Suguru; Kodaira, Kiichiro; Oyama, Masafumi; Ueno, Munehisa; Ikeda, Masaaki			The Impact of HIF1 alpha on the Per2 Circadian Rhythm in Renal Cancer Cell Lines	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE CK2; GENE-EXPRESSION; DNA-BINDING; HYPOXIA; CLOCK; BREAST; PERIOD2	In mammals, the circadian rhythm central generator consists of interactions among clock genes, including Per1/2/3, Cry1/2, Bmal1, and Clock. Circadian rhythm disruption may lead to increased risk of cancer in humans, and deregulation of clock genes has been implicated in many types of cancers. Among these genes, Per2 is reported to have tumor suppressor properties, but little is known about the correlation between Per2 and HIF, which is the main target of renal cell carcinoma (RCC) therapy. In this study, the rhythmic expression of the Per2 gene was not detectable in renal cancer cell lines, with the exception of Caki-2 cells. In Caki-2 cells, HIF1 alpha increased the amplitude of Per2 oscillation by directly binding to the HIF-binding site located on the Per2 promoter. These results indicate that HIF1 alpha may enhance the amplitude of the Per2 circadian rhythm.	[Okabe, Takashi; Shirotake, Suguru; Kodaira, Kiichiro; Oyama, Masafumi; Ueno, Munehisa] Saitama Med Univ, Int Med Ctr, Dept Urooncol, Saitama, Japan; [Kumagai, Megumi; Ikeda, Masaaki] Saitama Med Univ, Dept Physiol, Saitama, Japan; [Kumagai, Megumi; Ikeda, Masaaki] Saitama Med Univ, Res Ctr Genom Med, Project Res Div, Mol Clock Project, Saitama, Japan; [Nakajima, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Kagawa, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University; National Institute of Advanced Industrial Science & Technology (AIST)	Okabe, T (corresponding author), Saitama Med Univ, Int Med Ctr, Dept Urooncol, Saitama, Japan.	kmkc_p@yahoo.co.jp	Nakajima, Yoshihiro/M-6935-2018	Nakajima, Yoshihiro/0000-0002-7422-730X				Akashi M, 2006, MOL BIOL CELL, V17, P555, DOI 10.1091/mbc.E05-05-0396; Antoch MP, 2013, CELL CYCLE, V12, P3673, DOI 10.4161/cc.26614; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; Filipski E, 2002, J NATL CANCER I, V94, P690; Fu BB, 2007, MOL CANCER THER, V6, P220, DOI 10.1158/1535-7163.MCT-06-0526; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gery S, 2007, ONCOGENE, V26, P7916, DOI 10.1038/sj.onc.1210585; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hua H, 2007, CANCER GENE THER, V14, P815, DOI 10.1038/sj.cgt.7701061; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kanaya K, 2003, BIOCHEM BIOPH RES CO, V306, P750, DOI 10.1016/S0006-291X(03)01041-6; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Mazzoccoli G, 2012, BIOMED PHARMACOTHER, V66, P175, DOI 10.1016/j.biopha.2011.11.007; McLaughlin JK, 2000, SEMIN ONCOL, V27, P115; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Noguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037093; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rini BI, 2006, BJU INT, V98, P756, DOI 10.1111/j.1464-410X.2006.06376.x; Romieu-Mourez R, 2002, CANCER RES, V62, P6770; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shinojima T, 2007, CARCINOGENESIS, V28, P529, DOI 10.1093/carcin/bgl143; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tamaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082006; Thelen P, 1999, ANTICANCER RES, V19, P1563; Thomas KA, 2008, J NURS MEAS, V16, P201, DOI 10.1891/1061-3749.16.3.201; Tsuchiya Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000305; Wilkins AK, 2007, PLOS COMPUT BIOL, V3, P2476, DOI 10.1371/journal.pcbi.0030242; Yang F, 2009, BIOCHEM BIOPH RES CO, V380, P22, DOI 10.1016/j.bbrc.2008.12.186; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200	37	25	26	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109693	10.1371/journal.pone.0109693	http://dx.doi.org/10.1371/journal.pone.0109693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333958	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200017
J	Kempf, SJ; Buratovic, S; von Toerne, C; Moertl, S; Stenerlow, B; Hauck, SM; Atkinson, MJ; Eriksson, P; Tapio, S				Kempf, Stefan J.; Buratovic, Sonja; von Toerne, Christine; Moertl, Simone; Stenerlow, Bo; Hauck, Stefanie M.; Atkinson, Michael J.; Eriksson, Per; Tapio, Soile			Ionising Radiation Immediately Impairs Synaptic Plasticity-Associated Cytoskeletal Signalling Pathways in HT22 Cells and in Mouse Brain: An In Vitro/In Vivo Comparison Study	PLOS ONE			English	Article							DENDRITIC SPINES; ALZHEIMERS-DISEASE; HIPPOCAMPAL NEUROGENESIS; ACTIN CYTOSKELETON; CEREBRAL-CORTEX; RHO; COFILIN; GROWTH; MICE; IRRADIATION	Patients suffering from brain malignancies are treated with high-dose ionising radiation. However, this may lead to severe learning and memory impairment. Preventive treatments to minimise these side effects have not been possible due to the lack of knowledge of the involved signalling pathways and molecular targets. Mouse hippocampal neuronal HT22 cells were irradiated with acute gamma doses of 0.5 Gy, 1.0 Gy and 4.0 Gy. Changes in the cellular proteome were investigated by isotope-coded protein label technology and tandem mass spectrometry after 4 and 24 hours. To compare the findings with the in vivo response, male NMRI mice were irradiated on postnatal day 10 with a gamma dose of 1.0 Gy, followed by evaluation of the cellular proteome of hippocampus and cortex 24 hours post-irradiation. Analysis of the in vitro proteome showed that signalling pathways related to synaptic actin-remodelling were significantly affected at 1.0 Gy and 4.0 Gy but not at 0.5 Gy after 4 and 24 hours. We observed radiation-induced reduction of the miR-132 and Rac1 levels; miR-132 is known to regulate Rac1 activity by blocking the GTPase-activating protein p250GAP. In the irradiated hippocampus and cortex we observed alterations in the signalling pathways similar to those in vitro. The decreased expression of miR-132 and Rac1 was associated with an increase in hippocampal cofilin and phospho-cofilin. The Rac1-Cofilin pathway is involved in the modulation of synaptic actin filament formation that is necessary for correct spine and synapse morphology to enable processes of learning and memory. We suggest that acute radiation exposure leads to rapid dendritic spine and synapse morphology alterations via aberrant cytoskeletal signalling and processing and that this is associated with the immediate neurocognitive side effects observed in patients treated with ionising radiation.	[Kempf, Stefan J.; Moertl, Simone; Atkinson, Michael J.; Tapio, Soile] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Radiat Biol, Neuherberg, Germany; [Buratovic, Sonja; Eriksson, Per] Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden; [von Toerne, Christine; Hauck, Stefanie M.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Prot Sci, Neuherberg, Germany; [Stenerlow, Bo] Uppsala Univ, Rudbeck Lab, Div Biomed Radiat Sci, Uppsala, Sweden; [Atkinson, Michael J.] Tech Univ Munich, Chair Radiat Biol, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Uppsala University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Uppsala University; Technical University of Munich	Tapio, S (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Radiat Biol, Neuherberg, Germany.	soile.tapio@helmholtz-muenchen.de	Atkinson, Michael J/E-5537-2011; von Toerne, Christine/B-2233-2013; Tapio, Soile/CAJ-5871-2022; Atkinson, Michael/AAU-5127-2020; Moertl, Simone/M-7353-2014; Tapio, Soile/M-7358-2014; Hauck, Stefanie/B-3300-2013	Atkinson, Michael J/0000-0003-3358-2089; von Toerne, Christine/0000-0002-4132-4322; Atkinson, Michael/0000-0003-3358-2089; Moertl, Simone/0000-0003-0644-0878; Tapio, Soile/0000-0001-9860-3683; Hauck, Stefanie/0000-0002-1630-6827	European Community [295552]	European Community(European Commission)	The research was supported by a grant from the European Community's Seventh Framework Programme (EURATOM) contract no 295552 (CEREBRAD - Cognitive and Cerebrovascular Effects Induced by Low Dose Ionizing Radiation). The funder had no role in study design, data collection, analysis and interpretation, decision to publish, or preparation of the manuscript.	Allen AR, 2013, RADIAT RES, V180, P78, DOI 10.1667/RR3344.1; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Armstrong DD, 1998, J NEUROPATH EXP NEUR, V57, P1013, DOI 10.1097/00005072-199811000-00003; Bamburg James R, 2010, F1000 Biol Rep, V2, P62, DOI 10.3410/B2-62; BECKER LE, 1986, ANN NEUROL, V20, P520, DOI 10.1002/ana.410200413; Breitsprecher D, 2011, J CELL SCI, V124, P3305, DOI 10.1242/jcs.086934; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Chakraborti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040844; CIPOLLARO A C, 1959, N Y State J Med, V59, P3033; Clopath C, 2012, COGN NEURODYNAMICS, V6, P251, DOI 10.1007/s11571-011-9177-6; COHEN RS, 1985, CELL MOL NEUROBIOL, V5, P271, DOI 10.1007/BF00711012; Diana G, 2007, P NATL ACAD SCI USA, V104, P636, DOI 10.1073/pnas.0610059104; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Eriksson P, 1997, NEUROTOXICOLOGY, V18, P719; Eriksson P, 2000, BRAIN RES, V853, P41, DOI 10.1016/S0006-8993(99)02231-3; Eriksson P, 2010, NEUROTOXICOLOGY, V31, P223, DOI 10.1016/j.neuro.2010.01.002; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fortin DA, 2012, NEUROSCIENTIST, V18, P326, DOI 10.1177/1073858411407206; Fouladi M, 2005, J CLIN ONCOL, V23, P7152, DOI 10.1200/JCO.2005.01.214; Haditsch U, 2009, MOL CELL NEUROSCI, V41, P409, DOI 10.1016/j.mcn.2009.04.005; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Hoffman KE, 2009, J CHILD NEUROL, V24, P1387, DOI 10.1177/0883073809342275; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kempf SJ, 2013, RADIAT ENVIRON BIOPH, V52, P5, DOI 10.1007/s00411-012-0436-7; Kirwan CB, 2008, J NEUROSCI, V28, P10541, DOI 10.1523/JNEUROSCI.3456-08.2008; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; Martinez LA, 2011, NEUROPHARMACOLOGY, V61, P305, DOI 10.1016/j.neuropharm.2011.04.017; Merl J, 2012, PROTEOMICS, V12, P1902, DOI 10.1002/pmic.201100549; Mizumatsu S, 2003, CANCER RES, V63, P4021; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; OMRAN AR, 1978, AM J PUBLIC HEALTH, V68, P561, DOI 10.2105/AJPH.68.6.561; Parihar VK, 2013, P NATL ACAD SCI USA, V110, P12822, DOI 10.1073/pnas.1307301110; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; RON E, 1982, AM J EPIDEMIOL, V116, P149, DOI 10.1093/oxfordjournals.aje.a113389; Sahin M, 2006, FREE RADICAL RES, V40, P1113, DOI 10.1080/10715760600838191; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; SCHULZ RJ, 1968, ARCH ENVIRON HEALTH, V17, P935, DOI 10.1080/00039896.1968.10665350; Shaltiel G, 2013, BRAIN STRUCT FUNCT, V218, P59, DOI 10.1007/s00429-011-0376-z; Spiegler BJ, 2004, J CLIN ONCOL, V22, P706, DOI 10.1200/JCO.2004.05.186; Tatavarty V, 2012, MOL BIOL CELL, V23, P3167, DOI 10.1091/mbc.E12-02-0165; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Tsamis KI, 2010, CURR ALZHEIMER RES, V7, P84, DOI 10.2174/156720510790274482; Vadodaria Krishna C, 2013, Front Synaptic Neurosci, V5, P4, DOI 10.3389/fnsyn.2013.00004; van Rheenen J, 2009, J CELL SCI, V122, P305, DOI 10.1242/jcs.031146; von Toerne C, 2013, J PROTEOME RES, V12, P1331, DOI 10.1021/pr3009836; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Yentrapalli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070024	59	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110464	10.1371/journal.pone.0110464	http://dx.doi.org/10.1371/journal.pone.0110464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329592	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100064
J	Martin, RK; Brooks, KB; Henningsson, F; Heyman, B; Conrad, DH				Martin, Rebecca K.; Brooks, Keith B.; Henningsson, Frida; Heyman, Birgitta; Conrad, Daniel H.			Antigen Transfer from Exosomes to Dendritic Cells as an Explanation for the Immune Enhancement Seen by IgE Immune Complexes	PLOS ONE			English	Article							B-CELL; T-CELL; CD23; ANTIBODY; CLEAVAGE; ADAM10; MICE	IgE antigen complexes induce increased specific T cell proliferation and increased specific IgG production. Immediately after immunization, CD23(+) B cells capture IgE antigen complexes, transport them to the spleen where, via unknown mechanisms, dendritic cells capture the antigen and present it to T cells. CD23, the low affinity IgE receptor, binds IgE antigen complexes and internalizes them. In this study, we show that these complexes are processed onto B-cell derived exosomes (bexosomes) in a CD23 dependent manner. The bexosomes carry CD23, IgE and MHC II and stimulate antigen specific T-cell proliferation in vitro. When IgE antigen complex stimulated bexosomes are incubated with dendritic cells, dendritic cells induce specific T-cell proliferation in vivo, similar to IgE antigen complexes. This suggests that bexosomes can provide the essential transfer mechanism for IgE antigen complexes from B cells to dendritic cells.	[Martin, Rebecca K.; Brooks, Keith B.; Conrad, Daniel H.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Henningsson, Frida; Heyman, Birgitta] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden	Virginia Commonwealth University; Uppsala University	Conrad, DH (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	dconrad@vcu.edu		Heyman, Birgitta/0000-0003-0869-0483; Martin, Rebecca/0000-0001-9948-5463	National Insitutes of Health/National Institute of Allergy and Infectious Diseases [R01AI18697]; American Asthma Foundation [11-0094]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093857] Funding Source: NIH RePORTER	National Insitutes of Health/National Institute of Allergy and Infectious Diseases; American Asthma Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Insitutes of Health/National Institute of Allergy and Infectious Diseases (nih.gov) to Daniel H Conrad, Grant number R01AI18697 and American Asthma Foundation (www.americanasthmafoundation.org) to Daniel H Conrad, Grant number 11-0094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Chen BH, 2002, IMMUNOLOGY, V107, P373, DOI 10.1046/j.1365-2567.2002.01512.x; Folgosa L, 2013, J IMMUNOL, V191, P5951, DOI 10.4049/jimmunol.1302042; Getahun A, 2005, J IMMUNOL, V175, P1473, DOI 10.4049/jimmunol.175.3.1473; Gibb DR, 2011, J IMMUNOL, V186, P4244, DOI 10.4049/jimmunol.1003318; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Henningsson F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021760; Hjelm F, 2006, SCAND J IMMUNOL, V64, P177, DOI 10.1111/j.1365-3083.2006.01818.x; Hjelm F, 2008, J IMMUNOL, V180, P6604, DOI 10.4049/jimmunol.180.10.6604; KEHRY MR, 1989, P NATL ACAD SCI USA, V86, P7556, DOI 10.1073/pnas.86.19.7556; KIM KJ, 1979, J IMMUNOL, V122, P549; LIU FT, 1980, J IMMUNOL, V124, P2728; Mathews JA, 2010, J BIOL CHEM, V285, P37531, DOI 10.1074/jbc.M110.141556; Padro CJ, 2013, J IMMUNOL, V191, P5383, DOI 10.4049/jimmunol.1301019; Qazi KR, 2009, BLOOD, V113, P2673, DOI 10.1182/blood-2008-04-153536; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; STIEF A, 1994, J IMMUNOL, V152, P3378; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5	19	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110609	10.1371/journal.pone.0110609	http://dx.doi.org/10.1371/journal.pone.0110609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330118	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100076
J	Mei, SY; Zhu, H				Mei, Suyu; Zhu, Hao			AdaBoost Based Multi-Instance Transfer Learning for Predicting Proteome-Wide Interactions between Salmonella and Human Proteins	PLOS ONE			English	Article							GENE ONTOLOGY; DATABASE; SCALE; NETWORK; HIV-1	Pathogen-host protein-protein interaction (PPI) plays an important role in revealing the underlying pathogenesis of viruses and bacteria. The need of rapidly mapping proteome-wide pathogen-host interactome opens avenues for and imposes burdens on computational modeling. For Salmonella typhimurium, only 62 interactions with human proteins are reported to date, and the computational modeling based on such a small training data is prone to yield model overfitting. In this work, we propose a multi-instance transfer learning method to reconstruct the proteome-wide Salmonella-human PPI networks, wherein the training data is augmented by homolog knowledge transfer in the form of independent homolog instances. We use AdaBoost instance reweighting to counteract the noise from homolog instances, and deliberately design three experimental settings to validate the assumption that the homolog instances are effective to address the problems of data scarcity and data unavailability. The experimental results show that the proposed method outperforms the existing models and some predictions are validated by the findings from recent literature. Lastly, we conduct gene ontology based clustering analysis of the predicted networks to provide insights into the pathogenesis of Salmonella.	[Mei, Suyu] Shenyang Normal Univ, Software Coll, Shenyang, Peoples R China; [Mei, Suyu; Zhu, Hao] Southern Med Univ, Sch Basic Med Sci, Bioinformat Sect, Guangzhou, Guangdong, Peoples R China	Shenyang Normal University; Southern Medical University - China	Mei, SY (corresponding author), Shenyang Normal Univ, Software Coll, Shenyang, Peoples R China.	meisygle@gmail.com; zhuhao@smu.edu.cn			China Postdoctoral Science Foundation [2013M531869, 2014T70821]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The work is partly supported by China Postdoctoral Science Foundation Funded Projects (No. 2013M531869, No. 2014T70821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bhavsar AP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003518; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Davis J., 2006, P 23 INT C MACH LEAR, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; De Bodt S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-288; Dong JX, 2005, IEEE T PATTERN ANAL, V27, P603, DOI 10.1109/TPAMI.2005.77; Doolittle JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-82; Dyer MD, 2007, BIOINFORMATICS, V23, pI159, DOI 10.1093/bioinformatics/btm208; Dyer MD, 2011, INFECT GENET EVOL, V11, P917, DOI 10.1016/j.meegid.2011.02.022; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gonzalez MW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002819; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Kshirsagar M, 2013, BIOINFORMATICS, V29, P217, DOI 10.1093/bioinformatics/btt245; Kshirsagar M, 2012, BIOINFORMATICS, V28, pI466, DOI 10.1093/bioinformatics/bts375; Mei SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079606; Mei SY, 2014, J THEOR BIOL, V340, P105, DOI 10.1016/j.jtbi.2013.09.007; Mei SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037716; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Meir R, 2002, LECT NOTES ARTIF INT, V2600, P118; Mukhopadhyay A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032289; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Qi YJ, 2010, BIOINFORMATICS, V26, pi645, DOI 10.1093/bioinformatics/btq394; Schleker S, 2012, CHEM BIODIVERS, V9, P991, DOI 10.1002/cbdv.201100392; Schleker S, 2012, PROTEOM CLIN APPL, V6, P117, DOI 10.1002/prca.201100083; Schlumberger MC, 2005, CURR TOP MICROBIOL, V291, P29; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Srikanth CV, 2011, CELL MOL LIFE SCI, V68, P3687, DOI 10.1007/s00018-011-0841-0; Tastan O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P516; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Vezhnevets A, 2005, GRAPHICON, V5, P987; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wasylnka JA, 2008, INFECT IMMUN, V76, P2722, DOI 10.1128/IAI.00152-08; Wu XM, 2006, NUCLEIC ACIDS RES, V34, P2137, DOI 10.1093/nar/gkl219; Wuchty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026960; Yu JT, 2010, BIOINFORMATICS, V26, P2610, DOI 10.1093/bioinformatics/btq483	38	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110488	10.1371/journal.pone.0110488	http://dx.doi.org/10.1371/journal.pone.0110488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330226	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100083
J	Tai, V; Grey, A; Bolland, MJ				Tai, Vicky; Grey, Andrew; Bolland, Mark J.			Results of Observational Studies: Analysis of Findings from the Nurses' Health Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; POSTMENOPAUSAL ESTROGEN THERAPY; BREAST-CANCER; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; WOMENS HEALTH; VITAMIN-E; BETA-CAROTENE; OMEGA-3-FATTY-ACID INTAKE; SECONDARY PREVENTION	Background: The role of observational studies in informing clinical practice is debated, and high profile examples of discrepancies between the results of observational studies and randomised controlled trials (RCTs) have intensified that debate. We systematically reviewed findings from the Nurses' Health Study (NHS), one of the longest and largest observational studies, to assess the number and strength of the associations reported and to determine if they have been confirmed in RCTs. Methods: We reviewed NHS publication abstracts from 1978-2012, extracted information on associations tested, and graded the strength of the reported effect sizes. We searched PubMed for RCTs or systematic reviews for 3 health outcomes commonly reported in NHS publications: breast cancer, ischaemic heart disease (IHD) and osteoporosis. NHS results were compared with RCT results and deemed concordant when the difference in effect sizes between studies was <= 0.15. Findings: 2007 associations between health outcomes and independent variables were reported in 1053 abstracts. 58.0% (1165/2007) were statistically significant, and 22.2% (445/2007) were neutral (no association). Among the statistically significant results that reported a numeric odds ratio (OR) or relative risk (RR), 70.5% (706/1002) reported a weak association (OR/RR 0.5-2.0), 24.5% (246/1002) a moderate association (OR/RR 0.25-0.5 or 2.0-4.0) and 5.0% (50/1002) a strong association (OR/RR <= 0.25 or >= 4.0). 19 associations reported in NHS publications for breast cancer, IHD and osteoporosis have been tested in RCTs, and the concordance between NHS and RCT results was low (<= 25%). Conclusions: NHS publications contain a large number of analyses, the majority of which reported statistically significant but weak associations. Few of these associations have been tested in RCTs, and where they have, the agreement between NHS results and RCTs is poor.	[Tai, Vicky; Grey, Andrew; Bolland, Mark J.] Univ Auckland, Dept Med, Auckland, New Zealand	University of Auckland	Tai, V (corresponding author), Univ Auckland, Dept Med, Auckland, New Zealand.	vtai282@aucklanduni.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674				Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Avenell A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub3; BAIN C, 1981, CIRCULATION, V64, P42, DOI 10.1161/01.CIR.64.1.42; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Berger JS, 2011, AM HEART J, V162, P115, DOI 10.1016/j.ahj.2011.04.006; Bertone-Johnson ER, 2005, CANCER EPIDEM BIOMAR, V14, P1991, DOI 10.1158/1055-9965.EPI-04-0722; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Bristow SM, 2013, BRIT J NUTR, V110, P1384, DOI 10.1017/S0007114513001050; Chen WY, 2006, ARCH INTERN MED, V166, P1027, DOI 10.1001/archinte.166.9.1027; Colditz GA, 2000, AM J EPIDEMIOL, V152, P950, DOI 10.1093/aje/152.10.950; COLDITZ GA, 1990, JAMA-J AM MED ASSOC, V264, P2648, DOI 10.1001/jama.264.20.2648; COLDITZ GA, 1992, CANCER CAUSE CONTROL, V3, P433, DOI 10.1007/BF00051356; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Concato J, 2004, LANCET, V363, P1660, DOI 10.1016/S0140-6736(04)16285-5; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Druesne-Pecollo N, 2010, INT J CANCER, V127, P172, DOI 10.1002/ijc.25008; Egan KM, 1996, J NATL CANCER I, V88, P988, DOI 10.1093/jnci/88.14.988; Eliassen AH, 2005, ARCH INTERN MED, V165, P2264, DOI 10.1001/archinte.165.19.2264; Feskanich D, 2003, AM J CLIN NUTR, V77, P504, DOI 10.1093/ajcn/77.2.504; Feskanich D, 1997, AM J PUBLIC HEALTH, V87, P992, DOI 10.2105/AJPH.87.6.992; Feskanich D, 1999, AM J CLIN NUTR, V69, P74; Feskanich D, 1998, EPIDEMIOLOGY, V9, P412, DOI 10.1097/00001648-199807000-00011; Grimes DA, 2012, OBSTET GYNECOL, V120, P920, DOI 10.1097/AOG.0b013e31826af61a; Grodstein F, 2006, J WOMENS HEALTH, V15, P35, DOI 10.1089/jwh.2006.15.35; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 2001, ANN INTERN MED, V135, P1, DOI 10.7326/0003-4819-135-1-200107030-00003; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Holmes MD, 2011, BREAST CANCER RES TR, V130, P657, DOI 10.1007/s10549-011-1651-7; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Hu FB, 1999, AM J CLIN NUTR, V69, P890; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Hu FB, 2003, CIRCULATION, V107, P1852, DOI 10.1161/01.CIR.0000062644.42133.5F; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; HUNTER DJ, 1993, NEW ENGL J MED, V329, P234, DOI 10.1056/NEJM199307223290403; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Kotwal S, 2012, CIRC-CARDIOVASC QUAL, V5, P808, DOI 10.1161/CIRCOUTCOMES.112.966168; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; MANSON JE, 1991, JAMA-J AM MED ASSOC, V266, P521, DOI 10.1001/jama.266.4.521; Myung SK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f10; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Osganian SK, 2003, AM J CLIN NUTR, V77, P1390, DOI 10.1093/ajcn/77.6.1390; Oxford Centre for Evidence-Based Medicine Levels of Evidence Working Group, 2009, OXF LEV EV; PETO R, 1981, NATURE, V290, P201, DOI 10.1038/290201a0; Pfeffer MA, 2002, CIRCULATION, V105, P2341, DOI 10.1161/01.CIR.0000017634.00171.24; Prasad V, 2013, J CLIN EPIDEMIOL, V66, P361, DOI 10.1016/j.jclinepi.2012.11.005; Reid IR, 2014, MATURITAS, V77, P1, DOI 10.1016/j.maturitas.2013.10.003; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shapiro S, 2000, AM J EPIDEMIOL, V151, P939, DOI 10.1093/oxfordjournals.aje.a010135; Shapiro S, 2004, PHARMACOEPIDEM DR S, V13, P257, DOI 10.1002/pds.903; Shin MH, 2002, JNCI-J NATL CANCER I, V94, P1301, DOI 10.1093/jnci/94.17.1301; Sperati F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069269; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; Stevenson M, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13450; Tamimi RM, 2005, AM J EPIDEMIOL, V161, P153, DOI 10.1093/aje/kwi030; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2; Vestergaard P, 2008, OSTEOPOROSIS INT, V19, P257, DOI 10.1007/s00198-007-0437-6; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Yang DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059020, 10.1371/journal.pone.0054495, 10.1371/journal.pone.0062329]; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zhang SM, 2005, CANCER EPIDEM BIOMAR, V14, P2004, DOI 10.1158/1055-9965.EPI-05-0083; Zhang SM, 1999, JAMA-J AM MED ASSOC, V281, P1632, DOI 10.1001/jama.281.17.1632; Zhang XH, 2012, AM J CLIN NUTR, V95, P713, DOI 10.3945/ajcn.111.014415	71	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110403	10.1371/journal.pone.0110403	http://dx.doi.org/10.1371/journal.pone.0110403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330007	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100073
J	Akhoon, BA; Singh, KP; Varshney, M; Gupta, SK; Shukla, Y; Gupta, SK				Akhoon, Bashir A.; Singh, Krishna P.; Varshney, Megha; Gupta, Shishir K.; Shukla, Yogeshwar; Gupta, Shailendra K.			Understanding the Mechanism of Atovaquone Drug Resistance in Plasmodium falciparum Cytochrome b Mutation Y268S Using Computational Methods	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN-PROTEIN INTERACTIONS; STRUCTURE PREDICTION; HIV-1 PROTEASE; I-TASSER; SACCHAROMYCES-CEREVISIAE; BINDING; INHIBITORS; MALARIA; COMPLEX	The rapid appearance of resistant malarial parasites after introduction of atovaquone (ATQ) drug has prompted the search for new drugs as even single point mutations in the active site of Cytochrome b protein can rapidly render ATQ ineffective. The presence of Y268 mutations in the Cytochrome b (Cyt b) protein is previously suggested to be responsible for the ATQ resistance in Plasmodium falciparum (P. falciparum). In this study, we examined the resistance mechanism against ATQ in P. falciparum through computational methods. Here, we reported a reliable protein model of Cyt bc1 complex containing Cyt b and the Iron-Sulphur Protein (ISP) of P. falciparum using composite modeling method by combining threading, ab initio modeling and atomic-level structure refinement approaches. The molecular dynamics simulations suggest that Y268S mutation causes ATQ resistance by reducing hydrophobic interactions between Cyt bc1 protein complex and ATQ. Moreover, the important histidine contact of ATQ with the ISP chain is also lost due to Y268S mutation. We noticed the induced mutation alters the arrangement of active site residues in a fashion that enforces ATQ to find its new stable binding site far away from the wild-type binding pocket. The MM-PBSA calculations also shows that the binding affinity of ATQ with Cyt bc1 complex is enough to hold it at this new site that ultimately leads to the ATQ resistance.	[Akhoon, Bashir A.; Singh, Krishna P.; Gupta, Shailendra K.] CSIR Indian Inst Toxicol Res, Syst Toxicol Grp, Dept Bioinformat, Lucknow, Uttar Pradesh, India; [Varshney, Megha] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Gupta, Shishir K.] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97070 Wurzburg, Germany; [Shukla, Yogeshwar] CSIR Indian Inst Toxicol Res, Dept Prote, Lucknow, Uttar Pradesh, India; [Shukla, Yogeshwar; Gupta, Shailendra K.] Acad Sci & Innovat Res AcSIR, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Aligarh Muslim University; University of Wurzburg; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Academy of Scientific & Innovative Research (AcSIR)	Gupta, SK (corresponding author), Univ Rostock, Dept Syst Biol & Bioinformat, D-18055 Rostock, Germany.	skgupta@iitr.res.in	Gupta, Shishir K/L-1687-2019	Gupta, Shishir K/0000-0002-2335-1597; Gupta, Shailendra/0000-0002-3470-3260	Council of Scientific AMP; Industrial Research (CSIR) [GENESIS (BSC0121), INDEPTH (BSC0111)]	Council of Scientific AMP; Industrial Research (CSIR)	This work was supported by the Council of Scientific & Industrial Research (CSIR) - network project GENESIS (BSC0121) and INDEPTH (BSC0111). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhoon BA, 2010, J MOL GRAPH MODEL, V28, P664, DOI 10.1016/j.jmgm.2010.01.002; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baloria U, 2012, AMINO ACIDS, V42, P1349, DOI 10.1007/s00726-010-0830-x; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bradshaw RT, 2011, PROTEIN ENG DES SEL, V24, P197, DOI 10.1093/protein/gzq047; Brown SP, 2009, J MED CHEM, V52, P3159, DOI 10.1021/jm801444x; Cheng YA, 2010, J MOL GRAPH MODEL, V29, P171, DOI 10.1016/j.jmgm.2010.05.009; Cherkis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042633; Chiappori F, 2013, EUR J MED CHEM, V63, P423, DOI 10.1016/j.ejmech.2013.02.021; Crowther GJ, 2011, MOL BIOCHEM PARASIT, V175, P21, DOI 10.1016/j.molbiopara.2010.08.005; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feyfant E, 2007, PROTEIN SCI, V16, P2030, DOI 10.1110/ps.072855507; Fisher N, 2012, J BIOL CHEM, V287, P9731, DOI 10.1074/jbc.M111.324319; Fisher N, 2008, FEMS YEAST RES, V8, P183, DOI 10.1111/j.1567-1364.2007.00328.x; Fivelman Quinton L, 2002, Malar J, V1, P1; Frauer C, 2012, PLOS ONE, V6; Friedman SH, 1998, J MED CHEM, V41, P2424, DOI 10.1021/jm970689r; FRIEDMAN SH, 1993, J AM CHEM SOC, V115, P6506, DOI 10.1021/ja00068a005; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Garcia LS, 2010, CLIN LAB MED, V30, P93, DOI 10.1016/j.cll.2009.10.001; Gupta SK, 2012, INFECT GENET EVOL, V12, P1513, DOI 10.1016/j.meegid.2012.02.022; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hill P, 2003, ANTIMICROB AGENTS CH, V47, P2725, DOI 10.1128/AAC.47.9.2725-2731.2003; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Kessl JJ, 2007, TRENDS PARASITOL, V23, P494, DOI 10.1016/j.pt.2007.08.004; Kessl JJ, 2005, J BIOL CHEM, V280, P17142, DOI 10.1074/jbc.M500388200; Khositnithikul R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-23; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Kumar S, 2001, BIOPHYS J, V80, P2439, DOI 10.1016/S0006-3495(01)76213-3; Laberge M, 2008, BIOPHYS J, V94, P2737, DOI 10.1529/biophysj.107.114942; LASKOWSKI RA, 2003, STRUCTURAL BIOINFORM; Lee VS, 2007, J MOL GRAPH MODEL, V26, P558, DOI 10.1016/j.jmgm.2007.03.013; LO TP, 1995, BIOCHEMISTRY-US, V34, P5259, DOI 10.1021/bi00015a041; Ma BY, 2000, PROTEIN ENG, V13, P617, DOI 10.1093/protein/13.9.617; Malek K, 2005, NANOTECHNOLOGY, V16, pS522, DOI 10.1088/0957-4484/16/7/029; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Merlino A, 2005, J BIOL CHEM, V280, P17953, DOI 10.1074/jbc.M501339200; Musset L, 2006, MICROBES INFECT, V8, P2599, DOI 10.1016/j.micinf.2006.07.011; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Schwobel B, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-5; Sham YY, 2001, PROTEIN SCI, V10, P135, DOI 10.1110/ps.33301; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Spassov VZ, 1999, J COMPUT CHEM, V20, P1091, DOI 10.1002/(SICI)1096-987X(199908)20:11<1091::AID-JCC1>3.0.CO;2-3; Spiliotopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046902; Srivastava IK, 1997, J BIOL CHEM, V272, P3961, DOI 10.1074/jbc.272.7.3961; Srivastava M, 2012, J MOL MODEL, V18, P2971, DOI 10.1007/s00894-011-1320-0; Taly JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-6; VAIDYA AB, 1993, MOL BIOCHEM PARASIT, V58, P33, DOI 10.1016/0166-6851(93)90088-F; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhou HY, 2007, PROTEINS, V69, P90, DOI 10.1002/prot.21649	59	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110041	10.1371/journal.pone.0110041	http://dx.doi.org/10.1371/journal.pone.0110041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25334024	Green Published, gold			2022-12-27	WOS:000346766200083
J	Althaus, M; Groen, Y; van der Schaft, L; Minderaa, RB; Tucha, O; Mulder, LJM; Wijers, AA				Althaus, Monika; Groen, Yvonne; van der Schaft, Lutske; Minderaa, Ruud B.; Tucha, Oliver; Mulder, Lambertus J. M.; Wijers, Albertus A.			Sex Differences in Orienting to Pictures with and without Humans: Evidence from the Cardiac Evoked Response (ECR) and the Cortical Long Latency Parietal Positivity (LPP)	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; HIGH-FUNCTIONING AUTISM; SPECTRUM QUOTIENT AQ; HEART-RATE RESPONSES; SYSTEMATIZING QUOTIENT; ASPERGER-SYNDROME; EMPATHY QUOTIENT; EMOTION; PERFORMANCE; REPETITION	Objective: This study investigated the effect of social relevance in affective pictures on two orienting responses, i.e. the evoked cardiac response (ECR), and a long latency cortical evoked potential (LPP) and whether this effect would differ between males and females. Assuming that orienting to affective social information is fundamental to experiencing affective empathy, associations between self-report measures of empathy and the two orienting responses were investigated. Method: ECRs were obtained from 34 female and 30 male students, and LPPs from 25 female and 27 male students viewing 414 pictures from the International Affective Picture System. Pictures portrayed pleasant, unpleasant and neutral scenes with and without humans. Results: Both the ECR and LPP showed the largest response to pictures with humans in unpleasant situations. For both measures, the responses to pictures with humans correlated with self-report measures of empathy. While we found a greater male than female responsiveness to the pictures without humans in the ECR, a greater female than male responsiveness was observed in the LPP response to pictures with humans. Conclusion and Significance: The sensitivity of these orienting responses to social relevance and their differential contribution to the prediction of individual differences underline the validity of their combined use in clinical studies investigating individuals with social disabilities.	[Althaus, Monika; van der Schaft, Lutske; Minderaa, Ruud B.] Univ Groningen, Univ Med Ctr Groningen, Dept Child & Adolescent Psychiat, NL-9713 AV Groningen, Netherlands; [Groen, Yvonne; Tucha, Oliver; Mulder, Lambertus J. M.; Wijers, Albertus A.] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	University of Groningen; University of Groningen	Althaus, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Child & Adolescent Psychiat, NL-9713 AV Groningen, Netherlands.	m.althaus@accare.nl	Tucha, Oliver/AAD-1403-2019	Groen, Yvonne/0000-0002-7242-0317				Abercrombie HC, 2008, NEUROBIOL LEARN MEM, V90, P644, DOI 10.1016/j.nlm.2008.08.001; Aiello TP, 2011, ANAT REC, V294, P1663, DOI 10.1002/ar.21251; *Anttonen J., 2009, J MEDIA PSYCHOL-GER, V21, P69, DOI [DOI 10.1027/1864-1105.21.2.69, 10.1027/1864-1105.21.2.69]; Aupee AM, 2008, SCAND J PSYCHOL, V49, P325, DOI 10.1111/j.1467-9450.2008.00659.x; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S., 2007, ARGUING MIND, P310; Baron-Cohen S, 2009, ANN NY ACAD SCI, V1156, P68, DOI 10.1111/j.1749-6632.2009.04467.x; Barry RJ, 2006, INT J PSYCHOPHYSIOL, V62, P353, DOI 10.1016/j.ijpsycho.2006.01.004; Binder M, 2005, INT J PSYCHOPHYSIOL, V55, P61, DOI 10.1016/j.ijpsycho.2004.06.003; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; Bradley MM, 1996, PSYCHOPHYSIOLOGY, V33, P662, DOI 10.1111/j.1469-8986.1996.tb02362.x; Codispoti M, 2007, J COGNITIVE NEUROSCI, V19, P577, DOI 10.1162/jocn.2007.19.4.577; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1991, J RES PERS, V25, P70, DOI 10.1016/0092-6566(91)90006-C; Ettema J, 1986, SCL 90 HANDLEIDING B; Gard MG, 2007, EMOTION, V7, P429, DOI 10.1037/1528-3542.7.2.429; Groen Y, 2013, NEUROPSYCHOLOGIA, V51, P142, DOI 10.1016/j.neuropsychologia.2012.11.012; Groen Y, 2007, BIOL PSYCHOL, V76, P174, DOI 10.1016/j.biopsycho.2007.07.006; Ito T, 1998, PERS SOC PSYCHOL B, V24, P855, DOI 10.1177/0146167298248006; Jennings JR, 2009, PSYCHOPHYSIOLOGY, V46, P1170, DOI 10.1111/j.1469-8986.2009.00866.x; Kuniecki M, 2003, ACTA NEUROBIOL EXP, V63, P39; LACEY BC, 1977, PHYSIOL PSYCHOL, V5, P383, DOI 10.3758/BF03335349; Lang P.J., 2008, A8 U FLOR; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; MULDER LJM, 1992, BIOL PSYCHOL, V34, P205, DOI 10.1016/0301-0511(92)90016-N; Norman GJ, 2011, J PSYCHOPHARMACOL, V25, P1313, DOI 10.1177/0269881110367452; Palomba D, 1997, INT J PSYCHOPHYSIOL, V27, P55, DOI 10.1016/S0167-8760(97)00751-4; Proverbio AM, 2009, NEUROPSYCHOLOGIA, V47, P2374, DOI 10.1016/j.neuropsychologia.2008.10.030; Sabatinelli D, 2004, NEUROREPORT, V15, P1109, DOI 10.1097/00001756-200405190-00005; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; SKINNER JE, 1991, ELECTROEN CLIN NEURO, P270; Somsen RJM, 2004, PSYCHOPHYSIOLOGY, V41, P941, DOI 10.1111/j.1469-8986.2004.00241.x; Somsen RJM, 2000, ACTA PSYCHOL, V104, P227, DOI 10.1016/S0001-6918(00)00030-5; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012	40	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e108224	10.1371/journal.pone.0108224	http://dx.doi.org/10.1371/journal.pone.0108224			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25330003	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200009
J	Elahi, S; Van Kessel, J; Kiros, TG; Strom, S; Hayakawa, Y; Hyodo, M; Babiuk, LA; Gerdts, V				Elahi, Shokrollah; Van Kessel, Jill; Kiros, Tedele G.; Strom, Stacy; Hayakawa, Yoshihiro; Hyodo, Mamoru; Babiuk, Lorne A.; Gerdts, Volker			c-di-GMP Enhances Protective Innate Immunity in a Murine Model of Pertussis	PLOS ONE			English	Article							CELL-MEDIATED-IMMUNITY; CYCLIC DIGUANYLIC ACID; BORDETELLA-PERTUSSIS; NITRIC-OXIDE; RESPIRATORY-INFECTION; ACETOBACTER-XYLINUM; DENDRITIC CELLS; WHOLE-CELL; TH1 CELLS; IN-VIVO	Innate immunity represents the first line of defense against invading pathogens in the respiratory tract. Innate immune cells such as monocytes, macrophages, dendritic cells, NK cells, and granulocytes contain specific pathogen-recognition molecules which induce the production of cytokines and subsequently activate the adaptive immune response. c-di-GMP is a ubiquitous second messenger that stimulates innate immunity and regulates biofilm formation, motility and virulence in a diverse range of bacterial species with potent immunomodulatory properties. In the present study, c-di-GMP was used to enhance the innate immune response against pertussis, a respiratory infection mainly caused by Bordetella pertussis. Intranasal treatment with c-di-GMP resulted in the induction of robust innate immune responses to infection with B. pertussis characterized by enhanced recruitment of neutrophils, macrophages, natural killer cells and dendritic cells. The immune responses were associated with an earlier and more vigorous expression of Th1-type cytokines, as well as an increase in the induction of nitric oxide in the lungs of treated animals, resulting in significant reduction of bacterial numbers in the lungs of infected mice. These results demonstrate that c-di-GMP is a potent innate immune stimulatory molecule that can be used to enhance protection against bacterial respiratory infections. In addition, our data suggest that priming of the innate immune system by c-di-GMP could further skew the immune response towards a Th1 type phenotype during subsequent infection. Thus, our data suggest that c-di-GMP might be useful as an adjuvant for the next generation of acellular pertussis vaccine to mount a more protective Th1 phenotype immune response, and also in other systems where a Th1 type immune response is required.	[Elahi, Shokrollah; Babiuk, Lorne A.] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Van Kessel, Jill; Strom, Stacy; Gerdts, Volker] Univ Saskatchewan, Int Vaccine Ctr, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Kiros, Tedele G.; Gerdts, Volker] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Hayakawa, Yoshihiro; Hyodo, Mamoru] Aichi Inst Technol, Dept Appl Chem, Fac Engn, Toyota 47003, Japan	University of Alberta; University of Saskatchewan; University of Saskatchewan	Elahi, S (corresponding author), Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada.	elahi@ualberta.ca; volker.gerdts@usask.ca		Gerdts, Volker/0000-0001-8229-1611; Elahi, Shokrollah/0000-0002-7215-2009	Bill and Melinda Gates Foundation through Grand Challenges in Global Health Program; Canadian Institutes of Health Research	Bill and Melinda Gates Foundation through Grand Challenges in Global Health Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded through a grant from the Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Program, and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausiello CM, 1997, DEV BIOL STAND, V89, P315; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barbic J, 1997, INFECT IMMUN, V65, P4904, DOI 10.1128/IAI.65.12.4904-4908.1997; Brady MT, 1998, IMMUNOL TODAY, V19, P534, DOI 10.1016/S0167-5699(98)01359-0; Brouillette E, 2005, ANTIMICROB AGENTS CH, V49, P3109, DOI 10.1128/AAC.49.8.3109-3113.2005; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Byrne P, 2004, EUR J IMMUNOL, V34, P2579, DOI 10.1002/eji.200425092; Canthaboo C, 2002, INFECT IMMUN, V70, P679, DOI 10.1128/IAI.70.2.679-684.2002; Canthaboo C, 1999, Dev Biol Stand, V101, P95; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Elahi S, 2001, IMMUNOLOGY, V104, P447, DOI 10.1046/j.1365-2567.2001.01331.x; Elahi S, 2005, INFECT IMMUN UNPUB; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Greco D, 1996, NEW ENGL J MED, V334, P341, DOI 10.1056/NEJM199602083340601; Greenberger MJ, 1996, J IMMUNOL, V157, P3006; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; HALPERIN SA, 1991, J INFECT DIS, V163, P355, DOI 10.1093/infdis/163.2.355; HALPERIN SA, 1988, CLIN INVEST MED, V11, P297; HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995; Hellwig SMM, 2003, J INFECT DIS, V188, P738, DOI 10.1086/377283; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Karaolis DKR, 2007, INFECT IMMUN, V75, P4942, DOI 10.1128/IAI.01762-06; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Karaolis DKR, 2005, ANTIMICROB AGENTS CH, V49, P1029, DOI 10.1128/AAC.49.3.1029-1038.2005; Kawai Rie, 2003, Nucleic Acids Res Suppl, P103; Kenyon C., 2004, Morbidity and Mortality Weekly Report, V53, P131; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Kradin RL, 2000, AM J RESP CRIT CARE, V161, P535; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; Mahon BP, 2000, J INFECT DIS, V181, P2087, DOI 10.1086/315527; Mahon BP, 1999, IMMUNOL LETT, V68, P213, DOI 10.1016/S0165-2478(99)00070-X; Mahon BP, 1996, INFECT IMMUN, V64, P5295, DOI 10.1128/IAI.64.12.5295-5301.1996; Mahon BP, 1997, J EXP MED, V186, P1843, DOI 10.1084/jem.186.11.1843; MILLS KHG, 1993, INFECT IMMUN, V61, P399, DOI 10.1128/IAI.61.2.399-410.1993; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Mobberley-Schuman PS, 2005, INFECT IMMUN, V73, P7317, DOI 10.1128/IAI.73.11.7317-7323.2005; MOUNTZOUROS KT, 1992, INFECT IMMUN, V60, P5316, DOI 10.1128/IAI.60.12.5316-5318.1992; REDHEAD K, 1993, INFECT IMMUN, V61, P3190, DOI 10.1128/IAI.61.8.3190-3198.1993; Rodgers L, 2013, CLIN INFECT DIS, V56, P322, DOI 10.1093/cid/cis888; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P63, DOI 10.1016/S0145-305X(01)00041-6; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; ROSS P, 1990, J BIOL CHEM, V265, P18933; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; Ryan M, 1998, IMMUNOLOGY, V93, P1, DOI 10.1046/j.1365-2567.1998.00401.x; Sakurai S, 1996, INFECT IMMUN, V64, P1309, DOI 10.1128/IAI.64.4.1309-1313.1996; SHAHIN RD, 1994, INFECT IMMUN, V62, P722, DOI 10.1128/IAI.62.2.722-725.1994; SHAHIN RD, 1990, J EXP MED, V171, P63, DOI 10.1084/jem.171.1.63; TOEWS GB, 1979, AM REV RESPIR DIS, V120, P559; Torre D, 1996, FEMS IMMUNOL MED MIC, V13, P95; TORRE D, 1993, J INFECT DIS, V167, P762, DOI 10.1093/infdis/167.3.762; Tsai WC, 1997, INFECT IMMUN, V65, P1870, DOI 10.1128/IAI.65.5.1870-1875.1997; VALLA S, 1989, MOL GEN GENET, V217, P26, DOI 10.1007/BF00330938; Wolfe DN, 2007, J INFECT DIS, V196, P1228, DOI 10.1086/521303; Xing DKL, 2000, VACCINE, V18, P2110, DOI 10.1016/S0264-410X(99)00562-9; Yan HB, 2009, BIOCHEM BIOPH RES CO, V387, P581, DOI 10.1016/j.bbrc.2009.07.061; YE JP, 1995, J LEUKOCYTE BIOL, V58, P225, DOI 10.1002/jlb.58.2.225; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zepp F, 2011, LANCET INFECT DIS, V11, P557, DOI 10.1016/S1473-3099(11)70007-X	63	21	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109778	10.1371/journal.pone.0109778	http://dx.doi.org/10.1371/journal.pone.0109778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333720	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200051
J	Rand, DG; Epstein, ZG				Rand, David G.; Epstein, Ziv G.			Risking Your Life without a Second Thought: Intuitive Decision-Making and Extreme Altruism	PLOS ONE			English	Article							TIT-FOR-TAT; INDIRECT RECIPROCITY; EVOLUTIONARY GAMES; SOCIAL-EXCHANGE; COOPERATION; PUNISHMENT; PERSPECTIVE; REFLECTION; SELECTION; FAIRNESS	When faced with the chance to help someone in mortal danger, what is our first response? Do we leap into action, only later considering the risks to ourselves? Or must instinctive self-preservation be overcome by will-power in order to act? We investigate this question by examining the testimony of Carnegie Hero Medal Recipients (CHMRs), extreme altruists who risked their lives to save others. We collected published interviews with CHMRs where they described their decisions to help. We then had participants rate the intuitiveness versus deliberativeness of the decision-making process described in each CHMR statement. The statements were judged to be overwhelmingly dominated by intuition; to be significantly more intuitive than a set of control statements describing deliberative decision-making; and to not differ significantly from a set of intuitive control statements. This remained true when restricting to scenarios in which the CHMRs had sufficient time to reflect before acting if they had so chosen. Text-analysis software found similar results. These findings suggest that high-stakes extreme altruism may be largely motivated by automatic, intuitive processes.	[Rand, David G.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Rand, David G.] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Rand, David G.] Yale Univ, Sch Management, New Haven, CT USA; [Epstein, Ziv G.] Pomona Coll, Claremont, CA 91711 USA	Yale University; Yale University; Yale University; Claremont Colleges; Pomona College	Rand, DG (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	David.Rand@Yale.edu		Rand, David/0000-0001-8975-2783	John Templeton Foundation (through New Paths to Purpose Project at Chicago Booth)	John Templeton Foundation (through New Paths to Purpose Project at Chicago Booth)	Financial support for the John Templeton Foundation (through a subaward from the New Paths to Purpose Project at Chicago Booth) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Balliet D, 2013, PERSPECT PSYCHOL SCI, V8, P363, DOI 10.1177/1745691613488533; BATSON CD, 1981, J PERS SOC PSYCHOL, V40, P290, DOI 10.1037/0022-3514.40.2.290; Bowles S, 2003, DAHL WS ENV, P429; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Bowles S, 2002, EC EVOLVING COMPLEX, V3, P339; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1990, J THEOR BIOL, V145, P331, DOI 10.1016/S0022-5193(05)80113-4; Brethel-Haurwitz KM, 2014, PSYCHOL SCI, V25, P762, DOI 10.1177/0956797613516148; BROWN R, 1977, COGNITION, V5, P73, DOI 10.1016/0010-0277(77)90018-X; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; Cornelissen G, 2011, PERS SOC PSYCHOL B, V37, P1080, DOI 10.1177/0146167211405996; Crockett MJ, 2013, TRENDS COGN SCI, V17, P363, DOI 10.1016/j.tics.2013.06.005; CUSHMAN F, 2009, COEVOLUTION PUNISHME; de Hooge IE, 2007, COGNITION EMOTION, V21, P1025, DOI 10.1080/02699930600980874; DeSteno D, 2009, CURR DIR PSYCHOL SCI, V18, P280, DOI 10.1111/j.1467-8721.2009.01652.x; Dreber A., 2014, ALTRUISM SELF CONTRO; Ellingsen T., 2012, SSRN ELECT J, P2, DOI [10.2139/ssrn.2179575, DOI 10.2139/SSRN.2179575]; Engel C, 2014, ECON LETT, V122, P386, DOI 10.1016/j.econlet.2013.12.020; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; FUDENBERG D, 1990, AM ECON REV, V80, P274; Fudenberg D, 2012, AM ECON REV, V102, P720, DOI 10.1257/aer.102.2.720; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Galinsky AD, 2008, PSYCHOL SCI, V19, P378, DOI 10.1111/j.1467-9280.2008.02096.x; Goetz JL, 2010, PSYCHOL BULL, V136, P351, DOI 10.1037/a0018807; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauge KE, 2009, U GOTHENBURG WORKING; Hauser OP, 2014, NATURE, V511, P220, DOI 10.1038/nature13530; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; JORDAN JJ, MORAL BRAIN IN PRESS; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, THINKING FAST SLOW; KANDORI M, 1992, REV ECON STUD, V59, P63, DOI 10.2307/2297925; Kiyonari T, 2000, EVOL HUM BEHAV, V21, P411, DOI 10.1016/S1090-5138(00)00055-6; Kovarik J, 2009, ECON LETT, V102, P152, DOI 10.1016/j.econlet.2008.12.005; Lieberman D, 2007, NATURE, V445, P727, DOI 10.1038/nature05510; Marsh AA, 2007, EMOTION, V7, P239, DOI 10.1037/1528-3542.7.2.239; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Milinski M, 2001, P ROY SOC B-BIOL SCI, V268, P2495, DOI 10.1098/rspb.2001.1809; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, PHILOS T R SOC B, V365, P19, DOI 10.1098/rstb.2009.0215; Ohtsuki H, 2006, J THEOR BIOL, V239, P435, DOI 10.1016/j.jtbi.2005.08.008; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Ohtsuki H, 2009, NATURE, V457, P79, DOI 10.1038/nature07601; Pennebaker J. W., 2001, LINGUISTIC INQUIRY W, P71; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Peysakhovich A, NATURE COMMUNICATION; Peysakhovich A., 2013, HABITS VIRTUE CREATI; Pfeiffer T, 2012, J R SOC INTERFACE, V9, P2791, DOI 10.1098/rsif.2012.0332; Rand D., 2014, POSITIVE EMOTION DIS; Rand DG, 2015, J BEHAV DECIS MAKING, V28, P159, DOI 10.1002/bdm.1837; Rand DG, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00300; Rand DG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4677; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rand DG, 2009, J THEOR BIOL, V256, P45, DOI 10.1016/j.jtbi.2008.09.015; Rand DG, 2014, ITS THOUGHT COUNTS R; RIGHETTI F, 2013, PSYCHOL SCI; ROBERTS ME, AM J POLITI IN PRESS; Roch SG, 2000, ORGAN BEHAV HUM DEC, V83, P185, DOI 10.1006/obhd.2000.2915; Ruff CC, 2013, SCIENCE, V342, P482, DOI 10.1126/science.1241399; Schulz JF, 2014, J ECON PSYCHOL, V41, P77, DOI 10.1016/j.joep.2012.08.007; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Sigmund K., 2010, CALCULUS SELFISHNESS; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Sober E., 1998, OTHERS EVOLUTION PSY; Stanovich KE, 1998, J EXP PSYCHOL GEN, V127, P161, DOI 10.1037/0096-3445.127.2.161; Swann WB, J PERSONALITY SOCIAL; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tarnita CE, 2011, P NATL ACAD SCI USA, V108, P2334, DOI 10.1073/pnas.1016008108; Tarnita CE, 2009, J THEOR BIOL, V259, P570, DOI 10.1016/j.jtbi.2009.03.035; Tinghog G, 2013, NATURE, V498, pE1, DOI 10.1038/nature12194; TOI M, 1982, J PERS SOC PSYCHOL, V43, P281, DOI 10.1037/0022-3514.43.2.281; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van den Bos K, 2011, J PERS SOC PSYCHOL, V101, P791, DOI 10.1037/a0023556; van Veelen M, 2012, P NATL ACAD SCI USA, V109, P9929, DOI 10.1073/pnas.1206694109; Verkoeijen PPJL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096654; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; Yamagishi T, 2007, RATION SOC, V19, P259, DOI 10.1177/1043463107080449; Zaki J, 2013, CURR DIR PSYCHOL SCI, V22, P466, DOI 10.1177/0963721413492764	97	67	69	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109687	10.1371/journal.pone.0109687	http://dx.doi.org/10.1371/journal.pone.0109687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25333876	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200046
J	Roberts, TA; Norris, FC; Carnaghan, H; Savery, D; Wells, JA; Siow, B; Scambler, PJ; Pierro, A; De Coppi, P; Eaton, S; Lythgoe, MF				Roberts, Thomas A.; Norris, Francesca C.; Carnaghan, Helen; Savery, Dawn; Wells, Jack A.; Siow, Bernard; Scambler, Peter J.; Pierro, Agostino; De Coppi, Paolo; Eaton, Simon; Lythgoe, Mark F.			In Amnio MRI of Mouse Embryos	PLOS ONE			English	Article							MAGNETIC-RESONANCE MICROSCOPY; HIGH-RESOLUTION	Mouse embryo imaging is conventionally carried out on ex vivo embryos excised from the amniotic sac, omitting vital structures and abnormalities external to the body. Here, we present an in amnio MR imaging methodology in which the mouse embryo is retained in the amniotic sac and demonstrate how important embryonic structures can be visualised in 3D with high spatial resolution (100 mu m/px). To illustrate the utility of in amnio imaging, we subsequently apply the technique to examine abnormal mouse embryos with abdominal wall defects. Mouse embryos at E17.5 were imaged and compared, including three normal phenotype embryos, an abnormal embryo with a clear exomphalos defect, and one with a suspected gastroschisis phenotype. Embryos were excised from the mother ensuring the amnion remained intact and stereo microscopy was performed. Embryos were next embedded in agarose for 3D, high resolution MRI on a 9.4T scanner. Identification of the abnormal embryo phenotypes was not possible using stereo microscopy or conventional ex vivo MRI. Using in amnio MRI, we determined that the abnormal embryos had an exomphalos phenotype with varying severities. In amnio MRI is ideally suited to investigate the complex relationship between embryo and amnion, together with screening for other abnormalities located outside of the mouse embryo, providing a valuable complement to histology and existing imaging methods available to the phenotyping community.	[Roberts, Thomas A.; Norris, Francesca C.; Wells, Jack A.; Siow, Bernard; Lythgoe, Mark F.] UCL, UCL Ctr Adv Biomed Imaging, Div Med, London, England; [Roberts, Thomas A.; Norris, Francesca C.] UCL, UCL Ctr Math & Phys Life Sci & Expt Biol, London, England; [Carnaghan, Helen; Savery, Dawn; Scambler, Peter J.; Pierro, Agostino; De Coppi, Paolo; Eaton, Simon] UCL, UCL Inst Child Hlth, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Roberts, TA (corresponding author), UCL, UCL Ctr Adv Biomed Imaging, Div Med, London, England.	thomas.roberts.10@ucl.ac.uk	Scambler, Peter/AAZ-6026-2020; Siow, Bernard/ABC-4414-2020; Eaton, Simon/C-4942-2008	Scambler, Peter/0000-0002-1487-4628; Siow, Bernard/0000-0002-8687-8783; Eaton, Simon/0000-0003-0892-9204; Wells, Jack/0000-0002-4171-3539; Roberts, Tom/0000-0003-0385-1057; De Coppi, Paolo/0000-0002-1659-0207; Lythgoe, Mark/0000-0002-4945-0171	Physical Sciences Research Council [EP/I014667/1]; Medical Research Council [MR/J013110/1]; British Heart Foundation [CVII]; British Heart Foundation [RG/10/13/28570] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I014667/1] Funding Source: researchfish; National Centre for the Replacement [NC/K500276/1] Funding Source: researchfish; EPSRC [EP/I014667/1] Funding Source: UKRI; MRC [MR/J013110/1] Funding Source: UKRI	Physical Sciences Research Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Centre for the Replacement; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Physical Sciences Research Council (Grant no.: EP/I014667/1), Medical Research Council (Grant no.: MR/J013110/1), and British Heart Foundation (Grant no.: CVII). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2013, DIS MODEL MECH, V6, P571, DOI 10.1242/dmm.011833; Ahmed A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013663; Bamforth SD, 2012, COLD SPRING HARBOR P; Berrios-Otero CA, 2012, MAGN RESON MED, V67, P251, DOI 10.1002/mrm.22991; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; EFFMANN EL, 1988, TERATOLOGY, V38, P59, DOI 10.1002/tera.1420380109; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Hartleben B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036705; Jinhua LU, 2011, [Frontiers in Biology, 生物学前沿], V6, P300; Nieman BJ, 2010, METHOD ENZYMOL, V476, P379, DOI 10.1016/S0076-6879(10)76021-3; Norris FC, 2013, TRENDS GENET, V29, P700, DOI 10.1016/j.tig.2013.08.004; Norris FC, 2013, MAGN RESON MED, V69, P877, DOI 10.1002/mrm.24306; Petiet AE, 2008, P NATL ACAD SCI USA, V105, P12331, DOI 10.1073/pnas.0805747105; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; Ricklefs RE, 2010, FUNCT ECOL, V24, P588, DOI 10.1111/j.1365-2435.2009.01684.x; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sadler TW, 2010, SEMIN PEDIATR SURG, V19, P209, DOI 10.1053/j.sempedsurg.2010.03.006; Schneider JE, 2003, MAGN RESON MATER PHY, V16, P43, DOI 10.1007/s10334-003-0002-z; Smith BR, 2000, METH MOL B, V135, P211; SMITH BR, 1994, P NATL ACAD SCI USA, V91, P3530, DOI 10.1073/pnas.91.9.3530; Turnbull DH, 2007, NMR BIOMED, V20, P265, DOI 10.1002/nbm.1146	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109143	10.1371/journal.pone.0109143	http://dx.doi.org/10.1371/journal.pone.0109143			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25330230	Green Published, gold			2022-12-27	WOS:000346766200019
J	Jaworska-Wilczynska, M; Magalska, A; Piwocka, K; Szymanski, P; Kusmierczyk, M; Wasik, M; Hryniewiecki, T				Jaworska-Wilczynska, Maria; Magalska, Adriana; Piwocka, Katarzyna; Szymanski, Piotr; Kusmierczyk, Mariusz; Wasik, Maria; Hryniewiecki, Tomasz			Low Interleukin-8 Level Predicts the Occurrence of the Postpericardiotomy Syndrome	PLOS ONE			English	Article							POST-PERICARDIOTOMY SYNDROME; POSTCARDIAC INJURY SYNDROME; ANTI-HEART ANTIBODIES; CARDIOPULMONARY BYPASS; IMMUNOPATHOLOGICAL FINDINGS; CLINICAL SIGNIFICANCE; CELL-SURVIVAL; INFLAMMATION; RESPONSES; DISEASE	Aims: The objective of this study was to investigate inflammatory markers of the postpericardiotomy syndrome (PPS) and to determine individuals prone to develop the PPS. Methods and Results: The study included 75 patients with a stable coronary disease that had underwent coronary artery bypass surgery. Serum samples were collected prior to the surgery and on the 5th day after the operation, to measure the concentration of IL-8, IL-6, IL-1b, IL-10, TNF, IL-12p70. All included patients were screened for the PPS before discharge from the hospital and 6 months after the surgery. The 49 patients developed the PPS (65.4%), among them 42 (56%) patients had pleural effusion, and 23 (31%) had pericardial effusion. The cytokine analysis has shown an inverse correlation between IL-8 concentration before the surgery, and the occurrence of the PPS (p = 0.026). There were also positive correlations between the magnitude of increase of IL-8 and IL-1b concentrations on the 5th day after the surgery and the occurrence of the PPS (p = 0.006 and p = 0.049 respectively). Multivariate analysis revealed IL-8 concentration before surgery as an independent risk factor of the PPS development (HR = 0.976; 95% CI: 0.956-0.996, p = 0.02). Cut-off point was established to assess the predictive value of IL-8 concentration (21.1 pg/ml). The test parameters were: sensitivity: 62.5%, specificity: 75%, positive predictive value: 83% and negative predictive value: 50%. Clinical evaluation showed the relationship between the hemoglobin concentration before the surgery and the PPS occurrence (p = 0.01). Conclusion: The IL-8 and IL-1b may participate in the postpericardiotomy syndrome pathogenesis, and the IL-8 concentration measurement may select patients with the risk of the PPS development.	[Jaworska-Wilczynska, Maria; Szymanski, Piotr; Hryniewiecki, Tomasz] Inst Cardiol, Dept Valvular Heart Dis, Warsaw, Poland; [Kusmierczyk, Mariusz] Inst Cardiol, Dept Cardiac Surg & Transplantol, Warsaw, Poland; [Magalska, Adriana; Piwocka, Katarzyna] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland; [Wasik, Maria] Med Univ Warsaw, Dept Lab Diagnost & Clin Immunol Dev Age, Warsaw, Poland	Institute of Cardiology - Poland; Institute of Cardiology - Poland; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Medical University of Warsaw	Jaworska-Wilczynska, M (corresponding author), Inst Cardiol, Dept Valvular Heart Dis, Warsaw, Poland.	mjawil@gmail.com	Piwocka, Katarzyna/P-2451-2016	Magalska, Adriana/0000-0002-0517-7134; Szymanski, Piotr/0000-0001-9486-7892; Piwocka, Katarzyna/0000-0001-6676-5282	Institute of Cardiology	Institute of Cardiology	The study was supported by Institute of Cardiology statutory grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; BUTLER J, 1992, ANN THORAC SURG, V53, P833, DOI 10.1016/0003-4975(92)91446-G; BUTLER J, 1993, ANN THORAC SURG, V55, P552, DOI 10.1016/0003-4975(93)91048-R; Cevik C, 2009, HEART LUNG CIRC, V18, P379, DOI 10.1016/j.hlc.2009.04.001; Coraux C, 2005, J PATHOL, V206, P160, DOI 10.1002/path.1757; DRESSLER W, 1956, JAMA-J AM MED ASSOC, V160, P1379, DOI 10.1001/jama.1956.02960510005002; Erlich JF, 2010, CLIN REV ALLERG IMMU, V38, P156, DOI 10.1007/s12016-009-8147-9; Franke A, 2005, EUR J CARDIO-THORAC, V28, P569, DOI 10.1016/j.ejcts.2005.07.007; Gungor B, 2008, INT J CARDIOL, V128, pE19, DOI 10.1016/j.ijcard.2007.04.159; HAEFFNERCAVAILLON N, 1989, J THORAC CARDIOV SUR, V98, P1100; Hoffman M, 2002, AUTOIMMUNITY, V35, P241, DOI 10.1080/08916930290028166; Imazio M, 2012, CURR OPIN PULM MED, V18, P366, DOI 10.1097/MCP.0b013e32835311a2; Imazio M, 2011, AM J CARDIOL, V108, P1183, DOI 10.1016/j.amjcard.2011.06.025; Imazio M, 2010, EUR HEART J, V31, P2749, DOI 10.1093/eurheartj/ehq319; ITO T, 1958, CIRCULATION, V17, P549, DOI 10.1161/01.CIR.17.4.549; JANTON OH, 1952, CIRCULATION, V6, P321, DOI 10.1161/01.CIR.6.3.321; Jaworska-Wilczynska M, 2012, MED SCI MONITOR, V18, pCQ1; Jaworska-Wilczynska M, 2012, CENT EUR J IMMUNOL, V37, P154; Lai KN, 2010, NEPHRON CLIN PRACT, V116, pC11, DOI 10.1159/000314544; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; MAISCH B, 1979, CLIN EXP IMMUNOL, V38, P189; MAISCH B, 1979, CLIN EXP IMMUNOL, V38, P198; Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5; NKERE UU, 1994, ANN THORAC SURG, V58, P437, DOI 10.1016/0003-4975(94)92224-1; Prince SE, 1997, HEART LUNG, V26, P165, DOI 10.1016/S0147-9563(97)90077-7; Qazi BS, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/908468; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; SIMONET WS, 1994, J CLIN INVEST, V94, P1310, DOI 10.1172/JCI117450; TABATZNIK B, 1961, AM J CARDIOL, V7, P83, DOI 10.1016/0002-9149(61)90426-X; Terkeltaub RA, 2009, SEMIN ARTHRITIS RHEU, V38, P411, DOI 10.1016/j.semarthrit.2008.08.006; Tseng-Rogenski S, 2009, AM J PHYSIOL-RENAL, V297, pF816, DOI 10.1152/ajprenal.90733.2008; VANDERGELD H, 1964, LANCET, V2, P617; Wessman DE, 2006, SOUTH MED J, V99, P309, DOI 10.1097/01.smj.0000203330.15503.0b; Yung S, 2009, PERITON DIALYSIS INT, V29, pS21; Zheng LR, 2007, J INTERV CARD ELECTR, V18, P269, DOI 10.1007/s10840-007-9089-x	35	14	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e108822	10.1371/journal.pone.0108822	http://dx.doi.org/10.1371/journal.pone.0108822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333927	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200008
J	Mao, SZ; Ye, XB; Liu, G; Song, DM; Liu, SF				Mao, Sun-Zhong; Ye, Xiaobing; Liu, Gang; Song, Dongmei; Liu, Shu Fang			An Obligatory Role of NF-kappa B in Mediating Bone Marrow Derived Endothelial Progenitor Cell Recruitment and Proliferation Following Endotoxemic Multiple Organ Injury in Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INDUCED ACUTE LUNG; STROMAL CELLS; NITRIC-OXIDE; REPAIR; SURVIVAL; DYSFUNCTION; ACTIVATION; INHIBITION; EXPRESSION	Background: Recruitment of bone marrow derived endothelial progenitor cells (BMDEPCs) alleviates multiple organ injury (MOI) and improves outcomes. However, mechanisms mediating BMDEPC recruitment following septic MOI remain largely unknown. This study characterized the kinetics of BMDEPC recruitment and proliferation and defined the role of NF-kappa B in regulating BMDEPC recruitment and proliferation. Methods and Main Findings: Chimeric mice with an intact or disrupted NF-kappa B p50 gene and BMDEPC-restricted expression of green fluorescent protein were created and injected with LPS (2 mg/kg, i.p.). BMDEPC recruitment and proliferation in multiple organs were quantified. BMDEPC recruitment and proliferation are highly organ-dependent. Lungs had the highest number of BMDEPC recruitment, whereas heart, liver and kidney had only a small fraction of the number of BMDEPCs in lungs. Number of proliferating BMDEPCs was several-fold higher in lungs than in other 3 organs. Kinetically, BMDEPC recruitment into different organs showed different time course profiles. NF-kappa B plays obligatory roles in mediating BMDEPC recruitment and proliferation. Universal deletion of NF-kappa B p50 gene inhibited LPS-induced BMDEPC recruitment and proliferation by 95% and 69% in heart. However, the contribution of NF-kappa B to these regulations varies significantly between organs. In liver, universal p50 gene deletion reduced LPS-induced BMDEPC recruitment and proliferation only by 49% and 35%. NF-kappa B activities in different tissue compartments play distinct roles. Selective p50 gene deletion either in stromal/parenchymal cells or in BM/blood cells inhibited BMDEPC recruitment by a similar extent. However, selective p50 gene deletion in BM/blood cells inhibited, but in stromal/parenchymal cells augmented BMDEPC proliferation. Conclusions: BMDEPC recruitment and proliferation display different kinetics in different organs following endotoxemic MOI. NF-kappa B plays obligatory and organ-dependent roles in regulating BMDEPC recruitment and proliferation. NF-kappa B activities in different tissue compartments play distinct roles in regulating BMDEPC proliferation.	[Mao, Sun-Zhong; Ye, Xiaobing; Liu, Gang; Song, Dongmei; Liu, Shu Fang] Feinstein Inst Med Res, Ctr Heart & Lung Res & Pulm & Crit Care Med, Manhasset, NY USA; [Mao, Sun-Zhong; Liu, Shu Fang] Wenzhou Med Univ, Inst Hypoxia Med, Wenzhou, Zhejiang, Peoples R China	Northwell Health; Wenzhou Medical University	Liu, SF (corresponding author), Feinstein Inst Med Res, Ctr Heart & Lung Res & Pulm & Crit Care Med, Manhasset, NY USA.	Sliu@lij.edu			American Heart Association [12GRNT1214002]; National Nature Science Foundation of China [81370171]	American Heart Association(American Heart Association); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by American Heart Association, grant number 12GRNT1214002 (to S.L.), https://research.americanheart.org, and National Nature Science Foundation of China, grant number 81370171 (to S.L.), http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnham EL, 2005, AM J RESP CRIT CARE, V172, P854, DOI 10.1164/rccm.200410-1325OC; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Chade AR, 2010, STEM CELLS, V28, P1039, DOI 10.1002/stem.426; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Cribbs SK, 2012, INTENS CARE MED, V38, P429, DOI 10.1007/s00134-012-2480-9; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025; Fakhrzadeh L, 2004, AM J PHYSIOL-LUNG C, V287, pL279, DOI 10.1152/ajplung.00348.2003; Fan HK, 2014, AM J RESP CRIT CARE, V189, P1509, DOI 10.1164/rccm.201312-2163OC; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Grundstrom S, 2004, J BIOL CHEM, V279, P8460, DOI 10.1074/jbc.M312398200; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hohenstein B, 2010, AM J PHYSIOL-RENAL, V298, pF1504, DOI 10.1152/ajprenal.00025.2010; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Hristov M, 2007, THROMB HAEMOSTASIS, V98, P274, DOI 10.1160/TH07-03-0181; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Krasnodembskaya A, 2012, AM J PHYSIOL-LUNG C, V302, pL1003, DOI 10.1152/ajplung.00180.2011; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Liu G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05543; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Liu SF, 1997, J IMMUNOL, V159, P3976; Liu Y, 2012, DIGEST DIS SCI, V57, P390, DOI 10.1007/s10620-011-1902-9; Matthay MA, 2013, AM J RESP CRIT CARE, V188, P370, DOI 10.1164/rccm.201303-0522WS; Mitra A, 2007, NEPHROL DIAL TRANSPL, V22, P2349, DOI 10.1093/ndt/gfm216; Moon C, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-18; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nowak G, 2004, CIRCULATION, V110, P3699, DOI 10.1161/01.CIR.0000143626.16576.51; Ohle SJ, 2012, AM J RESP CELL MOL, V47, P11, DOI 10.1165/rcmb.2011-0180OC; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rafat N, 2013, AM J RESP CELL MOL, V48, P399, DOI 10.1165/rcmb.2011-0132TR; Rahman Arshad, 2011, Proc Am Thorac Soc, V8, P497, DOI 10.1513/pats.201101-009MW; Toya SP, 2011, AM J PATHOL; Voswinckel R, 2003, CIRC RES, V93, P372, DOI 10.1161/01.RES.0000087643.60150.C2; Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006; Yamada M, 2005, THORAX, V60, P410, DOI 10.1136/thx.2004.034058; Yamada M, 2004, J IMMUNOL, V172, P1266, DOI 10.4049/jimmunol.172.2.1266; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393; Zhao YDD, 2009, CIRC RES, V105, P696, DOI 10.1161/CIRCRESAHA.109.199778	46	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111087	10.1371/journal.pone.0111087	http://dx.doi.org/10.1371/journal.pone.0111087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333282	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200101
J	Fan, X; Xiao, M; Kong, FR; Kudinha, T; Wang, H; Xu, YC				Fan, Xin; Xiao, Meng; Kong, Fanrong; Kudinha, Timothy; Wang, He; Xu, Ying-Chun			A Rare Fungal Species, Quambalaria cyanescens, Isolated from a Patient after Augmentation Mammoplasty - Environmental Contaminant or Pathogen?	PLOS ONE			English	Article							FILLED BREAST IMPLANT; CANDIDA-ALBICANS INFECTION; SILICONE TISSUE EXPANDER; NEIGHBOR-JOINING METHOD; SPOROTHRIX-CYANESCENS; ASPERGILLUS-FLAVUS; IDENTIFICATION; AUSTRALIA; COLONIZATION; CULTURES	Some emerging but less common human fungal pathogens are known environmental species and could be of low virulence. Meanwhile, some species have natural antifungal drug resistance, which may pose significant clinical diagnosis and treatment challenges. Implant breast augmentation is one of the most frequently performed surgical procedures in China, and fungal infection of breast implants is considered rare. Here we report the isolation of a rare human fungal species, Quambalaria cyanescens, from a female patient in China. The patient had undergone bilateral augmentation mammoplasty 11 years ago and was admitted to Peking Union Medical College Hospital on 15 September 2011 with primary diagnosis of breast infection. She underwent surgery to remove the implant and fully recovered thereafter. During surgery, implants and surrounding tissues were removed and sent for histopathology and microbiology examination. Our careful review showed that there was no solid histopathologic evidence of infection apart from inflammation. However, a fungal strain, which was initially misidentified as "Candida tropicalis" because of the similar appearance on CHROMagar Candida, was recovered. The organism was later on re-identified as Q. cyanescens, based on sequencing of the rDNA internal transcribed spacer region rather than the D1/D2 domain of 26S rDNA. It exhibited high MICs to 5-flucytosine and all echinocandins, but appeared more susceptible to amphotericin B and azoles tested. The possible pathogenic role of Q. cyanescens in breast implants is discussed in this case, and the increased potential for misidentification of the isolate is a cause for concern as it may lead to inappropriate antifungal treatment.	[Fan, Xin; Xiao, Meng; Wang, He; Xu, Ying-Chun] Beijing Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China; [Fan, Xin; Xiao, Meng; Wang, He; Xu, Ying-Chun] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Kong, Fanrong; Kudinha, Timothy] Westmead Hosp, Ctr Infect Dis & Microbiol, Lab Serv, Westmead, NSW 2145, Australia; [Kudinha, Timothy] Charles Sturt Univ, Orange, NSW, Australia	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Sydney; Charles Sturt University	Xu, YC (corresponding author), Beijing Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China.	xycpumch@139.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008	Special Research Foundation for Capital Medical Development: Epidemiology [2011-4001-09]; Postgraduate Student Innovation Fund in Peking Union Medical College [S2012001012]	Special Research Foundation for Capital Medical Development: Epidemiology; Postgraduate Student Innovation Fund in Peking Union Medical College	This work was supported by Special Research Foundation for Capital Medical Development: Epidemiology and in vitro Antifungal Susceptibility of Yeast Species Causing Invasive Fungal Infections in Beijing (grant no. 2011-4001-09; URLs: http://www.bjhbkj.com/; identify author: YCX). This work is also supported by Postgraduate Student Innovation Fund in Peking Union Medical College (grant no. S2012001012; URLS: http://graduate.pumc.edu.cn/peiyang/view/86.aspx; identify author: FX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC., 2005, METHODS YEAST GENETI; Cheewangkoon R, 2009, PERSOONIA, V23, P55, DOI 10.3767/003158509X474752; Clsi, 2009, REF METH BROTH DIL A; COADY MSE, 1995, BRIT J PLAST SURG, V48, P428, DOI 10.1016/S0007-1226(95)90275-9; de Beer ZW, 2006, STUD MYCOL, P289, DOI 10.3114/sim.55.1.289; DEHOOG GS, 1973, A VAN LEEUW J MICROB, V39, P515, DOI 10.1007/BF02578895; Dessy LA, 2012, AESTHET PLAST SURG, V36, P153, DOI 10.1007/s00266-011-9777-x; Fleming RV, 2002, INFECT DIS CLIN N AM, V16, P915, DOI 10.1016/S0891-5520(02)00064-8; Fox PM, 2012, J PLAST RECONSTR AES, V65, pE286, DOI 10.1016/j.bjps.2012.04.049; Taverna CG, 2013, MEM I OSWALDO CRUZ, V108, P178, DOI 10.1590/0074-0276108022013009; Hall L, 2003, J CLIN MICROBIOL, V41, P5099, DOI 10.1128/JCM.41.11.5099-5102.2003; Hsueh PR, 2001, J FORMOS MED ASSOC, V100, P613; Huprikar S, 2013, AM J TRANSPLANT, V13, P262, DOI 10.1111/ajt.12118; JACKSON L, 1990, J MED VET MYCOL, V28, P455; Kainer MA, 2005, J INFECT DIS, V192, P170, DOI 10.1086/430613; Kolarik Miroslav, 2006, Czech Mycology, V58, P81; NETSCHER DT, 1995, PLAST RECONSTR SURG, V96, P1125, DOI 10.1097/00006534-199510000-00020; Niazi ZBM, 1996, ANN PLAS SURG, V37, P91, DOI 10.1097/00000637-199607000-00014; Paap T, 2008, MYCOL RES, V112, P57, DOI 10.1016/j.mycres.2007.10.005; Pegg GS, 2008, PLANT PATHOL, V57, P702, DOI 10.1111/j.1365-3059.2008.01840.x; Purcell J, 2011, J CLIN PATHOL, V64, P543, DOI 10.1136/jcp.2010.084517; Reddy BT, 2002, SCAND J INFECT DIS, V34, P143, DOI 10.1080/00365540110026895; Rosenblatt WB, 1997, PLAST RECONSTR SURG, V99, P1470, DOI 10.1097/00006534-199704001-00059; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saray A, 2002, BRIT J PLAST SURG, V55, P257, DOI 10.1054/bjps.2002.3796; Scholler M, 2007, MITTEILUNGEN POLLICH, V93, P41; Shoham S, 2013, INFECT DIS CLIN N AM, V27, P305, DOI 10.1016/j.idc.2013.02.004; SIGLER L, 1990, J CLIN MICROBIOL, V28, P1009, DOI 10.1128/JCM.28.5.1009-1015.1990; Sohpal Vipan Kumar, 2010, Int J Bioinform Res Appl, V6, P230, DOI 10.1504/IJBRA.2010.034072; Tambini R, 1996, J MED VET MYCOL, V34, P195; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tian H. H., 2007, SMJ Singapore Medical Journal, V48, P256; TRUPPMAN ES, 1979, PLAST RECONSTR SURG, V64, P804, DOI 10.1097/00006534-197912000-00008; Wang H, 2012, J CLIN MICROBIOL, V50, P3952, DOI 10.1128/JCM.01130-12; WILLIAMS K, 1983, PLAST RECONSTR SURG, V71, P260, DOI 10.1097/00006534-198302000-00023; Wright PK, 2006, J PLAST RECONSTR AES, V59, P1118, DOI 10.1016/j.bjps.2006.01.020; Xiao M, 2014, J CLIN MICR IN PRESS; YOUNG VL, 1995, PLAST RECONSTR SURG, V96, P1430, DOI 10.1097/00006534-199511000-00032; Zhang L, 2014, J CLIN MICROBIOL, V52, P572, DOI 10.1128/JCM.02543-13; Zhang ZG, 2011, EUR FOOD RES TECHNOL, V232, P861, DOI 10.1007/s00217-011-1454-4	40	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e106949	10.1371/journal.pone.0106949	http://dx.doi.org/10.1371/journal.pone.0106949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330078	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100005
J	Fox, MP; Shearer, K; Maskew, M; Meyer-Rath, G; Clouse, K; Sanne, I				Fox, Matthew P.; Shearer, Kate; Maskew, Mhairi; Meyer-Rath, Gesine; Clouse, Kate; Sanne, Ian			Attrition through Multiple Stages of Pre-Treatment and ART HIV Care in South Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; PREVENTION; INITIATION; INFECTION; RETENTION; OUTCOMES; COHORT	Introduction: While momentum for increasing treatment thresholds is growing, if patients cannot be retained in HIV care from the time of testing positive through long-term adherence to antiretroviral therapy (ART), such strategies may fall short of expected gains. While estimates of retention on ART exist, few cohorts have data on retention from testing positive through long-term ART care. Methods: We explored attrition (loss or death) at the Themba Lethu HIV clinic, Johannesburg, South Africa in 3 distinct cohorts enrolled at HIV testing, pre-ART initiation, and ART initiation. Results: Between March 2010 and August 2012 we enrolled 380 patients testing HIV+, 206 initiating pre-ART care, and 185 initiating ART. Of the 380 patients enrolled at testing HIV-positive, 38.7% (95% CI: 33.9-43.7%) returned for eligibility staging within <= 3 months of testing. Of the 206 enrolled at pre-ART care, 84.5% (95% CI: 79.0-88.9%) were ART eligible at their first CD4 count. Of those, 87.9% (95% CI: 82.4-92.2%) initiated ART within 6 months. Among patients not ART eligible at their first CD4 count, 50.0% (95% CI: 33.1-66.9%) repeated their CD4 count within one year of the first ineligible CD4. Among the 185 patients in the ART cohort, 22 transferred out and were excluded from further analysis. Of the remaining 163, 81.0% (95% CI: 74.4-86.5%) were retained in care through two years on treatment. Conclusions: Our findings from a well-resourced clinic demonstrate continual loss from all stages of HIV care and strategies to reduce attrition from all stages of care are urgently needed.	[Fox, Matthew P.; Meyer-Rath, Gesine] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Fox, Matthew P.; Shearer, Kate; Maskew, Mhairi; Meyer-Rath, Gesine; Clouse, Kate; Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med,Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [Clouse, Kate] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med,Clin HIV Res Unit, Johannesburg, South Africa	Boston University; University of Witwatersrand; Boston University; Vanderbilt University; University of Witwatersrand	Fox, MP (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	mfox@bu.edu	Sanne, Ian/ABH-2231-2020; Harding, Richard/G-9729-2012; Fox, Matthew/K-2004-2019	MASKEW, MHAIRI/0000-0003-4238-0200; Clouse, Kate/0000-0002-0190-7398	National Institute of Allergy And Infectious Diseases [K01AI083097]; United States Agency for International Development (USAID) [AID 674-A-12-00029]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI083097, T32AI102623] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was also supported by Award Number K01AI083097 from the National Institute of Allergy And Infectious Diseases. This study is also made possible by the generous support of the American people through Cooperative Agreement AID 674-A-12-00029 from the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2012, P NATL ACAD SCI USA, V109, P21271, DOI 10.1073/pnas.1209017110; Bendavid E, 2010, ARCH INTERN MED, V170, P1347, DOI 10.1001/archinternmed.2010.249; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2009, LANCET, V373, P1077, DOI 10.1016/S0140-6736(09)60640-1; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; El-Sadr WM, 2010, JAIDS-J ACQ IMM DEF, V55, pS116, DOI 10.1097/QAI.0b013e3181fbca6e; Fox MP, 2010, AIDS, V24, P2041, DOI 10.1097/QAD.0b013e32833c703e; Fox MP, 2013, INT J EPIDEMIOL, V42, P430, DOI 10.1093/ije/dys029; Fox MP, 2012, AIDS, V26, P1823, DOI 10.1097/QAD.0b013e328357058a; Fox MP, 2012, TROP MED INT HEALTH, V17, P1235, DOI 10.1111/j.1365-3156.2012.03055.x; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; Hontelez JAC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021919; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Klein DJ, 2014, AIDS, V28, pS47, DOI 10.1097/QAD.0000000000000081; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; National Department of Health SA, 2004, NAT ANT TREATM GUID; National Department of Health South Africa, 2010, CLIN GUID MAN HIV AI; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; World Health Organization, 2013, ANT THER HIV INF AD	32	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110252	10.1371/journal.pone.0110252	http://dx.doi.org/10.1371/journal.pone.0110252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330087	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100048
J	Kim, JH; Song, P; Lim, H; Lee, JH; Lee, JH; Park, SA				Kim, Jong Hun; Song, Pamela; Lim, Hyunsun; Lee, Jae-Hyung; Lee, Jun Hong; Park, Sun Ah		Alzheimer's Dis Neuroimaging Initi	Gene-Based Rare Allele Analysis Identified a Risk Gene of Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; GENOTYPE IMPUTATION; COMPLEX DISEASES; COMMON VARIANTS; PROTEIN; ONSET; METAANALYSIS; SPECIFICITY; EXPRESSION	Alzheimer's disease (AD) has a strong propensity to run in families. However, the known risk genes excluding APOE are not clinically useful. In various complex diseases, gene studies have targeted rare alleles for unsolved heritability. Our study aims to elucidate previously unknown risk genes for AD by targeting rare alleles. We used data from five publicly available genetic studies from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and the database of Genotypes and Phenotypes (dbGaP). A total of 4,171 cases and 9,358 controls were included. The genotype information of rare alleles was imputed using 1,000 genomes. We performed gene-based analysis of rare alleles (minor allele frequency <= 3%). The genome-wide significance level was defined as meta P<1.8x10(-6) (0.05/number of genes in human genome = 0.05/28,517). ZNF628, which is located at chromosome 19q13.42, showed a genome-wide significant association with AD. The association of ZNF628 with AD was not dependent on APOE epsilon 4. APOE and TREM2 were also significantly associated with AD, although not at genome-wide significance levels. Other genes identified by targeting common alleles could not be replicated in our gene-based rare allele analysis. We identified that rare variants in ZNF628 are associated with AD. The protein encoded by ZNF628 is known as a transcription factor. Furthermore, the associations of APOE and TREM2 with AD were highly significant, even in gene-based rare allele analysis, which implies that further deep sequencing of these genes is required in AD heritability studies.	[Kim, Jong Hun; Lee, Jun Hong] Ilsan Hosp, Dementia Ctr, Dept Neurol, Natl Hlth Insurance Serv,Stroke Ctr, Goyang Shi, South Korea; [Song, Pamela] Inje Univ, Ilsan Paik Hosp, Dept Neurol, Goyang Shi, South Korea; [Lim, Hyunsun] Ilsan Hosp, Clin Res Management Team, Natl Hlth Insurance Serv, Goyang Shi, South Korea; [Lee, Jae-Hyung] Kyung Hee Univ, Sch Dent, Dept Life & Nanopharmaceut Sci, Seoul, South Korea; [Lee, Jae-Hyung] Kyung Hee Univ, Sch Dent, Dept Maxillofacial Biomed Engn, Seoul, South Korea; [Park, Sun Ah] Soonchunhyang Univ, Bucheon Hosp, Dept Neurol, Bucheon Shi, South Korea	National Health Insurance Service; NHIS Ilsan Hospital; Inje University; National Health Insurance Service; NHIS Ilsan Hospital; Kyung Hee University; Kyung Hee University; Soonchunhyang University	Park, SA (corresponding author), Soonchunhyang Univ, Bucheon Hosp, Dept Neurol, Bucheon Shi, South Korea.	sapark@schmc.ac.kr	Lee, Jae-Hyung/AAI-9813-2020	Lee, Jae-Hyung/0000-0002-5085-6988	Korea Health 21 R&D Project, Ministry of Health, Welfare, and Family Affairs, Republic of Korea [HI10C2020, A092004]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004610, U01HG004438, U01HG004603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, R01AG007584, R01AG008122, P30AG010129, K01AG030514, R01AG033193, U01AG006781] Funding Source: NIH RePORTER	Korea Health 21 R&D Project, Ministry of Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Study design, meta-analysis, and preparation of the manuscript in this study were supported by a grant from the Korea Health 21 R&D Project, Ministry of Health, Welfare, and Family Affairs, Republic of Korea (HI10C2020 and A092004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Bansal V, 2011, BIOCOMPUT-PAC SYM, P76; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bertram L, 2011, CURR NEUROL NEUROSCI, V11, P246, DOI 10.1007/s11910-011-0193-z; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Chen GY, 2004, GENE, V340, P71, DOI 10.1016/j.gene.2004.06.016; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Filippini N, 2009, NEUROIMAGE, V44, P724, DOI 10.1016/j.neuroimage.2008.10.003; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Magi R, 2012, GENET EPIDEMIOL, V36, P785, DOI 10.1002/gepi.21675; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Pedersen NL, 2001, AM J MED GENET, V105, P724, DOI 10.1002/ajmg.1608; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rhinn H, 2013, NATURE, V500, P45, DOI 10.1038/nature12415; Rovelet-Lecrux A, 2012, EUR J HUM GENET, V20, P613, DOI 10.1038/ejhg.2011.225; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shea J, 2011, NAT GENET, V43, P801, DOI 10.1038/ng.871; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zheng J, 2011, GENET EPIDEMIOL, V35, P102, DOI 10.1002/gepi.20552	54	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e107983	10.1371/journal.pone.0107983	http://dx.doi.org/10.1371/journal.pone.0107983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329708	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100007
J	de Sousa-Pereira, P; Abrantes, J; Pinheiro, A; Colaco, B; Vitorino, R; Esteves, PJ				de Sousa-Pereira, Patricia; Abrantes, Joana; Pinheiro, Ana; Colaco, Bruno; Vitorino, Rui; Esteves, Pedro J.			Evolution of C, D and S-Type Cystatins in Mammals: An Extensive Gene Duplication in Primates	PLOS ONE			English	Article							MULTIGENE FAMILIES; DEATH EVOLUTION; SALIVA; PROTEINS; INHIBITION; PROTEOMICS; INFERENCE; IMPACT; WHOLE	Cystatins are a family of inhibitors of cysteine peptidases that comprises the salivary cystatins (D and S-type cystatins) and cystatin C. These cystatins are encoded by a multigene family (CST3, CST5, CST4, CST1 and CST2) organized in tandem in the human genome. Their presence and functional importance in human saliva has been reported, however the distribution of these proteins in other mammals is still unclear. Here, we performed a proteomic analysis of the saliva of several mammals and studied the evolution of this multigene family. The proteomic analysis detected S-type cystatins (S, SA, and SN) in human saliva and cystatin D in rat saliva. The evolutionary analysis showed that the cystatin C encoding gene is present in species of the most representative mammalian groups, i.e. Artiodactyla, Rodentia, Lagomorpha, Carnivora and Primates. On the other hand, D and S-type cystatins are mainly retrieved from Primates, and especially the evolution of S-type cystatins seems to be a dynamic process as seen in Pongo abelii genome where several copies of CST1-like gene (cystatin SN) were found. In Rodents, a group of cystatins previously identified as D and S has also evolved. Despite the high divergence of the amino acid sequence, their position in the phylogenetic tree and their genome organization suggests a common origin with those of the Primates. These results suggest that the D and S type cystatins have emerged before the mammalian radiation and were retained only in Primates and Rodents. Although the mechanisms driving the evolution of cystatins are unknown, it seems to be a dynamic process with several gene duplications evolving according to the birth-and-death model of evolution. The factors that led to the appearance of a group of saliva-specific cystatins in Primates and its rapid evolution remain undetermined, but may be associated with an adaptive advantage.	[de Sousa-Pereira, Patricia; Vitorino, Rui] Univ Aveiro, Dept Quim, Ctr Espectrometria Massa, QOPNA, P-3800 Aveiro, Portugal; [de Sousa-Pereira, Patricia; Abrantes, Joana; Pinheiro, Ana; Esteves, Pedro J.] Univ Porto, Lab Associado, InBio, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Pinheiro, Ana] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Porto, Portugal; [Pinheiro, Ana] CSIC UCLM JCCM, SaBio IREC, Ciudad Real, Spain; [Colaco, Bruno] Univ Tras Os Montes & Alto Douro, CECAV, Dept Ciencias Vet, Vila Real, Portugal; [Esteves, Pedro J.] CESPU, IPSN, Ctr Invest Tecnol Saude, Gandra, Portugal	Universidade de Aveiro; Universidade do Porto; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Tras-os-Montes & Alto Douro	Esteves, PJ (corresponding author), Univ Porto, Lab Associado, InBio, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal.	pjesteves@cibio.up.pt	de Sousa-Pereira, Patrícia/M-3148-2013; Colaço, Bruno/K-8682-2013; Vitorino, Rui/G-7356-2014; Abrantes, Joana/D-3819-2012; Vitorino, Rui/AAJ-3621-2021; Esteves, Pedro/A-7537-2010	de Sousa-Pereira, Patrícia/0000-0002-9703-0737; Colaço, Bruno/0000-0003-4879-8624; Vitorino, Rui/0000-0003-3636-5805; Abrantes, Joana/0000-0002-8391-7134; Vitorino, Rui/0000-0003-3636-5805; Pinheiro, Ana/0000-0002-9047-954X; Esteves, Pedro/0000-0002-6055-8298	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/71252/2010]; FCT [IF/01396/2013]; FEDER (Fundo Europeu de Desenvolvimento Regional) funds through the Programa Operacional Factores de Competitividade (COMPETE program) [FCOMP-01-0124-FEDER-028286]; Portuguese national funds through FCT (Fundacao para a Ciencia e a Tecnologia) - Quadro de Referencia Estrategico Nacional (QREN) funds from the European Social Fund [PTDC/BIA-ANM/3963/2012]; Portuguese Ministerio da Educacao e Ciencia; OE Funds - State budget through the FCT - Foundation for Science and Technology [FCT-ANR/BIA-BIC/0043/2012]; Genomics Applied To Genetic Resources; North Portugal Regional Operational Programme	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER (Fundo Europeu de Desenvolvimento Regional) funds through the Programa Operacional Factores de Competitividade (COMPETE program); Portuguese national funds through FCT (Fundacao para a Ciencia e a Tecnologia) - Quadro de Referencia Estrategico Nacional (QREN) funds from the European Social Fund; Portuguese Ministerio da Educacao e Ciencia(Portuguese Foundation for Science and Technology); OE Funds - State budget through the FCT - Foundation for Science and Technology; Genomics Applied To Genetic Resources; North Portugal Regional Operational Programme	The Portuguese Foundation for Science and Technology (FCT) supported the doctoral fellowship of Ana Pinheiro (SFRH/BD/71252/2010). Joana Abrantes is supported by an FCT Investigator grant (IF/01396/2013). This work was partially funded by FEDER (Fundo Europeu de Desenvolvimento Regional) funds through the Programa Operacional Factores de Competitividade (COMPETE program; FCOMP-01-0124-FEDER-028286) and Portuguese national funds through FCT (Fundacao para a Ciencia e a Tecnologia; research project PTDC/BIA-ANM/3963/2012) - Quadro de Referencia Estrategico Nacional (QREN) funds from the European Social Fund and Portuguese Ministerio da Educacao e Ciencia. This work was also supported by OE Funds - State budget through the FCT - Foundation for Science and Technology under the project FCT-ANR/BIA-BIC/0043/2012 and by "Genomics Applied To Genetic Resources" cofinanced by North Portugal Regional Operational Programme 2007/2013 (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; BJORCK L, 1990, MOL MICROBIOL, V4, P1439, DOI 10.1111/j.1365-2958.1990.tb02054.x; Blankenvoorde MFJ, 1996, BIOL CHEM, V377, P847; Castagnola M, 2011, TRENDS BIOTECHNOL, V29, P409, DOI 10.1016/j.tibtech.2011.04.002; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Sousa-Pereira P, 2013, ARCH ORAL BIOL, V58, P451, DOI 10.1016/j.archoralbio.2012.12.011; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P485, DOI 10.1177/154411130201300606; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P238, DOI 10.1177/154411130201300304; DICKINSON DP, 1994, GENOMICS, V24, P172, DOI 10.1006/geno.1994.1595; Eirin-Lopez JM, 2012, GENOME DYNAM, V7, P170, DOI 10.1159/000337119; Grzonka Z, 2001, ACTA BIOCHIM POL, V48, P1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Henskens YMC, 1996, J PERIODONTAL RES, V31, P57, DOI 10.1111/j.1600-0765.1996.tb00464.x; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Klein J, 1993, PROGR IMMUNOLOGY, V8, P137; Kordis D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-266; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMKIN MS, 1993, CRIT REV ORAL BIOL M, V4, P251, DOI 10.1177/10454411930040030101; Levasseur A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-11; Messana I, 2008, J SEP SCI, V31, P1948, DOI 10.1002/jssc.200800100; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Ochieng J, 2010, J HEALTH CARE POOR U, V21, P51, DOI 10.1353/hpu.0.0257; Ohno S., 1970, EVOLUTION GENE DUPLI; OTA T, 1994, MOL BIOL EVOL, V11, P469; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Rambaut A, 2007, TRACER V 1 4; RAWLINGS ND, 1990, J MOL EVOL, V30, P60, DOI 10.1007/BF02102453; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scarano E, 2010, ACTA OTORHINOLARYNGO, V30, P125; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; SHAW PA, 1988, J BIOL CHEM, V263, P18133; Sitnikova T, 1998, MOL BIOL EVOL, V15, P617, DOI 10.1093/oxfordjournals.molbev.a025965; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vitorino R, 2004, PROTEOMICS, V4, P1109, DOI 10.1002/pmic.200300638; Vitorino R, 2012, J PROTEOMICS, V75, P5140, DOI 10.1016/j.jprot.2012.05.045; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; ZIMMER EA, 1980, P NATL ACAD SCI-BIOL, V77, P2158, DOI 10.1073/pnas.77.4.2158	45	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109050	10.1371/journal.pone.0109050	http://dx.doi.org/10.1371/journal.pone.0109050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329717	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100009
J	Hu, WL; Chang, CH; Hung, YC; Tseng, YJ; Hung, IL; Hsu, SF				Hu, Wen-Long; Chang, Chih-Hao; Hung, Yu-Chiang; Tseng, Ying-Jung; Hung, I-Ling; Hsu, Sheng-Feng			Laser Acupuncture Therapy in Patients with Treatment-Resistant Temporomandibular Disorders	PLOS ONE			English	Article							LOW-LEVEL LASER; CONTROLLED-TRIALS; JOINT PAIN; PLACEBO	Objective: To investigate the clinical effects of laser acupuncture therapy for temporomandibular disorders (TMD) after ineffective previous treatments. Methods: A retrospective observational study was conducted in 29 treatment-resistant TMD patients (25 women, 4 men; age range, 17-67 years). Subjects were treated 3 times per week for 4 weeks with the Handylaser Trion (GaAlAs laser diode, 810 nm, 150 mW, pulsed waves), which delivered 0.375 J of energy (5 s) to ST7, ST6, and LI4 and 3 J (40 s) to each Ashi point, 7.5-26.25 J/cm(2) in total. The visual analog scale (VAS) and maximal mouth opening (MMO) were evaluated before and after treatment. Results: VAS analysis showed that the patients were free of pain at rest (endpoint) after 5.90 +/- 6.08 sessions of laser acupuncture for acute TMD and after 16.21 +/- 17.98 sessions for chronic TMD. The VAS score on palpation of the temporomandibular joint reduced to 0.30 +/- 0.67 for patients with acute TMD (p = 0.005) and to 0.47 +/- 0.84 for those with chronic TMD (p<0.001). The MMO significantly increased in patients with acute TMD (7.80 +/- 5.43 mm, p = 0.008) and in patients with chronic TMD (15.58 +/- 7.87 mm, p<0.001). Conclusions: Our study shows that laser acupuncture therapy improves the symptoms of treatment-resistant TMD. Further studies with a more appropriate design, involving long-term follow-up examinations in a larger patient sample, are needed to evaluate its efficacy.	[Hu, Wen-Long; Hung, Yu-Chiang; Tseng, Ying-Jung; Hung, I-Ling] Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung, Taiwan; [Hu, Wen-Long; Hung, Yu-Chiang; Tseng, Ying-Jung; Hung, I-Ling] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Hu, Wen-Long] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Hu, Wen-Long; Chang, Chih-Hao] Fooyin Univ, Coll Nursing, Kaohsiung, Taiwan; [Chang, Chih-Hao] Kaohsiung Municipal Chinese Med Hosp, Div Chinese Med, Kaohsiung, Taiwan; [Hung, Yu-Chiang] I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan; [Hsu, Sheng-Feng] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan; [Hsu, Sheng-Feng] China Med Univ Hosp, Dept Chinese Med, Taipei Branch, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Fooyin University; I Shou University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Hu, WL (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung, Taiwan.	oolonghu@gmail.com	Hung, yu-chiang/ABE-7636-2020; Hu, Wen-Long/N-1660-2014	Hu, Wen-Long/0000-0001-9549-6202				Bjordal JM, 2006, PHOTOMED LASER SURG, V24, P158, DOI 10.1089/pho.2006.24.158; De Leeuw R, 2008, GUIDELINES ASSESSMEN, P129; Dym Harry, 2012, Dent Clin North Am, V56, P149, DOI 10.1016/j.cden.2011.08.002; Emshoff R, 2008, ORAL SURG ORAL MED O, V105, P452, DOI 10.1016/j.tripleo.2007.09.012; Ferreira LA, 2013, LASER MED SCI, V28, P1549, DOI 10.1007/s10103-013-1273-x; Garza I, 2012, BRADLEYS NEUROLOGY C, P1714; Han JS, 2011, PAIN, V152, pS41, DOI 10.1016/j.pain.2010.10.012; Hu WL, 2010, AM J CHINESE MED, V38, P861, DOI 10.1142/S0192415X10008305; Hu WL, 2011, ACUPUNCTURE CLIN PRA, P3; Hu WL, 2013, ACUPUNCTURE MODERN M, P205; Jung A, 2011, J DENT, V39, P341, DOI 10.1016/j.jdent.2011.02.006; La Touche R, 2010, CLIN J PAIN, V26, P541, DOI 10.1097/AJP.0b013e3181e2697e; Salmos-Brito JAL, 2013, LASER MED SCI, V28, P57, DOI 10.1007/s10103-012-1065-8; Marini I, 2010, CLIN J PAIN, V26, P611, DOI 10.1097/AJP.0b013e3181e0190d; Melis M, 2012, CRANIO, V30, P304, DOI 10.1179/crn.2012.045; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Ohrbach R, 2013, CLIN EXAMINATION PRO; Okeson JP, 2012, CONNS CURRENT THERAP, P320; Serra APE, 2010, REV BRAS ANESTESIOL, V60, P302, DOI [10.1590/S0034-70942010000300008, 10.1016/S0034-7094(10)70037-4]; REIMERS & JANSSEN GmbH, 2008, RJ LAS THER, P26; Romaniello A, 2003, PAIN, V103, P31, DOI 10.1016/S0304-3959(02)00347-0; Rotter BE, 2010, CUMMINGS OTOLARYNGOL, P1279; Sandoval MC, 2009, PHOTOMED LASER SURG, V27, P63, DOI 10.1089/pho.2007.2216; Shen XY, 2009, LASER MED SCI, V24, P129, DOI 10.1007/s10103-007-0536-9; Shi DB, 2002, ENCY TRADITIONAL CHI; Simunovic Z, 1996, J Clin Laser Med Surg, V14, P163; Tuner J, 2010, NEW LASER THERAPY HD, P505; WILDERSMITH P, 1988, ORAL SURG ORAL MED O, V66, P654, DOI 10.1016/0030-4220(88)90311-8; World Health Organization Regional Office for the Western Pacific (WPRO), 2007, WORLD DEV IND, P56; Younger JW, 2010, PAIN, V149, P222, DOI 10.1016/j.pain.2010.01.006	30	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110528	10.1371/journal.pone.0110528	http://dx.doi.org/10.1371/journal.pone.0110528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329855	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100089
J	Wakade, C; Chong, R; Bradley, E; Thomas, B; Morgan, J				Wakade, Chandramohan; Chong, Raymond; Bradley, Eric; Thomas, Bobby; Morgan, John			Upregulation of GPR109A in Parkinson's Disease	PLOS ONE			English	Article							SLEEP BEHAVIOR DISORDER; NICOTINIC-ACID; POSTURAL INSTABILITY; RAPID ASSESSMENT; MESSENGER-RNA; SCALE; DYSFUNCTION; METABOLISM; EXPRESSION; PATHWAYS	Background: Anecdotal animal and human studies have implicated the symptomatic and neuroprotective roles of niacin in Parkinson's disease (PD). Niacin has a high affinity for GPR109A, an anti-inflammatory receptor. Niacin is also thought to be involved in the regulation of circadian rhythm. Here we evaluated the relationships among the receptor, niacin levels and EEG night-sleep in individuals with PD. Methods and Findings: GPR109A expression (blood and brain), niacin index (NAD-NADP ratio) and cytokine markers (blood) were analyzed. Measures of night-sleep function (EEG) and perceived sleep quality (questionnaire) were assessed. We observed significant up-regulation of GPR109A expression in the blood as well as in the substantia nigra (SN) in the PD group compared to age-matched controls. Confocal microscopy demonstrated co-localization of GPR109A staining with microglia in PD SN. Pro and anti-inflammatory cytokines did not show significant differences between the groups; however IL1-beta, IL-4 and IL-7 showed an upward trend in PD. Time to sleep (sleep latency), EEG REM and sleep efficiency were different between PD and age-matched controls. Niacin levels were lower in PD and were associated with increased frequency of experiencing body pain and decreased duration of deep sleep. Conclusions: The findings of associations among the GPR109A receptor, niacin levels and night-sleep function in individuals with PD are novel. Further studies are needed to understand the pathophysiological mechanisms of action of niacin, GPR109A expression and their associations with night-sleep function. It would be also crucial to study GPR109A expression in neurons, astrocytes, and microglia in PD. A clinical trial to determine the symptomatic and/or neuroprotective effect of niacin supplementation is warranted.	[Wakade, Chandramohan; Chong, Raymond; Bradley, Eric] Georgia Regents Univ, Dept Phys Therapy, Augusta, GA 30912 USA; [Thomas, Bobby] Georgia Regents Univ, Dept Pharmacol & Toxicol & Neurol, Augusta, GA USA; [Morgan, John] Georgia Regents Univ, Dept Neurol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Wakade, C (corresponding author), Georgia Regents Univ, Dept Phys Therapy, Augusta, GA 30912 USA.	cwakade@gru.edu; rchong@gru.edu		Chong, Raymond/0000-0002-2706-1300	National Parkinson's Foundation, CSRA [20000-01080000-12100-64076-PSG00028]; NIH [NS060885]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060885] Funding Source: NIH RePORTER	National Parkinson's Foundation, CSRA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The National Parkinson's Foundation, CSRA Augusta chapter provided the funding for this study (20000-01080000-12100-64076-PSG00028) and the NIH grant NS060885 paid for the human brain samples which were obtained from the NICHD Brain and Tissue Bank University of Maryland School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisky JM, 2005, NUTR NEUROSCI, V8, P327, DOI 10.1080/10284150500484638; Anderson DW, 2008, EUR J NEUROSCI, V28, P610, DOI 10.1111/j.1460-9568.2008.06356.x; Arduino DM, 2010, CNS NEUROL DISORD-DR, V9, P105, DOI 10.2174/187152710790966687; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Ban N, 2013, EXP GERONTOL, V48, P1212, DOI 10.1016/j.exger.2013.04.010; Banati RB, 1998, MOVEMENT DISORD, V13, P221, DOI 10.1002/mds.870130205; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; BENDER DA, 1979, CLIN SCI MOL MED, V56, P89, DOI 10.1042/cs0560089; BIRKMAYER JGD, 1993, ACTA NEUROL SCAND, V87, P32; Bjorklund A, 2010, PROG BRAIN RES, V184, P113, DOI 10.1016/S0079-6123(10)84006-3; Boeve BF, 2013, LANCET NEUROL, V12, P469, DOI 10.1016/S1474-4422(13)70054-1; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Chahine LM, 2013, MOVEMENT DISORD, V28, P1146, DOI 10.1002/mds.25438; Chai JT, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0325-9; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chaudhuri KR, 2002, J NEUROL NEUROSUR PS, V73, P629, DOI 10.1136/jnnp.73.6.629; Chen JL, 2007, ANN NEUROL, V62, P49, DOI 10.1002/ana.21160; Chong RKY, 2012, INT J CLIN PRACT, V66, P718, DOI 10.1111/j.1742-1241.2012.02927.x; Chong RKY, 2011, EUR J NEUROL, V18, P260, DOI 10.1111/j.1468-1331.2010.03115.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crotty S, 2008, EUR J NEUROSCI, V27, P294, DOI 10.1111/j.1460-9568.2007.06018.x; Digby JE, 2011, CIRCULATION, V124; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Digby JE, 2010, ATHEROSCLEROSIS, V209, P89, DOI 10.1016/j.atherosclerosis.2009.08.045; Fall PA, 1999, MOVEMENT DISORD, V14, P28, DOI 10.1002/1531-8257(199901)14:1&lt;28::AID-MDS1007&gt;3.0.CO;2-O; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gagne JJ, 2010, NEUROLOGY, V74, P995, DOI 10.1212/WNL.0b013e3181d5a4a3; Ganji SH, 2009, ATHEROSCLEROSIS, V202, P68, DOI 10.1016/j.atherosclerosis.2008.04.044; Ghosh S, 2010, BBA-GENE REGUL MECH, V1799, P681, DOI 10.1016/j.bbagrm.2010.08.002; Gille A, 2008, ANNU REV PHARMACOL, V48, P79, DOI 10.1146/annurev.pharmtox.48.113006.094746; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Han M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032383; Hasan D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-222; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Imai SI, 2010, BBA-PROTEINS PROTEOM, V1804, P1584, DOI 10.1016/j.bbapap.2009.10.024; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Jenkinson C, 2007, PARKINSONISM RELAT D, V13, P22, DOI 10.1016/j.parkreldis.2006.06.006; Jia HQ, 2008, J NEUROSCI RES, V86, P2083, DOI 10.1002/jnr.21650; Jung-Hynes B, 2010, J PINEAL RES, V48, P9, DOI 10.1111/j.1600-079X.2009.00729.x; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Maciejewski-Lenoir D, 2006, J INVEST DERMATOL, V126, P2637, DOI 10.1038/sj.jid.5700586; Martin PM, 2009, MOL VIS, V15, P362; Mendelsohn AR, 2014, REJUV RES, V17, P62, DOI 10.1089/rej.2014.1546; Offermanns S, 2006, TRENDS PHARMACOL SCI, V27, P384, DOI 10.1016/j.tips.2006.05.008; Pearl SM, 2000, SYNAPSE, V36, P95, DOI 10.1002/(SICI)1098-2396(200005)36:2<95::AID-SYN2>3.0.CO;2-U; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Peeraully T, 2012, MOVEMENT DISORD, V27, P1729, DOI 10.1002/mds.25197; Piper PW, 2006, MECH AGEING DEV, V127, P733, DOI 10.1016/j.mad.2006.05.004; Poewe W, 2006, J NEUROL, V253, P2, DOI 10.1007/s00415-006-7002-7; Postuma RB, 2012, BRAIN, V135, P1860, DOI 10.1093/brain/aws093; Ramsey KM, 2013, METHODS MOL BIOL, V1077, P285, DOI 10.1007/978-1-62703-637-5_19; REIMUND E, 1991, MED HYPOTHESES, V34, P275, DOI 10.1016/0306-9877(91)90224-M; Sancar G, 2014, CELLULAR MOL LIFE SC; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sassone-Corsi P, 2012, ENDOCRINOLOGY, V153, P1, DOI 10.1210/en.2011-1535; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Shambroom JR, 2011, J SLEEP RES; Sixel-Doring F, 2011, NEUROLOGY, V77, P1048, DOI 10.1212/WNL.0b013e31822e560e; Stebbins GT, 1999, MOVEMENT DISORD, V14, P585, DOI 10.1002/1531-8257(199907)14:4<585::AID-MDS1006>3.0.CO;2-3; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Wakade C, 2014, NIACIN SUPPLEM UNPUB; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Yoshino Jun, 2013, Nihon Rinsho, V71, P2187	69	50	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109818	10.1371/journal.pone.0109818	http://dx.doi.org/10.1371/journal.pone.0109818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329911	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100030
J	Ziv, D; Zviran, T; Zezak, O; Samach, A; Irihimovitch, V				Ziv, Dafna; Zviran, Tali; Zezak, Oshrat; Samach, Alon; Irihimovitch, Vered			Expression Profiling of FLOWERING LOCUS T-Like Gene in Alternate Bearing 'Hass' Avocado Trees Suggests a Role for PaFT in Avocado Flower Induction	PLOS ONE			English	Article							CONSISTENT ANNUAL YIELDS; VEGETATIVE GROWTH; FLORAL INDUCTION; PERSEA-AMERICANA; FT; ACID; INFLORESCENCE; CONTRIBUTES; CONSTRAINTS; DORMANCY	In many perennials, heavy fruit load on a shoot decreases the ability of the plant to undergo floral induction in the following spring, resulting in a pattern of crop production known as alternate bearing. Here, we studied the effects of fruit load on floral determination in 'Hass' avocado (Persea americana). De-fruiting experiments initially confirmed the negative effects of fruit load on return to flowering. Next, we isolated a FLOWERING LOCUS T-like gene, PaFT, hypothesized to act as a phloem-mobile florigen signal and examined its expression profile in shoot tissues of on (fully loaded) and off (fruit-lacking) trees. Expression analyses revealed a strong peak in PaFT transcript levels in leaves of off trees from the end of October through November, followed by a return to starting levels. Moreover and concomitant with inflorescence development, only off buds displayed up-regulation of the floral identity transcripts PaAP1 and PaLFY, with significant variation being detected from October and November, respectively. Furthermore, a parallel microscopic study of off apical buds revealed the presence of secondary inflorescence axis structures that only appeared towards the end of November. Finally, ectopic expression of PaFT in Arabidopsis resulted in early flowering transition. Together, our data suggests a link between increased PaFT expression observed during late autumn and avocado flower induction. Furthermore, our results also imply that, as in the case of other crop trees, fruit-load might affect flowering by repressing the expression of PaFT in the leaves. Possible mechanism(s) by which fruit crop might repress PaFT expression, are discussed.	[Ziv, Dafna; Zviran, Tali; Zezak, Oshrat; Irihimovitch, Vered] Agr Res Org, Volcani Ctr, Inst Plant Sci, IL-50250 Bet Dagan, Israel; [Ziv, Dafna; Zezak, Oshrat; Samach, Alon] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, Fac Agr Food & Environm, IL-76100 Rehovot, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem	Irihimovitch, V (corresponding author), Agr Res Org, Volcani Ctr, Inst Plant Sci, IL-50250 Bet Dagan, Israel.	veredi@agri.gov.il			Ministry of Agriculture, Israel [203-0813]; Israeli Science Foundation - the Charles H. Revson Foundation [1464/07]	Ministry of Agriculture, Israel; Israeli Science Foundation - the Charles H. Revson Foundation	Grant No. 203-0813 from the Chief Scientist of the Ministry of Agriculture, Israel to VI and by Grant No. 1464/07 from the Israeli Science Foundation - the Charles H. Revson Foundation to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Albani MC, 2010, CURR TOP DEV BIOL, V91, P323, DOI 10.1016/S0070-2153(10)91011-9; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Chanderbali AS, 2009, P NATL ACAD SCI USA, V106, P8929, DOI 10.1073/pnas.0811476106; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Dag A, 2010, SCI HORTIC-AMSTERDAM, V123, P469, DOI 10.1016/j.scienta.2009.11.014; Davenport T. L., 1986, Horticultural Reviews, V8, P257, DOI 10.1002/9781118060810.ch7; Endo T, 2005, TRANSGENIC RES, V14, P703, DOI 10.1007/s11248-005-6632-3; Freiman A, 2012, PLANTA, V235, P1239, DOI 10.1007/s00425-011-1571-0; Garner LC, 2008, J AM SOC HORTIC SCI, V133, P3, DOI 10.21273/JASHS.133.1.3; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Goldberg-Moeller R, 2013, PLANT SCI, V198, P46, DOI 10.1016/j.plantsci.2012.09.012; GOLDSCHMIDT EE, 1982, J AM SOC HORTIC SCI, V107, P206; GUARDIOLA JL, 1982, PHYSIOL PLANTARUM, V55, P136, DOI 10.1111/j.1399-3054.1982.tb02276.x; Hattasch C, 2008, TREE PHYSIOL, V28, P1459, DOI 10.1093/treephys/28.10.1459; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Jaeger KE, 2006, J EXP BOT, V57, P3415, DOI 10.1093/jxb/erl159; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; King RW, 2008, J EXP BOT, V59, P3811, DOI 10.1093/jxb/ern231; Kotoda N, 2010, PLANT CELL PHYSIOL, V51, P561, DOI 10.1093/pcp/pcq021; LAHAV E, 1977, AUST J AGR RES, V28, P869, DOI 10.1071/AR9770869; Li CY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00073; Li CY, 2003, ANN BOT-LONDON, V92, P137, DOI 10.1093/aob/mcg108; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Mimida N, 2001, GENES CELLS, V6, P327, DOI 10.1046/j.1365-2443.2001.00425.x; Monselise S. P., 1984, Horticultural Reviews, V4, P128, DOI 10.1002/9781118060773.ch5; Munoz-Fambuena N, 2012, ANN BOT-LONDON, V110, P1109, DOI 10.1093/aob/mcs190; Munoz-Fambuena N, 2011, ANN BOT-LONDON, V108, P511, DOI 10.1093/aob/mcr164; Nakagawa M, 2012, SCI HORTIC-AMSTERDAM, V139, P108, DOI 10.1016/j.scienta.2012.03.005; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Nishikawa F, 2007, J EXP BOT, V58, P3915, DOI 10.1093/jxb/erm246; Or E, 2000, PLANT MOL BIOL, V43, P483, DOI 10.1023/A:1006450516982; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Rinne PLH, 2011, PLANT CELL, V23, P130, DOI 10.1105/tpc.110.081307; Salazar-Garcia S, 2000, J AM SOC HORTIC SCI, V125, P25, DOI 10.21273/JASHS.125.1.25; Salazar-Garcia S, 1998, J AM SOC HORTIC SCI, V123, P537, DOI 10.21273/JASHS.123.4.537; Salazar-Garcia S, 2006, HORTSCIENCE, V41, P1541, DOI 10.21273/HORTSCI.41.7.1541; Samach A, 2013, PLANT SCI, V207, P168, DOI 10.1016/j.plantsci.2013.02.006; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Shalom L, 2014, J EXP BOT, V65, P3029, DOI 10.1093/jxb/eru148; Shalom L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046930; Siriwardana NS, 2012, INT J DEV BIOL, V56, P207, DOI 10.1387/ijdb.113450ns; Smith HM, 2013, PLANT SCI, V207, P158, DOI 10.1016/j.plantsci.2013.02.014; THORP TG, 1994, ANN BOT-LONDON, V73, P13, DOI 10.1006/anbo.1994.1002; Trankner C, 2010, PLANTA, V232, P1309, DOI 10.1007/s00425-010-1254-2; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Whiley A. W., 2002, AVOCADO BOT PRODUCTI; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yoo SJ, 2010, PLANT J, V63, P241, DOI 10.1111/j.1365-313X.2010.04234.x; Yoo SY, 2004, MOL CELLS, V17, P95	52	33	35	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110613	10.1371/journal.pone.0110613	http://dx.doi.org/10.1371/journal.pone.0110613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330324	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100096
J	Bernard, JJ; Lou, YR; Peng, QY; Li, T; Lu, YP				Bernard, Jamie J.; Lou, You-Rong; Peng, Qing-Yun; Li, Tao; Lu, Yao-Ping			PDE2 Is a Novel Target for Attenuating Tumor Formation in a Mouse Model of UVB-Induced Skin Carcinogenesis	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ULTRAVIOLET-B LIGHT; SKH-1 MICE; STIMULATED PHOSPHODIESTERASE; INDUCED APOPTOSIS; GREEN TEA; INHIBITORS; CAFFEINE; CANCER; CELLS	Our previous studies demonstrated that the topical application of caffeine is a potent inhibitor of UVB-induced carcinogenesis and selectively increases apoptosis in tumors but not in non-tumor areas of the epidermis in mice that are at a high risk for developing skin cancer. While this effect is mainly through a p53 independent pathway, the mechanism by which caffeine inhibits skin tumor formation has not been fully elucidated. Since caffeine is a non-specific phosphodiesterase inhibitor, we investigated the effects of several PDE inhibitors on the formation of sunburn cells in mouse skin after an acute exposure to ultraviolet light B (UVB). The topical application of a PDE2 inhibitor, erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA hydrochloride), stimulated epidermal apoptosis compared to control (P< 0.01) and to a greater extent than caffeine whereas a PDE4 inhibitor attenuated the epidermal apoptosis compared to control (P<0.01). Since PDE2 hydrolyzes cyclic nucleotides, mainly cGMP, the effects of EHNA hydrochloride on epidermal apoptosis following UVB exposure may be mediated, in part, by increased cGMP signaling. Data demonstrated that the topical application of dibutyryl cGMP stimulated epidermal apoptosis (P<0.01) following an acute exposure to UVB. Treating UVB-pretreated mice topically with 3.1 mu mole or 0.8 mu mole of EHNA hydrochloride attenuated tumor formation to a greater extent than treating with 6.2 mu mole caffeine when these compounds were applied once a day, five days a week for 18 weeks. These observations suggest a novel role for PDE2 in UVB-induced tumorigenesis and that PDE2 inhibitors that mediate cGMP signaling may be useful for the prevention and treatment of skin cancer.	[Bernard, Jamie J.; Lou, You-Rong; Peng, Qing-Yun; Li, Tao; Lu, Yao-Ping] Rutgers State Univ, Dept Biol Chem, Susan Lehman Cullman Lab Canc Res, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Lu, YP (corresponding author), Rutgers State Univ, Dept Biol Chem, Susan Lehman Cullman Lab Canc Res, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA.	yaoping.lu@pharmacy.rutgers.edu		Bernard, Jamie/0000-0002-3800-2576	National Cancer Institute [R01CA128997, R01CA114442]; National Institute of Environmental Health Sciences (NIEHS) [ES007148, ES005022]; NATIONAL CANCER INSTITUTE [R01CA114442, R01CA128997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007148] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project was supported by grants R01CA128997, R01CA114442 from the National Cancer Institute and in part, by Training Grant ES007148 and Center Grant ES005022 from the National Institute of Environmental Health Sciences (NIEHS). The content is solely the responsibility of the authors and does not necessary represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi AH, 2010, EUR J MED CHEM, V45, P1278, DOI 10.1016/j.ejmech.2009.10.046; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Borland G, 2009, BRIT J PHARMACOL, V158, P70, DOI 10.1111/j.1476-5381.2008.00087.x; Camici M, 2008, BIOMED PHARMACOTHER, V62, P70, DOI 10.1016/j.biopha.2007.04.010; Caretta Antonio, 2011, Cancers (Basel), V3, P913, DOI 10.3390/cancers3010913; Chen HJ, 2008, J BIOL CHEM, V283, P4439, DOI 10.1074/jbc.M709439200; Cho ES, 2004, ARCH PHARM RES, V27, P1258, DOI 10.1007/BF02975891; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; DAVIES GE, 1973, INT ARCH ALLER A IMM, V45, P467, DOI 10.1159/000231064; Fajardo AM, 2014, CANCERS, V6, P436, DOI 10.3390/cancers6010436; Haynes J, 1996, J PHARMACOL EXP THER, V276, P752; Hirsh L, 2004, BIOCHEM PHARMACOL, V68, P981, DOI 10.1016/j.bcp.2004.05.026; Idriss SD, 1999, J BIOL CHEM, V274, P9489, DOI 10.1074/jbc.274.14.9489; Jedlitschky G, 2000, J BIOL CHEM, V275, P30069, DOI 10.1074/jbc.M005463200; Kool M, 1997, CANCER RES, V57, P3537; Lee IH, 2008, J UROLOGY, V179, P1072, DOI 10.1016/j.juro.2007.10.053; Li P, 2007, GASTROENTEROLOGY, V133, P599, DOI 10.1053/j.gastro.2007.05.052; Lou YR, 2011, CARCINOGENESIS, V32, P1078, DOI 10.1093/carcin/bgr074; Lou YR, 1999, NUTR CANCER, V33, P146, DOI 10.1207/S15327914NC330205; Lu YP, 2007, CARCINOGENESIS, V28, P199, DOI 10.1093/carcin/bgl112; Lu YP, 2006, P NATL ACAD SCI USA, V103, P16301, DOI 10.1073/pnas.0607789103; Lu YP, 2012, P NATL ACAD SCI USA, V109, P9065, DOI 10.1073/pnas.1205810109; Lu YP, 2004, CANCER RES, V64, P5020, DOI 10.1158/0008-5472.CAN-04-0760; Lu YP, 2002, P NATL ACAD SCI USA, V99, P12455, DOI 10.1073/pnas.182429899; Lu YP, 2000, CANCER RES, V60, P4785; Lu YP, 2001, ONCOL RES, V13, P61; Lu YP, 2001, CANCER RES, V61, P5002; MERY PF, 1995, MOL PHARMACOL, V48, P121; Moon EY, 2003, BLOOD, V101, P4122, DOI 10.1182/blood-2002-10-3208; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Pilz RB, 2003, CIRC RES, V93, P1034, DOI 10.1161/01.RES.0000103311.52853.48; Pitari GM, 2001, P NATL ACAD SCI USA, V98, P7846, DOI 10.1073/pnas.141124698; PODZUWEIT T, 1995, CELL SIGNAL, V7, P733, DOI 10.1016/0898-6568(95)00042-N; Savai R, 2010, EXPERT OPIN INV DRUG, V19, P117, DOI 10.1517/13543780903485642; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Steinbrecher KA, 2002, AM J PATHOL, V161, P2169, DOI 10.1016/S0002-9440(10)64494-X; Verhoest PR, 2009, J MED CHEM, V52, P7946, DOI 10.1021/jm9015334; Zhu J, 2001, CNS DRUG REV, V7, P387	39	6	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109862	10.1371/journal.pone.0109862	http://dx.doi.org/10.1371/journal.pone.0109862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330380	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800044
J	Chao, QT; Lee, TF; Teng, SH; Peng, LY; Chen, PH; Teng, LJ; Hsueh, PR				Chao, Qiao-Ting; Lee, Tai-Fen; Teng, Shih-Hua; Peng, Li-Yun; Chen, Ping-Hung; Teng, Lee-Jene; Hsueh, Po-Ren			Comparison of the Accuracy of Two Conventional Phenotypic Methods and Two MALDI-TOF MS Systems with That of DNA Sequencing Analysis for Correctly Identifying Clinically Encountered Yeasts	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; MEDICALLY-IMPORTANT YEASTS; RUGOSA SPECIES COMPLEX; ANTIFUNGAL SUSCEPTIBILITY; CANDIDA-RUGOSA; CRYPTOCOCCUS-NEOFORMANS; MOLECULAR TYPES; IDENTIFICATION; TAIWAN	We assessed the accuracy of species-level identification of two commercially available matrix-assisted laser desorption ionization- time of flight mass spectrometry (MALDI-TOF MS) systems (Bruker Biotyper and Vitek MS) and two conventional phenotypic methods (Phoenix 100 YBC and Vitek 2 Yeast ID) with that of rDNA gene sequencing analysis among 200 clinical isolates of commonly encountered yeasts. The correct identification rates of the 200 yeast isolates to species or complex (Candida parapsilosis complex, C. guilliermondii complex and C. rugosa complex) levels by the Bruker Biotyper, Vitek MS (using in vitro devices [IVD] database), Phoenix 100 YBC and Vitek 2 Yeast ID (Sabouraud's dextrose agar) systems were 92.5%, 79.5%, 89%, and 74%, respectively. An additional 72 isolates of C. parapsilosis complex and 18 from the above 200 isolates (30 in each of C. parapsilosis, C. metapsilosis, and C. orthopsilosis) were also evaluated separately. Bruker Biotyper system could accurately identify all C. parapsilosis complex to species level. Using Vitek 2 MS (IVD) system, all C. parapsilosis but none of C. metapsilosis, or C. orthopsilosis could be accurately identified. Among the 89 yeasts misidentified by the Vitek 2 MS (IVD) system, 39 (43.8%), including 27 C. orthopsilosis isolates, could be correctly identified Using the Vitek MS Plus SARAMIS database for research use only. This resulted in an increase in the rate of correct identification of all yeast isolates (87.5%) by Vitek 2 MS. The two species in C. guilliermondii complex (C. guilliermondii and C. fermentati) isolates were correctly identified by cluster analysis of spectra generated by the Bruker Biotyper system. Based on the results obtained in the current study, MALDI-TOF MS systems present a promising alternative for the routine identification of yeast species, including clinically commonly and rarely encountered yeast species and several species belonging to C. parapsilosis complex, C. guilliermondii complex, and C. rugosa complex.	[Chao, Qiao-Ting; Lee, Tai-Fen; Peng, Li-Yun; Chen, Ping-Hung; Teng, Lee-Jene; Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 10764, Taiwan; [Lee, Tai-Fen; Teng, Lee-Jene] Natl Taiwan Univ, Dept & Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Teng, Shih-Hua] Chang Gung Univ, Dept Grad Inst Biomed Sci, Taoyuan, Taiwan; [Teng, Shih-Hua] Bruker Taiwan Co Ltd, Taipei, Taiwan; [Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung University; National Taiwan University; National Taiwan University Hospital	Hsueh, PR (corresponding author), Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 10764, Taiwan.	hsporen@ntu.edu.tw	Hsueh, Po-Ren/ABE-1594-2021	TENG, LEE-JENE/0000-0003-0104-741X; HSUEH, PO-REN/0000-0002-7502-9225				Ahmad S, 2013, CASE REP MED, V2013, DOI 10.1155/2013/560406; Bader O, 2011, CLIN MICROBIOL INFEC, V17, P1359, DOI 10.1111/j.1469-0691.2010.03398.x; Padovan ACB, 2013, FUNGAL GENET BIOL, V61, P33, DOI 10.1016/j.fgb.2013.10.007; Bertini A, 2013, INT J MED MICROBIOL, V303, P98, DOI 10.1016/j.ijmm.2012.12.006; Borman AM, 2008, J CLIN MICROBIOL, V46, P933, DOI 10.1128/JCM.02116-07; Castanheira M, 2013, J CLIN MICROBIOL, V51, P117, DOI 10.1128/JCM.01686-12; Chaves GM, 2013, MED MYCOL, V51, P231, DOI 10.3109/13693786.2012.710345; Chen CY, 2013, J ANTIMICROB CHEMOTH, V68, P2632, DOI 10.1093/jac/dkt214; Chen CY, 2012, INT J ANTIMICROB AG, V40, P533, DOI 10.1016/j.ijantimicag.2012.07.022; Chen JHK, 2013, J CLIN MICROBIOL, V51, P3981, DOI 10.1128/JCM.01437-13; Hsiue HC, 2010, CLIN MICROBIOL INFEC, V16, P493, DOI 10.1111/j.1469-0691.2009.02828.x; Hsueh PR, 2009, INT J ANTIMICROB AG, V34, P205, DOI 10.1016/j.ijantimicag.2009.03.014; Lacroix C, 2014, CLIN MICROBIOL INFEC, V20, P153, DOI 10.1111/1469-0691.12210; Leaw SN, 2006, J CLIN MICROBIOL, V44, P693, DOI 10.1128/JCM.44.3.693-699.2006; Liaw SJ, 2010, CLIN MICROBIOL INFEC, V16, P696, DOI 10.1111/j.1469-0691.2009.02930.x; Mancini N, 2013, J CLIN MICROBIOL, V51, P2453, DOI 10.1128/JCM.00841-13; Marcos Javier Yugueros, 2013, Methods Mol Biol, V968, P25, DOI 10.1007/978-1-62703-257-5_2; Nakagawa Y, 2004, MED MYCOL, V42, P267, DOI 10.1080/13693780310001597674; Nemeth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068704; Nwanguma V, 2011, J CLIN MICROBIOL, V49, P4024, DOI 10.1128/JCM.05305-11; Paredes K, 2012, J CLIN MICROBIOL, V50, P2397, DOI 10.1128/JCM.00688-12; Parmeland L, 2013, MED MYCOL, V51, P33, DOI 10.3109/13693786.2012.686673; Pereira GH, 2010, MED MYCOL, V48, P839, DOI 10.3109/13693780903580121; Pfaller M, 2012, DIAGN MICR INFEC DIS, V74, P323, DOI 10.1016/j.diagmicrobio.2012.10.003; Posteraro B, 2013, J CLIN MICROBIOL, V51, P3841, DOI 10.1128/JCM.01581-13; Posteraro B, 2012, J CLIN MICROBIOL, V50, P2472, DOI 10.1128/JCM.00737-12; Putignani L, 2011, MOL BIOSYST, V7, P620, DOI 10.1039/c0mb00138d; Ruan SY, 2009, CLIN INFECT DIS, V49, pE11, DOI 10.1086/599614; Sendid B, 2013, MED MYCOL, V51, P25, DOI 10.3109/13693786.2012.693631; Sharma V, 2006, EYE, V20, P945, DOI 10.1038/sj.eye.6702051; Simon MS, 2014, J CLIN MICROBIOL, V52, P374, DOI 10.1128/JCM.01950-13; Spiliopoulou A, 2012, MYCOPATHOLOGIA, V174, P301, DOI 10.1007/s11046-012-9552-9; Teng SH, 2013, J CLIN MICROBIOL, V51, P3113, DOI 10.1128/JCM.01239-13; Westblade LF, 2013, J CLIN MICROBIOL, V51, P2267, DOI 10.1128/JCM.00680-13	34	62	65	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109376	10.1371/journal.pone.0109376	http://dx.doi.org/10.1371/journal.pone.0109376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330370	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800021
J	Danel, C; Kabran, M; Inwoley, A; Badje, A; Herrmann, JL; Moh, R; Lecarrou, J; Gabillard, D; Ntakpe, JB; Deschamps, N; Ouattara, E; Perronne, C; Eholie, S; Anglaret, X				Danel, Christine; Kabran, Mathieu; Inwoley, Andre; Badje, Anani; Herrmann, Jean Louis; Moh, Raoul; Lecarrou, Jerome; Gabillard, Delphine; Ntakpe, Jean Baptiste; Deschamps, Nina; Ouattara, Eric; Perronne, Christian; Eholie, Serge; Anglaret, Xavier			Quantiferon-TB Gold: Performance for Ruling out Active Tuberculosis in HIV-Infected Adults with High CD4 Count in Cote d'Ivoire, West Africa	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; LATENT TUBERCULOSIS; METAANALYSIS; PREVENTION; DIAGNOSIS; THERAPY; PYRAZINAMIDE; RIFAMPIN; RATES; TESTS	Objective: To assess the performance of QuantiFERON-TB Gold In-Tube (QFT-GIT) test for active tuberculosis (TB) in HIV adults, and its variation over time in patients on antiretroviral therapy (ART) and/or isoniazide preventive therapy (IPT). Methods: Transversal study and cohort nested in the Temprano ANRS 12136 randomized controlled trial assessing benefits of initiating ART earlier than currently recommended by World Health Organization, with or without a 6-month IPT. Performance of QFT-GIT for detecting active TB at baseline in the first 50% participants, and 12-month incidence of conversion/reversion in the first 25% participants were assessed. QFT-GIT threshold for positivity was 0.35 IU/ml. Results: Among the 975 first participants (median baseline CD4 count 383/mm(3), positive QFT-GIT test 35%), 2.7% had active TB at baseline. QFT-GIT sensitivity, specificity, positive and negative predictive value for active TB were 88.0%, 66.6%, 6.5% and 99.5%. For the 444 patients with a second test at 12 months, rates for conversion and reversion were 9.3% and 14%. Reversion was more frequent in patients without ART and younger patients. IPT and early ART were not associated with reversion/conversion. Conclusion: A negative QFT-GIT could rule out active TB in HIV-infected adults not severely immunosuppressed, thus avoiding repeated TB testing and accelerating diagnosis and care for other diseases.	[Danel, Christine; Badje, Anani; Moh, Raoul; Lecarrou, Jerome; Gabillard, Delphine; Ntakpe, Jean Baptiste; Ouattara, Eric; Eholie, Serge; Anglaret, Xavier] INSERM, Ctr INSERM U897, Bordeaux, France; [Danel, Christine; Inwoley, Andre; Badje, Anani; Moh, Raoul; Lecarrou, Jerome; Gabillard, Delphine; Ntakpe, Jean Baptiste; Deschamps, Nina; Ouattara, Eric; Eholie, Serge; Anglaret, Xavier] CHU Treichville, PAC CI Program, Abidjan, Cote Ivoire; [Danel, Christine; Badje, Anani; Moh, Raoul; Lecarrou, Jerome; Gabillard, Delphine; Ntakpe, Jean Baptiste; Ouattara, Eric; Eholie, Serge; Anglaret, Xavier] Bordeaux Univ, ISPED, Bordeaux, France; [Kabran, Mathieu; Inwoley, Andre] CHU Treichville, CeDReS, Abidjan, Cote Ivoire; [Herrmann, Jean Louis] Hop Raymond Poincare, AP HP, Serv Bacteriol, Garches, France; [Perronne, Christian] Hop Raymond Poincare, AP HP, Dept Malad Infect & Trop, Garches, France; [Herrmann, Jean Louis] Univ Versailles St Quentin Yvelines, EA3647, Montigny Le Bretonneux, France; [Moh, Raoul; Eholie, Serge] CHU Treichville, Serv Malad Infect & Trop, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Danel, C (corresponding author), INSERM, Ctr INSERM U897, Bordeaux, France.	Christine.danel@pacci.ci	Anglaret, Xavier/T-2757-2019; Eholie, Serge/T-6008-2019; Ouattara, Eric/T-2833-2019; Anglaret, Xavier/F-7333-2013	Moh, Desmorys Raoul/0000-0002-1678-3340; Herrmann, Jean-Louis/0000-0003-2347-6418; Anglaret, Xavier/0000-0003-3319-8423; Badje, Anani Dodzi/0000-0001-8917-4266	Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS, Paris, France) [ANRS 12136, ANRS 12224]; Gilead Sciences; Merck	Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS, Paris, France)(ANRS); Gilead Sciences(Gilead Sciences); Merck(Merck & Company)	Funding provided by Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS, Paris, France) (Grant ANRS 12136 and ANRS 12224). Trial conducted with the support of Gilead Sciences and in part by Merck. The opinions expressed in this paper are those of authors and do not necessarily represent those of Merck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IM, 2013, AM J RESP CRIT CARE, V187, P439, DOI 10.1164/rccm.201208-1352OC; Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; [Anonymous], 2012, REF ACT HORS NOM BIO; [Anonymous], 2011, GLOB TUB CONTR; Bartalesi F, 2013, J INFECTION, V66, P346, DOI 10.1016/j.jinf.2012.10.017; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; Cellestis Inc, 2013, QUANTIFERONTB GOLD P; Center Diseases Control, 2010, MMWR-MORBID MORTAL W, V59, pRR5; Chaisson RE, 1996, J ACQ IMMUN DEF SYND, V11, P455, DOI 10.1097/00042560-199604150-00005; CHAPARAS SD, 1985, AM REV RESPIR DIS, V132, P175; Chen J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026827, 10.1371/journal.pone.0025286]; Cobelens FG, 2006, CLIN INFECT DIS, V43, P634, DOI 10.1086/506432; Corbett EL, 2007, CLIN INFECT DIS, V44, P317, DOI 10.1086/509926; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Dyrhol-Riise AM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-57; Elliott JH, 2009, J INFECT DIS, V200, P1736, DOI 10.1086/644784; Felber A, 2013, TUBERCULOSIS, V93, P647, DOI 10.1016/j.tube.2013.07.006; Fitzgerald DW, 2000, LANCET, V356, P1470, DOI 10.1016/S0140-6736(00)02870-1; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Halsey NA, 1998, LANCET, V351, P786, DOI 10.1016/S0140-6736(97)06532-X; Hawken MP, 1997, AIDS, V11, P875, DOI 10.1097/00002030-199707000-00006; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johnson JL, 2013, CHEST IN PRESS, V17, DOI [10.1378/chest.13-1232, DOI 10.1378/CHEST.13-1232]; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Lalvani A, 2005, LANCET INFECT DIS, V5, P322, DOI 10.1016/S1473-3099(05)70118-3; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lee SW, 2012, INFECTION, V40, P431, DOI 10.1007/s15010-012-0265-2; Lee SW, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-300; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Perry S, 2008, CLIN VACCINE IMMUNOL, V15, P425, DOI 10.1128/CVI.00398-07; Pouchot J, 1997, ANN INTERN MED, V126, P210, DOI 10.7326/0003-4819-126-3-199702010-00005; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Shanaube K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018206; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; World Health Organization, 2011, US TUB INT GAMM REL; World Health Organization, 2021, 10 THREATS GLOB HLTH	43	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e107245	10.1371/journal.pone.0107245	http://dx.doi.org/10.1371/journal.pone.0107245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330161	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800002
J	Lopes, PM; Bini, LM; Declerck, SAJ; Farjalla, VF; Vieira, LCG; Bonecker, CC; Lansac-Toha, FA; Esteves, FA; Bozelli, RL				Lopes, Paloma M.; Bini, Luis M.; Declerck, Steven A. J.; Farjalla, Vinicius F.; Vieira, Ludgero C. G.; Bonecker, Claudia C.; Lansac-Toha, Fabio A.; Esteves, Francisco A.; Bozelli, Reinaldo L.			Correlates of Zooplankton Beta Diversity in Tropical Lake Systems	PLOS ONE			English	Article							METACOMMUNITY STRUCTURE; SEXUAL REPRODUCTION; DISTURBANCE REGIME; GAMMA DIVERSITY; LOCAL FACTORS; COMMUNITY; DISPERSAL; PATTERNS; SCALES; PONDS	The changes in species composition between habitat patches (beta diversity) are likely related to a number of factors, including environmental heterogeneity, connectivity, disturbance and productivity. Here, we used data from aquatic environments in five Brazilian regions over two years and two seasons (rainy and dry seasons or high and low water level periods in floodplain lakes) in each year to test hypotheses underlying zooplankton beta diversity variation. The regions present different levels of hydrological connectivity, where three regions present lakes that are permanent and connected with the main river, while the water bodies of the other two regions consist of permanent lakes and temporary ponds, with no hydrological connections between them. We tested for relationships between zooplankton beta diversity and environmental heterogeneity, spatial extent, hydrological connectivity, seasonality, disturbance and productivity. Negative relationships were detected between zooplankton beta diversity and both hydrological connectivity and disturbance (periodic dry-outs). Hydrological connectivity is likely to affect beta diversity by facilitating dispersal between habitats. In addition, the harsh environmental filter imposed by disturbance selected for only a small portion of the species from the regional pool that were able to cope with periodic dry-outs (e.g., those with a high production of resting eggs). In summary, this study suggests that faunal exchange and disturbance play important roles in structuring local zooplankton communities.	[Lopes, Paloma M.; Farjalla, Vinicius F.; Esteves, Francisco A.; Bozelli, Reinaldo L.] Univ Fed Rio de Janeiro, CCS, Inst Biol, Lab Limnol,Dept Ecol, Rio De Janeiro, RJ, Brazil; [Bini, Luis M.] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil; [Declerck, Steven A. J.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Vieira, Ludgero C. G.] Univ Brasilia, Fac UnB Planaltina, Planaltina, DF, Brazil; [Bonecker, Claudia C.; Lansac-Toha, Fabio A.] Univ Estadual Maringa, Nucleo Pesquisas Limnol Ictiol & Aquicultura NUPE, Maringa, Parana, Brazil; [Esteves, Francisco A.] Nucleo Pesquisas Ecol & Desenvolvimento Socio Amb, Macae, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal de Goias; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Universidade de Brasilia; Universidade Estadual de Maringa	Lopes, PM (corresponding author), Univ Fed Rio de Janeiro, CCS, Inst Biol, Lab Limnol,Dept Ecol, Cidade Univ, Rio De Janeiro, RJ, Brazil.	paloma.marinho@gmail.com	Bozelli, Reinaldo/S-6414-2019; Vieira, Ludgero/C-7251-2015; Vieira, Ludgero/G-6985-2017; Declerck, Steven/E-4338-2010; Farjalla, Vinicius/G-4945-2010; Lansac-Toha, Fábio A/I-3556-2016; Bonecker, Claudia C/D-5946-2013; Bini, Luis Mauricio/D-5865-2013; Farjalla, Vinicius F/V-4351-2019; KNAW, NIOO-KNAW/A-4320-2012	Vieira, Ludgero/0000-0002-9411-6666; Vieira, Ludgero/0000-0002-9411-6666; Declerck, Steven/0000-0001-6179-667X; Farjalla, Vinicius/0000-0003-4084-5983; Bonecker, Claudia C/0000-0003-4338-9012; Bini, Luis Mauricio/0000-0003-3398-9399; Farjalla, Vinicius F/0000-0003-4084-5983; KNAW, NIOO-KNAW/0000-0002-3835-159X	Vale; Mineracao Rio do Norte; PELD site 6/CNPq; CAPES institution; CNPq institution; FAPERJ institution; CNPq productivity grants	Vale; Mineracao Rio do Norte; PELD site 6/CNPq; CAPES institution(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq institution(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ institution(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq productivity grants	Our research was financed by the Vale, Mineracao Rio do Norte and PELD site 6/CNPq. P. M. L is grateful to CAPES, CNPq and FAPERJ institutions for post-graduate scholarships. L. M. B., C. C. B., V. F. F., F. A. E. and R. L. B. are partially supported by CNPq productivity grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Akasaka M, 2012, ECOLOGY, V93, P967, DOI 10.1890/11-0879.1; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Barton K., 2014, MUMIN MULTIMODEL INF; Baselga A, 2013, BETAPART PARTITIONIN; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bates D, 2012, LME4 LINEAR MIXED EF; BEAVER RA, 1977, J ANIM ECOL, V46, P783, DOI 10.2307/3640; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bini LM, 2014, ECOLOGY, V95, P1569, DOI 10.1890/13-0656.1; BOZELLI RL, 1992, AMAZONIANA, V12, P239; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chase JM, 2004, ECOL LETT, V7, P676, DOI 10.1111/j.1461-0248.2004.00622.x; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2003, ECOL LETT, V6, P733, DOI 10.1046/j.1461-0248.2003.00482.x; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Declerck SAJ, 2011, ECOGRAPHY, V34, P296, DOI 10.1111/j.1600-0587.2010.06462.x; Farjalla VF, 2012, ECOLOGY, V93, P1752, DOI 10.1890/11-1144.1; Fox J., 2019, R COMPANION APPL REG, V.; Fox JW, 2013, TRENDS ECOL EVOL, V28, P86, DOI 10.1016/j.tree.2012.08.014; Gilbert JJ, 2010, FRESHWATER BIOL, V55, P1705, DOI 10.1111/j.1365-2427.2010.02405.x; Gonzalez A., 2009, METACOMMUNITIES SPAT; Gray DK, 2012, J APPL ECOL, V49, P1216, DOI 10.1111/j.1365-2664.2012.02203.x; Havel JE, 2004, LIMNOL OCEANOGR, V49, P1229, DOI 10.4319/lo.2004.49.4_part_2.1229; Hodge S, 1996, OIKOS, V76, P350, DOI 10.2307/3546207; Hubbell Stephen P., 2001, V32, pi; Jurasinski G, 2009, OECOLOGIA, V159, P15, DOI 10.1007/s00442-008-1190-z; Karp DS, 2012, ECOL LETT, V15, P963, DOI 10.1111/j.1461-0248.2012.01815.x; LAWLER SP, 1993, ECOLOGY, V74, P174, DOI 10.2307/1939512; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lepori F, 2009, OIKOS, V118, P471, DOI 10.1111/j.1600-0706.2008.16989.x; Lindo Z, 2008, OIKOS, V117, P1856, DOI 10.1111/j.1600-0706.2008.16920.x; Lopes PM, 2011, ECOL INDIC, V11, P1171, DOI 10.1016/j.ecolind.2010.12.017; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Melo AS, 2009, ECOGRAPHY, V32, P226, DOI 10.1111/j.1600-0587.2008.05502.x; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mysak J, 2011, ACTA OECOL, V37, P146, DOI 10.1016/j.actao.2011.01.012; Nabout JC, 2009, ACTA OECOL, V35, P720, DOI 10.1016/j.actao.2009.07.002; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pedruski MT, 2011, OECOLOGIA, V166, P221, DOI 10.1007/s00442-010-1814-y; Pinto-Coelho R, 2005, CAN J FISH AQUAT SCI, V62, P348, DOI 10.1139/F04-178; R Core Team, 2012, R LANG ENV STAT COMP; Roberto MC, 2009, BRAZ J BIOL, V69, P717, DOI 10.1590/S1519-69842009000300025; Schroder T, 2007, FRESHWATER BIOL, V52, P1033, DOI 10.1111/j.1365-2427.2007.01751.x; Shurin JB, 2009, OECOLOGIA, V159, P151, DOI 10.1007/s00442-008-1174-z; Silver CA, 2012, ACTA OECOL, V39, P1, DOI 10.1016/j.actao.2011.10.001; Simoes NR, 2013, AQUAT SCI, V75, P607, DOI 10.1007/s00027-013-0304-9; Smith HA, 2012, J EVOLUTION BIOL, V25, P2501, DOI 10.1111/j.1420-9101.2012.02614.x; Soininen J, 2007, ECOSCIENCE, V14, P146, DOI 10.2980/1195-6860(2007)14[146:NNADOP]2.0.CO;2; Sousa W, 2008, J PLANKTON RES, V30, P699, DOI 10.1093/plankt/fbn032; Steiner CF, ECOLOGY IN PRESS; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Vanschoenwinkel B, 2013, ECOLOGY, V94, P2547, DOI 10.1890/12-1576.1; Vanschoenwinkel B, 2010, J N AM BENTHOL SOC, V29, P1267, DOI 10.1899/09-114.1; Veech JA, 2007, GLOBAL ECOL BIOGEOGR, V16, P650, DOI 10.1111/j.1466-8238.2007.00315.x; Verleyen E, 2009, OIKOS, V118, P1239, DOI 10.1111/j.1600-0706.2009.17575.x; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563	73	65	68	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109581	10.1371/journal.pone.0109581	http://dx.doi.org/10.1371/journal.pone.0109581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330034	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800028
J	Serda, M; Kalinowski, DS; Rasko, N; Potuckova, E; Mrozek-Wilczkiewicz, A; Musiol, R; Malecki, JG; Sajewicz, M; Ratuszna, A; Muchowicz, A; Golab, J; Simunek, T; Richardson, DR; Polanski, J				Serda, Maciej; Kalinowski, Danuta S.; Rasko, Nathalie; Potuckova, Eliska; Mrozek-Wilczkiewicz, Anna; Musiol, Robert; Malecki, Jan G.; Sajewicz, Mieczyslaw; Ratuszna, Alicja; Muchowicz, Angelika; Golab, Jakub; Simunek, Tomas; Richardson, Des R.; Polanski, Jaroslaw			Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE INHIBITOR; ATOMIC PHYSICOCHEMICAL PARAMETERS; SELECTIVE ANTINEOPLASTIC ACTIVITY; IRON OVERLOAD DISEASE; PHASE-I TRIAL; 3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE; ANTIPROLIFERATIVE ACTIVITY; ANTITUMOR-ACTIVITY; METASTASIS SUPPRESSOR; REDOX ACTIVITY	Thiosemicarbazones (TSCs) are an interesting class of ligands that show a diverse range of biological activity, including antifungal, anti-viral and anti-cancer effects. Our previous studies have demonstrated the potent in vivo anti-tumor activity of novel TSCs and their ability to overcome resistance to clinically used chemotherapeutics. In the current study, 35 novel TSCs of 6 different classes were designed using a combination of retro-fragments that appear in other TSCs. Additionally, di-substitution at the terminal N4 atom, which was previously identified to be critical for potent anti-cancer activity, was preserved through the incorporation of an N4-based piperazine or morpholine ring. The anti-proliferative activity of the novel TSCs were examined in a variety of cancer and normal cell-types. In particular, compounds 1d and 3c demonstrated the greatest promise as anti-cancer agents with potent and selective anti-proliferative activity. Structure-activity relationship studies revealed that the chelators that utilized "soft'' donor atoms, such as nitrogen and sulfur, resulted in potent anticancer activity. Indeed, the N,N,S donor atom set was crucial for the formation of redox active iron complexes that were able to mediate the oxidation of ascorbate. This further highlights the important role of reactive oxygen species generation in mediating potent anti-cancer activity. Significantly, this study identified the potent and selective anti-cancer activity of 1d and 3c that warrants further examination.	[Serda, Maciej; Mrozek-Wilczkiewicz, Anna; Musiol, Robert; Malecki, Jan G.; Sajewicz, Mieczyslaw; Polanski, Jaroslaw] Silesian Univ, Inst Chem, PL-40006 Katowice, Poland; [Kalinowski, Danuta S.; Rasko, Nathalie; Richardson, Des R.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia; [Kalinowski, Danuta S.; Rasko, Nathalie; Richardson, Des R.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Potuckova, Eliska; Simunek, Tomas] Charles Univ Prague, Dept Biochem Sci, Fac Pharm Hradec Kralove, Hradec Kralove, Czech Republic; [Mrozek-Wilczkiewicz, Anna; Ratuszna, Alicja] Silesian Univ, A Chelkowski Inst Phys, Katowice, Poland; [Mrozek-Wilczkiewicz, Anna; Ratuszna, Alicja] Silesian Univ, Silesian Interdisciplinary Ctr Educ & Res, Katowice, Poland; [Muchowicz, Angelika; Golab, Jakub] Med Univ Warsaw, Dept Immunol, Warsaw, Mazovia, Poland; [Golab, Jakub] Polish Acad Sci, Inst Phys Chem, Warsaw, Mazovia, Poland	University of Silesia in Katowice; University of Sydney; University of Sydney; Charles University Prague; University of Silesia in Katowice; University of Silesia in Katowice; Medical University of Warsaw; Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au; polanski@us.edu.pl	Musioł, Robert/J-4790-2019; Muchowicz, Angelika/J-7494-2012; Golab, Jakub/K-6974-2013; Małecki, Jan Grzegorz/M-4022-2017; Serda, Maciej M/S-2623-2018; Simunek, Tomas/A-3938-2008	Muchowicz, Angelika/0000-0003-4707-1722; Golab, Jakub/0000-0002-2830-5100; Małecki, Jan Grzegorz/0000-0001-5571-3196; Serda, Maciej M/0000-0003-4926-5782; Simunek, Tomas/0000-0001-5464-4176; Musiol, Robert/0000-0002-6219-7369; Richardson, Des/0000-0003-0960-6415; Kalinowski, Danuta/0000-0002-9303-7405; Polanski, Jaroslaw/0000-0001-7361-2671; Richardson, Des/0000-0002-5506-3274; Mrozek-Wilczkiewicz, Anna/0000-0003-2228-1475; Sajewicz, Mieczyslaw/0000-0001-7575-0760	NCN [DEC-2011/01/N/NZ4/01166, 2013/09/B/NZ7/00423, N405/068440]; National Centre for Research and Development, Warsaw [PBS2/A5/40/2014]; National Health and Medical Research Council (NHMRC) Australia [632778]; DSK [1048972]; NHMRC [571123]; Sydney Medical School Foundation of The University of Sydney; Czech Science Foundation [13-15008S]	NCN; National Centre for Research and Development, Warsaw; National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); DSK; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School Foundation of The University of Sydney; Czech Science Foundation(Grant Agency of the Czech Republic)	The authors appreciated the financial support of TWING and DoktoRIS PhD scholarships, NCN (DEC-2011/01/N/NZ4/01166, 2013/09/B/NZ7/00423 and N405/068440), and the National Centre for Research and Development, Warsaw (ORGANOMET No: PBS2/A5/40/2014 grants). This work was also supported by a Project Grant from the National Health and Medical Research Council (NHMRC) Australia to DRR [Grant 632778]; and DSK [Grant 1048972]; a NHMRC Senior Principal Research Fellowship to DRR [Grant 571123]; and a Helen and Robert Ellis Fellowship to DSK from the Sydney Medical School Foundation of The University of Sydney. EP and TS also appreciate the support of a Czech Science Foundation Grant [13-15008S]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER E, 1992, HEPATOLOGY, V15, P492, DOI 10.1002/hep.1840150323; Becker EM, 2003, BRIT J PHARMACOL, V138, P819, DOI 10.1038/sj.bjp.0705089; Bemhardt PV, 2009, J MED CHEM, V52, P407, DOI 10.1021/jm801012z; Bernhardt PV, 2008, J BIOL INORG CHEM, V13, P107, DOI 10.1007/s00775-007-0300-4; Breen L, 2007, ANTICANCER RES, V27, P1361; BROTO P, 1984, EUR J MED CHEM, V19, P71; Chaston TB, 2003, CLIN CANCER RES, V9, P402; Chetan B, 2010, BIOORG MED CHEM LETT, V20, P3906, DOI 10.1016/j.bmcl.2010.05.020; Deraeve C, 2006, J INORG BIOCHEM, V100, P2117, DOI 10.1016/j.jinorgbio.2006.08.005; Di Vaira M, 2004, INORG CHEM, V43, P3795, DOI 10.1021/ic0494051; ELFORD HL, 1970, J BIOL CHEM, V245, P5228; Feun L, 2002, CANCER CHEMOTH PHARM, V50, P223, DOI 10.1007/s00280-002-0480-0; Gao HL, 2003, MOL PHARMACOL, V63, P1382, DOI 10.1124/mol.63.6.1382; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Gleeson MP, 2008, J MED CHEM, V51, P817, DOI 10.1021/jm701122q; Hann MM, 2012, NAT REV DRUG DISCOV, V11, P355, DOI 10.1038/nrd3701; Hann MM, 2011, MEDCHEMCOMM, V2, P349, DOI 10.1039/c1md00017a; Hou XL, 2006, BIOORG MED CHEM LETT, V16, P4214, DOI 10.1016/j.bmcl.2006.05.085; Hu WX, 2006, BIOORG MED CHEM LETT, V16, P2213, DOI 10.1016/j.bmcl.2006.01.048; Kalinowski DS, 2008, J MED CHEM, V51, P331, DOI 10.1021/jm7012562; Kalinowski DS, 2007, J MED CHEM, V50, P6212, DOI 10.1021/jm070839q; Kalinowski DS, 2007, J MED CHEM, V50, P3716, DOI 10.1021/jm070445z; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Karp JE, 2008, LEUKEMIA RES, V32, P71, DOI 10.1016/j.leukres.2007.05.003; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046; Kunos C, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-79; Kunos CA, 2013, GYNECOL ONCOL, V130, P75, DOI 10.1016/j.ygyno.2013.04.019; Kunos CA, 2010, CLIN CANCER RES, V16, P1298, DOI 10.1158/1078-0432.CCR-09-2469; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Lovejoy DB, 2002, BLOOD, V100, P666, DOI 10.1182/blood.V100.2.666; Lukmantara AY, 2013, BIOORG MED CHEM LETT, V23, P967, DOI 10.1016/j.bmcl.2012.12.044; Ma B, 2008, INVEST NEW DRUG, V26, P169, DOI 10.1007/s10637-007-9085-0; Mackenzie MJ, 2007, INVEST NEW DRUG, V25, P553, DOI 10.1007/s10637-007-9066-3; Meanwell NA, 2011, CHEM RES TOXICOL, V24, P1420, DOI 10.1021/tx200211v; Merlot AM, 2013, ANTIOXID REDOX SIGN, V18, P973, DOI 10.1089/ars.2012.4540; Mladenka P, 2009, CHEM RES TOXICOL, V22, P208, DOI 10.1021/tx800331j; Mrozek-Wilczkiewicz A, 2014, ACS MED CHEM LETT, V5, P336, DOI 10.1021/ml400422a; Nutting CM, 2009, ANN ONCOL, V20, P1275, DOI 10.1093/annonc/mdn775; Ocean AJ, 2011, CANCER CHEMOTH PHARM, V68, P379, DOI 10.1007/s00280-010-1481-z; Odenike OM, 2008, INVEST NEW DRUG, V26, P233, DOI 10.1007/s10637-008-9115-6; Proschak Ewgenij, 2008, P217, DOI 10.1039/9781847558879-00217; RICHARDSON D, 1992, J BIOL CHEM, V267, P13972; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Richardson DR, 2009, J MED CHEM, V52, P1459, DOI 10.1021/jm801585u; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Serda M, 2012, MOLECULES, V17, P13483, DOI 10.3390/molecules171113483; Serda M, 2012, BIOORG MED CHEM LETT, V22, P5527, DOI 10.1016/j.bmcl.2012.07.030; Shao JM, 2006, MOL CANCER THER, V5, P586, DOI 10.1158/1535-7163.MCT-05-0384; Silva JL, 2014, TRENDS IN PRESS 0425; Stanojkovic TP, 2010, J INORG BIOCHEM, V104, P467, DOI 10.1016/j.jinorgbio.2009.12.021; Stefani C, 2013, J MED CHEM, V56, P357, DOI 10.1021/jm301691s; Stefani C, 2011, J MED CHEM, V54, P6936, DOI 10.1021/jm200924c; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; Trinder D, 1996, HEPATOLOGY, V23, P1512, DOI 10.1002/hep.510230631; VISWANADHAN VN, 1989, J CHEM INF COMP SCI, V29, P163, DOI 10.1021/ci00063a006; Wadler S, 2004, J CLIN ONCOL, V22, P1553, DOI 10.1200/JCO.2004.07.158; Wang YX, 2011, J MED CHEM, V54, P2127, DOI 10.1021/jm101340q; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Yen Y, 2004, CANCER CHEMOTH PHARM, V54, P331, DOI 10.1007/s00280-004-0821-2; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Yu Y, 2012, BRIT J PHARMACOL, V165, P148, DOI 10.1111/j.1476-5381.2011.01526.x; Yu Y, 2009, J MED CHEM, V52, P5271, DOI 10.1021/jm900552r; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhu LJ, 2009, BIOCHEM PHARMACOL, V78, P1178, DOI 10.1016/j.bcp.2009.06.103	72	52	52	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110291	10.1371/journal.pone.0110291	http://dx.doi.org/10.1371/journal.pone.0110291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329549	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800074
J	Olden, JD; Tamayo, M				Olden, Julian D.; Tamayo, Mariana			Incentivizing the Public to Support Invasive Species Management: Eurasian Milfoil Reduces Lakefront Property Values	PLOS ONE			English	Article							WATER-QUALITY; WATERMILFOIL; SPREAD; IMPACTS; PRICES; PERSPECTIVE; FRAMEWORK; BENEFITS; ECOLOGY; MODELS	Economic evaluations of invasive species are essential for providing comprehensive assessments of the benefits and costs of publicly-funded management activities, yet many previous investigations have focused narrowly on expenditures to control spread and infestation. We use hedonic modeling to evaluate the economic effects of Eurasian milfoil (Myriophyllum spicatum) invasions on lakefront property values of single-family homes in an urban-suburban landscape. Milfoil often forms dense canopies at the water surface, diminishing the value of ecosystem services (e.g., recreation, fishing) and necessitating expensive control and management efforts. We compare 1,258 lakeshore property sale transactions (1995-2006) in 17 lakes with milfoil and 24 un-invaded lakes in King County, Washington (USA). After accounting for structural (e.g., house size), locational (e.g., boat launch), and environmental characteristics (e.g., water clarity) of lakes, we found that milfoil has a significant negative effect on property sales price ($94,385 USD lower price), corresponding to a 19% decline in mean property values. The aggregate cost of milfoil invading one additional lake in the study area is, on average, $377,542 USD per year. Our study illustrates that invasive aquatic plants can significantly impact property values (and associated losses in property taxes that reduce local government revenue), justifying the need for management strategies that prevent and control invasions. We recommend coordinated efforts across Lake Management Districts to focus institutional support, funding, and outreach to prevent the introduction and spread of milfoil. This effort will limit opportunities for reintroduction from neighboring lakes and incentivize private landowners and natural resource agencies to commit time and funding to invasive species management.	[Olden, Julian D.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Tamayo, Mariana] Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland	University of Washington; University of Washington Seattle; University of Iceland	Olden, JD (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	olden@uw.edu	Olden, Julian D/A-8535-2010; Tamayo, Mariana/L-8900-2015	Tamayo, Mariana/0000-0003-3966-4042; Olden, Julian/0000-0003-2143-1187	Washington Department of Ecology Aquatic Weeds Management Program; University of Washington Royalty Research Fund; University of Washington - School of Aquatic and Fishery Sciences H. Mason Keeler Endowed Professorship	Washington Department of Ecology Aquatic Weeds Management Program; University of Washington Royalty Research Fund(University of Washington); University of Washington - School of Aquatic and Fishery Sciences H. Mason Keeler Endowed Professorship	This work was supported by the Washington Department of Ecology Aquatic Weeds Management Program, University of Washington Royalty Research Fund, and the University of Washington - School of Aquatic and Fishery Sciences H. Mason Keeler Endowed Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ICAL EC, V82, P34, DOI [10.1086/260169, DOI 10.1086/260169]; Bao HXH, 2007, J REAL ESTATE RES, V29, P267; Bockstael NE, 2000, ENVIRON SCI TECHNOL, V34, P1384, DOI 10.1021/es990673l; Boylen C.W., 2001, 51 ANN M AQ PLANT MA; Boylen CW, 1999, HYDROBIOLOGIA, V415, P207, DOI 10.1023/A:1003804612998; Bremner A, 2007, BIOL CONSERV, V139, P306, DOI 10.1016/j.biocon.2007.07.005; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clapper J, 2014, APPL ECON, V46, P1122, DOI 10.1080/00036846.2013.851778; Colautti RI, 2006, BIOL INVASIONS, V8, P45, DOI 10.1007/s10530-005-0236-y; Colwell P, 2005, J REAL ESTATE FINANC, V30, P267, DOI 10.1007/s11146-005-6407-x; Connelly NA, 2007, ENVIRON MANAGE, V40, P105, DOI 10.1007/s00267-006-0296-5; Corrigan J.R., 2009, ENCY INLAND WATERS, V1st ed., P14, DOI [10.1016/B978-012370626-3.00003-X, DOI 10.1016/B978-012370626-3.00003-X]; Couch R., 1985, P 1 INT S WAT MYR SP, P8; Eiswerth ME, 2000, WEED TECHNOL, V14, P511, DOI 10.1614/0890-037X(2000)014[0511:PEIAED]2.0.CO;2; Epanchin-Niell RS, 2010, ECOL LETT, V13, P528, DOI 10.1111/j.1461-0248.2010.01440.x; Garcia-Llorente M, 2008, BIOL CONSERV, V141, P2969, DOI 10.1016/j.biocon.2008.09.003; Griliches Z, 1991, 50 YEARS EC MEASUREM, P185; Halstead JM, 2003, ENVIRON MANAGE, V32, P391, DOI 10.1007/s00267-003-3023-5; Homans FR, 2013, BIOL INVASIONS, V15, P7, DOI 10.1007/s10530-011-0134-4; Horsch EJ, 2009, LAND ECON, V85, P391; JAMES LR, 1978, PSYCHOL BULL, V85, P1104, DOI 10.1037/0033-2909.85.5.1104; Johnson PTJ, 2008, FRONT ECOL ENVIRON, V6, P359, DOI 10.1890/070156; Keller R. P., 2009, BIOECONOMICS INVASIV; Keller RP, 2008, CONSERV BIOL, V22, P80, DOI 10.1111/j.1523-1739.2007.00811.x; Lansford NH, 1995, J AGR RESOUR ECON, V20, P341; Larson DL, 2011, J ENVIRON MANAGE, V92, P14, DOI 10.1016/j.jenvman.2010.08.025; Leggett CG, 2000, J ENVIRON ECON MANAG, V39, P121, DOI 10.1006/jeem.1999.1096; Leung B, 2006, BIOL INVASIONS, V8, P241, DOI 10.1007/s10530-004-5573-8; Lovell S. J., 2006, Agricultural and Resource Economics Review, V35, P195; Madsen JD, 1998, J AQUAT PLANT MANAGE, V36, P28; Madsen JD, 1997, J AQUAT PLANT MANAGE, V35, P63; Madsen JD, 1991, J AQUATIC PLANT MANA; MCINTOSH CR, 2009, BIOECONOMICS INVASIV, P151; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Perrings C., 2001, EC BIOL INVASIONS; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Poor PJ, 2007, ECOL ECON, V60, P797, DOI 10.1016/j.ecolecon.2006.02.013; Provencher B, 2012, J ENVIRON ECON MANAG, V64, P169, DOI 10.1016/j.jeem.2012.04.002; Research WWCfRE, 2009, WASH STAT HOUS MARK; Richardson DM, 2008, DIVERS DISTRIB, V14, P161, DOI 10.1111/j.1472-4642.2007.00464.x; Rockwell Jr H. W., 2003, SUMMARY SURVEY LIT E; Rothlisberger JD, 2010, FISHERIES, V35, P121, DOI 10.1577/1548-8446-35.3.121; Selge S, 2011, BIOL CONSERV, V144, P3089, DOI 10.1016/j.biocon.2011.09.014; SMITH CS, 1990, J AQUAT PLANT MANAGE, V28, P55; Stokes KE, 2006, BIODIVERS CONSERV, V15, P2829, DOI 10.1007/s10531-005-3137-6; Tamayo M, 2014, INVAS PLANT SCI MANA, V7, P32, DOI 10.1614/IPSM-D-13-00036.1; Vander Zanden MJ, 2008, CAN J FISH AQUAT SCI, V65, P1512, DOI 10.1139/F08-099; Verbrugge LNH, 2013, ENVIRON MANAGE, V52, P1562, DOI 10.1007/s00267-013-0170-1; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Walton SP, 1996, AQUATIC PLANT MAPPIN; Zhang CW, 2010, ECOL ECON, V70, P394, DOI 10.1016/j.ecolecon.2010.09.011	51	19	19	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110458	10.1371/journal.pone.0110458	http://dx.doi.org/10.1371/journal.pone.0110458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25333619	Green Submitted, gold, Green Published			2022-12-27	WOS:000346766200119
J	Rentsch, S; Rand, MK				Rentsch, Sebastian; Rand, Miya K.			Eye-Hand Coordination during Visuomotor Adaptation with Different Rotation Angles	PLOS ONE			English	Article							SENSORIMOTOR ADAPTATION; VISUAL FEEDBACK; REACHING MOVEMENTS; ARM MOVEMENTS; SPATIOTEMPORAL CHARACTERISTICS; PARKINSONS-DISEASE; POINTING MOVEMENT; MANUAL ADAPTATION; 2-PHASE STRATEGY; OPTIMAL RESPONSE	This study examined adaptive changes of eye-hand coordination during a visuomotor rotation task. Young adults made aiming movements to targets on a horizontal plane, while looking at the rotated feedback (cursor) of hand movements on a monitor. To vary the task difficulty, three rotation angles (30 degrees, 75 degrees, and 150 degrees) were tested in three groups. All groups shortened hand movement time and trajectory length with practice. However, control strategies used were different among groups. The 30 degrees group used proportionately more implicit adjustments of hand movements than other groups. The 75 degrees group used more on-line feedback control, whereas the 150 degrees group used explicit strategic adjustments. Regarding eye-hand coordination, timing of gaze shift to the target was gradually changed with practice from the late to early phase of hand movements in all groups, indicating an emerging gaze-anchoring behavior. Gaze locations prior to the gaze anchoring were also modified with practice from the cursor vicinity to an area between the starting position and the target. Reflecting various task difficulties, these changes occurred fastest in the 30 degrees group, followed by the 75 degrees group. The 150 degrees group persisted in gazing at the cursor vicinity. These results suggest that the function of gaze control during visuomotor adaptation changes from a reactive control for exploring the relation between cursor and hand movements to a predictive control for guiding the hand to the task goal. That gaze-anchoring behavior emerged in all groups despite various control strategies indicates a generality of this adaptive pattern for eye-hand coordination in goal-directed actions.	[Rentsch, Sebastian; Rand, Miya K.] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Rand, MK (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	rand@ifado.de			Deutsche Forschungsgemeinschaft (DFG) [Ra 2183/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by grant Ra 2183/1-1 of the Deutsche Forschungsgemeinschaft (DFG), http://www.dfg.de/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeele S, 2001, EXP BRAIN RES, V140, P407, DOI 10.1007/s002210100846; ABRAMS RA, 1990, J EXP PSYCHOL HUMAN, V16, P248, DOI 10.1037/0096-1523.16.2.248; Adam JJ, 2012, J EXP PSYCHOL HUMAN, V38, P891, DOI 10.1037/a0027592; BEDFORD FL, 1989, J EXP PSYCHOL HUMAN, V15, P232, DOI 10.1037/0096-1523.15.2.232; BEKKERING H, 1995, EXP BRAIN RES, V106, P475, DOI 10.1007/BF00231070; Bock O, 2005, EXP BRAIN RES, V160, P259, DOI 10.1007/s00221-004-2133-5; BOCK O, 1993, BEHAV BRAIN RES, V56, P77, DOI 10.1016/0166-4328(93)90023-J; BOCK O, 1992, BEHAV BRAIN RES, V51, P41, DOI 10.1016/S0166-4328(05)80310-9; Bohan M, 2003, MOTOR CONTROL, V7, P278, DOI 10.1123/mcj.7.3.278; Bowman M, 2009, EXP BRAIN RES, V195, P273, DOI 10.1007/s00221-009-1781-x; Buch ER, 2003, LEARN MEMORY, V10, P55, DOI 10.1101/lm.50303; Contreras-Vidal JL, 2003, EXP BRAIN RES, V150, P25, DOI 10.1007/s00221-003-1403-y; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; Criscimagna-Hemminger SE, 2010, J NEUROPHYSIOL, V103, P2275, DOI 10.1152/jn.00822.2009; CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; CUNNINGHAM HA, 1990, BIOL CYBERN, V64, P117, DOI 10.1007/BF02331340; de Xivry JJO, 2013, J NEUROPHYSIOL, V109, P124, DOI 10.1152/jn.00785.2012; DRASDO N, 1974, BRIT J OPHTHALMOL, V58, P709, DOI 10.1136/bjo.58.8.709; Ferrel C, 2001, EXP BRAIN RES, V138, P313, DOI 10.1007/s002210100697; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Gaveau V, 2008, NEUROPSYCHOLOGIA, V46, P475, DOI 10.1016/j.neuropsychologia.2007.08.028; GIELEN CCAM, 1984, EXP BRAIN RES, V56, P154, DOI 10.1007/BF00237452; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Granek JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0086138; Grigorova V, 2006, EXP BRAIN RES, V175, P754, DOI 10.1007/s00221-006-0731-0; Grigorova V, 2006, EXP BRAIN RES, V171, P524, DOI 10.1007/s00221-005-0301-x; HAY JC, 1971, J EXP PSYCHOL, V91, P11, DOI 10.1037/h0031787; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Hegele M, 2010, PSYCHOL RES-PSYCH FO, V74, P21, DOI 10.1007/s00426-008-0221-z; Held R., 1958, PERCEPT MOTOR SKILL, V8, P83, DOI [10.2466/pms.1958.8.3.83, DOI 10.2466/PMS.1958.8.3.83]; HENDRICKSON AE, 1984, OPHTHALMOLOGY, V91, P603; Heuer H., 2013, AGE DIFFERENTIATED W, P369, DOI DOI 10.1007/978-3-642-35057-3_16; Heuer H, 2008, J MOTOR BEHAV, V40, P368, DOI 10.3200/JMBR.40.5.368-379; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Heuer H, 2008, EXP BRAIN RES, V185, P101, DOI 10.1007/s00221-007-1135-5; Hinder MR, 2008, EXP BRAIN RES, V191, P143, DOI 10.1007/s00221-008-1513-7; Hinder MR, 2010, EXP BRAIN RES, V201, P191, DOI 10.1007/s00221-009-2025-9; Huang VS, 2009, J NEUROPHYSIOL, V102, P931, DOI 10.1152/jn.00237.2009; IMAMIZU H, 1995, J EXP PSYCHOL HUMAN, V21, P719, DOI 10.1037/0096-1523.21.4.719; Ishihara S, 2005, ISHIHARA TESTS COLOU; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Ketcham CJ, 2002, J GERONTOL B-PSYCHOL, V57, pP54, DOI 10.1093/geronb/57.1.P54; Klassen J, 2005, EXP BRAIN RES, V164, P250, DOI 10.1007/s00221-005-2247-4; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Lunenburger L, 2000, EUR J NEUROSCI, V12, P4107, DOI 10.1046/j.1460-9568.2000.00298.x; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Paillard J., 1982, ANAL VISUAL BEHAV, P367; Peled A, 2012, J MOTOR BEHAV, V44, P185, DOI 10.1080/00222895.2012.672349; Polyak S. L., 1941, RETINA-J RET VIT DIS; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; PRABLANC C, 1979, BIOL CYBERN, V35, P183, DOI 10.1007/BF00337063; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Rand MK, 2014, EXP BRAIN RES, V232, P2753, DOI 10.1007/s00221-014-3951-8; Rand MK, 2013, EXP BRAIN RES, V230, P1, DOI 10.1007/s00221-013-3626-x; Rand MK, 2013, EXP BRAIN RES, V225, P55, DOI 10.1007/s00221-012-3348-5; Rand MK, 2010, EXP BRAIN RES, V207, P197, DOI 10.1007/s00221-010-2456-3; Rand MK, 2000, NEUROPSYCHOLOGIA, V38, P203, DOI 10.1016/S0028-3932(99)00059-7; Rand MK, 2013, SOC NEUR ABSTR, V471, P25; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; REDDING GM, 1975, PERCEPT PSYCHOPHYS, V17, P97, DOI 10.3758/BF03204006; Sailer U, 2005, J NEUROSCI, V25, P8833, DOI 10.1523/JNEUROSCI.2658-05.2005; Seidler RD, 2006, BRAIN RES BULL, V70, P337, DOI 10.1016/j.brainresbull.2006.06.008; Shabbott BA, 2010, EXP BRAIN RES, V203, P75, DOI 10.1007/s00221-010-2209-3; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Sulzenbruck S, 2012, EXP BRAIN RES, V218, P283, DOI 10.1007/s00221-012-3011-1; Sulzenbruck S, 2011, ERGONOMICS, V54, P34, DOI 10.1080/00140139.2010.535023; Sulzenbruck S, 2009, CONSCIOUS COGN, V18, P145, DOI 10.1016/j.concog.2008.12.001; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Taylor JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001096; Vindras P, 2002, EXP BRAIN RES, V147, P280, DOI 10.1007/s00221-002-1211-9; VIVIANI P, 1995, J EXP PSYCHOL HUMAN, V21, P32, DOI 10.1037/0096-1523.21.1.32; Werner S, 2007, EXP BRAIN RES, V178, P554, DOI 10.1007/s00221-007-0925-0; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; YAMADA E, 1969, ARCH OPHTHALMOL-CHIC, V82, P151	77	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109819	10.1371/journal.pone.0109819	http://dx.doi.org/10.1371/journal.pone.0109819			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25333942	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200054
J	Blanch, J; Sala, M; Ibanez, J; Domingo, L; Fernandez, B; Otegi, A; Barata, T; Zubizarreta, R; Ferrer, J; Castells, X; Rue, M; Salas, D				Blanch, Jordi; Sala, Maria; Ibanez, Josefa; Domingo, Laia; Fernandez, Belen; Otegi, Arantza; Barata, Teresa; Zubizarreta, Raquel; Ferrer, Joana; Castells, Xavier; Rue, Montserrat; Salas, Dolores		INCA Study Grp	Impact of Risk Factors on Different Interval Cancer Subtypes in a Population-Based Breast Cancer Screening Programme	PLOS ONE			English	Article							MAMMOGRAPHIC DENSITIES; TUMOR CHARACTERISTICS; DIGITAL MAMMOGRAPHY; MORTALITY; RATES	Background: Interval cancers are primary breast cancers diagnosed in women after a negative screening test and before the next screening invitation. Our aim was to evaluate risk factors for interval cancer and their subtypes and to compare the risk factors identified with those associated with incident screen-detected cancers. Methods: We analyzed data from 645,764 women participating in the Spanish breast cancer screening program from 2000-2006 and followed-up until 2009. A total of 5,309 screen-detected and 1,653 interval cancers were diagnosed. Among the latter, 1,012 could be classified on the basis of findings in screening and diagnostic mammograms, consisting of 489 true interval cancers (48.2%), 235 false-negatives (23.2%), 172 minimal-signs (17.2%) and 114 occult tumors (11.3%). Information on the screening protocol and women's characteristics were obtained from the screening program registry. Cause-specific Cox regression models were used to estimate the hazard ratios (HR) of risks factors for interval cancer and incident screen-detected cancer. A multinomial regression model, using screen-detected tumors as a reference group, was used to assess the effect of breast density and other factors on the occurrence of interval cancer subtypes. Results: A previous false-positive was the main risk factor for interval cancer (HR = 2.71, 95%CI: 2.28-3.23); this risk was higher for false-negatives (HR = 8.79, 95%CI: 6.24-12.40) than for true interval cancer (HR = 2.26, 95%CI: 1.59-3.21). A family history of breast cancer was associated with true intervals (HR = 2.11, 95%CI: 1.60-2.78), previous benign biopsy with a false-negatives (HR = 1.83, 95%CI: 1.23-2.71). High breast density was mainly associated with occult tumors (RRR = 4.92, 95%CI: 2.58-9.38), followed by true intervals (RRR = 1.67, 95%CI: 1.18-2.36) and false-negatives (RRR = 1.58, 95%CI: 1.00-2.49). Conclusion: The role of women's characteristics differs among interval cancer subtypes. This information could be useful to improve effectiveness of breast cancer screening programmes and to better classify subgroups of women with different risks of developing cancer.	[Blanch, Jordi; Sala, Maria; Domingo, Laia; Castells, Xavier] IMIM Hosp Mar Med Res Inst, Dept Epidemiol & Evaluat, Barcelona, Spain; [Blanch, Jordi; Sala, Maria; Castells, Xavier] UAB, Dept Pediat Obstet & Gynecol, European Higher Educ Area EHEA Doctoral Programme, Bellaterra, Barcelona, Spain; [Sala, Maria; Domingo, Laia; Castells, Xavier; Rue, Montserrat] Res Network Hlth Serv Chron Dis REDISSEC, Barcelona, Spain; [Ibanez, Josefa; Salas, Dolores] Gen Directorate Publ Hlth, Valencia, Spain; [Ibanez, Josefa; Salas, Dolores] FISABIO, Ctr Publ Hlth Res CSISP, Valencia, Spain; [Zubizarreta, Raquel] Directorate Innovat & Management Publ Hlth, Galician Breast Canc Screening Programme, Santiago De Compostela, Spain; [Otegi, Arantza] Basque Country Hlth Serv, Osakidetza Breast Canc Screening Programme, Bilbao, Spain; [Barata, Teresa] Canary Islands Hlth Serv, Gen Directorate Hlth Care Programmes, Las Palmas Gran Canaria, Spain; [Ferrer, Joana] Hosp Santa Caterina, Dept Radiol, Girona, Spain; [Rue, Montserrat] Univ Lleida, Biomed Res Inst Lleida IRBLLEIDA, Dept Basic Med Sci, Lleida, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; Universitat de Lleida	Sala, M (corresponding author), IMIM Hosp Mar Med Res Inst, Dept Epidemiol & Evaluat, Barcelona, Spain.	msalaserra@parcdesalutmar.cat	VICENS, GEMMA RENART/H-1872-2015; Marcos-Gragera, Rafael/A-1437-2017; Serra, Maria Sala/O-9420-2019; Bare, Marisa/H-4806-2011; Gregori, Aleix/E-8598-2019; Blanch, Jordi/U-1407-2019; Cabanell, Josefa Ibáñez/S-1131-2017; Rue, Montserrat/B-5663-2009; Macià, Francesc/N-2776-2017; SalasTrejo, Dolores/S-1139-2017; Blanch, Jordi/K-1685-2017; Forne, Carles/R-7652-2016; , 0000-0001-8085-2833/ABI-7466-2020; Vilaprinyo, Ester/A-6702-2010; Castells, Xavier/S-7798-2016; Sala, Maria/H-2562-2013; Domingo, Laia/E-5705-2016	VICENS, GEMMA RENART/0000-0001-6037-9225; Marcos-Gragera, Rafael/0000-0001-9824-3657; Serra, Maria Sala/0000-0002-9955-8746; Bare, Marisa/0000-0001-8085-2833; Gregori, Aleix/0000-0002-3131-9765; Blanch, Jordi/0000-0001-8211-3292; Cabanell, Josefa Ibáñez/0000-0002-7681-310X; Rue, Montserrat/0000-0002-7862-9365; Macià, Francesc/0000-0002-6090-5894; Blanch, Jordi/0000-0001-8211-3292; Forne, Carles/0000-0002-8133-3274; , 0000-0001-8085-2833/0000-0001-8085-2833; Vilaprinyo, Ester/0000-0002-5787-5890; Castells, Xavier/0000-0002-2528-0382; Sala, Maria/0000-0002-9955-8746; Roman, Marta/0000-0001-9076-8918; Domingo, Laia/0000-0003-4420-0891; Tora Suarez, Nuria/0000-0002-3934-4674	Instituto de Salud Carlos III-FEDER [PI 09/01153, PI09/02385, PI09/01340]	Instituto de Salud Carlos III-FEDER(Instituto de Salud Carlos III)	This study has received funding by Instituto de Salud Carlos III-FEDER (PI 09/01153, PI09/02385, PI09/01340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Ascunce N, 2010, ANN ONCOL, V21, piii43, DOI 10.1093/annonc/mdq085; Ashbeck EL, 2007, CANCER EPIDEM BIOMAR, V16, P467, DOI 10.1158/1055-9965.EPI-06-0394; Bennett RL, 2011, BRIT J CANCER, V104, P571, DOI 10.1038/bjc.2011.3; Blanch J, 2013, BREAST CANCER RES TR, V138, P869, DOI 10.1007/s10549-013-2458-5; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Bucchi L, 2008, J MED SCREEN, V15, P30, DOI 10.1258/jms.2008.007016; Bulliard JL, 2006, INT J CANCER, V119, P1158, DOI 10.1002/ijc.21941; Castells X, 2013, CANCER EPIDEMIOL, V37, P85, DOI 10.1016/j.canep.2012.10.004; de Gelder R, 2011, PREV MED, V53, P134, DOI 10.1016/j.ypmed.2011.06.009; Domingo L, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3595; Domingo L, 2013, EUR J CANCER PREV, V22, P21, DOI 10.1097/CEJ.0b013e328354d324; Domingo L, 2011, EUR RADIOL, V21, P2020, DOI 10.1007/s00330-011-2143-1; Domingo L, 2010, CANCER CAUSE CONTROL, V21, P1155, DOI 10.1007/s10552-010-9541-6; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Guo YP, 2001, CANCER EPIDEM BIOMAR, V10, P243; Halapy E, 2005, BREAST CANCER RES TR, V90, P299, DOI 10.1007/s10549-004-5168-1; Heidinger O, 2012, DTSCH ARZTEBL INT, V109, P781, DOI 10.3238/arztebl.2012.0781; Hoff SR, 2012, RADIOLOGY, V264, P378, DOI 10.1148/radiol.12112074; Hofvind S, 2014, RADIOLOGY; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Hofvind S, 2006, INT J CANCER, V118, P3112, DOI 10.1002/ijc.21742; Hofvind S, 2009, J MED SCREEN, V16, P131, DOI 10.1258/jms.2009.009012; Kabat GC, 2010, CANCER CAUSE CONTROL, V21, P821, DOI 10.1007/s10552-010-9508-7; Kirsh VA, 2011, JNCI-J NATL CANCER I, V103, P942, DOI 10.1093/jnci/djr138; Lowery JT, 2011, CANCER CAUSE CONTROL, V22, P23, DOI 10.1007/s10552-010-9663-x; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Navarro C, 2010, ANN ONCOL, V21, piii3, DOI 10.1093/annonc/mdq094; Njor S, 2012, J MED SCREEN, V19, P33, DOI 10.1258/jms.2012.012080; Otten JDM, 2013, ANN ONCOL, V24, P2501, DOI 10.1093/annonc/mdt227; Payne JI, 2013, RADIOLOGY, V266, P96, DOI 10.1148/radiol.12102348; Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699; Perry N., 2006, EUROPEAN GUIDELINES; Pollan M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3380; Seigneurin A, 2009, BREAST, V18, P284, DOI 10.1016/j.breast.2009.07.007; Therneau T.M., 2000, MODELING SURVIVAL DA; Tornberg S, 2010, EUR J CANCER PREV, V19, P87, DOI 10.1097/CEJ.0b013e32833548ed; Vilaprinyo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086858	40	22	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110207	10.1371/journal.pone.0110207	http://dx.doi.org/10.1371/journal.pone.0110207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333936	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200028
J	Hou, YF; Sun, ZL; Chong, YW; Zheng, CH				Hou, Yi-Fu; Sun, Zhan-Li; Chong, Yan-Wen; Zheng, Chun-Hou			Low-Rank and Eigenface Based Sparse Representation for Face Recognition	PLOS ONE			English	Article								In this paper, based on low-rank representation and eigenface extraction, we present an improvement to the well known Sparse Representation based Classification (SRC). Firstly, the low-rank images of the face images of each individual in training subset are extracted by the Robust Principal Component Analysis (Robust PCA) to alleviate the influence of noises (e. g., illumination difference and occlusions). Secondly, Singular Value Decomposition (SVD) is applied to extract the eigenfaces from these low-rank and approximate images. Finally, we utilize these eigenfaces to construct a compact and discriminative dictionary for sparse representation. We evaluate our method on five popular databases. Experimental results demonstrate the effectiveness and robustness of our method.	[Hou, Yi-Fu; Sun, Zhan-Li; Zheng, Chun-Hou] Anhui Univ, Coll Elect Engn & Automat, Hefei 230039, Peoples R China; [Chong, Yan-Wen] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430072, Peoples R China	Anhui University; Wuhan University	Zheng, CH (corresponding author), Anhui Univ, Coll Elect Engn & Automat, Hefei 230039, Peoples R China.	zhengch99@126.com			National Science Foundation of China [61272339]; Natural Science Foundation of Hubei Province [2012FFB04204]; Anhui Educational Committee [KJ2012A005]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Anhui Educational Committee	This work was supported by the National Science Foundation of China under Grant No. 61272339, the Natural Science Foundation of Hubei Province under Grant No. 2012FFB04204, and the Key Project of Anhui Educational Committee, under Grant No. KJ2012A005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Bertsekas D., 1999, NONLINEAR PROGRAMMIN; Bertsekas DP., 1982, CONSTRAINED OPTIMIZA, DOI [10.1016/C2013-0-10366-2, DOI 10.1016/C2013-0-10366-2]; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; De la Torre F, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P362, DOI 10.1109/ICCV.2001.937541; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; GNANADESIKAN R, 1972, BIOMETRICS, V28, P81, DOI 10.2307/2528963; Graham D., 1998, FACE RECOGNITION, V163, P446, DOI DOI 10.1007/978-3-642-72201-1_25; Huang DS, 2006, BIOINFORMATICS, V22, P1855, DOI 10.1093/bioinformatics/btl190; Huang JZ, 2009, IEEE I CONF COMP VIS, P64, DOI 10.1109/ICCV.2009.5459202; Ke Q, 2005, P IEEE INT C COMP VI, V1, P739, DOI [10.1109/CVPR.2005.309, DOI 10.1109/CVPR.2005.309]; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Lee KC, 2005, IEEE T PATTERN ANAL, V27, P684, DOI 10.1109/TPAMI.2005.92; Li KL, 2011, PROCEDIA ENGINEER, V15, DOI 10.1016/j.proeng.2011.08.375; Liebermeister W, 2002, BIOINFORMATICS, V18, P51, DOI 10.1093/bioinformatics/18.1.51; Lin Z., 2010, 100920105055 ARXIV, P1, DOI DOI 10.1016/J.JSB.2012.10.010; Liu GC, 2013, IEEE T PATTERN ANAL, V35, P171, DOI 10.1109/TPAMI.2012.88; Liu YN, 2010, PROC CVPR IEEE, P3578, DOI 10.1109/CVPR.2010.5539934; Ma L, 2012, PROC CVPR IEEE, P2586, DOI 10.1109/CVPR.2012.6247977; Mairal J., 2008, P IEEE C COMP VIS PA, V2, P1, DOI DOI 10.1109/CVPR.2008.4587652; Mairal J., 2009, ADV NEURAL INFORM PR, P1033; Mairal J., 2009, P 26 ANN INT C MACH, P689, DOI DOI 10.1145/1553374.1553463; Mairal J, 2008, IEEE T IMAGE PROCESS, V17, P53, DOI 10.1109/TIP.2007.911828; Martinez A., 1998, AR FACE DATABASE; Pujol O, 2009, IEEE T PATTERN ANAL, V31, P1140, DOI 10.1109/TPAMI.2009.31; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Shan SG, 2005, LECT NOTES COMPUT SC, V3723, P279; Sim T, 2002, FIFTH IEEE INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION, PROCEEDINGS, P53, DOI 10.1109/AFGR.2002.1004130; Wang HQ, 2006, PATTERN RECOGN LETT, V27, P116, DOI 10.1016/j.patrec.2005.07.007; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yang M, 2011, IEEE I CONF COMP VIS, P543, DOI 10.1109/ICCV.2011.6126286; Yang M, 2011, PROC CVPR IEEE, P625, DOI 10.1109/CVPR.2011.5995393; You D, 2011, IEEE T PATTERN ANAL, V33, P631, DOI 10.1109/TPAMI.2010.173; Zhang HC, 2012, PATTERN RECOGN, V45, P1290, DOI 10.1016/j.patcog.2011.09.009; Zheng CH, 2011, IEEE ACM T COMPUT BI, V8, P1273, DOI 10.1109/TCBB.2011.20; Zhou T., 2011, P 28 INT C MACH LEAR, P33	39	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110318	10.1371/journal.pone.0110318	http://dx.doi.org/10.1371/journal.pone.0110318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25334027	Green Published, gold			2022-12-27	WOS:000343731200031
J	Correia-Oliveira, CR; Santos, RA; Silva-Cavalcante, MD; Bertuzzi, R; Kiss, MAPD; Bishop, DJ; Lima-Silva, AE				Correia-Oliveira, Carlos Rafaell; Santos, Ralmony Alcantara; Silva-Cavalcante, Marcos David; Bertuzzi, Romulo; Dal'Molin Kiss, Maria Augusta Peduti; Bishop, David John; Lima-Silva, Adriano Eduardo			Prior Low- or High-Intensity Exercise Alters Pacing Strategy, Energy System Contribution and Performance during a 4-km Cycling Time Trial	PLOS ONE			English	Article							OXYGEN-UPTAKE KINETICS; GLYCOGEN DEPLETION; MUSCLE GLYCOGEN; CARBOHYDRATE-DIET; FATIGUE; EXPENDITURE; DURATION; HEAVY; POWER	We analyzed the influence of prior exercise designed to reduce predominantly muscle glycogen in either type I or II fibers on pacing and performance during a 4-km cycling time trial (TT). After preliminary and familiarization trials, in a randomized, repeated-measures crossover design, ten amateur cyclists performed: 1) an exercise designed to reduce glycogen of type I muscle fibers, followed by a 4-km TT (EX-FIB I); 2) an exercise designed to reduce glycogen of type II muscle fibers, followed by a 4-km TT (EX-FIB II) and; 3) a 4-km TT, without the prior exercise (CONT). The muscle-glycogen-reducing exercise in both EX-FIB I and EX-FIB II was performed in the evening, similar to 12 h before the 4-km TT. Performance time was increased and power output (PO) was reduced in EX-FIB I (432.8 +/- 8.3 s and 204.9 +/- 10.9 W) and EX-FIB II (428.7 +/- 6.7 s and 207.5 +/- 9.1 W) compared to CONT (420.8 +/- 6.4 s and 218.4 +/- 9.3 W; P<0.01), without a difference between EX-FIB I and EX-FIB II (P>0.05). The PO was lower in EX-FIB I than in CONT at the beginning and middle of the trial (P<0.05). The mean aerobic contribution during EX-FIB I was also significantly lower than in CONT (P<0.05), but there was no difference between CONT and EX-FIB II or between EX-FIB I and EX-FIB II (P>0.05). The integrated electromyography was unchanged between conditions (P>0.05). Performance may have been impaired in EX-FIB I due a more conservative pacing at the beginning and middle, which was associated with a reduced aerobic contribution. In turn, the PO profile adopted in EX-FIB II was also reduced throughout the trial, but the impairment in performance may be attributed to a reduced glycolytic contribution (i.e. reduced lactate accumulation).	[Correia-Oliveira, Carlos Rafaell; Santos, Ralmony Alcantara; Silva-Cavalcante, Marcos David; Lima-Silva, Adriano Eduardo] Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Sports Sci Res Grp, Vitoria de Santo Antao, Pernambuco, Brazil; [Correia-Oliveira, Carlos Rafaell; Silva-Cavalcante, Marcos David; Bertuzzi, Romulo; Dal'Molin Kiss, Maria Augusta Peduti] Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Performance Res Grp, Sao Paulo, Brazil; [Santos, Ralmony Alcantara] Univ Fed Sao Paulo, Dept Med, Div Nephrol, Sao Paulo, Brazil; [Bishop, David John] Victoria Univ, Coll Sport & Exercise Sci, Inst Sport Exercise & Active Living, Melbourne, Vic 8001, Australia	Universidade Federal de Pernambuco; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Victoria University	Lima-Silva, AE (corresponding author), Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Sports Sci Res Grp, Vitoria de Santo Antao, Pernambuco, Brazil.	adrianosilva@usp.br	Lima-Silva, Adriano/Y-2404-2019; Bishop, David John/X-9826-2019; Silva-Cavalcante, Marcos/E-9980-2012; Lima-Silva, Adriano Eduardo/C-2800-2013; Kiss, Maria Augusta/H-5902-2012; Bertuzzi, Romulo/E-7048-2012	Lima-Silva, Adriano/0000-0002-0613-5104; Bishop, David John/0000-0002-6956-9188; Silva-Cavalcante, Marcos/0000-0003-3943-3420; Lima-Silva, Adriano Eduardo/0000-0002-0613-5104; 	Foundation of Aids to Scientific Research of the State of Alagoas (FAPEAL)	Foundation of Aids to Scientific Research of the State of Alagoas (FAPEAL)	Carlos Rafaell Correia-Oliveira Oliveira is grateful to Foundation of Aids to Scientific Research of the State of Alagoas (FAPEAL) for his Masters scholarship. The authors thank all of the cyclists who took part in this study.	Abbiss CR, 2008, J APPL PHYSIOL, V104, P1021, DOI 10.1152/japplphysiol.00683.2007; Abbiss CR, 2008, SPORTS MED, V38, P239, DOI 10.2165/00007256-200838030-00004; Albertus-Kajee Y, 2011, J ELECTROMYOGR KINES, V21, P579, DOI 10.1016/j.jelekin.2011.03.009; Ansley L, 2004, MED SCI SPORT EXER, V36, P1819, DOI 10.1249/01.MSS.0000142409.70181.9D; Bentley DJ, 2007, SPORTS MED, V37, P575, DOI 10.2165/00007256-200737070-00002; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; Bishop D, 2002, MED SCI SPORT EXER, V34, P1041, DOI 10.1097/00005768-200206000-00022; Carter H, 2004, MED SCI SPORT EXER, V36, P965, DOI 10.1249/01.MSS.0000128202.73676.11; Corbett J, 2009, BRIT J SPORT MED, V43, P770, DOI 10.1136/bjsm.2008.056416; Correia-Oliveira C, 2013, SPORTS MED, V43, P707, DOI 10.1007/s40279-013-0054-9; Foster C, 2004, INT J SPORTS MED, V25, P198, DOI 10.1055/s-2003-45260; GARBY L, 1987, ACTA PHYSIOL SCAND, V129, P443, DOI 10.1111/j.1365-201X.1987.tb10613.x; GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45, DOI 10.1113/jphysiol.1974.sp010639; Hettinga FJ, 2007, MED SCI SPORT EXER, V39, P2212, DOI 10.1249/mss.0b013e318156e8d4; Hettinga FJ, 2006, MED SCI SPORT EXER, V38, P1484, DOI 10.1249/01.mss.0000228956.75344.91; Hopkins W.G., 2007, SPORTSCIENCE, V11, P16; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Jeukendrup A, 1997, INT J SPORTS MED, V18, P125, DOI 10.1055/s-2007-972607; Johnson ND, 2006, BRIT DENT J, V200, P62, DOI 10.1038/sj.bdj.4813181; Jones AM, 2008, SCAND J MED SCI SPOR, V18, P615, DOI 10.1111/j.1600-0838.2007.00725.x; Lima-Silva AE, 2013, INT J SPORTS MED, V34, P736, DOI 10.1055/s-0032-1331258; Lima-Silva AE, 2009, BRAZ J MED BIOL RES, V42, P404, DOI 10.1590/S0100-879X2009000500002; Lima-Silva AE, 2013, APPL PHYSIOL NUTR ME, V38, P928, DOI 10.1139/apnm-2012-0467; Lima-Silva AE, 2011, PSYCHOPHYSIOLOGY, V48, P277, DOI 10.1111/j.1469-8986.2010.01059.x; Magkos F, 2003, CURR OPIN CLIN NUTR, V6, P539, DOI 10.1097/00075197-200309000-00007; Miura A, 2000, ERGONOMICS, V43, P133, DOI 10.1080/001401300184693; Peiffer JJ, 2011, INT J SPORTS MED, V32, P353, DOI 10.1055/s-0031-1271772; Pringle JSM, 2003, EUR J APPL PHYSIOL, V89, P289, DOI 10.1007/s00421-003-0799-1; Racinais S, 2010, CHRONOBIOL INT, V27, P855, DOI 10.3109/07420521003668412; Rauch HGL, 2005, BRIT J SPORT MED, V39, P34, DOI 10.1136/bjsm.2003.010645; Silva-Cavalcante MD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075399, 10.1371/journal.pone.0072025]; Stone MR, 2011, EUR J APPL PHYSIOL, V111, P1807, DOI 10.1007/s00421-010-1818-7; THOMSON JA, 1979, PFLUG ARCH EUR J PHY, V379, P105, DOI 10.1007/BF00622912; Weir JP, 2006, BRIT J SPORT MED, V40, P573, DOI 10.1136/bjsm.2005.023028	35	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110320	10.1371/journal.pone.0110320	http://dx.doi.org/10.1371/journal.pone.0110320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330452	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000343942100053
J	Wangchuk, S; Mitui, MT; Tshering, K; Yahiro, T; Bandhari, P; Zangmo, S; Dorji, T; Tshering, K; Matsumoto, T; Nishizono, A; Ahmed, K				Wangchuk, Sonam; Mitui, Marcelo T.; Tshering, Kinlay; Yahiro, Takaaki; Bandhari, Purushotam; Zangmo, Sangay; Dorji, Tshering; Tshering, Karchung; Matsumoto, Takashi; Nishizono, Akira; Ahmed, Kamruddin			Dominance of Emerging G9 and G12 Genotypes and Polymorphism of VP7 and VP4 of Rotaviruses from Bhutanese Children with Severe Diarrhea Prior to the Introduction of Vaccine	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; MOLECULAR CHARACTERIZATION; INTUSSUSCEPTION RISK; STRAIN DIVERSITY; IDENTIFICATION; PREDOMINANCE; SURVEILLANCE; RARE	A prospective study was performed to determine the molecular characteristics of rotaviruses circulating among children aged,5 years in Bhutan. Stool samples were collected from February 2010 through January 2011 from children who attended two tertiary care hospitals in the capital Thimphu and the eastern regional headquarters, Mongar. The samples positive for rotavirus was mainly comprised genotype G1, followed by G12 and G9. The VP7 and VP4 genes of all genotypes clustered mainly with those of neighboring countries, thereby indicating that they shared common ancestral strains. The VP7 gene of Bhutanese G1 strains belonged to lineage 1c, which differed from the lineages of vaccine strains. Mutations were also identified in the VP7 gene of G1 strains, which may be responsible for neutralization escape strains. Furthermore, we found that lineage 4 of P[8] genotype differed antigenically from the vaccine strains, and mutations were identified in Bhutanese strains of lineage 3. The distribution of rotavirus genotypes varies among years, therefore further research is required to determine the distribution of rotavirus strain genotypes in Bhutan.	[Wangchuk, Sonam; Zangmo, Sangay; Dorji, Tshering; Tshering, Karchung] Dept Publ Hlth, Publ Hlth Lab, Minist Hlth, Thimphu, Bhutan; [Mitui, Marcelo T.; Yahiro, Takaaki; Matsumoto, Takashi; Nishizono, Akira; Ahmed, Kamruddin] Oita Univ, Fac Med, Dept Microbiol, Yufu, Japan; [Tshering, Kinlay] Jigme Dorji Wangchuk Natl Referral Hosp, Dept Pediat, Thimphu, Bhutan; [Bandhari, Purushotam] Mongar Reg Referral Hosp, Dept Pediat, Mongar, Bhutan; [Ahmed, Kamruddin] Oita Univ, Res Promot Inst, Yufu, Japan	Oita University; Oita University	Ahmed, K (corresponding author), Oita Univ, Fac Med, Dept Microbiol, Yufu, Japan.	ahmed@oita-u.ac.jp	Ahmed, Kamruddin/I-6423-2016	Ahmed, Kamruddin/0000-0002-1869-3701; Yahiro, Takaaki/0000-0003-1094-4497	Oita University [610000-N5010, 610000-N5040]	Oita University(Oita University)	This study was supported by the Research Funds at the Discretion of the President, Oita University [610000-N5010 and 610000-N5040] to Kamruddin Ahmed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2013, J NEGAT RESULTS BIOM, V12, DOI 10.1186/1477-5751-12-5; Ahmed K, 2010, VIRUS GENES, V40, P347, DOI 10.1007/s11262-010-0463-x; Ahmed K, 2010, ARCH VIROL, V155, P71, DOI 10.1007/s00705-009-0552-0; [Anonymous], 2006, RESULTS POPULATION H, P1; [Anonymous], 2011, ANN HLTH B 2011, V2011, P1; [Anonymous], 2012, BHUTAN MATERNAL NEWB; Aoki ST, 2009, SCIENCE, V324, P1444, DOI 10.1126/science.1170481; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Bozdayi G, 2008, J MED VIROL, V80, P733, DOI 10.1002/jmv.21120; Buttery JP, 2011, VACCINE, V29, P3061, DOI 10.1016/j.vaccine.2011.01.088; Cunliffe NA, 2001, J CLIN MICROBIOL, V39, P836, DOI 10.1128/JCM.39.3.836-843.2001; Donato C.M., 2014, INFECT GENET EVOL; Dormitzer PR, 2002, EMBO J, V21, P885, DOI 10.1093/emboj/21.5.885; Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412; Heatona PM, 2007, CLIN INFECT DIS, V45, P1618, DOI 10.1086/522997; Kirkwood CD, 2011, PEDIATR INFECT DIS J, V30, pS48, DOI 10.1097/INF.0b013e3181fefd90; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mandile MG, 2014, J CLIN VIROL, V60, P282, DOI 10.1016/j.jcv.2014.04.022; Matsumoto T, 2013, GENOME ANNOUNC, V1; Matthijnssens J, 2010, VIROLOGY, V403, P111, DOI 10.1016/j.virol.2010.04.004; Mitui MT, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-144; Mitui MT, 2011, J CLIN VIROL, V50, P325, DOI 10.1016/j.jcv.2011.01.008; Moon SS, 2013, PEDIATR INFECT DIS J, V32, P863, DOI 10.1097/INF.0b013e318290646d; Mukherjee A, 2010, INFECT GENET EVOL, V10, P311, DOI 10.1016/j.meegid.2010.01.002; Nagashima S, 2010, JPN J INFECT DIS, V63, P208; Nagashima S, 2009, ARCH VIROL, V154, P1223, DOI 10.1007/s00705-009-0436-3; Nguyen TA, 2008, CLIN MICROBIOL INFEC, V14, P235, DOI 10.1111/j.1469-0691.2007.01918.x; Parashar U, 2013, EXPERT REV VACCINES, V12, P113, DOI [10.1586/erv.12.148, 10.1586/ERV.12.148]; Parez N, 2008, COMP IMMUNOL MICROB, V31, P253, DOI 10.1016/j.cimid.2007.07.005; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Samajdar S, 2008, ARCH VIROL, V153, P1933, DOI 10.1007/s00705-008-0187-6; Shin S, 2012, VACCINE, V30, pA106, DOI 10.1016/j.vaccine.2011.11.091; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Theamboonlers A, 2008, VIRUS GENES, V36, P289, DOI 10.1007/s11262-008-0201-9; Ward R, 2009, PEDIATR INFECT DIS J, V28, pS57, DOI 10.1097/INF.0b013e3181967c16; Weintraub ES, 2014, NEW ENGL J MED, V370, P513, DOI 10.1056/NEJMoa1311738; Yahiro T, 2014, EMERG INFECT DIS, V20, P1037, DOI 10.3201/eid2006.131430; Yih WK, 2014, NEW ENGL J MED, V370, P503, DOI 10.1056/NEJMoa1303164; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; Zeller M, 2012, J CLIN MICROBIOL, V50, P966, DOI 10.1128/JCM.05590-11	42	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110795	10.1371/journal.pone.0110795	http://dx.doi.org/10.1371/journal.pone.0110795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330070	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100097
J	Wu, K; Hoy, MA				Wu, Ke; Hoy, Marjorie A.			Clathrin Heavy Chain Is Important for Viability, Oviposition, Embryogenesis and, Possibly, Systemic RNAi Response in the Predatory Mite Metaseiulus occidentalis	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; GENETICALLY-IMPROVED STRAINS; PHYTOSEIIDAE; CELLS; RESISTANCE; PATHWAY; ACARINA; MODELS; GROWTH; GENE	Clathrin heavy chain has been shown to be important for viability, embryogenesis, and RNA interference (RNAi) in arthropods such as Drosophila melanogaster. However, the functional roles of clathrin heavy chain in chelicerate arthropods, such as the predatory mite Metaseiulus occidentalis, remain unknown. We previously showed that dsRNA ingestion, followed by feeding on spider mites, induced systemic and robust RNAi in M. occidentalis females. In the current study, we performed a loss-of-function analysis of the clathrin heavy chain gene in M. occidentalis using RNAi. We showed that ingestion of clathrin heavy chain dsRNA by M. occidentalis females resulted in gene knockdown and reduced longevity. In addition, clathrin heavy chain dsRNA treatment almost completely abolished oviposition by M. occidentalis females and the few eggs produced did not hatch. Finally, we demonstrated that clathrin heavy chain gene knockdown in M. occidentalis females significantly reduced a subsequent RNAi response induced by ingestion of cathepsin L dsRNA. The last finding suggests that clathrin heavy chain may be involved in systemic RNAi responses mediated by orally delivered dsRNAs in M. occidentalis.	[Wu, Ke; Hoy, Marjorie A.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Wu, K (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	kewu@ufl.edu			Institute of Food and Agricultural Sciences; Davies, Fischer and Eckes Endowment in Biological Control	Institute of Food and Agricultural Sciences; Davies, Fischer and Eckes Endowment in Biological Control	This project was supported by the Institute of Food and Agricultural Sciences and the Davies, Fischer and Eckes Endowment in Biological Control to MAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACTON SL, 1990, J CELL BIOL, V111, P1419, DOI 10.1083/jcb.111.4.1419; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Aung KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028407; BAZINET C, 1993, GENETICS, V134, P1119; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; FIELD RP, 1985, ENTOMOL EXP APPL, V38, P113, DOI 10.1007/BF00361921; FIELD RP, 1986, HILGARDIA, V54, P1; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; HOY MA, 1985, ANNU REV ENTOMOL, V30, P345, DOI 10.1146/annurev.en.30.010185.002021; HOY MA, 1982, ENTOMOL EXP APPL, V31, P316, DOI 10.1111/j.1570-7458.1982.tb03151.x; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; LEMMON SK, 1987, SCIENCE, V238, P504, DOI 10.1126/science.3116672; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; OHALLORAN TJ, 1992, J CELL BIOL, V118, P1371, DOI 10.1083/jcb.118.6.1371; PAYNE GS, 1985, SCIENCE, V230, P1009, DOI 10.1126/science.2865811; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; ROUSH RT, 1981, J ECON ENTOMOL, V74, P142, DOI 10.1093/jee/74.2.142; Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Wu K, 2014, EXP APPL ACAROL, V63, P171, DOI 10.1007/s10493-014-9772-4; Wu K, 2012, J INVERTEBR PATHOL, V109, P20, DOI 10.1016/j.jip.2011.09.005; Wynant N, 2014, INSECT MOL BIOL, V23, P320, DOI 10.1111/imb.12083	32	15	15	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110874	10.1371/journal.pone.0110874	http://dx.doi.org/10.1371/journal.pone.0110874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329675	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100104
J	Calderon, R; Lucena, C; Trapero-Casas, JL; Zarco-Tejada, PJ; Navas-Cortes, JA				Calderon, Rocio; Lucena, Carlos; Trapero-Casas, Jose L.; Zarco-Tejada, Pablo J.; Navas-Cortes, Juan A.			Soil Temperature Determines the Reaction of Olive Cultivars to Verticillium dahliae Pathotypes	PLOS ONE			English	Article							WATER-STRESS DETECTION; CHLOROPHYLL FLUORESCENCE; ETHYLENE PRODUCTION; TOMATO PLANTS; GAS-EXCHANGE; WILT; PRI; MICROSCLEROTIA; EPIDEMIOLOGY; POPULATIONS	Background: Development of Verticillium wilt in olive, caused by the soil-borne fungus Verticillium dahliae, can be influenced by biotic and environmental factors. In this study we modeled i) the combined effects of biotic factors (i. e., pathotype virulence and cultivar susceptibility) and abiotic factors (i. e., soil temperature) on disease development and ii) the relationship between disease severity and several remote sensing parameters and plant stress indicators. Methodology: Plants of Arbequina and Picual olive cultivars inoculated with isolates of defoliating and non-defoliating V. dahliae pathotypes were grown in soil tanks with a range of soil temperatures from 16 to 32 degrees C. Disease progression was correlated with plant stress parameters (i. e., leaf temperature, steady-state chlorophyll fluorescence, photochemical reflectance index, chlorophyll content, and ethylene production) and plant growth-related parameters (i. e., canopy length and dry weight). Findings: Disease development in plants infected with the defoliating pathotype was faster and more severe in Picual. Models estimated that infection with the defoliating pathotype was promoted by soil temperatures in a range of 16 to 24 degrees C in cv. Picual and of 20 to 24 degrees C in cv. Arbequina. In the non-defoliating pathotype, soil temperatures ranging from 16 to 20 degrees C were estimated to be most favorable for infection. The relationship between stress-related parameters and disease severity determined by multinomial logistic regression and classification trees was able to detect the effects of V. dahliae infection and colonization on water flow that eventually cause water stress. Conclusions: Chlorophyll content, steady-state chlorophyll fluorescence, and leaf temperature were the best indicators for Verticillium wilt detection at early stages of disease development, while ethylene production and photochemical reflectance index were indicators for disease detection at advanced stages. These results provide a better understanding of the differential geographic distribution of V. dahliae pathotypes and to assess the potential effect of climate change on Verticillium wilt development.	[Calderon, Rocio; Lucena, Carlos; Trapero-Casas, Jose L.; Zarco-Tejada, Pablo J.; Navas-Cortes, Juan A.] CSIC, IAS, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Navas-Cortes, JA (corresponding author), CSIC, IAS, Apartado 4084, Cordoba, Spain.	j.navas@csic.es	Navas-Cortes, Juan A./M-2060-2019; Lucena, Carlos/GQP-2277-2022; Zarco-Tejada, Pablo J./AAZ-3704-2020; Navas-Cortes, Juan A/H-3381-2014; Zarco-Tejada, Pablo J./A-6874-2012	Navas-Cortes, Juan A/0000-0001-6480-1104; Zarco-Tejada, Pablo J./0000-0003-1433-6165; Calderon, Rocio/0000-0002-7639-1795	"Consejeria de Economia, Innovacion y Ciencia" of Junta de Andalucia [P08-AGR-03528]; European Social Fund; Spanish "Ministerio de Economia y Competitividad" [AGL-2012-37521, AGL2012-40053-C03-01]; Spanish "Ministerio de Ciencia e Innovacion" [BES-2010-035511]; "Consejo Superior de Investigaciones Cientificas" (CSIC)	"Consejeria de Economia, Innovacion y Ciencia" of Junta de Andalucia; European Social Fund(European Social Fund (ESF)); Spanish "Ministerio de Economia y Competitividad"(Spanish Government); Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); "Consejo Superior de Investigaciones Cientificas" (CSIC)	Financial support for this research was provided by Project P08-AGR-03528 from "Consejeria de Economia, Innovacion y Ciencia" of Junta de Andalucia and the European Social Fund (JANC), and projects AGL-2012-37521 (JANC) and AGL2012-40053-C03-01 (PJZT) from the Spanish "Ministerio de Economia y Competitividad" and the European Social Fund. R. Calderon is a recipient of research fellowship BES-2010-035511 from the Spanish "Ministerio de Ciencia e Innovacion" and C. Lucena was a recipient of a JAE-DOC postdoctoral contract from "Consejo Superior de Investigaciones Cientificas" (CSIC) co-funded by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2007, INTRO CATEGORICAL DA; Ayres P. G., 1978, Water Deficits and Plant Growth. Volume V. Water and Plant Disease, P1; Barranco D, 2004, CULTIVO OLIVO OLIVE; BejaranoAlcazar J, 1996, PLANT DIS, V80, P1233, DOI 10.1094/PD-80-1233; Birem F., 2009, 10 INT VERT S CORF I, P71; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BOWDEN RL, 1991, PHYTOPATHOLOGY, V81, P293, DOI 10.1094/Phyto-81-293; Calderon R, 2013, REMOTE SENS ENVIRON, V139, P231, DOI 10.1016/j.rse.2013.07.031; DEVAY JE, 1974, PHYTOPATHOLOGY, V64, P22, DOI 10.1094/Phyto-64-22; El Omari B, 2001, ANN FOREST SCI, V58, P165, DOI 10.1051/forest:2001116; Everitt BS, 2010, HANDBOOK OF STATISTICAL ANALYSES USING R, 2ND EDITION, P1; FANIZZA G, 1991, EUPHYTICA, V55, P27, DOI 10.1007/BF00022556; Flexas J, 2000, REMOTE SENS ENVIRON, V73, P283, DOI 10.1016/S0034-4257(00)00104-8; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Gamliel A, 1997, PLANT DIS, V81, P469, DOI 10.1094/PDIS.1997.81.5.469; GAMON JA, 1992, REMOTE SENS ENVIRON, V41, P35, DOI 10.1016/0034-4257(92)90059-S; Hau B, 1988, ERWEITERTES ANALYTIS; Hayat S, 2008, J PLANT INTERACT, V3, P297, DOI 10.1080/17429140802320797; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Jackson R D, 1981, SPECTRAL SIGNATURES, P399; Jimenez-Diaz RM, 2012, PLANT DIS, V96, P304, DOI 10.1094/PDIS-06-11-0496; Jimenez-Diaz RM, 2011, PHYTOPATHOLOGY, V101, P304, DOI 10.1094/PHYTO-07-10-0176; Jimenez-Diaz RM, 1998, COMPENDIUM VERTICILL, P13; Levin AG, 2003, PLANT PATHOL, V52, P212, DOI 10.1046/j.1365-3059.2003.00809.x; Lopez-Escudero FJ, 2007, PLANT DIS, V91, P1372, DOI 10.1094/PDIS-91-11-1372; Lopez-Escudero FJ, 2004, EUR J PLANT PATHOL, V110, P79, DOI 10.1023/B:EJPP.0000010150.08098.2d; Lorenzini G, 1997, PLANT SCI, V124, P143, DOI 10.1016/S0168-9452(97)04600-1; Madden L.V., 2007, STUDY PLANT DIS EPID, DOI DOI 10.1094/9780890545058; Maechler M, 2013, R PACKAGE; MARQUARD RD, 1987, HORTSCIENCE, V22, P1327; McKeen Colin D., 1943, CANADIAN JOUR RES SECT C BOT SCI, V21, P95; MENGISTU A, 1987, PLANT DIS, V71, P632, DOI 10.1094/PD-71-0632; Mercado-Blanco J, 2003, PLANT DIS, V87, P1487, DOI 10.1094/PDIS.2003.87.12.1487; Navas-Cortes JA, 2008, PHYTOPATHOLOGY, V98, P167, DOI 10.1094/PHYTO-98-2-0167; NILSSON HE, 1995, ANNU REV PHYTOPATHOL, V33, P489, DOI 10.1146/annurev.py.33.090195.002421; NILSSON HE, 1991, INT J REMOTE SENS, V12, P545, DOI 10.1080/01431169108929671; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Papageorgiou G.C., 1975, BIOENERG PHOTOSYNTH, P319, DOI DOI 10.1016/B978-0-12-294350-8.50011-8; PEGG GF, 1976, PHYSIOL PLANT PATHOL, V8, P279, DOI 10.1016/0048-4059(76)90022-9; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; PINTER PJ, 1979, SCIENCE, V205, P585, DOI 10.1126/science.205.4406.585; PULLMAN GS, 1981, PHYTOPATHOLOGY, V71, P954, DOI 10.1094/Phyto-71-954; Romera FJ, 1999, ANN BOT-LONDON, V83, P51, DOI 10.1006/anbo.1998.0793; Ruggieri Gaetano, 1946, ITALIA GRIC, V83, P369; Sadras VO, 2000, ANN BOT-LONDON, V86, P1007, DOI 10.1006/anbo.2000.1267; SCHREIBER LR, 1963, PHYTOPATHOLOGY, V53, P260; Simko I, 2012, PHYTOPATHOLOGY, V102, P381, DOI 10.1094/PHYTO-07-11-0216; SIT V, 1994, BIOMETRICS INFORM HD, V4; Suarez L, 2008, REMOTE SENS ENVIRON, V112, P560, DOI 10.1016/j.rse.2007.05.009; Suarez L, 2009, REMOTE SENS ENVIRON, V113, P730, DOI 10.1016/j.rse.2008.12.001; Talboys P. W., 1962, T BRIT MYCOLOGICAL S, V45, P280; Thenot F, 2002, INT J REMOTE SENS, V23, P5135, DOI 10.1080/01431160210163100; Therneau T., 2013, RPART RECURSIVE PART; TJAMOS EC, 1995, PHYTOPATHOLOGY, V85, P388, DOI 10.1094/Phyto-85-388; Tsror L, 2011, ISR J PLANT SCI, V59, P59, DOI 10.1560/IJPS.59.1.59; TU JC, 1985, PHYTOPATHOLOGY, V75, P840, DOI 10.1094/Phyto-75-840; Villaobos FJ, 2006, EUR J AGRON, V24, P296, DOI 10.1016/j.eja.2005.10.008; Warnes GR, 2013, GPLOTS VARIOUS R PRO; WILHELM S, 1955, PHYTOPATHOLOGY, V45, P180; Xu F, 2012, PHYTOPARASITICA, V40, P319, DOI 10.1007/s12600-012-0232-6; YADAVA UL, 1986, HORTSCIENCE, V21, P1449; Zarco-Tejada PJ, 2012, REMOTE SENS ENVIRON, V117, P322, DOI 10.1016/j.rse.2011.10.007; Zarco-Tejada PJ, 2009, REMOTE SENS ENVIRON, V113, P1262, DOI 10.1016/j.rse.2009.02.016	64	26	28	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110664	10.1371/journal.pone.0110664	http://dx.doi.org/10.1371/journal.pone.0110664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330093	gold, Green Published			2022-12-27	WOS:000345204100099
J	Cavas-Martinez, F; Fernandez-Pacheco, DG; De la Cruz-Sanchez, E; Martinez, JN; Canavate, FJF; Vega-Estrada, A; Plaza-Puche, AB; Alio, JL				Cavas-Martinez, Francisco; Fernandez-Pacheco, Daniel G.; De la Cruz-Sanchez, Ernesto; Nieto Martinez, Jose; Fernandez Canavate, Francisco J.; Vega-Estrada, Alfredo; Plaza-Puche, Ana B.; Alio, Jorge L.			Geometrical Custom Modeling of Human Cornea In Vivo and Its Use for the Diagnosis of Corneal Ectasia	PLOS ONE			English	Article							PHOTOGRAPHY-BASED SYSTEM; SCHEIMPFLUG PHOTOGRAPHY; INTRASUBJECT REPEATABILITY; KERATOCONUS; TOPOGRAPHY; ANTERIOR; SURGERY; SURFACE; LASER; SHAPE	Aim: To establish a new procedure for 3D geometric reconstruction of the human cornea to obtain a solid model that represents a personalized and in vivo morphology of both the anterior and posterior corneal surfaces. This model is later analyzed to obtain geometric variables enabling the characterization of the corneal geometry and establishing a new clinical diagnostic criterion in order to distinguish between healthy corneas and corneas with keratoconus. Method: The method for the geometric reconstruction of the cornea consists of the following steps: capture and preprocessing of the spatial point clouds provided by the Sirius topographer that represent both anterior and posterior corneal surfaces, reconstruction of the corneal geometric surfaces and generation of the solid model. Later, geometric variables are extracted from the model obtained and statistically analyzed to detect deformations of the cornea. Results: The variables that achieved the best results in the diagnosis of keratoconus were anterior corneal surface area (ROC area: 0.847, p<0.000, std. error: 0.038, 95% CI: 0.777 to 0.925), posterior corneal surface area (ROC area: 0.807, p<0.000, std. error: 0.042, 95% CI: 0,726 to 0,889), anterior apex deviation (ROC area: 0.735, p<0.000, std. error: 0.053, 95% CI: 0.630 to 0.840) and posterior apex deviation (ROC area: 0.891, p<0.000, std. error: 0.039, 95% CI: 0.8146 to 0.9672). Conclusion: Geometric modeling enables accurate characterization of the human cornea. Also, from a clinical point of view, the procedure described has established a new approach for the study of eye-related diseases.	[Cavas-Martinez, Francisco; Fernandez-Pacheco, Daniel G.; Nieto Martinez, Jose; Fernandez Canavate, Francisco J.] Tech Univ Cartagena, Dept Graph Express, Cartagena, Spain; [De la Cruz-Sanchez, Ernesto] Univ Murcia, Dept Phys Act & Sport, Murcia, Spain; [Vega-Estrada, Alfredo; Plaza-Puche, Ana B.; Alio, Jorge L.] Vissum Corp Oftalmol, Alicante, Spain	Universidad Politecnica de Cartagena; University of Murcia; VISSUM	Cavas-Martinez, F (corresponding author), Tech Univ Cartagena, Dept Graph Express, Cartagena, Spain.	francisco.cavas@upct.es	Fernández-Pacheco, Daniel G./K-9725-2015; Cavas-Martínez, Francisco/L-3143-2014; De la Cruz-Sánchez, Ernesto/F-7406-2010	Fernández-Pacheco, Daniel G./0000-0002-1504-8475; Cavas-Martínez, Francisco/0000-0002-8391-0688; De la Cruz-Sánchez, Ernesto/0000-0002-4718-7058				Alastrue V, 2006, J BIOMECH ENG-T ASME, V128, P150, DOI 10.1115/1.2132368; Alessio G, 2001, OPHTHALMOLOGY, V108, P1695, DOI 10.1016/S0161-6420(01)00706-0; Alio JL, 2006, J REFRACT SURG, V22, P539; Ambrosio R, 2011, J REFRACT SURG, V27, P753, DOI 10.3928/1081597X-20110721-01; Ang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065559; Ares M, 2006, APPL OPTICS, V45, P6954, DOI 10.1364/AO.45.006954; Auvinet E, 2012, IEEE ENG MED BIO, P5302, DOI 10.1109/EMBC.2012.6347191; Bao FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073412; Belin MW, 2009, CLIN EXP OPHTHALMOL, V37, P14, DOI 10.1111/j.1442-9071.2008.01821.x; Cheng RKC, 2014, INSIDE RHINOCEROS, V5; Ding SL, 2010, COMPUT MED IMAG GRAP, V34, P114, DOI 10.1016/j.compmedimag.2009.07.005; [段春岳 Duan Chunyue], 2012, [医用生物力学, Journal of Medical Biomechanics], V27, P159; Dubbelman M, 2006, VISION RES, V46, P993, DOI 10.1016/j.visres.2005.09.021; Elsheikh Ahmed, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P85, DOI 10.1080/10255840600976013; Han ZL, 2013, J REFRACT SURG, V29, P282, DOI 10.3928/1081597X-20130318-08; Kang JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070673; Klyce SD, 2004, J REFRACT SURG, V20, pS537; Levy D, 2004, OPHTHALMOLOGY, V111, P867, DOI 10.1016/j.ophtha.2003.12.024; Maldonado MJ, 2006, OPHTHALMOLOGY, V113, P1918, DOI 10.1016/j.ophtha.2006.05.053; Martinez-Finkelshtein A, 2011, INVEST OPHTH VIS SCI, V52, P4963, DOI 10.1167/iovs.10-6774; Merklinger HM, 1993, FOCUSING VIEW CAMERA; Montalban R, 2013, GRAEF ARCH CLIN EXP, V251, P1547, DOI 10.1007/s00417-013-2261-3; Montalban R, 2013, J CATARACT REFR SURG, V39, P211, DOI 10.1016/j.jcrs.2012.10.033; Montalban R, 2012, J CATARACT REFR SURG, V38, P971, DOI 10.1016/j.jcrs.2011.12.029; Navarro R, 2006, J OPT SOC AM A, V23, P219, DOI 10.1364/JOSAA.23.000219; Pandolfi A, 2009, ENG COMPUT-GERMANY, V25, P15, DOI 10.1007/s00366-008-0102-5; Piegl L., 1997, MONOGRAPHS VISUAL CO; Pinero DP, 2010, J CATARACT REFR SURG, V36, P814, DOI 10.1016/j.jcrs.2009.11.012; Pinero DP, 2009, J CATARACT REFR SURG, V35, P113, DOI 10.1016/j.jcrs.2008.10.010; Pinero DP, 2013, SEMIN OPHTHALMOL; Rabinowitz Y S, 1989, Refract Corneal Surg, V5, P400; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Ramos-Lopez D, 2011, OPTOMETRY VISION SCI, V88, P1220, DOI 10.1097/OPX.0b013e3182279ff8; Reiffel AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056506; Ribeiro FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046780; Rondeau MJ, 2004, J REFRACT SURG, V20, P454; Roy AS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002934; Sanchez P, 2014, J CATARACT REFR SURG, V40, P905, DOI 10.1016/j.jcrs.2014.03.020; Savini G, 2011, J CATARACT REFR SURG, V37, P302, DOI 10.1016/j.jcrs.2010.07.039; Smolek MK, 2003, INVEST OPHTH VIS SCI, V44, P4676, DOI 10.1167/iovs.03-0190; Studer HP, 2013, J BIOMECH, V46, P751, DOI 10.1016/j.jbiomech.2012.11.018; Vega-Estrada A, 2013, AM J OPHTHALMOL, V155, P575, DOI 10.1016/j.ajo.2012.08.020; Vryghem JC, 2010, J CATARACT REFR SURG, V36, P442, DOI 10.1016/j.jcrs.2009.09.030; Wang QM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045607; Wang XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059109; WILSON SE, 1991, CORNEA, V10, P2; Zheng SL, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.065002	47	31	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110249	10.1371/journal.pone.0110249	http://dx.doi.org/10.1371/journal.pone.0110249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329896	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100051
J	Heo, A; Jang, HJ; Sung, JS; Park, W				Heo, Aram; Jang, Hyun-Jin; Sung, Jung-Suk; Park, Woojun			Global Transcriptome and Physiological Responses of Acinetobacter oleivorans DR1 Exposed to Distinct Classes of Antibiotics	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; DNA-DAMAGE; PSEUDOMONAS-AERUGINOSA; GENOME SEQUENCE; REGULATORY RNAS; STRESS-RESPONSE; BACTERIAL SHAPE; SOS RESPONSE; PROTEIN	The effects of antibiotics on environment-originated nonpathogenic Acinetobacter species have been poorly explored. To understand the antibiotic-resistance mechanisms that function in nonpathogenic Acinetobacter species, we used an RNA-sequencing (RNA-seq) technique to perform global gene-expression profiling of soil-borne Acinetobacter oleivorans DR1 after exposing the bacteria to 4 classes of antibiotics (ampicillin, Amp; kanamycin, Km; tetracycline, Tc; norfloxacin, Nor). Interestingly, the well-known two global regulators, the soxR and the rpoE genes are present among 41 commonly upregulated genes under all 4 antibiotic-treatment conditions. We speculate that these common genes are essential for antibiotic resistance in DR1. Treatment with the 4 antibiotics produced diverse physiological and phenotypic changes. Km treatment induced the most dramatic phenotypic changes. Examination of mutation frequency and DNA-repair capability demonstrated the induction of the SOS response in Acinetobacter especially under Nor treatment. Based on the RNA-seq analysis, the glyoxylate-bypass genes of the citrate cycle were specifically upregulated under Amp treatment. We also identified newly recognized non-coding small RNAs of the DR1 strain, which were also confirmed by Northern blot analysis. These results reveal that treatment with antibiotics of distinct classes differentially affected the gene expression and physiology of DR1 cells. This study expands our understanding of the molecular mechanisms of antibiotic-stress response of environment-originated bacteria and provides a basis for future investigations.	[Heo, Aram; Park, Woojun] Korea Univ, Dept Environm Sci & Ecol Engn, Lab Mol Environm Microbiol, Seoul, South Korea; [Jang, Hyun-Jin; Sung, Jung-Suk] Dongguk Univ, Dept Life Sci, Seoul, South Korea	Korea University; Dongguk University	Park, W (corresponding author), Korea Univ, Dept Environm Sci & Ecol Engn, Lab Mol Environm Microbiol, Seoul, South Korea.	wpark@korea.ac.kr			Mid-career Researcher Program through an NRF2014R1A2A2A05007010; Mid-career Researcher Program through NRF - Ministry of Science, ICT & Future Planning (MSIP) [2014R1A2A2A05007010]	Mid-career Researcher Program through an NRF2014R1A2A2A05007010; Mid-career Researcher Program through NRF - Ministry of Science, ICT & Future Planning (MSIP)	This work was supported by the Mid-career Researcher Program through an NRF grant (2014R1A2A2A05007010) funded by the Ministry of Science, ICT & Future Planning (MSIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Alonso A, 2001, ENVIRON MICROBIOL, V3, P1, DOI 10.1046/j.1462-2920.2001.00161.x; Aranda J, 2011, J BACTERIOL, V193, P3740, DOI 10.1128/JB.00389-11; Baharoglu Z, 2011, ANTIMICROB AGENTS CH, V55, P2438, DOI 10.1128/AAC.01549-10; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Braga PC, 2011, METHODS MOL BIOL, V736, P391, DOI 10.1007/978-1-61779-105-5_23; BRAUN V, 1979, J SUPRAMOL STR CELL, V10, P329, DOI 10.1002/jss.400100305; Chen SH, 2012, CAN J MICROBIOL, V58, P158, DOI [10.1139/W11-121, 10.1139/w11-121]; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Eisenstadt Eric, 1994, P297; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Flechard M, 2012, J BACTERIOL, V194, P4550, DOI 10.1128/JB.00089-12; Forster DH, 1998, EUR J CLIN MICROBIOL, V17, P73, DOI 10.1007/BF01682159; Frirdich E, 2013, CURR OPIN MICROBIOL, V16, P767, DOI 10.1016/j.mib.2013.09.005; Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Gupta V, 2010, ANN BURNS FIRE DISAS, V26, P189; Hare JM, 2006, APPL ENVIRON MICROB, V72, P4036, DOI 10.1128/AEM.02774-05; Hare JM, 2012, MICROBIOL-SGM, V158, P601, DOI 10.1099/mic.0.054668-0; Hartzell Joshua D, 2007, MedGenMed, V9, P4; Hong H, 2014, MICROB ECOL, V67, P369, DOI 10.1007/s00248-013-0343-8; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; IDE H, 1994, BIOCHEMISTRY-US, V33, P7842, DOI 10.1021/bi00191a011; JONES C, 1985, P NATL ACAD SCI USA, V82, P6045, DOI 10.1073/pnas.82.18.6045; Jung J, 2011, APPL ENVIRON MICROB, V77, P7418, DOI 10.1128/AEM.05231-11; Jung J, 2010, J BACTERIOL, V192, P4794, DOI 10.1128/JB.00722-10; Kang YS, 2010, ENVIRON MICROBIOL, V12, P1304, DOI 10.1111/j.1462-2920.2010.02175.x; Kelley WL, 2006, MOL MICROBIOL, V62, P1228, DOI 10.1111/j.1365-2958.2006.05444.x; Kim J, 2013, J MICROBIOL BIOTECHN, V23, P1293, DOI 10.4014/jmb.1307.07059; Kindrachuk KN, 2011, ANTIMICROB AGENTS CH, V55, P1874, DOI 10.1128/AAC.00935-10; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Kummerer K, 2003, J ANTIMICROB CHEMOTH, V52, P5, DOI 10.1093/jac/dkg293; Lemuth K, 2008, APPL ENVIRON MICROB, V74, P7002, DOI 10.1128/AEM.01327-08; Li KF, 2012, FEMS MICROBIOL LETT, V335, P140, DOI 10.1111/j.1574-6968.2012.02646.x; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051; Manchanda V, 2010, J GLOB INFECT DIS, V2, P291, DOI 10.4103/0974-777X.68538; Marr AK, 2007, MICROBIOL-SGM, V153, P474, DOI 10.1099/mic.0.2006/002519-0; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; PHILLIPS I, 1987, J ANTIMICROB CHEMOTH, V20, P631, DOI 10.1093/jac/20.5.631; Pitout JDD, 1997, AM J MED, V103, P51, DOI 10.1016/S0002-9343(97)00044-2; Poirel L, 2011, IUBMB LIFE, V63, P1061, DOI 10.1002/iub.532; Prigent-Combaret C, 2012, ENVIRON MICROBIOL, V14, P2645, DOI 10.1111/j.1462-2920.2012.02802.x; Rui B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-122; Schroeter R, 2011, PROTEOMICS, V11, P2851, DOI 10.1002/pmic.201000461; Sharma R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093833; Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011; TOWNER KJ, 1991, FEMS SYMP, V57, P1; Turner RD, 2014, MOL MICROBIOL, V91, P862, DOI 10.1111/mmi.12513; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Yao ZZ, 2012, MOL CELL, V48, P705, DOI 10.1016/j.molcel.2012.09.016; Yi H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr617; Yonath A, 2004, ANNU REV MICROBIOL, V58, P233, DOI 10.1146/annurev.micro.58.030603.123822; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	59	27	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110215	10.1371/journal.pone.0110215	http://dx.doi.org/10.1371/journal.pone.0110215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330344	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100047
J	Zanchi, A; Tappy, L; Le, KA; Bortolotti, M; Theumann, N; Halabi, G; Gauthier, T; Mathieu, C; Tremblay, S; Bertrand, PC; Burnier, M; Teta, D				Zanchi, Anne; Tappy, Luc; Le, Kim-Anne; Bortolotti, Murielle; Theumann, Nicolas; Halabi, Georges; Gauthier, Thierry; Mathieu, Claudine; Tremblay, Sylvie; Bertrand, Pauline Coti; Burnier, Michel; Teta, Daniel			Pioglitazone Improves Fat Distribution, the Adipokine Profile and Hepatic Insulin Sensitivity in Non-Diabetic End-Stage Renal Disease Subjects on Maintenance Dialysis: A Randomized Cross-Over Pilot Study	PLOS ONE			English	Article							TYPE-2 DIABETIC-PATIENTS; CHRONIC-HEMODIALYSIS PATIENTS; PERITONEAL-DIALYSIS; ADIPONECTIN RATIO; CARDIOVASCULAR MORTALITY; INDEPENDENT PREDICTOR; LEPTIN; RESISTANCE; GLUCOSE; ROSIGLITAZONE	Background: Fat redistribution, increased inflammation and insulin resistance are prevalent in non-diabetic subjects treated with maintenance dialysis. The aim of this study was to test whether pioglitazone, a powerful insulin sensitizer, alters body fat distribution and adipokine secretion in these subjects and whether it is associated with improved insulin sensitivity. Trial Design: This was a double blind cross-over study with 16 weeks of pioglitazone 45 mg vs placebo involving 12 subjects. Methods: At the end of each phase, body composition (anthropometric measurements, dual energy X-ray absorptometry (DEXA), abdominal CT), hepatic and muscle insulin sensitivity (2-step hyperinsulinemic euglycemic clamp with 2H2-glucose) were measured and fasting blood adipokines and cardiometabolic risk markers were monitored. Results: Four months treatment with pioglitazone had no effect on total body weight or total fat but decreased the visceral/sub-cutaneous adipose tissue ratio by 16% and decreased the leptin/adiponectin (L/A) ratio from 3.63x10(-3) to 0.76x10(-3). This was associated with a 20% increase in hepatic insulin sensitivity without changes in muscle insulin sensitivity, a 12% increase in HDL cholesterol and a 50% decrease in CRP. Conclusions/Limitations: Pioglitazone significantly changes the visceral-subcutaneous fat distribution and plasma L/A ratio in non diabetic subjects on maintenance dialysis. This was associated with improved hepatic insulin sensitivity and a reduction of cardio-metabolic risk markers. Whether these effects may improve the outcome of non diabetic end-stage renal disease subjects on maintenance dialysis still needs further evaluation.	[Zanchi, Anne; Halabi, Georges; Gauthier, Thierry; Mathieu, Claudine; Tremblay, Sylvie; Burnier, Michel; Teta, Daniel] CHU Vaudois, Serv Nephrol, Dept Med, Univ Lausanne Hosp, CH-1011 Lausanne, Switzerland; [Tappy, Luc; Le, Kim-Anne; Bortolotti, Murielle] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Zanchi, Anne; Tappy, Luc; Bertrand, Pauline Coti] CHU Vaudois, Univ Lausanne Hosp, Dept Med, Serv Endocrinol Diabet & Metab, CH-1011 Lausanne, Switzerland; [Theumann, Nicolas] CHU Vaudois, Dept Radiol, Univ Lausanne Hosp, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Zanchi, A (corresponding author), CHU Vaudois, Serv Nephrol, Dept Med, Univ Lausanne Hosp, CH-1011 Lausanne, Switzerland.	Anne.Zanchi@chuv.ch	Tappy, Luc/A-8911-2017	Tappy, Luc/0000-0001-8469-4692	Service of Nephrology at the Lausanne University Hospital	Service of Nephrology at the Lausanne University Hospital	Funding of this study was internal to the Service of Nephrology at the Lausanne University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Investigators performed completely the study design, data collection and analysis and prepared the manuscript.	Abe M, 2010, EXPERT OPIN PHARMACO, V11, P1611, DOI 10.1517/14656566.2010.495119; Axelsson J, 2004, AM J CLIN NUTR, V80, P1222, DOI 10.1093/ajcn/80.5.1222; Bajaj M, 2004, J CLIN ENDOCR METAB, V89, P200, DOI 10.1210/jc.2003-031315; Barazzoni R, 2008, CLIN NUTR, V27, P142, DOI 10.1016/j.clnu.2007.06.013; Basu R, 2008, DIABETES, V57, P24, DOI 10.2337/db07-0827; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; DEBODO RC, 1963, RECENT PROG HORM RES, V19, P445; DEFRONZO RA, 1978, J CLIN INVEST, V62, P425, DOI 10.1172/JCI109144; Diez JJ, 2009, AM J NEPHROL, V30, P244, DOI 10.1159/000221147; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Hung AM, 2011, CONTRIB NEPHROL, V171, P127, DOI 10.1159/000327177; Hung AM, 2011, CLIN J AM SOC NEPHRO, V6, P767, DOI 10.2215/CJN.08070910; JALLUT D, 1990, JPEN-PARENTER ENTER, V14, P563, DOI 10.1177/0148607190014006563; Kallen CB, 1996, P NATL ACAD SCI USA, V93, P5793, DOI 10.1073/pnas.93.12.5793; Kobayashi S, 2005, AM J KIDNEY DIS, V45, P275, DOI 10.1053/j.ajkd.2004.09.034; Koenen TB, 2009, J CLIN ENDOCR METAB, V94, P4453, DOI 10.1210/jc.2009-0517; Li Y, 2012, PERITON DIALYSIS INT, V32, P507, DOI 10.3747/pdi.2011.00116; Lin SH, 2003, AM J KIDNEY DIS, V42, P774, DOI 10.1016/S0272-6386(03)00844-8; LIVESEY G, 1988, AM J CLIN NUTR, V47, P608, DOI 10.1093/ajcn/47.4.608; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Manley HJ, 2003, PHARMACOTHERAPY, V23, P861, DOI 10.1592/phco.23.7.861.32727; Miyazaki Y, 2004, J CLIN ENDOCR METAB, V89, P4312, DOI 10.1210/jc.2004-0190; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Nolan JJ, 1996, DIABETES, V45, P1276, DOI 10.2337/diabetes.45.9.1276; Norata GD, 2007, STROKE, V38, P2844, DOI 10.1161/STROKEAHA.107.485540; Odamaki M, 1999, NEPHROL DIAL TRANSPL, V14, P2427, DOI 10.1093/ndt/14.10.2427; Postorino M, 2009, J AM COLL CARDIOL, V53, P1265, DOI 10.1016/j.jacc.2008.12.040; Saraf N, 2012, J PHARM PHARMACOL, V64, P161, DOI 10.1111/j.2042-7158.2011.01366.x; Satoh N, 2004, DIABETES CARE, V27, P2488, DOI 10.2337/diacare.27.10.2488; Schneiter P, 1999, METABOLISM, V48, P1260, DOI 10.1016/S0026-0495(99)90265-2; Shinohara K, 2002, J AM SOC NEPHROL, V13, P1894, DOI 10.1097/01.ASN.0000019900.87535.43; Stenvinkel P, 2004, KIDNEY INT, V65, P274, DOI 10.1111/j.1523-1755.2004.00370.x; Teta D, 2008, KIDNEY INT, V73, pS112, DOI 10.1038/sj.ki.5002611; Teta D, 2012, J RENAL NUTR, V22, P81, DOI 10.1053/j.jrn.2011.10.029; Tonelli J, 2004, DIABETES, V53, P1621, DOI 10.2337/diabetes.53.6.1621; van Wijk JPH, 2005, ANN INTERN MED, V143, P337, DOI 10.7326/0003-4819-143-5-200509060-00009; Weigle DS, 1997, J CLIN ENDOCR METAB, V82, P561, DOI 10.1210/jc.82.2.561; Wong TYH, 2005, AM J KIDNEY DIS, V46, P713, DOI 10.1053/j.ajkd.2005.06.020; Yun JE, 2011, ENDOCR J, V58, P807, DOI 10.1507/endocrj.K11E-084; Zanchi A, 2004, J CLIN ENDOCR METAB, V89, P1140, DOI 10.1210/jc.2003-031526; Zanchi A, 2010, DIABETOLOGIA, V53, P1568, DOI 10.1007/s00125-010-1756-2	41	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109134	10.1371/journal.pone.0109134	http://dx.doi.org/10.1371/journal.pone.0109134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330088	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800015
J	Bender, MG; Machado, GR; Silva, PJD; Floeter, SR; Monteiro-Netto, C; Luiz, OJ; Ferreira, CEL				Bender, Mariana G.; Machado, Gustavo R.; de Azevedo Silva, Paulo Jose; Floeter, Sergio R.; Monteiro-Netto, Cassiano; Luiz, Osmar J.; Ferreira, Carlos E. L.			Local Ecological Knowledge and Scientific Data Reveal Overexploitation by Multigear Artisanal Fisheries in the Southwestern Atlantic	PLOS ONE			English	Article							SHIFTING BASE-LINES; GULF-OF-CALIFORNIA; COMMUNITY STRUCTURE; CORAL-REEFS; FISH; IMPACTS; TRENDS; BRAZIL; ARCHIPELAGO; EXTINCTION	In the last decades, a number of studies based on historical records revealed the diversity loss in the oceans and human-induced changes to marine ecosystems. These studies have improved our understanding of the human impacts in the oceans. They also drew attention to the shifting baseline syndrome and the importance of assessing appropriate sources of data in order to build the most reliable environmental baseline. Here we amassed information from artisanal fishermen's local ecological knowledge, fisheries landing data and underwater visual census to assess the decline of fish species in Southeastern Brazil. Interviews with 214 fishermen from line, beach seine and spearfishing revealed a sharp decline in abundance of the bluefish Pomatomus saltatrix, the groupers Epinephelus marginatus, Mycteroperca acutirostris, M. bonaci and M. microlepis, and large parrotfishes in the past six decades. Fisheries landing data from a 16-year period support the decline of bluefish as pointed by fishermen's local knowledge, while underwater visual census campaigns show reductions in groupers' abundance and a sharp population decline of the Brazilian endemic parrotfish Scarus trispinosus. Despite the marked decline of these fisheries, younger and less experienced fishermen recognized fewer species as overexploited and fishing sites as depleted than older and more experienced fishermen, indicating the occurrence of the shifting baseline syndrome. Here we show both the decline of multigear fisheries catches - combining anecdotal and scientific data - as well as changes in environmental perceptions over generations of fishermen. Managing ocean resources requires looking into the past, and into traditional knowledge, bringing historical baselines to the present and improving public awareness.	[Bender, Mariana G.; Floeter, Sergio R.] Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Machado, Gustavo R.; Monteiro-Netto, Cassiano; Ferreira, Carlos E. L.] Univ Fed Fluminense, Dept Biol Marinha, Niteroi, RJ, Brazil; [de Azevedo Silva, Paulo Jose] Fundacao Inst Pesca, Arraial Do Cabo, RJ, Brazil; [Luiz, Osmar J.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Universidade Federal de Santa Catarina (UFSC); Universidade Federal Fluminense; Macquarie University	Ferreira, CEL (corresponding author), Univ Fed Fluminense, Dept Biol Marinha, Niteroi, RJ, Brazil.	carlosferreira@id.uff.br	Machado, Gustavo/F-1009-2010; Floeter, S. R./B-1438-2012	Machado, Gustavo/0000-0001-7552-6144; Floeter, S. R./0000-0002-3201-6504; Ferreira, Carlos Eduardo/0000-0002-4311-0491; Luiz, Osmar/0000-0002-6995-6524	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - www.cnpq.org) provided individual grants to CELF, SRF and CMN. CNPq, Fundacao do Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ - www.faperj.br) and EcoHub (www.ecohub.com.br) supported field sampling. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth CH, 2008, BIOL CONSERV, V141, P848, DOI 10.1016/j.biocon.2008.01.006; Barrett JH, 2004, P ROY SOC B-BIOL SCI, V271, P2417, DOI 10.1098/rspb.2004.2885; Barrett JH, 1999, J ARCHAEOL SCI, V26, P353, DOI 10.1006/jasc.1998.0336; Bender MG, 2013, ORYX, V47, P259, DOI 10.1017/S003060531100144X; Bender MG, 2013, FISHERIES MANAG ECOL, V20, P58, DOI 10.1111/fme.12006; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Bohnsack J.A., 1988, NOAA NMFS TECHNICAL; Boudreau SA, 2010, MAR ECOL PROG SER, V403, P181, DOI 10.3354/meps08473; Brito R, 1999, MODERNIDADE TRADICAO; Brook R, 2008, BIODIVERS CONSERV, V17, P3501, DOI 10.1007/s10531-008-9445-x; Bunce M, 2008, OCEAN COAST MANAGE, V51, P285, DOI 10.1016/j.ocecoaman.2007.09.006; Craig MT, 2007, ICHTHYOL RES, V54, P1, DOI 10.1007/s10228-006-0367-x; Drew JA, 2005, CONSERV BIOL, V19, P1286, DOI 10.1111/j.1523-1739.2005.00158.x; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; ERLANDSON JM, 2004, VOYAGES DISCOVERY AR, P51; Erlandson JM, 2010, ANNU REV MAR SCI, V2, P231, DOI 10.1146/annurev.marine.010908.163749; Felizola Freire Katia Meirelle, 2009, Pan-American Journal of Aquatic Sciences, V4, P96; Ferreira CEL, 2006, J FISH BIOL, V69, P1533, DOI 10.1111/j.1095-8649.2006.01220.x; Ferreira CEL, 1999, CORAL REEFS, V18, P352, DOI 10.1007/s003380050211; Floeter SR, 2007, ENVIRON BIOL FISH, V78, P147, DOI 10.1007/s10641-006-9084-6; Floeter SR, 2006, BIOL CONSERV, V128, P391, DOI 10.1016/j.biocon.2005.10.005; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Fredou T, 2004, CYBIUM, V28, P274; Freire KMF, 2010, FISH RES, V105, P57, DOI 10.1016/j.fishres.2010.02.008; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Humphries P, 2009, BIOSCIENCE, V59, P673, DOI 10.1525/bio.2009.59.8.9; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; IUCN, 2013, IUCN RED LIST THREAT; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; JOHANNES RE, 1981, B MAR SCI, V31, P673; Johannes RE, 2000, FISH FISH, V1, P257, DOI 10.1046/j.1467-2979.2000.00019.x; Jones JPG, 2008, J APPL ECOL, V45, P1205, DOI 10.1111/j.1365-2664.2008.01487.x; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Luiz OJ, 2011, BIOL CONSERV, V144, P2873, DOI 10.1016/j.biocon.2011.08.004; Silvano RAM, 2010, HYDROBIOLOGIA, V637, P3, DOI 10.1007/s10750-009-9979-2; McClenachan L, 2009, CONSERV BIOL, V23, P636, DOI 10.1111/j.1523-1739.2008.01152.x; Morales A, 1994, CUEVA NERJA PROV MAL; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; O'Donnell KP, 2010, ANIM CONSERV, V13, P526, DOI 10.1111/j.1469-1795.2010.00377.x; Palumbi SR, 2003, ECOL APPL, V13, pS146; Papworth SK, 2009, CONSERVATION LETT; Paterson B, 2010, ANIM CONSERV, V13, P536, DOI 10.1111/j.1469-1795.2010.00419.x; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Rezende Sérgio de Magalhães, 2004, Braz. j. oceanogr., V52, P107, DOI 10.1590/S1679-87592004000200003; Rittenhouse CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011938; Roberts C., 2000, WWF ENDANGERED SEAS; Roberts CM, 2003, ORYX, V37, P166, DOI 10.1017/S0030605303000358; Saenz-Arroyo A, 2006, FISH FISH, V7, P128, DOI 10.1111/j.1467-2979.2006.00214.x; Saenz-Arroyo A, 2005, FISH FISH, V6, P121, DOI 10.1111/j.1467-2979.2005.00185.x; Saenz-Arroyo A, 2005, P ROY SOC B-BIOL SCI, V272, P1957, DOI 10.1098/rspb.2005.3175; Shackeroff J.M., 2007, CONSERV SOC, V5, P343; Silvano RAM, 2006, ENVIRON BIOL FISH, V76, P371, DOI 10.1007/s10641-006-9043-2; Smith I, 2005, EXPLOITATION AND CULTURAL IMPORTANCE OF SEA MAMMALS, P6; Turvey ST, 2010, CONSERV BIOL, V24, P778, DOI 10.1111/j.1523-1739.2009.01395.x; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; van der Hoeven Christiaan A., 2004, Journal for Nature Conservation (Jena), V12, P193, DOI 10.1016/j.jnc.2004.06.003; Wing SR, 2001, CORAL REEFS, V20, P1; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	66	108	108	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110332	10.1371/journal.pone.0110332	http://dx.doi.org/10.1371/journal.pone.0110332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333661	Green Published, gold			2022-12-27	WOS:000346766200115
J	Goulart, CO; Juergensen, S; Souto, A; Oliveira, JT; de Lima, S; Tonda-Turo, C; Marques, SA; de Almeida, FM; Martinez, AMB				Goulart, Camila Oliveira; Juergensen, Sofia; Souto, Allana; Oliveira, Julia Teixeira; de Lima, Silmara; Tonda-Turo, Chiara; Marques, Suelen Adriani; de Almeida, Fernanda Martins; Blanco Martinez, Ana Maria			A Combination of Schwann-Cell Grafts and Aerobic Exercise Enhances Sciatic Nerve Regeneration	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SPINAL-CORD-INJURY; AXONAL REGENERATION; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTORS; PERIPHERAL-NERVES; RATS; REPAIR; MICE; BRAIN	Background: Despite the regenerative potential of the peripheral nervous system, severe nerve lesions lead to loss of target-organ innervation, making complete functional recovery a challenge. Few studies have given attention to combining different approaches in order to accelerate the regenerative process. Objective: Test the effectiveness of combining Schwann-cells transplantation into a biodegradable conduit, with treadmill training as a therapeutic strategy to improve the outcome of repair after mouse nerve injury. Methods: Sciatic nerve transection was performed in adult C57BL/6 mice; the proximal and distal stumps of the nerve were sutured into the conduit. Four groups were analyzed: acellular grafts (DMEM group), Schwann cell grafts (3x10(5)/2 mu L; SC group), treadmill training (TMT group), and treadmill training and Schwann cell grafts (TMT + SC group). Locomotor function was assessed weekly by Sciatic Function Index and Global Mobility Test. Animals were anesthetized after eight weeks and dissected for morphological analysis. Results: Combined therapies improved nerve regeneration, and increased the number of myelinated fibers and myelin area compared to the DMEM group. Motor recovery was accelerated in the TMT + SC group, which showed significantly better values in sciatic function index and in global mobility test than in the other groups. The TMT + SC group showed increased levels of trophic-factor expression compared to DMEM, contributing to the better functional outcome observed in the former group. The number of neurons in L4 segments was significantly higher in the SC and TMT + SC groups when compared to DMEM group. Counts of dorsal root ganglion sensory neurons revealed that TMT group had a significant increased number of neurons compared to DMEM group, while the SC and TMT + SC groups had a slight but not significant increase in the total number of motor neurons. Conclusion: These data provide evidence that this combination of therapeutic strategies can significantly improve functional and morphological recovery after sciatic injury.	[Goulart, Camila Oliveira; Juergensen, Sofia; Souto, Allana; Oliveira, Julia Teixeira; de Lima, Silmara; de Almeida, Fernanda Martins; Blanco Martinez, Ana Maria] Univ Fed Rio de Janeiro, Lab Neurodegeneracao & Reparo, Dept Patol, Fac Med,HUCFF, Rio de Janeiro, RJ, Brazil; [Tonda-Turo, Chiara] Politecn Torino, Dept Mech, Turin, Italy; [Marques, Suelen Adriani] UFF, Lab Regeneracao Neural & Funcao, Dept Neurobiol, Inst Biol, Rio De Janeiro, Brazil; [de Almeida, Fernanda Martins] Polo Univ Macae, UFRJ, Macae, RJ, Brazil	Universidade Federal do Rio de Janeiro; Polytechnic University of Turin; Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro	Martinez, AMB (corresponding author), Univ Fed Rio de Janeiro, Lab Neurodegeneracao & Reparo, Dept Patol, Fac Med,HUCFF, Rio de Janeiro, RJ, Brazil.	martinez@histo.ufrj.br	MARTINEZ, Ana/AAE-8358-2019		FAPERJ; CNPq; CAPES; Ministerio da Saude	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministerio da Saude	This study was supported by FAPERJ (http://www.faperj.br/); CNPq (http://www.cnpq.br/); CAPES (http://www.capes.gov.br/); Ministerio da Saude (http://portalsaude.saude.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; Angius D, 2012, BIOMATERIALS, V33, P8034, DOI 10.1016/j.biomaterials.2012.07.056; Berchtold NC, 2005, NEUROSCIENCE, V133, P853, DOI 10.1016/j.neuroscience.2005.03.026; Berrocal YA, 2013, J NEUROSURG, V119, P720, DOI 10.3171/2013.4.JNS121189; Bobinski F, 2011, NEUROSCIENCE, V194, P337, DOI 10.1016/j.neuroscience.2011.07.075; Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277; Boyd JG, 2003, EXP NEUROL, V183, P610, DOI 10.1016/S0014-4886(03)00183-3; Bryan DJ, 1996, J RECONSTR MICROSURG, V12, P439, DOI 10.1055/s-2007-1006616; Chalfoun CT, 2006, J CELL MOL MED, V10, P309, DOI 10.1111/j.1582-4934.2006.tb00401.x; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Chen J, 2010, ADV MED SCI-POLAND, V55, P32, DOI 10.2478/v10039-010-0020-9; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Dai LG, 2013, CELL TRANSPLANT, V22, P2029, DOI 10.3727/096368912X658953; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; English AW, 2011, EUR J NEUROSCI, V33, P2265, DOI 10.1111/j.1460-9568.2011.07724.x; Felix SP, 2013, MICROSURG, V33, P468, DOI 10.1002/micr.22109; Frattini F, 2012, TISSUE ENG PT A, V18, P2030, DOI [10.1089/ten.tea.2011.0496, 10.1089/ten.TEA.2011.0496]; Gantus MAV, 2011, MOL CELL ENDOCRINOL, V337, P71, DOI 10.1016/j.mce.2011.02.001; Gordon T, 2010, J COMMUN DISORD, V43, P265, DOI 10.1016/j.jcomdis.2010.04.003; Gordon T, 2009, NEUROSURGERY, V65, pA132, DOI 10.1227/01.NEU.0000335650.09473.D3; Griffin JW, 2010, EXP NEUROL, V223, P60, DOI 10.1016/j.expneurol.2009.12.033; Gu Y, 2012, BIOMATERIALS, V33, P6672, DOI 10.1016/j.biomaterials.2012.06.006; Hall S, 2005, J BONE JOINT SURG BR, V87B, P1309, DOI 10.1302/0301-620X.87B10.16700; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; IDE C, 1983, BRAIN RES, V288, P61, DOI 10.1016/0006-8993(83)90081-1; IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0; Ilha J, 2008, NEUROREHAB NEURAL RE, V22, P355, DOI 10.1177/1545968307313502; Inserra MM, 1998, MICROSURG, V18, P119, DOI 10.1002/(SICI)1098-2752(1998)18:2<119::AID-MICR10>3.3.CO;2-Z; Johnson EO, 2005, INJURY, V36, pS24, DOI 10.1016/j.injury.2005.10.012; Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030; KIM DH, 1994, J NEUROSURG, V80, P254, DOI 10.3171/jns.1994.80.2.0254; Krityakiarana W, 2010, INT J NEUROSCI, V120, P280, DOI 10.3109/00207450903222741; Lopes FRP, 2013, NEUROSCIENCE, V230, P184, DOI 10.1016/j.neuroscience.2012.10.025; Lopes FRP, 2006, EXP NEUROL, V198, P457, DOI 10.1016/j.expneurol.2005.12.019; Lundborg G, 2003, J PERIPHER NERV SYST, V8, P209, DOI 10.1111/j.1085-9489.2003.03027.x; Luo JA, 2011, GLIA, V59, P424, DOI 10.1002/glia.21111; Madduri S, 2010, J PERIPHER NERV SYST, V15, P93, DOI 10.1111/j.1529-8027.2010.00257.x; Marques SA, 2009, J NEUROSCI METH, V177, P183, DOI 10.1016/j.jneumeth.2008.10.015; Masaeli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057157; Mietto BS, 2013, EUR J NEUROSCI, V37, P1682, DOI 10.1111/ejn.12161; Molteni R, 2004, P NATL ACAD SCI USA, V101, P8473, DOI 10.1073/pnas.0401443101; Monte-Raso VV, 2008, J NEUROSCI METH, V170, P255, DOI 10.1016/j.jneumeth.2008.01.022; Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846; Oliveira JT, 2010, NEUROSCIENCE, V170, P1295, DOI 10.1016/j.neuroscience.2010.08.042; Park HW, 2010, GLIA, V58, P1118, DOI 10.1002/glia.20992; Park JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090245; Lopes FRP, 2010, MICRON, V41, P783, DOI 10.1016/j.micron.2010.05.010; Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315; Sabatier MJ, 2008, EXP NEUROL, V211, P489, DOI 10.1016/j.expneurol.2008.02.013; Seo TB, 2006, MED SCI SPORT EXER, V38, P1267, DOI 10.1249/01.mss.0000227311.00976.68; Skinner RD, 1996, BRAIN RES, V729, P127, DOI 10.1016/S0006-8993(96)00556-2; Tonda-Turo C, 2011, ADV ENG MATER, V13, pB151, DOI 10.1002/adem.201080099; Udina E, 2011, MUSCLE NERVE, V43, P500, DOI 10.1002/mus.21912; Vogelin E, 2006, EXP NEUROL, V199, P348, DOI 10.1016/j.expneurol.2005.12.029; Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008	55	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110090	10.1371/journal.pone.0110090	http://dx.doi.org/10.1371/journal.pone.0110090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333892	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200091
J	Trembley, JH; Unger, GM; Korman, VL; Abedin, MJ; Nacusi, LP; Vogel, RI; Slaton, JW; Kren, BT; Ahmed, K				Trembley, Janeen H.; Unger, Gretchen M.; Korman, Vicci L.; Abedin, Md. Joynal; Nacusi, Lucas P.; Vogel, Rachel I.; Slaton, Joel W.; Kren, Betsy T.; Ahmed, Khalil			Tenfibgen Ligand Nanoencapsulation Delivers Bi-Functional Anti-CK2 RNAi Oligomer to Key Sites for Prostate Cancer Targeting Using Human Xenograft Tumors in Mice	PLOS ONE			English	Article							PROTEIN-KINASE CK2; SQUAMOUS-CELL CARCINOMA; TENASCIN-C; IN-VIVO; SIRNA; CK2-ALPHA; SUBUNIT; HEAD; PROGRESSION; ASSOCIATION	Protected and specific delivery of nucleic acids to malignant cells remains a highly desirable approach for cancer therapy. Here we present data on the physical and chemical characteristics, mechanism of action, and pilot therapeutic efficacy of a tenfibgen (TBG)-shell nanocapsule technology for tumor-directed delivery of single stranded DNA/RNA chimeric oligomers targeting CK2 alpha alpha' to xenograft tumors in mice. The sub-50 nm size TBG nanocapsule (s50-TBG) is a slightly negatively charged, uniform particle of 15 - 20 nm size which confers protection to the nucleic acid cargo. The DNA/RNA chimeric oligomer (RNAi-CK2) functions to decrease CK2 alpha alpha' expression levels via both siRNA and antisense mechanisms. Systemic delivery of s50-TBG-RNAi-CK2 specifically targets malignant cells, including tumor cells in bone, and at low doses reduces size and CK2-related signals in orthotopic primary and metastatic xenograft prostate cancer tumors. In conclusion, the s50-TBG nanoencapsulation technology together with the chimeric oligomer targeting CK2aa' offer significant promise for systemic treatment of prostate malignancy.	[Trembley, Janeen H.; Abedin, Md. Joynal; Kren, Betsy T.; Ahmed, Khalil] Minneapolis VA Hlth Care Syst, Res Serv, Minneapolis, MN 55417 USA; [Trembley, Janeen H.; Abedin, Md. Joynal; Ahmed, Khalil] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Trembley, Janeen H.; Vogel, Rachel I.; Kren, Betsy T.; Ahmed, Khalil] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Unger, Gretchen M.; Korman, Vicci L.; Nacusi, Lucas P.] GeneSegues Inc, Chaska, MN USA; [Kren, Betsy T.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Slaton, Joel W.; Ahmed, Khalil] Univ Minnesota, Dept Urol, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ahmed, K (corresponding author), Minneapolis VA Hlth Care Syst, Res Serv, Minneapolis, MN 55417 USA.	ahmedk@umn.edu		Trembley, Janeen/0000-0003-3597-2611; Vogel, Rachel/0000-0003-0149-8464	Department of Veterans Affairs [1IO1B001731]; National Cancer Institute, National Institutes of Health, Department of Health and Human Services [CA150182, HHS-N261-2008-00027/N42CM-2008-00027C, CA99366, CA119556]; National Cancer Institute [CA158730, DK067436-05]; National Institute of Diabetes, Digestive Diseases and Kidney Diseases, National Institutes of Health, Department of Health and Human Services; NATIONAL CANCER INSTITUTE [R01CA150182, R43CA099366, R43CA119556, R21CA158730, P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067436] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes, Digestive Diseases and Kidney Diseases, National Institutes of Health, Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Merit review research funds (1IO1B001731) awarded by the Department of Veterans Affairs www.va.gov (KA). Research grant CA150182 awarded by National Cancer Institute, National Institutes of Health, Department of Health and Human Services www.nih.gov (KA). Research grants CA158730 and DK067436-05 awarded by National Cancer Institute and National Institute of Diabetes, Digestive Diseases and Kidney Diseases, National Institutes of Health, Department of Health and Human Services www.nih.gov (BTK). Research grants HHS-N261-2008-00027/N42CM-2008-00027C, CA99366, and CA119556 awarded by National Cancer Institute, National Institutes of Health, Department of Health and Human Services www.nih.gov (GMU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the United States Department of Veterans Affairs or the United States government.	Ahmad KA, 2005, ANTI-CANCER DRUG, V16, P1037, DOI 10.1097/00001813-200511000-00001; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Alam MR, 2010, OLIGONUCLEOTIDES, V20, P103, DOI 10.1089/oli.2009.0211; AUKHIL I, 1993, J BIOL CHEM, V268, P2542; Bertrand N, 2014, ADV DRUG DELIVER REV, V66, P2, DOI 10.1016/j.addr.2013.11.009; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; CROOKE ST, 1995, BIOCHEM J, V312, P599, DOI 10.1042/bj3120599; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; ERICKSON HP, 1989, ANNU REV CELL BIOL, V5, P71, DOI 10.1146/annurev.cb.05.110189.000443; Faust RA, 1996, CANCER LETT, V101, P31, DOI 10.1016/0304-3835(96)04110-9; FDA-CDER, 2002, PHARM TOX; GAPANY M, 1995, MOL MED, V1, P659, DOI 10.1007/BF03401606; Giusiano S, 2011, EUR J CANCER, V47, P792, DOI 10.1016/j.ejca.2010.11.028; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; Juliano RL, 2012, BIOCONJUGATE CHEM, V23, P147, DOI 10.1021/bc200377d; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Kim JS, 2007, CLIN CANCER RES, V13, P1019, DOI 10.1158/1078-0432.CCR-06-1602; Kren BT, 2009, J CLIN INVEST, V119, P2086, DOI 10.1172/JCI34332; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Lightfoot HL, 2012, NUCLEIC ACIDS RES, V40, P10585, DOI 10.1093/nar/gks861; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu J, 2013, NUCLEIC ACIDS RES, V41, P9570, DOI 10.1093/nar/gkt693; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Sanhai WR, 2008, NAT NANOTECHNOL, V3, P242, DOI 10.1038/nnano.2008.114; Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P3, DOI 10.1093/ndt/gfh1092; Schrecengost R, 2013, SEMIN ONCOL, V40, P244, DOI 10.1053/j.seminoncol.2013.04.001; Seldin DC, 2008, MOL CELL BIOCHEM, V316, P141, DOI 10.1007/s11010-008-9811-8; Tabernero J, 2013, CANCER DISCOV, V3, P406, DOI 10.1158/2159-8290.CD-12-0429; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Tousignant JD, 2000, HUM GENE THER, V11, P2493, DOI 10.1089/10430340050207984; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Trembley JH, 2012, CANCER LETT, V315, P48, DOI 10.1016/j.canlet.2011.10.007; Trembley JH, 2011, MOL CELL BIOCHEM, V356, P21, DOI 10.1007/s11010-011-0943-x; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Ui-Tei K, 2008, NUCLEIC ACIDS RES, V36, P2136, DOI 10.1093/nar/gkn042; Unger GM, 2004, CURR CANCER DRUG TAR, V4, P77, DOI 10.2174/1568009043481687; Unger GM, 2014, MOL CANCER THER, V13, P2018, DOI 10.1158/1535-7163.MCT-14-0166; Van Obberghen-Schilling E, 2011, INT J DEV BIOL, V55, P511, DOI 10.1387/ijdb.103243eo; Wang GX, 2005, MOL CELL BIOCHEM, V274, P77, DOI 10.1007/s11010-005-3077-1; Yao YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003601; Yokoyama K, 2000, J BIOL CHEM, V275, P16891, DOI 10.1074/jbc.M000610200	52	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109970	10.1371/journal.pone.0109970	http://dx.doi.org/10.1371/journal.pone.0109970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333839	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200070
J	Juliant, S; Harduin-Lepers, A; Monjaret, F; Catieau, B; Violet, ML; Cerutti, P; Ozil, A; Duonor-Cerutti, M				Juliant, Sylvie; Harduin-Lepers, Anne; Monjaret, Francois; Catieau, Beatrice; Violet, Marie-Luce; Cerutti, Pierre; Ozil, Annick; Duonor-Cerutti, Martine			The alpha 1,6-Fucosyltransferase Gene (fut8) from the Sf9 Lepidopteran Insect Cell Line: Insights into fut8 Evolution	PLOS ONE			English	Article							N-GLYCANS; LINKED OLIGOSACCHARIDES; MOLECULAR-CLONING; CDNA CLONING; INTRON GAINS; EXPRESSION; SEQUENCE; GLYCOSYLATION; GLYCOPROTEINS; FUCOSE	The core alpha1,6-fucosyltransferase (FUT8) catalyzes the transfer of a fucosyl moiety from GDP-fucose to the innermost asparagine-linked N-acetylglucosamine residue of glycoproteins. In mammals, this glycosylation has an important function in many fundamental biological processes and although no essential role has been demonstrated yet in all animals, FUT8 amino acid (aa) sequence and FUT8 activity are very well conserved throughout the animal kingdom. We have cloned the cDNA and the complete gene encoding the FUT8 in the Sf9 (Spodoptera frugiperda) lepidopteran cell line. As in most animal genomes, fut8 is a single-copy gene organized in different exons. The open reading frame contains 12 exons, a characteristic that seems to be shared by all lepidopteran fut8 genes. We chose to study the gene structure as a way to characterize the evolutionary relationships of the fut8 genes in metazoans. Analysis of the intron-exon organization in 56 fut8 orthologs allowed us to propose a model for fut8 evolution in metazoans. The presence of a highly variable number of exons in metazoan fut8 genes suggests a complex evolutionary history with many intron gain and loss events, particularly in arthropods, but not in chordata. Moreover, despite the high conservation of lepidoptera FUT8 sequences also in vertebrates and hymenoptera, the exon-intron organization of hymenoptera fut8 genes is order-specific with no shared exons. This feature suggests that the observed intron losses and gains may be linked to evolutionary innovations, such as the appearance of new orders.	[Juliant, Sylvie; Monjaret, Francois; Violet, Marie-Luce; Cerutti, Pierre; Ozil, Annick; Duonor-Cerutti, Martine] CNRS, Baculovirus & Therapie UPS3044, St Christol Les Ales, France; [Harduin-Lepers, Anne; Catieau, Beatrice] Univ Lille Nord France, Unite Glycobiol Struct & Fonct, CNRS, UMR8576, Villeneuve Dascq, France; [Catieau, Beatrice] Lab Francais Fractionnement & Biotechnol Lille, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Duonor-Cerutti, M (corresponding author), CNRS, Baculovirus & Therapie UPS3044, St Christol Les Ales, France.	martine.cerutti@cnrs.fr	Anne, Harduin-Lepers/O-7503-2017	Anne, Harduin-Lepers/0000-0002-1233-3799	Centre National de la Recherche Scientifique; Institut National de la Recherche Agronomique; Laboratoire Francais du Fractionnement et des Biotechnologies de Lille; PPF Bioinformatique Lille1	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique; Laboratoire Francais du Fractionnement et des Biotechnologies de Lille; PPF Bioinformatique Lille1	This work was supported by Centre National de la Recherche Scientifique to MD-C, AH-L, FM, MLV, Institut National de la Recherche Agronomique to PC, SJ, AO, Laboratoire Francais du Fractionnement et des Biotechnologies de Lille to BC, and PPF Bioinformatique Lille1 to AH-L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; ALTMANN F, 1993, GLYCOBIOLOGY, V3, P619, DOI 10.1093/glycob/3.6.619; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Breton C, 1998, GLYCOBIOLOGY, V8, P87, DOI 10.1093/glycob/8.1.87; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; CHAABIHI H, 1993, J VIROL, V67, P2664, DOI 10.1128/JVI.67.5.2664-2671.1993; CROIZIER G, 1988, J GEN VIROL, V69, P177, DOI 10.1099/0022-1317-69-1-177; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Souza SJ, 1998, P NATL ACAD SCI USA, V95, P5094, DOI 10.1073/pnas.95.9.5094; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; FELGNER PL, 1989, NATURE, V337, P387, DOI 10.1038/337387a0; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Geisler C, 2012, J BIOL CHEM, V287, P7084, DOI 10.1074/jbc.M111.296814; GREGORY TR, 2007, ANIMAL GENOME SIZE D; Hancock K, 2008, J IMMUNOL METHODS, V330, P130, DOI 10.1016/j.jim.2007.08.002; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A., 2010, GLYCOBIOL INSIGHTS, V2, P29, DOI [10.4137/GBI.S3123, DOI 10.4137/GBI.S3123, 10.4137/gbi.s3123]; Hayashi H, 2000, DNA SEQUENCE, V11, P91, DOI 10.3109/10425170009033974; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hooker AD, 1999, BIOTECHNOL BIOENG, V63, P559, DOI 10.1002/(SICI)1097-0290(19990605)63:5<559::AID-BIT6>3.0.CO;2-L; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Javaud C, 2000, MOL BIOL EVOL, V17, P1661, DOI 10.1093/oxfordjournals.molbev.a026265; Javaud C, 2003, GENETICA, V118, P157, DOI 10.1023/A:1024101625214; Juliant Sylvie, 2013, Methods Mol Biol, V988, P59, DOI 10.1007/978-1-62703-327-5_5; Klopfstein S, 2013, MOL PHYLOGENET EVOL, V67, P266, DOI 10.1016/j.ympev.2013.01.015; Krauss V, 2005, MOL BIOL EVOL, V22, P74, DOI 10.1093/molbev/msh255; KUBELKA V, 1994, ARCH BIOCHEM BIOPHYS, V308, P148, DOI 10.1006/abbi.1994.1021; Kumar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022046; Landais I, 2003, BIOINFORMATICS, V19, P2343, DOI 10.1093/bioinformatics/btg324; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Long MY, 1999, MOL BIOL EVOL, V16, P1528, DOI 10.1093/oxfordjournals.molbev.a026065; Lopez M, 1997, GLYCOBIOLOGY, V7, P635, DOI 10.1093/glycob/7.5.635; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Marchal I, 1999, GLYCOBIOLOGY, V9, P645, DOI 10.1093/glycob/9.7.645; Marchal I, 2001, GLYCOBIOLOGY, V11, P593, DOI 10.1093/glycob/11.7.593; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Martinez-Duncker I, 2003, GLYCOBIOLOGY, V13, p1C, DOI 10.1093/glycob/cwg113; MOLLICONE R, 1995, TRANSFUS CLIN BIOL, V2, P235, DOI 10.1016/S1246-7820(05)80089-8; Nei M., 2000, MOL EVOLUTION PHYLOG; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; OREILLY DR, 1989, SCIENCE, V245, P1110, DOI 10.1126/science.2505387; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Petit Daniel, 2013, Methods Mol Biol, V1022, P73, DOI 10.1007/978-1-62703-465-4_7; Petit D, 2010, J BIOL CHEM, V285, P38399, DOI 10.1074/jbc.M110.163931; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; STAUDACHER E, 1992, EUR J BIOCHEM, V207, P987, DOI 10.1111/j.1432-1033.1992.tb17134.x; Summers M. D., 1987, TEXAS AGR EXP STATIO, V1, P1555; Takahashi T, 2000, GLYCOBIOLOGY, V10, P503, DOI 10.1093/glycob/10.5.503; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teylaert B, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-1; Tomiya N, 2004, GLYCOCONJUGATE J, V21, P343, DOI 10.1023/B:GLYC.0000046275.28315.87; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; VELARDO MA, 1993, J BIOL CHEM, V268, P17902; VOSS T, 1993, EUR J BIOCHEM, V217, P913, DOI 10.1111/j.1432-1033.1993.tb18321.x; Wagner R, 1996, GLYCOBIOLOGY, V6, P165, DOI 10.1093/glycob/6.2.165; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yamaguchi Y, 1999, CYTOGENET CELL GENET, V84, P58, DOI 10.1159/000015215; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x	73	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110422	10.1371/journal.pone.0110422	http://dx.doi.org/10.1371/journal.pone.0110422			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333276	Green Submitted, gold, Green Published			2022-12-27	WOS:000343731200037
J	Padgett, K; Bonilla, D; Kjemtrup, A; Vilcins, IM; Yoshimizu, MH; Hui, L; Sola, M; Quintana, M; Kramer, V				Padgett, Kerry; Bonilla, Denise; Kjemtrup, Anne; Vilcins, Inger-Marie; Yoshimizu, Melissa Hardstone; Hui, Lucia; Sola, Milagros; Quintana, Miguel; Kramer, Vicki			Large Scale Spatial Risk and Comparative Prevalence of Borrelia miyamotoi and Borrelia burgdorferi Sensu Lato in Ixodes pacificus	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; LYME-DISEASE SPIROCHETE; FEVER GROUP SPIROCHETE; ACARI IXODIDAE; TICK; INFECTION; CALIFORNIA; EXPOSURE; VECTOR; AGENT	Borrelia miyamotoi is a newly described emerging pathogen transmitted to people by Ixodes species ticks and found in temperate regions of North America, Europe, and Asia. There is limited understanding of large scale entomological risk patterns of B. miyamotoi and of Borreila burgdorferi sensu stricto (ss), the agent of Lyme disease, in western North America. In this study, B. miyamotoi, a relapsing fever spirochete, was detected in adult (n = 70) and nymphal (n = 36) Ixodes pacificus ticks collected from 24 of 48 California counties that were surveyed over a 13 year period. Statewide prevalence of B. burgdorferi sensu lato (sl), which includes B. burgdorferi ss, and B. miyamotoi were similar in adult I. pacificus (0.6% and 0.8%, respectively). In contrast, the prevalence of B. burgdorferi sl was almost 2.5 times higher than B. miyamotoi in nymphal I. pacificus (3.2% versus 1.4%). These results suggest similar risk of exposure to B. burgdorferi sl and B. miyamotoi from adult I. pacificus tick bites in California, but a higher risk of contracting B. burgdorferi sl than B. miyamotoi from nymphal tick bites. While regional risk of exposure to these two spirochetes varies, the highest risk for both species is found in north and central coastal California and the Sierra Nevada foothill region, and the lowest risk is in southern California; nevertheless, tick-bite avoidance measures should be implemented in all regions of California. This is the first study to comprehensively evaluate entomologic risk for B. miyamotoi and B. burgdorferi for both adult and nymphal I. pacificus, an important human biting tick in western North America.	[Padgett, Kerry; Bonilla, Denise; Kjemtrup, Anne; Vilcins, Inger-Marie; Yoshimizu, Melissa Hardstone; Hui, Lucia; Kramer, Vicki] Calif Dept Publ Hlth, Vector Borne Dis Sect, Richmond, CA 94804 USA; [Sola, Milagros; Quintana, Miguel] Joint Base Lewis McChord, Publ Hlth Command Reg West, Washington, DC USA	California Department of Public Health	Padgett, K (corresponding author), Calif Dept Publ Hlth, Vector Borne Dis Sect, Richmond, CA 94804 USA.	Kerry.Padgett@cdph.ca.gov		Kjemtrup, Anne/0000-0002-5788-7621; Padgett, Kerry/0000-0002-9535-3401				Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Barbour AG, 1996, J INFECT DIS, V173, P403, DOI 10.1093/infdis/173.2.403; Barbour AG, 2001, EMERGING INFECTIONS 5, P153; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; BECK M. D., 1942, Present Distribution of Relapsing Fever in California., P20; Bunikis J, 2004, EMERG INFECT DIS, V10, P1661, DOI 10.3201/eid1009.040236; Chowdri HR, 2013, ANN INTERN MED, V159, P21, DOI 10.7326/0003-4819-159-1-201307020-00005; CLOVER JR, 1995, AM J TROP MED HYG, V53, P237, DOI 10.4269/ajtmh.1995.53.237; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Dibernardo A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-183; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Dworkin MS, 2008, INFECT DIS CLIN N AM, V22, P449, DOI 10.1016/j.idc.2008.03.006; Eisen RJ, 2010, TICKS TICK-BORNE DIS, V1, P35, DOI 10.1016/j.ttbdis.2009.12.002; Eisen RJ, 2003, ENVIRON ENTOMOL, V32, P1010, DOI 10.1603/0046-225X-32.5.1010; Fomenko NV, 2010, ENTOMOL REV, V90, P1088, DOI DOI 10.1134/S0013873810080129; Fraenkel CJ, 2002, J CLIN MICROBIOL, V40, P3308, DOI 10.1128/JCM.40.9.3308-3312.2002; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; Furman DP., 1984, B CALIFORNIA INSECT, V25; Geller J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051914; Girard YA, 2011, J CLIN MICROBIOL, V49, P945, DOI 10.1128/JCM.01689-10; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Hamer SA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-231; Hovius JWR, 2013, LANCET, V382, P658, DOI 10.1016/S0140-6736(13)61644-X; Hue F, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00713-13; JOHNSON BJB, 1992, AM J TROP MED HYG, V47, P730, DOI 10.4269/ajtmh.1992.47.730; Kain DE, 1999, HEREDITY, V83, P378, DOI 10.1038/sj.hdy.6886110; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Kuno G, 2001, AM J TROP MED HYG, V65, P671, DOI 10.4269/ajtmh.2001.65.671; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; Lane RS, 2013, TICKS TICK-BORNE DIS, V4, P377, DOI 10.1016/j.ttbdis.2013.02.005; LANE RS, 1987, AM J TROP MED HYG, V37, P188, DOI 10.4269/ajtmh.1987.37.188; Margos G, 2010, TICKS TICK-BORNE DIS, V1, P151, DOI 10.1016/j.ttbdis.2010.09.002; Mun J, 2006, J MED ENTOMOL, V43, P120, DOI 10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2; Paddock CD, 2008, CLIN INFECT DIS, V47, P1188, DOI 10.1086/592254; Padgett KA, 2011, TICKS TICK-BORNE DIS, V2, P191, DOI 10.1016/j.ttbdis.2011.07.002; PERSING DH, 1990, J CLIN MICROBIOL, V28, P566, DOI 10.1128/JCM.28.3.566-572.1990; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Postic D, 1998, J CLIN MICROBIOL, V36, P3497, DOI 10.1128/JCM.36.12.3497-3504.1998; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Rich SM, 2001, J CLIN MICROBIOL, V39, P494, DOI 10.1128/JCM.39.2.494-497.2001; Richter D, 2003, EMERG INFECT DIS, V9, P697; Rollend L, 2013, TICKS TICK-BORNE DIS, V4, P46, DOI 10.1016/j.ttbdis.2012.06.008; ROSA PA, 1991, J CLIN MICROBIOL, V29, P524, DOI 10.1128/JCM.29.3.524-532.1991; Rosen ME, 2012, J MED ENTOMOL, V49, P1473, DOI 10.1603/ME11255; Rudenko N, 2011, TICKS TICK-BORNE DIS, V2, P123, DOI 10.1016/j.ttbdis.2011.04.002; Rudenko N, 2011, INT J SYST EVOL MICR, V61, P381, DOI 10.1099/ijs.0.021436-0; Rudenko N, 2009, J CLIN MICROBIOL, V47, P3875, DOI 10.1128/JCM.01050-09; Salkeld DJ, 2014, EMERG INFECT DIS, V20, P493, DOI 10.3201/eid2003.130668; Sato K, 2014, EMERG INFECT DIS, V20, P1391, DOI 10.3201/eid2008.131761; SCHOELER GB, 1993, J MED ENTOMOL, V30, P80, DOI 10.1093/jmedent/30.1.80; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Scott JD, 2010, J VECTOR ECOL, V35, P124, DOI 10.1111/j.1948-7134.2010.00038.x; Shapiro MR, 2010, CLIN INFECT DIS, V50, P541, DOI 10.1086/649926; Smith RP, 2006, EMERG INFECT DIS, V12, P1909; Swei A, 2011, J MED ENTOMOL, V48, P20, DOI 10.1603/ME10131; Talleklint-Eisen L, 1999, J PARASITOL, V85, P824, DOI 10.2307/3285817; Tokarz R, 2010, VECTOR-BORNE ZOONOT, V10, P217, DOI 10.1089/vbz.2009.0036; Travinsky B, 2010, EMERG INFECT DIS, V16, P1147, DOI 10.3201/eid1607.091452; Ullmann AJ, 2005, J MED ENTOMOL, V42, P1057, DOI 10.1603/0022-2585(2005)042[1057:TMAFDO]2.0.CO;2; Varela-Stokes AS, 2007, J MED ENTOMOL, V44, P478, DOI 10.1603/0022-2585(2007)44[478:TOBAFL]2.0.CO;2	60	45	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110853	10.1371/journal.pone.0110853	http://dx.doi.org/10.1371/journal.pone.0110853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333277	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200080
J	Tanaka-Okamoto, M; Itoh, Y; Miyoshi, J; Mizoguchi, A; Mizutani, K; Takai, Y; Inoue, M				Tanaka-Okamoto, Miki; Itoh, Yu; Miyoshi, Jun; Mizoguchi, Akira; Mizutani, Kiyohito; Takai, Yoshimi; Inoue, Masahiro			Genetic Ablation of Afadin Causes Mislocalization and Deformation of Paneth Cells in the Mouse Small Intestinal Epithelium	PLOS ONE			English	Article							SMALL G-PROTEINS; ADHERENS JUNCTION; E-CADHERIN; ADHESION MOLECULE; BINDING PROTEIN; TRANSGENIC MICE; NECTIN; RAP1; DIFFERENTIATION; AF-6	Afadin is an actin filament-binding protein that acts cooperatively in cell adhesion with the cell adhesion molecule nectin, and in directional cell movement with the small G protein Rap1 in a nectin-independent manner. We studied the role of afadin in the organization of the small intestinal epithelium using afadin conditional gene knockout (cKO) mice. Afadin was localized at adherens junctions of all types of epithelial cells throughout the crypt-villus axis. Paneth cells were localized at the base of the crypt in control mice, but not confined there, and migrated into the villi in afadin-cKO mice. The distribution of other types of epithelial cells did not change significantly in the mutant mice. The Paneth cells remaining in the crypt exhibited abnormal shapes, were buried between adjacent cells, and did not face the lumen. In these cells, the formation of adherens junctions and tight junctions was impaired. Rap1 and EphB3 were highly expressed in control Paneth cells but markedly down-regulated in the afadin-deficient Paneth cells. Taken together, the results indicate that afadin plays a role in the restricted localization of Paneth cells at the base of the crypt by maintaining their adhesion to adjacent crypt cells and inhibiting their movement toward the top of villi.	[Tanaka-Okamoto, Miki; Itoh, Yu; Miyoshi, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka, Japan; [Tanaka-Okamoto, Miki; Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Japan; [Itoh, Yu; Mizoguchi, Akira] Mie Univ, Grad Sch Med, Dept Neural Regenerat & Cell Commun, Tsu, Mie, Japan; [Mizutani, Kiyohito; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling, Kobe, Hyogo 657, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Mie University; Kobe University	Tanaka-Okamoto, M (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka, Japan.	okamoto-mi@mc.pref.osaka.jp; inoue-ma2@mc.pref.osaka.jp	Mizutani, Kiyohito/L-8474-2019	Tanaka-Okamoto, Miki/0000-0002-6429-7662	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23701071, 22300330]; Grants-in-Aid for Scientific Research [24790284, 26860190] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Young Scientists (to MTO, Grant No. 23701071 for the period 2011-2012) and Scientific Research (to JM, Grant No. 22300330 for the period 2010-2011) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (http://www.mext.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Boettner B, 2003, GENETICS, V165, P159; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; BRY L, 1994, P NATL ACAD SCI USA, V91, P10335, DOI 10.1073/pnas.91.22.10335; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Ebnet K, 2008, HISTOCHEM CELL BIOL, V130, P1, DOI 10.1007/s00418-008-0418-7; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kurita S, 2013, J BIOL CHEM, V288, P29356, DOI 10.1074/jbc.M113.453464; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Majima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068134; Majima T, 2009, BIOCHEM BIOPH RES CO, V385, P539, DOI 10.1016/j.bbrc.2009.05.097; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Mandai K, 2013, PROG MOL BIOL TRANSL, V116, P433, DOI 10.1016/B978-0-12-394311-8.00019-4; Melendez J, 2013, GASTROENTEROLOGY, V145, P808, DOI 10.1053/j.gastro.2013.06.021; Miyata M, 2009, J CELL SCI, V122, P4319, DOI 10.1242/jcs.048439; Miyata M, 2009, J BIOL CHEM, V284, P24595, DOI 10.1074/jbc.M109.016436; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; PRASAD R, 1993, CANCER RES, V53, P5624; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; Rikitake Y, 2011, INT REV CEL MOL BIO, V287, P97, DOI 10.1016/B978-0-12-386043-9.00003-7; Rindi G, 2004, ANN NY ACAD SCI, V1014, P1, DOI 10.1196/annals.1294.001; Sakamori R, 2012, J CLIN INVEST, V122, P1052, DOI 10.1172/JCI60282; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Tanaka-Okamoto M, 2011, J CELL SCI, V124, P2231, DOI 10.1242/jcs.081000; Tawa H, 2010, CIRC RES, V106, P1731, DOI 10.1161/CIRCRESAHA.110.216747; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Yamamoto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080356; Yang ZF, 2013, DEVELOPMENT, V140, P1774, DOI 10.1242/dev.087957; Yu TX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032492; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3	55	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110549	10.1371/journal.pone.0110549	http://dx.doi.org/10.1371/journal.pone.0110549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333284	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200053
J	Vassall, A; Chandrashekar, S; Pickles, M; Beattie, TS; Shetty, G; Bhattacharjee, P; Boily, MC; Vickerman, P; Bradley, J; Alary, M; Moses, S; Watts, C				Vassall, Anna; Chandrashekar, Sudhashree; Pickles, Michael; Beattie, Tara S.; Shetty, Govindraj; Bhattacharjee, Parinita; Boily, Marie-Claude; Vickerman, Peter; Bradley, Janet; Alary, Michel; Moses, Stephen; Watts, Charlotte		CHARME India Grp	Community Mobilisation and Empowerment Interventions as Part of HIV Prevention for Female Sex Workers in Southern India: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; CONDOM USE; KARNATAKA STATE; STRUCTURAL INTERVENTIONS; COMMERCIAL SEX; ANDHRA-PRADESH; IMPACT; RISK; HIV/AIDS; AVAHAN	Background: Most HIV prevention for female sex workers (FSWs) focuses on individual behaviour change involving peer educators, condom promotion and the provision of sexual health services. However, there is a growing recognition of the need to address broader societal, contextual and structural factors contributing to FSW risk behaviour. We assess the cost-effectiveness of adding community mobilisation (CM) and empowerment interventions (eg. community mobilisation, community involvement in programme management and services, violence reduction, and addressing legal policies and police practices), to core HIV prevention services delivered as part of Avahan in two districts (Bellary and Belgaum) of Karnataka state, Southern India. Methods: An ingredients approach was used to estimate economic costs in US$ 2011 from an HIV programme perspective of CM and empowerment interventions over a seven year period (2004-2011). Incremental impact, in terms of HIV infections averted, was estimated using a two-stage process. An 'exposure analysis' explored whether exposure to CM was associated with FSW's empowerment, risk behaviours and HIV/STI prevalence. Pathway analyses were then used to estimate the extent to which behaviour change may be attributable to CM and to inform a dynamic HIV transmission model. Findings: The incremental costs of CM and empowerment were US$ 307,711 in Belgaum and US$ 592,903 in Bellary over seven years (2004-2011). Over a 7-year period (2004-2011) the mean (standard deviation, sd.) number of HIV infections averted through CM and empowerment is estimated to be 1257 (308) in Belgaum and 2775 (1260) in Bellary. This translates in a mean (sd.) incremental cost per disability adjusted life year (DALY) averted of US$ 14.12 (3.68) in Belgaum and US$ 13.48 (6.80) for Bellary - well below the World Health Organisation recommended willingness to pay threshold for India. When savings from ART are taken into account, investments in CM and empowerment are cost saving. Conclusions: Our findings suggest that CM and empowerment is, at worst, highly cost-effective and, at best, a cost-saving investment from an HIV programme perspective. CM and empowerment interventions should therefore be considered as core components of HIV prevention programmes for FSWs.	[Vassall, Anna; Chandrashekar, Sudhashree; Pickles, Michael; Beattie, Tara S.; Vickerman, Peter; Watts, Charlotte] London Sch Hyg & Trop Med, London WC1, England; [Chandrashekar, Sudhashree; Bhattacharjee, Parinita] St Johns Res Inst, Bangalore, Karnataka, India; [Pickles, Michael; Boily, Marie-Claude] Univ London Imperial Coll Sci Technol & Med, London, England; [Shetty, Govindraj; Moses, Stephen] Karnataka Hlth Promot Trust, Bangalore, Karnataka, India; [Bradley, Janet; Alary, Michel] CHU Quebec, URESP, Ctr Rech, Quebec City, PQ, Canada; [Alary, Michel] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada	University of London; London School of Hygiene & Tropical Medicine; St. John's National Academy of Health Sciences; St. John's Research Institute; Imperial College London; Laval University; Laval University	Vassall, A (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	Anna.Vassall@lshtm.ac.uk		Boily, Marie-Claude/0000-0003-3919-006X; Vickerman, Peter/0000-0002-8291-5890; Blanchard, James/0000-0002-4701-590X; Pickles, Michael/0000-0002-6754-3945; Vassall, Anna/0000-0002-2911-1375; Beattie, Tara/0000-0001-9156-7341	Bill and Melinda Gates Foundation; Department for International Development (DFID) [201447] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department for International Development (DFID)	The funder of this work was the Bill and Melinda Gates Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, COST GUID HIV PREV S; Auerbach JD, 2011, GLOB PUBLIC HEALTH, V6, pS293, DOI 10.1080/17441692.2011.594451; Avahan-the India AIDS initiative, 2008, AV IND AIDS IN BUS H; Beattie TSH, 2014, AM J PUBLIC HEALTH, V104, P1516, DOI 10.2105/AJPH.2014.301911; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Beattie TS, 19 INT AIDS C; Bertozzi S, DIS CONTROL PRIOIRIT, P331; Bill and Melinda Gates Foundation, 2013, MICR PEER LED OUTR P; Bill and Melinda Gates Foundation, 2013, COMM LED CRIS RESP S; Bill and Melinda Gates Foundation, 2010, AV COMM MIN PROGR HI; Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; Blankenship KM, 2000, AIDS, V14, pS11, DOI 10.1097/00002030-200006001-00003; Boily MC, 2007, SEX TRANSM INFECT, V83, P582, DOI 10.1136/sti.2007.027516; Boily MC, 2013, POSITIVE IMPACT LARG; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Chandrashekar S, 2010, SEX TRANSM INFECT, V86, pI89, DOI 10.1136/sti.2009.038547; Chandrashekar S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S7; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Dandona L, 2009, AIDS, V23, P233, DOI 10.1097/QAD.0b013e328320accc; Dandona Lalit, 2010, BMC Health Serv Res, V10, P117, DOI 10.1186/1472-6963-10-117; Drummond MF, 2015, METHODS EC EVALUATIO; Erausquin JT, 2012, J EPIDEMIOL COMMUN H, V66, pII49, DOI 10.1136/jech-2011-200511; Evans C, 2009, GLOB PUBLIC HEALTH, P1; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Fung ICH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-195; Galarraga O, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S5; Ghose T, 2008, SOC SCI MED, V67, P311, DOI 10.1016/j.socscimed.2008.03.045; Gurnani V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-755; Halli SS, 2006, AIDS CARE, V18, P739, DOI 10.1080/09540120500466937; Kabeer N, 1999, DEV CHANGE, V30, P435, DOI 10.1111/1467-7660.00125; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; Laga M, 2012, LANCET, V379, P1003, DOI 10.1016/S0140-6736(12)60426-7; Lippman SA, 2012, SEX TRANSM DIS, V39, P209, DOI 10.1097/OLQ.0b013e31823b1937; Lowndes CM, 2010, SEX TRANSM INFECT, V86, pI49, DOI 10.1136/sti.2009.038802; National AIDS Control Organsation Ministry of Health and Family Welfare Government of India, 2010, ANN REP 2009 10; Parimi P, 2012, J EPIDEMIOL COMMUN H, V66, pII62, DOI 10.1136/jech-2011-200832; Parkhurst JO, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17367; Pickles M, 2013, LANCET GLOB HEALTH, V1, pE289, DOI 10.1016/S2214-109X(13)70083-4; Pickles M, 2010, SEX TRANSM INFECT, V86, pI33, DOI 10.1136/sti.2009.038950; Prinja S, 2011, SEX TRANSM INFECT; Prinja S, 2011, SEX TRANSM INFECT, V87, P354, DOI 10.1136/sti.2010.047829; Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513; Reserve Bank of India, 2009, RES BANK IND B; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Sandhya B, 2012, SPECTROCHIM ACTA A, V86, P410, DOI 10.1016/j.saa.2011.10.060; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; UNAIDS, 2011, AIDS 30 NAT CROSSR; Vassall A PM, 2014, LANCET GLOB IN PRESS; Vickerman P, 2010, AIDS, V24, P2554, DOI 10.1097/QAD.0b013e32833e8663; WHO, 2004, GLOB BURD DIS UPD	53	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110562	10.1371/journal.pone.0110562	http://dx.doi.org/10.1371/journal.pone.0110562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR7AB	25333501	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000343731200055
J	Bais, L; Vercammen, A; Stewart, R; van Es, F; Visser, B; Aleman, A; Knegtering, H				Bais, Leonie; Vercammen, Ans; Stewart, Roy; van Es, Frank; Visser, Bert; Aleman, Andre; Knegtering, Henderikus			Short and Long Term Effects of Left and Bilateral Repetitive Transcranial Magnetic Stimulation in Schizophrenia Patients with Auditory Verbal Hallucinations: A Randomized Controlled Trial	PLOS ONE			English	Article							SHAM-CONTROLLED TRIAL; LEFT TEMPOROPARIETAL CORTEX; RTMS; EFFICACY; BRAIN; DEPOTENTIATION; SYMPTOMS; FMRI	Background: Repetitive transcranial magnetic stimulation of the left temporo-parietal junction area has been studied as a treatment option for auditory verbal hallucinations. Although the right temporo-parietal junction area has also shown involvement in the genesis of auditory verbal hallucinations, no studies have used bilateral stimulation. Moreover, little is known about durability effects. We studied the short and long term effects of 1 Hz treatment of the left temporo-parietal junction area in schizophrenia patients with persistent auditory verbal hallucinations, compared to sham stimulation, and added an extra treatment arm of bilateral TPJ area stimulation. Methods: In this randomized controlled trial, 51 patients diagnosed with schizophrenia and persistent auditory verbal hallucinations were randomly allocated to treatment of the left or bilateral temporo-parietal junction area or sham treatment. Patients were treated for six days, twice daily for 20 minutes. Short term efficacy was measured with the Positive and Negative Syndrome Scale (PANSS), the Auditory Hallucinations Rating Scale (AHRS), and the Positive and Negative Affect Scale (PANAS). We included follow-up measures with the AHRS and PANAS at four weeks and three months. Results: The interaction between time and treatment for Hallucination item P3 of the PANSS showed a trend for significance, caused by a small reduction of scores in the left group. Although self-reported hallucination scores, as measured with the AHRS and PANAS, decreased significantly during the trial period, there were no differences between the three treatment groups. Conclusion: We did not find convincing evidence for the efficacy of left-sided rTMS, compared to sham rTMS. Moreover, bilateral rTMS was not superior over left rTMS or sham in improving AVH. Optimizing treatment parameters may result in stronger evidence for the efficacy of rTMS treatment of AVH. Moreover, future research should consider investigating factors predicting individual response.	[Bais, Leonie; Aleman, Andre; Knegtering, Henderikus] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Bais, Leonie; Aleman, Andre; Knegtering, Henderikus] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Bais, Leonie; Knegtering, Henderikus] Lentis Psychiat Inst, Groningen, Netherlands; [Vercammen, Ans] Australian Catholic Univ, Strathfield, Australia; [Stewart, Roy] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands; [van Es, Frank; Visser, Bert] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Aleman, Andre] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; [Knegtering, Henderikus] Univ Groningen, Univ Med Ctr Groningen, Rob Giel Res Ctr, Groningen, Netherlands	University of Groningen; University of Groningen; Australian Catholic University; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Bais, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands.	l.bais@umcg.nl		Vercammen, Ans/0000-0003-1229-9401; Stewart, Roy/0000-0001-9227-433X	University of Groningen	University of Groningen	This project was supported by the University of Groningen (www.rug.nl). The University of Groningen had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2007, J CLIN PSYCHIAT, V68, P416, DOI 10.4088/JCP.v68n0310; Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; ANDREASEN NC, 1991, SCHIZOPHRENIA BULL, V17, P27, DOI 10.1093/schbul/17.1.27; Blumberger DM, 2012, BRAIN STIMUL, V5, P577, DOI 10.1016/j.brs.2011.12.002; Brunelin J, 2006, SCHIZOPHR RES, V81, P41, DOI 10.1016/j.schres.2005.10.009; Brunelin J, 2012, AM J PSYCHIAT, V169, P719, DOI 10.1176/appi.ajp.2012.11071091; Chibbaro G, 2005, NEUROSCI LETT, V383, P54, DOI 10.1016/j.neulet.2005.03.052; Costanzo F, 2012, NEUROPSYCHOLOGIA, V50, P2645, DOI 10.1016/j.neuropsychologia.2012.07.017; Curcic-Blake B, 2013, SCHIZOPHRENIA BULL, V39, P1087, DOI 10.1093/schbul/sbs107; Daalman K, 2011, J CLIN PSYCHIAT, V72, P320, DOI 10.4088/JCP.09m05797yel; de Jesus DR, 2011, PSYCHIAT RES, V188, P203, DOI 10.1016/j.psychres.2010.11.022; Di Lazzaro V, 2002, EXP BRAIN RES, V147, P108, DOI 10.1007/s00221-002-1223-5; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Fitzgerald PB, 2007, PSYCHIAT RES-NEUROIM, V155, P83, DOI 10.1016/j.pscychresns.2006.12.011; Fitzgerald PB, 2005, J CLIN PSYCHOPHARM, V25, P358, DOI 10.1097/01.jcp.0000168487.22140.7f; Froc DJ, 2000, J NEUROSCI, V20, P438, DOI 10.1523/JNEUROSCI.20-01-00438.2000; Giel R., 1996, SCAN 2 1 SCHEDULES C; Heller W, 1998, CURR DIR PSYCHOL SCI, V7, P26, DOI 10.1111/1467-8721.ep11521823; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Hoffman RE, 2007, CEREB CORTEX, V17, P2733, DOI 10.1093/cercor/bhl183; Hoffman RE, 2013, BIOL PSYCHIAT, V73, P1008, DOI 10.1016/j.biopsych.2013.01.016; Hoffman RE, 2003, ARCH GEN PSYCHIAT, V60, P49, DOI 10.1001/archpsyc.60.1.49; Hoffman RE, 1999, BIOL PSYCHIAT, V46, P130, DOI 10.1016/S0006-3223(98)00358-8; Hoffman RE, 2005, BIOL PSYCHIAT, V58, P97, DOI 10.1016/j.biopsych.2005.03.041; Hoffman RE, 2000, LANCET, V355, P1073, DOI 10.1016/S0140-6736(00)02043-2; Hoffman RE, 2002, AM J PSYCHIAT, V159, P1093, DOI 10.1176/appi.ajp.159.7.1093; Homan P, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.114; Homan P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00304; Honig A, 1998, J NERV MENT DIS, V186, P646, DOI 10.1097/00005053-199810000-00009; Jandl M, 2006, NEUROPSYCHOBIOLOGY, V53, P63, DOI 10.1159/000091721; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kindler J, 2013, BIOL PSYCHIAT, V73, P518, DOI 10.1016/j.biopsych.2012.06.019; Klirova M, 2013, EUR ARCH PSY CLIN N, V263, P475, DOI 10.1007/s00406-012-0368-x; Lee SH, 2005, NEUROSCI LETT, V376, P177, DOI 10.1016/j.neulet.2004.11.048; Lennox BR, 2000, PSYCHIAT RES-NEUROIM, V100, P13, DOI 10.1016/S0925-4927(00)00068-8; Loo CK, 2010, PSYCHOL MED, V40, P541, DOI 10.1017/S0033291709990900; Maiza O, 2013, BRAIN SCI, V3, P728, DOI 10.3390/brainsci3020728; McIntosh AM, 2004, PSYCHIAT RES, V127, P9, DOI 10.1016/j.psychres.2004.03.005; Montagne-Larmurier A, 2009, SCHIZOPHR RES, V113, P77, DOI 10.1016/j.schres.2009.05.006; Moseley P, 2013, NEUROSCI BIOBEHAV R, V37, P2794, DOI 10.1016/j.neubiorev.2013.10.001; Pascual-Leone A., 2002, HDB TRANSCRANIAL MAG; POST RM, 1997, CNS SPECTRUMS, V2, P54; Poulet E, 2005, BIOL PSYCHIAT, V57, P188, DOI 10.1016/j.biopsych.2004.10.007; Rosa MO, 2007, J CLIN PSYCHIAT, V68, P1528, DOI 10.4088/JCP.v68n1009; Saba G, 2006, J PSYCHIATR RES, V40, P147, DOI 10.1016/j.jpsychires.2005.02.008; Schutter DJLG, 2006, J ECT, V22, P176, DOI 10.1097/01.yct.0000235924.60364.27; Seok JH, 2007, PSYCHIAT RES-NEUROIM, V156, P93, DOI 10.1016/j.pscychresns.2007.02.002; Shergill SS, 1998, SCHIZOPHR RES, V32, P137, DOI 10.1016/S0920-9964(98)00052-8; Shergill SS, 2000, ARCH GEN PSYCHIAT, V57, P1033, DOI 10.1001/archpsyc.57.11.1033; SILBERMAN EK, 1986, BRAIN COGNITION, V5, P322, DOI 10.1016/0278-2626(86)90035-7; Slotema CW, 2012, SCHIZOPHR RES, V142, P40, DOI 10.1016/j.schres.2012.08.025; Slotema CW, 2014, BIOL PSYCHIAT, V76, P101, DOI 10.1016/j.biopsych.2013.09.038; Slotema CW, 2011, BIOL PSYCHIAT, V69, P450, DOI 10.1016/j.biopsych.2010.09.051; Sommer IEC, 2007, SCHIZOPHR RES, V93, P406, DOI 10.1016/j.schres.2007.03.020; Sommer IE, 2012, AM J PSYCHIAT, V169, P1211, DOI 10.1176/appi.ajp.2012.12060741; Sommer IEC, 2008, BRAIN, V131, P3169, DOI 10.1093/brain/awn251; Spalletta G, 2003, SCHIZOPHR RES, V64, P15, DOI 10.1016/S0920-9964(03)00010-0; Vercammen A, 2010, J PSYCHIATR RES, V44, P725, DOI 10.1016/j.jpsychires.2009.12.011; Vercammen A, 2009, SCHIZOPHR RES, V114, P172, DOI 10.1016/j.schres.2009.07.013; Wang Carol Sheei-Meei, 2003, Kaohsiung Journal of Medical Sciences, V19, P464; Waters F, 2012, SCHIZOPHRENIA BULL, V38, P683, DOI 10.1093/schbul/sbs045; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609	63	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e108828	10.1371/journal.pone.0108828	http://dx.doi.org/10.1371/journal.pone.0108828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329799	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100013
J	Lachin, JM				Lachin, John M.			Applications of the Wei-Lachin Multivariate One-Sided Test for Multiple Outcomes on Possibly Different Scales	PLOS ONE			English	Article							LIKELIHOOD RATIO TEST; NORMAL-MEAN VECTOR; SAMPLE-SIZE; SURVIVAL; ESTIMATORS; COVARIATE; POWER	Many studies aim to assess whether a therapy has a beneficial effect on multiple outcomes simultaneously relative to a control. Often the joint null hypothesis of no difference for the set of outcomes is tested using separate tests with a correction for multiple tests, or using a multivariate T-2-like MANOVA or global test. However, a more powerful test in this case is a multivariate one-sided or one-directional test directed at detecting a simultaneous beneficial treatment effect on each outcome, though not necessarily of the same magnitude. The Wei-Lachin test is a simple 1 df test obtained from a simple sum of the component statistics that was originally described in the context of a multivariate rank analysis. Under mild conditions this test provides a maximin efficient test of the null hypothesis of no difference between treatment groups for all outcomes versus the alternative hypothesis that the experimental treatment is better than control for some or all of the component outcomes, and not worse for any. Herein applications are described to a simultaneous test for multiple differences in means, proportions or life-times, and combinations thereof, all on potentially different scales. The evaluation of sample size and power for such analyses is also described. For a test of means of two outcomes with a common unit variance and correlation 0.5, the sample size needed to provide 90% power for two separate one-sided tests at the 0.025 level is 64% greater than that needed for the single Wei-Lachin multivariate one-directional test at the 0.05 level. Thus, a Wei-Lachin test with these operating characteristics is 39% more efficient than two separate tests. Likewise, compared to a T-2-like omnibus test on 2 df, the Wei-Lachin test is 32% more efficient. An example is provided in which the Wei-Lachin test of multiple components has superior power to a test of a composite outcome.	George Washington Univ, Biostat Ctr, Rockville, MD 20052 USA	George Washington University	Lachin, JM (corresponding author), George Washington Univ, Biostat Ctr, Rockville, MD 20052 USA.	jml@bsc.gwu.edu		Lachin, John/0000-0001-9838-2841	NIDDK, NIH [1U01-DK-098246-01]; Massachusetts General Hospital; NIDDK for the Diabetes Prevention Program Outcomes Study [U01-DK-48489]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK098246, U01DK048489] Funding Source: NIH RePORTER	NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Massachusetts General Hospital(General Electric); NIDDK for the Diabetes Prevention Program Outcomes Study; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported with funding from NIDDK, NIH for the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study through grant 1U01-DK-098246-01, John M. Lachin and David M. Nathan (Massachusetts General Hospital) co-Principal Investigators. This work was also partially supported by funding from NIDDK for the Diabetes Prevention Program Outcomes Study through grant U01-DK-48489, Sarah Fowler, Principal Investigator). The funders had no role in the conduct of this methodological research, the decision to publish, or preparation of the manuscript.	Andersen P. K., 2012, STAT MODELS BASED CO; ANDERSEN PK, 1982, INT STAT REV, V50, P219, DOI 10.2307/1402489; Bloch DA, 2001, BIOMETRICS, V57, P1039, DOI 10.1111/j.0006-341X.2001.01039.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Demidenko E, 2005, MIXED MODELS THEORY; Fleming TR, 1991, COUNTING PROCESSES S; Follmann D, 1996, J AM STAT ASSOC, V91, P854, DOI 10.2307/2291680; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; Frick H, 1997, BIOMETRICAL J, V39, P125, DOI 10.1002/bimj.4710390112; FRICK H, 1995, BIOMETRICAL J, V37, P909, DOI 10.1002/bimj.4710370803; FRICK H, 1994, COMMUN STAT THEORY, V23, P1021, DOI 10.1080/03610929408831302; GASTWIRTH JL, 1966, J AM STAT ASSOC, V61, P929, DOI 10.2307/2283190; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; HOLM S, 1979, SCAND J STAT, V6, P65; Hougaard, 2000, ANAL MULTIVARIATE SU; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; KUDO A, 1963, BIOMETRIKA, V50, P403, DOI 10.2307/2333909; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; LACHIN JM, 1986, BIOMETRICS, V42, P507, DOI 10.2307/2531201; LACHIN JM, 1988, BIOMETRICS, V44, P513, DOI 10.2307/2531864; LACHIN JM, 1992, STAT MED, V11, P1151, DOI 10.1002/sim.4780110903; Lachin JM, 2011, BIOSTATICAL METHODS; LAKATOS E, 1988, BIOMETRICS, V44, P229, DOI 10.2307/2531910; Lauter J, 1996, BIOMETRICS, V52, P964, DOI 10.2307/2533057; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MARSHALL AW, 1967, J AM STAT ASSOC, V62, P30, DOI 10.2307/2282907; Nathan DM, 2013, DIABETES CARE, V36, P2254, DOI 10.2337/dc13-0356; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Orchard TJ, 2005, ANN INTERN MED, V142, P611, DOI 10.7326/0003-4819-142-8-200504190-00009; Pan Qing, 2013, Front Public Health, V1, P63, DOI 10.3389/fpubh.2013.00063; Perlman MD, 2004, BIOMETRICS, V60, P276, DOI 10.1111/j.0006-341X.2004.00159.x; PERLMAN MD, 1969, ANN MATH STAT, V40, P549, DOI 10.1214/aoms/1177697723; Pipper CB, 2012, J R STAT SOC C-APPL, V61, P315, DOI 10.1111/j.1467-9876.2011.01005.x; POCOCK SJ, 1987, BIOMETRICS, V43, P487, DOI 10.2307/2531989; Rahlfs V, 2012, PHARM MED, V14, P160; Robertson T., 1988, ORDER RESTRICTED STA; RUBINSTEIN LV, 1981, J CHRON DIS, V34, P469, DOI 10.1016/0021-9681(81)90007-2; Tamhane AC, 2002, BIOMETRICS, V58, P650, DOI 10.1111/j.0006-341X.2002.00650.x; Tamhane AC, 2003, 43 MED COLL WISC DEV; TANG DI, 1989, BIOMETRIKA, V76, P577, DOI 10.2307/2336122; THALL PF, 1986, STAT MED, V5, P73, DOI 10.1002/sim.4780050110; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; WEI LJ, 1984, J AM STAT ASSOC, V79, P653, DOI 10.2307/2288413	44	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e108784	10.1371/journal.pone.0108784	http://dx.doi.org/10.1371/journal.pone.0108784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329662	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100005
J	Yeung, TPC; Kurdi, M; Wang, Y; Al-Khazraji, B; Morrison, L; Hoffman, L; Jackson, D; Crukley, C; Lee, TY; Bauman, G; Yartsev, S				Yeung, Timothy Pok Chi; Kurdi, Maher; Wang, Yong; Al-Khazraji, Baraa; Morrison, Laura; Hoffman, Lisa; Jackson, Dwayne; Crukley, Cathie; Lee, Ting-Yim; Bauman, Glenn; Yartsev, Slav			CT Perfusion Imaging as an Early Biomarker of Differential Response to Stereotactic Radiosurgery in C6 Rat Gliomas	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; GLIOBLASTOMA-MULTIFORME; RADIATION-THERAPY; MALIGNANT GLIOMAS; HYPOFRACTIONATED RADIOTHERAPY; ADJUVANT TEMOZOLOMIDE; VASCULAR MATURATION; MODEL; SURVIVAL; GROWTH	Background: The therapeutic efficacy of stereotactic radiosurgery for glioblastoma is not well understood, and there needs to be an effective biomarker to identify patients who might benefit from this treatment. This study investigated the efficacy of computed tomography (CT) perfusion imaging as an early imaging biomarker of response to stereotactic radiosurgery in a malignant rat glioma model. Methods: Rats with orthotopic C6 glioma tumors received either mock irradiation (controls, N = 8) or stereotactic radiosurgery (N = 25, 12 Gy in one fraction) delivered by Helical Tomotherapy. Twelve irradiated animals were sacrificed four days after stereotactic radiosurgery to assess acute CT perfusion and histological changes, and 13 irradiated animals were used to study survival. Irradiated animals with survival > 15 days were designated as responders while those with survival <= 15 days were non-responders. Longitudinal CT perfusion imaging was performed at baseline and regularly for eight weeks post-baseline. Results: Early signs of radiation-induced injury were observed on histology. There was an overall survival benefit following stereotactic radiosurgery when compared to the controls (log-rank P < 0.04). Responders to stereotactic radiosurgery showed lower relative blood volume (rBV), and permeability-surface area (PS) product on day 7 post-stereotactic radiosurgery when compared to controls and non-responders (P < 0.05). rBV and PS on day 7 showed correlations with overall survival (P < 0.05), and were predictive of survival with 92% accuracy. Conclusions: Response to stereotactic radiosurgery was heterogeneous, and early selection of responders and nonresponders was possible using CT perfusion imaging. Validation of CT perfusion indices for response assessment is necessary before clinical implementation.	[Yeung, Timothy Pok Chi; Al-Khazraji, Baraa; Hoffman, Lisa; Jackson, Dwayne; Lee, Ting-Yim; Bauman, Glenn; Yartsev, Slav] Western Univ, Dept Med Biophys, London, ON, Canada; [Yeung, Timothy Pok Chi; Wang, Yong; Crukley, Cathie; Lee, Ting-Yim] Western Univ, Robarts Res Inst, London, ON, Canada; [Kurdi, Maher] Western Univ, Dept Pathol, London, ON, Canada; [Kurdi, Maher] King Abdulaziz Univ, Dept Pathol, Jeddah 21413, Makkah, Saudi Arabia; [Hoffman, Lisa] Western Univ, Dept Anat & Cell Biol, London, ON, Canada; [Morrison, Laura; Hoffman, Lisa; Lee, Ting-Yim] Lawson Imaging, Lawson Hlth Res Inst, London, ON, Canada; [Lee, Ting-Yim] Western Univ, Dept Med Imaging, London, ON, Canada; [Lee, Ting-Yim; Bauman, Glenn; Yartsev, Slav] Western Univ, Dept Oncol, London, ON, Canada; [Yeung, Timothy Pok Chi; Bauman, Glenn; Yartsev, Slav] London Reg Canc Program, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); King Abdulaziz University; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Yeung, TPC (corresponding author), Western Univ, Dept Med Biophys, London, ON, Canada.	timothy.pokchi.yeung@gmail.com	Yartsev, Slav/AAN-6279-2021; Lee, Ting-Yim/M-1721-2013; Bauman, Glenn S/D-5986-2011; Al-Khazraji, Baraa/AAI-6118-2021; Hoffman, Lisa/B-5324-2015; Yartsev, Slav/E-8814-2015; Al-Khazraji, Baraa/S-1994-2016; Wang, Yong/B-6207-2015	Al-Khazraji, Baraa/0000-0003-1075-4183; Al-Khazraji, Baraa/0000-0003-1075-4183; Wang, Yong/0000-0003-4707-5280; Bauman, Glenn/0000-0002-5279-7360	Brain Tumour Foundation of Canada; Canadian Institutes of Health Research; Canadian Institutes of Health Research Strategic Training Program in Cancer Research and Technology Transfer	Brain Tumour Foundation of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Strategic Training Program in Cancer Research and Technology Transfer(Canadian Institutes of Health Research (CIHR))	This project was funded by the Brain Tumour Foundation of Canada, the Canadian Institutes of Health Research (T.P.C.Y.), and the Canadian Institutes of Health Research Strategic Training Program in Cancer Research and Technology Transfer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch R, 1999, CANCER RES, V59, P5012; Burrell JS, 2012, INT J CANCER, V131, P1854, DOI 10.1002/ijc.27460; Cenic A, 2000, AM J NEURORADIOL, V21, P462; Du LY, 2007, PHYS MED BIOL, V52, P7087, DOI 10.1088/0031-9155/52/23/021; Flickinger JC, 2000, INT J RADIAT ONCOL, V46, P1143, DOI 10.1016/S0360-3016(99)00513-1; Gahramanov S, 2013, RADIOLOGY, V266, P842, DOI 10.1148/radiol.12111472; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gilead A, 2004, INT J CANCER, V108, P524, DOI 10.1002/ijc.11583; Grabham P, 2011, RADIAT RES, V175, P21, DOI 10.1667/RR2289.1; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Guan LM, 2011, J NEUROSURG, V114, P1672, DOI 10.3171/2011.1.JNS101513; Hingorani M, 2012, BRIT J RADIOL, V85, pE770, DOI 10.1259/bjr/83827377; Hong XH, 2014, NEURO-ONCOLOGY, V16, P856, DOI 10.1093/neuonc/not245; Hu LS, 2012, AM J NEURORADIOL, V33, P69, DOI 10.3174/ajnr.A2743; Iuchi T, 2014, INT J RADIAT ONCOL, V88, P793, DOI 10.1016/j.ijrobp.2013.12.011; JOHNSON JA, 1966, AM J PHYSIOL, V210, P1299, DOI 10.1152/ajplegacy.1966.210.6.1299; KONDZIOLKA D, 1992, NEUROSURGERY, V31, P280, DOI 10.1227/00006123-199208000-00013; Kondziolka D, 1996, J NEUROSURG, V84, P1033, DOI 10.3171/jns.1996.84.6.1033; Lee TY, 2003, Q J NUCL MED, V47, P171; Levegrun S, 2004, INT J RADIAT ONCOL, V59, P796, DOI 10.1016/j.ijrobp.2003.11.033; Mangla R, 2010, RADIOLOGY, V256, P575, DOI 10.1148/radiol.10091440; MEHTA MP, 1994, INT J RADIAT ONCOL, V30, P541, DOI 10.1016/0360-3016(92)90939-F; Park HJ, 2012, RADIAT RES, V177, P311, DOI 10.1667/RR2773.1; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Reddy K, 2013, J NEURO-ONCOL, V114, P111, DOI 10.1007/s11060-013-1159-6; Roduit N, JMICRO VISION IMAGE; Romanelli P, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.9.FOCUS09187; Sabatasso S, 2011, INT J RADIAT ONCOL, V80, P1522, DOI 10.1016/j.ijrobp.2011.03.018; SARKARIA JN, 1995, INT J RADIAT ONCOL, V32, P931, DOI 10.1016/0360-3016(94)00621-Q; Schuuring J, 2005, INT J RADIAT ONCOL, V61, P529, DOI 10.1016/j.ijrobp.2004.09.063; Souhami L, 2004, INT J RADIAT ONCOL, V60, P853, DOI 10.1016/j.ijrobp.2004.04.011; The WHO, 2020, CLASSIFICATION TUMOU; Tsao MN, 2005, INT J RADIAT ONCOL, V63, P47, DOI 10.1016/j.ijrobp.2005.05.024; WALKER MD, 1979, INT J RADIAT ONCOL, V5, P1725, DOI 10.1016/0360-3016(79)90553-4; Wang Jingli, 1999, Neoplasia (New York), V1, P138, DOI 10.1038/sj.neo.7900015; Wang JZ, 2005, INT J RADIAT ONCOL, V61, P220, DOI 10.1016/j.ijrobp.2004.09.043; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Yoon SM, 2013, TUMORI, V99, P480, DOI 10.1700/1361.15098; Zawaski JA, 2012, INT J RADIAT ONCOL, V82, P1075, DOI 10.1016/j.ijrobp.2011.06.1984	40	3	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109781	10.1371/journal.pone.0109781	http://dx.doi.org/10.1371/journal.pone.0109781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329655	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100028
J	Trinite, B; Chan, CN; Lee, CS; Mahajan, S; Luo, Y; Muesing, MA; Folkvord, JM; Pham, M; Connick, E; Levy, DN				Trinite, Benjamin; Chan, Chi N.; Lee, Caroline S.; Mahajan, Saurabh; Luo, Yang; Muesing, Mark A.; Folkvord, Joy M.; Michael Pham; Connick, Elizabeth; Levy, David N.			Suppression of Foxo1 Activity and Down-Modulation of CD62L (L-Selectin) in HIV-1 Infected Resting CD4 T Cells	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; KAPPA-B ACTIVATION; HIV-1 REPLICATION; GENE-EXPRESSION; PRIMARY LYMPHOCYTES; CCR5 EXPRESSION; AKT INHIBITORS; UP-REGULATION; NEF PROTEIN; IN-VITRO	HIV-1 hijacks and disrupts many processes in the cells it infects in order to suppress antiviral immunity and to facilitate its replication. Resting CD4 T cells are important early targets of HIV-1 infection in which HIV-1 must overcome intrinsic barriers to viral replication. Although resting CD4 T cells are refractory to infection in vitro, local environmental factors within lymphoid and mucosal tissues such as cytokines facilitate viral replication while maintaining the resting state. These factors can be utilized in vitro to study HIV-1 replication in resting CD4 T cells. In vivo, the migration of resting naive and central memory T cells into lymphoid tissues is dependent upon expression of CD62L (L-selectin), a receptor that is subsequently down-modulated following T cell activation. CD62L gene transcription is maintained in resting T cells by Foxo1 and KLF2, transcription factors that maintain T cell quiescence and which regulate additional cellular processes including survival, migration, and differentiation. Here we report that HIV-1 down-modulates CD62L in productively infected naive and memory resting CD4 T cells while suppressing Foxo1 activity and the expression of KLF2 mRNA. Partial T cell activation was further evident as an increase in CD69 expression. Several other Foxo1- and KLF2-regulated mRNA were increased or decreased in productively infected CD4 T cells, including IL-7r alpha, Myc, CCR5, Fam65b, S1P(1) (EDG1), CD52, Cyclin D2 and p21(CIP1), indicating a profound reprogramming of these cells. The Foxo1 inhibitor AS1842856 accelerated de novo viral gene expression and the sequella of infection, supporting the notion that HIV-1 suppression of Foxo1 activity may be a strategy to promote replication in resting CD4 T cells. As Foxo1 is an investigative cancer therapy target, the development of Foxo1 interventions may assist the quest to specifically suppress or activate HIV-1 replication in vivo.	[Trinite, Benjamin; Chan, Chi N.; Lee, Caroline S.; Mahajan, Saurabh; Levy, David N.] NYU, Coll Dent, Dept Basic Sci, New York, NY 10012 USA; [Luo, Yang; Muesing, Mark A.] Aaron Diamond AIDS Res Ctr, New York, NY USA; [Folkvord, Joy M.; Michael Pham; Connick, Elizabeth] Univ Colorado Denver, Dept Med, Aurora, CO USA	New York University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Levy, DN (corresponding author), NYU, Coll Dent, Dept Basic Sci, New York, NY 10012 USA.	dnlevy@nyu.edu			National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01 AI078783, R01 AI081615, R01 AI096966]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081615, R01AI096966, R01AI078783] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R01 AI078783, National Institute of Allergy and Infectious Diseases, National Institutes of Health to DNL; R01 AI081615, National Institute of Allergy and Infectious Diseases, National Institutes of Health to MAM; and R01 AI096966, National Institute of Allergy and Infectious Diseases, National Institutes of Health to EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Walter, 2011, P T, V36, P225; Amini S, 2004, J BIOL CHEM, V279, P46046, DOI 10.1074/jbc.M403792200; Aronica MA, 2000, CYTOKINE, V12, P578, DOI 10.1006/cyto.1999.0603; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Berstein G, 2008, NAT IMMUNOL, V9, P455, DOI 10.1038/ni0508-455; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Blazquez MV, 1999, AIDS RES HUM RETROV, V15, P1209, DOI 10.1089/088922299310304; BOISE LH, 1995, P NATL ACAD SCI USA, V92, P5491, DOI 10.1073/pnas.92.12.5491; Borgatti P, 1997, EUR J IMMUNOL, V27, P2805, DOI 10.1002/eji.1830271110; Bradley LM, 2005, TRENDS IMMUNOL, V26, P172, DOI 10.1016/j.it.2005.01.004; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carrette F, 2009, ADV EXP MED BIOL, V665, P3; Chao CC, 1997, J IMMUNOL, V159, P1686; Chowdhury IH, 2003, VIROLOGY, V305, P371, DOI 10.1006/viro.2002.1777; Chu Peter, 2003, J Biol, V2, P21, DOI 10.1186/1475-4924-2-21; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Coffer PJ, 2003, TRENDS IMMUNOL, V24, P470, DOI 10.1016/S1471-4906(03)00205-9; Cui M, 2009, ADV EXP MED BIOL, V665, P143; Dejean AS, 2011, ANTIOXID REDOX SIGN, V14, P663, DOI 10.1089/ars.2010.3414; Denisova OV, 2014, ANTIMICROB AGENTS CH, V58, P3689, DOI 10.1128/AAC.02798-13; Duchesneau P, 2007, EUR J IMMUNOL, V37, P2949, DOI 10.1002/eji.200737118; Ducrey-Rundquist O, 2002, J VIROL, V76, P9103, DOI 10.1128/JVI.76.18.9103-9111.2002; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Estes JD, 2013, IMMUNOL REV, V254, P65, DOI 10.1111/imr.12070; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Fulcher DA, 1999, IMMUNOL CELL BIOL, V77, P559, DOI 10.1046/j.1440-1711.1999.00870.x; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Garris CS, 2014, IMMUNOLOGY, V142, P347, DOI 10.1111/imm.12272; Gelderblom HC, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-60; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Gomez J, 1998, ONCOGENE, V17, P1235, DOI 10.1038/sj.onc.1202049; Haaland RE, 2005, MOL IMMUNOL, V42, P627, DOI 10.1016/j.molimm.2004.09.012; Hatziioannou T, 2014, SCIENCE, V344, P1401, DOI 10.1126/science.1250761; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Huang HJ, 2011, BBA-MOL CELL RES, V1813, P1961, DOI 10.1016/j.bbamcr.2011.01.007; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim D, 2010, J BIOL CHEM, V285, P8383, DOI 10.1074/jbc.M109.094060; Kim Young Sook, 2011, Evid Based Complement Alternat Med, V2011, P761859, DOI 10.1093/ecam/nep078; Kinter A, 2003, AIDS RES HUM RETROV, V19, P847, DOI 10.1089/088922203322493012; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Landi A, 2011, CURR HIV RES, V9, P496, DOI 10.2174/157016211798842116; Ledderose Carola, 2011, BMC Res Notes, V4, P427, DOI 10.1186/1756-0500-4-427; Leenders H, 2000, EUR J IMMUNOL, V30, P2980, DOI 10.1002/1521-4141(200010)30:10<2980::AID-IMMU2980>3.0.CO;2-9; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; LEVY DN, 1993, CELL, V72, P541, DOI 10.1016/0092-8674(93)90073-Y; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Li ZJ, 2012, CLIN CANCER RES, V18, P3603, DOI 10.1158/1078-0432.CCR-11-3321; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Marodon G, 1999, AIDS RES HUM RETROV, V15, P161, DOI 10.1089/088922299311583; Marschner S, 1999, P NATL ACAD SCI USA, V96, P9763, DOI 10.1073/pnas.96.17.9763; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Meditz AL, 2011, J VIROL, V85, P10189, DOI 10.1128/JVI.02529-10; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Misse D, 2005, AIDS, V19, P897, DOI 10.1097/01.aids.0000171403.07995.92; Moutsopoulos NM, 2006, J LEUKOCYTE BIOL, V80, P1145, DOI 10.1189/jlb.0306142; Mudd JC, 2013, BLOOD, V121, P2914, DOI 10.1182/blood-2012-07-445783; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Ostrowski MA, 1999, J VIROL, V73, P6430, DOI 10.1128/JVI.73.8.6430-6435.1999; Oswald-Richter K, 2004, EUR J IMMUNOL, V34, P1705, DOI 10.1002/eji.200424892; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Pan XY, 2013, CELL RES, V23, P876, DOI 10.1038/cr.2013.74; Preston GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077537; Radulovic K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065413; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Ramirez PW, 2014, CELL REP, V7, P2019, DOI 10.1016/j.celrep.2014.05.015; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; RHEE SS, 1994, J IMMUNOL, V152, P5128; Richardson MW, 2012, J IMMUNOL, V189, P3815, DOI 10.4049/jimmunol.1201431; Roederer M, 2001, CYTOMETRY, V45, P37, DOI 10.1002/1097-0320(20010901)45:1<37::AID-CYTO1142>3.0.CO;2-E; Rollins BJ, 2008, NAT IMMUNOL, V9, P233, DOI 10.1038/ni0308-233; Rougerie P, 2013, J IMMUNOL, V190, P748, DOI 10.4049/jimmunol.1201174; Rougerie P, 2012, IMMUNOL LETT, V142, P1, DOI 10.1016/j.imlet.2011.12.003; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schacker T, 2001, J INFECT DIS, V183, P555, DOI 10.1086/318524; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Schober SL, 1999, J IMMUNOL, V163, P3662; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Sedaghat AR, 2007, PLOS PATHOG, V3, P1165, DOI 10.1371/journal.ppat.0030122; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Shore AM, 2006, J VIROL, V80, P11191, DOI 10.1128/JVI.00983-06; SIEKEVITZ M, 1987, P NATL ACAD SCI USA, V84, P5389, DOI 10.1073/pnas.84.15.5389; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Steffens CM, 2002, BLOOD, V99, P3310, DOI 10.1182/blood.V99.9.3310; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Swann SA, 2001, VIROLOGY, V282, P267, DOI 10.1006/viro.2000.0816; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; Trinite B, 2013, J VIROL, V87, P12701, DOI 10.1128/JVI.01939-13; Tzachanis D, 2004, LEUKEMIA LYMPHOMA, V45, P1959, DOI 10.1080/1042819042000219494; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; van Grevenynghe J, 2008, NAT MED, V14, P266, DOI 10.1038/nm1728; van Grevenynghe J, 2012, CYTOKINE GROWTH F R, V23, P215, DOI 10.1016/j.cytogfr.2012.05.008; Vatakis DN, 2010, IMMUNOL RES, V48, P110, DOI 10.1007/s12026-010-8171-0; Vazquez N, 2005, J VIROL, V79, P4479, DOI 10.1128/JVI.79.7.4479-4491.2005; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Wang JF, 2004, BLOOD, V103, P1218, DOI 10.1182/blood-2003-02-0576; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; Wang LQ, 1997, VIROLOGY, V228, P141, DOI 10.1006/viro.1996.8397; Wang Y, 2010, J IMMUNOL, V184, P4447, DOI 10.4049/jimmunol.0902925; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yusuf I, 2003, TRENDS IMMUNOL, V24, P380, DOI 10.1016/S1471-4906(03)00141-8; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zack JA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-37; Zhang LQ, 2000, J CLIN INVEST, V106, P839, DOI 10.1172/JCI10565; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101; Zhou F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053145	138	32	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110719	10.1371/journal.pone.0110719	http://dx.doi.org/10.1371/journal.pone.0110719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330112	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210800108
J	Calvert, M; Kyte, D; Duffy, H; Gheorghe, A; Mercieca-Bebber, R; Ives, J; Draper, H; Brundage, M; Blazeby, J; King, M				Calvert, Melanie; Kyte, Derek; Duffy, Helen; Gheorghe, Adrian; Mercieca-Bebber, Rebecca; Ives, Jonathan; Draper, Heather; Brundage, Michael; Blazeby, Jane; King, Madeleine			Patient-Reported Outcome (PRO) Assessment in Clinical Trials: A Systematic Review of Guidance for Trial Protocol Writers	PLOS ONE			English	Article							QUALITY-OF-LIFE; NATIONAL-CANCER-INSTITUTE; RANDOMIZED-TRIALS; ISSUES; INTEGRATION; EXAMPLE; CLAIMS	Background: Evidence suggests there are inconsistencies in patient-reported outcome (PRO) assessment and reporting in clinical trials, which may limit the use of these data to inform patient care. For trials with a PRO endpoint, routine inclusion of key PRO information in the protocol may help improve trial conduct and the reporting and appraisal of PRO results; however, it is currently unclear exactly what PRO-specific information should be included. The aim of this review was to summarize the current PRO-specific guidance for clinical trial protocol developers. Methods and Findings: We searched the MEDLINE, EMBASE, CINHAL and Cochrane Library databases (inception to February 2013) for PRO-specific guidance regarding trial protocol development. Further guidance documents were identified via Google, Google scholar, requests to members of the UK Clinical Research Collaboration registered clinical trials units and international experts. Two independent investigators undertook title/abstract screening, full text review and data extraction, with a third involved in the event of disagreement. 21,175 citations were screened and 54 met the inclusion criteria. Guidance documents were difficult to access: electronic database searches identified just 8 documents, with the remaining 46 sourced elsewhere (5 from citation tracking, 27 from hand searching, 7 from the grey literature review and 7 from experts). 162 unique PRO-specific protocol recommendations were extracted from included documents. A further 10 PRO recommendations were identified relating to supporting trial documentation. Only 5/162 (3%) recommendations appeared in >= 50% of guidance documents reviewed, indicating a lack of consistency. Conclusions: PRO-specific protocol guidelines were difficult to access, lacked consistency and may be challenging to implement in practice. There is a need to develop easily accessible consensus-driven PRO protocol guidance. Guidance should be aimed at ensuring key PRO information is routinely included in appropriate trial protocols, in order to facilitate rigorous collection/reporting of PRO data, to effectively inform patient care.	[Calvert, Melanie; Kyte, Derek; Duffy, Helen] Univ Birmingham, Birmingham, W Midlands, England; [Calvert, Melanie; Draper, Heather] MRC Midland Hub Trials Methodol Res, Birmingham, W Midlands, England; [Kyte, Derek] Univ Birmingham, Sch Sport Exercise & Rehabil, Birmingham, W Midlands, England; [Gheorghe, Adrian] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Mercieca-Bebber, Rebecca; King, Madeleine] Univ Sydney, Psychooncol Cooperat Res Grp, Sydney, NSW 2006, Australia; [Ives, Jonathan; Draper, Heather] Univ Birmingham, Birmingham, W Midlands, England; [Brundage, Michael] Queens Univ, Kingston, ON, Canada; [Blazeby, Jane] Univ Bristol, Sch Social & Community Med, MRC ConDuCT Hub Trials Methodol Res 2, Bristol, Avon, England	University of Birmingham; University of Birmingham; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; University of Birmingham; Queens University - Canada; University of Bristol	Calvert, M (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	M.Calvert@bham.ac.uk	Blazeby, Jane/H-6703-2019; Ives, Jonathan/ABE-4437-2020; Calvert, Melanie/F-7055-2011	Blazeby, Jane/0000-0002-3354-3330; Ives, Jonathan/0000-0002-5233-5000; Calvert, Melanie/0000-0002-1856-837X; Mercieca-Bebber, Rebecca/0000-0003-3708-9099; kyte, Derek/0000-0002-7679-6741; Draper, Heather/0000-0002-0020-4252	National Institute for Health Research School for Primary Care Research; Medical Research Council [G0800808]; Medical Research Council [G0800800] Funding Source: researchfish; National Institute for Health Research [SPCR-017] Funding Source: researchfish; MRC [G0800808, G0800800] Funding Source: UKRI	National Institute for Health Research School for Primary Care Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the National Institute for Health Research School for Primary Care Research. Professors Calvert and Draper are members of the Medical Research Council Midland Hub for Trials Methodology Research (Medical Research Council grant G0800808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, LANCET, V375, P1225, DOI 10.1016/S0140-6736(10)60523-5; [Anonymous], 2014, NCIC CTG QUALITY LIF; Avery K, 2006, WORLD J SURG, V30, P1163, DOI 10.1007/s00268-006-0075-8; Basch, 2011, RECOMMENDATIONS INCO; Basch E, 2010, NEW ENGL J MED, V362, P865, DOI 10.1056/NEJMp0911494; Bernhard J, 1998, STAT MED, V17, P517, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<517::AID-SIM799>3.0.CO;2-S; Bernhard J, 1998, STAT MED, V17, P587, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<587::AID-SIM806>3.0.CO;2-#; BOTTOMLEY A, 2001, APPL CLIN TRIALS, V10, P40; Brooks MM, 1998, MED CARE, V36, P1515, DOI 10.1097/00005650-199810000-00009; Brundage M, 2011, QUAL LIFE RES, V20, P653, DOI 10.1007/s11136-010-9793-3; Buchanan DR, 2005, J CLIN ONCOL, V23, P591, DOI 10.1200/JCO.2005.12.181; Calvert M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-184; Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; Calvert MJ, 2004, J CLIN PHARM THER, V29, P85, DOI 10.1046/j.0269-4727.2003.00520.x; CELLA DF, 1993, QUAL LIFE RES, V2, P433, DOI 10.1007/BF00422217; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chassany O, 2002, DRUG INF J, V36, P209, DOI 10.1177/009286150203600127; Curran D, 1998, STAT MED, V17, P697, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<697::AID-SIM815>3.0.CO;2-Y; de Haes J, 2000, EUR J CANCER, V36, P821, DOI 10.1016/S0959-8049(00)00007-1; Dolan P, 2005, HEALTH ECON, V14, P197, DOI 10.1002/hec.924; Efficace F, 2012, J NEURO-ONCOL, V108, P221, DOI 10.1007/s11060-012-0819-2; EORTC, 2002, GUID ASS QUAL LIF EO; Fairclough DL, 2012, DESIGN ANAL QUALITY; Fayers PM, 1997, EUR J CANCER, V33, P20, DOI 10.1016/S0959-8049(96)00412-1; Fayers PM, 2007, QUALITY LIFE ASSESSM; FDA, 2009, PATT REP OUTC MEAS U; Fielding S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-51; Ganz PA, 2007, J CLIN ONCOL, V25, P5063, DOI 10.1200/JCO.2007.11.0197; Gotay C, 1992, ONCOLOGY WILLISTON P, V6, P30; Gotay C, 1992, ONCOLOGY WILLISTON P, V6, P37; Gotay C C, 1992, Oncology (Williston Park), V6, P25; GOTAY CC, 1992, J NATL CANCER I, V84, P575, DOI 10.1093/jnci/84.8.575; Hakamies-Blomqvist L, 2001, J ADV NURS, V35, P709, DOI 10.1046/j.1365-2648.2001.01903.x; Hao Y, 2010, PATIENT REPORTED OUT; Hayden K, 1993, PITFALLS QUALITY OF, P1415; iProspect, 2006, IPROSPECT SEARCH ENG; Jensen R. E., 2012, Clinical Investigation, V2, P563; Kiebert GM, 1997, EUR J CANCER, V33, pS31, DOI 10.1016/S0959-8049(97)00144-5; King M, 2011, QUALITY LIFE PROTOCO; Kyte D, 2013, PLOS ONE, P8; Kyte D, 2013, JAMA-J AM MED ASSOC, V310, P1229, DOI 10.1001/jama.2013.277222; Kyte DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060684; Land SR, 2007, J CLIN ONCOL, V25, P5113, DOI 10.1200/JCO.2007.12.1749; Leidy N K, 1999, Value Health, V2, P113, DOI 10.1046/j.1524-4733.1999.02210.x; Lipscomb J, 2004, OUTCOMES ASSESSMENT; Lipscomb J, 2007, J CLIN ONCOL, V25, P5133, DOI 10.1200/JCO.2007.12.4644; Macefield RC, 2013, BRIT J SURG, V100, P28, DOI 10.1002/bjs.8989; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moinpour CM, 1998, STAT MED, V17, P641, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<641::AID-SIM811>3.0.CO;2-W; MOINPOUR CM, 1989, J NATL CANCER I, V81, P485, DOI 10.1093/jnci/81.7.485; MOLIN C, 1995, EUR J CANCER, V31A, pS8, DOI 10.1016/0959-8049(95)00495-5; Movsas B, 2003, SEMIN RADIAT ONCOL, V13, P235, DOI 10.1016/S1053-4296(03)00029-8; Nayfield S G, 1992, Qual Life Res, V1, P203, DOI 10.1007/BF00635619; Novik, EUROPEAN HEMATOLOGY; Osoba D, 1999, EUR J CANCER, V35, P1565, DOI 10.1016/S0959-8049(99)00192-6; Osoba D, 1992, Qual Life Res, V1, P211, DOI 10.1007/BF00635620; Osoba D, 1998, STAT MED, V17, P603, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<603::AID-SIM807>3.0.CO;2-D; Patrick DL, 2007, VALUE HEALTH, V10, pS125, DOI 10.1111/j.1524-4733.2007.00275.x; Revicki DA, 2000, QUAL LIFE RES, V9, P887, DOI 10.1023/A:1008996223999; Revicki DA., 2005, ASSESSING QUALITY LI, P209; Revicki DA, 2007, VALUE HEALTH, V10, pS116, DOI 10.1111/j.1524-4733.2007.00274.x; SADURA A, 1992, J NATL CANCER I, V84, P1023, DOI 10.1093/jnci/84.13.1023; Santanello Nancy C, 2002, Value Health, V5, P14, DOI 10.1046/j.1524-4733.2002.51047.x; Schron E B, 1992, Prog Cardiovasc Nurs, V7, P21; Simes RJ, 1998, STAT MED, V17, P725; Sloan JA, 2007, VALUE HEALTH, V10, pS106, DOI 10.1111/j.1524-4733.2007.00273.x; Spilker, 1996, QUALITY LIFE PHARMAC; TROG, 2007, ASS HLTH REL QUAL LI; Wiklund I, 2004, FUND CLIN PHARMACOL, V18, P351, DOI 10.1111/j.1472-8206.2004.00234.x	70	52	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110216	10.1371/journal.pone.0110216	http://dx.doi.org/10.1371/journal.pone.0110216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25333995	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000346766200102
J	Fan, R; Zhao, JC; Chen, Y; Xu, K				Fan, Rui; Zhao, Jichang; Chen, Yan; Xu, Ke			Anger Is More Influential than Joy: Sentiment Correlation in Weibo	PLOS ONE			English	Article							HAPPINESS	Recent years have witnessed the tremendous growth of the online social media. In China, Weibo, a Twitter-like service, has attracted more than 500 million users in less than five years. Connected by online social ties, different users might share similar affective states. We find that the correlation of anger among users is significantly higher than that of joy. While the correlation of sadness is surprisingly low. Moreover, there is a stronger sentiment correlation between a pair of users if they share more interactions. And users with larger number of friends possess more significant sentiment correlation with their neighborhoods. Our findings could provide insights for modeling sentiment influence and propagation in online social networks.	[Fan, Rui; Chen, Yan; Xu, Ke] Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China; [Zhao, Jichang] Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China	Beihang University; Beihang University	Xu, K (corresponding author), Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China.	kexu@nlsde.buaa.edu.cn		Zhao, Jichang/0000-0002-5319-8060	863 Program [2012AA011005]; SKLSDE [SKLSDE-2013ZX-06]; Research Fund for the Doctoral Program of Higher Education of China [20111102110019]; Fundamental Research Funds for the Central Universities [YWF-14-RSC-109, YWF-14-JGXY-001]	863 Program(National High Technology Research and Development Program of China); SKLSDE; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by 863 Program (grant no. 2012AA011005), SKLSDE (grant no. SKLSDE-2013ZX-06), and Research Fund for the Doctoral Program of Higher Education of China (grant no. 20111102110019). Jichang Zhao was partially supported by the Fundamental Research Funds for the Central Universities (grant nos. YWF-14-RSC-109 and YWF-14-JGXY-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Aoki Sho, 2011, Recent Researchers in Applied Computer and Applied Computational Science. 10th WSEAS International Conference on Applied Computer and Applied Computational Science (ACACOS' 11), P132; Bliss CA, 2012, J COMPUT SCI-NETH, V3, P388, DOI 10.1016/j.jocs.2012.05.001; Bollen J, 2011, 5 ICWSM; Bollen J, 2011, ARTIF LIFE, V17, P237, DOI 10.1162/artl_a_00034; Chmiel A, 2011, PHYSICA A, V390, P2936, DOI 10.1016/j.physa.2011.03.040; Derks D, 2008, COMPUT HUM BEHAV, V24, P766, DOI 10.1016/j.chb.2007.04.004; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Dodds PS, 2010, J HAPPINESS STUD, V11, P441, DOI 10.1007/s10902-009-9150-9; Dunbar R., 1998, GROOMING GOSSIP EVOL; Fan R, 2013, ARXIV13092402; Go A, 2011, TECHNICAL REPORT; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Li C., 2012, P 21 ACM INT C INFOR, P155, DOI DOI 10.1145/2396761.2396785; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Liu B, 2010, CH CRC MACH LEARN PA, P627; Marchetti-Bowick Micol, 2012, P 13 C EUR CHAPT ASS, P603; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Parikh R, 2009, TECHNICAL REPORT; Read J., 2005, P ACL STUD RES WORKS, P43, DOI DOI 10.3115/1628960.1628969; Shalizi C, 2010, AM SCI, V98, P186, DOI 10.1511/2010.84.186; Sun GX, 2012, TANG 5 DYNASTIES BEI; Tossell CC, 2012, COMPUT HUM BEHAV, V28, P659, DOI 10.1016/j.chb.2011.11.012; TRAUD A. L., 2008, ARXIV08090690; Xiong XB, 2013, SCI CHINA INFORM SCI, V56, DOI 10.1007/s11432-013-4892-8; Zhao J., 2012, P 18 ACM SIGKDD INT, P1528, DOI DOI 10.1145/2339530.2339772; Zhao JC, 2014, NEUROCOMPUTING, V142, P343, DOI 10.1016/j.neucom.2014.04.025	29	85	90	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110184	10.1371/journal.pone.0110184	http://dx.doi.org/10.1371/journal.pone.0110184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333778	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200099
J	Launay, CP; de Decker, L; Kabeshova, A; Annweiler, C; Beauchet, O				Launay, Cyrille P.; de Decker, Laure; Kabeshova, Anastasiia; Annweiler, Cdric; Beauchet, Olivier			Screening for Older Emergency Department Inpatients at Risk of Prolonged Hospital Stay: The Brief Geriatric Assessment Tool	PLOS ONE			English	Article							ADVERSE HEALTH OUTCOMES; ELDERLY-PATIENTS; DISCHARGE; FRAILTY; ADULTS; CARE; LIMITATIONS; MORTALITY; PEOPLE; FALLS	Background: The aims of this study were 1) to confirm that combinations of brief geriatric assessment (BGA) items were significant risk factors for prolonged LHS among geriatric patients hospitalized in acute care medical units after their admission to the emergency department (ED); and 2) to determine whether these combinations of BGA items could be used as a prognostic tool of prolonged LHS. Methods: Based on a prospective observational cohort design, 1254 inpatients (mean age +/- standard deviation, 84.9 +/- 5.9 years; 59.3% female) recruited upon their admission to ED and discharged in acute care medical units of Angers University Hospital, France, were selected in this study. At baseline assessment, a BGA was performed and included the following 6 items: age >= 85years, male gender, polypharmacy (i.e., >= 5 drugs per day), use of home-help services, history of falls in previous 6 months and temporal disorientation (i.e., inability to give the month and/or year). The LHS in acute care medical units was prospectively calculated in number of days using the hospital registry. Results: Area under receiver operating characteristic (ROC) curves of prolonged LHS of different combinations of BGA items ranged from 0.50 to 0.57. Cox regression models revealed that combinations defining a high risk of prolonged LHS, identified from ROC curves, were significant risk factors for prolonged LHS (hazard ratio > 1.16 with P > 0.010). Kaplan-Meier distributions of discharge showed that inpatients classified in high-risk group of prolonged LHS were discharged later than those in low-risk group (P<0.003). Prognostic value for prolonged LHS of all combinations was poor with sensitivity under 77%, a high variation of specificity (from 26.6 to 97.4) and a low likelihood ratio of positive test under 5.6. Conclusion: Combinations of 6-item BGA tool were significant risk factors for prolonged LHS but their prognostic value was poor in the studied sample of older inpatients.	[Launay, Cyrille P.; Kabeshova, Anastasiia; Annweiler, Cdric; Beauchet, Olivier] Angers Univ Hosp, UPRES EA 4638, Dept Neurosci, Div Geriatr Med, Angers, France; [de Decker, Laure] Nantes Univ Hosp, Dept Geriatr, EA 1156 12, Nantes, France; [Annweiler, Cdric] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada; [Beauchet, Olivier] Biomathics, Paris, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Nantes Universite; CHU de Nantes; Western University (University of Western Ontario)	Beauchet, O (corresponding author), Angers Univ Hosp, UPRES EA 4638, Dept Neurosci, Div Geriatr Med, Angers, France.	olbeauchet@chu-angers.fr	Beauchet, Olivier/AAP-8108-2020	Annweiler, Cedric/0000-0002-7199-8109				Akl A, 2011, FORCASTING CLIN OUTC; Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Baxt WG, 1996, LANCET, V347, P12, DOI 10.1016/S0140-6736(96)91555-X; Beauchet O, 2013, J NUTR HEALTH AGING, V17, P695, DOI 10.1007/s12603-013-0333-z; Beauchet O, 2011, J NUTR HEALTH AGING, V15, P79, DOI 10.1007/s12603-011-0016-6; Beauchet O, 2013, J EMERG MED, V45, P739, DOI 10.1016/j.jemermed.2012.11.110; Berrut G, 2013, J NUTR HEALTH AGING, V17, P688, DOI 10.1007/s12603-013-0039-2; Byrne DG, 2010, AGE AGEING, V39, P694, DOI 10.1093/ageing/afq114; Conroy SP, 2014, AGE AGEING, V43, P109, DOI 10.1093/ageing/aft087; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; de Decker L, 2013, J AM GERIATR SOC, V61, P1224, DOI 10.1111/jgs.12345; Drame M, 2008, J NUTR HEALTH AGING, V12, P599, DOI 10.1007/BF02983207; Ellis G, 2011, BRIT MED J, V343, P1034, DOI DOI 10.1136/BMJ.D6553; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Graf CE, 2011, AGING CLIN EXP RES, V23, P244, DOI [10.3275/7284, 10.1007/BF03337751]; Hastings SN, 2009, J AM GERIATR SOC, V57, P1856, DOI 10.1111/j.1532-5415.2009.02434.x; Lang PO, 2006, J AM GERIATR SOC, V54, P1031, DOI 10.1111/j.1532-5415.2006.00767.x; Launay C, 2014, GERIATR PSYCHOL NEUR, V12, P43, DOI 10.1684/pnv.2014.0455; Launay C, 2013, J AM GERIATR SOC, V61, P1031, DOI 10.1111/jgs.12294; Lim SC, 2006, ANN ACAD MED SINGAP, V35, P27; McCusker J, 2003, ACAD EMERG MED, V10, P233, DOI 10.1111/j.1553-2712.2003.tb01997.x; McCusker J, 1999, J AM GERIATR SOC, V47, P1229, DOI 10.1111/j.1532-5415.1999.tb05204.x; Meldon SW, 2003, ACAD EMERG MED, V10, P224, DOI 10.1111/j.1553-2712.2003.tb01996.x; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Ravindrarajah R, 2013, ARCH GERONTOL GERIAT, V57, P360, DOI 10.1016/j.archger.2013.06.010; Rockwood K, 2012, CAN GERIATR J, V15, P31, DOI 10.5770/cgj.15.35; Rossat A, 2010, J NUTR HEALTH AGING, V14, P787, DOI 10.1007/s12603-010-0089-7; Rozzini R, 2009, J AM MED DIR ASSOC, V10, P554, DOI 10.1016/j.jamda.2009.04.005; Somme D, 2013, REV MED INTERNE, V34, P114, DOI 10.1016/j.revmed.2012.10.008; Sternberg SA, 2011, J AM GERIATR SOC, V59, P2129, DOI 10.1111/j.1532-5415.2011.03597.x; Stuck AE, 2011, BMJ-BRIT MED J, V343, P6799; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Xu KT, 2009, ANN EMERG MED, V54, P805, DOI 10.1016/j.annemergmed.2009.08.004; Yoo JW, 2014, GERIATR GERONTOL INT, V14, P71, DOI 10.1111/ggi.12056	39	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110135	10.1371/journal.pone.0110135	http://dx.doi.org/10.1371/journal.pone.0110135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25333271	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200095
J	Donate-Macian, P; Peralvarez-Marin, A				Donate-Macian, Pau; Peralvarez-Marin, Alex			Dissecting Domain-Specific Evolutionary Pressure Profiles of Transient Receptor Potential Vanilloid Subfamily Members 1 to 4	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; ANKYRIN REPEAT DOMAIN; ION-CHANNEL; TRP CHANNELS; MEMBRANE-PROTEINS; RESOURCE UNIPROT; PLASMA-MEMBRANE; C-TERMINUS; SEQUENCE; FAMILY	The transient receptor potential vanilloid family includes four ion channels-TRPV1, TRPV2, TRPV3 and TRPV4-that are represented within the vertebrate subphylum and involved in several sensory and physiological processes. These channels are related to adaptation to the environment, and probably under strong evolutionary pressure. Using multiple sequence alignments as source for evolutionary, bioinformatics and statistical analysis, we have analyzed the evolutionary profiles for TRPV1, TRPV2, TRPV3 and TRPV4. The evolutionary pressure exerted over vertebrate TRPV2 sequences compared to the other channels argues for a positive selection profile for TRPV2 compared to TRPV1, TRPV3 and TRPV4. We have analyzed the selective pressure on specific protein domains, observing a common selective pressure trend for the common TRPV scaffold, consisting of the ankyrin repeat domain, the membrane proximal domain, the transmembrane domain, and the TRP domain. Through a more detailed analysis we have identified evolutionary constraints involved in the subunit contact at the transmembrane domain level. Performing evolutionary comparison, we have translated specific channel structural information such as the transmembrane topology, and the interaction between the membrane proximal domain and the TRP box. We have also identified potential common regulatory domains among all TRPV1-4 members, such as protein-protein, lipid-protein and vesicle trafficking domains.	[Donate-Macian, Pau; Peralvarez-Marin, Alex] Univ Autonoma Barcelona, Ctr Estudis Biofis, Dept Bioquim & Biol Mol, Unitat Biofis, Bellaterra, Spain	Autonomous University of Barcelona	Peralvarez-Marin, A (corresponding author), Univ Autonoma Barcelona, Ctr Estudis Biofis, Dept Bioquim & Biol Mol, Unitat Biofis, Bellaterra, Spain.	peralvarezmarin@gmail.com	Peralvarez-Marin, Alex/A-8958-2017; Peralvarez-Marin, Alex/AAH-4305-2020; Donate-Macian, Pablo/L-3106-2014	Peralvarez-Marin, Alex/0000-0002-3457-0875; Donate-Macian, Pablo/0000-0002-8297-2035	Spanish Government [MICINN-SAF2010-21385]; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [PIOF- GA-2009-237120]; Generalitat de Catalunya [2013FIB00251]	Spanish Government(Spanish GovernmentEuropean Commission); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; Generalitat de Catalunya(Generalitat de Catalunya)	The authors want to acknowledge the funding from Spanish Government Young Researcher Grant (MICINN-SAF2010-21385 to A. P.-M.), a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (PIOF- GA-2009-237120 to A. P.-M.), and a Predoctoral Fellowship from the Generalitat de Catalunya (2013FIB00251 to P. D.-M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz J., 2007, V179, P379; Andrade MA, 1997, CURR OPIN BIOTECH, V8, P675, DOI 10.1016/S0958-1669(97)80118-8; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Arinaminpathy Y, 2009, DRUG DISCOV TODAY, V14, P1130, DOI 10.1016/j.drudis.2009.08.006; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Becker D, 2008, MOL MEMBR BIOL, V25, P139, DOI 10.1080/09687680701635237; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Edwards YJK, 2003, MOL BIOTECHNOL, V23, P139, DOI 10.1385/MB:23:2:139; Fischer MJM, 2013, J NEUROSCI, V33, P7407, DOI 10.1523/JNEUROSCI.3721-12.2013; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fuchs A, 2007, BIOINFORMATICS, V23, P3312, DOI 10.1093/bioinformatics/btm515; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Goswami C, 2007, J NEUROCHEM, V101, P250, DOI 10.1111/j.1471-4159.2006.04338.x; Gromiha MM, 2013, BRIEF BIOIN IN PRESS; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; Inada H, 2012, BIOCHEMISTRY-US, V51, P6195, DOI 10.1021/bi300279b; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Lundstrom K, 2006, CELL MOL LIFE SCI, V63, P2597, DOI 10.1007/s00018-006-6252-y; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Mercado J, 2010, J NEUROSCI, V30, P13338, DOI 10.1523/JNEUROSCI.2108-10.2010; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Penna A, 2006, CELL CALCIUM, V39, P495, DOI 10.1016/j.ceca.2006.01.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Saito S, 2006, PHYSIOL GENOMICS, V27, P219, DOI 10.1152/physiolgenomics.00322.2005; Sardar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031448; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398; Sokolchik I, 2005, J NEUROSCI, V25, P1015, DOI 10.1523/JNEUROSCI.3107-04.2005; Suzuki M, 2003, J BIOL CHEM, V278, P51448, DOI 10.1074/jbc.M308212200; Team RDC, 2019, R LANG ENV STAT COMP; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108	49	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110715	10.1371/journal.pone.0110715	http://dx.doi.org/10.1371/journal.pone.0110715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333484	Green Submitted, gold, Green Published			2022-12-27	WOS:000343731200072
J	Tapia, FJ; Largier, JL; Castillo, M; Wieters, EA; Navarrete, SA				Tapia, Fabian J.; Largier, John L.; Castillo, Manuel; Wieters, Evie A.; Navarrete, Sergio A.			Latitudinal Discontinuity in Thermal Conditions along the Nearshore of Central-Northern Chile	PLOS ONE			English	Article							COASTAL UPWELLING SYSTEM; INTERTIDAL INVERTEBRATES; BOTTOM-UP; INTERANNUAL VARIABILITY; SPATIAL-PATTERNS; WARM-WATER; RECRUITMENT; PHYTOPLANKTON; TEMPERATURE; CALIFORNIA	Over the past decade, evidence of abrupt latitudinal changes in the dynamics, structure and genetic variability of intertidal and subtidal benthic communities along central-northern Chile has been found consistently at 30-32 degrees S. Changes in the advective and thermal environment in nearshore waters have been inferred from ecological patterns, since analyses of in situ physical data have thus far been missing. Here we analyze a unique set of shoreline temperature data, gathered over 410 years at 15 sites between 28-35 degrees S, and combine it with satellite-derived winds and sea surface temperatures to investigate the latitudinal transition in nearshore oceanographic conditions suggested by recent ecological studies. Our results show a marked transition in thermal conditions at 30-31 degrees S, superimposed on a broad latitudinal trend, and small-scale structures associated with cape-and-bay topography. The seasonal cycle dominated temperature variability throughout the region, but its relative importance decreased abruptly south of 30-31 degrees S, as variability at synoptic and intra-seasonal scales became more important. The response of shoreline temperatures to meridional wind stress also changed abruptly at the transition, leading to a sharp drop in the occurrence of low-temperature waters at northern sites, and a concurrent decrease in corticated algal biomass. Together, these results suggest a limitation of nitrate availability in nearshore waters north of the transition. The localized alongshore change results from the interaction of latitudinal trends (e. g., wind stress, surface warming, inertial period) with a major headland-bay system (Punta Lengua de Vaca at 30.25 degrees S), which juxtaposes a southern stretch of coast characterized by upwelling with a northern stretch of coast characterized by warm surface waters and stratification. This transition likely generates a number of latitude-dependent controls on ecological processes in the nearshore that can explain species-specific effects, and add strength to the suggestion of an oceanography-driven, major spatial transition in coastal communities at 30-31 degrees S.	[Tapia, Fabian J.; Castillo, Manuel; Wieters, Evie A.; Navarrete, Sergio A.] Pontificia Univ Catolica Chile, Estn Costera Invest Marinas Las Cruces, Santiago, Chile; [Tapia, Fabian J.; Castillo, Manuel] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [Tapia, Fabian J.; Castillo, Manuel] Univ Concepcion, COPAS Sur Austral, Concepcion, Chile; [Largier, John L.] Univ Calif Davis, Bodega Marine Lab, Davis, CA 95616 USA; [Wieters, Evie A.; Navarrete, Sergio A.] Pontificia Univ Catolica Chile, Ctr Marine Conservat Las Cruces, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Concepcion; Universidad de Concepcion; University of California System; University of California Davis; Pontificia Universidad Catolica de Chile	Tapia, FJ (corresponding author), Pontificia Univ Catolica Chile, Estn Costera Invest Marinas Las Cruces, Alameda 340, Santiago, Chile.	ftapiaj@udec.cl	Castillo, Manuel I/L-4604-2016	Castillo, Manuel I/0000-0003-3984-8837; Tapia, Fabian/0000-0001-9661-6069	FONDECYT [1070335, 1120158, 3070014, 1120896, 1100920, 1130167]; Iniciativa Cientifica Milenio of the Ministerio de Economia, Fomento y Turismo [P10-033F]; Andrew W. Mellon Foundation; Center for Marine Conservation	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio of the Ministerio de Economia, Fomento y Turismo; Andrew W. Mellon Foundation; Center for Marine Conservation	Funding for this project and maintenance of long-term time series was provided primarily by FONDECYT grants #1070335 and #1120158, and by the Center for Marine Conservation, grant #P10-033F of Iniciativa Cientifica Milenio of the Ministerio de Economia, Fomento y Turismo to SAN. FJT was funded by a post-doctoral fellowship from the Andrew W. Mellon Foundation, by FONDECYT post-doctoral grant #3070014, and by FONDECYT grant #1120896. EAW further acknowledges support from FONDECYT grants #1100920 and #1130167. The support of a FONDECYT International Cooperation grant was instrumental for the completion of this collaborative work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CM, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001731; Blanchette CA, 2007, J EXP MAR BIOL ECOL, V340, P126, DOI 10.1016/j.jembe.2006.09.022; Blanchette CA, 2009, PROG OCEANOGR, V83, P107, DOI 10.1016/j.pocean.2009.07.038; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Caro AU, 2010, P NATL ACAD SCI USA, V107, P18528, DOI 10.1073/pnas.1007077107; Connolly SR, 2001, ECOLOGY, V82, P1799, DOI 10.1890/0012-9658(2001)082[1799:ALGIRO]2.0.CO;2; Daneri G, 2012, PROG OCEANOGR, V92-95, P92, DOI 10.1016/j.pocean.2011.07.013; Emery W.J., 1998, DATA ANAL METHODS PH; Falvey M, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010519; Fernandez M, 2007, MAR ECOL PROG SER, V348, P229, DOI 10.3354/meps07032; Figueroa D, 2000, GEOPHYS RES LETT, V27, P3905, DOI 10.1029/1999GL011302; Fonseca TR, 1987, INVESTIG PESQ, P34; Fuenzalida R, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004684; Garreaud RD, 2011, ATMOS CHEM PHYS, V11, P2015, DOI 10.5194/acp-11-2015-2011; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Halpin PM, 2004, REV CHIL HIST NAT, V77, P371; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; Hill E.A., 1998, SEA, P29; Hill EA, 1998, SEA, V11; Hormazabal S, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001956; Hormazabal S, 2001, J GEOPHYS RES-OCEANS, V106, P16657, DOI 10.1029/2001JC900008; JOHNSON DR, 1980, J MAR RES, V38, P1; Kaplan DM, 2003, ESTUAR COAST SHELF S, V57, P385, DOI 10.1016/S0272-7714(02)00363-3; Kudela RM, 2008, OCEANOGRAPHY, V21, P46, DOI 10.5670/oceanog.2008.04; Ladah LB, 2012, CONT SHELF RES, V42, P10, DOI 10.1016/j.csr.2012.03.010; Lagos NA, 2007, MAR ECOL PROG SER, V350, P29, DOI 10.3354/meps07105; Letelier J, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005171; Lucas A., 2011, LIMNOL OCEANOGR FLUI, V1, P56, DOI [10.1215/21573698-1258185, DOI 10.1215/21573698-1258185]; Lucas AJ, 2014, DEEP-SEA RES PT II, V101, P50, DOI 10.1016/j.dsr2.2013.01.016; Marin VH, 2001, CONT SHELF RES, V21, P1317, DOI 10.1016/S0278-4343(01)00022-X; Menge BA, 2003, P NATL ACAD SCI USA, V100, P12229, DOI 10.1073/pnas.1534875100; MENGE BA, 1992, ECOLOGY, V73, P755, DOI 10.2307/1940155; Montecinos A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-97; Munoz RC, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009957; Narvaez DA, 2006, MAR ECOL PROG SER, V309, P159, DOI 10.3354/meps309159; Narvaez DA, 2004, CONT SHELF RES, V24, P279, DOI 10.1016/j.csr.2003.09.008; Navarrete SA, 2005, P NATL ACAD SCI USA, V102, P18046, DOI 10.1073/pnas.0509119102; Navarrete SA, 2002, LIMNOL OCEANOGR, V47, P791, DOI 10.4319/lo.2002.47.3.0791; Navarrete SA, 2008, ECOLOGY, V89, P1308, DOI 10.1890/07-0728.1; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Phillips NE, 2005, MAR ECOL PROG SER, V295, P79, DOI 10.3354/meps295079; Pickett MH, 2003, J ATMOS OCEAN TECH, V20, P1869, DOI 10.1175/1520-0426(2003)020<1869:QSCWNB>2.0.CO;2; PINEDA J, 1994, J MAR RES, V52, P427, DOI 10.1357/0022240943077046; Rahn DA, 2014, INT J CLIMATOL, V34, P780, DOI 10.1002/joc.3724; Rutllant J., 1993, 4 INT C SO HEMISPHER, P268; SANTELICES B, 1990, OCEANOGR MAR BIOL, V28, P177; Shaffer G, 1997, J PHYS OCEANOGR, V27, P217, DOI 10.1175/1520-0485(1997)027<0217:CALFVN>2.0.CO;2; Sievers Hellmuth A., 2000, Revista de Biologia Marina y Oceanografia, V35, P153; Sobarzo M, 2007, PROG OCEANOGR, V75, P363, DOI 10.1016/j.pocean.2007.08.022; Strub P.T., 1998, SEA, P273; Tapia FJ, 2010, J EXP MAR BIOL ECOL, V392, P151, DOI 10.1016/j.jembe.2010.04.031; Tapia FJ, 2009, PROG OCEANOGR, V83, P278, DOI 10.1016/j.pocean.2009.07.035; Tellier F, 2009, MOL PHYLOGENET EVOL, V53, P679, DOI 10.1016/j.ympev.2009.07.030; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; THOMAS AC, 1994, J GEOPHYS RES-OCEANS, V99, P7355, DOI 10.1029/93JC02146; Thomas AC, 1999, J GEOPHYS RES-OCEANS, V104, P25877, DOI 10.1029/1999JC900171; Thomas AC, 2001, J GEOPHYS RES-OCEANS, V106, P899, DOI 10.1029/1999JC000052; Torres R, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006344; Wieters EA, 2005, MAR ECOL PROG SER, V301, P43, DOI 10.3354/meps301043; Wieters EA, 2003, MAR ECOL PROG SER, V249, P93, DOI 10.3354/meps249093; Wieters EA, 2009, LIMNOL OCEANOGR, V54, P1060, DOI 10.4319/lo.2009.54.4.1060; Wing SR, 1995, MAR ECOL PROG SER, V128, P199, DOI 10.3354/meps128199; Yuras G, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023946; Zakas C, 2009, MAR ECOL PROG SER, V394, P165, DOI 10.3354/meps08265	66	74	74	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110841	10.1371/journal.pone.0110841	http://dx.doi.org/10.1371/journal.pone.0110841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25334020	gold, Green Submitted, Green Published			2022-12-27	WOS:000343731200078
J	Thornton, SR; Butty, VL; Levine, SS; Boyer, LA				Thornton, Seraphim R.; Butty, Vincent L.; Levine, Stuart S.; Boyer, Laurie A.			Polycomb Repressive Complex 2 Regulates Lineage Fidelity during Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							H3 LYSINE-27 METHYLATION; GROUP PROTEIN EED; DNA METHYLATION; DEVELOPMENTAL REGULATORS; MOUSE DEVELOPMENT; CHROMATIN; EZH2; CANCER; GENES; EXPRESSION	Polycomb Repressive Complex 2 (PRC2) catalyzes histone H3 lysine 27 tri-methylation (H3K27me3), an epigenetic modification associated with gene repression. H3K27me3 is enriched at the promoters of a large cohort of developmental genes in embryonic stem cells (ESCs). Loss of H3K27me3 leads to a failure of ESCs to properly differentiate, making it difficult to determine the precise roles of PRC2 during lineage commitment. Moreover, while studies suggest that PRC2 prevents DNA methylation, how these two epigenetic regulators coordinate to regulate lineage programs is poorly understood. Using several PRC2 mutant ESC lines that maintain varying levels of H3K27me3, we found that partial maintenance of H3K27me3 allowed for proper temporal activation of lineage genes during directed differentiation of ESCs to spinal motor neurons (SMNs). In contrast, genes that function to specify other lineages failed to be repressed in these cells, suggesting that PRC2 is also necessary for lineage fidelity. We also found that loss of H3K27me3 leads to a modest gain in DNA methylation at PRC2 target regions in both ESCs and in SMNs. Our study demonstrates a critical role for PRC2 in safeguarding lineage decisions and in protecting genes against inappropriate DNA methylation.	[Thornton, Seraphim R.; Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Butty, Vincent L.; Levine, Stuart S.] MIT, BioMicro Ctr, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Boyer, LA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	lboyer@mit.edu		Butty, Vincent/0000-0003-1173-2429; Levine, Stuart/0000-0001-7363-562X	Richard and Susan Smith Family Foundation; Chestnut Hill, MA, Contract [LTR DATED 11/6/09]; National Institutes of Health (NIH) [T 32 GM007287]; National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	Richard and Susan Smith Family Foundation; Chestnut Hill, MA, Contract; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the Richard and Susan Smith Family Foundation (http://www.smithfamilyfoundation.net/), Chestnut Hill, MA, Contract Number LTR DATED 11/6/09 (to LAB); by National Institutes of Health (NIH) Training Grant T 32 GM007287 (to SRT); and by the National Cancer Institute Core Grant P30-CA14051 (to SSL and LAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bachmann IM, 2008, MODERN PATHOL, V21, P583, DOI 10.1038/modpathol.2008.17; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; FAUST C, 1995, DEVELOPMENT, V121, P273; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Hagarman JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053880; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1191, DOI 10.1038/nn.3490; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Neri F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r91; Neri F, 2013, CELL, V155, P121, DOI 10.1016/j.cell.2013.08.056; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Philipp S, 2010, P NATL ACAD SCI USA, V107, P1112, DOI 10.1073/pnas.0908486107; Piunti A, 2011, FUTURE ONCOL, V7, P57, DOI 10.2217/FON.10.157; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Raaphorst FM, 2000, AM J PATHOL, V157, P709, DOI 10.1016/S0002-9440(10)64583-X; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle Hynek, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01h01s5; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027	58	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110498	10.1371/journal.pone.0110498	http://dx.doi.org/10.1371/journal.pone.0110498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333635	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200048
J	Alic, L; Niessen, WJ; Veenland, JF				Alic, Lejla; Niessen, Wiro J.; Veenland, Jifke F.			Quantification of Heterogeneity as a Biomarker in Tumor Imaging: A Systematic Review	PLOS ONE			English	Review							COMPUTER-AIDED-DIAGNOSIS; FOCAL LIVER-LESIONS; SUPPORT VECTOR MACHINE; SOLITARY PULMONARY NODULES; CONTRAST-ENHANCED MRI; CT TEXTURE ANALYSIS; CELL LUNG-CANCER; CEREBRAL BLOOD-VOLUME; PAROTID-GLAND LESIONS; SOFT-TISSUE TUMORS	Background: Many techniques are proposed for the quantification of tumor heterogeneity as an imaging biomarker for differentiation between tumor types, tumor grading, response monitoring and outcome prediction. However, in clinical practice these methods are barely used. This study evaluates the reported performance of the described methods and identifies barriers to their implementation in clinical practice. Methodology: The Ovid, Embase, and Cochrane Central databases were searched up to 20 September 2013. Heterogeneity analysis methods were classified into four categories, i.e., non-spatial methods (NSM), spatial grey level methods (SGLM), fractal analysis (FA) methods, and filters and transforms (F&T). The performance of the different methods was compared. Principal Findings: Of the 7351 potentially relevant publications, 209 were included. Of these studies, 58% reported the use of NSM, 49% SGLM, 10% FA, and 28% F&T. Differentiation between tumor types, tumor grading and/or outcome prediction was the goal in 87% of the studies. Overall, the reported area under the curve (AUC) ranged from 0.5 to 1 (median 0.87). No relation was found between the performance and the quantification methods used, or between the performance and the imaging modality. A negative correlation was found between the tumor-feature ratio and the AUC, which is presumably caused by overfitting in small datasets. Cross-validation was reported in 63% of the classification studies. Retrospective analyses were conducted in 57% of the studies without a clear description. Conclusions: In a research setting, heterogeneity quantification methods can differentiate between tumor types, grade tumors, and predict outcome and monitor treatment effects. To translate these methods to clinical practice, more prospective studies are required that use external datasets for validation: these datasets should be made available to the community to facilitate the development of new and improved methods.	[Alic, Lejla; Niessen, Wiro J.; Veenland, Jifke F.] Erasmus MC, Dept Radiol & Med Informat, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands; [Alic, Lejla] Netherlands Org Appl Sci Res TNO, Dept Intelligent Imaging, The Hague, Netherlands; [Niessen, Wiro J.] Delft Univ Technol, Fac Sci Appl, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Netherlands Organization Applied Science Research; Delft University of Technology	Alic, L (corresponding author), Erasmus MC, Dept Radiol & Med Informat, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands.	LejlaResearch@gmail.com	Alic, Lejla/N-9589-2019; Hatzis, Christos/M-3867-2015	Niessen, Wiro/0000-0002-5822-1995; Hatzis, Christos/0000-0002-8120-2290; Alic, Lejla/0000-0001-6487-6958; Veenland, Jifke/0000-0003-0456-6143	Netherlands Organization for Scientific Research (NWO) [017.002.019]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by The Netherlands Organization for Scientific Research (NWO), grant number 017.002.019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2011, TECHNOL CANCER RES T, V10, P371, DOI 10.7785/tcrt.2012.500214; Acharya UR, 2012, COMPUT METH PROG BIO, V107, P233, DOI 10.1016/j.cmpb.2011.10.001; Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Aerts HJWL, 2012, LUNG CANCER, V75, P73, DOI 10.1016/j.lungcan.2011.06.003; Alic L, 2011, QUANTIFICATION HETER; AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Meinel LA, 2007, J MAGN RESON IMAGING, V25, P89, DOI 10.1002/jmri.20794; Asselin MC, 2012, EUR J CANCER, V48, P447, DOI 10.1016/j.ejca.2011.12.025; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Brown JR, 2014, LAB INVEST, V94, P98, DOI 10.1038/labinvest.2013.128; Chang RF, 2003, ULTRASOUND MED BIOL, V29, P679, DOI 10.1016/S0301-5629(02)00788-3; Chang RF, 2003, ACAD RADIOL, V10, P189, DOI 10.1016/S1076-6332(03)80044-2; Chen DR, 2011, COMPUT MED IMAG GRAP, V35, P220, DOI 10.1016/j.compmedimag.2010.11.003; Chen DR, 2000, ULTRASOUND MED BIOL, V26, P405, DOI 10.1016/S0301-5629(99)00156-8; Chen DR, 2002, ULTRASOUND MED BIOL, V28, P1301, DOI 10.1016/S0301-5629(02)00620-8; Chen DR, 1999, RADIOLOGY, V213, P407, DOI 10.1148/radiology.213.2.r99nv13407; Chen DR, 2000, SEMIN ULTRASOUND CT, V21, P308, DOI 10.1016/S0887-2171(00)90025-8; Chen DR, 1999, J MED ULTRASOUND, V7, P157; Chen SJ, 2012, CLIN IMAG, V36, P353, DOI 10.1016/j.clinimag.2011.10.018; Chen SJ, 2010, ULTRASOUND MED BIOL, V36, P2018, DOI 10.1016/j.ultrasmedbio.2010.08.019; Chen SJ, 2009, ULTRASOUND MED BIOL, V35, P201, DOI 10.1016/j.ultrasmedbio.2008.08.017; Chen SJ, 2005, J ULTRAS MED, V24, P651, DOI 10.7863/jum.2005.24.5.651; Chen SJ, 2005, J MED BIOL ENG, V25, P193; Chen W, 2007, MAGN RESON MED, V58, P562, DOI 10.1002/mrm.21347; Chen WJ, 2006, MED PHYS, V33, P2878, DOI 10.1118/1.2210568; Chen WM, 2005, ULTRASOUND MED BIOL, V31, P763, DOI 10.1016/j.ultrasmedbio.2005.01.014; Chikui T, 2005, ULTRASOUND MED BIOL, V31, P1297, DOI 10.1016/j.ultrasmedbio.2005.05.012; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; Cui CY, 2011, EUR RADIOL, V21, P2318, DOI 10.1007/s00330-011-2182-7; Cui J, 2009, MED PHYS, V36, P1553, DOI 10.1118/1.3110069; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; de Langen AJ, 2011, J NUCL MED, V52, P48, DOI 10.2967/jnumed.110.078261; De Lussanet QG, 2005, INT J RADIAT ONCOL, V63, P1309, DOI 10.1016/j.ijrobp.2005.04.052; Ding JR, 2011, J ULTRAS MED, V30, P1259, DOI 10.7863/jum.2011.30.9.1259; Dominietto M, 2013, MAGN RESON MED, V70, P1481, DOI 10.1002/mrm.24590; Dong XZ, 2013, NUCL MED COMMUN, V34, P40, DOI 10.1097/MNM.0b013e32835ae50c; Donohue KD, 2001, ULTRASOUND MED BIOL, V27, P1505, DOI 10.1016/S0301-5629(01)00468-9; Donohue KD, 1999, IEEE T ULTRASON FERR, V46, P300, DOI 10.1109/58.753018; Downey K, 2013, AM J ROENTGENOL, V200, P314, DOI 10.2214/AJR.12.9545; Drabycz S, 2010, NEUROIMAGE, V49, P1398, DOI 10.1016/j.neuroimage.2009.09.049; Dumrongpisutikul N, 2012, AM J NEURORADIOL, V33, P550, DOI 10.3174/ajnr.A2806; E-Liang Chen, 2001, Biomedical Engineering, Applications Basis Communications, V13, P159; Eary JF, 2008, J NUCL MED, V49, P1973, DOI 10.2967/jnumed.108.053397; Eliat PA, 2001, ANTICANCER RES, V21, P3857; Eliat PA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/195176; Emblem KE, 2008, RADIOLOGY, V247, P808, DOI 10.1148/radiol.2473070571; Engelbrecht M R, 1998, Eur J Ultrasound, V8, P157, DOI 10.1016/S0929-8266(98)00070-6; Farace P, 2009, BRIT J CANCER, V100, P1575, DOI 10.1038/sj.bjc.6605041; Fasching PA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-486; Faschingbauer F, 2013, ULTRASCHALL MED, V34, P145, DOI 10.1055/s-0031-1299331; Fetit AE, 2013, STUD HEALTH TECHNOL, V190, P169, DOI 10.3233/978-1-61499-276-9-169; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Fruehwald-Pallamar J, 2013, NMR BIOMED, V26, P1372, DOI 10.1002/nbm.2962; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Ganeshan B, 2012, CLIN RADIOL, V67, P157, DOI 10.1016/j.crad.2011.08.012; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Ganeshan B, 2010, CANCER IMAGING, V10, P137, DOI 10.1102/1470-7330.2010.0021; GARRA BS, 1993, ULTRASONIC IMAGING, V15, P267, DOI 10.1006/uimg.1993.1017; Gensure RH, 2012, ACAD RADIOL, V19, P1201, DOI 10.1016/j.acra.2012.04.015; Georgiadis P, 2008, COMPUT METH PROG BIO, V89, P24, DOI 10.1016/j.cmpb.2007.10.007; Georgiadis P, 2011, MAGN RESON IMAGING, V29, P525, DOI 10.1016/j.mri.2010.11.006; Georgiadis P, 2009, MAGN RESON IMAGING, V27, P120, DOI 10.1016/j.mri.2008.05.017; Gibbs P, 2003, MAGN RESON MED, V50, P92, DOI 10.1002/mrm.10496; Giger ML, 1999, ACAD RADIOL, V6, P665, DOI 10.1016/S1076-6332(99)80115-9; Gletsos M, 2003, IEEE T INF TECHNOL B, V7, P153, DOI 10.1109/TITB.2003.813793; Glotsos D, 2010, COMPUT METH PROG BIO, V97, P53, DOI 10.1016/j.cmpb.2009.07.003; Goh V, 2011, RADIOLOGY, V261, P165, DOI 10.1148/radiol.11110264; GOLDBERG V, 1992, MED PHYS, V19, P1475, DOI 10.1118/1.596804; Gomez W, 2012, IEEE T MED IMAGING, V31, P1889, DOI 10.1109/TMI.2012.2206398; Haney CR, 2013, TECHNOL CANCER RES T, V12, P71, DOI 10.7785/tcrt.2012.500255; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Harrison L, 2008, COMPUT BIOL MED, V38, P519, DOI 10.1016/j.compbiomed.2008.01.016; Hatt M, 2013, EUR J NUCL MED MOL I, V40, P1662, DOI 10.1007/s00259-013-2486-8; Hayes C, 2002, NMR BIOMED, V15, P154, DOI 10.1002/nbm.756; Herts BR, 2002, AM J ROENTGENOL, V178, P367, DOI 10.2214/ajr.178.2.1780367; Hirano M, 2012, AM J ROENTGENOL, V198, P717, DOI 10.2214/AJR.11.7093; HIRNING T, 1989, EUR J RADIOL, V9, P244; Holli K, 2010, ACAD RADIOL, V17, P135, DOI 10.1016/j.acra.2009.08.012; HOLM S, 1979, SCAND J STAT, V6, P65; Horsch K, 2002, MED PHYS, V29, P157, DOI 10.1118/1.1429239; Huang BS, 2012, AM J ROENTGENOL, V199, P169, DOI 10.2214/AJR.11.7336; Huang YL, 2006, ACAD RADIOL, V13, P713, DOI 10.1016/j.acra.2005.07.014; Huang YL, 2005, ULTRASOUND OBST GYN, V26, P558, DOI 10.1002/uog.1951; Huang Zhibin, 2012, J Cancer Sci Ther, V4, P254; Huber S, 2000, ULTRASOUND MED BIOL, V26, P1243, DOI 10.1016/S0301-5629(00)00274-X; Iakovidis DK, 2010, ARTIF INTELL MED, V50, P33, DOI 10.1016/j.artmed.2010.04.004; Issa B, 1999, J COMPUT ASSIST TOMO, V23, P615, DOI 10.1097/00004728-199907000-00024; Jansen JFA, 2012, INT J RADIAT ONCOL, V82, P299, DOI 10.1016/j.ijrobp.2010.11.022; Jung SC, 2012, ACTA RADIOL, V53, P112, DOI 10.1258/ar.2011.110221; Juntu J, 2010, J MAGN RESON IMAGING, V31, P680, DOI 10.1002/jmri.22095; Karahaliou A, 2010, BRIT J RADIOL, V83, P296, DOI 10.1259/bjr/50743919; Kidd EA, 2008, CLIN CANCER RES, V14, P5236, DOI 10.1158/1078-0432.CCR-07-5252; Kido S, 2003, J COMPUT ASSIST TOMO, V27, P56, DOI 10.1097/00004728-200301000-00011; Kido S, 2002, J COMPUT ASSIST TOMO, V26, P573, DOI 10.1097/01.RCT.0000029045.35986.9F; Kim DY, 2003, ACTA RADIOL, V44, P252, DOI 10.1034/j.1600-0455.2003.00061.x; Kim KG, 2005, ACAD RADIOL, V12, P58, DOI 10.1016/j.acra.2004.11.010; Kim KG, 2001, J DIGIT IMAGING, V14, P208, DOI 10.1007/BF03190341; KJAER L, 1995, ACTA RADIOL, V36, P127; KLEIN HM, 1993, ROFO FORTSCHR RONTG, V159, P10, DOI 10.1055/s-2008-1032713; Klein HM, 1996, INVEST RADIOL, V31, P6, DOI 10.1097/00004424-199601000-00002; KRATZIK C, 1988, UROL RES, V16, P395; Kuntz C, 1994, ENDOSKOPIE HEUTE, V7, P173; Kuo WJ, 2002, ACAD RADIOL, V9, P793, DOI 10.1016/S1076-6332(03)80349-5; Kuo WJ, 2002, ULTRASOUND MED BIOL, V28, P903, DOI 10.1016/S0301-5629(02)00541-0; KURKI T, 1995, MAGN RESON IMAGING, V13, P501, DOI 10.1016/0730-725X(95)00006-3; Lai YC, 2013, ULTRASOUND MED BIOL, V39, P555, DOI 10.1016/j.ultrasmedbio.2012.09.020; Lambin P, 2010, RADIOTHER ONCOL, V96, P145, DOI 10.1016/j.radonc.2010.07.001; Larkin TJ, 2013, MAGN RESON MED, V7; Lee CC, 2010, BIOMED ENG-APP BAS C, V22, P137, DOI 10.4015/S1016237210001852; Lefebvre F, 2000, ULTRASOUND MED BIOL, V26, P1421, DOI 10.1016/S0301-5629(00)00302-1; Li XJ, 2002, J MAGN RESON IMAGING, V16, P229, DOI 10.1002/jmri.10147; Liao YY, 2011, MED PHYS, V38, P2198, DOI 10.1118/1.3566064; Liu F, 2011, ACAD RADIOL, V18, P694, DOI 10.1016/j.acra.2011.01.005; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Liu Y, 2012, J MED SYST, V36, P3975, DOI 10.1007/s10916-012-9869-4; Liu YH, 2012, J MED BIOL ENG, V32, P22, DOI 10.5405/jmbe.813; Loren DE, 2002, GASTROINTEST ENDOSC, V56, P742, DOI 10.1067/mge.2002.128920; Ma JH, 2010, AM J NEURORADIOL, V31, P1699, DOI 10.3174/ajnr.A2161; Mandelbrot B.B., 1983, FRACTAL GEOMETRY NAT; Maruyama H, 2012, ULTRASOUND MED BIOL, V38, P383, DOI 10.1016/j.ultrasmedbio.2011.12.006; Mattonen SA, 2013, ACTA ONCOL, V52, P910, DOI 10.3109/0284186X.2012.731525; Mayerhoefer ME, 2008, MAGN RESON IMAGING, V26, P1316, DOI 10.1016/j.mri.2008.02.013; Mayerhoefer ME, 2010, J MAGN RESON IMAGING, V32, P352, DOI 10.1002/jmri.22268; Mayr NA, 2000, J MAGN RESON IMAGING, V12, P1027, DOI 10.1002/1522-2586(200012)12:6<1027::AID-JMRI31>3.0.CO;2-5; McLaren CE, 2009, ACAD RADIOL, V16, P842, DOI 10.1016/j.acra.2009.01.029; McNitt-Gray MF, 1999, MED PHYS, V26, P880, DOI 10.1118/1.598603; McNitt-Gray MF, 1999, COMPUT MED IMAG GRAP, V23, P339, DOI 10.1016/S0895-6111(99)00033-6; Miles KA, 2009, RADIOLOGY, V250, P444, DOI 10.1148/radiol.2502071879; Mitrea D, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/348135; Mittal D, 2011, COMPUT MED IMAG GRAP, V35, P315, DOI 10.1016/j.compmedimag.2011.01.007; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moon WK, 2011, ULTRASOUND MED BIOL, V37, P539, DOI 10.1016/j.ultrasmedbio.2011.01.006; Mougiakakou SG, 2007, ARTIF INTELL MED, V41, P25, DOI 10.1016/j.artmed.2007.05.002; Mouthuy N, 2012, J NEURORADIOLOGY, V39, P301, DOI 10.1016/j.neurad.2011.11.002; Mussurakis S, 1998, J COMPUT ASSIST TOMO, V22, P35, DOI 10.1097/00004728-199801000-00007; Nagarajan MB, 2013, J MED BIOL ENG, V33, P59, DOI 10.5405/jmbe.1183; NEGENDANK WG, 1990, RADIOLOGY, V177, P209, DOI 10.1148/radiology.177.1.2399318; Newell D, 2010, EUR RADIOL, V20, P771, DOI 10.1007/s00330-009-1616-y; Ng CKY, 2012, EXPERT REV ANTICANC, V12, P1021, DOI [10.1586/ERA.12.85, 10.1586/era.12.85]; Ng F, 2013, EUR J RADIOL, V82, P342, DOI 10.1016/j.ejrad.2012.10.023; Ng F, 2013, RADIOLOGY, V266, P177, DOI 10.1148/radiol.12120254; Nguyen VX, 2010, J ULTRAS MED, V29, P1345, DOI 10.7863/jum.2010.29.9.1345; Nie K, 2008, ACAD RADIOL, V15, P1513, DOI 10.1016/j.acra.2008.06.005; O'Connor JPB, 2011, BRIT J CANCER, V105, P139, DOI 10.1038/bjc.2011.191; O'Sullivan F, 2011, IEEE T MED IMAGING, V30, P2059, DOI 10.1109/TMI.2011.2160984; O'Sullivan F, 2003, BIOSTATISTICS, V4, P433, DOI 10.1093/biostatistics/4.3.433; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Padma A., 2013, Journal of Medical Engineering & Technology, V37, P1, DOI 10.3109/03091902.2012.712199; Pang YC, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/634907; Peeters F, 2012, J MAGN RESON IMAGING, V35, P409, DOI 10.1002/jmri.22836; Pekalska E, 2005, DISSIMILARITY REPRES; Peleg S, 1984, IEEE Trans Pattern Anal Mach Intell, V6, P518, DOI 10.1109/TPAMI.1984.4767557; Peng SL, 2013, NMR BIOMED, V26, P443, DOI 10.1002/nbm.2882; Nguyen P, 2012, CHEST, V141, P709, DOI 10.1378/chest.11-1016; Pickles MD, 2009, EUR J RADIOL, V71, P498, DOI 10.1016/j.ejrad.2008.05.007; Piliouras N, 2004, COMPUT MED IMAG GRAP, V28, P247, DOI 10.1016/j.compmedimag.2004.04.003; Plant RL, 1998, ANN OTO RHINOL LARYN, V107, P689, DOI 10.1177/000348949810700811; Preim U, 2012, EUR J RADIOL, V81, P1532, DOI 10.1016/j.ejrad.2011.04.045; Prescott JW, 2010, J DIGIT IMAGING, V23, P342, DOI 10.1007/s10278-009-9179-7; Raja JV, 2012, DENTOMAXILLOFAC RAD, V41, P475, DOI 10.1259/dmfr/83345935; Rakoczy M, 2013, J DIGIT IMAGING, V26, P198, DOI 10.1007/s10278-012-9506-2; REHN S, 1993, ACTA RADIOL, V34, P3; Rehn SM, 1997, LEUKEMIA LYMPHOMA, V24, P501, DOI 10.3109/10428199709055587; Retico A, 2009, COMPUT BIOL MED, V39, P1137, DOI 10.1016/j.compbiomed.2009.10.005; Revert Ventura AJ, 2012, RADIOLOGIA, V56; Rokita E, 2009, POL J RADIOL, V74, P28; Rose CJ, 2009, MAGN RESON MED, V62, P488, DOI 10.1002/mrm.22003; Sachdeva J, 2012, INT J NUMER METH BIO, V28, P1107, DOI 10.1002/cnm.2481; Sadeghi-Naini A, 2013, TRANSL ONCOL, V6, P234, DOI 10.1593/tlo.12385; Sahiner B, 2004, MED PHYS, V31, P744, DOI 10.1118/1.1649531; Sarty GE, 2004, MAGN RESON MATER PHY, V16, P182, DOI 10.1007/s10334-003-0027-3; Sasikala M., 2008, Journal of Medical Engineering & Technology, V32, P198, DOI 10.1080/03091900701455524; Scheipers U, 2005, ULTRASOUND MED BIOL, V31, P1287, DOI 10.1016/j.ultrasmedbio.2005.06.011; Schulte M, 2010, ULTRASCHALL MED, V31, P182, DOI 10.1055/s-0028-1109917; Shah SK, 2005, ACAD RADIOL, V12, P570, DOI 10.1016/j.acra.2005.01.018; Sidiropoulos KP, 2013, INT J COMPUT ASS RAD, V8, P547, DOI 10.1007/s11548-013-0813-y; Siebers S, 2010, ULTRASOUND MED BIOL, V36, P1525, DOI 10.1016/j.ultrasmedbio.2010.06.009; Sinha S, 1997, JMRI-J MAGN RESON IM, V7, P1016, DOI 10.1002/jmri.1880070613; Sivaramakrishna R, 2002, COMPUT MED IMAG GRAP, V26, P303, DOI 10.1016/S0895-6111(02)00027-7; Skogen K, 2013, J NEURO-ONCOL, V111, P213, DOI 10.1007/s11060-012-1010-5; Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5; Spector DI, 2011, VET RADIOL ULTRASOUN, V52, P71, DOI 10.1111/j.1740-8261.2010.01748.x; Spira D, 2013, CANCER IMAGING, V13, P323, DOI 10.1102/1470-7330.2013.0033; Spira D, 2011, CANCER IMAGING, V11, P155, DOI 10.1102/1470-7330.2011.0022; Stantz KM, 2011, MOL IMAGING BIOL, V13, P1183, DOI 10.1007/s11307-010-0441-7; Strzelecki M, 2006, COMPUT MED IMAG GRAP, V30, P95, DOI 10.1016/j.compmedimag.2005.11.004; Su Yanni, 2011, Open Med Inform J, V5, P26, DOI 10.2174/1874431101105010026; Sujana H, 1996, ULTRASOUND MED BIOL, V22, P1177, DOI 10.1016/S0301-5629(96)00144-5; Sun T, 2013, COMPUT METH PROG BIO, V111, P519, DOI 10.1016/j.cmpb.2013.04.016; Sun T, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054726, 10.1371/journal.pone.0063559]; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Tan S, 2013, INT J RADIAT ONCOL, V85, P1375, DOI 10.1016/j.ijrobp.2012.10.017; THIJSSEN JM, 1991, ULTRASOUND MED BIOL, V17, P127, DOI 10.1016/0301-5629(91)90120-L; THIJSSEN JM, 1992, ACTA OPHTHALMOL, V70, P26; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Tozer DJ, 2007, NMR BIOMED, V20, P49, DOI 10.1002/nbm.1091; Tsantis S, 2005, ULTRASOUND MED BIOL, V31, P1451, DOI 10.1016/j.ultrasmedbio.2005.07.009; Tse DML, 2012, BRIT J RADIOL, V85, P1272, DOI 10.1259/bjr/13374146; Tuma J, 2011, ULTRASCHALL MED, V32, P286, DOI 10.1055/s-0029-1245992; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; van Rijswijk CSP, 2003, EUR RADIOL, V13, P1849, DOI 10.1007/s00330-002-1785-4; Virmani Jitendra, 2013, Journal of Medical Engineering & Technology, V37, P292, DOI 10.3109/03091902.2013.794869; Virmani J, 2013, J DIGIT IMAGING, V26, P530, DOI 10.1007/s10278-012-9537-8; Wang H, 2010, EUR J RADIOL, V74, P124, DOI 10.1016/j.ejrad.2009.01.024; Way TW, 2006, MED PHYS, V33, P2323, DOI 10.1118/1.2207129; Way TW, 2009, MED PHYS, V36, P3086, DOI 10.1118/1.3140589; Willaime JMY, 2013, PHYS MED BIOL, V58, P187, DOI 10.1088/0031-9155/58/2/187; Win T, 2013, CLIN CANCER RES, V19, P3591, DOI 10.1158/1078-0432.CCR-12-1307; Wu HF, 2013, J DIGIT IMAGING, V26, P797, DOI 10.1007/s10278-012-9547-6; Wu WJ, 2008, ACAD RADIOL, V15, P873, DOI 10.1016/j.acra.2008.01.010; Wu WJ, 2012, COMPUT MED IMAG GRAP, V36, P627, DOI 10.1016/j.compmedimag.2012.07.004; Yan K, 2012, MED PHYS, V39, P1571, DOI 10.1118/1.3689811; Yang XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/732848; Yang XY, 2012, MAGN RESON IMAGING, V30, P1059, DOI 10.1016/j.mri.2012.04.026; Yoshida H, 2003, PHYS MED BIOL, V48, P3735, DOI 10.1088/0031-9155/48/22/008; Yoshida H, 2002, RADIOGRAPHICS, V22, P963, DOI 10.1148/radiographics.22.4.g02jl16963; Yoshiura K, 1997, DENTOMAXILLOFAC RAD, V26, P332, DOI 10.1038/sj.dmfr.4600295; Young T. Y., 1974, CLASSIFICATION ESTIM; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147; Zhang XJ, 2009, RADIOL PHYS TECHNOL, V2, P175, DOI 10.1007/s12194-009-0062-5; Zheng YJ, 2009, MED PHYS, V36, P3192, DOI 10.1118/1.3151811; Zhou SC, 2013, BIOMED SIGNAL PROCES, V8, P688, DOI 10.1016/j.bspc.2013.06.011; Zhu YJ, 2010, J DIGIT IMAGING, V23, P51, DOI 10.1007/s10278-009-9185-9	225	109	115	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110300	10.1371/journal.pone.0110300	http://dx.doi.org/10.1371/journal.pone.0110300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330171	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100051
J	Andersen, LM				Andersen, Laura Morch			Obtaining Reliable Likelihood Ratio Tests from Simulated Likelihood Functions	PLOS ONE			English	Article							DISCRETE-CHOICE MODELS; MIXED LOGIT; IDENTIFICATION	Mixed models: Models allowing for continuous heterogeneity by assuming that value of one or more parameters follow a specified distribution have become increasingly popular. This is known as 'mixing' parameters, and it is standard practice by researchers - and the default option in many statistical programs - to base test statistics for mixed models on simulations using asymmetric draws (e. g. Halton draws). Problem 1: Inconsistent LR tests due to asymmetric draws: This paper shows that when the estimated likelihood functions depend on standard deviations of mixed parameters this practice is very likely to cause misleading test results for the number of draws usually used today. The paper illustrates that increasing the number of draws is a very inefficient solution strategy requiring very large numbers of draws to ensure against misleading test statistics. The main conclusion of this paper is that the problem can be solved completely by using fully antithetic draws, and that using one dimensionally antithetic draws is not enough to solve the problem. Problem 2: Maintaining the correct dimensions when reducing the mixing distribution: A second point of the paper is that even when fully antithetic draws are used, models reducing the dimension of the mixing distribution must replicate the relevant dimensions of the quasi-random draws in the simulation of the restricted likelihood. Again this is not standard in research or statistical programs. The paper therefore recommends using fully antithetic draws replicating the relevant dimensions of the quasi-random draws in the simulation of the restricted likelihood and that this should become the default option in statistical programs. JEL classification: C15; C25.	Univ Copenhagen, Dept Food & Resource Econ, Copenhagen, Denmark	University of Copenhagen	Andersen, LM (corresponding author), Univ Copenhagen, Dept Food & Resource Econ, Copenhagen, Denmark.	la@ifro.ku.dk	Andersen, Laura Morch/K-8279-2013	Andersen, Laura Morch/0000-0001-8763-1670	Danish Social Science Research Council ('FSE')	Danish Social Science Research Council ('FSE')(European Social Fund (ESF))	The research was funded by The Danish Social Science Research Council ('FSE'). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LM, 2011, J AGR ECON, V62, P565, DOI 10.1111/j.1477-9552.2011.00310.x; Andersen LM, 2008, INFORM PROVISION CON, V130 - 2008; Bastin F, 2006, TRANSPORT RES B-METH, V40, P577, DOI 10.1016/j.trb.2005.09.002; Ben-Akiva M., 1993, TRANSPORT RES REC, V1413, P88; Ben-Akiva M., 1996, WORKING PAPER; BERRY S, 1995, ECONOMETRICA, V63, P841, DOI 10.2307/2171802; Bhat CR, 2003, TRANSPORT RES B-METH, V37, P837, DOI 10.1016/S0191-2615(02)00090-5; Bhat CR, 2001, TRANSPORT RES B-METH, V35, P677, DOI 10.1016/S0191-2615(00)00014-X; Bhat CR, 1996, WORKING PAPER; Brownstone D, 1999, J ECONOMETRICS, V89, P109; Cappellari L, 2006, 2112 IZA; Chang JB, 2011, J APPL ECONOMET, V26, P167, DOI 10.1002/jae.1201; Chiou L, 2007, J ECONOMETRICS, V141, P683, DOI 10.1016/j.jeconom.2006.10.012; GEWEKE J, 1988, J ECONOMETRICS, V38, P73, DOI 10.1016/0304-4076(88)90027-9; Geweke J, 1996, HDB COMPUTATIONAL EC, VL; Greene W. H., 1997, ECONOMETRIC ANAL; Halton J.H., 1960, NUMER MATH, V2, P84, DOI [10.1007/BF01386213, DOI 10.1007/BF01386213]; HAMMERSLEY JM, 1960, ANN NY ACAD SCI, V86, P844, DOI 10.1111/j.1749-6632.1960.tb42846.x; McFadden D, 2000, J APPL ECONOMET, V15, P447, DOI 10.1002/1099-1255(200009/10)15:5<447::AID-JAE570>3.0.CO;2-1; MOROKOFF WJ, 1995, J COMPUT PHYS, V122, P218, DOI 10.1006/jcph.1995.1209; Munger D, 2012, TRANSPORT RES B-METH, V46, P305, DOI 10.1016/j.trb.2011.10.005; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Revelt D, 1998, REV ECON STAT, V80, P647, DOI 10.1162/003465398557735; Sandor Z, 2004, TRANSPORT RES B-METH, V38, P313, DOI 10.1016/S0191-2615(03)00014-6; Sidharthan R, 2010, TRANSPORT RES REC, P1, DOI 10.3141/2175-01; Sivakumar A, 2005, TRANSPORT RES REC, P112; Train K, 2001, ECONOMETRICS, V001, P2001; Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1, DOI 10.1017/CBO9780511805271; Walker J.L., 2001, EXTENDED DISCRETE CH; Walker JL, 2007, J APPL ECONOMET, V22, P1095, DOI 10.1002/jae.971	30	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e106136	10.1371/journal.pone.0106136	http://dx.doi.org/10.1371/journal.pone.0106136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25329712	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100004
J	Chen, HZ; Gong, Y; Han, R				Chen, Huize; Gong, Yan; Han, Rong			Cadmium Telluride Quantum Dots (CdTe-QDs) and Enhanced Ultraviolet-B (UV-B) Radiation Trigger Antioxidant Enzyme Metabolism and Programmed Cell Death in Wheat Seedlings	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; LIPID-PEROXIDATION; DNA-DAMAGE; PLANTS; CYTOTOXICITY; NANOPARTICLES; TOLERANCE; TOXICITY; EXPOSURE	Nanoparticles (NPs) are becoming increasingly widespread in the environment. Free cadmium ions released from commonly used NPs under ultraviolet-B (UV-B) radiation are potentially toxic to living organisms. With increasing levels of UV-B radiation at the Earth's surface due to the depletion of the ozone layer, the potential additive effect of NPs and UV-B radiation on plants is of concern. In this study, we investigated the synergistic effect of CdTe quantum dots (CdTe-QDs), a common form of NP, and UV-B radiation on wheat seedlings. Graded doses of CdTe-QDs and UV-B radiation were tested, either alone or in combination, based on physical characteristics of 5-day-old seedlings. Treatments of wheat seedlings with either CdTe-QDs (200 mg/L) or UV-B radiation (10 KJ/m(2)/d) induced the activation of wheat antioxidant enzymes. CdTe-QDs accumulation in plant root cells resulted in programmed cell death as detected by DNA laddering. CdTe-QDs and UV-B radiation inhibited root and shoot growth, respectively. Additive inhibitory effects were observed in the combined treatment group. This research described the effects of UV-B and CdTe-QDs on plant growth. Furthermore, the finding that CdTe-QDs accumulate during the life cycle of plants highlights the need for sustained assessments of these interactions.	[Chen, Huize; Gong, Yan; Han, Rong] Shanxi Normal Univ, Higher Educ Key Lab Plant Mol & Environm Stress R, Linfen, Shanxi Province, Peoples R China; [Chen, Huize; Han, Rong] Shanxi Normal Univ, Sch Life Sci, Linfen, Peoples R China; [Gong, Yan] Shanxi Normal Univ, Sch Chem & Mat Sci, Linfen, Peoples R China	Shanxi Normal University; Shanxi Normal University; Shanxi Normal University	Han, R (corresponding author), Shanxi Normal Univ, Higher Educ Key Lab Plant Mol & Environm Stress R, Linfen, Shanxi Province, Peoples R China.	hhwrsl@163.com		Chen, Huize/0000-0003-2161-0089	National Natural Science Foundation of China [30671061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	R.H. received funding from the National Natural Science Foundation of China No. 30671061 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HuiZe, 2011, Plant Diversity and Resources, V33, P306; Chen N, 2012, BIOMATERIALS, V33, P1238, DOI 10.1016/j.biomaterials.2011.10.070; Cho SJ, 2007, LANGMUIR, V23, P1974, DOI 10.1021/la060093j; Choudhary KK, 2014, ECOTOX ENVIRON SAFE, V100, P178, DOI 10.1016/j.ecoenv.2013.10.032; Couee I, 2006, J EXP BOT, V57, P449, DOI 10.1093/jxb/erj027; Cuypers A, 2010, BIOMETALS, V23, P927, DOI 10.1007/s10534-010-9329-x; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Djikanovic D, 2012, COLLOID SURFACE B, V91, P41, DOI 10.1016/j.colsurfb.2011.10.032; Farage-Barhom S, 2011, MOL PLANT, V4, P1062, DOI 10.1093/mp/ssr045; Fernandez EL, 2003, TOXICOL SCI, V76, P162, DOI 10.1093/toxsci/kfg208; Gaponik N, 2002, J PHYS CHEM B, V106, P7177, DOI 10.1021/jp025541k; Gobe G, 2010, TOXICOL LETT, V198, P49, DOI 10.1016/j.toxlet.2010.04.013; Han R, 2002, CHINESE SCI BULL, V47, P818, DOI 10.1360/02tb9184; Heiss S, 2003, J EXP BOT, V54, P1833, DOI 10.1093/jxb/erg205; Hideg E, 2013, TRENDS PLANT SCI, V18, P107, DOI 10.1016/j.tplants.2012.09.003; Hossain MA, 2011, GLYOXALASE SYSTEM RE; Hu Y, 2010, PLANT PHYSIOL BIOCH, V48, P703, DOI 10.1016/j.plaphy.2010.04.001; Huang WJ, 2014, PLANT PHYSIOL BIOCH, V82, P76, DOI 10.1016/j.plaphy.2014.03.037; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; Jones R, 2009, NAT NANOTECHNOL, V4, P785, DOI 10.1038/nnano.2009.358; Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m; [李晓明 Li Xiaoming], 2013, [科学通报, Chinese Science Bulletin], V58, P1393; Liu YX, 2013, SMALL, V9, P2440, DOI 10.1002/smll.201300861; Lovric J, 2005, J MOL MED, V83, P377, DOI 10.1007/s00109-004-0629-x; Miralles P, 2012, ENVIRON SCI TECHNOL, V46, P9224, DOI 10.1021/es202995d; Nair R, 2011, J FLUORESC, V21, P2057, DOI 10.1007/s10895-011-0904-5; Navarro DA, 2012, J HAZARD MATER, V211, P427, DOI 10.1016/j.jhazmat.2011.12.012; Nawkar GM, 2013, INT J MOL SCI, V14, P1608, DOI 10.3390/ijms14011608; Nguyen KC, 2013, TOXICOLOGY, V306, P114, DOI 10.1016/j.tox.2013.02.010; Qi Z, 2002, PHOTOCHEM PHOTOBIOL, V75, P680, DOI 10.1562/0031-8655(2002)075<0680:TDRROH>2.0.CO;2; Ramel F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-28; Rao MV, 1996, PLANT PHYSIOL, V110, P125, DOI 10.1104/pp.110.1.125; Rico CM, 2013, ENVIRON SCI TECHNOL, V47, P5635, DOI 10.1021/es401032m; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Rousseaux MC, 1999, P NATL ACAD SCI USA, V96, P15310, DOI 10.1073/pnas.96.26.15310; Schlemmer MR, 2005, AGRON J, V97, P106, DOI 10.2134/agronj2005.0106; Shah K, 2001, PLANT SCI, V161, P1135, DOI 10.1016/S0168-9452(01)00517-9; Shen XF, 2010, J PLANT PHYSIOL, V167, P1248, DOI 10.1016/j.jplph.2010.04.011; Silva ECd, 2013, DROUGHT ITS CONSEQUE; Sozer N, 2014, FOOD RES INT, V57, P142, DOI 10.1016/j.foodres.2013.12.031; Su YY, 2010, BIOMATERIALS, V31, P4829, DOI 10.1016/j.biomaterials.2010.02.074; Taalas P, 2000, J GEOPHYS RES-ATMOS, V105, P4777, DOI 10.1029/1999JD901181; Valizadeh A, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-480; Verma S, 2003, PLANT SCI, V164, P645, DOI 10.1016/S0168-9452(03)00022-0; Wang GH, 2012, CHEMOSPHERE, V88, P413, DOI 10.1016/j.chemosphere.2012.02.056; Wang JX, 2012, COMP BIOCHEM PHYS C, V156, P195, DOI 10.1016/j.cbpc.2012.05.006; WMO, 2011, 52 WMO; Xu J, 2010, PLANT PHYSIOL, V154, P1319, DOI 10.1104/pp.110.162982; Yang AS, 2014, FOOD CHEM, V150, P73, DOI 10.1016/j.foodchem.2013.10.137; Young-Pyo L, 2007, PLANT CELL REP, V26, P591, DOI 10.1007/s00299-006-0253-z; Yu GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089241; Zhao SP, 2012, APPL BIOCHEM BIOTECH, V168, P2123, DOI 10.1007/s12010-012-9922-2	52	23	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110400	10.1371/journal.pone.0110400	http://dx.doi.org/10.1371/journal.pone.0110400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329900	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100062
J	Gamez-Pozo, A; Carrion, RMP; Manso, L; Crespo, C; Mendiola, C; Lopez-Vacas, R; Berges-Soria, J; Lopez, IA; Margeli, M; Calero, JLB; Farre, XG; Santaballa, A; Ciruelos, EM; Afonso, R; Lao, J; Catalan, G; Gallego, JVA; Lopez, JM; Bofill, FJS; Borrego, MR; Espinosa, E; Vara, JAF; Zamora, P				Gamez-Pozo, Angelo; Perez Carrion, Ramon M.; Manso, Luis; Crespo, Carmen; Mendiola, Cesar; Lopez-Vacas, Rocio; Berges-Soria, Julia; Alvarez Lopez, Isabel; Margeli, Mireia; Bayo Calero, Juan L.; Gonzalez Farre, Xavier; Santaballa, Ana; Ciruelos, Eva M.; Afonso, Ruth; Lao, Juan; Catalan, Gustavo; Alvarez Gallego, Jose V.; Miramon Lopez, Jose; Salvador Bofill, Francisco J.; Ruiz Borrego, Manuel; Espinosa, Enrique; Vara, Juan A. Fresno; Zamora, Pilar			The Long-HER Study: Clinical and Molecular Analysis of Patients with HER2+Advanced Breast Cancer Who Become Long-Term Survivors with Trastuzumab-Based Therapy	PLOS ONE			English	Article							PHASE-II TRIAL; RESISTANCE; MTOR; ACTIVATION; CHEMOTHERAPY; PLUS; RHEB; PACLITAXEL; GROWTH; WOMEN	Background: Trastuzumab improves survival outcomes in patients with HER2+ metastatic breast cancer. The Long-Her study was designed to identify clinical and molecular markers that could differentiate long-term survivors from patients having early progression after trastuzumab treatment. Methods: Data were collected from women with HER2-positive metastatic breast cancer treated with trastuzumab that experienced a response or stable disease during at least 3 years. Patients having a progression in the first year of therapy with trastuzumab were used as a control. Genes related with trastuzumab resistance were identified and investigated for network and gene functional interrelation. Models predicting poor response to trastuzumab were constructed and evaluated. Finally, a mutational status analysis of selected genes was performed in HER2 positive breast cancer samples. Results: 103 patients were registered in the Long-HER study, of whom 71 had obtained a durable complete response. Median age was 58 years. Metastatic disease was diagnosed after a median of 24.7 months since primary diagnosis. Metastases were present in the liver (25%), lungs (25%), bones (23%) and soft tissues (23%), with 20% of patients having multiple locations of metastases. Median duration of response was 55 months. The molecular analysis included 35 patients from the group with complete response and 18 patients in a control poor-response group. Absence of trastuzumab as part of adjuvant therapy was the only clinical factor associated with long-term survival. Gene ontology analysis demonstrated that PI3K pathway was associated with poor response to trastuzumab-based therapy: tumours in the control group usually had four or five alterations in this pathway, whereas tumours in the Long-HER group had two alterations at most. Conclusions: Trastuzumab may provide a substantial long-term survival benefit in a selected group of patients. Whole genome expression analysis comparing long-term survivors vs. a control group predicted early progression after trastuzumab-based therapy. Multiple alterations in genes related to the PI3K-mTOR pathway seem to be required to confer resistance to this therapy.	[Gamez-Pozo, Angelo; Lopez-Vacas, Rocio; Berges-Soria, Julia; Vara, Juan A. Fresno] Hosp La Paz, IdiPAZ, INGEMM, Madrid, Spain; [Perez Carrion, Ramon M.] Hosp Quiron Pozuelo Alarcon, Dept Med Oncol, Madrid, Spain; [Manso, Luis; Mendiola, Cesar; Ciruelos, Eva M.] Hosp 12 Octubre, Dept Med Oncol, E-28041 Madrid, Spain; [Crespo, Carmen] Hosp Ramon & Cajal, Dept Med Oncol, E-28034 Madrid, Spain; [Alvarez Lopez, Isabel] Hosp Donostia, Dept Med Oncol, San Sebastian, Pais Vasco, Spain; [Margeli, Mireia] Hosp Badalona Germans Trias & Pujol, Dept Med Oncol, Barcelona, Spain; [Bayo Calero, Juan L.] Hosp Juan Ramon Jimenez, Dept Med Oncol, Huelva, Spain; [Gonzalez Farre, Xavier] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain; [Santaballa, Ana] Hosp La Fe, Dept Med Oncol, E-46009 Valencia, Spain; [Afonso, Ruth] Hosp Nuestra Senora Candelaria, Dept Med Oncol, Santa Cruz De Tenerife, Spain; [Lao, Juan] Hosp Miguel Servet, Dept Med Oncol, Zaragoza, Spain; [Catalan, Gustavo] Hosp Son Llatzer, Dept Med Oncol, Palma de Mallorca, Spain; [Alvarez Gallego, Jose V.] Complejo Hospitalario Zamora, Dept Med Oncol, Zamora, Spain; [Miramon Lopez, Jose] Hosp Serrania Ronda, Dept Med Oncol, Malaga, Spain; [Salvador Bofill, Francisco J.] Hosp Virgen Valme, Dept Med Oncol, Seville, Spain; [Ruiz Borrego, Manuel] Hosp Virgen Rocio, Dept Med Oncol, Seville, Spain; [Espinosa, Enrique; Zamora, Pilar] Hosp La Paz, Dept Med Oncol, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario 12 de Octubre; Hospital Universitario Ramon y Cajal; University Hospital Donostia; Hospital Germans Trias i Pujol; Hospital Juan Ramon Jimenez; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitari i Politecnic La Fe; Miguel Servet University Hospital; Hospital Universitari Son Llatzer; Virgen del Rocio University Hospital; Hospital Universitario La Paz	Zamora, P (corresponding author), Hosp La Paz, Dept Med Oncol, Madrid, Spain.	zamorapilar@gmail.com	Zamora, Pilar/AAM-9336-2021; Fresno Vara, Juan Angel/F-6702-2010; manso, luis/AGZ-6467-2022; Vara, Juan Ángel Fresno/Y-9928-2019; Gamez-Pozo, Angelo/N-2506-2014	Fresno Vara, Juan Angel/0000-0003-1527-1252; manso, luis/0000-0002-1683-550X; Vara, Juan Ángel Fresno/0000-0003-1527-1252; Gamez-Pozo, Angelo/0000-0002-8931-0624; Espinosa Arranz, Enrique/0000-0001-6562-7902; Ciruelos, Eva/0000-0002-2796-1042; Gonzalez Farre, Xavier/0000-0002-5797-7037	Roche; Instituto de Salud Carlos III, Spain [CA12/00258, CA12/00264]	Roche(Roche Holding); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	The Long-HER study was supported by an unrestricted grant from Roche. AGP (CA12/00258) and RLV (CA12/00264) are supported by Instituto de Salud Carlos III, Spain. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bonifazi M, 2014, BREAST; Burstein HJ, 2001, J CLIN ONCOL, V19, P2722, DOI 10.1200/JCO.2001.19.10.2722; Choi BH, 2011, CURR OPIN PHARMACOL, V11, P354, DOI 10.1016/j.coph.2011.04.013; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI 10.1586/ERA.10.226; Gasparini G, 2007, BREAST CANCER RES TR, V101, P355, DOI 10.1007/s10549-006-9306-9; Gonzalez-Roca E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014418; Gullo G, 2012, ANN ONCOL, V23, P2204, DOI 10.1093/annonc/mds221; Gutierrez C, 2011, ARCH PATHOL LAB MED, V135, P55, DOI 10.1043/2010-0454-RAR.1; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kataoka Y, 2010, ANN ONCOL, V21, P255, DOI 10.1093/annonc/mdp304; Lam D, 2009, P NATL ACAD SCI USA, V106, P11978, DOI 10.1073/pnas.0900608106; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; Linton KM, 2009, BIOTECHNIQUES, V47, P587, DOI 10.2144/000113169; Ma DZ, 2008, J BIOL CHEM, V283, P25963, DOI 10.1074/jbc.M802356200; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; O'Brien NA, 2014, CLIN CANCER RES, V20, P3507, DOI 10.1158/1078-0432.CCR-13-2769; O'Regan R, 2013, J CLIN ONCOL, V31; Paik S, 2005, NAT CLIN PRACT ONCOL, V2, P246, DOI 10.1038/ncponc0171; Parikh JR, 2010, NUCLEIC ACIDS RES, V38, pW109, DOI 10.1093/nar/gkq424; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Robert N, 2006, J CLIN ONCOL, V24, P2786, DOI 10.1200/JCO.2005.04.1764; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vu T, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00062; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valero V, 2011, J CLIN ONCOL, V29, P149, DOI 10.1200/JCO.2010.28.6450; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Wang L, 2011, BMC CANCER, V11, P11, DOI DOI 10.2174/138955711797247716; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Weigelt B, 2012, ANN ONCOL, V23, P211, DOI 10.1093/annonc/mds323; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xie Y, 2011, CLIN CANCER RES, V17, P5705, DOI 10.1158/1078-0432.CCR-11-0196; Yardley DA, 2014, BRIT J CANCER, V110, P2756, DOI 10.1038/bjc.2014.174; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	48	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109611	10.1371/journal.pone.0109611	http://dx.doi.org/10.1371/journal.pone.0109611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330188	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100031
J	Khatri, C; Sugand, K; Anjum, S; Vivekanantham, S; Akhtar, K; Gupte, C				Khatri, Chetan; Sugand, Kapil; Anjum, Sharika; Vivekanantham, Sayinthen; Akhtar, Kash; Gupte, Chinmay			Does Video Gaming Affect Orthopaedic Skills Acquisition? A Prospective Cohort-Study	PLOS ONE			English	Article							LAPAROSCOPIC SKILLS; PERFORMANCE; GAMES; SURGEONS; IMPACT	Introduction: Previous studies have suggested that there is a positive correlation between the extent of video gaming and efficiency of surgical skill acquisition on laparoscopic and endovascular surgical simulators amongst trainees. However, the link between video gaming and orthopaedic trauma simulation remains unexamined, in particular dynamic hip screw (DHS) stimulation. Objective: To assess effect of prior video gaming experience on virtual-reality (VR) haptic-enabled DHS simulator performance. Methods: 38 medical students, naive to VR surgical simulation, were recruited and stratified relative to their video gaming exposure. Group 1 (n = 19, video-gamers) were defined as those who play more than one hour per day in the last calendar year. Group 2 (n = 19, non-gamers) were defined as those who play video games less than one hour per calendar year. Both cohorts performed five attempts on completing a VR DHS procedure and repeated the task after a week. Metrics assessed included time taken for task, simulated flouroscopy time and screw position. Median and Bonett-Price 95% confidence intervals were calculated for seven real-time objective performance metrics. Data was confirmed as non-parametric by the Kolmogorov-Smirnov test. Analysis was performed using the Mann-Whitney U test for independent data whilst the Wilcoxon signed ranked test was used for paired data. A result was deemed significant when a two-tailed p-value was less than 0.05. Results: All 38 subjects completed the study. The groups were not significantly different at baseline. After ten attempts, there was no difference between Group 1 and Group 2 in any of the metrics tested. These included time taken for task, simulated fluoroscopy time, number of retries, tip-apex distance, percentage cut-out and global score. Conclusion: Contrary to previous literature findings, there was no correlation between video gaming experience and gaining competency on a VR DHS simulator.	[Khatri, Chetan; Sugand, Kapil; Anjum, Sharika; Vivekanantham, Sayinthen; Akhtar, Kash; Gupte, Chinmay] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, MSk Lab, London, England	Imperial College London	Khatri, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, MSk Lab, London, England.	chetan.khatri@gmail.com	Sugand, Kapil/AAY-4107-2020	Sugand, Kapil/0000-0003-3185-954X; Khatri, Chetan/0000-0002-3961-1314				Association TES, IND FACTS; Badurdeen S, 2010, SURG ENDOSC, V24, P1824, DOI 10.1007/s00464-009-0862-z; BAUMGAERTNER MR, 1995, J BONE JOINT SURG AM, V77A, P1058, DOI 10.2106/00004623-199507000-00012; BRASINGTON R, 1990, NEW ENGL J MED, V322, P1473; Gentile DA, 2004, J ADOLESCENCE, V27, P5, DOI 10.1016/j.adolescence.2003.10.002; Giannotti D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057372; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Grantcharov TP, 2003, SURG ENDOSC, V17, P1082, DOI 10.1007/s00464-002-9176-0; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hislop SJ, 2006, J VASC SURG, V43, P47, DOI 10.1016/j.jvs.2005.09.035; Lemons R, NINTENDO ISSUES GAME; Lynch J, 2010, J SURG EDUC, V67, P184, DOI 10.1016/j.jsurg.2010.02.010; Rosenberg BH, 2005, J ENDOUROL, V19, P372, DOI 10.1089/end.2005.19.372; Rosser JC, 2007, ARCH SURG-CHICAGO, V142, P181, DOI 10.1001/archsurg.142.2.181; Rosser JC, 2012, JSLS-J SOC LAPAROEND, V16, P3, DOI 10.4293/108680812X13291597715664; Schlickum MK, 2008, ST HEAL T, V132, P210; Schlickum MK, 2009, WORLD J SURG, V33, P2360, DOI 10.1007/s00268-009-0151-y; Strauss RS, 2013, INFLUENCE HOME ENV D; van Dongen KW, 2011, SURG ENDOSC, V25, P2275, DOI 10.1007/s00464-010-1548-2; Van Hove C, 2008, WORLD J SURG, V32, P1917, DOI 10.1007/s00268-008-9643-4; Walter H, 2001, NEUROREPORT, V12, P1763, DOI 10.1097/00001756-200106130-00049	21	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110212	10.1371/journal.pone.0110212	http://dx.doi.org/10.1371/journal.pone.0110212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333959	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200101
J	Liu, SZ; Dai, JY; Yao, LN; Li, XH; Reid, B; Self, S; Ma, J; Chang, YX; Feng, SX; Tapsoba, JD; Sun, X; Sun, XB				Liu, Shuzheng; Dai, James Y.; Yao, Lena; Li, Xiaohong; Reid, Brian; Self, Steve; Ma, Jie; Chang, Yuxi; Feng, Shixian; Tapsoba, Jean de Dieu; Sun, Xin; Sun, Xibin			Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; GASTRIC CARDIA; PREVALENCE; CANCER; TREND; POPULATION; CARCINOMA; DYSPLASIA; SURVIVAL; REGIONS	Incidence of esophageal adenocarcinoma (EAC) has increased sharply in Western Europe and United States over the past three decades. Nearly all cases of EAC in the west are thought to be associated with Barrett's esophagus (BE) at the time of diagnosis. Regions in the Henan province of China have one of world's highest incidences of esophageal cancer, yet recent temporal trends in the relative rates of EAC with respect to esophageal squamous-cell carcinoma (ESCC), as well as its association with Barrett's esophagus (BE), have not been reported. In this report, we present large-scale longitudinal clinical and histological data on 5401 esophageal cancers (EC) patients diagnosed during the recent 10-year period (2002-2011) at Henan Cancer Hospital, China. All 217 esophageal adenocarcinoma (EAC) patients from these 5401 EC patients were examined to better understand the relationship between Barrett's esophagus (BE) and EAC. We found that EAC was relatively rare and accounted for approximately 5% of all esophageal cancers each year during 2002-2011. There is no evidence of significant temporal trends in the rate of EAC relative to ESCC. Only 10 out of 217 (4.6%) EAC cases were detected to have any evidence of Barrett's esophagus. This result raises the possibility of a different etiological basis for EAC in China motivating more detailed epidemiological, clinical and molecular characterization of EAC in China in order to better understand the neoplastic development of EAC.	[Liu, Shuzheng; Sun, Xibin] Henan Canc Hosp, Henan Off Canc Res & Control, Zhengzhou, Henan Province, Peoples R China; [Dai, James Y.; Yao, Lena; Self, Steve; Tapsoba, Jean de Dieu] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis & Publ Hlth Sci Div, Seattle, WA 98104 USA; [Li, Xiaohong; Reid, Brian] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Li, Xiaohong; Reid, Brian] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Ma, Jie; Chang, Yuxi] Henan Canc Hosp, Dept Mol Pathol, Zhengzhou, Henan Province, Peoples R China; [Feng, Shixian] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan Province, Peoples R China; [Sun, Xin] Chinese Ctr Dis Control & Prevent, Inst Occupat Hlth & Poison Control, Beijing, Peoples R China	Zhengzhou University; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Zhengzhou University; Chinese Center for Disease Control & Prevention; National Institute of Occupational Health & Poison Control, Chinese Center for Disease Control & Prevention	Sun, X (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Occupat Hlth & Poison Control, Beijing, Peoples R China.	sunxin@chinacdc.cn; xbsun21@sina.com	Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X	NATIONAL CANCER INSTITUTE [P01CA091955] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; Cameron AJ, 1997, AM J GASTROENTEROL, V92, P586; El-Serag H, 2009, ALIMENT PHARM THER, V29, P470, DOI 10.1111/j.1365-2036.2008.03901.x; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Fan YJ, 2008, WORLD J SURG, V32, P1980, DOI 10.1007/s00268-008-9674-x; Gerson LB, 2002, GASTROENTEROLOGY, V123, P461, DOI 10.1053/gast.2002.34748; HAMILTON SR, 1988, HUM PATHOL, V19, P942, DOI 10.1016/S0046-8177(88)80010-8; HAMILTON SR, 1987, AM J CLIN PATHOL, V87, P301, DOI 10.1093/ajcp/87.3.301; He J, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-94; Ho KY, 2011, J GASTROEN HEPATOL, V26, P816, DOI 10.1111/j.1440-1746.2011.06669.x; Hoff SJ, 1998, ANN THORAC SURG, V65, P176, DOI 10.1016/S0003-4975(97)01178-8; Hongo M, 2004, ALIMENT PHARM THER, V20, P50, DOI 10.1111/j.1365-2036.2004.02230.x; Huang Q, 2011, J DIGEST DIS, V12, P420, DOI 10.1111/j.1751-2980.2011.00535.x; Jeon J, 2006, CANCER CAUSE CONTROL, V17, P971, DOI 10.1007/s10552-006-0037-3; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kim R, 1997, CANCER EPIDEM BIOMAR, V6, P369; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lindblad M, 2005, CANCER CAUSE CONTROL, V16, P285, DOI 10.1007/s10552-004-3485-7; Liu SZ, 2013, ASIAN PAC J CANCER P, V14, P6031, DOI 10.7314/APJCP.2013.14.10.6031; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lu CL, 2010, CANCER CAUSE CONTROL, V21, P269, DOI 10.1007/s10552-009-9458-0; Miwa H, 2002, AM J GASTROENTEROL, V97, P1106, DOI 10.1111/j.1572-0241.2002.05663.x; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Powell J, 2002, INT J CANCER, V102, P422, DOI 10.1002/ijc.10721; REID BJ, 1991, GASTROENTEROL CLIN N, V20, P817; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Rex DK, 2003, GASTROENTEROLOGY, V125, P1670, DOI 10.1053/j.gastro.2003.09.030; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Sabel MS, 2000, ARCH SURG-CHICAGO, V135, P831, DOI 10.1001/archsurg.135.7.831; Sharma P, 2008, AM J GASTROENTEROL, V103, P2669, DOI 10.1111/j.1572-0241.2008.02089.x; Shibata A, 2008, JPN J CLIN ONCOL, V38, P464, DOI 10.1093/jjco/hyn064; SKINNER DB, 1983, ANN SURG, V198, P554, DOI 10.1097/00000658-198310000-00016; Stavrou EP, 2009, MED J AUSTRALIA, V191, P310, DOI 10.5694/j.1326-5377.2009.tb02813.x; Theisen J, 2002, SURG ENDOSC, V16, P671, DOI 10.1007/s00464-001-8307-3; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Ward EM, 2006, AM J GASTROENTEROL, V101, P12, DOI 10.1111/j.1572-0241.2006.00379.x; Wayman J, 2001, CANCER CAUSE CONTROL, V12, P943, DOI 10.1023/A:1013756531219; YANG CS, 1980, CANCER RES, V40, P2633; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yee YK, 2007, CANCER EPIDEM BIOMAR, V16, P2637, DOI 10.1158/1055-9965.EPI-07-0421	42	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110348	10.1371/journal.pone.0110348	http://dx.doi.org/10.1371/journal.pone.0110348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333822	Green Submitted, gold, Green Published			2022-12-27	WOS:000346766200116
J	Rodriguez, A; Burgan, G; Dann, P; Jessop, R; Negro, JJ; Chiaradia, A				Rodriguez, Airam; Burgan, Graeme; Dann, Peter; Jessop, Roz; Negro, Juan J.; Chiaradia, Andre			Fatal Attraction of Short-Tailed Shearwaters to Artificial Lights	PLOS ONE			English	Article							CANARY-ISLANDS; REUNION ISLAND; INDUCED MORTALITY; CORYS SHEARWATER; INDIAN-OCEAN; MOON PHASE; POLLUTION; PETRELS; POPULATION; TENERIFE	Light pollution is increasing around the world and altering natural nightscapes with potential ecological and evolutionary consequences. A severe ecological perturbation caused by artificial lights is mass mortalities of organisms, including seabird fledglings that are attracted to lights at night on their first flights to the sea. Here, we report on the number of fledging short-tailed shearwaters Ardenna tenuirostris found grounded in evening and morning rescue patrols conducted at Phillip Island, Australia, during a 15-year period (1999-2013). We assessed factors affecting numbers of grounded birds and mortality including date, moon phase, wind direction and speed, number of visitors and holiday periods. We also tested experimentally if birds were attracted to lights by turning the lights off on a section of the road. Of 8871 fledglings found, 39% were dead or dying. This mortality rate was 4-8 times higher than reported elsewhere for other shearwater species, probably because searching for fledglings was part of our systematic rescue effort rather than the opportunistic rescue used elsewhere. Thus, it suggests that light-induced mortality of seabirds is usually underestimated. We rescued more birds (dead and alive) in peak fledging, moonless and windy nights. Mortality increased through the fledging period, in the mornings and with increased traffic on holiday periods. Turning the road lights off decreased the number of grounded birds (dead and alive). While moon, wind and time are uncontrolled natural constraints, we demonstrated that reduction of light pollution and better traffic management can mitigate artificial light-induced mortality.	[Rodriguez, Airam; Burgan, Graeme; Dann, Peter; Jessop, Roz; Chiaradia, Andre] Phillip Isl Nat Pk, Res Dept, Cowes, Vic, Australia; [Rodriguez, Airam; Negro, Juan J.] CSIC, Estn Biol Donana, Dept Evolutionary, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Rodriguez, A (corresponding author), Phillip Isl Nat Pk, Res Dept, Cowes, Vic, Australia.	airamrguez@ebd.csic.es	Chiaradia, Andre/AFK-6634-2022; Chiaradia, Andre/AAG-4928-2022; Rodríguez, Airam/D-5110-2011; Negro, Juan Jose/I-2653-2015	Chiaradia, Andre/0000-0002-6178-4211; Chiaradia, Andre/0000-0002-6178-4211; Rodríguez, Airam/0000-0001-7882-135X; Negro, Juan Jose/0000-0002-8697-5647	European Community [330655 FP7-PEOPLE-2012-IOF]	European Community(European Commission)	AR was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (n 330655 FP7-PEOPLE-2012-IOF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2001, STUD AVIAN BIOL-SER, P108; BirdLife International, 2013, BIRDS SOM FAM NOT SE; BirdLife International, 2014, IMP BIRD AR FACTSH P; Bourgeois S, 2009, BIOL CONSERV, V142, P85, DOI 10.1016/j.biocon.2008.09.028; BOYLE SA, 1985, WILDLIFE SOC B, V13, P110; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Crawley MJ, 2005, STAT INTRO USING R; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Dann P, 2013, CLIM RES, V58, P67, DOI 10.3354/cr01187; Day RH, 2003, AUK, V120, P669, DOI 10.1642/0004-8038(2003)120[0669:DOTNSP]2.0.CO;2; Fontaine R, 2011, BIOL CONSERV, V144, P1998, DOI 10.1016/j.biocon.2011.04.022; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; HARRIS MP, 1981, EMU, V81, P20, DOI 10.1071/MU9810020; Holker F, 2010, ECOL SOC, V15; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; IMBER M J, 1975, Notornis, V22, P302; Jones J, 2003, J AVIAN BIOL, V34, P328, DOI 10.1111/j.0908-8857.2003.03183.x; Kyba CCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017307; Le Corre M, 2003, CONDOR, V105, P387; Le Corre M, 2002, BIOL CONSERV, V105, P93, DOI 10.1016/S0006-3207(01)00207-5; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; Lyytimaki J, 2012, LAND USE POLICY, V29, P598, DOI 10.1016/j.landusepol.2011.10.002; Miles W, 2010, BIRD STUDY, V57, P244, DOI 10.1080/00063651003605064; Podolsky R, 1998, COLON WATERBIRD, V21, P20, DOI 10.2307/1521727; Poot H, 2008, ECOL SOC, V13; REED JR, 1985, AUK, V102, P377, DOI 10.2307/4086782; Rich C., 2006, ECOLOGICAL CONSEQUEN; Rodrigues P, 2012, EUR J WILDLIFE RES, V58, P147, DOI 10.1007/s10344-011-0555-5; Rodriguez A, 2012, ANIM CONSERV, V15, P519, DOI 10.1111/j.1469-1795.2012.00544.x; Rodriguez A, 2012, IBIS, V154, P167, DOI 10.1111/j.1474-919X.2011.01175.x; Rodriguez A, 2009, IBIS, V151, P299, DOI 10.1111/j.1474-919X.2009.00925.x; Rodriguez Airam, 2008, Alauda, V76, P72; Salamolard M, 2007, OSTRICH, V78, P449, DOI 10.2989/OSTRICH.2007.78.2.52.132; SKIRA I, 1991, Corella, V15, P45; TELFER TC, 1987, WILDLIFE SOC B, V15, P406; Troy JR, 2013, ENDANGER SPECIES RES, V22, P225, DOI 10.3354/esr00547; Troy JR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00094.1; Villard P, 2006, IBIS, V148, P285, DOI 10.1111/j.1474-919X.2006.00528.x; WARHAM J, 1990, PETRELS THEIR ECOLOG	39	38	40	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110114	10.1371/journal.pone.0110114	http://dx.doi.org/10.1371/journal.pone.0110114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25334014	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200094
J	Schwind, JS; Wolking, DJ; Brownstein, JS; Mazet, JAK; Smith, WA				Schwind, Jessica S.; Wolking, David J.; Brownstein, John S.; Mazet, Jonna A. K.; Smith, Woutrina A.		PREDICT Consortium	Evaluation of Local Media Surveillance for Improved Disease Recognition and Monitoring in Global Hotspot Regions	PLOS ONE			English	Article							HEALTHMAP	Digital disease detection tools are technologically sophisticated, but dependent on digital information, which for many areas suffering from high disease burdens is simply not an option. In areas where news is often reported in local media with no digital counterpart, integration of local news information with digital surveillance systems, such as HealthMap (Boston Children's Hospital), is critical. Little research has been published in regards to the specific contribution of local health-related articles to digital surveillance systems. In response, the USAID PREDICT project implemented a local media surveillance (LMS) pilot study in partner countries to monitor disease events reported in print media. This research assessed the potential of LMS to enhance digital surveillance reach in five low-and middle-income countries. Over 16 weeks, select surveillance system attributes of LMS, such as simplicity, flexibility, acceptability, timeliness, and stability were evaluated to identify strengths and weaknesses in the surveillance method. Findings revealed that LMS filled gaps in digital surveillance network coverage by contributing valuable localized information on disease events to the global HealthMap database. A total of 87 health events were reported through the LMS pilot in the 16-week monitoring period, including 71 unique reports not found by the HealthMap digital detection tool. Furthermore, HealthMap identified an additional 236 health events outside of LMS. It was also observed that belief in the importance of the project and proper source selection from the participants was crucial to the success of this method. The timely identification of disease outbreaks near points of emergence and the recognition of risk factors associated with disease occurrence continue to be important components of any comprehensive surveillance system for monitoring disease activity across populations. The LMS method, with its minimal resource commitment, could be one tool used to address the information gaps seen in global 'hot spot' regions.	[Schwind, Jessica S.; Wolking, David J.; Mazet, Jonna A. K.; Smith, Woutrina A.; PREDICT Consortium] Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA; [Brownstein, John S.] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Brownstein, John S.] Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp Boston, Boston, MA 02115 USA	University of California System; University of California Davis; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Schwind, JS (corresponding author), Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA.	jsschwind@ucdavis.edu	Karesh, William/AAU-9084-2020; Shi, Zheng-Li/A-1013-2013; Jones, Kate/G-4768-2010; Ferrer-Paris, Jose R./M-3785-2015; Ali, Mohamed/N-8768-2017	Karesh, William/0000-0001-6042-2860; Suzan, Gerardo/0000-0003-2508-6376; Olival, Kevin/0000-0003-3211-1875; Rico, Oscar/0000-0002-9833-1101; Sullivan, Ava/0000-0003-4339-2430; Perez Lazo, Jocelyn/0000-0002-4887-2786; Thomas, Kate/0000-0001-6314-8326; Mendoza Becerra, Ana Patricia/0000-0002-8631-0119; Kumakamba, Charles/0000-0002-3170-5914; Pruvot, Mathieu/0000-0001-9325-3960; Shi, Zheng-Li/0000-0001-8089-163X; Horwood, Paul/0000-0001-9622-0742; Jones, Kate/0000-0001-5231-3293; Ferrer-Paris, Jose R./0000-0002-9554-3395; Ali, Mohamed/0000-0002-5615-3212				Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107; Cowen P, 2006, JAVMA-J AM VET MED A, V229, P1090, DOI 10.2460/javma.229.7.1090; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; German R R, 2001, MMWR Recomm Rep, V50, P1; German RR, 2001, MMWR RECOMM REP, V50, pCE31; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Lemon SM, 2007, GLOBAL INFECTIOUS DI, DOI [10.17226/11996, DOI 10.17226/11996]; Mondor L, 2012, EMERG INFECT DIS, V18, P1184, DOI 10.3201/eid1807.120249; Morse SS, 1996, EPIDEMIOL REV, V18, P1, DOI 10.1093/oxfordjournals.epirev.a017912; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Nicol AM, 2008, RISK ANAL, V28, P373, DOI 10.1111/j.1539-6924.2008.01024.x; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; *USAID, 2009, USAID LAUNCH EM PAND; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]; Woodall J, 1997, INT J MED INFORM, V47, P31, DOI 10.1016/S1386-5056(97)00079-8	18	16	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110236	10.1371/journal.pone.0110236	http://dx.doi.org/10.1371/journal.pone.0110236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333618	Green Published, Green Accepted, gold			2022-12-27	WOS:000346766200106
J	Fujiwara, T; Yagi, J; Homma, H; Mashiko, H; Nagao, K; Okuyama, M				Fujiwara, Takeo; Yagi, Junko; Homma, Hiroaki; Mashiko, Hirobumi; Nagao, Keizo; Okuyama, Makiko		Great East Japan Earthquake Follow	Clinically Significant Behavior Problems among Young Children 2 Years after the Great East Japan Earthquake	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HURRICANE KATRINA; PRESCHOOL-CHILDREN; TURKISH CHILDREN; FOLLOW-UP; SYMPTOMS; ADOLESCENTS; EXPOSURE; CONSEQUENCES; CHECKLIST	Background: On March 11, 2011, a massive undersea earthquake and tsunami struck East Japan. Few studies have investigated the impact of exposure to a natural disaster on preschool children. We investigated the association of trauma experiences during the Great East Japan Earthquake on clinically significant behavior problems among preschool children 2 years after the earthquake. Method: Participants were children who were exposed to the 2011 disaster at preschool age (affected area, n = 178; unaffected area, n = 82). Data were collected from September 2012 to June 2013 (around 2 years after the earthquake), thus participants were aged 5 to 8 years when assessed. Severe trauma exposures related to the earthquake (e.g., loss of family members) were assessed by interview, and trauma events in the physical environment related to the earthquake (e.g. housing damage), and other trauma exposure before the earthquake, were assessed by questionnaire. Behavior problems were assessed by caregivers using the Child Behavior Checklist (CBCL), which encompasses internalizing, externalizing, and total problems. Children who exceeded clinical cut-off of the CBCL were defined as having clinically significant behavior problems. Results: Rates of internalizing, externalizing, and total problems in the affected area were 27.7%, 21.2%, and 25.9%, respectively. The rate ratio suggests that children who lost distant relatives or friends were 2.36 times more likely to have internalizing behavior problems (47.6% vs. 20.2%, 95% CI: 1.10-5.07). Other trauma experiences before the earthquake also showed significant positive association with internalizing, externalizing, and total behavior problems, which were not observed in the unaffected area. Conclusions: One in four children still had behavior problems even 2 years after the Great East Japan Earthquake. Children who had other trauma experiences before the earthquake were more likely to have behavior problems. These data will be useful for developing future interventions in child mental health after a natural disaster.	[Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan; [Yagi, Junko] Iwate Med Univ, Dept Neuropsychiat, Morioka, Iwate, Japan; [Homma, Hiroaki] Miyagi Prefectural Comprehens Childrens Ctr, Kesennuma, Miyagi, Japan; [Mashiko, Hirobumi] Fukushima Med Univ, Dept Neuropsychiat, Fukushima, Japan; [Nagao, Keizo] Nagao Mental Clin, Tsu, Mie, Japan; [Okuyama, Makiko] Natl Ctr Child Hlth & Dev, Dept Psychosocial Med, Tokyo, Japan	National Center for Child Health & Development - Japan; Iwate Medical University; Fukushima Medical University; National Center for Child Health & Development - Japan	Fujiwara, T (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan.	fujiwara-tk@ncchd.go.jp			Ministry of Health, Labour and Welfare [H24-jisedai-shitei-007]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study is supported by a grant from the Ministry of Health, Labour and Welfare (H24-jisedai-shitei-007). The role of funders is implementation of this study.	Agustini EN, 2011, J PSYCHIATR MENT HLT, V18, P543, DOI 10.1111/j.1365-2850.2011.01702.x; [Anonymous], 1991, MANUAL CHILD BEHAV C; Bal A, 2007, EUR CHILD ADOLES PSY, V16, P449, DOI 10.1007/s00787-007-0618-z; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Chemtob CM, 2008, ARCH PEDIAT ADOL MED, V162, P126, DOI 10.1001/archpediatrics.2007.36; Dehon C, 2006, J PEDIATR PSYCHOL, V31, P431, DOI 10.1093/jpepsy/jsj006; Eksi A, 2009, EUR CHILD ADOLES PSY, V18, P384, DOI 10.1007/s00787-009-0745-9; Fire and Disaster Management Agency, 2013, HIG HOU; Itani T., 2001, PSYCHIATR NEUROL PAE, V41, P243; Japan Child and Family Research Institute, 2013, ALM DAT JAP CHILDR 2; Jia ZB, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-104; Kitayama Shinji, 2000, Kobe Journal of Medical Sciences, V46, P189; Laor N, 2002, J NERV MENT DIS, V190, P824, DOI 10.1097/00005053-200212000-00004; Liu MX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014706; Loeb J, 2011, J TRAUMA STRESS, V24, P430, DOI 10.1002/jts.20658; Lowe SR, 2013, J APPL DEV PSYCHOL, V34, P17, DOI 10.1016/j.appdev.2012.09.002; Lubit Roy, 2003, J Psychiatr Pract, V9, P128, DOI 10.1097/00131746-200303000-00004; Marsee MA, 2008, J CLIN CHILD ADOLESC, V37, P519, DOI 10.1080/15374410802148152; McLaughlin KA, 2009, J AM ACAD CHILD PSY, V48, P1069, DOI 10.1097/CHI.0b013e3181b76697; Oncu EC, 2010, CHILD DEV, V81, P1161, DOI 10.1111/j.1467-8624.2010.01460.x; Osofsky HJ, 2009, AM J ORTHOPSYCHIAT, V79, P212, DOI 10.1037/a0016179; Piyasil Vinadda, 2011, J Med Assoc Thai, V94 Suppl 3, pS138; Piyasil Vinadda, 2008, J Med Assoc Thai, V91 Suppl 3, pS15; Piyasil Vinadda, 2007, Journal of the Medical Association of Thailand, V90, P2370; Sahin NH, 2007, J TRAUMA STRESS, V20, P335, DOI 10.1002/jts.20217; Scheeringa MS, 2008, J CLIN CHILD ADOLESC, V37, P508, DOI 10.1080/15374410802148178; Shioyama A, 2000, Seishin Shinkeigaku Zasshi, V102, P481; Thienkrua W, 2006, JAMA-J AM MED ASSOC, V296, P549, DOI 10.1001/jama.296.5.549; Tural U, 2004, J TRAUMA STRESS, V17, P451, DOI 10.1007/s10960-004-5793-9; Uemoto M, 2000, Seishin Shinkeigaku Zasshi, V102, P459; Ularntinon Sirirat, 2008, J Med Assoc Thai, V91 Suppl 3, pS69; Yang R, 2013, J CHILD PSYCHOL PSYC; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhang Z, 2012, PSYCHOL MED, V42, P1687, DOI 10.1017/S0033291711002844	34	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109342	10.1371/journal.pone.0109342	http://dx.doi.org/10.1371/journal.pone.0109342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR7AB	25333762	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200013
J	Siefert, A; Fridley, JD; Ritchie, ME				Siefert, Andrew; Fridley, Jason D.; Ritchie, Mark E.			Community Functional Responses to Soil and Climate at Multiple Spatial Scales: When Does Intraspecific Variation Matter?	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; PLANT TRAITS; ENVIRONMENTAL GRADIENT; ECONOMICS SPECTRUM; BETA-DIVERSITY; LEAF-AREA; VARIABILITY; EVOLUTION; ECOLOGY; BIODIVERSITY	Despite increasing evidence of the importance of intraspecific trait variation in plant communities, its role in community trait responses to environmental variation, particularly along broad-scale climatic gradients, is poorly understood. We analyzed functional trait variation among early-successional herbaceous plant communities (old fields) across a 1200-km latitudinal extent in eastern North America, focusing on four traits: vegetative height, leaf area, specific leaf area (SLA), and leaf dry matter content (LDMC). We determined the contributions of species turnover and intraspecific variation to between-site functional dissimilarity at multiple spatial scales and community trait responses to edaphic and climatic factors. Among-site variation in community mean trait values and community trait responses to the environment were generated by a combination of species turnover and intraspecific variation, with species turnover making a greater contribution for all traits. The relative importance of intraspecific variation decreased with increasing geographic and environmental distance between sites for SLA and leaf area. Intraspecific variation was most important for responses of vegetative height and responses to edaphic compared to climatic factors. Individual species displayed strong trait responses to environmental factors in many cases, but these responses were highly variable among species and did not usually scale up to the community level. These findings provide new insights into the role of intraspecific trait variation in plant communities and the factors controlling its relative importance. The contribution of intraspecific variation to community trait responses was greatest at fine spatial scales and along edaphic gradients, while species turnover dominated at broad spatial scales and along climatic gradients.	[Siefert, Andrew; Fridley, Jason D.; Ritchie, Mark E.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Siefert, A (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	asiefert@syr.edu			National Science Foundation [DEB-1210609, DEB-1119743]	National Science Foundation(National Science Foundation (NSF))	AS was supported by National Science Foundation grant DEB-1210609. JDF was supported by National Science Foundation grant DEB-1119743. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly David D., 2003, International Journal of Plant Sciences, V164, pS165, DOI 10.1086/368401; Ackerly DD, 1999, AM J BOT, V86, P1272, DOI 10.2307/2656775; Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Auger S, 2013, J VEG SCI, V24, P419, DOI 10.1111/j.1654-1103.2012.01473.x; Baraloto C, 2010, FUNCT ECOL, V24, P208, DOI 10.1111/j.1365-2435.2009.01600.x; Baythavong BS, 2011, AM NAT, V178, P75, DOI 10.1086/660281; BOUYOUCOS GJ, 1962, AGRON J, V54, P464, DOI 10.2134/agronj1962.00021962005400050028x; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Dantas VD, 2013, OECOLOGIA, V171, P487, DOI 10.1007/s00442-012-2431-8; De Frenne P, 2013, J ECOL, V101, P784, DOI 10.1111/1365-2745.12074; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Furrer R., 2012, FIELDS TOOLS SPATIAL; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Grime JP, 2008, P NATL ACAD SCI USA, V105, P10028, DOI 10.1073/pnas.0711567105; Gross N, 2013, J ECOL, V101, P637, DOI 10.1111/1365-2745.12063; Jung V, 2014, J ECOL, V102, P45, DOI 10.1111/1365-2745.12177; Jung V, 2010, J ECOL, V98, P1134, DOI 10.1111/j.1365-2745.2010.01687.x; Kichenin E, 2013, FUNCT ECOL, V27, P1254, DOI 10.1111/1365-2435.12116; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; LECHOWICZ MJ, 1991, J ECOL, V79, P687, DOI 10.2307/2260661; Leps J, 2011, ECOGRAPHY, V34, P856, DOI 10.1111/j.1600-0587.2010.06904.x; Lloret F, 2012, GLOBAL CHANGE BIOL, V18, P797, DOI 10.1111/j.1365-2486.2011.02624.x; Marks CO, 2006, AM NAT, V167, P55, DOI 10.1086/498276; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; *NE CLIM IMP ASS, 2006, CLIM CHANG US NE; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pakeman RJ, 2009, J VEG SCI, V20, P148, DOI 10.1111/j.1654-1103.2009.05548.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Perez-Ramos IM, 2012, J ECOL, V100, P1315, DOI 10.1111/1365-2745.12000; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Ricotta C, 2011, OECOLOGIA, V167, P181, DOI 10.1007/s00442-011-1965-5; Roche P, 2004, PLANT ECOL, V174, P37, DOI 10.1023/B:VEGE.0000046056.94523.57; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Siefert A, 2013, GLOBAL ECOL BIOGEOGR, V22, P682, DOI 10.1111/geb.12030; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; Violle C, 2009, J PLANT ECOL-UK, V2, P87, DOI 10.1093/jpe/rtp007; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Wright JP, 2010, J BIOGEOGR, V37, P1584, DOI 10.1111/j.1365-2699.2010.02298.x	51	35	44	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e111189	10.1371/journal.pone.0111189	http://dx.doi.org/10.1371/journal.pone.0111189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329794	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100114
J	Chen, L; Marko, L; Kassmann, M; Zhu, Y; Wu, KY; Gollasch, M				Chen, Lan; Marko, Lajos; Kassmann, Mario; Zhu, Ye; Wu, Kaiyin; Gollasch, Maik			Role of TRPV1 Channels in Ischemia/Reperfusion-Induced Acute Kidney Injury	PLOS ONE			English	Article							INDUCED RENAL INJURY; VANILLOID 1 TRPV1; EPOXYEICOSATRIENOIC ACIDS; GANGLION NEURONS; BODY-TEMPERATURE; CAPSAICIN; RATS; HYPERTENSION; DENERVATION; INHIBITION	Objectives: Transient receptor potential vanilloid 1 (TRPV1)-positive sensory nerves are widely distributed in the kidney, suggesting that TRPV1-mediated action may participate in the regulation of renal function under pathophysiological conditions. Stimulation of TRPV1 channels protects against ischemia/reperfusion (I/R)-induced acute kidney injury (AKI). However, it is unknown whether inhibition of these channels is detrimental in AKI or not. We tested the role of TRPV1 channels in I/R-induced AKI by modulating these channels with capsaicin (TRPV1 agonist), capsazepine (TRPV1 antagonist) and using Trpv1-/- mice. Methods and Results: Anesthetized C57BL/6 mice were subjected to 25 min of renal ischemia and 24 hrs of reperfusion. Mice were pretreated with capsaicin (0.3 mg/kg body weight) or capsazepine (50 mg/kg body weight). Capsaicin ameliorated the outcome of AKI, as measured by serum creatinine levels, tubular damage, neutrophil gelatinase-associated lipocalin (NGAL) abundance and Ly-6B. 2 positive polymorphonuclear inflammatory cells in injured kidneys. Neither capsazepine nor deficiency of TRPV1 did deteriorate renal function or histology after AKI. Measurements of endovanilloids in kidney tissue indicate that 20-hydroxyeicosatetraeonic acid (20-HETE) or epoxyeicosatrienoic acids (EETs) are unlikely involved in the beneficial effects of capsaicin on I/R-induced AKI. Conclusions: Activation of TRPV1 channels ameliorates I/R-induced AKI, but inhibition of these channels does not affect the outcome of AKI. Our results may have clinical implications for long-term safety of renal denervation to treat resistant hypertension in man, with respect to the function of primary sensory nerves in the response of the kidney to ischemic stimuli.	[Chen, Lan; Marko, Lajos; Kassmann, Mario; Zhu, Ye; Gollasch, Maik] Fac Med Charite, ECRC, Berlin, Germany; [Chen, Lan; Marko, Lajos; Kassmann, Mario; Zhu, Ye; Gollasch, Maik] Max Delbruck Ctr Mol Med MDC, ECRC, Berlin, Germany; [Chen, Lan] Xiamen Univ, Xiamen Zhongshan Hosp, Xiamen, Fujian, Peoples R China; [Wu, Kaiyin] Inst Pathol, Charite Campus Mitte, Berlin, Germany; [Zhu, Ye] Med Clin Nephrol & Internal Intens Care, Charite Campus Virchow, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Xiamen University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gollasch, M (corresponding author), Fac Med Charite, ECRC, Lindenberger Weg 80, Berlin, Germany.	maik.gollasch@charite.de		Marko, Lajos/0000-0003-1888-5575	Deutsche Forschungsgemeinschaft (DFG); Deutsche Akademische Austauschdienst (DAAD)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Akademische Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The authors thank the Deutsche Forschungsgemeinschaft (DFG) and Deutsche Akademische Austauschdienst (DAAD) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINES AD, 1983, CLIN BIOCHEM, V16, P134, DOI 10.1016/S0009-9120(83)93900-0; BARAJAS L, 1992, CAN J PHYSIOL PHARM, V70, P735, DOI 10.1139/y92-098; Carlton SA, 2004, PAIN, V110, P616, DOI 10.1016/j.pain.2004.04.042; Ditting T, 2012, HYPERTENSION, V59, P467, DOI 10.1161/HYPERTENSIONAHA.111.185538; Feizi A, 2008, EXP TOXICOL PATHOL, V60, P405, DOI 10.1016/j.etp.2008.04.006; Fischer R, 2014, J LIPID RES; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Giani JF, 2012, AM J PHYSIOL-RENAL, V302, pF1606, DOI 10.1152/ajprenal.00063.2012; Gorham L, 2014, NEUROSCI LETT, V573, P35, DOI 10.1016/j.neulet.2014.04.042; Helyes Z, 2004, ARTHRITIS RHEUM-US, V50, P1677, DOI 10.1002/art.20184; Helyes Z, 2007, AM J PHYSIOL-LUNG C, V292, pL1173, DOI 10.1152/ajplung.00406.2006; Hercule HC, 2009, ARTERIOSCL THROM VAS, V29, P54, DOI 10.1161/ATVBAHA.108.171298; Hoff U, 2011, KIDNEY INT, V79, P57, DOI 10.1038/ki.2010.377; IAINA A, 1983, CLIN EXP DIAL A, V7, P115, DOI 10.3109/08860228309076043; Iliff JJ, 2010, J NEUROCHEM, V115, P1530, DOI 10.1111/j.1471-4159.2010.07059.x; Kassmann M, 2013, ACTA PHYSIOL, V207, P546, DOI 10.1111/apha.12051; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Lee J, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-32; Lieberthal W, 1996, AM J PHYSIOL-RENAL, V271, pF477, DOI 10.1152/ajprenal.1996.271.3.F477; Liu YM, 2012, J PHARMACOL EXP THER, V341, P725, DOI 10.1124/jpet.111.191247; MAGGI CA, 1993, BRIT J PHARMACOL, V108, P801, DOI 10.1111/j.1476-5381.1993.tb12881.x; Mahfoud F, 2013, HERZ, V38, P67, DOI 10.1007/s00059-012-3752-4; Mizutani A, 2009, ANESTHESIOLOGY, V110, P361, DOI 10.1097/ALN.0b013e3181942f3c; Morales-Lazaro SL, 2013, J PHYSIOL-LONDON, V591, P3109, DOI 10.1113/jphysiol.2013.251751; Patwardhan AM, 2010, J CLIN INVEST, V120, P1617, DOI 10.1172/JCI41678; Regner KR, 2009, KIDNEY INT, V75, P511, DOI 10.1038/ki.2008.600; Spandou E, 2006, NEPHROL DIAL TRANSPL, V21, P330, DOI 10.1093/ndt/gfi177; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Tsagogiorgas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043525; Ueda K, 2008, J CARDIOVASC PHARM, V51, P513, DOI 10.1097/FJC.0b013e31816f6884; Ueda K, 2009, J PHARMACOL EXP THER, V329, P202, DOI 10.1124/jpet.108.146241; WALPOLE CSJ, 1994, J MED CHEM, V37, P1942, DOI 10.1021/jm00039a006; Wang LH, 2005, CIRCULATION, V112, P3617, DOI 10.1161/CIRCULATIONAHA.105.556274; Wang YP, 2005, AM J PHYSIOL-HEART C, V289, pH2005, DOI 10.1152/ajpheart.00370.2005; Warchol-Celinska E, 2013, POSTEP KARDIOL INTER, V9, P362, DOI 10.5114/pwki.2013.38866; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Xie CQ, 2010, AM J NEPHROL, V32, P194, DOI 10.1159/000316528; Yang DC, 2010, CELL METAB, V12, P130, DOI 10.1016/j.cmet.2010.05.015; ZAGER RA, 1986, AM J PHYSIOL, V251, pF87, DOI 10.1152/ajprenal.1986.251.1.F87	39	22	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109842	10.1371/journal.pone.0109842	http://dx.doi.org/10.1371/journal.pone.0109842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330307	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000345204100033
J	Jiang, ZY; Du, CG; Jablensky, A; Liang, H; Lu, ZD; Ma, Y; Teo, KL				Jiang, Zhenyu; Du, Chengan; Jablensky, Assen; Liang, Hua; Lu, Zudi; Ma, Yang; Teo, Kok Lay			Analysis of Schizophrenia Data Using A Nonlinear Threshold Index Logistic Model	PLOS ONE			English	Article							REGRESSION	Genetic information, such as single nucleotide polymorphism (SNP) data, has been widely recognized as useful in prediction of disease risk. However, how to model the genetic data that is often categorical in disease class prediction is complex and challenging. In this paper, we propose a novel class of nonlinear threshold index logistic models to deal with the complex, nonlinear effects of categorical/discrete SNP covariates for Schizophrenia class prediction. A maximum likelihood methodology is suggested to estimate the unknown parameters in the models. Simulation studies demonstrate that the proposed methodology works viably well for moderate-size samples. The suggested approach is therefore applied to the analysis of the Schizophrenia classification by using a real set of SNP data from Western Australian Family Study of Schizophrenia (WAFSS). Our empirical findings provide evidence that the proposed nonlinear models well outperform the widely used linear and tree based logistic regression models in class prediction of schizophrenia risk with SNP data in terms of both Types I/II error rates and ROC curves.	[Jiang, Zhenyu; Teo, Kok Lay] Curtin Univ, Dept Math & Stat, Perth, WA 6845, Australia; [Du, Chengan; Liang, Hua] George Washington Univ, Dept Stat, Washington, DC 20052 USA; [Jablensky, Assen] Univ Western Australia, Ctr Clin Res Neuropsychiat, Crawley, Australia; [Lu, Zudi] Univ Southampton, Southampton Stat Sci Res Inst, Southampton, Hants, England; [Lu, Zudi] Univ Southampton, Math Sci Acad Unit, Southampton, Hants, England; [Ma, Yang] George Washington Univ, Ctr Biostat, Washington, DC USA	Curtin University; George Washington University; University of Western Australia; University of Southampton; University of Southampton; George Washington University	Liang, H (corresponding author), George Washington Univ, Dept Stat, Washington, DC 20052 USA.	hliang@gwu.edu	Jablensky, Assen/H-5116-2014	Jablensky, Assen/0000-0003-0602-6810; Lu, Zudi/0000-0003-0893-832X	Discovery Project grant; Australian Research Council; NSF [DMS-1207444, DMS-1418042]; National Natural Science Foundation of China [11228103]	Discovery Project grant(Australian Research Council); Australian Research Council(Australian Research Council); NSF(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Partially supported by a Discovery Project grant and Lu's research also by a Future Fellowships grant from the Australian Research Council, and Liang's research by NSF grants DMS-1207444 and DMS-1418042, and Award Number 11228103, made by National Natural Science Foundation of China, which are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; Carroll RJ, 1997, J AM STAT ASSOC, V92, P477, DOI 10.2307/2965697; CHAN KS, 1993, ANN STAT, V21, P520, DOI 10.1214/aos/1176349040; Collett D, 2003, MODELLING BINARY DAT, V56; Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3; Hersen M, 2011, ADULT PSYCHOPATHOLOG; Horowitz JL, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-92870-8_1; Hosmer D. W., 2013, APPL LOGISTIC REGRES; ICHIMURA H, 1993, J ECONOMETRICS, V58, P71, DOI 10.1016/0304-4076(93)90114-K; Jiang Z, 2011, STAT ANAL GENOMIC DA; Kendler KS, 1993, ARCH GEN PSYCHIAT; Lachin JM, 2011, BIOSTATISTICAL METHO, V807; Li JL, 2011, BIOSTATISTICS, V12, P143, DOI 10.1093/biostatistics/kxq044; Liang H, 2010, ANN STAT, V38, P3811, DOI 10.1214/10-AOS835; Ma SJ, 2011, BIOINFORMATICS, V27, P2119, DOI 10.1093/bioinformatics/btr318; Picchioni MM, 2007, BMJ-BRIT MED J, V335, P91, DOI 10.1136/bmj.39227.616447.BE; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Thomas DC, 2004, STAT METHODS GENETIC; Tong H, 1990, NONLINEAR TIME SERIE; Tong H., 1983, LECT NOTES STAT, V21; Wang JL, 2010, ANN STAT, V38, P246, DOI 10.1214/09-AOS712; Wei Z, 2007, BIOSTATISTICS, V8, P265, DOI 10.1093/biostatistics/kxl007; Xia YC, 2006, J MULTIVARIATE ANAL, V97, P1162, DOI 10.1016/j.jmva.2005.11.005; Xia YC, 2002, J R STAT SOC B, V64, P363, DOI 10.1111/1467-9868.03411; Yi GY, 2011, ANN I STAT MATH, V63, P511, DOI 10.1007/s10463-009-0239-z; Yu Y, 2002, J AM STAT ASSOC, V97, P1042, DOI 10.1198/016214502388618861; Zhang HP, 1999, RECURSIVE PARTITIONI	27	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109454	10.1371/journal.pone.0109454	http://dx.doi.org/10.1371/journal.pone.0109454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330160	Green Published, gold, Green Accepted			2022-12-27	WOS:000345204100015
J	Malinowska, AH; van Strien, AJ; Verboom, J; WallisdeVries, MF; Opdam, P				Malinowska, Agnieszka H.; van Strien, Arco J.; Verboom, Jana; WallisdeVries, Michiel F.; Opdam, Paul			No Evidence of the Effect of Extreme Weather Events on Annual Occurrence of Four Groups of Ectothermic Species	PLOS ONE			English	Article							CLIMATE-CHANGE; HABITAT FRAGMENTATION; POPULATION-DYNAMICS; EUROPEAN CLIMATE; RANGE EXPANSION; METAPOPULATION; DISPERSAL; IMPACT; SURVIVAL; SCALE	Weather extremes may have strong effects on biodiversity, as known from theoretical and modelling studies. Predicted negative effects of increased weather variation are found only for a few species, mostly plants and birds in empirical studies. Therefore, we investigated correlations between weather variability and patterns in occupancy, local colonisations and local extinctions (metapopulation metrics) across four groups of ectotherms: Odonata, Orthoptera, Lepidoptera, and Reptilia. We analysed data of 134 species on a 161 km-grid base, collected in the last 20 years from the Netherlands, combining standardised data and opportunistic data. We applied dynamic site-occupancy models and used the results as input for analyses of (i) trends in distribution patterns, (ii) the effect of temperature on colonisation and persistence probability, and (iii) the effect of years with extreme weather on all the three metapopulation metrics. All groups, except butterflies, showed more positive than negative trends in metapopulation metrics. We did not find evidence that the probability of colonisation or persistence increases with temperature nor that extreme weather events are reflected in higher extinction risks. We could not prove that weather extremes have visible and consistent negative effects on ectothermic species in temperate northern hemisphere. These findings do not confirm the general prediction that increased weather variability imperils biodiversity. We conclude that weather extremes might not be ecologically relevant for the majority of species. Populations might be buffered against weather variation (e. g. by habitat heterogeneity), or other factors might be masking the effects (e. g. availability and quality of habitat). Consequently, we postulate that weather extremes have less, or different, impact in real world metapopulations than theory and models suggest.	[Malinowska, Agnieszka H.; Opdam, Paul] Wageningen Univ, Spatial Planning Grp, NL-6700 AP Wageningen, Netherlands; [van Strien, Arco J.] Stat Netherlands, The Hague, Netherlands; [Verboom, Jana] ALTERRA Wageningen UR, Policy & Biodivers Grp, Wageningen, Netherlands; [WallisdeVries, Michiel F.] De Vlinderstichting Dutch Butterfly Conservat, Wageningen, Netherlands; [WallisdeVries, Michiel F.] Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands; [Opdam, Paul] ALTERRA Wageningen UR, Nat & Soc Grp, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Malinowska, AH (corresponding author), Wageningen Univ, Spatial Planning Grp, NL-6700 AP Wageningen, Netherlands.	agnieszka.malinowska@wur.nl	van Strien, Arco/AAG-1843-2020	Malinowska, Agnieszka H./0000-0001-8578-8439	Dutch Ministry of Economic Affairs	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This research was funded by the Dutch Ministry of Economic Affairs, as a part of the strategic research program KB IV "Sustainable spatial development of ecosystems, landscapes, seas and regions''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TP, 2010, GLOBAL CHANGE BIOL, V16, P2158, DOI 10.1111/j.1365-2486.2009.02120.x; Anders AD, 2006, J ANIM ECOL, V75, P221, DOI 10.1111/j.1365-2656.2006.01034.x; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Barrows CW, 2010, BIOL CONSERV, V143, P731, DOI 10.1016/j.biocon.2009.12.013; Battisti A, 2006, GLOBAL CHANGE BIOL, V12, P662, DOI 10.1111/j.1365-2486.2006.01124.x; Beniston M, 2007, CLIMATIC CHANGE, V81, P71, DOI 10.1007/s10584-006-9226-z; Bolger DT, 2005, OECOLOGIA, V142, P398, DOI 10.1007/s00442-004-1734-9; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Burkett VR, 2005, ECOL COMPLEX, V2, P357, DOI 10.1016/j.ecocom.2005.04.010; Chambert T, 2012, P ROY SOC B-BIOL SCI, V279, P4532, DOI 10.1098/rspb.2012.1733; Cormont A, 2011, BIODIVERS CONSERV, V20, P483, DOI 10.1007/s10531-010-9960-4; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Cushman SA, 2004, OIKOS, V105, P117, DOI 10.1111/j.0030-1299.2004.12524.x; DEANGELIS DL, 1987, ECOL MONOGR, V57, P1, DOI 10.2307/1942636; DENBOER PJ, 1981, OECOLOGIA, V50, P39, DOI 10.1007/BF00378792; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fischer EM, 2013, NAT CLIM CHANGE, V3, P1033, DOI [10.1038/NCLIMATE2051, 10.1038/nclimate2051]; Franzen M, 2012, J INSECT CONSERV, V16, P941, DOI 10.1007/s10841-012-9481-4; Frederiksen M, 2008, J ANIM ECOL, V77, P1020, DOI 10.1111/j.1365-2656.2008.01422.x; Gutschick VP, 2010, EOS, V91, P85, DOI [10.1029/2010EO090001, DOI 10.1029/2010E0090001]; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hanski I, 2005, ANN ZOOL FENN, V42, P379; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Jiguet F, 2010, P ROY SOC B-BIOL SCI, V277, P3601, DOI 10.1098/rspb.2010.0796; Jongman R. H. G., 1995, DATA ANAL COMMUNITY; Jongman RHG, 2002, LANDSCAPE URBAN PLAN, V58, P211, DOI 10.1016/S0169-2046(01)00222-5; Jonzen N, 2002, OIKOS, V97, P329, DOI 10.1034/j.1600-0706.2002.970303.x; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Ketelaar R, 2001, HANDLEIDING LANDELIJ; KINDVALL O, 1995, BIOL CONSERV, V73, P51, DOI 10.1016/0006-3207(95)90063-2; Lande R, 1999, EXTINCTION RISKS ANT; Levins R., 1970, SOME MATH PROBLEMS B, P77; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; Mckann PC, 2013, J WILDLIFE MANAGE, V77, P172, DOI 10.1002/jwmg.433; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Neve G, 1996, J APPL ECOL, V33, P14, DOI 10.2307/2405011; Oliver TH, 2013, ECOGRAPHY, V36, P579, DOI 10.1111/j.1600-0587.2012.07665.x; Oliver TH, 2012, GLOBAL CHANGE BIOL, V18, P2720, DOI 10.1111/j.1365-2486.2012.02737.x; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Parn H, 2012, P ROY SOC B-BIOL SCI, V279, P144, DOI 10.1098/rspb.2011.0673; Piessens K, 2009, OECOLOGIA, V159, P117, DOI 10.1007/s00442-008-1204-x; Plummer M., 2003, P 3 INT WORKSHOP DIS; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Core Team, 2021, R LANGUAGE ENV STAT; Rebetez M, 2006, ANN FOREST SCI, V63, P569, DOI 10.1051/forest:2006043; Royle J. A., 2008, HIERARCHICAL MODELIN; Saltz D, 2006, CONSERV BIOL, V20, P1402, DOI 10.1111/j.1523-1739.2006.00486.x; Schippers P, 2011, ECOGRAPHY, V34, P909, DOI 10.1111/j.1600-0587.2011.06712.x; Schtickzelle N, 2006, ECOLOGY, V87, P1057, DOI 10.1890/0012-9658(2006)87[1057:DDWHFI]2.0.CO;2; Smit G, 2003, HANDLEIDING TELLEN R; Smith MD, 2011, J ECOL, V99, P651, DOI 10.1111/j.1365-2745.2011.01833.x; Soldaat L, 2007, J ORNITHOL, V148, pS351, DOI 10.1007/s10336-007-0176-7; Stoutjesdijk P., 1992, Microclimate, vegetation and fauna.; Strayer DL, 1999, CONSERV BIOL, V13, P1034, DOI 10.1046/j.1523-1739.1999.98143.x; Suggitt AJ, 2012, BIOL LETTERS, V8, P590, DOI 10.1098/rsbl.2012.0112; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Tank AMGK, 2002, INT J CLIMATOL, V22, P1441, DOI 10.1002/joc.773; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Tryjanowski P, 2009, BASIC APPL ECOL, V10, P387, DOI 10.1016/j.baae.2008.08.002; van Strien AJ, 2013, J APPL ECOL, V50, P1450, DOI 10.1111/1365-2664.12158; van Strien AJ, 2011, ECOL APPL, V21, P2510, DOI 10.1890/10-1786.1; van Swaay C.A.M., 2002, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V13, P21; Verboom J, 2010, LANDSCAPE ECOL, V25, P1289, DOI 10.1007/s10980-010-9497-7; Visser H, 2004, ATMOS ENVIRON, V38, P4135, DOI 10.1016/j.atmosenv.2004.04.014; Vos CC, 2008, J APPL ECOL, V45, P1722, DOI 10.1111/j.1365-2664.2008.01569.x; Vos CC, 2010, LANDSCAPE ECOL, V25, P1465, DOI 10.1007/s10980-010-9535-5; WallisDeVries MF, 2011, OECOLOGIA, V167, P559, DOI 10.1007/s00442-011-2007-z; Walters RJ, 2006, P ROY SOC B-BIOL SCI, V273, P2017, DOI 10.1098/rspb.2006.3542; Wilson RJ, 2010, ECOGRAPHY, V33, P73, DOI 10.1111/j.1600-0587.2009.06038.x	83	12	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110219	10.1371/journal.pone.0110219	http://dx.doi.org/10.1371/journal.pone.0110219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330414	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204100048
J	Scholze, AR; Foo, LC; Mulinyawe, S; Barres, BA				Scholze, Anja R.; Foo, Lynette C.; Mulinyawe, Sara; Barres, Ben A.			BMP Signaling in Astrocytes Downregulates EGFR to Modulate Survival and Maturation	PLOS ONE			English	Article							MORPHOGENETIC PROTEINS INHIBIT; SUBVENTRICULAR ZONE; LINEAGE COMMITMENT; PROGENITOR CELLS; MICE LACKING; BRAIN; RAT; RECEPTOR; GROWTH; CORTEX	Astrocytes constitute a major cell population in the brain with a myriad of essential functions, yet we know remarkably little about the signaling pathways and mechanisms that direct astrocyte maturation. To explore the signals regulating astrocyte development, we prospectively purified and cultured immature postnatal rodent astrocytes. We identified fibroblast growth factors (FGFs) and bone morphogenetic proteins (BMPs) as robust trophic factors for immature astrocytes. We showed that astrocytes respond directly to BMPs via phosphorylation of the smad1/5/8 pathway. In vitro, BMP signaling promoted immature astrocytes to adopt multiple characteristics of mature astrocytes, including a more process-bearing morphology, aquaporin-4 (AQP4) and S100 beta immunoreactivity, limited proliferation, and strong downregulation of epidermal growth factor receptor (EGFR). In vivo, activation of the smad1/5/8 pathway in astrocytes was seen during early postnatal development, but inhibition of astrocyte proliferation was not observed. These insights can aid in the further dissection of the mechanisms and pathways controlling astrocyte biology and development.	[Scholze, Anja R.; Mulinyawe, Sara; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Foo, Lynette C.] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore	Stanford University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Scholze, AR (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	anjascholze@gmail.com			Myelin Repair Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER	Myelin Repair Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Myelin Repair Foundation, http://www.myelinrepair.org/, (AS, SM, BAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chaboub LS, 2012, DEV NEUROSCI-BASEL, V34, P379, DOI 10.1159/000343723; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P45, DOI 10.3109/08977199409015050; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P53, DOI 10.3109/08977199409015051; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Fuller ML, 2007, ANN NEUROL, V62, P288, DOI 10.1002/ana.21179; Gao WL, 2014, NEUROSCI LETT, V562, P54, DOI 10.1016/j.neulet.2014.01.018; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Greenblatt MB, 2010, ANN NY ACAD SCI, V1192, P385, DOI 10.1111/j.1749-6632.2009.05222.x; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; HAAS RJ, 1970, J ANAT, V107, P421; Hegarty SV, 2013, PROG NEUROBIOL, V109, P28, DOI 10.1016/j.pneurobio.2013.07.002; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Kalman B, 2013, NEUROMOL MED, V15, P420, DOI 10.1007/s12017-013-8229-y; Kohyama J, 2010, J CELL BIOL, V189, P159, DOI 10.1083/jcb.200908048; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Kornblum HI, 1998, J NEUROSCI RES, V53, P697, DOI 10.1002/(SICI)1097-4547(19980915)53:6<697::AID-JNR8>3.3.CO;2-M; KRUEGER BK, 1995, J NEUROSCI, V15, P3366; Laestander C, 2014, CELL PROLIFERAT, V47, P3, DOI 10.1111/cpr.12084; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Lillien L, 2000, DEVELOPMENT, V127, P4993; Liu ZP, 2009, BBA-MOL CELL RES, V1793, P1819, DOI 10.1016/j.bbamcr.2009.09.012; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Martynoga B, 2013, GENE DEV, V27, P1769, DOI 10.1101/gad.216804.113; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; See J, 2007, MOL CELL NEUROSCI, V35, P171, DOI 10.1016/j.mcn.2007.02.012; Shimizu T, 2012, BIOCHEM BIOPH RES CO, V417, P869, DOI 10.1016/j.bbrc.2011.12.064; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; SKOFF RP, 1991, GLIA, V4, P165, DOI 10.1002/glia.440040208; Sloan SA, 2014, CURR OPIN NEUROBIOL, V27, P75, DOI 10.1016/j.conb.2014.03.005; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sun YR, 2011, J CELL SCI, V124, P1867, DOI 10.1242/jcs.085506; Viti J, 2003, J NEUROSCI, V23, P3385; Walz W, 1998, NEUROSCI LETT, V257, P127, DOI 10.1016/S0304-3940(98)00813-1; Wang K, 2003, J NEUROSCI RES, V73, P497, DOI 10.1002/jnr.10683; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	57	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110668	10.1371/journal.pone.0110668	http://dx.doi.org/10.1371/journal.pone.0110668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330173	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100100
J	Shafi, A; Dogra, V; Gill, T; Ahuja, PS; Sreenivasulu, Y				Shafi, Amrina; Dogra, Vivek; Gill, Tejpal; Ahuja, Paramvir Singh; Sreenivasulu, Yelam			Simultaneous Over-Expression of PaSOD and RaAPX in Transgenic Arabidopsis thaliana Confers Cold Stress Tolerance through Increase in Vascular Lignifications	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; ASCORBATE PEROXIDASE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; CHILLING INJURY; LOW-TEMPERATURE; GROWTH; RESPONSES; RECOVERY; OXYGEN	Antioxidant enzymes play a significant role in eliminating toxic levels of reactive oxygen species (ROS), generated during stress from living cells. In the present study, two different antioxidant enzymes namely copper-zinc superoxide dismutase derived from Potentilla astrisanguinea (PaSOD) and ascorbate peroxidase (RaAPX) from Rheum austral both of which are high altitude cold niche area plants of Himalaya were cloned and simultaneously over-expressed in Arabidopsis thaliana to alleviate cold stress. It was found that the transgenic plants over-expressing both the genes were more tolerant to cold stress than either of the single gene expressing transgenic plants during growth and development. In both single (PaSOD, RaAPX) and double (PaSOD + RaAPX) transgenic plants higher levels of total antioxidant enzyme activities, chlorophyll content, total soluble sugars, proline content and lower levels of ROS, ion leakage were recorded when compared to the WT during cold stress (4 degrees C), besides increase in yield. In the present study, Confocal and SEM analysis in conjunction with qPCR data on the expression pattern of lignin biosynthetic pathway genes revealed that the cold stress tolerance of the transgenic plants might be because of the peroxide induced up-regulation of lignin by antioxidant genes mediated triggering.	[Shafi, Amrina; Dogra, Vivek; Gill, Tejpal; Ahuja, Paramvir Singh; Sreenivasulu, Yelam] CSIR, Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India; [Shafi, Amrina; Ahuja, Paramvir Singh; Sreenivasulu, Yelam] CSIR, Inst Himalayan Bioresource Technol, Acad Sci & Innovat Res AcSIR, Palampur, Himachal Prades, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Sreenivasulu, Y (corresponding author), CSIR, Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India.	sree_yelam@yahoo.com	Gill, Tejpal/A-1139-2014; Dogra, Vivek/D-9868-2011; Gill, Tejpal/AAV-1659-2020; Dogra, Vivek/S-6930-2019	Gill, Tejpal/0000-0001-6248-132X; Dogra, Vivek/0000-0003-1853-8274; Dogra, Vivek/0000-0003-1853-8274	Council of Scientific and Industrial Research, New Delhi, India; CSIR, New Delhi, India	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi, India. A.S., T.G. and V.D. acknowledge Fellowship by the CSIR, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Badawi GH, 2004, PHYSIOL PLANTARUM, V121, P231, DOI 10.1111/j.0031-9317.2004.00308.x; BAGNALL D, 1983, PLANT CELL ENVIRON, V6, P457; Barriere Y., 2007, GENES GENOMES GENOMI, V1, P133; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Denness L, 2011, PLANT PHYSIOL, V156, P1364, DOI 10.1104/pp.111.175737; Dogra V, 2013, J PROTEOMICS, V78, P26, DOI 10.1016/j.jprot.2012.10.025; Faize M, 2011, J EXP BOT, V62, P2599, DOI 10.1093/jxb/erq432; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Gajewska E, 2006, BIOL PLANTARUM, V50, P653, DOI 10.1007/s10535-006-0102-5; Gill T, 2010, J PLANT GENET TRANSG, V1, P1; Gill T, 2012, J PLANT RES, V125, P165, DOI 10.1007/s10265-011-0421-2; Gill T, 2010, J PLANT PHYSIOL, V167, P757, DOI 10.1016/j.jplph.2009.12.004; Hu DY, 2007, ANTIOXID REDOX SIGN, V9, P201, DOI 10.1089/ars.2007.9.201; Huang CS, 2002, CANCER RES, V62, P5689; IRIGOYEN JJ, 1992, PHYSIOL PLANTARUM, V84, P55, DOI 10.1111/j.1399-3054.1992.tb08764.x; Jensen W.A., 1962, BOT HISTOCHEMISTRY P, P408, DOI DOI 10.1126/SCIENCE.140.3567.634-A; Kaur G, 2008, J AGRON CROP SCI, V194, P457, DOI 10.1111/j.1439-037X.2008.00336.x; KOSTER KL, 1992, PLANT PHYSIOL, V98, P108, DOI 10.1104/pp.98.1.108; Kumar S, 2011, ACTA PHYSIOL PLANT, V33, P779, DOI 10.1007/s11738-010-0602-y; Kumar S, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00872; Kwon SY, 2002, PLANT CELL ENVIRON, V25, P873, DOI 10.1046/j.1365-3040.2002.00870.x; Lee SH, 2007, J PLANT PHYSIOL, V164, P1626, DOI 10.1016/j.jplph.2007.01.003; Lu YY, 2010, AFR J BIOTECHNOL, V9, P8378; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; Ma YY, 2009, AFR J BIOTECHNOL, V8, P2004; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; McKown R, 1996, J EXP BOT, V47, P1919, DOI 10.1093/jxb/47.12.1919; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nayyar H, 2005, AGRON SUSTAIN DEV, V25, P381, DOI 10.1051/agro:2005033; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Ohnishi S, 2010, ENVIRON EXP BOT, V69, P56, DOI 10.1016/j.envexpbot.2010.02.007; OKane D, 1996, PLANTA, V198, P371, DOI 10.1007/BF00620053; Pal AK, 2013, BIOL PLANTARUM, V57, P359, DOI 10.1007/s10535-012-0277-x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PRASAD TK, 1994, PLANT CELL, V6, P65, DOI 10.1105/tpc.6.1.65; Raven E L, 2000, Subcell Biochem, V35, P317; Rozen S, 2000, Methods Mol Biol, V132, P365; Rymen B, 2007, PLANT PHYSIOL, V143, P1429, DOI 10.1104/pp.106.093948; Sahoo R, 2001, J PLANT PHYSIOL, V158, P1093, DOI 10.1078/0176-1617-00224; Sato Y, 2001, J EXP BOT, V52, P145, DOI 10.1093/jexbot/52.354.145; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Scebba F, 1999, J PLANT PHYSIOL, V155, P762, DOI 10.1016/S0176-1617(99)80094-7; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sowinski P, 2005, J PLANT PHYSIOL, V162, P67, DOI 10.1016/j.jplph.2004.03.006; Suzuki K, 2008, PLANT CELL PHYSIOL, V49, P433, DOI 10.1093/pcp/pcn020; Wang YH, 2004, PLANT SCI, V167, P671, DOI 10.1016/j.plantsci.2004.03.032; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yang T, 2002, P NATL ACAD SCI USA, V99, P4097, DOI 10.1073/pnas.052564899; Yogavel M, 2008, ACTA CRYSTALLOGR D, V64, P892, DOI 10.1107/S0907444908019069; Yoshida R, 1996, PLANT PHYSIOL, V112, P585, DOI 10.1104/pp.112.2.585; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	60	30	31	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110302	10.1371/journal.pone.0110302	http://dx.doi.org/10.1371/journal.pone.0110302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330211	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100062
J	Debat, HJ; Grabiele, M; Aguilera, PM; Bubillo, RE; Otegui, MB; Ducasse, DA; Zapata, PD; Marti, DA				Debat, Humberto J.; Grabiele, Mauro; Aguilera, Patricia M.; Bubillo, Rosana E.; Otegui, Monica B.; Ducasse, Daniel A.; Zapata, Pedro D.; Marti, Dardo A.			Exploring the Genes of Yerba Mate (Ilex paraguariensis A. St.-Hil.) by NGS and De Novo Transcriptome Assembly	PLOS ONE			English	Article							NONCODING RNAS; CHLOROGENIC ACID; GENOME DATABASE; CAFFEINE; PATHWAY; AQUIFOLIACEAE; BIOSYNTHESIS; ARGONAUTE1; EXPRESSION; ROSACEAE	Yerba mate (Ilex paraguariensis A. St.-Hil.) is an important subtropical tree crop cultivated on 326,000 ha in Argentina, Brazil and Paraguay, with a total yield production of more than 1,000,000 t. Yerba mate presents a strong limitation regarding sequence information. The NCBI GenBank lacks an EST database of yerba mate and depicts only 80 DNA sequences, mostly uncharacterized. In this scenario, in order to elucidate the yerba mate gene landscape by means of NGS, we explored and discovered a vast collection of I. paraguariensis transcripts. Total RNA from I. paraguariensis was sequenced by Illumina HiSeq-2000 obtaining 72,031,388 pair-end 100 bp sequences. High quality reads were de novo assembled into 44,907 transcripts encompassing 40 million bases with an estimated coverage of 180X. Multiple sequence analysis allowed us to predict that yerba mate contains similar to 32,355 genes and 12,551 gene variants or isoforms. We identified and categorized members of more than 100 metabolic pathways. Overall, we have identified similar to 1,000 putative transcription factors, genes involved in heat and oxidative stress, pathogen response, as well as disease resistance and hormone response. We have also identified, based in sequence homology searches, novel transcripts related to osmotic, drought, salinity and cold stress, senescence and early flowering. We have also pinpointed several members of the gene silencing pathway, and characterized the silencing effector Argonaute1. We predicted a diverse supply of putative microRNA precursors involved in developmental processes. We present here the first draft of the transcribed genomes of the yerba mate chloroplast and mitochondrion. The putative sequence and predicted structure of the caffeine synthase of yerba mate is presented. Moreover, we provide a collection of over 10,800 SSR accessible to the scientific community interested in yerba mate genetic improvement. This contribution broadly expands the limited knowledge of yerba mate genes, and is presented as the first genomic resource of this important crop.	[Debat, Humberto J.; Ducasse, Daniel A.] Inst Nacl Tecnol Agr IPAVE CIAP INTA, Ctr Invest Agr, Inst Patol Vegetal, Cordoba, Argentina; [Grabiele, Mauro; Aguilera, Patricia M.; Marti, Dardo A.] Univ Nacl Misiones IBS UNaM CONICET, Inst Biol Subtrop, Posadas, Misiones, Argentina; [Bubillo, Rosana E.] Inst Nacl Tecnol Agr EEA Cerro Azul INTA, Estn Expt Cerro Azul, Cerro Azul, Misiones, Argentina; [Grabiele, Mauro; Aguilera, Patricia M.; Otegui, Monica B.; Zapata, Pedro D.; Marti, Dardo A.] Univ Nacl Misiones INBIOMIS FCEQyN UNaM, Fac Ciencias Exactas Quim & Nat, Inst Biotecnol Misiones, Posadas, Misiones, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Marti, DA (corresponding author), Univ Nacl Misiones IBS UNaM CONICET, Inst Biol Subtrop, Posadas, Misiones, Argentina.	darmarti@gmail.com	Zapata, Pedro Dario/GWR-1075-2022; Debat, Humberto Julio/GXF-9011-2022; Debat, Humberto/Y-6380-2019; Ducasse, Daniel Adrian/M-6347-2018	Zapata, Pedro Dario/0000-0001-6476-8324; Debat, Humberto/0000-0003-3056-3739; Aguilera, Patricia/0000-0002-5063-9350; Marti, Dardo/0000-0003-2256-3253; Ducasse, Daniel Adrian/0000-0001-6487-5007; Grabiele, Mauro/0000-0001-7386-4924				Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; Annadurai RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056217; Ashihara H, 1996, PLANT PHYSIOL, V111, P747, DOI 10.1104/pp.111.3.747; Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029; Barchuk ML, 2013, REV CIENCIA TECNOLOG, V19, P28; Bastos D.H.M., 2007, MED AROMATIC PLANT S, V1, P37; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Belingheri LD, 1997, 1 C SUL AM ERV MAT C, P267; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032; BURTNIK OJ, 2006, YERBA MATE MANUAL PR; Canitrot L, 2011, SERIE PRODUCCION REG; Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Debat HJ, 2014, PLANT MOL BIOL REP, V32, P1257, DOI 10.1007/s11105-014-0727-z; Deladino L., 2013, Food and Nutrition Sciences, V4, P154; Escamilla-Trevino L, 2014, PLANT MOL BIOL, V84, P565, DOI 10.1007/s11103-013-0152-y; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Fraser LG, 2004, THEOR APPL GENET, V108, P1010, DOI 10.1007/s00122-003-1517-4; Gauer L, 2000, HEREDITY, V84, P647, DOI 10.1046/j.1365-2540.2000.00687.x; Ge XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087693; Giberti GC, 1999, ACTA HORTIC, P137, DOI 10.17660/ActaHortic.1999.500.20; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x; Hotto AM, 2012, TRENDS PLANT SCI, V17, P737, DOI 10.1016/j.tplants.2012.08.002; Hotto AM, 2011, G3-GENES GENOM GENET, V1, P559, DOI 10.1534/g3.111.000752; Instituto Nacional de Tecnologia Agropecuaria EEA Cerro Azul Cambio Rural, 1998, YERB MAT; Jung S, 2008, NUCLEIC ACIDS RES, V36, pD1034, DOI 10.1093/nar/gkm803; Jung S, 2014, NUCLEIC ACIDS RES, V42, pD1237, DOI 10.1093/nar/gkt1012; Kato M, 2000, NATURE, V406, P956, DOI 10.1038/35023072; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lepelley M, 2007, PLANT SCI, V172, P978, DOI 10.1016/j.plantsci.2007.02.004; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Liu TM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-125; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Mantello CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102665; Gottlieb AM, 2015, PLANT GENET RESOUR-C, V13, P142, DOI 10.1017/S1479262114000756; Gottlieb AM, 2010, GENETICA, V138, P567, DOI 10.1007/s10709-010-9449-9; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Murakami ANN, 2013, FOOD CHEM, V141, P60, DOI 10.1016/j.foodchem.2013.02.119; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Oono Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-77; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Ricca J, 2012, MATE; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Silva RD, 2011, FITOTERAPIA, V82, P818, DOI 10.1016/j.fitote.2011.04.011; Small ID, 2013, CURR OPIN MICROBIOL, V16, P652, DOI 10.1016/j.mib.2013.07.011; Sosa DA, 2011, YERBA MATE; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang L, 2011, DEVELOPMENT, V138, P245, DOI 10.1242/dev.058578; Yang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069168; Yin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073767; Zenaro LC, 2014, INT J NATURAL SCI RE, V2, P30; Zhelyazkova P, 2012, PLANT CELL, V24, P123, DOI 10.1105/tpc.111.089441	64	18	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109835	10.1371/journal.pone.0109835	http://dx.doi.org/10.1371/journal.pone.0109835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330175	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800042
J	Apostolou, P; Toloudi, M; Kourtidou, E; Mimikakou, G; Vlachou, I; Chatziioannou, M; Kipourou, V; Papasotiriou, I				Apostolou, Panagiotis; Toloudi, Maria; Kourtidou, Eleni; Mimikakou, Georgia; Vlachou, Ioanna; Chatziioannou, Marina; Kipourou, Vasiliki; Papasotiriou, Ioannis			Potential Role for the Metnase Transposase Fusion Gene in Colon Cancer through the Regulation of Key Genes	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-IV; ENHANCES DNA-REPAIR; STEM-CELLS; EMBRYONIC STEM; NANOG; GROWTH; HYBRIDIZATION; RESISTANCE; DOMAIN; NOTCH	The Metnase fusion gene consists of a SET histone methyltransferase domain and a transposase domain from Mariner transposase. This transposable element is involved in chromosome decatenation, enhances DNA repair, promotes foreign DNA integration, and assists topoisomerase II function. This study investigates the role of Metnase in colon cancer homeostasis and maintenance of the stemness phenotype in colon cancer stem cells (CSCs). Silencing of Metnase was performed in human cancer cell lines before and after treatment with cisplatin, and in colon CSCs. Subsequent changes in the expression of genes involved in repair mechanisms, DNA synthesis, topoisomerase II function, and metastasis as well stemness transcription factors were studied with RT-qPCR experiments. Cellular viability and apoptosis were evaluated by flow cytometry. The results suggest that Metnase influences the expression of many genes involved in the above processes. Furthermore, Metnase levels appear to impact upon expression of NANOG, OCT3/4, and SOX2. Suppression of Metnase also led to an increase in apoptosis. Therefore, Metnase may possess an important role in DNA repair, topoisomerase II function, and the maintenance of stemness during colon cancer development.	[Apostolou, Panagiotis; Toloudi, Maria; Kourtidou, Eleni; Mimikakou, Georgia; Vlachou, Ioanna; Chatziioannou, Marina; Kipourou, Vasiliki; Papasotiriou, Ioannis] Res Genet Canc Ctr Ltd RGCC Ltd, Filotas, Florina, Greece		Papasotiriou, I (corresponding author), Res Genet Canc Ctr Ltd RGCC Ltd, Filotas, Florina, Greece.	office@rgcc-genlab.com		PAPASOTIRIOU, IOANNIS/0000-0002-6145-946X	Research Genetic Cancer Centre Ltd (R.G.C.C. Ltd)	Research Genetic Cancer Centre Ltd (R.G.C.C. Ltd)	All the authors are employees of Research Genetic Cancer Centre Ltd (R.G.C.C. Ltd), and received salary from the R.G.C.C. Ltd, which funded this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou P, 2013, J RECEPT SIG TRANSD, V33, P353, DOI 10.3109/10799893.2013.828072; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; Hromas R, 2012, ONCOGENE, V31, P4245, DOI 10.1038/onc.2011.586; Kim HS, 2014, J BIOL CHEM; Kirschner K, 2010, ANTICANCER RES, V30, P3223; Kornmann M, 2003, CLIN CANCER RES, V9, P4116; Liu DX, 2007, MOL CELL BIOL, V27, P1125, DOI 10.1128/MCB.01899-06; Liu Guo-yan, 2008, Zhonghua Zhongliu Zazhi, V30, P184; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; Sahlberg SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094621; Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465; Stella MC, 2005, MOL CELL BIOL, V25, P3982, DOI 10.1128/MCB.25.10.3982-3996.2005; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Takeuchi H, 2003, CLIN CANCER RES, V9, P1480; Toloudi M, 2011, CASE REP ONCOL, V4, P44, DOI 10.1159/000324403; WALLACE RB, 1979, NUCLEIC ACIDS RES, V6, P3543, DOI 10.1093/nar/6.11.3543; Williamson EA, 2012, CANCER RES, V72, P6200, DOI 10.1158/0008-5472.CAN-12-0313; Wray J, 2009, BLOOD, V114, P1852, DOI 10.1182/blood-2008-08-175760; Wray J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005323; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; YEN RWC, 1992, NUCLEIC ACIDS RES, V20, P2287, DOI 10.1093/nar/20.9.2287; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Zhu ZG, 2012, J BIOPHOTONICS, V5, P536, DOI 10.1002/jbio.201100106	34	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109741	10.1371/journal.pone.0109741	http://dx.doi.org/10.1371/journal.pone.0109741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333365	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200049
J	Mann, H; Garcia-Rada, X; Houser, D; Ariely, D				Mann, Heather; Garcia-Rada, Ximena; Houser, Daniel; Ariely, Dan			Everybody Else Is Doing It: Exploring Social Transmission of Lying Behavior	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; SCALE; ACCEPTABILITY; PERSONALITY; DECEPTION; EVOLUTION; OMISSION; CHINESE; ADULTS; LIARS	Lying is a common occurrence in social interactions, but what predicts whether an individual will tell a lie? While previous studies have focused on personality factors, here we asked whether lying tendencies might be transmitted through social networks. Using an international sample of 1,687 socially connected pairs, we investigated whether lying tendencies were related in socially connected individuals, and tested two moderators of observed relationships. Participants recruited through a massive open online course reported how likely they would be to engage in specific lies; a friend or relative responded to the same scenarios independently. We classified lies according to their beneficiary (antisocial vs. prosocial lies), and their directness (lies of commission vs. omission), resulting in four unique lying categories. Regression analyses showed that antisocial commission, antisocial omission, and prosocial commission lying tendencies were all uniquely related in connected pairs, even when the analyses were limited to pairs that were not biologically related. For antisocial lies of commission, these relationships were strongest, and were moderated by amount of time spent together. Randomly paired individuals from the same countries were also related in their antisocial commission lying tendencies, signifying country-level norms. Our results indicate that a person's lying tendencies can be predicted by the lying tendencies of his or her friends and family members.	[Mann, Heather; Garcia-Rada, Ximena; Ariely, Dan] Duke Univ, Durham, NC 27708 USA; [Houser, Daniel] George Mason Univ, Washington, DC USA	Duke University; George Mason University	Mann, H (corresponding author), Duke Univ, Durham, NC 27708 USA.	heather.e.mann@duke.edu						ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; BARON J, 1994, ORGAN BEHAV HUM DEC, V59, P475, DOI 10.1006/obhd.1994.1070; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; CAVALLISFORZA LL, 1982, SCIENCE, V218, P19, DOI 10.1126/science.7123211; CIALDINI RB, 1991, ADV EXP SOC PSYCHOL, V24, P201; Cole T, 2001, J SOC PERS RELAT, V18, P107, DOI 10.1177/0265407501181005; DePaulo BM, 1998, J PERS SOC PSYCHOL, V74, P63, DOI 10.1037/0022-3514.74.1.63; DePaulo BM, 1996, J PERS SOC PSYCHOL, V70, P979, DOI 10.1037/0022-3514.70.5.979; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; Ennis E, 2008, J SOC PERS RELAT, V25, P105, DOI 10.1177/0265407507086808; Erat S, 2012, MANAGE SCI, V58, P723, DOI 10.1287/mnsc.1110.1449; Eswara H.S., 1974, J PSYCHOL RES, V18, P88; Fu GY, 2001, J CROSS CULT PSYCHOL, V32, P720, DOI 10.1177/0022022101032006005; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Gino F, 2009, PSYCHOL SCI, V20, P393, DOI 10.1111/j.1467-9280.2009.02306.x; Gozna LF, 2001, PERS INDIV DIFFER, V31, P1203, DOI 10.1016/S0191-8869(00)00219-1; Gudjonsson GH, 2004, LEGAL CRIMINOL PSYCH, V9, P121, DOI 10.1348/135532504322776898; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Heyman GD, 2012, INT J PSYCHOL, P37; Jensen LA, 2002, CONTEMP EDUC PSYCHOL, V27, P209, DOI 10.1006/ceps.2001.1088; Kashy DA, 1996, J PERS SOC PSYCHOL, V70, P1037, DOI 10.1037/0022-3514.70.5.1037; Lakoff Robin, 1973, 9 REG M CHIC LING SO; Lee K, 1997, MERRILL PALMER QUART, V43, P255; Lee K, 1997, CHILD DEV, V68, P924, DOI 10.1111/j.1467-8624.1997.tb01971.x; Levine EE, 2014, J EXP SOC PSYCHOL, V53, P107, DOI 10.1016/j.jesp.2014.03.005; LINDSKOLD S, 1983, J SOC PSYCHOL, V120, P129, DOI 10.1080/00224545.1983.9712018; McCrae RR, 2011, PERS SOC PSYCHOL REV, V15, P28, DOI 10.1177/1088868310366253; McLeod BA, 2008, PERS INDIV DIFFER, V45, P591, DOI 10.1016/j.paid.2008.06.015; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Phillips MC, 2011, PERS INDIV DIFFER, V50, P783, DOI 10.1016/j.paid.2010.12.031; Ritov I., 1990, Journal of Behavioral Decision Making, V3, P263, DOI 10.1002/bdm.3960030404; SCHWARTZ SH, 1994, J SOC ISSUES, V50, P19, DOI 10.1111/j.1540-4560.1994.tb01196.x; Schwartz SH, 2007, J CROSS CULT PSYCHOL, V38, P711, DOI 10.1177/0022022107308992; SPRANCA M, 1991, J EXP SOC PSYCHOL, V27, P76, DOI 10.1016/0022-1031(91)90011-T; Sweetser Eve, 1989, CULTURAL MODELS LANG, P43, DOI DOI 10.1017/CBO9780511607660.003; Talwar V, 2011, ADV CHILD DEV BEHAV, V40, P139; Weaver JB., 2005, INDIVIDUAL DIFFERENC, V3, P59	39	19	19	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109591	10.1371/journal.pone.0109591	http://dx.doi.org/10.1371/journal.pone.0109591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25333483	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200042
J	Yokogawa, N; Murakami, H; Demura, S; Kato, S; Yoshioka, K; Hayashi, H; Ishii, T; Fujii, M; Igarashi, T; Tsuchiya, H				Yokogawa, Noriaki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Hayashi, Hiroyuki; Ishii, Takayoshi; Fujii, Moriyuki; Igarashi, Takashi; Tsuchiya, Hiroyuki			Motor Function of the Upper-Extremity after Transection of the Second Thoracic Nerve Root during Total En Bloc Spondylectomy	PLOS ONE			English	Article							BRACHIAL-PLEXUS; SURGICAL-TECHNIQUES; SPINAL TUMORS	Background: In total en bloc spondylectomy (TES) of upper thoracic spine including the second thoracic (T2) vertebra, T2 nerve roots are usually transected. In this study, we examined the association between transection of the T2 nerve roots and upper-extremity motor function in patients with upper thoracic TES. Methods: We assessed 16 patients who underwent upper thoracic TES with bilateral transection of the T2 nerve roots. Patients were divided into three groups: 3 patients without any processing of T1 and upper nerve roots (T2 group), 7 with extensive dissection of T1 nerve roots (T1-2 group), and 6 with extensive dissection of T1 and upper nerve roots (C-T2 group). Postoperative upper-extremity motor function was compared between the groups. Results: Postoperative deterioration of upper-extremity motor function was observed in 9 of the 16 patients (56.3%). Three of the 7 patients in the T1-2 group and all 6 patients in the C-T2 group showed deterioration of upper-extremity motor function, but there was no deterioration in the T2 group. In the T1-2 group, 3 patients showed mild deterioration that did not affect their activities of daily living and they achieved complete recovery at the latest follow-up examination. In contrast, severe dysfunction occurred frequently in the C-T2 group, without recovery at the latest follow-up. Conclusions: The transection of the T2 nerve roots alone did not result in upper-extremity motor dysfunction; rather, the dysfunction is caused by the extensive dissection of the T1 and upper nerve roots. Therefore, transection of the T2 nerve roots in upper thoracic TES seems to be an acceptable procedure with satisfactory outcomes.	[Yokogawa, Noriaki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Hayashi, Hiroyuki; Ishii, Takayoshi; Fujii, Moriyuki; Igarashi, Takashi; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan	Kanazawa University	Yokogawa, N (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Takara Machi, Kanazawa, Ishikawa, Japan.	chakkun1981chakkun@yahoo.co.jp	DEMURA, Satoru/X-8589-2019	Kato, Satoshi/0000-0003-4762-5932	Grants-in-Aid for Scientific Research [26293333] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Kawahara N, 2011, SPINE, V36, P74, DOI 10.1097/BRS.0b013e3181cded6c; Kawahara N, 2009, ORTHOP CLIN N AM, V40, P47, DOI 10.1016/j.ocl.2008.09.004; Kerr AT, 1918, AM J ANAT, V23, P285, DOI 10.1002/aja.1000230205; Louis R, 1983, SURG SPINE; Loukas M, 2010, SINGAP MED J, V51, P464; Loukas M, 2007, NEUROSURGERY, V60, P13, DOI 10.1227/01.NEU.0000249234.20484.2A; Murakami H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064818; Slingluff CL, 1987, MICRORECONSTRUCTION, P285; TOMITA K, 1994, INT ORTHOP, V18, P291; Tomita K, 1997, SPINE, V22, P324, DOI 10.1097/00007632-199702010-00018; Tomita K, 2006, J ORTHOP SCI, V11, P3, DOI 10.1007/s00776-005-0964-y; Uysal II, 2003, NEUROSURGERY, V53, P676, DOI 10.1227/01.NEU.0000079485.24016.70	12	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109838	10.1371/journal.pone.0109838	http://dx.doi.org/10.1371/journal.pone.0109838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333299	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200058
J	Hoppe, S; Bier, FF; von Nickisch-Rosenegk, M				Hoppe, Sebastian; Bier, Frank F.; von Nickisch-Rosenegk, Markus			Identification of Antigenic Proteins of the Nosocomial Pathogen Klebsiella pneumoniae	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; SWISS-MODEL; VACCINE CANDIDATE; MESSENGER-RNA; EXPRESSION; ENVIRONMENT; TOPOLOGY; GENE	The continuous expansion of nosocomial infections around the globe has become a precarious situation. Key challenges include mounting dissemination of multiple resistances to antibiotics, the easy transmission and the growing mortality rates of hospital-acquired bacterial diseases. Thus, new ways to rapidly detect these infections are vital. Consequently, researchers around the globe pursue innovative approaches for point-of-care devices. In many cases the specific interaction of an antigen and a corresponding antibody is pivotal. However, the knowledge about suitable antigens is lacking. The aim of this study was to identify novel antigens as specific diagnostic markers. Additionally, these proteins might be aptly used for the generation of vaccines to improve current treatment options. Hence, a cDNA-based expression library was constructed and screened via microarrays to detect novel antigens of Klebsiella pneumoniae, a prominent agent of nosocomial infections well-known for its extensive antibiotics resistance, especially by extended-spectrum beta-lactamases (ESBL). After screening 1536 clones, 14 previously unknown immunogenic proteins were identified. Subsequently, each protein was expressed in full-length and its immunodominant character examined by ELISA and microarray analyses. Consequently, six proteins were selected for epitope mapping and three thereof possessed linear epitopes. After specificity analysis, homology survey and 3d structural modelling, one epitope sequence GAVVALSTTFA of KPN_00363, an ion channel protein, was identified harboring specificity for K. pneumoniae. The remaining epitopes showed ambiguous results regarding the specificity for K. pneumoniae. The approach adopted herein has been successfully utilized to discover novel antigens of Campylobacter jejuni and Salmonella enterica antigens before. Now, we have transferred this knowledge to the key nosocomial agent, K. pneumoniae. By identifying several novel antigens and their linear epitope sites, we have paved the way for crucial future research and applications including the design of point-of-care devices, vaccine development and serological screenings for a highly relevant nosocomial pathogen.	[Hoppe, Sebastian; von Nickisch-Rosenegk, Markus] IZI BB, Fraunhofer Inst Cell Therapy & Immunol, Dept Bioanalyt & Biosensor, Branch Bioanalyt & Bioproc, Potsdam, Germany; [Bier, Frank F.] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Bier, Frank F.] IZI BB, Fraunhofer Inst Cell Therapy & Immunol, Dept Biosyst Integrat & Automat, Branch Bioanalyt & Bioproc, Potsdam, Germany	Fraunhofer Gesellschaft; University of Potsdam; Fraunhofer Gesellschaft	Hoppe, S (corresponding author), IZI BB, Fraunhofer Inst Cell Therapy & Immunol, Dept Bioanalyt & Biosensor, Branch Bioanalyt & Bioproc, Potsdam, Germany.	sebastian.hoppe@ibmt.fraunhofer.de	Bier, Frank/AAN-2532-2020	Bier, Frank/0000-0003-0375-9832	German Federal Ministry of Education and Research [03IS2201A]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grant 03IS2201A of the German Federal Ministry of Education and Research (www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bach HJ, 1999, J MICROBIOL METH, V37, P187, DOI 10.1016/S0167-7012(99)00066-4; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Benjamin DC, 1995, ADV EXP MED BIOL, V386, P95; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bogdanova EA, 2009, MOL BIOTECHNOL, V41, P247, DOI 10.1007/s12033-008-9131-y; CAO GJ, 1992, P NATL ACAD SCI USA, V89, P10380, DOI 10.1073/pnas.89.21.10380; Danckert L, 2014, MICROCHIM ACTA, V181, P1707, DOI 10.1007/s00604-014-1197-6; Drummond AJ, 2011, GENEIOUS, Vv5, P56; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esposito V, 2011, J BIOL CHEM, V286, P41767, DOI 10.1074/jbc.M111.289314; Findlay HE, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-5; Fournier PE, 2013, NAT REV MICROBIOL, V11, P574, DOI 10.1038/nrmicro3068; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harris JA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001428; Hoppe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065837; Hoppe S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-12; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuntumalla S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-147; Kurupati P, 2006, PROTEOMICS, V6, P836, DOI 10.1002/pmic.200500214; Kurupati P, 2011, CLIN VACCINE IMMUNOL, V18, P82, DOI 10.1128/CVI.00275-10; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Nakazato H, 1975, POLYADENYLIC ACID SE; Ohana RF, 2011, PROTEIN EXPRES PURIF, V76, P154, DOI 10.1016/j.pep.2010.11.014; Overdevest ITMA, 2014, CLIN MICROBIOL INFEC, V20, P251, DOI 10.1111/1469-0691.12277; Padlan EA, 1996, ADV PROTEIN CHEM, V49, P57, DOI 10.1016/S0065-3233(08)60488-X; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rozen S, 2000, Methods Mol Biol, V132, P365; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Singh B, 2013, INFECT IMMUN, V81, P801, DOI 10.1128/IAI.01111-12; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Su CL, 1998, MOL BIOTECHNOL, V10, P83, DOI 10.1007/BF02745865; Yang YJ, 2013, VACCINE, V31, P2930, DOI 10.1016/j.vaccine.2013.04.044; Yi H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr617; Zhu H, 2006, P NATL ACAD SCI USA, V103, P4011, DOI 10.1073/pnas.0510921103; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	46	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110703	10.1371/journal.pone.0110703	http://dx.doi.org/10.1371/journal.pone.0110703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333280	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200070
J	Pfiffner, PB; Oh, J; Miller, TA; Mandl, KD				Pfiffner, Pascal B.; Oh, JiWon; Miller, Timothy A.; Mandl, Kenneth D.			ClinicalTrials.gov as a Data Source for Semi-Automated Point-Of-Care Trial Eligibility Screening	PLOS ONE			English	Article							CLINICAL-TRIALS; CRITERIA; SEARCH	Background: Implementing semi-automated processes to efficiently match patients to clinical trials at the point of care requires both detailed patient data and authoritative information about open studies. Objective: To evaluate the utility of the ClinicalTrials.gov registry as a data source for semi-automated trial eligibility screening. Methods: Eligibility criteria and metadata for 437 trials open for recruitment in four different clinical domains were identified in ClinicalTrials.gov. Trials were evaluated for up to date recruitment status and eligibility criteria were evaluated for obstacles to automated interpretation. Finally, phone or email outreach to coordinators at a subset of the trials was made to assess the accuracy of contact details and recruitment status. Results: 24% (104 of 437) of trials declaring on open recruitment status list a study completion date in the past, indicating out of date records. Substantial barriers to automated eligibility interpretation in free form text are present in 81% to up to 94% of all trials. We were unable to contact coordinators at 31% (45 of 146) of the trials in the subset, either by phone or by email. Only 53% (74 of 146) would confirm that they were still recruiting patients. Conclusion: Because ClinicalTrials.gov has entries on most US and many international trials, the registry could be repurposed as a comprehensive trial matching data source. Semi-automated point of care recruitment would be facilitated by matching the registry's eligibility criteria against clinical data from electronic health records. But the current entries fall short. Ultimately, improved techniques in natural language processing will facilitate semi-automated complex matching. As immediate next steps, we recommend augmenting ClinicalTrials.gov data entry forms to capture key eligibility criteria in a simple, structured format.	[Pfiffner, Pascal B.; Miller, Timothy A.; Mandl, Kenneth D.] Boston Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Pfiffner, Pascal B.; Miller, Timothy A.; Mandl, Kenneth D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Oh, JiWon] Wellesley Coll, Wellesley, MA 02181 USA; [Mandl, Kenneth D.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Wellesley College; Harvard University; Harvard Medical School	Mandl, KD (corresponding author), Boston Childrens Hosp, Informat Program, Boston, MA 02115 USA.	Kenneth_Mandl@Harvard.edu		Pfiffner, Pascal Bruno/0000-0003-4808-3602	Strategic Health IT Advanced Research Projects Award from the Office of the National Coordinator of Health Information Technology [90TR000101]; National Institutes of Health; National Center for Advancing Translational Sciences [UL1TR001102]; National Institute of Child Health and Human Development [1R21HD072382]; National Institute on Aging [R21AG043715]; National Library of Medicine [R01LM010090, U54LM008748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD072382] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG043715] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748, R01LM010090] Funding Source: NIH RePORTER	Strategic Health IT Advanced Research Projects Award from the Office of the National Coordinator of Health Information Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The work was supported by the following: Strategic Health IT Advanced Research Projects Award 90TR000101 from the Office of the National Coordinator of Health Information Technology (www.healthit.gov): KM; National Institutes of Health (www.nih.gov); National Center for Advancing Translational Sciences (UL1TR001102): PP, KM; National Institute of Child Health and Human Development (1R21HD072382): KM; National Institute on Aging (R21AG043715): KM; National Library of Medicine (R01LM010090): TM, KM; and National Library of Medicine (U54LM008748): TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson NL, 2008, CONTEMP CLIN TRIALS, V29, P555, DOI 10.1016/j.cct.2008.01.007; Boland MR, 2013, METHOD INFORM MED, V52, P382, DOI 10.3414/ME12-01-0092; Boland Mary Regina, 2012, AMIA Jt Summits Transl Sci Proc, V2012, P71; Ferris M, 2013, CTS-CLIN TRANSL SCI, V6, P13, DOI 10.1111/cts.12003; Hawkes N, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8104; Huser V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068409; International Committee of Medical Journal Editors, 2009, UN REQ MAN SUBM MED; Korkontzelos I, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-S1-S3; Lilly, 2014, LILL CLIN OP INN; Luo ZH, 2013, J BIOMED INFORM, V46, P33, DOI 10.1016/j.jbi.2012.07.006; Mandl KD, 2012, J AM MED INFORM ASSN, V19, P597, DOI 10.1136/amiajnl-2011-000622; Mandl KD, 2012, NEW ENGL J MED, V366, P2240, DOI 10.1056/NEJMp1203102; Martin SS, 2013, J AM COLL CARDIOL, V61, P762, DOI 10.1016/j.jacc.2012.10.046; Miller TA, 2013, ACL; Miotto R, 2013, J BIOMED INFORM, V46, P1145, DOI 10.1016/j.jbi.2013.08.012; Opar A, 2013, NAT MED, V19, P793, DOI 10.1038/nm0713-793; Penberthy LT, 2012, J ONCOL PRACT, V8, P365, DOI 10.1200/JOP.2012.000646; Pfiffner P, 2014, CLIN TRIALS EVAL; Probstfield JL, 2011, JAMA-J AM MED ASSOC, V306, P1798, DOI 10.1001/jama.2011.1544; Ross Jessica, 2010, Summit Transl Bioinform, V2010, P46; Sibai Tarek, 2012, J Bone Joint Surg Am, V94 Suppl 1, P49, DOI 10.2106/JBJS.L.00240; Siminoff LA, 2000, J CLIN ONCOL, V18, P1203, DOI 10.1200/JCO.2000.18.6.1203; Sun WY, 2013, J AM MED INFORM ASSN, V20, P806, DOI 10.1136/amiajnl-2013-001628; Team RDC, 2009, R LANG ENV STAT COMP; Tu SW, 2011, J BIOMED INFORM, V44, P239, DOI 10.1016/j.jbi.2010.09.007; Weng CH, 2011, J AM MED INFORM ASSN, V18, pI116, DOI 10.1136/amiajnl-2011-000321; Weng CH, 2010, J BIOMED INFORM, V43, P451, DOI 10.1016/j.jbi.2009.12.004; Zarin DA, 2013, ANN INTERN MED, V159, P65, DOI 10.7326/0003-4819-159-1-201307020-00011	28	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111055	10.1371/journal.pone.0111055	http://dx.doi.org/10.1371/journal.pone.0111055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25334031	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200100
J	Schmidt, HG; Sewitz, S; Andrews, SS; Lipkow, K				Schmidt, Hugo G.; Sewitz, Sven; Andrews, Steven S.; Lipkow, Karen			An Integrated Model of Transcription Factor Diffusion Shows the Importance of Intersegmental Transfer and Quaternary Protein Structure for Target Site Finding	PLOS ONE			English	Article							ONE-DIMENSIONAL DIFFUSION; REPRESSOR-OPERATOR INTERACTION; NUCLEOSOME-FREE REGIONS; LAC REPRESSOR; RNA-POLYMERASE; DNA SEARCH; FACILITATED DIFFUSION; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; 1D DIFFUSION	We present a computational model of transcription factor motion that explains both the observed rapid target finding of transcription factors, and how this motion influences protein and genome structure. Using the Smoldyn software, we modelled transcription factor motion arising from a combination of unrestricted 3D diffusion in the nucleoplasm, sliding along the DNA filament, and transferring directly between filament sections by intersegmental transfer. This presents a fine-grain picture of the way in which transcription factors find their targets two orders of magnitude faster than 3D diffusion alone allows. Eukaryotic genomes contain sections of nucleosome free regions (NFRs) around the promoters; our model shows that the presence and size of these NFRs can be explained as their acting as antennas on which transcription factors slide to reach their targets. Additionally, our model shows that intersegmental transfer may have shaped the quaternary structure of transcription factors: sequence specific DNA binding proteins are unusually enriched in dimers and tetramers, perhaps because these allow intersegmental transfer, which accelerates target site finding. Finally, our model shows that a 'hopping' motion can emerge from 3D diffusion on small scales. This explains the apparently long sliding lengths that have been observed for some DNA binding proteins observed in vitro. Together, these results suggest that transcription factor diffusion dynamics help drive the evolution of protein and genome structure.	[Schmidt, Hugo G.; Sewitz, Sven; Lipkow, Karen] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Schmidt, Hugo G.; Sewitz, Sven; Lipkow, Karen] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Sewitz, Sven; Lipkow, Karen] Babraham Inst, Nucl Dynam Programme, Cambridge, England; [Andrews, Steven S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Cambridge; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Fred Hutchinson Cancer Center	Schmidt, HG (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	hugo.schmidt@st-hughs.oxon.org; karen.lipkow@babraham.ac.uk		Sewitz, Sven/0000-0002-7862-6105	BBSRC; University of Cambridge; MITRE [91687]; NIGMS [R01GM086615-01]; EU-India; Royal Society; Microsoft Research Faculty Fellowship; Apple Research & Technology Support; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086615] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Cambridge(University of Cambridge); MITRE; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EU-India; Royal Society(Royal Society of London); Microsoft Research Faculty Fellowship(Microsoft); Apple Research & Technology Support; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by: a BBSRC Doctoral Training Grant (http://www.bbsrc.ac.uk/home/home.aspx) (HGS), the University of Cambridge (http://www.cam.ac.uk) (HGS), MITRE (http://www.mitre.org) subcontract 91687 awarded to R. Brent (SSA), NIGMS grant R01GM086615-01 (http://www.nigms.nih.gov/Pages/default.aspx) awarded to R. Yu and R. Brent (SSA), the EU-IndiaGrid1 & 2 (http://www.euindiagrid.eu) (KL), a Royal Society University Research Fellowship (https://royalsociety.org) (KL), a Microsoft Research Faculty Fellowship (http://research.microsoft.com/en-us/) (KL), and Apple Research & Technology Support (http://www.apple.com/uk/education/hed/arts/ - funding programme discontinued) (KL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Andrews SS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000705; Andrews SS, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046015; Bauer M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053956, 10.1371/journal.pone.0059915]; BERG OG, 1982, TRENDS BIOCHEM SCI, V7, P52, DOI 10.1016/0968-0004(82)90075-5; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Biebricher A, 2009, BIOPHYS J, V96, pL50, DOI 10.1016/j.bpj.2009.01.035; Bordelon T, 2006, J MOL BIOL, V360, P168, DOI 10.1016/j.jmb.2006.05.005; Brantl S, 2010, CURR PROTEIN PEPT SC, V11, P274, DOI 10.2174/138920310791233396; Bryan D, 1999, J MOL ENDOCRINOL, V22, P241, DOI 10.1677/jme.0.0220241; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Coppey M, 2004, BIOPHYS J, V87, P1640, DOI 10.1529/biophysj.104.045773; Das RK, 2010, PHYS CHEM CHEM PHYS, V12, P2999, DOI 10.1039/b921303a; de la Rosa MAD, 2010, BIOPHYS J, V98, P2943, DOI 10.1016/j.bpj.2010.02.055; DePristo MA, 2009, PROG BIOPHYS MOL BIO, V100, P25, DOI 10.1016/j.pbiomolbio.2009.07.002; DeSantis MC, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021907; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Doucleff M, 2008, P NATL ACAD SCI USA, V105, P13871, DOI 10.1073/pnas.0805050105; Dross N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005041; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Esadze A, 2014, J MOL BIOL, V426, P230, DOI 10.1016/j.jmb.2013.09.019; Etson CM, 2010, P NATL ACAD SCI USA, V107, P1900, DOI 10.1073/pnas.0912664107; Givaty O, 2009, J MOL BIOL, V385, P1087, DOI 10.1016/j.jmb.2008.11.016; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Gowers DM, 2003, EMBO J, V22, P1410, DOI 10.1093/emboj/cdg125; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Halford SE, 2002, EUR BIOPHYS J BIOPHY, V31, P257, DOI 10.1007/s00249-002-0224-4; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; Hirayama H, 2004, J BIOL PHYS, V30, P1, DOI 10.1023/B:JOBP.0000016448.26081.01; Hsieh M, 1997, J BIOL CHEM, V272, P22092, DOI 10.1074/jbc.272.35.22092; Hu LH, 2008, BIOPHYS J, V95, P1151, DOI 10.1529/biophysj.108.129825; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Jayaram B, 1996, J MOL STRUCTURE THEO; Jeong EH, 2006, BIOCHEM BIOPH RES CO, V339, P392, DOI 10.1016/j.bbrc.2005.11.032; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Junier I, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000678; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Kepes F, 2004, J MOL BIOL, V340, P957, DOI 10.1016/j.jmb.2004.05.039; Kepes F, 2003, J MOL BIOL, V329, P859, DOI 10.1016/S0022-2836(03)00535-7; Kepes Francois, 2003, ComPlexUs, V1, P171, DOI 10.1159/000082184; Khan S, 2011, J COMPUT NEUROSCI, V31, P581, DOI 10.1007/s10827-011-0323-2; Kim JH, 2007, NUCLEIC ACIDS RES, V35, P3848, DOI 10.1093/nar/gkm332; Koslover EF, 2011, BIOPHYS J, V101, P856, DOI 10.1016/j.bpj.2011.06.066; Kumar N, 2008, BIOCHEMISTRY-US, V47, P13179, DOI 10.1021/bi801064j; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lipkow K, 2005, J BACTERIOL, V187, P45, DOI 10.1128/JB.187.1.45-53.2005; Lomholt MA, 2009, P NATL ACAD SCI USA, V106, P8204, DOI 10.1073/pnas.0903293106; Loverdo C, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.188101; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Majka J, 2007, ADV BIOCHEM ENG BIOT, V104, P13, DOI 10.1007/10_026; MANDELKERN M, 1981, J MOL BIOL, V152, P153, DOI 10.1016/0022-2836(81)90099-1; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Patikoglou G, 1997, ANNU REV BIOPH BIOM, V26, P289, DOI 10.1146/annurev.biophys.26.1.289; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Pingoud A, 1997, EUR J BIOCHEM, V246, P1, DOI 10.1111/j.1432-1033.1997.t01-6-00001.x; Poon KKH, 2001, J BIOL CHEM, V276, P9620, DOI 10.1074/jbc.M009864200; Rezania V, 2007, PHYS BIOL, V4, P256, DOI 10.1088/1478-3975/4/4/003; RICCHETTI M, 1988, P NATL ACAD SCI USA, V85, P4610, DOI 10.1073/pnas.85.13.4610; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; RIGGS AD, 1970, J MOL BIOL, V48, P67, DOI 10.1016/0022-2836(70)90219-6; RUUSALA T, 1992, P NATL ACAD SCI USA, V89, P4903, DOI 10.1073/pnas.89.11.4903; Ryazanova AY, 2011, ANALYST, V136, P1227, DOI 10.1039/c0an00545b; Schlick T, 2012, J BIOL CHEM, V287, P5183, DOI 10.1074/jbc.R111.305763; Schmidt H, 2013, THESIS U CAMBRIDGE; Schonhoft JD, 2012, NAT CHEM BIOL, V8, P205, DOI 10.1038/nchembio.764; Schreiber Gideon, 2006, V340, P235; SCHURR JM, 1979, BIOPHYS CHEM, V9, P413, DOI 10.1016/0301-4622(75)80057-3; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Sewitz S, 2013, CURRENT CHEM BIOL, V7, P214, DOI [10.2174/221279680703140508101810, DOI 10.2174/221279680703140508101810]; Shen CH, 2001, J BIOL CHEM, V276, P35209, DOI 10.1074/jbc.M104733200; Shimamoto N, 1999, J BIOL CHEM, V274, P15293, DOI 10.1074/jbc.274.22.15293; Shinde UP, 1992, CHAOS SOLITON FRACT, V1, P401; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Sidorova NY, 2013, BIOPHYS J, V104, P1296, DOI 10.1016/j.bpj.2013.01.041; Singh P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002106; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; Sokolov IM, 2005, BIOPHYS J, V89, P895, DOI 10.1529/biophysj.104.057612; Sun W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004721; Surby MA, 1996, BIOCHEMISTRY-US, V35, P2201, DOI 10.1021/bi951883n; Tafvizi A, 2008, BIOPHYS J, V95, pL1, DOI 10.1529/biophysj.108.134122; Ujvari A, 1996, BIOCHEMISTRY-US, V35, P14574, DOI 10.1021/bi961165g; Vainus D, 2004, THESIS U GOTTINGEN; van Berkum Nynke L, 2010, J Vis Exp, DOI 10.3791/1869; van den Broek B, 2008, P NATL ACAD SCI USA, V105, P15738, DOI 10.1073/pnas.0804248105; Veksler A, 2013, J PHYS CHEM B, V117, P12695, DOI 10.1021/jp311466f; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Vuzman D, 2012, BIOCOMPUT-PAC SYM, P188; Vuzman D, 2010, P NATL ACAD SCI USA, V107, P21004, DOI 10.1073/pnas.1011775107; Vuzman D, 2010, BIOPHYS J, V99, P1202, DOI 10.1016/j.bpj.2010.06.007; Vuzman D, 2010, J MOL BIOL, V396, P674, DOI 10.1016/j.jmb.2009.11.056; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wunderlich Z, 2008, NUCLEIC ACIDS RES, V36, P3570, DOI 10.1093/nar/gkn173; Xia YQ, 2010, BIOMACROMOLECULES, V11, P3158, DOI 10.1021/bm100969z; Yadon AN, 2010, MOL CELL BIOL, V30, P5110, DOI 10.1128/MCB.00602-10; Young MA, 1997, J AM CHEM SOC, V119, P59, DOI 10.1021/ja960459m; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zabet NR, 2012, MOL BIOSYST, V8, P2815, DOI 10.1039/c2mb25201e; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; Zharkov DO, 2003, DNA REPAIR, V2, P839, DOI 10.1016/S1568-7864(03)00084-3	113	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e108575	10.1371/journal.pone.0108575	http://dx.doi.org/10.1371/journal.pone.0108575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333780	Green Published, gold			2022-12-27	WOS:000343731200006
J	Verleyen, D; Luyten, FP; Tylzanowski, P				Verleyen, Daphne; Luyten, Frank P.; Tylzanowski, Przemko			Orphan G-Protein Coupled Receptor 22 (Gpr22) Regulates Cilia Length and Structure in the Zebrafish Kupffer's Vesicle	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; OSTEOARTHRITIS SUSCEPTIBILITY LOCUS; IN-SITU HYBRIDIZATION; CILIOGENESIS; EXPRESSION; LOCALIZATION; CELLS; ORGAN; CHONDROCYTES; TRAFFICKING	GPR22 is an orphan G protein-coupled receptor (GPCR). Since the ligand of the receptor is currently unknown, its biological function has not been investigated in depth. Many GPCRs and their intracellular effectors are targeted to cilia. Cilia are highly conserved eukaryotic microtubule-based organelles that protrude from the membrane of most mammalian cells. They are involved in a large variety of physiological processes and diseases. However, the details of the downstream pathways and mechanisms that maintain cilia length and structure are poorly understood. We show that morpholino knock down or overexpression of gpr22 led to defective left-right (LR) axis formation in the zebrafish embryo. Specifically, defective LR patterning included randomization of the left-specific lateral plate mesodermal genes (LPM) (lefty1, lefty2, southpaw and pitx2a), resulting in randomized cardiac looping. Furthermore, gpr22 inactivation in the Kupffer's vesicle (KV) alone was still able to generate the phenotype, indicating that Gpr22 mainly regulates LR asymmetry through the KV. Analysis of the KV cilia by immunofluorescence and transmission electron microscopy (TEM), revealed that gpr22 knock down or overexpression resulted in changes of cilia length and structure. Further, we found that Gpr22 does not act upstream of the two cilia master regulators, Foxj1a and Rfx2. To conclude, our study characterized a novel player in the field of ciliogenesis.	[Verleyen, Daphne; Luyten, Frank P.; Tylzanowski, Przemko] Univ Leuven, Skeletal Biol & Engn Res Ctr, Dept Dev & Regenerat, Lab Dev & Stem Cell Biol, Leuven, Belgium; [Tylzanowski, Przemko] Med Univ, Dept Biochem & Mol Biol, Lublin, Poland	KU Leuven; Medical University of Lublin	Tylzanowski, P (corresponding author), Univ Leuven, Skeletal Biol & Engn Res Ctr, Dept Dev & Regenerat, Lab Dev & Stem Cell Biol, Leuven, Belgium.	przemko@med.kuleuven.be	Luyten, Frank/GPS-7793-2022	Tylzanowski, Przemko/0000-0003-0769-559X	"TREAT-OA"- (Translational Research in Europe Applied Technologies for OsteoArthritis) consortium - Framework 7 European Research Program (FP7); IWT (Agency for Innovation by Science and 21 Technology) Strategic Basic Research grant	"TREAT-OA"- (Translational Research in Europe Applied Technologies for OsteoArthritis) consortium - Framework 7 European Research Program (FP7); IWT (Agency for Innovation by Science and 21 Technology) Strategic Basic Research grant	This study was supported by the "TREAT-OA"- (Translational Research in Europe Applied Technologies for OsteoArthritis) consortium, funded by the Framework 7 European Research Program (FP7) (http://www.treatoa.eu/) and a IWT (Agency for Innovation by Science and 21 Technology) Strategic Basic Research grant (http://www.iwt.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Majeed S, 2012, CELL MOL LIFE SCI, V69, P165, DOI 10.1007/s00018-011-0744-0; Adams JW, 2008, AM J PHYSIOL-HEART C, V295, pH509, DOI 10.1152/ajpheart.00368.2008; Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Ascenzi MG, 2011, J THEOR BIOL, V285, P147, DOI 10.1016/j.jtbi.2011.06.016; Avasthi P, 2012, ACS CHEM BIOL, V7, P911, DOI 10.1021/cb200349v; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Caron A, 2012, DEVELOPMENT, V139, P514, DOI 10.1242/dev.071746; Chang CF, 2012, OSTEOARTHR CARTILAGE, V20, P152, DOI 10.1016/j.joca.2011.11.009; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; Drummond I, 2009, METHOD CELL BIOL, V93, P197, DOI 10.1016/S0091-679X(08)93011-9; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Evangelou E, 2011, ANN RHEUM DIS, V70, P349, DOI 10.1136/ard.2010.132787; Ferrante MI, 2009, HUM MOL GENET, V18, P289, DOI 10.1093/hmg/ddn356; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Francescatto L, 2010, DEVELOPMENT, V137, P2753, DOI 10.1242/dev.049627; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Hashimoto H, 2004, DEVELOPMENT, V131, P1741, DOI 10.1242/dev.01070; Haycraft CJ, 2008, CURR TOP DEV BIOL, V85, P303, DOI 10.1016/S0070-2153(08)00811-9; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Hupfeld CJ, 2007, ANNU REV PHYSIOL, V69, P561, DOI 10.1146/annurev.physiol.69.022405.154626; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jaffe KM, 2010, METHOD CELL BIOL, V97, P415, DOI 10.1016/S0091-679X(10)97022-2; Kerkhof HJM, 2010, ARTHRITIS RHEUM-US, V62, P499, DOI 10.1002/art.27184; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Konvicka K, 1998, BIOPHYS J, V75, P601, DOI 10.1016/S0006-3495(98)77551-4; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058589; Lodowski KH, 2013, J NEUROSCI, V33, P13621, DOI 10.1523/JNEUROSCI.1520-13.2013; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; Lunt SC, 2009, DEV DYNAM, V238, P1744, DOI 10.1002/dvdy.21999; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; Malicki J, 2011, METHOD CELL BIOL, V101, P39, DOI 10.1016/B978-0-12-387036-0.00003-7; Matsui T, 2011, P NATL ACAD SCI USA, V108, P9881, DOI 10.1073/pnas.1017248108; McGlashan SR, 2008, DEV DYNAM, V237, P2013, DOI 10.1002/dvdy.21501; Molla-Herman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003728; Monteiro R, 2008, DEV BIOL, V315, P55, DOI 10.1016/j.ydbio.2007.11.038; ODowd BF, 1997, GENE, V187, P75, DOI 10.1016/S0378-1119(96)00722-6; Oteiza P, 2008, DEVELOPMENT, V135, P2807, DOI 10.1242/dev.022228; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Raine EVA, 2012, ANN RHEUM DIS, V71, P2020, DOI 10.1136/annrheumdis-2012-201304; Rivero-Muller A, 2013, PROG MOL BIOL TRANSL, V117, P163, DOI 10.1016/B978-0-12-386931-9.00007-6; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Song R, 2014, NATURE, V510, P115, DOI 10.1038/nature13413; Stooke-Vaughan GA, 2012, DEVELOPMENT, V139, P1777, DOI 10.1242/dev.079947; Sun Xun, 2012, Cilia, V1, P21, DOI 10.1186/2046-2530-1-21; Tang XL, 2012, ACTA PHARMACOL SIN, V33, P363, DOI 10.1038/aps.2011.210; Tay HG, 2013, DEVELOPMENT, V140, P1550, DOI 10.1242/dev.087130; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thomas J, 2010, BIOL CELL, V102, P499, DOI 10.1042/BC20100035; Van Craenenbroeck Kathleen, 2012, Subcell Biochem, V63, P43, DOI 10.1007/978-94-007-4765-4_3; Walther C, 2013, PROG MOL BIOL TRANSL, V118, P93, DOI 10.1016/B978-0-12-394440-5.00004-8; Wang GL, 2013, JOVE-J VIS EXP, DOI 10.3791/50038; Wann AKT, 2012, CELL MOL LIFE SCI, V69, P2967, DOI 10.1007/s00018-012-0980-y; Wilkinson CJ, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-17; Zhang X, 2013, MOL BIOSYST, V9, P586, DOI 10.1039/c2mb25429h	69	8	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110484	10.1371/journal.pone.0110484	http://dx.doi.org/10.1371/journal.pone.0110484			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25335082	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200045
J	Brouwer, MJ; van Kooij, BJM; van Haastert, IC; Koopman-Esseboom, C; Groenendaal, F; de Vries, LS; Benders, MJNL				Brouwer, Margaretha J.; van Kooij, Britt J. M.; van Haastert, Ingrid C.; Koopman-Esseboom, Corine; Groenendaal, Floris; de Vries, Linda S.; Benders, Manon J. N. L.			Sequential Cranial Ultrasound and Cerebellar Diffusion Weighted Imaging Contribute to the Early Prognosis of Neurodevelopmental Outcome in Preterm Infants	PLOS ONE			English	Article							CEREBRAL WHITE-MATTER; TERM-EQUIVALENT AGE; VENTRICULAR DILATATION; BRAIN-INJURY; HEMORRHAGE; BIRTH; CHILDREN; VOLUME; BORN; MRI	Objective: To evaluate the contribution of sequential cranial ultrasound (cUS) and term-equivalent age magnetic resonance imaging (TEA-MRI) including diffusion weighted imaging (DWI) to the early prognosis of neurodevelopmental outcome in a cohort of very preterm infants (gestational age [GA] <31 weeks). Study design: In total, 93 preterm infants (median [range] GA in weeks: 28.3 [25.0-30.9]) were enrolled in this prospective cohort study and underwent early and term cUS as well as TEA-MRI including DWI. Early cUS abnormalities were classified as normal, mild, moderate or severe. Term cUS was evaluated for ex-vacuo ventriculomegaly (VM) and enlargement of the extracerebral cerebrospinal fluid (eCSF) space. Abnormalities on T1- and T2-weighted TEA-MRI were scored according to Kidokoro et al. Using DWI at TEA, apparent diffusion coefficients (ADCs) were measured in four white matter regions bilaterally and both cerebellar hemispheres. Neurodevelopmental outcome was assessed at two years' corrected age (CA) using the Bayley Scales of Infant and Toddler Development, third edition. Linear regression analysis was conducted to explore the correlation between the different neuroimaging modalities and outcome. Results: Moderate/severe abnormalities on early cUS, ex-vacuo VM and enlargement of the eCSF space on term cUS and increased cerebellar ADC values on term DWI were independently associated with worse motor outcome (p<.05). Ex-vacuo VM on term cUS was also related to worse cognitive performance at two years' CA (p<.01). Conclusion: These data support the clinical value of sequential cUS and recommend repeating cUS at TEA. In particular, assessment of moderate/severe early cUS abnormalities and ex-vacuo VM on term cUS provides important prognostic information. Cerebellar ADC values may further aid in the prognostication of gross motor function.	[Brouwer, Margaretha J.; van Kooij, Britt J. M.; van Haastert, Ingrid C.; Koopman-Esseboom, Corine; Groenendaal, Floris; de Vries, Linda S.; Benders, Manon J. N. L.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Neonatol, Utrecht, Netherlands; [Benders, Manon J. N. L.] St Thomas Hosp, Kings Coll London, Ctr Developing Brain, Div Imaging Sci & Biomed Engn, London, England	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Benders, MJNL (corresponding author), Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Neonatol, Utrecht, Netherlands.	m.benders@umcutrecht.nl	Groenendaal, Floris/P-6872-2019; de Vries, Linda S/AAB-6454-2021	Groenendaal, Floris/0000-0002-9284-1637; 	Alexandre Suerman Stipendium, University Medical Center Utrecht, The Netherlands; ZonMW, The Netherlands Organization for Health Research and Development [94527022]	Alexandre Suerman Stipendium, University Medical Center Utrecht, The Netherlands; ZonMW, The Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	MJB was supported by Alexandre Suerman Stipendium, University Medical Center Utrecht, The Netherlands. BK was supported by ZonMW, The Netherlands Organization for Health Research and Development, project 94527022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylward GP, 2002, MENT RETARD DEV D R, V8, P234, DOI 10.1002/mrdd.10043; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; Brouwer MJ, 2012, RADIOLOGY, V262, P224, DOI 10.1148/radiol.11110334; Cheong JLY, 2009, AM J NEURORADIOL, V30, P623, DOI 10.3174/ajnr.A1399; Cornette LG, 2002, ARCH DIS CHILD-FETAL, V86, P171, DOI 10.1136/fn.86.3.F171; Counsell SJ, 2003, PEDIATRICS, V112, P1, DOI 10.1542/peds.112.1.1; Davies MW, 2000, ARCH DIS CHILD-FETAL, V82, pF218, DOI 10.1136/fn.82.3.F218; de Vries LS, 2011, SEMIN FETAL NEONAT M, V16, P279, DOI 10.1016/j.siny.2011.04.004; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Hart A, 2011, PEDIATR RADIOL, V41, P1284, DOI 10.1007/s00247-011-2155-7; Hart AR, 2010, DEV MED CHILD NEUROL, V52, P652, DOI 10.1111/j.1469-8749.2009.03590.x; Horsch S, 2005, ACTA PAEDIATR, V94, P1815, DOI 10.1080/08035250500297745; Huppi PS, 2001, PEDIATRICS, V107, P455, DOI 10.1542/peds.107.3.455; Kesler SR, 2004, PEDIATR NEUROL, V31, P318, DOI 10.1016/j.pediatrneurol.2004.06.008; Kidokoro H, 2013, AM J NEURORADIOL, V34, P2208, DOI 10.3174/ajnr.A3521; Kidokoro H, 2011, AM J NEURORADIOL, V32, P2005, DOI 10.3174/ajnr.A2703; Krishnan ML, 2007, PEDIATRICS, V120, pE604, DOI 10.1542/peds.2006-3054; LEVENE MI, 1981, ARCH DIS CHILD, V56, P900, DOI 10.1136/adc.56.12.900; Limperopoulos C, 2005, PEDIATRICS, V116, P844, DOI 10.1542/peds.2004-2282; Maalouf EF, 2001, PEDIATRICS, V107, P719, DOI 10.1542/peds.107.4.719; Maunu J, 2011, DEV MED CHILD NEUROL, V53, P48, DOI 10.1111/j.1469-8749.2010.03785.x; Nosarti C, 2011, DEV NEUROPSYCHOL, V36, P118, DOI 10.1080/87565641.2011.540546; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Rademaker KJ, 2005, ARCH DIS CHILD-FETAL, V90, pF489, DOI 10.1136/adc.2005.073908; SAKUMA H, 1991, RADIOLOGY, V180, P229, DOI 10.1148/radiology.180.1.2052700; Steggerda SJ, 2013, CEREBELLUM, V12, P794, DOI 10.1007/s12311-013-0487-6; Steggerda SJ, 2009, RADIOLOGY, V252, P190, DOI 10.1148/radiol.2521081525; Tam EWY, 2011, J PEDIATR-US, V158, P366, DOI 10.1016/j.jpeds.2010.09.005; Tam EWY, 2009, PEDIATR RES, V66, P102, DOI 10.1203/PDR.0b013e3181a1fb3d; Van Kooij BJM, 2012, DEV MED CHILD NEUROL, V54, P260, DOI 10.1111/j.1469-8749.2011.04168.x; Vollmer B, 2006, DEV MED CHILD NEUROL, V48, P348, DOI 10.1017/S0012162206000764; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792	36	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109556	10.1371/journal.pone.0109556	http://dx.doi.org/10.1371/journal.pone.0109556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329772	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100029
J	Ingre, M; Van Leeuwen, W; Klemets, T; Ullvetter, C; Hough, S; Kecklund, G; Karlsson, D; Akerstedt, T				Ingre, Michael; Van Leeuwen, Wessel; Klemets, Tomas; Ullvetter, Christer; Hough, Stephen; Kecklund, Goran; Karlsson, David; Akerstedt, Torbjorn			Validating and Extending the Three Process Model of Alertness in Airline Operations	PLOS ONE			English	Article							3-PROCESS MODEL; SUBJECTIVE SLEEPINESS; FATIGUE; PERFORMANCE; FLIGHTS; RISK; HAUL; READAPTATION; DEPRIVATION; ADAPTATION	Sleepiness and fatigue are important risk factors in the transport sector and bio-mathematical sleepiness, sleep and fatigue modeling is increasingly becoming a valuable tool for assessing safety of work schedules and rosters in Fatigue Risk Management Systems (FRMS). The present study sought to validate the inner workings of one such model, Three Process Model (TPM), on aircrews and extend the model with functions to model jetlag and to directly assess the risk of any sleepiness level in any shift schedule or roster with and without knowledge of sleep timings. We collected sleep and sleepiness data from 136 aircrews in a real life situation by means of an application running on a handheld touch screen computer device (iPhone, iPod or iPad) and used the TPM to predict sleepiness with varying level of complexity of model equations and data. The results based on multilevel linear and non-linear mixed effects models showed that the TPM predictions correlated with observed ratings of sleepiness, but explorative analyses suggest that the default model can be improved and reduced to include only two-processes (S+C), with adjusted phases of the circadian process based on a single question of circadian type. We also extended the model with a function to model jetlag acclimatization and with estimates of individual differences including reference limits accounting for 50%, 75% and 90% of the population as well as functions for predicting the probability of any level of sleepiness for ecological assessment of absolute and relative risk of sleepiness in shift systems for safety applications.	[Ingre, Michael; Van Leeuwen, Wessel; Kecklund, Goran; Akerstedt, Torbjorn] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Klemets, Tomas; Karlsson, David] Jeppesen Syst AB, Gothenburg, Sweden; [Ullvetter, Christer] Swedish Transport Agcy, Norrkoping, Sweden; [Hough, Stephen] Scandinavian Airline Syst AB, Stockholm, Sweden	Stockholm University; Boeing; Jeppesen	Ingre, M (corresponding author), Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden.	michael.ingre@su.se	van Leeuwen, Wessel M.A./A-5812-2019	van Leeuwen, Wessel M.A./0000-0003-0834-0811; Akerstedt, Torbjorn/0000-0001-8049-8504; Ingre, Michael/0000-0003-0678-4494	Vinnova Sweden; Jeppesen AB; Scandinavian Airline Systems AB	Vinnova Sweden(Vinnova); Jeppesen AB(HOGANAS ABStatisticon AB); Scandinavian Airline Systems AB	The study was partly funded by Vinnova Sweden (to Stress Research Institute) (www.vinnova.se) and partly by Jeppesen AB. The funder Vinnova had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Tomas Klemets and David Karlsson are employed by the funder Jeppesen AB. Jeppesen AB provided support in the form of salaries for authors TK and DK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Stephen Hough is employed by Scandinavian Airline Systems AB. Scandinavian Airline Systems AB provided support in the form of salaries for author SH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ACHERMANN P, 1994, BIOL CYBERN, V71, P115, DOI 10.1007/BF00197314; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T, 1997, CHRONOBIOL INT, V14, P115, DOI 10.3109/07420529709001149; AKERSTEDT T, 1995, SLEEP, V18, P1; Akerstedt T, 1996, PSYCHOPHYSIOLOGY, V33, P385, DOI 10.1111/j.1469-8986.1996.tb01063.x; Akerstedt T, 1996, OCCUP ENVIRON MED, V53, P136, DOI 10.1136/oem.53.2.136; Akerstedt T., 1990, SLEEP 90, P310; Akerstedt T, 2008, CHRONOBIOL INT, V25, P309, DOI 10.1080/07420520802110613; [Anonymous], 1982, ESTIMATING AIRCREW F; Beh HC, 1997, PERCEPT MOTOR SKILL, V84, P319; Belyavin AJ, 2004, AVIAT SPACE ENVIR MD, V75, pA93; Bjorvatn B, 1998, J OCCUP ENVIRON MED, V40, P601, DOI 10.1097/00043764-199807000-00004; Bourgeois-Bougrine S, 2003, AVIAT SPACE ENVIR MD, V74, P1072; Caldwell John A, 2005, Travel Med Infect Dis, V3, P85, DOI 10.1016/j.tmaid.2004.07.008; CZEISLER CA, 1989, SCIENCE, V244, P1328, DOI 10.1126/science.2734611; Darwent D, 2010, SLEEP, V33, P185, DOI 10.1093/sleep/33.2.185; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Evans L, 2003, HDB TRANSPORTATION S, V56, P67, DOI [10.1007/b101877, DOI 10.1007/B101877]; Gander PH, 1998, AVIAT SPACE ENVIR MD, V69, pB37; Goode JH, 2003, J SAFETY RES, V34, P309, DOI 10.1016/S0022-4375(03)00033-1; GUNDEL A, 1995, BIOL PSYCHOL, V40, P131, DOI 10.1016/0301-0511(95)05107-4; Harris WC, 1995, INT J AVIAT PSYCHOL, V5, P169, DOI 10.1207/s15327108ijap0502_3; Helmreich RL, 1993, COCKPIT RESOURCE MAN, P3; Horne J, 1999, OCCUP ENVIRON MED, V56, P289, DOI 10.1136/oem.56.5.289; HORNE JA, 1977, BIOL PSYCHOL, V5, P179, DOI 10.1016/0301-0511(77)90001-1; Hursh SR, 2004, AVIAT SPACE ENVIR MD, V75, pA44; Ingre M, 2006, J SLEEP RES, V15, P47, DOI 10.1111/j.1365-2869.2006.00504.x; Ingre M, 2008, CHRONOBIOL INT, V25, P349, DOI 10.1080/07420520802110704; Ingre M, 2006, J SLEEP RES, V15, P142, DOI 10.1111/j.1365-2869.2006.00517.x; Jackson CA, 2006, OCCUP MED-OXFORD, V56, P263, DOI 10.1093/occmed/kql021; Jewett ME, 1999, J BIOL RHYTHM, V14, P588, DOI 10.1177/074873099129000920; Lamond N, 2008, BEHAV RES METHODS, V40, P347, DOI 10.3758/BRM.40.1.347; Lindsey JK, 1998, STAT MED, V17, P447, DOI 10.1002/(SICI)1097-0258(19980228)17:4<447::AID-SIM752>3.0.CO;2-G; Loeb PD., 1994, CAUSES DETERRENTS TR; Mallis MM, 2004, AVIAT SPACE ENVIR MD, V75, pA4; Matschnigg G, 2011, FATIGUE RISK MANAGEM; McCauley P, 2013, SLEEP, V36, P1987, DOI 10.5665/sleep.3246; McFarland RA, 1941, NEW ENGL J MED, V225, P845, DOI 10.1056/NEJM194111272252201; MINORS DS, 1991, NEUROSCI LETT, V133, P36, DOI 10.1016/0304-3940(91)90051-T; MONK TH, 1983, CHRONOBIOLOGIA, V10, P49; Moore-Ede M, 2004, AVIAT SPACE ENVIR MD, V75, pA107; Previc FH, 2009, INT J AVIAT PSYCHOL, V19, P326, DOI 10.1080/10508410903187562; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Roach GD, 2004, AVIAT SPACE ENV MED, V75, P2004; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Saksvik IB, 2011, J OCCUP HEALTH PSYCH, V16, P331, DOI 10.1037/a0022770; Samel A, 1997, AVIAT SPACE ENVIR MD, V68, P679; StataCorp, 2013, STAT STAT SOFTW REL; Van Dongen HPA, 2004, SLEEP, V27, P423; [No title captured]; [No title captured]; [No title captured]	53	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e108679	10.1371/journal.pone.0108679	http://dx.doi.org/10.1371/journal.pone.0108679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25329575	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100012
J	Lanting, CP; de Kleine, E; Langers, DRM; van Dijk, P				Lanting, Cornelis P.; de Kleine, Emile; Langers, Dave R. M.; van Dijk, Pim			Unilateral Tinnitus: Changes in Connectivity and Response Lateralization Measured with fMRI	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; POSTERIOR CEREBELLAR VERMIS; SENSORINEURAL HEARING-LOSS; ACOUSTIC STARTLE RESPONSE; LONG-TERM HABITUATION; GAZE-EVOKED TINNITUS; NEURAL ACTIVITY; SOUND-LEVEL; MEDIAL CEREBELLUM; COCHLEAR NUCLEUS	Tinnitus is a percept of sound that is not related to an acoustic source outside the body. For many forms of tinnitus, mechanisms in the central nervous system are believed to play a role in the pathology. In this work we specifically assessed possible neural correlates of unilateral tinnitus. Functional magnetic resonance imaging (fMRI) was used to investigate differences in sound-evoked neural activity between controls, subjects with left-sided tinnitus, and subjects with right-sided tinnitus. We assessed connectivity patterns between auditory nuclei and the lateralization of the sound-evoked responses. Interestingly, these response characteristics did not relate to the laterality of tinnitus. The lateralization for left-or right ear stimuli, as expressed in a lateralization index, was considerably smaller in subjects with tinnitus compared to that in controls, reaching significance in the right primary auditory cortex (PAC) and the right inferior colliculus (IC). Reduced functional connectivity between the brainstem and the cortex was observed in subjects with tinnitus. These differences are consistent with two existing models that relate tinnitus to i) changes in the corticothalamic feedback loops or ii) reduced inhibitory effectiveness between the limbic system and the thalamus. The vermis of the cerebellum also responded to monaural sound in subjects with unilateral tinnitus. In contrast, no cerebellar response was observed in control subjects. This suggests the involvement of the vermis of the cerebellum in unilateral tinnitus.	[Lanting, Cornelis P.; de Kleine, Emile; Langers, Dave R. M.; van Dijk, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands; [Lanting, Cornelis P.; de Kleine, Emile; van Dijk, Pim] Univ Groningen, Univ Med Ctr Groningen, Res Sch Behav & Cognit Neurosci, Grad Sch Med Sci, Groningen, Netherlands; [Langers, Dave R. M.] Univ Nottingham, Queens Med Ctr, Sch Clin Sci, Natl Inst Hlth Res,Nottingham Hearing Biomed Res, Nottingham NG7 2RD, England	University of Groningen; University of Groningen; University of Nottingham	Lanting, CP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands.	c.p.lanting@umcg.nl	Lanting, Cris/S-6334-2017; Van Dijk, Pim/E-8019-2010; de Kleine, Emile/P-2350-2014	Lanting, Cris/0000-0001-9397-7766; Van Dijk, Pim/0000-0002-8023-7571; de Kleine, Emile/0000-0001-9525-3032	Heinsius Houbolt Foundation; Netherlands Organization for Scientific Research (NWO VENI) [016.096.011]; COST action TINNET (Tinnitus Research Network: New Treatments for Tinnitus)	Heinsius Houbolt Foundation; Netherlands Organization for Scientific Research (NWO VENI)(Netherlands Organization for Scientific Research (NWO)); COST action TINNET (Tinnitus Research Network: New Treatments for Tinnitus)	This work was financially supported by the Heinsius Houbolt Foundation and the Netherlands Organization for Scientific Research (NWO VENI research grant 016.096.011 awarded to DL), and the COST action TINNET (Tinnitus Research Network: New Treatments for Tinnitus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; AITKIN LM, 1975, J NEUROPHYSIOL, V38, P418, DOI 10.1152/jn.1975.38.2.418; Baumgart F, 1998, MED PHYS, V25, P2068, DOI 10.1118/1.598368; Boyen K, 2014, HEARING RES, V312, P48, DOI 10.1016/j.heares.2014.03.001; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Cherian A, 2013, IEEE T PATTERN ANAL, V35, P2161, DOI 10.1109/TPAMI.2012.259; Chrostowski M, 2011, J COMPUT NEUROSCI, V30, P279, DOI 10.1007/s10827-010-0256-1; Coad ML, 2001, OTOL NEUROTOL, V22, P650, DOI 10.1097/00129492-200109000-00016; Crippa Alessandro, 2010, Open Neuroimag J, V4, P16, DOI 10.2174/1874440001004010016; Dominguez M, 2006, NEURAL COMPUT, V18, P2942, DOI 10.1162/neco.2006.18.12.2942; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; EHRET G, 1997, CENTRAL AUDITORY SYS; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hall DA, 2001, J ACOUST SOC AM, V109, P1559, DOI 10.1121/1.1345697; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; HUANG C, 1990, EXP BRAIN RES, V81, P377; HUANG CM, 1990, BRAIN RES, V536, P327, DOI 10.1016/0006-8993(90)90044-C; HUANG CM, 1982, BRAIN RES, V244, P1, DOI 10.1016/0006-8993(82)90897-6; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Kaltenbach JA, 2005, HEARING RES, V206, P200, DOI 10.1016/j.heares.2005.02.013; Kaltenbach JA, 2004, NEUROSCI LETT, V355, P121, DOI 10.1016/j.neulet.2003.10.038; Langers DRM, 2007, NEUROIMAGE, V34, P264, DOI 10.1016/j.neuroimage.2006.09.002; Langers DRM, 2005, NEUROIMAGE, V28, P490, DOI 10.1016/j.neuroimage.2005.06.024; Langers DRM, 2003, NEUROIMAGE, V20, P265, DOI 10.1016/S1053-8119(03)00258-1; Langers DRM, 2005, MAGN RESON MED, V53, P49, DOI 10.1002/mrm.20315; Lanting CP, 2008, ACTA OTO-LARYNGOL, V128, P415, DOI 10.1080/00016480701793743; Lanting CP, 2010, HEARING RES, V267, P78, DOI 10.1016/j.heares.2010.04.006; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; LEATON RN, 1991, BEHAV NEUROSCI, V105, P804, DOI 10.1037/0735-7044.105.6.804; Leaver AM, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00021; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Lee CC, 2005, CEREB CORTEX, V15, P1804, DOI 10.1093/cercor/bhi057; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Martin JH., 2003, NEUROANATOMY TEXT AT; Maschke M, 2000, EXP BRAIN RES, V133, P359, DOI 10.1007/s002210000417; Melcher JR, 2009, HEARING RES, V257, P63, DOI 10.1016/j.heares.2009.08.005; Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058, DOI 10.1152/jn.2000.83.2.1058; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petacchi A, 2005, HUM BRAIN MAPP, V25, P118, DOI 10.1002/hbm.20137; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Rohl M, 2012, JARO-J ASSOC RES OTO, V13, P369, DOI 10.1007/s10162-012-0315-6; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; Sigalovsky IS, 2006, HEARING RES, V215, P67, DOI 10.1016/j.heares.2006.03.002; Timmann D, 1998, J NEUROL NEUROSUR PS, V65, P771, DOI 10.1136/jnnp.65.5.771; van Gendt MJ, 2012, J NEUROSCI, V32, P17528, DOI 10.1523/JNEUROSCI.2791-12.2012; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; WILSON PH, 1991, J SPEECH HEAR RES, V34, P197, DOI 10.1044/jshr.3401.197; Woolsey TA, 2003, BRAIN ATLAS VISUAL G; Zhang JS, 2013, HEARING RES, V295, P38, DOI 10.1016/j.heares.2012.05.007	59	48	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110704	10.1371/journal.pone.0110704	http://dx.doi.org/10.1371/journal.pone.0110704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329557	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100086
J	Orzaez, M; Sancho, M; Marchan, S; Mondragon, L; Montava, R; Valero, JG; Landeta, O; Basanez, G; Carbajo, RJ; Pineda-Lucena, A; Bujons, J; Moure, A; Messeguer, A; Lagunas, C; Herrero, C; Perez-Paya, E				Orzaez, Mar; Sancho, Monica; Marchan, Sandra; Mondragon, Laura; Montava, Rebeca; Garcia Valero, Juan; Landeta, Olatz; Basanez, Gorka; Carbajo, Rodrigo J.; Pineda-Lucena, Antonio; Bujons, Jordi; Moure, Alejandra; Messeguer, Angel; Lagunas, Carmen; Herrero, Carmen; Perez-Paya, Enrique			Apaf-1 Inhibitors Protect from Unwanted Cell Death in In Vivo Models of Kidney Ischemia and Chemotherapy Induced Ototoxicity	PLOS ONE			English	Article							CISPLATIN OTOTOXICITY; INDUCED APOPTOSIS; ACCURATE DOCKING; BINDING; ACTIVATION; GLIDE; IDENTIFICATION; EBSELEN; EVENTS; INJURY	Background: Excessive apoptosis induces unwanted cell death and promotes pathological conditions. Drug discovery efforts aimed at decreasing apoptotic damage initially targeted the inhibition of effector caspases. Although such inhibitors were effective, safety problems led to slow pharmacological development. Therefore, apoptosis inhibition is still considered an unmet medical need. Methodology and Principal Findings: The interaction between Apaf-1 and the inhibitors was confirmed by NMR. Target specificity was evaluated in cellular models by siRNa based approaches. Cell recovery was confirmed by MTT, clonogenicity and flow cytometry assays. The efficiency of the compounds as antiapoptotic agents was tested in cellular and in vivo models of protection upon cisplatin induced ototoxicity in a zebrafish model and from hypoxia and reperfusion kidney damage in a rat model of hot ischemia. Conclusions: Apaf-1 inhibitors decreased Cytc release and apoptosome-mediated activation of procaspase-9 preventing cell and tissue damage in ex vivo experiments and in vivo animal models of apoptotic damage. Our results provide evidence that Apaf-1 pharmacological inhibition has therapeutic potential for the treatment of apoptosis-related diseases.	[Orzaez, Mar; Sancho, Monica; Mondragon, Laura; Montava, Rebeca; Perez-Paya, Enrique] Ctr Invest Principe Felipe, Lab Peptide & Prot Chem, Valencia, Spain; [Marchan, Sandra; Lagunas, Carmen; Herrero, Carmen] Labs SALVAT SA, Barcelona, Spain; [Garcia Valero, Juan; Landeta, Olatz; Basanez, Gorka] Univ Basque Country, Unidad Biofis, CSIC, Leioa, Spain; [Carbajo, Rodrigo J.; Pineda-Lucena, Antonio] Ctr Invest Principe Felipe, Lab Struct Biochem, Valencia, Spain; [Bujons, Jordi; Moure, Alejandra; Messeguer, Angel] CSIC, Inst Quim Avanzada Cataluna, Dept Chem & Biomol Nanotechnol, Barcelona, Spain; [Bujons, Jordi; Moure, Alejandra; Messeguer, Angel] CSIC, Inst Quim Avanzada Cataluna, Dept Biol Chem & Mol Modeling, Barcelona, Spain; [Perez-Paya, Enrique] CSIC, Inst Biomed Valencia, Valencia, Spain	Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Orzaez, M (corresponding author), Ctr Invest Principe Felipe, Lab Peptide & Prot Chem, Valencia, Spain.	morzaez@cipf.es	Medina, Mónica Sancho/L-4660-2014; Pineda-Lucena, Antonio/B-1320-2014; Martinez, Laura Mondragon/X-1577-2019; Martinez, Laura Mondragon/P-1670-2018; Orzaez, Mar/B-4992-2014; Bujons, Jordi/K-8486-2012; Bujons, Jordi/AAA-9283-2020	Medina, Mónica Sancho/0000-0003-3707-062X; Pineda-Lucena, Antonio/0000-0002-3532-8781; Martinez, Laura Mondragon/0000-0002-3257-045X; Martinez, Laura Mondragon/0000-0002-3257-045X; Orzaez, Mar/0000-0003-3231-5835; Bujons, Jordi/0000-0003-2944-2905; Bujons, Jordi/0000-0003-2944-2905; Messeguer, Angel/0000-0002-8358-9425; Landeta, Olatz/0000-0002-5494-0271; Valero, Juan Garcia/0000-0003-3193-9099; Herrero, Carmen/0000-0002-9509-8033	Spanish Ministry of Science and Innovation [MICINN - BIO2007-60066, SAF2008-00048, SAF30542-C01-01, SAF2010-15512]; Laboratorios SALVAT, S.A.; Fundacion Renal Tomas de Osma; Generalitat Valenciana Prometeo [2010/005]; Consolider-Ingenio [MICINN - CSD2008-00005C]; Generalitat Valenciana through Prometeo [2014/061]; JAE-pre CSIC; ERDF	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Laboratorios SALVAT, S.A.; Fundacion Renal Tomas de Osma; Generalitat Valenciana Prometeo(Center for Forestry Research & Experimentation (CIEF)); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana through Prometeo; JAE-pre CSIC; ERDF(European Commission)	This work was supported by grants from the Spanish Ministry of Science and Innovation (MICINN - BIO2007-60066, SAF2008-00048, SAF30542-C01-01 and SAF2010-15512), Laboratorios SALVAT, S.A., Fundacion Renal Tomas de Osma, Generalitat Valenciana Prometeo 2010/005 (partially funded with ERDF), Consolider-Ingenio 2010 (MICINN - CSD2008-00005C) and by the Generalitat Valenciana through Prometeo 2014/061. Moure was funded by a predoctoral fellowship from JAE-pre CSIC. The funders provided financial support and had a role in the data collection, analysis and manuscript preparation of cellular and in vivo model of ototoxicity. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2011, SITEMAP VERS 2 5; [Anonymous], 2011, SCHROD SUIT 2011; [Anonymous], 2011, MACROMODEL VERS 9 9; [Anonymous], 2011, LIGPREP VERS 2 5; Ardura JA, 2013, KIDNEY INT, V83, P825, DOI 10.1038/ki.2012.476; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Burgess G, 2008, CELL A, ViiA-ivA, p1A; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fearnhead HO, 2001, METHOD CELL BIOL, V66, P167; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Ferraro E, 2011, J CELL SCI, V124, P3450, DOI 10.1242/jcs.086298; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gao YQ, 2010, STROKE, V41, P166, DOI 10.1161/STROKEAHA.109.561852; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hoglen NC, 2004, J PHARMACOL EXP THER, V309, P634, DOI 10.1124/jpet.103.062034; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Laskowski IA, 2001, TRANSPLANT P, V33, P909, DOI 10.1016/S0041-1345(00)02372-1; Linton SD, 2005, CURR TOP MED CHEM, V5, P1697, DOI 10.2174/156802605775009720; Linton SD, 2005, J MED CHEM, V48, P6779, DOI 10.1021/jm050307e; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Malet G, 2006, CELL DEATH DIFFER, V13, P1523, DOI 10.1038/sj.cdd.4401828; McCall M, 2011, SURGERY, V150, P48, DOI 10.1016/j.surg.2011.02.023; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Mochizuki H, 2001, P NATL ACAD SCI USA, V98, P10918, DOI 10.1073/pnas.191107398; Mondragon L, 2009, APOPTOSIS, V14, P182, DOI 10.1007/s10495-008-0310-x; Moure A, 2011, CHEM-EUR J, V17, P7927, DOI 10.1002/chem.201100216; Potokar M, 2006, AM J PHYSIOL-CELL PH, V290, pC672, DOI 10.1152/ajpcell.00331.2005; Reubold TF, 2011, STRUCTURE, V19, P1074, DOI 10.1016/j.str.2011.05.013; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rybak LP, 2009, TOHOKU J EXP MED, V219, P177, DOI 10.1620/tjem.219.177; Sadis C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000469; Sarker KP, 2003, J NEUROCHEM, V87, P1345, DOI 10.1046/j.1471-4159.2003.02096.x; Schrodinger LLC, 2011, MAESTR VERS 9 2; Slattery EL, 2010, J NEUROSCI, V30, P3473, DOI 10.1523/JNEUROSCI.4316-09.2010; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Thiele H, 2010, J AM COLL CARDIOL, V55, P2201, DOI 10.1016/j.jacc.2009.08.091; Ton C, 2005, HEARING RES, V208, P79, DOI 10.1016/j.heares.2005.05.005; Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850; Yaoita H, 2000, CARDIOVASC RES, V45, P630, DOI 10.1016/S0008-6363(99)00349-1; Yoo J, 2014, LARYNGOSCOPE; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	54	19	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110979	10.1371/journal.pone.0110979	http://dx.doi.org/10.1371/journal.pone.0110979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330150	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100107
J	van der Gronde, T; Kempes, M; van El, C; Rinne, T; Pieters, T				van der Gronde, Toon; Kempes, Maaike; van El, Carla; Rinne, Thomas; Pieters, Toine			Neurobiological Correlates in Forensic Assessment: A Systematic Review	PLOS ONE			English	Review							PSYCHOPATHIC PERSONALITY-TRAITS; CRIMINAL BEHAVIOR; VIOLENT BEHAVIOR; ANTISOCIAL-BEHAVIOR; DELINQUENT-BEHAVIOR; ENVIRONMENTAL-INFLUENCES; GENETIC PREDISPOSITION; MAOA GENOTYPE; COMT GENE; PCL-R	Background: With the increased knowledge of biological risk factors, interest in including this information in forensic assessments is growing. Currently, forensic assessments are predominantly focused on psychosocial factors. A better understanding of the neurobiology of violent criminal behaviour and biological risk factors could improve forensic assessments. Objective: To provide an overview of the current evidence about biological risk factors that predispose people to antisocial and violent behaviour, and determine its usefulness in forensic assessment. Methods: A systematic literature search was conducted using articles from PsycINFO, Embase and Pubmed published between 2000 and 2013. Results: This review shows that much research on the relationship between genetic predisposition and neurobiological alterations with aggression is performed on psychiatric patients or normal populations. However, the number of studies comparing offenders is limited. There is still a great need to understand how genetic and neurobiological alterations and/or deficits are related to violent behaviour, specifically criminality. Most studies focus on only one of the genetic or neurobiological fields related to antisocial and/or violent behaviour. To reliably correlate the findings of these fields, a standardization of methodology is urgently needed. Conclusion: Findings from the current review suggest that violent aggression, like all forms of human behaviour, both develops under specific genetic and environmental conditions, and requires interplay between these conditions. Violence should be considered as the end product of a chain of life events, during which risks accumulate and potentially reinforce each other, displaying or triggering a specific situation. This systematic review did not find evidence of predispositions or neurobiological alterations that solely explain antisocial or violent behaviour. With better designed studies, more correlation between diverse fields, and more standardisation, it might be possible to elucidate underlying mechanisms. Thus, we advocate maintaining the current case-by-case differentiated approach to evidence-based forensic assessment.	[van der Gronde, Toon; Pieters, Toine] Univ Utrecht, UIPS, Dept Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [van der Gronde, Toon; Pieters, Toine] Univ Utrecht, Freudenthal Inst, Utrecht, Netherlands; [Kempes, Maaike; Rinne, Thomas] Netherlands Inst Forens Psychiat & Psychol, Pieter Baan Ctr, Forens Psychiat Observat Clin, Utrecht, Netherlands; [van El, Carla] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Sect Community Genet, Amsterdam, Netherlands; [van El, Carla] Vrije Univ Amsterdam, Med Ctr, EMGO, Amsterdam, Netherlands	Utrecht University; Utrecht University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Pieters, T (corresponding author), Univ Utrecht, UIPS, Dept Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	t.pieters@uu.nl		Pieters, Toine/0000-0002-8156-8436; van der Gronde, Toon/0000-0002-8688-8180	Netherlands Genomics Initiative	Netherlands Genomics Initiative	The authors declare that the the research in the manuscript was part of the project "Genes, brains and criminality in context'' of the CSG Centre for Society and the Life Sciences, funded by the Netherlands Genomics Initiative. http://www.society-lifesciences.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni E, 2013, P NATL ACAD SCI USA, V110, P6223, DOI 10.1073/pnas.1219302110; Aluja A, 2011, PSYCHIAT GENET, V21, P229, DOI 10.1097/YPG.0b013e328345465e; Anckarsater H, 2006, BRAIN RES BULL, V69, P259, DOI 10.1016/j.brainresbull.2006.01.008; Anderson TR, 2004, COMMUNITY MENT HLT J, V40, P379, DOI 10.1023/B:COMH.0000035231.24472.bc; [Anonymous], J AGGRESSION MALTREA, DOI DOI 10.1300/J146v06n01_08; Aslund C, 2013, AGGRESSIVE BEHAV, V39, P52, DOI 10.1002/ab.21451; Barnes JC, 2013, CRIM JUSTICE BEHAV, V40, P519, DOI 10.1177/0093854812458907; Barnes JC, 2013, J INTERPERS VIOLENCE, V28, P92, DOI 10.1177/0886260512448847; Baum ML, 2013, NEUROETHICS-NETH, V6, P287, DOI 10.1007/s12152-011-9108-6; Baumbach Jeremy, 2002, Sex Abuse, V14, P313, DOI 10.1023/A:1019969503528; Beaver KM, 2013, PERS INDIV DIFFER, V54, P164, DOI 10.1016/j.paid.2012.08.014; Beaver KM, 2011, J ADOLESCENT RES, V26, P84, DOI 10.1177/0743558410384736; BEAVER KM, 2011, J CONT CRIMINAL JUST, V0027; Beech AR, 2005, CLIN PSYCHOL REV, V25, P153, DOI 10.1016/j.cpr.2004.10.002; Berman ME, 2000, EXP CLIN PSYCHOPHARM, V8, P601; Berryessa CM, 2013, ANNU REV GENOM HUM G, V14, P515, DOI 10.1146/annurev-genom-090711-163743; Beszterczey S, 2013, NEUROPSYCHOLOGY, V27, P491, DOI 10.1037/a0033162; Blackwood NJ, 2012, BIOL PSYCHIAT, V71, p127S; Blair RJR, 2005, DEV PSYCHOPATHOL, V17, P865, DOI 10.1017/S0954579405050418; Boisvert D, 2012, J CONTEMP CRIM JUST, V28, P293, DOI 10.1177/1043986212450224; Bourget D, 2004, CAN J PSYCHIAT, V49, P719, DOI 10.1177/070674370404901102; Boutwell BB, 2013, COMPR PSYCHIAT, VS0010-440X, DOI [10.1016/j.compp-sych.2013.11.005, DOI 10.1016/J.COMPP-SYCH.2013.11.005]; Bouvy PF, 2012, PSYCHOPHARMACOLOGY, V222, P499, DOI 10.1007/s00213-012-2668-2; Brewer-Smyth Kathleen, 2004, Health Care Women Int, V25, P835, DOI 10.1080/07399330490517118; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Casartelli L, 2013, CURR OPIN PSYCHIATR, V26, P468, DOI 10.1097/YCO.0b013e32836342e1; Chen BF, 2014, J MOL NEUROSCI, V52, P481, DOI 10.1007/s12031-013-0160-z; Cohen RA, 2003, J INT NEUROPSYCH SOC, V9, P760, DOI 10.1017/S1355617703950090; Connolly EJ, 2014, J INTERPERS VIOLENCE, V29, P707, DOI 10.1177/0886260513505209; Copeland WE, 2011, DRUG ALCOHOL DEPEN, V115, P183, DOI 10.1016/j.drugalcdep.2010.10.024; Arias JMC, 2011, PSYCHIAT GENET, V21, P115, DOI 10.1097/YPG.0b013e3283437175; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; DeLisi M, 2009, YOUTH VIOLENCE JUV J, V7, P256, DOI 10.1177/1541204009333834; Denney RL, 2000, J HEAD TRAUMA REHAB, V15, P804, DOI 10.1097/00001199-200004000-00005; DiLalla LF, 2002, DEV REV, V22, P593, DOI 10.1016/S0273-2297(02)00504-X; Dmitrieva J, 2011, SOC COGN AFFECT NEUR, V6, P82, DOI 10.1093/scan/nsq020; Dolan M, 2012, PSYCHOL MED, V42, P1715, DOI 10.1017/S0033291711002686; Dutton DG, 2002, AGGRESS VIOLENT BEH, V7, P407, DOI 10.1016/S1359-1789(01)00066-0; Ferguson CJ, 2013, J AGGRESS MALTREAT T, V22, P447, DOI 10.1080/10926771.2013.785457; Fonagy P, 2004, ANN NY ACAD SCI, V1036, P181, DOI 10.1196/annals.1330.012; Forzano F, 2010, EUR J HUM GENET, V18, P519, DOI 10.1038/ejhg.2010.31; Gao Y, 2009, CAN J PSYCHIAT, V54, P813, DOI 10.1177/070674370905401204; Glenn AL, 2008, PSYCHIAT CLIN N AM, V31, P463, DOI 10.1016/j.psc.2008.03.004; Glenn AL, 2014, NAT REV NEUROSCI, V15, P54, DOI 10.1038/nrn3640; Golkar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048107; Goodenough OR, 2004, PHILOS T R SOC B, V359, P1709, DOI 10.1098/rstb.2004.1552; Hall J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049033; Hanlon RE, 2012, J FAM VIOLENCE, V27, P105, DOI 10.1007/s10896-011-9410-4; Harden KP, 2012, J ABNORM PSYCHOL, V121, P73, DOI 10.1037/a0024160; Harden KP, 2011, J YOUTH ADOLESCENCE, V40, P825, DOI 10.1007/s10964-010-9601-y; Harden K, 2011, BEHAV GENET, V41, P911; Heilbronner RL, 2004, CLIN NEUROPSYCHOL, V18, P312, DOI 10.1080/13854040490501574; Hill J, 2002, J CHILD PSYCHOL PSYC, V43, P133, DOI 10.1111/1469-7610.00007; Hirata Y, 2013, AGGRESSIVE BEHAV, V39, P45, DOI 10.1002/ab.21448; Hoptman Matthew J, 2003, J Psychiatr Pract, V9, P265, DOI 10.1097/00131746-200307000-00002; Hughes V, 2010, NATURE, V464, P340, DOI 10.1038/464340a; Janssen PA, 2005, J INTERPERS VIOLENCE, V20, P61, DOI 10.1177/0886260504268120; Jordan K, 2011, J SEX MED, V8, P3008, DOI 10.1111/j.1743-6109.2011.02393.x; Joyal CC, 2014, SEX ABUSE-J RES TR, V26, P149, DOI 10.1177/1079063213482842; Kendler KS, 2013, PSYCHOL MED, V43, P2161, DOI 10.1017/S003329171300007X; Koh KB, 2012, J CLIN PSYCHIAT, V73, P159, DOI 10.4088/JCP.10m06443; Kunst JL, 2002, B MENNINGER CLIN, V66, P19, DOI 10.1521/bumc.66.1.19.23372; Kurtz A, 2002, J FORENSIC PSYCHIATR, V13, P671, DOI 10.1080/0958518021000019902; Laurell J, 2005, INT J LAW PSYCHIAT, V28, P255, DOI 10.1016/j.ijlp.2004.08.008; Levitt M, 2013, NEW GENET SOC, V32, P4, DOI 10.1080/14636778.2012.699352; Liu JH, 2005, INT J NURS STUD, V42, P229, DOI 10.1016/j.ijnurstu.2004.06.007; Marazziti D, 2013, ANN GEN PSYCHIATR, V12, DOI 10.1186/1744-859X-12-6; Martens WHJ, 2002, INT J OFFENDER THER, V46, P170, DOI 10.1177/0306624X02462004; May JS, 2014, INT J OFFENDER THER, V58, P265, DOI 10.1177/0306624X12469861; McEllistrem JE, 2004, AGGRESS VIOLENT BEH, V10, P1, DOI 10.1016/j.avb.2003.06.002; Meier NM, 2012, INT J PSYCHOPHYSIOL, V84, P1, DOI 10.1016/j.ijpsycho.2011.12.011; Miczek KA, 2004, ANN NY ACAD SCI, V1036, P278, DOI 10.1196/annals.1330.018; Miller HV, 2013, CRIM JUSTICE BEHAV, V40, P671, DOI 10.1177/0093854812468434; Mitchell IJ, 2011, CLIN PSYCHOL REV, V31, P872, DOI 10.1016/j.cpr.2011.04.001; Mong JA, 2003, NEUROBIOL AGING, V24, pS83, DOI 10.1016/S0197-4580(03)00053-8; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Morse SJ, 2011, TRENDS COGN SCI, V15, P378, DOI 10.1016/j.tics.2011.06.009; Muller JL, 2010, BEHAV SCI LAW, V28, P129, DOI 10.1002/bsl.926; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Olivier B, 2005, EUR J PHARMACOL, V526, P207, DOI 10.1016/j.ejphar.2005.09.066; Pallone NJ, 2000, J OFFENDER REHABILIT, V31, P87; Penney S, 2012, INT J LAW PSYCHIAT, V35, P99, DOI 10.1016/j.ijlp.2011.12.004; Philipp-Wiegmann F, 2011, EUR PSYCH C; Pontius AA, 2005, AGGRESS VIOLENT BEH, V10, P363, DOI 10.1016/j.avb.2004.05.002; Pope K, 2012, J AM ACAD CHILD PSY, V51, P341, DOI 10.1016/j.jaac.2012.01.003; Popova N K, 2008, Neurosci Behav Physiol, V38, P471, DOI 10.1007/s11055-008-9004-7; Pridmore S, 2005, AUST NZ J PSYCHIAT, V39, P856, DOI 10.1080/j.1440-1614.2005.01679.x; Raine A, 2002, J ABNORM CHILD PSYCH, V30, P311, DOI 10.1023/A:1015754122318; Raine A, 1997, J AM ACAD CHILD PSY, V36, P1457, DOI 10.1097/00004583-199710000-00029; Raine A, 2002, J CHILD PSYCHOL PSYC, V43, P417, DOI 10.1111/1469-7610.00034; Ramirez JM, 2003, AGGRESS VIOLENT BEH, V8, P621, DOI 10.1016/S1359-1789(02)00102-7; Rappaport N, 2004, J ADOLESCENT HEALTH, V35, P260, DOI 10.1016/j.jadohealth.2003.10.009; Reidy DE, 2011, AGGRESS VIOLENT BEH, V16, P512, DOI 10.1016/j.avb.2011.06.002; Rhee SH, 2002, PSYCHOL BULL, V128, P490, DOI 10.1037//0033-2909.128.3.490; Rothstein MA, 2005, NAT REV GENET, V6, P793, DOI 10.1038/nrg1687; Sapolsky RM, 2004, PHILOS T R SOC B, V359, P1787, DOI 10.1098/rstb.2004.1547; Sartori G, 2011, CURR OPIN NEUROL, V24, P371, DOI 10.1097/WCO.0b013e3283489754; Scarpa Angela, 2003, Trauma Violence Abuse, V4, P210, DOI 10.1177/1524838003004003002; Schiltz K, 2013, EUR ARCH PSY CLIN N, V263, P607, DOI 10.1007/s00406-013-0403-6; Schleim S, 2012, INT J LAW PSYCHIAT, V35, P104, DOI 10.1016/j.ijlp.2012.01.001; Schwartz JA, 2013, COMPR PSYCHIAT, VS0010-440X, DOI [10.1016/j.comppsych.2013.06.002, DOI 10.1016/J.COMPP-SYCH.2013.06.002]; Schwartz JA, 2011, J CRIM JUST, V39, P378, DOI 10.1016/j.jcrimjus.2011.05.003; Siegel A, 2011, INT J LAW PSYCHIAT, V34, P20, DOI 10.1016/j.ijlp.2010.11.004; Silva JA, 2004, BEHAV SCI LAW, V22, P787, DOI 10.1002/bsl.620; Spironelli C, 2013, J PSYCHIATR RES, V47, P622, DOI 10.1016/j.jpsychires.2013.01.001; Stein DJ, 2000, ETHNIC HEALTH, V5, P303, DOI 10.1080/713667458; Stone MH, 2001, J PERS DISORD, V15, P1, DOI 10.1521/pedi.15.1.1.18646; Sugranyes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025322; Takahashi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094657; Teichner G, 2000, AGGRESS VIOLENT BEH, V5, P509, DOI 10.1016/S1359-1789(98)00035-4; Tikkanen R, 2011, PSYCHIAT RES, V185, P382, DOI 10.1016/j.psychres.2010.08.026; Vaske J, 2012, DEV PSYCHOPATHOL, V24, P181, DOI 10.1017/S0954579411000769; Vaske J, 2011, INT J OFFENDER THER, V55, P251, DOI 10.1177/0306624X10361583; Vaske J, 2011, PSYCHIAT RES, V185, P376, DOI 10.1016/j.psychres.2010.07.044; Vassos E, 2014, MOL PSYCHIATR, V19, P471, DOI 10.1038/mp.2013.31; Victor TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046439; Viding E, 2004, ANN NY ACAD SCI, V1036, P267, DOI 10.1196/annals.1330.017; Viding E, 2004, J CHILD PSYCHOL PSYC, V45, P1329, DOI 10.1111/j.1469-7610.2004.00323.x; Wahlund K, 2009, INT J LAW PSYCHIAT, V32, P266, DOI 10.1016/j.ijlp.2009.04.007; Ward T, 2006, AGGRESS VIOLENT BEH, V11, P44, DOI 10.1016/j.avb.2005.05.002; Wasserman D, 2004, J LAW MED ETHICS, V32, P24, DOI 10.1111/j.1748-720X.2004.tb00445.x; Wilson LC, 2012, J CONTEMP CRIM JUST, V28, P366, DOI 10.1177/1043986212450232; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012	124	11	11	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110672	10.1371/journal.pone.0110672	http://dx.doi.org/10.1371/journal.pone.0110672			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25330208	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100081
J	Wang, L; Chen, YJ; Xu, K; Xu, H; Shen, XZ; Tu, RQ				Wang, Lin; Chen, Yan-Jie; Xu, Kai; Xu, Hua; Shen, Xi-Zhong; Tu, Rui-Qin			Circulating microRNAs as a Fingerprint for Endometrial Endometrioid Adenocarcinoma	PLOS ONE			English	Article							ONCOGENIC MICRORNA-27A; CANCER; BIOMARKERS; COMMUNICATION; INVASION; PROMOTES; TARGET; GENES	Background: Endometrial cancer is the most common malignancy of the female genital tract worldwide, and endometrial endometrioid adenocarcinoma (EEC) is the major histological type of endometrial cancer. There is a great need for better markers with high sensitivity and specificity to permit early diagnosis and proper management of EEC. The aim of our study is to identify a miRNA classifier within plasma as a noninvasive biomarker for EEC diagnosis. Methods: This study was a retrospective case-control analysis which contained two independent cohorts including 93 participants. First, we screened 375 miRNAs in 29 plasma samples. 9 of the miRNAs were selected to be evaluated their expression by quantitative reverse-transcriptase polymerase chain reaction. A stepwise logistic regression model was then used to establish a new classifier in the validation cohort. Area under the receiver operating characteristic curve was used to evaluate the diagnostic accuracy. Co-expression analysis was used to verify the independence of results. Results: miR-15b, -27a, and -223 were found to be differentially expressed in the EEC plasma between the two cohorts and had few connections with other miRNAs. The areas under the curve (AUC) were 0.768, 0.813, and 0.768 for miR-15b, -27a, and 223, respectively. miR-27a and CA125 can be combined as a potential non-invasive biomarker for detecting EEC, with the AUC of 0.894. Conclusion: Our study demonstrated three miRNAs, including miR-15b, -27a, and -233 have a good clinical value in EEC diagnosis. The classifier, including miR-27a and CA125, demonstrated a high accuracy in the diagnosis of EEC and might serve as a novel non-invasive biomarker in the future.	[Wang, Lin; Xu, Kai; Xu, Hua; Tu, Rui-Qin] Fudan Univ, Shanghai Zhongshan Hosp, Dept Obstet & Gynecol, Shanghai 200433, Peoples R China; [Chen, Yan-Jie; Shen, Xi-Zhong] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Shen, XZ (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	shen.xizhong@zs-hospital.sh.cn; tu.ruiqin@zh-hospital.sh.cn	Chen, Yan-Jie/GXM-9980-2022		Youth Foundation of Zhongshan Hospital [ZSQN2012-36]	Youth Foundation of Zhongshan Hospital	The study was funded by the Youth Foundation of Zhongshan Hospital (ZSQN2012-36). No additional funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizos I, 2010, NAT REV RHEUMATOL, V6, P391, DOI 10.1038/nrrheum.2010.81; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baker SG, 2009, JNCI-J NATL CANCER I, V101, P1116, DOI 10.1093/jnci/djp186; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066577; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Devaux Y, 2012, CLIN CHEM, V58, P559, DOI 10.1373/clinchem.2011.173823; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; HE L, 2004, NAT REV GENET, V5, P522; Huang BS, 2013, ONCOL REP, V30, P2263, DOI 10.3892/or.2013.2683; Ichikawa D, 2012, GASTROENTEROLOGY, V142, P1074, DOI 10.1053/j.gastro.2012.03.008; Jia WH, 2013, ONCOL LETT, V6, P261, DOI 10.3892/ol.2013.1338; Kim S, 2013, BMB REPORTS; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Kurashige J, 2012, BRIT J CANCER, V106, P182, DOI 10.1038/bjc.2011.509; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Li JH, 2012, J CANCER RES CLIN, V138, P763, DOI 10.1007/s00432-012-1154-x; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Liu XP, 2012, J AM MED INFORM ASSN, V19, P241, DOI 10.1136/amiajnl-2011-000658; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pan WB, 2014, CELL PHYSIOL BIOCHEM, V33, P402, DOI 10.1159/000356679; Vimalraj S, 2014, J CELLULAR PHYSL; Xu LL, 2013, ANTI-CANCER AGENT ME, V13, P1126, DOI 10.2174/18715206113139990006; Xu Y, 2014, BBA-MOL BASIS DIS, V1842, P712, DOI 10.1016/j.bbadis.2014.01.007; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang Y, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/862908; Zhao Z, 2012, CLIN CHEM, V58, P896, DOI 10.1373/clinchem.2011.179283	33	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110767	10.1371/journal.pone.0110767	http://dx.doi.org/10.1371/journal.pone.0110767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329674	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100094
J	Demic, S; Cheng, S				Demic, Selver; Cheng, Sen			Modeling the Dynamics of Disease States in Depression	PLOS ONE			English	Article							ADVERSE CHILDHOOD EXPERIENCES; ANTIDEPRESSANT DRUG-TREATMENT; MAJOR DEPRESSION; FOLLOW-UP; HIPPOCAMPAL NEUROGENESIS; REUPTAKE INHIBITOR; COGNITIVE THERAPY; PLACEBO-RESPONSE; CONTROLLED-TRIAL; GLOBAL BURDEN	Major depressive disorder (MDD) is a common and costly disorder associated with considerable morbidity, disability, and risk for suicide. The disorder is clinically and etiologically heterogeneous. Despite intense research efforts, the response rates of antidepressant treatments are relatively low and the etiology and progression of MDD remain poorly understood. Here we use computational modeling to advance our understanding of MDD. First, we propose a systematic and comprehensive definition of disease states, which is based on a type of mathematical model called a finite-state machine. Second, we propose a dynamical systems model for the progression, or dynamics, of MDD. The model is abstract and combines several major factors (mechanisms) that influence the dynamics of MDD. We study under what conditions the model can account for the occurrence and recurrence of depressive episodes and how we can model the effects of antidepressant treatments and cognitive behavioral therapy within the same dynamical systems model through changing a small subset of parameters. Our computational modeling suggests several predictions about MDD. Patients who suffer from depression can be divided into two sub-populations: a high-risk sub-population that has a high risk of developing chronic depression and a low-risk sub-population, in which patients develop depression stochastically with low probability. The success of antidepressant treatment is stochastic, leading to widely different times-to-remission in otherwise identical patients. While the specific details of our model might be subjected to criticism and revisions, our approach shows the potential power of computationally modeling depression and the need for different type of quantitative data for understanding depression.	[Demic, Selver; Cheng, Sen] Int Grad Sch Neurosci, Bochum, Germany; [Demic, Selver; Cheng, Sen] Mercator Res Grp Struct Memory, Bochum, Germany; [Demic, Selver; Cheng, Sen] Ruhr Univ Bochum, Fac Psychol, Bochum, Germany	Ruhr University Bochum	Cheng, S (corresponding author), Int Grad Sch Neurosci, Bochum, Germany.	sen.cheng@rub.de	Cheng, Sen/A-5722-2009	Cheng, Sen/0000-0002-6719-8029	Stiftung Mercator; International Graduate School of Neuroscience	Stiftung Mercator; International Graduate School of Neuroscience	S.C. was supported by a grant from the Stiftung Mercator. S.D. was supported by the International Graduate School of Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; ANDERSON IM, 1994, J PSYCHOPHARMACOL, V8, P238, DOI 10.1177/026988119400800407; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Angst F, 2002, J AFFECT DISORDERS, V68, P167, DOI 10.1016/S0165-0327(01)00377-9; Angst J, 1995, Schweiz Arch Neurol Psychiatr (1985), V146, P5; [Anonymous], 1985, Am J Psychiatry, V142, P469; BECK A T, 1976, P356; Beck J, 2020, COGNITIVE BEHAV THER, V3rd; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bernet C Z, 1999, Depress Anxiety, V9, P169, DOI 10.1002/(SICI)1520-6394(1999)9:4<169::AID-DA4>3.3.CO;2-U; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Cheng S, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00088; de Macedo-Soares MB, 2005, J ECT, V21, P31; DeRubeis RJ, 1998, J CONSULT CLIN PSYCH, V66, P37, DOI 10.1037/0022-006X.66.1.37; Drevets WC, 2002, EUR NEUROPSYCHOPHARM, V12, P527, DOI 10.1016/S0924-977X(02)00102-5; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Eaton WW, 2008, ARCH GEN PSYCHIAT, V65, P513, DOI 10.1001/archpsyc.65.5.513; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Ellis HC, 1997, J EXP PSYCHOL GEN, V126, P131, DOI 10.1037/0096-3445.126.2.131; Fava M, 2000, J CLIN PSYCHIAT, V61, P26; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.02.033, 10.1016/j.neuron.2014.01.027]; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Furukawa TA, 2000, BRIT J PSYCHIAT, V177, P331, DOI 10.1192/bjp.177.4.331; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Gladstone GL, 2004, AM J PSYCHIAT, V161, P1417, DOI 10.1176/appi.ajp.161.8.1417; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Hamilton JP, 2008, BIOL PSYCHIAT, V63, P1155, DOI 10.1016/j.biopsych.2007.12.015; Hardeveld F, 2010, ACTA PSYCHIAT SCAND, V122, P184, DOI 10.1111/j.1600-0447.2009.01519.x; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hasler G, 2010, WORLD PSYCHIATRY, V9, P155; Hayden EP, 2001, AM J PSYCHIAT, V158, P1864, DOI 10.1176/appi.ajp.158.11.1864; HOLLON SD, 1992, ARCH GEN PSYCHIAT, V49, P774; Hollon SD, 2002, PSYCHOL SCI, P39, DOI 10.1111/1529-1006.00008; Hornung OP, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00014; Jarrett RB, 1999, ARCH GEN PSYCHIAT, V56, P431, DOI 10.1001/archpsyc.56.5.431; Kaplan MJ, 2000, J NERV MENT DIS, V188, P596, DOI 10.1097/00005053-200009000-00006; KELLER MB, 1982, ARCH GEN PSYCHIAT, V39, P905; KELLER MB, 1986, AM J PSYCHIAT, V143, P24; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Kennedy Sidney H, 2008, Dialogues Clin Neurosci, V10, P271; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kirsch I., 1998, PREVENTION TREATMENT, V1, DOI 10.1037/1522-3736.1.1.12a; Lopez-Munoz F, 2009, CURR PHARM DESIGN, V15, P1563, DOI 10.2174/138161209788168001; Luty SE, 2007, BRIT J PSYCHIAT, V190, P496, DOI 10.1192/bjp.bp.106.024729; Machado-Vieira R, 2008, J CLIN PSYCHIAT, V69, P946, DOI 10.4088/JCP.v69n0610; Martinsen EW, 2008, NORD J PSYCHIAT, V62, P25, DOI 10.1080/08039480802315640; Moller HJ, 1996, PHARMACOPSYCHIATRY, V29, P57, DOI 10.1055/s-2007-979545; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Moore MT, 2012, CLIN PSYCHOL REV, V32, P496, DOI 10.1016/j.cpr.2012.05.004; Morilak DA, 2004, INT J NEUROPSYCHOPH, V7, P193, DOI 10.1017/S1461145704004080; Mueller TI, 1999, AM J PSYCHIAT, V156, P1000; Mueller TI, 1996, ARCH GEN PSYCHIAT, V53, P794; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Nelson JC, 1998, J CLIN PSYCHIAT, V59, P35; Nemeroff CB, 2003, P NATL ACAD SCI USA, V100, P14293, DOI 10.1073/pnas.2336126100; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Perry R, 2009, CLIN THER, V31, P1374, DOI 10.1016/j.clinthera.2009.07.012; QUITKIN FM, 1993, AM J PSYCHIAT, V150, P566; Ramel W, 2007, BIOL PSYCHIAT, V61, P231, DOI 10.1016/j.biopsych.2006.05.004; Ruhe HG, 2006, J CLIN PSYCHIAT, V67, P1836, DOI 10.4088/JCP.v67n1203; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SEGMAN RH, 1995, PSYCHOPHARMACOLOGY, V119, P440, DOI 10.1007/BF02245860; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Solomon DA, 1997, ARCH GEN PSYCHIAT, V54, P1001; Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208; Stassen H H, 1993, Eur Neuropsychopharmacol, V3, P127, DOI 10.1016/0924-977X(93)90264-M; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Thase ME, 1999, J CLIN PSYCHIAT, V60, P23; Thompson C, 2002, HUM PSYCHOPHARM CLIN, V17, pS27, DOI 10.1002/hup.386; Torpey Dana C, 2008, Curr Psychiatry Rep, V10, P458; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Widiger TA, 2005, J ABNORM PSYCHOL, V114, P494, DOI 10.1037/0021-843X.114.4.494; Zlotnick C, 2001, CHILD ABUSE NEGLECT, V25, P357, DOI 10.1016/S0145-2134(00)00251-9; ZLOTNICK C, 1995, CHILD ABUSE NEGLECT, V19, P1513, DOI 10.1016/0145-2134(95)00098-6	85	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110358	10.1371/journal.pone.0110358	http://dx.doi.org/10.1371/journal.pone.0110358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TF	25330102	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100068
J	Santos, M; Azevedo, T; Martins, T; Rodrigues, FJ; Lemos, MC				Santos, Marina; Azevedo, Teresa; Martins, Teresa; Rodrigues, Fernando J.; Lemos, Manuel C.			Association of RET Genetic Polymorphisms and Haplotypes with Papillary Thyroid Carcinoma in the Portuguese Population: A Case-Control Study	PLOS ONE			English	Article							CANCER; PROTOONCOGENE; SUSCEPTIBILITY; DNA; METAANALYSIS; VARIANTS; DISEASE; G691S; RISK	Thyroid cancer has a multifactorial aetiology resulting from the interaction of genetic and environmental factors. Several low penetrance susceptibility genes have been identified but their effects often vary between different populations. Somatic point mutations and translocations of the REarranged during Transfection (RET) proto-oncogene are frequently found in thyroid cancer. The aim of this case-control study was to determine the effect of four well known RET single nucleotide polymorphisms (SNPs) on the risk for differentiated thyroid carcinoma. A total of 545 Portuguese patients and 543 controls were genotyped by PCR and restriction enzyme analysis, for the following SNPs: G691S (exon 11, rs1799939 G/A), L769L (exon 13, rs1800861 T/G), S836S (exon 14, rs1800862 C/T), and S904S (exon 15, rs1800863 C/G). The minor allele of S836S was overrepresented in patients with papillary thyroid carcinoma (PTC) when compared to controls (OR 1.57; 95% CI 1.05-2.35; p = 0.026). The GGTC haplotype was also overrepresented in PTC (OR 2.51; 95% CI 1.07-5.91; p = 0.029). No associations were found in follicular thyroid carcinoma (FTC). Multivariate logistic regression analysis showed no differences regarding gender, age at diagnosis, lymph node or distant metastasis. However, a near significant overrepresentation of the minor alleles of G691S and S904S was found in patients with tumours greater than 10 mm of diameter at diagnosis. These data suggest that the RET S836S polymorphism in exon 14 and the GGTC haplotype are risk factors for PTC, but not FTC, and that the G691S/S904S polymorphisms might be associated with tumour behaviour.	[Santos, Marina; Lemos, Manuel C.] Univ Beira Interior, Fac Hlth Sci, Hlth Sci Res Ctr, CICS, Covilha, Portugal; [Azevedo, Teresa; Martins, Teresa; Rodrigues, Fernando J.] Portuguese Inst Oncol, Serv Endocrinol, Coimbra, Portugal	Universidade da Beira Interior; Universidade de Coimbra	Lemos, MC (corresponding author), Univ Beira Interior, Fac Hlth Sci, Hlth Sci Res Ctr, CICS, Covilha, Portugal.	mclemos@fcsaude.ubi.pt	Pinheiro, Maísa/E-7424-2012; Lemos, Manuel/D-9861-2013	Lemos, Manuel/0000-0001-9326-8900; Rodrigues, Fernando/0000-0002-4913-3889; Azevedo, Teresa/0000-0003-1791-0492	Portuguese Society for Endocrinology, Diabetes Metabolism	Portuguese Society for Endocrinology, Diabetes Metabolism	This work was supported by the Portuguese Society for Endocrinology, Diabetes & Metabolism "Bolsa Prof. E. Limbert SPEDM/Genzyme em Patologia da Tiroide - 2012". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjadj E, 2009, LANCET ONCOL, V10, P181, DOI 10.1016/S1470-2045(09)70020-8; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Ceolin L, 2012, EUR J ENDOCRINOL, V166, P847, DOI 10.1530/EJE-11-1060; Dang VP, 2014, MOL CELL ENDOCRINOL, V386, P55, DOI 10.1016/j.mce.2013.07.030; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Figlioli G, 2013, MUTAT RES-REV MUTAT, V752, P36, DOI 10.1016/j.mrrev.2012.09.002; Griebeler ML, 2013, ENDOCR PRACT, V19, P703, DOI 10.4158/EP12430.RA; Griseri P, 2000, EUR J HUM GENET, V8, P721, DOI 10.1038/sj.ejhg.5200521; Ho T, 2005, LARYNGOSCOPE, V115, P1035, DOI 10.1097/01.MLG.0000162653.22384.10; Jindrichova S, 2004, J ENDOCRINOL, V183, P257, DOI 10.1677/joe.1.05838; Landa I, 2011, J MOL ENDOCRINOL, V47, pR43, DOI 10.1530/JME-11-0005; Lantieri F, 2013, INT J CANCER, V132, P2808, DOI 10.1002/ijc.27967; Lesueur F, 2002, J MED GENET, V39, P260, DOI 10.1136/jmg.39.4.260; Lonn S, 2007, CANCER EPIDEM BIOMAR, V16, P174, DOI 10.1158/1055-9965.EPI-06-0665; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; Pacini F, 2012, BEST PRACT RES CL EN, V26, P421, DOI 10.1016/j.beem.2012.07.001; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Sawai H, 2005, CANCER RES, V65, P11536, DOI 10.1158/0008-5472.CAN-05-2843; Shaw AT, 2013, NAT REV CANCER, V13, P772, DOI 10.1038/nrc3612; Sigurdson AJ, 2009, RADIAT RES, V171, P77, DOI 10.1667/RR1327.1; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Wells SA, 2013, J CLIN ENDOCR METAB, V98, P3149, DOI 10.1210/jc.2013-1204	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109822	10.1371/journal.pone.0109822	http://dx.doi.org/10.1371/journal.pone.0109822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330015	gold, Green Published			2022-12-27	WOS:000345204100031
J	Arasaradnam, RP; Westenbrink, E; McFarlane, MJ; Harbord, R; Chambers, S; O'Connell, N; Bailey, C; Nwokolo, CU; Bardhan, KD; Savage, R; Covington, JA				Arasaradnam, Ramesh P.; Westenbrink, Eric; McFarlane, Michael J.; Harbord, Ruth; Chambers, Samantha; O'Connell, Nicola; Bailey, Catherine; Nwokolo, Chuka U.; Bardhan, Karna D.; Savage, Richard; Covington, James A.			Differentiating Coeliac Disease from Irritable Bowel Syndrome by Urinary Volatile Organic Compound Analysis - A Pilot Study	PLOS ONE			English	Article							ELECTRONIC E-NOSE; DIAGNOSTIC-ACCURACY; IGA DEFICIENCY; FERMENTONOMICS; ANTIBODIES; CHILDREN; INSIGHTS	Coeliac disease (CD), a T-cell-mediated gluten sensitive enteropathy, affects similar to 1% of the UK population and can present with wide ranging clinical features, often being mistaken for Irritable Bowel Syndrome (IBS). Heightened clinical awareness and serological screening identifies those with potential coeliac disease; the diagnosis is confirmed with duodenal biopsies, and symptom improvement with a gluten-free diet. Limitations to diagnosis are false negative serology and reluctance to undergo biopsy. The gut microbiome is altered in several gastrointestinal disorders, causing altered gut fermentation patterns recognisable by volatile organic compounds (VOC) analysis in urine, breath and faeces. We aimed to determine if CD alters the urinary VOC pattern, distinguishing it from IBS. 47 patients were recruited, 27 with established CD, on gluten free diets, and 20 with diarrhoea-predominant IBS (D-IBS). Collected urine was stored frozen in 10 ml aliquots. For assay, the specimens were heated to 40 +/- 0.1 degrees C and the headspace analysed by Field Asymmetric Ion Mobility Spectrometry (FAIMS). Machine learning algorithms were used for statistical evaluation. Samples were also analysed using Gas chromatography and mass spectroscopy (GC-MS). Sparse logistic regression showed that FAIMS distinguishes VOCs in CD vs D-IBS with ROC curve AUC of 0.91 (0.83-0.99), sensitivity and specificity of 85% respectively. GCMS showed a unique peak at 4'67 found only in CD, not D-IBS, which correlated with the compound 1,3,5,7 cyclooctatetraene. This study suggests that FAIMS offers a novel, non-invasive approach to identify those with possible CD, and distinguishes from D-IBS. It offers the potential for monitoring compliance with a gluten-free diet at home. The presence of cyclooctatetraene in CD specimens will need further validation.	[Arasaradnam, Ramesh P.] Univ Warwick, Clin Sci Res Inst, Coventry, Warwick, England; [Westenbrink, Eric; Covington, James A.] Univ Warwick, Sch Engn, Coventry, Warwick, England; [Arasaradnam, Ramesh P.; McFarlane, Michael J.; Chambers, Samantha; O'Connell, Nicola; Bailey, Catherine; Nwokolo, Chuka U.] Univ Hosp Coventry & Warwickshire, Dept Gastroenterol, Coventry, Warwick, England; [Harbord, Ruth] Univ Warwick, MOAC Doctoral Training Ctr, Coventry, Warwick, England; [Savage, Richard] Univ Warwick, Dept Bioinformat, Coventry, Warwick, England; [Bardhan, Karna D.] Rotherham Gen Hosp, Rotherham, Yorkshire, England	University of Warwick; University of Warwick; University of Warwick; University of Warwick; University of Warwick	Arasaradnam, RP (corresponding author), Univ Warwick, Clin Sci Res Inst, Coventry, Warwick, England.	r.arasaradnam@warwick.ac.uk	Covington, James A./Q-1934-2018	Covington, James A./0000-0003-1307-6488; Arasaradnam, Ramesh/0000-0002-2231-3062	BRET charity; Engineering and Physical Sciences Research Council [1228777] Funding Source: researchfish; Medical Research Council [G0902104] Funding Source: researchfish; MRC [G0902104] Funding Source: UKRI	BRET charity; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	BRET charity - support funding for materials and equipment costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann A, 2013, VOLATILE ORGANIC COM, P411; Arasaradnam RP, 2014, ALIMENT PHARM THER, V39, P780, DOI 10.1111/apt.12657; Arasaradnam R. P., 2012, Journal of Medical Engineering & Technology, V36, P333, DOI 10.3109/03091902.2012.690015; Arasaradnam R. P., 2011, Journal of Medical Engineering & Technology, V35, P87, DOI 10.3109/03091902.2010.539770; Arasaradnam RP, 2009, MED HYPOTHESES, V73, P753, DOI 10.1016/j.mehy.2009.04.027; Arasaradnam RP, 2013, INFLAMM BOWEL DIS, V19, P999, DOI 10.1097/MIB.0b013e3182802b26; Arasaradnam RP, 2010, BIOACTIVE FOODS EXTR; Benkebil F, 2013, WORLD J GASTROENTERO, V19, P5111, DOI 10.3748/wjg.v19.i31.5111; Buszewski B, 2007, BIOMED CHROMATOGR, V21, P553, DOI 10.1002/bmc.835; Caminero A, 2014, FEMS MICROBIOL ECOL, V88, P309, DOI 10.1111/1574-6941.12295; Chui Charles K., 1992, INTRO WAVELETS; Collado MC, 2009, J CLIN PATHOL, V62, P264, DOI 10.1136/jcp.2008.061366; Covington JA, 2013, SENSORS-BASEL, V13, P11899, DOI 10.3390/s130911899; Covington JA, 2012, SENSORS-BASEL, V12, P13002, DOI 10.3390/s121013002; Dahle C, 2010, ALIMENT PHARM THER, V32, P254, DOI 10.1111/j.1365-2036.2010.04337.x; de Meij TG, 2014, INT J CANCER, V134, P1132, DOI 10.1002/ijc.28446; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; Drossman DA, 2000, AM J GASTROENTEROL, V95, P999; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Harrison E, 2013, POSTGRAD MED J, V89, P4, DOI 10.1136/postgradmedj-2011-130188; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/b94608, DOI 10.1007/B94608]; Hopper AD, 2008, CLIN GASTROENTEROL H, V6, P314, DOI 10.1016/j.cgh.2007.12.008; McGowan KE, 2008, CLIN CHEM, V54, P1203, DOI 10.1373/clinchem.2008.103606; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; National Institute for Health and Clinical Excellence (NICE), 2009, COEL DIS REC ASS COE; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Probert CSJ, 2009, J GASTROINTEST LIVER, V18, P337; Reeves GEM, 2006, EUR J GASTROEN HEPAT, V18, P493, DOI 10.1097/00042737-200605000-00006; Stinson M, 2003, PLANT SCI, V165, P913, DOI 10.1016/S0168-9452(03)00299-1; Ting ASY, 2011, WORLD J MICROB BIOT, V27, P229, DOI 10.1007/s11274-010-0447-y; Vahedi K, 2003, AM J GASTROENTEROL, V98, P1079, DOI [10.1016/S0002-9270(02)06006-9, 10.1111/j.1572-0241.2003.07284.x]	32	54	56	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e107312	10.1371/journal.pone.0107312	http://dx.doi.org/10.1371/journal.pone.0107312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330367	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800003
J	Bekwelem, W; Misialek, JR; Konety, S; Solomon, SD; Soliman, EZ; Loehr, LR; Lopez, FL; Fox, ER; Mosley, TH; Alonso, A				Bekwelem, Wobo; Misialek, Jeffrey R.; Konety, Suma; Solomon, Scott D.; Soliman, Elsayed Z.; Loehr, Laura R.; Lopez, Faye L.; Fox, Ervin R.; Mosley, Thomas H.; Alonso, Alvaro			Echocardiographic Measures of Cardiac Structure and Function Are Associated with Risk of Atrial Fibrillation in Blacks: The Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; AFRICAN-AMERICANS; DIASTOLIC DYSFUNCTION; PREVALENCE; ADULTS; MANAGEMENT; MARKER; WHITES; COHORT; MASS	Background: Several studies have examined the link between atrial fibrillation (AF) and various echocardiographic measures of cardiac structure and function in whites and other racial groups but not in blacks. Exploring AF risk factors in blacks is important given that the lower incidence of AF in this racial group despite higher risk factors, is not completely explained. Methods: We examined the association of echocardiographic measures with AF incidence in 2283 blacks (64.5% women, mean age 58.8 years) free of diagnosed AF and enrolled in the Jackson cohort of Atherosclerosis Risk in Communities (ARIC) study, a prospective study of cardiovascular disease. Echocardiography was performed in 1993-1995, and incident AF was determined by electrocardiograms at a follow-up study exam, hospitalization discharge codes and death certificates through the end of 2009. Cox proportional hazards regression was used to estimate hazard ratios and 95% confidence intervals for AF associated with the echocardiographic measures, adjusting for age, sex, and known AF risk factors. Results: During an average follow-up of 13.5 years, 191 (8.4%) individuals developed AF. Left ventricular (LV) internal diameter 2-D (diastole) and percent fractional shortening of LV diameter displayed a U-shaped relationship with risk of AF, while left atrial diameter displayed a J-shaped nonlinear association. LV mass index was associated positively with AF. E/A ratio <0.7 or >1.5 and ejection fraction (EF <50%) were also associated with higher AF risk. These measures improved risk stratification for AF in addition to traditional risk factors, although not significantly {C-statistic of 0.767 (0.714-0.819) vs. 0.744 (0.691-0.797)}. Conclusions: In a community-based population of blacks, echocardiographic measures of cardiac structure and function are significantly associated with an increased risk of AF.	[Bekwelem, Wobo; Konety, Suma] Univ Minnesota, Div Cardiovasc, Minneapolis, MN 55455 USA; [Misialek, Jeffrey R.; Lopez, Faye L.; Alonso, Alvaro] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Solomon, Scott D.] Brigham & Womens Hosp, Dept Noninvas Cardiol, Boston, MA 02115 USA; [Soliman, Elsayed Z.] Wake Forest Univ, Sch Med, Epicare, Winston Salem, NC 27109 USA; [Loehr, Laura R.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Fox, Ervin R.] Univ Mississippi, Div Cardiol, Jackson, MS 39216 USA; [Mosley, Thomas H.] Univ Mississippi, Div Geriatr, Jackson, MS 39216 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; University of Mississippi; University of Mississippi	Bekwelem, W (corresponding author), Univ Minnesota, Div Cardiovasc, Minneapolis, MN 55455 USA.	bekwe001@umn.edu	Soliman, Elsayed Z/AAD-7135-2020; Norby, Faye/S-3729-2017; Alonso, Alvaro/A-4917-2010	Soliman, Elsayed Z/0000-0001-5632-8150; Norby, Faye/0000-0002-1975-0405; Misialek, Jeffrey/0000-0003-4583-786X; Loehr, Laura/0000-0002-9054-1825; Alonso, Alvaro/0000-0002-2225-8323	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, RC1-HL099452]; American Heart Association [09SDG2280087]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099452] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). This study was also supported by grants 09SDG2280087 from the American Heart Association and RC1-HL099452 from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Alonso A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000102; Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; CASALE PN, 1987, CIRCULATION, V75, P565, DOI 10.1161/01.CIR.75.3.565; Chamberlain AM, 2010, AM HEART J, V159, P850, DOI 10.1016/j.ahj.2010.02.005; Chang SL, 2007, J CARDIOVASC ELECTR, V18, P1134, DOI 10.1111/j.1540-8167.2007.00941.x; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; DESIMONE G, 1994, J AM COLL CARDIOL, V23, P1444, DOI 10.1016/0735-1097(94)90390-5; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Fox ER, 2006, AM HEART J, V152, P749, DOI 10.1016/j.ahj.2006.04.014; Gardin JM, 1998, AM J CARDIOL, V82, P345, DOI 10.1016/S0002-9149(98)00339-7; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goette A, 1996, CIRCULATION, V94, P2968, DOI 10.1161/01.CIR.94.11.2968; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Jons C, 2010, EUR J ECHOCARDIOGR, V11, P602, DOI 10.1093/ejechocard/jeq024; Kannel WB, 1998, AM J CARDIOL; Lindsay Bruce D., 1996, Cardiology Clinics, V14, P483; MACRUZ R, 1958, CIRCULATION, V17, P882, DOI 10.1161/01.CIR.17.5.882; Majeed A, 2001, HEART, V86, P284, DOI 10.1136/heart.86.3.284; Manolio TA, 2002, AM J CARDIOL, V90, P983, DOI 10.1016/S0002-9149(02)02665-6; Marcus GM, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.05.019; Marcus GM, 2010, CIRCULATION, V122, P2009, DOI 10.1161/CIRCULATIONAHA.110.958306; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Psaty BM, 1997, CIRCULATION, V96, P2455; Rosenberg MA, 2012, EUR HEART J, V33, P904, DOI 10.1093/eurheartj/ehr378; Sharp A, 2008, J AM COLL CARDIOL, V52, P1015, DOI 10.1016/j.jacc.2008.04.065; Skelton TN, 2003, ECHOCARDIOGR-J CARD, V20, P111, DOI 10.1046/j.1540-8175.2003.03000.x; Tsang TSM, 2001, MAYO CLIN PROC, V76, P467, DOI 10.4065/76.5.467; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wyse DG, 2004, CIRCULATION, V109, P3089, DOI 10.1161/01.CIR.0000132611.01101.DC	38	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110111	10.1371/journal.pone.0110111	http://dx.doi.org/10.1371/journal.pone.0110111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330035	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800057
J	Tosic, V; Thomas, DL; Kranz, DM; Liu, J; McFadden, G; Shisler, JL; MacNeill, AL; Roy, EJ				Tosic, Vesna; Thomas, Diana L.; Kranz, David M.; Liu, Jia; McFadden, Grant; Shisler, Joanna L.; MacNeill, Amy L.; Roy, Edward J.			Myxoma Virus Expressing a Fusion Protein of Interleukin-15 (IL15) and IL15 Receptor Alpha Has Enhanced Antitumor Activity	PLOS ONE			English	Article							IMMUNOCOMPETENT ANIMAL-MODELS; CANCER-CELLS; TUMOR-GROWTH; GM-CSF; IL-15; SUPERAGONIST; EFFICACY; IL-15R-ALPHA; VIROTHERAPY; BINDING	Myxoma virus, a rabbit poxvirus, can efficiently infect various types of mouse and human cancer cells. It is a strict rabbit-specific pathogen, and is thought to be safe as a therapeutic agent in all non-rabbit hosts tested including mice and humans. Interleukin-15 (IL15) is an immuno-modulatory cytokine with significant potential for stimulating anti-tumor T lymphocytes and NK cells. Co-expression of IL15 with the alpha subunit of IL15 receptor (IL15R alpha) greatly enhances IL15 stability and bioavailability. Therefore, we engineered a new recombinant myxoma virus (vMyx-IL15R alpha-tdTr), which expresses an IL15R alpha-IL15 fusion protein plus tdTomato red fluorescent reporter protein. Permissive rabbit kidney epithelial (RK-13) cells infected with vMyx-IL15R alpha-tdTr expressed and secreted the IL15R alpha-IL15 fusion protein. Functional activity was confirmed by demonstrating that the secreted fusion protein stimulated proliferation of cytokine-dependent CTLL-2 cells. Multi-step growth curves showed that murine melanoma (B16-F10 and B16.SIY) cell lines were permissive to vMyx-IL15R alpha-tdTr infection. In vivo experiments in RAG1(-/-) mice showed that subcutaneous B16-F10 tumors treated with vMyx-IL15R alpha-tdTr exhibited attenuated tumor growth and a significant survival benefit for the treated group compared to the PBS control and the control viruses (vMyx-IL15-tdTr and vMyx-tdTr). Immunohistological analysis of the subcutaneous tumors showed dramatically increased infiltration of NK cells in vMyx-IL15R alpha-tdTr treated tumors compared to the controls. In vivo experiments with immunocompetent C57BL/6 mice revealed a strong infiltrate of both NK cells and CD8(+) T cells in response to vMyx-IL15R alpha-tdTr, and prolonged survival. We conclude that delivery of IL15R alpha-IL15 in a myxoma virus vector stimulates both innate and adaptive components of the immune system.	[Tosic, Vesna; Roy, Edward J.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Thomas, Diana L.] Univ Illinois, Neurosci Program, Urbana, IL USA; [Kranz, David M.] Univ Illinois, Dept Biochem, Urbana, IL USA; [Liu, Jia; McFadden, Grant] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Shisler, Joanna L.] Univ Illinois, Dept Microbiol, Urbana, IL USA; [MacNeill, Amy L.] Univ Illinois, Dept Pathobiol, Coll Vet Med, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; State University System of Florida; University of Florida; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Roy, EJ (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	eroy@illinois.edu	MacNeill, Amy L./D-6066-2017	MacNeill, Amy L./0000-0002-1690-3787; Shisler, Joanna/0000-0003-4833-1557; Liu, Jia/0000-0001-8424-7972; McFadden, Grant/0000-0002-2556-3526	NIAID NIH HHS [K22 AI099184, R01 AI100987] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100987, K22AI099184] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barrett JW, 2007, J NEUROVIROL, V13, P549, DOI 10.1080/13550280701591526; Bartee E, 2012, BIOL BLOOD MARROW TR, V18, P1540, DOI 10.1016/j.bbmt.2012.04.004; Bessard A, 2009, MOL CANCER THER, V8, P2736, DOI 10.1158/1535-7163.MCT-09-0275; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Bouchaud G, 2008, J MOL BIOL, V382, P1, DOI 10.1016/j.jmb.2008.07.019; Castillo EF, 2012, CYTOKINE, V59, P479, DOI 10.1016/j.cyto.2012.06.017; Cawood R, 2012, TRENDS MOL MED, V18, P564, DOI 10.1016/j.molmed.2012.07.007; Chan WNM, 2013, VACCINE, V31, P4252, DOI 10.1016/j.vaccine.2013.05.056; Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; Doty RA, 2013, ONCOLYTIC VIROTHER, V2, P1, DOI 10.2147/OV.S37971; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Elpek KG, 2010, P NATL ACAD SCI USA, V107, P21647, DOI 10.1073/pnas.1012128107; Epardaud M, 2008, CANCER RES, V68, P2972, DOI 10.1158/0008-5472.CAN-08-0045; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Jakobisiak M, 2011, CYTOKINE GROWTH F R, V22, P99, DOI 10.1016/j.cytogfr.2011.04.001; Kaspar M, 2007, CANCER RES, V67, P4940, DOI 10.1158/0008-5472.CAN-07-0283; Kermer V, 2012, MOL CANCER THER, V11, P1279, DOI 10.1158/1535-7163.MCT-12-0019; Liu J, 2009, J VIROL, V83, P5933, DOI 10.1128/JVI.00204-09; Liu RB, 2012, CANCER RES, V72, P1964, DOI 10.1158/0008-5472.CAN-11-3208; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Lun XQ, 2007, CANCER RES, V67, P8818, DOI 10.1158/0008-5472.CAN-07-1214; Lun XQ, 2010, MOL THER, V18, P1927, DOI 10.1038/mt.2010.183; Lun XQ, 2010, CANCER RES, V70, P598, DOI 10.1158/0008-5472.CAN-09-1510; Marcais A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00450; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parmiani G, 2007, ANN ONCOL, V18, P226, DOI 10.1093/annonc/mdl158; Rahman MM, 2010, CYTOKINE GROWTH F R, V21, P169, DOI 10.1016/j.cytogfr.2010.02.010; Rowley J, 2008, J IMMUNOL, V181, P8237, DOI 10.4049/jimmunol.181.12.8237; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Senzer NN, 2009, J CLIN ONCOL, V27, P5763, DOI 10.1200/JCO.2009.24.3675; Spiotto MT, 2002, IMMUNITY, V17, P737, DOI 10.1016/S1074-7613(02)00480-6; Stanford MM, 2008, MOL THER, V16, P52, DOI 10.1038/sj.mt.6300348; Steel JC, 2012, TRENDS PHARMACOL SCI, V33, P35, DOI 10.1016/j.tips.2011.09.004; Stephenson KB, 2012, CANCER GENE THER, V19, P238, DOI 10.1038/cgt.2011.81; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Stone JD, 2012, BIOTECHNOL PROGR, V28, P1588, DOI 10.1002/btpr.1631; Sypula J., 2004, GENE THER MOL BIOL, V8, P103; Thomas DL, 2011, CANCER IMMUNOL IMMUN, V60, P1461, DOI 10.1007/s00262-011-1045-z; van der Loos CM, 2001, J HISTOCHEM CYTOCHEM, V49, P699, DOI 10.1177/002215540104900604; Wang G, 2006, P NATL ACAD SCI USA, V103, P4640, DOI 10.1073/pnas.0509341103; Wennier ST, 2012, MOL THER, V20, P759, DOI 10.1038/mt.2011.293; Wu Y, 2008, CLIN CANCER RES, V14, P1218, DOI 10.1158/1078-0432.CCR-07-1330; Xu WX, 2013, CANCER RES, V73, P3075, DOI 10.1158/0008-5472.CAN-12-2357; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056	45	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109801	10.1371/journal.pone.0109801	http://dx.doi.org/10.1371/journal.pone.0109801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329832	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800041
J	Zhao, XS; Fu, WY; Chien, WWY; Li, Z; Fu, AKY; Ip, NY				Zhao, Xiao-Su; Fu, Wing-Yu; Chien, Winnie W. Y.; Li, Zhen; Fu, Amy K. Y.; Ip, Nancy Y.			p35 Regulates the CRM1-Dependent Nucleocytoplasmic Shuttling of Nuclear Hormone Receptor Coregulator-Interacting Factor 1 (NIF-1)	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; NEURONAL CDK5 ACTIVATOR; NEURITE OUTGROWTH; EXPORT SIGNAL; CELL-CYCLE; TRANSCRIPTION; DIFFERENTIATION; CRM1; NEUROTOXICITY; TRANSLOCATION	Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/threonine kinase, which plays critical roles in a wide spectrum of neuronal functions including neuronal survival, neurite outgrowth, and synapse development and plasticity. Cdk5 activity is controlled by its specific activators: p35 or p39. While knockout studies reveal that Cdk5/p35 is critical for neuronal migration during early brain development, functions of Cdk5/p35 have been unraveled through the identification of the interacting proteins of p35, most of which are Cdk5/p35 substrates. However, it remains unclear whether p35 can regulate neuronal functions independent of Cdk5 activity. Here, we report that a nuclear protein, nuclear hormone receptor coregulator (NRC)-interacting factor 1 (NIF-1), is a new interacting partner of p35. Interestingly, p35 regulates the functions of NIF-1 independent of Cdk5 activity. NIF-1 was initially discovered as a transcriptional regulator that enhances the transcriptional activity of nuclear hormone receptors. Our results show that p35 interacts with NIF-1 and regulates its nucleocytoplasmic trafficking via the nuclear export pathway. Furthermore, we identified a nuclear export signal on p35; mutation of this site or blockade of the CRM1/exportin-dependent nuclear export pathway resulted in the nuclear accumulation of p35. Intriguingly, blocking the nuclear export of p35 attenuated the nuclear accumulation of NIF-1. These findings reveal a new p35-dependent mechanism in transcriptional regulation that involves the nucleocytoplasmic shuttling of transcription regulators.	[Zhao, Xiao-Su; Fu, Wing-Yu; Chien, Winnie W. Y.; Li, Zhen; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China; [Zhao, Xiao-Su; Fu, Wing-Yu; Chien, Winnie W. Y.; Li, Zhen; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Clear Water Bay, Hong Kong, Peoples R China; [Zhao, Xiao-Su; Fu, Wing-Yu; Chien, Winnie W. Y.; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Clear Water Bay, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China.	boip@ust.hk		Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Fu, Kit Yu/0000-0003-4085-6201	Research Grants Council of Hong Kong SAR [HKUST661109, 660810, 661111]; National Key Basic Research Program of China [2013CB530900]; Hong Kong Research Grants Council [T13-607/12R]; Innovation and Technology Fund for State Key Laboratory [ITCPT/17-9]	Research Grants Council of Hong Kong SAR(Hong Kong Research Grants Council); National Key Basic Research Program of China(National Basic Research Program of China); Hong Kong Research Grants Council(Hong Kong Research Grants Council); Innovation and Technology Fund for State Key Laboratory	This study was supported in part by the Research Grants Council of Hong Kong SAR (HKUST661109, 660810 and 661111), the National Key Basic Research Program of China (2013CB530900), the Hong Kong Research Grants Council Theme-based Research Scheme (T13-607/12R), and the Innovation and Technology Fund for State Key Laboratory (ITCPT/17-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Baek SH, 2004, BIOCHEM BIOPH RES CO, V319, P707, DOI 10.1016/j.bbrc.2004.04.169; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cheng K, 2002, J BIOL CHEM, V277, P31988, DOI 10.1074/jbc.M201161200; Cicero S, 2005, J NEUROSCI, V25, P9658, DOI 10.1523/JNEUROSCI.1773-05.2005; Corcoran J, 1999, NAT NEUROSCI, V2, P307, DOI 10.1038/7214; Delalle I, 1997, J NEUROCYTOL, V26, P283, DOI 10.1023/A:1018500617374; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fu AKY, 2004, P NATL ACAD SCI USA, V101, P6728, DOI 10.1073/pnas.0307606100; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Germain D, 2007, CLIN CANCER RES, V13, P5665, DOI 10.1158/1078-0432.CCR-06-2491; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Hamdane M, 2005, J CELL SCI, V118, P1291, DOI 10.1242/jcs.01724; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Li Z, 2004, J BIOL CHEM, V279, P54438, DOI 10.1074/jbc.M411002200; Mahajan MA, 2002, MOL CELL BIOL, V22, P6883, DOI 10.1128/MCB.22.19.6883-6894.2002; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Qu DB, 2002, J BIOL CHEM, V277, P7324, DOI 10.1074/jbc.M107270200; Simon-Areces J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055237; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Sugo N, 2010, EUR J NEUROSCI, V31, P1521, DOI 10.1111/j.1460-9568.2010.07218.x; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105; Zhang J, 2011, CELL CYCLE, V10, P1208, DOI 10.4161/cc.10.8.15328	35	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110584	10.1371/journal.pone.0110584	http://dx.doi.org/10.1371/journal.pone.0110584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329792	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800096
J	Das, F; Bera, A; Ghosh-Choudhury, N; Abboud, HE; Kasinath, BS; Choudhury, GG				Das, Falguni; Bera, Amit; Ghosh-Choudhury, Nandini; Abboud, Hanna E.; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh			TGF beta-Induced Deptor Suppression Recruits mTORC1 and Not mTORC2 to Enhance Collagen I (alpha 2) Gene Expression	PLOS ONE			English	Article							MESANGIAL CELL HYPERTROPHY; PLASMINOGEN-ACTIVATOR INHIBITOR-1; SMOOTH-MUSCLE-CELLS; DIABETIC-NEPHROPATHY; MAMMALIAN TARGET; HIGH GLUCOSE; CALCINEURIN INHIBITORS; MESENCHYMAL TRANSITION; RAPAMYCIN COMPLEXES; SIGNAL-TRANSDUCTION	Enhanced TGF beta activity contributes to the accumulation of matrix proteins including collagen I (alpha 2) by proximal tubular epithelial cells in progressive kidney disease. Although TGF beta rapidly activates its canonical Smad signaling pathway, it also recruits noncanonical pathway involving mTOR kinase to regulate renal matrix expansion. The mechanism by which chronic TGF beta treatment maintains increased mTOR activity to induce the matrix protein collagen I (alpha 2) expression is not known. Deptor is an mTOR interacting protein that suppresses mTOR activity in both mTORC1 and mTORC2. In proximal tubular epithelial cells, TGF beta reduced deptor levels in a time-dependent manner with concomitant increase in both mTORC1 and mTORC2 activities. Expression of deptor abrogated activity of mTORC1 and mTORC2, resulting in inhibition of collagen I (alpha 2) mRNA and protein expression via transcriptional mechanism. In contrast, neutralization of endogenous deptor by shRNAs increased activity of both mTOR complexes and expression of collagen I (alpha 2) similar to TGF beta treatment. Importantly, downregulation of deptor by TGF beta increased the expression of Hif1 alpha by increasing translation of its mRNA. TGF beta-induced deptor downregulation promotes Hif1 alpha binding to its cognate hypoxia responsive element in the collagen I (alpha 2) gene to control its protein expression via direct transcriptional mechanism. Interestingly, knockdown of raptor to specifically block mTORC1 activity significantly inhibited expression of collagen I (alpha 2) and Hif1 alpha while inhibition of rictor to prevent selectively mTORC2 activation did not have any effect. Critically, our data provide evidence for the requirement of TGF beta-activated mTORC1 only by deptor downregulation, which dominates upon the bystander mTORC2 activity for enhanced expression of collagen I (alpha 2). Our results also suggest the presence of a safeguard mechanism involving deptor-mediated suppression of mTORC1 activity against developing TGF beta-induced renal fibrosis.	[Das, Falguni; Bera, Amit; Abboud, Hanna E.; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA; [Ghosh-Choudhury, Nandini; Abboud, Hanna E.; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, VA Res, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu			National Institutes of Health [RO1 DK50190]; Veterans Administration Research Service Merit Review [5I01BX000926]; Veterans Administration Senior Research Career Scientist Award; National Institutes of Health; VA Merit Review grants; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Research Service Merit Review(US Department of Veterans Affairs); Veterans Administration Senior Research Career Scientist Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review grants(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health RO1 DK50190 and Veterans Administration Research Service Merit Review 5I01BX000926 grants to GGC. GGC is a recipient of Veterans Administration Senior Research Career Scientist Award. HEA is supported by National Institutes of Health. NGC and BSK are supported by VA Merit Review grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Basu RK, 2011, AM J PHYSIOL-RENAL, V300, pF898, DOI 10.1152/ajprenal.00335.2010; Bera A, 2013, CELL SIGNAL, V25, P2575, DOI 10.1016/j.cellsig.2013.08.005; BOHLE A, 1987, AM J NEPHROL, V7, P421, DOI 10.1159/000167514; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Bumbea V, 2005, NEPHROL DIAL TRANSPL, V20, P2517, DOI 10.1093/ndt/gfh957; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Chen CH, 2011, J BIOL CHEM, V286, P40386, DOI 10.1074/jbc.M111.282590; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Das F, 2013, J CELL PHYSIOL, V228, P1617, DOI 10.1002/jcp.24327; Das F, 2013, J BIOL CHEM, V288, P7756, DOI 10.1074/jbc.M113.455782; Das F, 2012, J BIOL CHEM, V287, P3808, DOI 10.1074/jbc.M111.246397; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042316; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037366; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Eid AA, 2013, DIABETES, V62, P2935, DOI 10.2337/db12-1504; Finer G, 2012, KIDNEY INT, V82, P525, DOI 10.1038/ki.2012.139; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Franz S, 2010, AM J KIDNEY DIS, V55, P335, DOI 10.1053/j.ajkd.2009.09.004; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hardt M, 2011, GENES CELLS, V16, P141, DOI 10.1111/j.1365-2443.2010.01482.x; Howell JJ, 2013, BIOCHEM SOC T, V41, P906, DOI 10.1042/BST20130041; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hubchak SC, 2009, AM J PHYSIOL-RENAL, V297, pF1316, DOI 10.1152/ajprenal.00345.2009; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Inoki K, 2008, DIABETES RES CLIN PR, V82, pS59, DOI 10.1016/j.diabres.2008.09.028; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kasivisvanathan V, 2011, CURR VASC PHARMACOL, V9, P333, DOI 10.2174/157016111795495602; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lieberthal W, 2009, J AM SOC NEPHROL, V20, P2493, DOI 10.1681/ASN.2008111186; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Lloberas N, 2006, J AM SOC NEPHROL, V17, P1395, DOI 10.1681/ASN.2005050549; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mahimainathan L, 2009, J BIOL CHEM, V284, P27790, DOI 10.1074/jbc.M109.028860; Mandal CC, 2011, J BIOL CHEM, V286, P11314, DOI 10.1074/jbc.M110.193714; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Morelon E, 2003, TRANSPLANT P, V35, p52S, DOI 10.1016/S0041-1345(03)00244-6; Mori H, 2009, BIOCHEM BIOPH RES CO, V384, P471, DOI 10.1016/j.bbrc.2009.04.136; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Pawlus MR, 2013, CELL SIGNAL, V25, P1895, DOI 10.1016/j.cellsig.2013.05.018; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Poncelet AC, 1999, KIDNEY INT, V56, P1354, DOI 10.1046/j.1523-1755.1999.00680.x; Proud CG, 2009, J MOL CELL BIOL, V1, P61, DOI 10.1093/jmcb/mjp012; Rozen-Zvi B, 2013, AM J PHYSIOL-RENAL, V305, pF485, DOI 10.1152/ajprenal.00215.2013; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Samarakoon R, 2005, J CELL PHYSIOL, V204, P236, DOI 10.1002/jcp.20279; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; Torras J, 2009, NEPHROL DIAL TRANSPL, V24, P3632, DOI 10.1093/ndt/gfp367; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	83	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109608	10.1371/journal.pone.0109608	http://dx.doi.org/10.1371/journal.pone.0109608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333702	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200044
J	Fu, X; Gao, HJ; Tian, FY; Gao, JZ; Lou, LP; Liang, Y; Ning, Q; Luo, XP				Fu, Xi; Gao, Hongjie; Tian, Fengyan; Gao, Jinzhi; Lou, Liping; Liang, Yan; Ning, Qin; Luo, Xiaoping			Mechanistic Effects of Amino Acids and Glucose in a Novel Glutaric Aciduria Type 1 Cell Model	PLOS ONE			English	Article							COA DEHYDROGENASE-DEFICIENCY; SHORT-TERM REGULATION; MOUSE MODEL; GENE-EXPRESSION; LYSINE-FREE; RAT-BRAIN; COMPLEX; NEURODEGENERATION; METABOLISM; TRANSPORT	Acute neurological crises involving striatal degeneration induced by a deficiency of glutaryl-CoA dehydrogenase (GCDH) and the accumulation of glutaric (GA) and 3-hydroxyglutaric acid (3-OHGA) are considered to be the most striking features of glutaric aciduria type I (GA1). In the present study, we investigated the mechanisms of apoptosis and energy metabolism impairment in our novel GA1 neuronal model. We also explored the effects of appropriate amounts of amino acids (2 mM arginine, 2 mM homoarginine, 0.45 g/L tyrosine and 10 mM leucine) and 2 g/L glucose on these cells. Our results revealed that the novel GA1 neuronal model effectively simulates the hypermetabolic state of GA1. We found that leucine, tyrosine, arginine, homoarginine or glucose treatment of the GA1 model cells reduced the gene expression of caspase-3, caspase-8, caspase-9, bax, fos, and jun and restored the intracellular NADH and ATP levels. Tyrosine, arginine or homoarginine treatment in particular showed anti-apoptotic effects; increased a-ketoglutarate dehydrogenase complex (OGDC), fumarase (FH), and citrate synthase (CS) expression; and relieved the observed impairment in energy metabolism. To the best of our knowledge, this study is the first to investigate the protective mechanisms of amino acids and glucose in GA1 at the cellular level from the point of view of apoptosis and energy metabolism. Our data support the results of previous studies, indicating that supplementation of arginine and homoarginine as a dietary control strategy can have a therapeutic effect on GA1. All of these findings facilitate the understanding of cell apoptosis and energy metabolism impairment in GA1 and reveal new therapeutic perspectives for this disease.	[Fu, Xi; Gao, Hongjie; Tian, Fengyan; Gao, Jinzhi; Liang, Yan; Luo, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pediat, Wuhan 430074, Peoples R China; [Lou, Liping] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pathol, Wuhan 430074, Peoples R China; [Ning, Qin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Luo, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pediat, Wuhan 430074, Peoples R China.	xpluo@tjh.tjmu.edu.cn		fu, xi/0000-0001-6928-4396	National Natural Science Foundation of China [81070699]; Twelfth Five-year National Science Supported Planning Project [2012BAI09B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Twelfth Five-year National Science Supported Planning Project	This study was supported by the National Natural Science Foundation of China (https://isisn.nsfc.gov.cn/egrantweb/) (No. 81070699) [XPL], Twelfth Five-year National Science Supported Planning Project (http://program.most.gov.cn/) (No. 2012BAI09B04) [XPL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANOS G, 1978, DEV MED CHILD NEUROL, V20, P335; BOURGERON T, 1994, J CLIN INVEST, V93, P2514, DOI 10.1172/JCI117261; Bunik VI, 2005, BIOCHEMISTRY-US, V44, P10552, DOI 10.1021/bi0503100; Coutant F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048644; CRAIG I, 1973, BIOCHEM GENET, V9, P351, DOI 10.1007/BF00486070; DANIEL PM, 1977, PROC R SOC SER B-BIO, V196, P347, DOI 10.1098/rspb.1977.0045; Das AM, 2003, MOL GENET METAB, V78, P108, DOI 10.1016/S1096-7192(02)00227-5; Dixon DP, 2006, PLANT SCI, V171, P360, DOI 10.1016/j.plantsci.2006.04.008; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fernstrom JD, 2005, J NUTR, V135, p1539S, DOI 10.1093/jn/135.6.1539S; Ferreira GD, 2005, INT J DEV NEUROSCI, V23, P687, DOI 10.1016/j.ijdevneu.2005.08.003; Frizzo MES, 2004, NEUROCHEM INT, V44, P345, DOI 10.1016/S0197-0186(03)00169-4; Gao JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063084; GOODMAN SI, 1975, BIOCHEM MED METAB B, V12, P12, DOI 10.1016/0006-2944(75)90091-5; GOODMAN SI, 1995, HUM MOL GENET, V4, P1493; Herdegen T, 2001, ONCOGENE, V20, P2424, DOI 10.1038/sj.onc.1204387; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jafari P, 2011, MOL GENET METAB, V104, P425, DOI 10.1016/j.ymgme.2011.08.027; Kolker S, 2012, MOL GENET METAB, V107, P72, DOI 10.1016/j.ymgme.2012.03.021; Kolker S, 2011, J INHERIT METAB DIS, V34, P677, DOI 10.1007/s10545-011-9289-5; Kolker S, 2003, NEUROPEDIATRICS, V34, P253; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lamp J, 2011, J BIOL CHEM, V286, P17777, DOI 10.1074/jbc.M111.232744; LEIBEL RL, 1980, NEUROLOGY, V30, P1163, DOI 10.1212/WNL.30.11.1163; Lidwell K, 2000, J NEUROSCI RES, V62, P427, DOI 10.1002/1097-4547(20001101)62:3<427::AID-JNR13>3.0.CO;2-O; McIntyre C, 2008, MOL GENET METAB, V93, P411, DOI 10.1016/j.ymgme.2007.11.008; Mello CC, 2007, CELL DEATH DIFFER, V14, P2013, DOI 10.1038/sj.cdd.4402252; MILLER AL, 1984, DEV BRAIN RES, V14, P33, DOI 10.1016/0165-3806(84)90006-3; Muhlhausen C, 2004, J INHERIT METAB DIS, V27, P885, DOI 10.1023/B:BOLI.0000045773.07785.83; Naughten ER, 2004, J INHERIT METAB DIS, V27, P917, DOI 10.1023/B:BOLI.0000045777.82784.74; OLDENDORF WH, 1971, AM J PHYSIOL, V221, P1629, DOI 10.1152/ajplegacy.1971.221.6.1629; Papes F, 2001, FEBS LETT, V488, P34, DOI 10.1016/S0014-5793(00)02401-7; RAO VV, 1992, COMP BIOCHEM PHYS B, V103, P221, DOI 10.1016/0305-0491(92)90435-T; Sauer SW, 2011, BRAIN, V134, P157, DOI 10.1093/brain/awq269; Sauer SW, 2005, J BIOL CHEM, V280, P21830, DOI 10.1074/jbc.M502845200; SMITH QR, 1987, J NEUROCHEM, V49, P1651, DOI 10.1111/j.1471-4159.1987.tb01039.x; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; Strauss KA, 2003, AM J MED GENET C, V121C, P53, DOI 10.1002/ajmg.c.20008; Strauss KA, 2011, MOL GENET METAB, V104, P93, DOI 10.1016/j.ymgme.2011.07.003; Strumilo S, 2005, ACTA BIOCHIM POL, V52, P759; Strumilo S, 2005, BIOCHEMISTRY-MOSCOW+, V70, P726, DOI 10.1007/s10541-005-0177-1; TEWS JK, 1983, AM J PHYSIOL, V245, pR556, DOI 10.1152/ajpregu.1983.245.4.R556; Uchiyama T, 2005, NAT BIOTECHNOL, V23, P88, DOI 10.1038/nbt1048; Ullrich K, 1999, J INHERIT METAB DIS, V22, P392, DOI 10.1023/A:1005595921323; van der Watt G, 2010, MOL GENET METAB, V101, P178, DOI 10.1016/j.ymgme.2010.07.018; Wallimann T, 1998, MAGN RESON MATER PHY, V6, P116; Yudkoff M, 2005, J NUTR, V135, p1531S, DOI 10.1093/jn/135.6.1531S; Zhong CY, 2005, CARCINOGENESIS, V26, P2187, DOI 10.1093/carcin/bgi189; Zinnanti WJ, 2007, J CLIN INVEST, V117, P3258, DOI 10.1172/JCI31617; Zinnanti WJ, 2010, MOL GENET METAB, V100, pS88, DOI 10.1016/j.ymgme.2010.02.022; Zinnanti WJ, 2006, BRAIN, V129, P899, DOI 10.1093/brain/awl009	51	2	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110181	10.1371/journal.pone.0110181	http://dx.doi.org/10.1371/journal.pone.0110181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333616	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200097
J	Vickers, TA; Freier, SM; Bui, HH; Watt, A; Crooke, ST				Vickers, Timothy A.; Freier, Susan M.; Bui, Huynh-Hoa; Watt, Andrew; Crooke, Stanley T.			Targeting of Repeated Sequences Unique to a Gene Results in Significant Increases in Antisense Oligonucleotide Potency	PLOS ONE			English	Article							MUTANT HUNTINGTIN; RNASE-H; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; RIBONUCLEASE-H; REDUCTION; INHIBITION; EXPRESSION; COMPLEX; CLONING	A new strategy for identifying potent RNase H-dependent antisense oligonucleotides (ASOs) is presented. Our analysis of the human transcriptome revealed that a significant proportion of genes contain unique repeated sequences of 16 or more nucleotides in length. Activities of ASOs targeting these repeated sites in several representative genes were compared to those of ASOs targeting unique single sites in the same transcript. Antisense activity at repeated sites was also evaluated in a highly controlled minigene system. Targeting both native and minigene repeat sites resulted in significant increases in potency as compared to targeting of non-repeated sites. The increased potency at these sites is a result of increased frequency of ASO/RNA interactions which, in turn, increases the probability of a productive interaction between the ASO/RNA heteroduplex and human RNase H1 in the cell. These results suggest a new, highly efficient strategy for rapid identification of highly potent ASOs.	[Vickers, Timothy A.; Freier, Susan M.; Bui, Huynh-Hoa; Watt, Andrew; Crooke, Stanley T.] ISIS Pharmaceut Inc, Dept Core Antisense Res, Carlsbad, CA 92010 USA	Isis Pharmaceuticals Inc	Vickers, TA (corresponding author), ISIS Pharmaceut Inc, Dept Core Antisense Res, Carlsbad, CA 92010 USA.	tvickers@isisph.com			Isis Pharmaceuticals	Isis Pharmaceuticals	This work was supported by Isis Pharmaceuticals. The funder provided support in the form of salaries for authors TAV, SMF, HHB, AW, and STC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Chalk AM, 2002, BIOINFORMATICS, V18, P1567, DOI 10.1093/bioinformatics/18.12.1567; Crooke S.T., 2007, ANTISENSE DRUG TECHN, VSecond, P47; Crooke ST, 2001, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, P1; Crooke ST, 1999, BIOCHIM BIOPHYS ACTA, V1489, P30; Crouch RJ, 1985, NUCLEASES, P211; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Far RKK, 2005, OLIGONUCLEOTIDES, V15, P223, DOI 10.1089/oli.2005.15.223; Freier S.M., 2007, ANTISENSE DRUG TECHN, P117; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hashimoto JG, 2004, BIOTECHNIQUES, V36, P54, DOI 10.2144/04361BM06; HODGE D, 1995, MOL PHARMACOL, V48, P905; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; ITAYA M, 1991, NUCLEIC ACIDS RES, V19, P4443, DOI 10.1093/nar/19.16.4443; ITAYA M, 1991, MOL GEN GENET, V227, P438, DOI 10.1007/BF00273935; KANAYA S, 1992, J BIOL CHEM, V267, P10184; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liang XH, 2014, NUCLEIC ACIDS RES, V42, P7819, DOI 10.1093/nar/gku484; Liang XH, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1121; Lima WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101752; Lima WF, 2003, J BIOL CHEM, V278, P14906, DOI 10.1074/jbc.M211279200; Lutzelberger M, 2006, HANDB EXP PHARM, V173, P243; Mathews DH, 1999, RNA, V5, P1458, DOI 10.1017/S1355838299991148; Ostergaard ME, 2013, NUCLEIC ACIDS RES, V41, P9634, DOI 10.1093/nar/gkt725; RONG YW, 1990, BIOCHEMISTRY-US, V29, P383, DOI 10.1021/bi00454a012; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Seth PP, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.34; Seth Punit P, 2008, Nucleic Acids Symp Ser (Oxf), P553, DOI 10.1093/nass/nrn280; Shen W, 2014, NUCLEIC ACIDS RES, V42, P8648, DOI 10.1093/nar/gku579; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Swayze E.E., 2007, ANTISENSE DRUG TECHN, P143; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Vickers TA, 2000, NUCLEIC ACIDS RES, V28, P1340, DOI 10.1093/nar/28.6.1340; Vickers TA, 2014, PLOS ONE IN PRESS; Vickers TA, 2006, J IMMUNOL, V176, P3652, DOI 10.4049/jimmunol.176.6.3652; Vickers TA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr150; Watts LM, 2005, DIABETES, V54, P1846, DOI 10.2337/diabetes.54.6.1846; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Wu HJ, 2004, J BIOL CHEM, V279, P17181, DOI 10.1074/jbc.M311683200; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002	41	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110615	10.1371/journal.pone.0110615	http://dx.doi.org/10.1371/journal.pone.0110615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25334092	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200127
J	Wang, Z; Guo, D; Yang, B; Wang, J; Wang, R; Wang, XW; Zhang, QY				Wang, Zhe; Guo, Dong; Yang, Bin; Wang, Jian; Wang, Rong; Wang, Xiaowei; Zhang, Qunye			Integrated Analysis of Microarray Data of Atherosclerotic Plaques: Modulation of the Ubiquitin-Proteasome System	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; DNA METHYLATION; NETWORK ANALYSIS; DEFICIENT MICE; IN-VIVO; EXPRESSION; INHIBITOR; OVEREXPRESSION; TECHNOLOGIES; INFLAMMATION	Atherosclerosis is a typical complex multi-factorial disease and many molecules at different levels and pathways were involved in its development. Some studies have investigated the dysregulation in atherosclerosis at mRNA, miRNA or DNA methylation level, respectively. However, to our knowledge, the studies that integrated these data and revealed the abnormal networks of atherosclerosis have not been reported. Using microarray technology, we analyzed the omics data in atherosclerosis at mRNA, miRNA and DNA methylation levels. Our results demonstrated that the global DNA methylation and expression of miRNA/mRNA were significantly decreased in atherosclerotic plaque than in normal vascular tissue. The interaction network constructed using the integrative data revealed many genes, cellular processes and signaling pathways which were widely considered to play crucial roles in atherosclerosis and also revealed some genes, miRNAs or signaling pathways which have not been investigated in atherosclerosis until now (e.g. miR-519d and SNTB2). Moreover, the overall protein ubiquitination in atherosclerotic plaque was significantly increased. The proteasome activity was increased early but decreased in advanced atherosclerosis. Our study revealed many classic and novel genes and miRNAs involved in atherosclerosis and indicated the effects of ubiquitin-proteasome system on atherosclerosis might be closely related to the course of atherosclerosis. However, the efficacy of proteasome inhibitors in the treatment of atherosclerosis still needs more research.	[Wang, Rong; Wang, Xiaowei; Zhang, Qunye] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China; [Wang, Rong; Wang, Xiaowei; Zhang, Qunye] Shandong Univ, Minist Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Wang, Zhe] Shandong Univ, Shandong Prov Hosp, Div Endocrinol & Metab, Jinan 250100, Shandong, Peoples R China; [Guo, Dong] Taishan Med Univ, Med Sch Liaocheng, Liaocheng Peoples Hosp, Dept Neurol, Liaocheng, Shandong, Peoples R China; [Yang, Bin] Zaozhuang Univ, Sch Informat Sci & Engn, Zaozhuang, Shandong, Peoples R China; [Wang, Jian] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Zaozhuang University; Shanghai University	Zhang, QY (corresponding author), Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China.	wz.zhangqy@sdu.edu.cn			Chinese National Key Basic Research Project [2011CB503906, 2010CB529202]; National Natural Science Foundation of China [81070224, 81370270]; Program for New Century Excellent Talents in University [NCET-10-0555]; Shandong Provincial Natural Science Foundation [2009ZRB14207]	Chinese National Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This work was supported by Chinese National Key Basic Research Project (2011CB503906 and 2010CB529202); the National Natural Science Foundation of China (81070224, 81370270); Program for New Century Excellent Talents in University (NCET-10-0555) and the Shandong Provincial Natural Science Foundation (2009ZRB14207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz N, 2011, INTERNET MATH, V7, P299, DOI 10.1080/15427951.2011.604548; Anand SS, 2011, LANCET, V377, P529, DOI 10.1016/S0140-6736(10)62346-X; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barringhaus Kurt G, 2007, Exp Clin Cardiol, V12, P119; Ben-Shoshan J, 2009, ARTERIOSCL THROM VAS, V29, P665, DOI 10.1161/ATVBAHA.108.183319; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Castillo-Diaz SA, 2010, INT J MOL MED, V26, P691, DOI 10.3892/ijmm_00000515; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen KC, 2011, FASEB J, V25, P1718, DOI 10.1096/fj.10-174904; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Civelek M, 2011, CIRC-CARDIOVASC GENE, V4, P243, DOI 10.1161/CIRCGENETICS.110.958926; de Nigris F, 2000, CIRCULATION, V102, P2111, DOI 10.1161/01.CIR.102.17.2111; Di Filippo C, 2008, J AM COLL CARDIOL, V52, P1350, DOI 10.1016/j.jacc.2008.06.045; Doring Y, 2012, ARTERIOSCL THROM VAS, V32, P182, DOI 10.1161/ATVBAHA.111.232686; Eberini I, 2013, J PROTEOMICS, V82, P92, DOI 10.1016/j.jprot.2013.02.007; Feng B, 2010, J CARDIOVASC PHARM, V55, P129, DOI 10.1097/FJC.0b013e3181c87f8e; Fornari F, 2012, J PATHOL, V227, P275, DOI 10.1002/path.3995; Garcia-Carpizo V, 2011, J MOL ENDOCRINOL, V47, pE75, DOI 10.1530/JME-11-0059; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Guilleret I, 2002, INT J CANCER, V101, P335, DOI 10.1002/ijc.10593; Herrmann J, 2002, J AM COLL CARDIOL, V40, P1919, DOI 10.1016/S0735-1097(02)02564-0; Herrmann J, 2007, CIRC RES, V101, P865, DOI 10.1161/CIRCRESAHA.107.152959; Hilgendorf I, 2011, ARTERIOSCL THROM VAS, V31, P1991, DOI 10.1161/ATVBAHA.111.230847; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang ZQ, 2013, METHODS MOL BIOL, V1049, P75, DOI 10.1007/978-1-62703-547-7_7; Jia L, 2013, ATHEROSCLEROSIS, V228, P346, DOI 10.1016/j.atherosclerosis.2013.01.027; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Martinelli R, 2010, OBESITY, V18, P2170, DOI 10.1038/oby.2009.474; Mercer J, 2006, CELL CYCLE, V5, P1907, DOI 10.4161/cc.5.17.3166; Muers M, 2013, NAT REV GENET, V14, P3535, DOI 10.1038/nrg3535; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Rodriguez I, 2007, CELL CYCLE, V6, P620, DOI 10.4161/cc.6.5.3927; Sun YF, 2013, CARDIOVASC RES, V100, P272, DOI 10.1093/cvr/cvt172; Van Herck JL, 2010, BASIC RES CARDIOL, V105, P39, DOI 10.1007/s00395-009-0054-y; Versari D, 2006, ARTERIOSCL THROM VAS, V26, P2132, DOI 10.1161/01.ATV.0000232501.08576.73; Vogel U, 2011, ATHEROSCLEROSIS, V219, P200, DOI 10.1016/j.atherosclerosis.2011.06.018; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yu CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047081; Zaina S, 2013, CURR OPIN LIPIDOL, V24, P369, DOI 10.1097/MOL.0b013e3283638c47; Zeng J, 2013, EXP CLIN ENDOCR DIAB, V121, P425, DOI 10.1055/s-0033-1345169; Zhang QY, 2009, P NATL ACAD SCI USA, V106, P3378, DOI 10.1073/pnas.0813142106	49	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110288	10.1371/journal.pone.0110288	http://dx.doi.org/10.1371/journal.pone.0110288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333956	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200110
J	Caffrey, JR; Hughes, BD; Britto, JM; Landman, KA				Caffrey, James R.; Hughes, Barry D.; Britto, Joanne M.; Landman, Kerry A.			An In Silico Agent-Based Model Demonstrates Reelin Function in Directing Lamination of Neurons during Cortical Development	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; INSIDE-OUT LAMINATION; MUTANT MOUSE; RADIAL MIGRATION; CELL-MIGRATION; NEOCORTEX; DISORDERS; FOREBRAIN; MUTATIONS; PATTERNS	The characteristic six-layered appearance of the neocortex arises from the correct positioning of pyramidal neurons during development and alterations in this process can cause intellectual disabilities and developmental delay. Malformations in cortical development arise when neurons either fail to migrate properly from the germinal zones or fail to cease migration in the correct laminar position within the cortical plate. The Reelin signalling pathway is vital for correct neuronal positioning as loss of Reelin leads to a partially inverted cortex. The precise biological function of Reelin remains controversial and debate surrounds its role as a chemoattractant or stop signal for migrating neurons. To investigate this further we developed an in silico agent-based model of cortical layer formation. Using this model we tested four biologically plausible hypotheses for neuron motility and four biologically plausible hypotheses for the loss of neuron motility (conversion from migration). A matrix of 16 combinations of motility and conversion rules was applied against the known structure of mouse cortical layers in the wild-type cortex, the Reelin-null mutant, the Dab1-null mutant and a conditional Dab1 mutant. Using this approach, many combinations of motility and conversion mechanisms can be rejected. For example, the model does not support Reelin acting as a repelling or as a stopping signal. In contrast, the study lends very strong support to the notion that the glycoprotein Reelin acts as a chemoattractant for neurons. Furthermore, the most viable proposition for the conversion mechanism is one in which conversion is affected by a motile neuron sensing in the near vicinity neurons that have already converted. Therefore, this model helps elucidate the function of Reelin during neuronal migration and cortical development.	[Caffrey, James R.; Hughes, Barry D.; Landman, Kerry A.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia; [Britto, Joanne M.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Landman, KA (corresponding author), Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia.	kerryl@unimelb.edu.au	Hughes, Barry Douglas/AAB-9382-2020	Hughes, Barry Douglas/0000-0003-3594-4303	Australian Research Council [DP140100339]	Australian Research Council(Australian Research Council)	The work was supported by Australian Research Council, Discovery project DP140100339. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara S, 1998, J NEUROSCI, V18, P7779; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Binder BJ, 2012, B MATH BIOL, V74, P474, DOI 10.1007/s11538-011-9703-z; Britto JM, 2014, CEREB CORTEX, V24, P2835, DOI 10.1093/cercor/bht123; Britto JM, 2011, CEREB CORTEX, V21, P1018, DOI 10.1093/cercor/bhq168; CAVINESS VS, 1976, J COMP NEUROL, V170, P435, DOI 10.1002/cne.901700404; CAVINESS VS, 1973, J COMP NEUROL, V147, P235, DOI 10.1002/cne.901470206; Chowdhury D, 2005, PHYS LIFE REV, V2, P318, DOI 10.1016/j.plrev.2005.09.001; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Courtes S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020430; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; Dekimoto H, 2010, DEV GROWTH DIFFER, V52, P181, DOI 10.1111/j.1440-169X.2009.01153.x; Deutsch A, 2005, CELLULAR AUTOMATON M; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; Fatemi SH, 2001, MOL PSYCHIATR, V6, P129, DOI 10.1038/sj.mp.4000129; Folsom TD, 2013, NEUROPHARMACOLOGY, V68, P122, DOI 10.1016/j.neuropharm.2012.08.015; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Frotscher M, 1997, CELL TISSUE RES, V290, P315, DOI 10.1007/s004410050936; Hammond V, 2001, J NEUROSCI, V21, P8798, DOI 10.1523/JNEUROSCI.21-22-08798.2001; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Lakoma J, 2011, DEVELOPMENT, V138, P5223, DOI 10.1242/dev.063776; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Sekine K, 2011, J NEUROSCI, V31, P9426, DOI 10.1523/JNEUROSCI.0650-11.2011; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; Simo S, 2010, J NEUROSCI, V30, P5668, DOI 10.1523/JNEUROSCI.0035-10.2010; Streit P, 1984, CEREB CORTEX, V2, P119; Xuejun C, 2009, COMM INTEG BIOL, V2, P375; Zhang DC, 2010, DEV BIOL, V339, P280, DOI 10.1016/j.ydbio.2009.12.014; Zubler F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003173	41	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110415	10.1371/journal.pone.0110415	http://dx.doi.org/10.1371/journal.pone.0110415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25334023	Green Published, gold			2022-12-27	WOS:000343731200036
J	Viard, A; Piolino, P; Belliard, S; de La Sayette, V; Desgranges, B; Eustache, F				Viard, Armelle; Piolino, Pascale; Belliard, Serge; de La Sayette, Vincent; Desgranges, Beatrice; Eustache, Francis			Episodic Future Thinking in Semantic Dementia: A Cognitive and fMRI Study	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; MENTAL TIME-TRAVEL; AUTOBIOGRAPHICAL MEMORY; ALZHEIMERS-DISEASE; DECLARATIVE MEMORY; AUTONOETIC CONSCIOUSNESS; TEMPORAL DISTANCE; AGED ADULTS; ATROPHY; PATTERNS	Semantic dementia (SD) is characterized by gradual loss of semantic memory. While episodic autobiographical memory seems relatively preserved, behavioral studies suggest that episodic future thinking is impaired. We used fMRI to measure brain activity in four SD patients (JPL, EP, LL, EG) while they envisioned future events and remembered personal past events. Twelve healthy elders served as controls. Episodic quality, emotion, mental imagery and level of consciousness (via remember/know judgements) were checked at debriefing. We analyzed the future compared to the past for each patient. All patients presented lateral temporal atrophy, but varied in terms of frontal and anterior hippocampal atrophy. Patient JPL presented atrophy in bilateral superior medial frontal gyri and left anterior hippocampus and was unable to engage in episodic future thinking, despite hyperactivations in frontal and occipital regions. Patient EP presented no atrophy in the anterior hippocampus, but atrophy in bilateral superior medial frontal gyrus and had difficulties to engage in episodic future thinking. Patient LL presented atrophy in left anterior hippocampus, but hyperactivated its right counterpart for future compared to past thinking, permitting her to project efficiently in the future in an episodic way. Patient EG presented no atrophy in the superior medial frontal gyri or anterior hippocampi and was able to engage in episodic future thinking. Altogether, patients' future projections differed depending on the severity and localization of their atrophy. The functional integrity of bilateral superior medial frontal gyri and anterior hippocampus appear crucial for episodic future thinking: atrophy of both structures strongly impairs future projection, while integrity of these structures or hyperactivation of residual tissue normalizes episodic future projection.	[Viard, Armelle; Belliard, Serge; de La Sayette, Vincent; Desgranges, Beatrice; Eustache, Francis] INSERM, U1077, Caen, France; [Viard, Armelle; Belliard, Serge; de La Sayette, Vincent; Desgranges, Beatrice; Eustache, Francis] Univ Caen Basse Normandie, UMR S1077, Caen, France; [Viard, Armelle; Belliard, Serge; de La Sayette, Vincent; Desgranges, Beatrice; Eustache, Francis] Ecole Prat Hautes Etud, UMR S1077, Caen, France; [Viard, Armelle; Belliard, Serge; de La Sayette, Vincent; Desgranges, Beatrice; Eustache, Francis] Ctr Hosp Univ, U1077, Caen, France; [Piolino, Pascale] Univ Paris 05, Inst Psychol, Memory & Cognit Lab, Paris, France; [Piolino, Pascale] INSERM, Ctr Psychiat & Neurosci, UMR S894, Paris, France; [Belliard, Serge] CHU Pontchaillou, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; CHU de Caen NORMANDIE; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Rennes	Viard, A (corresponding author), INSERM, U1077, Caen, France.	viard@cyceron.fr	Viard, Armelle/C-4346-2014; Desgranges, Béatrice/L-7739-2015; de la Sayette, Vincent/L-8074-2015; DESGRANGES, BEATRICE/AAK-4756-2021; Eustache, Francis/J-9465-2015; Piolino, pascale/F-8075-2014	Viard, Armelle/0000-0003-1563-3866; DESGRANGES, BEATRICE/0000-0002-3657-9996; Eustache, Francis/0000-0003-4460-8686; Piolino, pascale/0000-0002-7787-924X	University Hospital Center of Caen; Ecole Pratique de Hautes Etudes (EPHE); Fondation pour la Recherche sur le Cerveau (FRC); Inserm; UCBN (research unit U1077)	University Hospital Center of Caen; Ecole Pratique de Hautes Etudes (EPHE); Fondation pour la Recherche sur le Cerveau (FRC); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UCBN (research unit U1077)	This work was supported by the University Hospital Center of Caen, Ecole Pratique de Hautes Etudes (EPHE), Fondation pour la Recherche sur le Cerveau (FRC), Inserm, UCBN (research unit U1077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A, 2008, BRAIN RES, V1233, P106, DOI 10.1016/j.brainres.2008.07.084; Acosta-Cabronero J, 2011, BRAIN, V134, P2025, DOI 10.1093/brain/awr119; Addis DR, 2008, HIPPOCAMPUS, V18, P227, DOI 10.1002/hipo.20405; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Belliard S., 2001, REV NEUROL, V157, P10; Belliard S, 2007, PSYCHOL NEUROPSYCHIA, V5, P127, DOI 10.1684/pnv.2007.0080; Boxer AL, 2003, ARCH NEUROL-CHICAGO, V60, P949, DOI 10.1001/archneur.60.7.949; Brewer W. F., 1996, REMEMBERING OUR STUD, P16, DOI [10.1017/cbo9780511527913.002, DOI 10.1017/CBO9780511527913.002, 10.1017/CBO9780511527913.002]; Brewer W.F., 1988, REMEMBERING RECONSID, P21, DOI DOI 10.1017/CBO9780511664014.004; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Chan D, 2001, ANN NEUROL, V49, P433, DOI 10.1002/ana.92.abs; Chua EF, 2007, HIPPOCAMPUS, V17, P1071, DOI 10.1002/hipo.20340; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Crawford JR, 2011, CORTEX, V47, P1166, DOI 10.1016/j.cortex.2011.02.017; Crawford JR, 2006, NEUROPSYCHOLOGIA, V44, P666, DOI 10.1016/j.neuropsychologia.2005.06.001; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Crinion J, 2007, NEUROIMAGE, V37, P866, DOI 10.1016/j.neuroimage.2007.04.065; D'Argembeau A, 2004, CONSCIOUS COGN, V13, P844, DOI 10.1016/j.concog.2004.07.007; D'Argembeau A, 2006, CONSCIOUS COGN, V15, P342, DOI 10.1016/j.concog.2005.09.001; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Davies RR, 2004, EUR J NEUROSCI, V20, P2441, DOI 10.1111/j.1460-9568.2004.03710.x; de Partz MP, 2001, LEXIS TESTS EVALUATI; Deary IJ, 2010, INT J EPIDEMIOL, V39, P1362, DOI 10.1093/ije/dyq072; Deltour J. J., 1993, ADAPTATION FRANCAISE; Desgranges B, 1996, CORTEX, V32, P387, DOI 10.1016/S0010-9452(96)80001-3; Desgranges B, 2007, NEUROBIOL AGING, V28, P1904, DOI 10.1016/j.neurobiolaging.2006.08.006; DEWHURST SA, 1994, J EXP PSYCHOL LEARN, V20, P1088, DOI 10.1037/0278-7393.20.5.1088; Duval C, 2012, NEUROPSYCHOLOGIA, V50, P254, DOI 10.1016/j.neuropsychologia.2011.11.019; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gamboz N, 2010, EXP PSYCHOL, V57, P419, DOI 10.1027/1618-3169/a000052; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Graham KS, 1997, NEUROPSYCHOLOGY, V11, P77, DOI 10.1037/0894-4105.11.1.77; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2009, PHILOS T R SOC B, V364, P1263, DOI 10.1098/rstb.2008.0296; Hodges JR, 2007, LANCET NEUROL, V6, P1004, DOI 10.1016/S1474-4422(07)70266-1; Hodges JR, 2001, PHILOS T R SOC B, V356, P1423, DOI 10.1098/rstb.2001.0943; Holland AC, 2010, PHYS LIFE REV, V7, P88, DOI 10.1016/j.plrev.2010.01.006; Howard-Jones PA, 2005, COGNITIVE BRAIN RES, V25, P240, DOI 10.1016/j.cogbrainres.2005.05.013; Irish M, 2011, NEUROPSYCHOLOGIA, V49, P2694, DOI 10.1016/j.neuropsychologia.2011.05.017; Irish M, 2012, NEUROPSYCHOLOGIA, V50, P3488, DOI 10.1016/j.neuropsychologia.2012.09.012; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Jackson O, 2004, NEUROIMAGE, V21, P456, DOI 10.1016/j.neuroimage.2003.09.050; Jacques PLS, 2011, MEMORY, V19, P723, DOI 10.1080/09658211.2010.516266; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; La Joie R, 2013, NEUROIMAGE-CLIN, V3, P155, DOI 10.1016/j.nicl.2013.08.007; Lehmann M, 2010, NEUROIMAGE, V49, P2264, DOI 10.1016/j.neuroimage.2009.10.056; Maguire EA, 2010, NEUROPSYCHOLOGIA, V48, P123, DOI 10.1016/j.neuropsychologia.2009.08.020; Matuszewski V, 2009, CORTEX, V45, P456, DOI 10.1016/j.cortex.2007.11.006; Merck C, 2011, REV NEUROPSYCHOL, V3, P235, DOI DOI 10.3917/RNE.034.0235; Mummery CJ, 2000, ANN NEUROL, V47, P36; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nestor PJ, 2006, NEUROIMAGE, V30, P1010, DOI 10.1016/j.neuroimage.2005.10.008; NIGRO G, 1983, COGNITIVE PSYCHOL, V15, P467, DOI 10.1016/0010-0285(83)90016-6; Nyberg L, 2010, P NATL ACAD SCI USA, V107, P22356, DOI 10.1073/pnas.1016823108; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Piolino P, 2004, NEUROIMAGE, V22, P1371, DOI 10.1016/j.neuroimage.2004.02.025; Piolino P, 2003, BRAIN, V126, P2203, DOI 10.1093/brain/awg222; Piolino P, 2003, COGN NEUROPSYCHOL, V20, P619, DOI 10.1080/02643290242000899; Preston AR, 2004, HIPPOCAMPUS, V14, P148, DOI 10.1002/hipo.20009; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1970, EXAMEN CLIN PSYCHOL; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Rubin DC, 2003, MEM COGNITION, V31, P887, DOI 10.3758/BF03196443; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Snowden J., 1989, BEHAV NEUROL, V2, P167, DOI [DOI 10.1093/NEUCAS/1.1.39-Y, https://doi.org/10.1155/1989/124043, DOI 10.1155/1989/124043]; Snowden JS, 2001, J NEUROL NEUROSUR PS, V70, P323, DOI 10.1136/jnnp.70.3.323; Summerfield JJ, 2009, NEUROIMAGE, V44, P1188, DOI 10.1016/j.neuroimage.2008.09.033; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Thompson SA, 2003, NEUROLOGY, V61, P1196, DOI 10.1212/01.WNL.0000091868.28557.B8; Tulving E, 2001, PHILOS T R SOC B, V356, P1505, DOI 10.1098/rstb.2001.0937; van De Pol LA, 2006, J NEUROL NEUROSUR PS, V77, P439, DOI 10.1136/jnnp.2005.075341; Viard A, 2007, CEREB CORTEX, V17, P2453, DOI 10.1093/cercor/bhl153; Viard A, 2013, NEUROPSYCHOLOGIA, V51, P2620, DOI 10.1016/j.neuropsychologia.2013.08.007; Viard A, 2012, BRAIN COGNITION, V80, P111, DOI 10.1016/j.bandc.2012.05.004; Viard A, 2011, BRAIN COGNITION, V75, P1, DOI 10.1016/j.bandc.2010.10.009; Viard A, 2010, HIPPOCAMPUS, V20, P153, DOI 10.1002/hipo.20601; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	89	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111046	10.1371/journal.pone.0111046	http://dx.doi.org/10.1371/journal.pone.0111046			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333997	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200099
J	Gajewski, KN; Peterson, AE; Chitale, RA; Pavlin, JA; Russell, KL; Chretien, JP				Gajewski, Kimberly N.; Peterson, Amy E.; Chitale, Rohit A.; Pavlin, Julie A.; Russell, Kevin L.; Chretien, Jean-Paul			A Review of Evaluations of Electronic Event-Based Biosurveillance Systems	PLOS ONE			English	Review							PUBLIC-HEALTH; SURVEILLANCE; INTELLIGENCE; CLASSIFICATION; BIOSECURITY; BIOCASTER	Electronic event-based biosurveillance systems (EEBS's) that use near real-time information from the internet are an increasingly important source of epidemiologic intelligence. However, there has not been a systematic assessment of EEBS evaluations, which could identify key uncertainties about current systems and guide EEBS development to most effectively exploit web-based information for biosurveillance. To conduct this assessment, we searched PubMed and Google Scholar to identify peer-reviewed evaluations of EEBS's. We included EEBS's that use publicly available internet information sources, cover events that are relevant to human health, and have global scope. To assess the publications using a common framework, we constructed a list of 17 EEBS attributes from published guidelines for evaluating health surveillance systems. We identified 11 EEBS's and 20 evaluations of these EEBS's. The number of published evaluations per EEBS ranged from 1 (Gen-Db, GODsN, MiTAP) to 8 (GPHIN, HealthMap). The median number of evaluation variables assessed per EEBS was 8 (range, 3-15). Ten published evaluations contained quantitative assessments of at least one key variable. No evaluations examined usefulness by identifying specific public health decisions, actions, or outcomes resulting from EEBS outputs. Future EEBS assessments should identify and discuss critical indicators of public health utility, especially the impact of EEBS's on public health response.	[Gajewski, Kimberly N.] Fed Emergency Management Assoc, Response Directorate, Washington, DC USA; [Peterson, Amy E.; Chitale, Rohit A.; Chretien, Jean-Paul] Armed Forces Hlth Surveillance Ctr, Div Integrated Biosurveillance, Silver Spring, MD USA; [Pavlin, Julie A.; Russell, Kevin L.] Armed Forces Hlth Surveillance Ctr, Silver Spring, MD USA		Chretien, JP (corresponding author), Armed Forces Hlth Surveillance Ctr, Div Integrated Biosurveillance, Silver Spring, MD USA.	jean.chretien.mil@mail.mil		Chretien, Jean-Paul/0000-0001-8143-6823	Armed Forces Health Surveillance Center	Armed Forces Health Surveillance Center	This project was funded using internal operational funds of the Armed Forces Health Surveillance Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboza P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057252; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Buehler James W, 2004, MMWR Recomm Rep, V53, P1; Chan EH, 2011, LARGE SCALE EVALUATI; Collier N, 2012, GLOB PUBLIC HEALTH, V7, P731, DOI 10.1080/17441692.2012.699975; Collier N, 2012, BIOINFORMATICS, V28, P1186, DOI 10.1093/bioinformatics/bts099; Collier N, 2008, BIOINFORMATICS, V24, P2940, DOI 10.1093/bioinformatics/btn534; Corley CD, 2012, BIOSECUR BIOTERROR, V10, P131, DOI 10.1089/bsp.2011.0096; Damianos L, 2002, AI MAG, V23, P13; Deshpande A, 2013, SYSTEMATIC EVALUATIO; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; German R R, 2001, MMWR Recomm Rep, V50, P1; Hartley D, 2010, EMERG HLTH THREATS J, V3, P19; Hartley DM, 2013, CLIN MICROBIOL INFEC, V19, P1006, DOI 10.1111/1469-0691.12273; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Keller M, 2009, EMERG INFECT DIS, V15, P689, DOI 10.3201/eid1505.081114; Khan Sharib A, 2006, AMIA Annu Symp Proc, P983; Lyon A, 2012, TRANSBOUND EMERG DIS, V59, P223, DOI 10.1111/j.1865-1682.2011.01258.x; Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088; Mykhalovskiy E, 2006, CAN J PUBLIC HEALTH, V97, P42, DOI 10.1007/BF03405213; Torii M, 2011, INT J MED INFORM, V80, P56, DOI 10.1016/j.ijmedinf.2010.10.015; Tsai FJ, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-14; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]; Woodall JP, 2001, CAD SAUDE PUBLICA, V17, P1037; Yangarber Roman, 2009, P IMED 2009 INT M EM	25	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e111222	10.1371/journal.pone.0111222	http://dx.doi.org/10.1371/journal.pone.0111222			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329886	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100115
J	Kim, SH; Kim, JY; Lee, HJ; Gi, M; Kim, BG; Choi, JY				Kim, Sung Huhn; Kim, Jin Young; Lee, Hyun Jin; Gi, Mia; Kim, Bo Gyung; Choi, Jae Young			Autoimmunity as a Candidate for the Etiopathogenesis of Meniere's Disease: Detection of Autoimmune Reactions and Diagnostic Biomarker Candidate	PLOS ONE			English	Article							CIRCULATING IMMUNE-COMPLEXES; INNER-EAR; ENDOLYMPHATIC SAC; PROTEIN; ASSOCIATION; ANTIBODIES; PROTEOMICS	Meniere's disease is an inner ear disorder that can manifest as fluctuating vertigo, sensorineural hearing loss, tinnitus, and aural fullness. However, the pathologic mechanism of Meniere's disease is still unclear. In this study, we evaluated autoimmunity as a potential cause of Meniere's disease. In addition we tried to find useful biomarker candidates for diagnosis. We investigated the protein composition of human inner ear fluid using liquid column mass spectrometry, the autoimmune reaction between circulating autoantibodies in patient serum and multiple antigens using the Protoarray system, the immune reaction between patient serum and mouse inner ear tissues using western blot analysis. Nine proteins, including immunoglobulin and its variants and interferon regulatory factor 7, were found only in the inner ear fluid of patients with Meniere's disease. Enhanced immune reactions with 18 candidate antigens were detected in patients with Meniere's disease in Protoarray analysis; levels of 8 of these antigens were more than 10-fold higher in patients than in controls. Antigen-antibody reactions between mouse inner ear proteins with molecular weights of 23-48 kDa and 6375 kDa and patient sera were detected in 8 patients. These findings suggest that autoimmunity could be one of the pathologic mechanisms behind Meniere's disease. Multiple autoantibodies and antigens may be involved in the autoimmune reaction. Specific antigens that caused immune reactions with patient's serum in Protoarray analysis can be candidates for the diagnostic biomarkers of Meniere's disease.	[Kim, Sung Huhn; Lee, Hyun Jin; Kim, Bo Gyung; Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Kim, Sung Huhn; Choi, Jae Young] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul, South Korea; [Kim, Jin Young; Gi, Mia; Choi, Jae Young] Yonsei Univ, Coll Med, Res Ctr Human Nat Def Syst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Choi, JY (corresponding author), Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.	jychoi@yuhs.ac		Kim, Sung Huhn/0000-0003-4408-3066; choi, jae young/0000-0001-9493-3458	Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea [HI08C2149]; National Research Foundation of Korea (NRF) - Ministry of Science; ICT & Future planning [2012R1A1A1042980]	Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Science; ICT & Future planning	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (HI08C2149) to JYC and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT & Future planning (2012R1A1A1042980) to SHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander TH, 2010, OTOLARYNG CLIN N AM, V43, P965, DOI 10.1016/j.otc.2010.05.001; Alleman AM, 1997, LARYNGOSCOPE, V107, P211, DOI 10.1097/00005537-199702000-00013; ALTERMATT HJ, 1990, ORL J OTO-RHINO-LARY, V52, P143, DOI 10.1159/000276124; Anderson JP, 2001, OTOL NEUROTOL, V22, P888, DOI 10.1097/00129492-200111000-00030; Banks C, 2012, CURR ALLERGY ASTHM R, V12, P255, DOI 10.1007/s11882-012-0258-3; BROOKES GB, 1986, ARCH OTOLARYNGOL, V112, P536; Chiarella G, 2014, J CELL BIOCHEM, V115, P1097, DOI 10.1002/jcb.24747; Chiarella G, 2012, J CELL PHYSIOL, V227, P308, DOI 10.1002/jcp.22737; DanckwardtLilliestrom N, 1997, ANN OTO RHINOL LARYN, V106, P190, DOI 10.1177/000348949710600303; DEREBERY MJ, 1991, LARYNGOSCOPE, V101, P225; Elkan-Miller T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018195; Fattori B, 2008, CLIN EXP IMMUNOL, V152, P28, DOI 10.1111/j.1365-2249.2008.03595.x; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Gazquez I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026759; Greco A, 2012, AUTOIMMUN REV, V11, P731, DOI 10.1016/j.autrev.2012.01.004; Hausler R, 1988, Adv Otorhinolaryngol, V42, P116; Hietikko E, 2013, EUR J MED GENET, V56, P279, DOI 10.1016/j.ejmg.2013.03.010; Hornibrook J, 2011, ANN OTO RHINOL LARYN, V120, P651, DOI 10.1177/000348941112001004; Kim SH, 2011, PLOS ONE, V6; Lopez-Escamez JA, 2007, OTOL NEUROTOL, V28, P891; Lopez-Escamez JA, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-2; Lopez-Escamez JA, 2010, LARYNGOSCOPE, V120, P103, DOI 10.1002/lary.20650; Minor LB, 2004, CURR OPIN NEUROL, V17, P9, DOI 10.1097/00019052-200402000-00004; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; Nemzou RM, 2006, NEUROSCIENCE, V141, P1849, DOI 10.1016/j.neuroscience.2006.05.057; Perez Garrigues H, 1995, Ann Otolaryngol Chir Cervicofac, V112, P225; Pham BN, 2007, AUTOIMMUNITY, V40, P202, DOI 10.1080/08916930701248555; RASKANDERSEN H, 1980, ACTA OTO-LARYNGOL, V89, P283, DOI 10.3109/00016488009127140; Requena T, 2014, CLIN GENET, V85, P245, DOI 10.1111/cge.12150; Requena T, 2013, IMMUNOGENETICS, V65, P345, DOI 10.1007/s00251-013-0683-z; Sajjadi H, 2008, LANCET, V372, P406, DOI 10.1016/S0140-6736(08)61161-7; Shin SO, 1997, LARYNGOSCOPE, V107, P222, DOI 10.1097/00005537-199702000-00015; TOMIYAMA S, 1987, ACTA OTO-LARYNGOL, V103, P182, DOI 10.3109/00016488709107782; Wackym PA, 1997, OTOLARYNG CLIN N AM, V30, P947; Yazawa Y, 1989, Acta Otolaryngol Suppl, V468, P71	36	48	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e111039	10.1371/journal.pone.0111039	http://dx.doi.org/10.1371/journal.pone.0111039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330336	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100114
J	Reichman, JR; Vize, PD				Reichman, Jay R.; Vize, Peter D.			Separate Introns Gained within Short and Long Soluble Peridinin-Chlorophyll a-Protein Genes during Radiation of Symbiodinium (Dinophyceae) Clade A and B Lineages	PLOS ONE			English	Article							SYMBIOTIC DINOFLAGELLATE SYMBIODINIUM; CRYPTIC SPLICE SITES; GYMNODINIUM MICROADRIATICUM; MARINE-INVERTEBRATES; BINDING-PROTEIN; MOLECULAR EVOLUTION; DNA-SEQUENCES; DIVERSITY; SPECIFICITY; FREUDENTHAL	Here we document introns in two Symbiodinium clades that were most likely gained following divergence of this genus from other peridinin-containing dinoflagellate lineages. Soluble peridinin-chlorophyll a-proteins (sPCP) occur in short and long forms in different species. Duplication and fusion of short sPCP genes produced long sPCP genes. All short and long sPCP genes characterized to date, including those from free living species and Symbiodinium sp. 203 (clade C/type C2) are intronless. However, we observed that long sPCP genes from two Caribbean Symbiodinium clade B isolates each contained two introns. To test the hypothesis that introns were gained during radiation of clade B, we compared sPCP genomic and cDNA sequences from 13 additional distinct Caribbean and Pacific Symbiodinium clade A, B, and F isolates. Long sPCP genes from all clade B/B1 and B/B19 descendants contain orthologs of both introns. Short sPCP genes from S. pilosum (A/A2) and S. muscatinei (B/B4) plus long sPCP genes from S. microadriaticum (A/A1) and S. kawagutii (F/F1) are intronless. Short sPCP genes of S. microadriaticum have a third unique intron. Symbiodinium clade B long sPCP sequences are useful for assessing divergence among B1 and B19 descendants. Phylogenetic analyses of coding sequences from four dinoflagellate orders indicate that introns were gained independently during radiation of Symbiodinium clades A and B. Long sPCP introns were present in the most recent common ancestor of Symbiodinium clade B core types B1 and B19, which apparently diverged sometime during the Miocene. The clade A short sPCP intron was either gained by S. microadriaticum or possibly by the ancestor of Symbiodinium types A/A1, A3, A4 and A5. The timing of short sPCP intron gain in Symbiodinium clade A is less certain. But, all sPCP introns were gained after fusion of ancestral short sPCP genes, which we confirm as occurring once in dinoflagellate evolution.	[Reichman, Jay R.] US EPA, Western Ecol Div, Corvallis, OR 97333 USA; [Reichman, Jay R.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Vize, Peter D.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	United States Environmental Protection Agency; Oregon State University; University of Calgary	Reichman, JR (corresponding author), US EPA, Western Ecol Div, Corvallis, OR 97333 USA.	reichman.jay@epa.gov			National Undersea Research Program Caribbean Marine Research Center - Project Development Grant [CMRC-97-7106]; Oregon State University Agricultural Research Foundation-Molecular Evolution of Endosymbiotic Marine Microalgae Project; Natural Sciences and Engineering Research Council of Canada - Discovery Award	National Undersea Research Program Caribbean Marine Research Center - Project Development Grant; Oregon State University Agricultural Research Foundation-Molecular Evolution of Endosymbiotic Marine Microalgae Project; Natural Sciences and Engineering Research Council of Canada - Discovery Award(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the National Undersea Research Program Caribbean Marine Research Center - Project Development Grant CMRC-97-7106 to JRR (http://www.perryinstitute.org/research); and by the Oregon State University Agricultural Research Foundation-Molecular Evolution of Endosymbiotic Marine Microalgae Project donation to JRR (http://agresearchfoundation.oregonstate.edu). This work was also supported by the Natural Sciences and Engineering Research Council of Canada - Discovery Award to PDV (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P3724, DOI 10.1093/nar/gkh686; Bachvaroff TR, 2004, PROTIST, V155, P65, DOI 10.1078/1434461000165; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker Andrew C., 1997, P1301; Basu MK, 2008, MOL BIOL EVOL, V25, P111, DOI 10.1093/molbev/msm234; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bradley RD, 1997, MOL BIOL EVOL, V14, P592, DOI 10.1093/oxfordjournals.molbev.a025797; Buratti E, 2011, NUCLEIC ACIDS RES, V39, pD86, DOI 10.1093/nar/gkq887; Carlos AA, 1999, J PHYCOL, V35, P1054, DOI 10.1046/j.1529-8817.1999.3551054.x; CHANG SS, 1984, PROC R SOC SER B-BIO, V222, P259, DOI 10.1098/rspb.1984.0063; CHANG SS, 1982, PROC R SOC SER B-BIO, V215, P191, DOI 10.1098/rspb.1982.0037; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; COLEMAN AW, 1994, J PHYCOL, V30, P80, DOI 10.1111/j.0022-3646.1994.00080.x; Csuros M, 2008, MOL BIOL EVOL, V25, P903, DOI 10.1093/molbev/msn039; DIBB NJ, 1989, EMBO J, V8, P2015, DOI 10.1002/j.1460-2075.1989.tb03609.x; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Finney JC, 2010, MICROB ECOL, V60, P250, DOI 10.1007/s00248-010-9681-y; FREUDENTHAL HD, 1962, J PROTOZOOL, V9, P45, DOI 10.1111/j.1550-7408.1962.tb02579.x; GOVIND NS, 1990, PROC R SOC SER B-BIO, V240, P187, DOI 10.1098/rspb.1990.0033; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HAXO FT, 1976, PLANT PHYSIOL, V57, P297, DOI 10.1104/pp.57.2.297; Hiller RG, 2001, MOL GENET GENOMICS, V266, P254, DOI 10.1007/s004380100551; Hiller RG, 1999, NATO ASI 3 HIGH TECH, V64, P3; Hofmann E, 1996, SCIENCE, V272, P1788, DOI 10.1126/science.272.5269.1788; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hunter RL, 2007, J PHYCOL, V43, P120, DOI 10.1111/j.1529-8817.2006.00309.x; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; JOVINE RVM, 1992, PLANT CELL PHYSIOL, V33, P733; Kapustin Y, 2011, NUCLEIC ACIDS RES, V39, P5837, DOI 10.1093/nar/gkr203; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kuzoff RK, 1998, MOL BIOL EVOL, V15, P251, DOI 10.1093/oxfordjournals.molbev.a025922; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; Lajeunesse TC, 2012, J PHYCOL, V48, P1380, DOI 10.1111/j.1529-8817.2012.01217.x; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2009, BIOL INVASIONS, V11, P995, DOI 10.1007/s10530-008-9311-5; Le QH, 1997, MOL GEN GENET, V255, P595, DOI 10.1007/s004380050533; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; LIU MH, 1984, NUCLEIC ACIDS RES, V12, P1529, DOI 10.1093/nar/12.3.1529; Logsdon JM, 1998, CURR BIOL, V8, pR560, DOI 10.1016/S0960-9822(07)00361-2; Logsdon JM, 1998, CURR OPIN GENET DEV, V8, P637, DOI 10.1016/S0959-437X(98)80031-2; Matsumoto T, 2011, MOL PHYLOGENET EVOL, V60, P68, DOI 10.1016/j.ympev.2011.04.010; Nielsen CB, 2004, PLOS BIOL, V2, P2234, DOI 10.1371/journal.pbio.0020422; NORRIS BJ, 1994, PLANT MOL BIOL, V24, P673, DOI 10.1007/BF00023563; Okamoto OK, 2001, BIOCHEMISTRY-US, V40, P15862, DOI 10.1021/bi011651q; Patron NJ, 2005, J MOL BIOL, V348, P1015, DOI 10.1016/j.jmb.2005.03.030; Pettay DT, 2007, MOL ECOL NOTES, V7, P1271, DOI 10.1111/j.1471-8286.2007.01852.x; Pettay DT, 2009, MOL ECOL RESOUR, V9, P1022, DOI 10.1111/j.1755-0998.2009.02561.x; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Pochon X, 2004, MAR BIOL, V146, P17, DOI 10.1007/s00227-004-1427-2; Pochon X, 2001, MAR BIOL, V139, P1069; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PREZELIN BB, 1976, PLANTA, V128, P133, DOI 10.1007/BF00390314; Qiu WG, 2004, MOL BIOL EVOL, V21, P1252, DOI 10.1093/molbev/msh120; REDDY R, 1983, J BIOL CHEM, V258, P3965; Reichman JR, 2003, MOL BIOL EVOL, V20, P2143, DOI 10.1093/molbev/msg233; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; ROWAN R, 1992, P NATL ACAD SCI USA, V89, P3639, DOI 10.1073/pnas.89.8.3639; Rowan R, 1996, PLANT CELL, V8, P539, DOI 10.1105/tpc.8.3.539; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Sadusky T, 2004, CURR BIOL, V14, P505, DOI 10.1016/j.cub.2004.02.063; Saldarriaga JF, 2004, EUR J PROTISTOL, V40, P85, DOI 10.1016/j.ejop.2003.11.003; Santos SR, 2004, MOL ECOL, V13, P459, DOI 10.1046/j.1365-294X.2003.02058.x; Santos SR, 2003, MAR BIOTECHNOL, V5, P130, DOI 10.1007/s10126-002-0076-9; Santos SR, 2003, BIOL BULL-US, V204, P10, DOI 10.2307/1543491; Santos SR, 2001, J PHYCOL, V37, P900, DOI 10.1046/j.1529-8817.2001.00194.x; Santos SR, 2002, MOL PHYLOGENET EVOL, V23, P97, DOI 10.1016/S1055-7903(02)00010-6; SCHOENBERG DA, 1980, PROC R SOC SER B-BIO, V207, P429, DOI 10.1098/rspb.1980.0032; SCHOENBERG DA, 1980, PROC R SOC SER B-BIO, V207, P405, DOI 10.1098/rspb.1980.0031; SCHOENBERG DA, 1980, PROC R SOC SER B-BIO, V207, P445, DOI 10.1098/rspb.1980.0033; Sharples FP, 1996, BBA-BIOENERGETICS, V1276, P117, DOI 10.1016/0005-2728(96)00066-7; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; Siegelman HW, 1977, BROOKHAVEN SYM BIOL, V28, P162; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stochaj WR, 1997, J PHYCOL, V33, P44, DOI 10.1111/j.0022-3646.1997.00044.x; Stoltzfus A, 2004, CURR BIOL, V14, pR351, DOI 10.1016/j.cub.2004.04.024; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Tomita M, 1996, MOL BIOL EVOL, V13, P1219, DOI 10.1093/oxfordjournals.molbev.a025687; Tordai H, 2004, FEBS LETT, V575, P109, DOI 10.1016/j.febslet.2004.08.045; Triplett Edward L., 1993, Molecular Marine Biology and Biotechnology, V2, P246; Voolstra CR, 2009, COMP BIOCHEM PHYS D, V4, P67, DOI 10.1016/j.cbd.2008.11.001; Weis VM, 2002, J PHYCOL, V38, P157, DOI 10.1046/j.1529-8817.2002.01132.x; Wilcox TP, 1998, MOL PHYLOGENET EVOL, V10, P436, DOI 10.1006/mpev.1998.0546; Yoshikawa T, 1996, FISHERIES SCI, V62, P204, DOI 10.2331/fishsci.62.204; Yu J, 2010, SATE WIN RELEASE 0 0	98	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110608	10.1371/journal.pone.0110608	http://dx.doi.org/10.1371/journal.pone.0110608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330037	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100094
J	Ahamad, MS; Siddiqui, S; Jafri, A; Ahmad, S; Afzal, M; Arshad, M				Ahamad, Md Sultan; Siddiqui, Sahabjada; Jafri, Asif; Ahmad, Sheeba; Afzal, Mohammad; Arshad, Md			Induction of Apoptosis and Antiproliferative Activity of Naringenin in Human Epidermoid Carcinoma Cell through ROS Generation and Cell Cycle Arrest	PLOS ONE			English	Article							OXIDATIVE STRESS; GRAPEFRUIT JUICE; FLAVONOIDS; DAMAGE; BIOAVAILABILITY; CARCINOGENESIS; ACTIVATION; DEATH; LINES	A natural predominant flavanone naringenin, especially abundant in citrus fruits, has a wide range of pharmacological activities. The search for antiproliferative agents that reduce skin carcinoma is a task of great importance. The objective of this study was to analyze the anti-proliferative and apoptotic mechanism of naringenin using MTT assay, DNA fragmentation, nuclear condensation, change in mitochondrial membrane potential, cell cycle kinetics and caspase-3 as biomarkers and to investigate the ability to induce reactive oxygen species (ROS) initiating apoptotic cascade in human epidermoid carcinoma A431 cells. Results showed that naringenin exposure significantly reduced the cell viability of A431 cells (p<0.01) with a concomitant increase in nuclear condensation and DNA fragmentation in a dose dependent manner. The intracellular ROS generation assay showed statistically significant (p<0.001) dose-related increment in ROS production for naringenin. It also caused naringenin-mediated epidermoid carcinoma apoptosis by inducing mitochondrial depolarization. Cell cycle study showed that naringenin induced cell cycle arrest in G(0)/G(1) phase of cell cycle and caspase-3 analysis revealed a dose dependent increment in caspase-3 activity which led to cell apoptosis. This study confirms the efficacy of naringenin that lead to cell death in epidermoid carcinoma cells via inducing ROS generation, mitochondrial depolarization, nuclear condensation, DNA fragmentation, cell cycle arrest in G(0)/G(1) phase and caspase-3 activation.	[Ahamad, Md Sultan; Jafri, Asif] Shibli Natl PG Coll, Dept Zool, Azamgarh, Uttar Pradesh, India; [Siddiqui, Sahabjada; Arshad, Md] Univ Lucknow, Dept Zool, Mol Endocrinol Lab, Lucknow 226007, Uttar Pradesh, India; [Ahmad, Sheeba] DS Coll, Dept Zool, Aligarh, Uttar Pradesh, India; [Afzal, Mohammad] Aligarh Muslim Univ, Dept Zool, Human Genet & Toxicol Lab, Aligarh 202002, Uttar Pradesh, India	Lucknow University; Aligarh Muslim University	Arshad, M (corresponding author), Univ Lucknow, Dept Zool, Mol Endocrinol Lab, Lucknow 226007, Uttar Pradesh, India.	molendolab@gmail.com	Jafri, Asif/AAT-6238-2020; Siddiqui, Sahabjada/E-8383-2015	Jafri, Asif/0000-0001-9835-5261; Siddiqui, Sahabjada/0000-0003-0982-1465; Afzal, Mohammad/0000-0001-8189-8753	University Grant Commission (UGC), New Delhi, India [42-500/2013SR, 37-436/2009SR]; ICMR, New Delhi, India [45/26/2013/BMS/TRM]	University Grant Commission (UGC), New Delhi, India(University Grants Commission, India); ICMR, New Delhi, India(Indian Council of Medical Research (ICMR))	This study is supported by the University Grant Commission (UGC), New Delhi, India as major research projects (No. 42-500/2013SR and 37-436/2009SR). Author Sahabjada Siddiqui is thankful to ICMR, New Delhi, India for Senior Research Fellowship (No. 45/26/2013/BMS/TRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakal MF, 2010, FOOD CHEM TOXICOL, V48, P1688, DOI 10.1016/j.fct.2010.03.046; Alarifi S, 2013, INT J NANOMED, V8, P189, DOI 10.2147/IJN.S37924; Ameer B, 1996, CLIN PHARMACOL THER, V60, P34, DOI 10.1016/S0009-9236(96)90164-2; Ashfaq M, 2013, IND ENG CHEM RES, V52, P4672, DOI 10.1021/ie303273s; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Birt DF, 2001, PHARMACOL THERAPEUT, V90, P157, DOI 10.1016/S0163-7258(01)00137-1; Bugianesi R, 2004, EUR J NUTR, V43, P360, DOI 10.1007/s00394-004-0483-1; Chakravarti B, 2012, J ETHNOPHARMACOL, V142, P72, DOI 10.1016/j.jep.2012.04.015; Chaurasia D, 2013, ARABIAN J CHEM; Cohn SM, 1992, BIOCHEM J, V286, P331; Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Frydoonfar H R, 2003, Colorectal Dis, V5, P149, DOI 10.1046/j.1463-1318.2003.00444.x; FUHR U, 1995, CLIN PHARMACOL THER, V58, P365, DOI 10.1016/0009-9236(95)90048-9; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Harmon AW, 2003, BIOCHEM BIOPH RES CO, V305, P229, DOI 10.1016/S0006-291X(03)00720-4; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HERTOG MGL, 1993, NUTR CANCER, V20, P21, DOI 10.1080/01635589309514267; Ishii K, 1997, J CHROMATOGR B, V704, P299, DOI 10.1016/S0378-4347(97)00474-X; Jeyabal PVS, 2005, MOL CARCINOGEN, V44, P11, DOI 10.1002/mc.20115; Kanadaswami C, 2005, IN VIVO, V19, P895; Kanno S, 2005, BIOL PHARM BULL, V28, P527, DOI 10.1248/bpb.28.527; Kapoor R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041663; Kumari A, 2012, FOOD CHEM TOXICOL, V50, P1781, DOI 10.1016/j.fct.2012.02.042; Lee YS, 1998, PHARMACOLOGY, V56, P314, DOI 10.1159/000028215; Lewandowska U, 2013, J AGR FOOD CHEM, V61, P2987, DOI 10.1021/jf304269x; Lin CT, 2006, INT J CANCER, V119, P1776, DOI 10.1002/ijc.22068; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Matsuo M, 2005, BIOL PHARM BULL, V28, P253, DOI 10.1248/bpb.28.253; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Park JH, 2008, FOOD CHEM TOXICOL, V46, P3684, DOI 10.1016/j.fct.2008.09.056; Pierangela T, 2004, IUBMB LIFE, V56, P491; Prakasham RS, 2010, APPL BIOCHEM BIOTECH, V160, P72, DOI 10.1007/s12010-009-8679-8; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Selvendiran K, 2004, CLIN CHIM ACTA, V350, P73, DOI 10.1016/j.cccn.2004.07.004; Shen SC, 2003, J CELL BIOCHEM, V89, P1044, DOI 10.1002/jcb.10559; Sundari PN, 1997, BBA-MOL BASIS DIS, V1362, P169, DOI 10.1016/S0925-4439(97)00065-3; Thirunavukkarasu C, 2001, CELL BIOCHEM FUNCT, V19, P27, DOI 10.1002/cbf.895; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176; Zhao M, 2008, ORL-J OTO-RHIN-LARYN, V70, P257, DOI 10.1159/000133280	44	106	108	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110003	10.1371/journal.pone.0110003	http://dx.doi.org/10.1371/journal.pone.0110003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330158	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800051
J	Ercit, K; Martinez-Novoa, A; Gwynne, DT				Ercit, Kyla; Martinez-Novoa, Andrew; Gwynne, Darryl T.			Egg Load Decreases Mobility and Increases Predation Risk in Female Black-Horned Tree Crickets (Oecanthus nigricornis)	PLOS ONE			English	Article							MEXICANA SAUSSURE HYMENOPTERA; MATE CHOICE; ESCAPE PERFORMANCE; COURTSHIP BEHAVIOR; REPRODUCTIVE COSTS; DIGGER WASP; PREY; SEX; SPHECIDAE; POPULATION	Female-biased predation is an uncommon phenomenon in nature since males of many species take on riskier behaviours to gain more mates. Several species of sphecid wasps have been observed taking more female than male prey, and it is not fully understood why. The solitary sphecid Isodontia mexicana catches more adult female tree cricket (Oecanthus nigricornis) prey. Previous work has shown that, although female tree crickets are larger and thus likely to be more valuable as prey than males, body size alone cannot fully explain why wasps take more females. We tested the hypothesis that wasps catch adult female tree crickets more often because bearing eggs impedes a female's ability to escape predation. We compared female survivors to prey of I. mexicana, and found that females carrying more eggs were significantly more likely to be caught by wasps, regardless of their body size and jumping leg mass. We also conducted laboratory experiments where females' jumping responses to a simulated attack were measured and compared to her egg load and morphology. We found a significant negative relationship between egg load and jumping ability, and a positive relationship between body size and jumping ability. These findings support the hypothesis that ovarian eggs are a physical handicap that contributes to female-biased predation in this system. Predation on the most fecund females may have ecological-evolutionary consequences such as collapse of prey populations or selection for alternate life history strategies and behaviours.	[Ercit, Kyla] Univ Toronto, Mississauga, ON L5L 1C6, Canada; [Martinez-Novoa, Andrew; Gwynne, Darryl T.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga; University of Toronto; University Toronto Mississauga	Ercit, K (corresponding author), Univ Toronto, Mississauga, ON L5L 1C6, Canada.	kyla.ercit@utoronto.ca		Ercit, Kyla/0000-0002-5440-9771	National Science and Engineering Research Council of Canada [RGPIN 3786-10]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by a National Science and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) Discovery Grant to DTG (RGPIN 3786-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1967, TRAP NESTING WASPS B; ARNQVIST G, 1989, ANIM BEHAV, V38, P749, DOI 10.1016/S0003-3472(89)80107-1; Ayers H, 1884, TELEAS BOST SOC NAT, V3, P225; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; BERGLUND A, 1986, OIKOS, V46, P349, DOI 10.2307/3565833; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Boukal DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002687; Brown WD, 1997, ANIM BEHAV, V54, P1369, DOI 10.1006/anbe.1997.0541; BURK T, 1982, FLA ENTOMOL, V65, P90, DOI 10.2307/3494148; Capinera J. L., 2005, FIELD GUIDE GRASSHOP; Coelho JR, 1999, ECOL ENTOMOL, V24, P480, DOI 10.1046/j.1365-2311.1999.00219.x; COOPER WE, 1990, BEHAV ECOL SOCIOBIOL, V27, P153; Dangles O, 2007, J EXP BIOL, V210, P3165, DOI 10.1242/jeb.004648; Dukas R, 2005, ECOLOGY, V86, P1401, DOI 10.1890/04-1663; ENDLER JA, 1987, ANIM BEHAV, V35, P1376, DOI 10.1016/S0003-3472(87)80010-6; Ercit K, 2014, ECOL ENTOMOL, V39, P195, DOI 10.1111/een.12083; Frick Michael G., 2010, Endangered Species Research, V9, P91, DOI 10.3354/esr00227; Fulton B.B., 1915, NEW YORK AGR EXP STN, V42, P53; Funk DH, 2000, ANIM BEHAV, V59, P411, DOI 10.1006/anbe.1999.1310; Gotmark F, 1997, OIKOS, V80, P540, DOI 10.2307/3546627; Gwynne DT, 2007, ANIM BEHAV, V73, P1077, DOI 10.1016/j.anbehav.2006.11.011; Gwynne DT, 2002, BEHAVIOUR, V139, P1425, DOI 10.1163/15685390260514690; GWYNNE DT, 1983, ANN ENTOMOL SOC AM, V76, P434, DOI 10.1093/aesa/76.3.434; HAIRSTON NG, 1983, LIMNOL OCEANOGR, V28, P935, DOI 10.4319/lo.1983.28.5.0935; Hallett P, 2001, AM BEE J, V141, P441; Hawlena D, 2011, FUNCT ECOL, V25, P279, DOI 10.1111/j.1365-2435.2010.01767.x; HEDRICK AV, 1993, ANIM BEHAV, V46, P193, DOI 10.1006/anbe.1993.1176; Hook AW, 2004, J KANSAS ENTOMOL SOC, V77, P558, DOI 10.2317/E22.1; Irschick DJ, 2003, INTEGR COMP BIOL, V43, P396, DOI 10.1093/icb/43.3.396; Iwata K., 1976, EVOLUTION INSTINCT C; Kaitala A, 2000, OIKOS, V89, P254, DOI 10.1034/j.1600-0706.2000.890205.x; Kemp DJ, 2012, BEHAV ECOL, V23, P191, DOI 10.1093/beheco/arr173; Kullberg C, 2002, BEHAV ECOL, V13, P575, DOI 10.1093/beheco/13.4.575; Kurczewski FE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14143; Lewis SE, 2010, J FRESHWATER ECOL, V25, P395, DOI 10.1080/02705060.2010.9664382; Li DQ, 2003, BEHAV ECOL SOCIOBIOL, V55, P129, DOI 10.1007/s00265-003-0689-x; LIN N, 1979, P ENTOMOL SOC WASH, V81, P269; MADSEN T, 1987, OIKOS, V49, P129, DOI 10.2307/3566017; MEDLER J. T., 1965, ANN ENTOMOL SOC AMER, V58, P137; O'Neill KM, 2007, ENTOMOL NEWS, V118, P139, DOI 10.3157/0013-872X(2007)118[139:NAPOIE]2.0.CO;2; O'Neill KM, 2009, ENTOMOL AM, V115, P90, DOI 10.1664/07-RA-009.1; O'Neill KM, 2003, J KANSAS ENTOMOL SOC, V76, P447; POCKLINGTON R, 1995, ANIM BEHAV, V49, P1122, DOI 10.1006/anbe.1995.0141; Post P, 2006, J AVIAN BIOL, V37, P158, DOI 10.1111/j.2006.0908-8857.03338.x; Post P, 2006, AUK, V123, P162, DOI 10.1642/0004-8038(2006)123[0162:FBAPRI]2.0.CO;2; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; ROWE L, 1994, ANIM BEHAV, V48, P1049, DOI 10.1006/anbe.1994.1338; SAKALUK SK, 1984, ANIM BEHAV, V32, P659, DOI 10.1016/S0003-3472(84)80141-4; SEIGEL RA, 1987, OECOLOGIA, V73, P481, DOI 10.1007/BF00379404; SHINE R, 1980, Oecologia (Berlin), V46, P92, DOI 10.1007/BF00346972; Su KFY, 2006, ANIM BEHAV, V71, P531, DOI 10.1016/j.anbehav.2005.04.024; SVENSSON I, 1988, J ANIM ECOL, V57, P929, DOI 10.2307/5102; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vickery VR., 1985, GRASSHOPPERS CRICKET; Volkova T, 1999, J ENTOMOL SCI, V34, P322, DOI 10.18474/0749-8004-34.3.322; Zuk M, 2006, BIOL LETTERS, V2, P521, DOI 10.1098/rsbl.2006.0539	56	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110298	10.1371/journal.pone.0110298	http://dx.doi.org/10.1371/journal.pone.0110298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25330090	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200111
J	Foulquier, S; Lartaud, I; Dupuis, F				Foulquier, Sebastien; Lartaud, Isabelle; Dupuis, Francois			Impact of Short-Term Treatment with Telmisartan on Cerebral Arterial Remodeling in SHR	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; CONVERTING-ENZYME-INHIBITOR; BLOOD-FLOW; RESISTANCE ARTERIES; RECEPTOR BLOCKER; MYOGENIC TONE; AUTOREGULATION; CIRCULATION; PRESSURE; PERINDOPRIL	Background and Purpose: Chronic hypertension decreases internal diameter of cerebral arteries and arterioles. We recently showed that short-term treatment with the angiotensin II receptor blocker telmisartan restored baseline internal diameter of small cerebral arterioles in spontaneously hypertensive rats (SHR), via reversal of structural remodeling and inhibition of the angiotensin II vasoconstrictor response. As larger arteries also participate in the regulation of cerebral circulation, we evaluated whether similar short-term treatment affects middle cerebral arteries of SHR. Methods: Baseline internal diameters of pressurised middle cerebral arteries from SHR and their respective controls, Wistar Kyoto rats (WKY) and responses to angiotensin II were studied in a small vessel arteriograph. Pressure myogenic curves and passive internal diameters were measured following EDTA deactivation, and elastic modulus from stress-strain relationships. Results: Active baseline internal diameter was 23% lower in SHR compared to WKY, passive internal diameter (EDTA) 28% lower and elastic modulus unchanged. Pressure myogenic curves were shifted to higher pressure values in SHR. Telmisartan lowered blood pressure but had no effect on baseline internal diameter nor on structural remodeling (passive internal diameter and elastic modulus remained unchanged compared to SHR). Telmisartan shifted the pressure myogenic curve to lower pressure values than SHR. Conclusion: In the middle cerebral arteries of SHR, short-term treatment with telmisartan had no effect on structural remodeling and did not restore baseline internal diameter, but allowed myogenic tone to adapt towards lower pressure values.	[Foulquier, Sebastien; Lartaud, Isabelle; Dupuis, Francois] Univ Lorraine, CITHEFOR Drug Targets Formulat & Preclin Assessme, Fac Pharm, EA3452, Nancy, France	Universite de Lorraine	Foulquier, S (corresponding author), Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands.	francois.dupuis@univ-lorraine.fr	Foulquier, Sébastien/AAE-6998-2019	Foulquier, Sébastien/0000-0002-2523-0748; DUPUIS, Francois/0000-0003-1947-3839; Lartaud, Isabelle/0000-0001-9257-6311	French Ministry of Education, Research and Technology (Paris, France) [EA3452]; Lorraine Regional Development Committee (Metz, France); Regional Coordination and Research Council (Nancy, Metz, France); "Universite de Lorraine" (Nancy, France)	French Ministry of Education, Research and Technology (Paris, France); Lorraine Regional Development Committee (Metz, France); Regional Coordination and Research Council (Nancy, Metz, France); "Universite de Lorraine" (Nancy, France)	The work was funded by the French Ministry of Education, Research and Technology (Paris, France, EA3452), the Lorraine Regional Development Committee (Metz, France), the Regional Coordination and Research Council (Nancy, Metz, France), and the "Universite de Lorraine" (Nancy, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON J, 1990, EUR J PHARMACOL, V183, P2066, DOI 10.1016/0014-2999(90)92434-K; BAUMBACH GL, 1988, CIRC RES, V62, P56, DOI 10.1161/01.RES.62.1.56; BAUMBACH GL, 1989, HYPERTENSION, V13, P968, DOI 10.1161/01.HYP.13.6.968; BEVAN JA, 1985, ANN BIOMED ENG, V13, P281, DOI 10.1007/BF02584245; BRAY L, 1991, AM J HYPERTENS, V4, pS246, DOI 10.1093/ajh/4.3.246S; Dunn WR, 1998, J VASC RES, V35, P18, DOI 10.1159/000025561; Dupuis F, 2005, J HYPERTENS, V23, P1061, DOI 10.1097/01.hjh.0000166848.95592.a5; Dupuis F, 2010, J HYPERTENS, V28, P1566, DOI 10.1097/HJH.0b013e328339f1f3; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; Foulquier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042469; HALPERN W, 1985, ANN BIOMED ENG, V13, P287, DOI 10.1007/BF02584246; Izzard AS, 2003, AM J PHYSIOL-HEART C, V285, pH1489, DOI 10.1152/ajpheart.00352.2003; JOHNSON PC, 1986, CIRC RES, V59, P483, DOI 10.1161/01.RES.59.5.483; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; MACKENZIE ET, 1979, STROKE, V10, P711, DOI 10.1161/01.STR.10.6.711; New DI, 2004, KIDNEY INT, V65, P1818, DOI 10.1111/j.1523-1755.2004.00591.x; Nishimura Y, 2000, STROKE, V31, P2478, DOI 10.1161/01.STR.31.10.2478; Osmond JM, 2009, HYPERTENSION, V53, P381, DOI 10.1161/HYPERTENSIONAHA.108.124149; PAULSON OB, 1991, BLOOD VESSELS, V28, P231; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; TODA N, 1982, JPN CIRC J, V46, P1088, DOI 10.1253/jcj.46.1088; WINQUIST RJ, 1983, HYPERTENSION, V5, P292, DOI 10.1161/01.HYP.5.3.292	23	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110766	10.1371/journal.pone.0110766	http://dx.doi.org/10.1371/journal.pone.0110766			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333878	gold, Green Published			2022-12-27	WOS:000346766200130
J	Harandi, VM; Lindquist, S; Kolan, SS; Brannstrom, T; Liu, JX				Harandi, Vahid M.; Lindquist, Susanne; Kolan, Shrikant Shantilal; Brannstrom, Thomas; Liu, Jing-Xia			Analysis of Neurotrophic Factors in Limb and Extraocular Muscles of Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; SUPEROXIDE-DISMUTASE GENE; RAT SPINAL-CORD; SKELETAL-MUSCLE; MESSENGER-RNA; NEUROMUSCULAR-JUNCTION; EXPRESSION; BRAIN; GDNF; MOTONEURONS	Amyotrophic lateral sclerosis (ALS) is currently an incurable fatal motor neuron syndrome characterized by progressive weakness, muscle wasting and death ensuing 3-5 years after diagnosis. Neurotrophic factors (NTFs) are known to be important in both nervous system development and maintenance. However, the attempt to translate the potential of NTFs into the therapeutic options remains limited despite substantial number of approaches, which have been tested clinically. Using quantitative RT-PCR (qRT-PCR) technique, the present study investigated mRNA expression of four different NTFs: brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4/5 (NT-4) and glial cell line-derived neurotrophic factor (GDNF) in limb muscles and extraocular muscles (EOMs) from SOD1 G93A transgenic mice at early and terminal stages of ALS. General morphological examination revealed that muscle fibres were well preserved in both limb muscles and EOMs in early stage ALS mice. However, in terminal ALS mice, most muscle fibres were either atrophied or hypertrophied in limb muscles but unaffected in EOMs. qRT-PCR analysis showed that in early stage ALS mice, NT-4 was significantly down-regulated in limb muscles whereas NT-3 and GDNF were markedly up-regulated in EOMs. In terminal ALS mice, only GDNF was significantly up-regulated in limb muscles. We concluded that the early down-regulation of NT-4 in limb muscles is closely associated with muscle dystrophy and dysfunction at late stage, whereas the early up-regulations of GDNF and NT-3 in EOMs are closely associated with the relatively well-preserved muscle morphology at late stage. Collectively, the data suggested that comparing NTFs expression between limb muscles and EOMs from different stages of ALS animal models is a useful method in revealing the patho-physiology and progression of ALS, and eventually rescuing motor neuron in ALS patients.	[Harandi, Vahid M.; Kolan, Shrikant Shantilal; Liu, Jing-Xia] Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden; [Lindquist, Susanne] Umea Univ, Dept Clin Sci, Umea, Sweden; [Brannstrom, Thomas] Umea Univ, Dept Med Biosci, Umea, Sweden	Umea University; Umea University; Umea University	Liu, JX (corresponding author), Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden.	jingxia.liu@umu.se	Harandi, Vahid M./AAC-5959-2020	Harandi, Vahid M./0000-0001-9255-0517	The Swedish Research Council [K2012-63X-20399-06-3, 2011-2610]; Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for Synskadade; The Swedish Medical Society; Ogonfonden; County Council of Vasterbotten	The Swedish Research Council(Swedish Research Council); Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for Synskadade; The Swedish Medical Society; Ogonfonden; County Council of Vasterbotten	This work is supported by The Swedish Research Council (K2012-63X-20399-06-3 [FPD]; Dnr 2011-2610 [TB]); Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for Synskadade (JXL); The Swedish Medical Society (JXL); Ogonfonden (JXL); and the County Council of Vasterbotten including a Cutting Edge Medical Research Grant (FPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsadi G, 2002, HUM GENE THER, V13, P1047, DOI 10.1089/104303402753812458; Ahmadi M, 2010, INVEST OPHTH VIS SCI, V51, P3494, DOI 10.1167/iovs.09-5030; ANAND P, 1995, NAT MED, V1, P168, DOI 10.1038/nm0295-168; Andersen PM, 2007, AMYOTROPH LATERAL SC, V8, P195, DOI 10.1080/17482960701262376; Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; APPEL SH, 1981, ANN NEUROL, V10, P499, DOI 10.1002/ana.410100602; Beaumont E, 2003, MUSCLE NERVE, V27, P228, DOI 10.1002/mus.10308; Belluardo N, 2001, MOL CELL NEUROSCI, V18, P56, DOI 10.1006/mcne.2001.1001; Bemelmans AP, 2006, J NEUROSCI RES, V83, P50, DOI 10.1002/jnr.20704; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Braun S, 1996, J NEUROL SCI, V136, P17, DOI 10.1016/0022-510X(95)00315-S; Chen HH, 2002, J NEUROSCI, V22, P3512; Cohen S, 1960, BIOCHEMISTRY-US, V46, P302; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dobrowolny G, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-3; Duberley RM, 1997, J NEUROL SCI, V148, P33, DOI 10.1016/S0022-510X(96)00312-7; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390; Ekestern E, 2004, NEURODEGENER DIS, V1, P88, DOI 10.1159/000080049; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fischer MD, 2005, PHYSIOL GENOMICS, V22, P283, DOI 10.1152/physiolgenomics.00158.2004; Frey D, 2000, J NEUROSCI, V20, P2534; FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Gorokhova S, 2009, J NEUROSCI, V29, P10181, DOI 10.1523/JNEUROSCI.2741-09.2009; Gould TW, 2011, BRAIN RES REV, V67, P1, DOI 10.1016/j.brainresrev.2010.10.003; GRIESBECK O, 1995, J NEUROSCI RES, V42, P21, DOI 10.1002/jnr.490420104; Grundstrom E, 1999, J NEUROL SCI, V162, P169, DOI 10.1016/S0022-510X(98)00333-5; Grundstrom E, 2000, NEUROREPORT, V11, P1781, DOI 10.1097/00001756-200006050-00037; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Henriques A, 2010, FRONTIERS NEUROSCIEN, V4, P1; IKEDA K, 1995, ANN NEUROL, V37, P505, DOI 10.1002/ana.410370413; Ip FCF, 2001, NEUROSCI LETT, V301, P107, DOI 10.1016/S0304-3940(01)01603-2; KAMINSKI HJ, 1992, ANN NEUROL, V32, P586, DOI 10.1002/ana.410320418; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Kawamoto Y, 1998, J NEUROPATH EXP NEUR, V57, P822, DOI 10.1097/00005072-199809000-00003; Kust BM, 2002, EXP NEUROL, V177, P419, DOI 10.1006/exnr.2002.8011; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; Li W, 2007, EXP NEUROL, V203, P457, DOI 10.1016/j.expneurol.2006.08.028; Liu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057473; Liu JX, 2011, INVEST OPHTH VIS SCI, V52, P4842, DOI 10.1167/iovs.10-7132; Liu JX, 2009, INVEST OPHTH VIS SCI, V50, P3226, DOI 10.1167/iovs.08-3333; Mitsumoto H, 1999, MUSCLE NERVE, V22, P983, DOI 10.1002/(SICI)1097-4598(199908)22:8<983::AID-MUS1>3.0.CO;2-V; Nagano M, 2003, NEUROSCI RES, V45, P391, DOI 10.1016/S0168-0102(03)00010-5; Nystrom A, 2006, MATRIX BIOL, V25, P382, DOI 10.1016/j.matbio.2006.05.001; Pedrosa-Domellf F., 2010, ENCY EYE, V2, P99; Pitts EV, 2006, INT ANESTHESIOL CLIN, V44, P21, DOI 10.1097/00004311-200604420-00004; Porter JD, 2001, P NATL ACAD SCI USA, V98, P12062, DOI 10.1073/pnas.211257298; Rocha MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073846; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Saarma M, 1999, MICROSC RES TECHNIQ, V45, P292, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<292::AID-JEMT13>3.0.CO;2-8; Sadeh M, 1994, MYOLOGY, P119; Sakuma K, 2001, BRAIN RES, V907, P1, DOI 10.1016/S0006-8993(01)02288-0; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SEEBURGER JL, 1993, EXP NEUROL, V124, P64, DOI 10.1006/exnr.1993.1176; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; STEWART SS, 1988, ANNU REV MED, V39, P193, DOI 10.1146/annurev.med.39.1.193; Taylor MD, 2001, SOMATOSENS MOT RES, V18, P286; TIMMUSK T, 1993, EUR J NEUROSCI, V5, P605, DOI 10.1111/j.1460-9568.1993.tb00526.x; Tjust Anton E, 2012, Front Biosci (Schol Ed), V4, P1547; Wang LJ, 2002, J NEUROSCI, V22, P6920; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; Woolley AG, 2005, EUR J NEUROSCI, V21, P2100, DOI 10.1111/j.1460-9568.2005.04052.x; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; Zwick M, 2001, EXP NEUROL, V171, P342, DOI 10.1006/exnr.2001.7753	69	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109833	10.1371/journal.pone.0109833	http://dx.doi.org/10.1371/journal.pone.0109833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25334047	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200057
J	Irimia, C; Tuong, RN; Quach, T; Parsons, LH				Irimia, Cristina; Tuong, Roxanne N.; Quach, Tammy; Parsons, Loren H.			Impaired Response Inhibition in the Rat 5 Choice Continuous Performance Task during Protracted Abstinence from Chronic Alcohol Consumption	PLOS ONE			English	Article							REACTION-TIME-TASK; PREFRONTAL CORTEX; COGNITIVE CONTROL; IMPULSE CONTROL; 5-HT DEPLETION; WORKING-MEMORY; DEPENDENCE; DYSFUNCTION; ATTENTION; ADDICTION	Impaired cognitive processing is a hallmark of addiction. In particular, deficits in inhibitory control can propel continued drug use despite adverse consequences. Clinical evidence shows that detoxified alcoholics exhibit poor inhibitory control in the Continuous Performance Task (CPT) and related tests of motor impulsivity. Animal models may provide important insight into the neural mechanisms underlying this consequence of chronic alcohol exposure though pre-clinical investigations of behavioral inhibition during alcohol abstinence are sparse. The present study employed the rat 5 Choice-Continuous Performance Task (5C-CPT), a novel pre-clinical variant of the CPT, to evaluate attentional capacity and impulse control over the course of protracted abstinence from chronic intermittent alcohol consumption. In tests conducted with familiar 5C-CPT conditions EtOH-exposed rats exhibited impaired attentional capacity during the first hours of abstinence and impaired behavioral restraint (increased false alarms) during the first 5d of abstinence that dissipated thereafter. Subsequent tests employing visual distractors that increase the cognitive load of the task revealed significant increases in impulsive action (premature responses) at 3 and 5 weeks of abstinence, and the emergence of impaired behavioral restraint (increased false alarms) at 7 weeks of abstinence. Collectively, these findings demonstrate the emergence of increased impulsive action in alcohol-dependent rats during protracted alcohol abstinence and suggest the 5C-CPT with visual distractors may provide a viable behavioral platform for characterizing the neurobiological substrates underlying impaired behavioral inhibition resulting from chronic intermittent alcohol exposure.	[Irimia, Cristina; Tuong, Roxanne N.; Quach, Tammy; Parsons, Loren H.] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA	Scripps Research Institute	Parsons, LH (corresponding author), Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA.	lparsons@scripps.edu			National Institute of Alcohol Abuse and Alcoholism [R01 AA022249, P60 AA006420]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA006420, R01AA022249] Funding Source: NIH RePORTER	National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	LP received funding from National Institute of Alcohol Abuse and Alcoholism (R01 AA022249 and P60 AA006420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragues M, 2011, EUR ADDICT RES, V17, P64, DOI 10.1159/000321345; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Barnes SA, 2012, NEUROPHARMACOLOGY, V62, P1432, DOI 10.1016/j.neuropharm.2011.04.024; Barnes SA, 2012, PSYCHOPHARMACOLOGY, V220, P129, DOI 10.1007/s00213-011-2460-8; Bjork JM, 2004, ALCOHOL, V34, P133, DOI 10.1016/j.alcohol.2004.06.012; Bowden-Jones H, 2005, J NEUROPSYCH CLIN N, V17, P417, DOI 10.1176/appi.neuropsych.17.3.417; Chanraud S, 2010, NEUROPSYCHOPHARMACOL, V35, P1868, DOI 10.1038/npp.2010.56; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Demeter E, 2013, SCHIZOPHR RES, V144, P136, DOI 10.1016/j.schres.2013.01.003; Dick DM, 2010, ADDICT BIOL, V15, P217, DOI 10.1111/j.1369-1600.2009.00190.x; Duka T, 2003, ALCOHOL CLIN EXP RES, V27, P1563, DOI 10.1097/01.ALC.0000090142.11260.D7; Duka T, 2011, J PSYCHOPHARMACOL, V25, P1235, DOI 10.1177/0269881110388324; Duka T, 2011, BIOL PSYCHIAT, V70, P545, DOI 10.1016/j.biopsych.2011.04.006; Eagle DM, 2010, NEUROSCI BIOBEHAV R, V34, P50, DOI 10.1016/j.neubiorev.2009.07.003; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fein G, 2006, ALCOHOL CLIN EXP RES, V30, P1538, DOI 10.1111/j.1530-0277.2006.00185.x; Gilpin NW, 2009, ALCOHOL CLIN EXP RES, V33, P2113, DOI 10.1111/j.1530-0277.2009.01051.x; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Hahn B, 2002, PSYCHOPHARMACOLOGY, V162, P129, DOI 10.1007/s00213-002-1005-6; Harrison AA, 1997, PSYCHOPHARMACOLOGY, V133, P329, DOI 10.1007/s002130050410; Harrison AA, 1999, BEHAV BRAIN RES, V100, P99, DOI 10.1016/S0166-4328(98)00117-X; Homberg JR, 2007, EUR J NEUROSCI, V26, P2066, DOI 10.1111/j.1460-9568.2007.05839.x; Irimia C, 2014, ADDICTION B IN PRESS; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Jha Amishi P., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P517, DOI 10.3758/CABN.4.4.517; Jung YM, 2014, J MOL STRUCT, V1069, P1, DOI 10.1016/j.molstruc.2014.02.020; Kamarajan C, 2005, BIOL PSYCHOL, V69, P353, DOI 10.1016/j.biopsycho.2004.08.004; Lawrence AJ, 2009, PSYCHOPHARMACOLOGY, V207, P163, DOI 10.1007/s00213-009-1645-x; Li CSR, 2009, ALCOHOL CLIN EXP RES, V33, P740, DOI 10.1111/j.1530-0277.2008.00891.x; MacKillop J, 2009, DRUG ALCOHOL DEPEN, V104, P197, DOI 10.1016/j.drugalcdep.2009.04.020; McKenna BS, 2013, PSYCHIAT RES NEUROIM; Moselhy HF, 2001, ALCOHOL ALCOHOLISM, V36, P357, DOI 10.1093/alcalc/36.5.357; Noel X, 2001, ARCH GEN PSYCHIAT, V58, P1152, DOI 10.1001/archpsyc.58.12.1152; Noel X, 2013, DRUG ALCOHOL DEPEN, V128, P200, DOI 10.1016/j.drugalcdep.2012.08.021; Preuss UW, 2001, NEUROPSYCHOBIOLOGY, V43, P186, DOI 10.1159/000054888; Ragozzino ME, 2002, NEUROBIOL LEARN MEM, V77, P29, DOI 10.1006/nlme.2001.4003; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Robinson ESJ, 2009, BEHAV BRAIN RES, V196, P310, DOI 10.1016/j.bbr.2008.09.021; Rubio G, 2008, ALCOHOL CLIN EXP RES, V32, P1681, DOI 10.1111/j.1530-0277.2008.00746.x; Salgado JV, 2009, REV BRAS PSIQUIATR, V31, P4, DOI 10.1590/S1516-44462009000100003; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Semenova S, 2012, PSYCHOPHARMACOLOGY, V219, P433, DOI 10.1007/s00213-011-2458-2; Stavro K, 2013, ADDICT BIOL, V18, P203, DOI 10.1111/j.1369-1600.2011.00418.x; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Sullivan EV, 2000, NEUROPSYCHOLOGY, V14, P178, DOI 10.1037//0894-4105.14.2.178; Tucker JA, 2011, ALCOHOL RES HEALTH, V33, P371; Underwood MD, 2008, ALCOHOL CLIN EXP RES, V32, P593, DOI 10.1111/j.1530-0277.2007.00610.x; Walker SE, 2011, PSYCHOPHARMACOLOGY, V217, P433, DOI 10.1007/s00213-011-2298-0; Winstanley CA, 2004, PSYCHOPHARMACOLOGY, V176, P376, DOI 10.1007/s00213-004-1884-9; Young JW, 2011, BEHAV BRAIN RES, V222, P183, DOI 10.1016/j.bbr.2011.03.054; Young JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004227	58	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109948	10.1371/journal.pone.0109948	http://dx.doi.org/10.1371/journal.pone.0109948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333392	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200068
J	Kroll, A; Behra, R; Kaegi, R; Sigg, L				Kroll, Alexandra; Behra, Renata; Kaegi, Ralf; Sigg, Laura			Extracellular Polymeric Substances (EPS) of Freshwater Biofilms Stabilize and Modify CeO2 and Ag Nanoparticles	PLOS ONE			English	Article							ORGANIC-CARBON DETECTION; SILVER NANOPARTICLES; OXIDE NANOPARTICLES; GREEN SYNTHESIS; PERIPHYTON; CERIUM; BEHAVIOR; TOXICITY; MATTER; ALGAE	Streams are potential receiving compartments for engineered nanoparticles (NP). In streams, NP may remain dispersed or settle to the benthic compartment. Both dispersed and settling NP can accumulate in benthic biofilms called periphyton that are essential to stream ecosystems. Periphytic organisms excrete extracellular polymeric substances (EPS) that interact with any material reaching the biofilms. To understand the interaction of NP with periphyton it is therefore crucial to study the interaction of NP with EPS. We investigated the influence of EPS on the physicochemical properties of selected NP (CeO2, Ag) under controlled conditions at pH 6, 7.6, 8.6 and light or dark exposure. We extracted EPS from five different periphyton communities, characterized the extracts, and exposed CeO2 and carbonate-stabilized Ag NP (0.5 and 5 mg/L, both 25 nm primary particle size) and AgNO3 to EPS (10 mg/L) over two weeks. We measured NP size distribution, shape, primary particle size, surface plasmon resonance, and dissolution. All EPS extracts were composed of biopolymers, building blocks of humic substances, low molecular weight (M-r) acids, and small amphiphilic or neutral compounds in varying concentrations. CeO2 NP were stabilized by EPS independent of pH and light/dark while dissolution increased over time in the dark at pH 6. EPS induced a size increase in Ag NP in the light with decreasing pH and the formation of metallic Ag NP from AgNO3 at the same conditions via EPS-enhanced photoreduction. NP transformation and formation were slower in the extract with the lowest biopolymer and low Mr acid concentrations. Periphytic EPS in combination with naturally varying pH and light/dark conditions influence the properties of the Ag and CeO2 NP tested and thus the exposure conditions within biofilms. Our results indicate that periphytic organisms may be exposed to a constantly changing mixture of engineered and naturally formed Ag NP and Ag+.	[Kroll, Alexandra; Behra, Renata; Kaegi, Ralf; Sigg, Laura] Eawag, Swiss Fed Inst Aquat Sci & Technol, Environm Toxicol, Dubendorf, Switzerland; [Sigg, Laura] Swiss Fed Inst Technol Zurich ETHZ, Inst Biogeochem & Pollutant Dynam IBP, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Kroll, A (corresponding author), Eawag, Swiss Fed Inst Aquat Sci & Technol, Environm Toxicol, Dubendorf, Switzerland.	alexandra.kroll@eawag.ch	Sigg, Laura/AAI-3504-2020; Sigg, Laura/K-8558-2012	Sigg, Laura/0000-0002-2210-2951	SNF Ambizione grant [PZ00P2_142533]	SNF Ambizione grant	This work was financially supported by an SNF Ambizione grant (PZ00P2_142533, http://www.snf.ch/E/funding/individuals/ambizione/Pages/default.aspx) to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboyega NF, 2013, ENVIRON SCI TECHNOL, V47, P757, DOI 10.1021/es302305f; Akaighe N, 2011, ENVIRON SCI TECHNOL, V45, P3895, DOI 10.1021/es103946g; Allan JD CM, 2007, SREAM ECOLOGY, P67; Baalousha M, 2010, ENVIRON CHEM, V7, P377, DOI 10.1071/EN10003; Baalousha M, 2013, NAT NANOTECHNOL, V8, P308, DOI 10.1038/nnano.2013.78; Bellinger BJ, 2010, J PHYCOL, V46, P484, DOI 10.1111/j.1529-8817.2010.00829.x; Binnemans K, 2006, HBK PHYS CHEM RARE, V36, P281, DOI 10.1016/S0168-1273(06)36003-5; Bradac P, 2009, ENVIRON TOXICOL CHEM, V28, P2108, DOI [10.1897/08-511R1.1, 10.1897/08-511.1]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buschmann J, 2005, ENVIRON SCI TECHNOL, V39, P5335, DOI 10.1021/es050269o; Campbell CT, 2005, SCIENCE, V309, P713, DOI 10.1126/science.1113955; D'Souza F, 2005, AQUAT MICROB ECOL, V41, P199, DOI 10.3354/ame041199; de Brouwer JFC, 2002, J PHYCOL, V38, P464, DOI 10.1046/j.1529-8817.2002.t01-1-01164.x; Dubas ST, 2008, MATER LETT, V62, P2661, DOI 10.1016/j.matlet.2008.01.033; ELDERFIELD H, 1988, PHILOS T R SOC A, V325, P105, DOI 10.1098/rsta.1988.0046; Esposito S, 2006, PLANTA, V223, P796, DOI 10.1007/s00425-005-0110-2; Evanoff DD, 2005, CHEMPHYSCHEM, V6, P1221, DOI 10.1002/cphc.200500113; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Ferry JL, 2009, NAT NANOTECHNOL, V4, P441, DOI [10.1038/NNANO.2009.157, 10.1038/nnano.2009.157]; Flemming H.-C., 2000, BIOFILMS RECENT ADV, P19; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Glover RD, 2011, ACS NANO, V5, P8950, DOI 10.1021/nn2031319; Hayes SA, 2002, J ELECTROCHEM SOC, V149, pC623, DOI 10.1149/1.1516775; Huber SA, 2011, WATER RES, V45, P879, DOI 10.1016/j.watres.2010.09.023; Imagawa H, 2011, J PHYS CHEM C, V115, P1740, DOI 10.1021/jp109878j; Ivanov VK, 2009, RUSS CHEM REV+, V78, P855, DOI 10.1070/RC2009v078n09ABEH004058; Jiang XJ, 2010, J COLLOID INTERF SCI, V350, P427, DOI 10.1016/j.jcis.2010.06.063; Joshi N, 2012, J HAZARD MATER, V241, P363, DOI 10.1016/j.jhazmat.2012.09.057; Kaegi R, 2013, WATER RES, V47, P3866, DOI 10.1016/j.watres.2012.11.060; Kaegi R, 2011, ENVIRON SCI TECHNOL, V45, P3902, DOI 10.1021/es1041892; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Kent RD, 2012, ENVIRON SCI TECHNOL, V46, P6977, DOI 10.1021/es203475a; Khan SS, 2011, WATER RES, V45, P5184, DOI 10.1016/j.watres.2011.07.024; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Kulacki KJ, 2012, ENVIRON TOXICOL CHEM, V31, P2414, DOI 10.1002/etc.1962; LAMBERTI GA, 1996, ALGAL ECOLOGY FRESHW; Lawrence JR, 2012, CHEM GEOL, V329, P18, DOI 10.1016/j.chemgeo.2011.07.013; Lin XZ, 2003, LANGMUIR, V19, P10081, DOI 10.1021/la035185c; Lowe Rex L., 2007, P327, DOI 10.1016/B978-012332908-0.50018-8; Maynard AD, 2006, NATURE, V444, P267, DOI 10.1038/444267a; MOFFETT JW, 1994, LIMNOL OCEANOGR, V39, P1309, DOI 10.4319/lo.1994.39.6.1309; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Navarro E, 2007, J TOXICOL ENV HEAL A, V70, P760, DOI 10.1080/15287390701236454; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nikora VI, 1998, OIKOS, V81, P607, DOI 10.2307/3546782; Odzak N, 2014, ENVIRON POLLUT, V191, P132, DOI 10.1016/j.envpol.2014.04.010; Park Y, 2011, IET NANOBIOTECHNOL, V5, P69, DOI 10.1049/iet-nbt.2010.0033; Peulen TO, 2011, ENVIRON SCI TECHNOL, V45, P3367, DOI 10.1021/es103450g; Piccapietra F, 2012, ENVIRON SCI TECHNOL, V46, P818, DOI 10.1021/es202843h; Prasad TNVKV, 2013, J APPL PHYCOL, V25, P177, DOI 10.1007/s10811-012-9851-z; Quik JTK, 2010, CHEMOSPHERE, V81, P711, DOI 10.1016/j.chemosphere.2010.07.062; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Rodea-Palomares I, 2011, TOXICOL SCI, V119, P135, DOI 10.1093/toxsci/kfq311; Sack M, 2014, MOL CANCER THER, V13, P1740, DOI 10.1158/1535-7163.MCT-13-0950; Salant NL, 2011, GEOMORPHOLOGY, V126, P350, DOI 10.1016/j.geomorph.2010.08.015; Schulze C, 2008, NANOTOXICOLOGY, V2, P51, DOI 10.1080/17435390802018378; Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002; Stewart TJ, 2013, ENVIRON SCI POLLUT R, V20, P3214, DOI 10.1007/s11356-012-1228-y; Taeho Kim, 2014, NANOTECHNOLOGY, V25; Thill A, 2006, ENVIRON SCI TECHNOL, V40, P6151, DOI 10.1021/es060999b; Veriansyah B, 2011, CHEM ENG J, V168, P1346, DOI 10.1016/j.cej.2010.12.055; Vivekanandhan S, 2009, J NANOSCI NANOTECHNO, V9, P6828, DOI 10.1166/jnn.2009.2201; Wirth SM, 2012, ENVIRON SCI TECHNOL, V46, P12687, DOI 10.1021/es301521p; Xie JP, 2007, ACS NANO, V1, P429, DOI 10.1021/nn7000883	66	71	72	4	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110709	10.1371/journal.pone.0110709	http://dx.doi.org/10.1371/journal.pone.0110709			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333364	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200071
J	Gage-Bouchard, EA; Rodriguez, EM; Saad-Harfouche, FG; Miller, A; Erwin, DO				Gage-Bouchard, Elizabeth A.; Rodriguez, Elisa M.; Saad-Harfouche, Frances G.; Miller, Austin; Erwin, Deborah O.			Factors Influencing Patient Pathways for Receipt of Cancer Care at an NCI-Designated Comprehensive Cancer Center	PLOS ONE			English	Article							SUBJECTIVE SOCIAL-STATUS; LYMPH-NODE EVALUATION; CLINICAL-TRIALS; BREAST-CANCER; RACIAL-DIFFERENCES; COLORECTAL-CANCER; DISPARITIES; HEALTH; OUTCOMES; STAGE	Background: Within the field of oncology, increasing access to high quality care has been identified as a priority to reduce cancer disparities. Previous research reveals that the facilities where patients receive their cancer care have implications for cancer outcomes. However, there is little understanding of how patients decide where to seek cancer care. This study examined the factors that shape patients' pathways to seek their cancer care at a National Cancer Institute-designated comprehensive cancer center (NCI-CCC), and differences in these factors by race, income and education. Methods: In-depth interviews and survey questionnaires were administered to a random sample of 124 patients at one NCI-CCC in the Northeast US. In-depth interview data was first analyzed qualitatively to identify themes and patterns in patients' pathways to receive their cancer care at an NCI-CCC. Logistic Regression was used to examine if these pathways varied by patient race, income, and education. Results: Two themes emerged: following the recommendation of a physician and following advice from social network members. Quantitative data analysis shows that patient pathways to care at an NCI-CCC varied by education and income. Patients with lower income and education most commonly sought their cancer care at an NCI-CCC due to the recommendation of a physician. Patients with higher income and education most commonly cited referral by a specialist physician or the advice of a social network member. There were no statistically significant differences in pathways to care by race. Conclusions: Our findings show that most patients relied on physician recommendations or advice from a social network member in deciding to seek their cancer care at an NCI-CCC. Due to the role of physicians in shaping patients' pathways to the NCI-CCC, initiatives that strengthen partnerships between NCI-CCCs and community physicians who serve underserved communities may improve access to NCI-CCCs.	[Gage-Bouchard, Elizabeth A.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Community Hlth & Hlth Behav, Buffalo, NY 14260 USA; [Rodriguez, Elisa M.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Saad-Harfouche, Frances G.; Erwin, Deborah O.] Roswell Pk Canc Inst, Dept Canc Control Prevent & Populat Sci, Buffalo, NY 14263 USA; [Miller, Austin] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Gage-Bouchard, EA (corresponding author), SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Community Hlth & Hlth Behav, Buffalo, NY 14260 USA.	eagage@buffalo.edu			Roswell Park Cancer Institute Alliance Foundation/Community Foundation of Greater Buffalo; National Institutes of Health [R25CA114101]; NATIONAL CANCER INSTITUTE [R25CA114101, U54CA153598] Funding Source: NIH RePORTER	Roswell Park Cancer Institute Alliance Foundation/Community Foundation of Greater Buffalo; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Roswell Park Cancer Institute Alliance Foundation/Community Foundation of Greater Buffalo and the National Institutes of Health, grant R25CA114101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Azzopardi J, 2014, BREAST J, V20, P3, DOI 10.1111/tbj.12203; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Ball JK, 1996, MED CARE, V34, P970, DOI 10.1097/00005650-199609000-00008; Bilimoria KY, 2008, J NATL CANCER I, V100, P1310, DOI 10.1093/jnci/djn293; Bilimoria KY, 2008, ARCH SURG-CHICAGO, V143, P671, DOI 10.1001/archsurg.143.7.671; Birkmeyer NJO, 2005, CANCER-AM CANCER SOC, V103, P435, DOI 10.1002/cncr.20785; Bristow RE, 2014, GYNECOL ONCOL, V132, P403, DOI 10.1016/j.ygyno.2013.12.017; Burke NJ, 2009, HEALTH EDUC BEHAV, V36, p55S, DOI 10.1177/1090198109335338; Campbell C, 2000, J COMMUNITY APPL SOC, V10, P255, DOI 10.1002/1099-1298(200007/08)10:4<255::AID-CASP582>3.0.CO;2-M; Chen MS, 2014, CANCER-AM CANCER SOC, V120, P1091, DOI 10.1002/cncr.28575; Dang JH, 2014, J COMMUNITY GENETICS, P1; Epstein S, 2008, SOC STUD SCI, V38, P801, DOI 10.1177/0306312708091930; Eriksson M., 2010, Open Public Health Journal, V3, P1, DOI 10.2174/1874944501003010001; Eriksson M, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.5611; Ford JG, 2008, CANCER, V112, P228, DOI 10.1002/cncr.23157; Freeman HP, 2004, CA-CANCER J CLIN, V54, P72, DOI 10.3322/canjclin.54.2.72; Gross GR, 2008, CANCER-AM CANCER SOC, V112, P900, DOI 10.1002/cncr.23228; Guest G., 2011, APPL THEMAT ANAL; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Huang LC, 2014, CANCER-AM CANCER SOC, V120, P399, DOI 10.1002/cncr.28413; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Joseph G, 2012, MED ANTHROPOL Q, V26, P338, DOI 10.1111/j.1548-1387.2012.01222.x; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kilbourne AM, 2006, AM J PUBLIC HEALTH, V96, P2113, DOI 10.2105/AJPH.2005.077628; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Li CI, 2003, ARCH INTERN MED, V163, P49, DOI 10.1001/archinte.163.1.49; Onega T, 2008, CANCER-AM CANCER SOC, V112, P909, DOI 10.1002/cncr.23229; Onega T, 2010, CANCER-AM CANCER SOC, V116, P2698, DOI 10.1002/cncr.25097; Onega T, 2009, J GEN INTERN MED, V24, P205, DOI 10.1007/s11606-008-0863-y; Paulson EC, 2008, ANN SURG, V248, P675, DOI 10.1097/SLA.0b013e318187a757; Portes A., 2000, KNOWLEDGE SOCIAL CAP, P43, DOI DOI 10.1016/B978-0-7506-7222-1.50006-4; Putnam RD., 2000, BOWLING ALONE COLLAP; Richert-Boe KE, 2008, UROLOGY, V71, P1172, DOI 10.1016/j.urology.2007.10.010; Shavers VL, 2002, JNCI-J NATL CANCER I, V94, P334; Singh-Manoux A, 2005, PSYCHOSOM MED, V67, P855, DOI 10.1097/01.psy.0000188434.52941.a0; Singh-Manoux A, 2003, SOC SCI MED, V56, P1321, DOI 10.1016/S0277-9536(02)00131-4; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Wheeler SB, 2013, ONCOLOGIST, V18, P986, DOI 10.1634/theoncologist.2013-0243	39	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110649	10.1371/journal.pone.0110649	http://dx.doi.org/10.1371/journal.pone.0110649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25329653	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100079
J	Gao, CS; Xin, PF; Cheng, CH; Tang, Q; Chen, P; Wang, CB; Zang, GG; Zhao, LN				Gao, Chunsheng; Xin, Pengfei; Cheng, Chaohua; Tang, Qing; Chen, Ping; Wang, Changbiao; Zang, Gonggu; Zhao, Lining			Diversity Analysis in Cannabis sativa Based on Large-Scale Development of Expressed Sequence Tag-Derived Simple Sequence Repeat Markers	PLOS ONE			English	Article							GENIC MICROSATELLITE MARKERS; SSR-MARKERS; EST-SSRS; L.; TRANSFERABILITY; RAPD	Cannabis sativa L. is an important economic plant for the production of food, fiber, oils, and intoxicants. However, lack of sufficient simple sequence repeat (SSR) markers has limited the development of cannabis genetic research. Here, large-scale development of expressed sequence tag simple sequence repeat (EST-SSR) markers was performed to obtain more informative genetic markers, and to assess genetic diversity in cannabis (Cannabis sativa L.). Based on the cannabis transcriptome, 4,577 SSRs were identified from 3,624 ESTs. From there, a total of 3,442 complementary primer pairs were designed as SSR markers. Among these markers, trinucleotide repeat motifs (50.99%) were the most abundant, followed by hexanucleotide (25.13%), dinucleotide (16.34%), tetranucloetide (3.8%), and pentanucleotide (3.74%) repeat motifs, respectively. The AAG/CTT trinucleotide repeat (17.96%) was the most abundant motif detected in the SSRs. One hundred and seventeen EST-SSR markers were randomly selected to evaluate primer quality in 24 cannabis varieties. Among these 117 markers, 108 (92.31%) were successfully amplified and 87 (74.36%) were polymorphic. Forty-five polymorphic primer pairs were selected to evaluate genetic diversity and relatedness among the 115 cannabis genotypes. The results showed that 115 varieties could be divided into 4 groups primarily based on geography: Northern China, Europe, Central China, and Southern China. Moreover, the coefficient of similarity when comparing cannabis from Northern China with the European group cannabis was higher than that when comparing with cannabis from the other two groups, owing to a similar climate. This study outlines the first large-scale development of SSR markers for cannabis. These data may serve as a foundation for the development of genetic linkage, quantitative trait loci mapping, and marker-assisted breeding of cannabis.	[Gao, Chunsheng; Cheng, Chaohua; Tang, Qing; Chen, Ping; Zang, Gonggu; Zhao, Lining] Minist Agr, Key Lab Biol & Proc Bast Fiber Crops, Changsha, Hunan, Peoples R China; [Gao, Chunsheng; Xin, Pengfei; Cheng, Chaohua; Tang, Qing; Chen, Ping; Zang, Gonggu; Zhao, Lining] Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China; [Gao, Chunsheng; Xin, Pengfei; Cheng, Chaohua; Tang, Qing; Chen, Ping; Zang, Gonggu; Zhao, Lining] Chinese Acad Agr Sci, Ctr Southern Econ Crops, Changsha, Hunan, Peoples R China; [Wang, Changbiao] Shanxi Acad Agr Sci, Biotechnol Res Ctr, Taiyuan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS; Chinese Academy of Agricultural Sciences; Shanxi Agricultural University	Gao, CS (corresponding author), Minist Agr, Key Lab Biol & Proc Bast Fiber Crops, Changsha, Hunan, Peoples R China.	csgao06@163.com; csbtzln@163.com	Wang, Changbiao/S-8473-2019	Gao, Chunsheng/0000-0001-8917-0206	International Cooperation Project in Science and Technology [2010DFR30620-4]; National Modern Agro-industry Technology Research System [nycytx-19-E04]; National Natural Science Foundation of China [31301376]	International Cooperation Project in Science and Technology; National Modern Agro-industry Technology Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the International Cooperation Project in Science and Technology (2010DFR30620-4), National Modern Agro-industry Technology Research System (nycytx-19-E04), and National Natural Science Foundation of China (no. 31301376). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; Alghanim HJ, 2003, ANAL BIOANAL CHEM, V376, P1225, DOI 10.1007/s00216-003-1984-0; Amaducci S, 2008, EUR J AGRON, V28, P90, DOI 10.1016/j.eja.2007.05.006; Chandra S, 2011, PLANTA MED, V77-P_5; Cloutier S, 2009, THEOR APPL GENET, V119, P53, DOI 10.1007/s00122-009-1016-3; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; Coyle HM, 2003, J FORENSIC SCI, V48, P343; de Meijer EPM, 2003, GENETICS, V163, P335; Gao LF, 2003, MOL BREEDING, V12, P245, DOI 10.1023/A:1026346121217; GILLAN R, 1995, SCI JUSTICE, V35, P169, DOI 10.1016/S1355-0306(95)72658-2; Gilmore S, 2003, MOL ECOL NOTES, V3, P105, DOI 10.1046/j.1471-8286.2003.00367.x; Guo WZ, 2006, THEOR APPL GENET, V112, P1573, DOI 10.1007/s00122-006-0261-y; Hall J, 2012, J NAT FIBERS, V9, P23, DOI 10.1080/15440478.2012.651848; Hu JianBin, 2009, Acta Horticulturae Sinica, V36, P513; [胡尊红 Hu Zunhong], 2012, [植物遗传资源学报, Journal of Plant Genetic Resources], V13, P555; Jagadish V, 1996, FORENSIC SCI INT, V79, P113, DOI 10.1016/0379-0738(96)01898-1; Jiang Dong, 2006, Acta Genetica Sinica, V33, P345, DOI 10.1016/S0379-4172(06)60060-7; Karus, 1998, CULTIVATION HEMP BOT; Kashi Y, 1997, TRENDS GENET, V13, P74, DOI 10.1016/S0168-9525(97)01008-1; Kojoma M, 2002, PLANTA MED, V68, P60, DOI 10.1055/s-2002-19875; [李小白 LI Xiaobai], 2007, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V29, P20; Lisson SN, 2000, AUST J EXP AGR, V40, P413, DOI 10.1071/EA99059; Liu TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060346; LuJiaShu, 2010, Journal of Hunan Agricultural University, V36, P123; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Ramu P, 2013, THEOR APPL GENET, V126, P2051, DOI 10.1007/s00122-013-2117-6; Roder MS, 1998, GENOME, V41, P278, DOI 10.1139/gen-41-2-278; Roder MS, 1998, GENETICS, V149, P2007; Rohlf F.J., 2002, NTSYS PC NUMERICAL T; Rotherham D, 2011, FORENSIC SCI INT, V207, P193, DOI 10.1016/j.forsciint.2010.10.006; Rozen S, 2000, Methods Mol Biol, V132, P365; Saha MC, 2004, THEOR APPL GENET, V109, P783, DOI 10.1007/s00122-004-1681-1; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; [王长彪 WANG Chang-biao], 2009, [棉花学报, Cotton Science], V21, P243; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xin Ya, 2006, Acta Horticulturae Sinica, V33, P549; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157	40	39	42	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110638	10.1371/journal.pone.0110638	http://dx.doi.org/10.1371/journal.pone.0110638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329551	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100078
J	O'Grady, TJ; Kitahara, CM; DiRienzo, AG; Gates, MA				O'Grady, Thomas J.; Kitahara, Cari M.; DiRienzo, A. Gregory; Gates, Margaret A.			The Association between Selenium and Other Micronutrients and Thyroid Cancer Incidence in the NIH-AARP Diet and Health Study	PLOS ONE			English	Article							REGRESSION-MODELS; POOLED ANALYSIS; RISK-FACTORS; PATTERNS; FOOD; SUPPLEMENTS; COHORT; WOMEN; FRUIT	Background: Selenium is an essential trace element that is important for thyroid hormone metabolism and has antioxidant properties which protect the thyroid gland from oxidative stress. The association of selenium, as well as intake of other micronutrients, with thyroid cancer is unclear. Methods: We evaluated associations of dietary selenium, beta-carotene, calcium, vitamin D, vitamin C, vitamin E, folate, magnesium, and zinc intake with thyroid cancer risk in the National Institutes of Health - American Association of Retired Persons Diet and Health Study, a large prospective cohort of 566,398 men and women aged 50-71 years in 1995-1996. Multivariable-adjusted Cox proportional hazards regression was used to examine associations between dietary intake of micronutrients, assessed using a food frequency questionnaire, and thyroid cancer cases, ascertained by linkage to state cancer registries and the National Death Index. Results: With the exception of vitamin C, which was associated with an increased risk of thyroid cancer (HRQ5 (vs Q1), 1.34; 95% CI, 1.02-1.76; P-trend, <0.01), we observed no evidence of an association between quintile of selenium (HRQ5 (vs Q1), 1.23; 95% CI, 0.92-1.65; P-trend, 0.26) or other micronutrient intake and thyroid cancer. Conclusion: Our study does not suggest strong evidence for an association between dietary intake of selenium or other micronutrients and thyroid cancer risk. More studies are needed to clarify the role of selenium and other micronutrients in thyroid carcinogenesis.	[O'Grady, Thomas J.; DiRienzo, A. Gregory; Gates, Margaret A.] SUNY Albany, Sch Publ Hlth, Rensselaer, NY USA; [Kitahara, Cari M.] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	O'Grady, TJ (corresponding author), SUNY Albany, Sch Publ Hlth, Rensselaer, NY USA.	togrady@albany.edu	Kitahara, Cari M/R-8267-2016	Kitahara, Cari M/0000-0001-6416-4432; Gates Kuliszewski, Margaret/0000-0002-2111-6227	Intramural Research Program of the National Cancer Institute, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD044943] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no other funding of any type for the preparation of this manuscript.	Ambali SF, 2011, J THROID RES, V2011, DOI 10.4061/2011/214924; [Anonymous], 2012, USDA NAT NUTR DAT ST; Beckett GJ, 2005, J ENDOCRINOL, V184, P455, DOI 10.1677/joe.1.05971; Bendich A, 2001, DIETARY REFERENCE IN, DOI [10.1016/s0899-9007(00)00596-7, DOI 10.1016/S0899-9007(00)00596-7]; Bosetti C, 2002, CANCER CAUSE CONTROL, V13, P765, DOI 10.1023/A:1020243527152; Chun OK, 2010, J NUTR, V140, P317, DOI 10.3945/jn.109.114413; Clero E, 2012, NUTR CANCER, V64, P929, DOI 10.1080/01635581.2012.713538; Colonna M, 2002, EUR J CANCER, V38, P1762, DOI 10.1016/S0959-8049(02)00110-7; COX DR, 1972, J R STAT SOC B, V34, P187; Cramer JD, 2010, SURGERY, V148, P1147, DOI 10.1016/j.surg.2010.10.016; Dal Maso L, 2009, CANCER CAUSE CONTROL, V20, P75, DOI 10.1007/s10552-008-9219-5; Dora JM, 2010, EUR J ENDOCRINOL, V163, P427, DOI 10.1530/EJE-10-0419; Drutel A, 2013, CLIN ENDOCRINOL, V78, P155, DOI 10.1111/cen.12066; Duffield AJ, 1999, AM J CLIN NUTR, V70, P896; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Friday JE, 2006, MYPYRAMID EQUIVALENT; Fritz A, 2000, INT CLASSIFICATION D; Galanti MR, 1997, CANCER CAUSE CONTROL, V8, P205, DOI 10.1023/A:1018424430711; George SM, 2009, AM J CLIN NUTR, V89, P347, DOI 10.3945/ajcn.2008.26722; Hard GC, 1998, ENVIRON HEALTH PERSP, V106, P427, DOI 10.2307/3434174; Jubiz W, 2014, J CLIN ENDOCR METAB; Jung SK, 2013, BRIT J NUTR, V109, P118, DOI 10.1017/S0007114512000591; Key T, 2004, PUBLIC HEALTH NUTR, V7, P187, DOI 10.1079/PHN2003588; Kilfoy BA, 2011, INT J CANCER, V129, P160, DOI 10.1002/ijc.25650; Kilfoy BA, 2009, CANCER CAUSE CONTROL, V20, P525, DOI 10.1007/s10552-008-9260-4; Kitahara CM, 2012, INT J CANCER, V130, P1411, DOI 10.1002/ijc.26161; Kitahara CM, 2011, CANCER EPIDEM BIOMAR, V20, P464, DOI 10.1158/1055-9965.EPI-10-1220; Kohrle J, 2013, J ENDOCRINOL INVEST, V36, P1; Kohrle J, 1999, BIOCHIMIE, V81, P527, DOI 10.1016/S0300-9084(99)80105-9; Leitzmann MF, 2010, INT J CANCER, V126, P2947, DOI 10.1002/ijc.24913; Leung AM, 2012, NUTRIENTS, V4, P1740, DOI 10.3390/nu4111740; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; LONGNECKER MP, 1993, AM J CLIN NUTR, V57, P408, DOI 10.1093/ajcn/57.3.408; Mack WJ, 2002, ANN EPIDEMIOL, V12, P395, DOI 10.1016/S1047-2797(01)00281-2; Markaki I, 2003, EUR J CANCER, V39, P1912, DOI 10.1016/S0959-8049(03)00432-5; Michaud D, 2005, J REGISTRY MANAGE, V2, P70; Montanaro F, 2006, EUR J CANCER PREV, V15, P178, DOI 10.1097/01.cej.0000197450.94980.36; MUTANEN M, 1986, ANN CLIN RES, V18, P48; North American Association of Central Cancer Registries (NAACCR), 2008, STAND CANC REG, V3; Persson-Moschos M, 1998, EUR J CLIN NUTR, V52, P363, DOI 10.1038/sj.ejcn.1600565; Rahbari R, 2010, FUTURE ONCOL, V6, P1771, DOI 10.2217/FON.10.127; Roche L. M., 2011, J ENV PUBLIC HLTH, V2011; Ron E, 2006, CANC EPIDEMIOLOGY PR; Sprague BL, 2008, CANCER CAUSE CONTROL, V19, P585, DOI 10.1007/s10552-008-9122-0; Subar AF, 2000, AM J EPIDEMIOL, V152, P279, DOI 10.1093/aje/152.3.279; Sunde RA, 2012, MODERN NUTR HLTH DIS, P225; Sunde RA, 2006, SELENIUM PRESENT KNO, P480; Thompson FE, 2008, PUBLIC HEALTH NUTR, V11, P183, DOI 10.1017/S1368980007000419; VANDENBRANDT PA, 1993, J NATL CANCER I, V85, P224; Vinceti M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005195.pub3; Ward MH, 2010, EPIDEMIOLOGY, V21, P389, DOI 10.1097/EDE.0b013e3181d6201d; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Xiao Q, 2014, CANC EPIDEMIOL BIOMA; Zhang LR, 2013, EUR J CANCER PREV, V22, P158, DOI 10.1097/CEJ.0b013e32835849b0	54	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110886	10.1371/journal.pone.0110886	http://dx.doi.org/10.1371/journal.pone.0110886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329812	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100105
J	Tsuchimoto, A; Shinke, H; Uesugi, M; Kikuchi, M; Hashimoto, E; Sato, T; Ogura, Y; Hata, K; Fujimoto, Y; Kaido, T; Kishimoto, J; Yanagita, M; Matsubara, K; Uemoto, S; Masuda, S				Tsuchimoto, Ayami; Shinke, Haruka; Uesugi, Miwa; Kikuchi, Mio; Hashimoto, Emina; Sato, Tomoko; Ogura, Yasuhiro; Hata, Koichiro; Fujimoto, Yasuhiro; Kaido, Toshimi; Kishimoto, Junji; Yanagita, Motoko; Matsubara, Kazuo; Uemoto, Shinji; Masuda, Satohiro			Urinary Neutrophil Gelatinase-Associated Lipocalin: A Useful Biomarker for Tacrolimus-Induced Acute Kidney Injury in Liver Transplant Patients	PLOS ONE			English	Article							ACID-BINDING PROTEIN; ACUTE-RENAL-FAILURE; INDUCED NEPHROTOXICITY; RISK-FACTORS; NGAL; EXPRESSION; FIBROSIS; CHILDREN; DISEASE; MARKER	Tacrolimus is widely used as an immunosuppressant in liver transplantation, and tacrolimus-induced acute kidney injury (AKI) is a serious complication of liver transplantation. For early detection of AKI, various urinary biomarkers such as monocyte chemotactic protein-1, liver-type fatty acid-binding protein, interleukin-18, osteopontin, cystatin C, clusterin and neutrophil gelatinase-associated lipocalin (NGAL) have been identified. Here, we attempt to identify urinary biomarkers for the early detection of tacrolimus-induced AKI in liver transplant patients. Urine samples were collected from 31 patients after living-donor liver transplantation (LDLT). Twenty recipients developed tacrolimus-induced AKI. After the initiation of tacrolimus therapy, urine samples were collected on postoperative days 7, 14, and 21. In patients who experienced AKI during postoperative day 21, additional spot urine samples were collected on postoperative days 28, 35, 42, 49, and 58. The 8 healthy volunteers, whose renal and liver functions were normal, were asked to collect their blood and spot urine samples. The urinary levels of NGAL, monocyte chemotactic protein-1 and liver-type fatty acid-binding protein were significantly higher in patients with AKI than in those without, while those of interleukin-18, osteopontin, cystatin C and clusterin did not differ between the 2 groups. The area under the receiver operating characteristics curve of urinary NGAL was 0.876 (95% confidence interval, 0.800-0.951; P<0.0001), which was better than those of the other six urinary biomarkers. In addition, the urinary levels of NGAL at postoperative day 1 (p = 0.0446) and day 7 (p = 0.0006) can be a good predictive marker for tacrolimus-induced AKI within next 6 days, respectively. In conclusion, urinary NGAL is a sensitive biomarker for tacrolimus-induced AKI, and may help predict renal event caused by tacrolimus therapy in liver transplant patients.	[Tsuchimoto, Ayami; Shinke, Haruka; Uesugi, Miwa; Kikuchi, Mio; Hashimoto, Emina; Sato, Tomoko; Matsubara, Kazuo; Masuda, Satohiro] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto 606, Japan; [Kikuchi, Mio] Kagawa Univ Hosp, Dept Pharm, Miki, Kagawa, Japan; [Ogura, Yasuhiro; Hata, Koichiro; Fujimoto, Yasuhiro; Kaido, Toshimi; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg & Transplantat, Kyoto, Japan; [Kishimoto, Junji] Kyushu Univ, Fac Med Sci, Dept Res & Dev Next Generat Med, Fukuoka 812, Japan; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan	Kyoto University; Kagawa University; Kyoto University; Kyushu University; Kyoto University	Masuda, S (corresponding author), Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto 606, Japan.	satomsdb@pharm.med.kyushu-u.ac.jp	Yanagita, Motoko/AAJ-7731-2021; Masuda, Satohiro/E-6691-2010; Ogura, Yasuhiro/A-2557-2016	Masuda, Satohiro/0000-0002-3589-5989; Ogura, Yasuhiro/0000-0001-5768-6160; Yanagita, Motoko/0000-0002-0339-9008; Hata, Koichiro/0000-0002-3609-6396	Ministry of Education, Science, Culture, Sports, and Technology of Japan (MEXT); Ministry of Health, Labour, and Welfare of Japan [08062855]; funding program for Next Generation World-Leading Researchers (NEXT Program) [LS073]; Council for Science and Technology Policy of the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [14J07845] Funding Source: KAKEN	Ministry of Education, Science, Culture, Sports, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); funding program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy of the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Science, Culture, Sports, and Technology of Japan (MEXT); a grant-in-aid for Research on Biological Markers for New Drug Development and Health and Labour Sciences Research Grants from the Ministry of Health, Labour, and Welfare of Japan (08062855); and a funding program for Next Generation World-Leading Researchers (NEXT Program: LS073 to SM) initiated by the Council for Science and Technology Policy of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barri YM, 2009, LIVER TRANSPLANT, V15, P475, DOI 10.1002/lt.21682; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Cabezuelo JB, 2006, KIDNEY INT, V69, P1073, DOI 10.1038/sj.ki.5000216; Chariton MR, 2009, LIVER TRANSPLANT, V15, pS1, DOI 10.1002/lt.21877; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Devarajan P, 2011, CURR OPIN PEDIATR, V23, P194, DOI 10.1097/MOP.0b013e328343f4dd; Ferguson MA, 2008, TOXICOLOGY, V245, P182, DOI 10.1016/j.tox.2007.12.024; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Fraley DS, 1998, KIDNEY INT, V54, P518, DOI 10.1046/j.1523-1755.1998.00004.x; Gaspari F, 2010, NEPHRON CLIN PRACT, V115, pC154, DOI 10.1159/000312879; Gijsen VMGJ, 2012, ANN TRANSPL, V17, P111; Hirsch R, 2007, PEDIAT NEPHROLOGY, V22; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Lima EQ, 2003, RENAL FAILURE, V25, P553, DOI 10.1081/JDI-120022546; Manabe K, 2012, EUR J CLIN INVEST, V42, P557, DOI 10.1111/j.1365-2362.2011.02620.x; Masuda S, 2006, PHARMACOL THERAPEUT, V112, P184, DOI 10.1016/j.pharmthera.2006.04.006; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MCCAULEY J, 1990, NEPHRON, V55, P121, DOI 10.1159/000185938; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Morgan C, 2011, NEPHROL DIAL TRANSPL, V26, P2860, DOI 10.1093/ndt/gfq813; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; MURRAY BM, 1985, KIDNEY INT, V28, P767, DOI 10.1038/ki.1985.196; Nakamura T, 2009, SHOCK, V31, P454, DOI 10.1097/SHK.0b013e3181891131; Negishi K, 2007, KIDNEY INT, V72, P348, DOI 10.1038/sj.ki.5002304; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Niemann CU, 2009, LIVER TRANSPLANT, V15, P1852, DOI 10.1002/lt.21938; Nishihara K, 2013, BIOCH PHARM IN PRESS; O'Riordan A, 2007, AM J TRANSPLANT, V7, P168, DOI 10.1111/j.1600-6143.2006.01602.x; Ogutmen B, 2006, TRANSPLANT P, V38, P487, DOI 10.1016/j.transproceed.2005.12.048; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Peralta CA, 2012, AM J KIDNEY DIS, V60, P904, DOI 10.1053/j.ajkd.2012.05.014; Shihab FS, 1997, TRANSPLANTATION, V64, P1829, DOI 10.1097/00007890-199712270-00034; Uesugi M, 2014, PHARMACOGENET GENOM, V24, P356, DOI 10.1097/FPC.0000000000000060; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Wagener G, 2011, NEPHROL DIAL TRANSPL, V26, P1717, DOI 10.1093/ndt/gfq770; Wheeler DS, 2008, CRIT CARE MED, V36, P1297, DOI 10.1097/CCM.0b013e318169245a; WHITING PH, 1982, BRIT J EXP PATHOL, V63, P88	40	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110527	10.1371/journal.pone.0110527	http://dx.doi.org/10.1371/journal.pone.0110527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329716	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100068
J	Zennadi, R				Zennadi, Rahima			MEK Inhibitors, Novel Anti-Adhesive Molecules, Reduce Sickle Red Blood Cell Adhesion In Vitro and In Vivo, and Vasoocclusion In Vivo	PLOS ONE			English	Article							VASCULAR ENDOTHELIUM; PAINFUL CRISIS; POTENTIAL ROLE; MOUSE MODEL; DISEASE; ACTIVATION; ERYTHROCYTES; EXPRESSION; INFLAMMATION; EPINEPHRINE	In sickle cell disease, sickle erythrocyte (SSRBC) interacts with endothelial cells, leukocytes, and platelets, and activates coagulation and inflammation, promoting vessel obstruction, which leads to serious life-threatening complications, including acute painful crises and irreversible damage to multiple organs. The mitogen-activated protein kinase, ERK1/2, is abnormally activated in SSRBCs. However, the therapeutic potential of SSRBC ERK1/2 inactivation has never been investigated. I tested four different inhibitors of MEK1/2 (MEK), the kinase that activates ERK1/2, in a model of human SSRBC adhesion to TNF alpha-activated endothelial cells (ECs). SSRBC MEK inhibition abrogated adhesion to non-activated and TNF alpha-activated ECs to levels below baseline SSRBC adhesion to non-activated ECs in vitro. SSRBC MEK inhibition also prevented SSRBCs from activating naive neutrophils to adhere to endothelium. To determine the effect of MEK inhibitors on SSRBC adherence in vivo, sham-treated or MEK inhibitor-treated SSRBCs were infused to nude mice previously treated with TNF alpha. Sham-treated SSRBCs displayed marked adhesion and occlusion of enflamed vessels, both small and large. However, SSRBC treatment with MEK inhibitors ex vivo showed poor SSRBC adhesion to enflamed vessels with no visible vasoocclusion in vivo. In addition, MEK inhibitor treatment of SSRBCs reduced SSRBC organ trapping and increased the number of SSRBCs circulating in bloodstream. Thus, these data suggest that SSRBC ERK1/2 plays potentially a critical role in sickle pathogenesis, and that MEK inhibitors may represent a valuable intervention for acute sickle cell crises.	[Zennadi, Rahima] Duke Univ, Med Ctr, Div Hematol, Durham, NC 27710 USA; [Zennadi, Rahima] Duke Univ, Med Ctr, Duke Comprehens Sickle Cell Ctr, Dept Med, Durham, NC USA	Duke University; Duke University	Zennadi, R (corresponding author), Duke Univ, Med Ctr, Div Hematol, Durham, NC 27710 USA.	rahima.zennadi@duke.edu			National Blood Foundation; Duke School of Medicine	National Blood Foundation; Duke School of Medicine	This work was supported by an award from National Blood Foundation and a Bridge funding from Duke School of Medicine to RZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGIRE GH, 1949, J NATL CANCER I, V10, P225; Ataga Kenneth I, 2007, Hematology Am Soc Hematol Educ Program, P91; Baker Mari, 2012, Ann Emerg Med, V59, P515, DOI 10.1016/j.annemergmed.2011.11.026; Ballas SK, 2012, BLOOD, V120, P3647, DOI 10.1182/blood-2012-04-383430; BALLAS SK, 1992, BLOOD, V79, P2154, DOI 10.1182/blood.V79.8.2154.2154; Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Betal SG, 2008, TRANSL RES, V152, P165, DOI 10.1016/j.trsl.2008.07.007; BILLETT HH, 1986, BLOOD, V68, P301; De Castro LM, 2012, CTS-CLIN TRANSL SCI, V5, P437, DOI 10.1111/cts.12005; De Franceschi L, 2004, HAEMATOLOGICA, V89, P348; Dewhirst MW, 2002, DIS MARKERS, V18, P293, DOI 10.1155/2002/820102; Dworkis DA, 2011, AM J HEMATOL, V86, P220, DOI 10.1002/ajh.21928; Etienne-Julan M, 2004, HAEMATOLOGICA, V89, P863; Fadlon E, 1998, BLOOD, V91, P266, DOI 10.1182/blood.V91.1.266.266_266_274; FALTYNEK CR, 1995, BIOCHEMISTRY-US, V34, P12404, DOI 10.1021/bi00038a038; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Haynes J, 2008, AM J PHYSIOL-HEART C, V294, pH379, DOI 10.1152/ajpheart.01068.2007; Haynes J, 2006, AM J PHYSIOL-HEART C, V291, pH1679, DOI 10.1152/ajpheart.00256.2006; Hebbel RP, 2008, TRANSFUS CLIN BIOL, V15, P14, DOI 10.1016/j.tracli.2008.03.011; Hebbel RP, 2004, MICROCIRCULATION, V11, P129, DOI 10.1080/10739680490278402; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; Hines PC, 2003, BLOOD, V101, P3281, DOI 10.1182/blood-2001-12-0289; Hua J, 2005, CIRCULATION, V111, P3255, DOI 10.1161/CIRCULATIONAHA.104.485029; Infante JR, 2012, LANCET ONCOL, V13, P773, DOI 10.1016/S1470-2045(12)70270-X; Iverson C, 2008, MOL MARKERS; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Kalambur VS, 2004, AM J HEMATOL, V77, P117, DOI 10.1002/ajh.20143; KAUL DK, 1986, BLOOD, V68, P1162; KAUL DK, 1994, BLOOD, V83, P3006, DOI 10.1182/blood.V83.10.3006.3006; King MR, 2004, ANN BIOMED ENG, V32, P803, DOI 10.1023/B:ABME.0000030256.37022.02; Knight-Madden J, 2012, J INTERF CYTOK RES, V32, P1, DOI 10.1089/jir.2011.0030; KURANTSINMILLS J, 1987, MICROVASC RES, V34, P152, DOI 10.1016/0026-2862(87)90050-1; Lard LR, 1999, J LEUKOCYTE BIOL, V66, P411, DOI 10.1002/jlb.66.3.411; LAWRENCE C, 1985, J LAB CLIN MED, V105, P706; Lee SP, 2006, ARTERIOSCL THROM VAS, V26, P1626, DOI 10.1161/01.ATV.0000220374.00602.a2; Lim MY, 2013, CURR OPIN HEMATOL, V20, P472, DOI 10.1097/MOH.0b013e328363442f; Musa BOP, 2010, CLIN VACCINE IMMUNOL, V17, P602, DOI 10.1128/CVI.00145-09; Orringer EP, 2001, JAMA-J AM MED ASSOC, V286, P2099, DOI 10.1001/jama.286.17.2099; Qari MH, 2012, CLIN APPL THROMB-HEM, V18, P195, DOI 10.1177/1076029611420992; Sabaa N, 2008, J CLIN INVEST, V118, P1924, DOI 10.1172/JCI33308; Siciliano A, 2011, HAEMATOL-HEMATOL J, V96, P24, DOI 10.3324/haematol.2010.028506; Solovey AA, 2001, BLOOD, V97, P1937, DOI 10.1182/blood.V97.7.1937; Sultana C, 1998, BLOOD, V92, P3924, DOI 10.1182/blood.V92.10.3924.422k07_3924_3935; Tomer A, 2001, J LAB CLIN MED, V137, P398, DOI 10.1067/mlc.2001.115450; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; UNTHANK JL, 1993, MICROVASC RES, V45, P193, DOI 10.1006/mvre.1993.1018; Wilkinson-Berka JL, 2006, INVEST OPHTH VIS SCI, V47, P1600, DOI 10.1167/iovs.05-1314; Wun Ted, 2001, Hematology, V5, P403; Zennadi R, 2004, BLOOD, V104, P3774, DOI 10.1182/blood-2004-01-0042; Zennadi R, 2008, BLOOD, V112, P3474, DOI 10.1182/blood-2008-01-134346; Zennadi R, 2007, BLOOD, V110, P2708, DOI 10.1182/blood-2006-11-056101; Zennadi R, 2012, BLOOD, V119, P1217, DOI 10.1182/blood-2011-03-344440	52	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110306	10.1371/journal.pone.0110306	http://dx.doi.org/10.1371/journal.pone.0110306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330306	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100052
J	Ismail, HM; Scapozza, L; Ruegg, UT; Dorchies, OM				Ismail, Hesham M.; Scapozza, Leonardo; Ruegg, Urs T.; Dorchies, Olivier M.			Diapocynin, a Dimer of the NADPH Oxidase Inhibitor Apocynin, Reduces ROS Production and Prevents Force Loss in Eccentrically Contracting Dystrophic Muscle	PLOS ONE			English	Article							GREEN TEA EXTRACT; PHOSPHOLIPASE A(2); (-)-EPIGALLOCATECHIN GALLATE; MOUSE MODEL; SUPEROXIDE; PATHOPHYSIOLOGY; MEMBRANE; RADICALS; CA2+; INVOLVEMENT	Elevation of intracellular Ca2+, excessive ROS production and increased phospholipase A(2) activity contribute to the pathology in dystrophin-deficient muscle. Moreover, Ca2+, ROS and phospholipase A(2), in particular iPLA(2), are thought to potentiate each other in positive feedback loops. NADPH oxidases (NOX) have been considered as a major source of ROS in muscle and have been reported to be overexpressed in muscles of mdx mice. We report here on our investigations regarding the effect of diapocynin, a dimer of the commonly used NOX inhibitor apocynin, on the activity of iPLA(2), Ca2+ handling and ROS generation in dystrophic myotubes. We also examined the effects of diapocynin on force production and recovery ability of isolated EDL muscles exposed to eccentric contractions in vitro, a damaging procedure to which dystrophic muscle is extremely sensitive. In dystrophic myotubes, diapocynin inhibited ROS production, abolished iPLA(2) activity and reduced Ca2+ influx through stretch-activated and store-operated channels, two major pathways responsible for excessive Ca2+ entry in dystrophic muscle. Diapocynin also prevented force loss induced by eccentric contractions of mdx muscle close to the value of wild-type muscle and reduced membrane damage as seen by Procion orange dye uptake. These findings support the central role played by NOX-ROS in the pathogenic cascade leading to muscular dystrophy and suggest diapocynin as an effective NOX inhibitor that might be helpful for future therapeutic approaches.	[Ruegg, Urs T.] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland; Univ Lausanne, Geneva, Switzerland	University of Geneva; University of Lausanne	Ruegg, UT (corresponding author), Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.	urs.ruegg@unige.ch	Dorchies, Olivier M/M-8681-2013	Dorchies, Olivier M/0000-0002-6665-7887; Scapozza, Leonardo/0000-0003-1079-648X; RUEGG, Urs/0000-0001-6078-8280; Ismail, hesham/0000-0001-6831-3124	Swiss National Science Foundation [3100A0 109981]; AFM, France [15093, 15558]; Duchenne Parent Project-The Netherlands [DPPnl 2010-2012]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); AFM, France; Duchenne Parent Project-The Netherlands(Netherlands Government)	This work was supported by grants from the Swiss National Science Foundation number 3100A0 109981 (http://www.snf.ch/E/Pages/default.aspx), the Association Francaise contre les myopathies number 15093 and 15558 (AFM, France, http://www.afm-telethon.fr/), the Duchenne Parent Project-The Netherlands number DPPnl 2010-2012 (DPP-NL, http://www.duchenne.nl/) and the Parent Project Muscular Dystrophy number 329(PPMD, USA, http://www.parentprojectmd.org/site/PageServer?pagename=nws_inde. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balboa MA, 2002, J BIOL CHEM, V277, P40384, DOI 10.1074/jbc.M206155200; Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; Basset O, 2004, J BIOL CHEM, V279, P47092, DOI 10.1074/jbc.M405054200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Boittin FX, 2006, J CELL SCI, V119, P3733, DOI 10.1242/jcs.03184; Boittin FX, 2010, BIOCHEM BIOPH RES CO, V391, P401, DOI 10.1016/j.bbrc.2009.11.070; Buetler TM, 2004, NEWS PHYSIOL SCI, V19, P120, DOI 10.1152/nips.01514.2003; Buetler TM, 2002, AM J CLIN NUTR, V75, P749, DOI 10.1093/ajcn/75.4.749; Chakraborty S, 2011, J PHARMACOL EXP THER, V339, P329, DOI 10.1124/jpet.111.183673; De Luca Annamaria, 2012, Acta Myol, V31, P40; Dorchies OM, 2013, AM J PATHOL, V182, P485, DOI 10.1016/j.ajpath.2012.10.018; Dorchies OM, 2006, AM J PHYSIOL-CELL PH, V290, pC616, DOI 10.1152/ajpcell.00425.2005; Ducret T, 2006, J PHYSIOL-LONDON, V575, P913, DOI 10.1113/jphysiol.2006.115154; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Ghosh A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-241; Castor LRG, 2010, FREE RADICAL BIO MED, V48, P1636, DOI 10.1016/j.freeradbiomed.2010.03.010; Hibaoui Y, 2011, J PINEAL RES, V51, P163, DOI 10.1111/j.1600-079X.2011.00871.x; Hoffman EP, 2001, TRENDS PHARMACOL SCI, V22, P465, DOI 10.1016/S0165-6147(00)01770-3; Houser KR, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-6; Ismail HM, 2013, BR J PHARM IN PRESS; Jiang J, 2013, INT J MOL SCI, V14, P807, DOI 10.3390/ijms14010807; Johnson DK, 2002, ENDOTHELIUM-J ENDOTH, V9, P191, DOI 10.1080/10623320213638; Kanegae MPP, 2007, BIOCHEM PHARMACOL, V74, P457, DOI 10.1016/j.bcp.2007.05.004; Kanegae MPP, 2010, BIOCHEM BIOPH RES CO, V393, P551, DOI 10.1016/j.bbrc.2010.02.073; Khairallah RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002829; Kim JH, 2013, J MUSCLE RES CELL M, V34, P1, DOI 10.1007/s10974-012-9330-9; Kim JA, 2011, EXPERT OPIN THER PAT, V21, P1147, DOI 10.1517/13543776.2011.584870; Kleniewska P, 2012, ARCH IMMUNOL THER EX, V60, P277, DOI 10.1007/s00005-012-0176-z; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kondo K, 1999, FREE RADICAL BIO MED, V27, P855, DOI 10.1016/S0891-5849(99)00133-1; LINDAHL M, 1995, NEUROMUSCULAR DISORD, V5, P193, DOI 10.1016/0960-8966(94)00045-B; Luchtefeld R, 2008, J AGR FOOD CHEM, V56, P301, DOI 10.1021/jf072792n; Nakae Y, 2012, HISTOCHEM CELL BIOL, V137, P811, DOI 10.1007/s00418-012-0926-3; Nakagawa T, 2002, FOOD CHEM TOXICOL, V40, P1745, DOI 10.1016/S0278-6915(02)00169-2; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Prosser BL, 2013, J MOL CELL CARDIOL, V58, P172, DOI 10.1016/j.yjmcc.2012.11.011; Reggiani C, 2008, J PHYSIOL-LONDON, V586, P1779, DOI 10.1113/jphysiol.2008.152629; Reid MB, 2001, J APPL PHYSIOL, V90, P724, DOI 10.1152/jappl.2001.90.2.724; Reutenauer-Patte J, 2012, AM J PATHOL, V180, P749, DOI 10.1016/j.ajpath.2011.10.038; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Riganti C, 2004, J BIOL CHEM, V279, P47726, DOI 10.1074/jbc.M406314200; Ruegg UT, 2012, STORE OPERATED CALCI, P449; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Selsby JT, 2011, EXP PHYSIOL, V96, P194, DOI 10.1113/expphysiol.2010.054379; Shkryl VM, 2009, PFLUG ARCH EUR J PHY, V458, P915, DOI 10.1007/s00424-009-0670-2; SIMONS JM, 1990, FREE RADICAL BIO MED, V8, P251, DOI 10.1016/0891-5849(90)90070-Y; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; Stefanska J, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/106507; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; Vejrazka M, 2005, BBA-GEN SUBJECTS, V1722, P143, DOI 10.1016/j.bbagen.2004.12.008; Wang Q, 2008, PHYTOMEDICINE, V15, P496, DOI 10.1016/j.phymed.2007.09.019; WEIR EK, 1994, J APPL PHYSIOL, V76, P2611, DOI 10.1152/jappl.1994.76.6.2611; Whitehead NP, 2008, J PHYSIOL-LONDON, V586, P2003, DOI 10.1113/jphysiol.2007.148338; Whitehead NP, 2006, NEUROMUSCULAR DISORD, V16, P845, DOI 10.1016/j.nmd.2006.07.024; Whitehead NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015354; Wind S, 2010, BRIT J PHARMACOL, V161, P885, DOI 10.1111/j.1476-5381.2010.00920.x; Xia RH, 2003, AM J PHYSIOL-CELL PH, V285, pC215, DOI 10.1152/ajpcell.00034.2002; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275; Zheng W, 2001, J AGR FOOD CHEM, V49, P5165, DOI 10.1021/jf010697n	59	34	34	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110708	10.1371/journal.pone.0110708	http://dx.doi.org/10.1371/journal.pone.0110708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329652	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100101
J	Kim, DK; Rhee, CS; Han, DH; Won, TB; Kim, DY; Kim, JW				Kim, Dong-Kyu; Rhee, Chae Seo; Han, Doo Hee; Won, Tae-Bin; Kim, Dong-Young; Kim, Jeong-Whun			Treatment of Allergic Rhinitis Is Associated with Improved Attention Performance in Children: The Allergic Rhinitis Cohort Study for Kids (ARCO-Kids)	PLOS ONE			English	Article							QUALITY-OF-LIFE; DEFICIT/HYPERACTIVITY DISORDER; NONALLERGIC RHINITIS; SUSTAINED ATTENTION; SLEEP-DEPRIVATION; DIVIDED ATTENTION; EEG CHANGES; ADOLESCENTS; IMPAIRMENT; HYPERACTIVITY	Background: It has been well known that pediatric allergic rhinitis was associated with poor performance at school due to attention deficit. However, there were no cohort studies for the effect of treatment of allergic rhinitis on attention performance in pediatric population. Thus, the aim of this study was to investigate whether attention performance was improved after treatment in children with allergic rhinitis. Methods: In this ARCO-Kids (Allergic Rhinitis Cohort Study for Kids), consecutive pediatric patients with rhinitis symptoms underwent a skin prick test and computerized comprehensive attention test. According to the skin prick test results, the children were diagnosed as allergic rhinitis or non-allergic rhinitis. All of the patients were regularly followed up and treated with oral medication or intranasal corticosteroid sprays. The comprehensive attention tests consisted of sustained and divided attention tasks. Each of the tasks was assessed by the attention score which was calculated by the number of omission and commission errors. The comprehension attention test was repeated after 1 year. Results: A total of 797 children with allergic rhinitis and 239 children with non-allergic rhinitis were included. Initially, the attention scores of omission and commission errors on divided attention task were significantly lower in children with allergic rhinitis than in children with non-allergic rhinitis. After 1 year of treatment, children with allergic rhinitis showed improvement in attention: commission error of sustained (95.6 +/- 17.0 vs 97.0 +/- 16.6) and divided attention task (99.1 +/- 15.8 vs 91.8 +/- 23.5). Meanwhile, there was no significant difference of attention scores in children with non-allergic rhinitis. Conclusions: Our study showed that management of allergic rhinitis might be associated with improvement of attention.	[Kim, Dong-Kyu] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chunchon, South Korea; [Rhee, Chae Seo; Kim, Jeong-Whun] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea; [Rhee, Chae Seo; Han, Doo Hee; Won, Tae-Bin; Kim, Dong-Young] Seoul Natl Univ Hosp, Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 110744, South Korea	Hallym University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, DK (corresponding author), Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chunchon, South Korea.	kimemail@naver.com		Kim, Dong-Kyu/0000-0003-4917-0177	Korean Center for Disease Control and Prevention, Seoul, Korea [2008E0038200]	Korean Center for Disease Control and Prevention, Seoul, Korea	This study was supported by the Korean Center for Disease Control and Prevention (grant number 2008E0038200), Seoul, Korea. This funder had a role in the data collection.	Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Berger William E, 2004, Paediatr Drugs, V6, P233, DOI 10.2165/00148581-200406040-00003; Bezdjian S, 2009, BRIT J DEV PSYCHOL, V27, P365, DOI 10.1348/026151008X314919; Blaiss MS, 2008, ALLERGY ASTHMA PROC, V29, P1, DOI 10.2500/aap2008.29.3072; Blaiss MS, 2004, CURR MED RES OPIN, V20, P1937, DOI 10.1185/030079904X13266; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brawley A, 2004, ANN ALLERG ASTHMA IM, V92, P663, DOI 10.1016/S1081-1206(10)61434-2; Chang HY, 2013, ALLERGY ASTHMA IMMUN, V5, P315, DOI 10.4168/aair.2013.5.5.315; Chee MWL, 2008, J NEUROSCI, V28, P5519, DOI 10.1523/JNEUROSCI.0733-08.2008; Chervin RD, 2005, SLEEP, V28, P885, DOI 10.1093/sleep/28.7.885; Chervin RD, 2004, SLEEP, V27, P116, DOI 10.1093/sleep/27.1.116; Chervin RD, 2004, SLEEP, V27, P110, DOI 10.1093/sleep/27.1.110; Chou PH, 2013, EUR CHILD ADOLES PSY, V22, P301, DOI 10.1007/s00787-012-0369-3; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Dang-Vu TT, 2007, SLEEP MED, V8, P349, DOI 10.1016/j.sleep.2007.03.006; Flemons WW, 1997, J ALLERGY CLIN IMMUN, V99, pS750, DOI 10.1016/S0091-6749(97)70123-4; Gozal D, 2004, PEDIATR PULM, P166, DOI 10.1002/ppul.70094; Gozal D, 1998, PEDIATRICS, V102, P616, DOI 10.1542/peds.102.3.616; Gozal D, 2006, PAEDIATR RESPIR REV, V7, pS58, DOI 10.1016/j.prrv.2006.04.174; HORNE J, 1992, J CHILD PSYCHOL PSYC, V33, P473, DOI 10.1111/j.1469-7610.1992.tb00886.x; Hughes K, 2003, ALLERGY, V58, P380, DOI 10.1034/j.1398-9995.2003.00093.x; Ibiapina Cássio da Cunha, 2008, J. bras. pneumol., V34, P230, DOI 10.1590/S1806-37132008000400008; JUNIPER EF, 1994, J ALLERGY CLIN IMMUN, V93, P413, DOI 10.1016/0091-6749(94)90349-2; JUNIPER EF, 1990, J ALLERGY CLIN IMMUN, V86, P380, DOI 10.1016/S0091-6749(05)80101-0; KAHN A, 1989, PEDIATRICS, V84, P542; Kennedy JD, 2004, PEDIATR PULM, V37, P330, DOI 10.1002/ppul.10453; Kim SJ, 2012, J PSYCHIATR RES, V46, P1354, DOI 10.1016/j.jpsychires.2012.07.002; Kim SJ, 2011, ARCH PEDIAT ADOL MED, V165, P806, DOI 10.1001/archpediatrics.2011.128; Mander BA, 2008, BRAIN RES, V1217, P148, DOI 10.1016/j.brainres.2008.04.030; Mansfield LE, 2004, ANN ALLERG ASTHMA IM, V92, P240, DOI 10.1016/S1081-1206(10)61554-2; Meltzer EO, 2009, J ALLERGY CLIN IMMUN, V124, pS43, DOI 10.1016/j.jaci.2009.05.013; Meltzer EO, 1999, ANN ALLERG ASTHMA IM, V83, P311, DOI 10.1016/S1081-1206(10)62671-3; Meltzer EO, 1997, ALLERGY, V52, P33, DOI 10.1111/j.1398-9995.1997.tb04820.x; Meltzer EO, 2001, J ALLERGY CLIN IMMUN, V108, pS45, DOI 10.1067/mai.2001.115566; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Nathan RA, 2007, ALLERGY ASTHMA PROC, V28, P3, DOI 10.2500/aap.2007.28.2934; O'Brien L M, 2004, Minerva Pediatr, V56, P585; Owens J, 1998, PEDIATRICS, V102, P1178, DOI 10.1542/peds.102.5.1178; Rhee CS, 2014, AM J RHINOL ALLERGY, V28, pE107, DOI 10.2500/ajra.2014.28.4040; Scadding GK, 2008, CLIN EXP ALLERGY, V38, P19, DOI 10.1111/j.1365-2222.2007.02888.x; Schoenwetter WF, 2004, CURR MED RES OPIN, V20, P305, DOI 10.1185/030079903125003053; Settipane RA, 2003, ALLERGY ASTHMA PROC, V24, P147; Shyu CS, 2012, J MICROBIOL IMMUNOL, V45, P237, DOI 10.1016/j.jmii.2011.11.008; Spector Sheldon L., 1995, Am J Ther, V2, P290, DOI 10.1097/00045391-199504000-00013; Stins JF, 2005, CHILD NEUROPSYCHOL, V11, P285, DOI 10.1080/09297040490916938; Stokes J, 2006, ALLERGY ASTHMA PROC, V27, P12; Tsai JD, 2013, ANN EPIDEMIOL, V23, P185, DOI 10.1016/j.annepidem.2012.12.015; VUURMAN EFPM, 1993, ANN ALLERGY, V71, P121; Yang MT, 2014, PEDIATR NEONATOL, V55, P168, DOI 10.1016/j.pedneo.2013.09.003; Young T, 1997, J ALLERGY CLIN IMMUN, V99, pS757, DOI 10.1016/S0091-6749(97)70124-6	50	11	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109145	10.1371/journal.pone.0109145	http://dx.doi.org/10.1371/journal.pone.0109145			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TF	25330316	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100011
J	Li, X; Yang, MS				Li, Xue; Yang, Mao Sheng			Effects of T-Type Calcium Channel Blockers on Renal Function and Aldosterone in Patients with Hypertension: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CA2+ CHANNELS; PLASMA-ALDOSTERONE; PATHOPHYSIOLOGICAL SIGNIFICANCE; DIABETIC-PATIENTS; BLOOD-PRESSURE; EFONIDIPINE; INHIBITION; BENIDIPINE; AMLODIPINE	Background: High blood pressure can cause kidney damage, which can increase blood pressure, leading to a vicious cycle. It is not clear whether the protective effects of T-type calcium channel blockers (T-type CCBs) on renal function are better than those of L-type CCBs or renin-angiotensin system (RAS) antagonists in patients with hypertension. Methods and Findings: PUBMED, MEDLINE, EMBASE, OVID, Web of Science, Cochrane, CNKI, MEDCH, VIP, and WANFANG databases were searched for clinical trials published in English or Chinese from January 1, 1990, to December 31, 2013. The weighted mean difference (WMD) and 95% confidence interval (CI) were calculated and reported. A total of 1494 reports were collected, of which 24 studies with 1,696 participants (including 809 reports comparing T-type CCBs versus L-type CCBs and 887 reports comparing T-type CCB versus RAS antagonists) met the inclusion criteria. Compared with L-type CCBs, T-type CCBs resulted in a significant decline in aldosterone (mean difference = -15.19, 95% CI -19.65--10.72, p<1x10(-5)), proteinuria (mean difference = -0.73, 95% CI -0.88--0.57, p<1x10(-5)), protein to creatinine ratio (mean difference = -0.22, 95% CI -0.41--0.03, p = 0.02), and urinary albumin to creatinine ratio (mean difference = -55.38, 95% CI -86.67--24.09, p = 0.0005); no significant difference was noted for systolic blood pressure (SBP) (p = 0.76) and diastolic blood pressure (DBP) (p = 0.16). The effects of T-type CCBs did not significantly differ from those of RAS antagonists for SBP (p = 0.98), DBP (p = 0.86), glomerular filtration rate (p = 0.93), albuminuria (p = 0.97), creatinine clearance rate (p = 0.24), and serum creatinine (p = 0.27) in patients with hypertension. Conclusion: In a pooled analysis of data from 24 studies measuring the effects of T-type CCBs on renal function and aldosterone, the protective effects of T-type CCBs on renal function were enhanced compared with L-type CCBs but did not differ from RAS antagonists. Their protective effects on renal function were independent of blood pressure.	[Li, Xue; Yang, Mao Sheng] Chongqing Med Univ, Coll Pharm, Dept Pharmacol, Chongqing, Peoples R China	Chongqing Medical University	Yang, MS (corresponding author), Chongqing Med Univ, Coll Pharm, Dept Pharmacol, Chongqing, Peoples R China.	yangmaosheng@hotmail.com	Yang(秧), Maosheng(茂盛)/J-9581-2012	Yang(秧), Maosheng(茂盛)/0000-0002-0566-6093				Abe M, 2011, HYPERTENS RES, V34, P935, DOI 10.1038/hr.2011.67; Abe M, 2011, HYPERTENS RES, V34, P268, DOI 10.1038/hr.2010.221; Abe M, 2009, HYPERTENS RES, V32, P270, DOI 10.1038/hr.2009.11; ABE Y, 1983, J CARDIOVASC PHARM, V5, P254, DOI 10.1097/00005344-198303000-00015; Bellinghieri G, 2003, RENAL FAILURE, V25, P681, DOI 10.1081/JDI-120024284; Bezprozvann I, 1995, MOL PHARM, V48, P54; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; CALDICOTT WJH, 1981, KIDNEY INT, V19, P687, DOI 10.1038/ki.1981.68; Chen GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057854; Del Vecchio L, 2004, J NEPHROL, V17, P261; DIETZ JR, 1983, HYPERTENSION, V5, P482, DOI 10.1161/01.HYP.5.4.482; Dong B, 2011, J CHINA MODERN MED, V11, P54; Fan ZG, 2010, CHINESE PHARM, V42, P4011; Gan JS, 2012, CHINA PHARM GUIDE, V27, P201; Gong ML, 2012, CHINESE MED, V14, P95; Griffin KA, 1999, KIDNEY INT, V55, P1849, DOI 10.1046/j.1523-1755.1999.00434.x; Han RQ, 2013, CLIN DRUG WORLD, V7, P401; Hayashi K, 2005, J PHARMACOL SCI, V99, P221, DOI 10.1254/jphs.FMJ05002X6; Hayashi K, 1996, Hypertens Res, V19, P31, DOI 10.1291/hypres.19.31; Hayashi K, 2003, AM J HYPERTENS, V16, P116, DOI 10.1016/S0895-7061(02)03147-3; Hayashi K, 2007, CIRC RES, V100, P342, DOI 10.1161/01.RES.0000256155.31133.49; HELLER J, 1990, PFLUG ARCH EUR J PHY, V415, P751, DOI 10.1007/BF02584016; Imagawa K, 2006, J CARDIOVASC PHARM, V47, P133, DOI 10.1097/01.fjc.0000197539.12685.f5; Ishibashi H, 1998, BRAIN RES, V813, P121, DOI 10.1016/S0006-8993(98)01018-X; Ishimitsu T, 2007, HYPERTENS RES, V30, P621, DOI 10.1291/hypres.30.621; Konoshita T, 2013, INT J CARDIOL, V166, P448, DOI 10.1016/j.ijcard.2011.10.133; Marin R, 2005, KIDNEY INT, V68, P52; Martinez-Martin Francisco Javier, 2008, Expert Rev Cardiovasc Ther, V6, P1347, DOI 10.1586/14779072.6.10.1347; Masumiya H, 1998, EUR J PHARMACOL, V349, P351, DOI 10.1016/S0014-2999(98)00204-0; MISHRA SK, 1994, CIRC RES, V75, P144, DOI 10.1161/01.RES.75.1.144; Nakamura T, 2007, AM J MED SCI, V333, P321, DOI 10.1097/MAJ.0b013e318065c254; Nakamura T, 2011, CLIN CARDIOL, V34, P372, DOI 10.1002/clc.20885; Nakamura T, 2010, AM J MED SCI, V339, P157, DOI 10.1097/MAJ.0b013e3181c643df; Nakano N, 2010, INT HEART J, V51, P188, DOI 10.1536/ihj.51.188; Oshima T, 2005, HYPERTENS RES, V28, P889, DOI 10.1291/hypres.28.889; Peng T, 2009, ARZNEIMITTELFORSCH, V59, P647, DOI 10.1055/s-0031-1296454; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; ROY MW, 1983, AM J PHYSIOL, V245, pE410, DOI 10.1152/ajpendo.1983.245.4.E410; Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5; Sasaki H, 2009, J ATHEROSCLER THROMB, V16, P568, DOI 10.5551/jat.1628; Sato A, 2005, AM J HYPERTENS, V18, P44, DOI 10.1016/j.amjhyper.2004.06.029; Takenaka T, 2012, AM J NEPHROL, V35, P416, DOI 10.1159/000338132; Tanaka H, 2005, J PHARMACOL SCI, V99, P214, DOI 10.1254/jphs.FMJ05002X5; Tanaka T, 2007, HYPERTENS RES, V30, P691, DOI 10.1291/hypres.30.691; Tomino Y, 2011, J NEPHROL, V24, P756, DOI 10.5301/JN.2011.6383; Tsutamoto T, 2009, HYPERTENS RES, V32, P670, DOI 10.1038/hr.2009.78; Ueshiba H, 2004, INTERNAL MED, V43, P561, DOI 10.2169/internalmedicine.43.561; Wang T, 2005, HYPERTENS RES, V28, P611, DOI 10.1291/hypres.28.611	48	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109834	10.1371/journal.pone.0109834	http://dx.doi.org/10.1371/journal.pone.0109834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330103	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100032
J	Toh, CH; Wei, KC; Chang, CN; Ng, SH; Wong, HF; Lin, CP				Toh, Cheng Hong; Wei, Kuo-Chen; Chang, Chen-Nen; Ng, Shu-Hang; Wong, Ho-Fai; Lin, Ching-Po			Differentiation of Brain Abscesses from Glioblastomas and Metastatic Brain Tumors: Comparisons of Diagnostic Performance of Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging before and after Mathematic Contrast Leakage Correction	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; T-2-ASTERISK-DOMINANT EXTRAVASATION CORRECTION; APPARENT DIFFUSION-COEFFICIENT; NECROTIC GLIOBLASTOMAS; AGENT EXTRAVASATION; ORIGINAL REPORT; MASS LESIONS; GRADE; PERMEABILITY; DISTINCTION	Purpose: To compare the diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MRI before and after mathematic contrast leakage correction in differentiating pyogenic brain abscesses from glioblastomas and/or metastatic brain tumors. Materials and Methods: Cerebral blood volume (CBV), leakage-corrected CBV and leakage coefficient K-2 were measured in enhancing rims, perifocal edema and contralateral normal appearing white matter (NAWM) of 17 abscesses, 19 glioblastomas and 20 metastases, respectively. The CBV and corrected CBV were normalized by dividing the values in the enhancing rims or edema to those of contralateral NAWM. For each study group, a paired t test was used to compare the K2 of the enhancing rims or edema with those of NAWM, as well as between CBV and corrected CBV of the enhancing rims or edema. ANOVA was used to compare CBV, corrected CBV and K-2 among three lesion types. The diagnostic performance of CBV and corrected CBV was assessed with receiver operating characteristic (ROC) curve analysis. Results: The CBV and correction CBV of enhancing rim were 1.45 +/- 1.17 and 1.97 +/- 1.01 for abscesses, 3.85 +/- 2.19 and 4.39 +/- 2.33 for glioblastomas, and 2.39 +/- 0.90 and 2.97 +/- 0.78 for metastases, respectively. The CBV and corrected CBV in the enhancing rim of abscesses were significantly lower than those of glioblastomas and metastases (P = 0.001 and P = 0.007, respectively). In differentiating abscesses from glioblastomas and metastases, the AUC values of corrected CBV (0.822) were slightly higher than those of CBV (0.792). Conclusions: Mathematic leakage correction slightly increases the diagnostic performance of CBV in differentiating pyogenic abscesses from necrotic glioblastomas and cystic metastases. Clinically, DSC perfusion MRI may not need mathematic leakage correction in differentiating abscesses from glioblastomas and/or metastases.	[Toh, Cheng Hong; Ng, Shu-Hang; Wong, Ho-Fai] Linkou & Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Med Imaging,Dept Neurosurg, Tao Yuan, Taiwan; [Toh, Cheng Hong; Ng, Shu-Hang; Wong, Ho-Fai] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Intervent, Tao Yuan, Taiwan; [Wei, Kuo-Chen; Chang, Chen-Nen] Linkou & Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurosurg, Tao Yuan, Taiwan; [Toh, Cheng Hong; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Toh, Cheng Hong; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Brain Connect Lab, Taipei 112, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Toh, CH (corresponding author), Linkou & Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Med Imaging,Dept Neurosurg, Tao Yuan, Taiwan.	eldomtoh@hotmail.com		Wei, Kuochen/0000-0003-3505-2196; Toh, Cheng Hong/0000-0002-8871-5101	Ministry of Science and Technology; Chang Gung Memorial Hospital, Linkou, Taiwan [BMRPB07]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital, Linkou, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants from the Ministry of Science and Technology, and Chang Gung Memorial Hospital, Linkou, Taiwan (BMRPB07 to C. H. Toh). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjornerud A, 2011, J CEREBR BLOOD F MET, V31, P2041, DOI 10.1038/jcbfm.2011.52; Boxerman JL, 2012, AM J NEURORADIOL, V33, P1081, DOI 10.3174/ajnr.A2934; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; BRITT RH, 1981, J NEUROSURG, V55, P590, DOI 10.3171/jns.1981.55.4.0590; Chen XZ, 2012, AJNR AM J NEURORADIO; Chiang IC, 2009, BRIT J RADIOL, V82, P813, DOI 10.1259/bjr/90100265; Donahue KM, 2000, MAGNET RESON MED, V43, P845, DOI 10.1002/1522-2594(200006)43:6<845::AID-MRM10>3.0.CO;2-J; Ellison D, 2004, NEUROPATHOLOGY REFER, Vxii, P755; Emblem KE, 2011, P INT SOC MAG RESON, P1; Emblem KE, 2011, J CEREBR BLOOD F MET, V31, P2054, DOI 10.1038/jcbfm.2011.39; Erdogan C, 2005, J COMPUT ASSIST TOMO, V29, P663, DOI 10.1097/01.rct.0000168868.50256.55; Floriano VH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081509; Hakyemez B, 2005, BRIT J RADIOL, V78, P989, DOI 10.1259/bjr/12830378; Hakyemez B, 2006, J MAGN RESON IMAGING, V24, P817, DOI 10.1002/jmri.20707; Haris M, 2008, NEURORADIOLOGY, V50, P531, DOI 10.1007/s00234-008-0378-6; Hartmann M, 2001, AM J NEURORADIOL, V22, P1738; Holmes TM, 2004, AM J ROENTGENOL, V183, P1247, DOI 10.2214/ajr.183.5.1831247; Holtas S, 2000, NEURORADIOLOGY, V42, P824, DOI 10.1007/s002340000431; Hu LS, 2010, AM J NEURORADIOL, V31, P40, DOI 10.3174/ajnr.A1787; Lai PH, 2012, AM J NEURORADIOL, V33, P910, DOI 10.3174/ajnr.A2866; Law M, 2004, AM J NEURORADIOL, V25, P746; Lee E J, 2006, Br J Radiol, V79, pe156, DOI 10.1259/bjr/27055708; Muccio CF, 2008, RADIOL MED, V113, P747, DOI 10.1007/s11547-008-0254-9; Paulson ES, 2008, RADIOLOGY, V249, P601, DOI 10.1148/radiol.2492071659; Quarles CC, 2005, MAGN RESON MED, V53, P1307, DOI 10.1002/mrm.20497; Ramli N, 2009, Biomed Imaging Interv J, V5, pe6, DOI 10.2349/biij.5.1.e6; Reddy JS, 2006, SURG NEUROL, V66, P246, DOI 10.1016/j.surneu.2006.03.032; Reiche W, 2010, CLIN NEUROL NEUROSUR, V112, P218, DOI 10.1016/j.clineuro.2009.11.016; Sadeghi N, 2008, AM J NEURORADIOL, V29, P476, DOI 10.3174/ajnr.A0851; Server A, 2011, NEURORADIOLOGY, V53, P435, DOI 10.1007/s00234-010-0770-x; Toh CH, 2013, AM J NEURORADIOL, V34, P1145, DOI 10.3174/ajnr.A3383; Toh CH, 2012, AM J NEURORADIOL, V33, P1534, DOI 10.3174/ajnr.A2986; Toh CH, 2011, AM J NEURORADIOL, V32, P1646, DOI 10.3174/ajnr.A2581; Tomar V, 2011, AM J NEURORADIOL, V32, P2120, DOI 10.3174/ajnr.A2674; Tung GA, 2001, AM J ROENTGENOL, V177, P709, DOI 10.2214/ajr.177.3.1770709; Zaharchuk G, 2007, AM J NEURORADIOL, V28, P1850, DOI 10.3174/ajnr.A0831	36	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109172	10.1371/journal.pone.0109172	http://dx.doi.org/10.1371/journal.pone.0109172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330386	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100012
J	Wade, TJ; Lin, CJ; Jagai, JS; Hilborn, ED				Wade, Timothy J.; Lin, Cynthia J.; Jagai, Jyotsna S.; Hilborn, Elizabeth D.			Flooding and Emergency Room Visits for Gastrointestinal Illness in Massachusetts: A Case-Crossover Study	PLOS ONE			English	Article							UNITED-STATES; RISK; EVENTS; DESIGN; HEALTH; STRATEGIES; OUTBREAKS; EXPOSURE; ENGLAND; DISEASE	Introduction: Floods and other severe weather events are anticipated to increase as a result of global climate change. Floods can lead to outbreaks of gastroenteritis and other infectious diseases due to disruption of sewage and water infrastructure and impacts on sanitation and hygiene. Floods have also been indirectly associated with outbreaks through population displacement and crowding. Methods: We conducted a case-crossover study to investigate the association between flooding and emergency room visits for gastrointestinal illness (ER-GI) in Massachusetts for the years 2003 through 2007. We obtained ER-GI visits from the State of Massachusetts and records of floods from the National Oceanic and Atmospheric Association's Storm Events Database. ER-GI visits were considered exposed if a flood occurred in the town of residence within three hazard periods of the visit: 04 days; 5-9 days; and 10-14 days. A time-stratified bi-directional design was used for control selection, matching on day of the week with two weeks lead or lag time from the ER-GI visit. Fixed effect logistic regression models were used to estimate the risk of ER-GI visits following the flood. Results and Conclusions: A total of 270,457 ER-GI visits and 129 floods occurred in Massachusetts over the study period. Across all counties, flooding was associated with an increased risk for ER-GI in the 0-4 day period after flooding (Odds Ratio: 1.08; 95% Confidence Interval: 1.03-1.12); but not the 5-9 days (Odds Ratio: 0.995; 95% Confidence Interval: 0.955-1.04) or the 10-14 days after (Odds Ratio: 0.966, 95% Confidence Interval: 0.927-1.01). Similar results were observed for different definitions of ER-GI. The effect differed across counties, suggesting local differences in the risk and impact of flooding. Statewide, across the study period, an estimated 7% of ER-GI visits in the 0-4 days after a flood event were attributable to flooding.	[Wade, Timothy J.; Hilborn, Elizabeth D.] United States Environm Protect Agcy, Natl Hlth & Environm Effects Res Lab, Environm Publ Hlth Div, Chapel Hill, NC 27514 USA; [Lin, Cynthia J.] United States Environm Protect Agcy, ORISE, Res Participat Program, Chapel Hill, NC USA; [Lin, Cynthia J.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Jagai, Jyotsna S.] Univ Illinois, Sch Publ Hlth, Div Environm & Occupat Hlth Sci, Chicago, IL USA	United States Environmental Protection Agency; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wade, TJ (corresponding author), United States Environm Protect Agcy, Natl Hlth & Environm Effects Res Lab, Environm Publ Hlth Div, Chapel Hill, NC 27514 USA.	wade.tim@epa.gov		Hilborn, Elizabeth/0000-0002-3035-3101	United States Environmental Protection Agency	United States Environmental Protection Agency(United States Environmental Protection Agency)	This work was funded by the United States Environmental Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley WS, 2005, B AM METEOROL SOC, V86, P1577, DOI 10.1175/BAMS-86-11-1577; Bouza E, 2012, CLIN MICROBIOL INFEC, V18, P5, DOI 10.1111/1469-0691.12064; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; de Man H, 2014, WATER RES, V48, P90, DOI 10.1016/j.watres.2013.09.022; Ding GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065112; Greenough G, 2001, ENVIRON HEALTH PERSP, V109, P191, DOI 10.2307/3435009; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Harder-Lauridsen NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078371; Janes H, 2005, STAT MED, V24, P285, DOI 10.1002/sim.1889; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Malilay JF, 1997, PUBLIC HLTH CONSEQUE, P287; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; MITTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91, DOI 10.1093/oxfordjournals.aje.a117550; Natarajan S, 2007, STAT MED, V26, P3229, DOI 10.1002/sim.2779; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; Pall P, 2011, NATURE, V470, P382, DOI 10.1038/nature09762; R Core Team, 2011, R LANG ENV STAT COMP; Reacher M, 2004, Commun Dis Public Health, V7, P39; Schmid D., 2005, EUROSURVEILLANCE, V10; Schumacher RS, 2006, WEATHER FORECAST, V21, P69, DOI 10.1175/WAF900.1; Schwartz BS, 2006, AM J TROP MED HYG, V74, P1067, DOI 10.4269/ajtmh.2006.74.1067; Stata Corporation, 2012, STAT SE VERS 12 1 WI; Toole M.J., 1997, PUBLIC HLTH CONSEQUE; Wade TJ, 2004, AM J EPIDEMIOL, V159, P398, DOI 10.1093/aje/kwh050; Waring Stephen C, 2002, Disaster Manag Response, P3; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wojcik OP, 2013, EPIDEMIOL INFECT, V141, P1756, DOI 10.1017/S0950268812002038	30	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110474	10.1371/journal.pone.0110474	http://dx.doi.org/10.1371/journal.pone.0110474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329916	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100079
J	Martens, EA; Gatta-Cherifi, B; Gonnissen, HK; Westerterp-Plantenga, MS				Martens, Eveline A.; Gatta-Cherifi, Blandine; Gonnissen, Hanne K.; Westerterp-Plantenga, Margriet S.			The Potential of a High Protein-Low Carbohydrate Diet to Preserve Intrahepatic Triglyceride Content in Healthy Humans	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; QUESTIONNAIRE; METABOLISM; OBESITY; LIVER	Background: Protein supplementation has been shown to reduce the increases in intrahepatic triglyceride (IHTG) content induced by acute hypercaloric high-fat and high-fructose diets in humans. Objective: To assess the effect of a 12-wk iso-energetic high protein-low carbohydrate (HPLC) diet compared with an iso-energetic high carbohydrate-low protein (HCLP) diet on IHTG content in healthy non-obese subjects, at a constant body weight. Design: Seven men and nine women [mean +/- SD age: 24 +/- 5 y; BMI: 22.9 +/- 2.1 kg/m(2)] were randomly allocated to a HPLC [30/35/35% of energy (En%) from protein/carbohydrate/fat] or a HCLP (5/60/35 En%) diet by stratification on sex, age and BMI. Dietary guidelines were prescribed based on individual daily energy requirements. IHTG content was measured by H-1-magnetic resonance spectroscopy before and after the dietary intervention. Results: IHTG content changed in different directions with the HPLC (CH2H2O: 0.23 +/- 0.17 to 0.20 +/- 0.10; IHTG%: 0.25 +/- 0.20% to 0.22 +/- 0.11%) compared with the HCLP diet (CH2H2O: 0.34 +/- 0.20 vs. 0.38 +/- 0.21; IHTG%: 0.38 +/- 0.22% vs. 0.43 +/- 0.24%), which resulted in a lower IHTG content in the HPLC compared with the HCLP diet group after 12 weeks, which almost reached statistical significance (P=0.055). Conclusions: A HPLC vs. a HCLP diet has the potential to preserve vs. enlarge IHTG content in healthy non-obese subjects at a constant body weight.	[Martens, Eveline A.; Gatta-Cherifi, Blandine; Gonnissen, Hanne K.; Westerterp-Plantenga, Margriet S.] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands	Maastricht University	Martens, EA (corresponding author), Maastricht Univ, Dept Human Biol, Maastricht, Netherlands.	eap.martens@maastrichtuniversity.nl		Cherifi, Blandine/0000-0002-7399-1330	European Union [266408]; French Society of Endocrinology	European Union(European Commission); French Society of Endocrinology	This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 266408. BG-C was supported by grants from the French Society of Endocrinology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson KJ, 2013, EUR J CLIN NUTR, V67, P462, DOI 10.1038/ejcn.2012.194; Agius L, 2013, BIOCHEM PHARMACOL, V85, P306, DOI 10.1016/j.bcp.2012.09.019; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Boesch C, 1997, MAGN RESON MED, V37, P484, DOI 10.1002/mrm.1910370403; Bortolotti M, 2011, CLIN NUTR, V30, P494, DOI 10.1016/j.clnu.2011.01.006; Bortolotti M, 2009, AM J CLIN NUTR, V90, P1002, DOI 10.3945/ajcn.2008.27296; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Gannon MC, 2001, J CLIN ENDOCR METAB, V86, P1040, DOI 10.1210/jc.86.3.1040; Hamilton G, 2011, NMR BIOMED, V24, P784, DOI 10.1002/nbm.1622; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Hudgins LC, 2000, J LIPID RES, V41, P595; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Lettner A, 2008, CURR DIABETES REP, V8, P185, DOI 10.1007/s11892-008-0032-z; Magkos F, 2010, OBESITY, V18, P1510, DOI 10.1038/oby.2010.90; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Parks EJ, 2000, AM J CLIN NUTR, V71, P412; Philippaerts RM, 2006, INT J SPORTS MED, V27, P131, DOI 10.1055/s-2005-837619; SCHICK F, 1993, MAGN RESON MED, V29, P158, DOI 10.1007/BF01769418; Schrauwen-Hinderling VB, 2003, J APPL PHYSIOL, V95, P2328, DOI 10.1152/japplphysiol.00304.2003; Schwarz JM, 1995, J CLIN INVEST, V96, P2735, DOI 10.1172/JCI118342; Stubbs RJ, 2001, J NUTR, V131, p2775S, DOI 10.1093/jn/131.10.2775S; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Theytaz F, 2012, AM J CLIN NUTR, V96, P1008, DOI 10.3945/ajcn.112.035139; Torres N, 2007, NUTR REV, V65, pS64, DOI 10.1301/nr.2007.jun.S64-S68; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Veldhorst MAB, 2009, AM J CLIN NUTR, V90, P519, DOI 10.3945/ajcn.2009.27834; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Westerterp KR, 2006, PHYSIOL BEHAV, V89, P62, DOI 10.1016/j.physbeh.2005.12.014; Westerterp KR, 1996, INT J OBESITY, V20, P1022; WESTERTERP KR, 1995, OBES RES, V3, P49, DOI 10.1002/j.1550-8528.1995.tb00007.x; Westerterp-Plantenga MS, 2012, BRIT J NUTR, V108, pS105, DOI 10.1017/S0007114512002589; Wycherley TP, 2012, AM J CLIN NUTR, V96, P1281, DOI 10.3945/ajcn.112.044321	33	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109617	10.1371/journal.pone.0109617	http://dx.doi.org/10.1371/journal.pone.0109617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330327	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800030
J	Paulus, JD; Link, BA				Paulus, Jeremiah D.; Link, Brian A.			Loss of Optineurin In Vivo Results in Elevated Cell Death and Alters Axonal Trafficking Dynamics	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; AMYOTROPHIC-LATERAL-SCLEROSIS; NF-KAPPA-B; NORMAL-TENSION GLAUCOMA; POLYMERASE CHAIN-REACTION; MYOSIN-VI; PAGETS-DISEASE; OPTN GENE; AUTOPHAGIC CLEARANCE; JAPANESE POPULATION	Mutations in Optineurin have been associated with ALS, glaucoma, and Paget's disease of bone in humans, but little is known about how these mutations contribute to disease. Most of the cellular consequences of Optineurin loss have come from in vitro studies, and it remains unclear whether these same defects would be seen in vivo. To answer this question, we assessed the cellular consequences of Optineurin loss in zebrafish embryos to determine if they showed the same defects as have been described in the in vitro studies. We found that loss of Optineurin resulted in increased cell death, as well as subtle cell morphology, cell migration and vesicle trafficking defects. However, unlike experiments on cells in culture, we found no indication that the Golgi apparatus was disrupted or that NF-kappa B target genes were upregulated. Therefore, we conclude that in vivo loss of Optineurin shows some, but not all, of the defects seen in in vitro work.	[Paulus, Jeremiah D.; Link, Brian A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Link, BA (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	blink@mcw.edu			National Institutes of Health (NIH) [R01EY014167]; NIH [F32EY021053]; NATIONAL EYE INSTITUTE [P30EY001931, R01EY014167, F32EY021053, R01EY016060] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) grant R01EY014167 (BAL) and NIH F32EY021053 (JDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizuki M, 2013, J NEUROCHEM, V126, P699, DOI 10.1111/jnc.12326; Albagha OME, 2011, NAT GENET, V43, P685, DOI 10.1038/ng.845; Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; [Anonymous], 2012, NEUROBIOL AGING, DOI DOI 10.1016/J.NEUROBIOLA-GING.2011.05.019; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; Aung T, 2005, INVEST OPHTH VIS SCI, V46, P2816, DOI 10.1167/iovs.04-1133; Aung T, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e101; Ayala-Lugo RM, 2007, MOL VIS, V13, P151; Baird PN, 2004, CLIN EXP OPHTHALMOL, V32, P518, DOI 10.1111/j.1442-9071.2004.00886.x; Belzil VV, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.10.001; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Bond LM, 2011, MOL BIOL CELL, V22, P54, DOI 10.1091/mbc.E10-06-0553; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; Chalasani MLS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095758; Chi ZL, 2010, HUM MOL GENET, V19, P2606, DOI 10.1093/hmg/ddq146; Chibalina MV, 2010, TRAFFIC, V11, P1290, DOI 10.1111/j.1600-0854.2010.01101.x; Chio A, 2012, NEUROLOGY, V79, P1983, DOI 10.1212/WNL.0b013e3182735d36; Chung PYJ, 2010, HUM GENET, V128, P615, DOI 10.1007/s00439-010-0888-2; Correa RG, 2005, CURR BIOL, V15, P1291, DOI 10.1016/j.cub.2005.06.023; Crish SD, 2013, NEUROSCIENCE, V229, P55, DOI 10.1016/j.neuroscience.2012.10.069; Czell D, 2013, AMYOTROPH LAT SCL FR, V14, P138, DOI 10.3109/21678421.2012.756525; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Del Bo R, 2011, J NEUROL NEUROSUR PS, V82, P1239, DOI 10.1136/jnnp.2011.242313; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Dios S, 2010, FISH SHELLFISH IMMUN, V29, P1019, DOI 10.1016/j.fsi.2010.08.006; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fan BJ, 2005, MOL VIS, V11, P625; Fujita K, 2011, J NEUROL NEUROSUR PS, V82, P1402, DOI 10.1136/jnnp-2011-300783; Funayama T, 2004, INVEST OPHTH VIS SCI, V45, P4359, DOI 10.1167/iovs.03-1403; Funayama T, 2006, INVEST OPHTH VIS SCI, V47, P5368, DOI 10.1167/iovs.06-0196; Fuse N, 2004, J GLAUCOMA, V13, P299, DOI 10.1097/00061198-200408000-00007; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Hauser MA, 2006, J GLAUCOMA, V15, P358, DOI 10.1097/01.ijg.0000212255.17950.42; Hoffman TL, 2007, J EXP ZOOL PART B, V308B, P679, DOI 10.1002/jez.b.21189; Insinna C, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-12; Ito H, 2011, ACTA NEUROPATHOL, V122, P223, DOI 10.1007/s00401-011-0842-y; Ito H, 2011, ACTA NEUROPATHOL, V121, P555, DOI 10.1007/s00401-011-0809-z; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kachaner D, 2012, MOL CELL, V45, P553, DOI 10.1016/j.molcel.2011.12.030; Kamada M, 2014, NEUROPATHOLOGY, V34, P64, DOI 10.1111/neup.12051; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; Kawakami K, 2005, DEV DYNAM, V234, P244, DOI 10.1002/dvdy.20516; Keller BA, 2012, ACTA NEUROPATHOL, V124, P733, DOI 10.1007/s00401-012-1035-z; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koga T, 2010, AM J PATHOL, V176, P343, DOI 10.2353/ajpath.2010.090194; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lattante S, 2012, NEUROLOGY, V79, P66, DOI 10.1212/WNL.0b013e31825dceca; Leung YF, 2003, INVEST OPHTH VIS SCI, V44, P3880, DOI 10.1167/iovs.02-0693; Lewis ACF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002645; Li HY, 2011, MOL VIS, V17, P3314; Li X, 2008, NEUROREPORT, V19, P1643, DOI 10.1097/WNR.0b013e328315cd4c; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Marinkovic P, 2012, P NATL ACAD SCI USA, V109, P4296, DOI 10.1073/pnas.1200658109; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; Meng QF, 2012, MOL BIOL REP, V39, P1119, DOI 10.1007/s11033-011-0840-0; METCALFE WK, 1990, DEVELOPMENT, V110, P491; Michou L, 2012, BONE, V51, P720, DOI 10.1016/j.bone.2012.06.028; Millecamps S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.11.005; Morfini GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065235; Mori F, 2012, ACTA NEUROPATHOL, V123, P747, DOI 10.1007/s00401-012-0956-x; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Mukhopadhyay A, 2005, MOL VIS, V11, P792; Munitic I, 2013, J IMMUNOL, V191, P6231, DOI 10.4049/jimmunol.1301696; Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P233, DOI 10.1136/jnnp.2010.234963; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Naruse H, 2012, AMYOTROPH LATERAL SC, V13, P562, DOI 10.3109/17482968.2012.684213; Osawa T, 2011, NEUROPATHOLOGY, V31, P569, DOI 10.1111/j.1440-1789.2011.01199.x; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Patel HY, 2012, CLIN EXP OPHTHALMOL, V40, pE208, DOI 10.1111/j.1442-9071.2011.02714.x; Paulus JD, 2009, J NEUROSCI, V29, P13190, DOI 10.1523/JNEUROSCI.2179-09.2009; Rakhmanov V V, 2005, Genetika, V41, P1567; Rezaie T, 2005, GENOMICS, V85, P131, DOI 10.1016/j.ygeno.2004.10.011; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rogov VV, 2013, BIOCHEM J, V454, P459, DOI 10.1042/BJ20121907; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; SARKAR G, 1990, ANAL BIOCHEM, V186, P64, DOI 10.1016/0003-2697(90)90573-R; Schilling TF, 1996, DEVELOPMENT, V123, P329; Schwab C, 2012, ACTA NEUROPATHOL, V123, P289, DOI 10.1007/s00401-011-0915-y; Schwab C, 2012, NEUROSCI LETT, V506, P149, DOI 10.1016/j.neulet.2011.10.070; Sippl C, 2011, EXP EYE RES, V93, P669, DOI 10.1016/j.exer.2011.08.011; Skarie JM, 2008, HUM MOL GENET, V17, P2474, DOI 10.1093/hmg/ddn147; Skarie JM, 2009, INVEST OPHTH VIS SCI, V50, P5026, DOI 10.1167/iovs.09-3447; Soo KY, 2011, INT J MOL SCI, V12, P9057, DOI 10.3390/ijms12129057; Sripriya S, 2006, MOL VIS, V12, P816; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Sugihara K, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.03.024; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Tumer Z, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.001; Ueno Hiroki, 2011, J Med Case Rep, V5, P573, DOI 10.1186/1752-1947-5-573; Veth KN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001310; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang CX, 2014, CELL BIOL INT, V38, P16, DOI 10.1002/cbin.10174; Wang WL, 2011, FISH SHELLFISH IMMUN, V31, P10, DOI 10.1016/j.fsi.2011.01.015; Weishaupt JH, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.09.007; Weisschuh N, 2005, MOL VIS, V11, P284; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Willoughby CE, 2004, INVEST OPHTH VIS SCI, V45, P3122, DOI 10.1167/iovs.04-0107; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wolman MA, 2004, J NEUROSCI, V24, P8428, DOI 10.1523/JNEUROSCI.2349-04.2004; Xiao Z, 2009, MOL VIS, V15, P1649; Yao Hong-yan, 2006, Zhonghua Yi Xue Za Zhi, V86, P554; Yasuda Noriko, 2006, Nippon Ganka Gakkai Zasshi, V110, P594; Ying HY, 2012, INT REV CEL MOL BIO, V294, P223, DOI 10.1016/B978-0-12-394305-7.00005-7; Ying HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009168; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	117	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109922	10.1371/journal.pone.0109922	http://dx.doi.org/10.1371/journal.pone.0109922			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329564	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210800047
J	Blackwell, BF; Seamans, TW; DeVault, TL				Blackwell, Bradley F.; Seamans, Thomas W.; DeVault, Travis L.			White-Tailed Deer Response to Vehicle Approach: Evidence of Unclear and Present Danger	PLOS ONE			English	Article							FLIGHT-INITIATION DISTANCE; QUANTILE REGRESSION; STARTING DISTANCE; HUMAN DISTURBANCE; PREDATION RISK; BEHAVIOR; HABITAT; AVOIDANCE; LOCATIONS; MORTALITY	The fundamental causes of animal-vehicle collisions are unclear, particularly at the level of animal detection of approaching vehicles and decision-making. Deer-vehicle collisions (DVCs) are especially costly in terms of animal mortality, property damage, and safety. Over one year, we exposed free-ranging white-tailed deer (Odocoileus virginianus) to vehicle approach under low ambient light conditions, from varying start distances, and vehicle speeds from 20 km/h to approximately 90 km/h. We modeled flight response by deer to an approaching vehicle and tested four hypotheses: 1) flight-initiation distance (FID) would correlate positively with start distance (indicating a spatial margin of safety); 2) deer would react to vehicle speed using a temporal margin of safety; 3) individuals reacting at greater FIDs would be more likely to cross the path of the vehicle; and 4) crossings would correlate positively with start distance, approach speed, and distance to concealing/refuge cover. We examined deer responses by quantiles. Median FID was 40% of start distance, irrespective of start distance or approach speed. Converting FID to time-to-collision (TTC), median TTC was 4.6 s, but uncorrelated with start distance or approach speed. The likelihood of deer crossing in front of the vehicle was not associated with greater FIDs or other explanatory variables. Because deer flight response to vehicle approach was highly variable, DVCs should be more likely with increasing vehicle speeds because of lower TTCs for a given distance. For road sections characterized by frequent DVCs, we recommend estimating TTC relative to vehicle speed and candidate line-of-sight distances adjusted downward by (1-P), where P represents our findings for the proportion of start distance by which >75% of deer had initiated flight. Where road design or conservation goals limit effectiveness of line-of-sight maintenance, we suggest incorporation of roadway obstacles that force drivers to slow vehicles, in addition to posting advisory speed limits.	[Blackwell, Bradley F.; Seamans, Thomas W.; DeVault, Travis L.] US Anim & Plant Hlth Inspect Serv, USDA, Natl Wildlife Res Ctr, Ohio Field Stn, Sandusky, OH 44870 USA	United States Department of Agriculture (USDA)	Blackwell, BF (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Natl Wildlife Res Ctr, Ohio Field Stn, Sandusky, OH 44870 USA.	Bradley.F.Blackwell@aphis.usda.gov		DeVault, Travis/0000-0001-6413-1104	US Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center; US Federal Aviation Administration (FAA) [DTFACT-04-X-90003]	US Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center(United States Department of Agriculture (USDA)); US Federal Aviation Administration (FAA)	The research was supported by the US Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center, and the US Federal Aviation Administration (FAA) under agreement DTFACT-04-X-90003. Opinions and conclusions expressed in this manuscript are not necessarily those held by the FAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RE, 1976, J WILDLIFE MANAGE, V40, P317, DOI 10.2307/3800431; BASHORE TL, 1985, J WILDLIFE MANAGE, V49, P769, DOI 10.2307/3801709; BEHREND DF, 1968, J WILDLIFE MANAGE, V32, P615, DOI 10.2307/3798942; BELLIS ED, 1971, J WILDLIFE MANAGE, V35, P232, DOI 10.2307/3799596; Bernhardt GE, 2010, IBIS, V152, P830, DOI 10.1111/j.1474-919X.2010.01043.x; Blackwell, 2012, WILDLIFE SOC B, V169, P1; Blackwell BF, 2012, J APPL ECOL, V49, P758, DOI 10.1111/j.1365-2664.2012.02165.x; Blackwell BF, 2009, J WILDLIFE MANAGE, V73, P128, DOI 10.2193/2008-014; Blumstein DT, 2010, BEHAV ECOL, V21, P440, DOI 10.1093/beheco/arq030; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Bonenfant M, 1996, BEHAV ECOL, V7, P299, DOI 10.1093/beheco/7.3.299; Brown CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040505; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; CARACO T, 1980, ECOLOGY, V61, P119, DOI 10.2307/1937162; CARBAUGH B, 1975, J WILDLIFE MANAGE, V39, P570, DOI 10.2307/3800400; Cardenas YL, 2005, ANIM BEHAV, V70, P1395, DOI 10.1016/j.anbehav.2005.03.022; Caro T., 2005, ANTIPREDATOR DEFENCE; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Chamaille-Jammes S, 2012, BEHAV ECOL SOCIOBIOL, V66, P985, DOI 10.1007/s00265-012-1354-z; Cooper WE, 2009, BEHAV ECOL, V20, P542, DOI 10.1093/beheco/arp029; D'Angelo GJ, 2004, EVALUATION STRATEGIE; DeVault TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087944; Dumont F, 2012, ETHOLOGY, V118, P1051, DOI 10.1111/eth.12006; Finder RA, 1999, LANDSCAPE URBAN PLAN, V44, P77, DOI 10.1016/S0169-2046(99)00006-7; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Frid A, 1997, ANIM BEHAV, V53, P799, DOI 10.1006/anbe.1996.0345; Frid A, 2003, BIOL CONSERV, V110, P387, DOI 10.1016/S0006-3207(02)00236-7; Frid A, 2002, CONSERV ECOL, V6; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; HOREJSI BL, 1981, ARCTIC, V34, P180; Huijser M, 2008, FHWAHRT08034 US DEP; HUMPHRIE.DA, 1970, OECOLOGIA, V5, P285, DOI 10.1007/BF00815496; HUMPHRIES DA, 1967, SCIENCE, V156, P1767, DOI 10.1126/science.156.3783.1767; Isvaran K, 2007, OECOLOGIA, V154, P435, DOI 10.1007/s00442-007-0840-x; LAGORY KE, 1987, ANIM BEHAV, V35, P20, DOI 10.1016/S0003-3472(87)80206-3; Lee E, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P301; Lima SL, 2015, BIOL REV, V90, P60, DOI 10.1111/brv.12093; Lingle S, 2001, ETHOLOGY, V107, P125, DOI 10.1046/j.1439-0310.2001.00647.x; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Malo JE, 2004, J APPL ECOL, V41, P701, DOI 10.1111/j.0021-8901.2004.00929.x; Martin JGA, 2008, BEHAV PROCESS, V77, P66, DOI 10.1016/j.beproc.2007.06.004; MCCAFFERY KR, 1973, J WILDLIFE MANAGE, V37, P212, DOI 10.2307/3798906; Meisingset EL, 2014, J WILDLIFE MANAGE, V78, P679, DOI 10.1002/jwmg.712; Nielsen CK, 2013, J WILDLIFE MANAGE, V67, P46; Seiler A, 2005, J APPL ECOL, V42, P371, DOI 10.1111/j.1365-2664.2005.01013.x; Seiler A, 2006, ENVIRONM POLLUT SER, V10, P165, DOI 10.1007/1-4020-4504-2_8; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2006, BEHAV ECOL, V17, P246, DOI 10.1093/beheco/arj020; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; UNDERWOOD R, 1982, BEHAVIOUR, V79, P81, DOI 10.1163/156853982X00193; Walther FR, 1969, BEHAV, V34, P84; Whittington J, 2004, ECOL SOC, V9; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	54	13	13	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109988	10.1371/journal.pone.0109988	http://dx.doi.org/10.1371/journal.pone.0109988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333922	Green Published, gold			2022-12-27	WOS:000346766200071
J	Kyte, D; Duffy, H; Fletcher, B; Gheorghe, A; Mercieca-Bebber, R; King, M; Draper, H; Ives, J; Brundage, M; Blazeby, J; Calvert, M				Kyte, Derek; Duffy, Helen; Fletcher, Benjamin; Gheorghe, Adrian; Mercieca-Bebber, Rebecca; King, Madeleine; Draper, Heather; Ives, Jonathan; Brundage, Michael; Blazeby, Jane; Calvert, Melanie			Systematic Evaluation of the Patient-Reported Outcome (PRO) Content of Clinical Trial Protocols	PLOS ONE			English	Article							QUALITY-OF-LIFE; RANDOMIZED-TRIALS; PUBLICATIONS	Background: Qualitative evidence suggests patient-reported outcome (PRO) information is frequently absent from clinical trial protocols, potentially leading to inconsistent PRO data collection and risking bias. Direct evidence regarding PRO trial protocol content is lacking. The aim of this study was to systematically evaluate the PRO-specific content of UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme trial protocols. Methods and Findings: We conducted an electronic search of the NIHR HTA programme database (inception to August 2013) for protocols describing a randomised controlled trial including a primary/secondary PRO. Two investigators independently reviewed the content of each protocol, using a specially constructed PRO-specific protocol checklist, alongside the 'Standard Protocol Items: Recommendations for Interventional Trials' (SPIRIT) checklist. Disagreements were resolved through discussion with a third investigator. 75 trial protocols were included in the analysis. Protocols included a mean of 32/51 (63%) SPIRIT recommendations (range 16-41, SD 5.62) and 11/33 (33%) PRO-specific items (range 4-18, SD 3.56). Over half (61%) of the PRO items were incomplete. Protocols containing a primary PRO included slightly more PRO checklist items (mean 14/33 (43%)). PRO protocol content was not associated with general protocol completeness; thus, protocols judged as relatively 'complete' using SPIRIT were still likely to have omitted a large proportion of PRO checklist items. Conclusions: The PRO components of HTA clinical trial protocols require improvement. Information on the PRO rationale/hypothesis, data collection methods, training and management was often absent. This low compliance is unsurprising; evidence shows existing PRO guidance for protocol developers remains difficult to access and lacks consistency. Study findings suggest there are a number of PRO protocol checklist items that are not fully addressed by the current SPIRIT statement. We therefore advocate the development of consensus-based supplementary guidelines, aimed at improving the completeness and quality of PRO content in clinical trial protocols.	[Kyte, Derek; Duffy, Helen; Calvert, Melanie] Univ Birmingham, Birmingham, W Midlands, England; [Fletcher, Benjamin] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Gheorghe, Adrian] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Mercieca-Bebber, Rebecca; King, Madeleine] Univ Sydney, Psychooncol Cooperat Res Grp, Sch Psychol, Qual Life Off, Sydney, NSW 2006, Australia; [Draper, Heather; Ives, Jonathan] Univ Birmingham, Birmingham, W Midlands, England; [Brundage, Michael] Queens Univ, Kingston, ON, Canada; [Blazeby, Jane] Univ Bristol, Sch Social & Community Med, Med Res Council ConDuCT Hub Trials Methodol Res 2, Bristol, Avon, England; [Draper, Heather; Calvert, Melanie] Univ Birmingham, MRC Midland Hub Trials Methodol Res, Birmingham, W Midlands, England	University of Birmingham; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; University of Birmingham; Queens University - Canada; University of Bristol; University of Birmingham	Calvert, M (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	M.Calvert@bham.ac.uk	Blazeby, Jane/H-6703-2019; Calvert, Melanie/F-7055-2011; Ives, Jonathan/ABE-4437-2020	Blazeby, Jane/0000-0002-3354-3330; Calvert, Melanie/0000-0002-1856-837X; Ives, Jonathan/0000-0002-5233-5000; kyte, Derek/0000-0002-7679-6741; Mercieca-Bebber, Rebecca/0000-0003-3708-9099; Fletcher, Benjamin/0000-0003-3633-7716	National Institute for Health Research School for Primary Care Research; Medical Research Council [G0800808]; Medical Research Council [G0800800] Funding Source: researchfish; National Institute for Health Research [SPCR-017] Funding Source: researchfish; MRC [G0800808, G0800800] Funding Source: UKRI	National Institute for Health Research School for Primary Care Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the National Institute for Health Research School for Primary Care Research. Professors Calvert and Draper are members of the Medical Research Council Midland Hub for Trials Methodology Research (Medical Research Council grant G0800808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, MED CARE, V50, P1060, DOI 10.1097/MLR.0b013e318268aaff; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Calvert M, PLOS ONE IN PRESS; Calvert MJ, 2003, J CLIN PHARM THER, V28, P513, DOI 10.1046/j.0269-4727.2003.00521.x; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan A, 2013, SPIRIT 2013 STATEMEN; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Food and Drug Administration U.S. Department of Health and Human Services, 2009, GUID IND PAT REP OUT; Gotzsche PC, 2007, PLOS MED, V4, P47, DOI 10.1371/journal.pmed.0040019; Health Do, 2010, EQ EXC LIB NHS; Higginson IJ, 2001, BRIT MED J, V322, P1297, DOI 10.1136/bmj.322.7297.1297; Hrobjartsson A, 2009, J CLIN EPIDEMIOL, V62, P967, DOI 10.1016/j.jclinepi.2009.04.003; Kyte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076625; Kyte D, 2013, JAMA-J AM MED ASSOC, V310, P1229, DOI 10.1001/jama.2013.277222; NICE, 2002, GUID US TRAST TREATM; Ouwens M, 2010, SUPPORT CARE CANCER, V18, P121, DOI 10.1007/s00520-009-0638-y; Pildal J, 2005, BMJ-BRIT MED J, V330, P1049, DOI 10.1136/bmj.38414.422650.8F; Raftery J, 2013, LANCET, V382, P1278, DOI 10.1016/S0140-6736(13)61724-9; Tetzlaff JM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-176	21	50	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110229	10.1371/journal.pone.0110229	http://dx.doi.org/10.1371/journal.pone.0110229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333349	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000346766200105
J	Pots, WTM; Meulenbeek, PAM; Veehof, MM; Klungers, J; Bohlmeijer, ET				Pots, Wendy T. M.; Meulenbeek, Peter A. M.; Veehof, Martine M.; Klungers, Jorinde; Bohlmeijer, Ernst T.			The Efficacy of Mindfulness-Based Cognitive Therapy as a Public Mental Health Intervention for Adults with Mild to Moderate Depressive Symptomatology: A Randomized Controlled Trial	PLOS ONE			English	Article							SCALE CES-D; PSYCHOMETRIC PROPERTIES; SUBTHRESHOLD DEPRESSION; CRITERION VALIDITY; ANXIETY DISORDERS; HOSPITAL ANXIETY; RISK-FACTOR; PREVENTION; ACCEPTANCE; RELAPSE	Objective: Although there has been growing evidence for the efficacy of mindfulness-based cognitive therapy (MBCT) for different clinical populations, its effectiveness as a public mental health intervention has not been studied. The present study evaluates a community-based MBCT intervention for adults with mild to moderate depressive symptomatology in a large multi-site, pragmatic randomized controlled trial. Method: The participants with mild to moderate depressive symptomatology were recruited from the general population and randomized to the MBCT intervention (n = 76) or to a waiting list control group (n = 75). Participants completed measures before and after the intervention. Participants in the experimental condition also completed these measures at a 3-month follow-up. Results: In the experimental condition significant reductions in depression, anxiety, and experiential avoidance, and improvements in mindfulness and emotional-and psychological mental health were found, compared to the waiting list (effect sizes Cohen's d = 0.31-0.56). These effects were sustained at the 3-month follow-up. The likelihood of a clinically significant change in depressive symptoms was significantly higher for the MBCT group [ odds ratio (OR) 3.026, p<0.01 at post-treatment; NNT = 5.10]. Discussion: MBCT as a public mental health intervention for adults with mild to moderate depressive symptoms seems effective and applicable in a natural setting. Trial Registration: Nederlands Trial Register NTR2096	[Pots, Wendy T. M.; Meulenbeek, Peter A. M.; Veehof, Martine M.; Bohlmeijer, Ernst T.] Univ Twente, Dept Psychol Hlth & Technol, NL-7500 AE Enschede, Netherlands; [Pots, Wendy T. M.] Dimence, Community Mental Hlth Ctr, Almelo, Netherlands; [Meulenbeek, Peter A. M.; Klungers, Jorinde] GGNET, Community Mental Hlth Ctr, Warnsveld, Netherlands	University of Twente	Pots, WTM (corresponding author), Univ Twente, Dept Psychol Hlth & Technol, POB 217, NL-7500 AE Enschede, Netherlands.	w.t.m.pots@utwente.nl		Pots, Wendy/0000-0002-2429-6083	University of Twente	University of Twente	The study was funded by University of Twente (www.utwente.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldao A, 2010, BEHAV RES THER, V48, P974, DOI 10.1016/j.brat.2010.06.002; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Bohlmeijer E, 2011, ASSESSMENT, V18, P308, DOI 10.1177/1073191111408231; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Carmody J, 2009, J CLIN PSYCHOL, V65, P627, DOI 10.1002/jclp.20555; Cavanagh K, 2013, BEHAV RES THER, V51, P573, DOI 10.1016/j.brat.2013.06.003; Chiesa A, 2014, HOLIST NURS PRACT, V28, P124, DOI 10.1097/HNP.0000000000000017; Chiesa A, 2011, PSYCHIAT RES, V187, P441, DOI 10.1016/j.psychres.2010.08.011; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Cuijpers P, 2007, ACTA PSYCHIAT SCAND, V115, P434, DOI 10.1111/j.1600-0447.2007.00998.x; Cuijpers P, 2007, ACTA PSYCHIAT SCAND, V115, P229, DOI 10.1111/j.1600-0447.2006.00851.x; Cuijpers P, 2004, ACTA PSYCHIAT SCAND, V109, P325, DOI 10.1111/j.1600-0447.2004.00301.x; Cuijpers P, 2008, AM J PSYCHIAT, V165, P1272, DOI 10.1176/appi.ajp.2008.07091422; Cuijpers P, 2012, JAMA-J AM MED ASSOC, V307, P1033, DOI 10.1001/jama.2012.271; Cuijpers P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-181; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fava GA, 2009, J PERS, V77, P1903, DOI 10.1111/j.1467-6494.2009.00604.x; Fledderus M, 2012, PSYCHOL ASSESSMENT, V24, P925, DOI 10.1037/a0028200; Fledderus M, 2010, AM J PUBLIC HEALTH, V100, P2372, DOI 10.2105/AJPH.2010.196196; Haringsma R, 2004, INT J GERIATR PSYCH, V19, P558, DOI 10.1002/gps.1130; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Horn PJ, 2010, INT J PSYCHIAT CLIN, V14, P244, DOI 10.3109/13651501.2010.487979; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jane-Llopis Eva, 2005, Promot Educ, VSuppl 2, P9; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Kaviani H, 2012, ARCH PSYCHIATR PSYCH, V14, P21; Keyes CLM, 2008, CLIN PSYCHOL PSYCHOT, V15, P181, DOI 10.1002/cpp.572; Keyes CLM, 2010, AM J PUBLIC HEALTH, V100, P2366, DOI 10.2105/AJPH.2010.192245; Klatt MD, 2009, HEALTH EDUC BEHAV, V36, P601, DOI 10.1177/1090198108317627; Kuyken W, 2010, BEHAV RES THER, V48, P1105, DOI 10.1016/j.brat.2010.08.003; Kuyken W, 2008, J CONSULT CLIN PSYCH, V76, P966, DOI 10.1037/a0013786; Lamers SMA, 2012, J RES PERS, V46, P517, DOI 10.1016/j.jrp.2012.05.012; Lamers SMA, 2011, J CLIN PSYCHOL, V67, P99, DOI 10.1002/jclp.20741; LIPSEY MW, 1993, AM PSYCHOL, V48, P1181, DOI 10.1037/0003-066X.48.12.1181; Liu XH, 2013, STRESS HEALTH, V29, P199, DOI 10.1002/smi.2446; Ma SH, 2004, J CONSULT CLIN PSYCH, V72, P31, DOI 10.1037/0022-006X.72.1.31; McCarney RW, 2012, EUR J PSYCHOTHER COU, V14, P279, DOI 10.1080/13642537.2012.713186; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Munoz RF, 2010, ANNU REV CLIN PSYCHO, V6, P181, DOI 10.1146/annurev-clinpsy-033109-132040; Piet J, 2011, CLIN PSYCHOL REV, V31, P1032, DOI 10.1016/j.cpr.2011.05.002; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ruini C, 2012, CLIN PSYCHOL PSYCHOT, V19, P291, DOI 10.1002/cpp.1796; Ryff CD, 2012, ANNU REV GERONTOL GE, V32, P73, DOI 10.1891/0198-8794.32.73; Segal Z. V., 2002, MINDFULNESS BASED CO; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smit F, 2006, ARCH GEN PSYCHIAT, V63, P290, DOI 10.1001/archpsyc.63.3.290; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Strauss C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096110; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; van Vliet I M, 2007, Tijdschr Psychiatr, V49, P393; Vollestad J, 2012, BRIT J CLIN PSYCHOL, V51, P239, DOI 10.1111/j.2044-8260.2011.02024.x; Williams JMG, 2014, J CONSULT CLIN PSYCH, V82, P275, DOI 10.1037/a0035036; Wood AM, 2010, J AFFECT DISORDERS, V122, P213, DOI 10.1016/j.jad.2009.06.032; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	26	27	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109789	10.1371/journal.pone.0109789	http://dx.doi.org/10.1371/journal.pone.0109789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25333885	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200053
J	Chen, Y; Mo, HZ; Zheng, MY; Xian, M; Qi, ZQ; Li, YQ; Hu, LB; Chen, J; Yang, LF				Chen, Yi; Mo, Hai-Zhen; Zheng, Mei-Yu; Xian, Ming; Qi, Zhong-Qiang; Li, You-Qin; Hu, Liang-Bin; Chen, Jian; Yang, Li-Fei			Selenium Inhibits Root Elongation by Repressing the Generation of Endogenous Hydrogen Sulfide in Brassica rapa	PLOS ONE			English	Article							ALLEVIATES ALUMINUM TOXICITY; NITRIC-OXIDE; OXIDATIVE STRESS; ARABIDOPSIS-THALIANA; CADMIUM; GROWTH; GLUTATHIONE; POLLUTION; RESPONSES; ENZYMES	Selenium (Se) has been becoming an emerging pollutant causing severe phytotoxicity, which the biochemical mechanism is rarely known. Although hydrogen sulfide (H2S) has been suggested as an important exogenous regulator modulating plant physiological adaptions in response to heavy metal stress, whether and how the endogenous H2S regulates Se-induce phytotoxicity remains unclear. In this work, a self-developed specific fluorescent probe (WSP-1) was applied to track endogenous H2S in situ in the roots of Brassica rapa under Se(IV) stress. Se(IV)-induced root growth stunt was closely correlated with the inhibition of endogenous H2S generation in root tips. Se(IV) stress dampened the expression of most LCD and DCD homologues in the roots of B. rapa. By using various specific fluorescent probes for bio-imaging root tips in situ, we found that the increase in endogenous H2S by the application of H2S donor NaHS could significantly alleviate Se(IV)induced reactive oxygen species (ROS) over-accumulation, oxidative impairment, and cell death in root tips, which further resulted in the recovery of root growth under Se(IV) stress. However, dampening the endogenous H2S could block the alleviated effect of NaHS on Se(IV)-induced phytotoxicity. Finally, the increase in endogenous H2S resulted in the enhancement of glutathione (GSH) in Se(IV)-treated roots, which may share the similar molecular mechanism for the dominant role of H2S in removing ROS by activating GSH biosynthesis in mammals. Altogether, these data provide the first direct evidences confirming the pivotal role of endogenous H2S in modulating Se(IV)-induced phytotoxicity in roots.	[Chen, Yi; Yang, Li-Fei] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Chen, Yi; Qi, Zhong-Qiang; Li, You-Qin; Chen, Jian] Jiangsu Acad Agr Sci, Inst Food Qual & Safety, Nanjing, Jiangsu, Peoples R China; [Mo, Hai-Zhen; Hu, Liang-Bin] Henan Inst Sci & Technol, Dept Food Sci, Xinxiang, Henan Province, Peoples R China; [Zheng, Mei-Yu] Jiangsu Acad Agr Sci, Lishui Plant Sci Base, Nanjing, Jiangsu, Peoples R China; [Xian, Ming] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Henan Institute of Science & Technology; Jiangsu Academy of Agricultural Sciences; Washington State University	Chen, J (corresponding author), Jiangsu Acad Agr Sci, Inst Food Qual & Safety, Nanjing, Jiangsu, Peoples R China.	jacksonchen206@gmail.com; lfy@njau.edu.cn		/0000-0001-6876-6369	National Natural Science Foundation of China [31101537]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (31101537, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2011, BIOL TRACE ELEM RES, V140, P354, DOI 10.1007/s12011-010-8699-9; Ali B, 2014, ECOTOX ENVIRON SAFE, V102, P25, DOI 10.1016/j.ecoenv.2014.01.013; Alvarez C, 2010, PLANT PHYSIOL, V152, P656, DOI 10.1104/pp.109.147975; Bharwana SA, 2014, ENVIRON SCI POLLUT R, V21, P717, DOI 10.1007/s11356-013-1920-6; Brosche M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004112; Chen J, 2012, BIOMETALS, V25, P847, DOI 10.1007/s10534-012-9560-8; Chen J, 2013, PLANT SOIL, V362, P301, DOI 10.1007/s11104-012-1275-7; Dawood M, 2012, J HAZARD MATER, V209, P121, DOI 10.1016/j.jhazmat.2011.12.076; Dupuy L, 2010, J EXP BOT, V61, P2131, DOI 10.1093/jxb/erp389; Fang T, 2014, PLANT PHYSIOL BIOCH, V76, P44, DOI 10.1016/j.plaphy.2013.12.024; Fang Y, 2010, J AGR FOOD CHEM, V58, P9731, DOI 10.1021/jf100934p; Feng RW, 2013, ENVIRON EXP BOT, V87, P58, DOI 10.1016/j.envexpbot.2012.09.002; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Galant A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00045; Garcia-Mata C, 2013, PLANT SCI, V201, P66, DOI 10.1016/j.plantsci.2012.11.007; Gomez-Ros LV, 2012, PLANTA, V236, P327, DOI 10.1007/s00425-012-1604-3; Hartikainen H, 2001, AGR FOOD SCI FINLAND, V10, P53, DOI 10.23986/afsci.5679; Hu Y, 2012, CURR PHARM BIOTECHNO, V13, P165, DOI 10.2174/138920112798868809; Huang SS, 2009, J ENVIRON SCI, V21, P481, DOI 10.1016/S1001-0742(08)62295-0; Jin ZP, 2011, BIOCHEM BIOPH RES CO, V414, P481, DOI 10.1016/j.bbrc.2011.09.090; Kavlak G, 2013, RESOUR CONSERV RECY, V73, P17, DOI 10.1016/j.resconrec.2013.01.013; Kellermeier F, 2013, PLANT PHYSIOL, V161, P1421, DOI 10.1104/pp.112.211144; Kimura H, 2014, ANTIOXID REDOX SIGN, V20, P783, DOI 10.1089/ars.2013.5309; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Lehotai N, 2012, J EXP BOT, V63, P5677, DOI 10.1093/jxb/ers222; Lemly AD, 2004, ECOTOX ENVIRON SAFE, V59, P44, DOI 10.1016/S0147-6513(03)00095-2; Li L, 2012, BIOMETALS, V25, P617, DOI 10.1007/s10534-012-9551-9; Li YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090340; Lin YT, 2012, J PLANT GROWTH REGUL, V31, P519, DOI 10.1007/s00344-012-9262-z; Lisjak M, 2013, PLANT CELL ENVIRON, V36, P1607, DOI 10.1111/pce.12073; Liso R, 2004, J EXP BOT, V55, P2589, DOI 10.1093/jxb/erh262; Liu Chunrong, 2011, Angew Chem Int Ed Engl, V50, P10327, DOI 10.1002/anie.201104305; Martinka M, 2014, PLANT CELL MONOGR, V22, P209, DOI 10.1007/978-3-642-41787-0_7; Navarro-Alarcon M, 2008, SCI TOTAL ENVIRON, V400, P115, DOI 10.1016/j.scitotenv.2008.06.024; da Silva MAO, 2012, MICROCHIM ACTA, V176, P131, DOI 10.1007/s00604-011-0700-6; Paciolla C, 2011, PLANT BIOSYST, V145, P253, DOI 10.1080/11263504.2010.509942; Palmieri MC, 2008, J EXP BOT, V59, P177, DOI 10.1093/jxb/erm345; Panda SK, 2009, PLANT SIGNAL BEHAV, V4, P592, DOI 10.4161/psb.4.7.8903; Papenbrock J, 2007, PLANT BIOLOGY, V9, P582, DOI 10.1055/s-2007-965424; Pourrut B, 2011, REV ENVIRON CONTAM T, V213, P113, DOI 10.1007/978-1-4419-9860-6_4; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Riemenschneider A, 2005, FEBS J, V272, P1291, DOI 10.1111/j.1742-4658.2005.04567.x; Schiavon M, 2012, AQUAT TOXICOL, V122, P222, DOI 10.1016/j.aquatox.2012.06.014; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Shi HT, 2014, PLANT PHYSIOL BIOCH, V74, P99, DOI 10.1016/j.plaphy.2013.11.001; Sun J, 2013, PLANT PHYSIOL BIOCH, V65, P67, DOI 10.1016/j.plaphy.2013.01.003; Vandiver MS, 2012, J MOL MED, V90, P255, DOI 10.1007/s00109-012-0873-4; Wang BL, 2010, PLANTA, V231, P1301, DOI 10.1007/s00425-010-1134-9; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Wang YS, 2005, PLANT CELL PHYSIOL, V46, P1915, DOI 10.1093/pcp/pci202; Winkel LHE, 2012, ENVIRON SCI TECHNOL, V46, P571, DOI 10.1021/es203434d; Xie YJ, 2013, MOL BIOTECHNOL, V54, P737, DOI 10.1007/s12033-012-9621-9; Yamamoto Y, 2002, PLANT PHYSIOL, V128, P63, DOI 10.1104/pp.010417; Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199; Zhang H, 2010, BIOL PLANTARUM, V54, P743, DOI 10.1007/s10535-010-0133-9; Zhang H, 2008, J INTEGR PLANT BIOL, V50, P1518, DOI 10.1111/j.1744-7909.2008.00769.x; Zhang H, 2010, J INTEGR PLANT BIOL, V52, P556, DOI 10.1111/j.1744-7909.2010.00946.x; Zhang H, 2009, J INTEGR PLANT BIOL, V51, P1086, DOI 10.1111/j.1744-7909.2009.00885.x; Zhu YG, 2009, TRENDS PLANT SCI, V14, P436, DOI 10.1016/j.tplants.2009.06.006	62	49	53	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110904	10.1371/journal.pone.0110904	http://dx.doi.org/10.1371/journal.pone.0110904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333279	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200091
J	Hu, DK; Zhang, J; Wang, H; Liu, SC; Yu, LH; Sun, LF; Qu, Y				Hu, Dakang; Zhang, Jin; Wang, Hua; Liu, Shuangchun; Yu, Lianhua; Sun, Lingfen; Qu, Ying			Chikungunya Virus Glycoproteins Pseudotype with Lentiviral Vectors and Reveal a Broad Spectrum of Cellular Tropism	PLOS ONE			English	Article							AEDES-ALBOPICTUS MOSQUITOS; FUSION	Background: Outbreaks of the Chikungunya virus (CHIKV) infection has been documented in over 40 countries, resulting in clinical symptoms characterized by fever and joint pain. Diagnosing CHIKV in a clinical lab setting is often omitted because of the high lab safety requirement. An infection system that mimics CHIKV infection will permit clinical evaluation of the production of neutralizing antibody for both disease diagnostics and treatment. Methodology/Principal Findings: We generated a CHIKV construct expressing CHIKV structural proteins. This construct permits the production of CHIKV pseudo-viral particles with a luciferase reporter. The pseudo-virus was able to infect a wide range of cell lines. The pseudovirus could be neutralized by the addition of neutralizing antibodies from patients. Conclusions: Taken together, we have developed a powerful system that can be handled at biosafety level 2 laboratories for evaluation of existence of CHIKV neutralizing antibodies.	[Hu, Dakang; Zhang, Jin; Liu, Shuangchun; Yu, Lianhua; Sun, Lingfen; Qu, Ying] Taizhou Municipal Hosp, Dept Lab Med, Taizhou, Peoples R China; [Wang, Hua] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Infect Dis, Wuhan 430074, Hubei, Peoples R China	Taizhou University; Huazhong University of Science & Technology	Qu, Y (corresponding author), Taizhou Municipal Hosp, Dept Lab Med, Taizhou, Peoples R China.	89434436@qq.com			Taizhou Municipal Hospital internal funding	Taizhou Municipal Hospital internal funding	This study was sponsored by Taizhou Municipal Hospital internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; CLARRIS BJ, 1977, ANN RHEUM DIS, V36, P293, DOI 10.1136/ard.36.4.293; Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214; Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]; Kononchik JP, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-304; Kuo SC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-44; Leung Y M-LN, 2011, ADV VIROLOGY, V2011, P9; Niyas KP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-189; Salvador B, 2009, VIROLOGY, V393, P33, DOI 10.1016/j.virol.2009.07.013; Singh SK, 2011, REV MED VIROL; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Tsetsarkin KA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-376; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; Weber C, 2014, J VIROL METHODS, V201, P7, DOI 10.1016/j.jviromet.2014.02.001; Wu D, 2012, EMERG INFECT DIS, V18, P493, DOI 10.3201/eid1803.110034	15	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110893	10.1371/journal.pone.0110893	http://dx.doi.org/10.1371/journal.pone.0110893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333782	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200085
J	Ma, RL; Zhang, YM; Liu, HQ; Ning, PB				Ma, Ruili; Zhang, Yanming; Liu, Haiquan; Ning, Pengbo			Proteome Profile of Swine Testicular Cells Infected with Porcine Transmissible Gastroenteritis Coronavirus	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; QUANTITATIVE PROTEOMICS; GEL-ELECTROPHORESIS; MASS-SPECTROMETRY; IMMUNE-RESPONSE; GENE-EXPRESSION; IN-VITRO; PROTEINS; IDENTIFICATION; REPLICATION	The interactions occurring between a virus and a host cell during a viral infection are complex. The purpose of this paper was to analyze altered cellular protein levels in porcine transmissible gastroenteritis coronavirus (TGEV)-infected swine testicular (ST) cells in order to determine potential virus-host interactions. A proteomic approach using isobaric tags for relative and absolute quantitation (iTRAQ)-coupled two-dimensional liquid chromatography-tandem mass spectrometry identification was conducted on the TGEV-infected ST cells. The results showed that the 4-plex iTRAQ-based quantitative approach identified 4,112 proteins, 146 of which showed significant changes in expression 48 h after infection. At 64 h post infection, 219 of these proteins showed significant change, further indicating that a larger number of proteomic changes appear to occur during the later stages of infection. Gene ontology analysis of the altered proteins showed enrichment in multiple biological processes, including cell adhesion, response to stress, generation of precursor metabolites and energy, cell motility, protein complex assembly, growth, developmental maturation, immune system process, extracellular matrix organization, locomotion, cell-cell signaling, neurological system process, and cell junction organization. Changes in the expression levels of transforming growth factor beta 1 (TGF-beta 1), caspase-8, and heat shock protein 90 alpha (HSP90 alpha) were also verified by western blot analysis. To our knowledge, this study is the first time the response profile of ST host cells following TGEV infection has been analyzed using iTRAQ technology, and our description of the late proteomic changes that are occurring after the time of vigorous viral production are novel. Therefore, this study provides a solid foundation for further investigation, and will likely help us to better understand the mechanisms of TGEV infection and pathogenesis.	[Ma, Ruili; Zhang, Yanming; Ning, Pengbo] Northwest Agr Forestry Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Ma, Ruili] Northwest Agr Forestry Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Liu, Haiquan] Xian Technol Univ, Sch Comp Sci & Engn, Xian, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Xi'an Technological University	Zhang, YM (corresponding author), Northwest Agr Forestry Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	zhangym@nwsuaf.edu.cn			National Natural Science Foundation of China [31172339]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31172339). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudoux P, 1998, J VIROL, V72, P8636, DOI 10.1128/JVI.72.11.8636-8643.1998; Broquet AH, 2007, J VIROL, V81, P1297, DOI 10.1128/JVI.01336-06; Cao ZZ, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-24; Chiu HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093305; Cruz JLG, 2013, J VIROL, V87, P9754, DOI 10.1128/JVI.01032-13; Curtis KM, 2002, J VIROL, V76, P1422, DOI 10.1128/JVI.76.3.1422-1434.2002; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Ding L, 2012, VET MICROBIOL, V158, P12, DOI 10.1016/j.vetmic.2012.01.017; Eleouet JF, 1998, J VIROL, V72, P4918, DOI 10.1128/JVI.72.6.4918-4924.1998; Feng XS, 2011, J PROTEOMICS, V74, P567, DOI 10.1016/j.jprot.2011.01.017; Galan C, 2009, VIROLOGY, V391, P304, DOI 10.1016/j.virol.2009.06.006; Gao JT, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-64; Gomez-Laguna J, 2012, VET MICROBIOL, V158, P187, DOI 10.1016/j.vetmic.2012.02.003; He L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-176; Hung CY, 2011, J GEN VIROL, V92, P2803, DOI 10.1099/vir.0.033993-0; Jiang XS, 2005, MOL CELL PROTEOMICS, V4, P902, DOI 10.1074/mcp.M400112-MCP200; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Jones T, 1997, VET REC, V141, P427; Kim L, 2000, ARCH VIROL, V145, P1133, DOI 10.1007/s007050070114; Lahaye X, 2012, J VIROL, V86, P4743, DOI 10.1128/JVI.06501-11; Li HY, 2007, J PROTEOME RES, V6, P2615, DOI 10.1021/pr0700798; Li SW, 2012, PROTEOMICS, V12, P3193, DOI 10.1002/pmic.201200225; Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Q, 2012, J PROTEOME RES, V11, P2890, DOI 10.1021/pr201266z; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Munday DC, 2012, PROTEOMICS, V12, P666, DOI 10.1002/pmic.201100488; Navare AT, 2012, VIROLOGY, V429, P37, DOI 10.1016/j.virol.2012.03.026; Neuman BW, 2011, J STRUCT BIOL, V174, P11, DOI 10.1016/j.jsb.2010.11.021; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Ortego J, 2003, VIROLOGY, V308, P13, DOI 10.1016/S0042-6822(02)00096-X; Penzes Z, 2001, VIRUS GENES, V23, P105, DOI 10.1023/A:1011147832586; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Ruppen I, 2010, MOL CELL PROTEOMICS, V9, P2276, DOI 10.1074/mcp.M900255-MCP200; Sirinarumitr T, 1996, J VIROL METHODS, V56, P149, DOI 10.1016/0166-0934(95)01901-4; Smith DR, 2010, ANTIVIR RES, V87, P187, DOI 10.1016/j.antiviral.2010.04.015; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Sun JF, 2008, J PROTEOME RES, V7, P5263, DOI 10.1021/pr800546m; Sun LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04365; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tan YJ, 2007, CELL MICROBIOL, V9, P2552, DOI 10.1111/j.1462-5822.2007.01034.x; Trujillo JA, 2013, J VIROL, V87, P2376, DOI 10.1128/JVI.03089-12; Vlasova AN, 2011, J GEN VIROL, V92, P1369, DOI 10.1099/vir.0.025353-0; Wang RYL, 2013, VIROLOGY, V443, P236, DOI 10.1016/j.virol.2013.05.001; WEINGARTL HM, 1993, VET MICROBIOL, V35, P23, DOI 10.1016/0378-1135(93)90113-L; WEINGARTL HM, 1994, J VIROL, V68, P7253, DOI 10.1128/JVI.68.11.7253-7259.1994; Wesley RD, 2003, VET MICROBIOL, V95, P175, DOI 10.1016/S0378-1135(03)00150-0; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Yang Y, 2014, ALLERGY, V69, P699, DOI 10.1111/all.12403; Yang YQ, 2012, VET MICROBIOL, V158, P237, DOI 10.1016/j.vetmic.2012.01.021; Zhang X, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-31; Zhang X, 2009, J PROTEOME RES, V8, P5111, DOI 10.1021/pr900488q	54	11	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110647	10.1371/journal.pone.0110647	http://dx.doi.org/10.1371/journal.pone.0110647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333634	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200064
J	Maciel, C; Fujita, A; Gueroni, DI; Ramos, AD; Capurro, ML; Sa-Nunes, A				Maciel, Ceres; Fujita, Andre; Gueroni, Daniele I.; Ramos, Anderson D.; Capurro, Margareth L.; Sa-Nunes, Anderson			Evans Blue as a Simple Method to Discriminate Mosquitoes' Feeding Choice on Small Laboratory Animals	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; AEDES-AEGYPTI; SALIVARY-GLAND; HOST-SEEKING; OLFACTOMETER; ATTRACTION; REPELLENTS; DIPTERA; ODOR; ANOPHELES	Background: Temperature, humidity, vision, and particularly odor, are external cues that play essential roles to mosquito blood feeding and oviposition. Entomological and behavioral studies employ well-established methods to evaluate mosquito attraction or repellency and to identify the source of the blood meal. Despite the efficacy of such methods, the costs involved in the production or acquisition of all parts, components and the chemical reagents involved are unaffordable for most researchers from poor countries. Thus, a simple and relatively low-cost method capable of evaluating mosquito preferences and the blood volume ingested is desirable. Principal Findings: By using Evans blue (EB) vital dye and few standard laboratory supplies, we developed and validated a system capable of evaluating mosquito's choice between two different host sources of blood. EB-injected and PBS-injected mice submitted to a number of situations were placed side by side on the top of a rounded recipient covered with tulle fabric and containing Aedes aegypti mosquitoes. Homogenates from engorged mosquitoes clearly revealed the blood source (EB- or PBS-injected host), either visually or spectrometrically. This method was able to estimate the number of engorded mosquitoes, the volume of blood ingested, the efficacy of a commercial repellent and the attractant effects of black color and human sweat. Significance: Despite the obvious limitations due to its simplicity and to the dependence of a live source of blood, the present method can be used to assess a number of host variables (diet, aging, immunity, etc) and optimized for several aspects of mosquito blood feeding and vector-host interactions. Thus, it is proposed as an alternative to field studies, and it could be used for initial screenings of chemical compound candidates for repellents or attractants, since it replicates natural conditions of exposure to mosquitoes in a laboratory environment.	[Maciel, Ceres; Gueroni, Daniele I.; Ramos, Anderson D.; Sa-Nunes, Anderson] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Lab Imunol Expt, BR-05508 Sao Paulo, Brazil; [Fujita, Andre] Univ Sao Paulo, Inst Matemat Estat, Dept Ciencia Comp, BR-05508 Sao Paulo, Brazil; [Capurro, Margareth L.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Lab Mosquitos Geneticamente Modificados, BR-05508 Sao Paulo, Brazil; [Capurro, Margareth L.; Sa-Nunes, Anderson] INCT EM, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Sa-Nunes, A (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Lab Imunol Expt, BR-05508 Sao Paulo, Brazil.	sanunes@usp.br	Capurro, Margareth/M-5286-2019; Capurro, Margareth L/F-8679-2012; Sa-Nunes, Anderson/M-5654-2019; Sa-Nunes, Anderson/D-8667-2012; Fujita, Andre/Q-1271-2019	Capurro, Margareth L/0000-0002-7480-2116; Sa-Nunes, Anderson/0000-0002-1859-4973; Sa-Nunes, Anderson/0000-0002-1859-4973; Fujita, Andre/0000-0002-7756-7051	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/09892-6, 2009/53637-0, 2010/18216-1, 2011/06626-3, 2011/22669-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302194/2009-6]; Casadinho/PROCAD (MCTI/CNPq/MEC/CAPES ) [552258/2011-3]; Brazilian Malaria Network (MCT/CNPq/MS/SCTIE/DECIT/PRONEX) [555648/2009-5]; Research Network on Bioactive Molecules from Arthropod Vectors (NAP-MOBIARVE, University of Sao Paulo)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Casadinho/PROCAD (MCTI/CNPq/MEC/CAPES ); Brazilian Malaria Network (MCT/CNPq/MS/SCTIE/DECIT/PRONEX); Research Network on Bioactive Molecules from Arthropod Vectors (NAP-MOBIARVE, University of Sao Paulo)	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2009/09892-6 and 2009/53637-0), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 302194/2009-6), Casadinho/PROCAD (MCTI/CNPq/MEC/CAPES 552258/2011-3), Brazilian Malaria Network (MCT/CNPq/MS/SCTIE/DECIT/PRONEX 555648/2009-5), and Research Network on Bioactive Molecules from Arthropod Vectors (NAP-MOBIARVE, University of Sao Paulo). The following authors were recipients of fellowships: CM (FAPESP 2010/18216-1); DIG (FAPESP 2011/06626-3); ADR (FAPESP 2011/22669-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhalim MAK, 2012, AFR J BIOTECHNOL, V11, P8; Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164; ACREE F, 1968, SCIENCE, V161, P1346, DOI 10.1126/science.161.3848.1346; Alvarenga PH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000547; Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; BALZARINI J, 1986, BIOCHEM BIOPH RES CO, V136, P64, DOI 10.1016/0006-291X(86)90877-6; Benoit JB, 2007, AM J TROP MED HYG, V76, P987, DOI 10.4269/ajtmh.2007.76.987; Benoit JB, 2007, J EXP BIOL, V210, P217, DOI 10.1242/jeb.02630; Benoit JB, 2010, J INSECT PHYSIOL, V56, P151, DOI 10.1016/j.jinsphys.2009.09.012; Bizzarro B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-329; Bosch OJ, 2000, CHEM SENSES, V25, P323, DOI 10.1093/oxfordjournals.chemse.a014042; BOWEN MF, 1991, ANNU REV ENTOMOL, V36, P139, DOI 10.1146/annurev.en.36.010191.001035; Brett GA, 1938, T R SOC TROP MED HYG, V32, P12; Brighenti D, 1930, RIV MALARIOL, V9, P1; BROWN AWA, 1954, B ENTOMOL RES, V45, P67, DOI 10.1017/S0007485300026808; BROWN SJ, 1986, EXP PARASITOL, V62, P40, DOI 10.1016/0014-4894(86)90006-8; BROWNE SM, 1981, J MED ENTOMOL, V18, P505, DOI 10.1093/jmedent/18.6.505; Calvo E, 2011, J BIOL CHEM, V286, P27998, DOI 10.1074/jbc.M111.247924; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; CHINERY WA, 1981, J PARASITOL, V67, P15, DOI 10.2307/3280770; Cooksey CJ, 2014, BIOTECH HISTOCHEM, V89, P111, DOI 10.3109/10520295.2013.822560; Costa-da-Silva AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053816; Dogan EB, 1999, J MED ENTOMOL, V36, P788, DOI 10.1093/jmedent/36.6.788; Enserink M, 2002, SCIENCE, V298, P90, DOI 10.1126/science.298.5591.90; Evans HM, 1914, SCIENCE, V39, P443, DOI 10.1126/science.39.1004.443; Costa EDF, 2009, INVEST OPHTH VIS SCI, V50, P385, DOI 10.1167/iovs.08-2285; Geier M, 1999, CHEM SENSES, V24, P647, DOI 10.1093/chemse/24.6.647; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; Gibson JG, 1937, J CLIN INVEST, V16, P301, DOI 10.1172/JCI100859; Gilbert IH, 1957, J ECON ENTOMOL, V50, P3; GJULLIN CM, 1947, J ECON ENTOMOL, V40, P326, DOI 10.1093/jee/40.3.326; GOUCK HK, 1972, B WORLD HEALTH ORGAN, V47, P680; Hao HL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.7601; Howlett FM, 1910, PARASITOLOGY, V3, P1; Ignell R, 2010, PHYSIOL ENTOMOL, V35, P274, DOI 10.1111/j.1365-3032.2010.00740.x; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Jackson TS, 1996, AM J PHYSIOL-HEART C, V271, pH924, DOI 10.1152/ajpheart.1996.271.3.H924; Jiang SZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086407; KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4; Kwon HW, 2006, P NATL ACAD SCI USA, V103, P13526, DOI 10.1073/pnas.0601107103; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Lindh JM, 2006, ACTA TROP, V99, P173, DOI 10.1016/j.actatropica.2006.07.008; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005; Mathew N, 2013, PARASITOL RES, V112, P1305, DOI 10.1007/s00436-012-3266-2; Melo ACA, 2004, CHEM SENSES, V29, P403, DOI 10.1093/chemse/bjh041; MIRANPURI GS, 1986, VET PARASITOL, V22, P9, DOI 10.1016/0304-4017(86)90003-8; Omrani SM, 2010, J VECTOR DIS, V47, P17; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Posey KH, 1998, J MED ENTOMOL, V35, P330, DOI 10.1093/jmedent/35.3.330; Rinker DC, 2013, P NATL ACAD SCI USA, V110, P8260, DOI 10.1073/pnas.1302562110; SCHRECK CE, 1977, ANNU REV ENTOMOL, V22, P101, DOI 10.1146/annurev.en.22.010177.000533; Severson DW, 2012, ANNU REV ENTOMOL, V57, P143, DOI 10.1146/annurev-ento-120710-100651; Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009; SPIELMAN A, 1971, ANNU REV ENTOMOL, V16, P231, DOI 10.1146/annurev.en.16.010171.001311; SUGITA Y, 1975, J BIOL CHEM, V250, P1251; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; Turlings TCJ, 2004, PHYSIOL ENTOMOL, V29, P45, DOI 10.1111/j.1365-3032.2004.0362.x; Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08; WASHINO RK, 1983, ANNU REV ENTOMOL, V28, P179, DOI 10.1146/annurev.en.28.010183.001143; Wen Y, 1997, J AM MOSQUITO CONTR, V13, P150; Wheeler D, 1996, ANNU REV ENTOMOL, V41, P407, DOI 10.1146/annurev.en.41.010196.002203; Yoder JA, 2006, MED VET ENTOMOL, V20, P365, DOI 10.1111/j.1365-2915.2006.00642.x; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	65	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110551	10.1371/journal.pone.0110551	http://dx.doi.org/10.1371/journal.pone.0110551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333369	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200054
J	Sui, XX; Liu, YM; Li, Q; Liu, GF; Song, XH; Su, ZJ; Chang, XL; Zhou, YB; Liang, B; Huang, DY				Sui, Xuxia; Liu, Yanmin; Li, Qi; Liu, Gefei; Song, Xuhong; Su, Zhongjing; Chang, Xiaolan; Zhou, Yingbi; Liang, Bin; Huang, Dongyang			Oxidized Low-Density Lipoprotein Suppresses Expression of Prostaglandin E Receptor Subtype EP3 in Human THP-1 Macrophages	PLOS ONE			English	Article							FACTOR-KAPPA-B; CAROTID ATHEROSCLEROTIC PLAQUES; MOUSE PERITONEAL-MACROPHAGES; PPAR-GAMMA; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); BINDING-ACTIVITY; GENE-EXPRESSION; LIGAND; DIFFERENTIATION; INFLAMMATION	EP3, one of four prostaglandin E2 (PGE2) receptors, is significantly lower in atherosclerotic plaques than in normal arteries and is localized predominantly in macrophages of the plaque shoulder region. However, mechanisms behind this EP3 expression pattern are still unknown. We investigated the underlying mechanism of EP3 expression in phorbol 12-myristate 13-acetate (PMA)-differentiated THP-1 macrophages with oxidized low-density lipoprotein (oxLDL) treatment. We found that oxLDL decreased EP3 expression, in a dose-dependent manner, at both the mRNA and protein levels. Moreover, oxLDL inhibited nuclear factor-kappa B (NF-kappa B)-dependent transcription of the EP3 gene by the activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma). Finally, chromatin immunoprecipitation revealed decreased binding of NF-kappa B to the EP3 promoter with oxLDL and PPAR-gamma agonist treatment. Our results show that oxLDL suppresses EP3 expression by activation of PPAR-gamma and subsequent inhibition of NF-kappa B in macrophages. These results suggest that down-regulation of EP3 expression by oxLDL is associated with impairment of EP3-mediated anti-inflammatory effects, and that EP3 receptor activity may exert a beneficial effect on atherosclerosis.	[Sui, Xuxia; Liu, Yanmin; Li, Qi; Liu, Gefei; Song, Xuhong; Su, Zhongjing; Chang, Xiaolan; Liang, Bin; Huang, Dongyang] Shantou Univ, Coll Med, Guangdong Higher Educ Inst, Dept Cell Biol,Key Lab Mol Biol High Canc Inciden, Shantou, Guangdong, Peoples R China; [Zhou, Yingbi] Shantou Univ, Coll Med, Dept Cardiovasc Res Ctr, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University	Huang, DY (corresponding author), Shantou Univ, Coll Med, Guangdong Higher Educ Inst, Dept Cell Biol,Key Lab Mol Biol High Canc Inciden, Shantou, Guangdong, Peoples R China.	bliang@stu.edu.cn; huangdy@stu.edu.cn	Li, Qi/A-8311-2019	Li, Qi/0000-0001-5591-3761	National Basic Research Project of China (program 973) [2010CD912503]; National Natural Science Foundation of China [31371333, 31071153]; Guangdong Natural Science Foundation of China [S2012030006289]	National Basic Research Project of China (program 973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province)	National Basic Research Project of China (program 973, grant number 2010CD912503), the National Natural Science Foundation of China (grant numbers 31371333 and 31071153), and Guangdong Natural Science Foundation of China (grant number S2012030006289). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI H, 1992, J BIOCHEM-TOKYO, V112, P482, DOI 10.1093/oxfordjournals.jbchem.a123925; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; BONNEY RJ, 1980, BIOCHIM BIOPHYS ACTA, V633, P410, DOI 10.1016/0304-4165(80)90199-3; Brand K, 1997, ARTERIOSCL THROM VAS, V17, P1901, DOI 10.1161/01.ATV.17.10.1901; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chung SW, 2000, J BIOL CHEM, V275, P32681, DOI 10.1074/jbc.M002577200; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1925, DOI 10.1161/01.ATV.0000177814.41505.41; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; Di Taranto MD, 2012, ATHEROSCLEROSIS, V220, P93, DOI 10.1016/j.atherosclerosis.2011.10.022; Draczynska-Lusiak B, 1998, NEUROREPORT, V9, P527, DOI 10.1097/00001756-199802160-00028; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Foudi N, 2011, BRIT J PHARMACOL, V163, P826, DOI 10.1111/j.1476-5381.2011.01264.x; Fu YC, 2002, ATHEROSCLEROSIS, V165, P259, DOI 10.1016/S0021-9150(02)00305-2; Gomez-Hernandez A, 2006, J CARDIOVASC PHARM, V47, P60; Gomez-Hernandez A, 2006, ATHEROSCLEROSIS, V187, P139, DOI 10.1016/j.atherosclerosis.2005.08.035; Grigsby PL, 2006, BIOL REPROD, V75, P297, DOI 10.1095/biolreprod.106.051987; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hourton D, 2001, EUR J BIOCHEM, V268, P4489, DOI 10.1046/j.1432-1327.2001.02372.x; Huang JV, 2012, J LIPID RES, V53, P1738, DOI 10.1194/jlr.R024505; Kotani M, 1997, GENOMICS, V40, P425, DOI 10.1006/geno.1996.4585; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; KURLAND JI, 1978, J EXP MED, V147, P952, DOI 10.1084/jem.147.3.952; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Leitinger N, 2006, CIRC RES, V98, P587, DOI 10.1161/01.RES.0000215626.34470.e6; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Llaverias G, 2004, BIOCHEM BIOPH RES CO, V318, P265, DOI 10.1016/j.bbrc.2004.04.021; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Maess MB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-90; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Ohlsson BG, 1996, J CLIN INVEST, V98, P78, DOI 10.1172/JCI118780; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; SHACKELFORD RE, 1995, J BIOL CHEM, V270, P3475, DOI 10.1074/jbc.270.8.3475; Shoji Y, 2004, GUT, V53, P1151, DOI 10.1136/gut.2003.028787; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Ueta Mayumi, 2010, Cornea, V29 Suppl 1, pS57; Wang NP, 2011, CIRC J, V75, P528, DOI 10.1253/circj.CJ-11-0060; Whatling C, 2004, J LIPID RES, V45, P1768, DOI 10.1194/jlr.M400195-JLR200; Yedgar S, 2007, TRENDS PHARMACOL SCI, V28, P459, DOI 10.1016/j.tips.2007.07.005	47	4	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110828	10.1371/journal.pone.0110828	http://dx.doi.org/10.1371/journal.pone.0110828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333975	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200077
J	Killiny, N; Hajeri, S; Tiwari, S; Gowda, S; Stelinski, LL				Killiny, Nabil; Hajeri, Subhas; Tiwari, Siddharth; Gowda, Siddarame; Stelinski, Lukasz L.			Double-Stranded RNA Uptake through Topical Application, Mediates Silencing of Five CYP4 Genes and Suppresses Insecticide Resistance in Diaphorina citri	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; INTERFERENCE; EXPRESSION; P450; MANAGEMENT; PSYLLIDAE; OXIDASE	Silencing of genes through RNA interference (RNAi) in insects has gained momentum during the past few years. RNAi has been used to cause insect mortality, inhibit insect growth, increase insecticide susceptibility, and prevent the development of insecticide resistance. We investigated the efficacy of topically applied dsRNA to induce RNAi for five Cytochrome P-450 genes family 4 (CYP4) in Diaphorina citri. We previously reported that these CYP4 genes are associated with the development of insecticide resistance in D. citri. We targeted five CYP4 genes that share a consensus sequence with one dsRNA construct. Quantitative PCR confirmed suppressed expression of the five CYP4 genes as a result of dsRNA topically applied to the thoracic region of D. citri when compared to the expression levels in a control group. Western blot analysis indicated a reduced signal of cytochrome P-450 proteins (45 kDa) in adult D. citri treated with the dsRNA. In addition, oxidase activity and insecticide resistance were reduced for D. citri treated with dsRNA that targeted specific CYP4 genes. Mortality was significantly higher in adults treated with dsRNA than in adults treated with water. Our results indicate that topically applied dsRNA can penetrate the cuticle of D. citri and induce RNAi. These results broaden the scope of RNAi as a mechanism to manage pests by targeting a broad range of genes. The results also support the application of RNAi as a viable tool to overcome insecticide resistance development in D. citri populations. However, further research is needed to develop grower-friendly delivery systems for the application of dsRNA under field conditions. Considering the high specificity of dsRNA, this tool can also be used for management of D. citri by targeting physiologically critical genes involved in growth and development.	[Killiny, Nabil; Tiwari, Siddharth; Stelinski, Lukasz L.] Univ Florida, Citrus Res & Educ Ctr, IFAS, Dept Entomol & Nematol, Lake Alfred, FL 33850 USA; [Hajeri, Subhas; Gowda, Siddarame] Univ Florida, IFAS, Citrus Res & Educ Ctr, Dept Plant Pathol, Lake Alfred, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Killiny, N (corresponding author), Univ Florida, Citrus Res & Educ Ctr, IFAS, Dept Entomol & Nematol, Lake Alfred, FL 33850 USA.	nabikilliny@ufl.edu	Hajeri, Subhas/E-8180-2018	Hajeri, Subhas/0000-0002-5993-118X; Killiny, Nabil/0000-0002-3895-6943	Citrus Research and Development Foundation	Citrus Research and Development Foundation	This project was supported by a grant to LS from the Citrus Research and Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; El-Shesheny I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065392; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hodgson E, 1985, COMPREHENSIVE INSECT, P225; Hunter CP, 1999, CURR BIOL, V9, pR440, DOI 10.1016/S0960-9822(99)80276-0; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; IZANT JG, 1984, CELL, V36, P1007, DOI 10.1016/0092-8674(84)90050-3; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manjunath KL, 2008, PHYTOPATHOLOGY, V98, P387, DOI 10.1094/PHYTO-98-4-0387; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Qureshi JA, 2010, CROP PROT, V29, P860, DOI 10.1016/j.cropro.2010.04.013; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Scharf Michael E., 2008, V442, P205, DOI 10.1007/978-1-59745-191-8_15; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Serikawa RH, 2012, J ECON ENTOMOL, V105, P1492, DOI 10.1603/EC11211; Setamou M, 2010, J ECON ENTOMOL, V103, P1711, DOI 10.1603/EC09371; Surakasi VP, 2011, J INSECT PHYSIOL, V57, P1537, DOI 10.1016/j.jinsphys.2011.08.006; Tiwari S, 2011, INSECT MOL BIOL, V20, P733, DOI 10.1111/j.1365-2583.2011.01103.x; Tiwari S, 2013, PEST MANAG SCI, V69, P535, DOI 10.1002/ps.3407; Tiwari S, 2012, PEST MANAG SCI, V68, P1405, DOI 10.1002/ps.3323; Tiwari S, 2012, J ECON ENTOMOL, V105, P540, DOI 10.1603/EC11228; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Tiwari S, 2011, ANN ENTOMOL SOC AM, V104, P297, DOI 10.1603/AN10128; Tiwari S, 2011, PEST MANAG SCI, V67, P94, DOI 10.1002/ps.2038; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Wheeler MM, 2010, ARCH INSECT BIOCHEM, V73, P30, DOI 10.1002/arch.20333; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048	43	91	96	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110536	10.1371/journal.pone.0110536	http://dx.doi.org/10.1371/journal.pone.0110536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330026	Green Published, gold			2022-12-27	WOS:000343942100069
J	Abby, SS; Neron, B; Menager, H; Touchon, M; Rocha, EPC				Abby, Sophie S.; Neron, Bertrand; Menager, Herve; Touchon, Marie; Rocha, Eduardo P. C.			MacSyFinder: A Program to Mine Genomes for Molecular Systems with an Application to CRISPR-Cas Systems	PLOS ONE			English	Article							PALINDROMIC REPEATS; IDENTIFICATION; EVOLUTION; TIGRFAMS; CONTEXT; OPERONS; ORDER; TOOL	Motivation: Biologists often wish to use their knowledge on a few experimental models of a given molecular system to identify homologs in genomic data. We developed a generic tool for this purpose. Results: Macromolecular System Finder (MacSyFinder) provides a flexible framework to model the properties of molecular systems (cellular machinery or pathway) including their components, evolutionary associations with other systems and genetic architecture. Modelled features also include functional analogs, and the multiple uses of a same component by different systems. Models are used to search for molecular systems in complete genomes or in unstructured data like metagenomes. The components of the systems are searched by sequence similarity using Hidden Markov model (HMM) protein profiles. The assignment of hits to a given system is decided based on compliance with the content and organization of the system model. A graphical interface, MacSyView, facilitates the analysis of the results by showing overviews of component content and genomic context. To exemplify the use of MacSyFinder we built models to detect and class CRISPR-Cas systems following a previously established classification. We show that MacSyFinder allows to easily define an accurate "Cas-finder" using publicly available protein profiles. Availability and Implementation: MacSyFinder is a standalone application implemented in Python. It requires Python 2.7, Hmmer and makeblastdb (version 2.2.28 or higher). It is freely available with its source code under a GPLv3 license at https://github.com/gem-pasteur/macsyfinder. It is compatible with all platforms supporting Python and Hmmer/makeblastdb. The "Cas-finder" (models and HMM profiles) is distributed as a compressed tarball archive as Supporting Information.	[Abby, Sophie S.; Touchon, Marie; Rocha, Eduardo P. C.] Inst Pasteur, Paris, France; [Abby, Sophie S.; Touchon, Marie; Rocha, Eduardo P. C.] CNRS, UMR3525, Paris, France; [Neron, Bertrand; Menager, Herve] Inst Pasteur, Ctr Informat Biol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Abby, SS (corresponding author), Inst Pasteur, Paris, France.	sophie.abby@pasteur.fr	Abby, Sophie S/H-4817-2011; Rocha, Eduardo/B-7009-2009; Ménager, Hervé/I-2258-2019	Abby, Sophie S/0000-0002-5231-3346; Rocha, Eduardo/0000-0001-7704-822X; Ménager, Hervé/0000-0002-7552-1009; Neron, Bertrand/0000-0002-0220-0482; Touchon, marie/0000-0001-7389-447X	Institut Pasteur; European Research Council [281605]	Institut Pasteur(European Commission); European Research Council(European Research Council (ERC)European Commission)	This project was funded by the Institut Pasteur (http://www.pasteur.fr/en), the French "Centre National de la Recherche Scientifique" (http://www.cnrs.fr/index.php) and the European Research Council (http://erc.europa.eu/) (grant EVOMOBILOME, number 281605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Barrangou R, 2014, SCIENCE, V344, P707, DOI 10.1126/science.1252964; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-18; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Lathe WC, 2000, TRENDS BIOCHEM SCI, V25, P474, DOI 10.1016/S0968-0004(00)01663-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pereira-Leal JB, 2006, PHILOS T R SOC B, V361, P507, DOI 10.1098/rstb.2005.1807; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Staals RHJ, 2013, CRISPR CAS SYSTEMS R; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Zaslaver A, 2006, PHYS BIOL, V3, P183, DOI 10.1088/1478-3975/3/3/003	27	136	140	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110726	10.1371/journal.pone.0110726	http://dx.doi.org/10.1371/journal.pone.0110726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330359	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100103
J	Lancelot, S; Roche, R; Slimen, A; Bouillot, C; Levigoureux, E; Langlois, JB; Zimmer, L; Costes, N				Lancelot, Sophie; Roche, Roxane; Slimen, Afifa; Bouillot, Caroline; Levigoureux, Elise; Langlois, Jean-Baptiste; Zimmer, Luc; Costes, Nicolas			A Multi-Atlas Based Method for Automated Anatomical Rat Brain MRI Segmentation and Extraction of PET Activity	PLOS ONE			English	Article							SPATIAL NORMALIZATION; TEMPLATE; IMAGE; REGISTRATION; SELECTION	Introduction: Preclinical in vivo imaging requires precise and reproducible delineation of brain structures. Manual segmentation is time consuming and operator dependent. Automated segmentation as usually performed via single atlas registration fails to account for anatomo-physiological variability. We present, evaluate, and make available a multi-atlas approach for automatically segmenting rat brain MRI and extracting PET activies. Methods: High-resolution 7T 2DT2 MR images of 12 Sprague-Dawley rat brains were manually segmented into 27-VOI label volumes using detailed protocols. Automated methods were developed with 7/12 atlas datasets, i.e. the MRIs and their associated label volumes. MRIs were registered to a common space, where an MRI template and a maximum probability atlas were created. Three automated methods were tested: 1/registering individual MRIs to the template, and using a single atlas (SA), 2/using the maximum probability atlas (MP), and 3/registering the MRIs from the multi-atlas dataset to an individual MRI, propagating the label volumes and fusing them in individual MRI space (propagation & fusion, PF). Evaluation was performed on the five remaining rats which additionally underwent [F-18] FDG PET. Automated and manual segmentations were compared for morphometric performance (assessed by comparing volume bias and Dice overlap index) and functional performance (evaluated by comparing extracted PET measures). Results: Only the SA method showed volume bias. Dice indices were significantly different between methods (PF. MP. SA). PET regional measures were more accurate with multi-atlas methods than with SA method. Conclusions: Multi-atlas methods outperform SA for automated anatomical brain segmentation and PET measure's extraction. They perform comparably to manual segmentation for FDG-PET quantification. Multi-atlas methods are suitable for rapid reproducible VOI analyses.	[Lancelot, Sophie; Levigoureux, Elise; Zimmer, Luc] Univ Lyon 1, INSERM, CNRS, Lyon Neurosci Res Ctr,Radiopharmaceut & Neurochem, F-69365 Lyon, France; [Lancelot, Sophie; Levigoureux, Elise; Zimmer, Luc] Hosp Civils Lyon, Lyon, France; [Roche, Roxane; Slimen, Afifa; Bouillot, Caroline; Langlois, Jean-Baptiste; Zimmer, Luc; Costes, Nicolas] CERMEP Imagerie Vivant, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Costes, N (corresponding author), CERMEP Imagerie Vivant, Lyon, France.	costes@cermep.fr	Lancelot, Sophie/G-7520-2018; ZIMMER, Luc/AAG-1986-2019; Costes, Nicolas/D-4452-2013	ZIMMER, Luc/0000-0002-2805-7098; Costes, Nicolas/0000-0002-2954-9262				Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ballanger B, 2013, NEUROIMAGE, V77, P26, DOI 10.1016/j.neuroimage.2013.03.029; Casteels C, 2006, J NUCL MED, V47, P1858; Chakravarty MM, 2013, HUM BRAIN MAPP, V34, P2635, DOI 10.1002/hbm.22092; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Constantinescu CC, 2009, PHYS MED BIOL, V54, P2885, DOI 10.1088/0031-9155/54/9/020; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Gaser C, 2012, NEUROIMAGE, V63, P47, DOI 10.1016/j.neuroimage.2012.06.066; Hammers A, 2002, HUM BRAIN MAPP, V15, P165, DOI 10.1002/hbm.10016; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Jia HJ, 2012, NEUROIMAGE, V59, P422, DOI 10.1016/j.neuroimage.2011.07.036; Johnson GA, 2012, NEUROIMAGE, V62, P1848, DOI 10.1016/j.neuroimage.2012.05.041; Kochunov P, 2001, J COMPUT ASSIST TOMO, V25, P805, DOI 10.1097/00004728-200109000-00023; Lancelot S, 2010, TRENDS PHARMACOL SCI, V31, P411, DOI 10.1016/j.tips.2010.06.002; Nie B, 2013, HUM BRAIN MAPP, V34, P1306, DOI 10.1002/hbm.21511; Nie BB, 2010, J MAGN RESON IMAGING, V32, P830, DOI 10.1002/jmri.22283; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Rubins DJ, 2003, NEUROIMAGE, V20, P2100, DOI 10.1016/j.neuroimage.2003.07.011; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; TOGA AW, 1995, BRAIN RES BULL, V38, P77, DOI 10.1016/0361-9230(95)00074-O; Valdes-Hernandez Pedro Antonio, 2011, Front Neuroinform, V5, P26, DOI 10.3389/fninf.2011.00026	29	28	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109113	10.1371/journal.pone.0109113	http://dx.doi.org/10.1371/journal.pone.0109113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330005	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100010
J	Zhang, WJ; Wang, YYE; Zhang, Y; Leleu, X; Reagan, M; Zhang, Y; Mishima, Y; Glavey, S; Manier, S; Sacco, A; Jiang, B; Roccaro, AM; Ghobrial, IM				Zhang, Wenjing; Wang, Yaoyu E.; Zhang, Yu; Leleu, Xavier; Reagan, Michaela; Zhang, Yong; Mishima, Yuji; Glavey, Siobhan; Manier, Salomon; Sacco, Antonio; Jiang, Bo; Roccaro, Aldo M.; Ghobrial, Irene M.			Global Epigenetic Regulation of MicroRNAs in Multiple Myeloma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR MICRORNAS; DNA METHYLATION; MOLECULAR CLASSIFICATION; EXPRESSION PROFILES; GENE-EXPRESSION; DOWN-REGULATION; CPG ISLAND; CANCER; PROLIFERATION; CELLS	Epigenetic changes frequently occur during tumorigenesis and DNA hypermethylation may account for the inactivation of tumor suppressor genes in cancer cells. Studies in Multiple Myeloma (MM) have shown variable DNA methylation patterns with focal hypermethylation changes in clinically aggressive subtypes. We studied global methylation patterns in patients with relapsed/ refractory MM and found that the majority of methylation peaks were located in the intronic and intragenic regions in MM samples. Therefore, we investigated the effect of methylation on miRNA regulation in MM. To date, the mechanism by which global miRNA suppression occurs in MM has not been fully described. In this study, we report hypermethylation of miRNAs in MM and perform confirmation in MM cell lines using bisulfite sequencing and methylationspecific PCR (MSP) in the presence or absence of the DNA demethylating agent 5-aza-2'-deoxycytidine. We further characterized the hypermethylation-dependent inhibition of miR-152, -10b-5p and -34c-3p which was shown to exert a putative tumor suppressive role in MM. These findings were corroborated by the demonstration that the same miRNAs were down-regulated in MM patients compared to healthy individuals, alongside enrichment of miR-152-, -10b-5p, and miR-34c-3p-predicted targets, as shown at the mRNA level in primary MM cells. Demethylation or gain of function studies of these specific miRNAs led to induction of apoptosis and inhibition of proliferation as well as down-regulation of putative oncogene targets of these miRNAs such as DNMT1, E2F3, BTRC and MYCBP. These findings provide the rationale for epigenetic therapeutic approaches in subgroups of MM.	[Zhang, Wenjing; Zhang, Yu; Leleu, Xavier; Reagan, Michaela; Zhang, Yong; Mishima, Yuji; Glavey, Siobhan; Manier, Salomon; Sacco, Antonio; Roccaro, Aldo M.; Ghobrial, Irene M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Zhang, Wenjing; Jiang, Bo] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Wang, Yaoyu E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02115 USA; [Zhang, Yu] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Kunming, Peoples R China; [Leleu, Xavier] Hosp Lille CHRU, Dept Hematol, Hop Claude Huriez, Lille, France	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Southern Medical University - China; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Kunming University of Science & Technology; Universite de Lille - ISITE; CHU Lille	Roccaro, AM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	aldo_roccaro@dfci.harvard.edu; irene_ghobrial@dfci.harvard.edu	Roccaro, Aldo/AAA-8957-2022; Sacco, Antonio/AFL-7734-2022; Dimopoulos, Meletios Athanasios/AAD-4130-2019; Reagan, Michaela R/E-3549-2017; Sacco, Antonio/AAG-7676-2022; Sacco, Antonio/K-4681-2016	Roccaro, Aldo/0000-0002-1872-5128; Reagan, Michaela R/0000-0003-2884-6481; Sacco, Antonio/0000-0003-2945-9416	Research Project Grant (National Institutes of Health) [RO1CA154648]; NATIONAL CANCER INSTITUTE [R01CA154648] Funding Source: NIH RePORTER	Research Project Grant (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Research Project Grant (National Institutes of Health/RO1CA154648), and by the Multiple Myeloma Research Foundation (MMRF; www.themmrf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2012, LEUKEMIA, V26, P395, DOI 10.1038/leu.2011.344; Agnelli L, 2005, J CLIN ONCOL, V23, P7296, DOI 10.1200/JCO.2005.01.3870; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chim CS, 2007, LEUKEMIA, V21, P2527, DOI 10.1038/sj.leu.2404939; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; de Larrea CF, 2013, LEUKEMIA RES, V37, P641, DOI 10.1016/j.leukres.2013.01.013; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Formosa A, 2013, ONCOGENE; Hatzimichael E, 2009, LEUKEMIA RES, V33, P1272, DOI 10.1016/j.leukres.2009.04.009; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kaiser MF, 2013, BLOOD, V122, P219, DOI 10.1182/blood-2013-03-487884; Kim K, 2011, EPIGENETICS-US, V6, P740, DOI 10.4161/epi.6.6.15874; Kureel J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.4; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066982; Lopez-Serra P, 2012, ONCOGENE, V31, P1609, DOI 10.1038/onc.2011.354; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2007, CELL CYCLE, V6, P1455; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Ouyang H, 2013, ONCOGENE; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Rady B, 2013, CELL CYCLE, V12, P2691, DOI 10.4161/cc.25834; Rio-Machin A, 2013, LEUKEMIA, V27, P925, DOI 10.1038/leu.2012.302; Roccaro AM, 2009, BLOOD, V113, P6669, DOI 10.1182/blood-2009-01-198408; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Speigelman VS, 2001, J BIOL CHEM, V276, P27152, DOI 10.1074/jbc.M100031200; Stumpel DJPM, 2011, LEUKEMIA, V25, P429, DOI 10.1038/leu.2010.282; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Toedling J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000227; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Walker BA, 2011, BLOOD, V117, P553, DOI 10.1182/blood-2010-04-279539; Wang F, 2013, J PATHOL, V229, P12, DOI 10.1002/path.4078; Wei J, 2013, CANCER RES, V73, P3913, DOI 10.1158/0008-5472.CAN-12-4318; Wong KY, 2011, BLOOD, V118, P5901, DOI 10.1182/blood-2011-06-361022; Wu P, 2013, BRIT J HAEMATOL, V162, P348, DOI 10.1111/bjh.12394; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Xu Q, 2013, J MOL CELL BIOL, V5, P3, DOI 10.1093/jmcb/mjs049; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Yigit MV, 2013, ONCOGENE, V32, P1530, DOI 10.1038/onc.2012.173; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647	53	28	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110973	10.1371/journal.pone.0110973	http://dx.doi.org/10.1371/journal.pone.0110973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330074	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100112
J	Zhang, W; Qiao, HS; Lv, YZ; Wang, JJ; Chen, XQ; Hou, YY; Tan, RX; Li, EG				Zhang, Wei; Qiao, Haishi; Lv, Yuanzi; Wang, Jingjing; Chen, Xiaoqing; Hou, Yayi; Tan, Renxiang; Li, Erguang			Apigenin Inhibits Enterovirus-71 Infection by Disrupting Viral RNA Association with trans-Acting Factors	PLOS ONE			English	Article							HNRNP A1; REPLICATION; INTERACTS	Flavonoids are widely distributed natural products with broad biological activities. Apigenin is a dietary flavonoid that has recently been demonstrated to interact with heterogeneous nuclear ribonucleoproteins (hnRNPs) and interferes with their RNA editing activity. We investigated whether apigenin possessed antiviral activity against enterovirus-71 (EV71) infection since EV71 infection requires of hnRNP proteins. We found that apigenin selectively blocks EV71 infection by disrupting viral RNA association with hnRNP A1 and A2 proteins. The estimated EC50 value for apigenin to block EV71 infection was determined at 10.3 mu M, while the CC50 was estimated at 79.0 mu M. The anti-EV71 activity was selective since no activity was detected against several DNA and RNA viruses. Although flavonoids in general share similar structural features, apigenin and kaempferol were among tested compounds with significant activity against EV71 infection. hnRNP proteins function as trans-acting factors regulating EV71 translation. We found that apigenin treatment did not affect EV71-induced nucleocytoplasmic redistribution of hnRNP A1 and A2 proteins. Instead, it prevented EV71 RNA association with hnRNP A1 and A2 proteins. Accordingly, suppression of hnRNP A1 and A2 expression markedly reduced EV71 infection. As a positive sense, single strand RNA virus, EV71 has a type I internal ribosome entry site (IRES) that cooperates with host factors and regulates EV71 translation. The effect of apigenin on EV71 infection was further demonstrated using a bicistronic vector that has the expression of a GFP protein under the control of EV71 5'-UTR. We found that apigenin treatment selectively suppressed the expression of GFP, but not a control gene. In addition to identification of apigenin as an antiviral agent against EV71 infection, this study also exemplifies the significance in antiviral agent discovery by targeting host factors essential for viral replication.	[Zhang, Wei; Qiao, Haishi; Wang, Jingjing; Chen, Xiaoqing; Hou, Yayi; Tan, Renxiang; Li, Erguang] Nanjing Univ, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Wei; Qiao, Haishi; Wang, Jingjing; Chen, Xiaoqing; Hou, Yayi; Tan, Renxiang; Li, Erguang] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Lv, Yuanzi; Tan, Renxiang] Nanjing Univ, Coll Life Sci, Nanjing 210008, Jiangsu, Peoples R China; [Li, Erguang] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; China Pharmaceutical University	Tan, RX (corresponding author), Nanjing Univ, Sch Med, Nanjing 210008, Jiangsu, Peoples R China.	rxtan@nju.edu.cn; erguang@nju.edu.cn	chen, xia/GXM-5435-2022; Wang, Jingjing/GLS-7536-2022; qiao, haishi/ABE-5765-2021	Wang, Jingjing/0000-0003-2347-7824; Zhang, Wei/0000-0003-1928-5758	NSFC [81121062, 81371772, 21132004]; Scientific Research Foundation of Graduate School of Nanjing University	NSFC(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Graduate School of Nanjing University(Nanjing University)	This work was supported financially by grants from NSFC (81121062, 81371772, 21132004). WZ was supported by a fellowship from the Scientific Research Foundation of Graduate School of Nanjing University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango D, 2013, P NATL ACAD SCI USA, V110, pE2153, DOI 10.1073/pnas.1303726110; Bekenstein U, 2013, MOL CELL NEUROSCI, V56, P436, DOI 10.1016/j.mcn.2012.12.002; BIAMONTI G, 1994, NUCLEIC ACIDS RES, V22, P1996, DOI 10.1093/nar/22.11.1996; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Chen LL, 2013, J VIROL, V87, P3828, DOI 10.1128/JVI.02278-12; CONTI C, 1990, ANTIMICROB AGENTS CH, V34, P460, DOI 10.1128/AAC.34.3.460; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Junemann C, 2007, J BIOL CHEM, V282, P132, DOI 10.1074/jbc.M608750200; Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750; Kuo RL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-28; Levengood JD, 2013, RNA BIOL, V10, P1136, DOI 10.4161/rna.25107; Li ZH, 2008, J INFECT DIS, V197, P854, DOI 10.1086/527326; Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Lo CS, 2012, DIABETES, V61, P2597, DOI 10.2337/db11-1349; Manthey JA, 2001, CURR MED CHEM, V8, P135, DOI 10.2174/0929867013373723; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Orhan DD, 2010, MICROBIOL RES, V165, P496, DOI 10.1016/j.micres.2009.09.002; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shih SR, 2011, J VIROL, V85, P9658, DOI 10.1128/JVI.05063-11; Siafakas N, 2002, J CLIN LAB ANAL, V16, P59, DOI 10.1002/jcla.2063; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; SUPERTI F, 1989, ANTIVIR RES, V11, P247, DOI 10.1016/0166-3542(89)90034-X; Tait S, 2006, ANTIVIR RES, V72, P252, DOI 10.1016/j.antiviral.2006.07.003; Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0; Tsai FJ, 2011, FOOD CHEM, V128, P312, DOI 10.1016/j.foodchem.2011.03.022; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yeh MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027082; Zhang J, 2013, CANCER DISCOV, V3, P1228, DOI 10.1158/2159-8290.CD-13-0253	31	62	66	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110429	10.1371/journal.pone.0110429	http://dx.doi.org/10.1371/journal.pone.0110429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330384	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210800085
J	Chen, Y; Mo, HZ; Hu, LB; Li, YQ; Chen, J; Yang, LF				Chen, Yi; Mo, Hai-Zhen; Hu, Liang-Bin; Li, You-Qin; Chen, Jian; Yang, Li-Fei			The Endogenous Nitric Oxide Mediates Selenium-Induced Phytotoxicity by Promoting ROS Generation in Brassica rapa	PLOS ONE			English	Article							INDUCED ANTIOXIDANT DEFENSE; PROTEIN-KINASE CASCADE; NADPH OXIDASE; OXIDATIVE STRESS; ARABIDOPSIS-THALIANA; CROSS-TALK; CADMIUM TOXICITY; SUPEROXIDE-PRODUCTION; INDUCED INHIBITION; ROOT ELONGATION	Selenium (Se) is suggested as an emerging pollutant in agricultural environment because of the increasing anthropogenic release of Se, which in turn results in phytotoxicity. The most common consequence of Se-induced toxicity in plants is oxidative injury, but how Se induces reactive oxygen species (ROS) burst remains unclear. In this work, histofluorescent staining was applied to monitor the dynamics of ROS and nitric oxide (NO) in the root of Brassica rapa under Se(IV) stress. Se(IV)-induced faster accumulation of NO than ROS. Both NO and ROS accumulation were positively correlated with Se(IV)induced inhibition of root growth. The NO accumulation was nitrate reductase (NR)- and nitric oxide synthase (NOS)dependent while ROS accumulation was NADPH oxidase-dependent. The removal of NO by NR inhibitor, NOS inhibitor, and NO scavenger could alleviate Se(IV)-induced expression of Br_Rbohs coding for NADPH oxidase and the following ROS accumulation in roots, which further resulted in the amelioration of Se(IV)-induced oxidative injury and growth inhibition. Thus, we proposed that the endogenous NO played a toxic role in B. rapa under Se(IV) stress by triggering ROS burst. Such findings can be used to evaluate the toxic effects of Se contamination on crop plants.	[Chen, Yi; Yang, Li-Fei] Nanjing Agr Univ, Coll Hort, Xinxiang, Henan Province, Peoples R China; [Chen, Yi; Li, You-Qin; Chen, Jian] Jiangsu Acad Agr Sci, Inst Food Qual & Safety, Nanjing, Jiangsu, Peoples R China; [Mo, Hai-Zhen; Hu, Liang-Bin] Henan Inst Sci & Technol, Dept Food Sci, Xinxiang, Henan Province, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Henan Institute of Science & Technology	Chen, J (corresponding author), Jiangsu Acad Agr Sci, Inst Food Qual & Safety, Nanjing, Jiangsu, Peoples R China.	jacksonchen206@gmail.com; lfy@njau.edu.cn		/0000-0001-6876-6369; Hu, `Liangbin/0000-0003-0747-093X	National Natural Science Foundation of China [31101537]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (grant No. 31101537). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab T, 2012, ECOTOX ENVIRON SAFE, V80, P60, DOI 10.1016/j.ecoenv.2012.02.007; Aggarwal M, 2011, BIOL TRACE ELEM RES, V140, P354, DOI 10.1007/s12011-010-8699-9; Bellin D, 2013, MOL PLANT MICROBE IN, V26, P271, DOI 10.1094/MPMI-09-12-0214-CR; Besson-Bard A, 2009, PLANT PHYSIOL, V149, P1302, DOI 10.1104/pp.108.133348; Brandes RP, 2010, FREE RADICAL BIO MED, V49, P687, DOI 10.1016/j.freeradbiomed.2010.04.030; Cartes P, 2010, ANN APPL BIOL, V156, P297, DOI 10.1111/j.1744-7348.2010.00387.x; Chen J, 2013, CHEMOSPHERE, V93, P283, DOI 10.1016/j.chemosphere.2013.04.079; Chen J, 2012, WATER AIR SOIL POLL, V223, P4141, DOI 10.1007/s11270-012-1180-y; Chen M, 2014, J HAZARD MATER, V267, P40, DOI 10.1016/j.jhazmat.2013.12.029; De Michele R, 2009, PLANT PHYSIOL, V150, P217, DOI 10.1104/pp.108.133397; Djanaguiraman M, 2010, PLANT PHYSIOL BIOCH, V48, P999, DOI 10.1016/j.plaphy.2010.09.009; Dupuy L, 2010, J EXP BOT, V61, P2131, DOI 10.1093/jxb/erp389; Fang Y, 2010, J AGR FOOD CHEM, V58, P9731, DOI 10.1021/jf100934p; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Frahry G, 2001, PLANTA, V212, P175, DOI 10.1007/s004250000376; Frohlich A, 2011, PLANT SCI, V181, P401, DOI 10.1016/j.plantsci.2011.07.014; Gallego SM, 2012, ENVIRON EXP BOT, V83, P33, DOI 10.1016/j.envexpbot.2012.04.006; Gas E, 2009, PLANT CELL, V21, P18, DOI 10.1105/tpc.108.065243; Gomez-Ros LV, 2012, PLANTA, V236, P327, DOI 10.1007/s00425-012-1604-3; Groppa MD, 2012, BIOL PLANTARUM, V56, P167, DOI 10.1007/s10535-012-0036-z; Guo K, 2008, J EXP BOT, V59, P3443, DOI 10.1093/jxb/ern194; Harrison CB, 2010, CLIN EXP PHARMACOL P, V37, P429, DOI 10.1111/j.1440-1681.2009.05317.x; Hasanuzzaman M., 2013, PLANT ACCLIMATION EN, P269, DOI 10.1007/978-1-4614-5001-6_11; Hasanuzzaman M, 2011, BIOL TRACE ELEM RES, V143, P1704, DOI 10.1007/s12011-011-8958-4; Hladun KR, 2013, ENVIRON POLLUT, V172, P70, DOI 10.1016/j.envpol.2012.08.009; Hu XL, 2008, PLANT GROWTH REGUL, V55, P183, DOI 10.1007/s10725-008-9272-9; Jakubowicz M, 2010, J EXP BOT, V61, P3475, DOI 10.1093/jxb/erq177; Jiang M, 2003, PLANT CELL ENVIRON, V26, P929, DOI 10.1046/j.1365-3040.2003.01025.x; Kumar M, 2012, PLANT PHYSIOL BIOCH, V51, P129, DOI 10.1016/j.plaphy.2011.10.016; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lehotai N, 2012, J EXP BOT, V63, P5677, DOI 10.1093/jxb/ers222; Leterrier M, 2012, ENVIRON POLLUT, V166, P136, DOI 10.1016/j.envpol.2012.03.012; Li JL, 2013, ECOTOX ENVIRON SAFE, V96, P103, DOI 10.1016/j.ecoenv.2013.07.007; Li L, 2012, BIOMETALS, V25, P617, DOI 10.1007/s10534-012-9551-9; Lin F, 2009, J EXP BOT, V60, P3221, DOI 10.1093/jxb/erp157; Malik JA, 2012, ENVIRON EXP BOT, V77, P242, DOI 10.1016/j.envexpbot.2011.12.001; Marino D, 2012, TRENDS PLANT SCI, V17, P9, DOI 10.1016/j.tplants.2011.10.001; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Molnarova M, 2009, J HAZARD MATER, V172, P854, DOI 10.1016/j.jhazmat.2009.07.096; Mur LAJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/pls052; Neill S, 2008, J EXP BOT, V59, P25, DOI 10.1093/jxb/erm218; Opdenakker K, 2012, INT J MOL SCI, V13, P7828, DOI 10.3390/ijms13067828; da Silva MAO, 2012, MICROCHIM ACTA, V176, P131, DOI 10.1007/s00604-011-0700-6; Paciolla C, 2011, PLANT BIOSYST, V145, P253, DOI 10.1080/11263504.2010.509942; Palmieri MC, 2008, J EXP BOT, V59, P177, DOI 10.1093/jxb/erm345; Remans T, 2010, FUNCT PLANT BIOL, V37, P532, DOI 10.1071/FP09194; Rodriguez-Serrano M, 2009, PLANT PHYSIOL, V150, P229, DOI 10.1104/pp.108.131524; Sajedi Nour Ali, 2011, Physiology and Molecular Biology of Plants, V17, P215, DOI 10.1007/s12298-011-0067-5; Schiavon M, 2012, ENVIRON EXP BOT, V75, P41, DOI 10.1016/j.envexpbot.2011.08.016; Schiavon M, 2012, AQUAT TOXICOL, V122, P222, DOI 10.1016/j.aquatox.2012.06.014; Seppanen M, 2003, PLANT SCI, V165, P311, DOI 10.1016/S0168-9452(03)00085-2; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Sharma SS, 2006, J EXP BOT, V57, P711, DOI 10.1093/jxb/erj073; Smekalova V, 2014, BIOTECHNOL ADV, V32, P2, DOI 10.1016/j.biotechadv.2013.07.009; Srivastava S, 2012, ACTA PHYSIOL PLANT, V34, P819, DOI 10.1007/s11738-011-0863-0; Sun C, 2013, NEW PHYTOL; Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Tun NN, 2006, PLANT CELL PHYSIOL, V47, P346, DOI 10.1093/pcp/pci252; Umysova D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-58; Verma K, 2013, BIOMETALS, V26, P255, DOI 10.1007/s10534-013-9608-4; Wang YS, 2005, PLANT CELL PHYSIOL, V46, P1915, DOI 10.1093/pcp/pci202; Watanabe M, 2012, PR INT PLANT SULFUR, P123, DOI 10.1007/978-94-007-4450-9_17; Winkel LHE, 2012, ENVIRON SCI TECHNOL, V46, P571, DOI 10.1021/es203434d; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Xie YJ, 2011, PLANT J; Xiong J, 2010, ARCH BIOCHEM BIOPHYS, V497, P13, DOI 10.1016/j.abb.2010.02.014; Xiong J, 2009, PLANTA, V230, P599, DOI 10.1007/s00425-009-0970-y; Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199; Yao XQ, 2013, ECOTOX ENVIRON SAFE, V92, P320, DOI 10.1016/j.ecoenv.2013.03.024; Zhang AY, 2007, NEW PHYTOL, V175, P36, DOI 10.1111/j.1469-8137.2007.02071.x; Zhang YY, 2009, PLANT CELL, V21, P2357, DOI 10.1105/tpc.108.062992; Zhou Y, 2012, PHYTOCHEMISTRY, V76, P46, DOI 10.1016/j.phytochem.2011.12.004; Zhu YG, 2009, TRENDS PLANT SCI, V14, P436, DOI 10.1016/j.tplants.2009.06.006; Zrobek-Sokolnik A, 2009, ACTA PHYSIOL PLANT, V31, P43, DOI 10.1007/s11738-008-0197-8	75	31	33	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110901	10.1371/journal.pone.0110901	http://dx.doi.org/10.1371/journal.pone.0110901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333984	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200088
J	Drori, A; Messerle, M; Brune, W; Tirosh, B				Drori, Adi; Messerle, Martin; Brune, Wolfram; Tirosh, Boaz			Lack of XBP-1 Impedes Murine Cytomegalovirus Gene Expression	PLOS ONE			English	Article							UNFOLDED-PROTEIN-RESPONSE; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR XBP1; REGULATED IRE1-DEPENDENT DECAY; MESSENGER-RNA; ER STRESS; PLASMA-CELLS; IN-VIVO; B-CELLS; INFECTION	The unfolded protein response (UPR) is an endoplasmic reticulum (ER)-to-nucleus signaling cascade induced in response to ER stress. The UPR aims at restoring homeostasis, but can also induce apoptosis if stress persists. Infection by human and murine cytomegaloviruses (CMVs) provokes ER stress and induces the UPR. However, both CMVs manipulate the UPR to promote its prosurvival activity and delay apoptosis. The underlying mechanisms remain largely unknown. Recently, we demonstrated that MCMV and HCMV encode a late protein to target IRE1 for degradation. However, the importance of its downstream effector, X Box binding protein 1 (XBP-1), has not been directly studied. Here we show that deletion of XBP-1 prior to or early after infection confers a transient delay in viral propagation in fibroblasts that can be overcome by increasing the viral dose. A similar phenotype was demonstrated in peritoneal macrophages. In vivo, acute infection by MCMV is reduced in the absence of XBP-1. Our data indicate that removal of XBP-1 confers a kinetic delay in early stages of MCMV infection and suggest that the late targeting of IRE1 is aimed at inhibiting activities other than the splicing of XBP-1 mRNA.	[Drori, Adi; Tirosh, Boaz] Hebrew Univ Jerusalem, Inst Drug Res, Jerusalem, Israel; [Messerle, Martin] Hannover Med Sch, Dept Virol, Hannover, Germany; [Brune, Wolfram] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	Hebrew University of Jerusalem; Hannover Medical School; Heinrich Pette Institute	Tirosh, B (corresponding author), Hebrew Univ Jerusalem, Inst Drug Res, Jerusalem, Israel.	boazt@ekmd.huji.ac.il	Brune, Wolfram/H-5058-2019	Brune, Wolfram/0000-0002-6078-5255; Messerle, Martin/0000-0002-1227-3933	David R. Bloom Center for Pharmacy; Rosetrees Fund; Lower Saxony Research Fund; Israel Science Foundation [78/09]; Nechemia Lev Tzion predoctoral fellowship; Paula Goldberg predoctoral fellowship	David R. Bloom Center for Pharmacy; Rosetrees Fund; Lower Saxony Research Fund; Israel Science Foundation(Israel Science Foundation); Nechemia Lev Tzion predoctoral fellowship; Paula Goldberg predoctoral fellowship	Research was funded by grants from David R. Bloom Center for Pharmacy (BT), The Rosetrees Fund (BT), the Lower Saxony Research Fund (BT and MM) and Israel Science Foundation grant no. 78/09 (BT). AD was supported by a Nechemia Lev Tzion and Paula Goldberg predoctoral fellowships. Funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; [Anonymous], 2006, CYTOMEGALOVIRUSES; Benhamron S, 2014, EUR J IMMUNOL, V44, P867, DOI 10.1002/eji.201343953; Boeckh M, 2011, J CLIN INVEST, V121, P1673, DOI 10.1172/JCI45449; Borst EM, 2007, CURR PROTOC IMMUNOL; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Brune W, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1907s43; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cho JA, 2013, CELL HOST MICROBE, V13, P558, DOI 10.1016/j.chom.2013.03.011; Cicin-Sain L, 2005, J VIROL, V79, P9492, DOI 10.1128/JVI.79.15.9492-9502.2005; DORSCHHASLER K, 1985, P NATL ACAD SCI USA, V82, P8325, DOI 10.1073/pnas.82.24.8325; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Goldfinger M, 2011, EUR J IMMUNOL, V41, P491, DOI 10.1002/eji.201040677; Goldfinger M, 2009, J IMMUNOL, V182, P7038, DOI 10.4049/jimmunol.0802990; Hanson LK, 2009, J VIROL, V83, P7449, DOI 10.1128/JVI.00325-09; Hanson LK, 1999, J VIROL, V73, P5970, DOI 10.1128/JVI.73.7.5970-5980.1999; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Ho M, 2008, MED MICROBIOL IMMUN, V197, P65, DOI 10.1007/s00430-007-0066-x; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hsiao JR, 2009, CANCER RES, V69, P4461, DOI 10.1158/0008-5472.CAN-09-0277; Hu FL, 2011, EUR J IMMUNOL, V41, P1086, DOI 10.1002/eji.201040831; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Klenovsek K, 2007, BLOOD, V110, P3472, DOI 10.1182/blood-2007-06-095414; Krmpotic A, 2003, MICROBES INFECT, V5, P1263, DOI 10.1016/j.micinf.2003.09.007; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mathys S, 2003, J INFECT DIS, V187, P988, DOI 10.1086/368094; Mijimolle N, 2005, CANCER CELL, V7, P313, DOI 10.1016/j.ccr.2005.03.004; Presti RM, 2001, J EXP MED, V193, P483, DOI 10.1084/jem.193.4.483; Qian ZK, 2012, J VIROL, V86, P6712, DOI 10.1128/JVI.00200-12; Reddehase MJ, 2002, J CLIN VIROL, V25, pS23; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Sacher T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002366; Sacher T, 2012, EUR J CELL BIOL, V91, P70, DOI 10.1016/j.ejcb.2011.02.002; Siegel AM, 2010, J VIROL, V84, P674, DOI 10.1128/JVI.01306-09; So JS, 2012, CELL METAB, V16, P487, DOI 10.1016/j.cmet.2012.09.004; Stahl S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003544; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Tang CHA, 2014, J CLIN INVEST, V124, P2585, DOI 10.1172/JCI73448; Tirosh B, 2005, J EXP MED, V202, P505, DOI 10.1084/jem.20050575; Tirosh B, 2005, J VIROL, V79, P2768, DOI 10.1128/JVI.79.5.2768-2779.2005; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu FQ, 2007, FEBS LETT, V581, P3485, DOI 10.1016/j.febslet.2007.06.056; Yu YJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003266; Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052; Zhao Y, 2013, CELL RES, V23, P491, DOI 10.1038/cr.2013.2	63	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110942	10.1371/journal.pone.0110942	http://dx.doi.org/10.1371/journal.pone.0110942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333725	Green Submitted, gold, Green Published			2022-12-27	WOS:000343731200094
J	Mo, G; Gibbons, F; Schroeder, P; Krzyzanski, W				Mo, Gary; Gibbons, Frank; Schroeder, Patricia; Krzyzanski, Wojciech			Lifespan Based Pharmacokinetic-Pharmacodynamic Model of Tumor Growth Inhibition by Anticancer Therapeutics	PLOS ONE			English	Article							CELL-CYCLE; DOSE SCHEDULE; NATURAL CELLS; IN-VITRO; PHASE-I; CANCER; AGENTS; HETEROGENEITY; LEUKEMIA; DYNAMICS	Accurate prediction of tumor growth is critical in modeling the effects of anti-tumor agents. Popular models of tumor growth inhibition (TGI) generally offer empirical description of tumor growth. We propose a lifespan-based tumor growth inhibition (LS TGI) model that describes tumor growth in a xenograft mouse model, on the basis of cellular lifespan T. At the end of the lifespan, cells divide, and to account for tumor burden on growth, we introduce a cell division efficiency function that is negatively affected by tumor size. The LS TGI model capability to describe dynamic growth characteristics is similar to many empirical TGI models. Our model describes anti-cancer drug effect as a dose-dependent shift of proliferating tumor cells into a non-proliferating population that die after an altered lifespan T-A. Sensitivity analysis indicated that all model parameters are identifiable. The model was validated through case studies of xenograft mouse tumor growth. Data from paclitaxel mediated tumor inhibition was well described by the LS TGI model, and model parameters were estimated with high precision. A study involving a protein casein kinase 2 inhibitor, AZ968, contained tumor growth data that only exhibited linear growth kinetics. The LS TGI model accurately described the linear growth data and estimated the potency of AZ968 that was very similar to the estimate from an established TGI model. In the case study of AZD1208, a pan-Pim inhibitor, the doubling time was not estimable from the control data. By fixing the parameter to the reported in vitro value of the tumor cell doubling time, the model was still able to fit the data well and estimated the remaining parameters with high precision. We have developed a mechanistic model that describes tumor growth based on cell division and has the flexibility to describe tumor data with diverse growth kinetics.	[Mo, Gary; Krzyzanski, Wojciech] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA; [Mo, Gary; Gibbons, Frank; Schroeder, Patricia] AstraZeneca, iMED, DMPK Modeling & Simulat, Oncol, Waltham, MA USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; AstraZeneca	Krzyzanski, W (corresponding author), SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA.	wk@buffalo.edu			AstraZeneca MBDDx Predictive Science Programme; National Institutes of Health [GM57980]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057980] Funding Source: NIH RePORTER	AstraZeneca MBDDx Predictive Science Programme; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by a fellowship from AstraZeneca MBDDx Predictive Science Programme and National Institutes of Health grant GM57980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajzer Z, 1996, MATH COMPUT MODEL, V23, P31, DOI 10.1016/0895-7177(96)00018-0; BASSUKAS ID, 1994, CANCER RES, V54, P4385; BRATTAIN MG, 1981, CANCER RES, V41, P1751; BRUNTON GF, 1980, CELL TISSUE KINET, V13, P455, DOI 10.1111/j.1365-2184.1980.tb00486.x; Budha NR, 2011, AAPS J, V13, P650, DOI 10.1208/s12248-011-9302-9; Bueno L, 2008, EUR J CANCER, V44, P142, DOI 10.1016/j.ejca.2007.10.008; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Creton G, 2006, J EXP CLIN CANC RES, V25, P557; Danhof M, 2008, TRENDS PHARMACOL SCI, V29, P186, DOI 10.1016/j.tips.2008.01.007; DAYNEKA NL, 1993, J PHARMACOKINET BIOP, V21, P457, DOI 10.1007/BF01061691; DEXTER DL, 1978, CANCER RES, V38, P3174; FREI E, 1969, CANCER RES, V29, P1325; Friberg LE, 2003, INVEST NEW DRUG, V21, P183, DOI 10.1023/A:1023573429626; Hamed SS, 2013, CANCER CHEMOTH PHARM, V72, P553, DOI 10.1007/s00280-013-2226-6; Hart D, 1998, BRIT J CANCER, V78, P382, DOI 10.1038/bjc.1998.503; Hlatky L, 1996, CANCER RES, V56, P1660; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jumbe NL, 2010, J PHARMACOKINET PHAR, V37, P221, DOI 10.1007/s10928-010-9156-2; JUSKO WJ, 1973, J PHARMACOKINET BIOP, V1, P175, DOI 10.1007/BF01062346; Keeton EK, 2014, BLOOD, V123, P905, DOI 10.1182/blood-2013-04-495366; Kim M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00278; Koch G, 2012, J PHARMACOKINET PHAR, V39, P343, DOI 10.1007/s10928-012-9254-4; Koch G, 2009, J PHARMACOKINET PHAR, V36, P179, DOI 10.1007/s10928-009-9117-9; Kozusko F, 2001, MATH BIOSCI, V170, P1, DOI 10.1016/S0025-5564(00)00065-1; Krzyzanski W, 1999, J PHARMACOKINET BIOP, V27, P467, DOI 10.1023/A:1023249813106; Krzyzanski W, 2002, J PHARMACOKINET PHAR, V29, P311, DOI 10.1023/A:1020984823092; Krzyzanski W, 2008, J PHARMACOKINET PHAR, V35, P349, DOI 10.1007/s10928-008-9092-6; Krzyzanski W, 2012, J PHARMACOKINET PHAR, V39, P109, DOI 10.1007/s10928-011-9236-y; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; Lobo ED, 2002, AAPS PHARMSCI, V4; Macintosh CA, 1998, CANCER RES, V58, P23; Matsuo Y, 2003, LEUKEMIA RES, V27, P165, DOI 10.1016/S0145-2126(02)00081-4; ODWYER PJ, 1992, CANCER RES, V52, P6746; PANETTA JC, 1995, APPL MATH LETT, V8, P83, DOI 10.1016/0893-9659(95)00053-S; Panetta JC, 2006, BRIT J CANCER, V94, P93, DOI 10.1038/sj.bjc.6602893; Parker WB, 2009, CHEM REV, V109, P2880, DOI 10.1021/cr900028p; Ribba B, 2011, EUR J CANCER, V47, P479, DOI 10.1016/j.ejca.2010.10.003; Ribeiro D, 2009, COMPUT BIOL MED, V39, P368, DOI 10.1016/j.compbiomed.2009.01.014; Sachs RK, 2001, MATH COMPUT MODEL, V33, P1297, DOI 10.1016/S0895-7177(00)00316-2; SCHABEL FM, 1969, CANCER RES, V29, P2384; Schroeder P, 2012, CANC RES, V72; Shampine LF, 2001, APPL NUMER MATH, V37, P441, DOI 10.1016/S0168-9274(00)00055-6; Shivva V, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.25; Simeoni M, 2004, CANCER RES, V64, P1094, DOI 10.1158/0008-5472.CAN-03-2524; SKEHAN P, 1986, GROWTH, V50, P496; Tang L, 2012, ISRN BIOMATHEMATICS, V2012, P12, DOI DOI 10.1016/J.C0MP0SITESA.2012.09.012; Wei N, 2014, MOL CANCER THER, V13, P1130, DOI 10.1158/1535-7163.MCT-13-0880; WENNERBERG J, 1988, ARCH OTOLARYNGOL, V114, P781; WIERNIK PH, 1987, CANCER RES, V47, P2486; Yang J, 2010, AAPS J, V12, P1, DOI 10.1208/s12248-009-9155-7	50	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109747	10.1371/journal.pone.0109747	http://dx.doi.org/10.1371/journal.pone.0109747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333487	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200019
J	Timbo, RV; Hermes-Lima, M; Silva, LP; Mehta, A; Moraes, MCB; Paula, DP				Timbo, Renata Velozo; Hermes-Lima, Marcelo; Silva, Luciano Paulino; Mehta, Angela; Blassioli Moraes, Maria Carolina; Paula, Debora Pires			Biochemical Aspects of the Soybean Response to Herbivory Injury by the Brown Stink Bug Euschistus heros (Hemiptera: Pentatomidae)	PLOS ONE			English	Article							PARASITOID TELENOMUS-PODISI; GLYCINE-RICH PROTEINS; INDUCED VOLATILES; PLANT; RESISTANCE; DEFENSE; PROTOXYLEM; DIVERSITY; SYSTEM; LEAVES	Plant defense response is an elaborate biochemical process shown to depend on the plant genetic background and on the biological stressor. This work evaluated the soybean biochemical foliar response to brown stink bug herbivory injury through an analysis of redox metabolism and proteomic 2DE profiles of susceptible (BRS Silvania RR) and resistant (IAC-100) varieties. The activity of lipoxygenase-3, guaiacol peroxidase, catalase and ascorbate peroxidase was monitored every 24 h up to 96 h. In the susceptible variety, injury caused an increase in the activities of lipoxygenase 3 and guaiacol peroxidase, no change in ascorbate peroxidase, and a decrease in catalase. In the resistant variety, injury did not cause an alteration of any of these enzymes. The proteomic profiles were evaluated after 24 h of injury and revealed to have a similar proportion (4-5%) of differential protein expression in both varieties. The differential proteins, identified by mass spectrometry, in the susceptible variety were related to general stress responses, to plant defense, and to fungal infections. However, in the resistant variety, the identified change in protein profile was related to Calvin cycle enzymes. While the susceptible variety showed adaptive changes in redox metabolism and expression of stress-responsive proteins, the resistant showed a defense response to circumvent the biological stressor.	[Timbo, Renata Velozo; Hermes-Lima, Marcelo] Univ Brasilia, Dept Cell Biol, Brasilia, DF, Brazil; [Timbo, Renata Velozo; Silva, Luciano Paulino; Mehta, Angela; Blassioli Moraes, Maria Carolina; Paula, Debora Pires] Embrapa Genet Resources & Biotechnol, Dept Biol Control, Brasilia, DF, Brazil	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Paula, DP (corresponding author), Embrapa Genet Resources & Biotechnol, Dept Biol Control, Brasilia, DF, Brazil.	debora.pires@embrapa.br	Mehta, Angela/AAD-1197-2019; Blassioli-Moraes, Maria carolina/C-6072-2013; Silva, Luciano Paulino/G-4915-2012; Hermes-Lima, Marcelo/AAP-1167-2020	Mehta, Angela/0000-0002-5348-5123; Blassioli-Moraes, Maria carolina/0000-0001-7569-9985; Silva, Luciano Paulino/0000-0001-9075-7725; timbo, renata/0000-0003-1989-7412; Hermes-Lima, Marcelo/0000-0003-1732-0927	Embrapa; CNPq; CAPES	Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Embrapa (www.embrapa.br) (DPP AM LPS), CNPq (www.cnpq.br) (LPS), and CAPES (www.capes.gov.br) (RVT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; ANDERSON JV, 1992, PLANT PHYSIOL, V98, P501, DOI 10.1104/pp.98.2.501; Axelrod B., 1981, METH ENZYMOL, V441, P451, DOI [10.1016/0076-6879(81)71055-3, DOI 10.1016/0076-6879(81)71055-3]; Bi JL, 1997, J CHEM ECOL, V23, P97, DOI 10.1023/B:JOEC.0000006348.62578.fd; BI JL, 1995, J CHEM ECOL, V21, P1511, DOI 10.1007/BF02035149; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Chen YG, 2009, J ECON ENTOMOL, V102, P1262, DOI 10.1603/029.102.0353; Colazza S., 2013, CHEM ECOL INSECT PAR, P1; CONAB-COMPANHIA NACIONAL DE ABASTECIMENTO, 2019, AC SAFR BRAS GRAOS; Correa-Ferreira BS, 2002, AGR FOREST ENTOMOL, V4, P145, DOI 10.1046/j.1461-9563.2002.00136.x; Correa-Ferreira BS, 1999, CIRCULAR TECNICA, V24; Courtois EA, 2009, J CHEM ECOL, V35, P1349, DOI 10.1007/s10886-009-9718-1; Devi PUM, 2000, EUR J PLANT PATHOL, V106, P857, DOI 10.1023/A:1008797006206; Dicke M, 2003, BASIC APPL ECOL, V4, P3, DOI 10.1078/1439-1791-00129; FARMER EE, 1992, PLANT PHYSIOL, V98, P995, DOI 10.1104/pp.98.3.995; Fernandes AP, 2000, BIOCIENCIAS UNICEUB, V1, P87; Fu ZQ, 2007, NATURE, V447, P284, DOI 10.1038/nature05737; Michereff MFF, 2011, J CHEM ECOL, V37, P273, DOI 10.1007/s10886-011-9917-4; Gomez S. K., 2004, Journal of Cotton Science, V8, P99; Gris Cristiane Fortes, 2013, Rev. Ceres, V60, P286, DOI 10.1590/S0034-737X2013000200019; Hermes-Lima M, 2012, COMP BIOCHEM PHYS A, V163, P189, DOI 10.1016/j.cbpa.2012.06.006; ISHIGE F, 1993, PLANT PHYSIOL, V101, P193, DOI 10.1104/pp.101.1.193; Karuppanapandian T, 2011, AUST J CROP SCI, V5, P709; Kim JY, 2007, PLANT J, V50, P439, DOI 10.1111/j.1365-313X.2007.03057.x; Kim YO, 2005, PLANT J, V42, P890, DOI 10.1111/j.1365-313X.2005.02420.x; KUTCHAN TM, 1995, PLANT CELL, V7, P1059, DOI 10.2307/3870057; Laumann RA, 2008, 9 S NAC CERR 2 S INT; Li DC, 2012, CELL STRESS CHAPERON, V17, P103, DOI 10.1007/s12192-011-0289-z; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Mangeon A, 2010, PLANT SIGNAL BEHAV, V5, P99, DOI 10.4161/psb.5.2.10336; Mangeon A, 2009, PLANTA, V230, P253, DOI 10.1007/s00425-009-0940-4; MANTSALA P, 1984, J BIOL CHEM, V259, P4230; McPherson RM, 2007, J ECON ENTOMOL, V100, P962, DOI 10.1603/0022-0493(2007)100[962:ELDRIS]2.0.CO;2; Mechin Valerie, 2007, V355, P1; Moraes MCB, 2009, ENTOMOL EXP APPL, V131, P178, DOI 10.1111/j.1570-7458.2009.00836.x; Moraes MCB, 2008, J PLANT INTERACT, V3, P111, DOI 10.1080/17429140701810724; Moraes MCB, 2005, ENTOMOL EXP APPL, V115, P227, DOI 10.1111/j.1570-7458.2005.00290.x; Ni X, 2001, 113 DEP ENT; Panizzi AR, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P421; Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200; Perez FJ, 2002, PHYTOCHEMISTRY, V60, P573, DOI 10.1016/S0031-9422(02)00146-2; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Ringli C, 2001, PLANT PHYSIOL, V125, P673, DOI 10.1104/pp.125.2.673; Rostas M, 2008, CHEMOECOLOGY, V18, P29, DOI 10.1007/s00049-007-0390-z; Ruuhola T, 2006, ANN BOT-LONDON, V97, P29, DOI 10.1093/aob/mcj005; Ryser U, 2004, J CELL SCI, V117, P1179, DOI 10.1242/jcs.00966; Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6; Taiz L., 2006, PLANT PHYSIOL; Todd JW, 1980, SAMPLING PHYTOPHAGOU; Veiga RFA, 1999, B TECNICO, V175; Vieira CR, 2013, BIOL CONTROL, V64, P75, DOI 10.1016/j.biocontrol.2012.10.004; Vieira SS, 2011, NEOTROP ENTOMOL, V40, P117, DOI 10.1590/S1519-566X2011000100018; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Weiss Walter, 2007, V355, P121; Wildgruber R, 2002, PROTEOMICS, V2, P727, DOI 10.1002/1615-9861(200206)2:6<727::AID-PROT727>3.0.CO;2-2	57	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109735	10.1371/journal.pone.0109735	http://dx.doi.org/10.1371/journal.pone.0109735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333272	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200018
J	Barreto, DP; Conrad, R; Klose, M; Claus, P; Enrich-Prast, A				Barreto, Davi Pedroni; Conrad, Ralf; Klose, Melanie; Claus, Peter; Enrich-Prast, Alex			Distance-Decay and Taxa-Area Relationships for Bacteria, Archaea and Methanogenic Archaea in a Tropical Lake Sediment	PLOS ONE			English	Article							MICROBIAL BIOGEOGRAPHY; VERTICAL-DISTRIBUTION; DIVERSITY; COMMUNITY; BACTERIOPLANKTON; MICROORGANISMS; AMPLIFICATION; BIODIVERSITY; SEQUENCES; PATTERNS	The study of of the distribution of microorganisms through space (and time) allows evaluation of biogeographic patterns, like the species-area index (z). Due to their high dispersal ability, high reproduction rates and low rates of extinction microorganisms tend to be widely distributed, and they are thought to be virtually cosmopolitan and selected primarily by environmental factors. Recent studies have shown that, despite these characteristics, microorganisms may behave like larger organisms and exhibit geographical distribution. In this study, we searched patterns of spatial diversity distribution of bacteria and archaea in a contiguous environment. We collected 26 samples of a lake sediment, distributed in a nested grid, with distances between samples ranging from 0.01 m to 1000 m. The samples were analyzed using T-RFLP (Terminal restriction fragment length polymorphism) targeting mcrA (coding for a subunit of methyl-coenzyme M reductase) and the genes of Archaeal and Bacterial 16S rRNA. From the qualitative and quantitative results (relative abundance of operational taxonomic units) we calculated the similarity index for each pair to evaluate the taxa-area and distance decay relationship slopes by linear regression. All results were significant, with mcrA genes showing the highest slope, followed by Archaeal and Bacterial 16S rRNA genes. We showed that the microorganisms of a methanogenic community, that is active in a contiguous environment, display spatial distribution and a taxa-area relationship.	[Barreto, Davi Pedroni] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil; [Enrich-Prast, Alex] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Conrad, Ralf; Klose, Melanie; Claus, Peter] Max Planck Inst Terr Microbiol, D-35043 Marburg, Hessen, Germany; [Enrich-Prast, Alex] Linkoping Univ, Dept Water & Environm Studies, S-58183 Linkoping, Sweden	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Max Planck Society; Linkoping University	Enrich-Prast, A (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.	aeprast@biologia.ufrj.br	Prast, Alex Enrich/AAL-4722-2021; Enrich-Prast, Alex/H-5391-2012	Prast, Alex Enrich/0000-0003-3561-0936; 	National Council of Scientific and Technological Development (CNPq) (Brazil) [477260/2011-0]; Max Planck Society (Germany)	National Council of Scientific and Technological Development (CNPq) (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Max Planck Society (Germany)(Max Planck Society)	This study was funded by the National Council of Scientific and Technological Development (CNPq), trough the project 477260/2011-0. (Brazil - www.cnpq.br) and by the Max Planck Society (Germany - www.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel R, 2012, ISME J, V6, P847, DOI 10.1038/ismej.2011.141; Baas-Becking L, 1934, GEOBIOLOGIE INLEIDIN, P18; Bahl J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1167; Begon M., 2009, ECOLOGY INDIVIDUALS; Bell T, 2005, SCIENCE, V308, P1884, DOI 10.1126/science.1111318; Bell T, 2010, ISME J, V4, P1357, DOI 10.1038/ismej.2010.77; Bezerra M.A.O., 2008, OECOL BRAS, V12, P155, DOI [DOI 10.4257/oeco.2008.1201.14, 10.4257/oeco.2008.1201.14, DOI 10.4257/OECO.2008.1201.14]; Bowman JP, 2003, APPL ENVIRON MICROB, V69, P2463, DOI 10.1128/AEM.69.5.2463-2483.2003; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Chan OC, 2005, ENVIRON MICROBIOL, V7, P1139, DOI 10.1111/j.1462-2920.2005.00790.x; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Conrad R, 2007, ADV AGRON, V96, P1, DOI 10.1016/S0065-2113(07)96005-8; Diniz JAF, 2000, GENET MOL BIOL, V23, P541, DOI 10.1590/S1415-47572000000300007; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Falz KZ, 1999, APPL ENVIRON MICROB, V65, P2402; Fenchel T, 2003, SCIENCE, V301, P925, DOI 10.1126/science.1089242; Fenchel T, 1997, OIKOS, V80, P220, DOI 10.2307/3546589; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Finlay BJ, 1999, NATURE, V400, P828, DOI 10.1038/23616; Galand PE, 2010, ISME J, V4, P564, DOI 10.1038/ismej.2009.134; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Grosskopf R, 1998, DIVERSITY STRUCTURE; Guerrini V, 1978, BACIA ALTO RIO PARAG; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Harte J, 1999, OIKOS, V86, P45, DOI 10.2307/3546568; Head IM, 1998, MICROB ECOL, V35, P1, DOI 10.1007/s002489900056; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Lin W, 2013, SCI REP-UK, V3, DOI 10.1038/srep01643; Lindstrom ES, 2002, MICROB ECOL, V44, P1, DOI 10.1007/s00248-002-0007-6; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; LOVLEY DR, 1986, GEOCHIM COSMOCHIM AC, V50, P11, DOI 10.1016/0016-7037(86)90043-8; Marani L, 2007, ATMOS ENVIRON, V41, P1627, DOI 10.1016/j.atmosenv.2006.10.046; Marsh TL, 1999, CURR OPIN MICROBIOL, V2, P323, DOI 10.1016/S1369-5274(99)80056-3; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Noguez AM, 2005, GLOBAL ECOL BIOGEOGR, V14, P241, DOI 10.1111/j.1466-822x.2005.00156.x; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Oda Y, 2003, APPL ENVIRON MICROB, V69, P5186, DOI 10.1128/AEM.69.9.5186-5191.2003; Pagaling E, 2009, APPL ENVIRON MICROB, V75, P5750, DOI 10.1128/AEM.00040-09; Papke RT, 2004, FEMS MICROBIOL ECOL, V48, P293, DOI 10.1016/j.femsec.2004.03.013; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Rossello-Mora R, 2008, ISME J, V2, P242, DOI 10.1038/ismej.2007.93; Schauer R, 2010, ISME J, V4, P159, DOI 10.1038/ismej.2009.106; SPRINGER E, 1995, INT J SYST BACTERIOL, V45, P554, DOI 10.1099/00207713-45-3-554; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; Takacs-Vesbach C, 2008, ENVIRON MICROBIOL, V10, P1681, DOI 10.1111/j.1462-2920.2008.01584.x; van der Gast CJ, 2005, ENVIRON MICROBIOL, V7, P1220, DOI 10.1111/j.1462-2920.2005.00802.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Woodcock S, 2006, ECOL LETT, V9, P805, DOI 10.1111/j.1461-0248.2006.00929.x; Xiong JB, 2012, ENVIRON MICROBIOL, V14, P2457, DOI 10.1111/j.1462-2920.2012.02799.x; Yannarell AC, 2004, APPL ENVIRON MICROB, V70, P214, DOI 10.1128/AEM.70.1.214-223.2004	56	29	29	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110128	10.1371/journal.pone.0110128	http://dx.doi.org/10.1371/journal.pone.0110128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330320	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100040
J	Bradley, E; Dasgupta, S; Jiang, X; Zhao, XY; Zhu, G; He, Q; Dinkins, M; Bieberich, E; Wang, GH				Bradley, Eric; Dasgupta, Somsankar; Jiang, Xue; Zhao, Xiaying; Zhu, Gu; He, Qian; Dinkins, Michael; Bieberich, Erhard; Wang, Guanghu			Critical Role of Spns2, a Sphingosine-1-Phosphate Transporter, in Lung Cancer Cell Survival and Migration	PLOS ONE			English	Article							SPHINGOSINE KINASE 1; RESPONSE 4 PAR-4; MOUSE-BRAIN; 1-PHOSPHATE; APOPTOSIS; CERAMIDE; INHIBITION; ASTROCYTES; THERAPEUTICS; RESISTANCE	The sphingosine-1-phosphate (S1P) transporter Spns2 regulates myocardial precursor migration in zebrafish and lymphocyte trafficking in mice. However, its function in cancer has not been investigated. We show here that ectopic Spns2 expression induced apoptosis and its knockdown enhanced cell migration in non-small cell lung cancer (NSCLC) cells. Metabolically, Spns2 expression increased the extracellular S1P level while its knockdown the intracellular. Pharmacological inhibition of S1P synthesis abolished the augmented cell migration mediated by Spns2 knockdown, indicating that intracellular S1P plays a key role in this process. Cell signaling studies indicated that Spns2 expression impaired GSK-3 beta and Stat3 mediated pro-survival pathways. Conversely, these pathways were activated by Spns2 knockdown, which explains the increased cell migration since they are also crucial for migration. Alterations of Spns2 were found to affect several enzymes involved in S1P metabolism, including sphingosine kinases, S1P phosphatases, and S1P lyase 1. Genetically, Spns2 mRNA level was found to be reduced in advanced lung cancer (LC) patients as quantified by using a small scale qPCR array. These data show for the first time that Spns2 plays key roles in regulating the cellular functions in NSCLC cells, and that its downregulation is a potential risk factor for LC.	[Bradley, Eric; Dasgupta, Somsankar; Zhao, Xiaying; Zhu, Gu; He, Qian; Dinkins, Michael; Bieberich, Erhard; Wang, Guanghu] Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA USA; [Jiang, Xue] China Med Univ, Shengjing Hosp, Shenyang, Liaoning, Peoples R China	University System of Georgia; Augusta University; China Medical University	Wang, GH (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA USA.	gwang@gru.edu		Jiang, Xue/0000-0003-4835-4708	Georgia Regents University; American Heart Association; NATIONAL INSTITUTE ON AGING [F32AG044954] Funding Source: NIH RePORTER	Georgia Regents University; American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project is supported by an Intramural grant from Georgia Regents University and an SDG award from American Heart Association (GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2013, CANC EPIDEMIOL BIOMA; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; American Cancer Society, 2012, CANC FACTS FIG 2012; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bradley E, 2012, STEM CELLS, V30, P1624, DOI 10.1002/stem.1143; Brizuela L, 2012, MOL CANCER THER, V11, P1841, DOI 10.1158/1535-7163.MCT-12-0227; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Cuvillier O, 2008, EXPERT OPIN THER TAR, V12, P1009, DOI [10.1517/14728222.12.8.1009, 10.1517/14728222.12.8.1009 ]; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Heist RS, 2012, J THORAC ONCOL, V7, P924, DOI 10.1097/JTO.0b013e31824cc334; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hisano Y, 2012, J BIOCHEM, V152, P305, DOI 10.1093/jb/mvs090; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116; Huang Yuan-Li, 2011, World J Biol Chem, V2, P25, DOI 10.4331/wjbc.v2.i2.25; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Looyenga BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030820; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Mendoza A, 2012, CELL REP, V2, P1104, DOI 10.1016/j.celrep.2012.09.021; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Nagahashi M, 2012, FASEB J; Nagahashi M, 2012, CANCER RES, V72, P726, DOI 10.1158/0008-5472.CAN-11-2167; Nakata A, 2012, EXPERT OPIN THER TAR, V16, P771, DOI 10.1517/14728222.2012.697155; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; Osborne N, 2008, CURR BIOL, V18, P1882, DOI 10.1016/j.cub.2008.10.061; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shinjo Keiko, 2012, Methods Mol Biol, V863, P221, DOI 10.1007/978-1-61779-612-8_13; Spiegel S, 1998, BIOCHEMISTRY-MOSCOW+, V63, P69; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Takuwa N, 2011, AM J CANCER RES, V1, P460; Tanfin Z, 2011, CELL SIGNAL, V23, P1997, DOI 10.1016/j.cellsig.2011.07.010; Teng TS, 2009, J CELL SCI, V122, P4150, DOI 10.1242/jcs.057109; Wang G, 2006, APOPTOSIS, V11, P315, DOI 10.1007/s10495-006-3979-8; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; Wang G, 2008, J NEUROCHEM, V106, P718, DOI 10.1111/j.1471-4159.2008.05451.x; Wang G, 2008, GLIA, V56, P449, DOI 10.1002/glia.20626; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Wang GH, 2011, J NEUROCHEM, V117, P703, DOI 10.1111/j.1471-4159.2011.07239.x; Wang GH, 2009, J BIOL CHEM, V284, P14469, DOI 10.1074/jbc.M808909200; West L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031906; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; Zhu WG, 2001, CANCER RES, V61, P1327	50	44	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110119	10.1371/journal.pone.0110119	http://dx.doi.org/10.1371/journal.pone.0110119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330231	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100039
J	Feizpour, A; Boskabady, MH; Ghorbani, A				Feizpour, Azadeh; Boskabady, Mohammad Hossein; Ghorbani, Ahmad			Adipose-Derived Stromal Cell Therapy Affects Lung Inflammation and Tracheal Responsiveness in Guinea Pig Model of COPD	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CIGARETTE-SMOKE; AIRWAY HYPERRESPONSIVENESS; EMPHYSEMA; INJURY	The effects of adipose derived stromal cells (ASCs) were evaluated on tracheal responsiveness and biochemical parameters in guinea pigs model of chronic obstructive pulmonary disease (COPD). Thirty six guinea pigs were divided into 6 groups including: Control, COPD, COPD+intratracheal delivery of PBS (COPD+ITPBS), COPD+intravenous delivery of PBS (COPD+IVPBS), COPD+intratracheal delivery of ASCs (COPD+ITASC) and COPD+intravenous injection of ASCs (COPD+IVASC). COPD was induced by exposing animals to cigarette smoke for 3 months. Cell therapy was then performed and after 14 days, tracheal responsiveness, concentration of interleukin-8 (IL-8) in serum and broncho-alveolar lavage fluid (BALF), as well as total and differential white blood cells (WBC) counts were evaluated. Tracheal responsiveness, total WBC counts, neutrophil and eosinophil percentage in BALF as well as concentration of IL-8 in serum and BALF significantly increased but lymphocyte percentage decreased in COPD compared to the control group (P<0.05 to p<0.001). Cell therapy was able to restore the tracheal hyper-responsiveness and the increased IL-8 concentration in serum and BALF of COPD-ITASC but not COPD-IVASC animals (P<0.05 for all cases). Total WBC in BALF also showed a significant decrease in both treated groups and the percentages of eosinophils, neutrophils and lymphocytes in BALF were reversed in COPD-ITASC compared to COPD-ITPBS animals (P<0.05 to P<0.001). Therefore, intratracheal cell therapy with ASC can decrease tracheal hyperresponsiveness and lung inflammation in cigarette smoke induced-COPD which may be helpful in attenuation of the severity of disease in patients suffering from COPD.	[Feizpour, Azadeh; Boskabady, Mohammad Hossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Feizpour, Azadeh; Boskabady, Mohammad Hossein] Mashhad Univ Med Sci, Sch Med, Dept Physiol, Mashhad, Iran; [Ghorbani, Ahmad] Mashhad Univ Med Sci, Pharmacol Res Ctr Med Plants, Sch Med, Mashhad, Iran	Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science	Boskabady, MH (corresponding author), Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran.	boskabadymh@mums.ac.ir	Ghorbani, Ahmad/S-8164-2016; Boskabady, Mohammad Hossein/AAR-5552-2021	Ghorbani, Ahmad/0000-0002-1603-2619; naseri, shahrokh/0000-0001-8974-2120; Feizpour, Azadeh/0000-0003-0826-4011	Research Council of Mashhad University of Medical Sciences	Research Council of Mashhad University of Medical Sciences	This study was financially supported by the Research Council of Mashhad University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Barrett EG, 2002, AM J RESP CRIT CARE, V165, P1410, DOI 10.1164/rccm.2106029; Boskabady MH, 2010, PHARMAZIE, V65, P300, DOI 10.1691/ph.2010.9760; Boskabady M H, 2007, Pathophysiology, V14, P97, DOI 10.1016/j.pathophys.2007.06.003; Boskabady MH, 2005, MED SCI MONITOR, V11, pCR344; Boskabady MH, 2003, RESPIROLOGY, V8, P473, DOI 10.1046/j.1440-1843.2003.00511.x; Boskabady MH, 2006, RESPIROLOGY, V11, P572, DOI 10.1111/j.1440-1843.2005.00893.x; Boskabady Morteza, 2010, Indian J Med Sci, V64, P363; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Clark J.D., 1996, GUIDE CARE USE LAB A; Cruz FF, 2012, RESP PHYSIOL NEUROBI, V182, P26, DOI 10.1016/j.resp.2012.01.002; Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946; DUSSER DJ, 1989, J CLIN INVEST, V84, P900, DOI 10.1172/JCI114251; Ghorbani A, 2010, EXP CLIN ENDOCR DIAB, V118, P442, DOI 10.1055/s-0030-1247566; Ghorbani A, 2013, PAK J BIOL SCI, V7, P1; Ghorbani Ahmad, 2013, ISRN Endocrinol, V2013, P205385, DOI 10.1155/2013/205385; Ghorbani A, 2014, DARU, V22, DOI 10.1186/2008-2231-22-26; Ghorbani A, 2014, TISSUE CELL, V46, P54, DOI 10.1016/j.tice.2013.11.002; Gladysheva Ekaterina S, 2010, Int J Chron Obstruct Pulmon Dis, V5, P153; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Iyer SS, 2008, EXPERT OPIN BIOL TH, V8, P569, DOI 10.1517/14712598.8.5.569 ; Katsha AM, 2011, MOL THER, V19, P196, DOI 10.1038/mt.2010.192; Krampera M, 2006, CURR OPIN PHARMACOL, V6, P435, DOI 10.1016/j.coph.2006.02.008; Kubo S, 2005, EUR RESPIR J, V26, P993, DOI 10.1183/09031936.05.00042405; Kwong K, 2001, AM J RESP CELL MOL, V25, P299, DOI 10.1165/ajrcmb.25.3.4557; LEE LY, 1995, RESP PHYSIOL, V99, P173, DOI 10.1016/0034-5687(94)00088-H; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Pauwels R A, 2001, Respir Care, V46, P798; Raynaud CM, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/658356; Sakai Hiroyasu, 2011, Journal of Smooth Muscle Research, V47, P1; Schweitzer KS, 2011, AM J RESP CRIT CARE, V183, P215, DOI 10.1164/rccm.201001-0126OC; Shigemura N, 2006, AM J RESP CRIT CARE, V174, P1199, DOI 10.1164/rccm.200603-406OC; Wright JL, 2002, CHEST, V122, p301S, DOI 10.1378/chest.122.6_suppl.301S; WRIGHT JL, 1990, AM REV RESPIR DIS, V142, P1422, DOI 10.1164/ajrccm/142.6_Pt_1.1422; Wu ZX, 1999, J APPL PHYSIOL, V87, P1621, DOI 10.1152/jappl.1999.87.5.1621; XU LJ, 1993, LUNG, V171, P95, DOI 10.1007/BF00542337	36	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e108974	10.1371/journal.pone.0108974	http://dx.doi.org/10.1371/journal.pone.0108974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330334	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100015
J	Pei, Q; Wang, Y; Hu, ZY; Liu, SK; Tan, HY; Guo, CX; Zhang, RR; Xiang, YX; Huang, J; Huang, L; Yuan, H; Yang, GP				Pei, Qi; Wang, Yan; Hu, Zhe-Yi; Liu, Shi-Kun; Tan, Hong-Yi; Guo, Cheng-Xian; Zhang, Ran-Ran; Xiang, Yu-Xia; Huang, Jie; Huang, Lu; Yuan, Hong; Yang, Guo-Ping			Evaluation of the Highly Variable Agomelatine Pharmacokinetics in Chinese Healthy Subjects to Support Bioequivalence Study	PLOS ONE			English	Article							LC-MS/MS METHOD; DRUG PRODUCTS; HUMAN PLASMA; VOLUNTEERS; EFFICACY	Objectives: We aim to obtain the intra-subject coefficient of variability of a highly variable antidepressant agomelatine in humans, and propose an adjusted bioequivalence assessment strategy. Methods: A single-dose, randomized crossover design was conducted in four periods (reference administered thrice, placebo administered once) separated by seven days. A validated LC-MS/MS assay was used to measure drug concentrations in serial blood samples. Results: The intra-subject coefficient of variability was calculated using the residual variance of ANOVA analysis, and the results for Cmax and AUC0-t was 78.34% and 43.52%, respectively, in Chinese healthy subjects. The sample size required for standard BE study were 124(192, 340) if the expected deviation between the reference and generic products was set to 0 (5%, 10%). Conclusions: Agomelatine meets the criteria for highly variable drug in Chinese healthy male subjects, and the traditional BE criteria for agomelatine needs to be adjusted to alleviate the resource and ethical burden of using a large numbers of subjects in clinical trials. Our clinical data on the intra-subject variability of agomelatine PK in Chinese healthy population enables to adjust bioequivalence (BE) assessment approach for agomelatine based on the RSABE approaches recommended by regulatory agencies.	[Tan, Hong-Yi; Guo, Cheng-Xian; Zhang, Ran-Ran; Xiang, Yu-Xia; Huang, Jie; Huang, Lu; Yuan, Hong; Yang, Guo-Ping] Cent S Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha, Hunan, Peoples R China; [Wang, Yan] Changde First Peoples Hosp, Dept Pharm, Changde, Hunan, Peoples R China; [Pei, Qi; Liu, Shi-Kun] Cent S Univ, Xiangya Hosp 3, Dept Pharm, Changsha, Hunan, Peoples R China; [Hu, Zhe-Yi] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Clin Pharm, Memphis, TN 38163 USA	Central South University; Central South University; University of Tennessee System; University of Tennessee Health Science Center	Yang, GP (corresponding author), Cent S Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha, Hunan, Peoples R China.	ygp9880@126.com			National Scientific Foundation of China [81373476, 81302851, 81301924]; National Science and Technology Major Projects for "Major New Drugs Innovation and Development'' [2012ZX09303014-001]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects for "Major New Drugs Innovation and Development''	This work was supported by the National Scientific Foundation of China (No. 81373476, 81302851, 81301924, URL:http://www.nsfc.gov.cn), the National Science and Technology Major Projects for "Major New Drugs Innovation and Development'' (2012ZX09303014-001, URL:http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida S, 2006, ARZNEIMITTELFORSCH, V56, P70; BLUME HH, 1993, J PHARM SCI, V82, P1186, DOI 10.1002/jps.2600821125; China Food and Drug Administration, 2005, GUID CHEM PHARM PREP; Davit BM, 2008, AAPS J, V10, P148, DOI 10.1208/s12248-008-9015-x; Davit BM, 2012, AAPS J, V14, P915, DOI 10.1208/s12248-012-9406-x; European Medicines Agency, 2008, CHMP ASS REP VALD; European Medicines Agency, 2011, GUIDELINE BIOANALYTI; Food and Drug Administration, 2010, DRAFT GUID PROG; Food and Drug Administration, 2012, DRAFT GUID WARF SOD; Haidar SH, 2008, AAPS J, V10, P450, DOI 10.1208/s12248-008-9053-4; Haidar SH, 2008, PHARM RES, V25, P237, DOI 10.1007/s11095-007-9434-x; Heun R, 2013, J CLIN PSYCHIAT, V74, P587, DOI 10.4088/JCP.12m08250; Koesters M, 2013, BRIT J PSYCHIAT, V203, P179, DOI 10.1192/bjp.bp.112.120196; LIU JP, 1992, J PHARMACOKINET BIOP, V20, P101, DOI 10.1007/BF01143188; Midha KK, 2005, INT J CLIN PHARM TH, V43, P485; Owen RT, 2009, DRUG TODAY, V45, P599, DOI 1396673/dot.2009.45.8.1396673; Patil SR, 2012, J MASS SPECTROM, V47, P23, DOI 10.1002/jms.2020; Song L, 2014, J CLIN PHARM THER, V39, P204, DOI 10.1111/jcpt.12118; Tothfalusi L, 2012, J PHARM PHARM SCI, V15, P73; Wang XL, 2014, BIOMED CHROMATOGR, V28, P218, DOI 10.1002/bmc.3008	20	6	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109300	10.1371/journal.pone.0109300	http://dx.doi.org/10.1371/journal.pone.0109300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330096	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100021
J	Yamaguchi, M; Ando, M; Yamamoto, R; Akiyama, S; Kato, S; Katsuno, T; Kosugi, T; Sato, W; Tsuboi, N; Yasuda, Y; Mizuno, M; Ito, Y; Matsuo, S; Maruyama, S				Yamaguchi, Makoto; Ando, Masahiko; Yamamoto, Ryohei; Akiyama, Shinichi; Kato, Sawako; Katsuno, Takayuki; Kosugi, Tomoki; Sato, Waichi; Tsuboi, Naotake; Yasuda, Yoshinari; Mizuno, Masashi; Ito, Yasuhiko; Matsuo, Seiichi; Maruyama, Shoichi			Patient Age and the Prognosis of Idiopathic Membranous Nephropathy	PLOS ONE			English	Article							NEPHROTIC SYNDROME; CONTROLLED-TRIAL; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; CHLORAMBUCIL; CYCLOSPORINE	Background: Idiopathic membranous nephropathy (IMN) is increasingly seen in older patients. However, differences in disease presentation and outcomes between older and younger IMN patients remain controversial. We compared patient characteristics between younger and older IMN patients. Methods: We recruited 171 Japanese patients with IMN, including 90 (52.6%) patients <65 years old, 40 (23.4%) patients 65-70 years, and 41 (24.0%) patients >= 71 years. Clinical characteristics and outcomes were compared between younger and older IMN patients. Results: During a median observation period of 37 months, 103 (60.2%) patients achieved complete proteinuria remission, which was not significantly associated with patient age (P = 0.831). However, 13 (7.6%) patients were hospitalized because of infection. Multivariate Cox proportional hazards models identified older age [adjusted hazard ratio (HR) = 3.11, 95% confidence interval (CI): 1.45-7.49, per 10 years; P = 0.003], prednisolone use (adjusted HR = 11.8, 95% CI: 1.59-242.5; P = 0.014), and cyclosporine used in combination with prednisolone (adjusted HR = 10.3, 95% CI: 1.59-204.4; P = 0.012) as significant predictors of infection. A <25% decrease in proteinuria at 1 month after immunosuppressive therapy initiation also predicted infection (adjusted HR = 6.72, 95% CI: 1.51-37.8; P = 0.012). Conclusions: Younger and older IMN patients had similar renal outcomes. However, older patients were more likely to develop infection when using immunosuppressants. Patients with a poor response in the first month following the initiation of immunosuppressive therapy should be carefully monitored for infection and may require a faster prednisolone taper.	[Yamaguchi, Makoto; Akiyama, Shinichi; Kato, Sawako; Katsuno, Takayuki; Kosugi, Tomoki; Sato, Waichi; Tsuboi, Naotake; Yasuda, Yoshinari; Mizuno, Masashi; Ito, Yasuhiko; Matsuo, Seiichi; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Yamamoto, Ryohei] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan	Nagoya University; Nagoya University; Osaka University	Maruyama, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan.	marus@med.nagoya-u.ac.jp	YAMAMOTO, Ryohei/AAU-3059-2021; ANDO, Masahiko/F-7035-2015; Tsuboi, Naotake/L-5960-2019; Kato, Sawako/T-2422-2019; Yasuhiko, Ito/I-7497-2014	YAMAMOTO, Ryohei/0000-0003-2610-9824; Tsuboi, Naotake/0000-0003-0760-845X; Kato, Sawako/0000-0001-7210-1888; 	Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [25670408] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Kidney Int Suppl (2011), V2, P186; BERNARD DB, 1988, KIDNEY INT, V33, P1184, DOI 10.1038/ki.1988.129; Cameron JS, 1996, SEMIN NEPHROL, V16, P319; CATTRAN DC, 1995, KIDNEY INT, V47, P1130, DOI 10.1038/ki.1995.161; Cattran DC, 2001, KIDNEY INT, V59, P1484, DOI 10.1046/j.1523-1755.2001.0590041484.x; Eriguchi M, 2009, NEPHROL DIAL TRANSPL, V24, P3082, DOI 10.1093/ndt/gfp251; Glassock R J, 1998, Geriatr Nephrol Urol, V8, P149, DOI 10.1023/A:1008332921183; Hofstra JM, 2012, NEPHROL DIAL TRANSPL, V27, P6, DOI 10.1093/ndt/gfr371; Jha V, 2007, J AM SOC NEPHROL, V18, P1899, DOI 10.1681/ASN.2007020166; Makoto Y, 2014, PLOS ONE IN PRESS; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; PASSERINI P, 1993, NEPHROL DIAL TRANSPL, V8, P1321; Philibert D, 2008, NAT CLIN PRACT NEPHR, V4, P550, DOI 10.1038/ncpneph0915; PONTICELLI C, 1995, KIDNEY INT, V48, P1600, DOI 10.1038/ki.1995.453; Ponticelli C, 1998, J AM SOC NEPHROL, V9, P444; ROLLINO C, 1995, GERIAT NEPHROL UROL, V5, P97; Yokoyama H, 2012, CLIN EXP NEPHROL, V16, P903, DOI 10.1007/s10157-012-0673-8; Zent R, 1997, AM J KIDNEY DIS, V29, P200, DOI 10.1016/S0272-6386(97)90030-5	18	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110376	10.1371/journal.pone.0110376	http://dx.doi.org/10.1371/journal.pone.0110376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330372	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100059
J	Abate, M; Assefa, N; Alemayehu, T				Abate, Meskerem; Assefa, Nega; Alemayehu, Tadesse			Knowledge, Attitude, Practice, and Determinants Emergency Contraceptive Use among Women Seeking Abortion Services in Dire Dawa, Ethiopia	PLOS ONE			English	Article								Background: Unplanned pregnancy from casual sex, unplanned sexual activity, and sexual violence are increasing. Emergency Contraceptives (EC) are used to prevent unplanned pregnancies thereby preventing the occurrence and consequences of unplanned pregnancy. Emergency contraception is widely available in Ethiopia particularly in major cities. Yet the use of EC is very low and abortion rate in cities is high compared to the national average. Objectives: To assess knowledge, attitude and practice and determinants on the use of emergency contraception among women obtaining abortion service at selected health institutions in Dire Dawa, Eastern Ethiopia. Methods: A facility based cross-sectional study was conducted on 390 women selected by multi-stage random sampling technique. The samples were generated from government and private for non profit health facilities. Participant's knowledge and attitude towards emergency contraception were measured using composite index based on 7 and 9 questions, respectively and analyzed using mean score to classify them as knowledgeable or not, and have positive attitude or not. Practice was assessed if the women reported ever use of emergency contraception. Determinants of use of emergency contraception were analyzed using logistic regression. Result: Out of 390 women interviewed, 162 women (41.5%) heard about EC, only 133 (34.1%) had good knowledge, and 200 (51.3%) of the respondents had positive attitudes towards to EC. Ever use of EC was reported by 38 (9.7%). Age, living arrangement, education, marital status, religion were found to be significantly associated with the use of emergency contraceptives. Women with poor knowledge were less likely to use EC compared to the knowledgeable ones [AOR = 0.027, 95% CI (0.007, 0.105)]. Conclusion: The study identified that most respondents lack adequate knowledge on the method of EC. In addition ever use of EC is very low. Recommendations: Health professions should give attention in increasing knowledge and uptake of Emergency Contraception.	[Abate, Meskerem] Dire Dawa Hlth Off, Sabian Hlth Ctr, Dire Dawa, Ethiopia; [Assefa, Nega; Alemayehu, Tadesse] Haramaya Univ, Coll Hlth & Med Sci, East Harerge, Ethiopia	Haramaya University	Assefa, N (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, East Harerge, Ethiopia.	negaassefa@yahoo.com		Assefa, Nega/0000-0003-0341-2329; Alemayehu, Tadesse/0000-0002-1560-7636	Haramaya University	Haramaya University	Haramaya University supported the study. The study was part of masters thesis. The university has no role in the design and conduct of the study. One of the author is Haramaya University Employee, this does not have any influence on affecting the design, and implementation of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admasu A, 2009, ETHIOPIAN J REPROD H, V3; Babaee G, 2003, J SEX MARITAL THER, V29, P269, DOI 10.1080/00926230390195506; Chavuma N, 2010, MED J ZAMBIA LUSAKA, V37; Cheng L, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001324.pub3, 10.1002/14651858.CD001324.pub4]; Dire Dawa City Administration, 2010, DIR DAW PROF; Margaret OE, 2006, INT FAMILY PLANNING, V32, P89; Merchant RC, 2007, J EMERG MED, V33, P367, DOI 10.1016/j.jemermed.2007.02.031; Myer L, 2007, BMC WOMENS HEALTH, V7, P14, DOI DOI 10.1186/1472-6874-7-14; Neinstein LS., 2008, ADOLESCENT HLTH CARE, P533; Schwarz EB, 2007, CONTRACEPTION, V75, P285, DOI 10.1016/j.contraception.2006.11.002; Seife M, 2007, THESIS ADDIS ABABA U; Singh S, 2010, INT PERSPECT SEX R H, V36, P16, DOI 10.1363/ipsrh.36.016.10; Stella K, 2011, KNOWLEDGE ATTITUDES; Wegene T, 2007, ETHIOP J HEALTH DEV, V21, P112; WHO Gutmacher Institute, 2007, FACTS IND AB WORLDW; Worku A, 2011, ETHIOP J HEALTH DEV, V25, P176	16	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110008	10.1371/journal.pone.0110008	http://dx.doi.org/10.1371/journal.pone.0110008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330229	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100038
J	Cho, KI; Cha, TJ; Lee, SJ; Shim, IK; Zhang, YH; Heo, JH; Kim, HS; Kim, SJ; Kim, KL; Lee, JW				Cho, Kyoung-Im; Cha, Tae-Joon; Lee, Su-Jin; Shim, In-Kyeung; Zhang, Yin Hua; Heo, Jung-Ho; Kim, Hyun-Su; Kim, Sung Joon; Kim, Kyoung-Lyoung; Lee, Jae-Woo			Attenuation of Acetylcholine Activated Potassium Current (I-KACh) by Simvastatin, Not Pravastatin in Mouse Atrial Cardiomyocyte: Possible Atrial Fibrillation Preventing Effects of Statin	PLOS ONE			English	Article							POSSIBLE MOLECULAR MARKER; GISSI-HF TRIAL; ELECTRICAL CARDIOVERSION; NERVE ACTIVITY; HEART-FAILURE; K+ CHANNELS; ATORVASTATIN; ROSUVASTATIN; MODULATION; RECURRENCE	Statins, 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors, are associated with the prevention of atrial fibrillation (AF) by pleiotropic effects. Recent clinical trial studies have demonstrated conflicting results on anti-arrhythmia between lipophilic and hydrophilic statins. However, the underlying mechanisms responsible for anti-arrhythmogenic effects of statins are largely unexplored. In this study, we evaluated the different roles of lipophilic and hydrophilic statins (simvastatin and pravastatin, respectively) in acetylcholine (100 mu M)-activated K+ current (I-KACh, recorded by nystatin-perforated whole cell patch clamp technique) which are important for AF initiation and maintenance in mouse atrial cardiomyocytes. Our results showed that simvastatin (1-10 mu M) inhibited both peak and quasi-steady-state I-KACh in a dose-dependent manner. In contrast, pravastatin (10 mu M) had no effect on I-KACh. Supplementation of substrates for the synthesis of cholesterol (mevalonate, geranylgeranyl pyrophosphate or farnesyl pyrophosphate) did not reverse the effect of simvastatin on I-KACh, suggesting a cholesterol-independent effect on I-KACh. Furthermore, supplementation of phosphatidylinositol 4,5-bisphosphate, extracellular perfusion of phospholipase C inhibitor or a protein kinase C (PKC) inhibitor had no effect on the inhibitory activity of simvastatin on I-KACh. Simvastatin also inhibits adenosine activated I-KACh, however, simvastatin does not inhibit I-KACh after activated by intracellular loading of GTP gamma S. Importantly, shortening of the action potential duration by acetylcholine was restored by simvastatin but not by pravastatin. Together, these findings demonstrate that lipophilic statins but not hydrophilic statins attenuate I-KACh in atrial cardiomyocytes via a mechanism that is independent of cholesterol synthesis or PKC pathway, but may be via the blockade of acetylcholine binding site. Our results may provide important background information for the use of statins in patients with AF.	[Cho, Kyoung-Im; Cha, Tae-Joon; Lee, Su-Jin; Shim, In-Kyeung; Heo, Jung-Ho; Kim, Hyun-Su; Lee, Jae-Woo] Kosin Univ, Coll Med, Dept Internal Med, Cardiovasc Res Inst, Pusan, South Korea; [Zhang, Yin Hua; Kim, Sung Joon] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Kim, Kyoung-Lyoung] Kosin Univ, Coll Med, Dept Mol Biol, Pusan, South Korea	Seoul National University (SNU)	Cha, TJ (corresponding author), Kosin Univ, Coll Med, Dept Internal Med, Cardiovasc Res Inst, Pusan, South Korea.	chatjn@gmail.com	Kim, Sung Joon/H-1825-2012	Heo, Jung Ho/0000-0002-6491-2426; Kim, Sung-Joon/0000-0002-0289-121X	Korea Heart Rhythm Society [KHRS 2011-1]; Kosin University College of Medicine	Korea Heart Rhythm Society; Kosin University College of Medicine	This study was supported by grants from the Korea Heart Rhythm Society (KHRS 2011-1) and Kosin University College of Medicine (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Bergdahl A, 2003, PHARMACOL TOXICOL, V93, P128, DOI 10.1034/j.1600-0773.2003.930304.x; Cai H, 2002, CIRCULATION, V106, P2854, DOI 10.1161/01.CIR.0000039327.11661.16; Cha TJ, 2005, CIRCULATION, V111, P728, DOI 10.1161/01.CIR.0000155240.05251.D0; Chen PS, 2007, HEART RHYTHM, V4, pS61, DOI 10.1016/j.hrthm.2006.12.006; Cho H, 2001, BRIT J PHARMACOL, V134, P1066, DOI 10.1038/sj.bjp.0704347; Cho H, 2001, J BIOL CHEM, V276, P159, DOI 10.1074/jbc.M004826200; Davidson MH, 2004, PROG CARDIOVASC DIS, V47, P73, DOI 10.1016/j.pcad.2004.04.007; Dobrev D, 2003, BASIC RES CARDIOL, V98, P137, DOI 10.1007/s00395-003-0409-8; Ehrlich JR, 2008, J CARDIOVASC PHARM, V52, P129, DOI 10.1097/FJC.0b013e31816c4325; Ehrlich JR, 2004, J PHYSIOL-LONDON, V557, P583, DOI 10.1113/jphysiol.2004.061119; Escobales N, 1996, J HYPERTENS, V14, P115; Ganotakis Emmanuel S, 2006, Hellenic J Cardiol, V47, P51; Gomes ME, 2010, CIRC J, V74, P2622, DOI 10.1253/circj.CJ-10-0427; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Korantzopoulos Panagiotis, 2003, Med Sci Monit, V9, pRA225; Laszlo R, 2010, LIFE SCI, V87, P507, DOI 10.1016/j.lfs.2010.09.010; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Liu YB, 2009, HEART RHYTHM, V6, P69, DOI 10.1016/j.hrthm.2008.10.004; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; Maggioni AP, 2009, EUR HEART J, V30, P2327, DOI 10.1093/eurheartj/ehp357; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; Mason RP, 2006, J BIOL CHEM, V281, P9337, DOI 10.1074/jbc.M513000200; Matsuda T, 2008, J PHARMACOL EXP THER, V327, P130, DOI 10.1124/jpet.108.139659; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Ozaydin M, 2006, AM J CARDIOL, V97, P1490, DOI 10.1016/j.amjcard.2005.11.082; Patel P, 2010, J CARDIOVASC ELECTR, V21, P1064, DOI 10.1111/j.1540-8167.2010.01774.x; Pound EM, 2001, J LIPID RES, V42, P346; Riesen WF, 2002, EUR HEART J, V23, P794, DOI 10.1053/euhj.2001.2967; Sarr FS, 2008, J CHROMATOGR B, V868, P20, DOI 10.1016/j.jchromb.2008.03.034; Seto SW, 2007, BRIT J PHARMACOL, V151, P987, DOI 10.1038/sj.bjp.0707327; Sharifov OF, 2004, J AM COLL CARDIOL, V43, P483, DOI 10.1016/j.jacc.2003.09.030; Shiroshita-Takeshita A, 2007, CARDIOVASC RES, V74, P75, DOI 10.1016/j.cardiores.2007.01.002; Sicouri S, 2011, J AM COLL CARDIOL, V57, P986, DOI 10.1016/j.jacc.2010.08.649; Siu CW, 2003, AM J CARDIOL, V92, P1343, DOI 10.1016/j.amjcard.2003.08.023; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Tsadok MA, 2012, CIRCULATION, V126, P2680, DOI 10.1161/CIRCULATIONAHA.112.092494; Tsutamoto T, 2011, CIRC J, V75, P2160, DOI 10.1253/circj.CJ-11-0222; Tveit A, 2004, AM J CARDIOL, V93, P780, DOI 10.1016/j.amjcard.2003.12.009; Vaquero M, 2007, J MOL CELL CARDIOL, V42, P931, DOI 10.1016/j.yjmcc.2007.03.807; Welzig CM, 2010, AM J CARDIOL, V105, P1112, DOI 10.1016/j.amjcard.2009.12.011; Welzig CM, 2003, CIRCULATION, V108, P2743, DOI 10.1161/01.CIR.0000103680.61390.16; Zhu W, 2005, HEART RHYTHM, V2, P1231, DOI 10.1016/j.hrthm.2005.07.022	44	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e106570	10.1371/journal.pone.0106570	http://dx.doi.org/10.1371/journal.pone.0106570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329899	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210800001
J	Kaur, M; Izumi, K; Wilkens, AB; Chatfield, KC; Spinner, NB; Conlin, LK; Zhang, Z; Krantz, ID				Kaur, Maninder; Izumi, Kosuke; Wilkens, Alisha B.; Chatfield, Kathryn C.; Spinner, Nancy B.; Conlin, Laura K.; Zhang, Zhe; Krantz, Ian D.			Genome-Wide Expression Analysis in Fibroblast Cell Lines from Probands with Pallister Killian Syndrome	PLOS ONE			English	Article							AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; TETRASOMY 12P; MUTATIONS; INDIVIDUALS; MOSAICISM; KARYOTYPE; EXPANSION; HUMANS	Pallister Killian syndrome (OMIM: # 601803) is a rare multisystem disorder typically caused by tissue limited mosaic tetrasomy of chromosome 12p (isochromosome 12p). The clinical manifestations of Pallister Killian syndrome are variable with the most common findings including craniofacial dysmorphia, hypotonia, cognitive impairment, hearing loss, skin pigmentary differences and epilepsy. Isochromosome 12p is identified primarily in skin fibroblast cultures and in chorionic villus and amniotic fluid cell samples and may be identified in blood lymphocytes during the neonatal and early childhood period. We performed genomic expression profiling correlated with interphase fluorescent in situ hybridization and single nucleotide polymorphism array quantification of degree of mosaicism in fibroblasts from 17 Caucasian probands with Pallister Killian syndrome and 9 healthy age, gender and ethnicity matched controls. We identified a characteristic profile of 354 (180 up- and 174 down-regulated) differentially expressed genes in Pallister Killian syndrome probands and supportive evidence for a Pallister Killian syndrome critical region on 12p13.31. The differentially expressed genes were enriched for developmentally important genes such as homeobox genes. Among the differentially expressed genes, we identified several genes whose misexpression may be associated with the clinical phenotype of Pallister Killian syndrome such as downregulation of ZFPM2, GATA6 and SOX9, and overexpression of IGFBP2.	[Kaur, Maninder; Izumi, Kosuke; Wilkens, Alisha B.; Krantz, Ian D.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Izumi, Kosuke] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo, Japan; [Chatfield, Kathryn C.] Childrens Hosp Colorado, Pediat Cardiol Sect, Dept Pediat, Denver, CO USA; [Spinner, Nancy B.; Conlin, Laura K.] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA; [Spinner, Nancy B.; Conlin, Laura K.; Krantz, Ian D.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zhang, Zhe] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Tokyo; Children's Hospital Colorado; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Krantz, ID (corresponding author), Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA.	ian2@mail.med.upenn.edu			Children's Hospital of Philadelphia Institutional Development Fund	Children's Hospital of Philadelphia Institutional Development Fund	This research was supported by the Children's Hospital of Philadelphia Institutional Development Fund (IDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman KG, 2005, PLOS GENET, V1, P58, DOI 10.1371/journal.pgen.0010010; Aragon L, 2013, CURR OPIN GENET DEV, V23, P204, DOI 10.1016/j.gde.2012.11.004; Bjork KE, 2007, BIOINFORMATICS, V23, P2873, DOI 10.1093/bioinformatics/btm450; Conlin LK, 2012, AM J MED GENET A, V158A, P3046, DOI 10.1002/ajmg.a.35726; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; CormierDaire V, 1997, AM J MED GENET, V69, P166, DOI 10.1002/(SICI)1096-8628(19970317)69:2<166::AID-AJMG9>3.0.CO;2-N; DeScipio C, 2005, AM J MED GENET A, V137A, P276, DOI 10.1002/ajmg.a.30857; Dufke A, 2001, EUR J HUM GENET, V9, P572, DOI 10.1038/sj.ejhg.5200673; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Garavelli L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-42; Hoeflich A, 1999, ENDOCRINOLOGY, V140, P5488, DOI 10.1210/en.140.12.5488; HORN D, 1995, J MED GENET, V32, P68, DOI 10.1136/jmg.32.1.68; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Izumi K, 2012, AM J MED GENET A, V158A, P3033, DOI 10.1002/ajmg.a.35500; Jamuar S, 2012, EUR J MED GENET, V55, P167, DOI 10.1016/j.ejmg.2012.01.019; Kodo K, 2009, P NATL ACAD SCI USA, V106, P13933, DOI 10.1073/pnas.0904744106; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; Kremer SB, 2012, GENETICS, V191, P95, DOI 10.1534/genetics.111.135806; Leube B, 2003, AM J MED GENET A, V123A, P296, DOI 10.1002/ajmg.a.20339; Liehr T, 2004, CYTOGENET GENOME RES, V107, P55, DOI 10.1159/000079572; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; Nozell S, 2008, MOL CELL BIOL, V28, P6632, DOI 10.1128/MCB.00697-08; Pallister P D, 1977, Birth Defects Orig Artic Ser, V13, P103; PALLISTER PD, 1976, LANCET, V1, P431; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; PELTOMAKI P, 1987, CLIN GENET, V31, P399; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Pizzuti A, 2003, HUM MUTAT, V22, P372, DOI 10.1002/humu.10261; SCHINZEL A, 1991, J MED GENET, V28, P122, DOI 10.1136/jmg.28.2.122; Schubert R, 1997, AM J MED GENET, V72, P106, DOI 10.1002/(SICI)1096-8628(19971003)72:1<106::AID-AJMG21>3.0.CO;2-U; TESCHLERNICOLA M, 1981, SYND IDENT, V7, P6; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wilkens A, 2012, AM J MED GENET A, V158A, P3002, DOI 10.1002/ajmg.a.35722	36	10	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e108853	10.1371/journal.pone.0108853	http://dx.doi.org/10.1371/journal.pone.0108853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329894	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800011
J	Picco, R; Tomasella, A; Fogolari, F; Brancolini, C				Picco, Raffaella; Tomasella, Andrea; Fogolari, Federico; Brancolini, Claudio			Transcriptomic Analysis Unveils Correlations between Regulative Apoptotic Caspases and Genes of Cholesterol Homeostasis in Human Brain	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; HIGH-DENSITY-LIPOPROTEIN; CELL-DEATH; ENDOTHELIAL LIPASE; APOLIPOPROTEIN-M; HIPPOCAMPAL-NEURONS; SIGNALING PATHWAYS; CYTOCHROME P450S; GENECHIP DATA; EXPRESSION	Regulative circuits controlling expression of genes involved in the same biological processes are frequently interconnected. These circuits operate to coordinate the expression of multiple genes and also to compensate dysfunctions in specific elements of the network. Caspases are cysteine-proteases with key roles in the execution phase of apoptosis. Silencing of caspase-2 expression in cultured glioblastoma cells allows the up-regulation of a limited number of genes, among which some are related to cholesterol homeostasis. Lysosomal Acid Lipase A (LIPA) was up-regulated in two different cell lines in response to caspase-2 down-regulation and cells silenced for caspase-2 exhibit reduced cholesterol staining in the lipid droplets. We expanded this observation by large-scale analysis of mRNA expression. All caspases were analyzed in terms of co-expression in comparison with 166 genes involved in cholesterol homeostasis. In the brain, hierarchical clustering has revealed that the expression of regulative apoptotic caspases (CASP2, CASP8 CASP9, CASP10) and of the inflammatory CASP1 is linked to several genes involved in cholesterol homeostasis. These correlations resulted in altered GBM (Glioblastoma Multiforme), in particular for CASP1. We have also demonstrated that these correlations are tissue specific being reduced (CASP9 and CASP10) or different (CASP2) in the liver. For some caspases (CASP1, CASP6 and CASP7) these correlations could be related to brain aging.	[Picco, Raffaella; Tomasella, Andrea; Fogolari, Federico; Brancolini, Claudio] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy	University of Udine	Brancolini, C (corresponding author), Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy.	claudio.brancolini@uniud.it		BRANCOLINI, Claudio/0000-0002-6597-5373; Fogolari, Federico/0000-0001-9862-250X	Associazione Italiana Ricerca sul Cancro (AIRC) [IG-10437]; Programma di ricerca scientifica di rilevante interesse nazionale (PRIN) [2010W4J4RM_002]; AIRC	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Programma di ricerca scientifica di rilevante interesse nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)); AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC) (IG-10437) and Programma di ricerca scientifica di rilevante interesse nazionale (PRIN) (Progetto 2010W4J4RM_002) to CB. AT received a fellowship from AIRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Arakawa R, 2000, J LIPID RES, V41, P1952; Aviram M, 2013, CURR OPIN LIPIDOL, V24, P339, DOI 10.1097/MOL.0b013e32835ffcfd; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Basu-Modak S, 1999, J BIOL CHEM, V274, P35881, DOI 10.1074/jbc.274.50.35881; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya R, 2010, BBA-MOL CELL BIOL L, V1801, P960, DOI 10.1016/j.bbalip.2010.04.003; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; Brignull LM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-853; BROWN MS, 1979, P NATL ACAD SCI USA, V76, P3330, DOI 10.1073/pnas.76.7.3330; Brown RJ, 2010, CIRC RES, V107, P357, DOI 10.1161/CIRCRESAHA.110.219188; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; BYSKOV AG, 1995, NATURE, V374, P559, DOI 10.1038/374559a0; Carlsson Y, 2011, ANN NEUROL, V70, P781, DOI 10.1002/ana.22431; Chae SS, 2010, J NEUROSCI RES, V88, P1926, DOI 10.1002/jnr.22356; Chies R, 2003, J CELL SCI, V116, P987, DOI 10.1242/jcs.00326; Christoffersen C, 2008, J BIOL CHEM, V283, P1839, DOI 10.1074/jbc.M704576200; Christoffersen C, 2013, CURR OPIN LIPIDOL, V24, P295, DOI 10.1097/MOL.0b013e328361f6ad; Cornil CA, 2010, J NEUROENDOCRINOL, V22, P664, DOI 10.1111/j.1365-2826.2010.02023.x; Da Pozzo E, 2012, CURR MOL MED, V12, P426; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dassati S, 2014, NEUROBIOL AGING, V35, P1632, DOI 10.1016/j.neurobiolaging.2014.01.148; Davies BS, 2011, J LIPID RES, V53, P2690; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Fava LL, 2012, J CELL SCI, V125, P5911, DOI 10.1242/jcs.115105; Foti C, 2009, MOL CANCER THER, V8, P3140, DOI 10.1158/1535-7163.MCT-09-0431; Fouchier SW, 2013, CURR OPIN LIPIDOL, V24, P332, DOI 10.1097/MOL.0b013e328361f6c6; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gemma C, 2007, EUR J NEUROSCI, V26, P2795, DOI 10.1111/j.1460-9568.2007.05875.x; Gibot L, 2009, BIOCHEM J, V420, P473, DOI 10.1042/BJ20082057; GLASGOW BJ, 1995, CURR EYE RES, V14, P363, DOI 10.3109/02713689508999934; Graham RK, 2011, TRENDS NEUROSCI, V34, P646, DOI 10.1016/j.tins.2011.09.001; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Guo DL, 2011, CANCER DISCOV, V1, P442, DOI 10.1158/2159-8290.CD-11-0102; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Hayashi H, 2004, J BIOL CHEM, V279, P14009, DOI 10.1074/jbc.M313828200; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hu YW, 2010, BBA-MOL CELL BIOL L, V1801, P100, DOI 10.1016/j.bbalip.2009.10.013; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kallin A, 2007, J LIPID RES, V48, P1628, DOI 10.1194/jlr.M700136-JLR200; Kanuka H, 2005, EMBO J, V24, P3793, DOI 10.1038/sj.emboj.7600822; Karten B, 2006, J BIOL CHEM, V281, P4049, DOI 10.1074/jbc.M508915200; Kim WS, 2009, J NEUROCHEM, V109, P1053, DOI 10.1111/j.1471-4159.2009.06031.x; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KOO C, 1988, J CLIN INVEST, V81, P1332, DOI 10.1172/JCI113460; Kotas ME, 2013, P NATL ACAD SCI USA, V110, P4810, DOI 10.1073/pnas.1301996110; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Lamy L, 2013, CANCER CELL, V23, P435, DOI 10.1016/j.ccr.2013.02.017; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lepesheva GI, 2004, MOL CELL ENDOCRINOL, V215, P165, DOI 10.1016/j.mce.2003.11.016; Logette E, 2005, BBA-MOL CELL BIOL L, V1738, P1, DOI 10.1016/j.bbalip.2005.11.006; Logette E, 2005, MOL CELL BIOL, V25, P9621, DOI 10.1128/MCB.25.21.9621-9631.2005; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Martin C, 2001, BIOCHEM J, V355, P509, DOI 10.1042/0264-6021:3550509; Martin M, 2010, BBA-MOL CELL BIOL L, V1801, P934, DOI 10.1016/j.bbalip.2010.03.011; Martin MG, 2008, MOL BIOL CELL, V19, P2101, DOI 10.1091/mbc.E07-09-0897; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MILLER RH, 1988, AM J PHYSIOL, V255, pE475, DOI 10.1152/ajpendo.1988.255.4.E475; Morell P, 1996, NEUROCHEM RES, V21, P463, DOI 10.1007/BF02527711; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Murphy C, 2005, BBA-MOL CELL BIOL L, V1735, P167, DOI 10.1016/j.bbalip.2005.06.001; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Noshiro M, 2004, GENES CELLS, V9, P317, DOI 10.1111/j.1356-9597.2004.00722.x; Ojala J, 2009, NEUROBIOL AGING, V30, P198, DOI 10.1016/j.neurobiolaging.2007.06.006; Paradis E, 2004, NEUROBIOL DIS, V15, P312, DOI 10.1016/j.nbd.2003.09.017; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Paroni G, 2002, J BIOL CHEM, V277, P15147, DOI 10.1074/jbc.M112338200; Paroni G, 2001, J BIOL CHEM, V276, P21907, DOI 10.1074/jbc.M011565200; Pozueta J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2927; Puccini J, 2013, CELL DEATH DIFFER, V20, P1133, DOI 10.1038/cdd.2013.87; Puccini J, 2013, P NATL ACAD SCI USA, V110, P19920, DOI 10.1073/pnas.1311947110; Ramcharitar J, 2013, NEUROBIOL AGING, V34, P1815, DOI 10.1016/j.neurobiolaging.2013.01.007; Rapp A, 2006, BIOCHIMIE, V88, P473, DOI 10.1016/j.biochi.2005.10.007; REBECK GW, 1993, NEURON, V11, P575; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Segatto M, 2012, ACTA PHYSIOL, V206, P62, DOI 10.1111/j.1748-1716.2012.02450.x; Senapedis WT, 2011, MOL BIOL CELL, V22, P1791, DOI 10.1091/mbc.E10-10-0854; Sovic A, 2005, J NEUROCHEM, V94, P109, DOI 10.1111/j.1471-4159.2005.03175.x; SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802; Takahashi Y, 2012, BIOCHEM BIOPH RES CO, V417, P1151, DOI 10.1016/j.bbrc.2011.12.082; Talwar P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-199; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tiwari M, 2011, J BIOL CHEM, V286, P8493, DOI 10.1074/jbc.M110.163824; Trompet S, 2008, BRAIN, V131, P1069, DOI 10.1093/brain/awn023; Troy CM, 2000, J NEUROSCI, V20, P1386; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Tsukamoto K, 2013, P NATL ACAD SCI USA, V110, P17023, DOI 10.1073/pnas.1315986110; Uribe V, 2012, HUM MOL GENET, V21, P1954, DOI 10.1093/hmg/dds005; Vakifahmetoglu-Norberg H, 2010, TRENDS CELL BIOL, V20, P150, DOI 10.1016/j.tcb.2009.12.006; Vance JE, 2011, CURR OPIN LIPIDOL, V22, P204, DOI 10.1097/MOL.0b013e3283453e69; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Wagner T, 2012, EXP BRAIN RES, V217, P377, DOI 10.1007/s00221-011-2876-8; Wang JY, 2014, DEV CELL, V28, P670, DOI 10.1016/j.devcel.2014.02.009; Watson M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-509; Wolf AB, 2013, NEUROBIOL AGING, V34, P1007, DOI 10.1016/j.neurobiolaging.2012.10.011; Wu YG, 2011, MOL ENDOCRINOL, V25, P656, DOI 10.1210/me.2010-0367; Yan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030701; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271	118	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110610	10.1371/journal.pone.0110610	http://dx.doi.org/10.1371/journal.pone.0110610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330190	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800098
J	Rangarajan, S; Tram, HNB; Todd, CS; Thinh, T; Hung, V; Hieu, PT; Hanh, TM; Chau, KM; Lam, ND; Hung, PT; West, G; Colby, D				Rangarajan, Suresh; Hoang Nguyen Bao Tram; Todd, Catherine S.; Tran Thinh; Van Hung; Pham Thanh Hieu; Tran My Hanh; Khong Minh Chau; Nguyen Danh Lam; Pham Tri Hung; West, Gary; Colby, Donn			Risk Factors for Delayed Entrance into Care after Diagnosis among Patients with Late-Stage HIV Disease in Southern Vietnam	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; MEDICAL-CARE; RETENTION; OUTREACH; PREVENTION; ENTRY; INITIATION; MORTALITY; ADHERENCE	Background: We surveyed HIV patients with late-stage disease in southern Vietnam to determine if barriers to access and service quality resulted in late HIV testing and delays from initial diagnosis to entry into HIV care. Methodology: 196 adult patients at public HIV clinics with CD4 counts less than 250 cells/mm3 completed a standardized questionnaire. We used multivariate analysis to determine risk factors for delayed entry into care, defined as >3 months time from diagnosis to registration. Results: Common reasons for delayed testing were feeling healthy (71%), fear of stigma and discrimination in the community (43%), time conflicts with work or school (31%), did not want to know if infected (30%), and fear of lack of confidentiality (27%). Forty-five percent of participants delayed entry into care with a median CD4 count of 65 cells/mm3. The most common reasons for delayed entry were feeling healthy (51%), fear of stigma and discrimination in the community (41%), time conflicts with work or school (33%), and fear of lack of confidentiality (26%). Independent predictors for delayed entry were feeling healthy (aOR 3.7, 95% CI 1.5-9.1), first positive HIV test at other site (aOR 2.9, CI 1.2-7.1), history of injection drug use (IDU) (aOR 2.9, 95% CI 1.1-7.9), work/school conflicts (aOR 4.3, 95% CI 1.7-10.8), prior registration at another clinic (aOR 77.4, 95% CI 8.6-697), detention or imprisonment (aOR 10.3, 95% CI 1.8-58.2), and perceived distance to clinic (aOR 3.7, 95% CI 1.0-13.7). Conclusion: Delayed entry into HIV care in Vietnam is common and poses a significant challenge to preventing AIDS and opportunistic infections, decreasing mortality, and reducing HIV transmission. Improved linkages between testing and care are needed, particularly for patients who feel healthy, as well as incarcerated and drug-using populations who may face structural and social barriers to accessing care.	[Rangarajan, Suresh; Hoang Nguyen Bao Tram] FHI360 Vietnam, Ho Chi Minh City, Vietnam; [Todd, Catherine S.] FHI 360, Asia Pacific Reg Off, Bangkok, Thailand; [Tran Thinh; Van Hung] Ho Chi Minh City Prov AIDS Comm, Ho Chi Minh City, Vietnam; [Pham Thanh Hieu] Dist 8 Prevent Med Ctr, Ho Chi Minh City, Vietnam; [Tran My Hanh] An Giang Prov AIDS Ctr, Long Xuyen, An Giang, Vietnam; [Khong Minh Chau] Tinh Bien Hosp, An Giang, Vietnam; [Nguyen Danh Lam] Can Tho Prov AIDS Ctr, Can Tho, Vietnam; [Pham Tri Hung] Thot Not Outpatient Clin, Can Tho, Vietnam; [West, Gary] FHI360 Vietnam, Hanoi, Vietnam; [Colby, Donn] Ctr Appl Res Men & Hlth, Ho Chi Minh City, Vietnam; [Colby, Donn] Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand	Thai Red Cross Society	Rangarajan, S (corresponding author), FHI360 Vietnam, Ho Chi Minh City, Vietnam.	srangarajan@fhi360.org		colby, donn j./0000-0003-3931-5926	U.S. Agency for International Development (USAID) [AID-486-A-11-00011]	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID))	This quality improvement activity was supported through the Cooperative Agreement # AID-486-A-11-00011 "Sustainable Management of HIV/AIDS Responses and Transition to Technical Assistance (SMART TA) Project'' funded by the U.S. Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this paper are the sole responsibility of the authors and do not represent the views or opinions of USAID nor FHI 360.	Abaynew Y, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-8; Alvarez-Uria Gerardo, 2013, Interdiscip Perspect Infect Dis, V2013, P384805, DOI 10.1155/2013/384805; [Anonymous], 2013, VIETN ADM AIDS CONTR; [Anonymous], 2012, VIETN HIV AIDS EST P; [Anonymous], 2013, REP HIV DRUG NAT COM; Tran BX, 2013, DRUG ALCOHOL DEPEN, V127, P39, DOI 10.1016/j.drugalcdep.2012.06.009; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS85, DOI 10.1089/apc.2007.9983; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS49, DOI 10.1089/apc.2007.9987; Cabral HJ, 2007, AIDS PATIENT CARE ST, V21, pS59, DOI 10.1089/apc.2007.9986; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Centers for Disease C, 2012, HIV US STAG CAR CDC; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Craw J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-246; Tran DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073181; Tran DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051289; Cuong DD, 2012, SCAND J INFECT DIS, V44, P201, DOI 10.3109/00365548.2011.631937; Do HM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-154; Drain PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055305; Nguyen DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055750; Duong BD, 2013, VIETN ADM AIDS CONTR; Thanh DC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-428; Engsig FN, 2014, CLIN INFECT DIS, V58, P1312, DOI 10.1093/cid/ciu038; Finitsis DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088166; Ford M.A.S.C.M., 2012, MONITORING HIV CARE, DOI [10.17226/13225, DOI 10.17226/13225]; Grangeiro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014585; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Horvath T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009756; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Jean K, 2014, J INFECT DIS, V209, P431, DOI 10.1093/infdis/jit470; Jenness SM, 2012, AIDS CARE, V24, P1240, DOI 10.1080/09540121.2012.656569; Johnson DC, 2013, INT J STD AIDS, V24, P42, DOI 10.1177/0956462412472312; Kiertiburanakul S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18804; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kredo T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009987.pub2; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lo YC, 2011, J FORMOS MED ASSOC, V110, P306, DOI 10.1016/S0929-6646(11)60046-6; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Ministry of Health, 2013, SUMM REP HIV AIDS PR; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Naar-King S, 2007, AIDS PATIENT CARE ST, V21, pS40, DOI 10.1089/apc.2007.9988; Palella, 2014, HIGHER CD4 ART INITI; Rajabiun S, 2007, AIDS PATIENT CARE ST, V21, pS9, DOI 10.1089/apc.2007.9991; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Shastri S, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18502; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Thanawuth N, 2008, AIDS CARE, V20, P43, DOI 10.1080/09540120701439303; Thi MDA, 2008, AIDS BEHAV, V12, pS63, DOI 10.1007/s10461-008-9374-4; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Tran BX, 2013, TROP MED INT HEALTH, V18, P212, DOI 10.1111/tmi.12032; Vietnam Administration for HIV/AIDS Control, 2014, PROV REP HIV CAR TRE; Vietnam Ministry of Information and Communication, 2009, 2009 REP COUNTR DEM; Vu VT, 2011, AIDS CARE, V23, P139, DOI 10.1080/09540121.2010.507741; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; West GR, 2007, AIDS EDUC PREV, V19, P275, DOI 10.1521/aeap.2007.19.4.275; Wood E, 2012, CURR OPIN HIV AIDS, V7, P151, DOI 10.1097/COH.0b013e32834f9927; Yamashita TE, 2001, AIDS, V15, P735, DOI 10.1097/00002030-200104130-00009	58	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e108939	10.1371/journal.pone.0108939	http://dx.doi.org/10.1371/journal.pone.0108939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330196	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800013
J	Welte, S; Urbanik, T; Elssner, C; Kautz, N; Koehler, BC; Waldburger, N; Bermejo, JL; Pinna, F; Weiss, KH; Schemmer, P; Jaeger, D; Longerich, T; Breuhahn, K; Schulze-Bergkamen, H				Welte, Stefan; Urbanik, Toni; Elssner, Christin; Kautz, Nicole; Koehler, Bruno Christian; Waldburger, Nina; Bermejo, Justo Lorenzo; Pinna, Federico; Weiss, Karl-Heinz; Schemmer, Peter; Jaeger, Dirk; Longerich, Thomas; Breuhahn, Kai; Schulze-Bergkamen, Henning			Nuclear Expression of the Deubiquitinase CYLD Is Associated with Improved Survival in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; TUMOR; RECURRENCE; PROGNOSIS; APOPTOSIS; FIBROSIS; PROTEIN; DAMAGE	Background & Aims: The deubiquitinase CYLD removes (K-63)-linked polyubiquitin chains from proteins involved in NF-kappa B, Wnt/ss-catenin and Bcl-3 signaling. Reduced CYLD expression has been reported in different tumor entities, including hepatocellular carcinoma (HCC). Furthermore, loss of CYLD has been shown to contribute to HCC development in knockout animal models. This study aimed to assess subcellular CYLD expression in tumor tissues and its prognostic significance in HCC patients undergoing liver resection or liver transplantation. Methods: Subcellular localization of CYLD was assessed by immunohistochemistry in tumor tissues of 95 HCC patients undergoing liver resection or transplantation. Positive nuclear CYLD staining was defined as an immunhistochemical (IHC) score >= 3. Positive cytoplasmic CYLD staining was defined as an IHC score >= 6. The relationship with clinicopathological parameters was investigated. Cell culture experiments were performed to analyze subcellular CYLD expression in vitro. Results: Cytoplasmic CYLD expression was observed in 57 out of 95 (60%) HCC specimens ((CYLD+)-C-cyto). Nuclear CYLD staining was positive in 52 out of 95 specimens (55%, (CYLD+)-C-nuc). 13 out of 52 (CYLD+)-C-nuc patients (25%) showed a lack of cytoplasmic CYLD expression. (CYLD+)-C-nuc was associated with prolonged overall survival in patients after resection or liver transplantation (P = 0.007). 5-year overall survival rates were 63% in (CYLD+)-C-nuc vs. 26% in (CYLD-)-C-nuc patients. Nuclear CYLD staining strongly correlated with tumor grading (P < 0.001) and Ki67 positivity (P = 0.005). (CYLD+)-C-nuc did not prove to be an independent prognostic parameter. In vitro, Huh7, Hep3B and HepG2 showed reduced CYLD levels compared to the nonmalignant liver cell line THLE-2. Induction of CYLD expression by doxorubicin treatment led to increased cytoplasmic and nuclear expression of CYLD. Conclusions: Expression of nuclear CYLD is a novel prognostic factor for improved survival in patients with HCC undergoing liver resection or transplantation.	[Welte, Stefan; Urbanik, Toni; Elssner, Christin; Kautz, Nicole; Koehler, Bruno Christian; Jaeger, Dirk; Schulze-Bergkamen, Henning] Univ Heidelberg Hosp, Dept Med Oncol, Natl Ctr Tumor Dis, Heidelberg, Germany; [Waldburger, Nina; Pinna, Federico; Longerich, Thomas; Breuhahn, Kai] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Bermejo, Justo Lorenzo] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany; [Weiss, Karl-Heinz] Univ Heidelberg Hosp, Dept Gastroenterol Toxicol & Infect Dis, Heidelberg, Germany; [Schemmer, Peter] Univ Heidelberg Hosp, Dept Gen & Transplant Surg, Heidelberg, Germany; [Schulze-Bergkamen, Henning] Marien Hosp, Dept Gastroenterol Diabetol & Rheumatol, Wesel, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; St. Marien Hospital	Welte, S (corresponding author), Univ Heidelberg Hosp, Dept Med Oncol, Natl Ctr Tumor Dis, Heidelberg, Germany.	stefan.welte@med.uni-heidelberg.de	Weiss, Karl Heinz/AAA-9117-2022; Pinna, Federico/A-8244-2017	Pinna, Federico/0000-0002-6815-110X; Lorenzo Bermejo, Justo/0000-0002-6568-5333; Breuhahn, Kai/0000-0002-2462-1229	Deutsche Forschungsgemeinschaft, DFG [SCHU 1443/4-1 (SFB/TRR 77)]; Virtual Liver Network of the BMBF [FKZ 0315761]	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG)); Virtual Liver Network of the BMBF(Federal Ministry of Education & Research (BMBF))	This study was supported by research grants from the Deutsche Forschungsgemeinschaft, http:/www.dfg.de/, DFG SCHU 1443/4-1 (SFB/TRR 77; associated project to HSB, BJL, TL, and KB) and the Virtual Liver Network of the BMBF (FKZ 0315761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab M, 2010, LANGENBECK ARCH SURG, V395, P625, DOI 10.1007/s00423-010-0643-0; Atanassov BS, 2011, FEBS LETT, V585, P2016, DOI 10.1016/j.febslet.2010.10.042; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Breuhahn K, 2011, HEPATOLOGY, V53, P2111, DOI 10.1002/hep.24313; Carr BI, 2004, GASTROENTEROLOGY, V127, pS218, DOI 10.1053/j.gastro.2004.09.036; DERRICO A, 1994, PATHOL INT, V44, P682; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Garcia-Santisteban I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038570; Glittenberg M, 2007, FLY, V1, P330, DOI 10.4161/fly.5399; Hashimoto K, 2004, MODERN PATHOL, V17, P617, DOI 10.1038/modpathol.3800107; Hellerbrand C, 2007, CARCINOGENESIS, V28, P21, DOI 10.1093/carcin/bgl081; Hiroki Kinoshita HO, 2013, MOL CLIN ONCOLOGY; Hoffmann K, 2011, CLIN TRANSPLANT, V25, pE541, DOI 10.1111/j.1399-0012.2011.01465.x; Kikuchi LOO, 2009, J CLIN GASTROENTEROL, V43, P191, DOI 10.1097/MCG.0b013e31817ff199; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Kornberg A, 2012, LIVER TRANSPLANT, V18, P53, DOI 10.1002/lt.22416; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet Josep M, 2004, Curr Treat Options Gastroenterol, V7, P431, DOI 10.1007/s11938-004-0002-8; Macher-Goeppinger S, 2011, CANCER LETT, V301, P203, DOI 10.1016/j.canlet.2010.12.005; Massoumi R, TRENDS BIOCH SCI, V35, P392; Massoumi R, 2006, J INVEST DERMATOL, V126, P1182, DOI 10.1038/sj.jid.5700218; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; Nakanishi K, 2005, CANCER-AM CANCER SOC, V103, P307, DOI 10.1002/cncr.20774; Nanashima A, 2010, J SURG ONCOL, V101, P557, DOI 10.1002/jso.21534; Nikolaou K, 2012, CANCER CELL, V21, P738, DOI 10.1016/j.ccr.2012.04.026; Pannem RR, 2013, CARCINOGENESIS; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Urbanik T, 2012, J HEPATOL, V57, P995, DOI 10.1016/j.jhep.2012.06.017; Urbanik T, 2011, INT J ONCOL, V38, P121, DOI 10.3892/ijo_00000831; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Vick B, 2009, HEPATOLOGY, V49, P627, DOI 10.1002/hep.22664; Watanabe J, 2004, SURGERY, V135, P604, DOI 10.1016/j.surg.2003.11.015; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563	37	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110591	10.1371/journal.pone.0110591	http://dx.doi.org/10.1371/journal.pone.0110591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329885	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800097
J	Datta, S; Ghosh, A; Dasgupta, D; Ghosh, A; Roychoudhury, S; Roy, G; Das, S; Das, K; Gupta, S; Basu, K; Basu, A; Datta, S; Chowdhury, A; Banerjee, S				Datta, Somenath; Ghosh, Alip; Dasgupta, Debanjali; Ghosh, Amit; Roychoudhury, Shrabasti; Roy, Gaurav; Das, Soumyojit; Das, Kausik; Gupta, Subash; Basu, Keya; Basu, Analabha; Datta, Simanti; Chowdhury, Abhijit; Banerjee, Soma			Novel Point and Combo-Mutations in the Genome of Hepatitis B Virus-Genotype D: Characterization and Impact on Liver Disease Progression to Hepatocellular Carcinoma	PLOS ONE			English	Article							BASAL CORE PROMOTER; GENE-MUTATIONS; ENHANCER II; CHRONIC INFECTION; RISK; INCREASE; CANCER; REGION; HBV; EPITOPES	Background: The contribution of chronic hepatitis B virus (HBV) infection in the pathogenesis of hepatocellular carcinoma (HCC) through progressive stages of liver fibrosis is exacerbated by the acquisition of naturally occurring mutations in its genome. This study has investigated the prevalence of single and combo mutations in the genome of HBV-genotype D from treatment naive Indian patients of progressive liver disease stages and assessed their impact on the disease progression to HCC. Methods: The mutation profile was determined from the sequence analysis of the full-length HBV genome and compared with the reference HBV sequences. SPSS 16.0 and R software were used to delineate their statistical significance in predicting HCC occurrence. Results: Age was identified as associated risk factor for HCC development in chronic hepatitis B (CHB) patients (p <= 0.01). Beyond the classical mutations in basal core promoter (BCP) (A1762T/G1764A) and precore (G1862T), persistence of progressively accumulated mutations in enhancer-I, surface, HBx and core were showed significant association to liver disease progression. BCP_T1753C, core_T147C, surface_L213I had contributed significantly in the disease progression to HCC (p<0.05) in HBeAg positive patients whereas precore_T1858C, core_I116L, core_P130Q and preS1_S98T in HBeAg negative patients. Furthermore, the effect of individual mutation was magnified by the combination with A1762T/G1764A in HCC pathogenesis. Multivariate risk analysis had confirmed that core_P130Q [OR 20.71, 95% CI (1.64-261.77), p = 0.019] in B cell epitope and core_T147C [OR 14.58, 95% CI (1.17-181.76), p = 0.037] in CTL epitope were two independent predictors of HCC in HBeAg positive and negative patients respectively. Conclusions: Thus distinct pattern of mutations distributed across the entire HBV genome may be useful in predicting HCC in high-risk CHB patients and pattern of mutational combinations may exert greater impact on HCC risk prediction more accurately than point mutations and hence these predictors may support the existing surveillance strategies in proper management of the patients.	[Datta, Somenath; Ghosh, Alip; Dasgupta, Debanjali; Ghosh, Amit; Roychoudhury, Shrabasti; Das, Soumyojit; Das, Kausik; Basu, Keya; Datta, Simanti; Chowdhury, Abhijit; Banerjee, Soma] Inst Post Grad Med Educ & Res, Liver Res Ctr, Kolkata, India; [Roy, Gaurav] Jamia Millia Islamia, Mol Virol Lab, Dept Biotechnol, New Delhi 110025, India; [Gupta, Subash] Indraprastha Apollo Hosp, Ctr Liver & Biliary Surg, New Delhi, India; [Basu, Analabha] Natl Inst Biomed Genom, Kalyani, W Bengal, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Jamia Millia Islamia; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG)	Banerjee, S (corresponding author), Inst Post Grad Med Educ & Res, Liver Res Ctr, Kolkata, India.	somabanerjee70@gmail.com	Dasgupta, Debanjali/AGT-9408-2022; Datta, Somenath/AAD-7752-2021; Ghosh, Amit/AAB-3140-2019; ROY, GAURAV/AAG-3911-2019	Dasgupta, Debanjali/0000-0001-8307-9719; Das, Kausik/0000-0001-6602-5516	Indian Council of Medical Research [5/13/83/2008-NCD-III]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	Indian Council of Medical Research has funded this study (Project no: 5/13/83/2008-NCD-III). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKARCA US, 1995, HEPATOLOGY, V22, P50, DOI 10.1002/hep.1840220109; Asim M, 2013, INT J CANCER, V133, P437, DOI 10.1002/ijc.27993; Asim M, 2010, J MED VIROL, V82, P1115, DOI 10.1002/jmv.21774; Assar S, 2012, CLIN LAB, V58, P53; Bai X, 2011, CARCINOGENESIS, V32, P63, DOI 10.1093/carcin/bgq195; Baptista M, 1999, HEPATOLOGY, V29, P946, DOI 10.1002/hep.510290336; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; Bozkaya H, 1996, HEPATOLOGY, V24, P32, DOI 10.1053/jhep.1996.v24.pm0008707278; Chen CH, 2008, J INFECT DIS, V198, P1634, DOI 10.1086/592990; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chisari FV, 2000, AM J PATHOL, V156, P1117, DOI 10.1016/S0002-9440(10)64980-2; Cho EY, 2010, CANCER SCI, V101, P1905, DOI 10.1111/j.1349-7006.2010.01612.x; Das K, 2012, HEPATOLOGY, V55, P584, DOI 10.1002/hep.24694; Datta S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-156; Dhir V, 1998, Indian J Gastroenterol, V17, P100; Elkady A, 2008, J GASTROEN HEPATOL, V23, P474, DOI 10.1111/j.1440-1746.2008.05321.x; GUNTHER S, 1995, J VIROL, V69, P5437; Heriyanto DS, 2012, J MED VIROL, V84, P44, DOI 10.1002/jmv.22266; Hwang GY, 2003, VIRUS RES, V92, P157, DOI 10.1016/S0168-1702(03)00043-1; Ismail AM, 2014, INT J INFECT DIS, V20, P1, DOI 10.1016/j.ijid.2013.12.007; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Kao JH, 2003, INTERVIROLOGY, V46, P400, DOI 10.1159/000074999; Khan A, 2013, INT J CANCER, V133, P2864, DOI 10.1002/ijc.28307; Kim D, 2011, J MED VIROL, V83, P2082, DOI 10.1002/jmv.22226; Kim JK, 2009, J MED VIROL, V81, P1002, DOI 10.1002/jmv.21501; Koschel M, 2000, J VIROL, V74, P1, DOI 10.1128/JVI.74.1.1-7.2000; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Liu Z, 2005, J VIRAL HEPATITIS, V12, P146, DOI 10.1111/j.1365-2893.2005.00552.x; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Long Y, 2009, J VIRAL HEPATITIS, V16, P537, DOI 10.1111/j.1365-2893.2009.01089.x; Malik A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039028; Matsuura K, 2009, J CLIN MICROBIOL, V47, P1476, DOI 10.1128/JCM.02081-08; Mohebbi SR, 2012, J MED VIROL, V84, P414, DOI 10.1002/jmv.23200; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Park YM, 2014, J VIRAL HEPATITIS, V21, P171, DOI 10.1111/jvh.12134; Paul Shashi Bala, 2007, Indian J Gastroenterol, V26, P274; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Prange R, 1999, BIOL CHEM, V380, P305, DOI 10.1515/BC.1999.042; Qu LS, 2014, HEPATOL RES, V44, P1186, DOI 10.1111/hepr.12291; Revill P, 2013, ANTIVIR THER, V18, P1, DOI 10.3851/IMP2542; Song BC, 2006, INTERVIROLOGY, V49, P266, DOI 10.1159/000093456; Tai PC, 2002, VIROLOGY, V292, P44, DOI 10.1006/viro.2001.1239; Takahashi K, 1998, ARCH VIROL, V143, P2313, DOI 10.1007/s007050050463; Tanaka Y, 2004, HEPATOLOGY, V40, P747, DOI 10.1002/hep.20365; Tanaka Y, 2006, J HEPATOL, V45, P646, DOI 10.1016/j.jhep.2006.06.018; Tejpar S, 2010, ONCOLOGIST, V15, P390, DOI 10.1634/theoncologist.2009-0233; Tong MJ, 2007, LIVER INT, V27, P1356, DOI 10.1111/j.1478-3231.2007.01585.x; Torre F, 2004, J MED VIROL, V72, P370, DOI 10.1002/jmv.20016; Tseng TC, 2012, GASTROENTEROLOGY, V142, P1140, DOI 10.1053/j.gastro.2012.02.007; Wang JH, 2009, J GASTROENTEROL, V44, P439, DOI 10.1007/s00535-009-0017-y; Wu CF, 2008, CARCINOGENESIS, V29, P106, DOI 10.1093/carcin/bgm252; Wu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094864; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Yuan TTT, 1999, J VIROL, V73, P5731, DOI 10.1128/JVI.73.7.5731-5740.1999; Zhu Y, 2010, CANCER EPIDEM BIOMAR, V19, P2623, DOI 10.1158/1055-9965.EPI-10-0469	59	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110012	10.1371/journal.pone.0110012	http://dx.doi.org/10.1371/journal.pone.0110012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333524	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200076
J	Hou, YG; Wang, YL; Wang, Y; Zhong, T; Li, L; Zhang, HP; Wang, LJ				Hou, Yuguo; Wang, Yilin; Wang, Yan; Zhong, Tao; Li, Li; Zhang, Hongping; Wang, Linjie			Multiple Alternative Splicing and Differential Expression Pattern of the Glycogen Synthase Kinase-3 beta (GSK3 beta) Gene in Goat (Capra hircus)	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; KINASE 3-BETA; PHOSPHORYLATION; INSULIN; GSK-3; INHIBITION; MODULATION; ISOFORMS; MUSCLE; ROLES	Glycogen synthase kinase-3 beta (GSK3 beta) has been identified as a key protein kinase involved in several signaling pathways, such as Wnt, IGF-I and Hedgehog. However, knowledge regarding GSK3 beta in the goat is limited. In this study, we cloned and characterized the goat GSK3 beta gene. Six novel GSK3 beta transcripts were identified in different tissues and designated as GSK3 beta 1, 2, 3, 4, 5 and 6. RT-PCR was used to further determine whether the six GSK3 beta transcripts existed in different goat tissues. Bioinformatics analysis revealed that the catalytic domain (S_TKc domain) is missing from GSK3 beta 2 and GSK3 beta 4. GSK3 beta 3 and GSK3 beta 6 do not contain the negative regulatory sites that are controlled by p38 MAPK. Furthermore, qRT-PCR and western blot analysis revealed that all the GSK3 beta transcripts were expressed at the highest level in the heart, whereas their expression levels in the liver, spleen, kidney, brain, longissimus dorsi muscle and uterus were different. These studies provide useful information for further research on the functions of GSK3 beta isoforms.	[Hou, Yuguo; Wang, Yilin; Wang, Yan; Zhong, Tao; Li, Li; Zhang, Hongping; Wang, Linjie] Sichuan Agr Univ, Inst Anim Genet & Breeding, Coll Anim Sci & Technol, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Wang, LJ (corresponding author), Sichuan Agr Univ, Inst Anim Genet & Breeding, Coll Anim Sci & Technol, Chengdu, Sichuan, Peoples R China.	wanglinjie@sicau.edu.cn	Li, Li/T-4353-2017	Li, Li/0000-0003-2459-3499	National Natural Science Foundation of China [31101699]; Sichuan Province Science and Technology support program [2011NZ0003, 2011NZ0099-36]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province Science and Technology support program	This study was supported by the grants from National Natural Science Foundation of China (31101699) and Sichuan Province Science and Technology support program (2011NZ0003, 2011NZ0099-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Alon LT, 2011, FEBS LETT, V585, P1158, DOI 10.1016/j.febslet.2011.03.025; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Castano Z, 2010, J NEUROCHEM, V113, P117, DOI 10.1111/j.1471-4159.2010.06581.x; Cho J, 2009, J BIOL CHEM, V284, P36647, DOI 10.1074/jbc.M109.019109; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gillespie JR, 2011, ENDOCRINOLOGY, V152, P1755, DOI 10.1210/en.2010-1412; Henriksen EJ, 2003, AM J PHYSIOL-ENDOC M, V284, pE892, DOI 10.1152/ajpendo.00346.2002; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Hye A, 2005, NEUROSCI LETT, V373, P1, DOI 10.1016/j.neulet.2004.10.031; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kubic JD, 2012, MOL CANCER RES, V10, P1065, DOI 10.1158/1541-7786.MCR-11-0387; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Matsuda T, 2008, P NATL ACAD SCI USA, V105, P20900, DOI 10.1073/pnas.0808315106; Mukai F, 2002, J NEUROCHEM, V81, P1073, DOI 10.1046/j.1471-4159.2002.00918.x; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; RYLATT DB, 1980, EUR J BIOCHEM, V107, P529; Saeki K, 2011, BIOL PHARM BULL, V34, P146, DOI 10.1248/bpb.34.146; Schaffer B, 2003, GENE, V302, P73, DOI 10.1016/S0378-1119(02)01092-2; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Takashima A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P309; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Wang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040250; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Wood-Kaczmar A, 2009, MOL CELL NEUROSCI, V42, P184, DOI 10.1016/j.mcn.2009.07.002; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	36	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109555	10.1371/journal.pone.0109555	http://dx.doi.org/10.1371/journal.pone.0109555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25334049	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200039
J	Li, SY; Blain, EJ; Cao, J; Caterson, B; Duance, VC				Li, Siyuan; Blain, Emma J.; Cao, Junling; Caterson, Bruce; Duance, Victor C.			Effects of the Mycotoxin Nivalenol on Bovine Articular Chondrocyte Metabolism In Vitro	PLOS ONE			English	Article							KASHIN-BECK-DISEASE; TISSUE INHIBITOR; MESSENGER-RNA; CYTOSKELETAL ELEMENTS; INTERVERTEBRAL DISC; CYTOCHALASIN-B; T-2 TOXIN; CARTILAGE; EXPRESSION; METALLOPROTEINASES	Objective: Kashin-Beck Disease (KBD) is an endemic, age-related degenerative osteoarthropathy and its cause is hypothesised to involve Fusarium mycotoxins. This study investigated the Fusarium mycotoxin Nivalenol (NIV) on the metabolism of bovine articular chondrocytes in vitro. Design: The effect 0.0-0.5 mu g/ml NIV on transcript levels of types I and II collagen, aggrecan, matrix metalloproteinases (MMPs), a disintegrin and metalloproteinase with thrombospondin motif (ADAMTS) and the tissue inhibitors of MMPs (TIMPs) was investigated using quantitative PCR. Amounts of sulphated glycosaminoglycans, MMPs and TIMPs were assessed using the Dimethylmethylene Blue assay, gelatin zymography and reverse gelatin zymography respectively. Cytoskeletal organisation was analysed using confocal microscopy and cytoskeletal gene and protein levels were measured by quantitative PCR and Western blot analysis, respectively. Results: NIV caused a dose-dependent increase in aggrecan transcription with a concomitant retention of sGAG in the cell lysate. Furthermore, NIV significantly increased MMPs-2, -3 & -9, ADAMTS-4 and -5, and TIMP-2 and -3 transcript levels but inhibited type I collagen, MMP 1 and TIMP 1 mRNA levels. NIV promoted extensive cytoskeletal network remodelling, particularly with vimentin where a dose-dependent peri-nuclear aggregation occurred. Conclusion: NIV exposure to chondrocytes decreased matrix deposition, whilst enhancing selective catabolic enzyme production, suggesting its potential for induction of cellular catabolism. This NIV-induced extracellular matrix remodelling may be due to extensive remodelling/disassembly of the cytoskeletal elements. Collectively, these findings support the hypothesis that trichothecene mycotoxins, and in particular NIV, have the potential to induce matrix catabolism and propagate the pathogenesis of KBD.	[Li, Siyuan] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Anesthesiol, Xian 710049, Peoples R China; [Blain, Emma J.; Duance, Victor C.] Cardiff Univ, Arthrit Res UK Biomech & Bioengn Ctr, Cardiff CF10 3AX, S Glam, Wales; [Li, Siyuan; Blain, Emma J.; Caterson, Bruce; Duance, Victor C.] Cardiff Univ, Sch Biosci, Div Pathophysiol & Repair, Cardiff CF10 3AX, S Glam, Wales; [Cao, Junling] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Peoples R China	Xi'an Jiaotong University; Cardiff University; Cardiff University; Xi'an Jiaotong University	Duance, VC (corresponding author), Cardiff Univ, Arthrit Res UK Biomech & Bioengn Ctr, Cardiff CF10 3AX, S Glam, Wales.	duance@cardiff.ac.uk		Caterson, Bruce/0000-0001-6016-0661	Engineering and Physical Sciences Research Council Dorothy Hodgkin Postgraduate Award; Arthritis Research United Kingdom [18221, 18331]; National Natural Science Foundation of China [31070725]; Arthritis Research United Kingdom within the Biomechanics and Bioengineering Centre [18461]	Engineering and Physical Sciences Research Council Dorothy Hodgkin Postgraduate Award(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Arthritis Research United Kingdom(Versus Arthritis); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Arthritis Research United Kingdom within the Biomechanics and Bioengineering Centre	The authors acknowledge funding from the Engineering and Physical Sciences Research Council Dorothy Hodgkin Postgraduate Award (www.epsrc.ac.uk) to SL, Arthritis Research United Kingdom (www.arthritisresearchuk.org grant no. 18221 & 18331 to VCD/EJB & BC, respectively) and National Natural Science Foundation of China (www.nsfc.gov.cn/grant no. 31070725 to JC). EJB is an academic fellow funded by Arthritis Research United Kingdom within the Biomechanics and Bioengineering Centre (grant no. 18461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bau B, 2002, ARTHRITIS RHEUM, V46, P2648, DOI 10.1002/art.10531; Bernardo MM, 2003, BIOCHEM J, V374, P739, DOI 10.1042/BJ20030557; Billinghurst RC, 2000, ARTHRITIS RHEUM, V43, P664, DOI 10.1002/1529-0131(200003)43:3<664::AID-ANR24>3.0.CO;2-D; Blain EJ, 2001, ARCH BIOCHEM BIOPHYS, V396, P49, DOI 10.1006/abbi.2001.2575; Blain EJ, 2006, MATRIX BIOL, V25, P398, DOI 10.1016/j.matbio.2006.06.002; Blain EJ, 2009, INT J EXP PATHOL, V90, P1, DOI 10.1111/j.1365-2613.2008.00625.x; Bobick BE, 2010, J CELL BIOCHEM, V109, P265, DOI 10.1002/jcb.22419; Bodo M, 1996, CELL BIOL INT, V20, P177, DOI 10.1006/cbir.1996.0022; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Cao J, 2008, OSTEOARTHR CARTILAGE, V16, P680, DOI 10.1016/j.joca.2007.09.002; Cao J XY, 1995, CHIN J CONTROL ENDEM, V10, P69; Cao Pei-hua, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P313; Chen JH, 2006, FOOD CHEM TOXICOL, V44, P567, DOI 10.1016/j.fct.2005.09.004; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Gendron C, 2003, FEBS LETT, V555, P431, DOI 10.1016/S0014-5793(03)01295-X; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Gutleb AC, 2002, ENVIRON TOXICOL PHAR, V11, P309, DOI 10.1016/S1382-6689(02)00020-0; Hedman R, 1997, ARCH ANIM NUTR, V50, P13, DOI 10.1080/17450399709386115; Hsia CC, 2004, ONCOL REP, V12, P449; JANSEN HW, 1974, BIOCHIM BIOPHYS ACTA, V362, P150, DOI 10.1016/0304-4165(74)90036-1; Jortikka MO, 2000, ARCH BIOCHEM BIOPHYS, V374, P172, DOI 10.1006/abbi.1999.1543; Karagiannis ED, 2004, J BIOL CHEM, V279, P39105, DOI 10.1074/jbc.M403627200; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; KIM JJ, 1980, J BIOL CHEM, V255, P1586; LI FS, 1990, MECH AGEING DEV, V54, P103, DOI 10.1016/0047-6374(90)90059-O; Li SY, 2008, J ZHEJIANG UNIV-SC B, V9, P22, DOI 10.1631/jzus.B071322; Li SY, 2011, EUR CELLS MATER, V21, P508, DOI 10.22203/eCM.v021a38; Li S, 2008, J ANAT, V213, P725, DOI 10.1111/j.1469-7580.2008.00998.x; LOHMANDER S, 1979, ARCH BIOCHEM BIOPHYS, V192, P148, DOI 10.1016/0003-9861(79)90080-8; LOHMANDER S, 1976, EXP CELL RES, V99, P333, DOI 10.1016/0014-4827(76)90591-7; LOTY S, 1995, BIOL CELL, V83, P149, DOI 10.1016/0248-4900(96)81303-7; Lu ML, 2012, CELLS TISSUES ORGANS, V196, P241, DOI 10.1159/000335046; Minervini F, 2004, TOXICOL IN VITRO, V18, P21, DOI 10.1016/S0887-2333(03)00130-9; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagase H, 1998, Cell Res, V8, P179; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Su S, 1999, RHEUMATOL INT, V18, P183, DOI 10.1007/s002960050083; Suetens C, 2001, INT ORTHOP, V25, P180, DOI 10.1007/s002640100247; Takaishi H, 2008, CURR PHARM BIOTECHNO, V9, P47, DOI 10.2174/138920108783497659; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; UENO Y, 1986, TOXICON, V24, P618, DOI 10.1016/0041-0101(86)90184-4; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Vinall RL, 2002, EXP CELL RES, V272, P32, DOI 10.1006/excr.2001.5395; Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110; Zafarullah M, 1996, J CELL BIOCHEM, V60, P211, DOI 10.1002/(SICI)1097-4644(19960201)60:2<211::AID-JCB5>3.0.CO;2-#; Zhang JB, 2007, MYCOL RES, V111, P967, DOI 10.1016/j.mycres.2007.06.008	47	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109536	10.1371/journal.pone.0109536	http://dx.doi.org/10.1371/journal.pone.0109536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329658	Green Published, Green Accepted, gold			2022-12-27	WOS:000346766200036
J	Yerushalmi, R; Goldvaser, H; Sulkes, A; Ben-Aharon, I; Hendler, D; Neiman, V; Ciuraru, NB; Bonilla, L; Amit, L; Zer, A; Granot, T; Rizel, S; Stemmer, SM				Yerushalmi, Rinat; Goldvaser, Hadar; Sulkes, Aaron; Ben-Aharon, Irit; Hendler, Daniel; Neiman, Victoria; Ciuraru, Noa Beatrice; Bonilla, Luisa; Amit, Limor; Zer, Alona; Granot, Tal; Rizel, Shulamith; Stemmer, Salomon M.			Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 & 12 in Breast Cancer Patients: A Retrospective Analysis	PLOS ONE			English	Article							SINGLE-ADMINISTRATION PEGFILGRASTIM; DAILY FILGRASTIM; FEBRILE NEUTROPENIA; CHEMOTHERAPY; MULTICENTER; IMPACT; DOXORUBICIN; SURVIVAL; UPDATE; TRIALS	Purpose: Four cycles of docetaxel/cyclophosphamide (DC) resulted in superior survival than doxorubicin/cyclophosphamide in the treatment of early breast cancer. The original study reported a 5% incidence of febrile neutropenia (FN) recommending prophylactic antibiotics with no granulocyte colony-stimulating factor (G-CSF) support. The worldwide adoption of this protocol yielded several reports on substantially higher rates of FN events. We explored the use of growth factor (GF) support on days 8 and 12 of the cycle with the original DC protocol. Methods: Our study included all consecutive patients with stages I-II breast cancer who were treated with the DC protocol at the Institute of Oncology, Davidoff Center (Rabin Medical Center, Petah Tikva, Israel) from April, 2007 to March, 2012. Patient, tumor characteristics, and toxicity were reported. Results: In total, 123 patients received the DC regimen. Median age was 60 years, (range, 25-81 years). Thirty-three patients (26.8%) were aged 65 years and older. Most of the women (87%) adhered to the planned G-CSF protocol (days 8 & 12). 96% of the patients completed the 4 planned cycles of chemotherapy. Six patients (5%) had dose reductions, 6 (5%) had treatment delays due to non-medical reasons. Thirteen patients (10.6%) experienced at least one event of FN (3 patients had 2 events), all requiring hospitalization. Eight patients (6.5%) required additional support with G-CSF after the first chemotherapy cycle, 7 because of FN and one due to neutropenia and diarrhea. In Conclusion: Primary prophylactic G-CSF support on days 8 and 12 of the cycle provides a tolerable option to deliver the DC protocol. Our results are in line with other retrospective protocols using longer schedules of GF support.	[Yerushalmi, Rinat; Goldvaser, Hadar; Sulkes, Aaron; Ben-Aharon, Irit; Hendler, Daniel; Neiman, Victoria; Ciuraru, Noa Beatrice; Bonilla, Luisa; Amit, Limor; Zer, Alona; Granot, Tal; Rizel, Shulamith; Stemmer, Salomon M.] Beilinson Med Ctr, Rabin Med Ctr, Davidoff Ctr, Inst Oncol, Petah Tiqwa, Israel; [Yerushalmi, Rinat; Sulkes, Aaron; Ben-Aharon, Irit; Zer, Alona; Stemmer, Salomon M.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Yerushalmi, R (corresponding author), Beilinson Med Ctr, Rabin Med Ctr, Davidoff Ctr, Inst Oncol, Petah Tiqwa, Israel.	rinaty@clalit.org.il	Zer, Alona/AAW-8442-2020	Zer, Alona/0000-0001-6597-5261				Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; Aarts MJ, 2013, J CLIN ONCOL, V31, P4283, DOI 10.1200/JCO.2012.48.3644; Abe O, 1998, LANCET, V352, P930; Anderlini P, 1996, BLOOD, V88, P2819, DOI 10.1182/blood.V88.8.2819.bloodjournal8882819; Chan A, 2011, SUPPORT CARE CANCER, V19, P497, DOI 10.1007/s00520-010-0843-8; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Freyer G, 2011, CRIT REV ONCOL HEMAT, V80, P466, DOI 10.1016/j.critrevonc.2011.04.001; Green MD, 2003, ANN ONCOL, V14, P29, DOI 10.1093/annonc/mdg019; Hendler D, 2011, AM J CLIN ONCOL-CANC, V34, P619, DOI 10.1097/COC.0b013e3181f94716; Hershman DL, 2012, J CLIN ONCOL, V30, P806, DOI 10.1200/JCO.2011.37.7499; Holmes FA, 2002, J CLIN ONCOL, V20, P727, DOI 10.1200/JCO.20.3.727; Jones S, 2009, J CLIN ONCOL, V27, P1177, DOI 10.1200/JCO.2008.18.4028; Lyman GH, 2013, ANN ONCOL, V24, P2475, DOI 10.1093/annonc/mdt226; Ngamphaiboon N, 2012, MED ONCOL, V29, P1495, DOI 10.1007/s12032-011-0035-5; Papaldo P, 2005, J CLIN ONCOL, V23, P6908, DOI 10.1200/JCO.2005.03.099; Renner P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007913.pub2; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Takabatake D, 2009, JPN J CLIN ONCOL, V39, P478, DOI 10.1093/jjco/hyp050; Vandenberg T, 2010, CURR ONCOL, V17, P56; Vose JM, 2003, J CLIN ONCOL, V21, P514, DOI 10.1200/JCO.2003.03.040; Younis T, 2011, CURR ONCOL, V18, pE288	21	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e107273	10.1371/journal.pone.0107273	http://dx.doi.org/10.1371/journal.pone.0107273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25330205	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200004
J	Gianchecchi, E; Crino, A; Giorda, E; Luciano, R; Perri, V; Lo Russo, A; Cappa, M; Rosado, MM; Fierabracci, A				Gianchecchi, Elena; Crino, Antonino; Giorda, Ezio; Luciano, Rosa; Perri, Valentina; Lo Russo, Anna; Cappa, Marco; Rosado, M. Manuela; Fierabracci, Alessandra			Altered B Cell Homeostasis and Toll-Like Receptor 9-Driven Response in Type 1 Diabetes Carriers of the C1858T PTPN22 Allelic Variant: Implications in the Disease Pathogenesis	PLOS ONE			English	Article							LYMPHOID TYROSINE PHOSPHATASE; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY GENE; NOD MOUSE; T-CELLS; AUTOIMMUNITY; POLYMORPHISM; ASSOCIATION; ACTIVATION; LYMPHOCYTES	Type 1 diabetes is an autoimmune disease caused by the destruction of pancreatic beta cells by autoreactive T cells. Among the genetic variants associated with type 1 diabetes, the C1858T (Lyp) polymorphism of the protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene alters the function of T cells but also of B cells in innate and adaptive immunity. The Lyp variant was shown to diminish interferon production and responses upon Toll-like receptor stimulation in macrophages and dendritic cells, possibly leading to uncontrolled infections as triggers of the diabetogenic process. The aim of this study was to unravel the yet uncharacterized effects that the variant could exert on the immune and autoimmune responses, particularly regarding the B cell phenotype, in the peripheral blood lymphocytes of diabetic patients and healthy controls in basal conditions and after unmethylated bacterial DNA CpG stimulation. The presence of the Lyp variant resulted in a significant increase in the percentage of transitional B cells in C/T carriers patients and controls compared to C/C patients and controls, in C/T carrier patients compared to C/C controls and in C/T carrier patients compared to C/C patients. A significant reduction in the memory B cells was also observed in the presence of the risk variant. After four days of CpG stimulation, there was a significant increase in the abundance of IgM(+) memory B cells in C/T carrier diabetics than in C/C subjects and in the groups of C/T carrier individuals than in C/C individuals. IgM(-) memory B cells tended to differentiate more precociously into plasma cells than IgM(+) memory B cells in heterozygous C/T subjects compared to the C/C subjects. The increased Toll-like receptor response that led to expanded T cell-independent IgM(+) memory B cells should be further investigated to determine the putative contribution of innate immune responses in the disease pathogenesis.	[Gianchecchi, Elena; Perri, Valentina; Lo Russo, Anna; Fierabracci, Alessandra] IRCCS, Bambino Gesu Childrens Hosp, Autoimmun Lab, Immunol & Pharmacotherapy Area, Rome, Italy; [Crino, Antonino; Cappa, Marco] IRCCS, Bambino Gesu Childrens Hosp, Div Endocrinol, Rome, Italy; [Giorda, Ezio; Rosado, M. Manuela] IRCCS, Bambino Gesu Childrens Hosp, Cell Dev Lab B, Immunol & Pharmacotherapy Area, Rome, Italy; [Luciano, Rosa] IRCCS, Bambino Gesu Childrens Hosp, Res Labs, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Fierabracci, A (corresponding author), IRCCS, Bambino Gesu Childrens Hosp, Autoimmun Lab, Immunol & Pharmacotherapy Area, Rome, Italy.	alessandra.fierabracci@opbg.net	Fierabracci, Alessandra/K-5930-2016; Rosado, Maria Manuela/AAX-6495-2020; Giorda, Ezio/AAH-9950-2019	Fierabracci, Alessandra/0000-0003-3078-9754; Giorda, Ezio/0000-0002-5875-832X; CAPPA, MARCO/0000-0001-5647-7519; Crino, Antonino/0000-0003-3548-7114	Italian Ministry of Health Ricerca Corrente [201202R002822-201302R002984-201302R003158]	Italian Ministry of Health Ricerca Corrente(Ministry of Health, Italy)	AF received funding from Italian Ministry of Health Ricerca Corrente 201202R002822-201302R002984-201302R003158. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnisalo J, 2008, J AUTOIMMUN, V31, P13, DOI 10.1016/j.jaut.2008.01.001; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Burn GL, 2011, FEBS LETT, V585, P3689, DOI 10.1016/j.febslet.2011.04.032; Capolunghi F, 2008, J IMMUNOL, V180, P800, DOI 10.4049/jimmunol.180.2.800; Capolunghi F, 2013, IMMUNOL LETT, V152, P114, DOI 10.1016/j.imlet.2013.04.007; Capolunghi F, 2010, RHEUMATOLOGY, V49, P2281, DOI 10.1093/rheumatology/keq226; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; Chatenoud L, 1990, Semin Immunol, V2, P437; Corte-Real J, 2012, DIABETOLOGIA, V55, P1761, DOI 10.1007/s00125-012-2498-0; Diana J, 2013, J IMMUNOL, V191, P2335, DOI 10.4049/jimmunol.1300864; Dittmar M, 2010, THYROID, V20, P737, DOI 10.1089/thy.2010.1639; Fierabracci A, 2011, CURR MED CHEM, V18, P577, DOI 10.2174/092986711794480230; Fierabracci A, 2009, IMMUNOL LETT, V124, P35, DOI 10.1016/j.imlet.2009.04.001; Gallagher MP, 2011, ANN NY ACAD SCI, V1243, P119, DOI 10.1111/j.1749-6632.2011.06321.x; Gianchecchi E, 2013, AUTOIMMUN REV, V12, P717, DOI 10.1016/j.autrev.2012.12.003; Habib T, 2012, J IMMUNOL, V188, P487, DOI 10.4049/jimmunol.1102176; Herold KC, 2011, J IMMUNOL, V187, P1998, DOI 10.4049/jimmunol.1100539; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jagiello P, 2005, ARTHRITIS RHEUM-US, V52, P4039, DOI 10.1002/art.21487; Maine CJ, 2012, J IMMUNOL, V188, P5267, DOI 10.4049/jimmunol.1200150; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Menard L, 2011, J CLIN INVEST, V121, P3635, DOI 10.1172/JCI45790; Michou L, 2007, P NATL ACAD SCI USA, V104, P1649, DOI 10.1073/pnas.0610250104; Orozco G, 2005, ARTHRITIS RHEUM-US, V52, P219, DOI 10.1002/art.20771; Pescovitz MD, 2014, DIABETES CARE, V37, P453, DOI 10.2337/dc13-0626; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Serreze DV, 1998, J IMMUNOL, V161, P3912; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Tai NW, 2013, J IMMUNOL, V191, P2926, DOI 10.4049/jimmunol.1300547; Tang ST, 2012, DIABETES RES CLIN PR, V97, P446, DOI 10.1016/j.diabres.2012.04.011; Vandiedonck C, 2006, ANN NEUROL, V59, P404, DOI 10.1002/ana.20751; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Wang SF, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-78; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Wen L, 2004, J IMMUNOL, V172, P3173, DOI 10.4049/jimmunol.172.5.3173; Wong FS, 2008, ANN NY ACAD SCI, V1150, P146, DOI 10.1196/annals.1447.039; Wu H, 2005, ARTHRITIS RHEUM-US, V52, P2396, DOI 10.1002/art.21223; Yu LP, 2011, DIABETES, V60, P2560, DOI 10.2337/db11-0674	49	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110755	10.1371/journal.pone.0110755	http://dx.doi.org/10.1371/journal.pone.0110755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333705	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200074
J	Ren, Y; Black, DM; Mittendorf, EA; Liu, PJ; Li, X; Du, XLL; He, JJ; Yang, J; Hunt, KK; Yi, M				Ren, Yu; Black, Dalliah M.; Mittendorf, Elizabeth A.; Liu, Peijun; Li, Xu; Du, Xianglin L.; He, Jianjun; Yang, Jin; Hunt, Kelly K.; Yi, Min			Crossover Effects of Estrogen Receptor Status on Breast Cancer-Specific Hazard Rates by Age and Race	PLOS ONE			English	Article							ADJUVANT ENDOCRINE THERAPY; PRACTICE GUIDELINE UPDATE; AMERICAN SOCIETY; TAMOXIFEN; WOMEN; ANASTROZOLE; PERSISTENCE; PREVENTION; MORTALITY; DIAGNOSIS	Background: Previous studies found that the risk of breast cancer-related death is greater in estrogen receptor (ER)-negative disease than in ER-positive disease within 5 years of diagnosis, but greater for ER-positive disease than for ER-negative disease more than 5 years after diagnosis. This phenomenon is referred to as ER-positive and -negative crossover. Our aim was to evaluate this crossover by determining the timing of the hazard of breast cancer death by patient, clinical, and tumor factors. Methods: Patients with breast cancer diagnosed between 1990 and 2005 were identified from the Surveillance, Epidemiology, and End Results database. The cohort was evaluated by age at diagnosis, race, tumor ER status, tumor and nodal stage, and tumor grade. Disease-specific (DS) hazard rates were calculated. Results: Of the 439,444 patients identified, 77.5% had ER-positive disease. Overall, ER-negative to ER-positive DS hazard rates crossed between the years 7 and 8 after diagnosis. Earlier crossover was linked to black or Hispanic race, young age (<40 years), or tumors that were larger, higher grade, or affected the nodes. Young black (<40 years) patients who had a T3/T4 tumor with positive nodes, grade III or undifferentiated, had the earliest crossover, in year 4. Conclusions: The timing of crossover of death hazard for ER-positive and ER-negative disease varies by clinical and tumor factors. These findings may help guide recommendations regarding the duration of endocrine therapy for patients with ER-positive cancer.	[Ren, Yu; He, Jianjun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Surg Oncol, Sch Med, Xian, Peoples R China; [Black, Dalliah M.; Mittendorf, Elizabeth A.; Hunt, Kelly K.; Yi, Min] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Liu, Peijun; Li, Xu; Yi, Min] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Translat Med, Xian, Peoples R China; [Du, Xianglin L.] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Yang, Jin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, Xian, Peoples R China	Xi'an Jiaotong University; University of Texas System; UTMD Anderson Cancer Center; Xi'an Jiaotong University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Xi'an Jiaotong University	Yi, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	myi@mdanderson.org	Ren, Yuxun/AAZ-8569-2021; Yi, Min/J-8963-2017	Ren, Yuxun/0000-0002-9598-932X; Yi, Min/0000-0001-8662-6546				Ahn SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063510; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Burdette-Radoux S, 2009, CLIN BREAST CANCER, V9, pS37, DOI 10.3816/CBC.2009.s.004; Burstein HJ, 2010, J ONCOL PRACT, V6, P243, DOI 10.1200/JOP.000082; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Buzdar A, 2006, LANCET ONCOL, V7, P633, DOI 10.1016/S1470-2045(06)70767-7; Chlebowski RT, 2006, ONCOLOGY-BASEL, V71, P1, DOI 10.1159/000100444; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Day R, 1999, J CLIN ONCOL, V17, P2659, DOI 10.1200/JCO.1999.17.9.2659; Fisher B, 2001, JNCI-J NATL CANCER I, V93, P684, DOI 10.1093/jnci/93.9.684; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Freidlin B, 2013, J CLIN ONCOL, V31, P3158, DOI 10.1200/JCO.2012.48.3826; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Hadji P, 2014, ANN ONCOL, V25, P372, DOI 10.1093/annonc/mdt513; Hadji P, 2013, ANN ONCOL, V24, P1505, DOI 10.1093/annonc/mds653; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Jatoi I, 2011, J CLIN ONCOL, V29, P2301, DOI 10.1200/JCO.2010.32.3550; Malvezzi M, 2013, ANN ONCOL, V24, P792, DOI 10.1093/annonc/mdt010; Myrick ME, 2012, ACTA ONCOL, V51, P247, DOI 10.3109/0284186X.2011.619567; NEVEN P, 2014, BREAST; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Stephan P, 2012, COMPARE COST EFFECTI; Yu KD, 2012, J CLIN ENDOCR METAB, V97, pE2201, DOI 10.1210/jc.2012-2423	25	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110281	10.1371/journal.pone.0110281	http://dx.doi.org/10.1371/journal.pone.0110281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333877	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200030
J	Wilke, M				Wilke, Marko			Isolated Assessment of Translation or Rotation Severely Underestimates the Effects of Subject Motion in fMRI Data	PLOS ONE			English	Article							SPATIAL NORMALIZATION; HEAD MOTION; HUMAN BRAIN; CHILDREN; MRI; REGISTRATION; ACTIVATION; IMAGES; NOISE	Subject motion has long since been known to be a major confound in functional MRI studies of the human brain. For resting-state functional MRI in particular, data corruption due to motion artefacts has been shown to be most relevant. However, despite 6 parameters (3 for translations and 3 for rotations) being required to fully describe the head's motion trajectory between timepoints, not all are routinely used to assess subject motion. Using structural (n = 964) as well as functional MRI (n = 200) data from public repositories, a series of experiments was performed to assess the impact of using a reduced parameter set (translationonly and rotationonly) versus using the complete parameter set. It could be shown that the usage of 65 mm as an indicator of the average cortical distance is a valid approximation in adults, although care must be taken when comparing children and adults using the same measure. The effect of using slightly smaller or larger values is minimal. Further, both translationonly and rotationonly severely underestimate the full extent of subject motion; consequently, both translationonly and rotationonly discard substantially fewer datapoints when used for quality control purposes ("motion scrubbing''). Finally, both translationonly and rotationonly severely underperform in predicting the full extent of the signal changes and the overall variance explained by motion in functional MRI data. These results suggest that a comprehensive measure, taking into account all available parameters, should be used to characterize subject motion in fMRI.	[Wilke, Marko] Univ Tubingen, Childrens Hosp, Dept Pediat Neurol & Dev Med, Tubingen, Germany; [Wilke, Marko] Univ Hosp, Expt Pediat Neuroimaging Grp, Tubingen, Germany; [Wilke, Marko] Univ Hosp, Pediat Neurol & Dept Neuroradiol, Tubingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Wilke, M (corresponding author), Univ Tubingen, Childrens Hosp, Dept Pediat Neurol & Dev Med, Tubingen, Germany.	marko.wilke@med.uni-tuebingen.de			German Research Council (DFG) [WI3630/1-2]; H.W. & J. Hector Foundation, Mannheim [M66]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD023343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [N01MH090002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [N01NS092317, N01NS092315, N01NS092314, N01NS092319, N01NS092316, N01NS092320] Funding Source: NIH RePORTER	German Research Council (DFG)(German Research Foundation (DFG)); H.W. & J. Hector Foundation, Mannheim; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded in part by the German Research Council (DFG, WI3630/1-2) as well as the H.W. & J. Hector Foundation, Mannheim (M66). Neither sponsor had any role in study design, in the collection, analysis and interpretation of data, in the writing of the report, or in the decision to submit the article for publication.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; [Anonymous], 2014, ARTREPAIR SOFTW; [Anonymous], 2014, 1000 FUNCT CONN PROJ; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J., 2003, HUMAN BRAIN FUNCTION; Ball WS, 2012, CEREB CORTEX, V22, P1, DOI 10.1093/cercor/bhr018; Besle J, 2013, J NEUROPHYSIOL, V109, P2293, DOI 10.1152/jn.00499.2012; Biomedical Image Analysis Group, 2014, 91 INF EXTRACTION IM; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brown TT, 2010, NEUROIMAGE, V53, P139, DOI 10.1016/j.neuroimage.2010.06.017; Carr VA, 2013, NEUROPSYCHOLOGIA, V51, P1829, DOI 10.1016/j.neuropsychologia.2013.06.026; Churchill NW, 2012, HUM BRAIN MAPP, V33, P609, DOI 10.1002/hbm.21238; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Drobnjak I, 2006, MAGN RESON MED, V56, P364, DOI 10.1002/mrm.20939; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Grootoonk S, 2000, NEUROIMAGE, V11, P49, DOI 10.1006/nimg.1999.0515; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Lee CC, 1998, MAGN RESON MED, V39, P234, DOI 10.1002/mrm.1910390210; Lemieux L, 2007, MAGN RESON IMAGING, V25, P894, DOI 10.1016/j.mri.2007.03.009; Liu TT, 2001, NEUROIMAGE, V13, P759, DOI 10.1006/nimg.2000.0728; Loktyushin A, 2013, MAGN RESON MED, V70, P1608, DOI 10.1002/mrm.24615; Lund TE, 2005, NEUROIMAGE, V26, P960, DOI 10.1016/j.neuroimage.2005.02.021; Magnotta VA, 1999, CEREB CORTEX, V9, P151, DOI 10.1093/cercor/9.2.151; Mazaika PK, 2011, HBM C QUEB CIT; Morgan VL, 2007, COMPUT MED IMAG GRAP, V31, P436, DOI 10.1016/j.compmedimag.2007.04.002; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Nemani AK, 2009, NEUROIMAGE, V47, P1417, DOI 10.1016/j.neuroimage.2009.05.018; Oakes TR, 2005, NEUROIMAGE, V28, P529, DOI 10.1016/j.neuroimage.2005.05.058; Pernet CR, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00606; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rettmann ME, 2006, CEREB CORTEX, V16, P1584, DOI 10.1093/cercor/bhj095; Schulz J, 2014, NEUROIMAGE, V84, P124, DOI 10.1016/j.neuroimage.2013.08.006; Siegel JS, 2014, HUM BRAIN MAPP, V35, P1981, DOI 10.1002/hbm.22307; Unser M, 1999, IEEE SIGNAL PROC MAG, V16, P22, DOI 10.1109/79.799930; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vannest J, 2010, NEUROPEDIATRICS, V41, P235, DOI 10.1055/s-0030-1267982; Vannucci RC, 2011, NEUROIMAGE, V56, P1855, DOI 10.1016/j.neuroimage.2011.03.044; White T, 2010, BRAIN COGNITION, V72, P36, DOI 10.1016/j.bandc.2009.10.009; Wilke M, 2005, NEUROREPORT, V16, P915, DOI 10.1097/00001756-200506210-00008; Wilke M, 2003, MAGN RESON MED, V50, P749, DOI 10.1002/mrm.10606; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Wilke M, 2007, EXP BRAIN RES, V178, P296, DOI 10.1007/s00221-006-0732-z; Wilke M, 2014, HUM BRAIN MAPP, V35, P3199, DOI 10.1002/hbm.22395; Wilke M, 2012, NEUROIMAGE, V59, P2062, DOI 10.1016/j.neuroimage.2011.10.043; Yuan WH, 2009, HUM BRAIN MAPP, V30, P1481, DOI 10.1002/hbm.20616; Ziegler G, 2012, HUM BRAIN MAPP, V33, P2377, DOI 10.1002/hbm.21374	56	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e106498	10.1371/journal.pone.0106498	http://dx.doi.org/10.1371/journal.pone.0106498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333359	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200002
J	Dai, C; Liu, WX; Jiang, M; Sun, MJ				Dai, Cong; Liu, Wei-Xin; Jiang, Min; Sun, Ming-Jun			Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients with IBD after Discontinuation of One-Year Infliximab Therapy	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; ULCERATIVE-COLITIS; MAINTENANCE THERAPY; EPISODIC TREATMENT; SINGLE-CENTER; STRATEGIES; COHORT; TRIAL; SCORE	Aim: To assess the endoscopic activity and Clinical activity after a one-year period of infliximab therapy and to evaluate the association between mucosal healing and need for retreatment after stopping infliximab in patients with Inflammatory bowel disease (IBD). Methods: The data from 109 patients with Crohn's disease (CD) and 107 patients with Ulcerative colitis (UC) received one-year infliximab were assessed. The primary endpoint of the study was the proportion of clinical remission, mucosal healing and full remission in IBD after the one-year period of maintenance infliximab therapy. The secondary endpoint was the frequency of relapses in the next year. Results: A total of 84.4% (92/109) CD patients and 81.3% (87/107) UC patients achieved clinical remission, 71.56% (78/109) of CD patients and 69.16% (74/107) of UC patients achieved mucosal healing, 56.88% (62/109) of CD patients and 54.21% (58/107) of UC patients achieved full remission at the end of the year of infliximab therapy. Infliximab therapy was restarted in the 10.19% (22/216) patients (13 CD, 9 UC) who achieved mucosal healing, and 13.89% (30/216) patients (18 CD, 12 UC) who achieved clinical remission and 6.48% (14/216) patients (8 CD, 6 UC) who achieved full remission had to be retreated within the next year. Neither clinical remission nor mucosal healing was associated with the time to restarting Infliximab therapy in IBD. Conclusion: Mucosal healing did not predict sustained clinical remission in patients with IBD in whom the infliximab therapies had been stopped. And stopping or continuing infliximab therapy may be determined by assessing the IBD patient's general condition and the clinical activity.	[Dai, Cong; Liu, Wei-Xin; Jiang, Min; Sun, Ming-Jun] China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning, Peoples R China	China Medical University	Sun, MJ (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning, Peoples R China.	273159833@qq.com						Ananthakrishnan AN, 2013, INFLAMM BOWEL DIS, V19, P37, DOI [10.1002/ibd.22951, 10.1097/MIB.0b013e3182902ad9]; Armuzzi A, 2012, J CROHNS COLITIS, V6, P492, DOI 10.1016/j.crohns.2011.12.016; Baert F, 2010, GASTROENTEROLOGY, V138, P463, DOI 10.1053/j.gastro.2009.09.056; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; Dave Maneesh, 2012, Gastroenterol Hepatol (N Y), V8, P29; de Chambrun GP, 2010, NAT REV GASTRO HEPAT, V7, P15, DOI 10.1038/nrgastro.2009.203; Freeman HJ, 2010, WORLD J GASTROENTERO, V16, P15, DOI 10.3748/wjg.v16.i1.15; Froslie KF, 2007, GASTROENTEROLOGY, V133, P412, DOI 10.1053/j.gastro.2007.05.051; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Laharie D, 2013, ALIMENT PHARM THER, V37, P998, DOI 10.1111/apt.12289; Louis E, 2012, GASTROENTEROLOGY, V142, P63, DOI 10.1053/j.gastro.2011.09.034; Mulder DJ, 2013, J CROHNS COLITIS; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P402, DOI 10.1053/j.gastro.2003.11.014; Rutgeerts P, 2006, GASTROINTEST ENDOSC, V63, P433, DOI 10.1016/j.gie.2005.08.011; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Rutgeerts P, 2007, GUT, V56, P453, DOI 10.1136/gut.2005.088732; Schnitzler F, 2009, GUT, V58, P492, DOI 10.1136/gut.2008.155812; Schnitzler F, 2009, INFLAMM BOWEL DIS, V15, P1295, DOI 10.1002/ibd.20927; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Speight RA, 2013, CLIN MED, V13, P378, DOI 10.7861/clinmedicine.13-4-378; Steenholdt C, 2012, SCAND J GASTROENTERO, V47, P518, DOI 10.3109/00365521.2012.660541; Wardle RA, 2014, EUR J GASTROEN HEPAT, V26, P1, DOI 10.1097/MEG.0b013e328365d21a; Ye LN, 2013, SCI WORLD J, DOI 10.1155/2013/296470	28	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110797	10.1371/journal.pone.0110797	http://dx.doi.org/10.1371/journal.pone.0110797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330148	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100098
J	Tsubaki, R; Kato, M				Tsubaki, Remi; Kato, Makoto			A Novel Filtering Mutualism between a Sponge Host and Its Endosymbiotic Bivalves	PLOS ONE			English	Article							DEMOSPONGIAE; CYCLE	Sponges, porous filter-feeding organisms consisting of vast canal systems, provide unique substrates for diverse symbiotic organisms. The Spongia (Spongia) sp. massive sponge is obligately inhabited by the host-specific endosymbiotic bivalve Vulsella vulsella, which benefits from this symbiosis by receiving protection from predators. However, whether the host sponge gains any benefit from this association is unclear. Considering that the bivalves exhale filtered water into the sponge body rather than the ambient environment, the sponge is hypothesized to utilize water exhaled by the bivalves to circulate water around its body more efficiently. We tested this hypothesis by observing the sponge aquiferous structure and comparing the pumping rates of sponges and bivalves. Observations of water currents and the sponge aquiferous structure revealed that the sponge had a unique canal system enabling it to inhale water exhaled from bivalves, indicating that the host sponge adapted morphologically to receive water from the bivalves. In addition, the volume of water circulating in the sponge body was dramatically increased by the water exhaled from bivalves. Therefore, this sponge-bivalve association can be regarded as a novel mutualism in which two filter-feeding symbionts promote mutual filtering rates. This symbiotic association should be called a "filtering mutualism".	[Tsubaki, Remi; Kato, Makoto] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan	Kyoto University	Tsubaki, R (corresponding author), Japan Agcy Marine Earth Sci & Technol, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	remi.tsubaki@gmail.com			Japan Society for Promotion of Science [10J05594, 22247003]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	RT received funding from Japan Society for Promotion of Science (grant number 10J05594). MK received funding from Japan Society for Promotion of Science (grant number 22247003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAVESTRELLO G, 1988, ZOOMORPHOLOGY, V108, P161, DOI 10.1007/BF00363932; FORBES MILTON L., 1964, BULL MAR SCI GULF CARIBBEAN, V14, P453; FORBES ML, 1966, B MAR SCI, V16, P273; Hadas E, 2008, J EXP BIOL, V211, P2185, DOI 10.1242/jeb.015420; Hanson CE, 2009, ESTUAR COAST SHELF S, V84, P289, DOI 10.1016/j.ecss.2009.05.019; Leys SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027787; Mendola D, 2007, BIOLOGY LETT, V3, P595, DOI 10.1098/rsbl.2007.0357; Morton B., 1989, Partnerships in the sea: Hong Kong's marine symbioses; Pile AJ, 1996, MAR ECOL PROG SER, V141, P95, DOI 10.3354/meps141095; Reid RGB, 1980, MALACOFAUNA HONG KON; Ribes M, 1999, MAR ECOL PROG SER, V176, P179, DOI 10.3354/meps176179; Roberts B, 1984, J MOLLUS STUD, V50, P129; Savazzi Enrico, 2001, Paleontological Research, V5, P55; Simpson T., 1984, CELL BIOL SPONGES; Tsubaki R, 2012, ZOOL SCI, V29, P585, DOI 10.2108/zsj.29.585; Ward JE, 2004, J EXP MAR BIOL ECOL, V300, P83, DOI 10.1016/j.jembe.2004.03.002; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019	18	10	10	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e108885	10.1371/journal.pone.0108885	http://dx.doi.org/10.1371/journal.pone.0108885			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330073	gold, Green Submitted, Green Published			2022-12-27	WOS:000343942100014
J	Khan, MGM; Jacques, JF; Beaudoin, J; Labbe, S				Khan, Md. Gulam Musawwir; Jacques, Jean-Francois; Beaudoin, Jude; Labbe, Simon			Characterization of the Nuclear Import Mechanism of the CCAAT-Regulatory Subunit Php4	PLOS ONE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; GLOBAL TRANSCRIPTIONAL RESPONSES; BINDING FACTOR PHP4; FISSION YEAST; LOCALIZATION SIGNAL; GENE-EXPRESSION; NUCLEOCYTOPLASMIC TRANSPORT; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; GLUTAREDOXIN GRX4	Php4 is a nucleo-cytoplasmic shuttling protein that accumulates in the nucleus during iron deficiency. When present in the nucleus, Php4 associates with the CCAAT-binding protein complex and represses genes encoding iron-using proteins. Here, we show that nuclear import of Php4 is independent of the other subunits of the CCAAT-binding complex. Php4 nuclear import relies on two functionally independent nuclear localization sequences (NLSs) that are located between amino acid residues 171 to 174 (KRIR) and 234 to 240 (KSVKRVR). Specific substitutions of basic amino acid residues to alanines within these sequences are sufficient to abrogate nuclear targeting of Php4. The two NLSs are biologically redundant and are sufficient to target a heterologous reporter protein to the nucleus. Under low-iron conditions, a functional GFP-Php4 protein is only partly targeted to the nucleus in imp1 Delta and sal3 Delta mutant cells. We further found that cells expressing a temperature-sensitive mutation in cut15 exhibit increased cytosolic accumulation of Php4 at the nonpermissive temperature. Further analysis by pull-down experiments revealed that Php4 is a cargo of the karyopherins Imp1, Cut15 and Sal3. Collectively, these results indicate that Php4 can be bound by distinct karyopherins, connecting it into more than one nuclear import pathway.	[Khan, Md. Gulam Musawwir; Jacques, Jean-Francois; Beaudoin, Jude; Labbe, Simon] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Labbe, S (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X; Khan, Md Gulam Musawwir/0000-0001-7424-580X	Natural Sciences and Engineering Research Council of Canada [MOP-238238-2010-15, MOP-396029-2010-DAS]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	M. G. M. K. was recipient of a Studentship from the Faculte de medecine et des sciences de la sante of the Universite de Sherbrooke. This study was supported by the Natural Sciences and Engineering Research Council of Canada (Grants MOP-238238-2010-15 and MOP-396029-2010-DAS to S. L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beaudoin J, 2007, EUKARYOT CELL, V6, P764, DOI 10.1128/EC.00002-07; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen XQ, 2004, YEAST, V21, P495, DOI 10.1002/yea.1115; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Fries T, 2007, J BIOL CHEM, V282, P19292, DOI 10.1074/jbc.M700217200; Gsaller F, 2014, EMBO J; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoelz A, 2004, NATURE, V432, P815, DOI 10.1038/432815a; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Jacques JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098959; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Jung WH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001209; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kronstad JW, 2013, CURR OPIN MICROBIOL, V16, P659, DOI 10.1016/j.mib.2013.08.009; Kudo N, 1999, J BIOL CHEM, V274, P15151, DOI 10.1074/jbc.274.21.15151; Kuersten S, 2001, TRENDS CELL BIOL, V11, P497, DOI 10.1016/S0962-8924(01)02144-4; Labbe S, 2007, BIOMETALS, V20, P523, DOI 10.1007/s10534-006-9056-5; Labbe S, 2013, CURR OPIN MICROBIOL, V16, P669, DOI 10.1016/j.mib.2013.07.007; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Mallet PL, 2013, TRAFFIC, V14, P282, DOI 10.1111/tra.12036; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Moreno MB, 2000, YEAST, V16, P861; Nikolaev I, 2003, EUKARYOT CELL, V2, P209, DOI 10.1128/EC.2.2.209-221.2003; Pelletier B, 2005, J BIOL CHEM, V280, P25146, DOI 10.1074/jbc.M502947200; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Rustici G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r73; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Saydam N, 2001, J BIOL CHEM, V276, P25487, DOI 10.1074/jbc.M009154200; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; Tasto JJ, 2001, YEAST, V18, P657, DOI 10.1002/yea.713; Ueta R, 2003, J BIOL CHEM, V278, P50120, DOI 10.1074/jbc.M305046200; Umeda M, 2005, GENETICS, V171, P7, DOI 10.1534/genetics.105.042598; Vachon P, 2012, EUKARYOT CELL, V11, P806, DOI 10.1128/EC.00060-12; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200	48	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110721	10.1371/journal.pone.0110721	http://dx.doi.org/10.1371/journal.pone.0110721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330182	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204100102
J	Moller, P; Overloper, A; Forstner, KU; Wen, TN; Sharma, CM; Lai, EM; Narberhaus, F				Moeller, Philip; Overloeper, Aaron; Foerstner, Konrad U.; Wen, Tuan-Nan; Sharma, Cynthia M.; Lai, Erh-Min; Narberhaus, Franz			Profound Impact of Hfq on Nutrient Acquisition, Metabolism and Motility in the Plant Pathogen Agrobacterium tumefaciens	PLOS ONE			English	Article							RNA CHAPERONE HFQ; ESCHERICHIA-COLI; MESSENGER-RNA; STRESS RESISTANCE; TRANSPORT-SYSTEMS; REGULATORY RNAS; GENE-EXPRESSION; BINDING; VIRULENCE; MELILOTI	As matchmaker between mRNA and sRNA interactions, the RNA chaperone Hfq plays a key role in riboregulation of many bacteria. Often, the global influence of Hfq on the transcriptome is reflected by substantially altered proteomes and pleiotropic phenotypes in hfq mutants. Using quantitative proteomics and co-immunoprecipitation combined with RNA-sequencing (RIP-seq) of Hfq-bound RNAs, we demonstrate the pervasive role of Hfq in nutrient acquisition, metabolism and motility of the plant pathogen Agrobacterium tumefaciens. 136 of 2544 proteins identified by iTRAQ (isobaric tags for relative and absolute quantitation) were affected in the absence of Hfq. Most of them were associated with ABC transporters, general metabolism and motility. RIP-seq of chromosomally encoded Hfq 3xFlag revealed 1697 mRNAs and 209 non-coding RNAs (ncRNAs) associated with Hfq. 56 ncRNAs were previously undescribed. Interestingly, 55% of the Hfq-bound ncRNAs were encoded antisense (as) to a protein-coding sequence suggesting that A. tumefaciens Hfq plays an important role in asRNA-target interactions. The exclusive enrichment of 296 mRNAs and 31 ncRNAs under virulence conditions further indicates a role for post-transcriptional regulation in A. tumefaciens-mediated plant infection. On the basis of the iTRAQ and RIP-seq data, we assembled a comprehensive model of the Hfq core regulon in A. tumefaciens.	[Moeller, Philip; Overloeper, Aaron; Narberhaus, Franz] Ruhr Univ Bochum, Bochum, Germany; [Foerstner, Konrad U.; Sharma, Cynthia M.] Julius Maximilians Univ Wurzburg, Res Ctr Infect Dis ZINF, Wurzburg, Germany; [Wen, Tuan-Nan; Lai, Erh-Min] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan	Ruhr University Bochum; University of Wurzburg; Academia Sinica - Taiwan	Narberhaus, F (corresponding author), Ruhr Univ Bochum, Univ Str 150, Bochum, Germany.	franz.narberhaus@rub.de	Sharma, Cynthia/D-2869-2013; Förstner, Konrad U./B-1531-2010; Lai, Erh-Min/ABG-9558-2020	Förstner, Konrad U./0000-0002-1481-2996; Lai, Erh-Min/0000-0003-3630-8683; Sharma, Cynthia Mira/0000-0002-2321-9705; Narberhaus, Franz/0000-0002-8552-5310	German Research Foundation (DFG priority program) [SPP 1258, NA 240/8-1]; Academia Sinica; German Academic Exchange Service (DAAD); Taiwan National Science Council [100-2911-I-001-053]	German Research Foundation (DFG priority program)(German Research Foundation (DFG)); Academia Sinica(Academia Sinica - Taiwan); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the German Research Foundation (DFG priority program SPP 1258; NA 240/8-1) to FN, a grant from Academia Sinica to EML, and a joint grant from the German Academic Exchange Service (DAAD) and the Taiwan National Science Council (100-2911-I-001-053) to FN and EML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonyushkin T, 2005, NUCLEIC ACIDS RES, V33, P1678, DOI 10.1093/nar/gki313; AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; AIBA H, 1981, J BIOL CHEM, V256, P1905; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Antal M, 2005, J BIOL CHEM, V280, P7901, DOI 10.1074/jbc.M413071200; Bandyra KJ, 2012, MOL CELL, V47, P943, DOI 10.1016/j.molcel.2012.07.015; Barra-Bily L, 2010, J BACTERIOL, V192, P1719, DOI 10.1128/JB.01429-09; Barra-Bily L, 2010, J BACTERIOL, V192, P1710, DOI 10.1128/JB.01427-09; Berghoff BA, 2011, MOL MICROBIOL, V80, P1479, DOI 10.1111/j.1365-2958.2011.07658.x; Bilusic I, 2014, RNA BIOL, V11, P641, DOI 10.4161/rna.29299; Bohn C, 2010, NUCLEIC ACIDS RES, V38, P6620, DOI 10.1093/nar/gkq462; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Costa ED, 2012, MOL MICROBIOL, V84, P807, DOI 10.1111/j.1365-2958.2012.08037.x; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cui MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071933; Dambach M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055156; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Folichon M, 2005, FEBS J, V272, P454, DOI 10.1111/j.1742-4658.2004.04485.x; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Franze de Fernandez M T, 1972, J Biol Chem, V247, P824; Gao MS, 2010, MOL PLANT MICROBE IN, V23, P355, DOI 10.1094/MPMI-23-4-0355; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gimpel M, 2010, MOL MICROBIOL, V76, P990, DOI 10.1111/j.1365-2958.2010.07158.x; GOTTESMAN S, 2010, COLD SPRING HARB PER; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hu YH, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-23; Kakoschke T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086113; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Katz C, 2008, J BACTERIOL, V190, P7117, DOI 10.1128/JB.00871-08; Klusener S, 2010, MOL GENET GENOMICS, V283, P575, DOI 10.1007/s00438-010-0542-7; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Lee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070720; Lee T, 2008, RNA, V14, P514, DOI 10.1261/rna.531408; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Lorenz C, 2010, NUCLEIC ACIDS RES, V38, P3794, DOI 10.1093/nar/gkq032; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Michaux C, 2014, INFECT IMMUN; Mohanty BK, 2004, MOL MICROBIOL, V54, P905, DOI 10.1111/j.1365-2958.2004.04337.x; Morimoto YV, 2014, MOL MICROBIOL, V91, P1214, DOI 10.1111/mmi.12529; Mulley G, 2011, MOL MICROBIOL, V80, P149, DOI 10.1111/j.1365-2958.2011.07565.x; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Olejniczak M, 2011, BIOCHEMISTRY-US, V50, P4427, DOI 10.1021/bi102043f; Overloper A, 2014, RNA BIOL, V11; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Robertson GT, 1999, MOL MICROBIOL, V34, P690, DOI 10.1046/j.1365-2958.1999.01629.x; Ross JA, 2013, RNA, V19, P670, DOI 10.1261/rna.037747.112; Saad NY, 2012, J BIOL CHEM, V287, P20382, DOI 10.1074/jbc.M111.332304; Saijo-Hamano Y, 2004, J MOL BIOL, V339, P423, DOI 10.1016/j.jmb.2004.03.070; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sambrook J., 2001, MOL CLONING LAB MANU; Saramago M, 2014, CURR OPIN MICROBIOL, V18, P105, DOI 10.1016/j.mib.2014.02.009; Sauer E, 2013, RNA BIOL, V10, P610, DOI 10.4161/rna.24201; Sauer E, 2012, P NATL ACAD SCI USA, V109, P9396, DOI 10.1073/pnas.1202521109; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schluter JP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-156; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; Schmidtke C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003626; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sittka A, 2009, RNA BIOL, V6, P266, DOI 10.4161/rna.6.3.8332; Sobrero P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048494; Sobrero P, 2011, ARCH MICROBIOL, V193, P629, DOI 10.1007/s00203-011-0701-1; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Torres-Quesada O, 2014, RNA BIOL, V11, P563, DOI 10.4161/rna.28239; Torres-Quesada O, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-71; Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x; Vecerek B, 2005, RNA, V11, P976, DOI 10.1261/rna.2360205; Viegas SC, 2011, NUCLEIC ACIDS RES, V39, P2918, DOI 10.1093/nar/gkq1239; Vitreschak AG, 2008, RNA, V14, P717, DOI 10.1261/rna.819308; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wagner EGH, 2013, RNA BIOL, V10, P619, DOI 10.4161/rna.24044; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wilf NM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-822; Wilms I, 2012, J BACTERIOL, V194, P5209, DOI 10.1128/JB.00510-12; Wilms I, 2012, RNA BIOL, V9, P446, DOI 10.4161/rna.17212; Wilms I, 2011, MOL MICROBIOL, V80, P492, DOI 10.1111/j.1365-2958.2011.07589.x; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Worrall JAR, 2008, J MOL BIOL, V382, P870, DOI 10.1016/j.jmb.2008.07.059; Zeng Q, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-414; Zeng Q, 2013, J BACTERIOL, V195, P1706, DOI 10.1128/JB.02056-12; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3	90	22	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110427	10.1371/journal.pone.0110427	http://dx.doi.org/10.1371/journal.pone.0110427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330313	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100074
J	Nam, S; Ryu, H; Son, WJ; Kim, YH; Kim, KT; Balch, C; Nephew, KP; Lee, J				Nam, Seungyoon; Ryu, Hyojung; Son, Won-Joon; Kim, Yon Hui; Kim, Kyung Tae; Balch, Curt; Nephew, Kenneth P.; Lee, Jinhyuk			Mg2+ Effect on Argonaute and RNA Duplex by Molecular Dynamics and Bioinformatics Implications	PLOS ONE			English	Article							INDUCED SILENCING COMPLEX; CRYSTAL-STRUCTURE; AEOLICUS ARGONAUTE; MICRORNA; DNA; FLEXIBILITY; MAGNESIUM; PROSPECTS; CLEAVAGE; INSIGHTS	RNA interference (RNAi), mediated by small non-coding RNAs (e.g., miRNAs, siRNAs), influences diverse cellular functions. Highly complementary miRNA-target RNA (or siRNA-target RNA) duplexes are recognized by an Argonaute family protein (Ago2), and recent observations indicate that the concentration of Mg2+ ions influences miRNA targeting of specific mRNAs, thereby modulating miRNA-mRNA networks. In the present report, we studied the thermodynamic effects of differential [Mg2+] on slicing (RNA silencing cycle) through molecular dynamics simulation analysis, and its subsequent statistical analysis. Those analyses revealed different structural conformations of the RNA duplex in Ago2, depending on Mg2+ concentration. We also demonstrate that cation effects on Ago2 structural flexibility are critical to its catalytic/functional activity, with low [Mg2+] favoring greater Ago2 flexibility (e.g., greater entropy) and less miRNA/mRNA duplex stability, thus favoring slicing. The latter finding was supported by a negative correlation between expression of an Mg2+ influx channel, TRPM7, and one miRNA's (miR-378) ability to downregulate its mRNA target, TMEM245. These results imply that thermodynamics could be applied to siRNA-based therapeutic strategies, using highly complementary binding targets, because Ago2 is also involved in RNAi slicing by exogenous siRNAs. However, the efficacy of a siRNA-based approach will differ, to some extent, based on the Mg2+ concentration even within the same disease type; therefore, different siRNA-based approaches might be considered for patient-to-patient needs.	[Nam, Seungyoon] Natl Canc Ctr, Canc Genom Branch, Goyang, Kyunggi Do, South Korea; [Ryu, Hyojung; Lee, Jinhyuk] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr KOBIC, Taejon, South Korea; [Ryu, Hyojung; Lee, Jinhyuk] Univ Sci & Technol, Dept Bioinformat, Taejon, South Korea; [Son, Won-Joon] N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA; [Kim, Yon Hui] Natl Canc Ctr, Next Therapeut Branch, Goyang, Kyunggi Do, South Korea; [Kim, Kyung Tae] Natl Canc Ctr, Mol Epidemiol Branch, Goyang, Kyunggi Do, South Korea; [Balch, Curt] Biosci Advising, Indianapolis, IN USA; [Nephew, Kenneth P.] Indiana Univ Sch Med, Med Sci Program, Bloomington, IN USA	National Cancer Center - Korea (NCC); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of North Carolina; North Carolina State University; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Indiana University System; Indiana University Bloomington	Lee, J (corresponding author), Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr KOBIC, Taejon, South Korea.	jinhyuk@kribb.re.kr	Son, Won-Joon/F-7189-2011	Son, Won-Joon/0000-0003-4087-4661	National Cancer Center, Korea [NCC-1210460]; Korean Research Institute of Bioscience and Biotechnology Research Initiative Program; Korean Ministry of Education, Science and Technology (MEST) [2012R1A1A2002676]; Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2013M3C1A3064780]	National Cancer Center, Korea; Korean Research Institute of Bioscience and Biotechnology Research Initiative Program; Korean Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea)	The National Cancer Center, Korea [grant number NCC-1210460 to SN]; the Korean Research Institute of Bioscience and Biotechnology Research Initiative Program [to JL]; The Korean Ministry of Education, Science and Technology (MEST) [grant number 2012R1A1A2002676 to JL]; The Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning [grant number 2013M3C1A3064780 to JL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2007, ADV DRUG DELIVER REV, V59, P75, DOI 10.1016/j.addr.2007.03.005; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Baldoli E, 2012, ANGIOGENESIS, V15, P47, DOI 10.1007/s10456-011-9242-0; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011161; Chen SJ, 2008, ANNU REV BIOPHYS, V37, P197, DOI 10.1146/annurev.biophys.37.032807.125957; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; Dong MD, 2009, NAT NANOTECHNOL, V4, P514, DOI [10.1038/NNANO.2009.156, 10.1038/nnano.2009.156]; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Fields PA, 2001, COMP BIOCHEM PHYS A, V129, P417, DOI 10.1016/S1095-6433(00)00359-7; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kutner MH, 2005, APPL LINEAR STAT MOD, Vxxviii; Kwon C, 2014, BIOCHEM BIOPH RES CO, V446, P218, DOI 10.1016/j.bbrc.2014.02.112; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Ma Z, 2012, J MOL MODEL, V18, P3769, DOI 10.1007/s00894-012-1377-4; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Nam S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-732; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; Parker James S, 2010, Silence, V1, P3, DOI 10.1186/1758-907X-1-3; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; Rao DD, 2013, DISCOV MED, V15, P101; Rashid UJ, 2007, J BIOL CHEM, V282, P13824, DOI 10.1074/jbc.M608619200; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Sasaki HM, 2012, NAT STRUCT MOL BIOL, V19, P657, DOI 10.1038/nsmb.2302; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wolf FI, 2010, CELL CYCLE, V9, P3399, DOI 10.4161/cc.9.17.13072; Wu HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028580; Xie CQ, 2011, VITAM HORM, V87, P321, DOI 10.1016/B978-0-12-386015-6.00034-2; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	50	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109745	10.1371/journal.pone.0109745	http://dx.doi.org/10.1371/journal.pone.0109745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330448	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100024
J	Yu, FQ; Ye, R; Sun, SY; Carretie, L; Zhang, L; Dong, Y; Zhu, CY; Luo, YJ; Wang, K				Yu, Fengqiong; Ye, Rong; Sun, Shiyue; Carretie, Luis; Zhang, Lei; Dong, Yi; Zhu, Chunyan; Luo, Yuejia; Wang, Kai			Dissociation of Neural Substrates of Response Inhibition to Negative Information between Implicit and Explicit Facial Go/Nogo Tasks: Evidence from an Electrophysiological Study	PLOS ONE			English	Article							INFERIOR FRONTAL-CORTEX; BORDERLINE PERSONALITY-DISORDER; AUTISM SPECTRUM DISORDER; EVENT-RELATED POTENTIALS; EMOTION REGULATION; COGNITIVE CONTROL; MAJOR DEPRESSION; TIME-COURSE; PREFRONTAL CORTEX; INVOLUNTARY ATTENTION	Background: Although ample evidence suggests that emotion and response inhibition are interrelated at the behavioral and neural levels, neural substrates of response inhibition to negative facial information remain unclear. Thus we used event-related potential (ERP) methods to explore the effects of explicit and implicit facial expression processing in response inhibition. Methods: We used implicit (gender categorization) and explicit emotional Go/Nogo tasks (emotion categorization) in which neutral and sad faces were presented. Electrophysiological markers at the scalp and the voxel level were analyzed during the two tasks. Results: We detected a task, emotion and trial type interaction effect in the Nogo-P3 stage. Larger Nogo-P3 amplitudes during sad conditions versus neutral conditions were detected with explicit tasks. However, the amplitude differences between the two conditions were not significant for implicit tasks. Source analyses on P3 component revealed that right inferior frontal junction (rIFJ) was involved during this stage. The current source density (CSD) of rIFJ was higher with sad conditions compared to neutral conditions for explicit tasks, rather than for implicit tasks. Conclusions: The findings indicated that response inhibition was modulated by sad facial information at the action inhibition stage when facial expressions were processed explicitly rather than implicitly. The rIFJ may be a key brain region in emotion regulation.	[Yu, Fengqiong; Ye, Rong; Zhang, Lei; Zhu, Chunyan; Wang, Kai] Anhui Med Univ, Dept Med Psychol, Lab Cognit Neuropsychol, Hefei, Peoples R China; [Sun, Shiyue] Beijing Forestry Univ, Sch Humanities & Social Sci, Beijing, Peoples R China; [Carretie, Luis] Univ Autonoma Madrid, Fac Psychol, Madrid, Spain; [Wang, Kai] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Peoples R China; [Dong, Yi] Anhui Mental Hlth Ctr, Hefei, Peoples R China; [Luo, Yuejia] Shenzhen Univ, Inst Social & Affect Neurosci, Shenzhen, Peoples R China	Anhui Medical University; Beijing Forestry University; Autonomous University of Madrid; Anhui Medical University; Shenzhen University	Wang, K (corresponding author), Anhui Med Univ, Dept Med Psychol, Lab Cognit Neuropsychol, Hefei, Peoples R China.	wangkai1964@126.com	Carretié, Luis/B-7290-2008	Carretié, Luis/0000-0001-7375-6739; Ye, Rong/0000-0003-2529-7755	National Natural Science Foundation of China [31000503, 91232717, 31100812, 81301176, 81300944]; Ministry of Science and Technology [2011CB707805]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by the National Natural Science Foundation of China (31000503, 91232717, 31100812, 81301176, and 81300944) and the Ministry of Science and Technology (2011CB707805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2002, NEUROIMAGE, V16, P1052, DOI 10.1006/nimg.2002.1142; Albert J, 2012, HUM BRAIN MAPP, V33, P2147, DOI 10.1002/hbm.21347; Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Berkman ET, 2009, NEUROIMAGE, V47, P705, DOI 10.1016/j.neuroimage.2009.04.084; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Brassen S, 2010, NEUROIMAGE, V50, P545, DOI 10.1016/j.neuroimage.2009.12.073; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Carretie L, 2004, BRAIN TOPOGR, V17, P109, DOI 10.1007/s10548-004-1008-1; Chen CH, 2006, BIOL PSYCHIAT, V59, P31, DOI 10.1016/j.biopsych.2005.06.008; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Chiu PH, 2008, NEUROIMAGE, V42, P988, DOI 10.1016/j.neuroimage.2008.04.248; Cliff N., 1987, ANAL MULTIVARIATE DA; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.3.CO;2-Q; Dai Q, 2011, PSYCHIAT RES, V190, P206, DOI 10.1016/j.psychres.2011.05.007; Derrfuss J, 2009, HUM BRAIN MAPP, V30, P299, DOI 10.1002/hbm.20501; Dien J, 2005, CLIN NEUROPHYSIOL, V116, P1808, DOI 10.1016/j.clinph.2004.11.025; Dien J, 2010, PSYCHOPHYSIOLOGY, V47, P170, DOI 10.1111/j.1469-8986.2009.00885.x; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Dillon DG, 2007, APPL PREV PSYCHOL, V12, P99, DOI 10.1016/j.appsy.2007.09.004; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Duerden EG, 2013, BRAIN RES, V1533, P80, DOI 10.1016/j.brainres.2013.08.021; Dziobek I, 2011, NEUROIMAGE, V57, P539, DOI 10.1016/j.neuroimage.2011.05.005; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Frewen PA, 2006, ANN NY ACAD SCI, V1071, P110, DOI 10.1196/annals.1364.010; Gehricke JG, 2000, PSYCHIAT RES, V95, P157, DOI 10.1016/S0165-1781(00)00168-2; Gerber AJ, 2008, NEUROPSYCHOLOGIA, V46, P2129, DOI 10.1016/j.neuropsychologia.2008.02.032; Goldstein M, 2007, NEUROIMAGE, V36, P1026, DOI 10.1016/j.neuroimage.2007.01.056; Gorno-Tempini ML, 2001, NEUROIMAGE, V14, P465, DOI 10.1006/nimg.2001.0811; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hare TA, 2005, BIOL PSYCHIAT, V57, P624, DOI 10.1016/j.biopsych.2004.12.038; Henry JD, 2007, SCHIZOPHR RES, V95, P197, DOI 10.1016/j.schres.2007.06.002; Holmes AJ, 2008, NEUROPSYCHOLOGIA, V46, P2904, DOI 10.1016/j.neuropsychologia.2008.05.028; Hummer TA, 2013, BIOL PSYCHIAT, V73, P136, DOI 10.1016/j.biopsych.2012.06.036; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kahkonen S, 2002, CLIN NEUROPHYSIOL, V113, P1894, DOI 10.1016/S1388-2457(02)00305-X; Kayser J, 2003, CLIN NEUROPHYSIOL, V114, P2307, DOI 10.1016/S1388-2457(03)00241-4; Kiss M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.013.2008; Kobeleva X, 2014, PSYCHIAT RES, V218, P134, DOI 10.1016/j.psychres.2014.04.027; Korb S, 2010, BIOL PSYCHOL, V85, P347, DOI 10.1016/j.biopsycho.2010.07.012; Kret ME, 2011, NEUROPSYCHOLOGIA, V49, P1187, DOI 10.1016/j.neuropsychologia.2011.02.007; Krombholz A, 2007, BIOL PSYCHOL, V76, P156, DOI 10.1016/j.biopsycho.2007.07.004; Kropotov JD, 2011, NEUROIMAGE, V57, P565, DOI 10.1016/j.neuroimage.2011.04.060; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Linden SC, 2010, NEUROPSYCHOLOGIA, V48, P997, DOI 10.1016/j.neuropsychologia.2009.11.023; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Mazefsky CA, 2013, J AM ACAD CHILD PSY, V52, P679, DOI 10.1016/j.jaac.2013.05.006; McRae K, 2010, J COGNITIVE NEUROSCI, V22, P248, DOI 10.1162/jocn.2009.21243; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ocklenburg S, 2011, NEUROIMAGE, V55, P1771, DOI 10.1016/j.neuroimage.2011.01.035; Padmala S, 2010, NEUROPSYCHOLOGIA, V48, P558, DOI 10.1016/j.neuropsychologia.2009.10.017; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pessoa L, 2010, FRONT HUM NEUROSCI, V4; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Piguet C, 2013, NEUROIMAGE, V82, P489, DOI 10.1016/j.neuroimage.2013.06.015; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pizzagalli DA, 2004, MOL PSYCHIATR, V9, P393, DOI 10.1038/sj.mp.4001469; Rellecke J, 2012, BIOL PSYCHOL, V90, P23, DOI 10.1016/j.biopsycho.2012.02.002; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; Schroeter ML, 2012, BRAIN, V135, P201, DOI 10.1093/brain/awr311; Schulz KP, 2014, NEUROIMAGE-CLIN, V5, P1, DOI 10.1016/j.nicl.2014.05.016; Sehlmeyer C, 2010, NEUROPSYCHOLOGIA, V48, P2488, DOI 10.1016/j.neuropsychologia.2010.04.022; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shafritz KM, 2006, NEUROIMAGE, V31, P468, DOI 10.1016/j.neuroimage.2005.11.053; Silbersweig D, 1988, STAI MANUAL STATE TR; TAYLOR GJ, 1991, PSYCHOSOMATICS, V32, P153, DOI 10.1016/S0033-3182(91)72086-0; Taylor SF, 2003, NEUROIMAGE, V18, P650, DOI 10.1016/S1053-8119(02)00051-4; TERMINE NT, 1988, DEV PSYCHOL, V24, P223, DOI 10.1037/0012-1649.24.2.223; Todd RM, 2008, NEUROPSYCHOLOGIA, V46, P595, DOI 10.1016/j.neuropsychologia.2007.10.011; Valdes-Conroy B, 2014, INT J PSYCHOPHYSIOL, V92, P59, DOI 10.1016/j.ijpsycho.2014.02.005; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wessel JR, 2013, J NEUROSCI, V33, P19611, DOI 10.1523/JNEUROSCI.3468-13.2013; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3; Yu FQ, 2009, NEUROREPORT, V20, P25, DOI 10.1097/WNR.0b013e32831ac9b1; Yuan JJ, 2008, PSYCHOPHYSIOLOGY, V45, P986, DOI 10.1111/j.1469-8986.2008.00693.x; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773; Zhang WH, 2012, BIOL PSYCHOL, V89, P444, DOI 10.1016/j.biopsycho.2011.12.011	87	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109839	10.1371/journal.pone.0109839	http://dx.doi.org/10.1371/journal.pone.0109839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9XC	25330212	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800043
J	Menaca, A; Tagbor, H; Adjei, R; Bart-Plange, C; Collymore, Y; Ba-Nguz, A; Mertes, K; Bingham, A				Menaca, Arantza; Tagbor, Harry; Adjei, Rose; Bart-Plange, Constance; Collymore, Yvette; Ba-Nguz, Antoinette; Mertes, Kelsey; Bingham, Allison			Factors Likely to Affect Community Acceptance of a Malaria Vaccine in Two Districts of Ghana: A Qualitative Study	PLOS ONE			English	Article							INTERMITTENT PREVENTIVE TREATMENT; IMMUNIZATION; DELIVERY; VACCINATIONS; AFRICA; SYSTEM	Malaria is a leading cause of morbidity and mortality among children in Ghana. As part of the effort to inform local and national decision-making in preparation for possible malaria vaccine introduction, this qualitative study explored community-level factors that could affect vaccine acceptance in Ghana and provides recommendations for a health communications strategy. The study was conducted in two purposively selected districts: the Ashanti and Upper East Regions. A total of 25 focus group discussions, 107 in-depth interviews, and 21 semi-structured observations at Child Welfare Clinics were conducted. Malaria was acknowledged to be one of the most common health problems among children. While mosquitoes were linked to the cause and bed nets were considered to be the main preventive method, participants acknowledged that no single measure prevented malaria. The communities highly valued vaccines and cited vaccination as the main motivation for taking children to Child Welfare Clinics. Nevertheless, knowledge of specific vaccines and what they do was limited. While communities accepted the idea of minor vaccine side effects, other side effects perceived to be more serious could deter families from taking children for vaccination, especially during vaccination campaigns. Attendance at Child Welfare Clinics after age nine months was limited. Observations at clinics revealed that while two different opportunities for counseling were offered, little attention was given to addressing mothers' specific concerns and to answering questions related to child immunization. Positive community attitudes toward vaccines and the understanding that malaria prevention requires a comprehensive approach would support the introduction of a malaria vaccine. These attitudes are bolstered by a well-established child welfare program and the availability in Ghana of active, flexible structures for conveying health information to communities. At the same time, it would be important to improve the quality of Child Welfare Clinic services, particularly in relation to communication around vaccination.	[Menaca, Arantza] Univ Complutense Madrid, Dept Antropol Social, Madrid, Spain; [Tagbor, Harry; Adjei, Rose] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Community Hlth, Malaria Pregnancy Grp, Kumasi, Ghana; [Bart-Plange, Constance] Ghana Hlth Serv, Natl Malaria Control Programme, Accra, Ghana; [Collymore, Yvette; Mertes, Kelsey] PATH Malaria Vaccine Initiat, Washington, DC USA; [Ba-Nguz, Antoinette] PATH Malaria Vaccine Initiat, Nairobi, Kenya; [Bingham, Allison] PATH Kenya, Kisumu, Kenya	Complutense University of Madrid; Kwame Nkrumah University Science & Technology; Ghana Health Service	Menaca, A (corresponding author), Univ Complutense Madrid, Dept Antropol Social, Madrid, Spain.	arantzamenaca@gmail.com	Tagbor, Harry/B-9312-2018	Tagbor, Harry/0000-0002-9300-665X	PATH Malaria Vaccine Initiative (MVI), Washington, DC; Bill & Melinda Gates Foundation; ExxonMobil Foundation	PATH Malaria Vaccine Initiative (MVI), Washington, DC; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); ExxonMobil Foundation(Exxon Mobil Corporation)	This work was funded by the PATH Malaria Vaccine Initiative (MVI), Washington, DC, with support from the Bill & Melinda Gates Foundation and the ExxonMobil Foundation. MVI had a role in overall project management and in writing of the manuscript and decision to publish. The views expressed herein do not necessarily reflect the views of PATH or its funders.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Ahorlu CK, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-47; Andrus JK, 2008, VACCINE, V26, pL80, DOI 10.1016/j.vaccine.2008.05.040; [Anonymous], LYMPH FIL EL LFE; [Anonymous], MAPP MAL RISK AFR; [Anonymous], 2012, INT J TROPICAL DIS H; [Anonymous], GHAN MULT IND CLUST; [Anonymous], GHAN POP HOUS CENS 2; [Anonymous], 2013, MAL VACC TECHN ROADM; [Anonymous], 2005, MED ANTHR UNDERSTAND; [Anonymous], 2012, DIS REL EM FUND DREF; [Anonymous], GLOB HLTH P IN PRESS; [Anonymous], STRAT PLAN MAL CONTR; [Anonymous], MASS CAMP VACC NEARL; [Anonymous], 2005, VACC INTR GUID; [Anonymous], EXP PROGR IMM UPC EV; Bernard HR, 2011, RES METHODS ANTHR; Bingham A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-394; Browne ENL, 2002, ANN TROP MED PARASIT, V96, P93, DOI 10.1179/000349802125000556; Chandramohan D, 2007, TROP MED INT HEALTH, V12, P743, DOI 10.1111/j.1365-3156.2007.01844.x; Cockcroft A, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S4; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Febir LG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-156; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro., 2009, GHAN DEM HLTH SURV 2; Gysels M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-191; Jheeta M, 2008, B WORLD HEALTH ORGAN, V86, P419, DOI 10.2471/BLT.07.047159; Menaca A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-257; Muela SH, 2002, SOC SCI MED, V55, P403; Musoke D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-327; NICHTER M, 1995, SOC SCI MED, V41, P617, DOI 10.1016/0277-9536(95)00034-5; Ojakaa D, 2011, HUM VACCINES, V7, P1096, DOI 10.4161/hv.7.10.17496; Ojakaa DI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-147; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Pitt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032900; Pool R, 2006, TROP MED INT HEALTH, V11, P1670, DOI 10.1111/j.1365-3156.2006.01725.x; Sarpong N, 2010, TROP MED INT HEALTH, V15, P191, DOI 10.1111/j.1365-3156.2009.02439.x; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-18; Stanton BF, 2004, J HEALTH POPUL NUTR, V22, P286; Streefland P, 1999, SOC SCI MED, V49, P1705, DOI 10.1016/S0277-9536(99)00239-7; Streefland PH, 1999, B WORLD HEALTH ORGAN, V77, P722; Tolhurst R, 2006, T ROY SOC TROP MED H, V100, P321, DOI 10.1016/j.trstmh.2005.05.004; Tolhurst R, 2008, SOC SCI MED, V66, P1106, DOI 10.1016/j.socscimed.2007.11.032; Webster J, 2005, LANCET INFECT DIS, V5, P709, DOI 10.1016/S1473-3099(05)70269-3; WHO, 2012, WORLD MALARIA REPORT 2012, P1	45	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109707	10.1371/journal.pone.0109707	http://dx.doi.org/10.1371/journal.pone.0109707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25334094	gold, Green Submitted, Green Published			2022-12-27	WOS:000346766200048
J	Guan, J; Miah, SMS; Wilson, ZS; Erick, TK; Banh, C; Brossay, L				Guan, Jean; Miah, S. M. Shahjahan; Wilson, Zachary S.; Erick, Timothy K.; Banh, Cindy; Brossay, Laurent			Role of Type I Interferon Receptor Signaling on NK Cell Development and Functions	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MURINE BONE-MARROW; VIRAL-INFECTION; DENDRITIC CELLS; CUTTING EDGE; ACTIVATION; IDENTIFICATION; MATURATION; RESPONSES; REQUIRES	Type I interferons (IFN) are unique cytokines transcribed from intronless genes. They have been extensively studied because of their anti-viral functions. The anti-viral effects of type I IFN are mediated in part by natural killer (NK) cells. However, the exact contribution of type I IFN on NK cell development, maturation and activation has been somewhat difficult to assess. In this study, we used a variety of approaches to define the consequences of the lack of type I interferon receptor (IFNAR) signaling on NK cells. Using IFNAR deficient mice, we found that type I IFN affect NK cell development at the pre-pro NK stage. We also found that systemic absence of IFNAR signaling impacts NK cell maturation with a significant increase in the CD27(+) CD11b(+) double positive (DP) compartment in all organs. However, there is tissue specificity, and only in liver and bone marrow is the maturation defect strictly dependent on cell intrinsic IFNAR signaling. Finally, using adoptive transfer and mixed bone marrow approaches, we also show that cell intrinsic IFNAR signaling is not required for NK cell IFN-gamma production in the context of MCMV infection. Taken together, our studies provide novel insights on how type I IFN receptor signaling regulates NK cell development and functions.	[Brossay, Laurent] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; Brown Univ, Div Biol & Med, Grad Program Pathobiol, Providence, RI 02912 USA	Brown University; Brown University	Brossay, L (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.	Laurent_Brossay@Brown.edu		Brossay, Laurent/0000-0002-7497-8488; Simangan, Mon Erick/0000-0002-2480-245X	National Institutes of Health [AI46709]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046709, R21AI046709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE024360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health research grant AI46709 to LB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banh C, 2012, BLOOD, V120, P4583, DOI 10.1182/blood-2012-04-425009; Baranek T, 2012, CELL HOST MICROBE, V12, P571, DOI 10.1016/j.chom.2012.09.002; Beuneu H, 2011, J IMMUNOL, V187, P2084, DOI 10.4049/jimmunol.1004210; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Cella M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00282; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Geurs TL, 2009, J IMMUNOL, V183, P5830, DOI 10.4049/jimmunol.0901520; Gill N, 2011, CELL IMMUNOL, V269, P29, DOI 10.1016/j.cellimm.2011.03.007; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Henry SC, 2000, J VIROL METHODS, V89, P61, DOI 10.1016/S0166-0934(00)00202-0; Huntington ND, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00014; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Male V, 2014, J EXP MED, V211, P635, DOI 10.1084/jem.20132398; Martin-Fontecha A, 2011, CELL MOL LIFE SCI, V68, P3495, DOI 10.1007/s00018-011-0800-9; Martinez J, 2008, J IMMUNOL, V180, P1592, DOI 10.4049/jimmunol.180.3.1592; Mattei F, 2001, J IMMUNOL, V167, P1179, DOI 10.4049/jimmunol.167.3.1179; Mizutani T, 2012, ONCOIMMUNOLOGY, V1, P1027, DOI 10.4161/onci.21284; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Robbins SH, 2002, J IMMUNOL, V168, P2585, DOI 10.4049/jimmunol.168.6.2585; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Tessmer MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001254; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Xu W, 2013, J IMMUNOL, V191, P4489, DOI 10.4049/jimmunol.1301759; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	37	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111302	10.1371/journal.pone.0111302	http://dx.doi.org/10.1371/journal.pone.0111302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333658	gold, Green Published			2022-12-27	WOS:000343731200113
J	Marois, I; Cloutier, A; Meunier, I; Weingartl, HM; Cantin, AM; Richter, MV				Marois, Isabelle; Cloutier, Alexandre; Meunier, Isabelle; Weingartl, Hana M.; Cantin, Andre M.; Richter, Martin V.			Inhibition of Influenza Virus Replication by Targeting Broad Host Cell Pathways	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; MEMBRANE-FUSION; UNITED-STATES; MDCK CELLS; IN-VITRO; CHLOROQUINE; HEMAGGLUTININ; RESISTANCE; ENTRY; INFECTIONS	Antivirals that are currently used to treat influenza virus infections target components of the virus which can mutate rapidly. Consequently, there has been an increase in the number of resistant strains to one or many antivirals in recent years. Here we compared the antiviral effects of lysosomotropic alkalinizing agents (LAAs) and calcium modulators (CMs), which interfere with crucial events in the influenza virus replication cycle, against avian, swine, and human viruses of different subtypes in MDCK cells. We observed that treatment with LAAs, CMs, or a combination of both, significantly inhibited viral replication. Moreover, the drugs were effective even when they were administered 8 h after infection. Finally, analysis of the expression of viral acidic polymerase (PA) revealed that both drugs classes interfered with early events in the viral replication cycle. This study demonstrates that targeting broad host cellular pathways can be an efficient strategy to inhibit influenza replication. Furthermore, it provides an interesting avenue for drug development where resistance by the virus might be reduced since the virus is not targeted directly.	[Marois, Isabelle; Cloutier, Alexandre; Meunier, Isabelle; Cantin, Andre M.; Richter, Martin V.] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Med, Div Pulm, Sherbrooke, PQ J1K 2R1, Canada; [Weingartl, Hana M.] Natl Ctr Foreign Anim Dis, Canadian Food Inspect Agcy, Winnipeg, MB, Canada; [Weingartl, Hana M.] Univ Manitoba, Dept Med Microbiol, Coll Med, Winnipeg, MB, Canada; [Marois, Isabelle; Cloutier, Alexandre; Meunier, Isabelle; Cantin, Andre M.; Richter, Martin V.] Ctr Rech CHUS, Sherbrooke, PQ, Canada	University of Sherbrooke; Canadian Food Inspection Agency; University of Manitoba	Richter, MV (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Med, Div Pulm, Sherbrooke, PQ J1K 2R1, Canada.	Martin.Richter@USherbrooke.ca			Canadian Institutes of Health Research (CIHR) [OPP-86939]; Fonds de recherche en santedu Quebec (FRSQ) [16116]; Respiratory Health Research Chair of the Lung Association of Quebec; CIHR-Quebec Respiratory Health Training Program of the Reseau en santerespiratoire du FRSQ; Departement de Medecine de l'Universitede Sherbrooke; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche en santedu Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Respiratory Health Research Chair of the Lung Association of Quebec; CIHR-Quebec Respiratory Health Training Program of the Reseau en santerespiratoire du FRSQ(Canadian Institutes of Health Research (CIHR)); Departement de Medecine de l'Universitede Sherbrooke; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (CIHR grant OPP-86939 to M.V.R), the Fonds de recherche en santedu Quebec (FRSQ grant 16116 to M.V.R.), and the Respiratory Health Research Chair of the Lung Association of Quebec. A.C. was a recipient of a postdoctoral fellowship from the CIHR-Quebec Respiratory Health Training Program of the Reseau en santerespiratoire du FRSQ. I.M (Isabelle Meunier) was supported by fellowships from the Departement de Medecine de l'Universitede Sherbrooke and from the CIHR. M.V.R is a FRSQ Junior 2 Research Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brammer L, 2013, MMWR-MORBID MORTAL W, V62, P473; Cloutier A, 2012, J INFECT DIS, V205, P621, DOI 10.1093/infdis/jir804; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; Di Trani L, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-39; Eierhoff T, 2009, BIOL CHEM, V390, P509, DOI 10.1515/BC.2009.053; GUINEA R, 1995, J VIROL, V69, P2306, DOI 10.1128/JVI.69.4.2306-2312.1995; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Ison MG, 2011, CURR OPIN VIROL, V1, P563, DOI 10.1016/j.coviro.2011.09.002; Jones M, 2006, EXPERT OPIN DRUG SAF, V5, P603, DOI 10.1517/14740338.5.5.603; KLENK HD, 1984, EMBO J, V3, P2911, DOI 10.1002/j.1460-2075.1984.tb02231.x; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kuiken T, 2012, CURR OPIN VIROL, V2, P276, DOI 10.1016/j.coviro.2012.02.013; Lee SMY, 2012, ANTIVIR RES, V96, P391, DOI 10.1016/j.antiviral.2012.09.013; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marois I, 2012, J LEUKOCYTE BIOL, V92, P107, DOI 10.1189/jlb.1011490; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; McKimm-Breschkin JL, 2013, INFLUENZA OTHER RESP, V7, P25, DOI 10.1111/irv.12047; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Muller KH, 2012, TRENDS PHARMACOL SCI, V33, P89, DOI 10.1016/j.tips.2011.10.004; Muller KH, 2011, BRIT J PHARMACOL, V164, P344, DOI 10.1111/j.1476-5381.2011.01346.x; NUGENT KM, 1984, ARCH VIROL, V81, P163, DOI 10.1007/BF01309305; OCHIAI H, 1995, ANTIVIR RES, V27, P425, DOI 10.1016/0166-3542(95)00040-S; Okumura Y, 2010, J VIROL, V84, P5089, DOI 10.1128/JVI.02605-09; ONEILL TP, 1991, RESP MED, V85, P35, DOI 10.1016/S0954-6111(06)80252-0; Ooi EE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-39; Pizzorno A, 2011, SEMIN RESP CRIT CARE, V32, P409, DOI 10.1055/s-0031-1283281; Planz O, 2013, ANTIVIR RES, V98, P457, DOI 10.1016/j.antiviral.2013.04.008; RENNER EL, 1988, BIOCHIM BIOPHYS ACTA, V938, P386, DOI 10.1016/0005-2736(88)90136-8; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Savarino A, 2004, JAIDS-J ACQ IMM DEF, V35, P223, DOI 10.1097/00126334-200403010-00002; Savarino A, 2001, AIDS, V15, P2221, DOI 10.1097/00002030-200111230-00002; Savarino A, 2007, LANCET INFECT DIS, V7, P633, DOI 10.1016/S1473-3099(07)70217-7; Shaw ML, 2011, REV MED VIROL, V21, P358, DOI 10.1002/rmv.703; SHIBATA M, 1983, J GEN VIROL, V64, P1149, DOI 10.1099/0022-1317-64-5-1149; Sieczkarski SB, 2003, J VIROL, V77, P460, DOI 10.1128/JVI.77.1.460-469.2003; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Storms AD, 2012, EMERG INFECT DIS, V18, P308, DOI 10.3201/eid1802.111466; Taubenberger JK, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S305; Vigerust DJ, 2007, INFLUENZA OTHER RESP, V1, P189, DOI 10.1111/j.1750-2659.2007.00027.x; Wang N, 2008, J BIOL CHEM, V283, P33826, DOI 10.1074/jbc.M806897200; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Watanabe Y, 2012, TRENDS MICROBIOL, V20, P11, DOI 10.1016/j.tim.2011.10.003; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; *WHO, 2009, INFL A H1N1 VIR RES; YOSHII N, 1991, IMMUNOPHARMACOLOGY, V21, P13, DOI 10.1016/0162-3109(91)90003-H	47	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110631	10.1371/journal.pone.0110631	http://dx.doi.org/10.1371/journal.pone.0110631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333287	Green Submitted, gold, Green Published			2022-12-27	WOS:000343731200061
J	Rehbein, MA; Steinberg, C; Wessing, I; Pastor, MC; Zwitserlood, P; Keuper, K; Junghofer, M				Rehbein, Maimu A.; Steinberg, Christian; Wessing, Ida; Pastor, Maria Carmen; Zwitserlood, Pienie; Keuper, Kati; Junghoefer, Markus			Rapid Plasticity in the Prefrontal Cortex during Affective Associative Learning	PLOS ONE			English	Article							TOP-DOWN FACILITATION; VISUAL-CORTEX; HUMAN AMYGDALA; RESPONSES; EMOTION; EXTINCTION; ACTIVATION; STIMULI; BRAIN; DISCRIMINATION	MultiCS conditioning is an affective associative learning paradigm, in which affective categories consist of many similar and complex stimuli. Comparing visual processing before and after learning, recent MultiCS conditioning studies using time-sensitive magnetoencephalography (MEG) revealed enhanced activation of prefrontal cortex (PFC) regions towards emotionally paired versus neutral stimuli already during short-latency processing stages (i.e., 50 to 80 ms after stimulus onset). The present study aimed at showing that this rapid differential activation develops as a function of the acquisition and not the extinction of the emotional meaning associated with affectively paired stimuli. MEG data of a MultiCS conditioning study were analyzed with respect to rapid changes in PFC activation towards aversively (electric shock) paired and unpaired faces that occurred during the learning of stimulus-reinforcer contingencies. Analyses revealed an increased PFC activation towards paired stimuli during 50 to 80 ms already during the acquisition of contingencies, which emerged after a single pairing with the electric shock. Corresponding changes in stimulus valence could be observed in ratings of hedonic valence, although participants did not seem to be aware of contingencies. These results suggest rapid formation and access of emotional stimulus meaning in the PFC as well as a great capacity for adaptive and highly resolving learning in the brain under challenging circumstances.	[Rehbein, Maimu A.; Steinberg, Christian; Keuper, Kati; Junghoefer, Markus] Univ Hosp Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Rehbein, Maimu A.; Steinberg, Christian; Zwitserlood, Pienie; Keuper, Kati; Junghoefer, Markus] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, D-48149 Munster, Germany; [Wessing, Ida] Univ Hosp Munster, Dept Child & Adolescent Psychiat, Munster, Germany; [Pastor, Maria Carmen] Jaume I Univ, Dept Psychol, Castellon de La Plana, Spain; [Zwitserlood, Pienie] Univ Munster, Inst Psychol, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster; Universitat Jaume I; University of Munster	Rehbein, MA (corresponding author), Univ Hosp Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	maimu.rehbein@uni-muenster.de	Pastor, M. Carmen/H-7183-2015; Pastor, M. Carmen/N-1692-2019; Junghoefer, Markus/AAA-2892-2021	Pastor, M. Carmen/0000-0001-9909-3646; Pastor, M. Carmen/0000-0001-9909-3646; Roesmann (Keuper), Kati/0000-0001-6940-3551; Wessing, Ida/0000-0001-8248-6814; Junghoefer, Markus/0000-0002-8532-2986	Deutsche Forschungsgemeinschaft [SFB TRR-58 C01, JU445/4-2]; Marie Curie International Research Staff Exchange Scheme (IRSES) of the European Union; German National Merit Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Marie Curie International Research Staff Exchange Scheme (IRSES) of the European Union; German National Merit Foundation	MAR, CS, and MJ received funding from the Deutsche Forschungsgemeinschaft grants SFB TRR-58 C01 and JU445/4-2; MAR, MCP, and MJ received funding from the Marie Curie International Research Staff Exchange Scheme (IRSES) of the European Union; MAR received funding from the German National Merit Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; ALEXANDER J, 1984, J NEUROBIOL, V15, P67, DOI 10.1002/neu.480150107; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th, P943; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Beckers T, 2013, BIOL PSYCHOL, V92, P90, DOI 10.1016/j.biopsycho.2011.12.015; Benjamin PR, 2000, LEARN MEMORY, V7, P124, DOI 10.1101/lm.7.3.124; BERNSTEIN IL, 1980, PHYSIOL BEHAV, V25, P363, DOI 10.1016/0031-9384(80)90274-7; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Brockelmann AK, 2013, EUR J NEUROSCI, V37, P303, DOI 10.1111/ejn.12043; Brockelmann AK, 2011, J NEUROSCI, V31, P7801, DOI 10.1523/JNEUROSCI.6236-10.2011; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; CAREW TJ, 1983, SCIENCE, V219, P397, DOI 10.1126/science.6681571; Chaumon M, 2008, J VISION, V8, DOI 10.1167/8.3.10; Chaumon M, 2009, BRAIN RES, V1285, P77, DOI 10.1016/j.brainres.2009.05.087; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Gamond L, 2011, NEUROIMAGE, V54, P1415, DOI 10.1016/j.neuroimage.2010.08.081; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hauk O, 2004, NEUROIMAGE, V21, P1612, DOI 10.1016/j.neuroimage.2003.12.018; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Hermans D, 2002, BEHAV RES THER, V40, P217, DOI 10.1016/S0005-7967(01)00006-7; Hintze P, 2014, BIOL PSYCHOL, V99, P125, DOI 10.1016/j.biopsycho.2014.03.010; Hofmann SG, 2008, CLIN PSYCHOL REV, V28, P199, DOI 10.1016/j.cpr.2007.04.009; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Junghofer M, 2013, 53 ANN M SOC PSYCH R; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Keil A, 2007, NEUROIMAGE, V36, P472, DOI 10.1016/j.neuroimage.2007.02.048; Keil A, 2009, HUM BRAIN MAPP, V30, P532, DOI 10.1002/hbm.20521; Kirchner H, 2009, J NEUROSCI, V29, P7599, DOI 10.1523/JNEUROSCI.1233-09.2009; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Klinkenberg I, 2011, 11 INT C COGN NEUR I; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; Liu YL, 2012, HUM BRAIN MAPP, V33, P909, DOI 10.1002/hbm.21259; Lundqvist D., 1998, KAROLINSKA DIRECTED; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mechias ML, 2010, NEUROIMAGE, V49, P1760, DOI 10.1016/j.neuroimage.2009.09.040; Miskovic V, 2012, PSYCHOPHYSIOLOGY, V49, P1230, DOI 10.1111/j.1469-8986.2012.01398.x; Moratti S, 2005, COGNITIVE BRAIN RES, V25, P459, DOI 10.1016/j.cogbrainres.2005.07.006; Morel S, 2009, BRAIN RES, V1254, P84, DOI 10.1016/j.brainres.2008.11.079; OHMAN A, 1975, J COMP PHYSIOL PSYCH, V88, P619; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; Pizzagalli D, 1999, NEUROREPORT, V10, P2691, DOI 10.1097/00001756-199909090-00001; Pizzagalli D, 2003, ASYMMETRICAL BRAIN, P511; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Pourtois G, 2008, VISION RES, V48, P55, DOI 10.1016/j.visres.2007.10.027; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; ROZIN P, 1971, PSYCHOL REV, V78, P459, DOI 10.1037/h0031878; Rudrauf D, 2008, J NEUROSCI, V28, P2793, DOI 10.1523/JNEUROSCI.3476-07.2008; Rutishauser U, 2006, NEURON, V49, P805, DOI 10.1016/j.neuron.2006.02.015; Sabatinelli D, 2009, J NEUROSCI, V29, P14864, DOI 10.1523/JNEUROSCI.3278-09.2009; Salzman CD, 2007, ANN NY ACAD SCI, V1121, P336, DOI 10.1196/annals.1401.034; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Steinberg C, 2013, BIOL PSYCHOL, V92, P526, DOI 10.1016/j.biopsycho.2012.02.009; Steinberg C, 2012, J COGNITIVE NEUROSCI, V24, P17, DOI 10.1162/jocn_a_00067; Stolarova M, 2006, CEREB CORTEX, V16, P876, DOI 10.1093/cercor/bhj031; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Weisz N, 2007, CEREB CORTEX, V17, P1867, DOI 10.1093/cercor/bhl095; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	76	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110720	10.1371/journal.pone.0110720	http://dx.doi.org/10.1371/journal.pone.0110720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333631	Green Published, gold			2022-12-27	WOS:000343731200073
J	Rioux, RA; Shultz, J; Garcia, M; Willis, DK; Casler, M; Bonos, S; Smith, D; Kerns, J				Rioux, Renee A.; Shultz, Jeanette; Garcia, Michelle; Willis, David Kyle; Casler, Michael; Bonos, Stacy; Smith, Damon; Kerns, James			Sclerotinia homoeocarpa Overwinters in Turfgrass and Is Present in Commercial Seed	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; PCR-BASED ASSAY; DOLLAR SPOT DISEASE; CREEPING BENTGRASS; GENETIC-VARIATION; SURVIVAL; QUANTIFICATION; MANAGEMENT; SEVERITY; BIOLOGY	Dollar spot is the most economically important disease of amenity turfgrasses in the United States, yet little is known about the source of primary inoculum for this disease. With the exception of a few isolates from the United Kingdom, Sclerotinia homoeocarpa, the causal agent of dollar spot, does not produce spores. Consequently, it was assumed that overwintering of this organism in soil, thatch, and plant debris provides primary inoculum for dollar spot epidemics. Overwintering of S. homoeocarpa in roots and shoots of symptomatic and asymptomatic creeping bentgrass turfgrass was quantified over the course of a three-year field experiment. Roots did not consistently harbor S. homoeocarpa, whereas S. homoeocarpa was isolated from 30% of symptomatic shoots and 10% of asymptomatic shoots in the spring of two out of three years. The presence of stroma-like pathogen material on leaf blades was associated with an increase in S. homoeocarpa isolation and colony diameter at 48 hpi. Commercial seed has also been hypothesized to be a potential source of initial inoculum for S. homoeocarpa. Two or more commercial seed lots of six creeping bentgrass cultivars were tested for contamination with S. homoeocarpa using culture-based and molecular detection methods. A viable, pathogenic isolate of S. homoeocarpa was isolated from one commercial seed lot and contamination of this lot was confirmed with nested PCR using S. homoeocarpa specific primers. A sensitive nested PCR assay detected S. homoeocarpa contamination in eight of twelve (75%) commercial seed lots. Seed source, but not cultivar or resistance to dollar spot, influenced contamination by S. homoeocarpa. Overall, this research suggests that seeds are a potential source of initial inoculum for dollar spot epidemics and presents the need for further research in this area.	[Rioux, Renee A.; Shultz, Jeanette; Garcia, Michelle; Willis, David Kyle; Smith, Damon; Kerns, James] Univ Wisconsin, Dept Plant Plant Path Pathol, Madison, WI 53706 USA; [Rioux, Renee A.] NewLeaf Symbiot, St Louis, MO USA; [Shultz, Jeanette] Univ Wisconsin, Dept Neurosci, Madison, WI USA; [Garcia, Michelle] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Casler, Michael] USDA ARS, US Dairy Forage Res Ctr, Madison, WI 53706 USA; [Bonos, Stacy] Rutgers State Univ, Dept Plant Sci, New Brunswick, NJ 08903 USA; [Kerns, James] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas El Paso; United States Department of Agriculture (USDA); Rutgers State University New Brunswick; University of North Carolina; North Carolina State University	Rioux, RA (corresponding author), Univ Wisconsin, Dept Plant Plant Path Pathol, Madison, WI 53706 USA.	riouxra@gmail.com	Kerns, James/AAC-3208-2020	Kerns, James/0000-0002-1980-0126; Smith, Damon/0000-0003-3436-3718	Div Of Biological Infrastructure [1063085] Funding Source: National Science Foundation; ARS [ARS-0424141] Funding Source: Federal RePORTER	Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		Abd-Elmagid A, 2013, J MICROBIOL METH, V92, P293, DOI 10.1016/j.mimet.2012.12.020; Allen TW, 2005, PLANT HLTH INSTR, DOI 101094/PHI-I-2005-0217-02; [Anonymous], 1994, MANAGEMENT TURFGRASS; Baldwin N. A., 1992, Journal of the Sports Turf Research Institute, V68, P73; Bennett FT, 1937, ANN APPL BIOL, V24, P236, DOI 10.1111/j.1744-7348.1937.tb05032.x; Bonos SA, 2013, AGRON MONOGR, V56, P591, DOI 10.2134/agronmonogr56.c17; BREDE AD, 1991, HORTSCIENCE, V26, P1391, DOI 10.21273/HORTSCI.26.11.1391; Brede AD, 1988, P 42 NW TURFGR C, V42, P90; Breuninger JM, 2013, AGRON MONOGR, V56, P37, DOI 10.2134/agronmonogr56.c2; Couch H.B., 1962, DIS TURFGRASSES; Duressa D, 2012, PHYTOPATHOLOGY, V102, P443, DOI 10.1094/PHYTO-10-11-0280; Emmons R, 2005, TURFGRASS SCI MANAGE; Fenstermacher J. M., 1980, ADV TURFGRASS PATHOL, P49; Flowers J, 2003, PHYTOPATHOLOGY, V93, P1471, DOI 10.1094/PHYTO.2003.93.12.1471; FOSTER W. R., 1937, Canadian Journal of Research, V15, P547; Frost KE, 2011, J ECON ENTOMOL, V104, P1800, DOI 10.1603/EC11183; Glen M, 2007, PHYTOPATHOLOGY, V97, P132, DOI 10.1094/PHYTO-97-2-0132; Golembiewski RC, 1998, AGRON J, V90, P466, DOI 10.2134/agronj1998.00021962009000040004x; GOODMAN DM, 1991, PHYTOPATHOLOGY, V81, P1438, DOI 10.1094/Phyto-81-1438; Gossen BD, 2004, CAN J PLANT PATHOL, V26, P142; Gross PL, 2001, PLANT DIS, V85, P226, DOI 10.1094/PDIS.2001.85.2.226; Hamburger J, 2013, AM J TROP MED HYG, V88, P344, DOI 10.4269/ajtmh.2012.12-0208; Holb IJ, 2004, PLANT DIS, V88, P751, DOI 10.1094/PDIS.2004.88.7.751; Horvath BJ, 2007, CROP SCI, V47, P1206, DOI 10.2135/cropsci2006.09.0565; Hsiang T, 1999, PLANT PATHOL, V48, P83, DOI 10.1046/j.1365-3059.1999.00306.x; Ioos R, 2012, PHYTOPATHOLOGY, V102, P908, DOI 10.1094/PHYTO-04-12-0068-R; Jackson N., 1973, Journal of the Sports Turf Research Institute, P58; Jia Yulin, 2013, Methods Mol Biol, V956, P257, DOI 10.1007/978-1-62703-194-3_19; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Lee HK, 2001, CAN J PLANT PATHOL, V23, P315, DOI 10.1080/07060660109506947; Lee HK, 2001, PLANT DIS, V85, P220, DOI 10.1094/PDIS.2001.85.2.220; Liberti D, 2012, PHYTOPATHOLOGY, V102, P506, DOI 10.1094/PHYTO-06-11-0180; Mbofung GCY, 2010, PLANT DIS, V94, P860, DOI 10.1094/PDIS-94-7-0860; Montes-Borrego M, 2011, PLANT DIS, V95, P143, DOI 10.1094/PDIS-07-10-0499; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; NOVAK LA, 1991, APPL ENVIRON MICROB, V57, P525, DOI 10.1128/AEM.57.2.525-534.1991; Orshinsky AM, 2011, CAN J MICROBIOL, V57, P398, DOI [10.1139/w11-019, 10.1139/W11-019]; Pfender WF, 1999, PLANT DIS, V83, P1058, DOI 10.1094/PDIS.1999.83.11.1058; Powell JF, 2001, PLANT DIS, V85, P377, DOI 10.1094/PDIS.2001.85.4.377; Pryor BM, 2001, PLANT DIS, V85, P18, DOI 10.1094/PDIS.2001.85.1.18; Putman A, 2013, PHYTOPATHOLOGY, V103, P116; Raina K, 1997, MYCOL RES, V101, P585, DOI 10.1017/S0953756296002997; Rioux R, 2014, CAN J PLANT IN PRESS; Rioux R, 2011, CURR GENET, V57, P391, DOI 10.1007/s00294-011-0353-3; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Smiley RW., 2005, COMPENDIUM TURFGRASS, DOI DOI 10.1094/9780890546154; Smith JD, 1989, FUNGAL DIS AMENITY T; Sowley ENK, 2010, EUR J PLANT PATHOL, V126, P61, DOI 10.1007/s10658-009-9524-1; Testen AL, 2014, PHYTOPATHOLOGY, V104, P379, DOI 10.1094/PHYTO-07-13-0198-R; Walsh B, 1999, HORTSCIENCE, V34, P13, DOI 10.21273/HORTSCI.34.1.13; Watkins J. E., 2001, International Turfgrass Society Research Journal, V9, P729; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilson CM, 2011, THESIS U WISCONSIN M; Xu Z, 2008, PLANT DIS, V92, P719, DOI 10.1094/PDIS-92-5-0719; Yoshida S, 1999, PLANT DIS, V83, P465, DOI 10.1094/PDIS.1999.83.5.465	56	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110897	10.1371/journal.pone.0110897	http://dx.doi.org/10.1371/journal.pone.0110897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333928	gold, Green Submitted, Green Published			2022-12-27	WOS:000343731200087
J	Shneidman, L; Todd, R; Woodward, A				Shneidman, Laura; Todd, Roisleen; Woodward, Amanda			Why Do Child-Directed Interactions Support Imitative Learning in Young Children?	PLOS ONE			English	Article							OBSERVATIONAL CONTEXTS; COMMUNICATIVE SIGNALS; INFANTS; ATTENTION; PREFERENCE; COGNITION; PEDAGOGY; OTHERS; SPEECH; BIRTH	Child-directed cues support imitation of novel actions at 18 months, but not at two years of age. The current studies explore the mechanisms that underlie the propensity that children have to copy others at 18 months, and how the value of child-directed communication changes over development. We ask if attentional allocation accounts for children's failure to imitate observed actions at 18 months, and their success at two years of age, and we explore the informational value child-directed contexts may provide across ontogeny. Eighteen-month-old (Study 1) and two-year-old (Study 2) children viewed causally non-obvious actions performed by child-directed (Study 1 & 2), observed (Study 1 & 2), or non-interactive (Study 2) actors, and their visual attention and imitative behaviors were assessed. Results demonstrated that child-directed contexts supported imitative learning for 18-month-old children, independent of their effects on proximal attention. However, by two years of age, neither directness nor communication between social partners was a necessary condition for supporting social imitation. These findings suggest that developmental changes in children's propensity to extract information from observation cannot be accounted for by changes in children's interpretation of what counts as child-directed information, and are likely not due to changes in how children allocate attention to observed events.	[Shneidman, Laura; Todd, Roisleen; Woodward, Amanda] Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Shneidman, L (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	lauras@uchicago.edu		Shneidman, Laura/0000-0001-5981-4015; Woodward, Amanda/0000-0002-9383-9969	National Science Foundation [BCS-1226113]; Direct For Social, Behav & Economic Scie [1226113] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Research was supported by a National Science Foundation award BCS-1226113 to AW (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N., 1998, INTERSUBJECTIVE COMM, P316; Barresi J, 1996, BEHAV BRAIN SCI, V19, P107, DOI 10.1017/S0140525X00041790; Beisert M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032563; Brugger A, 2007, CHILD DEV, V78, P806, DOI 10.1111/j.1467-8624.2007.01034.x; Buttelmann D, 2013, CHILD DEV, V84, P422, DOI 10.1111/j.1467-8624.2012.01860.x; Collicott C, 2009, INFANCY, V14, P363, DOI 10.1080/15250000902839344; COOPER RP, 1990, CHILD DEV, V61, P1584, DOI 10.2307/1130766; Csibra G, 2006, ATTENTION PERFORM, P249; Csibra G, 2011, PHILOS T R SOC B, V366, P1149, DOI 10.1098/rstb.2010.0319; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; Daum MM, 2013, DEV PSYCHOL, V49, P1898, DOI 10.1037/a0031111; de Bordes PF, 2013, J EXP CHILD PSYCHOL, V116, P443, DOI 10.1016/j.jecp.2012.09.008; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Floor P, 2006, INFANCY, V9, P327, DOI 10.1207/s15327078in0903_4; Gampe A, 2012, FIRST LANG, V32, P385, DOI 10.1177/0142723711433584; Gaskins S., 1999, CHILDRENS ENGAGEMENT, P25; Haahr M, 2013, TRUE RANDOM NUMBER S; Herold KH, 2008, J EXP CHILD PSYCHOL, V101, P114, DOI 10.1016/j.jecp.2008.05.004; Howard L, 2014, CHILD DEV IN PRESS; Kiraly I, 2013, J EXP CHILD PSYCHOL, V116, P471, DOI 10.1016/j.jecp.2012.12.003; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Mangold P, 1998, INTERACT COMPUTER SO; Matheson H, 2013, J EXP CHILD PSYCHOL, V114, P161, DOI 10.1016/j.jecp.2012.09.003; Moll H, 2007, DEV PSYCHOL, V43, P309, DOI 10.1037/0012-1649.43.2.309; Moore C., 2010, SOCIOEMOTIONAL DEV T, P43; Nielsen M, 2014, CHILD DEV IN PRESS; Nielsen M, 2006, DEV PSYCHOL, V42, P555, DOI 10.1037/0012-1649.42.3.555; Nielsen M, 2012, J EXP CHILD PSYCHOL, V112, P73, DOI 10.1016/j.jecp.2012.01.001; Nielsen M, 2010, PSYCHOL SCI, V21, P729, DOI 10.1177/0956797610368808; Over H, 2012, J COMP PSYCHOL, V126, P182, DOI 10.1037/a0024555; PEGG JE, 1992, INFANT BEHAV DEV, V15, P325, DOI 10.1016/0163-6383(92)80003-D; Repacholi BM, 2007, CHILD DEV, V78, P503, DOI 10.1111/j.1467-8624.2007.01012.x; Rogoff B., 2003, CULTURAL NATURE HUMA; Sage KD, 2011, SOC DEV, V20, P825, DOI 10.1111/j.1467-9507.2011.00624.x; Senju A, 2008, CURR BIOL, V18, P668, DOI 10.1016/j.cub.2008.03.059; Shafto P, 2012, PERSPECT PSYCHOL SCI, V7, P341, DOI 10.1177/1745691612448481; Shimpi PM, 2013, J EXP CHILD PSYCHOL, V116, P309, DOI 10.1016/j.jecp.2013.06.008; Shneidman LA, 2009, LANG LEARN DEV, V5, P266, DOI 10.1080/15475440903001115; Szufnarowska J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05304; Tomasello M., 1995, JOINT ATTENTION ITS, P103; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4	42	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110891	10.1371/journal.pone.0110891	http://dx.doi.org/10.1371/journal.pone.0110891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR7AB	25333623	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200083
J	Xiang, YJ; Guo, MM; Zhou, CJ; Liu, L; Han, B; Kong, LY; Gao, ZC; Ma, ZB; Wang, L; Feng, M; Chen, HY; Jia, GT; Gao, DZ; Zhang, Q; Li, L; Li, YY; Yu, ZG				Xiang, Yu-Juan; Guo, Ming-Ming; Zhou, Cheng-Jun; Liu, Lu; Han, Bo; Kong, Ling-Yu; Gao, Zhong-Cheng; Ma, Zhong-Bing; Wang, Lu; Feng, Man; Chen, Hai-Ying; Jia, Guo-Tao; Gao, De-Zong; Zhang, Qiang; Li, Liang; Li, Yu-Yang; Yu, Zhi-Gang			Absence of Gamma-Interferon-Inducible Lysosomal Thiol Reductase (GILT) Is Associated with Poor Disease-Free Survival in Breast Cancer Patients	PLOS ONE			English	Article							IMMUNE-RESPONSE; LABELING INDEX; CUTTING EDGE; EXPRESSION; KI-67; KI67; INDUCTION; CELLS	Tumor immunosurveillance is known to be of critical importance in controlling tumorigenesis and progression in various cancers. The role of gamma-interferon-inducible lysosomal thiol reductase (GILT) in tumor immunosurveillance has recently been studied in several malignant diseases, but its role in breast cancer remains to be elucidated. In the present study, we found GILT as a significant different expressed gene by cDNA microarray analysis. To further determine the role of GILT in breast cancer, we examined GILT expression in breast cancers as well as noncancerous breast tissues by immunohistochemistry and real-time PCR, and assessed its association with clinicopathologic characteristics and patient outcome. The absence of GILT expression increased significantly from 2.02% (2/99) in noncancerous breast tissues to 15.6% (34/218) in breast cancer tissues (P<0.001). In accordance with its proliferation inhibiting function, GILT expression was inversely correlated with Ki67 index (P<0.05). In addition, absence of GILT was positively correlated with adverse characteristics of breast cancers, such as histological type, tumor size, lymph nodes status, and pTNM stage (P<0.05). Consistently, breast cancers with reduced GILT expression had poorer disease-free survival (P<0.005). Moreover, significantly decreased expression of GILT was found in both primary and metastatic breast cancer cells, in contrast to normal epithelial cells. These findings indicate that GILT may act as a tumor suppressor in breast cancer, in line with its previously suggested role in anti-tumor immunity. Thus, GILT has the potential to be a novel independent prognostic factor in breast cancer and further studies are needed to illustrate the underlying mechanism of this relationship.	[Xiang, Yu-Juan; Guo, Ming-Ming; Liu, Lu; Ma, Zhong-Bing; Gao, De-Zong; Zhang, Qiang; Li, Liang; Li, Yu-Yang; Yu, Zhi-Gang] Shandong Univ, Hosp 2, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China; [Zhou, Cheng-Jun] Shandong Univ, Hosp 2, Dept Pathol, Jinan 250100, Shandong, Peoples R China; [Han, Bo] Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Shandong, Peoples R China; [Kong, Ling-Yu] Linyi Tumor Hosp, Dept Breast Dis, Linyi, Shandong, Peoples R China; [Gao, Zhong-Cheng] Linyi Tumor Hosp, Dept Gen Surg, Linyi, Shandong, Peoples R China; [Wang, Lu] Shandong Univ, Sch Publ Hlth, Div Epidemiol & Biostat, Jinan 250100, Shandong, Peoples R China; [Feng, Man] Shandong Acad Med Sci, Affiliated Hosp, Dept Pathol, Jinan, Shandong, Peoples R China; [Chen, Hai-Ying] Liaocheng Peoples Hosp, Oral Maxillofacial Head & Neck Key Lab Med Biol, Liaocheng, Shandong, Peoples R China; [Chen, Hai-Ying] Liaocheng Peoples Hosp, Cent Lab Expt Med, Liaocheng, Shandong, Peoples R China; [Jia, Guo-Tao] Liaocheng Peoples Hosp, Dept Pathol, Liaocheng, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Yu, ZG (corresponding author), Shandong Univ, Hosp 2, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China.	yzg@medmail.com.cn	YU, ZHIGANG/AAA-4679-2022; Wang, Lu/O-7732-2019	Wang, Lu/0000-0003-0245-7226; Liu, Lu/0000-0002-8777-5209; Xiang, Yujuan/0000-0002-0629-640X	foundation of the minister-affiliated hospital key project of the Ministry of Health of the People's Republic of China [07090122]	foundation of the minister-affiliated hospital key project of the Ministry of Health of the People's Republic of China	This study is supported by the foundation of the minister-affiliated hospital key project of the Ministry of Health of the People's Republic of China (07090122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Murri AM, 2008, BRIT J CANCER, V99, P1013, DOI 10.1038/sj.bjc.6604667; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Arunachalam B, 1998, J IMMUNOL, V160, P5797; Bogunovic B, 2008, J BIOL CHEM, V283, P8855, DOI 10.1074/jbc.M708998200; Bogunovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010599; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chiang HS, 2011, FREE RADICAL BIO MED, V51, P688, DOI 10.1016/j.freeradbiomed.2011.05.015; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; de Kruijf EM, 2013, BREAST CANCER RES TR, V142, P355, DOI 10.1007/s10549-013-2752-2; Doonan Bently Patrick, 2010, Open Cancer Immunol J, V3, P1; DREW SI, 1979, HUM PATHOL, V10, P5, DOI 10.1016/S0046-8177(79)80068-4; Fu MG, 2003, GENE, V315, P33, DOI 10.1016/S0378-1119(03)00730-3; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldstein OG, 2008, CANCER IMMUNOL IMMUN, V57, P1461, DOI 10.1007/s00262-008-0483-8; Haque A, 2007, CANCER IMMUNOL IMMUN, V56, P615, DOI 10.1007/s00262-006-0219-6; Haque MA, 2002, J EXP MED, V195, P1267, DOI 10.1084/jem.20011853; Hastings KT, 2006, J IMMUNOL, V177, P8569, DOI 10.4049/jimmunol.177.12.8569; Hastings KT, 2011, ANTIOXID REDOX SIGN, V15, P657, DOI 10.1089/ars.2010.3684; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Hutchinson L, 2010, NAT REV CLIN ONCOL, V7, P669, DOI 10.1038/nrclinonc.2010.192; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones RL, 2010, BREAST CANCER RES TR, V119, P315, DOI 10.1007/s10549-009-0329-x; Jung SY, 2009, ANN SURG ONCOL, V16, P1112, DOI 10.1245/s10434-009-0334-7; Kawai H, 2005, CLIN CANCER RES, V11, P5084, DOI 10.1158/1078-0432.CCR-05-0200; LUSTER AD, 1988, J BIOL CHEM, V263, P12036; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Maric M, 2009, J IMMUNOL, V182, P746, DOI 10.4049/jimmunol.182.2.746; Niikura N, 2012, CANCER SCI, V103, P1508, DOI 10.1111/j.1349-7006.2012.02319.x; O'Donnell PW, 2004, J IMMUNOL, V173, P731, DOI 10.4049/jimmunol.173.2.731; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Phipps-Yonas H, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00425; Rausch MP, 2012, J INVEST DERMATOL, V132, P154, DOI 10.1038/jid.2011.236; Rausch MP, 2010, J IMMUNOL, V185, P2828, DOI 10.4049/jimmunol.1000945; Singh R, 2010, SCIENCE, V328, P1394, DOI 10.1126/science.1189176; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Srinivasan P, 2011, IMMUNOLOGY, V132, P209, DOI 10.1111/j.1365-2567.2010.03355.x; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Wenzel J, 2008, INT J CANCER, V123, P2605, DOI 10.1002/ijc.23799; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yerushalmi Rinat, 2010, Lancet Oncol, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Yu ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037784; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	42	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109449	10.1371/journal.pone.0109449	http://dx.doi.org/10.1371/journal.pone.0109449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333930	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200015
J	Youniss, FM; Sundaresan, G; Graham, LJ; Wang, L; Berry, CR; Dewkar, GK; Jose, P; Bear, HD; Zweit, J				Youniss, Fatma M.; Sundaresan, Gobalakrishnan; Graham, Laura J.; Wang, Li; Berry, Collin R.; Dewkar, Gajanan K.; Jose, Purnima; Bear, Harry D.; Zweit, Jamal			Near-Infrared Imaging of Adoptive Immune Cell Therapy in Breast Cancer Model Using Cell Membrane Labeling	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SODIUM-IODIDE SYMPORTER; T-CELLS; REPORTER GENE; METASTATIC MELANOMA; TUMOR-REGRESSION; PROSTATE-CANCER; MIGRATION; TRACKING; LYMPHOCYTES	The overall objective of this study is to non-invasively image and assess tumor targeting and retention of directly labeled T-lymphocytes following their adoptive transfer in mice. T-lymphocytes obtained from draining lymph nodes of 4T1 (murine breast cancer cell) sensitized BALB/C mice were activated in-vitro with Bryostatin/Ionomycin for 18 hours, and were grown in the presence of Interleukin-2 for 6 days. T-lymphocytes were then directly labeled with 1,1-dioctadecyltetramethyl indotricarbocyanine Iodide (DiR), a lipophilic near infrared fluorescent dye that labels the cell membrane. Assays for viability, proliferation, and function of labeled T-lymphocytes showed that they were unaffected by DiR labeling. The DiR labeled cells were injected via tail vein in mice bearing 4T1 tumors in the flank. In some cases labeled 4T1 specific T-lymphocytes were injected a week before 4T1 tumor cell implantation. Multi-spectral in vivo fluorescence imaging was done to subtract the autofluorescence and isolate the near infrared signal carried by the T-lymphocytes. In recipient mice with established 4T1 tumors, labeled 4T1 specific T-lymphocytes showed marked tumor retention, which peaked 6 days post infusion and persisted at the tumor site for up to 3 weeks. When 4T1 tumor cells were implanted 1-week post-infusion of labeled T-lymphocytes, T-lymphocytes responded to the immunologic challenge and accumulated at the site of 4T1 cell implantation within two hours and the signal persisted for 2 more weeks. Tumor accumulation of labeled 4T1 specific T-lymphocytes was absent in mice bearing Meth A sarcoma tumors. When lysate of 4T1 specific labeled T-lymphocytes was injected into 4T1 tumor bearing mice the near infrared signal was not detected at the tumor site. In conclusion, our validated results confirm that the near infrared signal detected at the tumor site represents the DiR labeled 4T1 specific viable T-lymphocytes and their response to immunologic challenge can be imaged in vivo.	[Youniss, Fatma M.; Sundaresan, Gobalakrishnan; Wang, Li; Berry, Collin R.; Dewkar, Gajanan K.; Jose, Purnima; Zweit, Jamal] Virginia Commonwealth Univ, Ctr Mol Imaging, Dept Radiol, Richmond, VA 23298 USA; [Graham, Laura J.; Bear, Harry D.] Virginia Commonwealth Univ, Dept Surg, Div Surg Oncol, Richmond, VA USA; [Bear, Harry D.; Zweit, Jamal] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Zweit, J (corresponding author), Virginia Commonwealth Univ, Ctr Mol Imaging, Dept Radiol, Richmond, VA 23298 USA.	jzweit@vcu.edu		Gobalakrishnan, Sundaresan/0000-0002-9620-5611	Massey Cancer Center; VCU School of Medicine; Libyan Government Student Scholarship; NIH-NCI Cancer Center Support Grant [P30 CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER	Massey Cancer Center; VCU School of Medicine; Libyan Government Student Scholarship; NIH-NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by a Massey Cancer Center pilot grant, VCU School of Medicine and a Libyan Government Student Scholarship to FMY. Services and products in support of this research project were generated by the VCU Massey Cancer Center Flow Cytometry Shared Resource Core, Biological Macromolecule Shared Resource Core and Molecular Imaging Shared Resource, supported, in part, with funding from NIH-NCI Cancer Center Support Grant P30 CA016059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Akins EJ, 2008, J NUCL MED, V49, p180S, DOI 10.2967/jnumed.107.045971; Cha E, 2010, BREAST CANCER RES TR, V122, P359, DOI 10.1007/s10549-009-0573-0; Costa GL, 2001, J IMMUNOL, V167, P2379, DOI 10.4049/jimmunol.167.4.2379; Dobrenkov K, 2008, J NUCL MED, V49, P1162, DOI 10.2967/jnumed.107.047324; Dotti G, 2009, MOL IMAGING, V8, P230, DOI 10.2310/7290.2009.00022; Du XH, 2012, EXP THER MED, V4, P221, DOI 10.3892/etm.2012.579; Dubey P, 2003, P NATL ACAD SCI USA, V100, P1232, DOI 10.1073/pnas.0337418100; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Granot D, 2007, CANCER RES, V67, P9180, DOI 10.1158/0008-5472.CAN-07-0684; Helfer BM, 2010, CYTOTHERAPY, V12, P238, DOI 10.3109/14653240903446902; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Hong H, 2010, CURR TOP MED CHEM, V10, P1237, DOI 10.2174/156802610791384234; Kalchenko V, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2364903; Kim YJ, 2004, MOL IMAGING BIOL, V6, P331, DOI 10.1016/j.mibio.2004.06.009; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Koehne G, 2003, NAT BIOTECHNOL, V21, P405, DOI 10.1038/nbt805; Kojima H, 2008, YAKUGAKU ZASSHI, V128, P1653, DOI 10.1248/yakushi.128.1653; Lassailly F, 2010, BLOOD, V115, P5347, DOI 10.1182/blood-2009-05-224030; Le HK, 2009, CANCER IMMUNOL IMMUN, V58, P1565, DOI 10.1007/s00262-009-0666-y; Lucignani G, 2006, TRENDS BIOTECHNOL, V24, P410, DOI 10.1016/j.tibtech.2006.07.003; Meier R, 2011, MAGN RESON MED, V65, P756, DOI 10.1002/mrm.22652; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Namavari M, 2011, MOL IMAGING BIOL, V13, P812, DOI 10.1007/s11307-010-0414-x; Ottobrini L, 2011, EUR J NUCL MED MOL I, V38, P949, DOI 10.1007/s00259-010-1687-7; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Patel MR, 2010, CANCER RES, V70, P10141, DOI 10.1158/0008-5472.CAN-10-1843; Penheiter AR, 2012, CURR GENE THER, V12, P33; Pittet MJ, 2007, P NATL ACAD SCI USA, V104, P12457, DOI 10.1073/pnas.0704460104; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; Seo JH, 2010, J NUCL MED, V51, P1637, DOI 10.2967/jnumed.110.077891; Shu CJ, 2009, INT IMMUNOL, V21, P155, DOI 10.1093/intimm/dxn133; Smirnov P, 2006, MAGN RESON MED, V56, P498, DOI 10.1002/mrm.20996; Srinivas M, 2010, ADV DRUG DELIVER REV, V62, P1080, DOI 10.1016/j.addr.2010.08.009; Su H, 2004, MOL IMAGING BIOL, V6, P139, DOI 10.1016/j.mibio.2004.02.001; Tromberg BJ, 2000, NEOPLASIA, V2, P26, DOI 10.1038/sj.neo.7900082; TUTTLE TM, 1994, ANN SURG ONCOL, V1, P53, DOI 10.1007/BF02303541; TUTTLE TM, 1992, J SURG RES, V52, P543, DOI 10.1016/0022-4804(92)90126-K; TUTTLE TM, 1993, CANCER RES, V53, P833; Wang H, 2009, STEM CELLS, V27, P1548, DOI 10.1002/stem.81; Wang Q, 2009, EXPERT REV VACCINES, V8, P1427, DOI [10.1586/erv.09.100, 10.1586/ERV.09.100]; Wei LH, 2008, J NUCL MED, V49, P1828, DOI 10.2967/jnumed.108.054452; Yaghoubi SS, 2012, THERANOSTICS, V2, P374, DOI 10.7150/thno.3677; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099	45	29	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109162	10.1371/journal.pone.0109162	http://dx.doi.org/10.1371/journal.pone.0109162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25334026	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200011
J	de Campos, WRL; Chirwa, N; London, G; Rotherham, LS; Morris, L; Mayosi, BM; Khati, M				de Campos, Walter R. Lopes; Chirwa, Nthato; London, Grace; Rotherham, Lia S.; Morris, Lynn; Mayosi, Bongani M.; Khati, Makobetsa			HIV-1 Subtype C Unproductively Infects Human Cardiomyocytes In Vitro and Induces Apoptosis Mitigated by an Anti-Gp120 Aptamer	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTRALIZES R5 STRAINS; CHEMOKINE RECEPTOR CXCR4; MEDIATED APOPTOSIS; CARDIAC MYOCYTES; T-LYMPHOCYTES; CYTOCHROME-C; CELL-DEATH; TYPE-1; GP120	HIV-associated cardiomyopathy (HIVCM) is of clinical concern in developing countries because of a high HIV-1 prevalence, especially subtype C, and limited access to highly active antiretroviral therapy (HAART). For these reasons, we investigated the direct and indirect effects of HIV-1 subtype C infection of cultured human cardiomyocytes and the mechanisms leading to cardiomyocytes damage; as well as a way to mitigate the damage. We evaluated a novel approach to mitigate HIVCM using a previously reported gp120 binding and HIV-1 neutralizing aptamer called UCLA1. We established a cell-based model of HIVCM by infecting human cardiomyocytes with cell-free HIV-1 or co-culturing human cardiomyocytes with HIV-infected monocyte derived macrophages (MDM). We discovered that HIV-1 subtype C unproductively (i.e. its life cycle is arrested after reverse transcription) infects cardiomyocytes. Furthermore, we found that HIV-1 initiates apoptosis of cardiomyocytes through caspase-9 activation, preferentially via the intrinsic or mitochondrial initiated pathway. CXCR4 receptor-using viruses were stronger inducers of apoptosis than CCR5 utilizing variants. Importantly, we discovered that HIV-1 induced apoptosis of cardiomyocytes was mitigated by UCLA1. However, UCLA1 had no protective effective on cardiomyocytes when apoptosis was triggered by HIV-infected MDM. When HIV-1 was treated with UCLA1 prior to infection of MDM, it failed to induce apoptosis of cardiomyocytes. These data suggest that HIV-1 causes a mitochondrial initiated apoptotic cascade, which signal through caspase-9, whereas HIV-1 infected MDM causes apoptosis predominantly via the death-receptor pathway, mediated by caspase-8. Furthermore the data suggest that UCLA1 protects cardiomyocytes from caspase-mediated apoptosis, directly by binding to HIV-1 and indirectly by preventing infection of MDM.	[de Campos, Walter R. Lopes; Chirwa, Nthato; London, Grace; Rotherham, Lia S.; Khati, Makobetsa] CSIR, Biosci Unit, Emerging Hlth Technol Competency Area, Pretoria, South Africa; [Morris, Lynn] Natl Inst Communicable Dis, Johannesburg, South Africa; [Mayosi, Bongani M.; Khati, Makobetsa] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Mayosi, Bongani M.; Khati, Makobetsa] Univ Cape Town, ZA-7925 Cape Town, South Africa	Council for Scientific & Industrial Research (CSIR) - South Africa; National Institute for Communicable Diseases (NICD); University of Cape Town; University of Cape Town	Khati, M (corresponding author), CSIR, Biosci Unit, Emerging Hlth Technol Competency Area, Pretoria, South Africa.	Mkhati@csir.co.za	Morris, Lynn/V-3941-2018	Morris, Lynn/0000-0003-3961-7828; Mayosi, Bongani/0000-0001-6641-8950	Department of Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066734] Funding Source: NIH RePORTER	Department of Science and Technology(Department of Science & Technology (India)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Department of Science and Technology (http://www.dst.gov.za/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 1998, J BIOL CHEM, V273, P19892, DOI 10.1074/jbc.273.31.19892; [Anonymous], 1997, Cardiovasc Res, V35, P2; Biard-Piechaczyk M, 2000, VIROLOGY, V268, P329, DOI 10.1006/viro.1999.0151; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bottarel F, 1999, AIDS RES HUM RETROV, V15, P1255, DOI 10.1089/088922299310151; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cilliers T, 2005, VIROLOGY, V339, P136, DOI 10.1016/j.virol.2005.05.027; Coetzer M, 2006, VIROLOGY, V356, P95, DOI 10.1016/j.virol.2006.07.030; Cohen C, 2008, VIROLOGY, V381, P46, DOI 10.1016/j.virol.2008.08.025; de Campos WRL, 2009, ANTIMICROB AGENTS CH, V53, P3056, DOI 10.1128/AAC.01502-08; Dey AK, 2005, J VIROL, V79, P13806, DOI 10.1128/JVI.79.21.13806-13810.2005; Dey AK, 2005, RNA, V11, P873, DOI 10.1261/rna.7205405; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Esser MT, 2001, J VIROL, V75, P1152, DOI 10.1128/JVI.75.3.1152-1164.2001; Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008; Fiala Milan, 2004, Cardiovasc Toxicol, V4, P97, DOI 10.1385/CT:4:2:097; FINKEL MS, 1992, SCIENCE, V257, P387, DOI 10.1126/science.1631560; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GRODY WW, 1990, AM J CARDIOL, V66, P203, DOI 10.1016/0002-9149(90)90589-S; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; HERSKOWITZ A, 1994, J AM COLL CARDIOL, V24, P1025, DOI 10.1016/0735-1097(94)90865-6; Jacotot E, 1997, APOPTOSIS, V2, P47, DOI 10.1023/A:1026435625144; Joubert MK, 2010, BIOCHEMISTRY-US, V49, P5880, DOI 10.1021/bi100301k; Kan H, 2006, J MOL CELL CARDIOL, V40, P131, DOI 10.1016/j.yjmcc.2005.10.006; Kan H, 2005, J APPL PHYSIOL, V98, P77, DOI 10.1152/japplphysiol.00171.2004; Kan H, 2000, AM J PHYSIOL-HEART C, V279, pH3138, DOI 10.1152/ajpheart.2000.279.6.H3138; Khati M, 2003, J VIROL, V77, P12692, DOI 10.1128/JVI.77.23.12692-12698.2003; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; LIPSHULTZ SE, 1990, AM J CARDIOL, V66, P246, DOI 10.1016/0002-9149(90)90603-X; Magula Nombulelo P, 2003, Cardiovasc J S Afr, V14, P231; Monsuez JJ, 2007, INT J CARDIOL, V120, P150, DOI 10.1016/j.ijcard.2006.11.143; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NARDELLI B, 1995, P NATL ACAD SCI USA, V92, P7312, DOI 10.1073/pnas.92.16.7312; Ntsekhe M, 2005, CIRCULATION, V112, P3602, DOI 10.1161/CIRCULATIONAHA.105.549220; Ntsekhe M, 2009, NAT CLIN PRACT CARD, V6, P120, DOI 10.1038/ncpcardio1437; Perez R, 2006, STEM CELL RES THER C; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Roggero R, 2001, J VIROL, V75, P7637, DOI 10.1128/JVI.75.16.7637-7650.2001; Schmidtmayerova H, 1998, J VIROL, V72, P4633, DOI 10.1128/JVI.72.6.4633-4642.1998; Twu C, 2002, P NATL ACAD SCI USA, V99, P14386, DOI 10.1073/pnas.212327899; Vlahakis SR, 2001, J CLIN INVEST, V107, P207, DOI 10.1172/JCI11109; Yuan YX, 2008, CARDIOVASC TOXICOL, V8, P173, DOI 10.1007/s12012-008-9026-y	42	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110930	10.1371/journal.pone.0110930	http://dx.doi.org/10.1371/journal.pone.0110930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329893	Green Published, gold			2022-12-27	WOS:000345204100111
J	Lucchesi, D; Russo, R; Gabriele, M; Longo, V; Del Prato, S; Penno, G; Pucci, L				Lucchesi, Daniela; Russo, Rossella; Gabriele, Morena; Longo, Vincenzo; Del Prato, Stefano; Penno, Giuseppe; Pucci, Laura			Grain and Bean Lysates Improve Function of Endothelial Progenitor Cells from Human Peripheral Blood: Involvement of the Endogenous Antioxidant Defenses	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GINKGO-BILOBA EXTRACT; OXIDATIVE STRESS; PHASEOLUS-VULGARIS; HEALTH-BENEFITS; UP-REGULATION; WHOLE GRAINS; LISOSAN-G; AUGMENTATION; RESVERATROL	Increased oxidative stress contributes to the functional impairment of endothelial progenitor cells (EPCs), the pivotal players in the servicing of the endothelial cell lining. Several evidences suggest that decreasing oxidative stress by natural compounds with antioxidant properties may improve EPCs bioactivity. Here, we investigated the effects of Lisosan G (LG), a Triticum Sativum grain powder, and Lady Joy (LJ), a bean lysate, on function of EPCs exposed to oxidative stress. Peripheral blood mononuclear cells were isolated and plated on fibronectin-coated culture dishes; adherent cells, identified as early EPCs, were pre-treated with different concentrations of LG and LJ and incubated with hydrogen peroxide (H2O2). Viability, senescence, adhesion, ROS production and antioxidant enzymes gene expression were evaluated. Lysate-mediated Nrf-2 (nuclear factor (erythroid-derived 2)-like 2)/ARE (antioxidant response element) activation, a modulator of oxidative stress, was assessed by immunocytochemistry. Lady Joy 0.35-0.7 mg/ml increases EPCs viability; pre-treatment with either LG 0.7 mg/ml and LJ 0.35-0.7 mg/ml protect EPCs viability against H2O2-induced injury. LG 0.7 and LJ 0.35-0.7 mg/ml improve EPCs adhesion; pre-treatment with either LG 0.35 and 0.7 mg/ml or LJ 0.35, 0.7 and 1.4 mg/ml preserve adhesiveness of EPCs exposed to H2O2. Senescence is attenuated in EPCs incubated with lysates 0.35 mg/ml. After exposure to H2O2, LG pretreated cells show a lower senescence than untreated EPCs. Lysates significantly decrease H2O2-induced ROS generation. Both lysates increase glutathione peroxidase-1 and superoxide dismutase-2 (SOD-2) expression; upon H2O2 exposure, pretreatment with LJ allows higher SOD-2 expression. Heme oxigenase-1 increases in EPCs pre-treated with LG even upon H2O2 exposure. Finally, incubation with LG 0.7 mg/ml results in Nrf-2 translocation into the nucleus both at baseline and after the oxidative challenge. Our data suggest a protective effect of lysates on EPCs exposed to oxidative stress through the involvement of antioxidant systems. Lisosan G seems to activate the Nrf-2/ARE pathways.	[Lucchesi, Daniela; Del Prato, Stefano; Penno, Giuseppe] Univ Pisa, Dept Clin & Expt Med, Sect Metab Dis, Pisa, Italy; [Russo, Rossella; Gabriele, Morena; Longo, Vincenzo; Pucci, Laura] CNR, Natl Res Council, Inst Agr Biol & Biotechnol, I-56100 Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR)	Pucci, L (corresponding author), CNR, Natl Res Council, Inst Agr Biol & Biotechnol, I-56100 Pisa, Italy.	lauric16@yahoo.it	Del+Prato, Stefano/AAC-9197-2021; Longo, Vincenzo/K-3695-2018; Gabriele, Morena/AAU-9725-2020; Gabriele, Morena/L-1631-2018; Del Prato, Stefano/K-3405-2016; Pucci, Laura/AAU-4653-2020	Longo, Vincenzo/0000-0001-8972-8564; Gabriele, Morena/0000-0002-9456-6755; Gabriele, Morena/0000-0002-9456-6755; Del Prato, Stefano/0000-0002-5388-0270; Pucci, Laura/0000-0001-7063-6192; PUCCI, LAURA/0000-0002-8162-4039	Regione Toscana, Italy [Resolution 1157, D55E11002680005]	Regione Toscana, Italy(Regione Toscana)	This work was supported by a grant from Regione Toscana, Italy, Resolution 1157 (December 19, 2011), ID number D55E11002680005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiero Mattia, 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P16; Alfadda AA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/936486; Angeloni C, 2012, OXID MED CELL LONGEV, DOI [10.1155/2012/585901, DOI 10.1155/2012/585901]; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Badimon L, 2010, CARDIOVASC THER, V28, P202, DOI 10.1111/j.1755-5922.2010.00189.x; BANWELL JG, 1985, APPL ENVIRON MICROB, V50, P68, DOI 10.1128/AEM.50.1.68-80.1985; Basile DP, 2014, J CELL PHYSIOL, V229, P10, DOI 10.1002/jcp.24423; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; BUETLER TM, 1995, TOXICOL APPL PHARM, V135, P45, DOI 10.1006/taap.1995.1207; Cao ZX, 2004, EUR J PHARMACOL, V489, P39, DOI 10.1016/j.ejphar.2004.02.031; Chan YH, 2011, EUR J CARDIOV PREV R, V18, P360, DOI 10.1177/1741826710389385; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; de Munter JSL, 2007, PLOS MED, V4, P1385, DOI 10.1371/journal.pmed.0040261; Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103; Desouza CV, 2013, J DIABETES COMPLICAT, V27, P519, DOI 10.1016/j.jdiacomp.2013.04.007; Diplock AT, 1999, BRIT J NUTR, V81, pS1, DOI 10.1017/S0007114599000471; Dong XX, 2007, J CARDIOVASC PHARM, V49, P111, DOI 10.1097/FJC.0b013e31802ef519; Eilat-Adar S, 2010, NUTR METAB CARDIOVAS, V20, P459, DOI 10.1016/j.numecd.2010.01.011; Everette JD, 2010, J AGR FOOD CHEM, V58, P8139, DOI 10.1021/jf1005935; Fadini GP, 2014, DIABETOLOGIA, V57, P4, DOI 10.1007/s00125-013-3087-6; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Felice F, 2010, MICROVASC RES, V80, P332, DOI 10.1016/j.mvr.2010.05.004; Flight I, 2006, EUR J CLIN NUTR, V60, P1145, DOI 10.1038/sj.ejcn.1602435; Fraga CG, 2010, MOL ASPECTS MED, V31, P435, DOI 10.1016/j.mam.2010.09.006; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; Gwarzo MY, 2009, AFR J BIOTECHNOL, V8, P5169; Hamed S, 2010, AM J CLIN NUTR, V92, P161, DOI 10.3945/ajcn.2009.28408; Harris KA, 2010, CURR ATHEROSCLER REP, V12, P368, DOI 10.1007/s11883-010-0136-1; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; He TR, 2004, ARTERIOSCL THROM VAS, V24, P2021, DOI 10.1161/01.ATV.0000142810.27849.8f; He W, 2011, J ASIAN NAT PROD RES, V13, P1, DOI 10.1080/10286020.2010.535519; Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529; Huang XS, 2014, MOL CELL BIOCHEM, V385, P33, DOI 10.1007/s11010-013-1812-6; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; Jonnalagadda SS, 2011, J NUTR, V141, p1011S, DOI 10.3945/jn.110.132944; Lee KW, 2003, J AGR FOOD CHEM, V51, P6516, DOI 10.1021/jf034475w; Lee SH, 2013, FREE RADICAL RES, V47, P526, DOI 10.3109/10715762.2013.797080; Li YJ, 2010, J ETHNOPHARMACOL, V131, P562, DOI 10.1016/j.jep.2010.07.040; Lin CP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/845037; Longo V, 2011, FOOD CHEM TOXICOL, V49, P233, DOI 10.1016/j.fct.2010.10.021; Longo V, 2007, BIOTECHNOL LETT, V29, P1155, DOI 10.1007/s10529-007-9378-6; Lubrano V, 2012, INDIAN J MED RES, V136, P82; Madonna R, 2011, VASC PHARMACOL, V54, P75, DOI 10.1016/j.vph.2011.03.007; Marin C, 2013, INT J MOL SCI, V14, P8869, DOI 10.3390/ijms14058869; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Obiro WC, 2008, BRIT J NUTR, V100, P1, DOI 10.1017/S0007114508879135; Okarter N, 2010, CRIT REV FOOD SCI, V50, P193, DOI 10.1080/10408390802248734; Parzonko A, 2013, PHYTOMEDICINE, V20, P1088, DOI 10.1016/j.phymed.2013.05.002; Pasciu V, 2010, TOXICOL SCI, V114, P101, DOI 10.1093/toxsci/kfp301; Preuss HG, 2009, J AM COLL NUTR, V28, P266, DOI 10.1080/07315724.2009.10719781; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Saragih H, 2014, THROMB HAEMOST, V111; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Tang YB, 2014, BRIT J PHARMACOL, V171, P2440, DOI 10.1111/bph.12611; Tang YB, 2011, EUR CELLS MATER, V21, P459, DOI 10.22203/eCM.v021a34; Turgeon J, 2013, ATHEROSCLEROSIS, V229, P295, DOI 10.1016/j.atherosclerosis.2013.05.020; Urbich C, 2002, CIRC RES, V90, P737, DOI 10.1161/01.RES.0000014081.30867.F8; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; van Oostrom O, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-47; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang XB, 2007, CLIN EXP PHARMACOL P, V34, P1109, DOI 10.1111/j.1440-1681.2007.04667.x; Wang XB, 2011, CHINESE MED J-PEKING, V124, P4310, DOI 10.3760/cma.j.issn.0366-6999.2011.24.033; Wong CY, 2010, DIABETIC MED, V27, P54, DOI 10.1111/j.1464-5491.2009.02869.x; Wu QQ, 2013, EUR J PHARMACOL, V707, P87, DOI 10.1016/j.ejphar.2013.03.027; Xu MG, 2009, CARDIOLOGY, V112, P279, DOI 10.1159/000157336; Yoder MC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006692; Zhang T, 2013, BRIT J NUTR, V109, P223, DOI 10.1017/S0007114512001110; Zhao M, 2014, GENET MOL RES, V13, P220, DOI 10.4238/2014.January.14.1; Zhu JH, 2008, VASC PHARMACOL, V49, P106, DOI 10.1016/j.vph.2008.07.002	72	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109298	10.1371/journal.pone.0109298	http://dx.doi.org/10.1371/journal.pone.0109298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329912	gold, Green Published			2022-12-27	WOS:000345204100014
J	Souza, RWA; Piedade, WP; Soares, LC; Souza, PAT; Aguiar, AF; Vechetti, IJ; Campos, DHS; Fernandes, AAH; Okoshi, K; Carvalho, RF; Cicogna, AC; Dal-Pai-Silva, M				Souza, Rodrigo W. A.; Piedade, Warlen P.; Soares, Luana C.; Souza, Paula A. T.; Aguiar, Andreo F.; Vechetti-Junior, Ivan J.; Campos, Dijon H. S.; Fernandes, Ana A. H.; Okoshi, Katashi; Carvalho, Robson F.; Cicogna, Antonio C.; Dal-Pai-Silva, Maeli			Aerobic Exercise Training Prevents Heart Failure-Induced Skeletal Muscle Atrophy by Anti-Catabolic, but Not Anabolic Actions	PLOS ONE			English	Article							GROWTH-FACTOR-I; TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION; PROTEIN-SYNTHESIS; COMPENSATED HYPERTROPHY; MYOSTATIN EXPRESSION; AORTIC-STENOSIS; CANCER CACHEXIA; RATS; PGC-1-ALPHA	Background: Heart failure (HF) is associated with cachexia and consequent exercise intolerance. Given the beneficial effects of aerobic exercise training (ET) in HF, the aim of this study was to determine if the ET performed during the transition from cardiac dysfunction to HF would alter the expression of anabolic and catabolic factors, thus preventing skeletal muscle wasting. Methods and Results: We employed ascending aortic stenosis (AS) inducing HF in Wistar male rats. Controls were sham-operated animals. At 18 weeks after surgery, rats with cardiac dysfunction were randomized to 10 weeks of aerobic ET (ASET) or to an untrained group (AS-UN). At 28 weeks, the AS-UN group presented HF signs in conjunction with high TNF-alpha serum levels; soleus and plantaris muscle atrophy; and an increase in the expression of TNF-alpha, NF kappa B (p65), MAFbx, MuRF1, FoxO1, and myostatin catabolic factors. However, in the AS-ET group, the deterioration of cardiac function was prevented, as well as muscle wasting, and the atrophy promoters were decreased. Interestingly, changes in anabolic factor expression (IGF-I, AKT, and mTOR) were not observed. Nevertheless, in the plantaris muscle, ET maintained high PGC1 alpha levels. Conclusions: Thus, the ET capability to attenuate cardiac function during the transition from cardiac dysfunction to HF was accompanied by a prevention of skeletal muscle atrophy that did not occur via an increase in anabolic factors, but through anti-catabolic activity, presumably caused by PGC1a action. These findings indicate the therapeutic potential of aerobic ET to block HF-induced muscle atrophy by counteracting the increased catabolic state.	[Souza, Rodrigo W. A.; Piedade, Warlen P.; Soares, Luana C.; Souza, Paula A. T.; Vechetti-Junior, Ivan J.; Carvalho, Robson F.; Dal-Pai-Silva, Maeli] Sao Paulo State Univ, Dept Morphol, Botucatu, SP, Brazil; [Campos, Dijon H. S.; Okoshi, Katashi] Sao Paulo State Univ, Dept Internal Med, Botucatu, SP, Brazil; [Fernandes, Ana A. H.; Cicogna, Antonio C.] Sao Paulo State Univ, Dept Biochem, Botucatu, SP, Brazil; [Aguiar, Andreo F.] North Univ Parana, Ctr Biol & Hlth Sci, Londrina, Parana, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Dal-Pai-Silva, M (corresponding author), Sao Paulo State Univ, Dept Morphol, Botucatu, SP, Brazil.	maeli@ibb.unesp.br	Aguiar, Andreo/GYD-3840-2022; Castro, Paula/P-7369-2015; Carvalho, Robson Francisco/AAE-4134-2020; Okoshi, Katashi/A-3955-2011; CASTRO, Paula A T S/AAS-3684-2020; Vechetti, Ivan/C-5406-2012; Carvalho, Robson Francisco/E-1161-2012; Dal-Pai-Silva, Maeli/GLR-1413-2022; Soares, Luana C/P-5908-2015; Fernandes, Ana Angelica Henrique/D-5291-2012	Castro, Paula/0000-0002-9746-6960; Carvalho, Robson Francisco/0000-0002-4901-7714; Okoshi, Katashi/0000-0001-8980-8839; CASTRO, Paula A T S/0000-0002-9746-6960; Vechetti, Ivan/0000-0003-1024-1011; Carvalho, Robson Francisco/0000-0002-4901-7714; Soares, Luana C/0000-0001-9127-7061; Aguiar, Andreo/0000-0003-3337-2444; Dal Pai, Maeli/0000-0001-7269-9197; Pereira Piedade, Warlen/0000-0002-6080-8701; Cicogna, Antonio Carlos/0000-0002-4402-6523	Sao Paulo Research Foundation, Brazil [FAPESP 2010/50332-1, 2010/10583-5]; National Council for Scientific and Technological Development, Brazil [CNPq 141120/2010-0]	Sao Paulo Research Foundation, Brazil; National Council for Scientific and Technological Development, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Sao Paulo Research Foundation, Brazil, (FAPESP 2010/50332-1 and 2010/10583-5) and the National Council for Scientific and Technological Development, Brazil (CNPq 141120/2010-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; De Souza RWA, 2011, ANAT REC, V294, P1393, DOI 10.1002/ar.21428; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Arcopinto M, 2013, ENDOCR METAB IMMUNE, V13, P76, DOI 10.2174/1871530311313010010; Argadine HM, 2009, J APPL PHYSIOL, V107, P438, DOI 10.1152/japplphysiol.91247.2008; Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bacurau AVN, 2009, J APPL PHYSIOL, V106, P1631, DOI 10.1152/japplphysiol.91067.2008; Baldari C, 2009, EUR J APPL PHYSIOL, V107, P105, DOI 10.1007/s00421-009-1107-5; BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; Batista ML, 2010, CYTOKINE, V49, P102, DOI 10.1016/j.cyto.2009.10.007; Boluyt MO, 2005, AM J HYPERTENS, V18, P202, DOI 10.1016/j.amjhyper.2004.08.034; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Braun TP, 2013, FASEB J, V27, P3572, DOI 10.1096/fj.13-230375; Bregagnollo EA, 2007, ARQ BRAS CARDIOL, V88, P225, DOI 10.1590/S0066-782X2007000200015; Brink M, 2001, ENDOCRINOLOGY, V142, P1489, DOI 10.1210/en.142.4.1489; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Carvalho JF, 2005, COMP BIOCHEM PHYS A, V140, P409, DOI 10.1016/j.cbpb.2004.12.002; Carvalho RF, 2003, INT J EXP PATHOL, V84, P201, DOI 10.1046/j.1365-2613.2003.00351.x; Carvalho RF, 2010, J MOL HISTOL, V41, P81, DOI 10.1007/s10735-010-9262-x; CHARTERS Y, 1989, BIOCHEM J, V258, P493, DOI 10.1042/bj2580493; Cicogna AC, 1999, HYPERTENSION, V33, P60, DOI 10.1161/01.HYP.33.1.60; Cunha TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041701; De Sousa E, 2002, CARDIOVASC RES, V56, P260, DOI 10.1016/S0008-6363(02)00540-0; dos Santos DP, 2010, GROWTH HORM IGF RES, V20, P149, DOI 10.1016/j.ghir.2009.11.007; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; FELDMAN AM, 1993, CIRC RES, V73, P184, DOI 10.1161/01.RES.73.1.184; Ferreira JCB, 2007, CLIN EXP PHARMACOL P, V34, P760, DOI 10.1111/j.1440-1681.2007.04635.x; Galasso G, 2010, EUR J HEART FAIL, V12, P1290, DOI 10.1093/eurjhf/hfq102; Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005; Giannuzzi P, 2003, CIRCULATION, V108, P554, DOI 10.1161/01.CIR.0000081780.38477.FA; Gielen S, 2005, EUR J CARDIOV PREV R, V12, P393, DOI 10.1097/01.hjr.0000174824.94892.43; Gielen S, 2003, J AM COLL CARDIOL, V42, P861, DOI 10.1016/S0735-1097(03)00848-9; Gielen S, 2012, CIRCULATION, V125, P2716, DOI 10.1161/CIRCULATIONAHA.111.047381; Grondard C, 2008, J CELL PHYSIOL, V214, P126, DOI 10.1002/jcp.21168; Hambrecht R, 2002, J AM COLL CARDIOL, V39, P1175, DOI 10.1016/S0735-1097(02)01736-9; Harrington D, 1997, J AM COLL CARDIOL, V30, P1758, DOI 10.1016/S0735-1097(97)00381-1; Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lenk K, 2009, EUR J HEART FAIL, V11, P342, DOI 10.1093/eurjhf/hfp020; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; LI JB, 1986, KIDNEY INT, V29, P1136, DOI 10.1038/ki.1986.119; Li P, 2007, AM J PATHOL, V170, P599, DOI 10.2353/ajpath.2007.060505; Libera LD, 2001, J MOL CELL CARDIOL, V33, P1871, DOI 10.1006/jmcc.2001.1453; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Matsakas A, 2005, ACTA PHYSIOL SCAND, V183, P299, DOI 10.1111/j.1365-201X.2005.01406.x; Matsakas A, 2006, EXP PHYSIOL, V91, P983, DOI 10.1113/expphysiol.2006.033571; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mendes OC, 2013, ARQ BRAS CARDIOL, V100, P44, DOI 10.1590/S0066-782X2012005000112; Minnaard R, 2005, MUSCLE NERVE, V31, P339, DOI 10.1002/mus.20268; MINOTTI JR, 1991, J CLIN INVEST, V88, P2077, DOI 10.1172/JCI115537; Moreira JBN, 2013, J APPL PHYSIOL, V114, P1029, DOI 10.1152/japplphysiol.00760.2012; Moreira VO, 2009, CLIN EXP PHARMACOL P, V36, P325, DOI 10.1111/j.1440-1681.2008.05086.x; Moreira Vanessa Oliveira, 2006, Arq. Bras. Cardiol., V86, P432, DOI 10.1590/S0066-782X2006000600005; Niebauer J, 1998, J AM COLL CARDIOL, V32, P393, DOI 10.1016/S0735-1097(98)00226-5; Pacagnelli FL., 2014, EXP CLIN CARDIOL, V20, P3889; Pena LL, 2003, CIRCULATION, V107, P1210, DOI 10.1161/01.CIR.0000055013.92097.40; Perez EH, 2008, INT J INFECT DIS, V12, P553, DOI 10.1016/j.ijid.2008.03.007; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Picard MH, 2011, J AM SOC ECHOCARDIOG, V24, P1, DOI 10.1016/j.echo.2010.11.006; Piepoli MF, 2011, EUR J HEART FAIL, V13, P347, DOI 10.1093/eurjhf/hfr017; Piepoli MF, 2004, BMJ-BRIT MED J, V328, P189, DOI 10.1136/bmj.37938.645220.EE; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Riley DA, 1998, MUSCLE NERVE, V21, P1280; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schulze PC, 2003, BASIC RES CARDIOL, V98, P267, DOI 10.1007/s00395-003-0411-1; Sinoway LI, 2005, J APPL PHYSIOL, V99, P5, DOI 10.1152/japplphysiol.01405.2004; Siu PM, 2004, J APPL PHYSIOL, V97, P277, DOI 10.1152/japplphysiol.00534.2004; Smart Neil A, 2011, Congest Heart Fail, V17, P110, DOI 10.1111/j.1751-7133.2011.00217.x; van Hees HWH, 2008, AM J PHYSIOL-LUNG C, V294, pL1260, DOI 10.1152/ajplung.00035.2008; WEINBERG EO, 1994, CIRCULATION, V90, P1410, DOI 10.1161/01.CIR.90.3.1410; Wilkinson J.H., 1965, INTRO DIAGNOSTIC ENZ; WING SS, 1995, BIOCHEM J, V307, P639, DOI 10.1042/bj3070639; Yu Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002086	79	40	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110020	10.1371/journal.pone.0110020	http://dx.doi.org/10.1371/journal.pone.0110020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330387	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100039
J	Khan, SB; Rahman, MM; Akhtar, K; Asiri, AM				Khan, Sher Bahadar; Rahman, Mohammed M.; Akhtar, Kalsoom; Asiri, Abdullah M.			Detection and Monitoring of Toxic Chemical at Ultra Trace Level by Utilizing Doped Nanomaterial	PLOS ONE			English	Article							OXIDE; NANOCOMPOSITE; NANOPARTICLES; CELLULOSE; ALUMINA; MARKER; FILMS	Composite nanoparticles were synthesized by eco-friendly hydrothermal process and characterized by different spectroscopic techniques. All the spectroscopic techniques suggested the synthesis of well crystalline optically active composite nanoparticles with average diameter of similar to 30 nm. The synthesized nanoparticles were applied for the development of chemical sensor which was fabricated by coating the nanoparticles on silver electrode for the recognition of phthalimide using simple I-V technique. The developed sensor exhibited high sensitivity (1.7361 mu A.mM(-1).cm(-2)), lower detection limit (8.0 mu M) and long range of detection (77.0 mu M to 0.38 M). Further the resistances of composite nanoparticles based sensor was found to be 2.7 M Omega which change from 2.7 to 1.7 with change in phthalimide concentration. The major advantages of the designed sensor over existing sensors are its simple technique, low cost, lower detection limit, high sensitivity and long range of detection. It can detect phthalimide even at trace level and sense over wide range of concentrations. Therefore the composite nanoparticals would be a better choice for the fabrication of phthalimide chemical sensor and would be time and cost substituted implement for environmental safety.	[Khan, Sher Bahadar; Rahman, Mohammed M.; Asiri, Abdullah M.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia; [Rahman, Mohammed M.; Asiri, Abdullah M.] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia; [Akhtar, Kalsoom] Ewha Womans Univ, Div Nano Sci, Seoul, South Korea; [Akhtar, Kalsoom] Ewha Womans Univ, Dept Chem, Seoul 120750, South Korea	King Abdulaziz University; King Abdulaziz University; Ewha Womans University; Ewha Womans University	Khan, SB (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia.	sbkhan@kau.edu.sa	Asiri, Abdullah M./C-3458-2009; Rahman, Mohammed M./H-5823-2012; Akhtar, Kalsoom/Q-4743-2016; Khan, Sher Bahadar/H-5833-2012; Khan, Prof. Sher Bahadar/M-7968-2019	Asiri, Abdullah M./0000-0001-7905-3209; Rahman, Mohammed M./0000-0003-2773-1244; Khan, Sher Bahadar/0000-0001-9635-7175; Khan, Prof. Sher Bahadar/0000-0001-9635-7175	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [130-117-D1434]	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (130-117-D1434). The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN H, 1978, ARCH TOXICOL, V40, P255, DOI 10.1007/BF00310330; Ansari SG, 2008, BIOSENS BIOELECTRON, V23, P1838, DOI 10.1016/j.bios.2008.02.022; Ansari SG, 2008, SENSOR ACTUAT B-CHEM, V132, P265, DOI 10.1016/j.snb.2008.01.036; Ansari SG, 2009, SENSOR ACTUAT B-CHEM, V137, P566, DOI 10.1016/j.snb.2009.01.018; Bin Asif SA, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-510; Dadashi-Silab S, 2014, J POLYM SCI POL CHEM, V52, P1500, DOI 10.1002/pola.27145; Dadashi-Silab S, 2014, MACROMOL RAPID COMM, V35, P454, DOI 10.1002/marc.201300704; Khan MM, 2013, MAT SCI ENG C-MATER, V33, P4692, DOI 10.1016/j.msec.2013.07.028; Khan SB, 2014, PHYSICA E, V62, P21, DOI 10.1016/j.physe.2014.04.007; Khan SB, 2014, TALANTA, V120, P443, DOI 10.1016/j.talanta.2013.11.089; Khan SB, 2014, COMPOS PART B-ENG, V56, P392, DOI 10.1016/j.compositesb.2013.08.056; Ling XY, 2014, NANO RES, V7, P132, DOI 10.1007/s12274-013-0380-0; Liu SQ, 2010, J MATER CHEM, V20, P24, DOI 10.1039/b911328m; Mahadeva SK, 2011, SENSOR ACTUAT B-CHEM, V157, P177, DOI 10.1016/j.snb.2011.03.046; Marwani HM, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-466; Mo YW, 2002, THIN SOLID FILMS, V416, P248, DOI 10.1016/S0040-6090(02)00608-9; Munir A, 2014, J ELECTROCHEM SOC, V161, pH370, DOI 10.1149/2.044406jes; Pedarnig JD, 2014, SPECTROCHIM ACTA B, V101, P183, DOI 10.1016/j.sab.2014.08.028; Potyrailo RA, 2008, CHEM REV, V108, P770, DOI 10.1021/cr068127f; Qusti AH, 2014, J IND ENG CHEM, V20, P3394, DOI 10.1016/j.jiec.2013.12.025; Rastakhiz N, 2010, INT J ELECTROCHEM SC, V5, P1203; Su S, 2012, J MATER CHEM, V22, P18101, DOI 10.1039/c2jm33284a; Tuysuz H, 2013, NANO RES, V6, P47, DOI 10.1007/s12274-012-0280-8; Wu CH, 2013, CHEM-ASIAN J, V8, P2354, DOI 10.1002/asia.201300717; Wu XH, 2003, MATER CHEM PHYS, V77, P588, DOI 10.1016/S0254-0584(02)00116-5; Yude W, 2000, SOLID STATE ELECTRON, V44, P2009, DOI 10.1016/S0038-1101(00)00151-9; Zhang TS, 1999, MATER CHEM PHYS, V61, P192, DOI 10.1016/S0254-0584(99)00133-9	27	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109423	10.1371/journal.pone.0109423	http://dx.doi.org/10.1371/journal.pone.0109423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329666	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800025
J	Grana, JL; Redondo, N; Munoz-Rivas, MJ; Cantos, AL				Luis Grana, Jose; Redondo, Natalia; Munoz-Rivas, Marina J.; Cantos, Arthur L.			Subtypes of Batterers in Treatment: Empirical Support for a Distinction between Type I, Type II and Type III	PLOS ONE			English	Article							VIOLENT MEN; PARTNER; AGGRESSION; PREDICTORS; TYPOLOGIES; BEHAVIOR; COUPLES	This study explores the existence of different types of batterers in a sample of 266 men who had been court referred for intimate partner violence. The data collected in the assessment that have been used to perform a hierarchical and a two-step cluster analysis fall into three areas: aggression towards the partner, general aggression and presence of psychopathology and personality traits, more specifically, alcohol use, borderline and antisocial personality traits, psychopathy traits, state anger and trait anger, anger expression and control, anger, hostility, and, finally, impulsivity. The results show a typology consisting of 3 types of batterers on the basis of violence level and psychopathology: low (65%), moderate (27.8%) and high (7.1%). This study provides empirical support for the development of batterer typologies. These typologies will help achieve early detection of different types of batterers, allowing us to tailor interventions on the basis of the needs of each of the types.	[Luis Grana, Jose; Redondo, Natalia] Univ Complutense Madrid, Fac Psychol, Madrid, Spain; [Munoz-Rivas, Marina J.] Univ Autonoma Madrid, Fac Psychol, Madrid, Spain; [Cantos, Arthur L.] Rosalind Franklin Univ Med & Sci, Dept Psychol, Chicago, IL USA	Complutense University of Madrid; Autonomous University of Madrid; Chicago Medical School; Rosalind Franklin University Medical & Science	Grana, JL (corresponding author), Univ Complutense Madrid, Fac Psychol, Madrid, Spain.	jlgrana@psi.ucm.es	Redondo, Natalia/ABC-4534-2021; GRAÑA, JOSE LUIS/D-4839-2011		Spanish Ministry of Science and Innovation (Plan Nacional I+D+I) [PSI2008-02215]	Spanish Ministry of Science and Innovation (Plan Nacional I+D+I)(Ministry of Science and Innovation, Spain (MICINN))	This research was supported by Spanish Ministry of Science and Innovation (Plan Nacional I+D+I; No. Referencia: PSI2008-02215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenderfer MS., 1984, CLUSTER ANAL; Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1111/j.1530-0277.1997.tb03811.x; Babcock JC, 2004, CLIN PSYCHOL REV, V23, P1023, DOI 10.1016/j.cpr.2002.07.001; Barrat E.S.., 1995, VIOLENCE MENTAL DISO, P61; Boyle DJ, 2008, J FAM VIOLENCE, V23, P47, DOI 10.1007/s10896-007-9133-8; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Cantos AL, 2014, PARTN ABUSE, V5, P204, DOI 10.1891/1946-6560.5.2.204; Capaldi DM, 2007, CLIN PSYCHOL REV, V27, P253, DOI 10.1016/j.cpr.2006.09.001; Capaldi DM, 2003, MERRILL PALMER QUART, V49, P1, DOI 10.1353/mpq.2003.0001; Cavanaugh MM, 2005, J INTERPERS VIOLENCE, V20, P155, DOI 10.1177/0886260504268763; Chase KA, 2001, J CONSULT CLIN PSYCH, V69, P567, DOI 10.1037//0022-006X.69.3.567; Clatworthy J, 2005, BRIT J HEALTH PSYCH, V10, P329, DOI 10.1348/135910705X25697; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; First M.B., 1999, GUIA USUARIO ENTREVI; Gondolf E W, 1988, Violence Vict, V3, P187; GOTTMAN JM, 1995, J FAM PSYCHOL, V9, P227, DOI 10.1037/0893-3200.9.3.227; Hamberger L K, 1996, Violence Vict, V11, P277; HAMBERGER LK, 1991, J FAM VIOLENCE, V6, P131, DOI 10.1007/BF00978715; Hamberger LK, 1986, J FAMILY VIOLENCE, V1, P323, DOI DOI 10.1007/BF00978276; Hanson RK, 2004, PSYCHOL CRIME LAW, V10, P413, DOI 10.1080/10683160310001629283; Holtzworth-Munroe A, 2003, TREATING DIFFICULT COUPLES: HELPING CLIENTS WITH COEXISTING MENTAL AND RELATIONSHIP DISORDERS, P201; Holtzworth-Munroe A, 2003, J CONSULT CLIN PSYCH, V71, P728, DOI 10.1037/0022-006X.71.4.728; Holtzworth-Munroe A, 2000, J CONSULT CLIN PSYCH, V68, P1000, DOI 10.1037/0022-006X.68.6.1000; HOLTZWORTHMUNROE A, 1994, PSYCHOL BULL, V116, P476, DOI 10.1037/0033-2909.116.3.476; HoltzworthMunroe A, 1997, AGGRESS VIOLENT BEH, V2, P285, DOI 10.1016/S1359-1789(96)00017-1; JOHNSON MP, 1995, J MARRIAGE FAM, V57, P283, DOI 10.2307/353683; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; Lilienfeld SO, 2010, DIAGNOSING PSYCHOPAT; Loinaz I, 2012, PSICOTHEMA, V24, P142; Lynam DR, 1999, J PERS ASSESS, V73, P110, DOI 10.1207/S15327752JPA730108; Miguel-Tobal J. J., 2001, INVENTARIO EXPRESION; O'Leary KD, 1999, CLIN PSYCHOL-SCI PR, V6, P400, DOI 10.1093/clipsy.6.4.400; O'Leary KD, 2003, J CLIN CHILD ADOLESC, V32, P314, DOI 10.1207/S15374424JCCP3203_01; Olver ME, 2011, J CONSULT CLIN PSYCH, V79, P6, DOI 10.1037/a0022200; PAN HS, 1994, J CONSULT CLIN PSYCH, V62, P975, DOI 10.1037/0022-006X.62.5.975; Rodriguez JMA, 2002, PSICOTHEMA, V14, P476; Saunders D G, 1996, Violence Vict, V11, P393; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Spielberger C.D., 1988, STATE TRAIT ANGER EX; Stoops C, 2010, J FAM VIOLENCE, V25, P325, DOI 10.1007/s10896-009-9294-8; Stover CS, 2009, PROF PSYCHOL-RES PR, V40, P223, DOI 10.1037/a0012718; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Tolan P, 2006, ANNU REV PSYCHOL, V57, P557, DOI 10.1146/annurev.psych.57.102904.190110; Waltz J, 2000, J CONSULT CLIN PSYCH, V68, P658, DOI 10.1037/0022-006X.68.4.658; White RJ, 2000, J INTERPERS VIOLENCE, V15, P467, DOI 10.1177/088626000015005002	45	21	21	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110651	10.1371/journal.pone.0110651	http://dx.doi.org/10.1371/journal.pone.0110651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9XC	25329828	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210800102
J	Powell, JD; Dlugolenski, D; Nagy, T; Gabbard, J; Lee, C; Tompkins, SM; Tripp, RA				Powell, Joshua D.; Dlugolenski, Daniel; Nagy, Tamas; Gabbard, Jon; Lee, Christopher; Tompkins, Stephen M.; Tripp, Ralph A.			Polymerase Discordance in Novel Swine Influenza H3N2v Constellations Is Tolerated in Swine but Not Human Respiratory Epithelial Cells	PLOS ONE			English	Article							A VIRUSES; INTERFERON INDUCTION; UNITED-STATES; H1N1; TRANSMISSION; PIGS; REASSORTMENT; INFECTION; IDENTIFICATION; ENDONUCLEASE	Swine-origin H3N2v, a variant of H3N2 influenza virus, is a concern for novel reassortment with circulating pandemic H1N1 influenza virus (H1N1pdm09) in swine because this can lead to the emergence of a novel pandemic virus. In this study, the reassortment prevalence of H3N2v with H1N1pdm09 was determined in swine cells. Reassortants evaluated showed that the H1N1pdm09 polymerase (PA) segment occurred within swine H3N2 with similar to 80% frequency. The swine H3N2-human H1N1pdm09 PA reassortant (swH3N2-huPA) showed enhanced replication in swine cells, and was the dominant gene constellation. Ferrets infected with swH3N2-huPA had increased lung pathogenicity compared to parent viruses; however, swH3N2-huPA replication in normal human bronchoepithelial cells was attenuated - a feature linked to expression of IFN-beta and IFN-lambda genes in human but not swine cells. These findings indicate that emergence of novel H3N2v influenza constellations require more than changes in the viral polymerase complex to overcome barriers to cross-species transmission. Additionally, these findings reveal that while the ferret model is highly informative for influenza studies, slight differences in pathogenicity may not necessarily be indicative of human outcomes after infection.	[Powell, Joshua D.; Dlugolenski, Daniel; Gabbard, Jon; Lee, Christopher; Tompkins, Stephen M.; Tripp, Ralph A.] Univ Georgia, Anim Hlth Res Ctr, Dept Infect Dis, Athens, GA 30602 USA; [Nagy, Tamas] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Tripp, RA (corresponding author), Univ Georgia, Anim Hlth Res Ctr, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu	Tompkins, Stephen/A-3317-2008	Tompkins, Stephen/0000-0002-1523-5588; Powell, Joshua/0000-0003-0869-3481	Center of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN266200700006C]	Center of Excellence for Influenza Research and Surveillance (CEIRS)	The studies were funded through a contract with the Center of Excellence for Influenza Research and Surveillance (CEIRS; HHSN266200700006C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2012, VET MICROBIOL, V158, P60, DOI 10.1016/j.vetmic.2012.02.014; Biggerstaff M, 2013, CLIN INFECT DIS, V57, pS12, DOI 10.1093/cid/cit273; Brammer L, 2013, MMWR-MORBID MORTAL W, V62, P1032; Bussey KA, 2011, J VIROL, V85, P7020, DOI 10.1128/JVI.00522-11; Campbell PJ, 2014, J VIROL; Chan RWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008713; Charoenvisal N, 2013, VIRUS GENES; Chou YY, 2011, J VIROL, V85, P11235, DOI 10.1128/JVI.05794-11; Cox CM, 2011, EMERG INFECT DIS, V17, P1143, DOI [10.3201/eid1706.101488, 10.3201/eid/1706.101488]; Crisci E, 2013, MOL IMMUNOL, V55, P200, DOI 10.1016/j.molimm.2013.02.008; Desmet EA, 2013, J VIROL, V87, P3108, DOI 10.1128/JVI.02826-12; Detmer S, 2013, CURR TOP MICROBIOL, V370, P85, DOI 10.1007/82_2012_220; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Harder TC, 2013, J VIROLOGY; Hauser MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070251; Howden KJ, 2009, CAN VET J, V50, P1153; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jhung MA, 2013, CLIN INFECT DIS, V57, P1703, DOI 10.1093/cid/cit649; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Kitikoon P, 2013, J GEN VIROL, V94, P1236, DOI [10.1099/vir.0.51839-0, 10.1099/vir.0.051839-0]; Kitikoon P, 2012, J VIROL, V86, P6804, DOI 10.1128/JVI.00197-12; Kogure T, 2006, GLYCOCONJUGATE J, V23, P101, DOI 10.1007/s10719-006-5442-z; Krueger WS, 2013, CURR TOP MICROBIOL, V370, P201, DOI 10.1007/82_2012_268; Ma W, 2009, ZOONOSES PUBLIC HLTH, V56, P326, DOI 10.1111/j.1863-2378.2008.01217.x; Ma WJ, 2010, J GEN VIROL, V91, P2314, DOI 10.1099/vir.0.021402-0; Manz B, 2013, J VIROL, V87, P7200, DOI 10.1128/JVI.00980-13; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Matsuu A, 2012, MICROBIOL IMMUNOL, V56, P792, DOI 10.1111/j.1348-0421.2012.00501.x; Nalluswami Kumar, 2011, Morbidity and Mortality Weekly Report, V60, P1213; Nelson MI, 2012, J VIROL, V86, P8872, DOI 10.1128/JVI.00259-12; Olsen CW, 2006, EMERG INFECT DIS, V12, P1132, DOI 10.3201/eid1207.060268; Oshansky CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021183; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sang YM, 2010, J INTERF CYTOK RES, V30, P801, DOI 10.1089/jir.2010.0016; Shu B, 2012, VIROLOGY, V422, P151, DOI 10.1016/j.virol.2011.10.016; SHU LL, 1994, VIROLOGY, V202, P825, DOI 10.1006/viro.1994.1404; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Smith JEH, 2011, NEW SYNTH HIST LIB, V67, P1, DOI 10.1007/978-94-007-0041-3_1; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Villenave R, 2012, P NATL ACAD SCI USA, V109, P5040, DOI 10.1073/pnas.1110203109; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	47	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110264	10.1371/journal.pone.0110264	http://dx.doi.org/10.1371/journal.pone.0110264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330303	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800073
J	Takasu, M; Yamagami, T; Nakamura, Y; Komoto, D; Kaichi, Y; Tani, C; Date, S; Kiguchi, M; Awai, K				Takasu, Miyuki; Yamagami, Takuji; Nakamura, Yuko; Komoto, Daisuke; Kaichi, Yoko; Tani, Chihiro; Date, Shuji; Kiguchi, Masao; Awai, Kazuo			Multidetector Computed Tomography-Based Microstructural Analysis Reveals Reduced Bone Mineral Content and Trabecular Bone Changes in the Lumbar Spine after Transarterial Chemoembolization Therapy for Hepatocellular Carcinoma	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; PREOPERATIVE RADIOTHERAPY; RECTAL-CARCINOMA; RADIATION; FRACTURES; PREVENTS; LESIONS; BIOPSY; MODEL	Purpose: It is well recognized that therapeutic irradiation can result in bone damage. However, long-term bone toxicity associated with computed tomography (CT) performed during interventional angiography has received little attention. The purpose of this study was to determine the prevalence of osteoporosis and trabecular microstructural changes in patients after transarterial chemoembolization (TACE) for hepatocellular carcinoma therapy using an interventional-CT system. Materials and Methods: Spinal microarchitecture was examined by 64-detector CT in 81 patients who underwent TACE, 35 patients with chronic hepatitis, and 79 controls. For each patient, the volumetric CT dose index (CTDIv) during TACE (CTDIv (TACE)), the dose-length product (DLP) during TACE (DLP (TACE)), and CTDIv and DLP of routine dynamic CT scans (CTDIv (CT) and DLP (CT), respectively), were calculated as the sum since 2008. Using a three dimensional (3D) image analysis system, the tissue bone mineral density (tBMD) and trabecular parameters of the 12th thoracic vertebra were calculated. Using tBMD at a reported cutoff value of 68 mg/cm(3), the prevalence of osteoporosis was assessed. Results: The prevalence of osteoporosis was significantly greater in the TACE vs. the control group (39.6% vs. 18.2% for males, P<0.05 and 60.6% vs. 34.8% for females, P<0.01). Multivariate regression analysis demonstrated that sex, age, and CTDIv (CT) significantly affected the risk of osteoporosis. Of these indices, CTDIv (CT) had the highest area under the curve (AUC) (0.735). Correlation analyses of tBMD with cumulative radiation dose revealed weak correlations between tBMD and CTDIv (CT) (r(2) = 0.194, P<0.001). Conclusion: The prevalence of osteoporosis was significantly higher in post TACE patients than in control subjects. The cumulative radiation dose related to routine dynamic CT studies was a significant contributor to the prevalence of osteoporosis.	[Takasu, Miyuki; Yamagami, Takuji; Nakamura, Yuko; Komoto, Daisuke; Kaichi, Yoko; Tani, Chihiro; Date, Shuji; Kiguchi, Masao; Awai, Kazuo] Hiroshima Univ, Dept Diagnost Radiol, Grad Sch Biomed Sci, Hiroshima, Japan	Hiroshima University	Takasu, M (corresponding author), Hiroshima Univ, Dept Diagnost Radiol, Grad Sch Biomed Sci, Hiroshima, Japan.	my-takasu@syd.odn.ne.jp	Takasu, Miyuki/AAG-7737-2019	Takasu, Miyuki/0000-0001-7375-6501	KAKENHI [23591768]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MT was supported by Grant-in-Aid for Scientific Research (KAKENHI) (C) [23591768] in Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], RADIOLOGY, V268, P120; Bankier AA, 2010, J THORAC IMAG, V25, P278, DOI 10.1097/RTI.0b013e3181eebc49; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Carlson SK, 2001, RADIOLOGY, V219, P515, DOI 10.1148/radiology.219.2.r01ma41515; Cedermark B, 1996, ANN SURG ONCOL, V3, P423; Chandra A, 2013, BONE, V55, P449, DOI 10.1016/j.bone.2013.02.023; Cheung AM, 2008, JAMA-J AM MED ASSOC, V299, P1468, DOI 10.1001/jama.299.12.1468; Compston J, 2010, NAT REV RHEUMATOL, V6, P82, DOI 10.1038/nrrheum.2009.259; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; ERGUN H, 1980, CRC CR REV DIAGN IM, V12, P225; European Commission, 1999, 16262 EUR EN EUR COM; EWING J, 1926, ACTA RADIOL, V6, P399; FRASERHILL MA, 1992, AM J ROENTGENOL, V158, P813, DOI 10.2214/ajr.158.4.1546598; Gyorkey Z, 1940, ARCH OTOLARYNGOL, V71, P793; Hamilton SA, 2006, J APPL PHYSIOL, V101, P789, DOI 10.1152/japplphysiol.01078.2005; HARRIGAN TP, 1984, J MATER SCI, V19, P761, DOI 10.1007/BF00540446; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hofbauer LC, 2010, EUR J ENDOCRINOL, V162, P1009, DOI 10.1530/EJE-10-0015; Hofbauer LC, 2009, ARTHRITIS RHEUM, V60, P1427, DOI 10.1002/art.24445; Holm T, 1996, CANCER, V78, P968, DOI 10.1002/(SICI)1097-0142(19960901)78:5<968::AID-CNCR5>3.0.CO;2-8; Hopewell JW, 1989, BIOL BASIS RADIOTHER, P101; HOWLAND WJ, 1975, RADIOLOGY, V117, P677, DOI 10.1148/117.3.677; Ishikawa M, 2014, J VASC INTERV RADIOL, V25, P389, DOI 10.1016/j.jvir.2013.11.009; Ito M, 2005, J BONE MINER RES, V20, P1828, DOI 10.1359/JBMR.050610; Joint Commission, 2006, RAD OV REV SENT EV; Laib A, 1998, Technol Health Care, V6, P329; Laib A, 1999, COMPUT MED IMAG GRAP, V23, P69, DOI 10.1016/S0895-6111(98)00071-8; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; MacNeil JA, 2007, MED ENG PHYS, V29, P1096, DOI 10.1016/j.medengphy.2006.11.002; Maricic M, 2011, RHEUM DIS CLIN N AM, V37, P415, DOI 10.1016/j.rdc.2011.07.003; Matsuzaki K, 2013, OSTEOPOROSIS JAPAN, V21, P102; McCollough CH, 2008, HEALTH PHYS, V95, P508, DOI 10.1097/01.HP.0000326343.35884.03; Miller DL, 2003, J VASC INTERV RADIOL, V14, P711, DOI 10.1097/01.RVI.0000079980.80153.4B; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; OVERGAARD M, 1988, ACTA ONCOL, V27, P117, DOI 10.3109/02841868809090331; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PITKANEN MA, 1983, ACTA RADIOL ONCOL, V22, P253, DOI 10.3109/02841868309134038; SAMS A, 1966, INT J RADIAT BIOL RE, V10, P123, DOI 10.1080/09553006614550181; SHOPE TB, 1981, MED PHYS, V8, P488, DOI 10.1118/1.594995; Silverman SG, 1998, RADIOLOGY, V206, P429, DOI 10.1148/radiology.206.2.9457196; Stein EM, 2012, J CLIN ENDOCR METAB, V97, pE1918, DOI 10.1210/jc.2012-1968; Stockholm Colorectal Cancer Study Group, 1995, CANCER, V75, P2269; Takasu M, 2011, RADIOLOGY, V260, P472, DOI 10.1148/radiol.11101746; U.S. Food and Drug Administration. Center for Devices and Radiological Health, 2010, IN RED UNN RAD EXP M; Warren S, 1994, PHYSIOL REV, V24, P225; Weinstein RS, 2011, NEW ENGL J MED, V365, P62, DOI 10.1056/NEJMcp1012926; Willey JS, 2010, BONE, V46, P101, DOI 10.1016/j.bone.2009.09.002; Xu D, 2014, J RAD RES       0403, V3	49	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110106	10.1371/journal.pone.0110106	http://dx.doi.org/10.1371/journal.pone.0110106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329933	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210800056
J	Wu, J; Zhang, YY; Li, J; Lin, SL; Wang, LL; Jiang, Y; Pan, QC; Shen, X				Wu, Jie; Zhang, Yangyi; Li, Jing; Lin, Senlin; Wang, Lili; Jiang, Yuan; Pan, Qichao; Shen, Xin			Increase in Nontuberculous Mycobacteria Isolated in Shanghai, China: Results from a Population-Based Study	PLOS ONE			English	Article							PREVALENCE; IDENTIFICATION; EPIDEMIOLOGY; INFECTION; KANSASII	Background: In China, the prevalence of nontuberculous mycobacteria (NTM) in isolates from mycobacterial culture-positive patients with pulmonary tuberculosis (TB) is largely unknown. Methods: We used conventional biochemical and 16S rRNA gene sequencing to identify species of mycobacteria in specimens from patients suspected of having TB. Drug-susceptibility testing was performed on NTM isolates using the proportion method. We also determined the independent risk factors associated with infection with NTM compared with infection with Mycobacterium tuberculosis. Results: The overall rate of NTM isolated from mycobacterial culture-positive patients was 5.9% in this population, with a significantly increasing trend from 3.0% in 2008 to 8.5% in 2012 (P for trend <0.001). The organism most frequently identified was M. kansasii (45.0%), followed by M. intracellulare (20.8%) and M. chelonae/abscessus (14.9%). The overall proportion of isolates resistant to the four first-line anti-TB agents were 64.6% for isoniazid, 77.6% for streptomycin, 63.3% for rifampicin and 75.1% for ethambutol. The risk factors most often associated with NTM infection were older age (P for trend <0.001), being a resident of Shanghai (adjusted odds ratio [aOR], 1.48; 95% CI, 1.10-2.00), having been treated for tuberculosis (aOR, 1.64; 95% CI, 1.18-2.29), having a cavity on chest X-ray (aOR, 1.51; 95% CI, 1.16-1.96), and being sputum smear-negative (aOR, 1.59; 95% CI, 1.16-2.18). Conclusions: The prevalence of NTM isolated in Shanghai increased between 2008 and 2012, thus clinicians should consider NTM as a possible cause of TB-like disease. Accurate species identification is imperative so that proper treatment can be administered for diseases caused by the diversity of NTM species.	[Wu, Jie; Zhang, Yangyi; Li, Jing; Lin, Senlin; Wang, Lili; Jiang, Yuan; Pan, Qichao; Shen, Xin] Shanghai Municipal Ctr Dis Control & Prevent, Dept TB Control, Shanghai, Peoples R China	Shanghai Center for Disease Control & Prevention	Pan, QC (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Dept TB Control, Shanghai, Peoples R China.	panqichao@scdc.sh.cn; shenxin@scdc.sh.cn			Chinese National Science and Technology Major Project [2013ZX10004903]; Shanghai Municipal Health Bureau [XYQ2011051, 2011Y033]	Chinese National Science and Technology Major Project; Shanghai Municipal Health Bureau	This study was supported in part by grants from The Chinese National Science and Technology Major Project (No. 2013ZX10004903), Shanghai Municipal Health Bureau grants (No. XYQ2011051, No. 2011Y033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugnera MF, 2013, WATER RES, V47, P6596, DOI 10.1016/j.watres.2013.08.027; Campbell I, 2000, THORAX, V55, P210; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; de CRM, 2000, BRAZ J INFECT DIS, P86; Falkinham JO, 2002, CLIN CHEST MED, V23, P529, DOI 10.1016/S0272-5231(02)00014-X; Ferreira RMC, 2002, MEM I OSWALDO CRUZ, V97, P725, DOI 10.1590/S0074-02762002000500024; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hall L, 2003, J CLIN MICROBIOL, V41, P1447, DOI 10.1128/JCM.41.4.1447-1453.2003; Jarzembowski JA, 2008, ARCH PATHOL LAB MED, V132, P1333, DOI 10.1043/1543-2165(2008)132[1333:NMI]2.0.CO;2; Jing H, 2012, EMERG INFECT DIS, V18, P527, DOI 10.3201/eid1803.110175; Khan K, 2007, AM J RESP CRIT CARE, V176, P306, DOI 10.1164/rccm.200702-201OC; Lai CC, 2014, FUTURE MICROBIOL, V9, P93, DOI 10.2217/fmb.13.138; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Lambden K., 1996, CDR REV, V11, P147; LEVYFREBAULT V, 1983, REV EPIDEMIOL SANTE, V31, P11; Liu Zhi-hui, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P424; Marras TK, 2002, CLIN CHEST MED, V23, P553, DOI 10.1016/S0272-5231(02)00019-9; Martin-Casabona N, 2004, INT J TUBERC LUNG D, V8, P1186; MCSWIGGAN D A, 1974, Tubercle, V55, P291, DOI 10.1016/0041-3879(74)90038-5; Shen GM, 2006, EMERG INFECT DIS, V12, P1776, DOI 10.3201/eid1211.051207; Simons S, 2011, EMERG INFECT DIS, V17, P343, DOI 10.3201/eid1703.100604; Slosarek M, 1994, Cent Eur J Public Health, V2, P103; TSUKAMURA M, 1988, AM REV RESPIR DIS, V137, P1280, DOI 10.1164/ajrccm/137.6.1280; Vaerewijck MJM, 2005, FEMS MICROBIOL REV, V29, P911, DOI 10.1016/j.femsre.2005.02.001; Wallace RJ, 1997, AM J RESP CRIT CARE, V156, pS1, DOI 10.1164/ajrccm.156.2.atsstatement; Wang HX, 2010, CHINESE MED J-PEKING, V123, P184, DOI 10.3760/cma.j.issn.0366-6999.2010.02.011; Winthrop KL, 2010, AM J RESP CRIT CARE, V182, P977, DOI 10.1164/rccm.201003-0503OC; WOLINSKY E, 1979, AM REV RESPIR DIS, V119, P107	28	52	71	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109736	10.1371/journal.pone.0109736	http://dx.doi.org/10.1371/journal.pone.0109736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330201	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210800035
J	Costa, LE; Goulart, LR; Pereira, NCD; Lima, MIS; Duarte, MC; Martins, VT; Lage, PS; Menezes-Souza, D; Ribeiro, TG; Melo, MN; Fernandes, AP; Soto, M; Tavares, CAP; Chavez-Fumagalli, MA; Coelho, EAF				Costa, Lourena Emanuele; Goulart, Luiz Ricardo; de Jesus Pereira, Nathalia Cristina; Sousa Lima, Mayara Ingrid; Duarte, Mariana Costa; Martins, Vivian Tamietti; Lage, Paula Sousa; Menezes-Souza, Daniel; Ribeiro, Tatiana Gomes; Melo, Maria Norma; Fernandes, Ana Paula; Soto, Manuel; Pereira Tavares, Carlos Alberto; Chavez-Fumagalli, Miguel Angel; Ferraz Coelho, Eduardo Antonio			Mimotope-Based Vaccines of Leishmania infantum Antigens and Their Protective Efficacy against Visceral Leishmaniasis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; HEPATITIS-B-VIRUS; PHAGE DISPLAY; IMMUNE-RESPONSES; BALB/C MICE; FILAMENTOUS BACTERIOPHAGE; TRICHINELLA-SPIRALIS; CANINE LEISHMANIASIS; MONOCLONAL-ANTIBODY; C57BL/6 MICE	Background: The development of cost-effective prophylactic strategies to prevent leishmaniasis has become a high-priority. The present study has used the phage display technology to identify new immunogens, which were evaluated as vaccines in the murine model of visceral leishmaniasis (VL). Epitope-based immunogens, represented by phage-fused peptides that mimic Leishmania infantum antigens, were selected according to their affinity to antibodies from asymptomatic and symptomatic VL dogs' sera. Methodology/Main Findings: Twenty phage clones were selected after three selection cycles, and were evaluated by means of in vitro assays of the immune stimulation of spleen cells derived from naive and chronically infected with L. infantum BALB/c mice. Clones that were able to induce specific Th1 immune response, represented by high levels of IFN-gamma and low levels of IL-4 were selected, and based on their selectivity and specificity, two clones, namely B10 and C01, were further employed in the vaccination protocols. BALB/c mice vaccinated with clones plus saponin showed both a high and specific production of IFN-gamma, IL-12, and GM-CSF after in vitro stimulation with individual clones or L. infantum extracts. Additionally, these animals, when compared to control groups (saline, saponin, wild-type phage plus saponin, or non-relevant phage clone plus saponin), showed significant reductions in the parasite burden in the liver, spleen, bone marrow, and paws' draining lymph nodes. Protection was associated with an IL-12-dependent production of IFN-gamma, mainly by CD8(+) T cells, against parasite proteins. These animals also presented decreased parasite-mediated IL-4 and IL-10 responses, and increased levels of parasite-specific IgG2a antibodies. Conclusions/Significance: This study describes two phage clones that mimic L. infantum antigens, which were directly used as immunogens in vaccines and presented Th1-type immune responses, and that significantly reduced the parasite burden. This is the first study that describes phage-displayed peptides as successful immunogens in vaccine formulations against VL.	[Costa, Lourena Emanuele; de Jesus Pereira, Nathalia Cristina; Duarte, Mariana Costa; Lage, Paula Sousa; Chavez-Fumagalli, Miguel Angel; Ferraz Coelho, Eduardo Antonio] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil; [Goulart, Luiz Ricardo; Sousa Lima, Mayara Ingrid] Univ Fed Uberlandia, Inst Genet & Bioquim, BR-38400 Uberlandia, MG, Brazil; [Goulart, Luiz Ricardo] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Martins, Vivian Tamietti; Pereira Tavares, Carlos Alberto] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Menezes-Souza, Daniel; Melo, Maria Norma] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Ribeiro, Tatiana Gomes] Univ Fed Minas Gerais, Fac Farm, Programa Posgrad Ciencias Farmaceut, Belo Horizonte, MG, Brazil; [Fernandes, Ana Paula] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil; [Soto, Manuel] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, CSIC UAM, Madrid, Spain; [Ferraz Coelho, Eduardo Antonio] Univ Fed Minas Gerais, Dept Patol Clin, COLTEC, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Uberlandia; University of California System; University of California Davis; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidade Federal de Minas Gerais	Coelho, EAF (corresponding author), Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.	eduardoferrazcoelho@yahoo.com.br	COELHO, EA/V-7926-2017; Chávez Fumagalli, Miguel Angel/I-6756-2016; Menezes-Souza, Daniel DMS/N-7389-2014; Goulart, Luiz/G-7357-2012; Soto Alvarez, Manuel/Q-5234-2018	COELHO, EA/0000-0002-6681-9014; Chávez Fumagalli, Miguel Angel/0000-0002-8394-4802; Goulart, Luiz/0000-0002-1803-4861; Soto Alvarez, Manuel/0000-0001-6825-841X	Pro-Reitoria de Pesquisa from UFMG [Edital 01/2014]; Instituto Nacional de Ciencia e Tecnologia em Nanobiofarmaceutica (INCT-Nanobiofar); FAPEMIG [PRONEX APQ-0101909, CBB-APQ-00496-11, CBB-APQ-00819-12]; CAPES (Rede Nanobiotec/Brasil); FAPEMIG/CAPES; CNPq	Pro-Reitoria de Pesquisa from UFMG; Instituto Nacional de Ciencia e Tecnologia em Nanobiofarmaceutica (INCT-Nanobiofar); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Rede Nanobiotec/Brasil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Pro-Reitoria de Pesquisa from UFMG (Edital 01/2014), Instituto Nacional de Ciencia e Tecnologia em Nanobiofarmaceutica (INCT-Nanobiofar), FAPEMIG (PRONEX APQ-0101909, CBB-APQ-00496-11 and CBB-APQ-00819-12), CAPES (Rede Nanobiotec/Brasil) and CNPq (APQ-472090/2011-9 and APQ-482976/2012-8). MACF is a grant recipient of FAPEMIG/CAPES. EAFC and LRG are grant recipient of CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhya S, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a012518; AFONSO LCC, 1993, INFECT IMMUN, V61, P2952, DOI 10.1128/IAI.61.7.2952-2959.1993; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Awasthi A, 2004, INDIAN J MED RES, V119, P238; Badaro R, 2001, Braz J Infect Dis, V5, P223; Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Beghetto E, 2003, INT J PARASITOL, V33, P163, DOI 10.1016/S0020-7519(02)00256-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruhn KW, 2012, CLIN VACCINE IMMUNOL, V19, P490, DOI 10.1128/CVI.05660-11; Carrion J, 2006, PARASITE IMMUNOL, V28, P173, DOI 10.1111/j.1365-3024.2006.00817.x; Chavez-Fumagalli MA, 2010, MICROBES INFECT, V12, P967, DOI 10.1016/j.micinf.2010.06.008; Clark JR, 2004, FEMS IMMUNOL MED MIC, V40, P21, DOI 10.1016/S0928-8244(03)00344-4; Coelho EAF, 2003, INFECT IMMUN, V71, P3988, DOI 10.1128/IAI.71.7.3988-3994.2003; Coelho EAF, 2009, CLIN VACCINE IMMUNOL, V16, P1774, DOI 10.1128/CVI.00295-09; Coelho VTS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001430; Coomber DWJ, 2001, CLIN CANCER RES, V7, P2802; Costa LE, 2014, CLIN VACCINE IMMUNOL, V21, P96, DOI 10.1128/CVI.00583-13; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Cruz I, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-342; Cui J, 2013, VACCINE, V31, P1171, DOI 10.1016/j.vaccine.2012.12.070; Cunha JP, 2010, IMMUNOBIOLOGY, V215, P26, DOI 10.1016/j.imbio.2009.01.008; Demangel C, 1996, MOL IMMUNOL, V33, P909, DOI 10.1016/S0161-5890(96)00058-2; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dumas C, 2003, INFECT IMMUN, V71, P6499, DOI 10.1128/IAI.71.11.6499-6509.2003; Duprey ZH, 2006, EMERG INFECT DIS, V12, P440, DOI 10.3201/eid1203.050811; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; Frenkel D, 2000, P NATL ACAD SCI USA, V97, P11455, DOI 10.1073/pnas.97.21.11455; Garg R, 2006, INDIAN J MED RES, V123, P439; Gaubin M, 2003, DNA CELL BIOL, V22, P11, DOI 10.1089/104454903321112451; GERMASCHEWSKI V, 1995, J MED VIROL, V45, P300, DOI 10.1002/jmv.1890450311; Gnanasekar M, 2004, INFECT IMMUN, V72, P4707, DOI 10.1128/IAI.72.8.4707-4715.2004; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; GREENWOOD J, 1991, J MOL BIOL, V220, P821, DOI 10.1016/0022-2836(91)90354-9; Gu Y, 2008, EXP PARASITOL, V118, P66, DOI 10.1016/j.exppara.2007.06.014; Gumy A, 2004, INT J PARASITOL, V34, P433, DOI 10.1016/j.ijpara.2003.11.021; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; Hardy B, 2005, VACCINE, V23, P4283, DOI 10.1016/j.vaccine.2005.04.009; Hashiguchi S, 2010, BIOCHEM BIOPH RES CO, V402, P19, DOI 10.1016/j.bbrc.2010.09.094; Huang J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/101932; Jayanna PK, 2010, PROTEIN ENG DES SEL, V23, P423, DOI 10.1093/protein/gzq011; Ledon T, 2012, MICROBES INFECT, V14, P968, DOI 10.1016/j.micinf.2012.04.004; Lehmann J, 2000, J INTERF CYTOK RES, V20, P63, DOI 10.1089/107999000312748; Lima MM, 2012, T ROY SOC TROP MED H, V106, P143, DOI 10.1016/j.trstmh.2011.10.013; Manoutcharian K, 2004, VET IMMUNOL IMMUNOP, V99, P11, DOI 10.1016/j.vetimm.2003.12.009; Manoutcharian K, 1999, INFECT IMMUN, V67, P4764, DOI 10.1128/IAI.67.9.4764-4770.1999; Martins VT, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002148, 10.1371/annotation/427655ac-c278-41f5-95ca-6279c562752f]; Mason KA, 2005, CLIN CANCER RES, V11, P361; Minodier Philippe, 2007, Travel Med Infect Dis, V5, P150, DOI 10.1016/j.tmaid.2006.09.004; Mizbani A, 2009, VACCINE, V28, P53, DOI 10.1016/j.vaccine.2009.09.114; Monette M, 2001, PROTEIN SCI, V10, P1150, DOI 10.1110/ps.35901; Murphy ML, 2001, EUR J IMMUNOL, V31, P2848, DOI 10.1002/1521-4141(2001010)31:10&lt;2848::AID-IMMU2848&gt;3.0.CO;2-T; MURRAY HW, 1995, J CLIN INVEST, V95, P1183, DOI 10.1172/JCI117767; Murray HW, 2002, INFECT IMMUN, V70, P6284, DOI 10.1128/IAI.70.11.6284-6293.2002; Costa CHN, 2011, PLOS NEGLECT TROP D, V5, DOI [10.1371/journal.pntd.0000965, 10.1371/journal.pntd.0000943]; Oliveira DM, 2012, PARASITOL RES, V110, P1277, DOI 10.1007/s00436-011-2628-5; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; Pitcovsky TA, 2001, INFECT IMMUN, V69, P1869, DOI 10.1128/IAI.69.3.1869-1875.2001; Pouyanfard S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049539; Prudencio CR, 2011, EXP PARASITOL, V129, P388, DOI 10.1016/j.exppara.2011.08.017; Ramirez L, 2014, PARASITE VECTOR, V2, P3, DOI DOI 10.1186/1756-3305-7-3; Ramirez L, 2013, VACCINE, V31, P1312, DOI 10.1016/j.vaccine.2012.12.071; Ribeiro VD, 2013, IMMUNOL LETT, V156, P59, DOI 10.1016/j.imlet.2013.09.005; Roque ALR, 2013, VET PARASITOL, V193, P71, DOI 10.1016/j.vetpar.2012.11.028; Ru BB, 2010, MOLECULES, V15, P8279, DOI 10.3390/molecules15118279; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Shtatland T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-280; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Spitzer N, 1999, VACCINE, V17, P1298, DOI 10.1016/S0264-410X(98)00363-6; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Vieira LQ, 1996, J IMMUNOL, V157, P827; Wagner S, 2005, J IMMUNOL, V174, P976, DOI 10.4049/jimmunol.174.2.976; Wan Y, 2001, VACCINE, V19, P2918, DOI 10.1016/S0264-410X(00)00561-2; Wang LF, 2004, CURR DRUG TARGETS, V5, P1, DOI 10.2174/1389450043490668; World Health Organization, 2010, M 399 WHO EXP COMM C; Wu HW, 2006, ACTA TROP, V99, P200, DOI 10.1016/j.actatropica.2006.08.006; Wu WH, 2010, EUR J IMMUNOL, V40, P2517, DOI 10.1002/eji.201040484; Yang Q, 2005, VACCINE, V23, P4088, DOI 10.1016/j.vaccine.2004.07.005; Zanin FHC, 2007, MICROBES INFECT, V9, P1070, DOI 10.1016/j.micinf.2007.05.012	79	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110014	10.1371/journal.pone.0110014	http://dx.doi.org/10.1371/journal.pone.0110014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333662	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200077
J	Kaczmarczyk, A; Sullivan, KF				Kaczmarczyk, Agnieszka; Sullivan, Kevin F.			CENP-W Plays a Role in Maintaining Bipolar Spindle Structure	PLOS ONE			English	Article							POLE ORGANIZATION; MITOTIC SPINDLE; CHROMOSOMAL INSTABILITY; MICROTUBULE ATTACHMENT; CENTROSOME SEPARATION; CENTROMERIC CHROMATIN; MAMMALIAN-CELLS; NDC80 COMPLEX; KINETOCHORE; TPX2	The CENP-W/T complex was previously reported to be required for mitosis. HeLa cells depleted of CENP-W displayed profound mitotic defects, with mitotic timing delay, disorganized prometaphases and multipolar spindles as major phenotypic consequences. In this study, we examined the process of multipolar spindle formation induced by CENP-W depletion. Depletion of CENP-W in HeLa cells labeled with histone H2B and tubulin fluorescent proteins induced rapid fragmentation of originally bipolar spindles in a high proportion of cells. CENP-W depletion was associated with depletion of Hec1 at kinetochores. The possibility of promiscuous centrosomal duplication was ruled out by immunofluorescent examination of centrioles. However, centrioles were frequently observed to be abnormally split. In addition, a large proportion of the supernumerary poles lacked centrioles, but were positively stained with different centrosomal markers. These observations suggested that perturbation in spindle force distribution caused by defective kinetochores could contribute to a mechanical mechanism for spindle pole disruption. 'Spindle free' nocodazole arrested cells did not exhibit pole fragmentation after CENP-W depletion, showing that pole fragmentation is microtubule dependent. Inhibition of centrosome separation by monastrol reduced the incidence of spindle pole fragmentation, indicating that Eg5 plays a role in spindle pole disruption. Surprisingly, CENP-W depletion rescued the monopolar spindle phenotype of monastrol treatment, with an increased frequency of bipolar spindles observed after CENP-W RNAi. We overexpressed the microtubule cross-linking protein TPX2 to create spindle poles stabilized by the microtubule cross-linking activity of TPX2. Spindle pole fragmentation was suppressed in a TPX2-dependent fashion. We propose that CENP-W, by influencing proper kinetochore assembly, particularly microtubule docking sites, can confer spindle pole resistance to traction forces exerted by motor proteins during chromosome congression. Taken together, our findings are consistent with a model in which centrosome integrity is controlled by the pathways regulating kinetochore-microtubule attachment stability.	[Kaczmarczyk, Agnieszka; Sullivan, Kevin F.] Natl Univ Ireland, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Sullivan, KF (corresponding author), Natl Univ Ireland, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland.	kevin.sullivan@nuigalway.ie		Sullivan, Kevin/0000-0002-5374-8245; Kaczmarczyk, Agnieszka/0000-0002-0928-5490	Science Foundation Ireland [SFI 05/RP1/B793]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by a grant from Science Foundation Ireland (SFI 05/RP1/B793). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Bock LJ, 2012, NAT CELL BIOL, V14, P614, DOI 10.1038/ncb2495; Borel F, 2002, P NATL ACAD SCI USA, V99, P9819, DOI 10.1073/pnas.152205299; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Dionne MA, 1999, CELL MOTIL CYTOSKEL, V42, P189, DOI 10.1002/(SICI)1097-0169(1999)42:3<189::AID-CM3>3.0.CO;2-X; Dornblut C, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130229; Dumont J, 2012, TRENDS CELL BIOL, V22, P241, DOI 10.1016/j.tcb.2012.02.007; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gordon MB, 2001, J CELL BIOL, V152, P425, DOI 10.1083/jcb.152.3.425; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Inanc B, 2010, MOL BIOL CELL, V21, P3866, DOI 10.1091/mbc.E10-02-0124; JORDAN MA, 1992, J CELL SCI, V102, P401; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Logarinho E, 2012, NAT CELL BIOL, V14, P295, DOI 10.1038/ncb2423; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; Ma N, 2011, J CELL BIOL, V195, P87, DOI 10.1083/jcb.201106149; Ma N, 2010, MOL BIOL CELL, V21, P979, DOI 10.1091/mbc.E09-07-0601; Manning AL, 2007, CURR BIOL, V17, P260, DOI 10.1016/j.cub.2006.11.071; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Mattiuzzo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016307; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Nigg EA, 2006, NATURE, V442, P874, DOI 10.1038/442874a; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Prendergast L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001082; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Schleiffer A, 2012, NAT CELL BIOL, V14, P604, DOI 10.1038/ncb2493; Screpanti E, 2011, CURR BIOL; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Takeuchi K, 2014, NUCLEIC ACIDS RES, V42, P1644, DOI 10.1093/nar/gkt1124; Tanenbaum ME, 2008, EMBO J, V27, P3235, DOI 10.1038/emboj.2008.242; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Thompson LH, 2010, MOL CELL, V37, P749, DOI 10.1016/j.molcel.2010.03.003; Uteng M, 2008, J CELL BIOL, V182, P715, DOI 10.1083/jcb.200801125; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Winey M, 1999, CURR BIOL, V9, pR449, DOI 10.1016/S0960-9822(99)80279-6; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405	60	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e106464	10.1371/journal.pone.0106464	http://dx.doi.org/10.1371/journal.pone.0106464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329824	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200002
J	McGregor, HW; Legge, S; Jones, ME; Johnson, CN				McGregor, Hugh W.; Legge, Sarah; Jones, Menna E.; Johnson, Christopher N.			Landscape Management of Fire and Grazing Regimes Alters the Fine-Scale Habitat Utilisation by Feral Cats	PLOS ONE			English	Article							SMALL MAMMAL COMMUNITIES; BIODIVERSITY CONSERVATION; NORTHERN AUSTRALIA; TROPICAL SAVANNAS; FELIS-CATUS; SELECTION; POPULATION; PREDATION; CATTLE; ENVIRONMENT	Intensification of fires and grazing by large herbivores has caused population declines in small vertebrates in many ecosystems worldwide. Impacts are rarely direct, and usually appear driven via indirect pathways, such as changes to predator-prey dynamics. Fire events and grazing may improve habitat and/or hunting success for the predators of small mammals, however, such impacts have not been documented. To test for such an interaction, we investigated fine-scale habitat selection by feral cats in relation to fire, grazing and small-mammal abundance. Our study was conducted in northwestern Australia, where small mammal populations are sensitive to changes in fire and grazing management. We deployed GPS collars on 32 cats in landscapes with contrasting fire and grazing treatments. Fine-scale habitat selection was determined using discrete choice modelling of cat movements. We found that cats selected areas with open grass cover, including heavily-grazed areas. They strongly selected for areas recently burnt by intense fires, but only in habitats that typically support high abundance of small mammals. Intense fires and grazing by introduced herbivores created conditions that are favoured by cats, probably because their hunting success is improved. This mechanism could explain why, in northern Australia, impacts of feral cats on small mammals might have increased. Our results suggest the impact of feral cats could be reduced in most ecosystems by maximising grass cover, minimising the incidence of intense fires, and reducing grazing by large herbivores.	[McGregor, Hugh W.; Jones, Menna E.; Johnson, Christopher N.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [McGregor, Hugh W.] Australian Wildlife Conservancy, Derby, WA, Australia; [Legge, Sarah] Mornington Wildlife Sanctuary, Australian Wildlife Conservancy, Derby, WA, Australia	University of Tasmania	McGregor, HW (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	hugh.mcgregor@australianwildlife.org	Legge, Sarah/GYE-1554-2022; McGregor, Hugh W/T-2283-2017; Legge, Sarah/AAB-7229-2019; Johnson, Christopher/J-7894-2014	McGregor, Hugh W/0000-0003-3255-9282; Legge, Sarah/0000-0001-6968-2781; Johnson, Christopher/0000-0002-9719-3771; Jones, Menna/0000-0001-7558-9022	Australian Research Council; Western Australian Department of Parks and Wildlife (Kimberley Science and Conservation Strategy); Australian Wildlife Conservancy	Australian Research Council(Australian Research Council); Western Australian Department of Parks and Wildlife (Kimberley Science and Conservation Strategy); Australian Wildlife Conservancy	The research was funded by the Australian Research Council, the Western Australian Department of Parks and Wildlife (Kimberley Science and Conservation Strategy), and supporters of the Australian Wildlife Conservancy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott I, 2002, WILDLIFE RES, V29, P51, DOI 10.1071/WR01011; Andersen AN, 2005, AUSTRAL ECOL, V30, P155, DOI 10.1111/j.1442-9993.2005.01441.x; Banks SC, 2011, OIKOS, V120, P26, DOI 10.1111/j.1600-0706.2010.18765.x; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Brook LA, 2013, PREDATOR GUILD INTER; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; BROWN RL, 1982, J RANGE MANAGE, V35, P727, DOI 10.2307/3898250; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Conner LM, 2011, J WILDLIFE MANAGE, V75, P938, DOI 10.1002/jwmg.110; Cooper AB, 1999, ECOLOGY, V80, P566, DOI 10.1890/0012-9658(1999)080[0566:TAODCM]2.0.CO;2; Dickman C., 1996, OVERVIEW IMPACTS FER; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; Firth RSC, 2010, BIOL CONSERV, V143, P1193, DOI 10.1016/j.biocon.2010.02.027; Fisher DO, 2014, GLOBAL ECOL BIOGEOGR, V23, P181, DOI 10.1111/geb.12088; Frank ASK, 2014, J APPL ECOL, V51, P1486, DOI 10.1111/1365-2664.12323; Genovesi P, 1995, WILDLIFE BIOL, V1, P233, DOI 10.2981/wlb.1995.0028; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; GRIFFITHS D, 1975, ECOLOGY, V56, P1209, DOI 10.2307/1936161; Hall LS, 2000, MAMMALIA, V64, P19, DOI 10.1515/mamm.2000.64.1.19; Hebblewhite M, 2005, OIKOS, V111, P101, DOI 10.1111/j.0030-1299.2005.13858.x; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Horn KJ, 2012, J ARID ENVIRON, V77, P54, DOI 10.1016/j.jaridenv.2011.10.003; Jones A, 2000, WEST N AM NATURALIST, V60, P155; Koenen MT, 1996, WILSON BULL, V108, P292; Krofel M, 2013, ECOL RES, V28, P103, DOI 10.1007/s11284-012-1005-x; Kutt AS, 2012, J ZOOL, V287, P292, DOI 10.1111/j.1469-7998.2012.00915.x; Kutt AS, 2007, J TROP ECOL, V23, P95, DOI 10.1017/S0266467406003579; Legge S, 2014, ECOLOGICAL HLTH MORN; Legge S, 2008, WILDLIFE RES, V35, P33, DOI 10.1071/WR07016; Legge S, 2011, AUSTRAL ECOL, V36, P791, DOI 10.1111/j.1442-9993.2010.02218.x; Liedloff AC, 2001, ENVIRON INT, V27, P173, DOI 10.1016/S0160-4120(01)00079-4; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Moseby KE, 2009, WILDLIFE RES, V36, P422, DOI 10.1071/WR08098; Moseby Katherine E., 2012, International Journal of Ecology, P1; Oakwood M, 2000, AUST J ZOOL, V48, P519, DOI 10.1071/ZO00028; Pardon LG, 2003, J ANIM ECOL, V72, P106, DOI 10.1046/j.1365-2656.2003.00686.x; R Core Team, 2018, R LANG ENV STAT COMP; Radford IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092341; Rajaratnam R, 2007, J TROP ECOL, V23, P209, DOI 10.1017/S0266467406003841; Recio MR, 2014, BIOL INVASIONS, V1, P1; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, P283, DOI 10.1071/WF03015; Russell-Smith J, 2002, BIOL CONSERV, V104, P91, DOI 10.1016/S0006-3207(01)00157-4; Southgate R, 1996, WILDLIFE RES, V23, P647, DOI 10.1071/WR9960647; Sutherland EF, 1999, WILDLIFE RES, V26, P405, DOI 10.1071/WR97045; Tabeni S, 2003, J ARID ENVIRON, V55, P715, DOI 10.1016/S0140-1963(02)00314-2; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Tomkins N, 2007, RANGELAND J, V29, P217, DOI 10.1071/RJ07024; Torre I, 2007, BASIC APPL ECOL, V8, P565, DOI 10.1016/j.baae.2006.09.016; Wang YW, 2012, WILDLIFE RES, V39, P611, DOI 10.1071/WR11210; Woinarski J, 2007, NATURE OF NORTHERN AUSTRALIA: NATURAL VALUES, ECOLOGICAL PROCESSES AND FUTURE PROSPECTS, P1; Woinarski JCZ, 2011, WILDLIFE RES, V38, P307, DOI 10.1071/WR10184; Woinarski JCZ, 2010, WILDLIFE RES, V37, P116, DOI 10.1071/WR09125; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Yarnell RW, 2007, OECOLOGIA, V154, P387, DOI 10.1007/s00442-007-0841-9; Ziembicki MR, 2013, BIOL CONSERV, V157, P78, DOI 10.1016/j.biocon.2012.07.004	58	157	165	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109097	10.1371/journal.pone.0109097	http://dx.doi.org/10.1371/journal.pone.0109097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329902	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200018
J	Tao, VQ; Chan, KYK; Chu, YWY; Mok, GTK; Tan, TY; Yang, WL; Lee, SL; Tang, WF; Tso, WWY; Lau, ET; Kan, ASY; Tang, MH; Lau, YL; Chung, BHY				Tao, Victoria Q.; Chan, Kelvin Y. K.; Chu, Yoyo W. Y.; Mok, Gary T. K.; Tan, Tiong Y.; Yang, Wanling; Lee, So Lun; Tang, Wing Fai; Tso, Winnie W. Y.; Lau, Elizabeth T.; Kan, Anita S. Y.; Tang, Mary H.; Lau, Yu-lung; Chung, Brian H. Y.			The Clinical Impact of Chromosomal Microarray on Paediatric Care in Hong Kong	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; AUTISM SPECTRUM DISORDERS; PRADER-WILLI-SYNDROME; INTELLECTUAL DISABILITY; DEVELOPMENTAL DELAY; ARRAY CGH; CONGENITAL-ANOMALIES; MENTAL-RETARDATION; MEDICAL-MANAGEMENT; DIAGNOSTIC-TEST	Objective: To evaluate the clinical impact of chromosomal microarray (CMA) on the management of paediatric patients in Hong Kong. Methods: We performed NimbleGen 135k oligonucleotide array on 327 children with intellectual disability (ID)/developmental delay (DD), autism spectrum disorders (ASD), and/or multiple congenital anomalies (MCAs) in a university-affiliated paediatric unit from January 2011 to May 2013. The medical records of patients were reviewed in September 2013, focusing on the pathogenic/likely pathogenic CMA findings and their "clinical actionability'' based on established criteria. Results: Thirty-seven patients were reported to have pathogenic/likely pathogenic results, while 40 had findings of unknown significance. This gives a detection rate of 11% for clinically significant (pathogenic/likely pathogenic) findings. The significant findings have prompted clinical actions in 28 out of 37 patients (75.7%), while the findings with unknown significance have led to further management recommendation in only 1 patient (p<0.001). Nineteen out of the 28 management recommendations are "evidence-based'' on either practice guidelines endorsed by a professional society (n = 9, Level 1) or peer-reviewed publications making medical management recommendation (n = 10, Level 2). CMA results impact medical management by precipitating referral to a specialist (n = 24); diagnostic testing (n = 25), surveillance of complications (n = 19), interventional procedure (n = 7), medication (n = 15) or lifestyle modification (n = 12). Conclusion: The application of CMA in children with ID/DD, ASD, and/or MCAs in Hong Kong results in a diagnostic yield of similar to 11% for pathogenic/likely pathogenic results. Importantly the yield for clinically actionable results is 8.6%. We advocate using diagnostic yield of clinically actionable results to evaluate CMA as it provides information of both clinical validity and clinical utility. Furthermore, it incorporates evidence-based medicine into the practice of genomic medicine. The same framework can be applied to other genomic testing strategies enabled by next-generation sequencing.	[Tao, Victoria Q.; Chu, Yoyo W. Y.; Mok, Gary T. K.; Tan, Tiong Y.; Yang, Wanling; Lee, So Lun; Tso, Winnie W. Y.; Lau, Yu-lung; Chung, Brian H. Y.] Univ Hong Kong, LKS Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Kelvin Y. K.; Kan, Anita S. Y.] Queen Mary Hosp, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China; [Tan, Tiong Y.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Victorian Clin Genet Serv,Dept Paediat, Melbourne, Vic, Australia; [Tang, Wing Fai; Lau, Elizabeth T.; Tang, Mary H.; Chung, Brian H. Y.] Univ Hong Kong, LKS Fac Med, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Hong Kong	Chung, BHY (corresponding author), Univ Hong Kong, LKS Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	bhychung@hku.hk	Chan, Kelvin/HGA-3097-2022; Tan, Tiong Yang/AAV-6563-2020; Tso, Wan Yee Winnie/C-4751-2009; Lau, Yu Lung/C-4322-2009	Tan, Tiong Yang/0000-0001-8455-7778; Tao, Qinchen Victoria/0000-0002-0614-9901; Lee, So Lun/0000-0003-3056-9778; Tso, Wan Yee Winnie/0000-0002-5859-015X; Lau, Yu Lung/0000-0002-4780-0289	SK Yee Medical Foundation [211203, 212210]; SK Yee Medical Research [20006551]; Overseas Training Fellowship - National Health and Medical Research Council of Australia [607431]	SK Yee Medical Foundation; SK Yee Medical Research; Overseas Training Fellowship - National Health and Medical Research Council of Australia	The study was funded by SK Yee Medical Foundation 2011 (#211203), SK Yee Medical Foundation 2012 (#212210), and SK Yee Medical Research 2012 (#20006551) applied by BHYC.(http://www.skyeemedicalfoundation.org/). TYT was funded by an Overseas Training Fellowship (#607431) provided by the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MP, 2009, J PEDIATR, V154, P143, DOI 10.1016/j.jpeds.2008.07.045; Adams SA, 2009, GENET MED, V11, P314, DOI 10.1097/GIM.0b013e3181a028a5; Aksglaede L, 2013, AM J MED GENET C, V163C, P55, DOI 10.1002/ajmg.c.31349; [Anonymous], 1993, GENEREVIEWS; Battaglia A, 2013, EUR J PAEDIATR NEURO, V17, P589, DOI 10.1016/j.ejpn.2013.04.010; Borgatti R, 2009, CLIN GENET, V76, P573, DOI 10.1111/j.1399-0004.2009.01262.x; Burke W, 2002, AM J EPIDEMIOL, V156, P311, DOI 10.1093/aje/kwf055; Byeon JH, 2014, EPILEPSIA, V55, P55; Caliebe A, 2010, EUR J MED GENET, V53, P179, DOI 10.1016/j.ejmg.2010.04.001; Coulter ME, 2011, GENET MED, V13, P770, DOI 10.1097/GIM.0b013e31821dd54a; Courtens W, 2006, AM J MED GENET A, V140A, P402, DOI 10.1002/ajmg.a.31053; Dierking A, 2014, EUR J HUM GENET; Edelmann L, 2009, ANN NY ACAD SCI, V1151, P157, DOI 10.1111/j.1749-6632.2008.03610.x; Ellison JW, 2012, PEDIATRICS, V130, pE1085, DOI 10.1542/peds.2012-0568; Groth KA, 2013, J CLIN ENDOCR METAB, V98, P20, DOI 10.1210/jc.2012-2382; Haddow J, 2004, ACCE MODEL PROCESS E, P217; Hastings R, 2012, EUR J HUM GENET, V20, P911, DOI 10.1038/ejhg.2012.56; Henderson LB, 2014, GENET MED; Ho ACC, 2012, EUR J MED GENET, V55, P758, DOI 10.1016/j.ejmg.2012.09.011; Hochstenbach R, 2009, EUR J MED GENET, V52, P161, DOI 10.1016/j.ejmg.2009.03.015; Iourov IY, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-46; Kan ASY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087988; Kang JU, 2012, INT J MOL MED, V30, P223, DOI 10.3892/ijmm.2012.988; Kearney HM, 2011, GENET MED, V13, P680, DOI 10.1097/GIM.0b013e3182217a3a; Lee CG, 2013, YONSEI MED J, V54, P1463, DOI 10.3349/ymj.2013.54.6.1463; Liu APY, 2013, AM J MED GENET A, V161A, P1309, DOI 10.1002/ajmg.a.35909; Lukusa T, 2000, GENET COUNSEL, V11, P119; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mills KI, 2013, AM J MED GENET A, V161A, P137, DOI 10.1002/ajmg.a.35701; Mroch AR, 2012, CURR PROB PEDIATR AD, V42, P74, DOI 10.1016/j.cppeds.2011.10.003; NOWINSKI GP, 1990, AM J HUM GENET, V46, P1101; Orellana C, 2009, CYTOGENET GENOME RES, V127, P5, DOI 10.1159/000279261; Palmer E, 2014, AM J MED GENET A, V164, P377, DOI 10.1002/ajmg.a.36279; Park SJ, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-12; Regier DA, 2010, AM J HUM GENET, V86, P765, DOI 10.1016/j.ajhg.2010.03.009; Riggs ER, 2014, CLIN GENET, V85, P147, DOI 10.1111/cge.12107; Saam J, 2008, GENET MED, V10, P181, DOI 10.1097/GIM.0b013e3181634eca; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Tsang JS, 2013, ESOPHAGUS-TOKYO, V10, P114, DOI 10.1007/s10388-012-0355-3; U.S. Department of Health and Human Services Secretary's Advisory Committee on Genetic Testing, 2000, FED REGISTER, V65, P76643; van Bon BWM, 2008, J MED GENET, V45, P346, DOI 10.1136/jmg.2007.055830; Verhagen JMA, 2012, AM J MED GENET A, V158A, P2412, DOI 10.1002/ajmg.a.35517; WALD N, 1989, BRIT J OBSTET GYNAEC, V96, P389, DOI 10.1111/j.1471-0528.1989.tb02411.x; Wu Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-72	47	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109629	10.1371/journal.pone.0109629	http://dx.doi.org/10.1371/journal.pone.0109629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333781	Green Published, gold			2022-12-27	WOS:000346766200045
J	Tomkins, JL; Aungier, J; Hazel, W; Gilbert, L				Tomkins, Joseph L.; Aungier, Jennifer; Hazel, Wade; Gilbert, Lucy			Towards an Evolutionary Understanding of Questing Behaviour in the Tick Ixodes ricinus	PLOS ONE			English	Article							CLIMATE-CHANGE; LYME-DISEASE; PHENOTYPIC PLASTICITY; BORNE DISEASES; DROSOPHILA-MELANOGASTER; SATURATION DEFICIT; POPULATION-DENSITY; TEMPERATURE; ACARI; IXODIDAE	The tick Ixodes ricinus finds its hosts by climbing vegetation and adopting a sit-and-wait tactic. This "questing'' behaviour is known to be temperature-dependent, such that questing increases with temperature up to a point where the vapor pressure deficit (drying effect) forces ticks down to rehydrate in the soil or mat layer. Little if any attention has been paid to understanding the questing of ticks from an evolutionary perspective. Here we ask whether populations from colder climatic conditions respond differently in terms of the threshold temperature for questing and the rate of response to a fixed temperature. We find significant variation between populations in the temperature sensitivity of questing, with populations from cooler climates starting questing at lower temperatures than populations from warmer temperatures. Cool climate populations also quest sooner when the temperature is held constant. These patterns are consistent with local adaptation to temperature either through direct selection or acclimation and challenge the use of fixed thresholds for questing in modeling the spread of tick populations. Our results also show how both time and temperature play a role in questing, but we are unable to explain the relationship in terms of degree-time used to model Arthropod development. We find that questing in response to temperature fits well with a quantitative genetic model of the conditional strategy, which reveals how selection on questing may operate and hence may be of value in understanding the evolutionary ecology of questing.	[Tomkins, Joseph L.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia; [Aungier, Jennifer] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Hazel, Wade] Depauw Univ, Dept Biol, Greencastle, IN 46135 USA; [Gilbert, Lucy] James Hutton Inst, Aberdeen, Scotland	University of Western Australia; University of Aberdeen; DePauw University; James Hutton Institute	Tomkins, JL (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia.	joseph.tomkins@uwa.edu.au	Tomkins, Joseph L/A-8091-2011	Tomkins, Joseph L/0000-0003-1259-7898	Australian Research Council [FT110100500]; Scottish Government Rural and Environment Science and Analytical Services Division; University of Aberdeen	Australian Research Council(Australian Research Council); Scottish Government Rural and Environment Science and Analytical Services Division; University of Aberdeen	This research was funded by an Australian Research Council Future Fellowship FT110100500, awarded to JLT. LG was supported by the Scottish Government Rural and Environment Science and Analytical Services Division. JA was part-supported by an MSc project research grant from the University of Aberdeen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayrinhac A, 2004, FUNCT ECOL, V18, P700, DOI 10.1111/j.0269-8463.2004.00904.x; BASKERVILLE GL, 1969, ECOLOGY, V50, P514, DOI 10.2307/1933912; Bentz BJ, 2011, EVOL ECOL, V25, P1269, DOI 10.1007/s10682-011-9474-x; Bridle JR, 2009, P ROY SOC B-BIOL SCI, V276, P1507, DOI 10.1098/rspb.2008.1601; CLARK DD, 1995, J MED ENTOMOL, V32, P449, DOI 10.1093/jmedent/32.4.449; Danielova V, 2006, INT J MED MICROBIOL, V296, P48, DOI 10.1016/j.ijmm.2006.02.007; de Meeus T, 2002, EVOLUTION, V56, P1802, DOI 10.1111/j.0014-3820.2002.tb00194.x; Dobson ADM, 2011, J APPL ECOL, V48, P1017, DOI 10.1111/j.1365-2664.2011.02003.x; Dobson ADM, 2011, J APPL ECOL, V48, P1029, DOI 10.1111/j.1365-2664.2011.02004.x; Estrada-Pena A, 2006, MED VET ENTOMOL, V20, P189, DOI 10.1111/j.1365-2915.2006.00622.x; FALCO RC, 1992, EXP APPL ACAROL, V14, P165, DOI 10.1007/BF01219108; Gilbert L, 2014, ECOL EVOL, V4, P1186, DOI 10.1002/ece3.1014; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Gray JS, 2002, WIEN KLIN WOCHENSCHR, V114, P473; Harrus S, 2005, INT J PARASITOL, V35, P1309, DOI 10.1016/j.ijpara.2005.06.005; Hazel W, 2004, AM NAT, V163, P888, DOI 10.1086/386313; HAZEL WN, 1990, P ROY SOC B-BIOL SCI, V242, P181, DOI 10.1098/rspb.1990.0122; Hazel WN, 2002, EVOLUTION, V56, P342, DOI 10.1111/j.0014-3820.2002.tb01344.x; Herrmann C, 2013, INT J PARASITOL, V43, P477, DOI 10.1016/j.ijpara.2012.12.010; Herrmann C, 2012, PARASITOLOGY, V139, P330, DOI 10.1017/S0031182011002095; Hoffmann AA, 2005, FUNCT ECOL, V19, P222, DOI 10.1111/j.1365-2435.2005.00959.x; Kahm M, 2010, J STAT SOFTW, V33, P1; Kivaria FM, 2006, TROP ANIM HEALTH PRO, V38, P291, DOI 10.1007/s11250-006-4181-2; Lindgren E, 1998, ECOL MODEL, V110, P55, DOI 10.1016/S0304-3800(98)00041-6; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; MacLEOD JOHN, 1935, PARASITOLOGY, V27, P123, DOI 10.1017/S0031182000015006; MeteoFrance, 2012, WORLD WEATH INF SERV; Mitton JB, 2012, AM NAT, V179, pE163, DOI 10.1086/665007; Mousseau TA, 1998, HEREDITY, V80, P218, DOI 10.1046/j.1365-2540.1998.00269.x; Murphy J.M, 2009, UK CLIMATE PROJECTIO; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Perret JL, 2008, PARASITOL RES, V103, pS156; Perret JL, 2000, PARASITOL RES, V86, P554, DOI 10.1007/s004360000209; Perret JL, 2004, J MED ENTOMOL, V41, P361, DOI 10.1603/0022-2585-41.3.361; Pinheiro J, 2001, MIXED EFFECTS MODELS; R DevelopmentCoreTeam, 2012, R LANG ENV STAT COMP; Rand PW, 2004, J VECTOR ECOL, V29, P164; Randolph SE, 2010, VET PARASITOL, V167, P92, DOI 10.1016/j.vetpar.2009.09.011; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Randolph SE, 2004, INT J MED MICROBIOL, V293, P5, DOI 10.1016/S1433-1128(04)80004-4; RICE WR, 1994, P NATL ACAD SCI USA, V91, P225, DOI 10.1073/pnas.91.1.225; Ritland K, 1996, EVOLUTION, V50, P1062, DOI [10.2307/2410647, 10.1111/j.1558-5646.1996.tb02347.x]; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SASInstitute, 2002, SAS SOFTW VERS; Tagliapietra V, 2011, VET PARASITOL, V183, P114, DOI 10.1016/j.vetpar.2011.07.022; Terblanche JS, 2006, AM J TROP MED HYG, V74, P786, DOI 10.4269/ajtmh.2006.74.786; Tisdell CA, 1999, REV SCI TECH OIE, V18, P380, DOI 10.20506/rst.18.2.1168; Tomkins JL, 2004, NATURE, V431, P1099, DOI 10.1038/nature02918; Tomkins JL, 2011, CURR BIOL, V21, P1; Tomkins Joseph, 2011, P107; Tomkins JL, 2007, TRENDS ECOL EVOL, V22, P522, DOI 10.1016/j.tree.2007.09.002; Vail SG, 2002, J MED ENTOMOL, V39, P842, DOI 10.1603/0022-2585-39.6.842; Van Es RP, 1999, EXP APPL ACAROL, V23, P977, DOI 10.1023/A:1006331331642; Wilson K, 2009, ECOLOGY, V90, P901, DOI 10.1890/08-2027.1; Wu XT, 2013, J THEOR BIOL, V319, P50, DOI 10.1016/j.jtbi.2012.11.014; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	57	25	26	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110028	10.1371/journal.pone.0110028	http://dx.doi.org/10.1371/journal.pone.0110028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333919	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000346766200080
J	Ekici, H; Amogne, W; Aderaye, G; Lindquist, L; Sonnerborg, A; Abdurahman, S				Ekici, Halime; Amogne, Wondwossen; Aderaye, Getachew; Lindquist, Lars; Sonnerborg, Anders; Abdurahman, Samir			Minority Drug-Resistant HIV-1 Variants in Treatment Naive East-African and Caucasian Patients Detected by Allele-Specific Real-Time PCR	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SUB-SAHARAN AFRICA; ANTIRETROVIRAL TREATMENT; LOW-FREQUENCY; MUTATIONS; THERAPY; IMPACT; K103N; QUANTIFICATION; EPIDEMIOLOGY	Objective: To assess the presence of two major non-nucleoside reverse transcriptase inhibitors (NNRTI) drug resistance mutations (DRMs), Y181C and K103N, in minor viral quasispecies of treatment naive HIV-1 infected East-African and Swedish patients by allele-specific polymerase chain reaction (AS-PCR). Methods: Treatment naive adults (n = 191) with three epidemiological backgrounds were included: 92 Ethiopians living in Ethiopia; 55 East-Africans who had migrated to Sweden; and 44 Caucasians living in Sweden. The pol gene was analysed by standard population sequencing and by AS-PCR for the detection of Y181C and K103N. Results: The Y181C was detected in the minority quasispecies of six Ethiopians (6.5%), in two Caucasians (4.5%), and in one East-African (1.8%). The K103N was detected in one East-African (1.8%), by both methods. The proportion of mutants ranged from 0.25% to 17.5%. Additional DRMs were found in all three treatment naive patient groups by population sequencing. Conclusions: Major NNRTI mutations can be found by AS-PCR in minor quasispecies of treatment naive HIV-1 infected Ethiopians living in Ethiopia, in East-African and Caucasian patients living in Sweden in whom population sequencing reveal wild-type virus only. Surveys with standard sequencing are likely to underestimate transmitted drug resistance and the presence of resistant minor quasispecies in treatment naive patients should be topic for future large scale studies.	[Ekici, Halime; Sonnerborg, Anders; Abdurahman, Samir] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Amogne, Wondwossen; Aderaye, Getachew] Univ Addis Ababa, Fac Med, Dept Med, Addis Ababa, Ethiopia; [Lindquist, Lars; Sonnerborg, Anders] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Infect Dis Unit, Stockholm, Sweden; [Abdurahman, Samir] Univ Orebro, Orebro Life Sci Ctr, Dept Sci & Technol, SE-70182 Orebro, Sweden	Karolinska Institutet; Addis Ababa University; Karolinska Institutet; Karolinska University Hospital; Orebro University	Abdurahman, S (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.	Samir.Abdurahman@oru.se	Degu, Wondwossen Amogne/GON-3590-2022; Sönnerborg, Anders/W-2011-2019; Amogne, Wondwossen/AGM-9855-2022	Sönnerborg, Anders/0000-0001-8928-3374; Abdurahman, Samir/0000-0003-0902-508X	European and Developing Countries Clinical Trial Partnership; SIDA; Swedish Civil Contingencies Agency; Swedish Research Council; 7th Framework Programme of European Union, Collaborative HIV and Anti-HIV Drug Resistance Network	European and Developing Countries Clinical Trial Partnership; SIDA; Swedish Civil Contingencies Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission); 7th Framework Programme of European Union, Collaborative HIV and Anti-HIV Drug Resistance Network	This study was supported by the European and Developing Countries Clinical Trial Partnership, SIDA, the Swedish Civil Contingencies Agency, Swedish Research Council and 7th Framework Programme of European Union, Collaborative HIV and Anti-HIV Drug Resistance Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurahman S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18841; Abegaz WE, 2008, ANTIVIR THER, V13, P89; Aghokeng AF, 2011, AIDS, V25, P2183, DOI 10.1097/QAD.0b013e32834bbbe9; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Balduin M, 2009, J CLIN VIROL, V45, P34, DOI 10.1016/j.jcv.2009.03.002; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Church JD, 2008, AIDS RES HUM RETROV, V24, P595, DOI 10.1089/aid.2007.0224; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Ekici H, 2014, J ANTIMICROB CHEMOTH; Frentz D, 2012, AIDS REV, V14, P17; Geretti AM, 2009, JAIDS-J ACQ IMM DEF, V52, P569, DOI 10.1097/QAI.0b013e3181ba11e8; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hamers RL, 2010, JAIDS-J ACQ IMM DEF, V55, P95, DOI 10.1097/QAI.0b013e3181e544e0; Hauser A, 2009, ANTIMICROB AGENTS CH, V53, P2965, DOI 10.1128/AAC.01672-08; Johnson J, 2009, PERSPECT POLIT, V7, P1, DOI 10.1017/S153759270909001X; Karlsson AC, 1998, AIDS, V12, P839, DOI 10.1097/00002030-199808000-00005; Karlsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033484; Kassu A, 2007, AIDS RES HUM RETROV, V23, P564, DOI 10.1089/aid.2006.0270; Lecossier D, 2005, JAIDS-J ACQ IMM DEF, V38, P37, DOI 10.1097/00126334-200501010-00007; Li JZ, 2011, AIDS; Liang BH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026745; Metzner K, 2014, AIDS; Paredes R, 2007, J VIROL METHODS, V146, P136, DOI 10.1016/j.jviromet.2007.06.012; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Sigaloff KCE, 2012, AIDS RES HUM RETROV, V28, P833, DOI [10.1089/aid.2011.0348, 10.1089/AID.2011.0348]; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Van Laethem K, 2007, J CLIN VIROL, V39, P43, DOI 10.1016/j.jcv.2007.02.003; WHO, 2010, EP UPD HLTH SECT PRO	33	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111042	10.1371/journal.pone.0111042	http://dx.doi.org/10.1371/journal.pone.0111042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333961	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200098
J	Hatse, S; Brouwers, B; Dalmasso, B; Laenen, A; Kenis, C; Schoffski, P; Wildiers, H				Hatse, Sigrid; Brouwers, Barbara; Dalmasso, Bruna; Laenen, Annouschka; Kenis, Cindy; Schoffski, Patrick; Wildiers, Hans			Circulating MicroRNAs as Easy-to-Measure Aging Biomarkers in Older Breast Cancer Patients: Correlation with Chronological Age but Not with Fitness/Frailty Status	PLOS ONE			English	Article							CELLULAR SENESCENCE; TELOMERE DYNAMICS; GROWTH ARREST; SOLID TUMORS; EXPRESSION; CELLS; CHEMOTHERAPY; P16(INK4A); ACCELERATION; SIGNATURE	Circulating microRNAs (miRNAs) hold great promise as easily accessible biomarkers for diverse (patho)physiological processes, including aging. We have compared miRNA expression profiles in cell-free blood from older versus young breast cancer patients, in order to identify "aging miRNAs" that can be used in the future to monitor the impact of chemotherapy on the patient's biological age. First, we assessed 175 miRNAs that may possibly be present in serum/plasma in an exploratory screening in 10 young and 10 older patients. The top-15 ranking miRNAs showing differential expression between young and older subjects were further investigated in an independent cohort consisting of another 10 young and 20 older subjects. Plasma levels of miR-20a-3p, miR-30b-5p, miR106b, miR191 and miR-301a were confirmed to show significant age-related decreases (all p <= 0.004). The remaining miRNAs included in the validation study (miR-21, miR-210, miR-320b, miR-378, miR-423-5p, let-7d, miR-140-5p, miR-200c, miR-374a, miR376a) all showed similar trends as observed in the exploratory screening but these differences did not reach statistical significance. Interestingly, the age-associated miRNAs did not show differential expression between fit/healthy and non-fit/frail subjects within the older breast cancer cohort of the validation study and thus merit further investigation as true aging markers that not merely reflect frailty.	[Hatse, Sigrid; Brouwers, Barbara; Dalmasso, Bruna; Kenis, Cindy; Schoffski, Patrick; Wildiers, Hans] Katholieke Univ Leuven, Dept Oncol, LEO, Leuven, Belgium; [Hatse, Sigrid; Brouwers, Barbara; Dalmasso, Bruna; Kenis, Cindy; Schoffski, Patrick; Wildiers, Hans] Univ Hosp Leuven, Leuven Canc Inst, Dept Gen Med Oncol, Leuven, Belgium; [Dalmasso, Bruna] AOU, IRCCS, San Martino Ist Nazl Tumori IST, Dept Internal Med, Genoa, Italy; [Laenen, Annouschka] Interuniv Ctr Biostat & Stat Bioinformat, Leuven, Belgium; [Kenis, Cindy] Univ Hosp Leuven, Dept Geriatr Med, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; University of Genoa; KU Leuven; University Hospital Leuven	Hatse, S (corresponding author), Katholieke Univ Leuven, Dept Oncol, LEO, Leuven, Belgium.	sigrid.hatse@med.kuleuven.be	Kenis, Cindy/GRF-1666-2022; wildiers, hans/AAV-8158-2021; Dalmasso, Bruna/AAB-7679-2019	Kenis, Cindy/0000-0002-7932-6817; Dalmasso, Bruna/0000-0002-1534-0521	Fonds voor Wetenschappelijk Onderzoek - Vlaanderen (FWO); Vlaamse Liga tegen Kanker (VLK)	Fonds voor Wetenschappelijk Onderzoek - Vlaanderen (FWO)(FWO); Vlaamse Liga tegen Kanker (VLK)	HW is a recipient of the 'Fonds voor Wetenschappelijk Onderzoek - Vlaanderen (FWO).' BB is a recipient of the 'Vlaamse Liga tegen Kanker (VLK).' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcedo Joy, 2013, Frontiers in Genetics, V4, P71, DOI 10.3389/fgene.2013.00071; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aw S, 2012, CELL RES, V22, P1218, DOI 10.1038/cr.2012.59; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Balducci L, 2000, CRIT REV ONCOL HEMAT, V33, P143, DOI 10.1016/S1040-8428(99)00063-3; Beeharry N, 2005, CURR MOL MED, V5, P187, DOI 10.2174/1566524053586554; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Brouckaert O, 2013, ANN ONCOL, V24, P1847, DOI 10.1093/annonc/mdt179; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Dellago H, 2013, AGING CELL, V12, P446, DOI 10.1111/acel.12069; ElSharawy A, 2012, AGING CELL, V11, P607, DOI 10.1111/j.1474-9726.2012.00824.x; Faraonio R, 2012, CELL DEATH DIFFER, V19, P713, DOI 10.1038/cdd.2011.143; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Franco S, 2003, LEUKEMIA, V17, P401, DOI 10.1038/sj.leu.2402815; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Grillari J, 2010, BIOGERONTOLOGY, V11, P501, DOI 10.1007/s10522-010-9272-9; Grillari J, 2010, EXP GERONTOL, V45, P302, DOI 10.1016/j.exger.2010.01.007; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Inukai S, 2013, J MOL BIOL, V425, P3601, DOI 10.1016/j.jmb.2013.01.023; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Kenis C, 2013, ANN ONCOL, V24, P1306, DOI 10.1093/annonc/mds619; Kumar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069807; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lena AM, 2012, BIOCHEM BIOPH RES CO, V423, P509, DOI 10.1016/j.bbrc.2012.05.153; Li P, 2012, INT J BIOCHEM CELL B, V44, P1531, DOI 10.1016/j.biocel.2012.06.020; Li XL, 2011, AGING-US, V3, P985, DOI 10.18632/aging.100371; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Maccormick RE, 2006, MED HYPOTHESES, V67, P212, DOI 10.1016/j.mehy.2006.01.045; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Mohan S., 1995, Progress in Growth Factor Research, V6, P465, DOI 10.1016/0955-2235(95)00027-5; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; Olivieri F., 2013, AGEING RES REV; Olivieri F, 2012, MECH AGEING DEV, V133, P675, DOI 10.1016/j.mad.2012.09.004; Pallis AG, 2013, J GERIATRIC IN PRESS; Roninson IB, 2003, CANCER RES, V63, P2705; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Schroder CP, 2001, BRIT J CANCER, V84, P1348, DOI 10.1054/bjoc.2001.1803; Serna E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00961; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Toiyama Y, 2013, ANN SURG; Unryn BM, 2006, CLIN CANCER RES, V12, P6345, DOI 10.1158/1078-0432.CCR-06-0486; Vandenberk B, 2011, J GERIATR ONCOL, V2, P259, DOI 10.1016/j.jgo.2011.08.004; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wynn RF, 1998, LANCET, V351, P178, DOI 10.1016/S0140-6736(97)08256-1; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143	59	46	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110644	10.1371/journal.pone.0110644	http://dx.doi.org/10.1371/journal.pone.0110644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333486	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200063
J	Lin, TF; Jow, GM; Fang, HY; Fu, SJ; Wu, HH; Chiu, MM; Jeng, CJ				Lin, Ting-Feng; Jow, Guey-Mei; Fang, Hsin-Yu; Fu, Ssu-Ju; Wu, Hao-Han; Chiu, Mei-Miao; Jeng, Chung-Jiuan			The Eag Domain Regulates the Voltage-Dependent Inactivation of Rat Eag1 K+ Channels	PLOS ONE			English	Article							HERG POTASSIUM CHANNEL; HUMAN INWARD RECTIFIER; S4-S5 LINKER; MOLECULAR DETERMINANTS; XENOPUS OOCYTES; FUNCTIONAL EXPRESSION; CARDIAC-ARRHYTHMIA; DOFETILIDE BLOCK; TERMINAL REGION; N-TERMINUS	Eag (Kv10) and Erg (Kv11) belong to two distinct subfamilies of the ether-a-go-go K+ channel family (KCNH). While Erg channels are characterized by an inward-rectifying current-voltage relationship that results from a C-type inactivation, mammalian Eag channels display little or no voltage-dependent inactivation. Although the amino (N)-terminal region such as the eag domain is not required for the C-type inactivation of Erg channels, an N-terminal deletion in mouse Eag1 has been shown to produce a voltage-dependent inactivation. To further discern the role of the eag domain in the inactivation of Eag1 channels, we generated N-terminal chimeras between rat Eag (rEag1) and human Erg (hERG1) channels that involved swapping the eag domain alone or the complete cytoplasmic N-terminal region. Functional analyses indicated that introduction of the homologous hERG1 eag domain led to both a fast phase and a slow phase of channel inactivation in the rEag1 chimeras. By contrast, the inactivation features were retained in the reverse hERG1 chimeras. Furthermore, an eag domain-lacking rEag1 deletion mutant also showed the fast phase of inactivation that was notably attenuated upon coexpression with the rEag1 eag domain fragment, but not with the hERG1 eag domain fragment. Additionally, we have identified a point mutation in the S4-S5 linker region of rEag1 that resulted in a similar inactivation phenotype. Biophysical analyses of these mutant constructs suggested that the inactivation gating of rEag1 was distinctly different from that of hERG1. Overall, our findings are consistent with the notion that the eag domain plays a critical role in regulating the inactivation gating of rEag1. We propose that the eag domain may destabilize or mask an inherent voltage-dependent inactivation of rEag1 K+ channels.	[Lin, Ting-Feng; Fang, Hsin-Yu; Fu, Ssu-Ju; Wu, Hao-Han; Chiu, Mei-Miao; Jeng, Chung-Jiuan] Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 112, Taiwan; [Jeng, Chung-Jiuan] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Jow, Guey-Mei] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Fu Jen Catholic University	Jeng, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 112, Taiwan.	cjjeng@ym.edu.tw		Lin, Ting-Feng/0000-0003-0261-8309	National Science Council, Taiwan [NSC101-2320-B-010-038-MY3]; Aim for the Top University Plan, Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Aim for the Top University Plan, Ministry of Education, Taiwan	This work was supported by research grants from National Science Council, Taiwan (NSC101-2320-B-010-038-MY3), and from the Aim for the Top University Plan, Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Carlson AE, 2013, J GEN PHYSIOL, V141, P347, DOI 10.1085/jgp.201210900; Chen ML, 2000, BIOPHYS J, V79, P1358, DOI 10.1016/S0006-3495(00)76388-0; Chen ML, 1996, NEURON, V17, P535, DOI 10.1016/S0896-6273(00)80185-3; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; de la Pena P, 2013, BIOCHEM J, V451, P463, DOI 10.1042/BJ20121717; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Fan JS, 1999, BIOPHYS J, V76, P3128, DOI 10.1016/S0006-3495(99)77464-3; Fernandez-Trillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024674; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Ficker E, 2001, MOL PHARMACOL, V60, P1343, DOI 10.1124/mol.60.6.1343; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Frings S, 1998, J GEN PHYSIOL, V111, P583, DOI 10.1085/jgp.111.4.583; Garg V, 2012, J GEN PHYSIOL, V140, P307, DOI 10.1085/jgp.201210826; Gustina AS, 2013, J GEN PHYSIOL, V141, P229, DOI 10.1085/jgp.201210870; Gustina AS, 2012, CELL SIGNAL, V24, P1592, DOI 10.1016/j.cellsig.2012.04.004; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Hegle AP, 2006, P NATL ACAD SCI USA, V103, P2886, DOI 10.1073/pnas.0505909103; Herzberg IM, 1998, J PHYSIOL-LONDON, V511, P3, DOI 10.1111/j.1469-7793.1998.003bi.x; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Ju M, 2002, FEBS LETT, V524, P204, DOI 10.1016/S0014-5793(02)03055-7; Kiehn J, 1999, AM J PHYSIOL-HEART C, V277, pH199, DOI 10.1152/ajpheart.1999.277.1.H199; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Ludwig J, 2000, MOL CELL NEUROSCI, V16, P59, DOI 10.1006/mcne.2000.0851; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Robertson GA, 1996, NEUROPHARMACOLOGY, V35, P841, DOI 10.1016/0028-3908(96)00113-X; Saganich MJ, 1999, J NEUROSCI, V19, P10789, DOI 10.1523/JNEUROSCI.19-24-10789.1999; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Stevens L, 2009, EUR BIOPHYS J BIOPHY, V38, P523, DOI 10.1007/s00249-009-0402-8; Tang CY, 1998, BIOPHYS J, V75, P1263, DOI 10.1016/S0006-3495(98)74046-9; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Van Slyke AC, 2010, BIOPHYS J, V99, P2841, DOI 10.1016/j.bpj.2010.08.030; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Waters LC, 2010, BIOMOL NMR ASSIGN, V4, P49, DOI 10.1007/s12104-009-9205-1; Wu W, 2011, BIOCHIM BIOPHYS ACTA, V1823, P282; ZHONG Y, 1993, J NEUROSCI, V13, P4669; ZHONG Y, 1991, SCIENCE, V252, P1562, DOI 10.1126/science.2047864	50	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110423	10.1371/journal.pone.0110423	http://dx.doi.org/10.1371/journal.pone.0110423			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333352	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200038
J	Martinez-Garcia, JF; Gallemi, M; Molina-Contreras, MJ; Llorente, B; Bevilaqua, MRR; Quail, PH				Martinez-Garcia, Jaime F.; Gallemi, Marcal; Jose Molina-Contreras, Maria; Llorente, Briardo; Bevilaqua, Maycon R. R.; Quail, Peter H.			The Shade Avoidance Syndrome in Arabidopsis: The Antagonistic Role of Phytochrome A and B Differentiates Vegetation Proximity and Canopy Shade	PLOS ONE			English	Article							FAR-RED LIGHT; SIGNALING NETWORKS; PHYSIOLOGICAL-RESPONSES; CRYPTOCHROME 1; BHLH PROTEINS; PLANTS; SEEDLINGS; AUXIN; LOOP; GENE	Light limitation caused by dense vegetation is one of the greatest threats to plant survival in natural environments. Plants detect such neighboring vegetation as a reduction in the red to far-red ratio (R:FR) of the incoming light. The low R:FR signal, perceived by phytochromes, initiates a set of responses collectively known as the shade avoidance syndrome, intended to reduce the degree of current or future shade from neighbors by overtopping such competitors or inducing flowering to ensure seed production. At the seedling stage these responses include increased hypocotyl elongation. We have systematically analyzed the Arabidopsis seedling response and the contribution of phyA and phyB to perception of decreased R:FR, at three different levels of photosynthetically active radiation. Our results show that the shade avoidance syndrome, induced by phyB deactivation, is gradually antagonized by phyA, operating through the so-called FR-High Irradiance Response, in response to high FR levels in a range that simulates plant canopy shade. The data indicate that the R:FR signal distinguishes between the presence of proximal, but non-shading, neighbors and direct foliar shade, via a intrafamily photosensory attenuation mechanism that acts to suppress excessive reversion toward skotomorphogenic development under prolonged direct vegetation shade.	[Martinez-Garcia, Jaime F.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Martinez-Garcia, Jaime F.; Gallemi, Marcal; Jose Molina-Contreras, Maria; Llorente, Briardo; Bevilaqua, Maycon R. R.] Consortium CSIC IRTA UAB UB, Barcelona, Spain; [Bevilaqua, Maycon R. R.] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Quail, Peter H.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Quail, Peter H.] USDA ARS, Ctr Plant Gene Express, Albany, CA 94710 USA	ICREA; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); University of California System; University of California Berkeley; United States Department of Agriculture (USDA)	Martinez-Garcia, JF (corresponding author), Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain.	jaume.martinez@cragenomica.es	Llorente, Briardo/B-1341-2014; Gallemí, Marçal/ABG-2359-2020; Llorente, Briardo/AAX-2422-2020; Martinez-Garcia, Jaime F/H-6868-2015	Llorente, Briardo/0000-0002-3727-1395; Llorente, Briardo/0000-0002-3727-1395; Martinez-Garcia, Jaime F/0000-0003-1516-0341; Gallemi, Marcal/0000-0003-4675-6893	Spanish Ministry of Economy and Competitivity (MINECO); European Union FP7; Spanish Ministry of Education; Generalitat de Catalunya and Spanish MINECO - Fondo Europeo de Desarrollo Regional (FEDER) [2009-SGR697, BIO2011-23489]; National Institutes of Health [2R01 GM-047475]; Department of Energy [DEFG03-87ER13742]; United States Department of Agriculture Agricultural Research Service Current Research Information System [5335-21000-032-00D]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047475] Funding Source: NIH RePORTER	Spanish Ministry of Economy and Competitivity (MINECO); European Union FP7(European Commission); Spanish Ministry of Education(Spanish Government); Generalitat de Catalunya and Spanish MINECO - Fondo Europeo de Desarrollo Regional (FEDER); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); United States Department of Agriculture Agricultural Research Service Current Research Information System; ICREA(ICREA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MG and MJMC received FPI fellowships from the Spanish Ministry of Economy and Competitivity (MINECO). BL received a Marie Curie IIF fellowship (CarotenActors) from the European Union FP7. JFMG received a 1-year fellowship from the Spanish Ministry of Education for a sabbatical stay in PHQ laboratory. The authors' research is supported by grants from the Generalitat de Catalunya and Spanish MINECO - Fondo Europeo de Desarrollo Regional (FEDER) to JFMG (2009-SGR697, Xarba and BIO2011-23489) and by National Institutes of Health (2R01 GM-047475), Department of Energy (DEFG03-87ER13742), and United States Department of Agriculture Agricultural Research Service Current Research Information System (5335-21000-032-00D) to PHQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; BALLARE CL, 1987, PLANT CELL ENVIRON, V10, P551, DOI 10.1111/1365-3040.ep11604091; Bou-Torrent J, 2014, J EXP BOT; Casal, 2012, SHADE AVOIDANCE; Casal JJ, 1998, PLANT PHYSIOL, V118, P19, DOI 10.1104/pp.118.1.19; Casal JJ, 2013, ANNU REV PLANT BIOL, V64, P403, DOI 10.1146/annurev-arplant-050312-120221; Cifuentes-Esquivel N, 2013, PLANT J, V75, P989, DOI 10.1111/tpj.12264; Crocco CD, 2010, PLANT J, V64, P551, DOI 10.1111/j.1365-313X.2010.04360.x; Devlin PF, 2003, PLANT PHYSIOL, V133, P1617, DOI 10.1104/pp.103.034397; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Galstyan A, 2012, MOL PLANT, V5, P669, DOI 10.1093/mp/sss006; Galstyan A, 2011, PLANT J, V66, P258, DOI 10.1111/j.1365-313X.2011.04485.x; Gangappa SN, 2013, PLANT CELL, V25, P1243, DOI 10.1105/tpc.113.109751; Hennig L, 2001, PLANT PHYSIOL, V125, P1036, DOI 10.1104/pp.125.2.1036; Hornitschek P, 2012, PLANT J, V71, P699, DOI 10.1111/j.1365-313X.2012.05033.x; Hudson M, 1999, GENE DEV, V13, P2017, DOI 10.1101/gad.13.15.2017; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Keuskamp DH, 2012, PLANT SIGNAL BEHAV, V7, P514, DOI 10.4161/psb.19340; Keuskamp DH, 2010, P NATL ACAD SCI USA, V107, P22740, DOI 10.1073/pnas.1013457108; LEE DW, 1987, BIOTROPICA, V19, P161, DOI 10.2307/2388739; Lei TT, 2006, PLANT ECOL, V184, P143, DOI 10.1007/s11258-005-9058-3; Leivar P, 2012, PLANT CELL, V24, P1398, DOI 10.1105/tpc.112.095711; Leivar P, 2012, MOL PLANT, V5, P734, DOI 10.1093/mp/sss031; Li L, 2012, GENE DEV, V26, P785, DOI 10.1101/gad.187849.112; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Martinez-Garcia JF, 2010, ADV BOT RES, V53, P65, DOI 10.1016/S0065-2296(10)53003-9; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; MCCORMAC AC, 1992, J PLANT PHYSIOL, V140, P707, DOI 10.1016/S0176-1617(11)81027-8; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Rausenberger J, 2011, CELL, V146, P813, DOI 10.1016/j.cell.2011.07.023; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Roig-Villanova I, 2006, PLANT PHYSIOL, V141, P85, DOI 10.1104/pp.105.076331; Roig-Villanova I, 2007, EMBO J, V26, P4756, DOI 10.1038/sj.emboj.7601890; Ruberti I, 2012, BIOTECHNOL ADV, V30, P1047, DOI 10.1016/j.biotechadv.2011.08.014; Ruckle ME, 2007, PLANT CELL, V19, P3944, DOI 10.1105/tpc.107.054312; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; Sessa G, 2005, GENE DEV, V19, P2811, DOI 10.1101/gad.364005; Sharrock RA, 2002, PLANT PHYSIOL, V130, P442, DOI 10.1104/pp.005389; Smith H, 1997, PLANT PHYSIOL, V114, P637, DOI 10.1104/pp.114.2.637; Smith H, 1997, PLANT CELL ENVIRON, V20, P840, DOI 10.1046/j.1365-3040.1997.d01-104.x; SMITH H, 1982, ANNU REV PLANT PHYS, V33, P481, DOI 10.1146/annurev.pp.33.060182.002405; SMITH H, 1995, ANNU REV PLANT PHYS, V46, P289, DOI 10.1146/annurev.pp.46.060195.001445; Sorin C, 2009, PLANT J, V59, P266, DOI 10.1111/j.1365-313X.2009.03866.x; Steindler C, 1999, DEVELOPMENT, V126, P4235; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; THORNBER JP, 1975, ANNU REV PLANT PHYS, V26, P127, DOI 10.1146/annurev.pp.26.060175.001015; Tsukaya H, 2002, PLANT CELL PHYSIOL, V43, P1221, DOI 10.1093/pcp/pcf147; Vandenbussche F, 2005, BIOESSAYS, V27, P275, DOI 10.1002/bies.20199; Yanovsky MJ, 1995, PLANT CELL ENV	58	61	64	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109275	10.1371/journal.pone.0109275	http://dx.doi.org/10.1371/journal.pone.0109275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333270	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200012
J	Zayachkivska, O; Havryluk, O; Hrycevych, N; Bula, N; Grushka, O; Wallace, JL				Zayachkivska, Oksana; Havryluk, Olena; Hrycevych, Nazar; Bula, Nazar; Grushka, Oksana; Wallace, John L.			Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; NITROSATIVE STRESS; INFLAMMATION; INJURY; PATHOGENESIS; ASSOCIATION; DYSFUNCTION; EXPRESSION; RESOLUTION; DIAGNOSIS	Non-erosive esophagitis is a chronic inflammatory condition of the esophagus and is a form of gastroesophageal reflux disease. There are limited treatment options for non-erosive esophagitis, and it often progresses to Barrett's esophagus and esophageal carcinoma. Hydrogen sulfide has been demonstrated to be a critical mediator of gastric and intestinal mucosal protection and repair. However, roles for H2S in esophageal mucosal defence, inflammation and responses to injury have not been reported. We therefore examined the effects of endogenous and exogenous H2S in rat models of non-erosive esophagitis. Mild-and moderate-severity non-erosive esophagitis was induced in rats through supplementation of drinking water with fructose, plus or minus exposure to water-immersion stress. The effects of inhibitors of H2S synthesis or of an H2S donor on severity of esophagitis was then examined, along with changes in serum levels of a pro-and an anti-inflammatory cytokine (IL-17 and IL-10, respectively). Exposure to water-immersion stress after consumption of the fructose-supplemented water for 28 days resulted in submucosal esophageal edema and neutrophil infiltration and the development of lesions in the muscular lamina and basal cell hyperplasia. Inhibition of H2S synthesis resulted in significant exacerbation of inflammation and injury. Serum levels of IL-17 were significantly elevated, while serum IL-10 levels were reduced. Treatment with an H2S donor significantly reduced the severity of esophageal injury and inflammation and normalized the serum cytokine levels. The rat models used in this study provide novel tools for studying non-erosive esophagitis with a range of severity. H2S contributes significantly to mucosal defence in the esophagus, and H2S donors may have therapeutic value in treating esophageal inflammation and injury.	[Zayachkivska, Oksana; Hrycevych, Nazar; Bula, Nazar] Danylo Halytsky Lviv Natl Med Univ, Dept Physiol, Lvov, Ukraine; [Havryluk, Olena] Danylo Halytsky Lviv Natl Med Univ, Dept Pathol, Lvov, Ukraine; [Grushka, Oksana] Danylo Halytsky Lviv Natl Med Univ, Cent Sci Res Lab, Lvov, Ukraine; [Wallace, John L.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	Danylo Halytsky Lviv National Medical University; Danylo Halytsky Lviv National Medical University; Danylo Halytsky Lviv National Medical University; University of Calgary	Wallace, JL (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada.	altapharm@hotmail.com	Bula, Nazar/M-2345-2019; Zayachkivska, Oksana/G-2326-2019; Gavrilyuk, Elena/AAN-5315-2020; Wallace, John/AAL-3763-2021	Zayachkivska, Oksana/0000-0002-4309-2473; Gavrilyuk, Elena/0000-0003-2580-5561; Bula, Nazar/0000-0001-6676-6234	Canadian Institutes of Health Research [FRN-12033]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work is supported by the Canadian Institutes of Health Research, FRN-12033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaany Z, 2014, CURRENT MED IN PRESS; Asimakopoulou A, 2013, BRIT J PHARMACOL, V169, P922, DOI 10.1111/bph.12171; Bai AP, 2005, DIGEST DIS SCI, V50, P1426, DOI 10.1007/s10620-005-2857-5; Blackett KL, 2013, ALIMENT PHARM THER, V37, P1084, DOI 10.1111/apt.12317; Blackler RW, 2014, CURR OPIN PHARMACOL, V19, P11, DOI 10.1016/j.coph.2014.05.008; Blackman RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029798; Chan MV, 2013, AM J PHYSIOL-GASTR L, V305, pG467, DOI 10.1152/ajpgi.00169.2013; Dufton N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00499; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Flannigan KL, 2014, P NATL ACAD SCI USA, V111, P13559, DOI 10.1073/pnas.1413390111; Flannigan KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071962; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Hershcovici T, 2012, J CLIN GASTROENTEROL, V46, P662, DOI 10.1097/MCG.0b013e31824e139b; Hrycevych N, 2010, ANN U M CURIE SKLODO, V28, P211; Hrynevych N, 2013, FASEB J, V27, P1169; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Kandulski A, 2012, NAT REV GASTRO HEPAT, V9, P15, DOI 10.1038/nrgastro.2011.210; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kinekawa F, 2008, J GASTROENTEROL, V43, P338, DOI 10.1007/s00535-008-2169-6; Konturek SJ, 2007, J PHYSIOL PHARMACOL, V58, P361; Kozar VV, 2009, BUK MED HERALD, V13, P141; Langner C, 2014, HISTOPATHOLOGY, V65, P81, DOI 10.1111/his.12367; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; Li QJ, 2013, AM J PHYSIOL-GASTR L, V305, pG503, DOI 10.1152/ajpgi.00160.2013; Long J D, 2007, Minerva Gastroenterol Dietol, V53, P127; Mard SA, 2012, DIGEST DIS SCI, V57, P1496, DOI 10.1007/s10620-012-2051-5; Mariggio MA, 1998, IMMUNOPHARM IMMUNOT, V20, P399, DOI 10.3109/08923979809034822; Mastrocola R, 2013, AM J PHYSIOL-GASTR L, V305, pG398, DOI 10.1152/ajpgi.00450.2012; Mirandola P, 2011, LAB INVEST, V91, P1188, DOI 10.1038/labinvest.2011.76; Miyashita T, 2013, DIGESTION, V87, P6, DOI 10.1159/000343896; Modlin IM, 2009, DIGESTION, V80, P74, DOI 10.1159/000219365; Motta JP, 2014, CANADIAN J GASTR SSA, V28, p88A; Nishida T, 2004, J GASTROEN HEPATOL, V19, P258, DOI 10.1111/j.1440-1746.2003.03288.x; Novosad VL, 2013, AM J PHYSIOL-GASTR L, V305, pG418, DOI 10.1152/ajpgi.00166.2013; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Promberger R, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-132; Savarino E, 2013, J GASTROENTEROL, V48, P473, DOI 10.1007/s00535-012-0672-2; Sellin JH, 2008, NAT CLIN PRACT GASTR, V5, P162, DOI 10.1038/ncpgasthep1054; Soderholm JD, 2007, GUT, V56, P1177, DOI 10.1136/gut.2007.120691; Szabo C, 2009, BRIT J PHARMACOL, V156, P713, DOI 10.1111/j.1476-5381.2008.00086.x; TAKAGI K, 1964, CHEM PHARM BULL, V12, P465; Takeuchi K, 2012, CURR MED CHEM, V19, P43, DOI 10.2174/092986712803413962; Wallace JL, 2014, ANTIOXIDANT IN PRESS; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2007, TRENDS PHARMACOL SCI, V28, P501, DOI 10.1016/j.tips.2007.09.003; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Wallace JL, 2010, BRIT J PHARMACOL, V159, P1236, DOI 10.1111/j.1476-5381.2009.00611.x; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wolin MS, 2009, AM J PHYSIOL-HEART C, V296, pH539, DOI 10.1152/ajpheart.01167.2008; Wu P, 2011, NEUROGASTROENT MOTIL, V23, P989, DOI 10.1111/j.1365-2982.2011.01786.x; Wu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037572; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zayachkivska O, 2008, J PHYSIOL PHARMACOL, V59, P77; Zayachkivska O. S., 2005, Fiziolohichnyi Zhurnal (Kiev), V51, P79; Zayachkivska OC, 2006, UKR MED ALMANAC, V9, P48; Zayachkivska O, 2012, FRONT GASTROINT RES, V30, P148; Zayachkivska O, 2009, J PHYSIOL SCI, V59, P389; Zhang Q, 2004, AM J PHYSIOL-GASTR L, V286, pG797, DOI 10.1152/ajpgi.00383.2003	61	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110688	10.1371/journal.pone.0110688	http://dx.doi.org/10.1371/journal.pone.0110688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333941	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200066
J	Bagnasco, SM; Gottipati, S; Kraus, E; Alachkar, N; Montgomery, RA; Racusen, LC; Arend, LJ				Bagnasco, Serena M.; Gottipati, Srinivas; Kraus, Edward; Alachkar, Nada; Montgomery, Robert A.; Racusen, Lorraine C.; Arend, Lois J.			Sarcoidosis in Native and Transplanted Kidneys: Incidence, Pathologic Findings, and Clinical Course	PLOS ONE			English	Article							RENAL-ALLOGRAFT; NEPHRITIS; REJECTION; BIOPSIES	Renal involvement by sarcoidosis in native and transplanted kidneys classically presents as non caseating granulomatous interstitial nephritis. However, the incidence of sarcoidosis in native and transplant kidney biopsies, its frequency as a cause of end stage renal disease and its recurrence in renal allograft are not well defined, which prompted this study. The electronic medical records and the pathology findings in native and transplant kidney biopsies reviewed at the Johns Hopkins Hospital from 1/1/2000 to 6/30/2011 were searched. A total of 51 patients with a diagnosis of sarcoidosis and renal abnormalities requiring a native kidney biopsy were identified. Granulomatous interstitial nephritis, consistent with renal sarcoidosis was identified in kidney biopsies from 19 of these subjects (37%). This is equivalent to a frequency of 0.18% of this diagnosis in a total of 10,023 biopsies from native kidney reviewed at our institution. Follow-up information was available in 10 patients with biopsy-proven renal sarcoidosis: 6 responded to treatment with prednisone, one progressed to end stage renal disease. Renal sarcoidosis was the primary cause of end stage renal disease in only 2 out of 2,331 transplants performed. Only one biopsy-proven recurrence of sarcoidosis granulomatous interstitial nephritis was identified. Conclusions: Renal involvement by sarcoidosis in the form of granulomatous interstitial nephritis was a rare finding in biopsies from native kidneys reviewed at our center, and was found to be a rare cause of end stage renal disease. However, our observations indicate that recurrence of sarcoid granulomatous inflammation may occur in the transplanted kidney of patients with sarcoidosis as the original kidney disease.	[Bagnasco, Serena M.; Gottipati, Srinivas; Racusen, Lorraine C.; Arend, Lois J.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA; [Kraus, Edward; Alachkar, Nada] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Montgomery, Robert A.] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Bagnasco, SM (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA.	sbagnas1@jhmi.edu	Arend, Lois/ABE-2002-2020	Arend, Lois/0000-0001-5434-7630; Alachkar, Nada/0000-0003-1249-2455				Aouizerate J, 2010, CLIN J AM SOC NEPHRO, V5, P2101, DOI 10.2215/CJN.03970510; Bagnasco SM, 2007, AM J TRANSPLANT, V7, P1968, DOI 10.1111/j.1600-6143.2007.01885.x; Bagnasco SM, 2009, NEPHROL DIAL TRANSPL, V24, P1319, DOI 10.1093/ndt/gfn697; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Berliner AR, 2006, AM J KIDNEY DIS, V48, P856, DOI 10.1053/j.ajkd.2006.07.022; Bijol V, 2006, INT J SURG PATHOL, V14, P57, DOI 10.1177/106689690601400110; BROWN JH, 1992, NEPHROL DIAL TRANSPL, V7, P173, DOI 10.1093/oxfordjournals.ndt.a092094; Joss N, 2007, CLIN J AM SOC NEPHRO, V2, P222, DOI 10.2215/CJN.01790506; Judson MA, 2014, EUROPEAN RESP J; Kukura S, 2004, NEPHROL DIAL TRANSPL, V19, P1640, DOI 10.1093/ndt/gfh197; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LONGCOPE WT, 1952, MEDICINE, V31, P1, DOI 10.1097/00005792-195202000-00001; Mahevas M, 2009, MEDICINE BALTIMORE, V88; Meehan SM, 2000, AM J KIDNEY DIS, V36, DOI 10.1053/ajkd.2000.17735; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Rossman Milton D, 2007, Proc Am Thorac Soc, V4, P453, DOI 10.1513/pats.200607-138MS; Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096; SHEN SY, 1986, AM J MED, V80, P699, DOI 10.1016/0002-9343(86)90828-4; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; TEKESTE H, 1984, AM J GASTROENTEROL, V79, P389; Vargas Federico, 2010, Pediatr Transplant, V14, pe54, DOI 10.1111/j.1399-3046.2009.01173.x; Wirnsberger RM, 1998, NETH J MED, V53, P53, DOI 10.1016/S0300-2977(98)00058-8	22	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110778	10.1371/journal.pone.0110778	http://dx.doi.org/10.1371/journal.pone.0110778			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329890	Green Submitted, gold, Green Published			2022-12-27	WOS:000343942100096
J	Vermund, SH; Blevins, M; Moon, TD; Jose, E; Moiane, L; Tique, JA; Sidat, M; Ciampa, PJ; Shepherd, BE; Vaz, LME				Vermund, Sten H.; Blevins, Meridith; Moon, Troy D.; Jose, Eurico; Moiane, Linda; Tique, Jose A.; Sidat, Mohsin; Ciampa, Philip J.; Shepherd, Bryan E.; Vaz, Lara M. E.			Poor Clinical Outcomes for HIV Infected Children on Antiretroviral Therapy in Rural Mozambique: Need for Program Quality Improvement and Community Engagement	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANT TUBERCULOSIS; RESOURCE-LIMITED SETTINGS; BASE-LINE CHARACTERISTICS; TERM-FOLLOW-UP; SOUTH-AFRICA; SCALING-UP; HIV-1-INFECTED CHILDREN; TREATING COINFECTIONS; UGANDAN CHILDREN	Introduction: Residents of Zambezia Province, Mozambique live from rural subsistence farming and fishing. The 2009 provincial HIV prevalence for adults 15-49 years was 12.6%, higher among women (15.3%) than men (8.9%). We reviewed clinical data to assess outcomes for HIV-infected children on combination antiretroviral therapy (cART) in a highly resource-limited setting. Methods: We studied rates of 2-year mortality and loss to follow-up (LTFU) for children <15 years of age initiating cART between June 2006-July 2011 in 10 rural districts. National guidelines define LTFU as >60 days following last-scheduled medication pickup. Kaplan-Meier estimates to compute mortality assumed non-informative censoring. Cumulative LTFU incidence calculations treated death as a competing risk. Results: Of 753 children, 29.0% (95% CI: 24.5, 33.2) were confirmed dead by 2 years and 39.0% (95% CI: 34.8, 42.9) were LTFU with unknown clinical outcomes. The cohort mortality rate was 8.4% (95% CI: 6.3, 10.4) after 90 days on cART and 19.2% (95% CI: 16.0, 22.3) after 365 days. Higher hemoglobin at cART initiation was associated with being alive and on cART at 2 years (alive: 9.3 g/dL vs. dead or LTFU: 8.3-8.4 g/dL, p<0.01). Cotrimoxazole use within 90 days of ART initiation was associated with improved 2-year outcomes Treatment was initiated late (WHO stage III/IV) among 48% of the children with WHO stage recorded in their records. Marked heterogeneity in outcomes by district was noted (p<0.001). Conclusions: We found poor clinical and programmatic outcomes among children taking cART in rural Mozambique. Expanded testing, early infant diagnosis, counseling/support services, case finding, and outreach are insufficiently implemented. Our quality improvement efforts seek to better link pregnancy and HIV services, expand coverage and timeliness of infant diagnosis and treatment, and increase follow-up and adherence.	[Vermund, Sten H.; Blevins, Meridith; Moon, Troy D.; Tique, Jose A.; Ciampa, Philip J.; Shepherd, Bryan E.; Vaz, Lara M. E.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Vermund, Sten H.; Moon, Troy D.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Blevins, Meridith; Shepherd, Bryan E.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Vaz, Lara M. E.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; [Vermund, Sten H.; Moon, Troy D.; Jose, Eurico; Moiane, Linda; Tique, Jose A.; Vaz, Lara M. E.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Vermund, Sten H.; Moon, Troy D.; Jose, Eurico; Moiane, Linda; Tique, Jose A.; Vaz, Lara M. E.] Friends Global Hlth, Quelimane, Mozambique; [Vermund, Sten H.; Moon, Troy D.; Jose, Eurico; Moiane, Linda; Tique, Jose A.; Vaz, Lara M. E.] Friends Global Hlth, Maputo, Mozambique; [Sidat, Mohsin] Univ Eduardo Mondlane, Sch Med, Maputo, Mozambique	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Eduardo Mondlane University	Vermund, SH (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA.	sten.vermund@vanderbilt.edu	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Sidat, Mohsin/0000-0002-8378-2014; Moon, Troy/0000-0002-1637-829X	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [U2GPS000631]; Fogarty AIDS International Training and Research Program, National Institutes of Health [D43TW001035]; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fogarty AIDS International Training and Research Program, National Institutes of Health; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (grant #U2GPS000631). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. Dr. Tique was supported by the Fogarty AIDS International Training and Research Program, National Institutes of Health #D43TW001035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adje-Toure C, 2008, AIDS RES HUM RETROV, V24, P911, DOI 10.1089/aid.2007.0264; Adjorlolo-Johnson G, 2012, J ACQUIR IMMUNE DEFI; Adjorlolo-Johnson G, 2013, JAIDS-J ACQ IMM DEF, V62, pE7, DOI 10.1097/QAI.0b013e3182706401; Agadjanian V, 2007, AM J PUBLIC HEALTH, V97, P362, DOI 10.2105/AJPH.2006.085662; Agadjanian V, 2011, GLOB PUBLIC HEALTH, V6, pS148, DOI 10.1080/17441692.2011.598869; Ahoua L, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-67; Anaky MF, 2010, B WORLD HEALTH ORGAN, V88, P490, DOI 10.2471/BLT.09.068015; Audet CM, 2012, AJAR-AFR J AIDS RES, V11, P327, DOI 10.2989/16085906.2012.754832; Audet CM, 2012, SAHARA J-J SOC ASP H, V9, P41, DOI 10.1080/17290376.2012.665257; Audet CM, 2012, HEALTH EDUC RES, V27, P544, DOI 10.1093/her/cys008; Audet CM, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-15; Audet CM, 2012, J SOCIAL AS IN PRESS; Audet CM, 2012, J ALTERN CO IN PRESS; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bakanda C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019261; Bandali S, 2011, AIDS CARE, V23, P1171, DOI 10.1080/09540121.2011.554529; Bandali S, 2012, J INT ASS PHYS AIDS; Bandali Sarah, 2013, J Int Assoc Provid AIDS Care, V12, P50, DOI 10.1177/1545109712453937; Bland RM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f550; Bland RM, 2011, ARCH DIS CHILD, V96, P911, DOI 10.1136/adc.2010.193789; Bock P, 2008, T ROY SOC TROP MED H, V102, P905, DOI 10.1016/j.trstmh.2008.06.010; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Bong CN, 2007, AIDS, V21, P1805, DOI 10.1097/QAD.0b013e3282c3a9e4; Braitstein P, 2009, PEDIATR INFECT DIS J, V28, P626, DOI 10.1097/INF.0b013e31819665c5; Buck WC, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-31; Bwakura-Dangarembizi M, 2014, NEW ENGL J MED, V370, P41, DOI 10.1056/NEJMoa1214901; Callens SFJ, 2009, PEDIATR INFECT DIS J, V28, P35, DOI 10.1097/INF.0b013e318184eeb9; Chen C, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-4; Chetty T, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-146; Chhagan MK, 2012, TROP MED INT HEALTH, V17, P1092, DOI 10.1111/j.1365-3156.2012.03026.x; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; Christie CDC, 2012, W INDIAN MED J, V61, P396, DOI 10.7727/wimj.2012.211; Ciampa PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048676; Ciampa PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039391; Ciampa PJ, 2012, JAIDS-J ACQ IMM DEF, V60, pE46, DOI 10.1097/QAI.0b013e31824c0267; Ciampa PJ, 2011, JAIDS-J ACQ IMM DEF, V58, P115, DOI 10.1097/QAI.0b013e31822149bf; Ciaranello AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020224; Ciaranello AL, 2009, CLIN INFECT DIS, V49, P1915, DOI 10.1086/648079; Collins IJ, 2010, CLIN INFECT DIS, V51, P1449, DOI 10.1086/657401; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; De Baets AJ, 2007, PEDIATR INFECT DIS J, V26, P163, DOI 10.1097/01.inf.0000253040.82669.22; De Maayer T, 2011, ARCH DIS CHILD, V96, P560, DOI 10.1136/adc.2010.205039; Decroo T, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/749718; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Decroo T, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-6; Desmonde S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-182; Eichbaum Q, 2012, J ACQUIR IMMUNE DEFI; Eley B, 2006, T ROY SOC TROP MED H, V100, P19, DOI 10.1016/j.trstmh.2005.04.015; Eley B, 2006, SAMJ S AFR MED J, V96, P988; Evans-Gilbert T, 2004, W INDIAN MED J, V53, P322; Fatti G, 2012, J INT AIDS SOC, V15, P265, DOI 10.7448/IAS.15.2.17381; Fatti G, 2011, JAIDS-J ACQ IMM DEF, V58, pE60, DOI 10.1097/QAI.0b013e3182303c7e; Fatti G, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-46; Fenner L, 2010, JAIDS-J ACQ IMM DEF, V54, P524, DOI 10.1097/QAI.0b013e3181e0c4cf; Feucht UD, 2007, J TROP PEDIATRICS, V53, P398, DOI 10.1093/tropej/fmm060; Frohoff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017273; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Geddes R, 2011, SAMJ S AFR MED J, V101, P651; Geelhoed D, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-207; Gormley W, 2011, JAIDS-J ACQ IMM DEF, V57, pS113, DOI 10.1097/QAI.0b013e31821e9320; Grimsrud AT, 2013, J CLIN EPIDEMIOL; Groh K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-650; Haberer JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036737; Hansudewechakul R, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17358; Heidari S, 2012, JAIDS-J ACQ IMM DEF, V59, P161, DOI 10.1097/QAI.0b013e3182427029; Hendriksen ICE, 2012, CLIN INFECT DIS, V55, P1144, DOI 10.1093/cid/cis590; Holmes CB, 2012, HEALTH AFFAIR, V31, P1553, DOI 10.1377/hlthaff.2012.0562; Institute NS, 2009, PRELIMINARY REPORT M; Instituto Nacional de Estastistica Ministerio da Saude US AID, 2013, MOC INQ DEM SAUD 201; Jani IV, 2012, J CLIN MICROBIOL, V50, P1458, DOI 10.1128/JCM.00107-12; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Janssen N, 2010, ARCH DIS CHILD, V95, P414, DOI 10.1136/adc.2009.169367; Janssens B, 2007, PEDIATRICS, V120, pE1134, DOI 10.1542/peds.2006-3503; Jaspan HB, 2008, PEDIATR INFECT DIS J, V27, P993, DOI 10.1097/INF.0b013e31817acf7b; Johnson LF, 2012, PEDIATR INFECT DIS J, V31, P474, DOI 10.1097/INF.0b013e3182456ba2; Kabue MM, 2008, AIDS PATIENT CARE ST, V22, P245, DOI 10.1089/apc.2007.0049; Kabue MM, 2012, PEDIATRICS, V130, pE591, DOI 10.1542/peds.2011-1187; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Kekitiinwa A, 2012, PEDIATR INFECT DIS J, V31, pE117, DOI 10.1097/INF.0b013e31825cb9d6; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; Kim MH, 2012, JAIDS-J ACQ IMM DEF, V59, P173, DOI 10.1097/QAI.0b013e3182405f8f; Kline MW, 2007, PEDIATRICS, V119, pE1116, DOI 10.1542/peds.2006-2802; Kline MW, 2004, PEDIATR INFECT DIS J, V23, P695, DOI 10.1097/01.inf.0000135454.46188.83; Kumarasamy N, 2009, J TROP PEDIATRICS, V55, P155, DOI 10.1093/tropej/fmn080; Lahuerta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037125; Lahuerta M, 2011, JAIDS-J ACQ IMM DEF, V58, pE75, DOI 10.1097/QAI.0b013e31822ac0a9; Lambdin BH, 2013, JAIDS-J ACQ IMM DEF, V62, pE146, DOI 10.1097/QAI.0b013e3182840d4e; Lambdin BH, 2011, JAIDS-J ACQ IMM DEF, V57, pE33, DOI 10.1097/QAI.0b013e3182167e90; Langat N Talam, 2012, East Afr J Public Health, V9, P101; Laughton B, 2012, AIDS, V26, P1685, DOI 10.1097/QAD.0b013e328355d0ce; Lehe JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047459; Leyenaar JK, 2010, PEDIATR INFECT DIS J, V29, P340, DOI 10.1097/INF.0b013e3181bf8ecb; Lumbiganon P, 2011, JAIDS-J ACQ IMM DEF, V56, P365, DOI 10.1097/QAI.0b013e318207a55b; Manders EJ, 2010, STUD HEALTH TECHNOL, V160, P411, DOI 10.3233/978-1-60750-588-4-411; Martinson NA, 2009, INT J TUBERC LUNG D, V13, P862; McCollum ED, 2011, PEDIATR INFECT DIS J, V30, pE75, DOI 10.1097/INF.0b013e3182103f8a; McConnell MS, 2010, JAIDS-J ACQ IMM DEF, V54, P423, DOI 10.1097/QAI.0b013e3181dc5eb0; McNairy ML, 2012, J ACQUIR IMMUNE DEFI; Memirie Solomon Tessema, 2009, Ethiop Med J, V47, P159; Meyers T, 2012, JAIDS-J ACQ IMM DEF, V60, P503, DOI 10.1097/QAI.0b013e318256b4f8; Meyers TM, 2011, PEDIATR INFECT DIS J, V30, P974, DOI 10.1097/INF.0b013e31822539f6; Ministerio da Saude Instituto Nacional de Saude (INS) Instituto Nacional de Estatistica (INE) ICF Macro, 2010, INQ NAC PREV RISC CO; Modjarrad K, 2011, LANCET INFECT DIS, V11, P81, DOI 10.1016/S1473-3099(11)70013-5; Modjarrad K, 2010, LANCET INFECT DIS, V10, P455, DOI 10.1016/S1473-3099(10)70093-1; Moon TD, 2011, INT J STD AIDS, V22, P621, DOI 10.1258/ijsa.2011.010442; Moon TD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17406; Moon Troy D, 2010, Retrovirology (Auckl), V3, P1; Mullan F, 2011, LANCET, V377, P1113, DOI 10.1016/S0140-6736(10)61961-7; Mullan F, 2012, HEALTH AFFAIR, V31, P1561, DOI 10.1377/hlthaff.2012.0219; Munyagwa M, 2012, TROP MED INT HEALTH, V17, P836, DOI 10.1111/j.1365-3156.2012.03000.x; Musiime V, 2012, AIDS RES HUM RETROV, V28, P1647, DOI [10.1089/aid.2011.0313, 10.1089/AID.2011.0313]; Musoke PM, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-56; Naniche D, 2011, AM J TROP MED HYG, V85, P776, DOI 10.4269/ajtmh.2011.10-0713; National Public Health Directorate MoH Republic of Mozambique, 2011, PREL REP NAT EV PREV; Ndondoki Camille, 2011, Presse Med, V40, pe338, DOI 10.1016/j.lpm.2010.11.02; NICOLL A, 1994, AIDS, V8, P995, DOI 10.1097/00002030-199407000-00019; Niekerk NKMV, 2006, J TROP PEDIATRICS, V52, P3, DOI 10.1093/tropej/fmi047; Noden BH, 2010, AIDS CARE, V22, P1285, DOI 10.1080/09540121003692193; Noel F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003723; Ntanda H, 2009, PEDIATR INFECT DIS J, V28, P153, DOI 10.1097/INF.0b013e318184eeeb; Nyandiko W M, 2009, East Afr Med J, V86, P364; Nyandiko W, 2013, JAIDS-J ACQ IMM DEF, V63, pE49, DOI 10.1097/QAI.0b013e31828e1e2c; Nyandiko WM, 2006, JAIDS-J ACQ IMM DEF, V43, P418, DOI 10.1097/01.qai.0000243122.52282.89; O'Brien DP, 2006, AIDS, V20, P1955, DOI 10.1097/01.aids.0000247117.66585.ce; Okomo U, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-28; Okomo U, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-95; Diniz LMO, 2011, J PEDIAT-BRAZIL, V87, P131, DOI [10.2223/JPED.2064, 10.1590/S0021-75572011000200008]; Oliveira R, 2010, CLIN INFECT DIS, V51, P1325, DOI 10.1086/657119; Patel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044914; Peacock-Villada E, 2011, PEDIATRICS, V127, pE423, DOI 10.1542/peds.2009-2701; Pierre RB, 2008, W INDIAN MED J, V57, P223; Posse M, 2009, AIDS PATIENT CARE ST, V23, P867, DOI 10.1089/apc.2009.0050; Prasitsuebsai W, 2010, AIDS PATIENT CARE ST, V24, P127, DOI 10.1089/apc.2009.0224; Puthanakit T, 2005, CLIN INFECT DIS, V41, P100, DOI 10.1086/430714; Puthanakit T, 2007, CLIN INFECT DIS, V44, P599, DOI 10.1086/510489; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Rath BA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-1; Reddi Anand, 2007, BMC Pediatr, V7, P13, DOI 10.1186/1471-2431-7-13; Reithinger R, 2007, BMJ-BRIT MED J, V334, P1143, DOI 10.1136/bmj.39211.527488.94; Republic of Mozambique Ministry of Health National Institute of Health, 2009, MOZ NAT CHILD MORT S; Republic of Mozambique National AIDS Council CNCS, 2012, 2012 GLOB AIDS RESP; Reubenson G, 2011, PEDIATR DRUGS, V13, P349, DOI 10.2165/11593160-000000000-00000; de Schiavi MSR, 2009, ARCH ARGENT PEDIATR, V107, P212, DOI 10.1590/S0325-00752009000300008; Satti H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037114; Sauvageot D, 2010, PEDIATRICS, V125, pE1039, DOI 10.1542/peds.2009-1062; Scanlon ML, 2013, HIV AIDS-RES PALLIAT, V5, P1, DOI 10.2147/HIV.S28912; Schneider K, 2011, AIDS, V25, P1143, DOI 10.1097/QAD.0b013e3283466fab; Sengayi M, 2013, GLOBAL HEALTH ACTION, V6, P169, DOI 10.3402/gha.v6i0.19248; Shepherd BE, 2013, AM J EPIDEMIOL; Song R, 2007, PEDIATRICS, V120, pE856, DOI 10.1542/peds.2006-1122; Souza E, 2010, J TROP PEDIATRICS, V56, P421, DOI 10.1093/tropej/fmq008; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P697, DOI 10.2471/BLT.07.045260; Stringer EM, 2010, JAMA-J AM MED ASSOC, V304, P293, DOI 10.1001/jama.2010.990; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Stringer JSA, 2005, AIDS, V19, P1309, DOI 10.1097/01.aids.0000180102.88511.7d; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; Sutcliffe CG, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-54; Taye Bineyam, 2010, Ethiop Med J, V48, P1; Thomas TA, 2010, INT J TUBERC LUNG D, V14, P1244; U.S. State Department, 2011, US PRES EM PLAN AIDS; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Van Winghem J, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-52; van Zyl GU, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-55; Vaz P, 2012, CLIN INFECT DIS, V54, pS369, DOI 10.1093/cid/cis006; Vermund SH, 2012, AIDS, V26, P1303, DOI 10.1097/QAD.0b013e3283552185; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; VUYLSTEKE B, 1993, GENITOURIN MED, V69, P427; Wachira J, 2012, SAHARA J-J SOC ASP H, V9, P20, DOI 10.1080/17290376.2012.665255; Walker AS, 2009, AIDS BEHAV, V13, P33, DOI 10.1007/s10461-008-9382-4; Wamalwa DC, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-33; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Workneh G, 2013, AIDS CARE, V25, P11, DOI 10.1080/09540121.2012.674096; World Health Organization, 2012, PARTN MAT NEWB CHILD; Yao J, 2012, APPL GEOGR, V32, P601, DOI 10.1016/j.apgeog.2011.07.009; Ylitalo N, 2006, ARCH PEDIAT ADOL MED, V160, P778, DOI 10.1001/archpedi.160.8.778; Zanoni BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022706	178	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110116	10.1371/journal.pone.0110116	http://dx.doi.org/10.1371/journal.pone.0110116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25330113	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100038
J	Cheng, JJ; Leng, MW; Li, LJ; Zhou, HH; Chen, XY				Cheng, Jianjun; Leng, Mingwei; Li, Longjie; Zhou, Hanhai; Chen, Xiaoyun			Active Semi-Supervised Community Detection Based on Must-Link and Cannot-Link Constraints	PLOS ONE			English	Article							COMPLEX NETWORKS; MODULARITY; ORGANIZATION	Community structure detection is of great importance because it can help in discovering the relationship between the function and the topology structure of a network. Many community detection algorithms have been proposed, but how to incorporate the prior knowledge in the detection process remains a challenging problem. In this paper, we propose a semi-supervised community detection algorithm, which makes full utilization of the must-link and cannot-link constraints to guide the process of community detection and thereby extracts high-quality community structures from networks. To acquire the high-quality must-link and cannot-link constraints, we also propose a semi-supervised component generation algorithm based on active learning, which actively selects nodes with maximum utility for the proposed semi-supervised community detection algorithm step by step, and then generates the must-link and cannot-link constraints by accessing a noiseless oracle. Extensive experiments were carried out, and the experimental results show that the introduction of active learning into the problem of community detection makes a success. Our proposed method can extract high-quality community structures from networks, and significantly outperforms other comparison methods.	[Cheng, Jianjun; Leng, Mingwei; Li, Longjie; Zhou, Hanhai; Chen, Xiaoyun] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou, Gansu, Peoples R China	Lanzhou University	Cheng, JJ (corresponding author), Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou, Gansu, Peoples R China.	chengjianjun@lzu.edu.cn; chenxy@lzu.edu.cn			Fundamental Research Funds for the Central Universities [lzujbky-2014-54]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Fundamental Research Funds for the Central Universities, grant id: lzujbky-2014-54. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.114102; Barber MJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026129; Bilgic M., 2010, P 27 INT C MACHINE L, P79; Bommarito MJ, 2010, PHYSICA A, V389, P4201, DOI 10.1016/j.physa.2010.06.003; Chauhan S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056114; Chen P, 2010, J INFORMETR, V4, P278, DOI 10.1016/j.joi.2010.01.001; Cheng XQ, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/04/P04024; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Cohn DA, 1996, J ARTIF INTELL RES, V4, P129, DOI 10.1613/jair.295; Dasgupta S., 2008, ADV NEURAL INFORM PR, P353; Donetti L, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/10/P10012; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Flake GW, 2002, COMPUTER, V35, P66, DOI 10.1109/2.989932; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fred ALN, 2003, PROC CVPR IEEE, P128; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Grira N, 2008, PATTERN RECOGN, V41, P1834, DOI 10.1016/j.patcog.2007.10.004; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; He XF, 2010, IEEE T IMAGE PROCESS, V19, P254, DOI 10.1109/TIP.2009.2032342; Hu YQ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016115; Ji M., 2012, P MACHINE LEARNING R, P556; Jierui Xie, 2011, 2011 IEEE First International Network Science Workshop (NSW 2011), P188, DOI 10.1109/NSW.2011.6004645; Kleinberg J, 2001, SCIENCE, V294, P1849, DOI 10.1126/science.1067014; Lewis ACF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-100; Liu X, 2010, PHYSICA A, V389, P1493, DOI 10.1016/j.physa.2009.12.019; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pan Y, 2010, PHYSICA A, V389, P2849, DOI 10.1016/j.physa.2010.03.006; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Qin HL, 2012, 2012 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P348, DOI 10.1109/ASONAM.2012.64; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018209; Settles B., 2010, TECHNICAL REPORT, DOI DOI 10.1016/J.MATLET.2010.11.072; Settles Burr, 2008, P C EMP METH NAT LAN, P1070, DOI DOI 10.3115/1613715.1613855; Shen HW, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/10/P10020; Shen HW, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016114; Steinhaeuser K, 2010, PATTERN RECOGN LETT, V31, P413, DOI 10.1016/j.patrec.2009.11.001; Tabrizi SA, 2013, PHYSICA A, V392, P5772, DOI 10.1016/j.physa.2013.07.021; van Dongen S, 2000, THESIS U UTRECHT; van Gennip Y, 2012, ABS12064969 CORR; Vu VV, 2010, PROC INT C TOOLS ART, DOI 10.1109/ICTAI.2010.11; Wang F, 2009, IEEE DATA MINING, P562, DOI 10.1109/ICDM.2009.66; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046103; Zhang SH, 2007, PHYSICA A, V374, P483, DOI 10.1016/j.physa.2006.07.023; Zhao WZ, 2012, KNOWL INF SYST, V30, P569, DOI 10.1007/s10115-011-0389-1; Zhou HJ, 2004, LECT NOTES COMPUT SC, V3038, P1062	53	15	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110088	10.1371/journal.pone.0110088	http://dx.doi.org/10.1371/journal.pone.0110088			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329660	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204100044
J	Smiderle, FR; Baggio, CH; Borato, DG; Santana, AP; Sassaki, GL; Iacomini, M; Van Griensven, LJLD				Smiderle, Fhernanda R.; Baggio, Cristiane H.; Borato, Debora G.; Santana-Filho, Arquimedes P.; Sassaki, Guilherme L.; Iacomini, Marcello; Van Griensven, Leo J. L. D.			Anti-Inflammatory Properties of the Medicinal Mushroom Cordyceps militaris Might Be Related to Its Linear (1 -> 3)-beta-D-Glucan	PLOS ONE			English	Article							FORMALIN TEST; FRUITING BODIES; CONGO-RED; POLYSACCHARIDES; EXTRACT; MICE; RECOGNITION; MACROPHAGES; ACTIVATION; SINENSIS	The Ascomycete Cordyceps militaris, an entomopathogenic fungus, is one of the most important traditional Chinese medicines. Studies related to its pharmacological properties suggest that this mushroom can exert interesting biological activities. Aqueous (CW and HW) and alkaline (K5) extracts containing polysaccharides were prepared from this mushroom, and a beta-D-glucan was purified. This polymer was analysed by GC-MS and NMR spectrometry, showing a linear chain composed of beta-D-Glcp (1 -> 3)-linked. The six main signals in the C-13-NMR spectrum were assigned by comparison to reported data. The aqueous (CW, HW) extracts stimulated the expression of IL-1 beta, TNF-alpha, and COX-2 by THP-1 macrophages, while the alkaline (K5) extract did not show any effect. However, when the extracts were added to the cells in the presence of LPS, K5 showed the highest inhibition of the pro-inflammatory genes expression. This inhibitory effect was also observed for the purified beta-(1 -> 3)-D-glucan, that seems to be the most potent anti-inflammatory compound present in the polysaccharide extracts of C. militaris. In vivo, beta-(1 -> 3)-D-glucan also inhibited significantly the inflammatory phase of formalin-induced nociceptive response, and, in addition, it reduced the migration of total leukocytes but not the neutrophils induced by LPS. In conclusion, this study clearly demonstrates the anti-inflammatory effect of beta-(1 -> 3)-D-glucan.	[Smiderle, Fhernanda R.; Santana-Filho, Arquimedes P.; Sassaki, Guilherme L.; Iacomini, Marcello] Univ Fed Parana, Dept Biochem & Mol Biol, BR-80060000 Curitiba, Parana, Brazil; [Baggio, Cristiane H.; Borato, Debora G.] Univ Fed Parana, Dept Pharmacol, BR-80060000 Curitiba, Parana, Brazil; [Van Griensven, Leo J. L. D.] Univ Wageningen & Res Ctr, Wageningen, Netherlands	Universidade Federal do Parana; Universidade Federal do Parana; Wageningen University & Research	Van Griensven, LJLD (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	leo.vangriensven@wur.nl	Baggio, Cristiane H/C-5633-2013; Smiderle, Fhernanda/AAF-4935-2019; Sassaki, Guilherme/AAM-1112-2020	Baggio, Cristiane H/0000-0001-5536-7561; Smiderle, Fhernanda/0000-0002-9094-2258; Sassaki, Guilherme/0000-0001-7420-168X; Santana-Filho, Arquimedes Paixao de/0000-0001-5106-8740	Conselho Nacional de Desenvolvimento Cientifico e Technologico (CNPq); Fundacao Araucaria; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Technologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Technologico (CNPq) for the postdoctoral scholarship of FRS; Fundacao Araucaria; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the doctoral scholarship of CHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LVG received no special funding for this work.	Alquini G, 2004, FEMS MICROBIOL LETT, V230, P47, DOI 10.1016/S0378-1097(03)00853-X; Borges FRM, 2014, J ETHNOPHARMACOL, V151, P144, DOI 10.1016/j.jep.2013.10.009; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Chanput W, 2012, MOL NUTR FOOD RES, V56, P822, DOI 10.1002/mnfr.201100715; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; Chen JZ, 2007, MYCOL RES, V111, P635, DOI 10.1016/j.mycres.2007.02.011; Chen WX, 2010, CELL IMMUNOL, V262, P69, DOI 10.1016/j.cellimm.2010.01.001; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; da Silva MD, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq036; Daba A. S., 2003, African Journal of Biotechnology, V2, P672; Das SK, 2010, FITOTERAPIA, V81, P961, DOI 10.1016/j.fitote.2010.07.010; de Santana AP, 2012, CARBOHYD POLYM, V87, P2730, DOI 10.1016/j.carbpol.2011.11.073; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; GORIN PAJ, 1984, CARBOHYD RES, V128, P119, DOI 10.1016/0008-6215(84)85090-9; Haworth WN, 1915, J CHEM SOC, V107, P8, DOI 10.1039/ct9150700008; Holliday J, 2008, INT J MED MUSHROOMS, V10, P219, DOI 10.1615/IntJMedMushr.v10.i3.30; HUNSKAAR S, 1985, J NEUROSCI METH, V14, P69, DOI 10.1016/0165-0270(85)90116-5; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Jo Wol Soon, 2010, Mycobiology, V38, P46, DOI 10.4489/MYCO.2010.38.1.046; Kim HS, 2010, FOOD CHEM TOXICOL, V48, P1926, DOI 10.1016/j.fct.2010.04.036; Komura DL, 2010, BIORESOURCE TECHNOL, V101, P6192, DOI 10.1016/j.biortech.2010.01.142; Lehtovaara BC, 2011, J AGR FOOD CHEM, V59, P6813, DOI 10.1021/jf200964u; Li XQ, 2011, J ETHNOPHARMACOL, V135, P1, DOI 10.1016/j.jep.2010.06.028; Li YM, 2014, CANCER LETT, V345, P242, DOI 10.1016/j.canlet.2013.08.034; Lin JG, 2012, INTEGR CANCER THER, V11, P29, DOI 10.1177/1534735411400314; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MALMBERG AB, 1995, J NEUROSCI, V15, P2768; Moradali MF, 2007, INT IMMUNOPHARMACOL, V7, P701, DOI 10.1016/j.intimp.2007.01.008; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Ni J, 2010, NEPHROL DIAL TRANSPL, V25, P86, DOI 10.1093/ndt/gfp415; OGAWA K, 1994, BIOSCI BIOTECH BIOCH, V58, P1870, DOI 10.1271/bbb.58.1870; OGAWA K, 1972, CHEM LETT, P689, DOI 10.1246/cl.1972.689; Ohta Y, 2007, J AGR FOOD CHEM, V55, P10194, DOI 10.1021/jf0721287; Palacios I, 2012, CARBOHYD RES, V358, P72, DOI 10.1016/j.carres.2012.06.016; Ramberg JE, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-54; Reilly TP, 1998, BIOCHEM PHARMACOL, V55, P803, DOI 10.1016/S0006-2952(97)00547-9; Santos ARS, 1998, INFLAMM RES, V47, P302, DOI 10.1007/s000110050333; Sassaki GL, 2005, CARBOHYD RES, V340, P731, DOI 10.1016/j.carres.2005.01.020; Sassaki GL, 2008, J CHROMATOGR A, V1208, P215, DOI 10.1016/j.chroma.2008.08.083; Sassaki GL, 2013, CHEM-BIOL INTERACT, V205, P29, DOI 10.1016/j.cbi.2013.05.014; Smiderle FR, 2008, EUR J PHARMACOL, V597, P86, DOI 10.1016/j.ejphar.2008.08.028; Smiderle FR, 2013, CARBOHYD POLYM, V97, P74, DOI 10.1016/j.carbpol.2013.04.049; Smiderle FR, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-58; Synytsya A, 2013, CARBOHYD POLYM, V92, P792, DOI 10.1016/j.carbpol.2012.09.077; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Wang M, 2012, CARBOHYD POLYM, V89, P461, DOI 10.1016/j.carbpol.2012.03.029; Won SY, 2005, J ETHNOPHARMACOL, V96, P555, DOI 10.1016/j.jep.2004.10.009; Wu YZ, 2014, CANCER LETT, V345, P164, DOI 10.1016/j.canlet.2013.08.014; Yan JK, 2014, J FUNCT FOODS, V6, P33, DOI 10.1016/j.jff.2013.11.024; Yu RM, 2009, CARBOHYD POLYM, V75, P166, DOI 10.1016/j.carbpol.2008.07.023; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	54	57	67	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110266	10.1371/journal.pone.0110266	http://dx.doi.org/10.1371/journal.pone.0110266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330371	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100054
J	Garrouste-Orgeas, M; Perier, A; Mouricou, P; Gregoire, C; Bruel, C; Brochon, S; Philippart, F; Max, A; Misset, B				Garrouste-Orgeas, Maite; Perier, Antoine; Mouricou, Philippe; Gregoire, Charles; Bruel, Cedric; Brochon, Sandie; Philippart, Francois; Max, Adeline; Misset, Benoit			Writing In and Reading ICU Diaries: Qualitative Study of Families' Experience in the ICU	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; VISITING POLICIES; CRITICAL ILLNESS; STRESS-DISORDER; RELATIVES; MEMBERS; SYMPTOMS; COMMUNICATION; PERCEPTIONS; SURVIVORS	Purpose: Keeping an ICU patient diary has been reported to benefit the patient's recovery. Here, we investigated the families' experience with reading and writing in patient ICU diaries kept by both the family and the staff. Methods: We conducted a qualitative study involving 32 semi-structured in-depth interviews of relatives of 26 patients (34% of all family members who visited patients) who met our ICU-diary criterion, i.e., ventilation for longer than 48 hours. Grounded theory was used to conceptualise the interview data via a three-step coding process (open coding, axial coding, and selective coding). Results: Communicative, emotional, and humanising experiences emerged from our data. First, family members used the diaries to access, understand, and assimilate the medical information written in the diaries by staff members, and then to share this information with other family members. Second, the diaries enabled family members to maintain a connection with the patient by documenting their presence and expressing their love and affection. Additionally, families confided in the diaries to maintain hope. Finally, family members felt the diaries humanized the medical staff and patient. Conclusions: Our findings indicate positive effects of diaries on family members. The diaries served as a powerful tool to deliver holistic patient-and family-centered care despite the potentially dehumanising ICU environment. The diaries made the family members aware of their valuable role in caring for the patient and enhanced their access to and comprehension of medical information. Diaries may play a major role in improving the well-being of ICU-patient families.	[Garrouste-Orgeas, Maite; Gregoire, Charles; Bruel, Cedric; Brochon, Sandie; Philippart, Francois; Max, Adeline; Misset, Benoit] St Joseph Hosp Network, Med Surg ICU, Paris, France; [Garrouste-Orgeas, Maite] Paris Diderot Univ, Sorbonne Paris Cite, UMR 1137, IAME, Paris, France; [Perier, Antoine] Univ Hosp Cochin, Maison Adolescents, Paris, France; [Perier, Antoine] Univ Paris 11, INSERM, U 669, Paris, France; [Perier, Antoine] Univ Paris 05, UMR S0669, Paris, France; [Mouricou, Philippe] UNAM, ESSCA Sch Management PRES, Dept Management, Boulogne, France; [Misset, Benoit] Univ Paris 05, Paris, France	Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; ESSCA Ecole de Management; UDICE-French Research Universities; Universite Paris Cite	Garrouste-Orgeas, M (corresponding author), St Joseph Hosp Network, Med Surg ICU, Paris, France.	mgarrouste@hpsj.fr	Philippart, Francois/AAF-2791-2019; Misset, Benoit/P-7817-2018	Philippart, Francois/0000-0002-7323-0742; Misset, Benoit/0000-0001-6466-0065				Aitken LM, 2013, CRIT CARE, V17, DOI 10.1186/cc13164; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Azoulay E, 2004, CRIT CARE MED, V32, P1832, DOI 10.1097/01.CCM.0000139693.88931.59; Berwick DM, 2004, JAMA-J AM MED ASSOC, V292, P736, DOI 10.1001/jama.292.6.736; CHARMAZ K, 1990, SOC SCI MED, V30, P1161, DOI 10.1016/0277-9536(90)90256-R; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Creswell J.W., 2009, RES DESIGN QUALITATI, DOI DOI 10.1007/S11252-005-3264-6; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Di Gangi S, 2013, J CRIT CARE, V28, P483, DOI 10.1016/j.jcrc.2012.11.001; Dodek PM, 2012, CRIT CARE MED, V40, P1506, DOI 10.1097/CCM.0b013e318241e368; Egerod I, 2011, CRIT CARE MED, V39, P1922, DOI 10.1097/CCM.0b013e31821e89c8; Egerod Ingrid, 2010, Intensive Crit Care Nurs, V26, P278, DOI 10.1016/j.iccn.2010.07.002; Egerod Ingrid, 2007, Nurs Crit Care, V12, P159, DOI 10.1111/j.1478-5153.2007.00219.x; Ewens B, 2014, AUST CRIT CARE, V27, P28, DOI 10.1016/j.aucc.2013.07.001; Garrouste-Orgeas M, 2008, CRIT CARE MED, V36, P30, DOI 10.1097/01.CCM.0000295310.29099.F8; Garrouste-Orgeas M, 2012, CRIT CARE MED, V40, P2033, DOI 10.1097/CCM.0b013e31824e1b43; Garrouste-Orgeas M, 2010, J CRIT CARE, V25, P634, DOI 10.1016/j.jcrc.2010.03.001; Giannini A, 2008, INTENS CARE MED, V34, P1256, DOI 10.1007/s00134-008-1037-4; Giannini A, 2014, INTENS CARE MED, V40, P730, DOI 10.1007/s00134-014-3267-y; Giannini A, 2011, INTENS CARE MED, V37, P1890, DOI 10.1007/s00134-011-2331-0; Hale Mandy, 2010, Nurs Manag (Harrow), V17, P14; Hodge Bryan, 2013, Fam Pract Manag, V20, P24; Jones C, 2012, AM J CRIT CARE, V21, P172, DOI 10.4037/ajcc2012569; Jones C, 2010, CRIT CARE, V14, DOI 10.1186/cc9260; Kloos JA, 2008, CRIT CARE NURS Q, V31, P96, DOI 10.1097/01.CNQ.0000314469.41507.cb; Knowles RE, 2009, CRIT CARE MED, V37, P184, DOI 10.1097/CCM.0b013e31819287f7; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; McAdam JL, 2012, AM J CRIT CARE, V21, P386, DOI 10.4037/ajcc2012582; Mehlhorn J, 2014, CRIT CARE MED, V42, P1263, DOI 10.1097/CCM.0000000000000148; MOLTER NC, 1979, HEART LUNG, V8, P332; Perier A, 2013, CRIT CARE, V17, DOI 10.1186/cc11938; Roulin MJ, 2007, QUAL HEALTH RES, V17, P893, DOI 10.1177/1049732307303304; Stephenson Pamela L, 2006, Clin J Oncol Nurs, V10, P241, DOI 10.1188/06.CJON.241-245; Strauss A., 1998, BASICS QUALITATIVE R; Urizzi F, 2007, REV LAT-AM ENFERM, V15, P598, DOI 10.1590/S0104-11692007000400012	36	52	57	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110146	10.1371/journal.pone.0110146	http://dx.doi.org/10.1371/journal.pone.0110146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329581	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210800064
J	Ko, SY; Ko, HA; Shieh, TM; Chang, WC; Chen, HI; Chang, SS; Lin, IH				Ko, Shun-Yao; Ko, Hshin-An; Shieh, Tzong-Ming; Chang, Weng-Cheng; Chen, Hong-I; Chang, Shu-Shing; Lin, I-Hsuan			Cell Migration Is Regulated by AGE-RAGE Interaction in Human Oral Cancer Cells In Vitro	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; HUMAN DNA; AUTOIMMUNE-RESPONSE; RECEPTOR; EXPRESSION; PROLIFERATION; METASTASIS; MMP-9; IMMUNOGENICITY; ASSOCIATION	Advanced glycation end products (AGEs) are produced in an irreversible non-enzymatic reaction of carbohydrates and proteins. Patients with diabetes mellitus (DM) are known to have elevated AGE levels, which is viewed as a risk factor of diabetes-related complications. In a clinical setting, it has been shown that patients with oral cancer in conjunction with DM have a higher likelihood of cancer metastasis and lower cancer survival rates. AGE-RAGE (a receptor of AGEs) is also correlated with metastasis and angiogenesis. Recent studies have suggested that the malignancy of cancer may be enhanced by glyceraldehyde-derived AGEs; however, the underlying mechanism remains unclear. This study examined the apparently close correlation between AGE-RAGE and the malignancy of SAS oral cancer cell line. In this study, AGEs increased ERK phosphorylation, enhanced cell migration, and promoted the expression of RAGE, MMP2, and MMP9. Using PD98059, RAGE antibody, and RAGE RNAi to block RAGE pathway resulted in the inhibition of ERK phosphorylation. Cell migration, MMP2 and MMP9 expression were also reduced by this treatment. Our findings demonstrate the importance of AGE-RAGE with regard to the malignancy of oral cancer, and help to explain the poor prognosis of DM subjects with oral cancer.	[Ko, Shun-Yao; Chang, Weng-Cheng; Chen, Hong-I; Lin, I-Hsuan] Chang Jung Christian Univ, Coll Hlth Sci, Grad Inst Med Sci, Tainan, Taiwan; [Ko, Shun-Yao; Ko, Hshin-An; Chen, Hong-I; Chang, Shu-Shing] Chang Jung Christian Univ, Innovate Res Ctr Med, Tainan, Taiwan; [Shieh, Tzong-Ming] China Med Univ, Dept Dent Hyg, Taichung, Taiwan	Chang Jung Christian University; Chang Jung Christian University; China Medical University Taiwan	Ko, SY (corresponding author), Chang Jung Christian Univ, Coll Hlth Sci, Grad Inst Med Sci, Tainan, Taiwan.	syko@mail.cjcu.edu.tw			National Science Council, Taiwan [NSC 100-2314-B-309-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council, Taiwan (NSC 100-2314-B-309-002-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2004, J INVEST DERMATOL, V122, P461, DOI 10.1046/j.0022-202X.2004.22218.x; Abe R, 2008, CURR PHARM DESIGN, V14, P940, DOI 10.2174/138161208784139765; Ahmad S, 2014, GLYCOBIOLOGY; Ahmad S, 2014, J CLIN TRANSL ENDOCR, V1, P66, DOI 10.1016/j.jcte.2014.05.002; Ahmad S, 2014, GLYCOBIOLOGY, V24, P281, DOI 10.1093/glycob/cwt109; Ahmad S, 2013, INT J BIOL MACROMOL, V62, P167, DOI 10.1016/j.ijbiomac.2013.08.037; Ahmad S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072128; Ahmad S, 2011, BIOCHEM BIOPH RES CO, V407, P568, DOI 10.1016/j.bbrc.2011.03.064; Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Akhter F, 2013, INT J BIOL MACROMOL, V58, P206, DOI 10.1016/j.ijbiomac.2013.03.036; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Bhawal UK, 2005, ONCOLOGY-BASEL, V69, P246, DOI 10.1159/000087910; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Buckley ST, 2011, AM J PHYSIOL-LUNG C, V300, pL548, DOI 10.1152/ajplung.00230.2010; Cai Q, 2011, BIOSCI BIOTECH BIOCH, V75, P1692, DOI 10.1271/bbb.110194; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Girtan Mihaela, 2009, Rom J Intern Med, V47, P201; Jin QE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019375; Jules J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078267; Kim JY, 2008, INT J ONCOL, V33, P493, DOI 10.3892/ijo_00000032; Ko SY, 2010, FREE RADICAL BIO MED, V49, P474, DOI 10.1016/j.freeradbiomed.2010.05.005; Kuniyasu H, 2003, INT J CANCER, V104, P722, DOI 10.1002/ijc.11016; Kuniyasu H, 2003, ONCOL REP, V10, P445; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Lin LG, 2012, J CANCER RES CLIN, V138, P11, DOI 10.1007/s00432-011-1067-0; Luth HJ, 2005, CEREB CORTEX, V15, P211, DOI 10.1093/cercor/bhh123; Meghnani V, 2014, BBA-MOL BASIS DIS, V1842, P1017, DOI 10.1016/j.bbadis.2014.02.013; Mustafa I, 2012, DIABETES RES CLIN PR, V95, P98, DOI 10.1016/j.diabres.2011.09.018; Okamoto T, 2002, FASEB J, V16, P1928, DOI 10.1096/fj.02-0030fje; Patel BP, 2007, HEAD NECK-J SCI SPEC, V29, P564, DOI 10.1002/hed.20561; Patel BP, 2005, J SURG ONCOL, V90, P81, DOI 10.1002/jso.20240; Riuzzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028700; Sasahira T, 2007, HISTOPATHOLOGY, V51, P166, DOI 10.1111/j.1365-2559.2007.02739.x; Sasahira T, 2008, CANCER SCI, V99, P1806, DOI 10.1111/j.1349-7006.2008.00894.x; Shahab U, 2014, CHEM-BIOL INTERACT, V219, P229, DOI 10.1016/j.cbi.2014.06.012; Takino JI, 2010, J ONCOL, V2010, DOI 10.1155/2010/739852; Tan KCB, 2006, DIABETOLOGIA, V49, P2756, DOI 10.1007/s00125-006-0394-1; Vairaktaris E, 2008, INT J ORAL MAX SURG, V37, P60, DOI 10.1016/j.ijom.2007.06.012; Vairaktaris E, 2007, ANTICANCER RES, V27, P4185; Vairaktaris E, 2009, HISTOL HISTOPATHOL, V24, P531, DOI 10.14670/HH-24.531; Valencia JV, 2004, DIABETES, V53, P743, DOI 10.2337/diabetes.53.3.743; Welten AGA, 2003, PERITON DIALYSIS INT, V23, P213; Wu CH, 2010, ANN SURG ONCOL, V17, P2175, DOI 10.1245/s10434-010-0996-1; Xu X, 2014, SCAND J IMMUNOL, V79, P386, DOI 10.1111/sji.12174; Yamamoto K, 2006, PATHOBIOLOGY, V73, P317, DOI 10.1159/000099127; Zhang F, 2011, J SURG RES, V171, P871, DOI 10.1016/j.jss.2010.04.027; Zhu P, 2012, EXP DERMATOL, V21, P123, DOI 10.1111/j.1600-0625.2011.01408.x; Zhu P, 2011, ARCH DERMATOL RES, V303, P339, DOI 10.1007/s00403-010-1102-z	49	31	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110542	10.1371/journal.pone.0110542	http://dx.doi.org/10.1371/journal.pone.0110542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330185	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800092
J	Boisen, MK; Dehlendorff, C; Linnemann, D; Nielsen, BS; Larsen, JS; Osterlind, K; Nielsen, SE; Tarpgaard, LS; Qvortrup, C; Pfeiffer, P; Hollander, NH; Keldsen, N; Hansen, TF; Jensen, BB; Hogdall, EVS; Jensen, BV; Johansen, JS				Boisen, Mogens K.; Dehlendorff, Christian; Linnemann, Dorte; Nielsen, Boye S.; Larsen, Jim S.; Osterlind, Kell; Nielsen, Svend E.; Tarpgaard, Line S.; Qvortrup, Camilla; Pfeiffer, Per; Hollander, Niels H.; Keldsen, Nina; Hansen, Torben F.; Jensen, Brita B.; Hogdall, Estrid V. S.; Jensen, Benny V.; Johansen, Julia S.			Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab	PLOS ONE			English	Article							REPORTING RECOMMENDATIONS; 1ST-LINE THERAPY; SURVIVAL; COMBINATION; EXPRESSION; FLUOROURACIL; NEUROLIGINS; LEUCOVORIN; EFFICACY	Purpose: We tested the hypothesis that expression of microRNAs (miRNAs) in cancer tissue can predict effectiveness of bevacizumab added to capecitabine and oxaliplatin (CAPEOX) in patients with metastatic colorectal cancer (mCRC). Experimental Design: Patients with mCRC treated with first line CAPEOX and bevacizumab (CAPEOXBEV): screening (n = 212) and validation (n = 121) cohorts, or CAPEOX alone: control cohort (n = 127), were identified retrospectively and archival primary tumor samples were collected. Expression of 754 miRNAs was analyzed in the screening cohort using polymerase chain reaction (PCR) arrays and expression levels were related to time to disease progression (TTP) and overall survival (OS). Significant miRNAs from the screening study were analyzed in all three cohorts using custom PCR arrays. In situ hybridization (ISH) was done for selected miRNAs. Results: In the screening study, 26 miRNAs were significantly correlated with outcome in multivariate analyses. Twenty-two miRNAs were selected for further study. Higher miR-664-3p expression and lower miR-455-5p expression were predictive of improved outcome in the CAPEOXBEV cohorts and showed a significant interaction with bevacizumab effectiveness. The effects were strongest for OS. Both miRNAs showed high expression in stromal cells. Higher expression of miR-196b-5p and miR-592 predicted improved outcome regardless of bevacizumab treatment, with similar effect estimates in all three cohorts. Conclusions: We have identified potentially predictive miRNAs for bevacizumab effectiveness and additional miRNAs that could be related to chemotherapy effectiveness or prognosis in patients with mCRC. Our findings need further validation in large cohorts, preferably from completed randomized trials.	[Boisen, Mogens K.; Jensen, Benny V.; Johansen, Julia S.] Herlev Univ Hosp, Dept Oncol, DK-2730 Herlev, Denmark; [Dehlendorff, Christian] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Linnemann, Dorte; Hogdall, Estrid V. S.] Herlev Univ Hosp, Dept Pathol, DK-2730 Herlev, Denmark; [Nielsen, Boye S.] Bioneer, Horsholm, Denmark; [Larsen, Jim S.] Roskilde Hosp, Dept Oncol, Roskilde, Denmark; [Osterlind, Kell] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark; [Nielsen, Svend E.] Hillerod Hosp, Dept Oncol & Palliat, Hillerod, Denmark; [Tarpgaard, Line S.; Qvortrup, Camilla; Pfeiffer, Per] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; [Hollander, Niels H.] Naestved Hosp, Dept Oncol, Naestved, Denmark; [Keldsen, Nina] Herning Hosp, Dept Oncol, Herning, Denmark; [Hansen, Torben F.] Vejle Hosp, Dept Oncol, Vejle, Denmark; [Jensen, Brita B.] Queen Ingrid Hosp, Dept Med, Nuuk, Greenland; [Jensen, Brita B.] Sydvestjysk Hosp, Dept Oncol, Esbjerg, Denmark; [Johansen, Julia S.] Herlev Univ Hosp, Dept Med, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Danish Cancer Society; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; Naestved Hospital; Aarhus University; University of Southern Denmark; Lillebaelt Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Boisen, MK (corresponding author), Herlev Univ Hosp, Dept Oncol, DK-2730 Herlev, Denmark.	mogens.karsboel.boisen@regionh.dk	Qvortrup, Camilla/AAD-3366-2019; Hansen, Torben F/J-8065-2012; Hansen, Torben Frøstrup/K-5583-2019; Dehlendorff, Christian/AAG-9421-2019	Hansen, Torben Frøstrup/0000-0001-7476-671X; Hogdall, Estrid/0000-0003-4689-5658; Pfeiffer, Per/0000-0002-2925-0586; Tarpgaard, Line/0000-0001-8505-2544; Boisen, Mogens Karsbol/0000-0002-9891-5449; Qvortrup, Camilla/0000-0001-9338-9841; Dehlendorff, Christian/0000-0001-6161-4565	Roche Denmark; Herlev Hospital Research Foundation; Technical University of Denmark	Roche Denmark(Roche Holding); Herlev Hospital Research Foundation; Technical University of Denmark	This study was supported by an unrestricted grant from Roche Denmark (www.roche.dk), the Herlev Hospital Research Foundation (www.herlevhospital.dk), and a proof-of-concept grant from the Technical University of Denmark (www.dtu.dk). All grants were given to MKB alone, or to both MKB and JSJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Boisen MK, 2013, ANN ONCOL, V24, P2554, DOI 10.1093/annonc/mdt253; Bottos A, 2011, CELL MOL LIFE SCI, V68, P2655, DOI 10.1007/s00018-011-0664-z; Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; COX DR, 1972, J R STAT SOC B, V34, P187; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Ferlay J, 2013, IARC CANCERBASE; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hurwitz HI, 2013, ONCOLOGIST, V18, P1004, DOI 10.1634/theoncologist.2013-0107; Jubb AM, 2010, LANCET ONCOL, V11, P1172, DOI 10.1016/S1470-2045(10)70232-1; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Lambrechts D, 2013, J CLIN ONCOL, V31, P1219, DOI 10.1200/JCO.2012.46.2762; Lee K, 2013, P NATL ACAD SCI USA, V110, P336, DOI 10.1073/pnas.1219987110; Mazeh H, 2013, J CANCER, V4, P281, DOI 10.7150/jca.5836; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Mosakhani N, 2012, CANCER GENET-NY, V205, P545, DOI 10.1016/j.cancergen.2012.08.003; Nana-Sinkam SP, 2010, ANN NY ACAD SCI, V1210, P25, DOI 10.1111/j.1749-6632.2010.05822.x; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; Nosho K, 2014, CARCINOGENESIS, V35, P776, DOI 10.1093/carcin/bgt374; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Qvortrup C, 2010, ANN ONCOL, V21, P87, DOI 10.1093/annonc/mdp272; R Core Team, 2021, R LANGUAGE ENV STAT; Rissone A, 2012, ARTERIOSCL THROM VAS, V32, P1563, DOI 10.1161/ATVBAHA.111.243006; Sakamoto MIGKY, 1986, AKAIKE INFORM CRITER; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Schee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066165; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Svoboda M, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-195; Van Cutsem E, 2010, ANN ONCOL, V21, pv93, DOI 10.1093/annonc/mdq222; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907	38	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109430	10.1371/journal.pone.0109430	http://dx.doi.org/10.1371/journal.pone.0109430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329796	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200029
J	Cohen, ND; Bourquin, JR; Bordin, AI; Kuskie, KR; Brake, CN; Weaver, KB; Liu, M; Felippe, MJB; Kogut, MH				Cohen, Noah D.; Bourquin, Jessica R.; Bordin, Angela I.; Kuskie, Kyle R.; Brake, Courtney N.; Weaver, Kaytee B.; Liu, Mei; Felippe, M. Julia B.; Kogut, Michael H.			Intramuscular Administration of a Synthetic CpG-Oligodeoxynucleotide Modulates Functional Responses of Neutrophils of Neonatal Foals	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; RHODOCOCCUS-EQUI; PERIPHERAL-BLOOD; INNATE IMMUNITY; CYTOKINE EXPRESSION; INTERFERON-GAMMA; INDUCTION; CATTLE; VACCINATION; FORMULATION	Neutrophils play an important role in protecting against infection. Foals have age-dependent deficiencies in neutrophil function that may contribute to their predisposition to infection. Thus, we investigated the ability of a CpG-ODN formulated with Emulsigen to modulate functional responses of neutrophils in neonatal foals. Eighteen foals were randomly assigned to receive either a CpG-ODN with Emulsigen (N = 9) or saline intramuscularly at ages 1 and 7 days. At ages 1, 3, 9, 14, and 28, blood was collected and neutrophils were isolated from each foal. Neutrophils were assessed for basal and Rhodococcus equi-stimulated mRNA expression of the cytokines interferon-gamma (IFN-gamma), interleukin (IL)-4, IL-6, and IL-8 using real-time PCR, degranulation by quantifying the amount of beta-D glucuronidase activity, and reactive oxygen species (ROS) generation using flow cytometry. In vivo administration of the CpG-ODN formulation on days 1 and 7 resulted in significantly (P<0.05) increased IFN-gamma mRNA expression by foal neutrophils on days 3, 9, and 14. Degranulation was significantly (P<0.05) lower for foals in the CpG-ODN-treated group than the control group at days 3 and 14, but not at other days. No effect of treatment on ROS generation was detected. These results indicate that CpG-ODN administration to foals might improve innate and adaptive immune responses that could protect foals against infectious diseases and possibly improve responses to vaccination.	[Cohen, Noah D.; Bourquin, Jessica R.; Bordin, Angela I.; Kuskie, Kyle R.; Brake, Courtney N.; Weaver, Kaytee B.; Liu, Mei] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, Equine Infect Dis Lab, College Stn, TX 77843 USA; [Felippe, M. Julia B.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Kogut, Michael H.] ARS, Southern Plains Agr Res Ctr, USDA, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Cornell University; United States Department of Agriculture (USDA)	Cohen, ND (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, Equine Infect Dis Lab, College Stn, TX 77843 USA.	ncohen@cvm.tamu.edu	Kogut, Michael H./Z-3119-2019	Liu, Mei/0000-0003-1156-2722; Kogut, Michael/0000-0001-5821-3728	USDA-CSREES [TEX018399]; Link Equine Research Endowment, College of Veterinary Medicine & Biomedical Sciences, Texas AM University; Fort Dodge Animal Health/Zoetis	USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Link Equine Research Endowment, College of Veterinary Medicine & Biomedical Sciences, Texas AM University; Fort Dodge Animal Health/Zoetis	This work was supported by a grant from the USDA-CSREES (TEX018399), with additional support from the Link Equine Research Endowment, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Bordin was supported by a fellowship from Fort Dodge Animal Health/Pfizer Animal Health (now Zoetis). The corporate support for Dr. Bordin's scholarship had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The CpG-ODN used in this study was provided by Merial, Ltd. Merial had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MP, 2009, CLIN VACCINE IMMUNOL, V16, P1151, DOI 10.1128/CVI.00018-09; [Anonymous], 1999, BASELINE REFERENCE 1, P34; BOBER LA, 1995, CLIN EXP IMMUNOL, V99, P129; Bordin AI, 2012, VET IMMUNOL IMMUNOP, V145, P290, DOI 10.1016/j.vetimm.2011.11.012; Boyd NK, 2003, VET IMMUNOL IMMUNOP, V92, P75, DOI 10.1016/S0165-2427(03)00021-7; Brandt E, 2000, J LEUKOCYTE BIOL, V68, P125; Breathnach CC, 2006, VET IMMUNOL IMMUNOP, V112, P199, DOI 10.1016/j.vetimm.2006.02.010; Burton AJ, 2010, VET PARASITOL, V174, P139, DOI 10.1016/j.vetpar.2010.08.019; Chaffin MK, 2004, VET IMMUNOL IMMUNOP, V100, P33, DOI 10.1016/j.vetimm.2004.02.010; COHEN ND, 1994, J AM VET MED ASSOC, V204, P1644; Corley KTT, 2007, EQUINE VET J, V39, P84, DOI 10.2746/042516407X157585; Cuenca AG, 2013, AM J PERINAT, V30, P105, DOI 10.1055/s-0032-1333412; Dawson DR, 2011, AM J VET RES, V72, P1465, DOI 10.2460/ajvr.72.11.1465; Deng JC, 2004, J IMMUNOL, V173, P5148, DOI 10.4049/jimmunol.173.8.5148; East LM, 2000, PREV VET MED, V46, P61, DOI 10.1016/S0167-5877(00)00131-8; Fabri M, 2011, SCI TRANSL MED, V3, P1, DOI DOI 10.1126/SCITRANSLMED.3003045; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Flaminio MJBF, 2000, VET IMMUNOL IMMUNOP, V73, P267, DOI 10.1016/S0165-2427(00)00149-5; Frederick J, 2009, J VET INTERN MED, V23, P1254, DOI 10.1111/j.1939-1676.2009.0383.x; Giguere S, 2011, J VET INTERN MED, V25, P1209, DOI 10.1111/j.1939-1676.2011.00835.x; Girard D, 1997, BIOCHEM J, V325, P147, DOI 10.1042/bj3250147; Grondahl G, 1999, VET MICROBIOL, V65, P241, DOI 10.1016/S0378-1135(98)00299-5; HARVEY JW, 1984, EQUINE VET J, V16, P347, DOI 10.1111/j.2042-3306.1984.tb01940.x; Ioannou XP, 2002, J VIROL, V76, P9002, DOI 10.1128/JVI.76.18.9002-9010.2002; Jaillon S, 2013, SEMIN IMMUNOPATHOL, V35, P377, DOI 10.1007/s00281-013-0374-8; Kirby AC, 2002, J IMMUNOL, V169, P4450, DOI 10.4049/jimmunol.169.8.4450; Koenig JM, 2004, CLIN PERINATOL, V31, P39, DOI 10.1016/j.clp.2004.03.013; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liu M, 2011, CYTOKINE, V56, P356, DOI 10.1016/j.cyto.2011.07.017; Liu M, 2009, CYTOKINE, V48, P280, DOI 10.1016/j.cyto.2009.08.012; Liu T, 2009, VACCINE, V27, P674, DOI 10.1016/j.vaccine.2008.11.040; Lopez AM, 2006, VET IMMUNOL IMMUNOP, V114, P103, DOI 10.1016/j.vetimm.2006.07.013; Magdesian KG, 2002, J AM VET MED ASSOC, V220, P67, DOI 10.2460/javma.2002.220.67; Marsh PS, 2001, J AM VET MED ASSOC, V218, P1608, DOI 10.2460/javma.2001.218.1608; MARTENS JG, 1988, AM J VET RES, V49, P295; Martens RJ, 2005, INFECT IMMUN, V73, P7040, DOI 10.1128/IAI.73.10.7040-7042.2005; McTaggart C, 2001, RES VET SCI, V71, P73, DOI 10.1053/rvsc.2001.0490; Mutwiri GK, 2004, J CONTROL RELEASE, V97, P1, DOI 10.1016/j.jcornel.2004.02.022; Nerren JR, 2009, VET IMMUNOL IMMUNOP, V127, P212, DOI 10.1016/j.vetimm.2008.10.004; Nichani AK, 2004, CELL IMMUNOL, V227, P24, DOI 10.1016/j.cellimm.2004.01.004; Nichani AK, 2004, VET IMMUNOL IMMUNOP, V98, P17, DOI 10.1016/j.vetimm.2003.10.001; Oumouna M, 2005, J VIROL, V79, P2024, DOI 10.1128/JVI.79.4.2024-2032.2005; Shafique M, 2012, VACCINE, V30, P597, DOI 10.1016/j.vaccine.2011.11.054; SNOECK HW, 1993, EUR J IMMUNOL, V23, P1072, DOI 10.1002/eji.1830230514; Sumino K, 2012, J ALLERGY CLIN IMMUN, V129, P1267, DOI 10.1016/j.jaci.2012.02.033; Vordermeier HM, 2005, VACCINE, V23, P4375, DOI 10.1016/j.vaccine.2005.04.022; Wedlock DN, 2005, VET IMMUNOL IMMUNOP, V106, P53, DOI 10.1016/j.vetimm.2005.01.002; Wedlock DN, 2005, INFECT IMMUN, V73, P3540, DOI 10.1128/IAI.73.6.3540-3546.2005; WICHTEL MG, 1991, EQUINE VET J, V23, P466, DOI 10.1111/j.2042-3306.1991.tb03763.x; Yamaguchi Y, 2012, J VIROL, V86, P10456, DOI 10.1128/JVI.01082-12; Yin JY, 2009, J IMMUNOL, V182, P7069, DOI 10.4049/jimmunol.0802410	51	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109865	10.1371/journal.pone.0109865	http://dx.doi.org/10.1371/journal.pone.0109865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333660	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200061
J	Liu, CX; Wan, XY; Ye, TT; Fang, F; Chen, XR; Chen, YW; Dong, Y				Liu, Chongxiao; Wan, Xiaoyu; Ye, Tingting; Fang, Fang; Chen, Xueru; Chen, Yuanwen; Dong, Yan			Matrix Metalloproteinase 2 Contributes to Pancreatic Beta Cell Injury Induced by Oxidative Stress	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MITOCHONDRIAL DYSFUNCTION; DIABETIC-RETINOPATHY; EXPRESSION; DEATH; RATS	Objective: To investigate the role of matrix metalloproteinase 2 (MMP2) in pancreatic beta cell injury induced by oxidative stress. Methods: Rat pancreatic beta cell line INS-1 cells were treated with advanced glycation end-products (AGE) to induce intracellular oxidative stress. Intracellular MMP2 expression and activity were determined by quantitative reverse transcription polymerase chain reaction (RT-PCR), Western blotting, and zymography, respectively. MMP2 expression and activity were manipulated by over-expression with recombinant MMP2 plasmids or knockdown with either MMP2 specific siRNA or inhibitors, and effects on apoptosis and insulin-secretion were measured by flow cytometry and ELISA. Results: AGE treatment induced intracellular oxidative stress in INS-1 cells, as indicated by elevated ROS levels, apoptotic cell death, and suppressed insulin secretion. This was accompanied by increased MMP2 expression and activity. However, Antioxidant N-acetylcysteine (NAC) treatment inhibited MMP2 expression and activity, and partially reversed cell apoptosis and insulin secretion dysfunction induced by AGE. Forced expression of MMP2 mimicked the effects of AGE treatment while inhibition of MMP2 either by a specific MMP2 inhibitor or MMP2 siRNA protected oxidative stress induced by AGE. Conclusion: MMP2 expression and intracellular activity are increased by oxidative stress, contributing to cellular dysfunction and apoptosis in INS-1 cells after AGE challenge.	[Liu, Chongxiao; Wan, Xiaoyu; Ye, Tingting; Fang, Fang; Chen, Xueru; Dong, Yan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Endocrinol, Shanghai 200030, Peoples R China; [Chen, Yuanwen] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gastroenterol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Dong, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Endocrinol, Shanghai 200030, Peoples R China.	yandong00@hotmail.com	Chen, Yuanwen/AAL-6421-2020		National Natural Science Foundation of China [81170757]; Fund of Shanghai Jiao Tong University School of Medicine [09xj21011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Shanghai Jiao Tong University School of Medicine	This work was supported by the grants from the National Natural Science Foundation of China (No. 81170757) and the Fund of Shanghai Jiao Tong University School of Medicine (No 09xj21011). The author YD received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2008, CURR DIABETES REP, V8, P173, DOI 10.1007/s11892-008-0030-1; Alfonso-Jaume MA, 2006, AM J PHYSIOL-HEART C, V291, pH1838, DOI 10.1152/ajpheart.00026.2006; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Drews G, 2010, PFLUG ARCH EUR J PHY, V460, P703, DOI 10.1007/s00424-010-0862-9; Fiory F, 2011, DIABETOLOGIA, V54, P2941, DOI 10.1007/s00125-011-2280-8; Grote K, 2003, CIRC RES, V92, pE80, DOI 10.1161/01.RES.0000077044.60138.7C; Jonas JC, 2009, DIABETES OBES METAB, V11, P65, DOI 10.1111/j.1463-1326.2009.01112.x; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Kowluru RA, 2009, FREE RADICAL BIO MED, V46, P1677, DOI 10.1016/j.freeradbiomed.2009.03.024; Lin N, 2012, DIABETES METAB, V38, P250, DOI 10.1016/j.diabet.2012.01.003; Martinez MLL, 2008, EUR J PHARMACOL, V599, P110, DOI 10.1016/j.ejphar.2008.10.007; Mohammad G, 2011, INVEST OPHTH VIS SCI, V52, P3832, DOI 10.1167/iovs.10-6368; Mohammad G, 2010, LAB INVEST, V90, P1365, DOI 10.1038/labinvest.2010.89; Mohammed FF, 2003, ANN RHEUM DIS, V62, P43; Mulder H, 2009, MOL CELL ENDOCRINOL, V297, P34, DOI 10.1016/j.mce.2008.05.015; Pitocco Dario, 2010, Rev Diabet Stud, V7, P15, DOI 10.1900/RDS.2010.7.15; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Robertson RP, 2007, CELL BIOCHEM BIOPHYS, V48, P139, DOI 10.1007/s12013-007-0026-5; Roy R, 2006, EXP CELL RES, V312, P608, DOI 10.1016/j.yexcr.2005.11.022; Sawicki G, 2005, CIRCULATION, V112, P544, DOI 10.1161/CIRCULATIONAHA.104.531616; Song YM, 2013, ENDOCRINOLOGY, V154, P2626, DOI 10.1210/en.2013-1031; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Wang WJ, 2002, CARDIOVASC RES, V53, P165, DOI 10.1016/S0008-6363(01)00445-X; Yoshida M, 2001, J IMMUNOL, V166, P7514, DOI 10.4049/jimmunol.166.12.7514; Zhou YP, 2005, DIABETES, V54, P2612, DOI 10.2337/diabetes.54.9.2612	27	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110227	10.1371/journal.pone.0110227	http://dx.doi.org/10.1371/journal.pone.0110227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333278	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200104
J	Mulamba, C; Riveron, JM; Ibrahim, SS; Irving, H; Barnes, KG; Mukwaya, LG; Birungi, J; Wondji, CS				Mulamba, Charles; Riveron, Jacob M.; Ibrahim, Sulaiman S.; Irving, Helen; Barnes, Kayla G.; Mukwaya, Louis G.; Birungi, Josephine; Wondji, Charles S.			Widespread Pyrethroid and DDT Resistance in the Major Malaria Vector Anopheles funestus in East Africa Is Driven by Metabolic Resistance Mechanisms	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; KNOCKDOWN RESISTANCE; GAMBIAE S.S.; IDENTIFICATION; GENE; TRANSMISSION; SEQUENCE; MUTATION; POPULATIONS; SENSITIVITY	Background: Establishing the extent, geographical distribution and mechanisms of insecticide resistance in malaria vectors is a prerequisite for resistance management. Here, we report a widespread distribution of insecticide resistance in the major malaria vector An. funestus across Uganda and western Kenya under the control of metabolic resistance mechanisms. Methodology/Principal Findings: Female An. funestus collected throughout Uganda and western Kenya exhibited a Plasmodium infection rate between 4.2 to 10.4%. Widespread resistance against both type I (permethrin) and II (deltamethrin) pyrethroids and DDT was observed across Uganda and western Kenya. All populations remain highly susceptible to carbamate, organophosphate and dieldrin insecticides. Knockdown resistance plays no role in the pyrethroid and DDT resistance as no kdr mutation associated with resistance was detected despite the presence of a F1021C replacement. Additionally, no signature of selection was observed on the sodium channel gene. Synergist assays and qRT-PCR indicated that metabolic resistance plays a major role notably through elevated expression of cytochrome P450s. DDT resistance mechanisms differ from West Africa as the L119F-GSTe2 mutation only explains a small proportion of the genetic variance to DDT resistance. Conclusion: The extensive distribution of pyrethroid and DDT resistance in East African An. funestus populations represents a challenge to the control of this vector. However, the observed carbamate and organophosphate susceptibility offers alternative solutions for resistance management.	[Mulamba, Charles; Riveron, Jacob M.; Ibrahim, Sulaiman S.; Irving, Helen; Wondji, Charles S.] Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England; [Mulamba, Charles; Mukwaya, Louis G.; Birungi, Josephine] Uganda Virus Res Inst, Entebbe, Uganda	Liverpool School of Tropical Medicine; University of Liverpool; Uganda Virus Research Institute	Wondji, CS (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	c.s.wondji@liverpool.ac.uk	Ibrahim, Sulaiman S/N-1426-2014; Wondji, Charles/AAG-1510-2020; Ibrahim, Sulaiman S/R-5466-2019	Ibrahim, Sulaiman S/0000-0003-0744-802X; Ibrahim, Sulaiman S/0000-0003-0744-802X; Wondji, Charles S./0000-0003-0791-3673	Wellcome Trust Master Fellowship in Public Health and Tropical Medicine [092794/Z/10/Z]; Wellcome Trust Research Career Development Fellowship [083515/Z/07/Z]	Wellcome Trust Master Fellowship in Public Health and Tropical Medicine(Wellcome Trust); Wellcome Trust Research Career Development Fellowship(Wellcome Trust)	This work was supported by a Wellcome Trust Master Fellowship in Public Health and Tropical Medicine to CM (092794/Z/10/Z) and a Wellcome Trust Research Career Development Fellowship to CSW (083515/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, WHOCDCMAL98; Bass C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-177; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Chanda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024336; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Coetzee M, 2004, INSECT BIOCHEM MOLEC, V34, P599, DOI 10.1016/j.ibmb.2004.03.012; Coetzee M, 2013, ANNU REV ENTOMOL, V58, P393, DOI 10.1146/annurev-ento-120811-153628; Cuamba N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011010; Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x; Dia I, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P197, DOI 10.5772/55389; Djouaka R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027760; Echodu R., 2010, Journal of Parasitology and Vector Biology, V2, P28; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; HUDSON RR, 1992, GENETICS, V132, P583; Hunt RH, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-122; Kawada H, 2011, PLOS ONE, V6; Kigozi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042857; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Kwiatkowska RM, 2013, GENE, V519, P98, DOI 10.1016/j.gene.2013.01.036; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIVAK KJ, 1984, GENETICS, V107, P611; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Michel AP, 2005, MOL ECOL, V14, P4235, DOI 10.1111/j.1365-294X.2005.02754.x; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Mulamba C, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-71; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Okia M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-130; Okoye PN, 2008, T ROY SOC TROP MED H, V102, P591, DOI 10.1016/j.trstmh.2008.02.022; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Riveron JM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r27; Riveron JM, 2013, P NATL ACAD SCI USA, V110, P252, DOI 10.1073/pnas.1216705110; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wondji CS, 2008, TROP MED INT HEALTH, V13, P548, DOI 10.1111/j.1365-3156.2008.02033.x; Wondji CS, 2012, P NATL ACAD SCI USA, V109, P19063, DOI 10.1073/pnas.1217229109; Wondji CS, 2011, INSECT BIOCHEM MOLEC, V41, P484, DOI 10.1016/j.ibmb.2011.03.012; World Health Organization, 2012, WHO GLOB MAL PROGR G	47	73	76	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110058	10.1371/journal.pone.0110058	http://dx.doi.org/10.1371/journal.pone.0110058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333491	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000346766200087
J	Tang, X; Wadsworth, WG				Tang, Xia; Wadsworth, William G.			SAX-3 (Robo) and UNC-40 (DCC) Regulate a Directional Bias for Axon Guidance in Response to Multiple Extracellular Cues	PLOS ONE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; CYTOPLASMIC DOMAINS; COMMISSURAL AXONS; BROWNIAN-MOTION; NETRIN CUES; RECEPTORS; SLIT; MIGRATIONS; PROTEINS	Axons in Caenorhabditis elegans are guided by multiple extracellular cues, including UNC-6 (netrin), EGL-20 (wnt), UNC-52 (perlecan), and SLT-1 (slit). How multiple extracellular cues determine the direction of axon guidance is not well understood. We have proposed that an axon's response to guidance cues can be modeled as a random walk, i.e., a succession of randomly directed movement. Guidance cues dictate the probability of axon outgrowth activity occurring in each direction, which over time creates a directional bias. Here we provide further evidence for this model. We describe the effects that the UNC-40 (DCC) and SAX-3 (Robo) receptors and the UNC-6, EGL-20, UNC-52, and SLT-1 extracellular cues have on the directional bias of the axon outgrowth activity for the HSN and AVM neurons. We find that the directional bias created by the cues depend on UNC-40 or SAX-3. UNC-6 and EGL-20 affect the directional bias for both neurons, whereas UNC-52 and SLT-1 only affect the directional bias for HSN and AVM, respectively. The direction of the bias created by the loss of a cue can vary and the direction depends on the other cues. The random walk model predicts this combinatorial regulation. In a random walk a probability is assigned for each direction of outgrowth, thus creating a probability distribution. The probability distribution for each neuron is determined by the collective effect of all the cues. Since the sum of the probabilities must equal one, each cue affects the probability of outgrowth in multiple directions.	[Tang, Xia; Wadsworth, William G.] Rutgers Robert Wood Johnson Med Sch, Dept Pathol, Piscataway, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Wadsworth, WG (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Pathol, Piscataway, NJ 08901 USA.	william.wadsworth@rwjms.rutgers.edu	Wadsworth, William G/N-7866-2014	Wadsworth, William G/0000-0003-3824-2948	National Institutes of Health [R01 NS033156, R01 NS061805]; New Jersey Commission on Spinal Cord; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061805, R01NS033156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Spinal Cord; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants R01 NS033156 and R01 NS061805, and grants from the New Jersey Commission on Spinal Cord. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Asakura T, 2007, DEV BIOL, V304, P800, DOI 10.1016/j.ydbio.2007.01.028; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Duplantier B, 2006, PROG MATH PHYS, V47, P201; Einstein A, 1906, ANN PHYS-BERLIN, V19, P371; Einstein A, 1956, INVESTIGATIONS THEOR; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kolodkin AL, 2011, COLD SPRING HARB PER, V3; Kulkarni G, 2013, BIOL OPEN, V2, P1300, DOI 10.1242/bio.20136346; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Mullen GP, 1999, MOL BIOL CELL, V10, P3205, DOI 10.1091/mbc.10.10.3205; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Quinn CC, 2006, CURR BIOL, V16, P845, DOI 10.1016/j.cub.2006.03.025; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Wang Z, 2014, J CELL BIOL; Wang ZP, 2013, NEURON, V79, P903, DOI 10.1016/j.neuron.2013.06.035; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xu ZN, 2009, GENETICS, V183, P941, DOI 10.1534/genetics.109.108654; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097258; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	33	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110031	10.1371/journal.pone.0110031	http://dx.doi.org/10.1371/journal.pone.0110031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333948	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200081
J	Harms, L; Fulham, WR; Todd, J; Budd, TW; Hunter, M; Meehan, C; Penttonen, M; Schall, U; Zavitsanou, K; Hodgson, DM; Michie, PT				Harms, Lauren; Fulham, W. Ross; Todd, Juanita; Budd, Timothy W.; Hunter, Michael; Meehan, Crystal; Penttonen, Markku; Schall, Ulrich; Zavitsanou, Katerina; Hodgson, Deborah M.; Michie, Patricia T.			Mismatch Negativity (MMN) in Freely-Moving Rats with Several Experimental Controls	PLOS ONE			English	Article							STIMULUS-SPECIFIC ADAPTATION; EVENT-RELATED POTENTIALS; AUDITORY CHANGE-DETECTION; EVOKED-POTENTIALS; ANESTHETIZED RATS; CORTICAL-NEURONS; ANIMAL-MODELS; SOUND CHANGES; PITCH CHANGE; CORTEX	Mismatch negativity (MMN) is a scalp-recorded electrical potential that occurs in humans in response to an auditory stimulus that defies previously established patterns of regularity. MMN amplitude is reduced in people with schizophrenia. In this study, we aimed to develop a robust and replicable rat model of MMN, as a platform for a more thorough understanding of the neurobiology underlying MMN. One of the major concerns for animal models of MMN is whether the rodent brain is capable of producing a human-like MMN, which is not a consequence of neural adaptation to repetitive stimuli. We therefore tested several methods that have been used to control for adaptation and differential exogenous responses to stimuli within the oddball paradigm. Epidural electroencephalographic electrodes were surgically implanted over different cortical locations in adult rats. Encephalographic data were recorded using wireless telemetry while the freely-moving rats were presented with auditory oddball stimuli to assess mismatch responses. Three control sequences were utilized: the flip-flop control was used to control for differential responses to the physical characteristics of standards and deviants; the many standards control was used to control for differential adaptation, as was the cascade control. Both adaptation and adaptation-independent deviance detection were observed for high frequency (pitch), but not low frequency deviants. In addition, the many standards control method was found to be the optimal method for observing both adaptation effects and adaptation-independent mismatch responses in rats. Inconclusive results arose from the cascade control design as it is not yet clear whether rats can encode the complex pattern present in the control sequence. These data contribute to a growing body of evidence supporting the hypothesis that rat brain is indeed capable of exhibiting human-like MMN, and that the rat model is a viable platform for the further investigation of the MMN and its associated neurobiology.	[Harms, Lauren; Fulham, W. Ross; Todd, Juanita; Budd, Timothy W.; Hunter, Michael; Meehan, Crystal; Hodgson, Deborah M.; Michie, Patricia T.] Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia; [Harms, Lauren; Fulham, W. Ross; Todd, Juanita; Budd, Timothy W.; Hunter, Michael; Meehan, Crystal; Schall, Ulrich; Hodgson, Deborah M.; Michie, Patricia T.] Univ Newcastle, Prior Ctr Translat Neuroscience & Mental Hlth Res, Newcastle, NSW 2300, Australia; [Harms, Lauren; Fulham, W. Ross; Todd, Juanita; Budd, Timothy W.; Meehan, Crystal; Schall, Ulrich; Hodgson, Deborah M.; Michie, Patricia T.] Schizophrenia Res Inst, Darlinghurst, NSW, Australia; [Harms, Lauren; Fulham, W. Ross; Todd, Juanita; Budd, Timothy W.; Hunter, Michael; Schall, Ulrich; Hodgson, Deborah M.; Michie, Patricia T.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Fulham, W. Ross; Schall, Ulrich] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Penttonen, Markku] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland; [Zavitsanou, Katerina] Univ New S Wales, Fac Med, Sch Psychiat, Sydney, NSW, Australia; [Zavitsanou, Katerina] Neurosci Res Australia, Randwick, NSW, Australia	University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Jyvaskyla; University of New South Wales Sydney; Neuroscience Research Australia	Harms, L (corresponding author), Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia.	lauren.harms@newcastle.edu.au	SCHALL, ULRICH ANDREAS/G-7452-2013; Meehan, Crystal/L-5766-2018; Harms, Lauren R/J-8698-2012; , Juanita/B-6191-2013; Penttonen, Markku/B-8348-2013; Budd, Timothy/G-7680-2013	SCHALL, ULRICH ANDREAS/0000-0001-9041-4562; Meehan, Crystal/0000-0002-2408-5112; Hunter, Michael/0000-0002-3668-6476; , Juanita/0000-0002-0443-600X; Harms, Lauren/0000-0003-2268-8654; Penttonen, Markku/0000-0002-1033-7286; Budd, Timothy/0000-0003-3027-3889	National Health and Medical Research Council of Australia [1026070]; University of Newcastle Near Miss grant; University of Newcastle CAPEX funding; University of Newcastle travel fellowship schemes; Hunter Medical Research Institute; Schizophrenia Research Institute - NSW Health	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Newcastle Near Miss grant; University of Newcastle CAPEX funding; University of Newcastle travel fellowship schemes; Hunter Medical Research Institute; Schizophrenia Research Institute - NSW Health	This project was funded by a National Health and Medical Research Council of Australia Project Grant, ID 1026070. The contents of this article are solely the responsibility of the authors and do not reflect the views of the NHMRC (http://nhmrc.gov.au). Support was received from the University of Newcastle Near Miss grant, CAPEX funding and travel fellowship schemes (http://www.newcastle.edu.au). Further support was provided by the Hunter Medical Research Institute (http://www.hmri.com.au) and the Schizophrenia Research Institute (http://www.schizophreniaresearch.org.au), which are supported by infrastructure funding from NSW Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00283; ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; ALHO K, 1994, ELECTROEN CLIN NEURO, V91, P353, DOI 10.1016/0013-4694(94)00173-1; Astikainen P, 2006, NEUROREPORT, V17, P1561, DOI 10.1097/01.wnr.0000233097.13032.7d; Astikainen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024208; Bickel S, 2009, BEHAV BRAIN RES, V204, P352, DOI 10.1016/j.bbr.2009.05.005; Brudzynski SM, 2013, CURR OPIN NEUROBIOL, V23, P310, DOI 10.1016/j.conb.2013.01.014; Duque D, 2012, J NEUROSCI, V32, P17762, DOI 10.1523/JNEUROSCI.3190-12.2012; Eriksson J, 2005, BIOSYSTEMS, V79, P207, DOI 10.1016/j.biosystems.2004.09.017; Farley BJ, 2010, J NEUROSCI, V30, P16475, DOI 10.1523/JNEUROSCI.2793-10.2010; Fishman YI, 2014, BRAIN TOPOGR, V27, P500, DOI 10.1007/s10548-013-0337-3; Fishman YI, 2012, J NEUROSCI, V32, P15747, DOI 10.1523/JNEUROSCI.2835-12.2012; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Fulham W.R., 2012, EEG DISPLAY; Grimm S, 2012, BIOL PSYCHOL, V89, P232, DOI 10.1016/j.biopsycho.2011.10.014; Grimm S, 2012, INT J PSYCHOPHYSIOL, V85, P88, DOI 10.1016/j.ijpsycho.2011.05.012; Grimm S, 2011, PSYCHOPHYSIOLOGY, V48, P377, DOI 10.1111/j.1469-8986.2010.01073.x; HARI R, 1984, NEUROSCI LETT, V50, P127, DOI 10.1016/0304-3940(84)90474-9; Imada A, 2013, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00127; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; Jacobsen T, 2003, CLIN NEUROPHYSIOL, V114, P1133, DOI 10.1016/S1388-2457(03)00043-9; Jacobsen T, 2003, NEUROSCI LETT, V344, P79, DOI 10.1016/S0304-3940(03)00408-7; Jung F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063203; KELLY JB, 1977, J COMP PHYSIOL PSYCH, V91, P930, DOI 10.1037/h0077356; Maess B, 2007, NEUROIMAGE, V37, P561, DOI 10.1016/j.neuroimage.2007.05.040; Mazurek B, 2010, HEARING RES, V259, P55, DOI 10.1016/j.heares.2009.10.006; Michie PT, 2001, INT J PSYCHOPHYSIOL, V42, P177, DOI 10.1016/S0167-8760(01)00166-0; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Naatanen R, 2000, AUDIOL NEURO-OTOL, V5, P105, DOI 10.1159/000013874; Naatanen R., 2018, ATTENTION BRAIN FUNC; Nakamura T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00367; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Opitz B, 2005, EUR J NEUROSCI, V21, P531, DOI 10.1111/j.1460-9568.2005.03839.x; Peter V, 2010, NEUROSCI LETT, V482, P71, DOI 10.1016/j.neulet.2010.07.010; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Pratt H, 2009, CLIN NEUROPHYSIOL, V120, P360, DOI 10.1016/j.clinph.2008.10.158; Rinne T, 1999, NEUROIMAGE, V10, P620, DOI 10.1006/nimg.1999.0495; Ruhnau P, 2012, CLIN NEUROPHYSIOL, V123, P507, DOI 10.1016/j.clinph.2011.07.035; Ruusuvirta T, 1998, NEUROSCI LETT, V248, P45, DOI 10.1016/S0304-3940(98)00330-9; Shiramatsu TI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082663; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Tikhonravov D, 2010, NEUROSCIENCE, V167, P1175, DOI 10.1016/j.neuroscience.2010.03.014; Tikhonravov D, 2008, BRAIN RES, V1203, P97, DOI 10.1016/j.brainres.2008.02.006; Todd Juanita, 2013, Front Psychiatry, V4, P171, DOI 10.3389/fpsyt.2013.00171; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; WINKLER I, 1990, PSYCHOPHYSIOLOGY, V27, P228, DOI 10.1111/j.1469-8986.1990.tb00374.x; Winkler I, 1996, BRAIN RES, V742, P239, DOI 10.1016/S0006-8993(96)01008-6	51	58	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110892	10.1371/journal.pone.0110892	http://dx.doi.org/10.1371/journal.pone.0110892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333698	Green Published, gold			2022-12-27	WOS:000343731200084
J	Mitchell, RM; Bakker, JD				Mitchell, Rachel M.; Bakker, Jonathan D.			Intraspecific Trait Variation Driven by Plasticity and Ontogeny in Hypochaeris radicata	PLOS ONE			English	Article							PLANT FUNCTIONAL TRAITS; LIFE-HISTORY TRAITS; PHENOTYPIC PLASTICITY; LEAF TRAITS; TRANSGENERATIONAL PLASTICITY; LOCAL ADAPTATION; BETA-DIVERSITY; VARIABILITY; PATTERNS; LIMITS	The importance of intraspecific variation in plant functional traits for structuring communities and driving ecosystem processes is increasingly recognized, but mechanisms governing this variation are less studied. Variation could be due to adaptation to local conditions, plasticity in observed traits, or ontogeny. We investigated 1) whether abiotic stress caused individuals, maternal lines, and populations to exhibit trait convergence, 2) whether trait variation was primarily due to ecotypic differences or trait plasticity, and 3) whether traits varied with ontogeny. We sampled three populations of Hypochaeris radicata that differed significantly in rosette diameter and specific leaf area (SLA). We grew nine maternal lines from each population (27 lines total) under three greenhouse conditions: ambient conditions (control), 50% drought, or 80% shade. Plant diameter and relative chlorophyll content were measured throughout the experiment, and leaf shape, root: shoot ratio, and SLA were measured after five weeks. We used hierarchical mixed-models and variance component analysis to quantify differences in treatment effects and the contributions of population of origin and maternal line to observed variation. Observed variation in plant traits was driven primarily by plasticity. Shade significantly influenced all measured traits. Plant diameter was the only trait that had a sizable proportion of trait variation (30%) explained by population of origin. There were significant ontogenetic differences for both plant diameter and relative chlorophyll content. When subjected to abiotic stress in the form of light or water limitation, Hypochaeris radicata exhibited significant trait variability. This variation was due primarily to trait plasticity, rather than to adaptation to local conditions, and also differed with ontogeny.	[Mitchell, Rachel M.; Bakker, Jonathan D.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Bakker, Jonathan D.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA	University of Washington; University of Washington Seattle; Smithsonian Institution; Smithsonian Environmental Research Center	Mitchell, RM (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	rmm57@duke.edu	Bakker, Jonathan/I-6960-2013	Bakker, Jonathan/0000-0002-8973-2771				Albert CH, 2010, FUNCT ECOL, V24, P1192, DOI 10.1111/j.1365-2435.2010.01727.x; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Ramirez-Valiente JA, 2010, TREE PHYSIOL, V30, P618, DOI 10.1093/treephys/tpq013; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2004, PERMDISP FORTRAN COM; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Balaguer L, 2001, FUNCT ECOL, V15, P124, DOI 10.1046/j.1365-2435.2001.00505.x; Boege K, 2010, ECOLOGY, V91, P2628, DOI 10.1890/09-0543.1; Bonser SP, 2010, ANN BOT-LONDON, V106, P979, DOI 10.1093/aob/mcq195; Bradshaw AD, 2006, NEW PHYTOL, V170, P644, DOI 10.1111/j.1469-8137.2006.01761.x; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornelissen JHC, 2003, J VEG SCI, V14, P311, DOI 10.1111/j.1654-1103.2003.tb02157.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Crutsinger GM, 2008, ECOL LETT, V11, P16, DOI 10.1111/j.1461-0248.2007.01118.x; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Fajardo A, 2011, NEW PHYTOL, V189, P259, DOI 10.1111/j.1469-8137.2010.03468.x; Firn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035870; Fonseca CR, 2000, J ECOL, V88, P964, DOI 10.1046/j.1365-2745.2000.00506.x; Freschet GT, 2013, ECOL EVOL, V3, P1065, DOI 10.1002/ece3.520; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Gorley C.K., 2006, GETTING STARTED PRIM; Grassein F, 2010, ANN BOT-LONDON, V106, P637, DOI 10.1093/aob/mcq154; Hansen CF, 2013, J EVOLUTION BIOL, V26, P993, DOI 10.1111/jeb.12114; Herman JJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00102; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Jung V, 2014, J ECOL, V102, P45, DOI 10.1111/1365-2745.12177; Jung V, 2010, J ECOL, V98, P1134, DOI 10.1111/j.1365-2745.2010.01687.x; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Laughlin DC, 2011, J ECOL, V99, P1489, DOI 10.1111/j.1365-2745.2011.01885.x; Lecerf A, 2008, BASIC APPL ECOL, V9, P598, DOI 10.1016/j.baae.2007.11.003; Long WX, 2011, OECOLOGIA, V167, P1103, DOI 10.1007/s00442-011-2050-9; Mediavilla S, 2004, FOREST ECOL MANAG, V187, P281, DOI 10.1016/j.foreco.2003.07.006; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Mitchell RM, 2014, FUNCT ECOL, V28, P258, DOI 10.1111/1365-2435.12167; Mix C, 2006, MOL ECOL, V15, P1749, DOI 10.1111/j.1365-294X.2006.02887.x; Mokany K, 2008, J VEG SCI, V19, P119, DOI 10.3170/2007-8-18340; Moreira B, 2012, OECOLOGIA, V168, P671, DOI 10.1007/s00442-011-2127-5; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Nicotra AB, 2011, FUNCT PLANT BIOL, V38, P535, DOI 10.1071/FP11057; Ortiz MA, 2006, AM J BOT, V93, P234, DOI 10.3732/ajb.93.2.234; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pico FX, 2004, BOT J LINN SOC, V146, P163, DOI 10.1111/j.1095-8339.2004.00330.x; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Pratt JD, 2013, GLOBAL CHANGE BIOL, V19, P2454, DOI 10.1111/gcb.12199; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Robson TM, 2012, TREE GENET GENOMES, V8, P1111, DOI 10.1007/s11295-012-0496-5; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Siefert A, 2012, OECOLOGIA, V170, P767, DOI 10.1007/s00442-012-2351-7; Smith EA, 2011, TREE PHYSIOL, V31, P68, DOI 10.1093/treephys/tpq100; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Sultan SE, 2009, ECOLOGY, V90, P1831, DOI 10.1890/08-1064.1; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Swenson NG, 2010, ECOLOGY, V91, P2234, DOI 10.1890/09-1743.1; Thuiller W, 2004, ECOLOGY, V85, P1688, DOI 10.1890/03-0148; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; Wellstein C, 2013, BIODIVERS CONSERV, V22, P2353, DOI 10.1007/s10531-013-0484-6; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729	67	30	32	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109870	10.1371/journal.pone.0109870	http://dx.doi.org/10.1371/journal.pone.0109870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333738	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200020
J	Simoliunas, E; Kaliniene, L; Stasilo, M; Truncaite, L; Zajanckauskaite, A; Staniulis, J; Nainys, J; Kaupinis, A; Valius, M; Meskys, R				Simoliunas, Eugenijus; Kaliniene, Laura; Stasilo, Miroslav; Truncaite, Lidija; Zajanckauskaite, Aurelija; Staniulis, Juozas; Nainys, Juozas; Kaupinis, Algirdas; Valius, Mindaugas; Meskys, Rolandas			Isolation and Characterization of vB_ArS-ArV2-First Arthrobacter sp Infecting Bacteriophage with Completely Sequenced Genome	PLOS ONE			English	Article							SP-NOV.; PHAGE; RHODOCOCCUS; PROTEINS; EVOLUTION; SOIL; ENDONUCLEASE; SIPHOVIRIDAE; PROTEOME; CLEAVAGE	This is the first report on a complete genome sequence and biological characterization of the phage that infects Arthrobacter. A novel virus vB_ArS-ArV2 (ArV2) was isolated from soil using Arthrobacter sp. 68b strain for phage propagation. Based on transmission electron microscopy, ArV2 belongs to the family Siphoviridae and has an isometric head (similar to 63 nm in diameter) with a non-contractile flexible tail (similar to 194 x 10 nm) and six short tail fibers. ArV2 possesses a linear, double-stranded DNA genome (37,372 bp) with a G+C content of 62.73%. The genome contains 68 ORFs yet encodes no tRNA genes. A total of 28 ArV2 ORFs have no known functions and lack any reliable database matches. Proteomic analysis led to the experimental identification of 14 virion proteins, including 9 that were predicted by bioinformatics approaches. Comparative phylogenetic analysis, based on the amino acid sequence alignment of conserved proteins, set ArV2 apart from other siphoviruses. The data presented here will help to advance our understanding of Arthrobacter phage population and will extend our knowledge about the interaction between this particular host and its phages.	[Simoliunas, Eugenijus; Kaliniene, Laura; Stasilo, Miroslav; Truncaite, Lidija; Zajanckauskaite, Aurelija; Meskys, Rolandas] Vilnius Univ, Inst Biochem, Dept Mol Microbiol & Biotechnol, Vilnius, Lithuania; [Staniulis, Juozas] Nat Res Ctr, Inst Bot, Lab Plant Viruses, Vilnius, Lithuania; [Nainys, Juozas] Vilnius Univ, Inst Biotechnol, Dept Eukaryote Gene Engn, Vilnius, Lithuania; [Kaupinis, Algirdas; Valius, Mindaugas] Vilnius Univ, Prote Ctr, Inst Biochem, Vilnius, Lithuania	Vilnius University; Nature Research Center - Lithuania; Vilnius University; Vilnius University	Simoliunas, E (corresponding author), Vilnius Univ, Inst Biochem, Dept Mol Microbiol & Biotechnol, Vilnius, Lithuania.	eugenijus.simoliunas@bchi.vu.lt	Valius, Mindaugas/N-1220-2019; Kaupinis, Algirdas/AAE-3889-2019; Kaliniene, Laura/L-2250-2019; Valius, Mindaugas/F-2734-2012; Kaliniene, Laura/C-3965-2019; Truncaitė, Lidija/ADN-3047-2022	Valius, Mindaugas/0000-0001-8478-8517; Kaliniene, Laura/0000-0002-2989-9537; Kaliniene, Laura/0000-0002-2989-9537; Simoliunas, Eugenijus/0000-0001-5712-3587	Research Council of Lithuania [MIP-042/2012]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	This research was funded by a grant (No. MIP-042/2012) from the Research Council of Lithuania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2012, ARCH VIROL, V157, P1843, DOI 10.1007/s00705-012-1383-y; Ackermann HW, 2001, ARCH VIROL, V146, P843, DOI 10.1007/s007050170120; Adams MH, 1959, BACTERIOPHAGES; Belfort Marlene, 2002, P761; BRADLEY DE, 1967, BACTERIOL REV, V31, P230, DOI 10.1128/MMBR.31.4.230-314.1967; BROWN DR, 1978, APPL ENVIRON MICROB, V35, P185, DOI 10.1128/AEM.35.1.185-191.1978; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Brussow H, 2001, MOL MICROBIOL, V39, P213, DOI 10.1046/j.1365-2958.2001.02228.x; Brussow H, 2006, BACTERIOPHAGES, P17; Cacciari I., 1987, Arid Soil Research and Rehabilitation, V1, P1, DOI 10.1080/15324988709381125; Calendar, 2006, BACTERIOPHAGES, P49; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Carlson K., 1994, BACTERIOPHAGE T4, P419; CASIDA LE, 1974, APPL MICROBIOL, V28, P951, DOI 10.1128/AEM.28.6.951-959.1974; Chang JR, 2008, VIROLOGY, V370, P352, DOI 10.1016/j.virol.2007.08.039; Collins MD, 2002, INT J SYST EVOL MICR, V52, P569, DOI 10.1099/00207713-52-2-569; CONN HJ, 1945, J BACTERIOL, V49, P359, DOI 10.1128/JB.49.4.359-373.1945; DAEMS WT, 1963, ANTON VAN LEE J M S, V29, P16, DOI 10.1007/BF02046034; Davidson AR, 2012, ADV EXP MED BIOL, V726, P115, DOI 10.1007/978-1-4614-0980-9_6; Desiere F, 2002, ANTON LEEUW INT J G, V82, P73, DOI 10.1023/A:1020676825358; EINCK KH, 1973, J VIROL, V12, P1031, DOI 10.1128/JVI.12.5.1031-1033.1973; Fraser JS, 2007, CURR OPIN MICROBIOL, V10, P382, DOI 10.1016/j.mib.2007.05.018; Fredrickson JK, 2004, APPL ENVIRON MICROB, V70, P4230, DOI 10.1128/AEM.70.7.4230-4241.2004; Friedrich NC, 2007, P NATL ACAD SCI USA, V104, P6176, DOI 10.1073/pnas.0609915104; Gasparaviciute R., 2006, Biologija, P41; GERMIDA JJ, 1981, APPL ENVIRON MICROB, V41, P1389, DOI 10.1128/AEM.41.6.1389-1393.1981; GILLESPIE DC, 1960, CAN J MICROBIOL, V6, P477, DOI 10.1139/m60-054; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; HAGEDORN C, 1975, CAN J MICROBIOL, V21, P353, DOI 10.1139/m75-050; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; HENDRIX RW, 1974, VIROLOGY, V61, P156, DOI 10.1016/0042-6822(74)90250-5; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Heyrman J, 2005, INT J SYST EVOL MICR, V55, P1457, DOI 10.1099/ijs.0.63358-0; Huang Y, 2005, J CLIN MICROBIOL, V43, P1451, DOI 10.1128/JCM.43.3.1451-1455.2005; Jones D, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P945, DOI 10.1007/0-387-30743-5_36; Kaliniene L, 2010, ARCH VIROL, V155, P871, DOI 10.1007/s00705-010-0656-6; KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8; KOLODNER R, 1994, MOL MICROBIOL, V11, P23, DOI 10.1111/j.1365-2958.1994.tb00286.x; Kropinski Andrew M., 2009, V501, P151, DOI 10.1007/978-1-60327-164-6_15; Kutanovas S, 2013, CHEMIJA, V24, P67; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMARREC C, 1994, MICROBIOL-UK, V140, P3071; Li PZ, 2012, GENE, V507, P125, DOI 10.1016/j.gene.2012.07.029; Li Y, 2004, INT J SYST EVOL MICR, V54, P827, DOI 10.1099/ijs.0.02828-0; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Lu Z, 2010, APPL ENVIRON MICROB, V76, P1955, DOI 10.1128/AEM.02126-09; Mageeney C, 2012, J VIROL, V86, P4762, DOI 10.1128/JVI.00075-12; Marinus MG, 1996, ESCHERICHIA COLI SAL, V1, P697; Marshall SJ, 2001, APPL ENVIRON MICROB, V67, P2622, DOI 10.1128/AEM.67.6.2622-2626.2001; MATTHEWS BW, 1982, COLD SPRING HARB SYM, V47, P427, DOI 10.1101/SQB.1983.047.01.050; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Monnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015489; Nunes-Duby SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/nar/26.2.391; OSTLE AG, 1979, APPL ENVIRON MICROB, V38, P59, DOI 10.1128/AEM.38.1.59-65.1979; Petrovski S, 2012, J VIROL, V86, P358, DOI 10.1128/JVI.05460-11; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P3923, DOI 10.1128/AEM.00025-11; Pindi PK, 2010, INT J SYST EVOL MICR, V60, P2263, DOI 10.1099/ijs.0.012989-0; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Roberts MD, 2004, VIROLOGY, V318, P245, DOI 10.1016/j.virol.2003.09.020; ROBINSON JB, 1959, CAN J MICROBIOL, V5, P479, DOI 10.1139/m59-059; Roh SW, 2008, J MICROBIOL, V46, P40, DOI 10.1007/s12275-007-0239-8; Sambrook J., 2001, MOL CLONING LAB MANU; Scheublin TR, 2013, MICROBIOLOGYOPEN, V2, P205, DOI 10.1002/mbo3.59; SCHINDLER CA, 1965, BIOCHIM BIOPHYS ACTA, V97, P242, DOI 10.1016/0304-4165(65)90088-7; SCHIPPERSLAMMER.AF, 1963, ANTON VAN LEE J M S, V29, P1, DOI 10.1007/BF02046033; Semenaite R, 2003, BIOLOGIJA, V2, P27; SHARPLES GJ, 1994, EMBO J, V13, P6133, DOI 10.1002/j.1460-2075.1994.tb06960.x; Simoliunas E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060717; Smith KC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-410; Stahl MM, 1997, GENETICS, V147, P961; Stana Roxana, 2011, Buletinul Institutului Politehnic din Iasi, Sectia III (Electrotehnica, Energetica, Electronica), V57, P45; Stanislauskiene R, 2012, FEMS MICROBIOL LETT, V327, P78, DOI 10.1111/j.1574-6968.2011.02462.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavares P, 2012, ADV EXP MED BIOL, V726, P585, DOI 10.1007/978-1-4614-0980-9_25; TRAUTWETTER A, 1988, APPL ENVIRON MICROB, V54, P1466, DOI 10.1128/AEM.54.6.1466-1471.1988; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; WARREN RAJ, 1980, ANNU REV MICROBIOL, V34, P137, DOI 10.1146/annurev.mi.34.100180.001033; Werten S, 2013, BACTERIOPHAGE, V3; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhang HB, 2004, FEMS MICROBIOL ECOL, V49, P333, DOI 10.1016/j.femsec.2004.04.009; Zimmer M, 2003, GENOME PROTEOME LIST; ZYLICZ M, 1984, MOL GEN GENET, V196, P401, DOI 10.1007/BF00436186	86	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111230	10.1371/journal.pone.0111230	http://dx.doi.org/10.1371/journal.pone.0111230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333962	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200109
J	Solaroglu, I; Izci, Y; Yeter, HG; Metin, MM; Keles, GE				Solaroglu, Ihsan; Izci, Yusuf; Yeter, H. Gokce; Metin, M. Mert; Keles, G. Evren			Health Transformation Project and Defensive Medicine Practice among Neurosurgeons in Turkey	PLOS ONE			English	Article							REFORM	Background: The term "Defensive'' medicine was coined in the early 19709s and has been an important topic of scientific investigation and professional debate ever since. Objective: The aim of this study was to investigate the characteristics of defensive medicine, its reasons, and the extent to which it is practiced in the Turkish health care system. This is the first national survey to study the practice of defensive medicine among neurosurgeons in Turkey. Methods: The present cross-sectional study on defensive medicine assessed neurosurgeons registered at the Turkish Neurosurgical Society, who are actively working in various centers and hospitals within the Turkish health care system. A 40-question survey was adapted from existing measures described in the literature and was completed by a total of 404 neurosurgeons, representing 36.7% of the neurosurgeons registered at the Turkish Neurosurgical Society. Results: Seventy-two percent of the participants in the current study reported practicing defensive medicine. This practice was mainly reported among inexperienced neurosurgeons (74.4%). Most were younger than 40 years of age (75.2%), working in state hospitals/universities (72.7%), and living in the Marmara region (38%). Respondents reported engaging in defensive medicine by avoiding high-risk surgery (62.6%), ordering additional imaging studies (60.9%) and laboratory tests (33.7%), and referring patients to consultants (31.2%). Most participants consider every patient as a potential threat in terms of a medical lawsuit (68.3%) and do not believe the courts can distinguish malpractice from complications (89.6%). Conclusion: Concerns and perceptions about medical liability lead neurosurgeons to practice defensive medicine. By avoiding high-risk surgery, ordering unnecessary diagnostic tests, and referring the patients to consultants, neurosurgeons try to minimize the risk of malpractice and protect themselves from legal risks, resulting in higher healthcare expenditure and longer treatment periods.	[Solaroglu, Ihsan; Keles, G. Evren] Koc Univ, Sch Med, Dept Neurosurg, Istanbul, Turkey; [Izci, Yusuf] Gulhane Mil Med Acad, Sch Med, Dept Neurosurg, Ankara, Turkey; [Yeter, H. Gokce; Metin, M. Mert] Koc Univ, Sch Med, Istanbul, Turkey	Koc University; Gulhane Military Medical Academy; Koc University	Solaroglu, I (corresponding author), Koc Univ, Sch Med, Dept Neurosurg, Istanbul, Turkey.	isolaroglu@ku.edu.tr	Solaroglu, Ihsan/ABF-7606-2020; Solaroglu, Ihsan/ABE-8816-2020	Solaroglu, Ihsan/0000-0002-9472-1735	Koc University, School of Medicine	Koc University, School of Medicine(Koc University)	This work is partially supported by Koc University, School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Asher E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057108; Asher E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042613; Aynaci Y, 2008, THESIS SELCUK U KONV; Bergen RP, 1974, JAMA-J AM MED ASSOC, V27, P1188; Budetti PP, 2005, JAMA-J AM MED ASSOC, V293, P2660, DOI 10.1001/jama.293.21.2660; Cunningham W, 2011, BMJ QUAL SAF, V20, P449, DOI 10.1136/bmjqs.2011.051722; Editorial board and staff of the Duke Law Journal, 1971, DUKE LAW J, V939, P939; Elmendorf DW, 2009, C BUDGET OFFICES ANA, V2009; Feess E, 2012, EUR J HEALTH ECON, V13, P157, DOI 10.1007/s10198-010-0294-7; Kachalia A, 2013, JAMA INTERN MED, V173, P1056, DOI 10.1001/jamainternmed.2013.7293; Keren-Paz T, 2010, MED LAW REV, V18, P363, DOI 10.1093/medlaw/fwq015; Manner Paul, 2007, PRACTICING DEFENSIVE; Nahed BV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039237; Pricewaterhouse Coopers' Health Research Institute, 2008, PRIC EXC ID WAST HEA; Rizzolo Denise, 2009, JAAPA, V22, P56; Sathiyakumar V, 2013, J ORTHOP TRAUMA, V27, P592, DOI 10.1097/BOT.0b013e31828b7ab4; Segal J, 2012, MED ECON, V25, P70; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Tippett TM, 2010, J NEUROSURG, V113, P1127, DOI 10.3171/2010.6.JNS10930; Ugurlu M, 2013, EVALUATION 2012 PUBL	20	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111446	10.1371/journal.pone.0111446	http://dx.doi.org/10.1371/journal.pone.0111446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333736	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200114
J	Gularte-Merida, R; DiCarlo, LM; Robertson, G; Simon, J; Johnson, WD; Kappen, C; Medrano, JF; Richards, BK				Gularte-Merida, Rodrigo; DiCarlo, Lisa M.; Robertson, Ginger; Simon, Jacob; Johnson, William D.; Kappen, Claudia; Medrano, Juan F.; Richards, Brenda K.			High-Resolution Mapping of a Genetic Locus Regulating Preferential Carbohydrate Intake, Total Kilocalories, and Food Volume on Mouse Chromosome 17	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; MACRONUTRIENT DIET INTAKE; INOSITOL 1,4,5-TRISPHOSPHATE; PHYSICAL-ACTIVITY; ENERGY-INTAKE; FAT INTAKE; OBESITY; EXPRESSION; SELECTION; STRAIN	The specific genes regulating the quantitative variation in macronutrient preference and food intake are virtually unknown. We fine mapped a previously identified mouse chromosome 17 region harboring quantitative trait loci (QTL) with large effects on preferential macronutrient intake-carbohydrate (Mnic1), total kilcalories (Kcal2), and total food volume (Tfv1) using interval-specific strains. These loci were isolated in the [C57BL/6J.CAST/EiJ-17.1-(D17Mit19-D17Mit50); B6.CAST-17.1] strain, possessing a similar to 40.1 Mb region of CAST DNA on the B6 genome. In a macronutrient selection paradigm, the B6.CAST-17.1 subcongenic mice eat 30% more calories from the carbohydrate-rich diet similar to 10% more total calories, and, similar to 9% more total food volume per body weight. In the current study, a cross between carbohydrate-preferring B6.CAST-17.1 and fat-preferring, inbred B6 mice was used to generate a subcongenic-derived F-2 mapping population; genotypes were determined using a high-density, custom SNP panel. Genetic linkage analysis substantially reduced the 95% confidence interval for Mnic1 (encompassing Kcal2 and Tfv1) from 40.1 to 29.5 Mb and more precisely established its boundaries. Notably, no genetic linkage for self-selected fat intake was detected, underscoring the carbohydrate-specific effect of this locus. A second key finding was the separation of two energy balance QTLs: Mnic1/Kcal2/Tfv1 for food intake and a newly discovered locus regulating short term body weight gain. The Mnic1/Kcal2/Tfv1 QTL was further de-limited to 19.0 Mb, based on the absence of nutrient intake phenotypes in subcongenic HQ17IIa mice. Analyses of available sequence data and gene ontologies, along with comprehensive expression profiling in the hypothalamus of non-recombinant, cast/cast and b6/b6 F-2 controls, focused our attention on candidates within the QTL interval. Zfp811, Zfp870, and Btnl6 showed differential expression and also contain stop codons, but have no known biology related to food intake regulation. The genes Decr2, Ppard and Agapt1 are more appealing candidates because of their involvement in lipid metabolism and down-regulation in carbohydrate-preferring animals.	[Gularte-Merida, Rodrigo; Medrano, Juan F.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [DiCarlo, Lisa M.; Robertson, Ginger; Simon, Jacob; Richards, Brenda K.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Genet Eating Behav Lab, Baton Rouge, LA USA; [Kappen, Claudia] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Dev Biol, Baton Rouge, LA USA; [Johnson, William D.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Biostat, Baton Rouge, LA USA	University of California System; University of California Davis; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Richards, BK (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Genet Eating Behav Lab, Baton Rouge, LA USA.	richarbk@pbrc.edu		Gularte Merida, Rodrigo/0000-0002-4383-2523	National Institutes of Health [DK-53113]; Center of Biomedical Research Excellence (COBRE) [NIH 8 P20 GM103528]; Nutrition Obesity Research Center (NORC) center grants from the National Institutes of Health [NIH 2P30DK072476]; National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053113, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940, P20GM103528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Biomedical Research Excellence (COBRE); Nutrition Obesity Research Center (NORC) center grants from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded through National Institutes of Health grant DK-53113 to B. K. R. The Genomics Core Facility (GCF) was supported, in part, by Center of Biomedical Research Excellence (COBRE) (NIH 8 P20 GM103528) and Nutrition Obesity Research Center (NORC), (NIH 2P30DK072476) center grants from the National Institutes of Health. W.D.J. was funded by 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Allan MF, 2005, GENOMIC MAPPING DIRE; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arbilly M, 2006, ANIM GENET, V37, P7, DOI 10.1111/j.1365-2052.2006.01472.x; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Cai GW, 2006, OBESITY, V14, P1596, DOI 10.1038/oby.2006.184; Cai GW, 2004, AM J CLIN NUTR, V80, P1410, DOI 10.1093/ajcn/80.5.1410; Cheverud JM, 2001, MAMM GENOME, V12, P3, DOI 10.1007/s003350010218; Choquette AC, 2008, AM J CLIN NUTR, V88, P1142, DOI 10.1093/ajcn/88.4.1142; CHURCHILL GA, 1994, GENETICS, V138, P963; Collaku A, 2004, AM J CLIN NUTR, V79, P881; Cox A, 2010, HEREDITY, V105, P426, DOI 10.1038/hdy.2010.75; Flint J, 2011, METHODS, V53, P163, DOI 10.1016/j.ymeth.2010.07.007; Grimm ER, 2011, NUTR REV, V69, P52, DOI 10.1111/j.1753-4887.2010.00361.x; Hegg CC, 2010, EUR J NEUROSCI, V32, P1632, DOI 10.1111/j.1460-9568.2010.07449.x; Hisatsune C, 2007, J BIOL CHEM, V282, P37225, DOI 10.1074/jbc.M705641200; Horvat S, 2001, GENOMICS, V72, P209, DOI 10.1006/geno.2000.6441; Ishimori N, 2004, J LIPID RES, V45, P1624, DOI 10.1194/jlr.M400098-JLR200; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Kocalis HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042981; Koegler FH, 1999, PHYSIOL BEHAV, V67, P809, DOI 10.1016/S0031-9384(99)00104-3; Kumar KG, 2008, AM J PHYSIOL-REG I, V294, pR362, DOI 10.1152/ajpregu.00640.2007; Kumar KG, 2007, AM J PHYSIOL-REG I, V292, pR207, DOI 10.1152/ajpregu.00491.2006; Kumar KG, 2010, MAMM GENOME, V21, P52, DOI 10.1007/s00335-009-9243-0; Kumar KG, 2008, J NUTRIGENET NUTRIGE, V1, P155, DOI 10.1159/000113657; Manichaikul A, 2009, GENETICS, V181, P1077, DOI 10.1534/genetics.108.094565; Marissal-Arvy N, 2013, OBESITY SILVER SPRIN; Mather R, 1977, INTRO BIOMETRICAL GE; Mathes WF, 2011, AM J PHYSIOL-ENDOC M, V300, pE1124, DOI 10.1152/ajpendo.00707.2010; MAYER J, 1951, SCIENCE, V113, P745, DOI 10.1126/science.113.2948.745-a; Mehrabian M, 1998, J CLIN INVEST, V101, P2485, DOI 10.1172/JCI1748; Millward CA, 2009, MAMM GENOME, V20, P71, DOI 10.1007/s00335-008-9165-2; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Nakashima K, 1999, CELL PHYSIOL BIOCHEM, V9, P90, DOI 10.1159/000016305; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; R Core Team, 2021, R LANGUAGE ENV STAT; Rankinen T, 2006, ANNU REV NUTR, V26, P413, DOI 10.1146/annurev.nutr.26.061505.111218; Reed DR, 1997, BEHAV GENET, V27, P373, DOI 10.1023/A:1025692031673; Richards BKS, 2004, AM J PHYSIOL-REG I, V286, pR311, DOI 10.1152/ajpregu.00488.2003; Richards BKS, 2002, PHYSIOL GENOMICS, V11, P205, DOI 10.1152/physiolgenomics.00037.2002; Schoeller DA, 2013, AM J CLIN NUTR, V97, P1413, DOI 10.3945/ajcn.113.062125; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Smith BK, 1999, AM J PHYSIOL-REG I, V277, pR776, DOI 10.1152/ajpregu.1999.277.3.R776; Smith BK, 2000, AM J PHYSIOL-REG I, V278, pR797, DOI 10.1152/ajpregu.2000.278.4.R797; Smith BK, 1997, AM J PHYSIOL-REG I, V272, pR357, DOI 10.1152/ajpregu.1997.272.1.R357; Smith JD, 2008, MOL BIOMETHODS HDB; South T, 2006, DIABETES OBES METAB, V8, P302, DOI 10.1111/j.1463-1326.2005.00506.x; Stylianou IM, 2006, MAMM GENOME, V17, P22, DOI 10.1007/s00335-005-0091-2; Takasaki M, 2012, J NUTR BIOCHEM, V23, P640, DOI 10.1016/j.jnutbio.2011.03.008; Taylor BA, 1997, GENOMICS, V43, P249, DOI 10.1006/geno.1997.4835; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Tordoff MG, 2012, PHYSIOL BEHAV, V106, P556, DOI 10.1016/j.physbeh.2012.03.030; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; York B, 1996, MAMM GENOME, V7, P677, DOI 10.1007/s003359900204	57	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110424	10.1371/journal.pone.0110424	http://dx.doi.org/10.1371/journal.pone.0110424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330228	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100063
J	Braeckman, U; Van Colen, C; Guilini, K; Van Gansbeke, D; Soetaert, K; Vincx, M; Vanaverbeke, J				Braeckman, Ulrike; Van Colen, Carl; Guilini, Katja; Van Gansbeke, Dirk; Soetaert, Karline; Vincx, Magda; Vanaverbeke, Jan			Empirical Evidence Reveals Seasonally Dependent Reduction in Nitrification in Coastal Sediments Subjected to Near Future Ocean Acidification	PLOS ONE			English	Article							SEAWATER ACIDIFICATION; ECOSYSTEM FUNCTION; NORTH-SEA; PH; IMPACT; AMMONIA; CO2; DENITRIFICATION; TEMPERATURE; REWORKING	Research so far has provided little evidence that benthic biogeochemical cycling is affected by ocean acidification under realistic climate change scenarios. We measured nutrient exchange and sediment community oxygen consumption (SCOC) rates to estimate nitrification in natural coastal permeable and fine sandy sediments under pre-phytoplankton bloom and bloom conditions. Ocean acidification, as mimicked in the laboratory by a realistic pH decrease of 0.3, significantly reduced SCOC on average by 60% and benthic nitrification rates on average by 94% in both sediment types in February (pre-bloom period), but not in April (bloom period). No changes in macrofauna functional community (density, structural and functional diversity) were observed between ambient and acidified conditions, suggesting that changes in benthic biogeochemical cycling were predominantly mediated by changes in the activity of the microbial community during the short-term incubations (14 days), rather than by changes in engineering effects of bioturbating and bio-irrigating macrofauna. As benthic nitrification makes up the gross of ocean nitrification, a slowdown of this nitrogen cycling pathway in both permeable and fine sediments in winter, could therefore have global impacts on coupled nitrification-denitrification and hence eventually on pelagic nutrient availability.	[Braeckman, Ulrike; Van Colen, Carl; Guilini, Katja; Van Gansbeke, Dirk; Vincx, Magda; Vanaverbeke, Jan] Univ Ghent, Marine Biol Res Grp, Dept Biol, B-9000 Ghent, Belgium; [Soetaert, Karline] Netherlands Inst Sea Res, Dept Ecosyst Studies, Yerseke, Netherlands	Ghent University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Braeckman, U (corresponding author), Univ Ghent, Marine Biol Res Grp, Dept Biol, B-9000 Ghent, Belgium.	Ulrike.Braeckman@UGent.be	Braeckman, Ulrike/AAJ-4801-2021; Soetaert, Karline E/A-9839-2011	Soetaert, Karline E/0000-0003-4603-7100; Braeckman, Ulrike/0000-0002-7558-6363	FWO [G.0033.11]; Ghent University; Flemish Fund for Scientific Research (FWO); European Community [265847]; Ghent University [BOF-GOA 01GA1911W]	FWO(FWO); Ghent University(Ghent University); Flemish Fund for Scientific Research (FWO)(FWO); European Community(European Commission); Ghent University(Ghent University)	U.B. was financially supported by FWO project nr G.0033.11 and the Special Research Fund of Ghent University. C.V.C. and K.G. acknowledge a postdoctoral fellowship from the Flemish Fund for Scientific Research (FWO). K.G. also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 265847. Additional funding was provided by the Special Research Fund of Ghent University (BOF-GOA 01GA1911W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2008, PERMANOVA PRIMER GUI; Andersson A.J., 2011, OCEAN ACIDIFICATION, P122; Beman JM, 2011, P NATL ACAD SCI USA, V108, P208, DOI 10.1073/pnas.1011053108; Braeckman U, 2014, ECOSYSTEMS, V17, P720, DOI 10.1007/s10021-014-9755-7; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Brewer PG, 2009, P NATL ACAD SCI USA, V106, P12213, DOI 10.1073/pnas.0906815106; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Clarke K.R., 2006, PRIMER V6 USER MANUA; Dashfield SL, 2008, J EXP MAR BIOL ECOL, V365, P46, DOI 10.1016/j.jembe.2008.07.039; Dickson A.G., 2007, GUIDE BEST PRACTICES; Gazeau F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094068; Gehlen M, 2011, BIOGEOCHEMICAL CONSE, P230; Gilbertson WW, 2012, FEMS MICROBIOL ECOL, V82, P11, DOI 10.1111/j.1574-6941.2012.01400.x; Godbold JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0186; Huesemann MH, 2002, MAR POLLUT BULL, V44, P142, DOI 10.1016/S0025-326X(01)00194-1; Huettel M, 2000, LIMNOL OCEANOGR, V45, P534, DOI 10.4319/lo.2000.45.3.0534; Hutchins DA, 2009, OCEANOGRAPHY, V22, P128, DOI 10.5670/oceanog.2009.103; Jourabchi P, 2005, AM J SCI, V305, P919, DOI 10.2475/ajs.305.9.919; KEMP WM, 1990, LIMNOL OCEANOGR, V35, P1545, DOI 10.4319/lo.1990.35.7.1545; Kitidis V, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049095; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Kuhn M., 2013, CONTRAST COLLECTION; Lancelot C, 2005, MAR ECOL PROG SER, V289, P63, DOI 10.3354/meps289063; Laverock B, 2014, ENV MICROBIOL REP, V6, P113, DOI 10.1111/1758-2229.12115; Laverock B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0441; LOHSE L, 1993, MAR ECOL PROG SER, V101, P283, DOI 10.3354/meps101283; Maire O, 2006, MAR ECOL PROG SER, V319, P135, DOI 10.3354/meps319135; Morse JW, 2006, GEOCHIM COSMOCHIM AC, V70, P5814, DOI 10.1016/j.gca.2006.08.017; Murray F, 2013, MAR POLLUT BULL, V73, P435, DOI 10.1016/j.marpolbul.2012.11.023; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Ouellette D, 2004, MAR ECOL PROG SER, V266, P185, DOI 10.3354/meps266185; Parsons T.R., 1984, MANUAL CHEM BIOL MET; Pierrot D, 2006, CO2SYS DOS PROGRAM D; Pinheiro J, 2001, MIXED EFFECTS MODELS; Portner H-O, 2011, EFFECTS OCEAN ACIDIF, P154; Provoost P, 2010, BIOGEOSCIENCES, V7, P3869, DOI 10.5194/bg-7-3869-2010; Queiros AM, 2013, ECOL EVOL, V3, P3958, DOI 10.1002/ece3.769; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Riebesell U., 2011, GUIDE BEST PRACTICES, DOI DOI 10.2777/58454; Soetaert K, 2001, DEEP-SEA RES PT II, V48, P3141, DOI 10.1016/S0967-0645(01)00035-2; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stief P, 2013, BIOGEOSCIENCES, V10, P7829, DOI 10.5194/bg-10-7829-2013; Sunda WG, 2012, ENVIRON SCI TECHNOL, V46, P10651, DOI 10.1021/es300626f; SUZUKI I, 1974, J BACTERIOL, V120, P556, DOI 10.1128/JB.120.1.556-558.1974; Tait K, 2013, ESTUAR COAST, P1; Tait K, 2013, ENV MICROBIOL REP, V5, P851, DOI 10.1111/1758-2229.12087; Underwood A, 1997, EXPT ECOLOGY THEIR L; van Oevelen D, 2009, MAR ECOL PROG SER, V380, P19, DOI 10.3354/meps07921; Voss M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0121; WARD BB, 1987, ARCH MICROBIOL, V147, P126, DOI 10.1007/BF00415273; Wenzhofer F, 2001, GEOCHIM COSMOCHIM AC, V65, P2677, DOI 10.1016/S0016-7037(01)00620-2; West B. T., 2006, LINEAR MIXED MODELS, P180; Widdicombe S, 2007, MAR ECOL PROG SER, V341, P111, DOI 10.3354/meps341111; Widdicombe S, 2013, MAR POLLUT BULL, V73, P416, DOI 10.1016/j.marpolbul.2012.11.008; Widdicombe S, 2009, MAR ECOL PROG SER, V379, P59, DOI 10.3354/meps07894; Widdicombe S, 2011, EFFECTS OCEAN ACIDIF, P113; Wood HL, 2009, BIOGEOSCIENCES, V6, P2015, DOI 10.5194/bg-6-2015-2009; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Wright SW, 1997, HIGH RESOLUTION HPLC, P327; Wyatt NJ, 2010, J PLANKTON RES, V32, P631, DOI 10.1093/plankt/fbp140; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE; Zuur A, 2009, MIXED EFFECTS MODELS	64	20	21	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e108153	10.1371/journal.pone.0108153	http://dx.doi.org/10.1371/journal.pone.0108153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329898	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210800008
J	Fang, YT; Wan, SW; Lu, YT; Yao, JH; Lin, CF; Hsu, LJ; Brown, MG; Marshall, JS; Anderson, R; Lin, YS				Fang, Yi-Ting; Wan, Shu-Wen; Lu, Yi-Tien; Yao, Ju-Han; Lin, Chiou-Feng; Hsu, Li-Jin; Brown, Michael G.; Marshall, Jean S.; Anderson, Robert; Lin, Yee-Shin			Autophagy Facilitates Antibody-Enhanced Dengue Virus Infection in Human Pre-Basophil/Mast Cells	PLOS ONE			English	Article							HUMAN MAST-CELLS; ENDOPLASMIC-RETICULUM STRESS; DEPENDENT ENHANCEMENT; HEMORRHAGIC-FEVER; PATHOGENESIS; REPLICATION; LINE; MATURATION; PATHWAY; MACROPHAGES	Background: Dengue virus (DENV) infection can cause severe hemorrhagic disease in humans. Although the pathogenic mechanisms underlying severe DENV disease remain unclear, one of the possible contributing factors is antibody-dependent enhancement (ADE) which occurs when sub-neutralizing antibodies derived from a previous DENV infection enhance viral infection through interaction between virus-antibody complexes and FcR-bearing cells, such as macrophages and basophil/mast cells. Although recent reports showed that DENV induces autophagy, the relationship between antibody-enhanced DENV infection and autophagy is not clear. Methodology/Principal Findings: We showed that sub-neutralizing antibodies derived from dengue patient sera enhanced DENV infection and autophagy in the KU812 pre-basophil-like cell line as well as the HMC-1 immature mast cell line. Antibody-enhanced DENV infection of KU812 cells increased the number of autophagosome vesicles, LC3 punctation, LC3-II accumulation, and p62 degradation over that seen in cells infected with DENV alone. The percentages of DENV envelope (E) protein-positive cells and LC3 puncta following antibody-enhanced DENV infection of KU812 cells were reduced by the autophagy inhibitor 3-MA. Antibody-enhanced DENV infection of HMC-1 cells showed co-localization of DENV E protein and dsRNA with autophagosomes, which was inhibited by 3-MA treatment. Furthermore, DENV infection and replication were reduced when KU812 cells were transfected with the autophagy-inhibiting Atg4B(C74A) mutant. Conclusions/Significance: Our results demonstrate a significant induction of autophagy in antibody-enhanced DENV infection of pre-basophil-like KU812 and immature mast cell-like HMC-1 cells. Also, autophagy plays an important role in DENV infection and replication in these cells. Given the importance of ADE and FcR-bearing cells such as monocytes, macrophages and basophil/mast cells in dengue disease, the results provide insights into dengue pathogenesis and therapeutic means of control.	[Fang, Yi-Ting; Wan, Shu-Wen; Lu, Yi-Tien; Lin, Chiou-Feng; Lin, Yee-Shin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Wan, Shu-Wen; Lin, Chiou-Feng; Hsu, Li-Jin; Lin, Yee-Shin] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Yao, Ju-Han] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA USA; [Lin, Chiou-Feng] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Hsu, Li-Jin] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Brown, Michael G.; Marshall, Jean S.; Anderson, Robert] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada	National Cheng Kung University; National Cheng Kung University; Emory University; National Cheng Kung University; National Cheng Kung University; Dalhousie University	Anderson, R (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	roband@dal.ca; yslin1@mail.ncku.edu.tw	Hsu, Li-Jin/G-7822-2011	Marshall, Jean S./0000-0002-5642-1379	Ministry of Science and Technology, Taiwan [NSC101-2325-B-006-006, NSC102-2325-B-006-006]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants NSC101-2325-B-006-006 and NSC102-2325-B-006-006 from Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Al-Zeer MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004588; Anderson R, 1997, J VIROL, V71, P4226, DOI 10.1128/JVI.71.6.4226-4232.1997; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; BHAMARAP.N, 1967, ANN TROP MED PARASIT, V61, P500, DOI 10.1080/00034983.1967.11686519; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brown MG, 2006, J LEUKOCYTE BIOL, V80, P1242, DOI 10.1189/jlb.0805441; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Brown MG, 2011, J VIROL, V85, P1145, DOI 10.1128/JVI.01630-10; Brown MG, 2009, J LEUKOCYTE BIOL, V85, P71, DOI 10.1189/jlb.0308167; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0; Chu LW, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.011018; Chung YC, 2012, PLOS ONE, V7; Dichlberger A, 2011, J LIPID RES, V52, P2198, DOI 10.1194/jlr.M019737; Espina LM, 2003, AM J TROP MED HYG, V68, P48, DOI 10.4269/ajtmh.2003.68.48; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2009, AUTOPHAGY, V5, P88, DOI 10.4161/auto.5.1.7183; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; GULATI L, 1982, BRIT J EXP PATHOL, V63, P194; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Halstead SB, 2002, CURR OPIN INFECT DIS, V15, P471, DOI 10.1097/00001432-200210000-00003; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; HE RT, 1995, J MED VIROL, V45, P451, DOI 10.1002/jmv.1890450417; Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332; Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Herrero LJ, 2013, PHARMACOL THERAPEUT, V137, P266, DOI 10.1016/j.pharmthera.2012.10.007; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jan JT, 2000, J VIROL, V74, P8680, DOI 10.1128/JVI.74.18.8680-8691.2000; Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0; King CA, 2000, J VIROL, V74, P7146, DOI 10.1128/JVI.74.15.7146-7150.2000; King CA, 2002, J VIROL, V76, P8408, DOI 10.1128/JVI.76.16.8408-8419.2002; KISHI K, 1985, LEUKEMIA RES, V9, P381, DOI 10.1016/0145-2126(85)90060-8; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946; MACPHERSON I, 1962, VIROLOGY, V16, P147, DOI 10.1016/0042-6822(62)90290-8; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12; McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; NAKAZAWA M, 1989, BLOOD, V73, P2003; Oishi Kazunori, 2007, Journal of Infection and Chemotherapy, V13, P125, DOI 10.1007/s10156-007-0516-9; Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0; Panyasrivanit M, 2011, VIROLOGY, V418, P74, DOI 10.1016/j.virol.2011.07.010; PHAN DT, 1991, HAEMATOLOGIA, V24, P13; RUSSELL PK, 1967, JPN J MED SCI BIOL, VS 20, P103; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; St John AL, 2013, PLOS PATHOG, V9; St John AL, 2013, ELIFE, V2, DOI 10.7554/eLife.00481; St John AL, 2011, P NATL ACAD SCI USA, V108, P9190, DOI 10.1073/pnas.1105079108; TUCHINDA M, 1977, Southeast Asian Journal of Tropical Medicine and Public Health, V8, P80; Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018; Ushio H, 2011, J ALLERGY CLIN IMMUN, V127, P1267, DOI 10.1016/j.jaci.2010.12.1078; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06	68	20	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110655	10.1371/journal.pone.0110655	http://dx.doi.org/10.1371/journal.pone.0110655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329914	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210800103
J	Summers, AF; Pohlmeier, WE; Sargent, KM; Cole, BD; Vinton, RJ; Kurz, SG; Mcfee, RM; Cushman, RA; Cupp, AS; Wood, JR				Summers, Adam F.; Pohlmeier, William E.; Sargent, Kevin M.; Cole, Brizett D.; Vinton, Rebecca J.; Kurz, Scott G.; Mcfee, Renee M.; Cushman, Robert A.; Cupp, Andrea S.; Wood, Jennifer R.			Altered Theca and Cumulus Oocyte Complex Gene Expression, Follicular Arrest and Reduced Fertility in Cows with Dominant Follicle Follicular Fluid Androgen Excess	PLOS ONE			English	Article							OVARY-SYNDROME PCOS; LUTEINIZING-HORMONE; STIMULATING-HORMONE; RNA AMPLIFICATION; ESTROUS SYNCHRONY; GRANULOSA-CELLS; GROWTH; STEROIDOGENESIS; ACTIVATION; IGF1	Aspiration of bovine follicles 12-36 hours after induced corpus luteum lysis serendipitously identified two populations of cows, one with High androstenedione (A4; >40 ng/ml; mean = 102) and another with Low A4 (<20 ng/ml; mean = 9) in follicular fluid. We hypothesized that the steroid excess in follicular fluid of dominant follicles in High A4 cows would result in reduced fertility through altered follicle development and oocyte maternal RNA abundance. To test this hypothesis, estrous cycles of cows were synchronized and ovariectomy was performed 36 hours later. HPLC MS/MS analysis of follicular fluid showed increased dehydroepiandrosterone (6-fold), A4 (158-fold) and testosterone (31-fold) in the dominant follicle of High A4 cows. However, estrone (3-fold) and estradiol (2-fold) concentrations were only slightly elevated, suggesting a possible inefficiency in androgen to estrogen conversion in High A4 cows. Theca cell mRNA expression of LHCGR, GATA6, CYP11A1, and CYP17A1 was greater in High A4 cows. Furthermore, abundance of ZAR1 was decreased 10-fold in cumulus oocyte complexes from High A4 cows, whereas NLRP5 abundance tended to be 19.8-fold greater (P = 0.07). There was a tendency for reduction in stage 4 follicles in ovarian cortex samples from High A4 cows suggesting that progression to antral stages were impaired. High A4 cows tended (P<0.07) to have a 17% reduction in calving rate compared with Low A4 cows suggesting reduced fertility in the High A4 population. These data suggest that the dominant follicle environment of High A4 cows including reduced estrogen conversion and androgen excess contributes to infertility in part through altered follicular and oocyte development.	[Summers, Adam F.; Pohlmeier, William E.; Sargent, Kevin M.; Cole, Brizett D.; Vinton, Rebecca J.; Kurz, Scott G.; Mcfee, Renee M.; Cupp, Andrea S.; Wood, Jennifer R.] Univ Nebraska, Dept Anim Sci, Lincoln, NE 68588 USA; [Cushman, Robert A.] USDA ARS, Roman L Hruska US Meat Anim Res Ctr, Clay Ctr, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA)	Cupp, AS (corresponding author), Univ Nebraska, Dept Anim Sci, Lincoln, NE 68588 USA.	acupp2@unl.edu	Wood, Jennifer R/S-3213-2019	Wood, Jennifer R/0000-0001-9337-5837; Sargent, Kevin/0000-0001-6059-0776	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2013-67015-20965]; USDA State of Nebraska Hatch Grants [NEB 13-154, NEB-ANHL 26-85, NEB-26-198]; Nebraska Experiment Station Multi-State Research Funds [NEB 26-202, NEB 26-206]; Undergraduate Creative Activities and Research Experiences (UCARE) from University of Nebraska Foundation; ARS [ARS-0423658] Funding Source: Federal RePORTER	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; USDA State of Nebraska Hatch Grants; Nebraska Experiment Station Multi-State Research Funds; Undergraduate Creative Activities and Research Experiences (UCARE) from University of Nebraska Foundation; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-67015-20965 from the USDA National Institute of Food and Agriculture. The project was also supported in part by USDA State of Nebraska Hatch Grants (NEB 13-154, NEB-ANHL 26-85, NEB-26-198) Nebraska Experiment Station Multi-State Research Funds (NEB 26-202, NEB 26-206) and the Undergraduate Creative Activities and Research Experiences (UCARE) Funding from University of Nebraska Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2012, THERIOGENOLOGY, V78, P1733, DOI 10.1016/j.theriogenology.2012.04.010; ADAMS GP, 1995, THERIOGENOLOGY, V43, P113, DOI 10.1016/0093-691X(94)00015-M; Akhtar M, 1997, J STEROID BIOCHEM, V61, P127; Bennett J, 2013, ENDOCRINOLOGY, V154, P4845, DOI 10.1210/en.2013-1410; Bortvin Alex, 2004, BMC Developmental Biology, V4; BrawTal R, 1997, J REPROD FERTIL, V109, P165, DOI 10.1530/jrf.0.1090165; Caretti E, 2008, J CELL BIOCHEM, V103, P556, DOI 10.1002/jcb.21426; Carmina E, 1999, J CLIN ENDOCR METAB, V84, P1897, DOI 10.1210/jc.84.6.1897; Clouaire T, 2008, CELL MOL LIFE SCI, V65, P1509, DOI 10.1007/s00018-008-7324-y; Conley AJ, 1997, BIOL REPROD, V56, P789, DOI 10.1095/biolreprod56.4.789; Cushman RA, 2001, BIOL REPROD, V65, P581, DOI 10.1095/biolreprod65.2.581; De Sousa PA, 1998, BIOL REPROD, V59, P969, DOI 10.1095/biolreprod59.4.969; Echternkamp SE, 2004, J ANIM SCI, V82, P459; Forsdike RA, 2007, J ENDOCRINOL, V192, P421, DOI 10.1677/joe.1.07097; Fru KN, 2006, BIOL REPROD, V75, P568, DOI 10.1095/biolreprod.106.053470; Glister C, 2005, ENDOCRINOLOGY, V146, P1883, DOI 10.1210/en.2004-1303; Goff LA, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-76; Hillier SG, 2001, MOL CELL ENDOCRINOL, V179, P39, DOI 10.1016/S0303-7207(01)00469-5; Ho CKM, 2005, J CLIN ENDOCR METAB, V90, P6596, DOI 10.1210/jc.2005-0890; Hu JJ, 2010, DEV DYNAM, V239, P407, DOI 10.1002/dvdy.22170; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Inskeep E K, 2004, J Anim Sci, V82 E-Suppl, pE24; King SR, 2012, FRONT BIOSCI-LANDMRK, V17, P824, DOI 10.2741/3959; Koal T, 2012, J STEROID BIOCHEM, V129, P129, DOI 10.1016/j.jsbmb.2011.12.001; Kojima FN, 2003, ANIM REPROD SCI, V77, P187, DOI 10.1016/S0378-4320(03)00038-1; KOJIMA FN, 1995, BIOL REPROD, V52, P455, DOI 10.1095/biolreprod52.2.455; KOJIMA N, 1992, BIOL REPROD, V47, P1009, DOI 10.1095/biolreprod47.6.1009; Kumar P, 2013, MOL CELL BIOL, V33, P1782, DOI 10.1128/MCB.01228-12; LaVoie HA, 2009, EXP BIOL MED, V234, P880, DOI 10.3181/0903-MR-97; Lei H, 1996, DEVELOPMENT, V122, P3195; Li XD, 2001, ENDOCRINOLOGY, V142, P2435, DOI 10.1210/en.142.6.2435; Lindeman RE, 2010, MOL REPROD DEV, V77, P299, DOI 10.1002/mrd.21128; Mack EM, 2012, REPRODUCTION, V144, P595, DOI 10.1530/REP-12-0225; Mani AM, 2010, REPRODUCTION, V139, P139, DOI 10.1530/REP-09-0050; Martinez-Arguelles DB, 2010, STEROIDS, V75, P467, DOI 10.1016/j.steroids.2010.02.004; Mcfee RM, 2009, BIOL REPROD, V81, P966, DOI 10.1095/biolreprod.109.078071; Miller WL, 2007, MOL ENDOCRINOL, V21, P589, DOI 10.1210/me.2006-0303; MOLEY KH, 1995, ADV EXP MED BIOL, V377, P103; Morel O, 2012, THERIOGENOLOGY, V78, P1763, DOI 10.1016/j.theriogenology.2012.06.012; Nelson VL, 1999, MOL ENDOCRINOL, V13, P946, DOI 10.1210/me.13.6.946; Nelson VL, 2001, J CLIN ENDOCR METAB, V86, P5925, DOI 10.1210/jc.86.12.5925; Nguyen PTT, 2013, J THEOR BIOL, V332, P52, DOI 10.1016/j.jtbi.2013.04.021; Orisaka M, 2013, ENDOCRINOLOGY, V154, P2870, DOI 10.1210/en.2012-2173; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Robker RL, 2009, J CLIN ENDOCR METAB, V94, P1533, DOI 10.1210/jc.2008-2648; SAGLE M, 1988, BMJ-BRIT MED J, V297, P1027, DOI 10.1136/bmj.297.6655.1027; Sen A, 2014, P NATL ACAD SCI USA, V111, P3008, DOI 10.1073/pnas.1318978111; Sneeringer R, 2011, FERTIL STERIL, V95, P182, DOI 10.1016/j.fertnstert.2010.06.028; Spicer LJ, 2007, BIOL REPROD, V77, P18, DOI 10.1095/biolreprod.106.058230; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Webb R, 1999, ANIM SCI, V68, P257, DOI 10.1017/S1357729800050293; Wood JR, 2007, J CLIN ENDOCR METAB, V92, P705, DOI 10.1210/jc.2006-2123; Wood JR, 2004, J REPROD IMMUNOL, V63, P51, DOI 10.1016/j.jri.2004.01.010; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Wu YG, 2011, MOL ENDOCRINOL, V25, P656, DOI 10.1210/me.2010-0367; Yang MY, 2006, BIOL REPROD, V75, P924, DOI 10.1095/biolreprod.106.051813; YOUNGQUIST RS, 1995, J AM VET MED ASSOC, V207, P474	58	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110683	10.1371/journal.pone.0110683	http://dx.doi.org/10.1371/journal.pone.0110683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330369	gold, Green Published			2022-12-27	WOS:000343210800105
J	Villa, MM; Wang, LP; Rowe, DW; Wei, M				Villa, Max M.; Wang, Liping; Rowe, David W.; Wei, Mei			Effects of Cell-Attachment and Extracellular Matrix on Bone Formation In Vivo in Collagen-Hydroxyapatite Scaffolds	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; STROMAL CELLS; REPAIR; DIFFERENTIATION; REGENERATION; GROWTH; VITRO; MICROENVIRONMENT; MIGRATION; DEFECTS	Cell-based tissue engineering can be used to replace missing or damaged bone, but the optimal methods for delivering therapeutic cells to a bony defect have not yet been established. Using transgenic reporter cells as a donor source, two different collagen-hydroxyapatite (HA) scaffolds, and a critical-size calvarial defect model, we investigated the effect of a cell-attachment period prior to implantation, with or without an extracellular matrix-based seeding suspension, on cell engraftment and osteogenesis. When quantitatively compared, the in-house scaffold implanted immediately had a higher mean radiopacity than in-house scaffolds incubated overnight. Both scaffold types implanted immediately had significantly higher area fractions of donor cells, while the in-house collagen-HA scaffolds implanted immediately had higher area fractions of the mineralization label compared with groups incubated overnight. When the cell loading was compared in vitro for each delivery method using the in-house scaffold, immediate loading led to higher numbers of delivered cells. Immediate loading may be preferable in order to ensure robust bone formation in vivo. The use of a secondary ECM carrier improved the distribution of donor cells only when a pre-attachment period was applied. These results have improved our understanding of cell delivery to bony defects in the context of in vivo outcomes.	[Villa, Max M.; Wei, Mei] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA; [Wang, Liping; Rowe, David W.] Univ Connecticut, Ctr Hlth, Ctr Regenerat Med & Skeletal Dev, Dept Reconstruct Sci,Sch Dent Med, Farmington, CT USA	University of Connecticut; University of Connecticut	Wei, M (corresponding author), Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.	meiwei@engr.uconn.edu			GAANN pre-doctoral fellowship from the Department of Education [P200A09315]; National Institutes of Health [1R21AR059962-01A1]; National Science Foundation [CBET-1133883]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064381, R21AR059962] Funding Source: NIH RePORTER	GAANN pre-doctoral fellowship from the Department of Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a GAANN pre-doctoral fellowship from the Department of Education (P200A09315, ed.gov), National Institutes of Health (1R21AR059962-01A1, nih.gov) and National Science Foundation (CBET-1133883, nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Grayson WL, 2008, TISSUE ENG PT A, V14, P1809, DOI 10.1089/ten.tea.2007.0255; Grayson WL, 2011, BIOTECHNOL BIOENG, V108, P1159, DOI 10.1002/bit.23024; Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106; Harburger DS, 2009, J CELL SCI, V122, P1472, DOI 10.1242/jcs.052910; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Impens S, 2010, TISSUE ENG PART C-ME, V16, P1575, DOI [10.1089/ten.tec.2010.0069, 10.1089/ten.TEC.2010.0069]; Kemppainen JM, 2010, BIOMATERIALS, V31, P279, DOI 10.1016/j.biomaterials.2009.09.041; Krebsbach PH, 1998, TRANSPLANTATION, V66, P1272, DOI 10.1097/00007890-199811270-00002; Kuhn LT, 2014, TISSUE ENG PT A, V20, P365, DOI [10.1089/ten.tea.2013.0321, 10.1089/ten.TEA.2013.0321]; Lin H, 2012, BIOMATERIALS, V33, P4480, DOI 10.1016/j.biomaterials.2012.03.012; Liu YL, 2010, BONE, V47, P916, DOI 10.1016/j.bone.2010.07.022; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; Mitsak AG, 2011, TISSUE ENG PT A, V17, P1831, DOI [10.1089/ten.tea.2010.0560, 10.1089/ten.TEA.2010.0560]; Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211; Papadimitropoulos A, 2011, J TISSUE ENG REGENER; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qu HB, 2008, J BIOMED MATER RES B, V87B, P204, DOI 10.1002/jbm.b.31096; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Reichert JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003720; Rosen, 2013, PRIMER METABOLIC BON, P90, DOI DOI 10.1002/9781118453926.CH11; Rosen C.J., 2013, PRIMER METABOLIC BON, P49; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126; Strecker S, 2013, GENESIS, V51, P246, DOI 10.1002/dvg.22360; Villa MM, 2015, J BIOMED MATER RES B, V103, P243, DOI 10.1002/jbm.b.33225; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Wiedmann-Al-Ahmad M, 2002, BIOMATERIALS, V23, P3319, DOI 10.1016/S0142-9612(02)00019-4; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zeitouni S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003396	46	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109568	10.1371/journal.pone.0109568	http://dx.doi.org/10.1371/journal.pone.0109568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329879	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800027
J	Wang, DS; Wang, YQ; Wang, YY; Li, RN; Zhou, CL				Wang, Dongshi; Wang, Yanqiu; Wang, Yingying; Li, Rena; Zhou, Chenglin			Impact of Physical Exercise on Substance Use Disorders: A Meta-Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; TREATING TOBACCO DEPENDENCE; MODERATE-INTENSITY EXERCISE; TAI CHI EXERCISE; SMOKING-CESSATION; METHADONE-MAINTENANCE; CIGARETTE CRAVINGS; SYSTEMATIC REVIEWS; AEROBIC EXERCISE; PARTIAL AGONIST	Objective: The goal of this meta-analysis was to examine whether long-term physical exercise could be a potential effective treatment for substance use disorders (SUD). Methods: The PubMed, Web of Science, Elsevier, CNKI and China Info were searched for randomized controlled trials (RCT) studies in regards to the effects of physical exercise on SUD between the years 1990 and 2013. Four main outcome measures including abstinence rate, withdrawal symptoms, anxiety, and depression were evaluated. Results: Twenty-two studies were integrated in the meta-analysis. The results indicated that physical exercise can effectively increase the abstinence rate (OR = 1.69 (95% CI: 1.44, 1.99), z = 6.33, p < 0.001), ease withdrawal symptoms (SMD = -1.24 (95% CI: -2.46, -0.02), z = -2, p < 0.05), and reduce anxiety (SMD = -0.31 (95% CI: -0.45, -0.16), z = -4.12, p < 0.001) and depression (SMD = -0.47 (95% CI: -0.80, -0.14), z = -2.76, p < 0.01). The physical exercise can more ease the depression symptoms on alcohol and illicit drug abusers than nicotine abusers, and more improve the abstinence rate on illicit drug abusers than the others. Similar treatment effects were found in three categories: exercise intensity, types of exercise, and follow-up periods. Conclusions: The moderate and high-intensity aerobic exercises, designed according to the Guidelines of American College of Sports Medicine, and the mind-body exercises can be an effective and persistent treatment for those with SUD.	[Wang, Dongshi; Wang, Yanqiu; Wang, Yingying; Li, Rena; Zhou, Chenglin] Shanghai Univ Sport, Sch Kinesiol, Dept Sport Psychol, Shanghai, Peoples R China; [Li, Rena] Roskamp Inst, Ctr Hormone Adv Sci & Educ, Sarasota, FL USA	Shanghai University of Sport	Zhou, CL (corresponding author), Shanghai Univ Sport, Sch Kinesiol, Dept Sport Psychol, Shanghai, Peoples R China.	chenglin_600@126.com	wang, yan/GSE-6489-2022; wang, yi/GVT-8516-2022; wang, yixuan/GXW-2866-2022; Wang, Yijun/GXW-1763-2022; Wang, Yixuan/GZK-6559-2022; wang, yingying/GRS-3058-2022		ISP grant from Scientific and Technological Commission of Shanghai [13490503600]; National Science Foundation of China [31171004]; Project of Scientific and Technological Innovation grant from Shanghai University of Sport [yjscx201324]	ISP grant from Scientific and Technological Commission of Shanghai; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Scientific and Technological Innovation grant from Shanghai University of Sport	This work was supported by the ISP grant (No. 13490503600) from Scientific and Technological Commission of Shanghai, National Science Foundation of China (No. 31171004), and the Project of Scientific and Technological Innovation grant (No. yjscx201324) from Shanghai University of Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi THN, 2013, ALCOHOL, V47, P309, DOI 10.1016/j.alcohol.2013.01.008; Ahn S, 2012, J ALTERN COMPLEM MED, V18, P1172, DOI 10.1089/acm.2011.0690; [Anonymous], 2012, WORLD DRUG REP 2012; Berrettini W, 2013, ALCOHOL SCI POLICY P, V3, P97; Bock BC, 2012, J WOMENS HEALTH, V21, P240, DOI 10.1089/jwh.2011.2963; Brown Richard A, 2010, Ment Health Phys Act, V3, P27; Brown RA, 2009, BEHAV MODIF, V33, P220, DOI 10.1177/0145445508329112; Buchowski MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017465; Burling T A, 1992, J Subst Abuse, V4, P407, DOI 10.1016/0899-3289(92)90047-2; Carim-Todd L, 2013, DRUG ALCOHOL DEPEN, V132, P399, DOI 10.1016/j.drugalcdep.2013.04.014; CNNCC, 2013, ANN REP DRUG CONTR C; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Corbin C.B., 2000, DEFINITIONS HLTH FIT; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Coelho FGD, 2013, ARCH GERONTOL GERIAT, V56, P10, DOI 10.1016/j.archger.2012.06.003; Deng QJ, 2012, ADDICTION, V107, P610, DOI 10.1111/j.1360-0443.2011.03648.x; DiPietro L, 1998, J AM GERIATR SOC, V46, P875, DOI 10.1111/j.1532-5415.1998.tb02722.x; Donaghy M. E., 1997, INVESTIGATION EXERCI; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elibero A, 2011, NICOTINE TOB RES, V13, P1140, DOI 10.1093/ntr/ntr163; Engelmann AJ, 2014, BRAIN STRUCT FUNCT, V219, P657, DOI 10.1007/s00429-013-0525-7; Fareed A, 2009, J PSYCHIATR PRACT, V15, P227, DOI 10.1097/01.pra.0000351884.83377.e2; Fischer B, 2004, EUROPEAN ADDICTION R, V11, P1; Gilman JM, 2008, J NEUROSCI, V28, P4583, DOI 10.1523/JNEUROSCI.0086-08.2008; Gomez-Pinilla F, 2013, COMPR PHYSIOL, V3, P403, DOI 10.1002/cphy.c110063; Haasova M, 2013, ADDICTION, V108, P26, DOI 10.1111/j.1360-0443.2012.04034.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hillman CH, 2012, CHILD DEV PERSPECT, V6, P367, DOI 10.1111/cdep.12000; Hopkins ME, 2012, NEUROSCIENCE, V215, P59, DOI 10.1016/j.neuroscience.2012.04.056; Huang H, 2000, CHINESE J DRUG PREV, V26, P30; Huang H, 2000, CHIN J PHYS THER, V23, P267; Joseph H, 2000, MT SINAI J MED, V67, P347; Karoly HC, 2013, ALCOHOL CLIN EXP RES, V37, P1508, DOI 10.1111/acer.12135; Khalsa Sat Bir S, 2008, J Ethn Subst Abuse, V7, P67, DOI 10.1080/15332640802081968; Khanna S, 2013, COMPLEMENT THER MED, V21, P244, DOI 10.1016/j.ctim.2013.01.008; Kinnunen T, 2008, NICOTINE TOB RES, V10, P689, DOI 10.1080/14622200801979043; Kinnunen TH, 2010, INT J SPORT EXERC PS, V8, P48, DOI 10.1080/1612197X.2010.9671933; Kjos V, 2006, J AGING PHYS ACTIV, V14, P241, DOI 10.1123/japa.14.3.241; Koo JW, 2012, SCIENCE, V338, P124, DOI 10.1126/science.1222265; Korhonen T, 2009, TWIN RES HUM GENET, V12, P261, DOI 10.1375/twin.12.3.261; Lan C, 1998, MED SCI SPORT EXER, V30, P345, DOI 10.1097/00005768-199803000-00003; Li DX, 2013, AM J CHINESE MED, V41, P43, DOI 10.1142/S0192415X13500043; Li M, 2002, ALTERN THER HEALTH M, V8, P50; Lin TW, 2013, BRAIN SCI, V3, P39, DOI 10.3390/brainsci3010039; Linke SE, 2013, WOMENS HEALTH, V9, P69, DOI [10.2217/WHE.12.63, 10.2217/whe.12.63]; Lynch WJ, 2013, NEUROSCI BIOBEHAV R, V37, P1622, DOI 10.1016/j.neubiorev.2013.06.011; Lynch WJ, 2010, BIOL PSYCHIAT, V68, P774, DOI 10.1016/j.biopsych.2010.06.022; Marcus BH, 1999, ARCH INTERN MED, V159, P1229, DOI 10.1001/archinte.159.11.1229; MARCUS BH, 1995, ADDICT BEHAV, V20, P87, DOI 10.1016/0306-4603(94)00048-4; Marcus BH, 2005, NICOTINE TOB RES, V7, P871, DOI 10.1080/14622200500266056; Martin JE, 1997, J CONSULT CLIN PSYCH, V65, P190, DOI 10.1037/0022-006X.65.1.190; Maruyama A, 2013, DRUG ALCOHOL REV, V32, P412, DOI 10.1111/dar.12031; Mattick RP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub4; McMorris T, 2000, INT J SPORT PSYCHOL, V31, P66; Miladi-Gorji H, 2012, PHYSIOL BEHAV, V105, P195, DOI 10.1016/j.physbeh.2011.08.010; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Pan L, 2013, EUR J HEART FAIL, V15, P316, DOI 10.1093/eurjhf/hfs170; Pareja-Galeano H, 2013, SUBST ABUS, V34, P87, DOI 10.1080/08897077.2012.752778; Pattison LP, 2014, SYNAPSE; Posadzki P., 2014, FOCUS ALTERNATIVE CO, V19, P1, DOI DOI 10.1111/FCT.12080; Prapavessis H, 2007, ADDICT BEHAV, V32, P1416, DOI 10.1016/j.addbeh.2006.10.005; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts V, 2012, PSYCHOPHARMACOLOGY, V222, P1, DOI 10.1007/s00213-012-2731-z; Roessler KK, 2013, SPORT SCI REV, V22, P205, DOI DOI 10.2478/SSR-2013-0010; Sala M, 2013, BRIT J PHARMACOL, V168, P835, DOI 10.1111/j.1476-5381.2012.02204.x; Sanchez V, 2013, PSYCHOPHARMACOLOGY, V227, P403, DOI 10.1007/s00213-012-2964-x; Sareen S, 2007, WORLD J GASTROENTERO, V13, P391, DOI 10.3748/wjg.v13.i3.391; Sarkar DK, 2012, J BIOL CHEM, V287, P16734, DOI 10.1074/jbc.M112.347583; Silveri MM, 2014, PHARMACOL THERAPEUT, V143, P197, DOI 10.1016/j.pharmthera.2014.03.001; Smelson D, 2013, J ALTERN COMPLEM MED, V19, P97, DOI 10.1089/acm.2012.0052; Smith Mark A, 2011, Front Psychiatry, V2, P82, DOI 10.3389/fpsyt.2011.00082; Strohle A, 2007, PSYCHOL MED, V37, P1657, DOI 10.1017/S003329170700089X; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Taylor AH, 2013, MENT HEALTH PHYS ACT, V6, P220, DOI 10.1016/j.mhpa.2013.09.004; Thanos PK, 2013, BEHAV BRAIN RES, V239, P8, DOI 10.1016/j.bbr.2012.10.035; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; Thompson W. R., 2009, ACSMS GUIDELINES EXE; Ussher M, 2003, ADDICTION, V98, P523, DOI 10.1046/j.1360-0443.2003.00346.x; Ussher M, 2007, ADDICT BEHAV, V32, P3060, DOI 10.1016/j.addbeh.2007.04.009; Ussher MH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002295.pub3; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Vedamurthachar A, 2006, J AFFECT DISORDERS, V94, P249, DOI 10.1016/j.jad.2006.04.025; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Vickers KS, 2009, NICOTINE TOB RES, V11, P985, DOI 10.1093/ntr/ntp101; Wapf V, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-10; Ward S, 2013, J YOGA PHYS THER, V3, P1; Weinstock J, 2012, SUBST ABUS, V33, P350, DOI 10.1080/08897077.2012.663327; Whiteley JA, 2012, AM J PREV MED, V43, P256, DOI 10.1016/j.amepre.2012.05.025; WHO, 2013, MAN SUBST AB; Williams DM, 2010, PSYCHOL ADDICT BEHAV, V24, P349, DOI 10.1037/a0018332; Wu Y, 2013, J SPORT HEALTH SCI, V2, P193, DOI 10.1016/j.jshs.2013.09.001; Zhuang SM, 2013, NURS RES, V62, P260, DOI 10.1097/NNR.0b013e318292379b; Zschucke E, 2012, SCI WORLD J, DOI 10.1100/2012/901741	94	135	141	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110728	10.1371/journal.pone.0110728	http://dx.doi.org/10.1371/journal.pone.0110728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9XC	25330437	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800109
J	Blything, RP; Ambridge, B; Lieven, EVM				Blything, Ryan P.; Ambridge, Ben; Lieven, Elena V. M.			Children Use Statistics and Semantics in the Retreat from Overgeneralization	PLOS ONE			English	Article							LANGUAGE-ACQUISITION; ARGUMENT-STRUCTURE; ERRORS; VERBS; JUDGMENT	How do children learn to restrict their productivity and avoid ungrammatical utterances? The present study addresses this question by examining why some verbs are used with un-prefixation (e.g., unwrap) and others are not (e.g., *unsqueeze). Experiment 1 used a priming methodology to examine children's (3-4; 5-6) grammatical restrictions on verbal un-prefixation. To elicit production of un-prefixed verbs, test trials were preceded by a prime sentence, which described reversal actions with grammatical un-prefixed verbs (e.g., Marge folded her arms and then she unfolded them). Children then completed target sentences by describing cartoon reversal actions corresponding to (potentially) un-prefixed verbs. The younger age-group's production probability of verbs in un- form was negatively related to the frequency of the target verb in bare form (e.g., squeez/e/ed/es/ing), while the production probability of verbs in un-form for both age groups was negatively predicted by the frequency of synonyms to a verb's un- form (e.g., release/*unsqueeze). In Experiment 2, the same children rated the grammaticality of all verbs in un-form. The older age-group's grammaticality judgments were (a) positively predicted by the extent to which each verb was semantically consistent with a semantic "cryptotype'' of meanings - where "cryptotype'' refers to a covert category of overlapping, probabilistic meanings that are difficult to access - hypothesised to be shared by verbs which take un-, and (b) negatively predicted by the frequency of synonyms to a verb's un-form. Taken together, these experiments demonstrate that children as young as 4; 0 employ pre-emption and entrenchment to restrict generalizations, and that use of a semantic cryptotype to guide judgments of overgeneralizations is also evident by age 6;0. Thus, even early developmental accounts of children's restriction of productivity must encompass a mechanism in which a verb's semantic and statistical properties interact.	[Blything, Ryan P.; Lieven, Elena V. M.] Univ Manchester, Dept Psychol Sci, Manchester, Lancs, England; [Ambridge, Ben] Univ Liverpool, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England; [Ambridge, Ben; Lieven, Elena V. M.] Univ Manchester, Dept Psychol Sci, ESRC Int Ctr Language & Commun Dev LuCiD, Manchester, Lancs, England	University of Manchester; University of Liverpool; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Manchester	Blything, RP (corresponding author), Univ Manchester, Dept Psychol Sci, Manchester, Lancs, England.	ryan.blything@postgrad.manchester.ac.uk		Ambridge, Ben/0000-0003-2389-8477; Blything, Ryan/0000-0003-2285-7219	Economic and Social Research Council Doctoral Training Centre +3 [ES/J500094/1]; Economic and Social Research Council [ES/L008955/1] Funding Source: researchfish; ESRC [ES/L008955/1] Funding Source: UKRI	Economic and Social Research Council Doctoral Training Centre +3; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by an Economic and Social Research Council Doctoral Training Centre +3 (Ph.D.) award to Ryan Blything. http://www.esrc.ac.uk/. Account Code: ES/J500094/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot-Smith K, 2006, LINGUIST REV, V23, P275, DOI 10.1515/TLR.2006.011; Ambridge B, 2011, GUIDE RES METHODS CH, P113; Ambridge B, 2009, P 9 INT C COGN MOD I, P158; Ambridge B., 2011, CHILD LANGUAGE ACQUI; Ambridge B, 2008, COGNITION, V106, P87, DOI 10.1016/j.cognition.2006.12.015; Ambridge B, 2014, LANG COGN NEUROSCI, V29, P218, DOI 10.1080/01690965.2012.738300; Ambridge B, 2013, COGNITIVE SCI, V37, P508, DOI 10.1111/cogs.12018; Ambridge B, 2013, WIRES COGN SCI, V4, P47, DOI 10.1002/wcs.1207; Ambridge B, 2012, COGNITION, V123, P260, DOI 10.1016/j.cognition.2012.01.002; Ambridge B, 2011, COGN LINGUIST, V22, P303, DOI 10.1515/COGL.2011.012; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bowerman Melissa., 1982, LANG ACQUIS, V2nd ed., P319; Braine MartinD.S., 1995, NAMES THINGS YOUNG C, P352; Brooks PJ, 1999, CHILD DEV, V70, P1325, DOI 10.1111/1467-8624.00097; Brooks PJ, 1999, LANGUAGE, V75, P720, DOI 10.2307/417731; CLARK EV, 1979, LANGUAGE, V55, P767, DOI 10.2307/412745; Clark EV, 1995, J CHILD LANG, V22, P633, DOI 10.1017/S0305000900009983; Langacker R. W., 2000, USAGE BASED MODELL, P1; LI P, 1996, CONNECT SCI, V0008; MacWhinney B, 2004, J CHILD LANG, V31, P883, DOI 10.1017/S0305000904006336; MacWhinney B., 2000, CHILDES PROJECT, V2; MCNEILL D, 1966, VOLTA REV, V68, P17; Miwa K, 2014, Q J EXP PSYCHOL, V67, P79, DOI 10.1080/17470218.2013.790910; Pinker Steven., 1989, LEARNABILITY COGNITI; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rowland CF, 2012, COGNITION, V125, P49, DOI 10.1016/j.cognition.2012.06.008; Tomasello M., 2003, CONSTRUCTING LANGUAG; Whorf B.L., 2012, LANGUAGE THOUGHT REA; Wonnacott E, 2011, J MEM LANG, V65, P1, DOI 10.1016/j.jml.2011.03.001; Wurm LH, 2014, J MEM LANG, V72, P37, DOI 10.1016/j.jml.2013.12.003	32	16	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110009	10.1371/journal.pone.0110009	http://dx.doi.org/10.1371/journal.pone.0110009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25333407	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000346766200075
J	Chatterjee, V; Beard, RS; Reynolds, JJ; Haines, R; Guo, MZ; Rubin, M; Guido, J; Wu, MH; Yuan, SY				Chatterjee, Victor; Beard, Richard S., Jr.; Reynolds, Jason J.; Haines, Ricci; Guo, Mingzhang; Rubin, Matthew; Guido, Jenny; Wu, Mack H.; Yuan, Sarah Y.			MicroRNA-147b Regulates Vascular Endothelial Barrier Function by Targeting ADAM15 Expression	PLOS ONE			English	Article							LET-7 MICRORNA; METALLOPROTEINASE ADAM15; CATALYTIC-ACTIVITY; GROWTH-FACTOR; UP-REGULATION; LUNG INJURY; DISINTEGRIN; SEPSIS; INFLAMMATION; EPIDEMIOLOGY	A disintegrin and metalloproteinase15 (ADAM15) has been shown to be upregulated and mediate endothelial hyperpermeability during inflammation and sepsis. This molecule contains multiple functional domains with the ability to modulate diverse cellular processes including cell adhesion, extracellular matrix degradation, and ectodomain shedding of transmembrane proteins. These characteristics make ADAM15 an attractive therapeutic target in various diseases. The lack of pharmacological inhibitors specific to ADAM15 prompted our efforts to identify biological or molecular tools to alter its expression for further studying its function and therapeutic implications. The goal of this study was to determine if ADAM15-targeting microRNAs altered ADAM15-induced endothelial barrier dysfunction during septic challenge by bacterial lipopolysaccharide (LPS). An in silico analysis followed by luciferase reporter assay in human vascular endothelial cells identified miR-147b with the ability to target the 3' UTR of ADAM15. Transfection with a miR-147b mimic led to decreased total, as well as cell surface expression of ADAM15 in endothelial cells, while miR-147b antagomir produced an opposite effect. Functionally, LPS-induced endothelial barrier dysfunction, evidenced by a reduction in transendothelial electric resistance and increase in albumin flux across endothelial monolayers, was attenuated in cells treated with miR-147b mimics. In contrast, miR-147b antagomir exerted a permeability-increasing effect in vascular endothelial cells similar to that caused by LPS. Taken together, these data suggest the potential role of miR147b in regulating endothelial barrier function by targeting ADAM15 expression.	[Chatterjee, Victor; Beard, Richard S., Jr.; Reynolds, Jason J.; Rubin, Matthew; Guido, Jenny; Yuan, Sarah Y.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Haines, Ricci; Wu, Mack H.] Univ S Florida, Dept Surg, Morsani Coll Med, Tampa, FL 33620 USA; [Guo, Mingzhang] Univ Calif Davis, Sch Med, Dept Surg, Sacramento, CA 95817 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of California System; University of California Davis	Yuan, SY (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	syuan@health.usf.edu	Beard Jr., Richard/E-2051-2013; Yuan, Sarah Y/A-2111-2012; Beard, Richard Scott/I-3695-2019	Beard Jr., Richard/0000-0001-8545-3014; Beard, Richard Scott/0000-0001-8545-3014	NIH [RO1 GM097270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097270] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The above study was supported by the NIH grant RO1 GM097270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Adyshev DM, 2013, AM J RESP CELL MOL, V49, P58, DOI 10.1165/rcmb.2012-0397OC; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Becherer JD, 2003, CURR TOP DEV BIOL, V54, P101, DOI 10.1016/S0070-2153(03)54006-6; Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756; Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066; Boehm M, 2006, CELL CYCLE, V5, P837, DOI 10.4161/cc.5.8.2688; Breslin JW, 2008, SHOCK, V29, P349, DOI 10.1097/shk.0b013e3181454975; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Charrier-Hisamuddin L, 2008, FASEB J, V22, P641, DOI 10.1096/fj.07-8876rev; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fourie AM, 2003, J BIOL CHEM, V278, P30469, DOI 10.1074/jbc.M213157200; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Herren B, 1997, FASEB J, V11, P173, DOI 10.1096/fasebj.11.2.9039960; Horiuchi K, 2003, MOL CELL BIOL, V23, P5614, DOI 10.1128/MCB.23.16.5614-5624.2003; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Kleinpell RM, 2006, AACN ADV CRIT CARE, V17, P385, DOI 10.1097/01256961-200610000-00005; Kobayashi A, 2008, FUTURE ONCOL, V4, P351, DOI 10.2217/14796694.4.3.351; Komiya K, 2005, ARTHRITIS RES THER, V7, pR1158, DOI 10.1186/ar1796; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kratzschmar J, 1996, J BIOL CHEM, V271, P4593; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Lucas N, 2009, CURR PHARM DESIGN, V15, P2311, DOI 10.2174/138161209788682370; Lucas N, 2009, J CELL BIOCHEM, V106, P967, DOI 10.1002/jcb.22087; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; Maretzky T, 2009, BIOCHEM J, V420, P105, DOI 10.1042/BJ20082127; Marshall JC, 2001, CRIT CARE MED, V29, pS99, DOI 10.1097/00003246-200107001-00032; Matthay MA, 2014, AM J RESP CRIT CARE, V189, P1301, DOI 10.1164/rccm.201403-0535OE; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mosnier JF, 2006, LAB INVEST, V86, P1064, DOI 10.1038/labinvest.3700465; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Najy AJ, 2008, CANCER RES, V68, P1092, DOI 10.1158/0008-5472.CAN-07-2432; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Sanchez FA, 2013, TISSUE BARRIERS, V1, DOI [10.1161/CIRCRESAHA.112.274548, 10.4161/tisb.23896]; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Sun CX, 2013, AM J PHYSIOL-LUNG C, V304, pL135, DOI 10.1152/ajplung.00133.2012; Sun CX, 2012, ARTERIOSCL THROM VAS, V32, P2444, DOI 10.1161/ATVBAHA.112.252205; Sun CX, 2010, CARDIOVASC RES, V87, P348, DOI 10.1093/cvr/cvq060; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Tharakan B, 2012, SHOCK, V37, P306, DOI 10.1097/SHK.0b013e318240b564; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; Wu FS, 2009, BIOCHEM BIOPH RES CO, V386, P549, DOI 10.1016/j.bbrc.2009.06.075; Wu Z, 2011, INFECT IMMUN, V79, P2865, DOI 10.1128/IAI.01317-10; Xie B, 2008, FASEB J, V22, P2775, DOI 10.1096/fj.07-099283; Yuan SY, 2007, MICROCIRCULATION, V14, P363, DOI 10.1080/10739680701283091; Yuan SY, 2012, MICROVASC RES, V83, P82, DOI 10.1016/j.mvr.2011.06.015; Yuan SY., 2010, REGULATION ENDOTHELI; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345	55	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110286	10.1371/journal.pone.0110286	http://dx.doi.org/10.1371/journal.pone.0110286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333931	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200109
J	Siqueira, FM; Gerber, AL; Guedes, RLM; Almeida, LG; Schrank, IS; Vasconcelos, ATR; Zaha, A				Siqueira, Franciele Maboni; Gerber, Alexandra Lehmkuhl; Muniz Guedes, Rafael Lucas; Almeida, Luiz Gonzaga; Schrank, Irene Silveira; Ribeiro Vasconcelos, Ana Tereza; Zaha, Arnaldo			Unravelling the Transcriptome Profile of the Swine Respiratory Tract Mycoplasmas	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GENOME SEQUENCE; CILIUM ADHESIN; CELL-DIVISION; BINDS FIBRONECTIN; MOLECULAR-CLONING; SURFACE-PROTEINS; SMALL RNAS; HYOPNEUMONIAE; HYORHINIS	The swine respiratory ciliary epithelium is mainly colonized by Mycoplasma hyopneumoniae, Mycoplasma flocculare and Mycoplasma hyorhinis. While colonization by M. flocculare is virtually asymptomatic, M. hyopneumoniae and M. hyorhinis infections may cause respiratory disease. Information regarding transcript structure and gene abundance provides valuable insight into gene function and regulation, which has not yet been analyzed on a genome-wide scale in these Mycoplasma species. In this study, we report the construction of transcriptome maps for M. hyopneumoniae, M. flocculare and M. hyorhinis, which represent data for conducting comparative studies on the transcriptional repertory. For each species, three cDNA libraries were generated, yielding averages of 415,265, 695,313 and 93,578 reads for M. hyopneumoniae, M. flocculare and M. hyorhinis, respectively, with an average read length of 274 bp. The reads mapping showed that 92%, 98% and 96% of the predicted genes were transcribed in the M. hyopneumoniae, M. flocculare and M. hyorhinis genomes, respectively. Moreover, we showed that the majority of the genes are co-expressed, confirming the previously predicted transcription units. Finally, our data defined the RNA populations in detail, with the map transcript boundaries and transcription unit structures on a genome-wide scale.	[Siqueira, Franciele Maboni; Schrank, Irene Silveira; Zaha, Arnaldo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Siqueira, Franciele Maboni] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil; [Gerber, Alexandra Lehmkuhl; Muniz Guedes, Rafael Lucas; Almeida, Luiz Gonzaga; Ribeiro Vasconcelos, Ana Tereza] LNCC, Lab Bioinformat, Rio De Janeiro, Brazil; [Schrank, Irene Silveira; Zaha, Arnaldo] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biol Mol & Biotecnol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Laboratorio Nacional de Computacao Cientifica (LNCC); Universidade Federal do Rio Grande do Sul	Zaha, A (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.	zaha@cbiot.ufrgs.br	Siqueira, Franciele M/K-4043-2014; Guedes, Rafael Lucas/P-3029-2015; Gerber, Alexandra Lehmkuhl/P-9412-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Vasconcelos, Ana Tereza R/I-1011-2012; Zaha, Arnaldo/D-3165-2013; Almeida, Luiz GP/G-5829-2012	Siqueira, Franciele M/0000-0001-7282-6117; Gerber, Alexandra Lehmkuhl/0000-0001-5724-6106; Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Almeida, Luiz GP/0000-0002-7124-2715; Zaha, Arnaldo/0000-0001-6336-474X; Muniz Guedes, Rafael Lucas/0000-0002-9163-6674	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); CAPES	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), the Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). FMS has received scholarships from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhya Sankar, 2003, Sci STKE, V2003, ppe22, DOI 10.1126/stke.2003.185.pe22; Bejerano-Sagie M, 2007, CURR OPIN MICROBIOL, V10, P189, DOI 10.1016/j.mib.2007.03.009; Benders GA, 2005, J BACTERIOL, V187, P4542, DOI 10.1128/JB.187.13.4542-4551.2005; Bogema DR, 2012, MBIO, V3, DOI 10.1128/mBio.00282-11; Bogema DR, 2011, J BIOL CHEM, V286, P41217, DOI 10.1074/jbc.M111.226084; Burnett TA, 2006, MOL MICROBIOL, V60, P669, DOI 10.1111/j.1365-2958.2006.05139.x; Calcutt MJ, 2012, J BACTERIOL, V194, P1848, DOI 10.1128/JB.00033-12; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chou SY, 1997, BIOCHEM MOL BIOL INT, V41, P821; Citti C, 1995, MOL MICROBIOL, V18, P649, DOI 10.1111/j.1365-2958.1995.mmi_18040649.x; Citti C, 2000, J BACTERIOL, V182, P1356, DOI 10.1128/JB.182.5.1356-1363.2000; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; de Hoon MJL, 2005, PLOS COMPUT BIOL, V1, P212, DOI 10.1371/journal.pcbi.0010025; Deutscher AT, 2012, J PROTEOME RES, V11, P1924, DOI 10.1021/pr201115v; Deutscher AT, 2010, MOL MICROBIOL, V78, P444, DOI 10.1111/j.1365-2958.2010.07345.x; Doudna JA, 2004, ANNU REV BIOCHEM, V73, P539, DOI 10.1146/annurev.biochem.73.011303.074048; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; FRIIS NF, 1994, ACTA VET SCAND, V35, P93; FRIIS NF, 1975, NORD VET MED, V27, P337; Gilson PR, 2001, RES MICROBIOL, V152, P3, DOI 10.1016/S0923-2508(00)01162-1; Goodison S, 2013, GENOME ANNOUNC, V1; Guell M, 2011, NAT REV MICROBIOL, V9, P658, DOI 10.1038/nrmicro2620; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Haas ES, 1996, NUCLEIC ACIDS RES, V24, P4775, DOI 10.1093/nar/24.23.4775; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jenkins C, 2006, INFECT IMMUN, V74, P481, DOI 10.1128/IAI.74.1.481-487.2006; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Kobisch M, 1996, REV SCI TECH OIE, V15, P1569, DOI 10.20506/rst.15.4.983; Koide T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.42; Kornspan JD, 2011, J BACTERIOL, V193, P4543, DOI 10.1128/JB.05505-11; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lathe WC, 2000, TRENDS BIOCHEM SCI, V25, P474, DOI 10.1016/S0968-0004(00)01663-7; Lee HJ, 2008, J MOL BIOL, V378, P318, DOI 10.1016/j.jmb.2008.02.067; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2011, GENET MOL RES, V10, P834, DOI 10.4238/vol10-2gmr1193; Liu W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-80; Liu W, 2011, J BACTERIOL, V193, P1016, DOI 10.1128/JB.01305-10; Liu W, 2010, J BACTERIOL, V192, P5844, DOI 10.1128/JB.00946-10; Lluch-Senar M, 2010, MOL MICROBIOL, V78, P278, DOI 10.1111/j.1365-2958.2010.07306.x; Makita Y, 2004, NUCLEIC ACIDS RES, V32, pD75, DOI 10.1093/nar/gkh074; MARE C J, 1965, Vet Med Small Anim Clin, V60, P841; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Mengin-Lecreulx D, 1998, J BACTERIOL, V180, P4406, DOI 10.1128/JB.180.17.4406-4412.1998; MEYLING A, 1972, ACTA VET SCAND, V13, P287; Minion FC, 2004, J BACTERIOL, V186, P7123, DOI 10.1128/JB.186.21.7123-7133.2004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rasoli M, 2010, ACTA VIROL, V54, P33, DOI 10.4149/av_2010_01_33; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Scherm B, 2002, VET MICROBIOL, V89, P141, DOI 10.1016/S0378-1135(02)00158-X; Seymour LM, 2012, CELL MICROBIOL, V14, P81, DOI 10.1111/j.1462-5822.2011.01702.x; Seymour LM, 2011, J BIOL CHEM, V286, P10097, DOI 10.1074/jbc.M110.208140; Seymour LM, 2010, J BIOL CHEM, V285, P33971, DOI 10.1074/jbc.M110.104463; Siqueira FM, 2014, MOL BIOL REP, V41, P5395, DOI 10.1007/s11033-014-3411-3; Siqueira FM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-175; Siqueira FM, 2011, DNA RES, V18, P413, DOI 10.1093/dnares/dsr028; STEMKE GW, 1992, INT J SYST BACTERIOL, V42, P220, DOI 10.1099/00207713-42-2-220; Tacchi JL, 2014, J PROTEOME RES, V13, P2920, DOI 10.1021/pr500087c; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Torigoe T, 2009, INT J HYPERTHER, V25, P610, DOI 10.3109/02656730903315831; van Heijenoort J, 2001, GLYCOBIOLOGY, V11, p25R; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; Weber SD, 2012, DNA RES, V19, P103, DOI 10.1093/dnares/dsr045; Wilton J, 2009, MOL MICROBIOL, V71, P566, DOI 10.1111/j.1365-2958.2008.06546.x; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132; YOGEV D, 1995, J BACTERIOL, V177, P5636, DOI 10.1128/jb.177.19.5636-5643.1995; Young TF, 2000, VET MICROBIOL, V71, P269, DOI 10.1016/S0378-1135(99)00176-5	69	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110327	10.1371/journal.pone.0110327	http://dx.doi.org/10.1371/journal.pone.0110327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333523	Green Published, gold			2022-12-27	WOS:000346766200114
J	Yu, S; Wang, CP; Cheng, Q; Xu, H; Zhang, SB; Li, L; Zhang, Q; Gu, XS; Ding, F				Yu, Shu; Wang, Caiping; Cheng, Qiong; Xu, Hui; Zhang, Shibo; Li, Lu; Zhang, Qi; Gu, Xiaosong; Ding, Fei			An Active Component of Achyranthes bidentata Polypeptides Provides Neuroprotection through Inhibition of Mitochondrial-Dependent Apoptotic Pathway in Cultured Neurons and in Animal Models of Cerebral Ischemia	PLOS ONE			English	Article							CELL-DEATH; PERMEABILITY TRANSITION; SH-SY5Y CELLS; DYSFUNCTION; MECHANISMS; HYPOXIA; BRAIN; RECEPTORS; STROKE; OXYGEN	An active component has been isolated by reverse-phase high performance liquid chromatography (HPLC) from Achyranthes bidentata Blume polypeptides that are extracted from Achyranthes bidentata Blume, a Chinese medicinal herb. The active component is called ABPPk based on the order of HPLC elution. In this study, we used in vitro and in vivo experimental models of cerebral ischemia to investigate the possible neuroprotective effect of ABPPk. ABPPk treatment promoted neuronal survival and inhibited neuronal apoptosis in primary cortical neurons exposed to oxygen and glucose deprivation and in rats subjected to transient middle cerebral artery occlusion. The role of ABPPk in protection against ischemia-induced neuronal damage might be mediated by mitochondrial-dependent pathways, including modulation of apoptosis-related gene expression, regulation of mitochondrial dysfunction through restoring mitochondrial membrane potential, reducing release of mitochondrial apoptogenic factors, and inhibiting intracellular ROS production. The neuroprotective effect of ABPPk may suggest the possible use of this agent in the treatment and prevention of cerebral ischemic stroke.	[Yu, Shu; Wang, Caiping; Cheng, Qiong; Xu, Hui; Zhang, Shibo; Li, Lu; Zhang, Qi; Gu, Xiaosong; Ding, Fei] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Collaborat Innovat Ctr Neuroregenerat, Nantong, Jiangsu, Peoples R China	Nantong University	Ding, F (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Collaborat Innovat Ctr Neuroregenerat, Nantong, Jiangsu, Peoples R China.	dingfei@ntu.edu.cn			National Key Basic Research Program of China (973 program) [2014CB542202]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Nantong Science and Technology Innovation Project [HS2013003]; Nantong University [11Z035, 13ZY009]	National Key Basic Research Program of China (973 program)(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Nantong Science and Technology Innovation Project; Nantong University	This study was supported by National Key Basic Research Program of China (973 program, Grant No. 2014CB542202), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Nantong Science and Technology Innovation Project (Grant No. HS2013003), and the natural science research project of Nantong University (Grant No. 11Z035 and 13ZY009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli T, 2008, CEREB CORTEX, V18, P1748, DOI 10.1093/cercor/bhm217; Aquilani R, 2011, NUTR CLIN PRACT, V26, P339, DOI 10.1177/0884533611405793; Brenner C, 2012, CIRC RES, V111, P1237, DOI 10.1161/CIRCRESAHA.112.265942; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Chazotte B, 2011, COLD SPRING HARB PRO, V2011; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Davis RE, 2012, J PHARMACOL EXP THER, V342, P598, DOI 10.1124/jpet.112.192104; Ding F, 2008, FITOTERAPIA, V79, P161, DOI 10.1016/j.fitote.2007.10.002; Faraci FM, 2011, AM J PHYSIOL-HEART C, V300, pH1566, DOI 10.1152/ajpheart.01310.2010; Ferrer I, 2003, J NEUROPATH EXP NEUR, V62, P329, DOI 10.1093/jnen/62.4.329; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Gao YQ, 2010, STROKE, V41, P166, DOI 10.1161/STROKEAHA.109.561852; Gong X, 2002, PHYTOMEDICINE, V9, P478, DOI 10.1078/09447110260571760; Hirooka Y, 2011, AM J PHYSIOL-REG I, V300, pR818, DOI 10.1152/ajpregu.00426.2010; Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263; Jang S, 2009, J PHARMACOL EXP THER, V328, P435, DOI 10.1124/jpet.108.144014; Johri A, 2012, J PHARMACOL EXP THER, V342, P619, DOI 10.1124/jpet.112.192138; Joshi CN, 2004, BRAIN RES PROTOC, V13, P11, DOI 10.1016/j.brainresprot.2003.12.001; Kondo K, 2010, J BIOL CHEM, V285, P13079, DOI 10.1074/jbc.M109.044206; Konstantinidou AE, 2007, APOPTOSIS, V12, P695, DOI 10.1007/s10495-006-0001-4; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Luchetti F, 2010, FASEB J, V24, P3603, DOI 10.1096/fj.10-154450; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; McFarland AJ, 2013, INT J TOXICOL, V32, P209, DOI 10.1177/1091581813482146; Mergenthaler P, 2011, J PHYSIOL-LONDON, V589, P4147, DOI 10.1113/jphysiol.2011.209718; Nijboer CHA, 2008, STROKE, V39, P2129, DOI 10.1161/STROKEAHA.107.504175; Ouyang YB, 2004, CELL CALCIUM, V36, P303, DOI 10.1016/j.ceca.2004.02.015; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V303, pH243, DOI 10.1152/ajpheart.00185.2012; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Plesnila N, 2004, ACTA NEUROCHIR SUPPL, V89, P15; Ronaldson PT, 2013, PHARMACOL REV, V65, P291, DOI 10.1124/pr.112.005991; Russo R, 2005, NEUROTOXICOLOGY, V26, P905, DOI 10.1016/j.neuro.2005.01.009; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Sheikh AY, 2008, AM J PHYSIOL-HEART C, V294, pH88, DOI 10.1152/ajpheart.00935.2007; Shen HM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057055, 10.1371/journal.pone.0057746]; Shen HM, 2010, J NEUROSCI RES, V88, P669, DOI 10.1002/jnr.22221; Shen HM, 2008, BRAIN RES BULL, V77, P274, DOI 10.1016/j.brainresbull.2008.08.002; Shen YT, 2011, NEUROCHEM RES, V36, P2186, DOI 10.1007/s11064-011-0543-x; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Stefanis L, 2005, NEUROSCIENTIST, V11, P50, DOI 10.1177/1073858404271087; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Vosler PS, 2009, STROKE, V40, P3149, DOI 10.1161/STROKEAHA.108.543769; Wang X, 2009, STROKE, V40, P1877, DOI 10.1161/STROKEAHA.108.540765; Wang YX, 2013, NEUROCHEM RES, V38, P538, DOI 10.1007/s11064-012-0946-3; Xing BZ, 2008, STROKE, V39, P2362, DOI 10.1161/STROKEAHA.107.507939; Yuan Y, 2010, BRAIN RES BULL, V81, P25, DOI 10.1016/j.brainresbull.2009.07.013	49	30	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109923	10.1371/journal.pone.0109923	http://dx.doi.org/10.1371/journal.pone.0109923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25334016	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200066
J	Siucinska, E; Hamed, A; Jasinska, M				Siucinska, Ewa; Hamed, Adam; Jasinska, Malgorzata			Increases in the Numerical Density of GAT-1 Positive Puncta in the Barrel Cortex of Adult Mice after Fear Conditioning	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; INHIBITORY SYNAPTIC-TRANSMISSION; EXPERIENCE-DEPENDENT PLASTICITY; PLASMA-MEMBRANE TRANSPORTERS; CEREBRAL-CORTEX; SOMATOSENSORY CORTEX; CORTICAL PLASTICITY; GABA TRANSPORTER; ARBITRARY PARTICLES; GABAERGIC NEURONS	Three days of fear conditioning that combines tactile stimulation of a row of facial vibrissae (conditioned stimulus, CS) with a tail shock (unconditioned stimulus, UCS) expands the representation of "trained" vibrissae, which can be demonstrated by labeling with 2-deoxyglucose in layer IV of the barrel cortex. We have also shown that functional reorganization of the primary somatosensory cortex (S1) increases GABAergic markers in the hollows of "trained" barrels of the adult mouse. This study investigated how whisker-shock conditioning (CS+UCS) affected the expression of puncta of a high-affinity GABA plasma membrane transporter GAT-1 in the barrel cortex of mice 24 h after associative learning paradigm. We found that whisker-shock conditioning (CS+UCS) led to increase expression of neuronal and astroglial GAT-1 puncta in the "trained" row compared to controls: Pseudoconditioned, CS-only, UCS-only and Naive animals. These findings suggest that fear conditioning specifically induces activation of systems regulating cellular levels of the inhibitory neurotransmitter GABA.	[Siucinska, Ewa] Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, Warsaw, Poland; [Hamed, Adam] Inst Psychiat & Neurol, Dept Neurochem, Warsaw, Poland; [Jasinska, Malgorzata] Jagiellonian Univ, Coll Med, Dept Histol, Krakow, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Institute of Psychiatry & Neurology; Jagiellonian University; Collegium Medicum Jagiellonian University	Siucinska, E (corresponding author), Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, Warsaw, Poland.	e.siucinska@nencki.gov.pl	Hamed, Adam/M-8545-2019; Siucinska, Ewa/W-7969-2018	Siucinska, Ewa/0000-0002-4541-2864; Jasinska, Malgorzata/0000-0002-8102-6039; Hamed, Adam/0000-0003-1477-9177	Polish Ministry of Science and Higher Education [NN401 0188 33, 6420/B/P01/2011/40]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The study was supported by Scientific Research grant NN401 0188 33; 6420/B/P01/2011/40 from the Polish Ministry of Science and Higher Education to ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld DS, 2003, NEURON, V40, P389, DOI 10.1016/S0896-6273(03)00607-X; Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Bekkers JM, 2005, J NEUROSCI, V25, P4031, DOI 10.1523/JNEUROSCI.4969-04.2005; Blake DT, 2002, BEHAV BRAIN RES, V135, P179, DOI 10.1016/S0166-4328(02)00163-8; Bragina L, 2008, J NEUROCHEM, V105, P1781, DOI 10.1111/j.1471-4159.2008.05273.x; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Chau LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095317; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; Conti F, 1998, J COMP NEUROL, V396, P51, DOI 10.1002/(SICI)1096-9861(19980622)396:1<51::AID-CNE5>3.0.CO;2-H; Conti F, 2004, BRAIN RES REV, V45, P196, DOI 10.1016/j.brainresrev.2004.03.003; DAVIES CH, 1993, J PHYSIOL-LONDON, V472, P245, DOI 10.1113/jphysiol.1993.sp019945; DeFelipe J, 1998, NEUROREPORT, V9, P467, DOI 10.1097/00001756-199802160-00020; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Engel D, 2001, J PHYSIOL-LONDON, V535, P473, DOI 10.1111/j.1469-7793.2001.00473.x; Eulenburg V, 2010, BRAIN RES REV, V63, P103, DOI 10.1016/j.brainresrev.2010.01.003; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Fox K, 2005, NEURON, V48, P465, DOI 10.1016/j.neuron.2005.10.013; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Galvez R, 2006, J NEUROSCI, V26, P6062, DOI 10.1523/JNEUROSCI.5582-05.2006; Gdalyahu A, 2012, NEURON, V75, P121, DOI 10.1016/j.neuron.2012.04.035; Gierdalski M, 2001, CEREB CORTEX, V11, P806, DOI 10.1093/cercor/11.9.806; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; HENDRY SHC, 1988, NEURON, V1, P701, DOI 10.1016/0896-6273(88)90169-9; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; IVERSEN LL, 1975, BIOCHEM PHARMACOL, V24, P933, DOI 10.1016/0006-2952(75)90422-0; Jasinska M, 2010, J NEUROSCI, V30, P1176, DOI 10.1523/JNEUROSCI.2970-09.2010; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; Johnson J, 1996, J COMP NEUROL, V375, P212; JONES EG, 1993, CEREB CORTEX, V3, P361, DOI 10.1093/cercor/3.5.361-a; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kuhlman SJ, 2014, J NEUROSCI, V34, P6078, DOI 10.1523/JNEUROSCI.4919-12.2014; Lech M, 2001, MOL BRAIN RES, V96, P82, DOI 10.1016/S0169-328X(01)00271-6; Li PJ, 2009, P NATL ACAD SCI USA, V106, P12156, DOI 10.1073/pnas.0900922106; MASLIAH E, 1990, J HISTOCHEM CYTOCHEM, V38, P837, DOI 10.1177/38.6.2110586; Mayhew TM, 1996, J ANAT, V188, P1; MINELLI A, 1995, J NEUROSCI, V15, P7734, DOI 10.1523/jneurosci.15-11-07734.1995; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Peterson DA, 1999, METHODS, V18, P493, DOI 10.1006/meth.1999.0818; Piet R, 2004, P NATL ACAD SCI USA, V101, P2151, DOI 10.1073/pnas.0308408100; RADIAN R, 1990, J NEUROSCI, V10, P1319; Raiteri L, 2005, J NEUROSCI RES, V80, P422, DOI 10.1002/jnr.20437; Ribak CE, 1996, ANAT EMBRYOL, V194, P379; Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#; Schousboe A, 2003, NEUROCHEM RES, V28, P347, DOI 10.1023/A:1022397704922; Shi L, 2004, J COMP NEUROL, V478, P282, DOI 10.1002/cne.20303; Siucinska E, 1996, CEREB CORTEX, V6, P506, DOI 10.1093/cercor/6.3.506; Siucinska E, 2006, NEUROSCIENCE, V138, P715, DOI 10.1016/j.neuroscience.2005.11.053; Siucinska E, 1999, BRAIN RES, V843, P62, DOI 10.1016/S0006-8993(99)01881-8; Siucinska E, 2006, BRAIN RES, V1106, P52, DOI 10.1016/j.brainres.2006.05.061; Sloviter RS, 1999, EPILEPSIA, V40, pS34, DOI 10.1111/j.1528-1157.1999.tb00876.x; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Tokarski K, 2007, EUR J NEUROSCI, V26, P134, DOI 10.1111/j.1460-9568.2007.05629.x; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Urban-Ciecko J, 2005, ACTA NEUROBIOL EXP, V65, P195; Urban-Ciecko J, 2010, J NEUROPHYSIOL, V104, P746, DOI 10.1152/jn.00988.2009; WELKER E, 1989, EXP BRAIN RES, V78, P659, DOI 10.1007/BF00230256; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wouterlood FG, 1998, BRAIN RES PROTOC, V2, P149, DOI 10.1016/S1385-299X(97)00038-X; Wu YM, 2007, NEURON, V56, P851, DOI 10.1016/j.neuron.2007.10.021; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	71	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110493	10.1371/journal.pone.0110493	http://dx.doi.org/10.1371/journal.pone.0110493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333489	gold, Green Published			2022-12-27	WOS:000343731200047
J	Vuolteenaho, K; Leppanen, T; Kekkonen, R; Korpela, R; Moilanen, E				Vuolteenaho, Katriina; Leppanen, Tiina; Kekkonen, Riina; Korpela, Riitta; Moilanen, Eeva			Running a Marathon Induces Changes in Adipokine Levels and in Markers of Cartilage Degradation - Novel Role for Resistin	PLOS ONE			English	Article							OLIGOMERIC MATRIX PROTEIN; HUMAN ARTICULAR CHONDROCYTES; KNEE CARTILAGE; SERUM LEPTIN; EXERCISE; PLASMA; EXPRESSION; GAMMA; COMP; INFLAMMATION	Running a marathon causes strenuous joint loading and increased energy expenditure. Adipokines regulate energy metabolism, but recent studies have indicated that they also exert a role in cartilage degradation in arthritis. Our aim was to investigate the effects of running a marathon on the levels of adipokines and indices of cartilage metabolism. Blood samples were obtained from 46 male marathoners before and after a marathon run. We measured levels of matrix metalloproteinase-3 (MMP-3), cartilage oligomeric protein (COMP) and chitinase 3-like protein 1 (YKL-40) as biomarkers of cartilage turnover and/or damage and plasma concentrations of adipokines adiponectin, leptin and resistin. Mean marathon time was 3:30:46 +/- 0:02:46 (h:min:sec). The exertion more than doubled MMP-3 levels and this change correlated negatively with the marathon time (r = -0.448, p = 0.002). YKL-40 levels increased by 56% and the effect on COMP release was variable. Running a marathon increased the levels of resistin and adiponectin, while leptin levels remained unchanged. The marathon-induced changes in resistin levels were positively associated with the changes in MMP-3 (r = 0.382, p = 0.009) and YKL-40 (r = 0.588, p<0.001) and the pre-marathon resistin levels correlated positively with the marathon induced change in YKL-40 (r = 0.386, p = 0.008). The present results show the impact of running a marathon, and possible load frequency, on cartilage metabolism: the faster the marathon was run, the greater was the increase in MMP-3 levels. Further, the results introduce pro-inflammatory adipocytokine resistin as a novel factor, which enhances during marathon race and associates with markers of cartilage degradation.	[Vuolteenaho, Katriina; Leppanen, Tiina; Moilanen, Eeva] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland; [Vuolteenaho, Katriina; Leppanen, Tiina; Moilanen, Eeva] Tampere Univ Hosp, Tampere, Finland; [Kekkonen, Riina; Korpela, Riitta] Univ Helsinki, Inst Biomed Pharmacol, Helsinki, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Helsinki	Moilanen, E (corresponding author), Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland.	eeva.moilanen@uta.fi		Vuolteenaho, Katriina/0000-0003-0017-1291; Korpela, Riitta/0000-0003-0337-9186	Pirkanmaa Hospital District; Paivikki and Sakari Sohlberg Foundation	Pirkanmaa Hospital District; Paivikki and Sakari Sohlberg Foundation	This study was financially supported by the Competitive Research Funding of the Pirkanmaa Hospital District and by Paivikki and Sakari Sohlberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; Bernecker C, 2013, SCAND J MED SCI SPOR, V23, P207, DOI 10.1111/j.1600-0838.2011.01372.x; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; Bouassida A, 2010, BRIT J SPORT MED, V44, P620, DOI 10.1136/bjsm.2008.046151; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Ferguson MA, 2004, EUR J APPL PHYSIOL, V91, P324, DOI 10.1007/s00421-003-0985-1; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Helmark IC, 2012, RHEUMATOL INT, V32, P1009, DOI 10.1007/s00296-010-1716-7; Henrotin Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-92; Holzmann J, 2006, OSTEOARTHR CARTILAGE, V14, P519, DOI 10.1016/j.joca.2005.12.005; Hunter DJ, 2009, J ANAT, V214, P197, DOI 10.1111/j.1469-7580.2008.01013.x; Ihalainen J, 2014, EUR J APPL PHYSL; Karamouzis I, 2002, CLIN CHEM LAB MED, V40, P132, DOI 10.1515/CCLM.2002.023; Kersting UG, 2005, OSTEOARTHR CARTILAGE, V13, P925, DOI 10.1016/j.joca.2005.06.005; Kim HJ, 2007, EUR J APPL PHYSIOL, V99, P443, DOI 10.1007/s00421-006-0362-y; Kim HJ, 2009, EUR J APPL PHYSIOL, V105, P765, DOI 10.1007/s00421-008-0961-x; Koistinen HA, 1998, MED SCI SPORT EXER, V30, P805, DOI 10.1097/00005768-199806000-00005; Koskinen A, 2011, CLIN EXP RHEUMATOL, V29, P57; Koskinen A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3512; Kraus VB, 2011, OSTEOARTHR CARTILAGE, V19, P515, DOI 10.1016/j.joca.2010.08.019; Leal-Cerro A, 1998, J CLIN ENDOCR METAB, V83, P2376, DOI 10.1210/jc.83.7.2376; Lee JH, 2009, OSTEOARTHR CARTILAGE, V17, P613, DOI 10.1016/j.joca.2008.08.007; Mosher TJ, 2010, OSTEOARTHR CARTILAGE, V18, P358, DOI 10.1016/j.joca.2009.11.011; Neidhart M, 2000, OSTEOARTHR CARTILAGE, V8, P222, DOI 10.1053/joca.1999.0293; Niehoff A, 2011, OSTEOARTHR CARTILAGE, V19, P1003, DOI 10.1016/j.joca.2011.04.012; Niehoff A, 2010, EUR J APPL PHYSIOL, V110, P651, DOI 10.1007/s00421-010-1529-0; Otero M, 2003, ARTHRITIS RHEUM, V48, P404, DOI 10.1002/art.10811; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Perseghin G, 2006, DIABETOLOGIA, V49, P1893, DOI 10.1007/s00125-006-0267-7; Punyadeera C, 2005, EUR J ENDOCRINOL, V152, P427, DOI 10.1530/eje.1.01872; Rowe GC, 2014, CIRCULATION, V129, P798, DOI 10.1161/CIRCULATIONAHA.113.001590; Scotece M, 2014, DRUG DISCOV TODAY, V19, P241, DOI 10.1016/j.drudis.2013.07.012; Tarkowski A, 2010, J CELL MOL MED, V14, P1419, DOI 10.1111/j.1582-4934.2009.00899.x; Thomas AW, 2012, J APPL PHYSIOL, V112, P806, DOI 10.1152/japplphysiol.00864.2011; Thommesein L, 2006, J CELL BIOCHEM, V99, P824, DOI 10.1002/jcb.20915; Tsao TS, 2002, EUR J PHARMACOL, V440, P213, DOI 10.1016/S0014-2999(02)01430-9; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Vuolteenaho K, 2001, OSTEOARTHR CARTILAGE, V9, P597, DOI 10.1053/joca.2001.0431; Vuolteenaho K, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/345838; Zaccaria M, 2002, EUR J APPL PHYSIOL, V87, P108, DOI 10.1007/s00421-002-0606-4; Zhang ZQ, 2010, ARTHRITIS RHEUM-US, V62, P1993, DOI 10.1002/art.27473	41	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110481	10.1371/journal.pone.0110481	http://dx.doi.org/10.1371/journal.pone.0110481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333960	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200043
J	Barbisan, F; Motta, JD; Trott, A; Azzolin, V; Dornelles, EB; Marcon, M; Algarve, TD; Duarte, MMMF; Mostardeiro, CP; Unfer, TC; Schott, KL; da Cruz, IBM				Barbisan, Fernanda; Motta, Jessica de Rosso; Trott, Alexis; Azzolin, Veronica; Dornelles, Eduardo Bortoluzzi; Marcon, Matheus; Algarve, Thais Doeler; Medeiros Frescura Duarte, Marta Maria; Mostardeiro, Clarice Pinheiro; Unfer, Tais Cristina; Schott, Karen Lilian; Manica da Cruz, Ivana Beatrice			Methotrexate-Related Response on Human Peripheral Blood Mononuclear Cells May Be Modulated by the Ala16Val-SOD2 Gene Polymorphism	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; IN-VITRO; OXIDATIVE STRESS; RHEUMATOID-ARTHRITIS; SOD2 POLYMORPHISM; APOPTOSIS; THERAPY; HEPATOTOXICITY; CHEMOTHERAPY; ASSOCIATION	Methotrexate (MTX) is a folic acid antagonist used in high doses as an anti-cancer treatment and in low doses for the treatment of some autoimmune diseases. MTX use has been linked to oxidative imbalance, which may cause multi-organ toxicities that can be attenuated by antioxidant supplementation. Despite the oxidative effect of MTX, the influence of antioxidant gene polymorphisms on MTX toxicity is not well studied. Therefore, we analyzed here whether a genetic imbalance of the manganese-dependent superoxide dismutase (SOD2) gene could have some impact on the MTX cytotoxic response. An in vitro study using human peripheral blood mononuclear cells (PBMCs) obtained from carriers with different Ala16Val-SOD2 genotypes (AA, VV and AV) was carried out, and the effect on cell viability and proliferation was analyzed, as well as the effect on oxidative, inflammatory and apoptotic markers. AA-PBMCs that present higher SOD2 efficiencies were more resistance to high MTX doses (10 and 100 mu M) than were the VV and AV genotypes. Both lipoperoxidation and ROS levels increased significantly in PBMCs exposed to MTX independent of Ala16Val-SOD2 genotypes, whereas increased protein carbonylation was observed only in PBMCs from V allele carriers. The AA-PBMCs exposed to MTX showed decreasing SOD2 activity, but a concomitant up regulation of the SOD2 gene was observed. A significant increase in glutathione peroxidase (GPX) levels was observed in all PBMCs exposed to MTX. However, this effect was more intense in AA-PBMCs. Caspase-8 and -3 levels were increased in cells exposed to MTX, but the modulation of these genes, as well as that of the Bax and Bcl-2 genes involved in the apoptosis pathway, presented a modulation that was dependent on the SOD2 genotype. MTX at a concentration of 10 mu M also increased inflammatory cytokines (IL-1 beta, IL-6, TNF alpha and Ig gamma) and decreased the level of IL-10 anti-inflammatory cytokine, independent of SOD2 genetic background. The results suggest that potential pharmacogenetic effect on the cytotoxic response to MTX due differential redox status of cells carriers different SOD2 genotypes.	[Motta, Jessica de Rosso; Marcon, Matheus; Medeiros Frescura Duarte, Marta Maria; Mostardeiro, Clarice Pinheiro; Unfer, Tais Cristina; Manica da Cruz, Ivana Beatrice] Univ Fed Santa Maria, Biogen Lab, BR-97119900 Santa Maria, RS, Brazil; [Barbisan, Fernanda; Azzolin, Veronica; Manica da Cruz, Ivana Beatrice] Univ Fed Santa Maria, Pharmacol Grad Program, BR-97119900 Santa Maria, RS, Brazil; [Dornelles, Eduardo Bortoluzzi; Algarve, Thais Doeler; Schott, Karen Lilian; Manica da Cruz, Ivana Beatrice] Univ Fed Santa Maria, Biochem Toxicol Grad Program, BR-97119900 Santa Maria, RS, Brazil; [Trott, Alexis] Univ Western Santa Catarina, UNOESC, Mol Biol Lab, Chapeco, SC, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidade do Oeste de Santa Catarina	da Cruz, IBM (corresponding author), Univ Fed Santa Maria, Biogen Lab, BR-97119900 Santa Maria, RS, Brazil.	ibmcruz@hotmail.com	da Cruz, Ivana BM/G-4329-2012; Algarve, Thaís Doeler/N-4803-2018; Barbisan, Fernanda/AAS-5551-2020	da Cruz, Ivana BM/0000-0003-3008-6899; Algarve, Thaís Doeler/0000-0002-9937-4672; Barbisan, Fernanda/0000-0002-2960-7047; Schott, Karen/0000-0001-8007-1607; Unfer, Tais Cristina/0000-0001-6725-4003	CNPq - Conselho Nacional do Desenvolvimento Cientifico e Tecnologico; CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; FAPERGS - Fundacao de Amparo a Pesquisa do Rio Grande do Sul	CNPq - Conselho Nacional do Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERGS - Fundacao de Amparo a Pesquisa do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This study was funded by CNPq - Conselho Nacional do Desenvolvimento Cientifico e Tecnologico, CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and FAPERGS - Fundacao de Amparo a Pesquisa do Rio Grande do Sul. All funders are no-profit Brazilian Governmental Agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Algarve TD, 2013, GENET MOL RES, V12, P5134, DOI 10.4238/2013.October.29.7; Ali N, 2014, MOL CELL BIOCHEM, V385, P215, DOI 10.1007/s11010-013-1830-4; Bresciani G, 2013, FREE RADICAL RES, V47, P781, DOI 10.3109/10715762.2013.836275; Brock S, 2004, PHARMACOTHERAPY, V24, P673, DOI 10.1592/phco.24.6.673.34742; Burow ME, 1998, CANCER RES, V58, P4940; Caron JE, 2009, PEDIATR BLOOD CANCER, V53, P551, DOI 10.1002/pbc.22128; Chibber S, 2011, J PHOTOCH PHOTOBIO B, V104, P387, DOI 10.1016/j.jphotobiol.2011.04.005; Costa F, 2012, REPROD BIOMED ONLINE, V24, P474, DOI 10.1016/j.rbmo.2012.01.009; D'Andrea N, 2010, MULTIDISCIP RESP MED, V5, P312, DOI 10.1186/2049-6958-5-5-312; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Duarte MMMF, 2010, CLIN BIOCHEM, V43, P1118, DOI 10.1016/j.clinbiochem.2010.07.002; Montano MAE, 2012, CYTOKINE, V60, P30, DOI 10.1016/j.cyto.2012.05.022; Elango T, 2013, CLIN EXP MED; Montagner GFFD, 2010, TOXICOL IN VITRO, V24, P1410, DOI 10.1016/j.tiv.2010.04.010; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Hartmann A, 2003, MUTAGENESIS, V18, P45, DOI 10.1093/mutage/18.1.45; Herman S, 2005, INFLAMM RES, V54, P273, DOI 10.1007/s00011-005-1355-8; Ibrahim MA, 2014, IMMUNOPHARM IMMUNOT, V36, P130, DOI 10.3109/08923973.2014.884135; Ruiz-Sanz JI, 2011, FERTIL STERIL, V95, P1601, DOI 10.1016/j.fertnstert.2010.11.022; Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-8; Khan ZA, 2012, EXPERT OPIN DRUG DEL, V9, P151, DOI 10.1517/17425247.2012.642362; Kozub P, 2011, BRATISL MED J, V112, P390; Ma XX, 2013, BIOMED REP, V1, P177, DOI 10.3892/br.2012.42; Malik F, 2013, PHARMACOGENOMICS, V14, P305, DOI [10.2217/PGS.12.214, 10.2217/pgs.12.214]; MCCORD JM, 1988, FREE RADICAL BIO MED, V5, P363, DOI 10.1016/0891-5849(88)90109-8; Montano Marco Aurelio Echart, 2009, Mol Cell Biochem, V328, P33, DOI 10.1007/s11010-009-0071-z; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nicholls P, 2012, ARCH BIOCHEM BIOPHYS, V525, P95, DOI 10.1016/j.abb.2012.01.015; Olsen NJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4618; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Paludo FJO, 2013, MOL CELL BIOCHEM, V372, P127, DOI 10.1007/s11010-012-1453-1; Sakuma S, 2001, INT IMMUNOPHARMACOL, V1, P749, DOI 10.1016/S1567-5769(01)00008-X; Shandala T, 2012, J CELL PHYSIOL, V227, P2889, DOI 10.1002/jcp.23034; ShimodaMatsubayashi S, 1996, BIOCHEM BIOPH RES CO, V226, P561, DOI 10.1006/bbrc.1996.1394; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sutton A, 2003, PHARMACOGENETICS, V13, P145, DOI 10.1097/00008571-200303000-00004; Tabassum H, 2010, FOOD CHEM TOXICOL, V48, P1973, DOI 10.1016/j.fct.2010.04.047; TOBIAS H, 1973, ARCH INTERN MED, V132, P391, DOI 10.1001/archinte.132.3.391; Vardi N, 2009, FERTIL STERIL, V92, P2028, DOI 10.1016/j.fertnstert.2008.09.015; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200	41	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e107299	10.1371/journal.pone.0107299	http://dx.doi.org/10.1371/journal.pone.0107299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330300	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100006
J	He, YH; Li, W; Li, Y; Zhang, SC; Wang, YW; Sun, CH				He, Yonghan; Li, Wen; Li, Ying; Zhang, Shuocheng; Wang, Yanwen; Sun, Changhao			Ursolic Acid Increases Glucose Uptake through the PI3K Signaling Pathway in Adipocytes	PLOS ONE			English	Article							FATTY LIVER-DISEASE; GLUT4 TRANSLOCATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; MECHANISMS; OBESITY; MUSCLE; ACTIVATION; TRANSPORT; COMPOUND	Background: Ursolic acid (UA), a triterpenoid compound, is reported to have a glucose-lowering effect. However, the mechanisms are not fully understood. Adipose tissue is one of peripheral tissues that collectively control the circulating glucose levels. Objective: The objective of the present study was to determine the effect and further the mechanism of action of UA in adipocytes. Methods and Results: The 3T3-L1 preadipocytes were induced to differentiate and treated with different concentrations of UA. NBD-fluorescent glucose was used as the tracer to measure glucose uptake and Western blotting used to determine the expression and activity of proteins involved in glucose transport. It was found that 2.5, 5 and 10 mu M of UA promoted glucose uptake in a dose-dependent manner (17%, 29% and 35%, respectively). 10 mM UA-induced glucose uptake with insulin stimulation was completely blocked by the phosphatidylinositol (PI) 3-kinase (PI3K) inhibitor wortmannin (1 mu M), but not by SB203580 (10 mu M), the inhibitor of mitogen-activated protein kinase (MAPK), or compound C (2.5 mM), the inhibitor of AMP-activated kinase (AMPK) inhibitor. Furthmore, the downstream protein activities of the PI3K pathway, phosphoinositide-dependent kinase (PDK) and phosphoinositide-dependent serine/threoninekinase (AKT) were increased by 10 mM of UA in the presence of insulin. Interestingly, the activity of AS160 and protein kinase C (PKC) and the expression of glucose transporter 4 (GLUT4) were stimulated by 10 mM of UA under either the basal or insulin-stimulated status. Moreover, the translocation of GLUT4 from cytoplasm to cell membrane was increased by UA but decreased when the PI3K inhibitor was applied. Conclusions: Our results suggest that UA stimulates glucose uptake in 3T3-L1 adipocytes through the PI3K pathway, providing important information regarding the mechanism of action of UA for its anti-diabetic effect.	[He, Yonghan; Li, Ying; Sun, Changhao] Harbin Med Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Harbin, Heilongjiang, Peoples R China; [He, Yonghan; Zhang, Shuocheng; Wang, Yanwen] Natl Res Council Canada, Aquat & Crop Resource Dev, Life Sci Branch, Charlottetown, PE, Canada; [He, Yonghan] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Li, Wen] Third Peoples Hosp Yunnan Prov, Dept Endocrinol, Kunming, Yunnan, Peoples R China; [Zhang, Shuocheng; Wang, Yanwen] Univ Prince Edward Isl, Dept Biomed Sci, Charlottetown, PE C1A 4P3, Canada	Harbin Medical University; National Research Council Canada; Chinese Academy of Sciences; Kunming Institute of Zoology; University of Prince Edward Island	Wang, YW (corresponding author), Natl Res Council Canada, Aquat & Crop Resource Dev, Life Sci Branch, Charlottetown, PE, Canada.	yanwen.wang@nrc.ca; sun2002changhao@yahoo.com	SUN, CHANG/GXM-3680-2022; He, Yonghan/P-7271-2014	He, Yonghan/0000-0003-4409-4590	Internal Research Project of the Third People's Hospital of Yunnan Province [YJ201202]; National Natural Science Fund of China [81130049]	Internal Research Project of the Third People's Hospital of Yunnan Province; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Internal Research Project of the Third People's Hospital of Yunnan Province (YJ201202) and the National Natural Science Fund of China (81130049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Azevedo MF, 2010, PHYTOTHER RES, V24, pS220, DOI 10.1002/ptr.3118; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Bazuine M, 2003, EUR J BIOCHEM, V270, P3891, DOI 10.1046/j.1432-1033.2003.03771.x; Bosch RR, 2004, BIOCHEM J, V384, P349, DOI 10.1042/BJ20040797; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Guerre-Millo M, 2004, DIABETES METAB, V30, P13, DOI 10.1016/S1262-3636(07)70084-8; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; He YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070135; He YH, 2013, BIOCHEM BIOPH RES CO, V436, P169, DOI 10.1016/j.bbrc.2013.05.068; Ikeda Y, 2008, MOL NUTR FOOD RES, V52, P26, DOI 10.1002/mnfr.200700389; Jang SM, 2010, METABOLISM, V59, P512, DOI 10.1016/j.metabol.2009.07.040; Jang SM, 2009, INT IMMUNOPHARMACOL, V9, P113, DOI 10.1016/j.intimp.2008.10.013; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kazmi I, 2012, FITOTERAPIA, V83, P142, DOI 10.1016/j.fitote.2011.10.004; Khan AH, 2002, DIABETOLOGIA, V45, P1475, DOI 10.1007/s00125-002-0974-7; Kim J, 2009, ARCH PHARM RES, V32, P983, DOI 10.1007/s12272-009-1702-3; Krook A, 2004, MED SCI SPORT EXER, V36, P1212, DOI 10.1249/01.MSS.0000132387.25853.3B; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lee J, 2010, CHEM-BIOL INTERACT, V188, P635, DOI 10.1016/j.cbi.2010.09.019; Li Y, 2010, MOL NUTR FOOD RES, V54, P1609, DOI 10.1002/mnfr.200900564; Liu H, 2005, J ETHNOPHARMACOL, V100, P92, DOI 10.1016/j.jep.2005.05.024; Pagano C, 2006, J CLIN ENDOCR METAB, V91, P1081, DOI 10.1210/jc.2005-1056; Rao VS, 2011, J MED FOOD, V14, P1375, DOI 10.1089/jmf.2010.0267; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Somwar R, 2001, BIOCHEM J, V359, P639, DOI 10.1042/0264-6021:3590639; Turmelle YP, 2006, FASEB J, V20, P2609, DOI 10.1096/fj.06-6511fje; Yamaguchi S, 2005, AM J PHYSIOL-ENDOC M, V289, pE643, DOI 10.1152/ajpendo.00456.2004; Zhang W, 2006, BBA-GEN SUBJECTS, V1760, P1505, DOI 10.1016/j.bbagen.2006.05.009	38	26	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110711	10.1371/journal.pone.0110711	http://dx.doi.org/10.1371/journal.pone.0110711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329874	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100088
J	Jeon, YJ; Zhou, YL; Li, YH; Guo, QW; Chen, JC; Quan, SM; Zhang, AH; Zheng, HL; Zhu, XQ; Lin, J; Xu, H; Wu, AY; Park, SG; Kim, BC; Joo, HJ; Chen, HL; Bhak, J				Jeon, Young Joo; Zhou, Yulin; Li, Yihan; Guo, Qiwei; Chen, Jinchun; Quan, Shengmao; Zhang, Ahong; Zheng, Hailing; Zhu, Xingqiang; Lin, Jin; Xu, Huan; Wu, Ayang; Park, Sin-Gi; Kim, Byung Chul; Joo, Hee Jae; Chen, Hongliang; Bhak, Jong			The Feasibility Study of Non-Invasive Fetal Trisomy 18 and 21 Detection with Semiconductor Sequencing Platform	PLOS ONE			English	Article							NUCHAL TRANSLUCENCY THICKNESS; MATERNAL PLASMA; 1ST TRIMESTER; PRENATAL-DIAGNOSIS; DNA; ANEUPLOIDIES; IMPACT	Objective: Recent non-invasive prenatal testing (NIPT) technologies are based on next-generation sequencing (NGS). NGS allows rapid and effective clinical diagnoses to be determined with two common sequencing systems: Illumina and Ion Torrent platforms. The majority of NIPT technology is associated with Illumina platform. We investigated whether fetal trisomy 18 and 21 were sensitively and specifically detectable by semiconductor sequencer: Ion Proton. Methods: From March 2012 to October 2013, we enrolled 155 pregnant women with fetuses who were diagnosed as high risk of fetal defects at Xiamen Maternal & Child Health Care Hospital (Xiamen, Fujian, China). Adapter-ligated DNA libraries were analyzed by the Ion Proton (TM) System (Life Technologies, Grand Island, NY, USA) with an average 0.3x sequencing coverage per nucleotide. Average total raw reads per sample was 6.5 million and mean rate of uniquely mapped reads was 59.0%. The results of this study were derived from BWA mapping. Z-score was used for fetal trisomy 18 and 21 detection. Results: Interactive dot diagrams showed the minimal z-score values to discriminate negative versus positive cases of fetal trisomy 18 and 21. For fetal trisomy 18, the minimal z-score value of 2.459 showed 100% positive predictive and negative predictive values. The minimal z-score of 2.566 was used to classify negative versus positive cases of fetal trisomy 21. Conclusion: These results provide the evidence that fetal trisomy 18 and 21 detection can be performed with semiconductor sequencer. Our data also suggest that a prospective study should be performed with a larger cohort of clinically diverse obstetrics patients.	[Jeon, Young Joo; Park, Sin-Gi; Joo, Hee Jae; Bhak, Jong] TheragenEtex Bio Inst, Suwon, South Korea; [Jeon, Young Joo; Park, Sin-Gi; Joo, Hee Jae; Bhak, Jong] Genome Care, Seoul, South Korea; [Zhou, Yulin; Guo, Qiwei] Xiamen Maternal & Child Hlth Hosp, Prenatal Diag Ctr, Dept Med Genet, Mol Diagnost Lab, Xiamen, Fujian, Peoples R China; [Li, Yihan; Chen, Jinchun] Fujian Univ Tradit Chinese Med, Xiamen Hosp Tradit Chinese Med, Xiamen, Fujian, Peoples R China; [Quan, Shengmao; Zhang, Ahong; Zheng, Hailing; Zhu, Xingqiang; Lin, Jin; Xu, Huan; Chen, Hongliang] Xiamen Vangenes BioTech, Xiamen, Fujian, Peoples R China; [Wu, Ayang] Fujian Med Univ, Zhangzhou Affiliated Hosp, Zhangzhou, Fujian, Peoples R China; [Kim, Byung Chul] Clinomics, Ulsan, South Korea; [Kim, Byung Chul; Bhak, Jong] Genome Res Fdn, Personal Genom Inst, Suwon, South Korea; [Bhak, Jong] UNIST, BioMed Engn, Ulsan, South Korea	Fujian University of Traditional Chinese Medicine; Fujian Medical University; Ulsan National Institute of Science & Technology (UNIST)	Chen, HL (corresponding author), Xiamen Vangenes BioTech, Xiamen, Fujian, Peoples R China.	hongliangchen@gmail.com; jongbhak@genomics.org			Industrial Strategic Technology Development Program - Ministry of Knowledge Economy (MKE, Korea) [10040231]	Industrial Strategic Technology Development Program - Ministry of Knowledge Economy (MKE, Korea)	This work was supported by the Industrial Strategic Technology Development Program, 10040231, 'Bioinformatics platform development for next generation bioinformation analysis' funded by the Ministry of Knowledge Economy (MKE, Korea). Co-authors Young Joo Jeon, Sin-Gi Park, Hee Jae Joo, and Jong Bhak are employed by TheragenEtex Bio Institute. TheragenEtex Bio Institute provided support in the form of salaries for authors YJJ, SGP, HJJ, and JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Co-authors Young Joo Jeon, Sin-Gi Park, Hee Jae Joo, and Jong Bhak are employed by Genome Care. Genome Care provided support in the form of salaries for authors YJJ, SGP, HJJ, and JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Co-authors Shengmao Quan, Ahong Zhang, Hailing Zheng, Xingqiang Zhu, Jin Lin, Huan Xu, and Hongliang Chen are employed by Xiamen Vangenes BioTech. Xiamen Vangenes BioTech provided support in the form of salaries for authors SQ, AZ, HZ, XZ, JL, HX, and HC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Co-author Byung Chul Kim is employed by Clinomics. Clinomics provided support in the form of salaries for author BCK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; Barch MJ, 1997, AGT CYTOGENETICS LAB; Benn P, 2013, ULTRASOUND OBST GYN, V42, P15, DOI 10.1002/uog.12513; Berktold L, 2013, ARCH GYNECOL OBSTET, V287, P413, DOI 10.1007/s00404-012-2585-y; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Boland JF, 2013, HUM GENET, V132, P1153, DOI 10.1007/s00439-013-1321-4; Borrell A, 2004, PRENATAL DIAG, V24, P541, DOI 10.1002/pd.949; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chen SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092192; CRANDALL BF, 1994, PRENATAL DIAG, V14, P913, DOI 10.1002/pd.1970141004; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; FORTUNY A, 1995, PRENATAL DIAG, V15, P541, DOI 10.1002/pd.1970150607; Grati FR, 2014, GENET MED, V16, P620, DOI 10.1038/gim.2014.3; Henry GP, 2008, FETAL DIAGN THER, V23, P308, DOI 10.1159/000123619; Kagan KO, 2008, ULTRASOUND OBST GYN, V31, P618, DOI 10.1002/uog.5331; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau TK, 2014, ULTRASOUND OBST GYN, V43, P254, DOI 10.1002/uog.13277; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liao C, 2014, P NATL ACAD SCI USA, V111, P7415, DOI 10.1073/pnas.1321997111; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; McNamara CJ, 2014, OBSTET GYNECOL, V123, p69S, DOI 10.1097/01.AOG.0000447381.48282.c3; Morgan S, 2013, ULTRASOUND OBST GYN, V41, P526, DOI 10.1002/uog.12384; Munoz-Cortes M, 2012, ULTRASOUND OBST GYN, V39, P396, DOI 10.1002/uog.9075; Nicolaides KH, 2011, PRENATAL DIAG, V31, P7, DOI 10.1002/pd.2637; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Sainz JA, 2012, J MATERN-FETAL NEO M, V25, P2221, DOI 10.3109/14767058.2012.684168; Smid M, 2003, HUM GENET, V112, P617, DOI 10.1007/s00439-003-0919-3; Song K, 2013, J MATERN-FETAL NEO M, V26, P1180, DOI 10.3109/14767058.2013.770464; Sparks AB, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.030; Tabor A, 2010, FETAL DIAGN THER, V27, P1, DOI 10.1159/000271995; van den Berg M, 2005, PRENATAL DIAG, V25, P84, DOI 10.1002/pd.1090; Wang YL, 2014, CLIN CHEM, V60, P251, DOI 10.1373/clinchem.2013.215145	37	76	95	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110240	10.1371/journal.pone.0110240	http://dx.doi.org/10.1371/journal.pone.0110240			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329639	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100046
J	Lima, AP; Pereira, FC; Almeida, MAP; Mello, FMS; Pires, WC; Pinto, TM; Delella, FK; Felisbino, SL; Moreno, V; Batista, AA; Silveira-Lacerda, ED				Lima, Aliny Pereira; Pereira, Flavia Castro; Pinheiro Almeida, Marcio Aurelio; Santos Mello, Francyelli Mariana; Pires, Wanessa Carvalho; Pinto, Thallita Monteiro; Delella, Flavia Karina; Felisbino, Sergio Luis; Moreno, Virtudes; Batista, Alzir Azevedo; Silveira-Lacerda, Elisangela de Paula			Cytoxicity and Apoptotic Mechanism of Ruthenium(II) Amino Acid Complexes in Sarcoma-180 Tumor Cells	PLOS ONE			English	Article							DNA-DAMAGE; CANCER; PROLIFERATION; DERIVATIVES; INHIBITION; BINDING; BAX; P53	Over the past several decades, much attention has been focused on ruthenium complexes in antitumor therapy. Ruthenium is a transition metal that possesses several advantages for rational antitumor drug design and biological applications. In the present study, five ruthenium complexes containing amino acids were studied in vitro to determine their biological activity against sarcoma-180 tumor cells. The cytotoxicity of the complexes was evaluated by an MTT assay, and their mechanism of action was investigated. The results demonstrated that the five complexes inhibited the growth of the S180 tumor cell line, with IC50 values ranging from 22.53 mu M to 50.18 mu M, and showed low cytotoxicity against normal L929 fibroblast cells. Flow cytometric analysis revealed that the [Ru(gly)(bipy)(dppb)] PF6 complex (2) inhibited the growth of the tumor cells by inducing apoptosis, as evidenced by an increased number of Annexin V-positive cells and G0/G1 phase cell cycle arrest. Further investigation showed that complex 2 caused a loss of mitochondrial membrane potential; activated caspases 3, caspase-8, and caspase-9 and caused a change in the mRNA expression levels of caspase 3, caspase-9 as well as the bax genes. The levels of the pro-apoptotic Bcl-2 family protein Bak were increased. Thus, we demonstrated that ruthenium amino acid complexes are promising drugs against S180 tumor cells, and we recommend further investigations of their role as chemotherapeutic agents for sarcomas.	[Lima, Aliny Pereira; Pereira, Flavia Castro; Santos Mello, Francyelli Mariana; Pires, Wanessa Carvalho; Pinto, Thallita Monteiro; Silveira-Lacerda, Elisangela de Paula] Univ Fed Goias, Inst Biol Sci, Lab Mol Genet & Cytogen, Goiania, Go, Brazil; [Pinheiro Almeida, Marcio Aurelio] Univ Fed Maranhao, Sao Luis, Maranhao, Brazil; [Batista, Alzir Azevedo] Univ Fed Sao Carlos, Dept Chem, BR-13560 Sao Carlos, SP, Brazil; [Delella, Flavia Karina; Felisbino, Sergio Luis] UNESP, Inst Biosci, Dept Morphol, Botucatu, SP, Brazil; [Moreno, Virtudes] Univ Barcelona, Dept Inorgan Chem, Barcelona, Spain	Universidade Federal de Goias; Universidade Federal do Maranhao; Universidade Federal de Sao Carlos; Universidade Estadual Paulista; University of Barcelona	Silveira-Lacerda, ED (corresponding author), Univ Fed Goias, Inst Biol Sci, Lab Mol Genet & Cytogen, Goiania, Go, Brazil.	silveiralacerda@gmail.com	Mello-Andrade, Francyelli/B-1418-2019; Mello-Andrade, Francyelli/Z-3574-2019; Delella, Flavia K/C-7731-2012; Almeida, Marcio/W-2857-2019; Felisbino, Sergio L/K-7641-2012; Batista, Alzir A./C-3492-2012	Mello-Andrade, Francyelli/0000-0001-7389-6125; Mello-Andrade, Francyelli/0000-0001-7389-6125; Delella, Flavia K/0000-0001-6362-5882; Almeida, Marcio/0000-0003-2494-7912; Silveira-Lacerda, Elisangela/0000-0002-4143-9007	Sao Paulo Research foundation [FAPESP 2012/06013-4]; FINEP [Proc. 01.06.0941.00/CT]; Coordination for the Advancement of Higher Education Staff (CAPES); Foundation for Research and Scientific and Technological Development of Maranhao-FAPEMA [Proc. 00629/2008]; Brazilian National Counsel of Technological and Scientific Development - CNPq [Proc. 141648/2010-4]	Sao Paulo Research foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); Coordination for the Advancement of Higher Education Staff (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foundation for Research and Scientific and Technological Development of Maranhao-FAPEMA(Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA)); Brazilian National Counsel of Technological and Scientific Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge the financial support of the following Brazilian research financing institutions: Sao Paulo Research foundation (FAPESP 2012/06013-4), FINEP (Proc. 01.06.0941.00/CT), Coordination for the Advancement of Higher Education Staff (CAPES), Foundation for Research and Scientific and Technological Development of Maranhao-FAPEMA (Proc. 00629/2008), and Brazilian National Counsel of Technological and Scientific Development - CNPq (Proc. 141648/2010-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allardyce CS, 2001, PLATIN MET REV, V45, P62; Almeida MAP, 2014, POLYHEDRON IN PRESS, DOI [10.1016/j.poly.2014.1007.1024, DOI 10.1016/J.POLY.2014.1007.1024]; Benadiba M, 2010, J INORG BIOCHEM, V104, P928, DOI 10.1016/j.jinorgbio.2010.04.011; Bergamo A, 2008, INT J ONCOL, V33, P1281, DOI 10.3892/ijo_00000119; Brabec V, 2006, DRUG RESIST UPDATE, V9, P111, DOI 10.1016/j.drup.2006.05.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen TF, 2010, INORG CHEM, V49, P6366, DOI 10.1021/ic100277w; Clarke MJ, 2003, COORDIN CHEM REV, V236, P207, DOI 10.1016/S0010-8545(02)00311-9; Demetri GD, 2010, J NATL COMPR CANC NE, V8, P630, DOI 10.6004/jnccn.2010.0049; Du KJ, 2011, EUR J MED CHEM, V46, P1056, DOI 10.1016/j.ejmech.2011.01.019; Gaiddon C, 2005, J PHARMACOL EXP THER, V315, P1403, DOI 10.1124/jpet.105.089342; Gogvadze V, 2006, CHEM-BIOL INTERACT, V163, P4, DOI 10.1016/j.cbi.2006.04.010; Graminha AE, 2008, SPECTROCHIM ACTA A, V69, P1073, DOI 10.1016/j.saa.2007.06.005; Hayward RL, 2005, CANCER CHEMOTH PHARM, V55, P577, DOI 10.1007/s00280-004-0932-9; Heinrich TA, 2011, EUR J MED CHEM, V46, P3616, DOI 10.1016/j.ejmech.2011.04.064; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kapitza S, 2005, CANCER LETT, V226, P115, DOI 10.1016/j.canlet.2005.01.002; Khan RA, 2014, LIGHT STABL IN PRESS; Kostova I, 2006, CURR MED CHEM, V13, P1085, DOI 10.2174/092986706776360941; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Li LL, 2012, DALTON T, V41, P12766, DOI 10.1039/c2dt30665d; Li LL, 2012, DALTON T, V41, P1138, DOI 10.1039/c1dt11950h; Martinez A, 2011, J INORG BIOCHEM, V105, P39, DOI 10.1016/j.jinorgbio.2010.09.005; Milano A, 2006, CRIT REV ONCOL HEMAT, V59, P74, DOI 10.1016/j.critrevonc.2005.12.002; Moreno V, 2011, J INORG BIOCHEM, V105, P241, DOI 10.1016/j.jinorgbio.2010.10.009; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pavan FR, 2011, EUR J MED CHEM, V46, P5099, DOI 10.1016/j.ejmech.2011.08.023; Queiroz SL, 1998, INORG CHIM ACTA, V267, P209, DOI 10.1016/S0020-1693(97)05615-6; Sava G, 2003, CLIN CANCER RES, V9, P1898; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108	30	55	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e105865	10.1371/journal.pone.0105865	http://dx.doi.org/10.1371/journal.pone.0105865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329644	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100002
J	Morgan, JT; Barger, N; Amaral, DG; Schumann, CM				Morgan, John T.; Barger, Nicole; Amaral, David G.; Schumann, Cynthia M.			Stereological Study of Amygdala Glial Populations in Adolescents and Adults with Autism Spectrum Disorder	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MICROGLIAL ACTIVATION; POSTNATAL-DEVELOPMENT; NEURAL CIRCUITRY; IMMUNE-RESPONSE; FETAL-BRAIN; CHILDREN; FACE; ANTIBODIES; NUMBERS	The amygdala undergoes aberrant development in autism spectrum disorder (ASD). We previously found that there are reduced neuron numbers in the adult postmortem amygdala from individuals with ASD compared to typically developing controls. The current study is a comprehensive stereological examination of four non-neuronal cell populations: microglia, oligodendrocytes, astrocytes, and endothelial cells, in the same brains studied previously. We provide a detailed neuroanatomical protocol for defining each cell type that may be applied to other studies of the amygdala in neurodevelopmental and psychiatric disorders. We then assess whether cell numbers and average volumes differ between ASD and typically developing brains. We hypothesized that a reduction in neuron numbers in ASD might relate to altered immune function and/or aberrant microglial activation, as indicated by increased microglial number and cell body volume. Overall, average non-neuronal cell numbers and volumes did not differ between ASD and typically developing brains. However, there was evident heterogeneity within the ASD cohort. Two of the eight ASD brains displayed strong microglial activation. Contrary to our original hypothesis, there was a trend toward a positive correlation between neuronal and microglial numbers in both ASD and control cases. There were fewer oligodendrocytes in the amygdala of adult individuals with ASD ages 20 and older compared to typically developing controls. This finding may provide a possible sign of altered connectivity or impaired neuronal communication that may change across the lifespan in ASD.	[Schumann, Cynthia M.] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Schumann, CM (corresponding author), Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA.	cschumann@ucdavis.edu			National Institutes of Health [R01 MH41479, R01 MH097236, F32 MH088275]; Brain & Behavior Research Foundation NARSAD grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097236, R01MH041479, F32MH088275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain & Behavior Research Foundation NARSAD grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (http://www.nih.gov) grants R01 MH41479, R01 MH097236, and F32 MH088275 and by a Brain & Behavior Research Foundation (http://www.bbrfoundation.org) NARSAD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Barnea-Goraly N, 2014, PROG NEURO-PSYCHOPH, V48, P124, DOI 10.1016/j.pnpbp.2013.09.010; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; BAUMAN M, 1985, NEUROLOGY, V35, P866, DOI 10.1212/WNL.35.6.866; Berretta S, 2007, BIOL PSYCHIAT, V62, P884, DOI 10.1016/j.biopsych.2007.04.023; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Bowley MP, 2002, BIOL PSYCHIAT, V52, P404, DOI 10.1016/S0006-3223(02)01404-X; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Braunschweig D, 2008, NEUROTOXICOLOGY, V29, P226, DOI 10.1016/j.neuro.2007.10.010; Burger RA, 1998, MENT RETARD DEV D R, V4, P137, DOI 10.1002/(SICI)1098-2779(1998)4:2<137::AID-MRDD11>3.0.CO;2-W; Careaga M, 2010, NEUROTHERAPEUTICS, V7, P283, DOI 10.1016/j.nurt.2010.05.003; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Chareyron LJ, 2012, J COMP NEUROL, V520, P3745, DOI 10.1002/cne.23132; Chareyron LJ, 2012, J COMP NEUROL, V520, P1965, DOI 10.1002/cne.23023; Chareyron LJ, 2011, J COMP NEUROL, V519, P3218, DOI 10.1002/cne.22677; Connolly AM, 2006, BIOL PSYCHIAT, V59, P354, DOI 10.1016/j.biopsych.2005.07.004; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dawson T. P., 2003, NEUROPATHOLOGY TECHN; Fatemi SH, 2008, SYNAPSE, V62, P501, DOI 10.1002/syn.20519; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Hamidi M, 2004, BIOL PSYCHIAT, V55, P563, DOI 10.1016/j.biopsych.2003.11.006; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Kleinhans NM, 2009, AM J PSYCHIAT, V166, P467, DOI 10.1176/appi.ajp.2008.07101681; Kreczmanski P, 2007, BRAIN, V130, P678, DOI 10.1093/brain/awl386; Laurence JA, 2005, CEREBELLUM, V4, P206, DOI 10.1080/14734220500208846; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Minghetti L, 2005, BRAIN RES REV, V48, P251, DOI 10.1016/j.brainresrev.2004.12.015; Monk CS, 2010, J PSYCHIATR NEUROSCI, V35, P105, DOI 10.1503/jpn.090085; Morgan J. T, 2012, NEUROSCIENCE AUTISM, P297; Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024; Mosconi MW, 2009, ARCH GEN PSYCHIAT, V66, P509, DOI 10.1001/archgenpsychiatry.2009.19; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Nordahl CW, 2012, ARCH GEN PSYCHIAT, V69, P53, DOI 10.1001/archgenpsychiatry.2011.145; Nordahl CW, 2011, P NATL ACAD SCI USA, V108, P20195, DOI 10.1073/pnas.1107560108; Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013; Perry VH, 2008, NAT REV NEUROSCI, V9, P807, DOI 10.1038/nrn2394; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rubinow MJ, 2009, J COMP NEUROL, V512, P717, DOI 10.1002/cne.21924; Schumann CM, 2005, J COMP NEUROL, V491, P320, DOI 10.1002/cne.20704; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Schumann CM, 2006, J NEUROSCI, V26, P7674, DOI 10.1523/JNEUROSCI.1285-06.2006; Schumann CM, 2009, BIOL PSYCHIAT, V66, P942, DOI 10.1016/j.biopsych.2009.07.007; Singer HS, 2008, J NEUROIMMUNOL, V194, P165, DOI 10.1016/j.jneuroim.2007.11.004; SINGH VK, 1993, BRAIN BEHAV IMMUN, V7, P97, DOI 10.1006/brbi.1993.1010; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Streit WJ, 2005, NEUROL RES, V27, P685, DOI 10.1179/016164105X49463; Suzuki K, 2013, JAMA PSYCHIAT, V70, P49, DOI 10.1001/jamapsychiatry.2013.272; Tetreault NA, 2012, J AUTISM DEV DISORD, V42, P2569, DOI 10.1007/s10803-012-1513-0; TODD RD, 1988, BIOL PSYCHIAT, V23, P644, DOI 10.1016/0006-3223(88)90012-1; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Ullrich O, 2001, FASEB J, V15, P1460, DOI 10.1096/fj.00-0540fje; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; ZAJICEK JP, 1992, BRAIN, V115, P1611, DOI 10.1093/brain/115.6.1611	64	62	62	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110356	10.1371/journal.pone.0110356	http://dx.doi.org/10.1371/journal.pone.0110356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330013	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100067
J	Murakami, M; Kaneko, T; Nakatsuji, T; Kameda, K; Okazaki, H; Dai, XJ; Hanakawa, Y; Tohyama, M; Ishida-Yamamoto, A; Sayama, K				Murakami, Masamoto; Kaneko, Takaaki; Nakatsuji, Teruaki; Kameda, Kenji; Okazaki, Hidenori; Dai, Xiuju; Hanakawa, Yasushi; Tohyama, Mikiko; Ishida-Yamamoto, Akemi; Sayama, Koji			Vesicular LL-37 Contributes to Inflammation of the Lesional Skin of Palmoplantar Pustulosis	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE LL-37; PROTEIN-SYNTHESIS SYSTEM; HUMAN KERATINOCYTES; HUMAN CATHELICIDIN; SWEAT GLANDS; BONE-MARROW; EXPRESSION; IL-8; CELLS; ACROSYRINGIUM	"Pustulosis palmaris et plantaris'', or palmoplantar pustulosis (PPP), is a chronic pustular dermatitis characterized by intraepidermal palmoplantar pustules. Although early stage vesicles (preceding the pustular phase) formed in the acrosyringium contain the antimicrobial peptides cathelicidin (hCAP-18/LL-37) and dermcidin, the details of hCAP-18/LL-37 expression in such vesicles remain unclear. The principal aim of the present study was to clarify the manner of hCAP-18/LL-37 expression in PPP vesicles and to determine whether this material contributed to subsequent inflammation of lesional skin. PPP vesicle fluid (PPP-VF) induced the expression of mRNAs encoding IL-17C, IL-8, IL-1 alpha, and IL-1 beta in living skin equivalents, but the level of only IL-8 mRNA decreased significantly upon stimulation of PPP vesicle with depletion of endogenous hCAP-18/LL-37 by affinity chromatography (dep-PPP-VF). Semi-quantitative dot-blot analysis revealed higher concentrations of hCAP-18/LL-37 in PPP-VF compared to healthy sweat (2.87 +/- 0.93 mu M vs. 0.09 +/- 0.09 mu M). This concentration of hCAP-18/LL-37 in PPP-VF could upregulate expression of IL-17C, IL-8, IL-1 alpha, and IL-1 beta at both the mRNA and protein levels. Recombinant hCAP-18 was incubated with dep-PPP-VF. Proteinase 3, which converts hCAP-18 to the active form (LL-37), was present in PPP-VF. Histopathological and immunohistochemical examination revealed that early stage vesicles contained many mononuclear cells but no polymorphonuclear cells, and the mononuclear cells were CD68-positive. The epidermis surrounding the vesicle expresses monocyte chemotactic chemokine, CCL2. In conclusion, PPP-VF contains the proteinase required for LL-37 processing and also may directly upregulate IL-8 in lesional keratinocytes, in turn contributing to the subsequent inflammation of PPP lesional skin.	[Murakami, Masamoto; Okazaki, Hidenori; Dai, Xiuju; Hanakawa, Yasushi; Tohyama, Mikiko; Sayama, Koji] Ehime Univ, Grad Sch Med, Dept Dermatol, Matsuyama, Ehime 790, Japan; [Kaneko, Takaaki; Ishida-Yamamoto, Akemi] Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 078, Japan; [Nakatsuji, Teruaki] Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA; [Nakatsuji, Teruaki] VA San Diego Healthcare Ctr, San Diego, CA USA; [Kameda, Kenji] Ehime Univ, Grad Sch Med, Integrated Ctr Sci, Matsuyama, Ehime 790, Japan	Ehime University; Asahikawa Medical College; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Ehime University	Murakami, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Dermatol, Matsuyama, Ehime 790, Japan.	mamuraka@m.ehime-u.ac.jp	Nakatsuji, Teruaki/O-6794-2014	Nakatsuji, Teruaki/0000-0002-6187-2991	Japan Society for the Promotion of Science (JSPS) [25461670]; Ehime University	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ehime University	This study was supported by a Grant-in-Aid for Scientific Research (c) 25461670, Japan Society for the Promotion of Science (JSPS), and a grant for creative bioscience research at Ehime University, 2012-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGERBERTH B, 1995, P NATL ACAD SCI USA, V92, P195, DOI 10.1073/pnas.92.1.195; Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Ali RS, 2001, J INVEST DERMATOL, V117, P106; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; BRAUN MG, 1991, AM J PATHOL, V139, P831; CHARLES LA, 1992, J LEUKOCYTE BIOL, V51, P65, DOI 10.1002/jlb.51.1.65; Chen X, 2013, BIOCHEM BIOPH RES CO, V433, P532, DOI 10.1016/j.bbrc.2013.03.024; Cowland JB, 1999, J IMMUNOL METHODS, V232, P191, DOI 10.1016/S0022-1759(99)00176-3; Dai XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067666; Dai XJ, 2011, J ALLERGY CLIN IMMUN, V127, P806, DOI 10.1016/j.jaci.2010.12.006; Dorschner RA, 2003, PEDIATR RES, V53, P566, DOI 10.1203/01.PDR.0000057205.64451.B7; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gallo RL, 2002, J ALLERGY CLIN IMMUN, V110, P823, DOI 10.1067/mai.2002.129801; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Hagforsen E, 2010, BRIT J DERMATOL, V163, P572, DOI 10.1111/j.1365-2133.2010.09819.x; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Just J, 1999, FEBS LETT, V457, P437, DOI 10.1016/S0014-5793(99)01098-4; Kaneko T, 2012, J DERMATOL SCI, V67, P73, DOI 10.1016/j.jdermsci.2012.03.009; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Mirandola P, 2011, LAB INVEST, V91, P1188, DOI 10.1038/labinvest.2011.76; Murakami M, 2002, J INVEST DERMATOL, V119, P1090, DOI 10.1046/j.1523-1747.2002.19507.x; Murakami M, 2004, J IMMUNOL, V172, P3070, DOI 10.4049/jimmunol.172.5.3070; Murakami M, 2011, EXP DERMATOL, V20, P845, DOI 10.1111/j.1600-0625.2011.01325.x; Murakami M, 2010, J INVEST DERMATOL, V130, P2010, DOI 10.1038/jid.2010.87; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Ozawa M, 2005, DERMATOLOGY, V211, P249, DOI 10.1159/000087019; Rieg S, 2004, BRIT J DERMATOL, V151, P534, DOI 10.1111/j.1365-2133.2004.06081.x; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Skov L, 2008, J IMMUNOL, V181, P669, DOI 10.4049/jimmunol.181.1.669; Sorensen O, 1999, J BIOL CHEM, V274, P22445, DOI 10.1074/jbc.274.32.22445; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Stolzenberg ED, 1997, P NATL ACAD SCI USA, V94, P8686, DOI 10.1073/pnas.94.16.8686; UEHARA M, 1974, ARCH DERMATOL, V109, P518, DOI 10.1001/archderm.109.4.518; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang LJ, 2005, J DERMATOL SCI, V40, P105, DOI 10.1016/j.jdermsci.2005.07.001; Yang LJ, 2009, J DERMATOL SCI, V56, P188, DOI 10.1016/j.jdermsci.2009.09.009; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O; Zuyderduyn S, 2006, J ALLERGY CLIN IMMUN, V117, P1328, DOI 10.1016/j.jaci.2006.03.022	40	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110677	10.1371/journal.pone.0110677	http://dx.doi.org/10.1371/journal.pone.0110677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330301	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210800104
J	Oka, M; Hashimoto, Y; Ikegami, T				Oka, Mizuki; Hashimoto, Yasuhiro; Ikegami, Takashi			Self-Organization on Social Media: Endo-Exo Bursts and Baseline Fluctuations	PLOS ONE			English	Article								A salient dynamic property of social media is bursting behavior. In this paper, we study bursting behavior in terms of the temporal relation between a preceding baseline fluctuation and the successive burst response using a frequency time series of 3,000 keywords on Twitter. We found that there is a fluctuation threshold up to which the burst size increases as the fluctuation increases and that above the threshold, there appears a variety of burst sizes. We call this threshold the critical threshold. Investigating this threshold in relation to endogenous bursts and exogenous bursts based on peak ratio and burst size reveals that the bursts below this threshold are endogenously caused and above this threshold, exogenous bursts emerge. Analysis of the 3,000 keywords shows that all the nouns have both endogenous and exogenous origins of bursts and that each keyword has a critical threshold in the baseline fluctuation value to distinguish between the two. Having a threshold for an input value for activating the system implies that Twitter is an excitable medium. These findings are useful for characterizing how excitable a keyword is on Twitter and could be used, for example, to predict the response to particular information on social media.	[Oka, Mizuki; Hashimoto, Yasuhiro] Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki, Japan; [Ikegami, Takashi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	University of Tsukuba; University of Tokyo	Oka, M (corresponding author), Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki, Japan.	mizuki@cs.tsukuba.ac.jp	Hashimoto, Yasuhiro/AAF-1190-2020	Hashimoto, Yasuhiro/0000-0002-7046-7162	Japan Society for the Promotion of Science [25730184, 24120704]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists (B) (#25730184 "Burst Analysis of Twitter time series based on RT diffusion and its application to Web services'') and partially by Grant-in-Aid for Scientific Research on Innovative Areas (#24120704 "The study on the neural dynamics for understanding communication in terms of complex hetero systems''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064679; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Ferrara E., 2013, P 1 ACM C ONL SOC NE, P213, DOI DOI 10.1145/2512938.2512956; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Kleinberg J., 2002, BURSTY HIERARCHICAL, DOI 10.1145/775060.775061; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lehmann J., 2012, P 21 INT C WORLD WID, P251, DOI [10.1145/2187836.2187871, DOI 10.1145/2187836.2187871]; Mestyan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071226; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Oka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060398; OOSAWA F, 1975, J THEOR BIOL, V52, P175, DOI 10.1016/0022-5193(75)90049-1; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Reichl L. E., 1998, MODERN COURSE STAT P; Ruelle D, 2004, PHYS TODAY, V57, P48, DOI 10.1063/1.1768674; Sato K, 2003, P NATL ACAD SCI USA, V100, P14086, DOI 10.1073/pnas.2334996100; Sornette D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228701; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127	20	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109293	10.1371/journal.pone.0109293	http://dx.doi.org/10.1371/journal.pone.0109293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329610	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800018
J	Wang, JX; Chen, S; Jiang, F; You, CY; Mao, CJ; Yu, JG; Han, JD; Zhang, ZH; Yan, H				Wang, Jiaxing; Chen, Song; Jiang, Feng; You, Caiyun; Mao, Chunjie; Yu, Jinguo; Han, Jindong; Zhang, Zhuhong; Yan, Hua			Vitreous and Plasma VEGF Levels as Predictive Factors in the Progression of Proliferative Diabetic Retinopathy after Vitrectomy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTRAVITREAL INJECTION; RISK-EVALUATION; COMPLICATIONS; BEVACIZUMAB; SURGERY; FLUID; EYES	Purpose: To investigate the vitreous and plasma levels of vascular endothelial growth factor (VEGF) in patients with proliferative diabetic retinopathy (PDR) and to determine whether they predict a disease prognosis after primary vitrectomy. Methods: Fifty patients (50 eyes) with PDR who underwent pars plana vitrectomy (PPV) and 56 healthy controls (56 eyes) were enrolled in this retrospective study. Clinical data were collected and analyzed. Vitreous and plasma VEGF concentrations were measured using enzyme-linked immunosorbent assays. VEGF levels and clinical data were compared and analyzed to see if they provide a prognosis of PDR progression after primary vitrectomy at more than 6 months followup. Correlation of VEGF concentrations between vitreous fluid and plasma was analyzed. Results: The average BCVA was significantly improved after surgery (P<0.001). Vitreous and plasma VEGF levels were significantly elevated in PDR patients than those in healthy controls (P-vitreous<0.001; P-plasma<0.001). Both vitreous and plasma VEGF levels were significantly higher in PDR progression group than in stable group (P-vitreous<0.001; P-plasma = 0.004). Multivariate logistic regression analyses showed that the increased vitreous VEGF level was associated with the progression of PDR after primary PPV (OR = 1.539; P = 0.036). Vitreous VEGF level was positively associated with plasma VEGF level in PDR patients (P<0.001). Conclusion: The increased VEGF level in vitreous fluid may be identified as a significant predictive factor for the outcome of vitrectomy in patients with PDR.	[Wang, Jiaxing; Chen, Song; Jiang, Feng; You, Caiyun; Mao, Chunjie; Yu, Jinguo; Han, Jindong; Zhang, Zhuhong; Yan, Hua] Tianjin Med Univ, Gen Hosp, Dept Ophthalmol, Tianjin, Peoples R China	Tianjin Medical University	Yan, H (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Ophthalmol, Tianjin, Peoples R China.	phuayan2000@163.com	wang, jiaxing/I-1193-2019	wang, jiaxing/0000-0001-8958-6893; Yan, Hua/0000-0002-7651-840X				ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; AIELLO LP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1538, DOI 10.1001/archopht.1995.01100120068012; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; [Anonymous], 2000, Pathologica, V92, P338; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Baharivand N, 2012, CLIN OPHTHALMOL, V6, P185, DOI 10.2147/OPTH.S27423; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Funatsu H, 2007, EYE, V21, P377, DOI 10.1038/sj.eye.6702213; Funatsu H, 2004, BRIT J OPHTHALMOL, V88, P1064, DOI 10.1136/bjo.2003.032656; Gupta N, 2013, OPEN OPHTHALMOL J, V7, P4, DOI 10.2174/1874364101307010004; Itakura H, 2004, OPHTHALMOLOGY, V111, P1880, DOI 10.1016/j.ophtha.2004.03.035; Kim I, 1999, INVEST OPHTH VIS SCI, V40, P2115; Kocak N, 2010, ANN OPHTHALMOL, V42; Lip PL, 2000, INVEST OPHTH VIS SCI, V41, P2115; Ma Y, 2012, AM J OPHTHALMOL, V153, P307, DOI 10.1016/j.ajo.2011.08.006; Matsuyama K, 2010, BRIT J OPHTHALMOL, V94, P1215, DOI 10.1136/bjo.2008.156810; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Mohamed TA, 2010, INT J OPHTHALMOL-CHI, V3, P19, DOI 10.3980/j.issn.2222-3959.2010.01.05; Ockrim Z, 2010, BMJ-BRIT MED J, V341, pc5400; Oshima Y, 2009, OPHTHALMOLOGY, V116, P927, DOI 10.1016/j.ophtha.2008.11.005; Petrovic MG, 2010, ACTA OPHTHALMOL, V88, pe311, DOI 10.1111/j.1755-3768.2010.02030.x; Qian J, 2011, RETINA-J RET VIT DIS, V31, P161, DOI 10.1097/IAE.0b013e3181e46ad8; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Smith JM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008214.pub2; Wakabayashi Y, 2012, INVEST OPHTH VIS SCI, V53, P6403, DOI 10.1167/iovs.12-10367; Wirostko B, 2008, PROG RETIN EYE RES, V27, P608, DOI 10.1016/j.preteyeres.2008.09.002; Yan H, 2010, CURR EYE RES, V35, P308, DOI 10.3109/02713680903572491; Yan Hua, 2009, Zhonghua Yan Ke Za Zhi, V45, P206; Yoshida S, 2012, INVEST OPHTH VIS SCI, V53, P6997, DOI 10.1167/iovs.12-9671; Zhu Hong, 2007, Zhonghua Yi Xue Za Zhi, V87, P2837	30	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110531	10.1371/journal.pone.0110531	http://dx.doi.org/10.1371/journal.pone.0110531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329921	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800091
J	Chung, JJ; Markiewicz, MA; Polic, B; Shaw, AS				Chung, Jun-Jae; Markiewicz, Mary A.; Polic, Bojan; Shaw, Andrey S.			Role of NKG2D in Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance	PLOS ONE			English	Article							T-CELLS; IKK-BETA; IN-VIVO; METABOLIC DISEASE; ER STRESS; KAPPA-B; MICE; HYPOXIA; ACTIVATION; EXPRESSION	The early events that initiate inflammation in the adipose tissue during obesity are not well defined. It is unclear whether the recruitment of CD8 T cells to the adipose tissue during onset of obesity occurs through antigen-dependent or independent processes. We have previously shown that interaction between NKG2D (natural-killer group 2, member D) and its ligand Rae-1 epsilon is sufficient to recruit cytotoxic T lymphocytes to the pancreas and induce insulitis. Here, we tested whether NKG2D-NKG2D ligand interaction is also involved in obesity-induced adipose tissue inflammation and insulin resistance. We observed a significant induction of NKG2D ligand expression in the adipose tissue of obese mice, especially during the early stages of obesity. However, mice lacking NKG2D developed similar levels of insulin resistance and adipose tissue inflammation compared to control mice when placed on a high-fat diet. Moreover, overexpression of Rae-1 epsilon in the adipose tissue did not increase immune cell infiltration to the adipose tissue either in the setting of a normal or high-fat diet. These results indicate that, unlike in the pancreas, NKG2D-NKG2D ligand interaction does not play a critical role in obesity-induced inflammation in the adipose tissue.	[Chung, Jun-Jae; Markiewicz, Mary A.; Shaw, Andrey S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Polic, Bojan] Univ Rijeka, Sch Med, Dept Histol & Embryol, Rijeka, Croatia; [Shaw, Andrey S.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); University of Rijeka; Howard Hughes Medical Institute; Washington University (WUSTL)	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	shaw@pathology.wustl.edu	Polic, Bojan/B-8622-2014	Polic, Bojan/0000-0003-3930-9630; Markiewicz, Mary/0000-0001-5685-8573; Chung, Jun-Jae/0000-0002-3053-5693; Shaw, Andrey/0000-0001-5685-0272	Howard Hughes Medical Institute; National Institutes of Health [R01DK058366]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, R01DK058366] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Howard Hughes Medical Institute and National Institutes of Health grant R01DK058366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kahraman A, 2010, HEPATOLOGY, V51, P92, DOI 10.1002/hep.23253; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Lam QLK, 2007, CELL MOL IMMUNOL, V4, P1; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Markiewicz MA, 2012, IMMUNITY, V36, P132, DOI 10.1016/j.immuni.2011.11.014; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Petkova SB, 2008, PHYSIOL GENOMICS, V34, P304, DOI 10.1152/physiolgenomics.00185.2007; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Samarakoon A, 2009, MOL IMMUNOL, V46, P1011, DOI 10.1016/j.molimm.2008.09.035; Song XM, 2008, J BIOL CHEM, V283, P12571, DOI 10.1074/jbc.M800838200; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yoshiuchi K, 2008, BIOCHEM BIOPH RES CO, V366, P545, DOI 10.1016/j.bbrc.2007.11.182; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zafirova B, 2009, IMMUNITY, V31, P270, DOI 10.1016/j.immuni.2009.06.017	48	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110108	10.1371/journal.pone.0110108	http://dx.doi.org/10.1371/journal.pone.0110108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333972	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200093
J	Hajje, G; Saliba, Y; Itani, T; Moubarak, M; Aftimos, G; Fares, N				Hajje, Georges; Saliba, Youakim; Itani, Tarek; Moubarak, Majed; Aftimos, Georges; Fares, Nassim			Hypothyroidism and Its Rapid Correction Alter Cardiac Remodeling	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; CARDIOVASCULAR MAGNETIC-RESONANCE; SERUM LEPTIN CONCENTRATIONS; THYROID-HORMONE RECEPTOR; COLLAGEN GENE-EXPRESSION; SMOOTH MUSCLE ACTIN; GROWTH-FACTOR-I; HEART-FAILURE; MYOCARDIAL-INFARCTION; SUBCLINICAL HYPOTHYROIDISM	The cardiovascular effects of mild and overt thyroid disease include a vast array of pathological changes. As well, thyroid replacement therapy has been suggested for preserving cardiac function. However, the influence of thyroid hormones on cardiac remodeling has not been thoroughly investigated at the molecular and cellular levels. The purpose of this paper is to study the effect of hypothyroidism and thyroid replacement therapy on cardiac alterations. Thirty Wistar rats were divided into 2 groups: a control (n = 10) group and a group treated with 6-propyl-2-thiouracil (PTU) (n = 20) to induce hypothyroidism. Ten of the 20 rats in the PTU group were then treated with L-thyroxine to quickly re-establish euthyroidism. The serum levels of inflammatory markers, such as C-reactive protein (CRP), tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL6) and pro-fibrotic transforming growth factor beta 1 (TGF-beta 1), were significantly increased in hypothyroid rats; elevations in cardiac stress markers, brain natriuretic peptide (BNP) and cardiac troponin T (cTnT) were also noted. The expressions of cardiac remodeling genes were induced in hypothyroid rats in parallel with the development of fibrosis, and a decline in cardiac function with chamber dilation was measured by echocardiography. Rapidly reversing the hypothyroidism and restoring the euthyroid state improved cardiac function with a decrease in the levels of cardiac remodeling markers. However, this change further increased the levels of inflammatory and fibrotic markers in the plasma and heart and led to myocardial cellular infiltration. In conclusion, we showed that hypothyroidism is related to cardiac function decline, fibrosis and inflammation; most importantly, the rapid correction of hypothyroidism led to cardiac injuries. Our results might offer new insights for the management of hypothyroidism-induced heart disease.	[Hajje, Georges; Saliba, Youakim; Moubarak, Majed; Fares, Nassim] Univ St Joseph, Fac Med, Lab Rech Physiol & Physiopathol, Pole Technol Sante, Beirut, Lebanon; [Itani, Tarek; Aftimos, Georges] Inst Natl Pathol, Baabda, Lebanon	Saint Joseph University Beirut	Fares, N (corresponding author), Univ St Joseph, Fac Med, Lab Rech Physiol & Physiopathol, Pole Technol Sante, Beirut, Lebanon.	nassim.fares@usj.edu.lb	Saliba, Youakim/ABA-8627-2020; Itani, Tarek/AAI-2987-2021	Saliba, Youakim/0000-0001-8093-2593; Itani, Tarek/0000-0002-2113-6543	Research Council of the Saint Joseph University - Faculty of Medicine	Research Council of the Saint Joseph University - Faculty of Medicine	This work was funded and supported by the Research Council of the Saint Joseph University - Faculty of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABER CP, 1963, BRIT HEART J, V25, P421; AIZAWA T, 1978, J CLIN ENDOCR METAB, V47, P560, DOI 10.1210/jcem-47-3-560; Aksoy DY, 2013, MED SCI MONITOR, V19, P210, DOI 10.12659/MSM.883847; ATA, 2014, PREV IMP THYR DIS; Bahouth SW, 1997, J MOL CELL CARDIOL, V29, P3223, DOI 10.1006/jmcc.1997.0549; Baum PD, 2011, ANAL BIOCHEM, V411, P106, DOI 10.1016/j.ab.2010.11.035; Biernacka A, 2011, AGING DIS, V2, P158; Biondi B, 2004, ENDOCRINE, V24, P1, DOI 10.1385/ENDO:24:1:001; Biondi B, 2002, J CLIN ENDOCR METAB, V87, P968, DOI 10.1210/jc.87.3.968; Biondi B, 2014, ENDOCR REV, V35, P433, DOI 10.1210/er.2013-1083; Biondi B, 2012, EUR J ENDOCRINOL, V167, P609, DOI 10.1530/EJE-12-0627; BLACK FM, 1991, J CLIN INVEST, V88, P1581, DOI 10.1172/JCI115470; BOLUYT MO, 1994, CIRC RES, V75, P23, DOI 10.1161/01.RES.75.1.23; Boron WaB EL, 2008, MED PHYSL; BRAND T, 1995, J MOL CELL CARDIOL, V27, P5, DOI 10.1016/S0022-2828(08)80003-X; Brenta G, 2007, NAT CLIN PRACT ENDOC, V3, P632, DOI 10.1038/ncpendmet0590; BROWN ME, 1980, ANN INTERN MED, V92, P491, DOI 10.7326/0003-4819-92-4-491; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Camelliti P, 2006, ADV CARDIOL, V42, P132, DOI 10.1159/000092566; Carr AN, 2002, THYROID, V12, P453, DOI 10.1089/105072502760143818; Chapman E, 2005, DEV CARDIOVASC MED, V253, P181; Chen JH, 2012, J CELL MOL MED, V16, P2726, DOI 10.1111/j.1582-4934.2012.01593.x; Chen W, 2013, BBA-MOL CELL RES, V1833, P945, DOI 10.1016/j.bbamcr.2012.08.023; Chen WJ, 2004, CIRCULATION, V110, P1313, DOI 10.1161/01.CIR.0000140764.15398.F3; Chen WJ, 2000, MOL CELL ENDOCRINOL, V162, P45, DOI 10.1016/S0303-7207(00)00203-3; Chen YF, 2008, J MOL CELL CARDIOL, V44, P180, DOI 10.1016/j.yjmcc.2007.09.009; Chen YF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-40; Cinar N, 2013, ENDOCR CONNECT, V2, pR30, DOI 10.1530/EC-13-0061; Cini G, 2009, BIOMED PHARMACOTHER, V63, P742, DOI 10.1016/j.biopha.2009.08.003; Coceani M, 2011, J ENDOCRINOL INVEST, V34, pE144, DOI [10.3275/7351, 10.1007/BF03346723]; COOPER DS, 1983, ENDOCRINOLOGY, V113, P921, DOI 10.1210/endo-113-3-921; Cusin I, 2000, DIABETES, V49, P1101, DOI 10.2337/diabetes.49.7.1101; Danzi S, 2004, Minerva Endocrinol, V29, P139; Davis PJ, 2008, FRONT NEUROENDOCRIN, V29, P211, DOI 10.1016/j.yfrne.2007.09.003; DAVIS PJ, 1993, ANN THORAC SURG, V56, pS16, DOI 10.1016/0003-4975(93)90550-2; de Haas HJ, 2014, CIRC RES, V114, P903, DOI 10.1161/CIRCRESAHA.113.302680; De Sibio MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056913; Diez JJ, 2002, CLIN ENDOCRINOL, V57, P515, DOI 10.1046/j.1365-2265.2002.01629.x; DIFFEE GM, 1991, AM J PHYSIOL, V261, pC1099, DOI 10.1152/ajpcell.1991.261.6.C1099; Dillmann WH, 2002, THYROID, V12, P447, DOI 10.1089/105072502760143809; Dillmann W, 2010, HEART FAIL REV, V15, P125, DOI 10.1007/s10741-008-9125-7; Diniz GP, 2007, PFLUG ARCH EUR J PHY, V454, P75, DOI 10.1007/s00424-006-0192-0; Diniz GP, 2009, BASIC RES CARDIOL, V104, P653, DOI 10.1007/s00395-009-0043-1; Dizdarevic-Bostandic Amela, 2013, Med Arch, V67, P160; Dobaczewski M, 2012, J CARDIOVASC TRANSL, V5, P837, DOI 10.1007/s12265-012-9406-3; Drobnik J, 2009, J PHYSIOL PHARMACOL, V60, P57; Enia G, 2007, NEPHROL DIAL TRANSPL, V22, P538, DOI 10.1093/ndt/gfl605; EscobarMorreale HF, 1997, ENDOCRINOLOGY, V138, P4485, DOI 10.1210/en.138.10.4485; Euler-Taimor G, 2006, CARDIOVASC RES, V69, P15, DOI 10.1016/j.cardiores.2005.07.007; Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31; Flynn RWV, 2006, J CLIN ENDOCR METAB, V91, P2159, DOI 10.1210/jc.2005-1833; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Galli E, 2010, HEART FAIL REV, V15, P155, DOI 10.1007/s10741-008-9126-6; Gencer B, 2012, CIRCULATION, V126, P1040, DOI 10.1161/CIRCULATIONAHA.112.096024; GERDES AM, 1992, CIRCULATION, V86, P426, DOI 10.1161/01.CIR.86.2.426; GERDES AM, 1995, J MOL CELL CARDIOL, V27, P849, DOI 10.1016/0022-2828(95)90000-4; Gerdes AM, 2002, J CARD FAIL, V8, pS264, DOI 10.1054/jcaf.2002.129280; Gerdes AM, 2010, CIRCULATION, V122, P385, DOI 10.1161/CIRCULATIONAHA.109.917922; Giannocco G, 2004, MOL CELL ENDOCRINOL, V226, P19, DOI 10.1016/j.mce.2004.07.007; GICK GG, 1990, J MEMBRANE BIOL, V115, P273, DOI 10.1007/BF01868642; GosteliPeter MA, 1996, J CLIN INVEST, V98, P1737, DOI 10.1172/JCI118972; GRAETTINGER JS, 1958, J CLIN INVEST, V37, P502, DOI 10.1172/JCI103631; Grais IM, 2014, AM J MED; Grieve DJ, 1999, BRIT J PHARMACOL, V127, P1, DOI 10.1038/sj.bjp.0702501; Gullo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022552; Han GW, 2012, INT J BIOL SCI, V8, P228, DOI 10.7150/ijbs.8.228; Hedayat M, 2010, HEART FAIL REV, V15, P543, DOI 10.1007/s10741-010-9168-4; Iervasi G, 2013, INTERN EMERG MED, V8, pS71, DOI 10.1007/s11739-013-0911-4; Iossa S, 2001, INT J OBESITY, V25, P417, DOI 10.1038/sj.ijo.0801516; Januzzi JL, 2013, CIRCULATION, V127, P500, DOI 10.1161/CIRCULATIONAHA.112.120485; Johnson EO, 2013, PITUITARY, V16, P275, DOI 10.1007/s11102-012-0417-5; Jugdutt B, 2006, DEV CARDIOVASC MED, V253, P23; Kahaly GJ, 2000, THYROID, V10, P665, DOI 10.1089/10507250050137743; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; KISS E, 1994, CIRC RES, V75, P245, DOI 10.1161/01.RES.75.2.245; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Klein I, 2002, THYROID, V12, P439, DOI 10.1089/105072502760143782; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; LADENSON PW, 1992, P NATL ACAD SCI USA, V89, P5251, DOI 10.1073/pnas.89.12.5251; Lal H, 2014, CIRCULATION; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Leonhardt U, 1999, J ENDOCRINOL, V163, P115, DOI 10.1677/joe.0.1630115; LESLIE KO, 1991, AM J PATHOL, V139, P207; Li RK, 1997, CIRCULATION, V96, P874; Liu YH, 2010, VASC PHARMACOL, V52, P146, DOI 10.1016/j.vph.2009.10.003; LIU Z, 1990, J MOL CELL CARDIOL, V22, P1339, DOI 10.1016/0022-2828(90)90979-C; LOMPRE AM, 1979, NATURE, V282, P105, DOI 10.1038/282105a0; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; Lopez JE, 2011, CIRC RES, V109, P629, DOI 10.1161/CIRCRESAHA.111.243410; Lupon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085466; McBride K, 2001, CAN J PHYSIOL PHARM, V79, P673, DOI 10.1139/cjpp-79-8-673; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Mitchell JE, 2013, JACC-HEART FAIL, V1, P48, DOI 10.1016/j.jchf.2012.10.004; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; MORUZZI P, 1994, AM J CARDIOL, V73, P374, DOI 10.1016/0002-9149(94)90011-6; Nakamura H, 2007, J CLIN ENDOCR METAB, V92, P2157, DOI 10.1210/jc.2006-2135; NAKASHIMA T, 1978, ENDOCRINOLOGY, V103, P2187, DOI 10.1210/endo-103-6-2187; Nicolini G, 2013, J THROID RES, V2013, DOI 10.1155/2013/264387; NICOLOFF JT, 1990, J CLIN ENDOCR METAB, V71, P553, DOI 10.1210/jcem-71-3-553; Novitzky D, 1996, CARDIOLOGY, V87, P509, DOI 10.1159/000177147; Ojamaa K, 1999, ENDOCRINOLOGY, V140, P3170, DOI 10.1210/en.140.7.3170; Ojamaa K, 2000, AM J PHYSIOL-ENDOC M, V279, pE1319, DOI 10.1152/ajpendo.2000.279.6.E1319; Onodera T, 1998, HYPERTENSION, V32, P753, DOI 10.1161/01.HYP.32.4.753; Ooe H, 2009, DRUG METAB DISPOS, V37, P1963, DOI 10.1124/dmd.108.022905; OPPENHEI.JH, 1972, J CLIN INVEST, V51, P2493, DOI 10.1172/JCI107063; Pandya K, 2011, CIRC RES, V109, P609, DOI 10.1161/CIRCRESAHA.111.252619; Pantos C, 2003, J ENDOCRINOL, V178, P427, DOI 10.1677/joe.0.1780427; Pingitore A, 2005, VASC HEALTH RISK MAN, V1, P97, DOI 10.2147/vhrm.1.2.97.64076; Pingitore A, 2012, ANN MED, V44, P745, DOI 10.3109/07853890.2011.573501; Plateroti M, 2006, MOL CELL BIOL, V26, P3204, DOI 10.1128/MCB.26.8.3204-3214.2006; Rainer PP, 2014, CIRC RES, V114, P1246, DOI 10.1161/CIRCRESAHA.114.302653; Razvi S, 2012, ARCH INTERN MED, V172, P811, DOI 10.1001/archinternmed.2012.1159; Refetoff S, 2000, 6E EVALUATION THYROI; Rhee SS, 2011, REV ESP CARDIOL, V64, P220, DOI 10.1016/j.recesp.2010.10.015; Samuels MH, 2007, THYROID, V17, P249, DOI 10.1089/thy.2006.0252; Samuels MH, 2014, J CLIN ENDOCR METAB, V99, P843, DOI 10.1210/jc.2013-3686; SANCHEZF.F, 1974, J CLIN ENDOCR METAB, V38, P1098, DOI 10.1210/jcem-38-6-1098; Savarese G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058287; Savinova OV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025054; Schelbert EB, 2014, J AM COLL CARDIOL, V63, P2188, DOI 10.1016/j.jacc.2014.01.068; SCHWARTZ K, 1982, J BIOL CHEM, V257, P4412; SCHWARTZ K, 1986, CIRC RES, V59, P551, DOI 10.1161/01.RES.59.5.551; Shao Y, 2000, THYROID, V10, P753, DOI 10.1089/thy.2000.10.753; SHIROOZU A, 1983, ENDOCRINOLOGY, V113, P362, DOI 10.1210/endo-113-1-362; Soukup T, 2001, PHYSIOL RES, V50, P619; Syed MA, 1999, THYROID, V9, P503, DOI 10.1089/thy.1999.9.503; Tang YD, 2005, CIRCULATION, V112, P3122, DOI 10.1161/CIRCULATIONAHA.105.572883; TAUROG A, 1976, ENDOCRINOLOGY, V98, P1031, DOI 10.1210/endo-98-4-1031; Tschirgi ML, 2006, J PHYSIOL-LONDON, V574, P263, DOI 10.1113/jphysiol.2006.107417; Tuzcu A, 2005, ENDOCR J, V52, P89, DOI 10.1507/endocrj.52.89; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Venkatesh BA, 2014, HYPERTENSION; Wacker Michael J, 2005, J Biomol Tech, V16, P266; WALKER JD, 1994, J THORAC CARDIOV SUR, V108, P672; Wang JL, 2000, AM J PHYSIOL-ENDOC M, V279, pE1278, DOI 10.1152/ajpendo.2000.279.6.E1278; Wang YY, 2010, CARDIOVASC RES, V87, P636, DOI 10.1093/cvr/cvq133; Weber KT, 1995, EUR HEART J, V16, P12, DOI 10.1093/eurheartj/16.suppl_N.12; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4; Weltman NY, 2013, ENDOCRINOLOGY, V154, P2542, DOI 10.1210/en.2012-2087; Weltman NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046655; WINEGRAD S, 1990, P NATL ACAD SCI USA, V87, P2456, DOI 10.1073/pnas.87.7.2456; Wong TC, 2014, CURR CARDIOVASC IMAG, V7, DOI 10.1007/s12410-014-9267-z; Wong TC, 2014, EUR HEART J, V35, P657, DOI 10.1093/eurheartj/eht193; Wong TC, 2012, CIRCULATION, V126, P1206, DOI 10.1161/CIRCULATIONAHA.111.089409; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055599; Wu YM, 2007, J MOL CELL CARDIOL, V42, P186, DOI 10.1016/j.yjmcc.2006.09.017; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; YAO JL, 1992, CIRC RES, V71, P831, DOI 10.1161/01.RES.71.4.831; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhang Y, 2014, MOL THER, V22, P974, DOI 10.1038/mt.2014.25; Zhang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059489; Ziegelhoffer-Mihalovicova B, 2003, MOL CELL BIOCHEM, V247, P61, DOI 10.1023/A:1024153003249; ZIMMER HG, 1990, J MOL CELL CARDIOL, V22, P1231, DOI 10.1016/0022-2828(90)90060-F; Zoccali C, 2005, J AM SOC NEPHROL, V16, P2789, DOI 10.1681/ASN.2005040356	159	32	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109753	10.1371/journal.pone.0109753	http://dx.doi.org/10.1371/journal.pone.0109753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333636	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200050
J	Helgeland, E; Breivik, LE; Vaudel, M; Svendsen, OS; Garberg, H; Nordrehaug, JE; Berven, FS; Jonassen, AK				Helgeland, Erik; Breivik, Lars Ertesvag; Vaudel, Marc; Svendsen, Oyvind Sverre; Garberg, Hilde; Nordrehaug, Jan Erik; Berven, Frode Steingrimsen; Jonassen, Anne Kristine			Exploring the Human Plasma Proteome for Humoral Mediators of Remote Ischemic Preconditioning - A Word of Caution	PLOS ONE			English	Article							MASS-SPECTROMETRY DATA; ARTERY-BYPASS SURGERY; REPERFUSION INJURY; OXIDATIVE STRESS; KININ SYSTEM; COMPLEMENT; KALLISTATIN; ISCHEMIA/REPERFUSION; CARDIOPROTECTION; IDENTIFICATIONS	Despite major advances in early revascularization techniques, cardiovascular diseases are still the leading cause of death worldwide, and myocardial infarctions contribute heavily to this. Over the past decades, it has become apparent that reperfusion of blood to a previously ischemic area of the heart causes damage in and of itself, and that this ischemia reperfusion induced injury can be reduced by up to 50% by mechanical manipulation of the blood flow to the heart. The recent discovery of remote ischemic preconditioning (RIPC) provides a non-invasive approach of inducing this cardioprotection at a distance. Finding its endogenous mediators and their operative mode is an important step toward increasing the ischemic tolerance. The release of humoral factor(s) upon RIPC was recently demonstrated and several candidate proteins were published as possible mediators of the cardioprotection. Before clinical applicability, these potential biomarkers and their efficiency must be validated, a task made challenging by the large heterogeneity in reported data and results. Here, in an attempt to reproduce and provide more experimental data on these mediators, we conducted an unbiased in-depth analysis of the human plasma proteome before and after RIPC. From the 68 protein markers reported in the literature, only 28 could be mapped to manually reviewed (Swiss-Prot) protein sequences. 23 of them were monitored in our untargeted experiment. However, their significant regulation could not be reproducibly estimated. In fact, among the 394 plasma proteins we accurately quantified, no significant regulation could be confidently and reproducibly assessed. This indicates that it is difficult to both monitor and reproduce published data from experiments exploring for RIPC induced plasma proteomic regulations, and suggests that further work should be directed towards small humoral factors. To simplify this task, we made our proteomic dataset available via ProteomeXchange, where scientists can mine for novel potential targets.	[Helgeland, Erik; Breivik, Lars Ertesvag; Vaudel, Marc; Garberg, Hilde; Berven, Frode Steingrimsen; Jonassen, Anne Kristine] Univ Bergen, Fac Med & Dent, Dept Biomed, Bergen, Norway; [Nordrehaug, Jan Erik] Univ Bergen, Fac Med & Dent, Dept Clin Sci, Bergen, Norway; [Svendsen, Oyvind Sverre] Haukeland Hosp, Dept Anaesthesia & Surg Serv, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Jonassen, AK (corresponding author), Univ Bergen, Fac Med & Dent, Dept Biomed, Bergen, Norway.	anne.jonassen@biomed.uib.no	Svendsen, Øyvind Sverre/R-6549-2019	Breivik, Lars/0000-0003-2889-7342; Vaudel, Marc/0000-0003-1179-9578	F. Mohn foundation; Grieg Foundation; Bergen Heart Foundation; Laerdal Foundation for Acute Medicine; Bergen Medical Research Foundation; University of Bergen; Norwegian Council on Cardiovascular disease	F. Mohn foundation; Grieg Foundation; Bergen Heart Foundation; Laerdal Foundation for Acute Medicine; Bergen Medical Research Foundation; University of Bergen; Norwegian Council on Cardiovascular disease	This study was funded by the F. Mohn foundation, the Grieg Foundation, Bergen Heart Foundation, Laerdal Foundation for Acute Medicine and Bergen Medical Research Foundation. Erik Helgeland was supported by the University of Bergen. Lars Breivik was supported by the Norwegian Council on Cardiovascular disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2013, MOL CELL PROTEOMICS, V12, P2381, DOI 10.1074/mcp.E113.031658; Ahmed U, 2008, ANN NY ACAD SCI, V1126, P262, DOI 10.1196/annals.1433.035; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Barsnes H, 2013, AMINO ACIDS, V44, P1129, DOI 10.1007/s00726-012-1455-z; Barsnes H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-70; Boix F, 2002, J PHYSIOL-LONDON, V544, P127, DOI 10.1113/jphysiol.2002.025106; Bossi F, 2011, IMMUNOL LETT, V140, P7, DOI 10.1016/j.imlet.2011.06.006; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Breivik L, 2011, BASIC RES CARDIOL, V106, P135, DOI 10.1007/s00395-010-0133-0; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Burkhart JM, 2011, PROTEOMICS, V11, P1125, DOI 10.1002/pmic.201000711; Chao JL, 1997, J CLIN INVEST, V100, P11, DOI 10.1172/JCI119502; Chao J, 2006, HUM GENE THER, V17, P1201, DOI 10.1089/hum.2006.17.1201; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Cote RG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-401; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Davidson SM, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0377-6; Dickson EW, 2001, J MOL CELL CARDIOL, V33, P1751, DOI 10.1006/jmcc.2001.1436; Dickson EW, 1999, AM J PHYSIOL-HEART C, V277, pH2451, DOI 10.1152/ajpheart.1999.277.6.H2451; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Dietze GJ, 1996, DIABETES, V45, pS110, DOI 10.2337/diab.45.1.S110; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; EDERY H, 1962, BRIT J PHARM CHEMOTH, V19, P299, DOI 10.1111/j.1476-5381.1962.tb01192.x; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Engelbrecht B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065195; Gao L, 2008, LAB INVEST, V88, P1157, DOI 10.1038/labinvest.2008.85; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gho BCG, 1996, CIRCULATION, V94, P2193, DOI 10.1161/01.CIR.94.9.2193; Gosho M, 2012, SENSORS-BASEL, V12, P8966, DOI 10.3390/s120708966; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hausenloy DJ, 2013, CURR PHARM DESIGN, V19, P4544, DOI 10.2174/1381612811319250004; Hepponstall M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048284; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Heusch G, 2012, CIRC RES, V110, P111, DOI 10.1161/CIRCRESAHA.111.259556; Hibert P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085669; Hibert P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077211; Hong DM, 2012, CIRC J, V76, P884, DOI 10.1253/circj.CJ-11-1068; Inagi R, 2010, ADV EXP MED BIOL, V662, P49, DOI 10.1007/978-1-4419-1241-1_6; Karpel-Massler G, 2003, J SURG RES, V115, P247, DOI 10.1016/S0022-4804(03)00192-6; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kinsinger CR, 2012, PROTEOMICS, V12, P11, DOI 10.1002/pmic.201100562; Lim SY, 2010, BASIC RES CARDIOL, V105, P651, DOI 10.1007/s00395-010-0099-y; Liu YY, 2012, AM J PHYSIOL-RENAL, V303, pF1230, DOI 10.1152/ajprenal.00257.2012; Loukogeorgakis SP, 2007, CIRCULATION, V116, P1386, DOI 10.1161/CIRCULATIONAHA.106.653782; Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303; Martens L, 2005, PROTEOMICS, V5, P3501, DOI 10.1002/pmic.200401302; McClanahan TB, 1993, FASEB J, V7; Pang T, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/859056; PEMBERTON M, 1993, J IMMUNOL, V150, P5104; Phillips HL, 2010, PROTEOMICS, V10, P2950, DOI 10.1002/pmic.200900669; Powell DW, 2004, MOL CELL BIOL, V24, P7249, DOI 10.1128/MCB.24.16.7249-7259.2004; Przyklenk K, 2013, ANESTH ANALG; Przyklenk K, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0382-9; Renaux JL, 1999, KIDNEY INT, V55, P1097, DOI 10.1046/j.1523-1755.1999.0550031097.x; Saxena P, 2011, J SURG RES, V171, P311, DOI 10.1016/j.jss.2009.11.011; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Serejo FC, 2007, J CARDIOVASC PHARM, V49, P214, DOI 10.1097/FJC.0b013e3180325ad9; Shen B, 2010, AM J PHYSIOL-HEART C, V299, pH1419, DOI 10.1152/ajpheart.00591.2010; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Stahl GL, 2003, AM J PATHOL, V162, P449, DOI 10.1016/S0002-9440(10)63839-4; Thielmann M, 2013, LANCET, V382, P597, DOI 10.1016/S0140-6736(13)61450-6; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Trialists G, 2014, INT J CARDIOL; Udby L, 2004, BIOCHEMISTRY-US, V43, P12877, DOI 10.1021/bi048823e; Vaudel M, 2013, BIOCH BIOPHYS ACTA; Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595; Vaudel M, 2010, PROTEOMICS, V10, P650, DOI 10.1002/pmic.200900481; Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wada K, 2001, GASTROENTEROLOGY, V120, P126, DOI 10.1053/gast.2001.20873; Wautier JL, 2004, CIRC RES, V95, P233, DOI 10.1161/01.RES.0000137876.28454.64; Weinbrenner C, 2002, CARDIOVASC RES, V55, P590, DOI 10.1016/S0008-6363(02)00446-7; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Yadav AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024442; Zhao H, 2002, J APPL PHYSIOL, V93, P338, DOI 10.1152/japplphysiol.00159.2002	76	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109279	10.1371/journal.pone.0109279	http://dx.doi.org/10.1371/journal.pone.0109279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333471	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200021
J	Marsillach, J; Suzuki, SM; Richter, RJ; McDonald, MG; Rademacher, PM; MacCoss, MJ; Hsieh, EJ; Rettie, AE; Furlong, CE				Marsillach, Judit; Suzuki, Stephanie M.; Richter, Rebecca J.; McDonald, Matthew G.; Rademacher, Peter M.; MacCoss, Michael J.; Hsieh, Edward J.; Rettie, Allan E.; Furlong, Clement E.			Human Valacyclovir Hydrolase/Biphenyl Hydrolase-Like Protein Is a Highly Efficient Homocysteine Thiolactonase	PLOS ONE			English	Article							BLEOMYCIN HYDROLASE; ALZHEIMERS-DISEASE; CARDIOVASCULAR-DISEASE; PROTECTIVE ROLE; PARAOXONASE 1; METABOLISM; PRODRUG; MICE; PON1; HYPERHOMOCYSTEINEMIA	Homocysteinylation of lysine residues by homocysteine thiolactone (HCTL), a reactive homocysteine metabolite, results in protein aggregation and malfunction, and is a well-known risk factor for cardiovascular, autoimmune and neurological diseases. Human plasma paraoxonase-1 (PON1) and bleomycin hydrolase (Blmh) have been reported as the physiological HCTL detoxifying enzymes. However, the catalytic efficiency of HCTL hydrolysis by Blmh is low and not saturated at 20 mM HCTL. The catalytic efficiency of PON1 for HCTL hydrolysis is 100-fold lower than that of Blmh. A homocysteine thiolactonase (HCTLase) was purified from human liver and identified by mass spectrometry (MS) as the previously described human biphenyl hydrolase-like protein (BPHL). To further characterize this newly described HCTLase activity, BPHL was expressed in Escherichia coli and purified. The sequence of the recombinant BPHL (rBPHL) and hydrolytic products of the substrates HCTL and valacyclovir were verified by MS. We found that the catalytic efficiency (k(cat)/K-m) of rBPHL for HCTL hydrolysis was 7.7 x 10(4) M-1 s(-1), orders of magnitude higher than that of PON1 or Blmh, indicating a more significant physiological role for BPHL in detoxifying HCTL.	[Marsillach, Judit; Suzuki, Stephanie M.; Richter, Rebecca J.; Furlong, Clement E.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Marsillach, Judit; MacCoss, Michael J.; Hsieh, Edward J.; Furlong, Clement E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [McDonald, Matthew G.; Rademacher, Peter M.; Rettie, Allan E.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Furlong, CE (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	clem@uw.edu	Marsillach, Judit/I-1329-2015	Marsillach, Judit/0000-0002-3061-6266	National Institutes of Health [P42 ES04696, R01 ES09883, P41 GM103533, P01 GM32165]; National Institute of Environmental Health Sciences [T32 ES007032]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009883, P42ES004696, T32ES007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM032165, P41GM103533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (http://www.nih.gov/)to CEF (P42 ES04696 and R01 ES09883), MJM (P41 GM103533), and AER (P01 GM32165); Drug Metabolism, Transport and Pharmacogenetics Research Fund within the School of Pharmacy at the University of Washington (http://sop.washington.edu/)to AER; and National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) to SMS (training grant T32 ES007032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barathi S, 2010, DIABETES CARE, V33, P2031, DOI 10.2337/dc10-0132; Bayrak A, 2011, J CHROMATOGR B, V879, P49, DOI 10.1016/j.jchromb.2010.11.006; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Borowczyk K, 2012, AMINO ACIDS, V43, P1339, DOI 10.1007/s00726-011-1207-5; Borowczyk K, 2012, J ALZHEIMERS DIS, V30, P225, DOI 10.3233/JAD-2012-111940; Bromme D, 1996, BIOCHEMISTRY-US, V35, P6706, DOI 10.1021/bi960092y; BURNETTE TC, 1995, J BIOL CHEM, V270, P15827, DOI 10.1074/jbc.270.26.15827; Camps J, 2011, NAT MED, V17, P1041, DOI 10.1038/nm.2386; Costa LG, 2003, ANNU REV MED, V54, P371, DOI 10.1146/annurev.med.54.101601.152421; Dansette PM, 2012, CHEM RES TOXICOL, V25, P1058, DOI 10.1021/tx3000279; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Finkelstein JD, 1998, EUR J PEDIATR, V157, pS40, DOI 10.1007/PL00014300; Furlong CE, 2008, PROTEINS CELL REGUL, V6, P3, DOI 10.1007/978-1-4020-6561-3_1; Jacovina AT, 2009, J CLIN INVEST, V119, P3384, DOI 10.1172/JCI39591; Jakubowski H, 2000, J BIOL CHEM, V275, P3957, DOI 10.1074/jbc.275.6.3957; Jakubowski H, 2002, ANAL BIOCHEM, V308, P112, DOI 10.1016/S0003-2697(02)00224-5; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jakubowski H, 2000, J NUTR, V130, p377S, DOI 10.1093/jn/130.2.377S; Jakubowski H, 2010, ADV EXP MED BIOL, V660, P113, DOI 10.1007/978-1-60761-350-3_11; Joseph J, 2009, CARDIOVASC TOXICOL, V9, P53, DOI 10.1007/s12012-009-9042-6; Kajiya A, 2006, PROTEIN PEPTIDE LETT, V13, P119, DOI 10.2174/092986606775101562; Kim I, 2003, J BIOL CHEM, V278, P25348, DOI 10.1074/jbc.M302055200; Kim I, 2004, MOL PHARMACEUT, V1, P117, DOI 10.1021/mp0499757; KORENOVSKY A, 1990, BIOL PSYCHIAT, V27, P871, DOI 10.1016/0006-3223(90)90468-H; Kosaka T, 2005, CLIN CHIM ACTA, V359, P156, DOI 10.1016/j.cccn.2005.03.046; Koubaa N, 2008, CLIN CHEM LAB MED, V46, P187, DOI 10.1515/CCLM.2008.046; La Du BN, 2000, PARAOXONASE PON1 HLT, P1; Lai LS, 2008, J BIOL CHEM, V283, P9318, DOI 10.1074/jbc.M709530200; Lentz SR, 2005, J THROMB HAEMOST, V3, P1646, DOI 10.1111/j.1538-7836.2005.01364.x; Li WF, 2000, PHARMACOGENETICS, V10, P767, DOI 10.1097/00008571-200012000-00002; Lin YS, 2002, MOL PHARMACOL, V62, P162, DOI 10.1124/mol.62.1.162; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; MCCULLY KS, 1969, AM J PATHOL, V56, P111; McCully KS, 2005, CLIN CHEM LAB MED, V43, P980, DOI 10.1515/CCLM.2005.172; Molina DK, 2012, AM J FOREN MED PATH, V33, P368, DOI 10.1097/PAF.0b013e31823d29ad; Montoya SE, 1998, NAT GENET, V18, P211, DOI 10.1038/ng0398-211; Puente XS, 1998, GENOMICS, V51, P459, DOI 10.1006/geno.1998.5351; PUENTE XS, 1995, J BIOL CHEM, V270, P12926, DOI 10.1074/jbc.270.21.12926; Seshadri S, 2006, J ALZHEIMERS DIS, V9, P393; Suszynska J, 2010, J ALZHEIMERS DIS, V19, P1177, DOI 10.3233/JAD-2010-1311; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Yilmaz N, 2012, ARCH MED SCI, V8, P138, DOI 10.5114/aoms.2012.27294; Zimny J, 2006, J BIOL CHEM, V281, P22485, DOI 10.1074/jbc.M603656200	45	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110054	10.1371/journal.pone.0110054	http://dx.doi.org/10.1371/journal.pone.0110054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333274	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200085
J	Naslund, JA; Grande, SW; Aschbrenner, KA; Elwyn, G				Naslund, John A.; Grande, Stuart W.; Aschbrenner, Kelly A.; Elwyn, Glyn			Naturally Occurring Peer Support through Social Media: The Experiences of Individuals with Severe Mental Illness Using YouTube	PLOS ONE			English	Article							SELF-MANAGEMENT; HEALTH; INTERNET; ONLINE; INFORMATION; COMMUNICATION; PATIENT; ADULTS; INTERVENTION; ETHNOGRAPHY	Increasingly, people with diverse health conditions turn to social media to share their illness experiences or seek advice from others with similar health concerns. This unstructured medium may represent a platform on which individuals with severe mental illness naturally provide and receive peer support. Peer support includes a system of mutual giving and receiving where individuals with severe mental illness can offer hope, companionship, and encouragement to others facing similar challenges. In this study we explore the phenomenon of individuals with severe mental illness uploading videos to YouTube, and posting and responding to comments as a form of naturally occurring peer support. We also consider the potential risks and benefits of self-disclosure and interacting with others on YouTube. To address these questions, we used qualitative inquiry informed by emerging techniques in online ethnography. We analyzed n = 3,044 comments posted to 19 videos uploaded by individuals who self-identified as having schizophrenia, schizoaffective disorder, or bipolar disorder. We found peer support across four themes: minimizing a sense of isolation and providing hope; finding support through peer exchange and reciprocity; sharing strategies for coping with day-to-day challenges of severe mental illness; and learning from shared experiences of medication use and seeking mental health care. These broad themes are consistent with accepted notions of peer support in severe mental illness as a voluntary process aimed at inclusion and mutual advancement through shared experience and developing a sense of community. Our data suggest that the lack of anonymity and associated risks of being identified as an individual with severe mental illness on YouTube seem to be overlooked by those who posted comments or uploaded videos. Whether or not this platform can provide benefits for a wider community of individuals with severe mental illness remains uncertain.	[Naslund, John A.; Aschbrenner, Kelly A.; Elwyn, Glyn] Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA; [Grande, Stuart W.; Elwyn, Glyn] Dartmouth Coll, Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH 03755 USA; [Aschbrenner, Kelly A.] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA	Dartmouth College; Dartmouth College; Dartmouth College	Naslund, JA (corresponding author), Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA.	John.A.Naslund@gmail.com	Elwyn, G./L-4292-2015; Elwyn, Glyn/B-4798-2009	Elwyn, Glyn/0000-0002-0917-6286; Grande, Stuart/0000-0002-6796-7991				Anthony WilliamA, 1993, PSYCHOSOC REHABIL, V16, P11, DOI [10.1037/h0095655, DOI 10.1037/H0095655]; Barak A, 2008, COMPUT HUM BEHAV, V24, P1867, DOI 10.1016/j.chb.2008.02.004; Bargh JA, 2004, ANNU REV PSYCHOL, V55, P573, DOI 10.1146/annurev.psych.55.090902.141922; Basset T., 2010, LIVED EXPERIENCE LEA; Bender JL, 2011, J MED INTERNET RES, V13, P165, DOI 10.2196/jmir.1560; Beneito-Montagut R, 2011, QUAL RES, V11, P716, DOI 10.1177/1468794111413368; Berger M, 2005, SOC SCI MED, V61, P1821, DOI 10.1016/j.socscimed.2005.03.025; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Bracke P, 2008, J APPL SOC PSYCHOL, V38, P436, DOI 10.1111/j.1559-1816.2008.00312.x; Burt RS, 2005, BROKERAGE CLOSURE IN; Chinman M, 2014, PSYCHIAT SERV, V65, P429, DOI 10.1176/appi.ps.201300244; Chou WYS, 2011, J MED INTERNET RES, V13, P108, DOI 10.2196/jmir.1569; Chou WYS, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1249; Christofides E, 2009, CYBERPSYCHOL BEHAV, V12, P341, DOI 10.1089/cpb.2008.0226; Coniglio FD, 2012, COMMUNITY MENT HLT J, V48, P153, DOI 10.1007/s10597-010-9358-5; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Corrigan P, 2003, PSYCHIAT SERV, V54, P1105, DOI 10.1176/appi.ps.54.8.1105; Coursaris CK, 2009, COMPUT HUM BEHAV, V25, P911, DOI 10.1016/j.chb.2009.03.006; Davidson L, 1999, CLIN PSYCHOL-SCI PR, V6, P165, DOI 10.1093/clipsy/6.2.165; Davidson L, 2007, J MENTAL HLTH, V16, P459, DOI DOI 10.1080/09638230701482394; Davidson L, 2006, SCHIZOPHRENIA BULL, V32, P443, DOI 10.1093/schbul/sbj043; Davison KP, 2000, AM PSYCHOL, V55, P205, DOI 10.1037/0003-066X.55.2.205; Druss BG, 2010, SCHIZOPHR RES, V118, P264, DOI 10.1016/j.schres.2010.01.026; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; Entwistle V, 2007, HEALTH EXPECT, V10, P307, DOI 10.1111/j.1369-7625.2007.00469.x; Entwistle VA, 2011, PATIENT EDUC COUNS, V85, pE291, DOI 10.1016/j.pec.2011.05.014; Fernandez-Luque L, 2009, STUD HEALTH TECHNOL, V150, P292, DOI 10.3233/978-1-60750-044-5-292; Flicker S, 2004, QUAL HEALTH RES, V14, P124, DOI 10.1177/1049732303259842; Freeman B, 2007, TOB CONTROL, V16, P207, DOI 10.1136/tc.2007.020024; Frohlich DO, 2012, HEALTH COMMUN, V27, P421, DOI 10.1080/10410236.2011.606524; Frost JH, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1053; Gatson Sarah N., 2011, SAGE HDB QUALITATIVE, P245; Goldberg RW, 2013, PSYCHIAT SERV, V64, P51, DOI 10.1176/appi.ps.201200034; Gowen K, 2012, PSYCHIATR REHABIL J, V35, P245, DOI 10.2975/35.3.2012.245.250; Greene JA, 2011, J GEN INTERN MED, V26, P287, DOI 10.1007/s11606-010-1526-3; Jones S., 2009, GENERATIONS ONLINE 2; Kaplan K, 2011, SOC SCI MED, V72, P54, DOI 10.1016/j.socscimed.2010.09.037; Kosner A. W, 2013, WATCH OUT FACEBOOK G; Lehavot K, 2012, J DUAL DIAGN, V8, P341, DOI 10.1080/15504263.2012.718928; Mazanderani F, 2013, PATIENT EDUC COUNS, V93, P420, DOI 10.1016/j.pec.2013.06.006; McKay CE, 2012, J DUAL DIAGN, V8, P104, DOI 10.1080/15504263.2012.670847; McKee R, 2013, HEALTH POLICY, V110, P298, DOI 10.1016/j.healthpol.2013.02.006; Mead S, 2001, PSYCHIATR REHABIL J, V25, P134, DOI 10.1037/h0095032; Mo PKH, 2008, CYBERPSYCHOL BEHAV, V11, P371, DOI 10.1089/cpb.2007.0118; Mo PKH, 2012, PSYCHOL HEALTH, V27, P445, DOI 10.1080/08870446.2011.592981; Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933; Patton M. Q., 1990, QUALITATIVE EVALUATI; Rissmiller DJ, 2006, PSYCHIAT SERV, V57, P863, DOI 10.1176/appi.ps.57.6.863; Savage J, 2000, BMJ-BRIT MED J, V321, P1400, DOI 10.1136/bmj.321.7273.1400; Skeels MM, 2009, GROUP 2009 PROCEEDINGS, P95; Solomon P, 2004, PSYCHIATR REHABIL J, V27, P392, DOI 10.2975/27.2004.392.401; Spinzy Y, 2012, PSYCHIAT RES, V198, P319, DOI 10.1016/j.psychres.2012.02.022; Steffen V, 1997, SOC SCI MED, V45, P99, DOI 10.1016/S0277-9536(96)00319-X; Tomes N, 2006, HEALTH AFFAIR, V25, P720, DOI 10.1377/hlthaff.25.3.720; van Gestel-Timmermans H, 2012, PSYCHIAT SERV, V63, P54, DOI 10.1176/appi.ps.201000450; Vance K, 2009, DERMATOL CLIN, V27, P133, DOI 10.1016/j.det.2008.11.010; Veretilo P, 2012, PSYCHIAT QUART, V83, P385, DOI 10.1007/s11126-012-9207-5; Zhu Q, 2011, SELF DISCLOSURE ONLI; Ziebland S, 2012, MILBANK Q, V90, P219, DOI 10.1111/j.1468-0009.2012.00662.x; Zimmer M, 2010, ETHICS INF TECHNOL, V12, P313, DOI 10.1007/s10676-010-9227-5	60	137	138	20	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110171	10.1371/journal.pone.0110171	http://dx.doi.org/10.1371/journal.pone.0110171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25333470	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200096
J	Wang, Y; Li, RD; Ji, CG; Shi, SL; Cheng, YF; Sun, H; Li, YX				Wang, Yin; Li, Rudong; Ji, Chunguang; Shi, Shuliang; Cheng, Yufan; Sun, Hong; Li, Yixue			Quantitative Dynamic Modelling of the Gene Regulatory Network Controlling Adipogenesis	PLOS ONE			English	Article							TRANSCRIPTIONAL CONTROL; POSITIVE FEEDBACK; DIFFERENTIATION; PATHWAY; SWITCH; CELLS	Gene regulatory networks (GRNs) coherently coordinate the expressions of genes and control the behaviors of cellular systems. The complexity in modeling a quantitative GRN usually results from inaccurate parameter estimation, which is mostly due to small sample sizes. For better modeling of GRNs, we have designed a small-sample iterative optimization algorithm (SSIO) to quantitatively model GRNs with nonlinear regulatory relationships. The algorithm utilizes gene expression data as the primary input and it can be applied in case of small-sized samples. Using SSIO, we have quantitatively constructed the dynamic models for the GRNs controlling human and mouse adipogenesis. Compared with two other commonly-used methods, SSIO shows better performance with relatively lower residual errors, and it generates rational predictions on the adipocyte responses to external signals and steady-states. Sensitivity analysis further indicates the validity of our method. Several differences are observed between the GRNs of human and mouse adipocyte differentiations, suggesting the differences in regulatory efficiencies of the transcription factors between the two species. In addition, we use SSIO to quantitatively determine the strengths of the regulatory interactions as well as to optimize regulatory models. The results indicate that SSIO facilitates better investigation and understanding of gene regulatory processes.	[Wang, Yin; Li, Yixue] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Li, Rudong; Sun, Hong; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Ji, Chunguang] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China; [Shi, Shuliang] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Cheng, Yufan] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Sun, Hong; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harbin Institute of Technology; Harbin Institute of Technology; Fudan University; Chinese Academy of Sciences	Sun, H (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	sunhong@scbit.org; yxli@sibs.ac.cn	Li, Rudong/HGA-8169-2022		National '973' Basic Research Program [2011CB910204, 2010CB529202, 2011CB510100, 2010CB912702]; Natural Science Foundation of China [31371343, 30900272, 31070752]; Research Program of CAS [KSCX2-EW-R-04, KSCX2-YW-R-190, 2011KIP204]	National '973' Basic Research Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Program of CAS	This work was supported by the National '973' Basic Research Program (2011CB910204, 2010CB529202, 2011CB510100, 2010CB912702), Natural Science Foundation of China (31371343, 30900272, 31070752) and Research Program of CAS (KSCX2-EW-R-04, KSCX2-YW-R-190, 2011KIP204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieu C, 2010, J R STAT SOC B, V72, P269, DOI 10.1111/j.1467-9868.2009.00736.x; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bar-Joseph Z, 2003, J COMPUT BIOL, V10, P341, DOI 10.1089/10665270360688057; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Boguski MS, 2002, NATURE, V420, P515, DOI 10.1038/420515a; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dinicola S, 2011, OMICS, V15, P93, DOI 10.1089/omi.2010.0091; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gerard C, 2009, P NATL ACAD SCI USA, V106, P21643, DOI 10.1073/pnas.0903827106; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; H?skuldsson A., 1988, J CHEMOMETR, V2, P211, DOI DOI 10.1002/CEM.1180020306; Haixin W, 2007, MODELING GENETIC REG, P324; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; HAMBY DM, 1995, HEALTH PHYS, V68, P195, DOI 10.1097/00004032-199502000-00005; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Jung HS, 2012, STEM CELLS DEV, V21, P465, DOI 10.1089/scd.2010.0591; Line SRP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-268; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Moody J. E., 1992, ADV NEURAL INFORM PR, P847; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Park BO, 2012, CELL REP, V2, P976, DOI 10.1016/j.celrep.2012.08.038; Polynikis A, 2009, J THEOR BIOL, V261, P511, DOI 10.1016/j.jtbi.2009.07.040; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Shampine LF, 1999, SIAM REV, V41, P538, DOI 10.1137/S003614459933425X; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Sweetkind-Singer JA, 2003, INF THEOR 2003 P IEE, P286; Tautz D, 2000, CURR OPIN GENET DEV, V10, P575, DOI 10.1016/S0959-437X(00)00130-1; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wagener T, 2007, ENVIRON MODELL SOFTW, V22, P1021, DOI 10.1016/j.envsoft.2006.06.017; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266	41	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110563	10.1371/journal.pone.0110563	http://dx.doi.org/10.1371/journal.pone.0110563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333650	gold, Green Submitted, Green Published			2022-12-27	WOS:000343731200056
J	Bellante, GJ; Powell, SL; Lawrence, RL; Repasky, KS; Dougher, T				Bellante, Gabriel J.; Powell, Scott L.; Lawrence, Rick L.; Repasky, Kevin S.; Dougher, Tracy			Hyperspectral Detection of a Subsurface CO2 Leak in the Presence of Water Stressed Vegetation	PLOS ONE			English	Article							PHOTOCHEMICAL REFLECTANCE INDEX; RADIATION-USE-EFFICIENCY; VOSTOK ICE CORE; CARBON-DIOXIDE; PLANT STRESS; SPECTRAL MEASUREMENTS; RANDOM FORESTS; RESPONSES; CLIMATE; FLUORESCENCE	Remote sensing of vegetation stress has been posed as a possible large area monitoring tool for surface CO2 leakage from geologic carbon sequestration (GCS) sites since vegetation is adversely affected by elevated CO2 levels in soil. However, the extent to which remote sensing could be used for CO2 leak detection depends on the spectral separability of the plant stress signal caused by various factors, including elevated soil CO2 and water stress. This distinction is crucial to determining the seasonality and appropriateness of remote GCS site monitoring. A greenhouse experiment tested the degree to which plants stressed by elevated soil CO2 could be distinguished from plants that were water stressed. A randomized block design assigned Alfalfa plants (Medicago sativa) to one of four possible treatment groups: 1) a CO2 injection group; 2) a water stress group; 3) an interaction group that was subjected to both water stress and CO2 injection; or 4) a group that received adequate water and no CO2 injection. Single date classification trees were developed to identify individual spectral bands that were significant in distinguishing between CO2 and water stress agents, in addition to a random forest classifier that was used to further understand and validate predictive accuracies. Overall peak classification accuracy was 90% (Kappa of 0.87) for the classification tree analysis and 83% (Kappa of 0.77) for the random forest classifier, demonstrating that vegetation stressed from an underground CO2 leak could be accurately discerned from healthy vegetation and areas of co-occurring water stressed vegetation at certain times. Plants appear to hit a stress threshold, however, that would render detection of a CO2 leak unlikely during severe drought conditions. Our findings suggest that early detection of a CO2 leak with an aerial or ground-based hyperspectral imaging system is possible and could be an important GCS monitoring tool.	[Bellante, Gabriel J.; Powell, Scott L.; Lawrence, Rick L.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Repasky, Kevin S.] Montana State Univ, Dept Elect & Comp Engn, Bozeman, MT 59717 USA; [Dougher, Tracy] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Bellante, GJ (corresponding author), Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA.	gabriel.bellante@gmail.com			U.S. Department of Energy; National Energy Technology Laboratory [DE-FC26-05NT42587]	U.S. Department of Energy(United States Department of Energy (DOE)); National Energy Technology Laboratory(United States Department of Energy (DOE))	This research was funded by the U.S. Department of Energy and the National Energy Technology Laboratory through Award number: DE-FC26-05NT42587. Neither the United States Government nor any agency thereof, nor any of their employees, makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States Government or any agency thereof. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIER W, 1969, AGR METEOROL, V6, P165, DOI 10.1016/0002-1571(69)90002-8; Bergfeld D, 2006, J VOLCANOL GEOTH RES, V152, P140, DOI 10.1016/j.jvolgeores.2005.11.003; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BUSCHMANN C, 1993, INT J REMOTE SENS, V14, P711, DOI 10.1080/01431169308904370; CARTER GA, 1994, REMOTE SENS ENVIRON, V50, P295, DOI 10.1016/0034-4257(94)90079-5; CARTER GA, 1993, AM J BOT, V80, P239, DOI 10.2307/2445346; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; CARTER GA, 1991, AM J BOT, V78, P916, DOI 10.2307/2445170; Congalton R.G., 2019, ASSESSING ACCURACY R, VThird, DOI 10.1201/9780429052729; Cortis A, 2008, INT J GREENH GAS CON, V2, P640, DOI 10.1016/j.ijggc.2008.04.008; Cuffey KM, 2001, NATURE, V412, P523, DOI 10.1038/35087544; DENMEAD OT, 1962, AGRON J, V54, P385, DOI 10.2134/agronj1962.00021962005400050005x; Fitzgerald Glenn J., 2004, Precision Agriculture, V5, P275, DOI 10.1023/B:PRAG.0000032766.88787.5f; Gamon JA, 1999, NEW PHYTOL, V143, P105, DOI 10.1046/j.1469-8137.1999.00424.x; Gamon JA, 1997, OECOLOGIA, V112, P492, DOI 10.1007/s004420050337; Gislason PO, 2006, PATTERN RECOGN LETT, V27, P294, DOI 10.1016/j.patrec.2005.08.011; GOETZ AFH, 1985, SCIENCE, V228, P1147, DOI 10.1126/science.228.4704.1147; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; HARSANYI JC, 1994, IEEE T GEOSCI REMOTE, V32, P779, DOI 10.1109/36.298007; Hepple RP, 2005, ENVIRON GEOL, V47, P576, DOI 10.1007/s00254-004-1181-2; Hepple RP, 2002, LBNL51267; Herzog H, 2001, ENVIRON SCI TECHNOL, V35, p148A, DOI 10.1021/es012307j; Intergovernmental Panel on Climate Change (IPCC), 2005, IPCC SPECIAL REPORT; Ji RR, 2014, IEEE T GEOSCI REMOTE, V52, P1811, DOI 10.1109/TGRS.2013.2255297; Jong SM, 1998, ITC J, P1; Keith CJ, 2009, INT J GREENH GAS CON, V3, P626, DOI 10.1016/j.ijggc.2009.03.003; Kling GW, 2005, P NATL ACAD SCI USA, V102, P14185, DOI 10.1073/pnas.0502274102; KNIPLING E B, 1970, Remote Sensing of Environment, V1, P155; Lawrence Berkeley National Laboratory (LBNL), 2000, ENERGEX 2000 P 8 INT; Lawrence R, 2003, WEST J APPL FOR, V18, P202, DOI 10.1093/wjaf/18.3.202; Lawrence RL, 2006, REMOTE SENS ENVIRON, V100, P356, DOI 10.1016/j.rse.2005.10.014; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Macek I, 2005, ENVIRON EXP BOT, V54, P90, DOI 10.1016/j.envexpbot.2004.06.003; Male EJ, 2010, ENVIRON EARTH SCI, V60, P251, DOI 10.1007/s12665-009-0372-2; MASARIE KA, 1995, J GEOPHYS RES-ATMOS, V100, P11593, DOI 10.1029/95JD00859; Meroni M, 2008, SENSORS-BASEL, V8, P1740, DOI 10.3390/s8031740; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Muhammed HH, 2005, BIOSYST ENG, V91, P9, DOI 10.1016/j.biosystemseng.2005.02.007; Naumann JC, 2009, PLANT ECOL, V202, P285, DOI 10.1007/s11258-008-9482-2; Noomen MF, 2008, INT J REMOTE SENS, V29, P5987, DOI 10.1080/01431160801961383; Noomen MF, 2009, INT J REMOTE SENS, V30, P481, DOI 10.1080/01431160802339431; Norby RJ, 2004, NEW PHYTOL, V162, P281, DOI 10.1111/j.1469-8137.2004.01047.x; Oldenburg CM, 2009, INT J GREENH GAS CON, V3, P444, DOI 10.1016/j.ijggc.2009.02.009; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peguero-Pina JJ, 2008, OECOLOGIA, V156, P1, DOI 10.1007/s00442-007-0957-y; Penuelas J, 1997, INT J REMOTE SENS, V18, P2863, DOI 10.1080/014311697217387; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pickles WL, 2001, GEOTHERMAL RESOURCES, V25, P307; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Pu RL, 2008, PHOTOGRAMM ENG REM S, V74, P65, DOI 10.14358/PERS.74.1.65; ROCK BN, 1988, REMOTE SENS ENVIRON, V24, P109, DOI 10.1016/0034-4257(88)90008-9; Rodarmel C., 2002, SURV LAND INF SCI, V62, P115; Schuerger AC, 2003, REMOTE SENS ENVIRON, V84, P572, DOI 10.1016/S0034-4257(02)00181-5; Scripps Institute of Oceanography, 2007, MONTHL AV CARB DIOX; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Smith KL, 2004, REMOTE SENS ENVIRON, V92, P207, DOI 10.1016/j.rse.2004.06.002; Smith KL, 2004, INT J REMOTE SENS, V25, P4395, DOI 10.1080/01431160410001729172; Smith WK, 1997, BIOSCIENCE, V47, P785, DOI 10.2307/1313100; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Spangler LH, 2009, ENV EARTH SCI; Strachan IB, 2002, REMOTE SENS ENVIRON, V80, P213, DOI 10.1016/S0034-4257(01)00299-1; Suarez L, 2008, REMOTE SENS ENVIRON, V112, P560, DOI 10.1016/j.rse.2007.05.009; Tucker C. J., 1980, International Journal of Remote Sensing, V1, P69, DOI 10.1080/01431168008948211; VENABLES WN, 1997, MODERN APPL STAT S P; VOGELMANN JE, 1993, INT J REMOTE SENS, V14, P1563, DOI 10.1080/01431169308953986; Wilson EJ, 2007, ENVIRON SCI TECHNOL, V41, P5945, DOI 10.1021/es062272t; Zarco-Tejada PJ, 2000, REMOTE SENS ENVIRON, V74, P582, DOI 10.1016/S0034-4257(00)00148-6	69	13	14	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e108299	10.1371/journal.pone.0108299	http://dx.doi.org/10.1371/journal.pone.0108299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330232	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100009
J	Pan, YS; Chen, QD; Zhao, XQ; Liao, XL; Wang, CJ; Du, WL; Liu, GF; Liu, LP; Wang, CX; Wang, YL; Wang, YJ				Pan, Yuesong; Chen, Qidong; Zhao, Xingquan; Liao, Xiaoling; Wang, Chunjuan; Du, Wanliang; Liu, Gaifen; Liu, Liping; Wang, Chunxue; Wang, Yilong; Wang, Yongjun		TIMS-CHINA Investigators	Cost-Effectiveness of Thrombolysis within 4.5 Hours of Acute Ischemic Stroke in China	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; INTRAVENOUS THROMBOLYSIS; UTILITY ANALYSIS; POOLED ANALYSIS; ALTEPLASE; HEALTH; PREVENTION; REIMBURSEMENT; ATLANTIS; WINDOW	Background: Previous economic studies conducted in developed countries showed intravenous tissue-type plasminogen activator (tPA) is cost-effective for acute ischemic stroke. The present study aimed to determine the cost-effectiveness of tPA treatment in China, the largest developing country. Methods: A combination of decision tree and Markov model was developed to determine the cost-effectiveness of tPA treatment versus non-tPA treatment within 4.5 hours after stroke onset. Outcomes and costs data were derived from the database of Thrombolysis Implementation and Monitor of acute ischemic Stroke in China (TIMS-China) study. Efficacy data were derived from a pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Costs and quality-adjusted life-years (QALYs) were compared in both short term (2 years) and long term (30 years). One-way and probabilistic sensitivity analyses were performed to test the robustness of the results. Results: Comparing to non-tPA treatment, tPA treatment within 4.5 hours led to a short-term gain of 0.101 QALYs at an additional cost of CNY 9,520 (US$ 1,460), yielding an incremental cost-effectiveness ratio (ICER) of CNY 94,300 (US$ 14,500) per QALY gained in 2 years; and to a long-term gain of 0.422 QALYs at an additional cost of CNY 6,530 (US$ 1,000), yielding an ICER of CNY 15,500 (US$ 2,380) per QALY gained in 30 years. Probabilistic sensitivity analysis showed that tPA treatment is cost-effective in 98.7% of the simulations at a willingness-to-pay threshold of CNY 105,000 (US$ 16,200) per QALY. Conclusions: Intravenous tPA treatment within 4.5 hours is highly cost-effective for acute ischemic strokes in China.	[Pan, Yuesong; Chen, Qidong; Zhao, Xingquan; Liao, Xiaoling; Wang, Chunjuan; Du, Wanliang; Liu, Gaifen; Liu, Liping; Wang, Chunxue; Wang, Yilong; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University	Wang, YL (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	yongjunwang1962@gmail.com	liu, li/HGC-0900-2022; Pan, Yuesong/AAI-6303-2020	Pan, Yuesong/0000-0003-3082-6789; Xu, An-Ding/0000-0003-3154-0985; Wang, Shaoshi/0000-0003-2547-0247	State Key Development Program of Basic Research of China [2009CB521905]; National Science and Technology Major Project of China [2011BAI08B02]	State Key Development Program of Basic Research of China(State Key Development Program for Basic Research of China); National Science and Technology Major Project of China	This study was funded by the State Key Development Program of Basic Research of China (2009CB521905), and National Science and Technology Major Project of China (2011BAI08B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beijing Municipal Commission of Development and Reform, MAX RET PRIC W MED C; Boudreau DM, 2013, ANN EMERG MED, V61, P46, DOI 10.1016/j.annemergmed.2012.04.020; Commission on Macroeconomics and Health of World Health Organization, CHOOSING INT AR COST; Demaerschalk BM, 2007, STROKE, V38, P1309, DOI 10.1161/01.STR.0000260185.74694.a7; Ehlers L, 2007, STROKE, V38, P85, DOI 10.1161/01.STR.0000251790.19419.a8; Fagan SC, 1998, NEUROLOGY, V50, P883, DOI 10.1212/WNL.50.4.883; Gao YL, 2009, CHIN J CONVALESCENT, V18, P472; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Heeley E, 2009, STROKE, V40, P2149, DOI 10.1161/STROKEAHA.108.540054; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Jung KT, 2010, J CLIN NEUROL, V6, P117, DOI 10.3988/jcn.2010.6.3.117; Kim AS, 2013, STROKE, V44, pS123, DOI 10.1161/STROKEAHA.111.000067; Kim AS, 2011, STROKE, V42, P2013, DOI 10.1161/STROKEAHA.110.606889; Lee S, 2012, AM J CARDIOL, V110, P845, DOI 10.1016/j.amjcard.2012.05.011; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Liao XL, 2012, CNS NEUROSCI THER, V19, P43; Liu H.T., 2009, CHIN J REHABIL THEOR, V15, P252; Ma RH, 2008, NEUROL RES, V30, P383, DOI 10.1179/174313208X300404; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Ministry of Health of the People's Republic of China, 2012, CHIN HLTH STAT YB 20; National Bureau of Statistics of China, 2010 POP CENS PEOPL; Peltola M, 2013, CEREBROVASC DIS, V35, P113, DOI 10.1159/000346092; Samsa GP, 1999, J CLIN EPIDEMIOL, V52, P259, DOI 10.1016/S0895-4356(98)00151-6; Sandercock P, 2004, STROKE, V35, P1490, DOI 10.1161/01.STR.0000126871.98801.6E; Sinclair SE, 2001, PHARMACOECONOMICS, V19, P927, DOI 10.2165/00019053-200119090-00004; Tanny SPT, 2013, STROKE, V44, P2269, DOI 10.1161/STROKEAHA.113.001295; Tung CE, 2011, STROKE, V42, P2257, DOI 10.1161/STROKEAHA.111.615682; Wahlgren N, 2008, LANCET, V372, P1303, DOI 10.1016/S0140-6736(08)61339-2; Wang YL, 2011, STROKE, V42, P1658, DOI 10.1161/STROKEAHA.110.604249; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Wei JW, 2010, STROKE, V41, P967, DOI 10.1161/STROKEAHA.109.571463; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; You JHS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039640	36	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110525	10.1371/journal.pone.0110525	http://dx.doi.org/10.1371/journal.pone.0110525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329637	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100067
J	Santarnecchi, E; D'Arista, S; Egiziano, E; Gardi, C; Petrosino, R; Vatti, G; Reda, M; Rossi, A				Santarnecchi, Emiliano; D'Arista, Sicilia; Egiziano, Eutizio; Gardi, Concetta; Petrosino, Roberta; Vatti, Giampaolo; Reda, Mario; Rossi, Alessandro			Interaction between Neuroanatomical and Psychological Changes after Mindfulness-Based Training	PLOS ONE			English	Article							TORONTO-ALEXITHYMIA-SCALE; STRESS REDUCTION MBSR; LONG-TERM MEDITATION; CORTICAL THICKNESS; EMOTION REGULATION; CROSS-VALIDATION; BRAIN STRUCTURE; MATTER DENSITY; ACTIVE CONTROL; GRAY	Several cross-sectional studies have documented neuroanatomical changes in individuals with a long history of meditation, while a few evidences are available about the interaction between neuroanatomical and psychological changes even during brief exposure to meditation. Here we analyzed several morphometric indexes at both cortical and subcortical brain level, as well as multiple psychological dimensions, before and after a brief -8 weeks- Mindfulness Based Stress Reduction ( MBSR) training program, in a group of 23 meditation naive-subjects compared to age-gender matched subjects. We found a significant cortical thickness increase in the right insula and the somatosensory cortex of MBSR trainees, coupled with a significant reduction of several psychological indices related to worry, state anxiety, depression and alexithymia. Most importantly, an interesting correlation between the increase in right insula thickness and the decrease in alexithymia levels during the MBSR training were observed. Moreover, a multivariate pattern classification approach allowed to identify a cluster of regions more responsive to MBSR training across subjects. Taken together, these findings documented the significant impact of a brief MBSR training on brain structures, as well as stressing the idea of MBSR as a valuable tool for alexithymia modulation, also originally providing a plausible neurobiological evidence of a major role of right insula into mediating the observed psychological changes.	[Santarnecchi, Emiliano; Vatti, Giampaolo; Rossi, Alessandro] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy; [Santarnecchi, Emiliano; D'Arista, Sicilia; Egiziano, Eutizio; Petrosino, Roberta; Reda, Mario] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy; [Santarnecchi, Emiliano] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; [Gardi, Concetta] Univ Siena, Dept Mol & Dev Med, I-53100 Siena, Italy	University of Siena; University of Siena; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Siena	Santarnecchi, E (corresponding author), Univ Siena, Dept Med Surg & Neurosci, Via Laterina 8, I-53100 Siena, Italy.	emilianosantarnecchi@gmail.com	Santarnecchi, Emiliano/H-7528-2017	Santarnecchi, Emiliano/0000-0002-6533-7427				Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bowen S, 2006, PSYCHOL ADDICT BEHAV, V20, P343, DOI 10.1037/0893-164X.20.3.343; Bressi C, 1996, J PSYCHOSOM RES, V41, P551, DOI 10.1016/S0022-3999(96)00228-0; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Campbell TS, 2012, J BEHAV MED, V35, P262, DOI 10.1007/s10865-011-9357-1; Chiesa A, 2009, J ALTERN COMPLEM MED, V15, P593, DOI 10.1089/acm.2008.0495; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Dong WK, 2004, MENT RETARD DEV D R, V10, P85, DOI 10.1002/mrdd.20016; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; Farb NAS, 2013, SOC COGN AFFECT NEUR, V8, P15, DOI 10.1093/scan/nss066; Farb NAS, 2010, EMOTION, V10, P25, DOI 10.1037/a0017151; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Goldin PR, 2010, EMOTION, V10, P83, DOI 10.1037/a0018441; Grant JA, 2010, EMOTION, V10, P43, DOI 10.1037/a0018334; Grossman P, 2007, PSYCHOTHER PSYCHOSOM, V76, P226, DOI 10.1159/000101501; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hutton C, 2008, NEUROIMAGE, V40, P1701, DOI 10.1016/j.neuroimage.2008.01.027; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Irving Julie Anne, 2009, Complement Ther Clin Pract, V15, P61, DOI 10.1016/j.ctcp.2009.01.002; Kabat-Zinn J, 1998, PSYCHOSOM MED, V60, P625, DOI 10.1097/00006842-199809000-00020; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; KABATZINN J, 1985, J BEHAV MED, V8, P163, DOI 10.1007/BF00845519; KABATZINN J, 1992, AM J PSYCHIAT, V149, P936; Kang DH, 2013, SOC COGN AFFECT NEUR, V8, P27, DOI 10.1093/scan/nss056; Kano M, 2007, PAIN, V132, P252, DOI 10.1016/j.pain.2007.01.032; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Leung MK, 2013, SOC COGN AFFECT NEUR, V8, P34, DOI 10.1093/scan/nss076; Luders E, 2009, NEUROIMAGE, V45, P672, DOI 10.1016/j.neuroimage.2008.12.061; MacCoon DG, 2012, BEHAV RES THER, V50, P3, DOI 10.1016/j.brat.2011.10.011; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Murakami H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046377; Nieuwenhuys R, 2012, PROG BRAIN RES, V195, P123, DOI 10.1016/B978-0-444-53860-4.00007-6; Paul NA, 2013, SOC COGN AFFECT NEUR, V8, P56, DOI 10.1093/scan/nss070; Roemer L, 2009, BEHAV THER, V40, P142, DOI 10.1016/j.beth.2008.04.001; Rosenkranz MA, 2013, BRAIN BEHAV IMMUN, V27, P174, DOI 10.1016/j.bbi.2012.10.013; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; SHIPKO S, 1982, PSYCHOTHER PSYCHOSOM, V37, P193, DOI 10.1159/000287573; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vestergaard-Poulsen P, 2009, NEUROREPORT, V20, P170, DOI 10.1097/WNR.0b013e328320012a; Vigneau F, 2008, J PERS ASSESS, V90, P280, DOI 10.1080/00223890701885027; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032; Yezzi AJ, 2003, IEEE T MED IMAGING, V22, P1332, DOI 10.1109/TMI.2003.817775; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zeidan F, 2011, J NEUROSCI, V31, P5540, DOI 10.1523/JNEUROSCI.5791-10.2011	55	46	46	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e108359	10.1371/journal.pone.0108359	http://dx.doi.org/10.1371/journal.pone.0108359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25330321	Green Published, gold			2022-12-27	WOS:000343942100010
J	Evanoff, A; Sabbath, EL; Carton, M; Czernichow, S; Zins, M; Leclerc, A; Descatha, A				Evanoff, Anastasia; Sabbath, Erika L.; Carton, Matthieu; Czernichow, Sebastien; Zins, Marie; Leclerc, Annette; Descatha, Alexis			Does Obesity Modify the Relationship between Exposure to Occupational Factors and Musculoskeletal Pain in Men? Results from the GAZEL Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; BIOMECHANICAL EXPOSURE; KNEE OSTEOARTHRITIS; RISK-FACTORS; DISORDERS; HEALTH; WORK; ASSOCIATIONS; SYMPTOMS; SHOULDER	Objective: To analyze relationships between physical occupational exposures, post-retirement shoulder/knee pain, and obesity. Methods: 9 415 male participants (aged 63-73 in 2012) from the French GAZEL cohort answered self-administered questionnaires in 2006 and 2012. Occupational exposures retrospectively assessed in 2006 included arm elevation and squatting (never, <10 years, >= 10 years). "Severe'' shoulder and knee pain were defined as >= 5 on an 8-point scale. BMI was self-reported. Results: Mean BMI was 26.59 kg/m(2) +/-3.5 in 2012. Long-term occupational exposure to arm elevation and squatting predicted severe shoulder and knee pain after retirement. Obesity (BMI >= 30 kg/m(2)) was a risk factor for severe shoulder pain (adjusted OR 1.28; 95% CI 1.03, 1.90). Overweight (adjusted OR 1.71; 1.28,2.29) and obesity (adjusted OR 3.21; 1.90,5.41) were risk factors for severe knee pain. In stratified models, associations between long-term squatting and severe knee pain varied by BMI. Conclusion: Obesity plays a role in relationships between occupational exposures and musculoskeletal pain. Further prospective studies should use BMI in analyses of musculoskeletal pain and occupational factors, and continue to clarify this relationship.	[Evanoff, Anastasia; Carton, Matthieu; Czernichow, Sebastien; Zins, Marie; Leclerc, Annette; Descatha, Alexis] Univ Versailles St Quentin, Versailles, France; [Evanoff, Anastasia; Carton, Matthieu; Czernichow, Sebastien; Zins, Marie; Leclerc, Annette; Descatha, Alexis] INSERM, Populat Based Epidemiol Cohorts Unit, UMS 011, Villejuif, France; [Evanoff, Anastasia] Harvard Univ, Cambridge, MA USA; [Sabbath, Erika L.] Harvard Ctr Populat & Dev Studies, Cambridge, MA USA; [Czernichow, Sebastien] Ambroise Pare Univ Hosp, AP HP, Dept Nutr, Boulogne, France; [Descatha, Alexis] Univ Hosp Poincare, AP HP, EMS Samu92, Occupat Hlth Unit, Garches, France	UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Descatha, A (corresponding author), Univ Versailles St Quentin, Versailles, France.	alexis.descatha@uvsq.fr	carton, matthieu/F-8544-2017; Zins, Marie/AAX-6551-2021	carton, matthieu/0000-0002-6793-3273; 	EDF-GDF; INSERM; Cohortes Sante TGIR Program; Harvard College	EDF-GDF; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Cohortes Sante TGIR Program; Harvard College	The GAZEL Cohort Study was funded by EDF-GDF and INSERM and received grants from the "Cohortes Sante TGIR Program" (http://www.iresp.net/appel-a-projet/10-financement-de-cohortes-tres-grandes-infrastructures-de-recherche-2009/). This study is part of the French Agency for Environmental and Occupational Health Safety (Anses, TEMIS project http://www.afssa.fr/ET/PPN0848.htm?pageid = 2843&parentid = 672&ongletlstid = 5553#content). Ms. Evanoff's contributions were supported by the Dunwalke Fund for International Research by Undergraduates from Harvard College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; Bonde JPE, 2013, SCAND J WORK ENV HEA, V39, P217, DOI 10.5271/sjweh.3362; Charles MA, 2008, OBESITY, V16, P2180, DOI [10.1038/oby.2008.285, 10.1038/oby.2008.286]; Coggon D, 2001, INT J OBESITY, V25, P622, DOI 10.1038/sj.ijo.0801585; Descatha A, 2012, SCAND J WORK ENV HEA, V38, P568, DOI 10.5271/sjweh.3300; Descatha A, 2011, SCAND J WORK ENV HEA, V37, P37, DOI 10.5271/sjweh.3123; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Hagberg M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-109; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Luckhaupt SE, 2014, AM J PREV MED, V46, P237, DOI 10.1016/j.amepre.2013.11.002; Martin KR, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-219; McWilliams DF, 2011, OSTEOARTHR CARTILAGE, V19, P829, DOI 10.1016/j.joca.2011.02.016; Miranda H, 2002, OSTEOARTHR CARTILAGE, V10, P623, DOI 10.1053/joca.2002.0796; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pandalai SP, 2013, SCAND J WORK ENV HEA, V39, P221, DOI 10.5271/sjweh.3363; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; van Rijn RM, 2010, SCAND J WORK ENV HEA, V36, P189, DOI 10.5271/sjweh.2895; Viester L, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-238; Wearing SC, 2006, OBES REV, V7, P239, DOI 10.1111/j.1467-789X.2006.00251.x	19	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109633	10.1371/journal.pone.0109633	http://dx.doi.org/10.1371/journal.pone.0109633			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330397	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100017
J	Husain, S; Abdul, Y; Singh, S; Ahmad, A; Husain, M				Husain, Shahid; Abdul, Yasir; Singh, Sudha; Ahmad, Anis; Husain, Mahvash			Regulation of Nitric Oxide Production by delta-Opioid Receptors during Glaucomatous Injury	PLOS ONE			English	Article							OPTIC-NERVE HEAD; RETINAL GANGLION-CELLS; HYPERTENSIVE-RAT MODEL; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; AXONAL-TRANSPORT; MOUSE MODEL; TNF-ALPHA; SYNTHASE; APOPTOSIS	To determine the roles of nitric oxide in glaucomatous injury and its regulation by d-opioid-receptor activation, animals were treated with: 1) a selective inducible nitric oxide synthase (iNOS) inhibitor (aminoguanidine; AG; 25 mg/kg, i. p.); 2) delta-opioid- receptor agonist (SNC-121; 1 mg/kg, i. p.); or 3) with both drugs simultaneously for 7 days, once daily. The loss in retinal ganglion cell (RGC) numbers and their function in glaucomatous eyes were significantly improved in the presence of AG or SNC-121; however, we did not see any significant additive or synergistic effects when animals were treated with both drugs simultaneously. The levels of nitrate-nitrite were significantly increased in the glaucomatous retina when compared with normal retina (normal retina 86 +/- 9 vs. glaucomatous retina 174 +/- 10 mM/mg protein), which was reduced significantly when animals were treated either with SNC-121 (121 +/- 7 mM/mg protein; P<0.05) or AG (128610 mM/mg protein; P< 0.05). Additionally, SNC-121-mediated reduction in nitrate-nitrite levels was not only blocked by naltrindole (a d-opioid-receptor antagonist), but naltrindole treatment potentiated the nitrate-nitrite production in glaucomatous retina (235 +/- 4 mM/mg protein; P< 0.001). As expected, naltrindole treatment also fully-blocked SNC-121-mediated retina neuroprotection. The nitrotyrosine level in the glaucomatous retina was also increased, which was significantly reduced in the SNC-121-treated animals. Additionally, the expression level of iNOS was clearly increased over the control levels in the glaucomatous retina and optic nerves, which was also reduced by SNC-121 treatment. In conclusion, our data support the notion that nitric oxide plays a detrimental role during glaucomatous injury and inhibition of nitric oxide production provided RGC neuroprotection. Furthermore, delta-opioid receptor activation regulates the production of nitric oxide via inhibiting the activity of iNOS in the retina and optic nerve.	[Husain, Shahid; Abdul, Yasir; Singh, Sudha; Ahmad, Anis; Husain, Mahvash] Med Univ S Carolina, Storm Eye Inst, Dept Ophthalmol, Ola B Williams Glaucoma Ctr,Hewitt Lab, Charleston, SC 29425 USA	Medical University of South Carolina	Husain, S (corresponding author), Med Univ S Carolina, Storm Eye Inst, Dept Ophthalmol, Ola B Williams Glaucoma Ctr,Hewitt Lab, Charleston, SC 29425 USA.	Husain@musc.edu	Ahmad, Anis/AAA-7263-2019	Ahmad, Anis/0000-0001-9820-2126; Abdul, Yasir/0000-0002-4973-1918	National Institutes of Health/National Eye Institute [EY019081]; MUSC-SEI from Research to Prevent Blindness, New York, New York; National Institutes of Health from Extramural Research Facilities Program of the National Center for Research Resources [C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019081] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); MUSC-SEI from Research to Prevent Blindness, New York, New York; National Institutes of Health from Extramural Research Facilities Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by National Institutes of Health/National Eye Institute grant EY019081 (SH), and an unrestricted grant to MUSC-SEI from Research to Prevent Blindness, New York, New York. This work was conducted in a facility constructed with support from the National Institutes of Health, Grant Number C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Y, 2013, INVEST OPHTH VIS SCI, V54, P1816, DOI 10.1167/iovs.12-10741; ANDERSON DR, 1969, ARCH OPHTHALMOL-CHIC, V82, P800; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; DAWSON VL, 1993, J NEUROSCI, V13, P2651; Dawson VL, 1998, PROG BRAIN RES, V118, P215; Dortch-Carnes J, 2007, EXP EYE RES, V84, P185, DOI 10.1016/j.exer.2006.09.014; Dortch-Carnes J, 2006, PHARMACOLOGY, V77, P17, DOI 10.1159/000091993; Fuchs C, 2005, INVEST OPHTH VIS SCI, V46, P2983, DOI 10.1167/iovs.04-1177; GEYER O, 1995, FEBS LETT, V374, P399, DOI 10.1016/0014-5793(95)01147-7; Goyagi T, 2003, STROKE, V34, P1533, DOI 10.1161/01.STR.0000072512.30658.E7; Gupta N, 1997, Curr Opin Ophthalmol, V8, P38, DOI 10.1097/00055735-199704000-00007; Husain S, 2012, INVEST OPHTH VIS SCI, V53, P4289, DOI 10.1167/iovs.12-9467; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Koeberle PD, 1999, EXP NEUROL, V158, P366, DOI 10.1006/exnr.1999.7113; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Lichter PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI 10.1016/S0161-6420(01)00873-9; Liu B, 2000, GLIA, V30, P178, DOI 10.1002/(SICI)1098-1136(200004)30:2<178::AID-GLIA7>3.0.CO;2-C; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; McKinnon SJ, 2002, MOL THER, V5, P780, DOI 10.1006/mthe.2002.0608; Muijsers RBM, 1997, LIFE SCI, V60, P1833, DOI 10.1016/S0024-3205(96)00651-0; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Neufeld AH, 1999, P NATL ACAD SCI USA, V96, P9944, DOI 10.1073/pnas.96.17.9944; Neufeld AH, 1997, ARCH OPHTHALMOL-CHIC, V115, P497, DOI 10.1001/archopht.1997.01100150499009; Neufeld AH, 2000, J COMP NEUROL, V416, P269, DOI 10.1002/(SICI)1096-9861(20000110)416:2<269::AID-CNE11>3.0.CO;2-2; Pang IH, 2005, INVEST OPHTH VIS SCI, V46, P1313, DOI 10.1167/iovs.04-0829; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Reichstein D, 2007, EXP EYE RES, V84, P13, DOI 10.1016/j.exer.2006.08.009; Sennlaub F, 2002, J NEUROSCI, V22, P3987, DOI 10.1523/JNEUROSCI.22-10-03987.2002; Shareef S, 1999, INVEST OPHTH VIS SCI, V40, P2884; Sugiyama T, 2000, INVEST OPHTH VIS SCI, V41, P1149; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Varela HJ, 1997, J GLAUCOMA, V6, P303; Yang YL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-55; Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483	37	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110397	10.1371/journal.pone.0110397	http://dx.doi.org/10.1371/journal.pone.0110397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329670	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204100072
J	Moreira-Vilar, FC; Siqueira-Soares, RD; Finger-Teixeira, A; de Oliveira, DM; Ferro, AP; da Rocha, GJ; Ferrarese, MDL; dos Santos, WD; Ferrarese, O				Moreira-Vilar, Flavia Carolina; Siqueira-Soares, Rita de Cassia; Finger-Teixeira, Aline; de Oliveira, Dyoni Matias; Ferro, Ana Paula; da Rocha, George Jackson; Ferrarese, Maria de Lourdes L.; dos Santos, Wanderley Dantas; Ferrarese-Filho, Osvaldo			The Acetyl Bromide Method Is Faster, Simpler and Presents Best Recovery of Lignin in Different Herbaceous Tissues than Klason and Thioglycolic Acid Methods	PLOS ONE			English	Article							CHEMICAL-CHARACTERIZATION; BIOMASS; QUANTIFICATION; BIOSYNTHESIS	We compared the amount of lignin as determined by the three most traditional methods for lignin measurement in three tissues (sugarcane bagasse, soybean roots and soybean seed coat) contrasting for lignin amount and composition. Although all methods presented high reproducibility, major inconsistencies among them were found. The amount of lignin determined by thioglycolic acid method was severely lower than that provided by the other methods (up to 95%) in all tissues analyzed. Klason method was quite similar to acetyl bromide in tissues containing higher amounts of lignin, but presented lower recovery of lignin in the less lignified tissue. To investigate the causes of the inconsistencies observed, we determined the monomer composition of all plant materials, but found no correlation. We found that the low recovery of lignin presented by the thioglycolic acid method were due losses of lignin in the residues disposed throughout the procedures. The production of furfurals by acetyl bromide method does not explain the differences observed. The acetyl bromide method is the simplest and fastest among the methods evaluated presenting similar or best recovery of lignin in all the tissues assessed.	[Moreira-Vilar, Flavia Carolina] Univ Estadual Maringa, Dept Agron, Maringa, Parana, Brazil; [Siqueira-Soares, Rita de Cassia; Finger-Teixeira, Aline; de Oliveira, Dyoni Matias; Ferro, Ana Paula; Ferrarese, Maria de Lourdes L.; dos Santos, Wanderley Dantas; Ferrarese-Filho, Osvaldo] Univ Estadual Maringa, Dept Biochem, Maringa, Parana, Brazil; [da Rocha, George Jackson] Brazilian Bioethanol Sci & Technol Lab, Campinas, SP, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	dos Santos, WD (corresponding author), Univ Estadual Maringa, Dept Biochem, Maringa, Parana, Brazil.	wanderley.dantasdossantos@gmail.br	Santos, Wanderley Dantas dos/AAT-7860-2020; Ferrarese-Filho, Osvaldo/J-1829-2012; /L-5229-2019; FERRO, Ana PAULA/GZL-2980-2022; Santos, Wanderley Dantas dos/A-9019-2013; Oliveira, Dyoni Matias/L-4156-2016	Santos, Wanderley Dantas dos/0000-0002-6072-2860; Ferrarese-Filho, Osvaldo/0000-0002-3477-4544; Oliveira, Dyoni Matias/0000-0002-4871-098X	CNPq [310303/2011-7]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CNPq (http://www.cnpq.br/) grant 310303/2011-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Brinkmann K, 2002, J CHEM ECOL, V28, P2483, DOI 10.1023/A:1021484002582; Bubna GA, 2011, J PLANT PHYSIOL, V168, P1627, DOI 10.1016/j.jplph.2011.03.005; Buckeridge MS, 2012, GCB BIOENERGY, V4, P119, DOI 10.1111/j.1757-1707.2011.01122.x; Bunzel M, 2011, J AGR FOOD CHEM, V59, P12506, DOI 10.1021/jf2031378; Capeleti I, 2005, SEED SCI TECHNOL, V33, P511, DOI 10.15258/sst.2005.33.2.25; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Dean JF., 1997, METHODS PLANT BIOCH, P199; dos Santos WD, 2004, J CHEM ECOL, V30, P1203, DOI 10.1023/B:JOEC.0000030272.83794.f0; Ferrarese MDL, 2002, BIOLOGIA, V57, P541; Fukushima RS, 2011, J AGR FOOD CHEM, V59, P3505, DOI 10.1021/jf104826n; Fukushima RS, 2004, J AGR FOOD CHEM, V52, P3713, DOI 10.1021/jf035497l; Fukushima RS, 2001, J AGR FOOD CHEM, V49, P3133, DOI 10.1021/jf010449r; Goldschmid O., 1971, LIGNINS OCCURRENCE F, P241; Gouveia ER, 2009, QUIM NOVA, V32, P1500, DOI 10.1590/S0100-40422009000600026; Hatfield R, 2005, CROP SCI, V45, P832, DOI 10.2135/cropsci2004.0238; Hatfield RD, 1999, J AGR FOOD CHEM, V47, P628, DOI 10.1021/jf9808776; HE LF, 1990, J WOOD CHEM TECHNOL, V10, P435, DOI 10.1080/02773819008050251; JUNG HG, 1989, AGRON J, V81, P33, DOI 10.2134/agronj1989.00021962008100010006x; Jung HG, 1999, J AGR FOOD; Kline LM, 2010, BIORESOURCES, V5, P1366; Lacerda R. S., 2006, Brazilian Journal of Veterinary Research and Animal Science, V43, P400; Lal R, 2005, ENVIRON INT, V31, P575, DOI 10.1016/j.envint.2004.09.005; Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Novaes E, 2010, PLANT PHYSIOL, V154, P555, DOI 10.1104/pp.110.161281; Raiskila S, 2007, SILVA FENN, V41, P351, DOI 10.14214/sf.301; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Sjostrom E., 1993, WOOD CHEM, V2nd, P1, DOI [DOI 10.1016/B978-0-08-092589-9.50005-X, 10.1016/B978-0-08-092589-9.50005-X]; Su GX, 2005, J PLANT PHYSIOL, V162, P1297, DOI 10.1016/j.jplph.2005.04.033; Suzuki S, 2009, PLANT BIOTECHNOL-NAR, V26, P337, DOI 10.5511/plantbiotechnology.26.337; Van Acker R, 2013, BIOTECHNOL BIOFUELS, V6, P1; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Zobiole LHS, 2010, LIGNIN PROPERTIES AP, P419	35	156	159	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110000	10.1371/journal.pone.0110000	http://dx.doi.org/10.1371/journal.pone.0110000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330077	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800050
J	Park, H; Shin, JW; Park, SG; Kim, W				Park, HeeKuk; Shin, Jong Wook; Park, Sang-Gue; Kim, Wonyong			Microbial Communities in the Upper Respiratory Tract of Patients with Asthma and Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							MYCOPLASMA-PNEUMONIAE; AIRWAY; UNIFRAC; EXACERBATIONS; SIMILARITIES; MENINGITIS	Respiratory infections are well-known triggers of chronic respiratory diseases. Recently, culture-independent tools have indicated that lower airway microbiota may contribute to pathophysiologic processes associated with asthma and chronic obstructive pulmonary disease (COPD). However, the relationship between upper airway microbiota and chronic respiratory diseases remains unclear. This study was undertaken to define differences of microbiota in the oropharynx of asthma and COPD patients relative to those in healthy individuals. To account for the qualitative and quantitative diversity of the 16S rRNA gene in the oropharynx, the microbiomes of 18 asthma patients, 17 COPD patients, and 12 normal individuals were assessed using a high-throughput next-generation sequencing analysis. In the 259,572 total sequence reads, alpha and beta diversity measurements and a generalized linear model revealed that the oropharynx microbiota are diverse, but no significant differences were observed between asthma and COPD patients. Pseudomonas spp. of Proteobacteria and Lactobacillus spp. of Firmicutes were highly abundant in asthma and COPD. By contrast, Streptococcus, Veillonella, Prevotella, and Neisseria of Bacteroidetes dominated in the healthy oropharynx. These findings are consistent with previous studies conducted in the lower airways and suggest that oropharyngeal airway microbiota are important for understanding the relationships between the various parts of the respiratory tract with regard to bacterial colonization and comprehensive assessment of asthma and COPD.	[Park, HeeKuk; Kim, Wonyong] Chung Ang Univ, Coll Med, Dept Microbiol, Seoul 156756, South Korea; [Shin, Jong Wook] Chung Ang Univ, Coll Med, Dept Internal Med, Div Pulmonol & Allergol, Seoul 156756, South Korea; [Park, Sang-Gue] Chung Ang Univ, Dept Appl Stat, Fac Business & Econ, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University	Kim, W (corresponding author), Chung Ang Univ, Coll Med, Dept Microbiol, Seoul 156756, South Korea.	kimwy@cau.ac.kr	Park, Heekuk/G-5292-2016; PARK, Sang-Gue/V-7768-2019; Park, Heekuk/Y-2097-2019	Park, Heekuk/0000-0001-5815-9717; Park, Heekuk/0000-0001-5815-9717	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2013R1A1A2A10012148]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea, which is funded by the Ministry of Education (2013R1A1A2A10012148). The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alamoudi OS, 2007, RESPIROLOGY, V12, P283, DOI 10.1111/j.1440-1843.2006.01002.x; Athanazio R, 2012, CLINICS, V67, P1335, DOI 10.6061/clinics/2012(11)19; Ausubel FM, 1993, MINIPREP BACTERIAL G; Balkundi DR, 1997, J PEDIAT HEMATOL ONC, V19, P82, DOI 10.1097/00043426-199701000-00013; BATES JH, 1992, CHEST, V101, P1005, DOI 10.1378/chest.101.4.1005; Bourdin A, 2009, THORAX, V64, P999, DOI 10.1136/thx.2008.112862; Buist AS, 2003, EUR RESPIR J, V21, p30S, DOI 10.1183/09031936.03.00404903; Cabellos C, 1999, CLIN INFECT DIS, V28, P1104, DOI 10.1086/514758; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Dang Hien Thanh, 2013, Journal of Bacteriology and Virology, V43, P270, DOI 10.4167/jbv.2013.43.4.270; de Vrankrijker AMM, 2010, PAEDIATR RESPIR REV, V11, P246, DOI 10.1016/j.prrv.2010.07.003; Emerson J, 2010, PEDIATR PULM, V45, P363, DOI 10.1002/ppul.21198; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Garzoni C, 2013, THORAX, V68, P1150, DOI 10.1136/thoraxjnl-2012-202917; Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hofer U, 2014, NAT REV MICROBIOL, V12, DOI 10.1038/nrmicro3180; Huang YJ, 2014, J CLIN MICROBIOL; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Kraft M, 2008, EUR RESPIR J, V31, P43, DOI 10.1183/09031936.00103307; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; Kurai D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00293; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lu HZ, 2003, J CLIN MICROBIOL, V41, P3051, DOI 10.1128/JCM.41.7.3051-3055.2003; Lyytikainen O, 2004, J ANTIMICROB CHEMOTH, V53, P631, DOI 10.1093/jac/dkh159; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Millar FA, 2009, J CYST FIBROS, V8, P386, DOI 10.1016/j.jcf.2009.08.003; MLB.com, 2013, 1 4 GAM 2013 WORLD S; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; National Institutes of Health, 1997, 2 NAT ASTHM ED PREV, P97; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Ramsey CD, 2007, J ALLERGY CLIN IMMUN, V119, P150, DOI 10.1016/j.jaci.2006.09.012; Rd J., 2013, HUPE J, V12, P57; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sethi S, 2007, AM J RESP CRIT CARE, V176, P356, DOI 10.1164/rccm.200703-417OC; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Tamada K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015126; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Wedzicha JA, 2003, THORAX, V58, P1, DOI 10.1136/thorax.58.1.1; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; World Health Organization, 2006, ASTHMA	52	29	32	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109710	10.1371/journal.pone.0109710	http://dx.doi.org/10.1371/journal.pone.0109710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329665	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210800032
J	Tao, CJ; Lin, L; Zhou, GQ; Tang, LL; Chen, L; Mao, YP; Zeng, MS; Kang, TB; Jia, WH; Shao, JY; Mai, HQ; Lin, AH; Ma, J; Sun, Y				Tao, Chang-Juan; Lin, Li; Zhou, Guan-Qun; Tang, Ling-Long; Chen, Lei; Mao, Yan-Ping; Zeng, Mu-Sheng; Kang, Tie-Bang; Jia, Wei-Hua; Shao, Jian-Yong; Mai, Hai-Qiang; Lin, Ai-Hua; Ma, Jun; Sun, Ying			Comparison of Long-Term Survival and Toxicity of Cisplatin Delivered Weekly versus Every Three Weeks Concurrently with Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; PHASE-III; RANDOMIZED-TRIAL; CHEMORADIOTHERAPY; CANCER; METAANALYSIS	Background: We aimed to compare the long-term survival outcomes and acute toxicity of cisplatin administered weekly versus every three weeks concurrently with intensity-modulated radiotherapy (IMRT) in patients with nasopharyngeal carcinoma (NPC). Methods: This was a retrospective review of 154 patients with histologically proven, non-disseminated NPC who were treated using IMRT between January 2003 and December 2007. Seventy-three patients (47.4%) received 5-7 weeks of 30-40 mg/m(2) cisplatin weekly; 81 patients (52.6%) received two or three cycles of 80 mg/m(2) cisplatin every three weeks. IMRT was delivered at 68 Gy/30 fractions to the nasopharyngeal gross target volume and 60-66 Gy to the involved neck area. Results: The clinical characteristics and treatment factors of the two groups were well-balanced. The median follow-up was 74 months (range, 6-123 months), and the 5-year overall survival, disease-free survival, locoregional relapse-free survival, and distant metastasis-free survival rates were 85.2% vs. 78.9% (P = 0.318), 71.6% vs. 71.0% (P = 0.847), 93.5% vs. 92.6% (P = 0.904), and 80.9% vs. 80.1% (P = 0.925) for the group treated every three weeks and weekly, respectively. Subgroup analyses indicated no significant differences in the survival rates of the two groups among patients with early-or advanced-stage disease. The incidence of acute toxicities was similar between groups. Conclusion: IMRT with concurrent cisplatin administered weekly or every three weeks leads to similar long-term survival outcomes and acute toxicity in NPC regardless of whether patients have early- or advanced-stage disease.	[Tao, Chang-Juan; Lin, Li; Zhou, Guan-Qun; Tang, Ling-Long; Chen, Lei; Mao, Yan-Ping; Ma, Jun; Sun, Ying] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Tao, Chang-Juan] Zhejiang Canc Hosp, Dept Radiat Oncol, Hangzhou, Zhejiang, Peoples R China; [Zeng, Mu-Sheng; Kang, Tie-Bang; Jia, Wei-Hua] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Shao, Jian-Yong] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Mai, Hai-Qiang] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Nasopharynge, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Ai-Hua] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Zhejiang Cancer Hospital; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Sun, Y (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China.	sunying@sysucc.org.cn			National Natural Science Foundation of China [8172409]; Sun Yat-Sen University Clinical Research 5010 Program [2012011]; Natural Science Foundation of Guangdong Province [S2013010012220]; Science and Technology project of Guangzhou City, China [132000507]; Health & Medical Collaborative Innovation Project of Guangzhou City, China [201400000001]; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2014BAI09B10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun Yat-Sen University Clinical Research 5010 Program; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology project of Guangzhou City, China; Health & Medical Collaborative Innovation Project of Guangzhou City, China; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period	This work was supported by grants from the National Natural Science Foundation of China (No. 8172409), the Sun Yat-Sen University Clinical Research 5010 Program (No. 2012011), the Natural Science Foundation of Guangdong Province (No. S2013010012220), the Science and Technology project of Guangzhou City, China (No. 132000507), the Health & Medical Collaborative Innovation Project of Guangzhou City, China (201400000001), and the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2014BAI09B10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Chan ATC, 2005, J NATL CANCER I, V97, P536, DOI 10.1093/jnci/dji084; Chen L, 2012, RADIOTHER ONCOL, V104, P331, DOI 10.1016/j.radonc.2011.10.009; Chen L, 2012, LANCET ONCOL, V13, P163, DOI 10.1016/S1470-2045(11)70320-5; Chen QY, 2011, JNCI-J NATL CANCER I, V103, P1761, DOI 10.1093/jnci/djr432; Chen Y, 2013, CANCER-AM CANCER SOC, V119, P2230, DOI 10.1002/cncr.28049; COX DR, 1972, J R STAT SOC B, V34, P187; Edge SB, 2009, AM JOINT COMMITTEE C; Ho KF, 2008, ACTA ONCOL, V47, P1513, DOI 10.1080/02841860701846160; Jagdis A, 2012, AM J CLIN ONCOL 1029, P29; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lee AWM, 2012, J RADIOL ONCOL, V1, P107, DOI 10.1007/s13566-012-0032-0; Lee AWM, 2010, JNCI-J NATL CANCER I, V102, P1188, DOI 10.1093/jnci/djq258; Lee AWM, 2005, J CLIN ONCOL, V23, P6966, DOI 10.1200/JCO.2004.00.7542; Liang SB, 2009, INT J RADIAT ONCOL, V75, P742, DOI 10.1016/j.ijrobp.2008.11.053; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Loong HH, 2012, RADIOTHER ONCOL, V104, P300, DOI 10.1016/j.radonc.2011.12.022; OuYang PY, 2013, ANN ONCOL, V24, P2136, DOI 10.1093/annonc/mdt146; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Zhao Chong, 2004, Ai Zheng, V23, P1532	22	27	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110765	10.1371/journal.pone.0110765	http://dx.doi.org/10.1371/journal.pone.0110765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329593	gold, Green Published			2022-12-27	WOS:000343210800110
J	Gautrais, J; Buhl, J; Valverde, S; Kuntz, P; Theraulaz, G				Gautrais, Jacques; Buhl, Jerome; Valverde, Sergi; Kuntz, Pascale; Theraulaz, Guy			The Role of Colony Size on Tunnel Branching Morphogenesis in Ant Nests	PLOS ONE			English	Article							ARCHITECTURE; HYMENOPTERA; EXCAVATION; BEHAVIOR; AGGREGATION; COMPLEXITY; NETWORKS; PATTERNS; GROWTH	Many ant species excavate nests that are made up of chambers and interconnecting tunnels. There is a general trend of an increase in nest complexity with increasing population size. This complexity reflects a higher ramification and anastomosis of tunnels that can be estimated by the meshedness coefficient of the tunnelling networks. It has long been observed that meshedness increases with colony size within and across species, but no explanation has been provided so far. Since colony size is a strong factor controlling collective digging, a high value of the meshedness could simply be a side effect of a larger number of workers. To test this hypothesis, we study the digging dynamics in different group size of ants Messor sancta. We build a model of collective digging that is calibrated from the experimental data. Model's predictions successfully reproduce the topological properties of tunnelling networks observed in experiments, including the increase of the meshedness with group size. We then use the model to investigate situations in which collective digging progresses outward from a centre corresponding to the way tunnelling behaviour occurs in field conditions. Our model predicts that, when all other parameters are kept constant, an increase of the number of workers leads to a higher value of the meshedness and a transition from tree-like structures to highly meshed networks. Therefore we conclude that colony size is a key factor determining tunnelling network complexity in ant colonies.	[Gautrais, Jacques; Theraulaz, Guy] Univ Toulouse, Ctr Rech Cognit Anim, Toulouse, France; [Gautrais, Jacques; Theraulaz, Guy] CNRS, UMR5169, Ctr Rech Cognit Anim, Toulouse, France; [Buhl, Jerome] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Valverde, Sergi] Complex Syst Lab ICREA UPF, Barcelona, Spain; [Valverde, Sergi] Inst Biol Evolut CSIC UPF, Barcelona, Spain; [Kuntz, Pascale] Polytech Nantes, Lab Informat Nantes Atlantique, Nantes, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Adelaide; ICREA; Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Nantes Universite	Gautrais, J (corresponding author), Univ Toulouse, Ctr Rech Cognit Anim, Toulouse, France.	jacques.gautrais@univ-tlse3.fr	Gautrais, Jacques/B-4523-2008; Buhl, Jerome/AAE-1687-2020; Valverde, Sergi/J-3275-2012; Theraulaz, Guy/H-8464-2016	Gautrais, Jacques/0000-0002-7002-9920; Buhl, Jerome/0000-0002-7506-6835; Valverde, Sergi/0000-0002-2150-9610; Theraulaz, Guy/0000-0002-3062-4215	Ministry of Higher Education and Research of France (Programme Cognitique); MESOMORPH project [ANR-06-BYOS-0008]; Australian Research Council; ICREA Funding Source: Custom	Ministry of Higher Education and Research of France (Programme Cognitique); MESOMORPH project; Australian Research Council(Australian Research Council); ICREA(ICREA)	This study was supported by grants from the Ministry of Higher Education and Research of France (Programme Cognitique) and MESOMORPH project grant ANR-06-BYOS-0008. Jerome Buhl was supported by grants from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2001, BIOL REV, V76, P211, DOI 10.1017/S1464793101005656; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bollazzi M, 2008, OECOLOGIA, V158, P165, DOI 10.1007/s00442-008-1113-z; Bollazzi M, 2007, ANIM BEHAV, V74, P1349, DOI 10.1016/j.anbehav.2007.02.021; Bollazzi M, 2010, J ETHOL, V28, P399, DOI 10.1007/s10164-010-0207-3; BRIAN MV, 1983, SOCIAL INSECTS ECOLO; BRISTOW CM, 1992, INSECT SOC, V39, P385, DOI 10.1007/BF01240623; Buhl J, 2005, BEHAV ECOL SOCIOBIOL, V58, P9, DOI 10.1007/s00265-004-0906-2; Buhl J, 2004, NATURWISSENSCHAFTEN, V91, P602, DOI 10.1007/s00114-004-0577-x; Buhl J, 2004, EUR PHYS J B, V42, P123, DOI 10.1140/epjb/e2004-00364-9; Buhl J, 2006, J THEOR BIOL, V243, P287, DOI 10.1016/j.jtbi.2006.06.018; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Cassill D, 2002, INSECT SOC, V49, P158, DOI 10.1007/s00040-002-8296-9; Cerdan P, 1989, ETUDE BIOL ECOLOGIE; DELYE G, 1971, INSECT SOC, V18, P15, DOI 10.1007/BF02223160; Detrain C, 2006, PHYS LIFE REV, V3, P162, DOI 10.1016/j.plrev.2006.07.001; Forel A., 1874, ALLG SCHWEIZ GES GES, V26, P1, DOI DOI 10.5962/BHL.TITLE.125537; Franks NR, 1997, ANIM BEHAV, V54, P779, DOI 10.1006/anbe.1996.0496; Gautrais J, 2002, J THEOR BIOL, V215, P363, DOI 10.1006/jtbi.2001.2506; Gautrais J, 2004, INTERACT STUD, V5, P245, DOI 10.1075/is.5.2.05gau; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Halley JD, 2005, INSECT SOC, V52, P350, DOI 10.1007/s00040-005-0818-9; Hasiotis ST, 2003, PALAEOGEOGR PALAEOCL, V192, P259, DOI 10.1016/S0031-0182(02)00689-2; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Khuong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076531; Kuhnert C, 2006, PHYSICA A, V363, P96, DOI 10.1016/j.physa.2006.01.058; Mikheyev AS, 2004, INSECT SOC, V51, P30, DOI 10.1007/s00040-003-0703-3; Minter NJ, 2012, J R SOC INTERFACE, V9, P586, DOI 10.1098/rsif.2011.0377; Rasse P, 2001, J INSECT BEHAV, V14, P433, DOI 10.1023/A:1011163804217; Rasse P, 1999, ETUDE REGULATION TAI; Schueller S., 2004, THESIS U RENNES 1; Theraulaz G, 2002, P NATL ACAD SCI USA, V99, P9645, DOI 10.1073/pnas.152302199; Toffin E, 2010, P ROY SOC B-BIOL SCI, V277, P2617, DOI 10.1098/rspb.2010.0176; Toffin E, 2009, P NATL ACAD SCI USA, V106, P18616, DOI 10.1073/pnas.0902685106; TOHME G, 1972, INSECT SOC, V19, P95, DOI 10.1007/BF02224727; Tschinkel WR, 2010, J INSECT SCI, V10, DOI [10.1673/031.010.8801, 10.1673/031.010.6501]; Tschinkel WR, 2011, J INSECT SCI, V11; Tschinkel WR, 1999, ANN ENTOMOL SOC AM, V92, P80, DOI 10.1093/aesa/92.1.80; TSCHINKEL WR, 1987, INSECT SOC, V34, P143, DOI 10.1007/BF02224081; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2003, PALAEOGEOGR PALAEOCL, V192, P321, DOI 10.1016/S0031-0182(02)00690-9; von Frish K, 1975, ANIMAL ARCHITECTURE	42	11	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109436	10.1371/journal.pone.0109436	http://dx.doi.org/10.1371/journal.pone.0109436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25330080	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200030
J	Makarevic, J; Rutz, J; Juengel, E; Kaulfuss, S; Tsaur, I; Nelson, K; Pfitzenmaier, J; Haferkamp, A; Blaheta, RA				Makarevic, Jasmina; Rutz, Jochen; Juengel, Eva; Kaulfuss, Silke; Tsaur, Igor; Nelson, Karen; Pfitzenmaier, Jesco; Haferkamp, Axel; Blaheta, Roman A.			Amygdalin Influences Bladder Cancer Cell Adhesion and Invasion In Vitro	PLOS ONE			English	Article							CARCINOMA-CELLS; EXPRESSION; MIGRATION; COMPLEMENTARY; LAETRILE; LINES; COLLAGEN; ACID	The cyanogenic diglucoside amygdalin, derived from Rosaceae kernels, is employed by many patients as an alternative anticancer treatment. However, whether amygdalin indeed acts as an anti-tumor agent is not clear. Metastasis blocking properties of amygdalin on bladder cancer cell lines was, therefore, investigated. Amygdalin (10 mg/ml) was applied to UMUC-3, TCCSUP or RT112 bladder cancer cells for 24 h or for 2 weeks. Tumor cell adhesion to vascular endothelium or to immobilized collagen as well as tumor cell migration was examined. Effects of drug treatment on integrin alpha and beta subtypes, on integrin-linked kinase (ILK) and total and activated focal adhesion kinase (FAK) were also determined. Integrin knockdown was carried out to evaluate integrin influence on migration and adhesion. A 24 h or 2 week amygdalin application distinctly reduced tumor cell adhesion and migration of UMUC-3 and RT112 cells. TCCSUP adhesion was also reduced, but migration was elevated under amygdalin. Integrin subtype expression was significantly and specifically altered by amygdalin depending on the cell line. ILK was moderately, and activated FAK strongly, lost in all tumor cell lines in the presence of amygdalin. Knock down of beta 1 integrin caused a significant decrease in both adhesion and migration of UMUC-3 cells, but a significant increase in TCCSUP adhesion. Knock down of beta 4 integrin caused a significant decrease in migration of RT112 cells. Since the different actions of amygdalin on the different cell lines was mirrored by beta 1 or beta 4 knock down, it is postulated that amygdalin influences adhesion and migratory properties of bladder cancer cells by modulating beta 1 or beta 4 integrin expression. The amygdalin induced increase in TCCSUP migratory behavior indicates that any anti-tumor benefits from amygdalin (seen with the other two cell lines) may depend upon the cancer cell type.	[Makarevic, Jasmina; Rutz, Jochen; Juengel, Eva; Tsaur, Igor; Haferkamp, Axel; Blaheta, Roman A.] Goethe Univ Hosp, Dept Urol, Frankfurt, Germany; [Kaulfuss, Silke] Univ Med Ctr Gottingen, Inst Human Genet, Gottingen, Germany; [Nelson, Karen] Goethe Univ Hosp, Dept Vasc & Endovasc Surg, Frankfurt, Germany; [Pfitzenmaier, Jesco] Evangel Hosp Bielefeld, Dept Urol, Bielefeld, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Gottingen; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Blaheta, RA (corresponding author), Goethe Univ Hosp, Dept Urol, Frankfurt, Germany.	Blaheta@em.uni-frankfurt.de	Tsaur, Igor/ACG-6445-2022	Tsaur, Igor/0000-0001-5107-3523; Kaulfuss, Silke/0000-0003-2577-9711	Brigitta und Norbert Muth Stiftung; Freunde und Forderer der Goethe-Universitat Frankfurt	Brigitta und Norbert Muth Stiftung; Freunde und Forderer der Goethe-Universitat Frankfurt	This work was supported by the "Brigitta und Norbert Muth Stiftung" and the "Freunde und Forderer der Goethe-Universitat Frankfurt" (funding received by RAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay C, 2012, SENSORS-BASEL, V12, P5951, DOI 10.3390/s120505951; Chakraborty A, 2006, UROLOGY, V68, P208, DOI 10.1016/j.urology.2006.01.046; Chen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017933; Citrin DL, 2012, ONCOLOGIST, V17, P607, DOI 10.1634/theoncologist.2011-0468; Fischer FH, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-46; Genua M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040148; Geraldo S, 2012, EUR J CELL BIOL, V91, P930, DOI 10.1016/j.ejcb.2012.07.005; Gillett J, 2012, J ALTERN COMPLEM MED, V18, P1014, DOI 10.1089/acm.2011.0334; Green TP, 2009, MOL ONCOL, V3, P248, DOI 10.1016/j.molonc.2009.01.002; Heyder C, 2005, CLIN EXP METASTAS, V22, P99, DOI 10.1007/s10585-005-4335-z; Huebner J, 2014, ANTICANCER RES, V34, P943; Jacquemet G, 2013, J CELL BIOL, V202, P917, DOI 10.1083/jcb.201302041; Juengel E, 2014, NEOPLASIA, V16, P291, DOI 10.1016/j.neo.2014.03.011; Juengel E, 2013, EXP BIOL MED, V238, P1297, DOI 10.1177/1535370213498975; Lai KC, 2011, HUM EXP TOXICOL, V30, P1045, DOI 10.1177/0960327110386257; Laidler P, 2000, ACTA BIOCHIM POL, V47, P1159, DOI 10.18388/abp.2000_3968; LIEBERT M, 1994, AM J PATHOL, V144, P1016; Litynska A, 2002, ACTA BIOCHIM POL, V49, P643; Makarevic J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105590; Matsui Y, 2012, INT J CANCER, V130, P521, DOI 10.1002/ijc.26008; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; Milazzo S, 2007, SUPPORT CARE CANCER, V15, P583, DOI 10.1007/s00520-006-0168-9; MOERTEL CG, 1982, NEW ENGL J MED, V306, P201, DOI 10.1056/NEJM198201283060403; Moss Ralph W, 2005, Integr Cancer Ther, V4, P65, DOI 10.1177/1534735404273918; NEWELL GR, 1980, CANCER TREAT REP, V64, P363; Oertl A, 2006, INT J MOL MED, V18, P347; Saghatchian M, 2014, BREAST IN PRESS; Wedel S, 2011, CLIN EXP METASTAS, V28, P479, DOI 10.1007/s10585-011-9386-8; Weiger MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058859; Xiong D, 2014, EXP MOL PAT IN PRESS; Yamasaki M, 2014, J CLIN BIOCHEM NUTR, V54, P18, DOI 10.3164/jcbn.13-57	31	25	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110244	10.1371/journal.pone.0110244	http://dx.doi.org/10.1371/journal.pone.0110244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333694	Green Published, gold			2022-12-27	WOS:000346766200107
J	Schauwecker, PE				Schauwecker, Paula Elyse			Susceptibility to Seizure-Induced Excitotoxic Cell Death Is Regulated by an Epistatic Interaction between Chr 18 (Sicd1) and Chr 15 (Sicd2) Loci in Mice	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; SYSTEMIC KAINIC ACID; QUANTITATIVE TRAIT LOCUS; HYBRID MOUSE STRAINS; STATUS EPILEPTICUS; NEURONAL DAMAGE; DIFFERENTIAL SUSCEPTIBILITY; SYNAPTIC REORGANIZATION; CONVULSANT PILOCARPINE; CONGENIC STRAINS	Seizure-induced cell death is believed to be regulated by multiple genetic components in addition to numerous external factors. We previously defined quantitative trait loci that control susceptibility to seizure-induced cell death in FVB/NJ (susceptible) and C57BL/6J (resistant) mice. Two of these quantitative trait loci assigned to chromosomes 18 (Sicd1) and 15 (Sicd2), control seizure-induced cell death resistance. In this study, through the use of a series of novel congenic strains containing the Sicd1 and Sicd2 congenic strains and different combinations of the Sicd1 or Sicd2 sub region(s), respectively, we defined these genetic interactions. We generated a double congenic strain, which contains the two C57BL/6J differential segments from chromosome 18 and 15, to determine how these two segments interact with one another. Phenotypic comparison between FVB-like littermates and the double congenic FVB.B6-Sicd1/Sicd2 strain identified an additive effect with respect to resistance to seizure-induced excitotoxic cell death. It thus appears that C57BL/6J alleles located on chromosomes 18 and 15 interact epistatically in an additive manner to control the extent of seizure-induced excitotoxic cell death. Three interval-specific congenic lines were developed, in which either segments of C57BL/6J Chr 18 or C57BL/6J Chr 15 were introduced in the FVB/NJ genetic background, and progeny were treated with kainate and examined for the extent of seizure-induced cell death. All of the interval-specific congenic lines exhibited reduced cell death in both area CA3 and the dentate hilus, associated with the C57BL/6J phenotype. These experiments demonstrate functional interactions between Sicd1 and Sicd2 that improve resistance to seizure-induced excitotoxic cell death, validating the critical role played by gene-gene interactions in excitotoxic cell death.	USC Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	University of Southern California	Schauwecker, PE (corresponding author), USC Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA.	schauwec@usc.edu			National Institutes of Health (NIH) [NS38696]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038696] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health (NIH) NS38696. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Babb T L, 1986, Adv Neurol, V44, P949; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BENARI Y, 1984, DEV BRAIN RES, V14, P284, DOI 10.1016/0165-3806(84)90314-6; Berger M L, 1986, Adv Exp Med Biol, V203, P199; Berkovic SF, 2006, TRENDS NEUROSCI, V29, P391, DOI 10.1016/j.tins.2006.05.009; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; COYLE JT, 1983, J NEUROCHEM, V41, P1; Engel J Jr, 1989, Acta Neurochir Suppl (Wien), V46, P3; Ferraro TN, 2007, PHYSIOL GENOMICS, V31, P458, DOI 10.1152/physiolgenomics.00123.2007; FERRARO TN, 1995, EPILEPSIA, V36, P301, DOI 10.1111/j.1528-1157.1995.tb00999.x; Ferraro TN, 2004, MAMM GENOME, V15, P239, DOI 10.1007/s00335-003-2270-3; Ferraro TN, 1997, MAMM GENOME, V8, P200, DOI 10.1007/s003359900389; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Ferraro TN, 2001, GENOMICS, V75, P35, DOI 10.1006/geno.2001.6577; Ferraro TN, 1998, BRAIN RES, V813, P207, DOI 10.1016/S0006-8993(98)01013-0; FISHER RS, 1989, BRAIN RES REV, V14, P245, DOI 10.1016/0165-0173(89)90003-9; Frankel WN, 2001, GENOMICS, V74, P306, DOI 10.1006/geno.2001.6564; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; FUJIKAWA DG, 1994, EPILEPSY RES, V17, P207, DOI 10.1016/0920-1211(94)90051-5; Fujikawa DG, 1996, BRAIN RES, V725, P11, DOI 10.1016/0006-8993(96)00203-X; Fujikawa DG, 1995, EPILEPSIA, V36, P185; Galanopoulou AS, 2002, DEV NEUROSCI-BASEL, V24, P355, DOI 10.1159/000069047; GOLDEN GT, 1995, EPILEPSY RES, V20, P151, DOI 10.1016/0920-1211(94)00079-C; Holmes GL, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.9_suppl_5.S3; Hu RQ, 1998, BRAIN RES, V810, P229, DOI 10.1016/S0006-8993(98)00863-4; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Lorenzana A, 2007, EUR J NEUROSCI, V25, P1998, DOI 10.1111/j.1460-9568.2007.05443.x; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Mathern GW, 2002, PROG BRAIN RES, V135, P237; MATHERN GW, 1993, ELECTROEN CLIN NEURO, V87, P326, DOI 10.1016/0013-4694(93)90186-Y; McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1; McLin JP, 2006, EUR J NEUROSCI, V24, P3134, DOI 10.1111/j.1460-9568.2006.05198.x; McLin JP, 2006, EUR J NEUROSCI, V24, P2191, DOI 10.1111/j.1460-9568.2006.05111.x; Morrison RS, 1996, J NEUROSCI, V16, P1337; Muller CJ, 2009, GENES BRAIN BEHAV, V8, P481, DOI 10.1111/j.1601-183X.2009.00490.x; Muller CJ, 2009, EUR J PHARMACOL, V619, P15, DOI 10.1016/j.ejphar.2009.07.020; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; NADLER JV, 1983, METHOD ENZYMOL, V103, P393; NADLER JV, 1980, BRAIN RES, V195, P47; NADLER JV, 1980, J COMP NEUROL, V192, P333, DOI 10.1002/cne.901920209; NITECKA L, 1984, NEUROSCIENCE, V13, P1073, DOI 10.1016/0306-4522(84)90289-6; Olney J W, 1986, Adv Neurol, V44, P857; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Santos JB, 2003, EPILEPSIA, V44, P995, DOI 10.1046/j.1528-1157.2003.66302.x; Schauwecker PE, 2011, GENES BRAIN BEHAV, V10, P100, DOI 10.1111/j.1601-183X.2010.00644.x; Schauwecker PE, 2004, J COMP NEUROL, V477, P96, DOI 10.1002/cne.20245; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Schauwecker PE, 2000, BRAIN RES, V884, P116, DOI 10.1016/S0006-8993(00)02888-2; Scheffer IE, 2010, BRAIN, V133, P7, DOI 10.1093/brain/awp332; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Sidman Richard L., 1971, ATLAS MOUSE BRAIN SP; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Steinlein OK, 2010, N-S ARCH PHARMACOL, V382, P109, DOI 10.1007/s00210-010-0531-8; Suchomelova L, 2006, PEDIATR RES, V59, P237, DOI 10.1203/01.pdr.0000196333.16608.30; Tan NCK, 2006, CURR OPIN NEUROL, V19, P157, DOI 10.1097/01.wco.0000218232.66054.46; TURSKI L, 1987, POL J PHARMACOL PHAR, V39, P545; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Upton N, 2003, CURR OPIN PHARMACOL, V3, P19, DOI 10.1016/S1471-4892(02)00010-3; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Winawer MR, 2007, NEUROSCIENCE, V149, P465, DOI 10.1016/j.neuroscience.2007.06.009; WOLF HK, 1993, J NEUROPATH EXP NEUR, V52, P499, DOI 10.1097/00005072-199309000-00008	66	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110515	10.1371/journal.pone.0110515	http://dx.doi.org/10.1371/journal.pone.0110515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333963	gold, Green Published			2022-12-27	WOS:000346766200124
J	Zhao, K; Kang, WZ; Liu, QQ; Li, Y; Liu, Q; Jiang, W; Zhuang, Y; Guo, ZS; Yu, ZR; Li, XH; Wang, CF; Yao, N; Sun, YT				Zhao, Ke; Kang, Wenzhen; Liu, Qingquan; Li, Yuan; Liu, Qing; Jiang, Wei; Zhuang, Yan; Guo, Zisheng; Yu, Zhuoran; Li, Xinhong; Wang, Chunfu; Yao, Na; Sun, Yongtao			Genotypes and Transmitted Drug Resistance among Treatment-Naive HIV-1-Infected Patients in a Northwestern Province, China: Trends from 2003 to 2013	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; ANTIRETROVIRAL THERAPY; GENETIC DIVERSITY; PREVALENCE; VIRUS; RECOMBINATION; TRANSMISSION; MUTATIONS; CRF07-BC; CRF01-AE	Background: Transmitted drug resistance (TDR) reduces the efficacy of initial antiretroviral treatment and has become a public health concern. Little information is available regarding the genetic diversity of HIV-1 and the prevalence of TDR among treatment-naive patients in a northwestern province of China since the implementation of national free antiretroviral therapy (ART). Methods: Blood samples from 372 HIV-1 treatment-naive patients were collected between 2003 and 2013 in Shaanxi province. Viral RNA was extracted for nested PCR, and phylogenetic reconstruction and recombination analyses were performed to characterize patterns of the HIV-1 subtypes. Genotypic drug resistance testing was performed using an in-house assay to determine trends in the prevalence of HIV-1 transmitted drug resistance. Results: Multiple genotypes were identified among the patients in Shaanxi, including B (25.0%), C (0.3%), G (0.3%), and CRF01_AE (39.2%), CRF07_BC (32.7%), CRF08_BC (0.8%), CRF55_01B (1.1%), and URFs (0.6%). The subtypes were associated with the transmission routes (chi(2) = 77.113, p<0.01). In this study, a low baseline CD4(+) T cell count and a high viral load were found among CRF01_AE-infected patients compared with patients who were infected with non-CRF01_AE (p<0.01) through sexual transmission; however, the CRF01_AE subtype was not associated with a low baseline CD4+ T cell count or a high viral load in Chinese patients infected through blood transmission (p = 0.249). The overall TDR rate in this population was 4.4% between 2003 and 2013. A univariate logistic regression model revealed that a low CD4 T cell count (<= 100 cells/mL) was associated with the development of drug-resistant strains. Conclusion: Our work revealed diverse HIV-1 subtype distributions in Shaanxi province. We identified a low and stable TDR time trend among ART-naive patients. These findings enhance our understanding of HIV-1 genetic diversity and provide some guidelines for the improvement and implementation of a comprehensive public health strategy of HIV-1 TDR prevention.	[Zhao, Ke; Kang, Wenzhen; Li, Yuan; Liu, Qing; Jiang, Wei; Zhuang, Yan; Guo, Zisheng; Yu, Zhuoran; Li, Xinhong; Wang, Chunfu; Yao, Na; Sun, Yongtao] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi Provinc, Peoples R China; [Liu, Qingquan] Fourth Mil Med Univ, Tangdu Hosp, Dept Endocrinol, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Sun, YT (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi Provinc, Peoples R China.	yongtaos@hotmail.com	yao, na/HDL-8772-2022		National Grand Program on Key Infectious Disease Control [2014ZX10001002, 2013ZX10001002-002-003]; Tangdu Technology Innovation and Development Program [2012LCYJ002]	National Grand Program on Key Infectious Disease Control; Tangdu Technology Innovation and Development Program	This work was supported by the National Grand Program on Key Infectious Disease Control (No. 2014ZX10001002, 2013ZX10001002-002-003), Tangdu Technology Innovation and Development Program (No. 2012LCYJ002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GENOME ANNOUNC; Baden LR, 2012, NEW ENGL J MED, V366, P1343, DOI 10.1056/NEJMe1202492; Beijing Health and Family planning Commission website, 2013, HIV AIDS SIT BEIJ; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Chen M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-382; Chinese Centers for Disease Control Prevention website, 2013 CHIN AIDS RESP; Chun TW, 2012, AIDS, V26, P1261, DOI 10.1097/QAD.0b013e328353f3f1; Frentz D, 2012, AIDS REV, V14, P17; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hamimi C, 2013, CURR OPIN HIV AIDS, V8, P196, DOI 10.1097/COH.0b013e32835f94d5; Huang DD, 2010, DIAGN MICR INFEC DIS, V68, P208, DOI 10.1016/j.diagmicrobio.2010.06.007; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JZ, 2013, CLIN INFECT DIS, V56, P1667, DOI 10.1093/cid/cit125; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075777; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li LN, 2014, AIDS RES HUM RETROV, V30, P160, DOI [10.1089/aid.2013.0144, 10.1089/AID.2013.0144]; Li XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089462; Li YJ, 2014, AIDS, V28, P521, DOI 10.1097/QAD.0000000000000125; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Pan Xiao-hong, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P638; Pingen M, 2011, J ANTIMICROB CHEMOTH, V66, P1467, DOI 10.1093/jac/dkr157; Poon AFY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021189; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ruan YH, 2005, JAIDS-J ACQ IMM DEF, V39, P459, DOI 10.1097/01.qai.0000152398.47025.0f; Saravanan S, 2009, J VIROL METHODS, V159, P211, DOI 10.1016/j.jviromet.2009.03.021; Shaanxi Health and Family planning Commission website, 2013, HIV AIDS SIT SHAANX; Shaanxi Provincial Bureau of Statistics website, B 6 NAT POP CENS SHA; Shao B, 2014, J INFECTION, V68, P273, DOI 10.1016/j.jinf.2013.10.014; SIEPEL AC, 1995, AIDS RES HUM RETROV, V11, P1413, DOI 10.1089/aid.1995.11.1413; Sungkanuparph S, 2011, CLIN INFECT DIS, V52, P1053, DOI 10.1093/cid/cir107; UNAIDS, UNAIDS REP GLOB AIDS; Wong KH, 2010, AIDS RES HUM RETROV, V26, P1079, DOI 10.1089/aid.2009.0272; World Health Organization, WHO DRUG RES REP; Xin RL, 2009, J GEN VIROL, V90, P1757, DOI 10.1099/vir.0.009290-0; XING Ai-hua, 2007, CHIN J PUBLIC HLTH, V23; Yang CF, 2012, AIDS RES HUM RETROV, V28, P1723, DOI [10.1089/aid.2011.0320, 10.1089/AID.2011.0320]; Yang J, 2013, ARCH VIROL, V158, P839, DOI 10.1007/s00705-012-1557-7; Zeng PB, 2013, VIRUS GENES, V47, P408, DOI 10.1007/s11262-013-0958-3; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	41	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109821	10.1371/journal.pone.0109821	http://dx.doi.org/10.1371/journal.pone.0109821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333965	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200055
J	Zhuang, MZ; Zhao, MM; Qiu, HJ; Shi, DB; Wang, JS; Tian, Y; Lin, LZ; Deng, WG				Zhuang, Mingzhu; Zhao, Mouming; Qiu, Huijuan; Shi, Dingbo; Wang, Jingshu; Tian, Yun; Lin, Lianzhu; Deng, Wuguo			Effusanin E Suppresses Nasopharyngeal Carcinoma Cell Growth by Inhibiting NF-kappa B and COX-2 Signaling	PLOS ONE			English	Article							MEDIATED REPRESSION; BREAST-CANCER; CYCLOOXYGENASE-2; TRANSCRIPTION; BINDING; DITERPENOIDS; ACTIVATION; APOPTOSIS; RESPONSES; MELANOMA	Rabdosia serra is well known for its antibacterial, anti-inflammatory and antitumor activities, but no information has been available for the active compounds derived from this plant in inhibiting human nasopharyngeal carcinoma (NPC) cell growth. In this study, we isolated and purified a natural diterpenoid from Rabdosia serra and identified its chemical structure as effusanin E and elucidated its underlying mechanism of action in inhibiting NPC cell growth. Effusanin E significantly inhibited cell proliferation and induced apoptosis in NPC cells. Effusanin E also induced the cleavage of PARP, caspase-3 and -9 proteins and inhibited the nuclear translocation of p65 NF-kappa B proteins. Moreover, effusanin E abrogated the binding of NF-kappa B to the COX-2 promoter, thereby inhibiting the expression and promoter activity of COX-2. Pretreatment with a COX-2 or NF-kappa B-selective inhibitor (celecoxib or ammonium pyrrolidinedithiocarbamate) had an additive effect on the effusanin E-mediated inhibition of proliferation, while pretreatment with an activator of NF-kappa B/COX-2 (lipopolysaccharides) abrogated the effusanin E-mediated inhibition of proliferation. Effusanin E also significantly suppressed tumor growth in a xenograft mouse model without obvious toxicity, furthermore, the expression of p50 NF-kappa B and COX-2 were down-regulated in the tumors of nude mice. These data suggest that effusanin E suppresses p50/p65 proteins to down-regulate COX-2 expression, thereby inhibiting NPC cell growth. Our findings provide new insights into exploring effusanin E as a potential therapeutic compound for the treatment of human nasopharyngeal carcinoma.	[Zhuang, Mingzhu; Zhao, Mouming; Lin, Lianzhu] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China; [Qiu, Huijuan; Shi, Dingbo; Wang, Jingshu; Tian, Yun; Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Mouming] S China Univ Technol, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China	South China University of Technology; State Key Lab Oncology South China; Sun Yat Sen University; South China University of Technology	Lin, LZ (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China.	felzlin@scut.edu.cn; dengwg@sysucc.org.cn			National Natural Science Foundation of China [81071687, 81272195]; State "863 Program" of China [SS2012AA0204030]; Doctoral Programs Foundation of Ministry of Education of China [20110171110077]; State Key Laboratory of Oncology in Southern China; Fundamental Research Funds for the Central Universities [2014ZB0010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State "863 Program" of China(National High Technology Research and Development Program of China); Doctoral Programs Foundation of Ministry of Education of China(Ministry of Education, China); State Key Laboratory of Oncology in Southern China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by funds from the National Natural Science Foundation of China (81071687, 81272195), the State "863 Program" of China (SS2012AA0204030), the Doctoral Programs Foundation of Ministry of Education of China (20110171110077), and the State Key Laboratory of Oncology in Southern China and Fundamental Research Funds for the Central Universities (Project No. 2014ZB0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Busson P, 2004, TRENDS MICROBIOL, V12, P356, DOI 10.1016/j.tim.2004.06.005; China Flora Editorial Committee of Flora of Chinese Academy of Sciences, 1977, FLOR CHIN, P433; Cui Q, 2007, J PHARMACOL SCI, V105, P317, DOI 10.1254/jphs.FP0070336; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; Fang HY, 2013, MAR DRUGS, V11, P1853, DOI 10.3390/md11061853; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hu HZ, 2007, ACTA PHARMACOL SIN, V28, P1819, DOI 10.1111/j.1745-7254.2007.00667.x; Huang J, 2007, CANCER RES, V67, P1589, DOI 10.1158/0008-5472.CAN-06-2472; Kang CH, 2008, UROLOGY, V72, P153, DOI 10.1016/j.urology.2007.12.029; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kim JY, 2013, INT IMMUNOPHARMACOL, V15, P84, DOI 10.1016/j.intimp.2012.11.002; Leung CH, 2005, MOL PHARMACOL, V68, P286, DOI 10.1124/mol.105.012765; Lin LZ, 2012, FOOD CHEM, V131, P1009, DOI 10.1016/j.foodchem.2011.09.105; Liu B, 2011, CELL DEATH DIS, V2, P1; Mankan AK, 2009, J CELL MOL MED, V13, P631, DOI 10.1111/j.1582-4934.2009.00632.x; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nitoda T, 2008, PHYTOTHER RES, V22, P867, DOI 10.1002/ptr.2373; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Singh B, 2002, J SURG RES, V108, P173, DOI 10.1006/jsre.2002.6532; Sinicrope FA, 2004, CANCER METAST REV, V23, P63, DOI 10.1023/A:1025863029529; Wang JS, 2012, J PINEAL RES, V53, P77, DOI 10.1111/j.1600-079X.2012.00973.x; Wu E, 2000, CLIN LAB MED, V20, P731; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754; Xu Y, 2013, ONCOL LETT, V5, P655, DOI 10.3892/ol.2012.1063; Yamamoto Y, 1999, J BIOL CHEM, V274, P27307, DOI 10.1074/jbc.274.38.27307; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948	31	13	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109951	10.1371/journal.pone.0109951	http://dx.doi.org/10.1371/journal.pone.0109951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333664	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200023
J	Ma, LQ; Zou, T; Yuan, YP; Lv, JJ; Dong, XQ; Yang, G; Zhu, YZ; Luo, J; Zhang, ZG; Yang, JF				Ma, Lanqing; Zou, Tong; Yuan, Yuping; Lv, Jiajun; Dong, Xiangqian; Yang, Gang; Zhu, Yunzhen; Luo, Juan; Zhang, Zhigang; Yang, Jiefu			Duodenal Ferroportin Is Up-Regulated in Patients with Chronic Hepatitis C	PLOS ONE			English	Article							HEPCIDIN EXPRESSION; PEPTIDE HEPCIDIN; IRON; GENE; VIRUS; LIVER; REPLICATION; LEVEL; BLOOD	Hepatitis C virus (HCV) infection is a leading cause of liver-related mortality. Chronic hepatitis C (CHC) is frequently associated with disturbances in iron homeostasis, with serum iron and hepatic iron stores being elevated. Accumulating evidence indicates that chronic HCV infection suppresses expression of hepatic hepcidin, a key mediator of iron homeostasis, leading to iron overload conditions. Since hepcidin mediates degradation of ferroportin, a basolateral transporter involved in the release of iron from cells, diminished hepcidin expression probably leads to up-regulation of ferroportin-1 (Fpn1) in patients with CHC. In this study, we determined the protein levels of duodenal Fpn1, and found that its expression was significantly up-regulated in patients with CHC. The expression of duodenal Fpn1 is negatively correlated with mRNA levels of hepcidin, and positively correlated with serum iron parameters. Although iron is a critical factor for growth of a variety of pathogenic bacteria, our results suggest that iron overload in blood does not increase the infection rate of bacteria in patients with CHC.	[Ma, Lanqing; Yuan, Yuping; Lv, Jiajun; Dong, Xiangqian; Yang, Gang; Zhu, Yunzhen; Luo, Juan] Kunming Med Univ, Affiliated Hosp 1, Dept Digest Dis, Kunming, Yunnan, Peoples R China; [Zou, Tong; Yang, Jiefu] Beijing Hosp, Dept Cardiol, Minist Hlth, Beijing, Peoples R China; [Zhang, Zhigang] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China	Kunming Medical University; Beijing Hospital; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhang, ZG (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	zhzhg2007@gmail.com; yangjiefu2011@126.com			Yunnan Department of Science and Technology [2010ZC126]; National Natural Science Foundation of China [81170171]	Yunnan Department of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge funding from a grant (2010ZC126) from Yunnan Department of Science and Technology (to LM), and a grant (81170171) from the National Natural Science Foundation of China (to JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fillebeen C, 2005, J BIOL CHEM, V280, P9049, DOI 10.1074/jbc.M412687200; Fillebeen C, 2010, J HEPATOL, V53, P995, DOI 10.1016/j.jhep.2010.04.044; Fraenkel PG, 2005, J CLIN INVEST, V115, P1532, DOI 10.1172/JCI23780; Fujita N, 2007, MOL MED, V13, P97, DOI 10.2119/2006-00057.Fujita; Fujita N, 2007, FREE RADICAL BIO MED, V42, P353, DOI 10.1016/j.freeradbiomed.2006.11.001; Girelli D, 2009, J HEPATOL, V51, P845, DOI 10.1016/j.jhep.2009.06.027; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hezode C, 1999, J HEPATOL, V31, P979, DOI 10.1016/S0168-8278(99)80308-0; Horl WH, 2013, NEPHROL DIAL TRANSPL; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Mackenzie B, 2005, AM J PHYSIOL-GASTR L, V289, pG981, DOI 10.1152/ajpgi.00363.2005; Markel TA, 2007, J LEUKOCYTE BIOL, V81, P393, DOI 10.1189/jlb.0906579; McLaughlin RW, 2002, J CLIN MICROBIOL, V40, P4771, DOI 10.1128/JCM.40.12.4771-4775.2002; Migita K, 2006, HUM IMMUNOL, V67, P27, DOI 10.1016/j.humimm.2006.02.025; Miura K, 2008, HEPATOLOGY, V48, P1420, DOI 10.1002/hep.22486; Moriyama K, 2008, MICROBIOL IMMUNOL, V52, P375, DOI 10.1111/j.1348-0421.2008.00048.x; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nikkari S, 2001, J CLIN MICROBIOL, V39, P1956, DOI 10.1128/JCM.39.5.1956-1959.2001; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; Paradkar PN, 2008, BLOOD, V112, P866, DOI 10.1182/blood-2007-12-126854; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Rapisarda C, 2010, AM J PHYSIOL-GASTR L, V299, pG778, DOI 10.1152/ajpgi.00157.2010; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Rocha M, 2005, GUT, V54, P396, DOI 10.1136/gut.2004.042168; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Viatte L, 2005, BLOOD, V105, P4861, DOI 10.1182/blood-2004-12-4608; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Zhang ZG, 2014, ISME J, V8, P881, DOI 10.1038/ismej.2013.185; Zhang ZG, 2013, AM J GASTROENTEROL, V108, P1601, DOI 10.1038/ajg.2013.221	31	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110658	10.1371/journal.pone.0110658	http://dx.doi.org/10.1371/journal.pone.0110658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330009	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100080
J	Popova, TG; Espina, V; Zhou, WD; Mueller, C; Liotta, L; Popov, SG				Popova, Taissia G.; Espina, Virginia; Zhou, Weidong; Mueller, Claudius; Liotta, Lance; Popov, Serguei G.			Whole Proteome Analysis of Mouse Lymph Nodes in Cutaneous Anthrax	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; MESENTERIC LYMPH; MASS-SPECTROMETRY; LEG LYMPH; ACTIVATION; PLASMA; SHOCK; METALLOPROTEASES; MICROARRAYS; APOPTOSIS	This study aimed to characterize a soluble proteome of popliteal lymph nodes during lymphadenitis induced by intradermal injection of Bacillus anthracis Sterne spores in mice using tandem LC-MS/MS and reverse-phase protein microarray with antibodies specific to epitopes of phosphorylated proteins. More than 380 proteins were detected in the normal intra-nodal lymph, while the infectious process resulted in the profound changes in the protein abundances and appearance of 297 unique proteins. These proteins belong to an array of processes reflecting response to wounding, inflammation and perturbations of hemostasis, innate immune response, coagulation and fibrinolysis, regulation of body fluid levels and vascular disturbance among others. Comparison of lymph and serum revealed 83 common proteins. Also, using 71 antibodies specific to total and phosphorylated forms of proteins we carried initial characterization of circulating lymph phosphoproteome which brought additional information regarding signaling pathways operating in the lymphatics. The results demonstrate that the proteome of intra-nodal lymph serves as a sensitive sentinel of the processes occurring within the lymph nodes during infection. The acute innate response of the lymph nodes to anthrax is accompanied by cellular damage and inflammation with a large number of up-and down-regulated proteins many of which are distinct from those detected in serum. MS data are available via ProteomeXchange with identifier PXD001342.	[Popova, Taissia G.; Espina, Virginia; Zhou, Weidong; Mueller, Claudius; Liotta, Lance; Popov, Serguei G.] George Mason Univ, Sch Syst Biol, Manassas, VA USA	George Mason University	Popov, SG (corresponding author), George Mason Univ, Sch Syst Biol, Manassas, VA USA.	spopov@gmu.edu		Espina, Virginia/0000-0001-5080-5972	National Institutes of Health, USA [5R21AI099851-2]; George Mason University Libraries Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099851] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Mason University Libraries Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the grant 5R21AI099851-2 from the National Institutes of Health, USA (SP, VE, and LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication of this article was funded in part by the George Mason University Libraries Open Access Publishing Fund.	Akbani R, 2014, MOL CELL PROTEOMICS, V13, P1625, DOI 10.1074/mcp.O113.034918; Ali SR, 2011, IMMUNITY, V35, P34, DOI 10.1016/j.immuni.2011.04.015; [Anonymous], 2014, GUT MICROBES, V5, P1, DOI 10.4161/jkst.25530; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Bertacchini J, 2014, LEUKEMIA, V28, P2197, DOI 10.1038/leu.2014.123; Chung MC, 2008, J BIOL CHEM, V283, P9531, DOI 10.1074/jbc.M705871200; Chung MC, 2006, J BIOL CHEM, V281, P31408, DOI 10.1074/jbc.M605526200; Chung MC, 2013, BIOCHEM BIOPH RES CO, V430, P125, DOI 10.1016/j.bbrc.2012.11.042; Chung MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018119; Chung MC, 2009, J MED MICROBIOL, V58, P737, DOI 10.1099/jmm.0.007427-0; Chung MC, 2008, FEMS IMMUNOL MED MIC, V54, P309, DOI 10.1111/j.1574-695X.2008.00480.x; Clement CC, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00424; Clement CC, 2013, J PROTEOMICS, V78, P172, DOI 10.1016/j.jprot.2012.11.013; Clement CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009863; Coiras M, 2008, PROTEOMICS, V8, P852, DOI 10.1002/pmic.200700664; Cremona M, 2014, EXPERT REV PROTEOMIC, V11, P237, DOI 10.1586/14789450.2014.893193; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dzieciatkowska M, 2011, SHOCK, V35, P331, DOI 10.1097/SHK.0b013e318206f654; Echan LA, 2005, PROTEOMICS, V5, P3292, DOI 10.1002/pmic.200401228; Einspahr JG, 2012, CANCER PREV RES, V5, P403, DOI 10.1158/1940-6207.CAPR-11-0427; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Fang JF, 2010, SHOCK, V34, P291, DOI 10.1097/SHK.0b013e3181ceef5e; Gallagher RI, 2011, METHODS MOL BIOL, V723, P275, DOI 10.1007/978-1-61779-043-0_18; Goldfinch GM, 2008, PROTEOMICS, V8, P1909, DOI 10.1002/pmic.200700531; Goldman DL, 2008, FRONT BIOSCI-LANDMRK, V13, P4009, DOI 10.2741/2988; Guichard A, 2012, MICROBES INFECT, V14, P97, DOI 10.1016/j.micinf.2011.08.016; Harsha HC, 2010, MOL ONCOL, V4, P482, DOI 10.1016/j.molonc.2010.09.004; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Interewicz B, 2004, LYMPHOLOGY, V37, P65; Jordan JR, 2008, J APPL PHYSIOL, V104, P1161, DOI 10.1152/japplphysiol.00022.2007; Kaiser VL, 2005, PEPTIDES, V26, P2491, DOI 10.1016/j.peptides.2005.05.001; Kaiser VL, 2005, SHOCK, V23, P417, DOI 10.1097/01.shk.0000160524.14235.6c; Klichko VI, 2003, BIOCHEM BIOPH RES CO, V303, P855, DOI 10.1016/S0006-291X(03)00440-6; Knight JS, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-51; Leak LV, 2004, PROTEOMICS, V4, P753, DOI 10.1002/pmic.200300573; Manes NP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000927; Mittal A, 2008, AM J PHYSIOL-GASTR L, V295, pG895, DOI 10.1152/ajpgi.90378.2008; Mittal A, 2010, SHOCK, V34, P140, DOI 10.1097/SHK.0b013e3181cd8631; Mittal A, 2009, J PANCREAS, V10, P130; Mukherjee DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017921; Nanjee MN, 2000, J LIPID RES, V41, P1317; Narayanan A, 2009, J PROTEOM BIOINFORM, V2, P408; OH SK, 1990, J LEUKOCYTE BIOL, V47, P142, DOI 10.1002/jlb.47.2.142; Olszewski WL, 2001, ARTHRITIS RHEUM, V44, P541, DOI 10.1002/1529-0131(200103)44:3<541::AID-ANR102>3.3.CO;2-Y; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Peltz ED, 2009, SURGERY, V146, P347, DOI 10.1016/j.surg.2009.02.022; Pierobon M, 2015, ONCOGENE, V34, P805, DOI 10.1038/onc.2014.16; Pierobon M, 2011, METHODS MOL BIOL, V785, P3, DOI 10.1007/978-1-61779-286-1_1; Popov SG, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-25; Popov SG, 2002, BIOCHEM BIOPH RES CO, V293, P349, DOI 10.1016/S0006-291X(02)00227-9; Popova T, 2009, FEMS IMMUNOL MED MIC, V56, P129, DOI 10.1111/j.1574-695X.2009.00558.x; Popova TG, 2011, FEMS IMMUNOL MED MIC, V61, P15, DOI 10.1111/j.1574-695X.2010.00740.x; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; Popova TG, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-8; Martins RP, 2013, COMP IMMUNOL MICROB, V36, P149, DOI 10.1016/j.cimid.2012.11.003; Ramirez-Boo M, 2011, PROTEOMICS, V11, P3452, DOI 10.1002/pmic.201000610; Reddy RC, 2010, CURR OPIN HEMATOL, V17, P18, DOI 10.1097/MOH.0b013e32833338f3; Shen ZX, 2006, J PROTEOME RES, V5, P3154, DOI 10.1021/pr060327k; Takano S, 2010, BRIT J CANCER, V103, P223, DOI 10.1038/sj.bjc.6605734; Tan YK, 2009, AUTOPHAGY, V5, P734, DOI 10.4161/auto.5.5.8567; Weiner ZP, 2012, INFECT IMMUN, V80, P1626, DOI 10.1128/IAI.06061-11; Yuan KC, 2013, CHINESE J PHYSIOL, V56, P163, DOI 10.4077/CJP.2013.BAB116; Zhou WD, 2009, J PROTEOME RES, V8, P5523, DOI 10.1021/pr900603n; Zupa A, 2012, J THORAC ONCOL, V7, P1755, DOI 10.1097/JTO.0b013e3182725fc7	66	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110873	10.1371/journal.pone.0110873	http://dx.doi.org/10.1371/journal.pone.0110873			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329596	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100103
J	Dong, YP; Ito, T; Velayo, C; Sato, T; Iida, K; Endo, M; Funamoto, K; Sato, N; Yaegashi, N; Kimura, Y				Dong, Yupeng; Ito, Takuya; Velayo, Clarissa; Sato, Takafumi; Iida, Keita; Endo, Miyuki; Funamoto, Kiyoe; Sato, Naoaki; Yaegashi, Nobuo; Kimura, Yoshitaka			Intrauterine Ischemic Reperfusion Switches the Fetal Transcriptional Pattern from HIF-1 alpha- to P53-Dependent Regulation in the Murine Brain	PLOS ONE			English	Article							EXPERIMENTAL SUBARACHNOID HEMORRHAGE; RAT-BRAIN; P53; EXPRESSION; APOPTOSIS; NEURONS; INJURY; DEATH; INHIBITOR; EDEMA	Ischemic reperfusion (IR) during the perinatal period is a known causative factor of fetal brain damage. So far, both morphologic and histologic evidence has shown that fetal brain damage can be observed only several hours to days after an IR insult has occurred. Therefore, to prevent fetal brain damage under these circumstances, a more detailed understanding of the underlying molecular mechanisms involved during an acute response to IR is necessary. In the present work, pregnant mice were exposed to IR on day 18 of gestation by clipping one side of the maternal uterine horn. Simultaneous fetal electrocardiography was performed during the procedure to verify that conditions resulting in fetal brain damage were met. Fetal brain sampling within 30 minutes after IR insult revealed molecular evidence that a fetal response was indeed triggered in the form of inhibition of the Akt-mTOR-S6 synthesis pathway. Interestingly, significant changes in mRNA levels for both HIF-1 alpha and p53 were apparent and gene regulation patterns were observed to switch from a HIF-1 alpha-dependent to a p53-dependent process. Moreover, pre-treatment with pifithrin-alpha, a p53 inhibitor, inhibited protein synthesis almost completely, revealing the possibility of preventing fetal brain damage by prophylactic pifithrin-a treatment.	[Dong, Yupeng; Ito, Takuya; Velayo, Clarissa; Sato, Takafumi; Iida, Keita; Endo, Miyuki; Funamoto, Kiyoe; Sato, Naoaki; Kimura, Yoshitaka] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Yaegashi, Nobuo; Kimura, Yoshitaka] Tohoku Univ Hosp, Dept Obstet & Gynecol, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Dong, YP (corresponding author), Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan.	dongyupeng7@gmail.com	ITO, Takuya/AAD-1718-2019	Velayo, Clarissa/0000-0001-7727-2838	Translational Research Network Program (Yoshitaka Kimura Tohoku university) [09019016]	Translational Research Network Program (Yoshitaka Kimura Tohoku university)	This work was supported by Translational Research Network Program (grant numbers 09019016, Yoshitaka Kimura Tohoku university, URL: http://www.tr.mext.go.jp/seeds/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger R, 1999, BRAIN RES REV, V30, P107, DOI 10.1016/S0165-0173(99)00009-0; Berger R, 2000, J PERINAT MED, V28, P261, DOI 10.1515/JPM.2000.034; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Campagne MV, 1998, J COMP NEUROL, V397, P181; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Choi J, 1999, CELL MOL LIFE SCI, V55, P38, DOI 10.1007/s000180050268; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Correa-Costa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049569; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Esposito E, 2010, CURR MED CHEM, V17, P2764, DOI 10.2174/092986710791859324; Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003; Gomez-Sanchez JC, 2011, J EXP MED, V208, P429, DOI 10.1084/jem.20101523; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Koshino T, 2003, AM J PHYSIOL-HEART C, V284, pH1858, DOI 10.1152/ajpheart.00268.2002; Lu YY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3852; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Nijboer CH, 2011, ANN NEUROL, V70, P255, DOI 10.1002/ana.22413; Oillet J, 1996, PEDIATR RES, V39, P598, DOI 10.1203/00006450-199604000-00006; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Sato M, 2007, IEEE T BIO-MED ENG, V54, P49, DOI 10.1109/TBME.2006.883791; SCHMID P, 1991, DEVELOPMENT, V113, P857; Sendoel A, 2010, NATURE, V465, P577, DOI 10.1038/nature09141; Sutton TA, 2008, AM J PHYSIOL-RENAL, V295, pF1666, DOI 10.1152/ajprenal.90304.2008; Velayo C, 2012, PRENATAL DIAG, V32, P1059, DOI 10.1002/pd.3956; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wakatsuki A, 1999, AM J OBSTET GYNECOL, V181, P731, DOI 10.1016/S0002-9378(99)70520-X; Yan JH, 2012, CNS NEUROSCI THER, V18, P334, DOI 10.1111/j.1755-5949.2012.00299.x; Yan JH, 2008, EXP NEUROL, V214, P37, DOI 10.1016/j.expneurol.2008.07.006; Zhou CM, 2005, J CEREBR BLOOD F MET, V25, P572, DOI 10.1038/sj.jcbfm.9600069; Zwanenburg A, 2013, PEDIATR RES, V73, P420, DOI 10.1038/pr.2013.15	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110577	10.1371/journal.pone.0110577	http://dx.doi.org/10.1371/journal.pone.0110577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329663	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204100092
J	Ge, J; Chen, ZH; Huang, J; Chen, JX; Yuan, WJ; Deng, ZH; Chen, ZK				Ge, Jie; Chen, Zihua; Huang, Jin; Chen, Jinxiang; Yuan, Weijie; Deng, Zhenghao; Chen, Zhikang			Upregulation of Autophagy-Related Gene-5 (ATG-5) Is Associated with Chemoresistance in Human Gastric Cancer	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; EXPRESSION; CELLS; 5-FLUOROURACIL; CHEMOTHERAPY; INHIBITION; MECHANISMS; PROGNOSIS; MORTALITY; BCL-2	Autophagy-related gene-5 (ATG-5) is one of the key regulators of autophagic cell death. It has been widely regarded as a protective molecular mechanism for tumor cells during the course of chemotherapy. In the present study, we investigated the expression pattern of ATG-5 and multidrug resistance-associated protein-1 (MRP-1) in 135 gastric cancers (GC) patients who were treated with epirubicin, cisplatin and 5-FU adjuvant chemotherapy (ECF) following surgical resection and explored their potential clinical significance. We found that both ATG-5 (77.78%) and MRP-1 (79.26%) were highly expressed in GC patients. ATG-5 expression was significantly associated with depth of wall invasion, TNM stages and distant metastasis of GC (P<0.05), whereas MRP-1 expression was significantly linked with tumor size, depth of wall invasion, lymph node metastasis, TNM stages and differentiation status (P<0.05). ATG-5 expression was positively correlated with MRP-1 (rp = 0.616, P<0.01). Increased expression of ATG-5 and MPR-1 was significantly correlated with poor overall survival (OS; P<0.01) and disease free survival (DFS; P<0.01) of our GC cohort. Furthermore, we demonstrated that ATG-5 was involved in drug resistant of GC cells, which was mainly through regulating autophagy. Our data suggest that upregulated expression of ATG-5, an important molecular feature of protective autophagy, is associated with chemoresistance in GC. Expression of ATG-5 and MRP-1 may be independent prognostic markers for GC treatment.	[Ge, Jie; Chen, Zihua; Chen, Zhikang] Cent South Univ, Xiangya Hosp, Dept Gastrointestinal Surg, Changsha, Hunan, Peoples R China; [Huang, Jin; Chen, Jinxiang; Yuan, Weijie] Cent South Univ, Xiangya Hosp, Dept Oncol, Changsha, Hunan, Peoples R China; [Deng, Zhenghao] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Chen, ZK (corresponding author), Cent South Univ, Xiangya Hosp, Dept Gastrointestinal Surg, Changsha, Hunan, Peoples R China.	4059653@qq.com			National Natural Science Foundation of Hunan Province, China [2012FJ6088]	National Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province)	This work was supported by National Natural Science Foundation of Hunan Province, China (No. 2012FJ6088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; An CH, 2011, PATHOL RES PRACT, V207, P433, DOI 10.1016/j.prp.2011.05.002; Black RJ, 1997, EUR J CANCER, V33, P1075, DOI 10.1016/S0959-8049(96)00492-3; Bray F, 2002, EUR J CANCER, V38, P99, DOI 10.1016/S0959-8049(01)00350-1; Cervantes A, 2008, ANN ONCOL, V19, P103, DOI 10.1093/annonc/mdn321; Edge S.B., 2010, AJCC CANC STAGING MA, V7th ed., P143; Fan KC, 2000, ANTICANCER RES, V20, P4809; Fu L, 2009, CANCER RES, V69, P8967, DOI 10.1158/0008-5472.CAN-09-2190; Ge J, 2009, DIGESTION, V80, P148, DOI 10.1159/000226089; Han Z, 2007, J EXP CLIN CANC RES, V26, P261; Hwang MS, 2010, BIOCHEM BIOPH RES CO, V399, P111, DOI 10.1016/j.bbrc.2010.07.050; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Ko JSK, 2013, CURR PHARM DESIGN, V19, P48, DOI 10.2174/13816128130109; Lacueva J, 2005, HISTOPATHOLOGY, V46, P389, DOI 10.1111/j.1365-2559.2005.02100.x; Le XF, 2010, CANCER-AM CANCER SOC, V116, P4980, DOI 10.1002/cncr.25426; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Liu J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-183; Marx J, 2006, SCIENCE, V312, P1160, DOI 10.1126/science.312.5777.1160; Maycotte P, 2011, CANCER BIOL THER, V11, P127, DOI 10.4161/cbt.11.2.14627; Mirzoeva OK, 2011, J MOL MED, V89, P877, DOI 10.1007/s00109-011-0774-y; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Suh YS, 2012, ANN SURG ONCOL, V19, P1240, DOI 10.1245/s10434-011-2125-1; Sun Xiu-di, 2004, Zhonghua Zhongliu Zazhi, V26, P4; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhang DX, 2007, EXPERT REV ANTICANC, V7, P1369, DOI 10.1586/14737140.7.10.1369; Zhang DX, 2010, FUTURE ONCOL, V6, P527, DOI [10.2217/fon.10.21, 10.2217/FON.10.21]	32	74	79	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110293	10.1371/journal.pone.0110293	http://dx.doi.org/10.1371/journal.pone.0110293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329677	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100058
J	Wang, DJ; Zhang, PZ; Gao, K; Tang, Y; Jin, XF; Zhang, YY; Yi, Q; Wang, CJ; Yu, L				Wang, Dejie; Zhang, Pingzhao; Gao, Kun; Tang, Yan; Jin, Xiaofeng; Zhang, Yuanyuan; Yi, Qing; Wang, Chenji; Yu, Long			PLK1 and beta-TrCP-Dependent Ubiquitination and Degradation of Rap1GAP Controls Cell Proliferation	PLOS ONE			English	Article							SUPPRESSOR GENE RAP1GAP; F-BOX PROTEINS; DOWN-REGULATION; PHOSPHORYLATION; CARCINOMA; KINASE; CYCLE; INVASION; CANCER; SCF	Rap1GAP is a GTPase-activating protein (GAP) that specifically stimulates the GTP hydrolysis of Rap1 GTPase. Although Rap1GAP is recognized as a tumor suppressor gene and downregulated in various cancers, little is known regarding the regulation of Rap1GAP ubiquitination and degradation under physiological conditions. Here, we demonstrated that Rap1GAP is ubiquitinated and degraded through proteasome pathway in mitosis. Proteolysis of Rap1GAP requires the PLK1 kinase and beta-TrCP ubiquitin ligase complex. We revealed that PLK1 interacts with Rap1GAP in vivo through recognition of an SSP motif within Rap1GAP. PLK1 phosphorylates Ser525 in conserved (524)DSGHVS(529) degron of Rap1GAP and promotes its interaction with beta-TrCP. We also showed that Rap1GAP was a cell cycle regulator and that tight regulation of the Rap1GAP degradation in mitosis is required for cell proliferation.	[Wang, Dejie; Zhang, Pingzhao; Gao, Kun; Tang, Yan; Jin, Xiaofeng; Zhang, Yuanyuan; Wang, Chenji; Yu, Long] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Pingzhao; Yu, Long] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Wang, Dejie] Nanchang Univ, Affiliated Hosp 1, Jiangxi Inst Gastroenterol & Hepatol, Dept Gastroenterol, Nanchang, Jiangxi, Peoples R China; [Yi, Qing] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Div Canc Med, Dept Lymphoma & Myeloma, Houston, TX 77030 USA	Fudan University; Fudan University; Nanchang University; University of Texas System; UTMD Anderson Cancer Center	Wang, CJ (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	chenjiwang@fudan.edu.cn; longyu@fudan.edu.cn	zhang, yuanyuan/GYA-4428-2022; Wang, Dejie/AAJ-9461-2020		National Natural Science Foundation of China [30872947, 31071193, 81171964]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30872947, 31071193, and 81171964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang XL, 2008, J BIOL CHEM, V283, P29424, DOI 10.1074/jbc.M802475200; Banerjee R, 2011, ONCOGENE, V30, P4339, DOI 10.1038/onc.2011.141; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JANOUEIXLEROSEY I, 1994, BIOCHEM BIOPH RES CO, V202, P967, DOI 10.1006/bbrc.1994.2024; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; Kim WJ, 2012, CANCER LETT, V320, P65, DOI 10.1016/j.canlet.2012.01.022; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; POLAKIS P, 1992, J BIOL CHEM, V267, P10780; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tsygankova OM, 2004, J BIOL CHEM, V279, P5501, DOI 10.1074/jbc.M305824200; Tsygankova OA, 2007, MOL CELL BIOL, V27, P6647, DOI 10.1128/MCB.00155-07; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wu YD, 2009, J BIOL CHEM, V284, P640, DOI 10.1074/jbc.M806916200; Zhang LZ, 2006, CANCER RES, V66, P898, DOI 10.1158/0008-5472.CAN-05-3025; Zhang ZC, 2006, AM J PATHOL, V168, P585, DOI 10.2353/ajpath.2006.050132; Zheng H, 2009, CANCER RES, V69, P449, DOI 10.1158/0008-5472.CAN-08-2399; Zuo H, 2010, CANCER RES, V70, P1389, DOI 10.1158/0008-5472.CAN-09-2812	21	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110296	10.1371/journal.pone.0110296	http://dx.doi.org/10.1371/journal.pone.0110296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329897	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100060
J	Sze, MA; Abbasi, M; Hogg, JC; Sin, DD				Sze, Marc A.; Abbasi, Meysam; Hogg, James C.; Sin, Don D.			A Comparison between Droplet Digital and Quantitative PCR in the Analysis of Bacterial 16S Load in Lung Tissue Samples from Control and COPD GOLD 2	PLOS ONE			English	Article							SMALL-AIRWAY OBSTRUCTION; REAL-TIME PCR; MICROBIOME; QUANTIFICATION	Background: Low biomass in the bacterial lung tissue microbiome utilizes quantitative PCR (qPCR) 16S bacterial assays at their limit of detection. New technology like droplet digital PCR (ddPCR) could allow for higher sensitivity and accuracy of quantification. These attributes are needed if specific bacteria within the bacterial lung tissue microbiome are to be evaluated as potential contributors to diseases such as chronic obstructive pulmonary disease (COPD). We hypothesize that ddPCR is better at quantifying the total bacterial load in lung tissue versus qPCR. Methods: Control (n = 16) and COPD GOLD 2 (n = 16) tissue samples were obtained from patients who underwent lung resection surgery, were cut on a cryotome, and sections were assigned for use in quantitative histology or for DNA extraction. qPCR and ddPCR were performed on these samples using primers spanning the V2 region on the 16S rRNA gene along with negative controls. Total 16S counts were compared between the two methods. Both methods were assessed for correlations with quantitative histology measurements of the tissue. Results: There was no difference in the average total 16S counts (P>0.05) between the two methods. However, the negative controls contained significantly lower counts in the ddPCR (0.55 +/- 0.28 16S/uL) than in the qPCR assay (1.00 +/- 0.70 16S copies) (P <0.05). The coefficient of variation was significantly lower for the ddPCR assay (0.18 +/- 0.14) versus the qPCR assay (0.62 +/- 0.29) (P<0.05). Conclusion: Overall the ddPCR 16S assay performed better by reducing the background noise in 16S of the negative controls compared with 16S qPCR assay.	[Sze, Marc A.; Hogg, James C.; Sin, Don D.] Univ British Columbia, Ctr Heart Lung Innovat, St Pauls Hosp, Dept Pathol & Med, Vancouver, BC V5Z 1M9, Canada; [Sze, Marc A.; Hogg, James C.; Sin, Don D.] Univ British Columbia, Dept Lab Med, Vancouver, BC V5Z 1M9, Canada; [Abbasi, Meysam] BioRad Labs, Mississauga, ON, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia	Sin, DD (corresponding author), Univ British Columbia, Ctr Heart Lung Innovat, St Pauls Hosp, Dept Pathol & Med, Vancouver, BC V5Z 1M9, Canada.	don.sin@hli.ubc.ca	Sin, Don/AAC-2219-2021	Sze, Marc/0000-0002-3532-9653				Brankatschk R, 2012, APPL ENVIRON MICROB, V78, P4481, DOI 10.1128/AEM.07878-11; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hogg James C, 2009, Proc Am Thorac Soc, V6, P546, DOI 10.1513/pats.200905-029DS; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Kiley James P, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS66, DOI 10.1513/AnnalsATS.201308-285MG; Laboratories B-R, LAB B R DROPLET DIGI, P94; Ma J, 2013, BIOMARK INSIGHTS, V8, P127, DOI [10.4137/BMI.S13154, 10.4137/BMIMI.S13154]; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Ott SJ, 2004, J CLIN MICROBIOL, V42, P2566, DOI 10.1128/JCM.42.6.2566-2572.2004; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Roberts CH, 2013, J CLIN MICROBIOL, V51, P2195, DOI 10.1128/JCM.00622-13; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2000, CHEST, V117, p286S, DOI 10.1378/chest.117.5_suppl_1.286S; Strain MC, 2013, CURR OPIN HIV AIDS, V8, P106, DOI 10.1097/COH.0b013e32835d811b; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Sze MA, 2014, INT J CHRONIC OBSTR, V9, P229, DOI 10.2147/COPD.S38932; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Tajadini Mohamadhasan, 2014, Adv Biomed Res, V3, P85, DOI 10.4103/2277-9175.127998; Utokaparch S, 2014, COPD, V11, P197, DOI 10.3109/15412555.2013.836166	28	44	44	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110351	10.1371/journal.pone.0110351	http://dx.doi.org/10.1371/journal.pone.0110351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329701	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210800078
J	Barry, EL; Mott, LA; Melamed, ML; Rees, JR; Ivanova, A; Sandler, RS; Ahnen, DJ; Bresalier, RS; Summers, RW; Bostick, RM; Baron, JA				Barry, Elizabeth L.; Mott, Leila A.; Melamed, Michal L.; Rees, Judith R.; Ivanova, Anastasia; Sandler, Robert S.; Ahnen, Dennis J.; Bresalier, Robert S.; Summers, Robert W.; Bostick, Roberd M.; Baron, John A.			Calcium Supplementation Increases Blood Creatinine Concentration in a Randomized Controlled Trial	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; BONE LOSS; POOLED ANALYSIS; CLINICAL-TRIAL; RISK; DIETARY; HEALTH; PREVENTION; WOMEN; MORTALITY	Background: Calcium supplements are widely used among older adults for osteoporosis prevention and treatment. However, their effect on creatinine levels and kidney function has not been well studied. Methods: We investigated the effect of calcium supplementation on blood creatinine concentration in a randomized controlled trial of colorectal adenoma chemoprevention conducted between 2004-2013 at 11 clinical centers in the United States. Healthy participants (N = 1,675) aged 45-75 with a history of colorectal adenoma were assigned to daily supplementation with calcium (1200 mg, as carbonate), vitamin D-3 (1000 IU), both, or placebo for three or five years. Changes in blood creatinine and total calcium concentration were measured after one year of treatment and multiple linear regression was used to estimate effects on creatinine concentrations. Results: After one year of treatment, blood creatinine was 0.013+/-0.006 mg/dL higher on average among participants randomized to calcium compared to placebo after adjustment for other determinants of creatinine (P = 0.03). However, the effect of calcium treatment appeared to be larger among participants who consumed the most alcohol (2-6 drinks/day) or whose estimated glomerular filtration rate (eGFR) was less than 60 ml/min/1.73 m(2) at baseline. The effect of calcium treatment on creatinine was only partially mediated by a concomitant increase in blood total calcium concentration and was independent of randomized vitamin D treatment. There did not appear to be further increases in creatinine after the first year of calcium treatment. Conclusions: Among healthy adults participating in a randomized clinical trial, daily supplementation with 1200 mg of elemental calcium caused a small increase in blood creatinine. If confirmed, this finding may have implications for clinical and public health recommendations for calcium supplementation.	[Barry, Elizabeth L.; Mott, Leila A.; Rees, Judith R.; Baron, John A.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Lebanon, NH 03756 USA; [Baron, John A.] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA; [Melamed, Michal L.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Melamed, Michal L.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Ivanova, Anastasia] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Sandler, Robert S.; Baron, John A.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Ahnen, Dennis J.] Dept Vet Affairs Eastern Colorado Hlth Care Syst, Denver, CO USA; [Ahnen, Dennis J.] Univ Colorado, Sch Med, Denver, CO USA; [Bresalier, Robert S.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Summers, Robert W.] Univ Iowa, Dept Med, Carver Coll Med, Iowa City, IA 52242 USA; [Bostick, Roberd M.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	Dartmouth College; Dartmouth College; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Texas System; UTMD Anderson Cancer Center; University of Iowa; Emory University; Rollins School Public Health	Barry, EL (corresponding author), Geisel Sch Med Dartmouth, Dept Community & Family Med, Lebanon, NH 03756 USA.	Elizabeth.L.Barry@dartmouth.edu	Barry, Elizabeth/AAB-7916-2019	Bresalier, Robert/0000-0002-9740-281X	National Institutes of Health, National Cancer Institute [CA098286]; National Institute of Diabetes, Digestive and Kidney Diseases [DK078774]; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA098286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK078774] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health, National Cancer Institute (#CA098286 to JAB) and National Institute of Diabetes, Digestive and Kidney Diseases (#DK078774 to MLM). Pfizer Consumer Healthcare provided the study pills. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, KIDNEY INT, V80, P1073, DOI 10.1038/ki.2011.207; Bailey RL, 2010, J NUTR, V140, P817, DOI 10.3945/jn.109.118539; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Bolland MJ, 2008, BMJ-BRIT MED J, V336, P262, DOI 10.1136/bmj.39440.525752.BE; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Bonithon-Kopp C, 2000, LANCET, V356, P1300, DOI 10.1016/S0140-6736(00)02813-0; Bonnick S, 2007, CURR MED RES OPIN, V23, P1341, DOI 10.1185/030079907X188035; Boudville N, 2012, NEPHRON CLIN PRACT, V121, pC36, DOI 10.1159/000342375; Cho E, 2004, JNCI-J NATL CANCER I, V96, P1015, DOI 10.1093/jnci/djh185; Curhan GC, 2004, ARCH INTERN MED, V164, P885, DOI 10.1001/archinte.164.8.885; Dawson-Hughes B, 2008, J CLIN ENDOCR METAB, V93, P2463, DOI 10.1210/jc.2008-0926; DAWSONHUGHES B, 1990, NEW ENGL J MED, V323, P878, DOI 10.1056/NEJM199009273231305; DAZAI Y, 1993, AM J HYPERTENS, V6, P933; ELDERS PJM, 1991, J CLIN ENDOCR METAB, V73, P533, DOI 10.1210/jcem-73-3-533; Favus MJ, 2011, AM J CLIN NUTR, V94, P5, DOI 10.3945/ajcn.111.018481; Gahche Jamie, 2011, NCHS Data Brief, P1; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Green JH, 2003, ASIA PAC J CLIN NUTR, V12, P109; Hofstad B, 1998, EUR J CANCER PREV, V7, P287, DOI 10.1097/00008469-199808000-00004; Holtkamp FA, 2011, KIDNEY INT, V80, P282, DOI 10.1038/ki.2011.79; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis JR, 2011, J BONE MINER RES, V26, P35, DOI 10.1002/jbmr.176; Li KR, 2012, HEART, V98, P920, DOI 10.1136/heartjnl-2011-301345; Mangano KM, 2011, J AM DIET ASSOC, V111, P687, DOI 10.1016/j.jada.2011.02.014; Moyer VA, 2013, ANN INTERN MED, V158, P691, DOI 10.7326/0003-4819-158-9-201305070-00603; Mulholland CA, 2007, AM J CLIN NUTR, V85, p318S, DOI 10.1093/ajcn/85.1.318S; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Mursu J, 2011, ARCH INTERN MED, V171, P1625, DOI 10.1001/archinternmed.2011.445; Patel AM, 2013, NUTRIENTS, V5, P4880, DOI 10.3390/nu5124880; Peacock M, 2000, J CLIN ENDOCR METAB, V85, P3011, DOI 10.1210/jc.85.9.3011; Prentice RL, 2013, OSTEOPOROSIS INT, V24, P567, DOI 10.1007/s00198-012-2224-2; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; Recker RR, 1996, J BONE MINER RES, V11, P1961; Reid IR, 2008, OSTEOPOROSIS INT, V19, P1119, DOI 10.1007/s00198-008-0563-9; Reid IR, 2006, AM J MED, V119, P777, DOI 10.1016/j.amjmed.2006.02.038; REID IR, 1993, NEW ENGL J MED, V328, P460, DOI 10.1056/NEJM199302183280702; Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328; Rifkin DE, 2008, ARCH INTERN MED, V168, P2212, DOI 10.1001/archinte.168.20.2212; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Shaukat A, 2005, AM J GASTROENTEROL, V100, P390, DOI 10.1111/j.1572-0241.2005.41220.x; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; SMITH EL, 1989, AM J CLIN NUTR, V50, P833, DOI 10.1093/ajcn/50.4.833; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wallace RB, 2011, AM J CLIN NUTR, V94, P270, DOI 10.3945/ajcn.110.003350; Woo JJY, 2007, AM J CLIN NUTR, V85, p323S, DOI 10.1093/ajcn/85.1.323S; Xiao Q, 2013, JAMA INTERN MED, V173, P639, DOI 10.1001/jamainternmed.2013.3283	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e108094	10.1371/journal.pone.0108094	http://dx.doi.org/10.1371/journal.pone.0108094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329821	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200008
J	Damsgaard, CT; Eidner, MB; Stark, KD; Hjorth, MF; Sjodin, A; Andersen, MR; Andersen, R; Tetens, I; Astrup, A; Michaelsen, KF; Lauritzen, L				Damsgaard, Camilla T.; Eidner, Maj B.; Stark, Ken D.; Hjorth, Mads F.; Sjodin, Anders; Andersen, Malene R.; Andersen, Rikke; Tetens, Inge; Astrup, Arne; Michaelsen, Kim F.; Lauritzen, Lotte			Eicosapentaenoic Acid and Docosahexaenoic Acid in Whole Blood Are Differentially and Sex-Specifically Associated with Cardiometabolic Risk Markers in 8-11-Year-Old Danish Children	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; FISH-OIL SUPPLEMENTATION; BODY-MASS INDEX; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; CARDIOVASCULAR RISK; LIPID PROFILE; SERUM-LIPIDS; PRESSURE; PLASMA	n-3 long-chain polyunsaturated fatty acids improve cardiovascular risk markers in adults. These effects may differ between eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), but we lack evidence in children. Using baseline data from the OPUS School Meal Study we 1) investigated associations between EPA and DHA in whole blood and early cardiometabolic risk markers in 713 children aged 8-11 years and 2) explored potential mediation through waist circumference and physical activity and potential dietary confounding. We collected data on parental education, pubertal stage, 7-day dietary records, physical activity by accelerometry and measured anthropometry, blood pressure, and heart rate. Blood samples were analyzed for whole blood fatty acid composition, cholesterols, triacylglycerol, insulin resistance by the homeostatic model of assessment (HOMA-IR), and inflammatory markers. Whole blood EPA was associated with a 2.7 mmHg (95% CI 0.4; 5.1) higher diastolic blood pressure per weight% EPA, but only in boys. Heart rate was negatively associated with both EPA and DHA status (P = 0.02 and P = 0.002, respectively). Whole blood EPA was negatively associated with triacylglycerol (P = 0.003) and positively with total cholesterol, low density and high density lipoprotein (HDL) cholesterol and HDL: triacylglycerol (all P<0.01) whereas DHA was negatively associated with insulin and HOMA-IR (P = 0.003) and tended to be negatively associated with a metabolic syndrome-score (P = 0.05). Adjustment for waist circumference and physical activity did not change the associations. The association between DHA and HOMA-IR was attenuated but remained after adjustment for fiber intake and none of the other associations were confounded by dietary fat, protein, fiber or energy intake. This study showed that EPA status was negatively associated with triacylglycerol and positively with cholesterols whereas DHA was negatively associated with insulin resistance, and both were inversely associated with heart rate in children. The sex-specific associations with blood pressure confirm our previous findings and warrant further investigation.	[Damsgaard, Camilla T.; Eidner, Maj B.; Hjorth, Mads F.; Sjodin, Anders; Astrup, Arne; Michaelsen, Kim F.; Lauritzen, Lotte] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Frederiksberg, Denmark; [Stark, Ken D.] Univ Waterloo, Dept Kinesiol, Waterloo, AB, Canada; [Andersen, Malene R.] Copenhagen Univ Hosp, Dept Clin Biochem, Gentofte, Denmark; [Andersen, Rikke; Tetens, Inge] Tech Univ Denmark, Natl Food Inst, Div Nutr, Soborg, Denmark	University of Copenhagen; University of Waterloo; University of Copenhagen; Technical University of Denmark	Damsgaard, CT (corresponding author), Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Frederiksberg, Denmark.	ctd@nexs.ku.dk	Damsgaard, Camilla T/B-4866-2015; Lauritzen, Lotte/F-2921-2013; Stark, Ken D/I-1347-2016; Andersen, Rikke/GRS-3064-2022; Astrup, Arne/B-1407-2015; Hjorth, Mads/A-1760-2015; Sjodin, Anders/B-6975-2015; Tetens, Inge/B-8965-2017	Lauritzen, Lotte/0000-0001-7184-5949; Stark, Ken D/0000-0001-7828-4072; Astrup, Arne/0000-0001-8968-8996; Andersen, Rikke/0000-0002-5091-6995; Hjorth, Mads/0000-0001-9440-2737; Sjodin, Anders/0000-0002-6451-3847; Michaelsen, Kim F/0000-0003-0449-0839; Damsgaard, Camilla T/0000-0002-5013-0562; Tetens, Inge/0000-0002-2495-2511	Nordea Foundation [02-2010-0389]; Canada Research Chair in Nutritional Lipidomics	Nordea Foundation; Canada Research Chair in Nutritional Lipidomics	The Optimal Well-Being, Development, and Health for Danish Children through a Healthy New Nordic Diet (OPUS) Centre was supported by the Nordea Foundation (grant number 02-2010-0389). KDS is supported by a Canada Research Chair in Nutritional Lipidomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinkuolie AO, 2011, CLIN NUTR, V30, P702, DOI 10.1016/j.clnu.2011.08.013; Armstrong JM, 2008, LIPIDS, V43, P187, DOI 10.1007/s11745-007-3141-6; Asserhoj M, 2009, J NUTR, V139, P298, DOI 10.3945/jn.108.095745; Bender N, 2014, OBES REV, V15, P657, DOI 10.1111/obr.12189; Biltoft-Jensen A, 2014, J HUM NUTR DIET, V27, P43, DOI 10.1111/j.1365-277X.2012.01257.x; Biltoft-Jensen A, 2013, BRIT J NUTR, V110, P186, DOI 10.1017/S0007114512004746; Black AE, 2000, EUR J CLIN NUTR, V54, P395, DOI 10.1038/sj.ejcn.1600971; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; Burdge GC, 2007, PROSTAG LEUKOTR ESS, V77, P59, DOI 10.1016/j.plefa.2007.06.003; Burrows T, 2011, INT J PEDIATR OBES, V6, pE532, DOI 10.3109/17477166.2010.549489; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Damsgaard CT, 2013, BRIT J NUTR, V110, P1304, DOI 10.1017/S0007114513000585; Damsgaard CT, 2013, J NUTR, V143, P810, DOI 10.3945/jn.112.173427; Damsgaard CT, 2012, SCAND J PUBLIC HEALT, V40, P693, DOI 10.1177/1403494812463173; Damsgaard CT, 2006, J NUTR, V136, P94, DOI 10.1093/jn/136.1.94; Duncan GE, 2004, DIABETES CARE, V27, P2438, DOI 10.2337/diacare.27.10.2438; Eisenmann JC, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-17; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010; Gobel RJ, 2012, ACTA PAEDIATR, V101, P192, DOI 10.1111/j.1651-2227.2011.02493.x; Hamazaki T, 1996, J CLIN INVEST, V97, P1129, DOI 10.1172/JCI118507; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Hjorth MF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-808; Hooper L, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003177.PUB2; Janssen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079124; Juhola J, 2011, J PEDIATR-US, V159, P584, DOI 10.1016/j.jpeds.2011.03.021; Lauritzen L, 2012, BRIT J NUTR, V107, P697, DOI 10.1017/S0007114511002418; Laursen RP, 2014, EUR J CLIN NUTR, V68, P277, DOI 10.1038/ejcn.2013.259; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metherel AH, 2009, PROSTAG LEUKOTR ESS, V81, P23, DOI 10.1016/j.plefa.2009.05.018; Metherel AH, 2009, PROSTAG LEUKOTR ESS, V81, P417, DOI 10.1016/j.plefa.2009.07.003; MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471; Morrison JA, 2008, J PEDIATR-US, V152, P201, DOI 10.1016/j.jpeds.2007.09.010; Mozaffarian D, 2012, J NUTR, V142, p614S, DOI 10.3945/jn.111.149633; National Food Institute, 2010, DANSK KOSTV 2003 200; Okubo H, 2010, ASIA PAC J CLIN NUTR, V19, P555; Patterson AC, 2014, BRIT J NUTR, V111, P270, DOI 10.1017/S0007114513002225; Pearson S, 2010, ACTA PAEDIATR, V99, P1675, DOI 10.1111/j.1651-2227.2010.01897.x; Pedersen MH, 2010, J PEDIATR-US, V157, P395, DOI 10.1016/j.jpeds.2010.04.001; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rockett BD, 2012, PROSTAG LEUKOTR ESS, V86, P137, DOI 10.1016/j.plefa.2011.12.001; Ruottinen S, 2010, AM J CLIN NUTR, V91, P651, DOI 10.3945/ajcn.2009.28461; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Stark KD, 2012, PROSTAG LEUKOTR ESS, V87, P49, DOI 10.1016/j.plefa.2012.05.002; Statistics Denmark, 2012, FORSP 1 UDD; Stene LC, 2003, AM J CLIN NUTR, V78, P1128, DOI 10.1093/ajcn/78.6.1128; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; WEBBER LS, 1991, AM J EPIDEMIOL, V133, P884, DOI 10.1093/oxfordjournals.aje.a115968; Wei MY, 2011, CURR ATHEROSCLER REP, V13, P474, DOI 10.1007/s11883-011-0210-3; World Health Organization, 2012, WHO ANTHR MACR STATA; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	54	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109368	10.1371/journal.pone.0109368	http://dx.doi.org/10.1371/journal.pone.0109368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25330302	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200026
J	de Heer, EW; Gerrits, MMJG; Beekman, ATF; Dekker, J; van Marwijk, HWJ; de Waal, MWM; Spinhoven, P; Penninx, BWJH; van der Feltz-Cornelis, CM				de Heer, Eric W.; Gerrits, Marloes M. J. G.; Beekman, Aartjan T. F.; Dekker, Jack; van Marwijk, Harm W. J.; de Waal, Margot W. M.; Spinhoven, Philip; Penninx, Brenda W. J. H.; van der Feltz-Cornelis, Christina M.			The Association of Depression and Anxiety with Pain: A Study from NESDA	PLOS ONE			English	Article							STAR-ASTERISK-D; MENTAL-HEALTH SURVEYS; LOW-BACK-PAIN; PRIMARY-CARE; PSYCHOMETRIC PROPERTIES; RISK-FACTORS; INFLAMMATORY CYTOKINES; MUSCULOSKELETAL PAIN; GENERAL-POPULATION; CARDIAC-DISEASE	Chronic pain is commonly co-morbid with a depressive or anxiety disorder. Objective of this study is to examine the influence of depression, along with anxiety, on pain-related disability, pain intensity, and pain location in a large sample of adults with and without a depressive and/or anxiety disorder. The study population consisted of 2981 participants with a depressive, anxiety, co-morbid depressive and anxiety disorder, remitted disorder or no current disorder (controls). Severity of depressive and anxiety symptoms was also assessed. In separate multinomial regression analyses, the association of presence of depressive or anxiety disorders and symptom severity with the Chronic Pain Grade and location of pain was explored. Presence of a depressive (OR = 6.67; P<.001), anxiety (OR = 4.84; P<.001), or co-morbid depressive and anxiety disorder (OR = 30.26; P<.001) was associated with the Chronic Pain Grade. Moreover, symptom severity was associated with more disabling and severely limiting pain. Also, a remitted depressive or anxiety disorder showed more disabling and severely limiting pain (OR = 3.53; P<.001) as compared to controls. A current anxiety disorder (OR = 2.96; p<.001) and a co-morbid depressive and anxiety disorder (OR = 5.15; P<.001) were more strongly associated with cardio-respiratory pain, than gastro-intestinal or musculoskeletal pain. These findings remain after adjustment for chronic cardio respiratory illness. Patients with a current and remitted depressive and/or anxiety disorder and those with more severe symptoms have more disabling pain and pain of cardio-respiratory nature, than persons without a depressive or anxiety disorder. This warrants further research.	[de Heer, Eric W.; van der Feltz-Cornelis, Christina M.] GGz Breburg Tilburg, TopClin Ctr Body Mind & Hlth, Tilburg, Netherlands; [de Heer, Eric W.; van der Feltz-Cornelis, Christina M.] Tilburg Univ, Tilburg Sch Behav & Social Sci, Tranzo Dept, NL-5000 LE Tilburg, Netherlands; [Gerrits, Marloes M. J. G.; Beekman, Aartjan T. F.; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Psychiat, Amsterdam, Netherlands; [Beekman, Aartjan T. F.] GGZ inGeest, Mental Hlth Inst, Amsterdam, Netherlands; [Dekker, Jack] Arkin, Mental Hlth Inst, Amsterdam, Netherlands; [Dekker, Jack] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [van Marwijk, Harm W. J.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Gen Practice, Amsterdam, Netherlands; [de Waal, Margot W. M.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Spinhoven, Philip] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Spinhoven, Philip] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [van der Feltz-Cornelis, Christina M.] Trimbos Inst, Utrecht, Netherlands	Tilburg University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Trimbos Institute	de Heer, EW (corresponding author), GGz Breburg Tilburg, TopClin Ctr Body Mind & Hlth, Tilburg, Netherlands.	e.deheer@ggzbreburg.nl	Van Marwijk, Harm/K-6306-2013; De Waal, Margot/HHZ-5204-2022; Penninx, Brenda WJH/S-7627-2017; Van der Feltz-Cornelis, Christina/R-7107-2016	Van Marwijk, Harm/0000-0001-6206-485X; Penninx, Brenda WJH/0000-0001-7779-9672; Van der Feltz-Cornelis, Christina/0000-0001-6925-8956	Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-MW) [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; IQ Healthcare; Netherlands Institute for Health Services Research [NIVEL]; Netherlands Institute of Mental Health and Addiction [Trimbos]	Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-MW)(Netherlands Organization for Health Research and Development); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; IQ Healthcare; Netherlands Institute for Health Services Research [NIVEL]; Netherlands Institute of Mental Health and Addiction [Trimbos]	The infrastructure for the NESDA study is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-MW, grant number 10-000-1002) and is supported by participating universities and mental health care organisations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, IQ Healthcare, Netherlands Institute for Health Services Research [NIVEL], and the Netherlands Institute of Mental Health and Addiction [Trimbos]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmundson GJG, 2009, DEPRESS ANXIETY, V26, P888, DOI 10.1002/da.20600; Bair MJ, 2004, PSYCHOSOM MED, V66, P17, DOI 10.1097/01.PSY.0000106883.94059.C5; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; de Oliveira CMB, 2011, REV BRAS ANESTESIOL, V61, P255, DOI 10.1016/S0034-7094(11)70029-0; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck JG, 2011, PSYCHOL TRAUMA-US, V3, P101, DOI 10.1037/a0021263; Beesdo K, 2010, SOC PSYCH PSYCH EPID, V45, P89, DOI 10.1007/s00127-009-0045-1; BURLOUX G, 1989, PSYCHOTHER PSYCHOSOM, V52, P119, DOI 10.1159/000288311; Campbell LC, 2003, BIOL PSYCHIAT, V54, P399, DOI 10.1016/S0006-3223(03)00545-6; Celano CM, 2011, CARDIOL REV, V19, P130, DOI 10.1097/CRD.0b013e31820e8106; Cheng C, 2003, PSYCHOSOM MED, V65, P443, DOI 10.1097/01.PSY.0000041623.24456.99; Croft PR, 2001, PAIN, V93, P317, DOI 10.1016/S0304-3959(01)00334-7; Demyttenaere K, 2007, PAIN, V129, P332, DOI 10.1016/j.pain.2007.01.022; Farmer C, 2009, DEPRESS ANXIETY, V26, P222, DOI 10.1002/da.20514; Fava M, 2004, PSYCHOL MED, V34, P1299, DOI 10.1017/S0033291704002612; Fava M, 2008, AM J PSYCHIAT, V165, P342, DOI 10.1176/appi.ajp.2007.06111868; Fava M, 2006, CAN J PSYCHIAT, V51, P823, DOI 10.1177/070674370605101304; Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060; Fink P, 2007, PSYCHOSOM MED, V69, P30, DOI 10.1097/PSY.0b013e31802e46eb; Fraguas R, 2007, PSYCHOSOMATICS, V48, P418, DOI 10.1176/appi.psy.48.5.418; Gerhardt A, 2011, PAIN MED, V12, P1231, DOI 10.1111/j.1526-4637.2011.01190.x; Gerrits MMJG, 2012, PAIN, V153, P429, DOI 10.1016/j.pain.2011.11.001; Gilkey DP, 2010, J MANIP PHYSIOL THER, V33, P88, DOI 10.1016/j.jmpt.2009.12.005; Gladigau EL, 2014, INTERN MED J, V44, P65, DOI 10.1111/imj.12319; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Gureje O, 2008, PAIN, V135, P82, DOI 10.1016/j.pain.2007.05.005; Jang Y, 2002, GERONTOLOGIST, V42, P807, DOI 10.1093/geront/42.6.807; Janwantanakul P, 2012, J MANIP PHYSIOL THER, V35, P568, DOI 10.1016/j.jmpt.2012.07.008; Kabacoff RI, 1997, J ANXIETY DISORD, V11, P33, DOI 10.1016/S0887-6185(96)00033-3; Karp JF, 2005, J CLIN PSYCHIAT, V66, P591, DOI 10.4088/JCP.v66n0508; Kindler LL, 2010, J PAIN, V11, P1320, DOI 10.1016/j.jpain.2010.03.007; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; LEAVITT F, 1979, PAIN, V6, P191, DOI 10.1016/0304-3959(79)90126-X; Lucchetti G, 2012, CURR PAIN HEADACHE R, V16, P399, DOI 10.1007/s11916-012-0286-7; Maes M, 1998, CYTOKINE, V10, P313, DOI 10.1006/cyto.1997.0290; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; MATEOS JLA, 1989, PSYCHOTHER PSYCHOSOM, V52, P92; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Means-Christensen AJ, 2008, DEPRESS ANXIETY, V25, P593, DOI 10.1002/da.20342; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Nielsen TJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003045; Nimnuan C, 2001, J PSYCHOSOM RES, V51, P361, DOI 10.1016/S0022-3999(01)00223-9; Ohayon MM, 2003, ARCH GEN PSYCHIAT, V60, P39, DOI 10.1001/archpsyc.60.1.39; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Papakostas GI, 2003, PSYCHIAT RES, V118, P39, DOI 10.1016/S0165-1781(03)00063-5; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pincus T, 1999, J PSYCHOSOM RES, V47, P211, DOI 10.1016/S0022-3999(99)00045-8; Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034; Roth RS, 2008, J PAIN, V9, P588, DOI 10.1016/j.jpain.2008.01.333; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Saito T, 2012, ARCH GERONTOL GERIAT, V55, P539, DOI 10.1016/j.archger.2012.04.002; Sareen J, 2005, DEPRESS ANXIETY, V21, P193, DOI 10.1002/da.20072; Scholten WD, 2013, J AFFECT DISORDERS, V147, P180, DOI 10.1016/j.jad.2012.10.031; Schulz E, 2012, CEREB CORTEX, V22, P1118, DOI 10.1093/cercor/bhr186; Shahid Muhammad, 2004, J Coll Physicians Surg Pak, V14, P700; Sharpley CF, 2011, REV NEUROSCIENCE, V22, P295, DOI 10.1515/RNS.2011.030; Shubayev VI, 2010, TRANSLATIONAL PAIN R; Smith BH, 1997, PAIN, V71, P141, DOI 10.1016/S0304-3959(97)03347-2; Stahl S, 2004, HUM PSYCHOPHARM CLIN, V19, pS9, DOI 10.1002/hup.619; Tossani E, 2013, PSYCHOTHER PSYCHOSOM, V82, P67, DOI 10.1159/000343003; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Walter SA, 2013, NEUROGASTROENT MOTIL, V25, P741, DOI 10.1111/nmo.12155; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Wise TN, 2007, PAIN MED, V8, pS75, DOI 10.1111/j.1526-4637.2007.00352.x; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; Ziv M, 2010, HUM BRAIN MAPP, V31, P326, DOI 10.1002/hbm.20867	69	172	176	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e106907	10.1371/journal.pone.0106907	http://dx.doi.org/10.1371/journal.pone.0106907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25330004	Green Published, gold			2022-12-27	WOS:000346766200003
J	Frediani, JK; Jones, DP; Tukvadze, N; Uppal, K; Sanikidze, E; Kipiani, M; Tran, VT; Hebbar, G; Walker, DI; Kempker, RR; Kurani, SS; Colas, RA; Dalli, J; Tangpricha, V; Serhan, CN; Blumberg, HM; Ziegler, TR				Frediani, Jennifer K.; Jones, Dean P.; Tukvadze, Nestan; Uppal, Karan; Sanikidze, Eka; Kipiani, Maia; Tran, ViLinh T.; Hebbar, Gautam; Walker, Douglas I.; Kempker, Russell R.; Kurani, Shaheen S.; Colas, Romain A.; Dalli, Jesmond; Tangpricha, Vin; Serhan, Charles N.; Blumberg, Henry M.; Ziegler, Thomas R.			Plasma Metabolomics in Human Pulmonary Tuberculosis Disease: A Pilot Study	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; MYCOBACTERIUM-TUBERCULOSIS; LIPID MEDIATORS; HUMAN PHAGOCYTES; CELL-WALL; RESOLUTION; IDENTIFICATION; RESOLVINS; HOST; INFLAMMATION	We aimed to characterize metabolites during tuberculosis (TB) disease and identify new pathophysiologic pathways involved in infection as well as biomarkers of TB onset, progression and resolution. Such data may inform development of new anti-tuberculosis drugs. Plasma samples from adults with newly diagnosed pulmonary TB disease and their matched, asymptomatic, sputum culture-negative household contacts were analyzed using liquid chromatography high-resolution mass spectrometry (LC-MS) to identify metabolites. Statistical and bioinformatics methods were used to select accurate mass/charge (m/z) ions that were significantly different between the two groups at a false discovery rate (FDR) of q<0.05. Two-way hierarchical cluster analysis (HCA) was used to identify clusters of ions contributing to separation of cases and controls, and metabolomics databases were used to match these ions to known metabolites. Identity of specific D-series resolvins, glutamate and Mycobacterium tuberculosis (Mtb)-derived trehalose-6-mycolate was confirmed using LC-MS/MS analysis. Over 23,000 metabolites were detected in untargeted metabolomic analysis and 61 metabolites were significantly different between the two groups. HCA revealed 8 metabolite clusters containing metabolites largely upregulated in patients with TB disease, including anti-TB drugs, glutamate, choline derivatives, Mycobacterium tuberculosis-derived cell wall glycolipids (trehalose-6-mycolate and phosphatidylinositol) and pro-resolving lipid mediators of inflammation, known to stimulate resolution, efferocytosis and microbial killing. The resolvins were confirmed to be RvD1, aspirin-triggered RvD1, and RvD2. This study shows that high-resolution metabolomic analysis can differentiate patients with active TB disease from their asymptomatic household contacts. Specific metabolites upregulated in the plasma of patients with active TB disease, including Mtb-derived glycolipids and resolvins, have potential as biomarkers and may reveal pathways involved in TB disease pathogenesis and resolution.	[Frediani, Jennifer K.; Jones, Dean P.; Tangpricha, Vin; Ziegler, Thomas R.] Emory Univ, Laney Grad Sch, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA; [Frediani, Jennifer K.; Jones, Dean P.; Tangpricha, Vin; Ziegler, Thomas R.] Emory Univ, Sch Med, Ctr Clin & Mol Nutr, Atlanta, GA USA; [Frediani, Jennifer K.; Jones, Dean P.; Uppal, Karan; Tran, ViLinh T.; Hebbar, Gautam; Walker, Douglas I.; Kempker, Russell R.; Kurani, Shaheen S.; Tangpricha, Vin; Blumberg, Henry M.; Ziegler, Thomas R.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Tukvadze, Nestan; Sanikidze, Eka; Kipiani, Maia; Blumberg, Henry M.] Natl Ctr TB & Lung Dis, Tbilisi, Georgia; [Walker, Douglas I.] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA; [Colas, Romain A.; Dalli, Jesmond; Serhan, Charles N.] Harvard Univ, Sch Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA USA; [Tangpricha, Vin] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Blumberg, Henry M.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Tufts University; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Rollins School Public Health	Jones, DP (corresponding author), Emory Univ, Laney Grad Sch, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA.	dpjones@emory.edu; tzieg01@emory.edu	Kurani, Shaheen/AAL-2614-2020; Tangpricha, Vin/A-8645-2009; Frediani, Jennifer/GZL-2734-2022; Blumberg, Henry/W-2156-2019	Kurani, Shaheen/0000-0003-2366-7505; Tangpricha, Vin/0000-0002-4021-5853; Blumberg, Henry/0000-0002-3110-2443; Dalli, Jesmond/0000-0001-6328-3640; Frediani, Jennifer/0000-0002-4634-0591; Uppal, Karan/0000-0001-5985-1668	National Institutes of Health [UL1 TR000454, K24 DK096574, R01 ES016731, P30ES019776, HHSN272201200031C, P20HL113451, R01 AG038746, D43 TW007124, P01 GM095467, K23 AR054334, K23 AI103044]; Emory University Global Health Institute; FOGARTY INTERNATIONAL CENTER [D43TW007124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI103044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR054334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK096574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870, P30ES019776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health (www.nih.gov) grants UL1 TR000454 (Atlanta Clinical and Translational Science Institute www.actsi.org), K24 DK096574 (TRZ), R01 ES016731, P30ES019776, HHSN272201200031C, P20HL113451 and R01 AG038746 (DPJ), D43 TW007124 (HMB), P01 GM095467 (CNS, JD, RAC), K23 AR054334 (VT), K23 AI103044 (RRK) and the Emory University Global Health Institute (http://www.globalhealth.emory.edu/) (TRZ, VT, HMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anishetty S, 2005, COMPUT BIOL CHEM, V29, P368, DOI 10.1016/j.compbiolchem.2005.07.001; Behrends V, 2013, ENVIRON MICROBIOL, V15, P398, DOI 10.1111/j.1462-2920.2012.02840.x; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Che NY, 2013, CLIN CHIM ACTA, V423, P5, DOI 10.1016/j.cca.2013.04.010; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Cribbs SK, 2014, AIDS RES HUM RETROV, V30, P579, DOI [10.1089/aid.2013.0198, 10.1089/AID.2013.0198]; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Desai NS, 2012, NUTRITION, V28, P362, DOI 10.1016/j.nut.2011.08.012; Dobson CM, 2013, CELL MOL LIFE SCI, V70, P2849, DOI 10.1007/s00018-012-1193-0; du Preez I, 2013, TUBERCULOSIS, V93, P330, DOI 10.1016/j.tube.2013.02.008; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Frediani JK, 2013, CLIN NUTR, V32, P1023, DOI 10.1016/j.clnu.2013.02.013; Godfrey AR, 2012, ANAL BIOANAL CHEM, V404, P1159, DOI 10.1007/s00216-012-6136-y; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Johnson JM, 2010, ANALYST, V135, P2864, DOI 10.1039/c0an00333f; Jones DP, 2012, ANNU REV NUTR, V32, P183, DOI 10.1146/annurev-nutr-072610-145159; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Li F, 2011, DRUG METAB PHARMACOK, V26, P569, DOI 10.2133/dmpk.DMPK-11-RG-055; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Loots DT, 2014, ANTIMICROB AGENTS CH, V58, P2144, DOI 10.1128/AAC.02344-13; LYON R H, 1970, Infection and Immunity, V1, P513; Maertzdorf J, 2012, INT J TUBERC LUNG D, V16, P1140, DOI 10.5588/ijtld.12.0246; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Osborn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072737; Park YH, 2012, TOXICOLOGY, V295, P47, DOI 10.1016/j.tox.2012.02.007; Patterson JH, 2003, BIOCHEM J, V372, P77, DOI 10.1042/BJ20021700; Peregrin-Alvarez JM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r63; Rivera-Betancourt OE, 2013, ANALYST, V138, P6774, DOI 10.1039/c3an01157g; Rivera-Marrero CA, 2002, MICROBIOL-SGM, V148, P783, DOI 10.1099/00221287-148-3-783; Roede JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077629; Sana TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060840; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Seymour CW, 2013, INTENS CARE MED, V39, P1423, DOI 10.1007/s00134-013-2935-7; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soltow QA, 2013, METABOLOMICS, V9, pS132, DOI 10.1007/s11306-011-0332-1; Somashekar BS, 2012, J PROTEOME RES, V11, P4873, DOI 10.1021/pr300345x; Sonawat HM, 2012, CLIN LAB MED, V32, P129, DOI 10.1016/j.cll.2012.04.005; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tukvadze N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031563; Uppal K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-15; Vuilleumier Nicolas, 2006, Eur J Clin Pharmacol, V62, P423; Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; WIETZERBIN J, 1975, BIOCHEM BIOPH RES CO, V62, P246, DOI 10.1016/S0006-291X(75)80130-6; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; World Health Organization, 2013, WHO GLOB REP; Worley B, 2013, ANAL BIOCHEM, V433, P102, DOI 10.1016/j.ab.2012.10.011; Yang J, 2012, FREE RADICAL BIO MED, V53, P160, DOI 10.1016/j.freeradbiomed.2012.05.001; Yang Rong, 2011, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1426s95; Yu TW, 2013, J PROTEOME RES, V12, P1419, DOI 10.1021/pr301053d; Zhou AP, 2013, J PROTEOME RES, V12, P4642, DOI 10.1021/pr4007359; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	65	105	105	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e108854	10.1371/journal.pone.0108854	http://dx.doi.org/10.1371/journal.pone.0108854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329995	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200012
J	Grouzdev, DS; Dziuba, MV; Kurek, DV; Ovchinnikov, AI; Zhigalova, NA; Kuznetsov, BB; Skryabin, KG				Grouzdev, Denis S.; Dziuba, Marina V.; Kurek, Denis V.; Ovchinnikov, Alexander I.; Zhigalova, Nadezhda A.; Kuznetsov, Boris B.; Skryabin, Konstantin G.			Optimized Method for Preparation of IgG-Binding Bacterial Magnetic Nanoparticles	PLOS ONE			English	Article							BIOGENIC MAGNETOSOME NANOPARTICLES; RESPONSE-SURFACE METHODOLOGY; MEMBRANE-PROTEIN EXPRESSION; MAGNETOTACTIC BACTERIA; MAGNETOSPIRILLUM-GRYPHISWALDENSE; PARTICLE MEMBRANE; ESCHERICHIA-COLI; IN-VITRO; INTEGRATION; RECEPTORS	In this study, the optimized method for designing IgG-binding magnetosomes based on integration of IgG-binding fusion proteins into magnetosome membrane in vitro is presented. Fusion proteins Mbb and Mistbb consisting of magnetosome membrane protein MamC and membrane associating protein Mistic from Bacillus subtilis as anchors and BB-domains of Staphylococcus aureus protein A as IgG-binding region were used. With Response Surface Methodology (RSM) the highest level of proteins integration into magnetosome membrane was achieved under the following parameters: pH 8.78, without adding NaCl and 55 s of vortexing for Mbb; pH 9.48, 323 mM NaCl and 55 s of vortexing for Mistbb. Modified magnetosomes with Mbb and Mistbb displayed on their surface demonstrated comparable levels of IgG-binding activity, suggesting that both proteins could be efficiently used as anchor molecules. We also demonstrated that such modified magnetosomes are stable in PBS buffer during at least two weeks. IgG-binding magnetosomes obtained by this approach could serve as a multifunctional platform for displaying various types of antibodies.	[Grouzdev, Denis S.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Grouzdev, Denis S.; Dziuba, Marina V.; Kurek, Denis V.; Ovchinnikov, Alexander I.; Zhigalova, Nadezhda A.; Kuznetsov, Boris B.; Skryabin, Konstantin G.] Russian Acad Sci, Ctr Bioengn, Moscow, Russia	Lomonosov Moscow State University; Research Center of Biotechnology RAS; Russian Academy of Sciences	Grouzdev, DS (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia.	denisgrouzdev@gmail.com	Grouzdev, Denis/N-7650-2019; Дзюба, Марина/K-4159-2014; Zhigalova, Nadezhda A/I-4545-2014; Grouzdev, Denis S/K-2114-2018	Grouzdev, Denis/0000-0002-1358-5146; Дзюба, Марина/0000-0002-0873-213X; Zhigalova, Nadezhda A/0000-0002-4805-6586; Grouzdev, Denis S/0000-0002-1358-5146	RAS; Russian Federation [14.120.14.6150-NSh]	RAS(Russian Academy of SciencesRegione Sardegna); Russian Federation(Russian Federation)	This work was supported by RAS program "Fundamental Basis of Technologies of Nanostructures and Nanomaterials'' http://www.ras.ru and by grant #14.120.14.6150-NSh of President of Russian Federation https://grants.extech.ru/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphandery E, 2011, ACS NANO, V5, P6279, DOI 10.1021/nn201290k; Bas D, 2007, J FOOD ENG, V78, P836, DOI 10.1016/j.jfoodeng.2005.11.024; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Ceyhan B, 2006, SMALL, V2, P1251, DOI 10.1002/smll.200600282; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; Dziuba MV, 2013, MICROBIOLOGY+, V82, P335, DOI 10.1134/S0026261713030028; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Grouzdev DS, 2013, APPL BIOCHEM MICRO+, V49, P220, DOI 10.1134/S0003683813030095; Huh YM, 2005, J AM CHEM SOC, V127, P12387, DOI 10.1021/ja052337c; Ito A, 2005, J BIOSCI BIOENG, V100, P1, DOI 10.1263/jbb.100.1; Kefala Georgia, 2007, Journal of Structural and Functional Genomics, V8, P167, DOI 10.1007/s10969-007-9033-4; Lang C, 2008, APPL ENVIRON MICROB, V74, P4944, DOI 10.1128/AEM.00231-08; Matsunaga T, 2000, BIOTECHNOL BIOENG, V70, P704, DOI 10.1002/1097-0290(20001220)70:6<704::AID-BIT14>3.0.CO;2-E; Matsunaga T, 2002, BIOTECHNOL BIOENG, V77, P614, DOI 10.1002/bit.10114; MOSKOWITZ BM, 1995, REV GEOPHYS, V33, P123, DOI 10.1029/95RG00443; Petrovskaya LE, 2010, BIOCHEMISTRY-MOSCOW+, V75, P881, DOI 10.1134/S0006297910070102; PFENNIG N, 1966, ARCH MIKROBIOL, V55, P245, DOI 10.1007/BF00410246; Pollithy A, 2011, APPL ENVIRON MICROB, V77, P6165, DOI 10.1128/AEM.05282-11; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; QIANG L, 2013, PLOS ONE, V0008; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Sambrook J., 1989, MOL CLONING; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun JB, 2007, CANCER LETT, V258, P109, DOI 10.1016/j.canlet.2007.08.018; Takahashi M, 2010, BIOMATERIALS, V31, P4952, DOI 10.1016/j.biomaterials.2010.02.048; TAKEYAMA H, 1995, BIOTECHNOL TECH, V9, P355, DOI 10.1007/BF00638870; Tanaka T, 2004, ANAL CHEM, V76, P3764, DOI 10.1021/ac035361m; Wacker R, 2007, BIOCHEM BIOPH RES CO, V357, P391, DOI 10.1016/j.bbrc.2007.03.156; Xiang L, 2007, LETT APPL MICROBIOL, V45, P75, DOI 10.1111/j.1472-765X.2007.02143.x; Xu Y, 2013, MICROBIOL-SGM, V159, P1002, DOI 10.1099/mic.0.066621-0; Yoshino T, 2006, APPL ENVIRON MICROB, V72, P465, DOI 10.1128/AEM.72.1.465-471.2006; Yoza B, 2003, J BIOSCI BIOENG, V95, P21, DOI 10.1263/jbb.95.21	33	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109914	10.1371/journal.pone.0109914	http://dx.doi.org/10.1371/journal.pone.0109914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333971	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200065
J	Ikeda, K; Fujimoto, S; Morling, B; Ayano-Takahara, S; Carroll, AE; Harashima, S; Uchida, Y; Inagaki, N				Ikeda, Kaori; Fujimoto, Shimpei; Morling, Beth; Ayano-Takahara, Shiho; Carroll, Andrew E.; Harashima, Shin-ichi; Uchida, Yukiko; Inagaki, Nobuya			Social Orientation and Diabetes-Related Distress in Japanese and American Patients with Type 2 Diabetes	PLOS ONE			English	Article							PROBLEM-AREAS; CULTURAL-DIFFERENCES; EMOTIONAL DISTRESS; SELF-ESTEEM; FAMILY; SCALE	Objective: Recent evidence in cultural and social psychology suggests Eastern cultures' emphasis on harmony and connection with others and Western cultures' emphasis on self-direction and autonomy. In Eastern society, relational harmony is closely linked to people's well-being. The impact of this cultural and social orientation on diabetes-related distress was investigated. Research Design and Methods: Japanese and American patients with type 2 diabetes were surveyed by well-established questionnaire in Japan and in the United States, respectively. The association of personal values for interdependence, perceived emotional support, and the Problem Areas in Diabetes scale (PAID) were analyzed. Results: A positive correlation between interdependence and PAID (r = 0.18; P = 0.025) and a negative correlation between perceived emotional support and PAID (r = 2 0.24; P = 0.004) were observed after adjustments for other factors in Japanese data (n = 149), but not in American data (r = 0.00; P = 0.990, r = 0.02; P = 0.917, respectively, n = 50). In Japanese data, the three-factor structure of PAID (negative feelings about total life with diabetes, about living conditions with diabetes, and about treatment of diabetes) was identified, and interdependence showed significant positive correlations with the first and second factors and perceived emotional support showed significant negative correlations with all three factors of PAID. Conclusions: These results suggest that personal values for interdependence may be linked to the level of diabetes-related distress and that the distress may be relieved by perception of emotional support, especially in an interdependent cultural context.	[Ikeda, Kaori; Fujimoto, Shimpei; Ayano-Takahara, Shiho; Harashima, Shin-ichi; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan; [Fujimoto, Shimpei] Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Nankoku, Kochi, Japan; [Morling, Beth; Carroll, Andrew E.] Univ Delaware, Dept Psychol, Newark, DE USA; [Uchida, Yukiko] Kyoto Univ, Kokoro Res Ctr, Kyoto, Japan	Kyoto University; Kochi University; University of Delaware; Kyoto University	Inagaki, N (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan.	inagaki@metab.kuhp.kyoto-u.ac.jp		Ikeda, Kaori/0000-0003-2273-9693; Uchida, Yukiko/0000-0002-8336-2423; Inagaki, Nobuya/0000-0001-8261-2593	Kokoro Research Center Kyoto University; Grants-in-Aid for Scientific Research [25293210] Funding Source: KAKEN	Kokoro Research Center Kyoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Kokoro Research Center Kyoto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181; Albright TL, 2001, FAM MED, V33, P354; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010; Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025; Chan JCN, 2014, DIABETES RES CLIN PR, V103, P244, DOI 10.1016/j.diabres.2013.11.012; Chesla CA, 2009, DIABETES CARE, V32, P1812, DOI 10.2337/dc09-0278; Chiao JY, 2009, HUM BRAIN MAPP, V30, P2813, DOI 10.1002/hbm.20707; Essau CA, 2013, SOC PSYCH PSYCH EPID, V48, P2017, DOI 10.1007/s00127-013-0673-3; Fisher L, 2000, DIABETES CARE, V23, P267, DOI 10.2337/diacare.23.3.267; Funnell MM, 2006, DIABETES EDUCATOR, V32, P359, DOI 10.1177/0145721706288041; Han SH, 2013, ANNU REV PSYCHOL, V64, P335, DOI 10.1146/annurev-psych-071112-054629; Ishii H, 1999, DIABETES S, V48; Kang CM, 2010, INT J NURS STUD, V47, P1363, DOI 10.1016/j.ijnurstu.2010.03.009; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; King GL, 2012, DIABETES CARE, V35, P1181, DOI 10.2337/dc12-0210; KITAYAMA S, 2006, HDB CULTURAL PSYCHOL, P136; Kitayama S, 2011, ANNU REV PSYCHOL, V62, P419, DOI 10.1146/annurev-psych-120709-145357; Morling B, 2002, PERS SOC PSYCHOL B, V28, P311, DOI 10.1177/0146167202286003; Na JY, 2011, PSYCHOL SCI, V22, P1025, DOI 10.1177/0956797611414727; Na J, 2010, P NATL ACAD SCI USA, V107, P6192, DOI 10.1073/pnas.1001911107; Ogihara Y, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00135; Oishi S, 2003, PERS SOC PSYCHOL B, V29, P939, DOI 10.1177/0146167203252802; Peyrot M, 2007, DIABETES CARE, V30, P2433, DOI 10.2337/dc07-1222; POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305; Tafarodi RW, 2011, J CROSS CULT PSYCHOL, V42, P155, DOI 10.1177/0022022110386373; Tafarodi RW, 2001, PERS INDIV DIFFER, V31, P653, DOI 10.1016/S0191-8869(00)00169-0; Uchida Y, 2008, PERS SOC PSYCHOL B, V34, P741, DOI 10.1177/0146167208315157; Varnum MEW, 2010, CURR DIR PSYCHOL SCI, V19, P9, DOI 10.1177/0963721409359301; Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760	32	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109323	10.1371/journal.pone.0109323	http://dx.doi.org/10.1371/journal.pone.0109323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25333692	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200025
J	Lopez-Campos, JL; Asensio-Cruz, MI; Castro-Acosta, A; Calero, C; Pozo-Rodriguez, F				Luis Lopez-Campos, Jose; Isabel Asensio-Cruz, M.; Castro-Acosta, Ady; Calero, Carmen; Pozo-Rodriguez, Francisco		AUDIPOC; European COPD Audit Studies	Results from an Audit Feedback Strategy for Chronic Obstructive Pulmonary Disease In-Hospital Care: A Joint Analysis from the AUDIPOC and European COPD Audit Studies	PLOS ONE			English	Article							CLINICAL-PRACTICE; CONTROLLED-TRIAL; QUALITY; EXACERBATIONS; IMPROVEMENT; MORTALITY; MONITOR	Background: Clinical audits have emerged as a potential tool to summarize the clinical performance of healthcare over a specified period of time. However, the effectiveness of audit and feedback has shown inconsistent results and the impact of audit and feedback on clinical performance has not been evaluated for COPD exacerbations. In the present study, we analyzed the results of two consecutive nationwide clinical audits performed in Spain to evaluate both the in-hospital clinical care provided and the feedback strategy. Methods: The present study is an analysis of two clinical audits performed in Spain that evaluated the clinical care provided to COPD patients who were admitted to the hospital for a COPD exacerbation. The first audit was performed from November-December 2008. The feedback strategy consisted of personalized reports for each participant center, the presentation and discussion of the results at regional, national and international meetings and the creation of health-care quality standards for COPD. The second audit was part of a European study during January and February 2011. The impact of the feedback strategy was evaluated in term of clinical care provided and in-hospital survival. Results: A total of 94 centers participated in the two audits, recruiting 8,143 admissions (audit 1: 3,493 and audit 2: 4,650). The initially provided clinical care was reasonably acceptable even though there was considerable variability. Several diagnostic and therapeutic procedures improved in the second audit. Although the differences were significant, the degree of improvement was small to moderate. We found no impact on in-hospital mortality. Conclusions: The present study describes COPD hospital care in Spanish hospitals and evaluates the impact of peer-benchmarked, individually written and group-oral feedback strategy on the clinical outcomes for treating COPD exacerbations. It describes small to moderate improvements in the clinical care provided to COPD patients with no impact on in-hospital mortality.	[Luis Lopez-Campos, Jose; Isabel Asensio-Cruz, M.; Calero, Carmen] Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Unidad Med Quirurg Enfermedades Resp, Seville, Spain; [Luis Lopez-Campos, Jose; Castro-Acosta, Ady; Calero, Carmen; Pozo-Rodriguez, Francisco] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Castro-Acosta, Ady; Pozo-Rodriguez, Francisco] Hosp 12 Octubre, Inst Invest I 12, E-28041 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre	Lopez-Campos, JL (corresponding author), Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Unidad Med Quirurg Enfermedades Resp, Seville, Spain.	lcampos@separ.es	Bodineau, José Luis López-Campos/AAG-5203-2019; Guardia, Sergi Pascual/L-7652-2014; Castro-Acosta, Ady Angelica/H-4163-2011; Asensio, Maria Isabel MAC/F-1431-2015; López-Quílez, Antonio/H-5945-2011	Bodineau, José Luis López-Campos/0000-0003-1703-1367; Guardia, Sergi Pascual/0000-0002-6567-0916; Castro-Acosta, Ady Angelica/0000-0001-7591-6011; López-Quílez, Antonio/0000-0002-7022-9260; Asensio-Cruz, Maria Isabel/0000-0002-7377-9065; CORBACHO, DOLORES/0000-0003-1239-5276	Fondo de Investigacion Sanitaria, Spanish Ministry of Health [PI07/90129, PI07/90309, PI07/90486, PI07/90503, PI07/90516, PI07/90721, PI08/90129, PI08/90578, PI08/90251, PI08/90529, PI07/90403, PI08/90447, PI08/90457, PI08/90486, PI08/90550]; European Respiratory Society	Fondo de Investigacion Sanitaria, Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European Respiratory Society	AUDIPOC study was funded by Fondo de Investigacion Sanitaria, Spanish Ministry of Health, project numbers PI07/90129, PI07/90309, PI07/90486, PI07/90503, PI07/90516, PI07/90721, PI08/90129, PI08/90578, PI08/90251, PI08/90529, PI08/90129, PI07/90403, PI08/90447, PI08/90457, PI08/90486, and PI08/90550. The European COPD audit was funded by the European Respiratory Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti N, 2010, EUR RESPIR J, V35, P1031, DOI 10.1183/09031936.00056209; Asch SM, 2006, NEW ENGL J MED, V354, P1147, DOI 10.1056/NEJMsa044464; Berwick DM, 2003, MED CARE, V41, pI30; Dalal AA, 2011, RESP MED, V105, P454, DOI 10.1016/j.rmed.2010.09.003; Flottorp SA, 2010, COPENHAGEN EUROPEAN; Hopkinson NS, 2012, THORAX, V67, P90, DOI 10.1136/thoraxjnl-2011-200233; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Ivers NM, 2014, J GEN INTERN MED; Soler-Cataluna JJ, 2009, ARCH BRONCONEUMOL, V45, P196, DOI 10.1016/j.arbres.2008.05.008; Kiefe CI, 2001, JAMA-J AM MED ASSOC, V285, P2871, DOI 10.1001/jama.285.22.2871; Lilford RJ, 2007, BMJ-BRIT MED J, V335, P648, DOI 10.1136/bmj.39317.641296.AD; Lopez-Campos JL, 2014, INT J CLIN IN PRESS; Lopez-Campos JL, 2014, LANCET RESP MED, V2, P54, DOI 10.1016/S2213-2600(13)70232-7; Lopez-Campos JL, 2013, CHEST, V144, P601, DOI 10.1378/chest.12-2690; Lopez-Campos JL, 2013, EUR RESPIR J, V41, P270, DOI 10.1183/09031936.00021812; McCarthy C, 2013, INT J CHRONIC OBSTR, V8, P605, DOI 10.2147/COPD.S52883; Miravitlles M, 2004, THORAX, V59, P387, DOI 10.1136/thx.2003.008730; Miravitlles M, 2009, THORAX, V64, P863, DOI 10.1136/thx.2009.115725; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P1, DOI 10.1016/S0300-2896(14)70070-5; MUGFORD M, 1991, BRIT MED J, V303, P398, DOI 10.1136/bmj.303.6799.398; Pozo-Rodriguez F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042156; Roberts CM, 2013, THORAX, V68, P1169, DOI 10.1136/thoraxjnl-2013-203465; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Sondergaard J, 2003, SCAND J PRIM HEALTH, V21, P47, DOI 10.1080/02813430310000564; Stone EG, 2002, ANN INTERN MED, V136, P641, DOI 10.7326/0003-4819-136-9-200205070-00006; Tsai CL, 2009, INT J EMERG MED, V2, P111, DOI 10.1007/s12245-009-0089-8; van der Veer SN, 2010, INT J MED INFORM, V79, P305, DOI 10.1016/j.ijmedinf.2010.01.011	27	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110394	10.1371/journal.pone.0110394	http://dx.doi.org/10.1371/journal.pone.0110394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333953	Green Submitted, gold, Green Published			2022-12-27	WOS:000346766200117
J	Washburn, RA; Szabo, AN; Lambourne, K; Willis, EA; Ptomey, LT; Honas, JJ; Herrmann, SD; Donnelly, JE				Washburn, Richard A.; Szabo, Amanda N.; Lambourne, Kate; Willis, Erik A.; Ptomey, Lauren T.; Honas, Jeffery J.; Herrmann, Stephen D.; Donnelly, Joseph E.			Does the Method of Weight Loss Effect Long-Term Changes in Weight, Body Composition or Chronic Disease Risk Factors in Overweight or Obese Adults? A Systematic Review	PLOS ONE			English	Review							RESTING METABOLIC-RATE; LOW-CARBOHYDRATE DIET; LOW-CALORIE DIET; LOW-FAT DIET; PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; AEROBIC EXERCISE; LOSS MAINTENANCE; APPETITE CONTROL; ADAPTIVE THERMOGENESIS	Background: Differences in biological changes from weight loss by energy restriction and/or exercise may be associated with differences in long-term weight loss/regain. Objective: To assess the effect of weight loss method on long-term changes in weight, body composition and chronic disease risk factors. Data Sources: PubMed and Embase were searched (January 1990-October 2013) for studies with data on the effect of energy restriction, exercise (aerobic and resistance) on long-term weight loss. Twenty articles were included in this review. Study Eligibility Criteria: Primary source, peer reviewed randomized trials published in English with an active weight loss period of >6 months, or active weight loss with a follow-up period of any duration, conducted in overweight or obese adults were included. Study Appraisal and Synthesis Methods: Considerable heterogeneity across trials existed for important study parameters, therefore a meta-analysis was considered inappropriate. Results were synthesized and grouped by comparisons (e.g. diet vs. aerobic exercise, diet vs. diet + aerobic exercise etc.) and study design (long-term or weight loss/follow-up). Results: Forty percent of trials reported significantly greater long-term weight loss with diet compared with aerobic exercise, while results for differences in weight regain were inconclusive. Diet+aerobic exercise resulted in significantly greater weight loss than diet alone in 50% of trials. However, weight regain (similar to 55% of loss) was similar in diet and diet+aerobic exercise groups. Fat-free mass tended to be preserved when interventions included exercise.	[Washburn, Richard A.; Szabo, Amanda N.; Lambourne, Kate; Willis, Erik A.; Ptomey, Lauren T.; Honas, Jeffery J.; Donnelly, Joseph E.] Univ Kansas, Med Ctr, Dept Internal Med, Cardiovasc Res Inst, Kansas City, KS 66103 USA; [Herrmann, Stephen D.] Sanford Res, Dept Childrens Hlth Res Ctr, Sioux Falls, SD USA	University of Kansas; University of Kansas Medical Center; Sanford Health	Donnelly, JE (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Cardiovasc Res Inst, Kansas City, KS 66103 USA.	jdonnelly@ku.edu	Herrmann, Stephen/HCI-3993-2022; Willis, Erik/B-7055-2018; Biguzzi, Felipe A/E-4724-2015	Herrmann, Stephen/0000-0003-1933-5938; Willis, Erik/0000-0002-0114-1660; Szabo-Reed, Amanda/0000-0002-4927-1501; Ptomey, Lauren/0000-0002-1705-1643	International Life Sciences Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK103493] Funding Source: NIH RePORTER	International Life Sciences Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This review was funded by the International Life Sciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2001, AM J CLIN NUTR, V74, P579; ANDERSSEN SA, 1995, NUTR METAB CARDIOVAS, V5, P189; Andreou E, 2011, ANN NUTR METAB, V59, P187, DOI 10.1159/000334755; Astrup A, 2000, Obes Rev, V1, P17, DOI 10.1046/j.1467-789x.2000.00004.x; Barte JCM, 2010, OBESITY REV, DOI 10.111/j.1467-789X2010.00740.x; Bonomi AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059641; BRAY GA, 1969, LANCET, V2, P397; Broom DR, 2009, AM J PHYSL, V296; Camps SGJA, 2013, AM J CLIN NUTR, V97, P990, DOI 10.3945/ajcn.112.050310; Catenacci VA, 2007, NAT CLIN PRACT ENDOC, V3, P518, DOI 10.1038/ncpendmet0554; Cornier MA, 2012, PHYSIOL BEHAV, V105, P1028, DOI 10.1016/j.physbeh.2011.11.023; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; Curioni CC, 2005, INT J OBESITY, V29, P1168, DOI 10.1038/sj.ijo.0803015; Das SK, 2003, AM J CLIN NUTR, V78, P22, DOI 10.1093/ajcn/78.1.22; DeLany JP, 2014, OBESITY, V22, P363, DOI 10.1002/oby.20525; DENGEL DR, 1994, METABOLISM, V43, P867, DOI 10.1016/0026-0495(94)90268-2; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Donnelly JE, 2003, ARCH INTERN MED, V163, P1343, DOI 10.1001/archinte.163.11.1343; Donnelly JE, 2013, OBESITY, V21, pE219, DOI 10.1002/oby.20145; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Doucet E, 2001, BRIT J NUTR, V85, P715, DOI 10.1079/BJN2001348; Doucet E, 2000, J CLIN ENDOCR METAB, V85, P1550, DOI 10.1210/jc.85.4.1550; Essah PA, 2010, INT J OBESITY, V34, P1239, DOI 10.1038/ijo.2010.48; Filozof CM, 2000, OBES RES, V8, P205, DOI 10.1038/oby.2000.23; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; GARROW JS, 1995, EUR J CLIN NUTR, V49, P1; Hagobian TA, 2010, EXERC SPORT SCI REV, V38, P25, DOI 10.1097/JES.0b013e3181c5cd98; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hopkins M, 2014, EUR J CLIN NUTR; Hunter GR, 2010, OBESITY, V18, P690, DOI 10.1038/oby.2009.316; Janssen I, 1999, INT J OBESITY, V23, P1035, DOI 10.1038/sj.ijo.0801038; Janssen I, 2002, DIABETES CARE, V25, P431, DOI 10.2337/diacare.25.3.431; Johnstone AM, 2004, EUR J ENDOCRINOL, V150, P185, DOI 10.1530/eje.0.1500185; King NA, 1997, MED SCI SPORT EXER, V29, P1076, DOI 10.1097/00005768-199708000-00014; King NA, 2009, AM J CLIN NUTR, V90, P921, DOI 10.3945/ajcn.2009.27706; Kozlowska L, 2004, ENDOCRINE, V24, P147, DOI 10.1385/ENDO:24:2:147; Kraschnewski JL, 2010, INT J OBESITY, V34, P1644, DOI 10.1038/ijo.2010.94; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Long SJ, 2002, BRIT J NUTR, V87, P517, DOI 10.1079/BJN2002560; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MacLean PS, 2011, AM J PHYSIOL-REG I, V301, pR581, DOI 10.1152/ajpregu.00755.2010; Martin CK, 2011, J APPL PHYSIOL, V110, P956, DOI 10.1152/japplphysiol.00846.2009; Martins C, 2010, J CLIN ENDOCR METAB, V95, P1609, DOI 10.1210/jc.2009-2082; Martins C, 2007, BRIT J NUTR, V98, P834, DOI 10.1017/S000711450774922X; Martins C, 2013, MED SCI SPORT EXER, V45, P805, DOI 10.1249/MSS.0b013e31827d1618; MAYER J, 1956, AM J CLIN NUTR, V4, P169, DOI 10.1093/ajcn/4.2.169; Meckling KA, 2004, J CLIN ENDOCR METAB, V89, P2717, DOI 10.1210/jc.2003-031606; Melanson KJ, 2006, J AM DIET ASSOC, V106, P1380, DOI 10.1016/j.jada.2006.06.003; Melanson KJ, 2004, NUTRITION, V20, P849, DOI 10.1016/j.nut.2004.06.004; Miller WC, 1997, INT J OBESITY, V21, P941, DOI 10.1038/sj.ijo.0800499; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Molenaar EA, 2010, FAM PRACT, V27, P143, DOI 10.1093/fampra/cmp104; Murgatroyd PR, 1999, INT J OBESITY, V23, P1269, DOI 10.1038/sj.ijo.0801062; Neumark-Sztainer D, 1995, Public Health Rev, V23, P237; Ochner CN, 2013, PHYSIOL BEHAV, V120, P106, DOI 10.1016/j.physbeh.2013.07.009; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; PAVLOU KN, 1989, AM J CLIN NUTR, V49, P1115, DOI 10.1093/ajcn/49.5.1115; Pfluger PT, 2007, J CLIN ENDOCR METAB, V92, P583, DOI 10.1210/jc.2006-1425; Phelan S, 2010, AM J PREV MED, V39, P546, DOI 10.1016/j.amepre.2010.08.008; Potteiger JA, 2008, INT J SPORT NUTR EXE, V18, P79, DOI 10.1123/ijsnem.18.1.79; Pritchard JE, 1997, J AM DIET ASSOC, V97, P37, DOI 10.1016/S0002-8223(97)00015-1; Racette SB, 2006, J GERONTOL A-BIOL, V61, P943, DOI 10.1093/gerona/61.9.943; Redman LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004377; Reed JL, 2013, CAN J DIABETES, V37, P121, DOI 10.1016/j.jcjd.2013.03.022; Reinehr T, 2007, OBESITY, V15, P2006, DOI 10.1038/oby.2007.239; Rice B, 1999, DIABETES CARE, V22, P684, DOI 10.2337/diacare.22.5.684; Rissanen P, 2001, OBES RES, V9, P637, DOI 10.1038/oby.2001.84; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Rosenkilde M, 2012, AM J PHYSIOL-REG I, V303, pR571, DOI 10.1152/ajpregu.00141.2012; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Schwartz A, 2010, OBES REV, V11, P531, DOI 10.1111/j.1467-789X.2009.00654.x; Schwartz A, 2012, OBESITY, V20, P2307, DOI 10.1038/oby.2012.34; Skender ML, 1996, J AM DIET ASSOC, V96, P342, DOI 10.1016/S0002-8223(96)00096-X; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Snel M, 2011, FOOD CHEM TOXICOL, V49, P3104, DOI 10.1016/j.fct.2011.09.032; Straznicky NE, 2005, J CLIN ENDOCR METAB, V90, P5998, DOI 10.1210/jc.2005-0961; Straznicky NE, 2010, CURR OPIN LIPIDOL, V21, P21, DOI 10.1097/MOL.0b013e3283329c62; Strohacker K, 2014, INT J OBESITY, V38, P388, DOI 10.1038/ijo.2013.118; Stubbs RJ, 2004, AM J CLIN NUTR, V79, P62; Sumithran P, 2013, CLIN SCI, V124, P231, DOI 10.1042/CS20120223; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; SVENDSEN OL, 1994, INT J OBESITY, V18, P692; Tomiyama AJ, 2010, PSYCHOSOM MED, V72, P357, DOI 10.1097/PSY.0b013e3181d9523c; van Aggel-Leijssen DP, 2002, METABOLISM, V51, P1003, DOI 10.1053/meta.2002.34028; Van Walleghen EL, 2007, INT J OBESITY, V31, P1277, DOI 10.1038/sj.ijo.0803579; Volpe SL, 2008, J AM COLL NUTR, V27, P195, DOI 10.1080/07315724.2008.10719691; Wadden TA, 1998, J CONSULT CLIN PSYCH, V66, P429, DOI 10.1037/0022-006X.66.2.429; WADDEN TA, 1990, INT J OBESITY, V14, P249; Wang XW, 2008, MED SCI SPORT EXER, V40, P1781, DOI 10.1249/MSS.0b013e31817d8176; Weinheimer EM, 2010, NUTR REV, V68, P375, DOI 10.1111/j.1753-4887.2010.00298.x; Weinsier RL, 2000, AM J CLIN NUTR, V72, P1088; Weiss EC, 2007, AM J PREV MED, V33, P34, DOI 10.1016/j.amepre.2007.02.040; Weiss EP, 2008, REJUV RES, V11, P605, DOI 10.1089/rej.2007.0622; Wilmore JH, 1998, AM J CLIN NUTR, V68, P66, DOI 10.1093/ajcn/68.1.66; Wing RR, 1998, DIABETES CARE, V21, P350, DOI 10.2337/diacare.21.3.350; Wing RR, 1999, MED SCI SPORT EXER, V31, pS547, DOI 10.1097/00005768-199911001-00010; WOOD PD, 1991, NEW ENGL J MED, V325, P461, DOI 10.1056/NEJM199108153250703; Wu T, 2009, OBES REV, V10, P313, DOI 10.1111/j.1467-789X.2008.00547.x	102	42	42	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109849	10.1371/journal.pone.0109849	http://dx.doi.org/10.1371/journal.pone.0109849			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333384	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200059
J	Jin, J; Yu, MX; Hu, C; Ye, L; Xie, LL; Jin, J; Chen, FF; Tong, HY				Jin, Jie; Yu, Mengxia; Hu, Chao; Ye, Li; Xie, Lili; Jin, Jin; Chen, Feifei; Tong, Hongyan			Pesticide Exposure as a Risk Factor for Myelodysplastic Syndromes: A Meta-Analysis Based on 1,942 Cases and 5,359 Controls	PLOS ONE			English	Article							MYELOID LEUKEMIAS; HODGKINS-LYMPHOMA; CANCER; ASSOCIATION; DISEASE; UPDATE; AGENTS; BIAS	Objective: Pesticide exposure has been linked to increased risk of cancer at several sites, but its association with risk of myelodysplastic syndromes (MDS) is still unclear. A meta-analysis of studies published through April, 2014 was performed to investigate the association of pesticide exposure with the risk of MDS. Methods: Studies were identified by searching the Web of Science, Cochrane Library and PubMed databases. Summary odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were calculated using random- or fixed-effect models. Results: This meta-analysis included 11 case-control studies, all of which demonstrated a correlation between pesticide exposure and a statistically significant increased risk of MDS (OR = 1.95, 95% CI 1.23-3.09). In subgroup analyses, patients with pesticide exposure had increased risk of developing MDS if they were living in the Europe or Asia and had refractory anemia (RA) or RA with ringed sideroblasts (RARS). Moreover, in the analysis by specific pesticides, increased risk was associated with exposure to insecticides (OR = 1.71, 95% CI 1.22-2.40) but not exposure to herbicides or fungicides. Conclusion: This meta-analysis supports the hypothesis that exposure to pesticides increases the risk of developing MDS. Further prospective cohort studies are warranted to verify the association and guide clinical practice in MDS prevention.	[Jin, Jie; Yu, Mengxia; Hu, Chao; Ye, Li; Xie, Lili; Jin, Jin; Chen, Feifei; Tong, Hongyan] Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Jie; Yu, Mengxia; Hu, Chao; Ye, Li; Xie, Lili; Jin, Jin; Chen, Feifei; Tong, Hongyan] Zhejiang Univ, Sch Med, Inst Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Tong, Hongyan] Zhejiang Univ, Sch Med, Myelodysplast Syndromes Diag & Therapy Ctr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Tong, HY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China.	zjuhongyantong@163.com			Key Innovation Team Foundation of Zhejiang Province [2011R50015]; major program fund of the Science Technology Department of Zhejiang Province [2013c03043-2]; Zhejiang Province Fund for Distinguished Young Scholars [LR12H08001]; National Public Health Grand Research Foundation [201202017]; National Natural Science Foundation of China [30870914, 81270582]	Key Innovation Team Foundation of Zhejiang Province; major program fund of the Science Technology Department of Zhejiang Province; Zhejiang Province Fund for Distinguished Young Scholars; National Public Health Grand Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Key Innovation Team Foundation of Zhejiang Province (2011R50015), major program fund of the Science Technology Department of Zhejiang Province (2013c03043-2), Zhejiang Province Fund for Distinguished Young Scholars (LR12H08001), National Public Health Grand Research Foundation (201202017) and the National Natural Science Foundation of China (No. 30870914, No. 81270582). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian J, 2009, J EXP MED, V206, P1473, DOI 10.1084/jem.20082842; Alavanja MCR, 2013, CA-CANCER J CLIN, V63, P120, DOI 10.3322/caac.21170; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Boros LG, 2001, LEUKEMIA RES, V25, P883, DOI 10.1016/S0145-2126(01)00043-1; BROWN LM, 1990, CANCER RES, V50, P6585; Castillo JJ, 2011, J CLIN ONCOL, V29, P3900, DOI 10.1200/JCO.2011.35.4449; Chiu BCH, 2009, J AGROMEDICINE, V14, P250, DOI 10.1080/10599240902773140; CICCONE G, 1993, CANCER GENET CYTOGEN, V68, P135, DOI 10.1016/0165-4608(93)90010-J; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GOLDBERG H, 1990, CANCER RES, V50, P6876; Hu ZH, 2013, ASIAN PAC J CANCER P, V14, P393, DOI 10.7314/APJCP.2013.14.1.393; Infante-Rivard C, 2007, J TOXICOL ENV HEAL B, V10, P81, DOI 10.1080/10937400601034589; Kasner MT, 2009, AM J HEMATOL, V84, P177, DOI 10.1002/ajh.21352; Kokouva M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-5; LaFiura KM, 2007, PEDIATR BLOOD CANCER, V49, P624, DOI 10.1002/pbc.21283; Lv L, 2011, AM J HEMATOL, V86, P163, DOI 10.1002/ajh.21941; Malek AM, 2012, ENVIRON RES, V117, P112, DOI 10.1016/j.envres.2012.06.007; MELE A, 1994, AM J EPIDEMIOL, V139, P609, DOI 10.1093/oxfordjournals.aje.a117050; Merhi M, 2007, CANCER CAUSE CONTROL, V18, P1209, DOI 10.1007/s10552-007-9061-1; Newman K, 2012, ASIAN PAC J CANCER P, V13, P1081, DOI 10.7314/APJCP.2012.13.4.1081; Nisse C, 2001, BRIT J HAEMATOL, V112, P927, DOI 10.1046/j.1365-2141.2001.02645.x; Pekmezovic T, 2006, ANN HEMATOL, V85, P514, DOI 10.1007/s00277-006-0128-y; Rigolin GM, 1998, BRIT J HAEMATOL, V103, P189, DOI 10.1046/j.1365-2141.1998.00963.x; SAARNI MI, 1973, AM J MED, V55, P38, DOI 10.1016/0002-9343(73)90148-4; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Smith MT, 2005, TOXICOL APPL PHARM, V206, P237, DOI 10.1016/j.taap.2004.11.026; Strom SS, 2005, LEUKEMIA, V19, P1912, DOI 10.1038/sj.leu.2403945; Van Maele-Fabry G, 2007, CANCER CAUSE CONTROL, V18, P457, DOI 10.1007/s10552-007-0122-2; Warlick ED, 2007, CURR CANCER DRUG TAR, V7, P541, DOI 10.2174/156800907781662284; Wells G.A., 2000, VIS COMMUN Q; WEST RR, 1995, LEUKEMIA RES, V19, P127, DOI 10.1016/0145-2126(94)00141-V; Xu X, 2014, EUR J NUTR	33	15	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110850	10.1371/journal.pone.0110850	http://dx.doi.org/10.1371/journal.pone.0110850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25335083	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200079
J	Tschismarov, R; Firner, S; Gil-Cruz, C; Goschl, L; Boucheron, N; Steiner, G; Matthias, P; Seiser, C; Ludewig, B; Ellmeier, W				Tschismarov, Roland; Firner, Sonja; Gil-Cruz, Cristina; Goeschl, Lisa; Boucheron, Nicole; Steiner, Guenter; Matthias, Patrick; Seiser, Christian; Ludewig, Burkhard; Ellmeier, Wilfried			HDAC1 Controls CD8(+) T Cell Homeostasis and Antiviral Response	PLOS ONE			English	Article							II HISTONE DEACETYLASES; HISTONE/PROTEIN DEACETYLASES; REGULATORY CELLS; IMMUNE-RESPONSES; EOMESODERMIN; EFFECTOR; MICE; INFLAMMATION; PROGRESSION; EXPRESSION	Reversible lysine acetylation plays an important role in the regulation of T cell responses. HDAC1 has been shown to control peripheral T helper cells, however the role of HDAC1 in CD8+ T cell function remains elusive. By using conditional gene targeting approaches, we show that LckCre-mediated deletion of HDAC1 led to reduced numbers of thymocytes as well as peripheral T cells, and to an increased fraction of CD8+CD4 cells within the CD3/TCR blo population, indicating that HDAC1 is essential for the efficient progression of immature CD8+CD4 cells to the DP stage. Moreover, CD44hi effector CD8+ T cells were enhanced in mice with a T cell-specific deletion of HDAC1 under homeostatic conditions and HDAC1-deficient CD44hi CD8+ T cells produced more IFN? upon ex vivo PMA/ionomycin stimulation in comparison to wild-type cells. Naive (CD44 1 degrees CD62L+) HDAC1-null CD8+ T cells displayed a normal proliferative response, produced similar amounts of IL-2 and TNFa, slightly enhanced amounts of IFN, and their in vivo cytotoxicity was normal in the absence of HDAC1. However, T cell-specific loss of HDAC1 led to a reduced anti-viral CD8+ T cell response upon LCMV infection and impaired expansion of virus-specific CD8+ T cells. Taken together, our data indicate that HDAC1 is required for the efficient generation of thymocytes and peripheral T cells, for proper CD8+ T cell homeostasis and for an efficient in vivo expansion and activation of CD8+ T cells in response to LCMV infection.	[Tschismarov, Roland; Goeschl, Lisa; Boucheron, Nicole; Ellmeier, Wilfried] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Div Immunobiol, Vienna, Austria; [Firner, Sonja; Gil-Cruz, Cristina; Ludewig, Burkhard] Cantonal Hosp St Gallen, Inst Immunobiol, St Gallen, Switzerland; [Goeschl, Lisa; Steiner, Guenter] Med Univ Vienna, Div Rheumatol Med 3, Vienna, Austria; [Matthias, Patrick] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Matthias, Patrick] Univ Basel, Fac Sci, Basel, Switzerland; [Seiser, Christian] Med Univ Vienna, Vienna Bioctr, Dept Med Biochem, Max F Perutz Labs, Vienna, Austria	Medical University of Vienna; Kantonsspital St. Gallen; Medical University of Vienna; Friedrich Miescher Institute for Biomedical Research; Novartis; University of Basel; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Ellmeier, W (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Div Immunobiol, Vienna, Austria.	wilfried.ellmeier@meduniwien.ac.at		Seiser, Christian/0000-0002-7046-9352; Boucheron, Nicole/0000-0002-4979-8311; Gil Cruz, Cristina/0000-0001-5285-6503; Steiner, Guenter/0000-0002-5089-7405; Ellmeier, Wilfried/0000-0001-8192-8481	Austrian Science Fund (FWF); MedUni Vienna doctoral program [DK W1212]; FWF projects [P19930, P23641, P26193]; Vienna Science and Technology Fund (WWTF) [LS09-031]; Innovative Medicines Initiative [115142]; FP7 of the European Union; EFPIA; Austrian Science Fund (FWF) [P 23641] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); MedUni Vienna doctoral program; FWF projects; Vienna Science and Technology Fund (WWTF); Innovative Medicines Initiative; FP7 of the European Union; EFPIA; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The work in the laboratory of W.E. was supported by the Austrian Science Fund (FWF) and MedUni Vienna doctoral program (DK W1212) "inflammation and Immunity," by FWF projects (P19930, P23641, P26193) and by the Vienna Science and Technology Fund (WWTF) through project LS09-031. L.G. and G.S. have been supported from the Innovative Medicines Initiative Joint Undertaking under grant agreement no 115142 (BTCure), resources of which are composed of financial contribution from the FP7 of the European Union and EFPIA companies in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2012, BLOOD, V119, P2443, DOI 10.1182/blood-2011-10-292003; Beier UH, 2011, CURR OPIN IMMUNOL, V23, P670, DOI 10.1016/j.coi.2011.07.002; BRANDLE D, 1991, EUR J IMMUNOL, V21, P2195, DOI 10.1002/eji.1830210930; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; de Zoeten EF, 2011, MOL CELL BIOL, V31, P2066, DOI 10.1128/MCB.05155-11; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Dovey OM, 2013, BLOOD, V121, P1335, DOI 10.1182/blood-2012-07-441949; Dubois S, 2006, P NATL ACAD SCI USA, V103, P12075, DOI 10.1073/pnas.0605212103; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Grausenburger R, 2010, J IMMUNOL, V185, P3489, DOI 10.4049/jimmunol.0903610; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hassan H, 2011, P NATL ACAD SCI USA, V108, P18330, DOI 10.1073/pnas.1105835108; Heideman MR, 2013, BLOOD, V121, P2038, DOI 10.1182/blood-2012-08-450916; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Junt T, 2002, J IMMUNOL, V168, P6032, DOI 10.4049/jimmunol.168.12.6032; Kasler HG, 2007, MOL CELL BIOL, V27, P5184, DOI 10.1128/MCB.02091-06; Kasler HG, 2011, J IMMUNOL, V186, P4782, DOI 10.4049/jimmunol.1001179; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Moser MA, 2013, CHROMOSOMA; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Rui JX, 2012, J IMMUNOL, V189, P1380, DOI 10.4049/jimmunol.1201077; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Verdin E, 2004, NOVART FDN SYMP, V259, P163; Verdin E, 2004, NOVART FDN SYMP, V259, P129, DOI DOI 10.1002/0470862637.CH8; Verdin Eric, 2004, Novartis Found Symp, V259, P115; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Wilting RH, 2010, EMBO J, V29, P2586, DOI 10.1038/emboj.2010.136; Winter M, 2013, EMBO J; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310	37	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110576	10.1371/journal.pone.0110576	http://dx.doi.org/10.1371/journal.pone.0110576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333902	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200058
J	Pearlman, DM; Brown, JR; MacKenzie, TA; Hernandez, F; Najjar, S				Pearlman, Daniel M.; Brown, Jeremiah R.; MacKenzie, Todd A.; Hernandez, Felix, Jr.; Najjar, Souhel			Blood Levels of S-100 Calcium-Binding Protein B, High-Sensitivity C-Reactive Protein, and Interleukin-6 for Changes in Depressive Symptom Severity after Coronary Artery Bypass Grafting: Prospective Cohort Nested within a Randomized, Controlled Trial	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; INTERCELLULAR-ADHESION MOLECULE-1; DORSOLATERAL PREFRONTAL CORTEX; NUTRITION EXAMINATION SURVEY; REMITTED MAJOR DEPRESSION; BRAIN-BARRIER DYSFUNCTION; SERUM S100B LEVELS; INTERFERON-ALPHA; CEREBROSPINAL-FLUID; CARDIAC-SURGERY	Background: Cross-sectional and retrospective studies have associated major depressive disorder with glial activation and injury as well as blood-brain barrier disruption, but these associations have not been assessed prospectively. Here, we aimed to determine the relationship between changes in depressive symptom severity and in blood levels of S-100 calcium-binding protein B (S-100B), high-sensitivity C-reactive protein, and interleukin-6 following an inflammatory challenge. Methods: Fifty unselected participants were recruited from a randomized, controlled trial comparing coronary artery bypass grafting procedures performed with versus without cardiopulmonary bypass for the risk of neurocognitive decline. Depressive symptom severity was measured at baseline, discharge, and six-month follow-up using the Beck Depression Inventory II (BDI-II). The primary outcome of the present biomarker study was acute change in depressive symptom severity, defined as the intra-subject difference between baseline and discharge BDI-II scores. Blood biomarker levels were determined at baseline and 2 days postoperative. Results: Changes in S-100B levels correlated positively with acute changes in depressive symptom severity (Spearman rho, 0.62; P = 0.0004) and accounted for about one-fourth of their observed variance (R-2, 0.23; P = 0.0105). This association remained statistically significant after adjusting for baseline S-100B levels, age, weight, body-mass index, or beta-blocker use, but not baseline BDI-II scores (P = 0.064). There was no statistically significant association between the primary outcome and baseline S-100B levels, baseline high-sensitivity C-reactive protein or interleukin-6 levels, or changes in high-sensitivity Creactive protein or interleukin-6 levels. Among most participants, levels of all three biomarkers were normal at baseline and markedly elevated at 2 days postoperative. Conclusions: Acute changes in depressive symptom severity were specifically associated with incremental changes in S-100B blood levels, largely independent of covariates associated with either. These findings support the hypothesis that glial activation and injury and blood-brain barrier disruption can be mechanistically linked to acute exacerbation of depressive symptoms in some individuals.	[Pearlman, Daniel M.; Najjar, Souhel] NYU, Sch Med, Dept Neurol, Epilepsy Ctr Div,Neuroinflammat Res Grp, New York, NY 10016 USA; [Pearlman, Daniel M.; Brown, Jeremiah R.; MacKenzie, Todd A.] Audrey & Theodor Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA; [Brown, Jeremiah R.; MacKenzie, Todd A.] Audrey & Theodor Geisel Sch Med Dartmouth, Dept Community & Family Med, Epidemiol & Biostat Sect, Hanover, NH USA; [Brown, Jeremiah R.; MacKenzie, Todd A.] Audrey & Theodor Geisel Sch Med Dartmouth, Dept Med, Cardiol Sect, Hanover, NH USA; [Hernandez, Felix, Jr.] Eastern Maine Med Ctr, Bangor, ME USA	New York University; Dartmouth College; Eastern Maine Medical Center	Najjar, S (corresponding author), NYU, Sch Med, Dept Neurol, Epilepsy Ctr Div,Neuroinflammat Res Grp, New York, NY 10016 USA.	mna1024231@aol.com	Pearlman, Daniel/I-2666-2012	Pearlman, Daniel/0000-0002-8823-4551	Audrey and Theodor Geisel School of Medicine (Hanover, New Hampshire, United States); Agency for Healthcare Research and Quality [K01HS018443]; Medtronic Inc. (Minneapolis, Minnesota, United States); Genzyme Surgical (Fall River, Massachusetts, United States); Somanetics Corporation (Troy, Michigan, United States)	Audrey and Theodor Geisel School of Medicine (Hanover, New Hampshire, United States); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Medtronic Inc. (Minneapolis, Minnesota, United States); Genzyme Surgical (Fall River, Massachusetts, United States); Somanetics Corporation (Troy, Michigan, United States)	DMP received funding from the Audrey and Theodor Geisel School of Medicine (Hanover, New Hampshire, United States). JRB was supported in part by a grant from the Agency for Healthcare Research and Quality (K01HS018443). For the original randomized, controlled trial (Scarecrow trial, 2001-2004), FH received donated funds, donated supplies, biomarker assays, and loaned equipment from Medtronic Inc. (Minneapolis, Minnesota, United States), Genzyme Surgical (Fall River, Massachusetts, United States), and Somanetics Corporation (Troy, Michigan, United States). FH also received biomarker assays from the Northern New England Cardiovascular Disease Study Group (Hanover, New Hampshire, United States). Loaned equipment included the Genzyme Off-Pump Coronary Artery Bypass (OPCAB) Elite apparatus and the Medtronic Octopus system, both of which used to stabilize target vessels during off-pump coronary artery bypass grafting procedures performed in the trial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler LL, 2010, BIPOLAR DISORD, V12, P541, DOI 10.1111/j.1399-5618.2010.00838.x; Arolt V, 2003, EUR NEUROPSYCHOPHARM, V13, P235, DOI 10.1016/S0924-977X(03)00016-6; Ashraf S, 1999, EUR J CARDIO-THORAC, V16, P32, DOI 10.1016/S1010-7940(99)00136-0; Bargerstock E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101477; Baufreton C, 2005, ANN THORAC SURG, V79, P1597, DOI 10.1016/j.athoracsur.2004.08.061; Bayram H, 2013, J SURG RES, V182, P198, DOI 10.1016/j.jss.2012.10.047; Bechter K, 2010, J PSYCHIATR RES, V44, P321, DOI 10.1016/j.jpsychires.2009.08.008; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beer C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-71; Benros ME, 2013, JAMA PSYCHIAT, V70, P812, DOI 10.1001/jamapsychiatry.2013.1111; Blennow K, 2011, ACTA NEUROL SCAND, V123, P245, DOI 10.1111/j.1600-0404.2010.01408.x; Bloch MH, 2012, MOL PSYCHIATR, V17, P1272, DOI 10.1038/mp.2011.100; Capuron L, 2003, AM J PSYCHIAT, V160, P1342, DOI 10.1176/appi.ajp.160.7.1342; Cremeans-Smith JK, 2009, BRAIN BEHAV IMMUN, V23, P1096, DOI 10.1016/j.bbi.2009.06.148; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dereure O, 2002, BRIT J DERMATOL, V147, P1142, DOI 10.1046/j.1365-2133.2002.04897.x; Derkach DN, 2000, ANESTH ANALG, V91, P1066, DOI 10.1097/00000539-200011000-00005; Dietrich DE, 2004, NEUROSCI LETT, V354, P69, DOI 10.1016/j.neulet.2003.09.062; Dimopoulos N, 2006, INT J GERIATR PSYCH, V21, P965, DOI 10.1002/gps.1592; Do DP, 2010, PSYCHOSOM MED, V72, P613, DOI 10.1097/PSY.0b013e3181e2cca5; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Eisenberger NI, 2010, BIOL PSYCHIAT, V68, P748, DOI 10.1016/j.biopsych.2010.06.010; Falcone T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011089; Fazio V, 2004, ANN THORAC SURG, V78, P46, DOI 10.1016/j.athoracsur.2003.11.042; Ford DE, 2004, ARCH INTERN MED, V164, P1010, DOI 10.1001/archinte.164.9.1010; Goncalves FM, 2013, NEUROCHEM RES, V38, P2375, DOI 10.1007/s11064-013-1150-9; Gos T, 2013, J PSYCHIATR RES, V47, P1694, DOI 10.1016/j.jpsychires.2013.07.005; Grocott HP, 2001, BRIT J ANAESTH, V86, P289; Gudmundsson P, 2007, AM J GERIAT PSYCHIAT, V15, P832, DOI 10.1097/JGP.0b013e3180547091; Hernandez F, 2007, ANN THORAC SURG, V84, P1897, DOI 10.1016/j.athoracsur.2007.07.036; Hickman RJ, 2014, J BEHAV MED, V37, P621, DOI 10.1007/s10865-013-9510-0; Hiles SA, 2012, PSYCHOL MED, V42, P2015, DOI 10.1017/S0033291712000128; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Jang BS, 2008, PSYCHIAT INVEST, V5, P193, DOI 10.4306/pi.2008.5.3.193; Johnsson P, 1995, J CARDIOTHOR VASC AN, V9, P694, DOI 10.1016/S1053-0770(05)80231-9; Johnston-Wilson NL, 2000, MOL PSYCHIATR, V5, P142, DOI 10.1038/sj.mp.4000696; Jonsson H, 1998, ANN THORAC SURG, V65, P1639, DOI 10.1016/S0003-4975(98)00229-X; Kayser M, 2014, EVID-BASED MENT HEAL, V17, P20, DOI 10.1136/eb-2013-101567; Kinoshita H, 2003, ANESTH ANALG, V97, P1657, DOI 10.1213/01.ANE.0000089963.42295.FC; Kuo HK, 2005, LANCET NEUROL, V4, P371, DOI 10.1016/S1474-4422(05)70099-5; Laskowitz D T, 1998, J Stroke Cerebrovasc Dis, V7, P234, DOI 10.1016/S1052-3057(98)80032-3; Lavoie KL, 2010, PSYCHOSOM MED, V72, P20, DOI 10.1097/PSY.0b013e3181c2d6b8; Liu Y, 2012, J AFFECT DISORDERS, V139, P230, DOI 10.1016/j.jad.2011.08.003; Luo KR, 2010, PROG NEURO-PSYCHOPH, V34, P1433, DOI 10.1016/j.pnpbp.2010.07.033; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2003, J NEUROSCI, V23, P1949; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; Miguel-Hidalgo JJ, 2000, BIOL PSYCHIAT, V48, P861, DOI 10.1016/S0006-3223(00)00999-9; Miguel-Hidalgo JJ, 2011, J AFFECT DISORDERS, V132, P422, DOI 10.1016/j.jad.2011.03.052; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI [10.1586/erm.10.104, 10.1586/ERM.10.104]; Muller N, 2006, MOL PSYCHIATR, V11, P680, DOI 10.1038/sj.mp.4001805; Musselman DL, 2001, NEW ENGL J MED, V344, P961, DOI 10.1056/NEJM200103293441303; Musselman DL, 2001, AM J PSYCHIAT, V158, P1252, DOI 10.1176/appi.ajp.158.8.1252; Na KS, 2014, PROG NEURO-PSYCHOPH, V48, P79, DOI 10.1016/j.pnpbp.2013.09.006; Najjar S, 2014, BIOL PSYCHIAT, V75, pE23, DOI 10.1016/j.biopsych.2013.07.041; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-142; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Newman MF, 2006, LANCET, V368, P694, DOI 10.1016/S0140-6736(06)69254-4; NIKLASSON F, 1984, BIOL PSYCHIAT, V19, P1183; Kessler FHP, 2007, REV BRAS PSIQUIATR, V29, P134, DOI 10.1590/S1516-44462006005000029; Permoda-Osip A, 2013, NEUROPSYCHOBIOLOGY, V68, P193, DOI 10.1159/000355292; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Poole L, 2014, BRAIN BEHAV IMMUN, V37, P115, DOI 10.1016/j.bbi.2013.11.008; Raison CL, 2007, ALIMENT PHARM THER, V25, P1163, DOI 10.1111/j.1365-2036.2007.03316.x; Raison CL, 2010, MOL PSYCHIATR, V15, P535, DOI 10.1038/mp.2008.58; Raison CL, 2010, BIOL PSYCHIAT, V68, P942, DOI 10.1016/j.biopsych.2010.04.019; Raison CL, 2009, BIOL PSYCHIAT, V65, P296, DOI 10.1016/j.biopsych.2008.08.010; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Raison CL, 2005, J CLIN PSYCHIAT, V66, P41, DOI 10.4088/JCP.v66n0106; Raison CL, 2005, BRAIN BEHAV IMMUN, V19, P23, DOI 10.1016/j.bbi.2004.05.001; Rajkowska G, 2013, CURR DRUG TARGETS, V14, P1225; Rajkowska G, 2013, BIOL PSYCHIAT, V73, P613, DOI 10.1016/j.biopsych.2012.09.024; Reiber H, 1998, MULT SCLER, V4, P99, DOI 10.1177/135245859800400302; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Reinsfelt B, 2012, ANN THORAC SURG, V94, P549, DOI 10.1016/j.athoracsur.2012.04.044; Rothermundt M, 2001, J AFFECT DISORDERS, V66, P89, DOI 10.1016/S0165-0327(00)00321-9; Schaefer M, 2004, BRAIN BEHAV IMMUN, V18, P555, DOI 10.1016/j.bbi.2004.02.002; Schroeter Matthias L, 2010, Cardiovasc Psychiatry Neurol, V2010, P780645, DOI 10.1155/2010/780645; Schroeter ML, 2008, J AFFECT DISORDERS, V111, P271, DOI 10.1016/j.jad.2008.03.005; Sellner J, 2014, EUR J NEUROL, V21, P845, DOI 10.1111/ene.12390; Serlin Yonatan, 2011, Cardiovasc Psychiatry Neurol, V2011, P609202, DOI 10.1155/2011/609202; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Steiner J, 2008, J PSYCHIATR RES, V42, P151, DOI 10.1016/j.jpsychires.2006.10.013; Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94; Szelenyi A, 2014, ACTA NEUROCHIR, V156, P733, DOI 10.1007/s00701-013-1969-5; Thomas AJ, 2000, AM J PSYCHIAT, V157, P1682, DOI 10.1176/appi.ajp.157.10.1682; Thomas AJ, 2003, INT J GERIATR PSYCH, V18, P7, DOI 10.1002/gps.720; Tukey JW, 1977, EXPLORATORY DATA ANA; Udina M, 2012, J CLIN PSYCHIAT, V73, P1128, DOI 10.4088/JCP.12r07694; Uher T, 2012, NEUROSCI LETT, V529, P139, DOI 10.1016/j.neulet.2012.09.003; Valkanova V, 2013, BIOL PSYCHIAT, V73, P406, DOI 10.1016/j.biopsych.2012.10.028; Veena J, 2009, NEUROSCI LETT, V455, P178, DOI 10.1016/j.neulet.2009.03.059; Webster MJ, 2005, NEUROSCIENCE, V133, P453, DOI 10.1016/j.neuroscience.2005.02.037; Whitaker DC, 2007, PERFUSION-UK, V22, P267, DOI 10.1177/0267659107083243; Yang K, 2008, J NEURAL TRANSM, V115, P1687, DOI 10.1007/s00702-008-0130-8; Yang LM, 2012, J THORAC CARDIOV SUR, V144, P500, DOI 10.1016/j.jtcvs.2012.01.034; Ye YY, 2011, NEUROSCI LETT, V503, P15, DOI 10.1016/j.neulet.2011.07.055; Zhang YY, 2009, NEUROPSYCHOBIOLOGY, V59, P172, DOI 10.1159/000219304; Zill P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040479; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	104	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e111110	10.1371/journal.pone.0111110	http://dx.doi.org/10.1371/journal.pone.0111110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25329583	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100113
J	Zhang, M; Shang, MQ; Yang, WW; Chen, JL; Wang, Z; Shang, H				Zhang, Min; Shang, Mingquan; Yang, Weiwei; Chen, Junli; Wang, Zhe; Shang, Hong			Treatment Effect and Drug-Resistant Mutations in Chinese AIDS Patients Switching to Second-Line Antiretroviral Therapy	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; COUNTRIES; MORTALITY	This study aimed to investigate treatment effect, drug resistance changes, and their influencing factors in Chinese AIDS patients after switching to second-line antiretroviral therapy, and thus provide important information for the scale-up of second-line antiretroviral treatment in China. In Weishi county of Henan province, where second-line antiretroviral therapy was introduced early in China, 195 AIDS patients were enrolled, of which 127 patients met the switching criterion and 68 patients volunteered to switch drugs without meeting the switching criterion. CD4 cell count, viral load and in-house PCR genotyping for drug resistance were measured for all 195 subjects before drug switch, as well as 6 and 12 months after drug switch. Extensive secondary mutations to the protease inhibitor were observed, which suggested that long-term drug resistance surveillance is necessary for patients switching to second-line antiretroviral therapy. Multidrug resistance and cross-resistance were extensive in Chinese patients that experienced first-line treatment failure. Patients need timely CD4 count, viral load, and drug resistance monitoring in order to switch to second-line therapy under conditions of relatively good immunity and low viral duplication levels.	[Zhang, Min; Shang, Mingquan; Yang, Weiwei; Chen, Junli; Shang, Hong] China Med Univ, Affiliated Hosp 1, Dept Lab Med, Key Lab AIDS Immunol Natl Hlth & Family Planning, Shenyang, Peoples R China; [Zhang, Min; Shang, Mingquan; Yang, Weiwei; Chen, Junli; Shang, Hong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Wang, Zhe] Dis Prevent & Control Ctr Henan Prov, Zhengzhou, Peoples R China	China Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Shang, H (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Lab Med, Key Lab AIDS Immunol Natl Hlth & Family Planning, Shenyang, Peoples R China.	hongshang100@hotmail.com			Twelfth Five-Year Project on Tackling Key Problems of National Science and Technology [2012ZX10001002-002-013]; National Natural Science Foundation of China [81171619]	Twelfth Five-Year Project on Tackling Key Problems of National Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Twelfth Five-Year Project on Tackling Key Problems of National Science and Technology (2012ZX10001002-002-013) and National Natural Science Foundation of China (81171619). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, CHINESE NATL FREE AI; Boyd MA, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000279707.01557.b2; Galarraga O, 2007, AIDS, V21, pS97, DOI 10.1097/01.aids.0000279712.32051.29; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Kempf DJ, 2004, J INFECT DIS, V189, P51, DOI 10.1086/380509; Pujades-Rodriguez M, 2008, AIDS, V22, P1305, DOI 10.1097/QAD.0b013e3282fa75b9; Pujades-Rodriguez M, 2010, JAMA-J AM MED ASSOC, V304, P303, DOI 10.1001/jama.2010.980; World Health Organization, 2009, RAP ADV ANT THER HIV; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang M, 2008, JPN J INFECT DIS, V61, P361; [张昊 ZHANG Min], 2008, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V31, P1101	11	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110259	10.1371/journal.pone.0110259	http://dx.doi.org/10.1371/journal.pone.0110259			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330204	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204100053
J	Koo, BK; Lee, CH; Yang, BR; Hwang, SS; Choi, NK				Koo, Bo Kyung; Lee, Chang-Hoon; Yang, Bo Ram; Hwang, Seung-sik; Choi, Nam-Kyong			The Incidence and Prevalence of Diabetes Mellitus and Related Atherosclerotic Complications in Korea: A National Health Insurance Database Study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; POPULATION; TCF7L2; CHINA; US; INDIVIDUALS; VARIANTS; OBESITY; DISEASE; BURDEN	Aims/Introduction: The incidence and prevalence of type 2 diabetes mellitus (T2DM) and related macrovascular complications in Korea were estimated using the Health Insurance Review and Assessment (HIRA) database from 2007-2011, which covers the claim data of 97.0% of the Korean population. Materials and Methods: T2DM, coronary artery disease (CAD), cerebrovascular disease (CVD), and peripheral artery disease (PAD) were defined according to ICD-10 codes. We used the Healthcare Common Procedure Coding System codes provided by HIRA to identify associated procedures or surgeries. When calculating incidence, we excluded cases with preexisting T2DM within two years before the index year. A Poisson distribution was assumed when calculating 95% confidence intervals for prevalence and incidence rates. Results: The prevalence of T2DM in Korean adults aged 20-89 years was 6.1-6.9% and the annual incidence rates of T2DM ranged from 9.5-9.8/1,000 person-year (PY) during the study period. The incidence rates of T2DM in men and women aged 20-49 years showed decreasing patterns from 2009 to 2011 (P<0.001); by contrast, the incidence in subjects aged 70-79 years showed increased patterns from 2009 to 2011 (P<0.001). The incidence rates of CAD and CVD in patients newly diagnosed with T2DM were 18.84/1,000 PY and 11.32/1,000 PY, respectively, in the year of diagnosis. Among newly diagnosed individuals with T2DM who were undergoing treatment for PAD, 14.6% underwent angioplasty for CAD during the same period. Conclusions: Our study measured the national incidences of T2DM, CAD, CVD, and PAD, which are of great concern for public health. We also confirmed the relatively higher risk of CAD and CVD newly detected T2DM patients compared to the general population in Korea.	[Koo, Bo Kyung; Lee, Chang-Hoon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Koo, Bo Kyung] Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Yang, Bo Ram; Choi, Nam-Kyong] Seoul Natl Univ, Coll Med, Med Res Collaborating Ctr, Div Clin Epidemiol, Seoul, South Korea; [Yang, Bo Ram] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Hwang, Seung-sik] Inha Univ, Sch Med, Dept Social & Prevent Med, Inchon, South Korea; [Choi, Nam-Kyong] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Inha University; Seoul National University (SNU)	Choi, NK (corresponding author), Seoul Natl Univ, Coll Med, Med Res Collaborating Ctr, Div Clin Epidemiol, Seoul, South Korea.	likei1@snu.ac.kr	Koo, Bo Kyung/ABB-7170-2020	Choi, Nam-Kyong/0000-0003-1153-9928	Korean Diabetes Association [2012-228]	Korean Diabetes Association	This study was supported by a grant from the Korean Diabetes Association (2012-228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang Hoo-Sun, 2012, J Prev Med Public Health, V45, P291, DOI 10.3961/jpmph.2012.45.5.291; Cho Nam H, 2010, Korean Diabetes J, V34, P10, DOI 10.4093/kdj.2010.34.1.10; Choi NK, 2010, PHARMACOEPIDEM DR S, V19, P238, DOI 10.1002/pds.1902; Choi YJ, 2009, DIABETES CARE, V32, P2016, DOI 10.2337/dc08-2228; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Goto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074699; Hirsch AT, 2008, VASC MED, V13, P209, DOI 10.1177/1358863X08089277; Hong KS, 2011, J CLIN NEUROL, V7, P77, DOI 10.3988/jcn.2011.7.2.77; International Diabetes Federation, 2009, IDF DIABETES ATLAS, V4; International Diabetes Federation, 2000, IDF DIABETES ATLAS, V1st; Kim DJ, 2011, DIABETES METAB J, V35, P303, DOI 10.4093/dmj.2011.35.4.303; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Koo BK, 2013, DIABETES CARE, V36, pE95, DOI 10.2337/dc13-0247; Korea Centers for Disease Control and Prevention, 2005, KOR NAT HLTH NUTR EX; Korea Centers for Disease Control and Prevention, 2008, RES 2 FOLL UP SURV A; Korea Health Industry Development Institute (KHIDI), 2019, KOR NAT HLTH NUTR EX; Li H, 2012, DIABETES RES CLIN PR, V98, P226, DOI 10.1016/j.diabres.2012.05.010; Lim Seung-Ji, 2009, J Prev Med Public Health, V42, P251, DOI 10.3961/jpmph.2009.42.4.251; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Margolis Jay, 2005, J Manag Care Pharm, V11, P727; Miyake K, 2008, J HUM GENET, V53, P174, DOI 10.1007/s10038-007-0231-5; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ng MCY, 2007, J CLIN ENDOCR METAB, V92, P3733, DOI 10.1210/jc.2007-0849; Ngo Duyen L, 2003, J Public Health Manag Pract, V9, P542; Ning F, 2009, DIABETIC MED, V26, P855, DOI 10.1111/j.1464-5491.2009.02791.x; Park IB, 2013, DIABETES METAB J, V37, P233, DOI 10.4093/dmj.2013.37.4.233; Ramachandran A, 2002, DIABETES RES CLIN PR, V58, P55, DOI 10.1016/S0168-8227(02)00125-0; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Selvin E, 2006, DIABETES CARE, V29, P2415, DOI 10.2337/dc06-1058; Shen J, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/178675; Sloan FA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1548, DOI 10.1001/archopht.126.11.1548; Southern DA, 2010, CAN J PUBLIC HEALTH, V101, P61, DOI 10.1007/BF03405564; Statistics Korea, 2011, POP PROJ KOR; Statistics Korea, 2010, 2010 POP HOUS CENS; Su Kyung Park M-KP, 2009, CAUSE OF DEATH TREND, V33, P65; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	37	62	61	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110650	10.1371/journal.pone.0110650	http://dx.doi.org/10.1371/journal.pone.0110650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329714	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800101
J	Laermans, J; Broers, C; Beckers, K; Vancleef, L; Steensels, S; Thijs, T; Tack, J; Depoortere, I				Laermans, Jorien; Broers, Charlotte; Beckers, Kelly; Vancleef, Laurien; Steensels, Sandra; Thijs, Theo; Tack, Jan; Depoortere, Inge			Shifting the Circadian Rhythm of Feeding in Mice Induces Gastrointestinal, Metabolic and Immune Alterations Which Are Influenced by Ghrelin and the Core Clock Gene Bmal1	PLOS ONE			English	Article							HIGH-FAT-DIET; ADIPOSE-TISSUE; FOOD-INTAKE; OBESITY; INFLAMMATION; DISORDERS; COMPONENT; TIME; RECEPTORS; MOTILITY	Background: In our 24-hour society, an increasing number of people are required to be awake and active at night. As a result, the circadian rhythm of feeding is seriously compromised. To mimic this, we subjected mice to restricted feeding (RF), a paradigm in which food availability is limited to short and unusual times of day. RF induces a food-anticipatory increase in the levels of the hunger hormone ghrelin. We aimed to investigate whether ghrelin triggers the changes in body weight and gastric emptying that occur during RF. Moreover, the effect of genetic deletion of the core clock gene Bmal1 on these physiological adaptations was studied. Methods: Wild-type, ghrelin receptor knockout and Bmal1 knockout mice were fed ad libitum or put on RF with a normal or high-fat diet (HFD). Plasma ghrelin levels were measured by radioimmunoassay. Gastric contractility was studied in vitro in muscle strips and in vivo (C-13 breath test). Cytokine mRNA expression was quantified and infiltration of immune cells was assessed histologically. Results: The food-anticipatory increase in plasma ghrelin levels induced by RF with normal chow was abolished in HFD-fed mice. During RF, body weight restoration was facilitated by ghrelin and Bmal1. RF altered cytokine mRNA expression levels and triggered contractility changes resulting in an accelerated gastric emptying, independent from ghrelin signaling. During RF with a HFD, Bmal1 enhanced neutrophil recruitment to the stomach, increased gastric IL-1 alpha expression and promoted gastric contractility changes. Conclusions: This is the first study demonstrating that ghrelin and Bmal1 regulate the extent of body weight restoration during RF, whereas Bmal1 controls the type of inflammatory infiltrate and contractility changes in the stomach. Disrupting the circadian rhythm of feeding induces a variety of diet-dependent metabolic, immune and gastrointestinal alterations, which may explain the higher prevalence of obesity and immune-related gastrointestinal disorders among shift workers.	[Laermans, Jorien; Broers, Charlotte; Beckers, Kelly; Vancleef, Laurien; Steensels, Sandra; Thijs, Theo; Tack, Jan; Depoortere, Inge] Univ Louvain, Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Gut Peptide Res Lab, Louvain, Belgium	KU Leuven	Depoortere, I (corresponding author), Univ Louvain, Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Gut Peptide Res Lab, Louvain, Belgium.	inge.depoortere@med.kuleuven.be	; Depoortere, Inge/I-5019-2013	Laermans, Jorien/0000-0002-6695-6019; Steensels, Sandra/0000-0001-6544-1884; Depoortere, Inge/0000-0002-0289-2175; Tack, Jan/0000-0002-3206-6704; Thijs, Theo/0000-0001-5226-2633	Research Foundation Flanders (FWO) [11A8414N]; University of Leuven	Research Foundation Flanders (FWO)(FWO); University of Leuven(KU Leuven)	Jorien Laermans is supported by the Research Foundation Flanders (FWO) as an aspirant (11A8414N) (http://www.fwo.be/). Sandra Steensels is holder of a PhD grant of the Agency for Innovation by Science and Technology (IWT) (http://www.iwt.be/). This work is supported by a Methusalem grant from the University of Leuven for research on "The Brain-Gut Axis in Health and Disease: from Mucosal Integrity to Cortical Processing.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiho H, 2007, AM J PHYSIOL-GASTR L, V293, pG250, DOI 10.1152/ajpgi.00545.2006; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Ariga H, 2008, AM J PHYSIOL-GASTR L, V294, pG655, DOI 10.1152/ajpgi.00484.2007; Avau B, 2013, NEUROGASTROENT MOTIL, V25, P720, DOI 10.1111/nmo.12193; Barnea M, 2009, ENDOCRINOLOGY, V150, P161, DOI 10.1210/en.2008-0944; Blum ID, 2009, NEUROSCIENCE, V164, P351, DOI 10.1016/j.neuroscience.2009.08.009; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Calder PC, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S0007114511005460; Cummings DE, 2004, AM J PHYSIOL-ENDOC M, V287, pE297, DOI 10.1152/ajpendo.00582.2003; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; De Smet B, 2007, NEUROGASTROENT MOTIL, V19, P211, DOI 10.1111/j.1365-2982.2006.00883.x; Delhanty PJD, 2013, FASEB J, V27, P1690, DOI 10.1096/fj.12-221143; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Giovannini M, 2008, J INT MED RES, V36, P613, DOI 10.1177/147323000803600401; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hemmeryckx B, 2012, EXP GERONTOL, V47, P256, DOI 10.1016/j.exger.2012.01.001; Hemmeryckx B, 2011, OBESITY, V19, P659, DOI 10.1038/oby.2010.266; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Kindt S, 2010, NEUROGASTROENT MOTIL, V22, P321; Kitazawa T, 2005, GUT, V54, P1078, DOI 10.1136/gut.2005.065896; Knutson A, 2010, SCAND J WORK ENV HEA, V36, P85, DOI 10.5271/sjweh.2897; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Luna-Moreno D, 2009, CHRONOBIOL INT, V26, P1409, DOI 10.3109/07420520903417003; Martinez-Merlos MT, 2004, J ENDOCRINOL, V181, P53, DOI 10.1677/joe.0.1810053; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Mistlberger RE, 1998, APPETITE, V30, P255, DOI 10.1006/appe.1997.0134; Moreels TG, 2001, AM J PHYSIOL-GASTR L, V280, pG1030, DOI 10.1152/ajpgi.2001.280.5.G1030; Murphy B. A., 2008, Open Veterinary Science Journal, V2, P96, DOI 10.2174/1874318800802010096; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Ohama T, 2007, AM J PHYSIOL-GASTR L, V292, pG1429, DOI 10.1152/ajpgi.00315.2006; Patton DF, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00185; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Sherman H, 2012, FASEB J, V26, P3493, DOI 10.1096/fj.12-208868; Sherman H, 2011, J CELL MOL MED, V15, P2745, DOI 10.1111/j.1582-4934.2010.01160.x; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Spiegel K, 2011, J CLIN ENDOCR METAB, V96, P486, DOI 10.1210/jc.2010-1978; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Stunkard AJ, 2009, OBES REV, V10, P69, DOI 10.1111/j.1467-789X.2009.00668.x; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Verhulst PJ, 2008, GASTROENTEROLOGY, V135, P1267, DOI 10.1053/j.gastro.2008.06.044; Wadden D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045748	52	18	18	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110176	10.1371/journal.pone.0110176	http://dx.doi.org/10.1371/journal.pone.0110176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329803	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800065
J	Zhang, TM; Yang, D; Zeng, ZL; Zhao, W; Liu, AQ; Piao, DX; Jiang, T; Cao, JP; Shen, YJ; Liu, H; Zhang, WZ				Zhang, Tiemin; Yang, Dong; Zeng, Zhaolin; Zhao, Wei; Liu, Aiqin; Piao, Daxun; Jiang, Tao; Cao, Jianping; Shen, Yujuan; Liu, Hua; Zhang, Weizhe			Genetic Characterization of Human-Derived Hydatid Cysts of Echinococcus granulosus Sensu Lato in Heilongjiang Province and the First Report of G7 Genotype of E-canadensis in Humans in China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; SPANISH STRAINS; G6 GENOTYPE; IDENTIFICATION; MITOCHONDRIAL; EPIDEMIOLOGY; INFECTION; PIGS; DISCRIMINATION; LIVESTOCK	Cystic echinococcosis (CE) caused by the larval stage of Echinococcus granulosus sensu lato (s. l.) is one of the most important zoonotic parasitic diseases worldwide and 10 genotypes (G1-G10) have been reported. In China, almost all the epidemiological and genotyping studies of E. granulosus s. l. are from the west and northwest pasturing areas. However, in Heilongjiang Province of northeastern China, no molecular information is available on E. granulosus s. l. To understand and to speculate on possible transmission patterns of E. granulosus s. l., we molecularly identified and genotyped 10 hydatid cysts from hepatic CE patients in Heilongjiang Province based on mitochondrial cytochrome c oxidase subunit I (cox1), cytochrome b (cytb) and NADH dehydrogenase subunit 1 (nad1) genes. Two genotypes were identified, G1 genotype (n = 6) and G7 genotype (n = 4). All the six G1 genotype isolates were identical to each other at the cox1 locus; three and two different sequences were obtained at the cytb and nad1 loci, respectively, with two cytb gene sequences not being described previously. G7 genotype isolates were identical to each other at the cox1, cytb and nad1 loci; however, the cytb gene sequence was not described previously. This is the first report of G7 genotype in humans in China. Three new cytb gene sequences from G1 and G7 genotypes might reflect endemic genetic characterizations. Pigs might be the main intermediate hosts of G7 genotype in our investigated area by homology analysis. The results will aid in making more effective control strategies for the prevention of transmission of E. granulosus s. l.	[Zhang, Tiemin; Piao, Daxun; Jiang, Tao] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin, Heilongjiang, Peoples R China; [Yang, Dong; Zhao, Wei; Liu, Aiqin; Zhang, Weizhe] Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China; [Zeng, Zhaolin] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin, Heilongjiang, Peoples R China; [Cao, Jianping; Shen, Yujuan; Liu, Hua] WHO Collaborating Ctr Malaria Schistosomiasis & F, Natl Inst Parasit Dis, Key Lab Parasite & Vector Biol, Chinese Ctr Dis Control & Prevent,Minist Hlth, Shanghai, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization	Liu, AQ (corresponding author), Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China.	liuaiqin1128@126.com; zhangweizhe526@163.com	Cao, Jianping/AFL-5468-2022	Cao, Jianping/0000-0002-1974-0047	Heilongjiang Province Education Bureau [11531173, 12531266]; National S & T Major Program for Infectious Disease of China [2012ZX10004-201, 2009ZX10004-201]	Heilongjiang Province Education Bureau; National S & T Major Program for Infectious Disease of China	T. Z. and A. L. were supported in part by the Heilongjiang Province Education Bureau (grants 11531173 and 12531266) and J. C. was supported by grants from the National S & T Major Program for Infectious Disease of China Nos. 2012ZX10004-201 and 2009ZX10004-201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Rojas CA, 2014, INT J PARASITOL, V44, P9, DOI 10.1016/j.ijpara.2013.08.008; Badaraco JL, 2008, EXP PARASITOL, V119, P453, DOI 10.1016/j.exppara.2008.02.004; Bardonnet K, 2003, VET PARASITOL, V116, P35, DOI 10.1016/S0304-4017(03)00255-3; Bart JM, 2006, PARASITOLOGY, V133, P571, DOI 10.1017/S0031182006000734; Bart JM, 2006, PARASITOL RES, V98, P130, DOI 10.1007/s00436-005-0015-9; Beato S, 2013, VET PARASITOL, V198, P235, DOI 10.1016/j.vetpar.2013.08.021; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; Cardona GA, 2013, VET PARASITOL, V192, P10, DOI 10.1016/j.vetpar.2012.09.027; Casulli A, 2010, T ROY SOC TROP MED H, V104, P29, DOI 10.1016/j.trstmh.2009.08.001; Cruz-Reyes A, 2007, J HELMINTHOL, V81, P287, DOI 10.1017/S0022149X07787564; Dybicz M, 2013, PARASITOL INT, V62, P364, DOI 10.1016/j.parint.2013.03.005; Eren B, 2010, BRATISL MED J, V111, P351; Gonzalez L. M., 2002, Experimental Parasitology, V102, P46, DOI 10.1016/S0014-4894(02)00146-7; Grosso G, 2012, WORLD J GASTROENTERO, V18, P1425, DOI 10.3748/wjg.v18.i13.1425; Haag KL, 2004, J PARASITOL, V90, P234, DOI 10.1645/GE-173R; Hu D, 2013, ACTA VET, V44, P14; Kamenetzky L, 2000, EXP PARASITOL, V95, P122, DOI 10.1006/expr.2000.4518; Kamenetzky L, 2002, INFECT GENET EVOL, V2, P129, DOI 10.1016/S1567-1348(02)00131-4; Li TY, 2008, T ROY SOC TROP MED H, V102, P585, DOI 10.1016/j.trstmh.2008.02.019; Liu C, 2010, MED INFORM, V23, P341; Liu Q, 2013, VECTOR-BORNE ZOONOT, V13, P134, DOI 10.1089/vbz.2012.1050; Ma SM, 2008, PARASITOL RES, V102, P1201, DOI 10.1007/s00436-008-0894-7; Ma XiuMin, 2008, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V3, P281; Mahmud AL, 2011, XINJIANG MED J, V41, P96; McManus DP, 2006, PARASITOL INT, V55, pS31, DOI 10.1016/j.parint.2005.11.004; Mogoye BK, 2013, VET PARASITOL, V196, P427, DOI 10.1016/j.vetpar.2013.03.033; Monteiro DU, 2014, VET PARASITOL, V202, P335, DOI 10.1016/j.vetpar.2014.01.023; Moro PL, 2009, PARASITOL INT, V58, P184, DOI 10.1016/j.parint.2009.01.005; Mwambete KD, 2004, ACTA TROP, V91, P87, DOI 10.1016/j.actatropica.2004.04.001; Nakao M, 2013, INT J PARASITOL, V43, P1017, DOI 10.1016/j.ijpara.2013.06.002; Nakao M, 2010, INT J PARASITOL, V40, P379, DOI 10.1016/j.ijpara.2009.09.006; Nejad M. R., 2010, Gastroenterology and Hepatology - From Bed to Bench, V3, P169; Nejad MR, 2012, J HELMINTHOL, V86, P485, DOI 10.1017/S0022149X1100071X; Qu H, 2000, CHIN J VET SCI TECH, V30, P13; Rosenzvit MC, 1999, PARASITOLOGY, V118, P523, DOI 10.1017/S0031182099004035; Sanchez E, 2012, MEM I OSWALDO CRUZ, V107, P275, DOI 10.1590/S0074-02762012000200019; Schneider R, 2010, AM J TROP MED HYG, V82, P871, DOI 10.4269/ajtmh.2010.09-0639; Scott JC, 1997, PARASITOLOGY, V114, P37, DOI 10.1017/S0031182096008062; Snabel V, 2000, J HELMINTHOL, V74, P177; Snabel V, 2009, PARASITOL RES, V105, P145, DOI 10.1007/s00436-009-1376-2; Soriano SV, 2010, PARASITOL INT, V59, P626, DOI 10.1016/j.parint.2010.07.003; Soriano SV, 2013, J HELMINTHOL, V10, P1; Turcekova L, 2003, ACTA TROP, V85, P223, DOI 10.1016/S0001-706X(02)00229-2; Varcasia A, 2007, PARASITOL RES, V101, P1135, DOI 10.1007/s00436-007-0568-x; Varcasia A, 2006, PARASITOL RES, V98, P273, DOI 10.1007/s00436-005-0059-x; Villalobos N, 2007, VET PARASITOL, V147, P185, DOI 10.1016/j.vetpar.2007.03.021; Wang N, 2013, MITOCHONDR DNA; Xiao N, 2003, AM J TROP MED HYG, V69, P445, DOI 10.4269/ajtmh.2003.69.445; Yan N, 2013, VET PARASITOL, V196, P179, DOI 10.1016/j.vetpar.2013.02.010; Yang JunKe, 2004, Chinese Journal of Veterinary Science and Technology, V34, P12; Yang YR, 2005, PARASITOLOGY, V131, P547, DOI 10.1017/S0031182005007973; Yang YR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000518; Yang YR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000426; Zhang HongWei, 2002, Chinese Journal of Veterinary Science and Technology, V32, P15; Zhang J, 1958, CHIN J OBSTET GYNECO, V6, P93; Zhang LH, 1998, PARASITOLOGY, V116, P29, DOI 10.1017/S0031182097001881; Zhang YL, 2006, VET PARASITOL, V139, P244, DOI 10.1016/j.vetpar.2006.03.003	57	26	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109059	10.1371/journal.pone.0109059	http://dx.doi.org/10.1371/journal.pone.0109059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329820	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800014
J	Bast, F; John, AA; Bhushan, S				Bast, Felix; John, Aijaz Ahmad; Bhushan, Satej			Strong Endemism of Bloom-Forming Tubular Ulva in Indian West Coast, with Description of Ulva paschima Sp Nov (Ulvales, Chlorophyta)	PLOS ONE			English	Article							COMPRESSA CHLOROPHYTA; ENTEROMORPHA; ULVOPHYCEAE; INTESTINALIS; MORPHOLOGY	Ulva intestinalis and Ulva compressa are two bloom-forming morphologically-cryptic species of green seaweeds widely accepted as cosmopolitan in distribution. Previous studies have shown that these are two distinct species that exhibit great morphological plasticity with changing seawater salinity. Here we present a phylogeographic assessment of tubular Ulva that we considered belonging to this complex collected from various marine and estuarine green-tide occurrences in a ca. 600 km stretch of the Indian west coast. Maximum Likelihood and Bayesian Inference phylogenetic reconstructions using ITS nrDNA revealed strong endemism of Indian tubular Ulva, with none of the Indian isolates forming part of the already described phylogenetic clades of either U. compressa or U. intestinalis. Due to the straightforward conclusion that Indian isolates form a robust and distinct phylogenetic clade, a description of a new bloom-forming species, Ulva paschima Bast, is formally proposed. Our phylogenetic reconstructions using Neighbor-Joining method revealed evolutionary affinity of this new species with Ulva flexuosa. This is the first molecular assessment of Ulva from the Indian Subcontinent.	[Bast, Felix; John, Aijaz Ahmad; Bhushan, Satej] Cent Univ Punjab, Ctr Biosci, Bathinda, Punjab, India	Central University of Punjab	Bast, F (corresponding author), Cent Univ Punjab, Ctr Biosci, Bathinda, Punjab, India.	felix.bast@cup.ac.in	Bhushan, Satej/AAH-5147-2020	Bhushan, Satej/0000-0003-0790-5673; Bast, Felix/0000-0002-5090-0109	INSPIRE Faculty award from Department of Science and Technology, Government of India [IFA-LSPA-02]	INSPIRE Faculty award from Department of Science and Technology, Government of India	Supported by INSPIRE Faculty award (IFA-LSPA-02) from Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bast F, 2013, NATURE PROTOCOL EXCH; Bast F, 2014, SCI WORLD J, DOI 10.1155/2014/847482; Blomster J, 2002, AM J BOT, V89, P1756, DOI 10.3732/ajb.89.11.1756; Blomster J, 1998, J PHYCOL, V34, P319, DOI 10.1046/j.1529-8817.1998.340319.x; Brodie J, 2007, GREEN SEAWEEDS OF BR; Burrows E.M., 1973, J MAR BIOL ASSOC UK, V53, P895, DOI [10.1017/S0025315400022554, DOI 10.1017/S0025315400022554]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gabrielson P. W., 2006, KEYS SEAWEEDS SEAGRA; Guidone M, 2013, J PHYCOL, V49, P979, DOI 10.1111/jpy.12108; Hayden HS, 2004, PHYCOLOGIA, V43, P364, DOI 10.2216/i0031-8884-43-4-364.1; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; HENNIG W, 1965, ANNU REV ENTOMOL, V10, P97, DOI 10.1146/annurev.en.10.010165.000525; Hiraoka M, 2008, J APPL PHYCOL, V20, P97, DOI 10.1007/s10811-007-9186-3; Kester DR, 1967, LIMNOLOGY OCEANOGRAP, V12; Kirkendale L, 2013, J PHYCOL, V49, P69, DOI 10.1111/jpy.12016; Kraft LGK, 2010, J PHYCOL, V46, P1257, DOI 10.1111/j.1529-8817.2010.00909.x; Leskinen E, 2004, MOL ECOL, V13, P2257, DOI 10.1111/j.1365-294X.2004.02219.x; MacArtain P, 2007, NUTR REV, V65, P535, DOI 10.1111/j.1753-4887.2007.tb00278.x; O'Kelly CJ, 2010, J PHYCOL, V46, P728, DOI 10.1111/j.1529-8817.2010.00860.x; Pang SJ, 2010, MAR ENVIRON RES, V69, P207, DOI 10.1016/j.marenvres.2009.10.007; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shimada S, 2008, J APPL PHYCOL, V20, P979, DOI 10.1007/s10811-007-9296-y; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan IH, 1999, MOL BIOL EVOL, V16, P1011, DOI 10.1093/oxfordjournals.molbev.a026190; Wang JF, 2010, CHIN J OCEANOL LIMN, V28, P762, DOI 10.1007/s00343-010-9069-3; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wolf MA, 2012, J PHYCOL, V48, P1510, DOI 10.1111/jpy.12005	28	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109295	10.1371/journal.pone.0109295	http://dx.doi.org/10.1371/journal.pone.0109295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329833	gold, Green Submitted, Green Published			2022-12-27	WOS:000346766200024
J	Patino, LC; Battu, R; Ortega-Recalde, O; Nallathambi, J; Anandula, VR; Renukaradhya, U; Laissue, P				Catherine Patino, Liliana; Battu, Rajani; Ortega-Recalde, Oscar; Nallathambi, Jeyabalan; Anandula, Venkata Ramana; Renukaradhya, Umashankar; Laissue, Paul			Exome Sequencing Is an Efficient Tool for Variant Late-Infantile Neuronal Ceroid Lipofuscinosis Molecular Diagnosis	PLOS ONE			English	Article							MUTATIONS; TRANSPORTER	The neuronal ceroid-lipofuscinoses (NCL) is a group of neurodegenerative disorders characterized by epilepsy, visual failure, progressive mental and motor deterioration, myoclonus, dementia and reduced life expectancy. Classically, NCL-affected individuals have been classified into six categories, which have been mainly defined regarding the clinical onset of symptoms. However, some patients cannot be easily included in a specific group because of significant variation in the age of onset and disease progression. Molecular genetics has emerged in recent years as a useful tool for enhancing NCL subtype classification. Fourteen NCL genetic forms (CLN1 to CLN14) have been described to date. The variant late-infantile form of the disease has been linked to CLN5, CLN6, CLN7 (MFSD8) and CLN8 mutations. Despite advances in the diagnosis of neurodegenerative disorders mutations in these genes may cause similar phenotypes, which rends difficult accurate candidate gene selection for direct sequencing. Three siblings who were affected by variant late-infantile NCL are reported in the present study. We used whole-exome sequencing, direct sequencing and in silico approaches to identify the molecular basis of the disease. We identified the novel c.1219T>C (p.Trp407Arg) and c.1361T>C(p.Met454Thr) MFSD8 pathogenic mutations. Our results highlighted next generation sequencing as a novel and powerful methodological approach for the rapid determination of the molecular diagnosis of NCL. They also provide information regarding the phenotypic and molecular spectrum of CLN7 disease.	[Catherine Patino, Liliana; Ortega-Recalde, Oscar; Laissue, Paul] Univ Rosario, Escuela Med & Ciencias Salud, Unidad Genet, Grp GENIUROS, Bogota, Colombia; [Battu, Rajani] Narayana Nethralaya, Dept Vitreoretina, Bangalore, Karnataka, India; [Nallathambi, Jeyabalan] Narayana Nethralaya, GROW Res Lab, Narayana Hlth City, Bangalore, Karnataka, India; [Anandula, Venkata Ramana; Renukaradhya, Umashankar] Narayana Nethralaya, Dept Mol Diagnost, Bangalore, Karnataka, India	Universidad del Rosario	Laissue, P (corresponding author), Univ Rosario, Escuela Med & Ciencias Salud, Unidad Genet, Grp GENIUROS, Bogota, Colombia.	paul.laissue@urosario.edu.co	Laissue, Paul/C-6787-2012	Laissue, Paul/0000-0003-4180-4796; Ortega-Recalde, Oscar/0000-0002-8076-0346; Patino, Liliana C./0000-0002-1710-9809	The Universidad del Rosario [CS/Genetics 014]	The Universidad del Rosario	This study was financed by The Universidad del Rosario (Grant CS/Genetics 014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GW, 2013, BBA-MOL BASIS DIS, V1832, P1807, DOI 10.1016/j.bbadis.2012.11.014; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Haltia M, 2003, J NEUROPATH EXP NEUR, V62, P1; Haltia M, 2013, BBA-MOL BASIS DIS, V1832, P1795, DOI 10.1016/j.bbadis.2012.08.012; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Kousi M, 2009, BRAIN, V132, P810, DOI 10.1093/brain/awn366; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Ortega-Recalde O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064692; Sharifi A, 2010, HUM MOL GENET, V19, P4497, DOI 10.1093/hmg/ddq381; Siintola E, 2007, AM J HUM GENET, V81, P136, DOI 10.1086/518902; Williams RE, 2012, NEUROLOGY, V79, P183, DOI 10.1212/WNL.0b013e31825f0547	13	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109576	10.1371/journal.pone.0109576	http://dx.doi.org/10.1371/journal.pone.0109576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333361	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200041
J	Cerrada, A; de la Torre, P; Grande, J; Haller, T; Flores, AI; Perez-Gil, J				Cerrada, Alejandro; de la Torre, Paz; Grande, Jesus; Haller, Thomas; Flores, Ana I.; Perez-Gil, Jesus			Human Decidua-Derived Mesenchymal Stem Cells Differentiate into Functional Alveolar Type II-Like Cells that Synthesize and Secrete Pulmonary Surfactant Complexes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-I; HUMAN AMNIOTIC-FLUID; EPITHELIAL-CELLS; PROTEIN-B; PRIMARY CULTURE; LUNG; DERIVATION; ADSORPTION; EXPRESSION; TRANSPLANTATION	Lung alveolar type II (ATII) cells are specialized in the synthesis and secretion of pulmonary surfactant, a lipid-protein complex that reduces surface tension to minimize the work of breathing. Surfactant synthesis, assembly and secretion are closely regulated and its impairment is associated with severe respiratory disorders. At present, well-established ATII cell culture models are not available. In this work, Decidua-derived Mesenchymal Stem Cells (DMSCs) have been differentiated into Alveolar Type II-Like Cells (ATII-LCs), which display membranous cytoplasmic organelles resembling lamellar bodies, the organelles involved in surfactant storage and secretion by native ATII cells, and accumulate disaturated phospholipid species, a surfactant hallmark. Expression of characteristic ATII cells markers was demonstrated in ATII-LCs at gene and protein level. Mimicking the response of ATII cells to secretagogues, ATII-LCs were able to exocytose lipid-rich assemblies, which displayed highly surface active capabilities, including faster interfacial adsorption kinetics than standard native surfactant, even in the presence of inhibitory agents. ATII-LCs could constitute a highly useful ex vivo model for the study of surfactant biogenesis and the mechanisms involved in protein processing and lipid trafficking, as well as the packing and storage of surfactant complexes.	[Cerrada, Alejandro; Perez-Gil, Jesus] Univ Complutense, Fac Biol, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain; [de la Torre, Paz; Flores, Ana I.] Hosp 12 Octubre, Inst Invest, E-28041 Madrid, Spain; [Grande, Jesus] Hosp 12 Octubre, Dept Obstet & Ginecol, E-28041 Madrid, Spain; [Haller, Thomas] Med Univ Innsbruck, Dept Physiol, A-6020 Innsbruck, Austria	Complutense University of Madrid; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Medical University of Innsbruck	Flores, AI (corresponding author), Hosp 12 Octubre, Inst Invest, E-28041 Madrid, Spain.	aflores.hdoc@salud.madrid.org; jperezgil@bio.ucm.es	Haller, Thomas/H-9036-2015; Flores, Ana I/L-2104-2015; Perez-Gil, Jesus/H-3102-2019	Haller, Thomas/0000-0001-9147-4081; Flores, Ana I/0000-0002-5019-0434; Perez-Gil, Jesus/0000-0003-3587-7147	Spanish Ministry of Economy [BIO2012-30733]	Spanish Ministry of Economy(Spanish Government)	This work has been funded by a grant from the Spanish Ministry of Economy (BIO2012-30733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali NN, 2002, TISSUE ENG, V8, P541, DOI 10.1089/107632702760240463; Berger MJ, 2006, CYTOTHERAPY, V8, P480, DOI 10.1080/14653240600941549; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; Bornstein R, 2012, CYTOTHERAPY, V14, P1182, DOI 10.3109/14653249.2012.706706; Canals D, 2009, BIOORGAN MED CHEM, V17, P235, DOI 10.1016/j.bmc.2008.11.026; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Carraro G, 2008, STEM CELLS, V26, P2902, DOI 10.1634/stemcells.2008-0090; DOBBS LG, 1985, BIOCHIM BIOPHYS ACTA, V846, P155, DOI 10.1016/0167-4889(85)90121-1; DOBBS LG, 1989, ANNU REV MED, V40, P431; Duchesneau P, 2010, MOL THER, V18, P1830, DOI 10.1038/mt.2010.142; Fehrenbach H, 2012, EUR RESPIR J, V39, P240, DOI 10.1183/09031936.00162111; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Frick M, 2001, AM J RESP CELL MOL, V25, P306, DOI 10.1165/ajrcmb.25.3.4493; Frick M, 2004, AM J PHYSIOL-LUNG C, V286, P22; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; Gonzalez Robert F, 2013, Methods Mol Biol, V945, P145, DOI 10.1007/978-1-62703-125-7_10; Haller T, 2004, AM J PHYSIOL-LUNG C, V286, pL1009, DOI 10.1152/ajplung.00342.2003; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Hallman M, 2001, COMP BIOCHEM PHYS A, V129, P287, DOI 10.1016/S1095-6433(01)00324-5; Hemberger M, 2008, PLACENTA, V29, P21; Jennings P, 2005, CELL PHYSIOL BIOCHEM, V15, P159, DOI 10.1159/000083648; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Knoll Ab, 2013, Open Respir Med J, V7, P46, DOI 10.2174/1874306401307010046; Ma N, 2011, CELL BIOL INT, V35, P1261, DOI 10.1042/CBI20110026; Macias MI, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.045; Marcus AJ, 2008, J CELL MOL MED, V12, P730, DOI 10.1111/j.1582-4934.2008.00221.x; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; Mason RJ, 2002, AM J PHYSIOL-LUNG C, V282, pL249, DOI 10.1152/ajplung.00027.2001; MENDELSON CR, 1991, ANNU REV PHYSIOL, V53, P415, DOI 10.1146/annurev.ph.53.030191.002215; MENDELSON CR, 1990, BAILLIERE CLIN ENDOC, V4, P351, DOI 10.1016/S0950-351X(05)80055-2; Miklavc P, 2011, P NATL ACAD SCI USA, V108, P14503, DOI 10.1073/pnas.1101039108; MIYAMURA K, 1994, BBA-LIPID LIPID MET, V1210, P303, DOI 10.1016/0005-2760(94)90233-X; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; NEWMAN GE, 1991, REPROD FERT DEVELOP, V3, P421, DOI 10.1071/RD9910421; Okamoto K, 2007, EXP CELL RES, V313, P2550, DOI 10.1016/j.yexcr.2007.04.028; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101; PRYHUBER GS, 1991, PEDIATR RES, V30, P597, DOI 10.1203/00006450-199112000-00023; Ravasio A, 2008, J LIPID RES, V49, P2479, DOI 10.1194/jlr.D800029-JLR200; Ravasio A, 2010, J BIOL CHEM, V285, P28174, DOI 10.1074/jbc.M110.106518; Rippon HJ, 2006, STEM CELLS, V24, P1389, DOI 10.1634/stemcells.2005-0465; Roszell B, 2009, TISSUE ENG PT A, V15, P3351, DOI 10.1089/ten.TEA.2008.0664; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Samadikuchaksaraei Ali, 2006, V330, P233; Samadikuchaksaraei A, 2006, TISSUE ENG, V12, P867, DOI 10.1089/ten.2006.12.867; Sati L, 2010, HISTOCHEM CELL BIOL, V133, P85, DOI 10.1007/s00418-009-0642-9; Schmeckebier S, 2013, TISSUE ENG PT A, V19, P938, DOI [10.1089/ten.tea.2012.0066, 10.1089/ten.TEA.2012.0066]; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Siti-Ismail N, 1089, TISSUE ENG PART C-ME, V18, P263; Soncini M, 2007, J TISSUE ENG REGEN M, V1, P296, DOI 10.1002/term.40; Spitalieri P, 1183, EUR RESPIR J, V39, P446; Stahlman MT, 2007, J HISTOCHEM CYTOCHEM, V55, P71, DOI 10.1369/jhc.6A6962.2006; STAHLMAN MT, 1992, J HISTOCHEM CYTOCHEM, V40, P1471, DOI 10.1177/40.10.1527371; Steimer A, 2006, PHARM RES-DORDR, V23, P2078, DOI 10.1007/s11095-006-9057-7; Sun K, 2006, J CLIN ENDOCR METAB, V91, P4988, DOI 10.1210/jc.2006-1472; Taeusch HW, 2005, BIOPHYS J, V89, P1769, DOI 10.1529/biophysj.105.062620; Van Vranken BE, 2007, CURR PROTOC STEM CEL; Vegh I, 2013, CANCER GENE THER, V20, P8, DOI 10.1038/cgt.2012.71; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wang YY, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt193; Winkler ME, 2008, CLONING STEM CELLS, V10, P49, DOI 10.1089/clo.2007.0075; Wong Amy P, 2013, Curr Pathobiol Rep, V1, P137; Wong AP, 2009, J CLIN INVEST, V119, P336, DOI 10.1172/JCI36882; Wong AP, 2007, AM J PHYSIOL-LUNG C, V293, P6; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	69	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110195	10.1371/journal.pone.0110195	http://dx.doi.org/10.1371/journal.pone.0110195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333871	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200100
J	Foo, NP; Chang, JH; Su, SB; Chen, KT; Cheng, CF; Chen, PC; Lin, TY; Guo, HR				Foo, Ning-Ping; Chang, Jer-Hao; Su, Shih-Bin; Chen, Kow-Tong; Cheng, Ching-Fa; Chen, Pei-Chung; Lin, Tsung-Yi; Guo, How-Ran			A Stabilization Device That Promotes the Efficiency of Cardiopulmonary Resuscitation during Ambulance Transportation to the Level as under Non-Moving Conditions	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; CLOSED-CHEST COMPRESSION; RANDOMIZED-TRIAL; QUALITY; SURVIVAL	Background: The survival rate of patients with out-of-hospital cardiac arrest is low, and measures to improve the quality of cardiopulmonary resuscitation (CPR) during ambulance transportation are desirable. We designed a stabilization device, and in a randomized crossover trial we found performing CPR in a moving ambulance with the device (MD) could achieve better efficiency than that without the device (MND), but the efficiency was lower than that in a non-moving ambulance (NM). Purpose: To evaluate whether a modified version of the stabilization device, can promote further the quality of CPR during ambulance transportation. Methods: Participants of the previous study were recruited, and they performed CPR for 10 minutes in a moving ambulance with the modified version of the stabilization device (MVSD). The primary outcomes were effective chest compressions and no-flow fraction recorded by a skill-reporter manikin. The secondary outcomes included back pain, physiological parameters, and the participants' rating about the device after performing CPR. Results: The overall effective compressions in 10 minutes were 86.4+/-17.5% for NM, 60.9+/-14.6% for MND, 69.7+/-22.4% for MD, and 86.6%+/-13.2% for MVSD (p<0.001). Whereas changes in back pain severity and physiology parameters were similar under all conditions, MVSD had the lowest no-flow fraction. Differences in effective compressions and the no-flow fraction between MVSD and NM did not reach statistical significance. Conclusions: The use of the modified device can improve quality of CPR in a moving ambulance to a level similar to that in a non-moving condition without increasing the severity of back pain.	[Foo, Ning-Ping] China Med Univ, An Nan Hosp, Dept Emergency Med, Taichung, Taiwan; [Foo, Ning-Ping; Guo, How-Ran] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Foo, Ning-Ping] Chiayi Christian Hosp, Ditmanson Med Fdn, Dept Emergency Med, Chiayi, Taiwan; [Chang, Jer-Hao] Natl Cheng Kung Univ, Coll Med, Dept Occupat Therapy, Tainan 70101, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Occupat Med, Tainan, Taiwan; [Su, Shih-Bin] Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management, Tainan, Taiwan; [Chen, Kow-Tong] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Chen, Kow-Tong] Tainan Municipal Hosp, Dept Occupat Med, Tainan, Taiwan; [Cheng, Ching-Fa] Tainan City Fire Bur, Div Emergency Med Serv, Tainan, Taiwan; [Chen, Pei-Chung; Lin, Tsung-Yi] Southern Taiwan Univ Sci & Technol, Dept Mech Engn, Tainan, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan	China Medical University Taiwan; National Cheng Kung University; Chia-Yi Christian Hospital; National Cheng Kung University; Chi Mei Hospital; Southern Taiwan University of Science & Technology; National Cheng Kung University; Southern Taiwan University of Science & Technology; National Cheng Kung University; National Cheng Kung University Hospital	Guo, HR (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hrguo@mail.ncku.edu.tw	Guo, How-Ran/AAK-9063-2020; Chang, Jer-Hao/HDN-8114-2022	Guo, How-Ran/0000-0003-3343-3446; 	Ministry of Science and Technology of Taiwan, R.O.C. [NSC 101-2314-B-705-002]	Ministry of Science and Technology of Taiwan, R.O.C.	This study was supported by Grants NSC 101-2314-B-705-002 from the National Science Council (currently the Ministry of Science and Technology) of Taiwan, R.O.C.(http://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Brooks SC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007260.pub3; Chung TN, 2010, RESUSCITATION, V81, P841, DOI 10.1016/j.resuscitation.2010.02.024; Cleeland C S, 1985, Semin Oncol Nurs, V1, P87, DOI 10.1016/S0749-2081(85)80041-3; Foo NP, 2013, RESUSCITATION, V84, P1579, DOI 10.1016/j.resuscitation.2013.06.015; Fox Julia, 2013, Acute Card Care, V15, P1, DOI 10.3109/17482941.2012.735675; Ger LP, 1999, J PAIN SYMPTOM MANAG, V18, P316, DOI 10.1016/S0885-3924(99)00087-1; Hallstrom A, 2006, JAMA-J AM MED ASSOC, V295, P2620, DOI 10.1001/jama.295.22.2620; Havel C, 2007, RESUSCITATION, V73, P264, DOI 10.1016/j.resuscitation.2006.09.007; Jones AYM, 2004, RESUSCITATION, V61, P63, DOI 10.1016/j.resuscitation.2003.12.007; Kim JA, 2006, PREHOSP EMERG CARE, V10, P68, DOI 10.1080/10903120500373108; Kurz MC, 2012, RESUSCITATION, V83, P1085, DOI 10.1016/j.resuscitation.2012.01.033; Odegaard S, 2009, RESUSCITATION, V80, P843, DOI 10.1016/j.resuscitation.2009.03.032; Olasveengen TM, 2008, RESUSCITATION, V76, P185, DOI 10.1016/j.resuscitation.2007.07.001; Ong MEH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-39; Rubertsson S, 2014, JAMA-J AM MED ASSOC, V311, P53, DOI 10.1001/jama.2013.282538; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Stone C K, 1995, Prehosp Disaster Med, V10, P121; Travers AH, 2010, CIRCULATION, V122, pS676, DOI 10.1161/CIRCULATIONAHA.110.970913; Valenzuela TD, 2005, CIRCULATION, V112, P1259, DOI 10.1161/CIRCULATIONAHA.105.537282; Wik L, 2005, JAMA-J AM MED ASSOC, V293, P299, DOI 10.1001/jama.293.3.299	21	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e107960	10.1371/journal.pone.0107960	http://dx.doi.org/10.1371/journal.pone.0107960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329643	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200007
J	Liu, SL; Qi, L; Han, WQ; Wan, XX; Jiang, SS; Li, Y; Xie, Y; Liu, LF; Zeng, FH; Liu, ZZ; Zu, X				Liu, Sulai; Qi, Lin; Han, Weqing; Wan, Xinxing; Jiang, Shusuan; Li, Yuan; Xie, Yu; Liu, Longfei; Zeng, Fuhua; Liu, Zhizhong; Zu, Xiongbing			Overexpression of Wip1 Is Associated with Biologic Behavior in Human Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; PHOSPHATASE PPM1D; HLA-I; GAMMA-H2AX; EXPRESSION; SURVIVAL; KINASE; REPAIR	Wild-type p53-induced phosphatase (Wip1 or PPM1D) has been reported to be aberrantly expressed in various cancers and correlated with the malignant behavior of cancer cells. However, the function of Wip1 in RCC remains unclear. The present study investigated its abnormal expression and dysfunctions in clear cell renal cell carcinoma (ccRCC) in vitro. With the combination of immunohistochemistry, western blotting, immunofluorescence, qRT-PCR, and cell proliferation, migration and invasion assays, we found that levels of Wip1 mRNA and protein were dramatically increased in human ccRCC tissues (P<0.001 for both), and upregulation of Wip1 was significantly associated with depth of invasion (P<0.001), Distant metastasis (P = 0.001), lymph node status (P<0.001) and Fuhrman grade (P<0.001). Wip1 knockdown inhibited the proliferation, migration and invasion of 786-O and RLC-310 cells, whereas Wip1 overexpression promoted the growth and aggressive phenotype of 786-O and RLC-310 cells in vitro. The uni- and multivariate analyses indicated that expression of Wip1 was an independent predictor for survival of ccRCC patients (P = 0.003, P = 0.027 respectively). Wip1-negative patients had a higher tumor-free/overall survival rate than patients with high Wip1 expression (P = 0.001, P = 0.002 respectively). Overexpression of Wip1 is useful in the prediction of survival in ccRCC patients.	[Liu, Sulai; Qi, Lin; Li, Yuan; Liu, Longfei; Zu, Xiongbing] Cent S Univ, Xiangya Hosp, Dept Urol, Changsha, Hunan, Peoples R China; [Han, Weqing; Jiang, Shusuan; Xie, Yu; Zeng, Fuhua; Liu, Zhizhong] Cent S Univ, Xiangya Med Sch, Affiliated Tumor Hosp, Dept Urol, Changsha, Hunan, Peoples R China; [Wan, Xinxing] Cent S Univ, Xiangya Hosp 3, Dept Endocrinol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Qi, L (corresponding author), Cent S Univ, Xiangya Hosp, Dept Urol, Changsha, Hunan, Peoples R China.	urinologist_xyql@163.com	Li, Yuan/GXV-1310-2022	Liu, Sulai/0000-0002-5257-3922	Hunan Provincial Innovation Foundation for Postgraduate [250171380100015]; Central Universities of Central South University [2014zzts079]	Hunan Provincial Innovation Foundation for Postgraduate; Central Universities of Central South University	This work was supported by Hunan Provincial Innovation Foundation for Postgraduate (NO. 250171380100015) and supported by the Fundamental Research Funds for the Central Universities of Central South University (NO. 2014zzts079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Buss MC, 2014, ONCOGENE; Cheng C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097406; Choi J, 2000, GENOMICS, V64, P298, DOI 10.1006/geno.2000.6134; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Dudgeon C, 2013, CELL CYCLE, V12, P2656, DOI 10.4161/cc.25694; Fang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062823; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fu ZZ, 2014, TUMOR BIOL, V35, P2975, DOI 10.1007/s13277-013-1382-y; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Grimm MO, 2010, THER ADV UROL, V2, P11, DOI 10.1177/1756287210364959; Leibovich BC, 2010, J UROLOGY, V183, P1309, DOI 10.1016/j.juro.2009.12.035; Liu SL, 2014, TUMOR BIOL, V35, P8281, DOI 10.1007/s13277-014-2058-y; Lu XB, 2005, CELL CYCLE, V4, P1060; Macurek L, 2010, ONCOGENE, V29, P2281, DOI 10.1038/onc.2009.501; Moon SH, 2010, CELL CYCLE, V9, P2092, DOI 10.4161/cc.9.11.11810; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Nannenga B, 2006, MOL CARCINOGEN, V45, P594, DOI 10.1002/mc.20195; Oliva-Trastoy M, 2007, ONCOGENE, V26, P1449, DOI 10.1038/sj.onc.1209927; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Satoh N, 2011, CANCER SCI, V102, P1101, DOI 10.1111/j.1349-7006.2011.01898.x; Sun GG, 2014, PATHOL ONCOL RES; Tan DSP, 2009, CLIN CANCER RES, V15, P2269, DOI 10.1158/1078-0432.CCR-08-2403; Yuan JY, 2013, ACTA HISTOCHEM, V115, P470, DOI 10.1016/j.acthis.2012.11.002; Zhu YH, 2014, J CLIN INVEST, V124, P3263, DOI 10.1172/JCI73015	26	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110218	10.1371/journal.pone.0110218	http://dx.doi.org/10.1371/journal.pone.0110218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25334029	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200103
J	Shipov, A; Segev, G; Meltzer, H; Milrad, M; Brenner, O; Atkins, A; Shahar, R				Shipov, Anna; Segev, Gilad; Meltzer, Hagar; Milrad, Moran; Brenner, Ori; Atkins, Ayelet; Shahar, Ron			The Effect of Naturally Occurring Chronic Kidney Disease on the Micro-Structural and Mechanical Properties of Bone	PLOS ONE			English	Article							CORTICAL BONE; MINERAL DENSITY; HIP FRACTURE; RAT MODEL; VITAMIN-D; CALCIUM; RISK; SIZE; METABOLISM; FRAGILITY	Chronic kidney disease (CKD) is a growing public health concern worldwide, and is associated with marked increase of bone fragility. Previous studies assessing the effect of CKD on bone quality were based on biopsies from human patients or on laboratory animal models. Such studies provide information of limited relevance due to the small size of the samples (biopsies) or the non-physiologic CKD syndrome studied (rodent models with artificially induced CKD). Furthermore, the type, architecture, structure and biology of the bone of rodents are remarkably different from human bones; therefore similar clinicopathologic circumstances may affect their bones differently. We describe the effects of naturally occurring CKD with features resembling human CKD on the skeleton of cats, whose bone biology, structure and composition are remarkably similar to those of humans. We show that CKD causes significant increase of resorption cavity density compared with healthy controls, as well as significantly lower cortical mineral density, cortical cross-sectional area and cortical cross-sectional thickness. Young's modulus, yield stress, and ultimate stress of the cortical bone material were all significantly decreased in the skeleton of CKD cats. Cancellous bone was also affected, having significantly lower trabecular thickness and bone volume over total volume in CKD cats compared with controls. This study shows that naturally occurring CKD has deleterious effects on bone quality and strength. Since many similarities exist between human and feline CKD patients, including the clinicopathologic features of the syndrome and bone microarchitecture and biology, these results contribute to better understanding of bone abnormalities associated with CKD.	[Shipov, Anna; Segev, Gilad; Meltzer, Hagar; Milrad, Moran; Atkins, Ayelet; Shahar, Ron] Hebrew Univ Jerusalem, Koret Sch Vet Med, IL-76100 Rehovot, Israel; [Brenner, Ori] Weizmann Inst Sci, Dept Vet Resources, Rehovot, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science	Shipov, A (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, IL-76100 Rehovot, Israel.	anna.shipov@mail.huji.ac.il	Segev, Gilad/AFL-5339-2022	Atkins, Ayelet/0000-0001-9060-9298; Shipov, Anna/0000-0002-5760-1355	Israel Science Foundation [151/08]	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation (Grant No 151/08) to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; Bach-Gansmo FL, 2013, CALCIFIED TISSUE INT, V92, P330, DOI 10.1007/s00223-012-9682-6; Balon BP, 2002, AM J NEPHROL, V22, P14; Barou O, 2002, INVEST RADIOL, V37, P40, DOI 10.1097/00004424-200201000-00008; Bousson V, 2001, J BONE MINER RES, V16, P1308, DOI 10.1359/jbmr.2001.16.7.1308; Cao HH, 2010, BONE, V46, P1582, DOI 10.1016/j.bone.2010.02.020; Coco M, 2000, AM J KIDNEY DIS, V36, P1115, DOI 10.1053/ajkd.2000.19812; Cohen L, 2012, J EXP BIOL, V215, P1983, DOI 10.1242/jeb.064790; Cozzolino M, 2009, BLOOD PURIFICAT, V27, P338, DOI 10.1159/000209246; Currey JD, 2013, J STRUCT BIOL, V183, P107, DOI 10.1016/j.jsb.2013.04.012; Danese MD, 2006, AM J KIDNEY DIS, V47, P149, DOI 10.1053/j.ajkd.2005.09.024; Draper ERC, 2003, J BIOMECH, V36, P1497, DOI 10.1016/S0021-9290(03)00129-5; Hillier ML, 2007, J FORENSIC SCI, V52, P249, DOI 10.1111/j.1556-4029.2006.00368.x; Iwasaki Y, 2013, BONE, V57, P477, DOI 10.1016/j.bone.2013.07.037; Iwasaki Y, 2011, BONE, V48, P1260, DOI 10.1016/j.bone.2011.03.672; Jokihaara J, 2006, BONE, V39, P353, DOI 10.1016/j.bone.2006.01.157; Ketteler M, 2013, NEPHROL DIAL TRANSPL, V28, P821, DOI 10.1093/ndt/gfs557; Kuchler U, 2013, CLIN ORAL IMPLAN RES, V24, P285, DOI 10.1111/j.1600-0501.2012.02533.x; Leonard MB, 2009, SEMIN NEPHROL, V29, P133, DOI 10.1016/j.semnephrol.2009.01.006; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Lora CM, 2009, ETHNIC DIS, V19, P466; McClellan WM, 2013, NEPHROL DIAL TRANSPL, V28, P37, DOI 10.1093/ndt/gft030; Miller MA, 1998, BONE, V23, P257, DOI 10.1016/S8756-3282(98)00098-2; Montanari S, 2011, BIOL LETTERS, V7, P751, DOI 10.1098/rsbl.2011.0173; Nabeshima Y, 2008, CELL MOL LIFE SCI, V65, P3218, DOI 10.1007/s00018-008-8177-0; Nickolas TL, 2008, KIDNEY INT, V74, P721, DOI 10.1038/ki.2008.264; Nickolas TL, 2013, J BONE MINER RES, V28, P1811, DOI 10.1002/jbmr.1916; Nickolas TL, 2010, J AM SOC NEPHROL, V21, P1371, DOI 10.1681/ASN.2009121208; Parfitt AM, 1998, J BONE MINER RES, V13, P1213, DOI 10.1359/jbmr.1998.13.8.1213; Polzin D.J., 2010, TXB VET INTERNAL MED, V2, P1990; Rix M, 1999, KIDNEY INT, V56, P1084, DOI 10.1046/j.1523-1755.1999.00617.x; Saito H, 2003, J BIOL CHEM, V278, P2206, DOI 10.1074/jbc.M207872200; Segev G, 2013, J VET INTERN MED, V27, P1362, DOI 10.1111/jvim.12180; Sharir A, 2008, VET J, V177, P8, DOI 10.1016/j.tvjl.2007.09.012; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shipov A, 2013, J STRUCT BIOL, V183, P132, DOI 10.1016/j.jsb.2013.04.010; Spasovski GB, 2003, NEPHROL DIAL TRANSPL, V18, P1159, DOI 10.1093/ndt/gfg116; Spatz HC, 1996, P ROY SOC B-BIOL SCI, V263, P287, DOI 10.1098/rspb.1996.0044; Stehman-Breen CO, 2000, KIDNEY INT, V58, P2200, DOI 10.1046/j.1523-1755.2000.00394.x; Tazawa K, 2004, J BONE MINER METAB, V22, P524, DOI 10.1007/s00774-004-0519-x; Torcasio Antonia, 2008, Journal of Biomechanics, V41, DOI 10.1016/S0021-9290(08)70014-9; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Urbanova P, 2005, ANTHROPOL-INT J HUM, V43, P77; van Lenthe GH, 2008, BONE, V43, P717, DOI 10.1016/j.bone.2008.06.008; WASNICH RD, 1989, J NUCL MED, V30, P1166; Yenchek RH, 2012, CLIN J AM SOC NEPHRO, V7, P1130, DOI 10.2215/CJN.12871211; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	47	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110057	10.1371/journal.pone.0110057	http://dx.doi.org/10.1371/journal.pone.0110057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333360	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200086
J	Wang, Z; Wu, M				Wang, Zhang; Wu, Martin			Phylogenomic Reconstruction Indicates Mitochondrial Ancestor Was an Energy Parasite	PLOS ONE			English	Article							BACTERIAL ENDOSYMBIONTS; RICKETTSIA-PROWAZEKII; ATP/ADP TRANSLOCASES; GENOME EVOLUTION; ORIGIN; GENES; DNA; CHLAMYDIAE; SYMBIONTS; TRANSPORT	Reconstruction of mitochondrial ancestor has great impact on our understanding of the origin of mitochondria. Previous studies have largely focused on reconstructing the last common ancestor of all contemporary mitochondria (proto-mitochondria), but not on the more informative pre-mitochondria (the last common ancestor of mitochondria and their alphaproteobacterial sister clade). Using a phylogenomic approach and leveraging on the increased taxonomic sampling of alphaproteobacterial and eukaryotic genomes, we reconstructed the metabolisms of both proto-mitochondria and pre-mitochondria. Our reconstruction depicts a more streamlined proto-mitochondrion than these predicted by previous studies, and revealed several novel insights into the mitochondria-derived eukaryotic metabolisms including the lipid metabolism. Most strikingly, pre-mitochondrion was predicted to possess a plastid/parasite type of ATP/ADP translocase that imports ATP from the host, which posits pre-mitochondrion as an energy parasite that directly contrasts with the current role of mitochondria as the cell's energy producer. In addition, pre-mitochondrion was predicted to encode a large number of flagellar genes and several cytochrome oxidases functioning under low oxygen level, strongly supporting the previous finding that the mitochondrial ancestor was likely motile and capable of oxidative phosphorylation under microoxic condition.	[Wang, Zhang; Wu, Martin] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA	University of Virginia	Wu, M (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	mw4yv@virginia.edu		Wu, Martin/0000-0003-3093-4077	Thomas F. & Kate Miller Jeffress Memorial Trust	Thomas F. & Kate Miller Jeffress Memorial Trust	This research was funded by an award from Thomas F. & Kate Miller Jeffress Memorial Trust to MW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri H, 2003, J MOL EVOL, V56, P137, DOI 10.1007/s00239-002-2387-0; Andersson SGE, 2003, PHILOS T R SOC B, V358, P165, DOI 10.1098/rstb.2002.1193; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; Audia JP, 2006, J BACTERIOL, V188, P6261, DOI 10.1128/JB.00371-06; Boscaro V, 2013, SCI REP-UK, V3, DOI 10.1038/srep03305; Bradley-Dunlop DJ, 2004, DIS AQUAT ORGAN, V60, P233, DOI 10.3354/dao060233; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Desler C, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/701518; Driscoll T, 2013, GENOME BIOL EVOL, V5, P621, DOI 10.1093/gbe/evt036; Duarte A., 2012, PLOS ONE, V7; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; EWALD PW, 1987, ANN NY ACAD SCI, V503, P295, DOI 10.1111/j.1749-6632.1987.tb40616.x; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Fritsche TR, 1999, APPL ENVIRON MICROB, V65, P206; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Gabaldon T, 2007, PLOS COMPUT BIOL, V3, P2209, DOI 10.1371/journal.pcbi.0030219; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Greub G, 2003, APPL ENVIRON MICROB, V69, P5530, DOI 10.1128/AEM.69.9.5530-5535.2003; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; HILARIO E, 1993, BIOSYSTEMS, V31, P111, DOI 10.1016/0303-2647(93)90038-E; Holzl G, 2005, GLYCOBIOLOGY, V15, P874, DOI 10.1093/glycob/cwi066; Horn M, 1999, ENVIRON MICROBIOL, V1, P357, DOI 10.1046/j.1462-2920.1999.00045.x; Ingavale SS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000155; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Mavromatis K, 2006, J BACTERIOL, V188, P4015, DOI 10.1128/JB.01837-05; Moreno E, 1998, FEMS MICROBIOL REV, V22, P255, DOI 10.1111/j.1574-6976.1998.tb00370.x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Perez-Moreno G, 2012, INT J PARASITOL, V42, P975, DOI 10.1016/j.ijpara.2012.07.012; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prince FP, 2004, ANAT REC PART A, V278A, P454, DOI 10.1002/ar.a.20019; Rodriguez-Ezpeleta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030520; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Sassera D, 2011, MOL BIOL EVOL, V28, P3285, DOI 10.1093/molbev/msr159; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tjaden J, 1999, J BACTERIOL, V181, P1196, DOI 10.1128/JB.181.4.1196-1202.1999; Vahling CM, 2010, J BACTERIOL, V192, P834, DOI 10.1128/JB.01279-09; Vanderpoorten A, 2006, SYSTEMATIC BIOL, V55, P957, DOI 10.1080/10635150601088995; WHATLEY JM, 1979, PROC R SOC SER B-BIO, V204, P165, DOI 10.1098/rspb.1979.0020; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6; Wolf YI, 1999, TRENDS GENET, V15, P173, DOI 10.1016/S0168-9525(99)01704-7; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079; Wu MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030288	61	19	20	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110685	10.1371/journal.pone.0110685	http://dx.doi.org/10.1371/journal.pone.0110685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333787	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200128
J	Carzoli, KL; Hyson, RL				Carzoli, Kathryn L.; Hyson, Richard L.			Activation of Metabotropic Glutamate Receptors Regulates Ribosomes of Cochlear Nucleus Neurons	PLOS ONE			English	Article							STEM AUDITORY NUCLEI; ACTIVITY-DEPENDENT REGULATION; AFFERENT ACTIVITY BLOCKADE; PROTEIN-SYNTHESIS; INTRACELLULAR CALCIUM; TRANSNEURONAL REGULATION; MAGNOCELLULARIS NEURONS; SYNAPTIC-TRANSMISSION; SYSTEM-DEVELOPMENT; OLFACTORY-BULB	The brain stem auditory system of the chick is an advantageous model for examining changes that occur as a result of deafness. Elimination of acoustic input through cochlear ablation results in the eventual death of approximately 30% of neurons in the chick cochlear nucleus, nucleus magnocellularis (NM). One early change following deafness is an alteration in NM ribosomes, evidenced both by a decrease in protein synthesis and reduction in antigenicity for Y10B, a monoclonal antibody that recognizes a ribosomal epitope. Previous studies have shown that mGluR activation is necessary to maintain Y10B antigenicity and NM viability. What is still unclear, however, is whether or not mGluR activation is sufficient to prevent deafness-induced changes in these neurons, or if other activity-dependent factors are also necessary. The current study investigated the ability of mGluR activation to regulate cochlear nucleus ribosomes in the absence of auditory nerve input. In vitro methods were employed to periodically pressure eject glutamate or mGluR agonists over neurons on one side of a slice preparation leaving the opposite side of the same slice untreated. Immunohistochemistry was then performed using Y10B in order to assess ribosomal changes. Application of glutamate and both group I and II selective mGluR agonists effectively rescued ribosomal antigenicity on the treated side of the slice in comparison to ribosomes on the untreated side. These findings suggest that administration of mGluR agonists is sufficient to reduce the early interruption of normal ribosomal integrity that is typically seen following loss of auditory nerve activity.	[Carzoli, Kathryn L.; Hyson, Richard L.] Florida State Univ, Dept Psychol, Program Neurosci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Carzoli, KL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Anat & Cell Biol, New Orleans, LA 70119 USA.	kcarzo@lsuhsc.edu		Carzoli, Kathryn/0000-0002-4039-7597	PHS grants [DC000585, DC011121]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011121] Funding Source: NIH RePORTER	PHS grants; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by PHS grants DC000585 and DC011121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi A, 2000, EUR J NEUROSCI, V12, P2281, DOI 10.1046/j.1460-9568.2000.00119.x; BOORD RL, 1969, ANN NY ACAD SCI, V167, P186, DOI 10.1111/j.1749-6632.1969.tb20444.x; BORN DE, 1985, J COMP NEUROL, V231, P435, DOI 10.1002/cne.902310403; BORN DE, 1988, J NEUROSCI, V8, P901; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Bruno V, 1997, J NEUROSCI, V17, P1891; CANADY KS, 1992, J NEUROSCI, V12, P1001; CANADY KS, 1994, J NEUROSCI, V14, P5973; Carzoli KL, 2011, HEARING RES, V272, P49, DOI 10.1016/j.heares.2010.10.020; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; DURHAM D, 1985, J COMP NEUROL, V231, P446, DOI 10.1002/cne.902310404; FENG AS, 1980, BRAIN RES, V189, P530, DOI 10.1016/0006-8993(80)90112-2; FRAZIER LL, 1988, J COMP NEUROL, V269, P355, DOI 10.1002/cne.902690304; GARDEN GA, 1994, J NEUROSCI, V14, P1994; GARDEN GA, 1995, J COMP NEUROL, V359, P412, DOI 10.1002/cne.903590305; GARDEN GA, 1995, MOL CELL NEUROSCI, V6, P293, DOI 10.1006/mcne.1995.1023; Gegelashvili G, 2000, NEUROCHEM INT, V37, P163, DOI 10.1016/S0197-0186(00)00019-X; HASHISAKI GT, 1989, J COMP NEUROL, V283, P465, DOI 10.1002/cne.902830402; HYDE GE, 1990, J COMP NEUROL, V297, P329, DOI 10.1002/cne.902970302; HYSON RL, 1995, BRAIN RES, V677, P117, DOI 10.1016/0006-8993(95)00130-I; Hyson RL, 1997, BRAIN RES, V749, P61, DOI 10.1016/S0006-8993(96)01160-2; Hyson RL, 1998, BRAIN RES, V809, P214, DOI 10.1016/S0006-8993(98)00873-7; HYSON RL, 1995, BRAIN RES, V672, P196, DOI 10.1016/0006-8993(94)01390-4; HYSON RL, 1989, J NEUROSCI, V9, P2835; LACHICA EA, 1995, J NEUROSCI, V15, P1724, DOI 10.1523/JNEUROSCI.15-03-01724.1995; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; LEVIMONTALCINI R, 1949, J COMP NEUROL, V91, P209, DOI 10.1002/cne.900910204; Liu QS, 2004, NEURON GLIA BIOL, V1, P307, DOI 10.1017/S1740925X05000190; Lu T, 2001, J PHYSIOL-LONDON, V535, P125, DOI 10.1111/j.1469-7793.2001.t01-1-00125.x; Lu Y, 2014, NEUROSCIENCE, V274, P429, DOI 10.1016/j.neuroscience.2014.05.057; Lu Y, 2007, J NEUROPHYSIOL, V97, P1018, DOI 10.1152/jn.00883.2006; McBride EG, 2013, J COMP NEUROL, V521, P1165, DOI 10.1002/cne.23227; MEISAMI E, 1981, BRAIN RES, V221, P81, DOI 10.1016/0006-8993(81)91065-9; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; NEMETH EF, 1983, NEUROSCI LETT, V40, P39, DOI 10.1016/0304-3940(83)90089-7; Nicholas AH, 2004, BRAIN RES, V1014, P110, DOI 10.1016/j.brainres.2004.03.066; Nucci C, 2003, EUR J OPHTHALMOL, V13, pS36; PARKS TN, 1978, J COMP NEUROL, V180, P439, DOI 10.1002/cne.901800303; PEUSNER KD, 1977, NEUROSCIENCE, V2, P253, DOI 10.1016/0306-4522(77)90092-6; RUBEL E W, 1991, Brain Dysfunction, V4, P55; RUBEL EW, 1992, J COMP NEUROL, V318, P415, DOI 10.1002/cne.903180406; Rubel EW, 2004, SPR HDB AUD, V23, P8; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; RUBEL EW, 1990, J NEUROBIOL, V21, P169, DOI 10.1002/neu.480210112; SKEEN LC, 1985, NEUROSCI LETT, V54, P301, DOI 10.1016/S0304-3940(85)80095-1; SMITH ZDJ, 1983, J COMP NEUROL, V220, P199, DOI 10.1002/cne.902200207; STEWARD O, 1985, J COMP NEUROL, V231, P385, DOI 10.1002/cne.902310308; Tierney TS, 1997, J COMP NEUROL, V387, P421; Turecek R, 2000, J NEUROSCI, V20, P2054; WARCHOL ME, 1990, J COMP PHYSIOL A, V166, P721; WEBSTER DB, 1977, ARCH OTOLARYNGOL, V103, P392; ZIRPEL L, 1995, J NEUROSCI, V15, P214; ZIRPEL L, 1995, J NEUROPHYSIOL, V74, P1355, DOI 10.1152/jn.1995.74.3.1355; Zirpel L, 1996, J NEUROPHYSIOL, V76, P4127, DOI 10.1152/jn.1996.76.6.4127; ZIRPEL L, 1994, NEUROSCI LETT, V168, P163, DOI 10.1016/0304-3940(94)90441-3	55	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111243	10.1371/journal.pone.0111243	http://dx.doi.org/10.1371/journal.pone.0111243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25334004	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200110
J	McLaughlin, D; Faller, E; Sugden, S; MacPherson, P				McLaughlin, Denny; Faller, Elliott; Sugden, Scott; MacPherson, Paul			Expression of the IL-7 Receptor Alpha-Chain Is Down Regulated on the Surface of CD4 T-Cells by the HIV-1 Tat Protein	PLOS ONE			English	Article							INTERLEUKIN-7 RECEPTOR; CD127 EXPRESSION; IL-7R-ALPHA EXPRESSION; INFECTED PATIENTS; LYMPHOCYTES; APOPTOSIS; DEPLETION; GROWTH; INTERNALIZATION; TRANSACTIVATOR	HIV infection elicits defects in CD4 T-cell homeostasis in both a quantitative and qualitative manner. Interleukin-7 (IL-7) is essential to T-cell homeostasis and several groups have shown reduced levels of the IL-7 receptor alpha-chain (CD127) on both CD4 and CD8 T-cells in viremic HIV+ patients. We have shown previously that soluble HIV Tat protein specifically down regulates cell surface expression of CD127 on human CD8 T-cells in a paracrine fashion. The effects of Tat on CD127 expression in CD4 T-cells has yet to be described. To explore this effect, CD4 T-cells were isolated from healthy individuals and expression levels of CD127 were examined on cells incubated in media alone or treated with Tat protein. We show here that, similar to CD8 T-cells, the HIV-1 Tat protein specifically down regulates CD127 on primary human CD4 T-cells and directs the receptor to the proteasome for degradation. Down regulation of CD127 in response to Tat was seen on both memory and naive CD4 T-cell subsets and was blocked using either heparin or anti-Tat antibodies. Tat did not induce apoptosis in cultured primary CD4 T-cells over 72 hours as determined by Annexin V and PI staining. Pre-incubation of CD4 T-cells with HIV-1 Tat protein did however reduce the ability of IL-7 to up regulate Bcl-2 expression. Similar to exogenous Tat, endogenously expressed HIV Tat protein also suppressed CD127 expression on primary CD4 T-cells. In view of the important role IL-7 plays in lymphocyte proliferation, homeostasis and survival, down regulation of CD127 by Tat likely plays a central role in immune dysregulation and CD4 T-cell decline. Understanding this effect could lead to new approaches to mitigate the CD4 T-cell loss evident in HIV infection.	[McLaughlin, Denny; Faller, Elliott; Sugden, Scott; MacPherson, Paul] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [MacPherson, Paul] Univ Ottawa, Fac Med, Dept Med, Ottawa, ON, Canada; [MacPherson, Paul] Ottawa Hosp Gen Campus, Div Infect Dis, Ottawa, ON, Canada; [Faller, Elliott; MacPherson, Paul] Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	MacPherson, P (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	pmacpherson@toh.on.ca			CIHR [200709HOP-180274-VVP-ADYP-39720]	CIHR(Canadian Institutes of Health Research (CIHR))	Funding for this study was provided by CIHR, grant number 200709HOP-180274-VVP-ADYP-39720 (http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 1996, ONCOGENE, V12, P289; Albuquerque AS, 2007, J IMMUNOL, V178, P3252, DOI 10.4049/jimmunol.178.5.3252; ALDERSON MR, 1990, J EXP MED, V172, P577, DOI 10.1084/jem.172.2.577; ARMITAGE RJ, 1990, J IMMUNOL, V144, P938; Bellino S, 2009, REV RECENT CLIN TRIA, V4, P195, DOI 10.2174/157488709789957529; Benito JM, 2008, J INFECT DIS, V198, P1466, DOI 10.1086/592716; Beq S, 2004, AIDS, V18, P563, DOI 10.1097/00002030-200402200-00025; Boutboul F, 2005, AIDS, V19, P1981, DOI 10.1097/01.aids.0000191919.24185.46; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Clark DR, 1999, ADV IMMUNOL, V73, P301, DOI 10.1016/S0065-2776(08)60789-0; Col E, 2001, J BIOL CHEM, V276, P28179, DOI 10.1074/jbc.M101385200; Colle JH, 2006, JAIDS-J ACQ IMM DEF, V42, P277, DOI 10.1097/01.qai.0000214823.11034.4e; Colle JH, 2006, CLIN EXP IMMUNOL, V143, P398, DOI 10.1111/j.1365-2249.2006.03022.x; Dabrowska A, 2008, TAT INDUCED FOXO3A K; Di Mascio M, 2009, BLOOD, V114, P328, DOI 10.1182/blood-2008-12-192203; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Dunham RM, 2008, J IMMUNOL, V180, P5582, DOI 10.4049/jimmunol.180.8.5582; EMBRETSON J, 1993, P NATL ACAD SCI USA, V90, P357, DOI 10.1073/pnas.90.1.357; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Faller EM, 2006, JAIDS-J ACQ IMM DEF, V43, P257, DOI 10.1097/01.qai.0000230319.78288.f4; Faller EM, 2010, J IMMUNOL, V185, P2854, DOI 10.4049/jimmunol.0902207; Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9; Fevrier M, 2011, VIRUSES-BASEL, V3, P586, DOI 10.3390/v3050586; Fittipaldi A, 2005, ADV DRUG DELIVER REV, V57, P597, DOI 10.1016/j.addr.2004.10.011; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gibellini D, 2001, CELL IMMUNOL, V207, P89, DOI 10.1006/cimm.2000.1746; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; HELLAND DE, 1991, J VIROL, V65, P4547, DOI 10.1128/JVI.65.8.4547-4549.1991; Huigen MCDG, 2004, EUR J CLIN INVEST, V34, P57, DOI 10.1111/j.1365-2362.2004.01282.x; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; JICHA DL, 1991, J EXP MED, V174, P1511, DOI 10.1084/jem.174.6.1511; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Koesters SA, 2006, EUR J IMMUNOL, V36, P336, DOI 10.1002/eji.200535111; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Lerner P, 2011, J VIROL, V85, P4772, DOI 10.1128/JVI.02409-10; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Mercier F, 2008, CLIN EXP IMMUNOL, V152, P72, DOI 10.1111/j.1365-2249.2008.03610.x; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Poggi A, 2004, BLOOD, V103, P2205, DOI 10.1182/blood-2003-08-2928; Pugliese A, 2005, CELL BIOCHEM FUNCT, V23, P223, DOI 10.1002/cbf.1147; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313; Sasson SC, 2006, CURR DRUG TARGETS, V7, P1571, DOI 10.2174/138945006779025365; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Soares MVD, 1998, J IMMUNOL, V161, P5909; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Vanderford TH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002048; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Vingerhoets J, 1998, IMMUNOL LETT, V61, P53, DOI 10.1016/S0165-2478(97)00162-4; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; WELCH PA, 1989, J IMMUNOL, V143, P3562; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Westermann J, 1998, GENE THER, V5, P264, DOI 10.1038/sj.gt.3300568	67	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111193	10.1371/journal.pone.0111193	http://dx.doi.org/10.1371/journal.pone.0111193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333710	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200105
J	Sawanobori, Y; Ueta, H; Dijkstra, CD; Park, CG; Satou, M; Kitazawa, Y; Matsuno, K				Sawanobori, Yasushi; Ueta, Hiashi; Dijkstra, Christine D.; Park, Chae Gyu; Satou, Motoyasu; Kitazawa, Yusuke; Matsuno, Kenjiro			Three Distinct Subsets of Thymic Epithelial Cells in Rats and Mice Defined by Novel Antibodies	PLOS ONE			English	Article							THYMOMA BUF/MNA RATS; VERSUS-HOST-DISEASE; DENDRITIC CELLS; NURSE CELLS; T-CELLS; CENTRAL TOLERANCE; IMMUNE DEVIATION; LYMPHOID ORGANS; MICROENVIRONMENT; DIFFERENTIATION	Aim: Thymic epithelial cells (TECs) are thought to play an essential role in T cell development and have been detected mainly in mice using lectin binding and antibodies to keratins. Our aim in the present study was to create a precise map of rat TECs using antibodies to putative markers and novel monoclonal antibodies (i.e., ED 18/19/21 and anti-CD205 antibodies) and compare it with a map from mouse counterparts and that of rat thymic dendritic cells. Results: Rat TECs were subdivided on the basis of phenotype into three subsets; ED18(+)ED19(+/-) keratin 5 (K5)(+)K(8+)CD205(+) class II MHC (MHCII)(+) cortical TECs (cTECs), ED18(+)ED21(-)K5(-)K8(+)Ulex europaeus lectin 1 (UEA-1)(+)CD205(-) medullary TECs (mTEC1s), and ED18(+)ED21(+)K5(+)K8(dull)UEA-1(-)CD205(-) medullary TECs (mTEC2s). Thymic nurse cells were defined in cytosmears as an ED18(+)ED19(+/-)K5(+)K8(+) subset of cTECs. mTEC1s preferentially expressed MHCII, claudin-3, claudin-4, and autoimmune regulator (AIRE). Use of ED18 and ED21 antibodies revealed three subsets of TECs in mice as well. We also detected two distinct TEC-free areas in the subcapsular cortex and in the medulla. Rat dendritic cells in the cortex were MHCII(+)CD103(+) but negative for TEC markers, including CD205. Those in the medulla were MHCII(+)CD103(+) and CD205(+) cells were found only in the TEC-free area. Conclusion: Both rats and mice have three TEC subsets with similar phenotypes that can be identified using known markers and new monoclonal antibodies. These findings will facilitate further analysis of TEC subsets and DCs and help to define their roles in thymic selection and in pathological states such as autoimmune disorders.	[Sawanobori, Yasushi; Ueta, Hiashi; Kitazawa, Yusuke; Matsuno, Kenjiro] Dokkyo Med Univ, Dept Anat Macro, Mibu, Tochigi, Japan; [Dijkstra, Christine D.] Vrije Univ Amsterdam, Med Ctr Amsterdam, Amsterdam, Netherlands; [Park, Chae Gyu] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Immunol Lab,Brain Korea PLUS Project Med Sci 21, Seoul 120749, South Korea; [Satou, Motoyasu] Dokkyo Med Univ, Dept Biochem, Mibu, Tochigi, Japan	Dokkyo Medical University; Vrije Universiteit Amsterdam; Yonsei University; Yonsei University Health System; Dokkyo Medical University	Matsuno, K (corresponding author), Dokkyo Med Univ, Dept Anat Macro, Mibu, Tochigi, Japan.	kenjiro@dokkyomed.ac.jp	UETA, HISASHI/AAJ-1695-2020; Ueta, Hisashi/S-2314-2018	UETA, HISASHI/0000-0003-2237-2262; Ueta, Hisashi/0000-0003-2237-2262; Park, Chae Gyu/0000-0003-1906-1308	Japan Society for the Promotion of Science KAKENHI [26860138]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 26860138 (http://www.jsps.go.jp/english/index.html) and by an official donation from Mr. Jin Sasanuma (no conflict of interest). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS B, 1988, IMMUNOGENETICS, V27, P180, DOI 10.1007/BF00346584; BRUIJNTJES JP, 1993, DEV IMMUNOL, V3, P113, DOI 10.1155/1993/90759; Chiffoleau E, 2002, J IMMUNOL, V168, P5058, DOI 10.4049/jimmunol.168.10.5058; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Dooley J, 2008, J IMMUNOL, V181, P5225, DOI 10.4049/jimmunol.181.8.5225; Ezaki T, 1997, ARCH HISTOL CYTOL, V60, P39, DOI 10.1679/aohc.60.39; EZAKI T, 1991, IMMUNOLOGY, V73, P151; FARR AG, 1985, J IMMUNOL, V134, P2971; Goverman J, 1997, IMMUNOL TODAY, V18, P204; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; Kuo T, 2000, HISTOPATHOLOGY, V36, P403; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; KYEWSKI BA, 1982, J IMMUNOL, V128, P2287; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lee EN, 2011, ANAT CELL BIOL, V44, P14, DOI 10.5115/acb.2011.44.1.14; Li B, 2011, CLIN IMMUNOL, V140, P244, DOI 10.1016/j.clim.2011.04.004; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Nakagawa Y, 2012, P NATL ACAD SCI USA, V109, P20572, DOI 10.1073/pnas.1213069109; Nonaka D, 2007, AM J SURG PATHOL, V31, P1038, DOI 10.1097/PAS.0b013e31802b4917; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Park CG, 2012, J IMMUNOL METHODS, V377, P15, DOI 10.1016/j.jim.2011.12.009; Pearse G, 2006, TOXICOL PATHOL, V34, P504, DOI 10.1080/01926230600865549; Popa I, 2007, INT IMMUNOL, V19, P1249, DOI 10.1093/intimm/dxm092; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; RITTER MA, 1981, IMMUNOLOGY, V44, P439; Sakoda Y, 2007, BLOOD, V109, P1756, DOI 10.1182/blood-2006-08-042853; Shrimpton RE, 2009, MOL IMMUNOL, V46, P1229, DOI 10.1016/j.molimm.2008.11.016; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; SWIGGARD WJ, 1995, CELL IMMUNOL, V165, P302, DOI 10.1006/cimm.1995.1218; Teshima T, 2003, BLOOD, V102, P429, DOI 10.1182/blood-2003-01-0266; Ueta H, 2008, HEPATOLOGY, V47, P1352, DOI 10.1002/hep.22161; Wang YF, 2001, J LEUKOCYTE BIOL, V69, P741; Wang YF, 1997, J IMMUNOL, V158, P2150; WEKERLE H, 1980, J EXP MED, V151, P925, DOI 10.1084/jem.151.4.925; WEKERLE H, 1980, NATURE, V283, P402, DOI 10.1038/283402a0; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; Zhou S, 2008, INT IMMUNOL, V20, P385, DOI 10.1093/intimm/dxm153	42	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109995	10.1371/journal.pone.0109995	http://dx.doi.org/10.1371/journal.pone.0109995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25334032	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200024
J	Zhao, C; Ji, NJ; Sun, P; Feng, WP; Wei, J; Chang, YQ				Zhao, Chong; Ji, Nanjing; Sun, Ping; Feng, Wenping; Wei, Jing; Chang, Yaqing			Effects of Light and Covering Behavior on PAX6 Expression in the Sea Urchin Strongylocentrotus intermedius	PLOS ONE			English	Article							TUBE FEET; DROSOPHILA; DROEBACHIENSIS; PHOTORECEPTORS; RHODOPSIN; GENES	We studied the diel expression pattern of PAX6 (a structural gene that is commonly involved in the eye development and photoreception of eye forming animals) and the effects of light and covering behavior on PAX6 expression in the sea urchin Strongylocentrotus intermedius. We confirmed that aphotic condition significantly reduced covering behavior in S. intermedius. The diel expression pattern of PAX6 was significantly different in S. intermedius under photic and aphotic conditions. The gene expression of PAX6 significantly deceased in covered S. intermedius both under natural light and in darkness. The present finding provides valuable insight into the probable link between covering and PAX6 expression of sea urchins. Further studies are required to investigate the detailed expression network of light detection involved genes in order to fully reveal the molecular mechanism of the light-induced covering behavior of sea urchins.	[Zhao, Chong; Ji, Nanjing; Sun, Ping; Feng, Wenping; Wei, Jing; Chang, Yaqing] Dalian Ocean Univ, Key Lab Mariculture & Stock Enhancement North Chi, Minist Agr, Dalian, Peoples R China; [Zhao, Chong] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China	Dalian Ocean University; Ministry of Agriculture & Rural Affairs; Ocean University of China	Chang, YQ (corresponding author), Dalian Ocean Univ, Key Lab Mariculture & Stock Enhancement North Chi, Minist Agr, Dalian, Peoples R China.	changlab@hotmail.com		Feng, Wenping/0000-0003-1768-8721	Chinese National 863 Project [2012AA10A412]	Chinese National 863 Project	This work was supported by the Chinese National 863 Project (2012AA10A412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NL, 2001, MAR ECOL PROG SER, V213, P87, DOI 10.3354/meps213087; Agatsuma Y, 2013, DEV AQUAC FISH SCI, V38, P437, DOI 10.1016/B978-0-12-396491-5.00028-9; Dumont CP, 2007, ANIM BEHAV, V73, P979, DOI 10.1016/j.anbehav.2006.11.008; Kehas AJ, 2005, MAR BIOL, V146, P1111, DOI 10.1007/s00227-004-1514-4; Kim KC, 2014, MOL NEUROBIOL, V49, P512, DOI 10.1007/s12035-013-8535-2; Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3; Lesser MP, 2011, P ROY SOC B-BIOL SCI, V278, P3371, DOI 10.1098/rspb.2011.0336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ooka S, 2010, DEV GROWTH DIFFER, V52, P195, DOI 10.1111/j.1440-169X.2009.01154.x; Pawson DL, 2013, DEEP-SEA RES PT II, V92, P207, DOI 10.1016/j.dsr2.2013.01.023; Pennisi E, 2013, SCIENCE, V339, P754, DOI 10.1126/science.339.6121.754; Raible F, 2006, DEV BIOL, V300, P461, DOI 10.1016/j.ydbio.2006.08.070; Senthilan PR, 2012, CELL, V150, P1042, DOI 10.1016/j.cell.2012.06.043; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Sigg JE, 2007, J MAR BIOL ASSOC UK, V87, P1257, DOI 10.1017/S0025315407055865; Ullrich-Luter EM, 2011, P NATL ACAD SCI USA, V108, P8367, DOI 10.1073/pnas.1018495108; Verling E, 2002, MAR BIOL, V140, P391, DOI 10.1007/s002270100689; Zhou Zun-Chun, 2008, Yichuan, V30, P1453, DOI 10.3724/SP.J.1005.2008.01453	19	4	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110895	10.1371/journal.pone.0110895	http://dx.doi.org/10.1371/journal.pone.0110895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333874	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200086
J	Gao, L; Zhang, M; Zhao, WY; Hao, L; Chen, HC; Zhang, R; Batzer, JC; Gleason, ML; Sun, GY				Gao, Liu; Zhang, Mian; Zhao, Wanyu; Hao, Lu; Chen, Hongcai; Zhang, Rong; Batzer, Jean C.; Gleason, Mark L.; Sun, Guangyu			Molecular and Morphological Analysis Reveals Five New Species of Zygophiala Associated with Flyspeck Signs on Plant Hosts from China	PLOS ONE			English	Article							SOOTY BLOTCH; PRIMER SETS; APPLE; COMPLEX; FUNGI; DIVERSITY	Species in the genus Zygophiala are associated with sooty blotch and flyspeck disease on a wide range of hosts. In this study, 63 Zygophiala isolates collected from flyspeck colonies on a range of plants from several regions of China were used for phylogeny, host range and geographic distribution analysis. Phylogenetic trees were constructed on four genes internal transcribed spacer (ITS), partial translation elongation factor 1-alpha (TEF), beta-tubulin (TUB2), and actin (ACT) - both individually and in combination. Isolates were grouped into 11 clades among which five new species, Z. emperorae, Z. trispora, Z. musae, Z. inaequalis and Z. longispora, were described. Species of Zygophiala differed in observed host range and geographic distribution. Z. wisconsinensis and Z. emperorae were the most prevalent throughout the sampled regions of China, whereas Z. trispora, Z. musae, Z. inaequalis and Z. longispora were collected only in southern China. The hosts of Z. wisconsinensis and Z. emperorae were mainly in the family Rosaceae whereas Z. trispora, Z. musae, Z. inaequalis and Z. longispora were found mainly on banana (Musa spp.). Cross inoculation tests provided evidence of host specificity among SBFS species.	[Gao, Liu; Zhang, Mian; Zhao, Wanyu; Hao, Lu; Chen, Hongcai; Zhang, Rong; Sun, Guangyu] Northwest A&F Univ, Dept State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi Provinc, Peoples R China; [Gao, Liu; Zhang, Mian; Zhao, Wanyu; Hao, Lu; Chen, Hongcai; Zhang, Rong; Sun, Guangyu] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi Provinc, Peoples R China; [Batzer, Jean C.; Gleason, Mark L.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA	Northwest A&F University - China; Northwest A&F University - China; Iowa State University	Sun, GY (corresponding author), Northwest A&F Univ, Dept State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi Provinc, Peoples R China.	sgy@nwsuaf.edu.cn	gao, Liu/AAH-5970-2019		National Natural Science Foundation of China [31170015, 31171797]; 111 Project from Education Ministry of China [B07049]; earmarked fund for China Agriculture Research System [CARS-28]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project from Education Ministry of China(Ministry of Education, China - 111 Project); earmarked fund for China Agriculture Research System	This work was supported by the National Natural Science Foundation of China (31170015, 31171797), the 111 Project from Education Ministry of China (B07049), the earmarked fund for China Agriculture Research System (CARS-28), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias MMD, 2010, PHYTOPATHOLOGY, V100, P345, DOI 10.1094/PHYTO-100-4-0345; BAINES RC, 1940, PHYTOPATHOLOGY, V30, P2; BAKER KF, 1977, PHYTOPATHOLOGY, V67, P580, DOI 10.1094/Phyto-67-580; Batzer JC, 2008, MYCOLOGIA, V100, P246, DOI 10.3852/mycologia.100.2.246; Batzer JC, 2005, MYCOLOGIA, V97, P1268, DOI 10.3852/mycologia.97.6.1268; Bensch K, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.67.01; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; COLBY AS, 1920, T ILLINOIS STATE ACA, V13, P139; Crous PW, 2004, STUD MYCOL, P19; DURBIN RD, 1953, PHYTOPATHOLOGY, V43, P470; Gao L, 2014, EUR J PLANT PATHOL, V139, P117, DOI 10.1007/s10658-013-0370-9; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Gleason ML, 2011, PLANT DIS, V95, P368, DOI 10.1094/PDIS-08-10-0590; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Ivanovic MM, 2010, J PLANT PATHOL, V92, P65; Kim J, 2011, PLANT DIS, V95, P616, DOI 10.1094/PDIS-12-10-0917; Latinovic J, 2007, PLANT DIS, V91, P1685, DOI 10.1094/PDIS-91-12-1685B; Li HY, 2011, FUNGAL DIVERS, V46, P53, DOI 10.1007/s13225-010-0074-9; Li HY, 2010, MYCOL PROG, V9, P245, DOI 10.1007/s11557-009-0633-1; Ma YQ, 2010, MYCOL PROG, V9, P151, DOI 10.1007/s11557-009-0635-z; Martyn EB, 1945, MYCOL PAP, V13, P1; Mayfield DA, 2013, EUR J PLANT PATHOL, V135, P805, DOI 10.1007/s10658-012-0123-1; NASU H, 1987, PLANT DIS, V71, P361, DOI 10.1094/PD-71-0361; Nylander J. A. A., 2004, MRMODELTEST V2; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHWEINITZ LD, 1834, T AM PHILOS SOC NS, V4, P232; SUN G, 2008, PHYTOPATHOLOGY S, V98, pS153; Sun GuangYu, 2003, Acta Phytopathologica Sinica, V33, P479; SUTTON TB, 1988, PLANT DIS, V72, P801, DOI 10.1094/PD-72-0801B; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Williamson SM, 2000, PLANT DIS, V84, P714, DOI 10.1094/PDIS.2000.84.7.714; Yang HL, 2010, PERSOONIA, V24, P29, DOI 10.3767/003158510X492101; Zhai XR, 2008, MYCOTAXON, V105, P325	38	8	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110717	10.1371/journal.pone.0110717	http://dx.doi.org/10.1371/journal.pone.0110717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329930	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100089
J	Ji, XM; Zhang, WD; Gui, J; Fan, X; Zhang, WW; Li, YF; An, GY; Zhu, DK; Hu, Q				Ji, Xuemei; Zhang, Weidong; Gui, Jiang; Fan, Xia; Zhang, Weiwei; Li, Yafang; An, Guangyu; Zhu, Dakai; Hu, Qiang			Role of a Genetic Variant on the 15q25.1 Lung Cancer Susceptibility Locus in Smoking-Associated Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CIGARETTE-SMOKING; NICOTINE DEPENDENCE; TOBACCO SMOKING; FAMILY-HISTORY; EPIDEMIOLOGIC EVIDENCE; CELL-PROLIFERATION; RISK; EXPRESSION; RECEPTORS; SURVIVAL	Background: The 15q25.1 lung cancer susceptibility locus, containing CHRNA5, could modify lung cancer susceptibility and multiple smoking related phenotypes. However, no studies have investigated the association between CHRNA5 rs3841324, which has been proven to have the highest association with CHRNA5 mRNA expression, and the risk of other smoking-associated cancers, except lung cancer. In the current study we examined the association between rs3841324 and susceptibility to smoking-associated nasopharyngeal carcinoma (NPC). Methods: In this case-control study we genotyped the CHRNA5 rs3841324 polymorphism with 400 NPC cases and 491 healthy controls who were Han Chinese and frequency-matched by age (+/- 5 years), gender, and alcohol consumption. Univariate and multivariate logistic regression analyses were used to calculate the odds ratio (OR) and 95% confidence intervals (95% CI). Results: We found that individuals with CHRNA5 rs3841324 combined variant genotypes (ins/del+del/del) had a >1.5-fold elevated risk for NPC than those with the ins/ins genotype (adjusted OR = 1.52; 95% CI, 1.16-2.00), especially among ever smokers (adjusted OR = 2.07; 95% CI, 1.23-3.48). The combined variant genotypes acted jointly with cigarette smoking to contribute to a 4.35-fold increased NPC risk (adjusted OR = 4.35; 95% CI, 2.57-7.38). There was a dose-response relationship between deletion alleles and NPC susceptibility (trend test, P = 0.011). Conclusions: Our results suggest that genetic variants on the 15q25.1 lung cancer susceptibility locus may influence susceptibility to NPC, particularly for smoking-associated NPC. Such work may be helpful to facilitate an understanding of the etiology of smoking-associated cancers and improve prevention efforts.	[Ji, Xuemei; Hu, Qiang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Radiat Oncol, Beijing, Peoples R China; [Ji, Xuemei; Gui, Jiang; Li, Yafang; Zhu, Dakai] Dartmouth Coll, Geisel Sch Med Dartmouth, Dept Community & Family Med, Hanover, NH 03755 USA; [Zhang, Weidong; Fan, Xia] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430072, Peoples R China; [Zhang, Weiwei] Binzhou Med Univ, Dept Anesthesia, Binzhou, Peoples R China; [An, Guangyu] Capital Med Univ, Beijing Chaoyang Hosp, Dept Oncol, Beijing, Peoples R China	Capital Medical University; Dartmouth College; Wuhan University; Binzhou Medical University; Capital Medical University	Ji, XM (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Radiat Oncol, Beijing, Peoples R China.	xuemei.ji@yahoo.com	Ji, Xuemei/B-9774-2015	Ji, Xuemei/0000-0001-7416-9122	National Natural Science Foundation of China [81101561]; UICC American Cancer Society Beginning Investigators Fellowship - American Cancer Society; Beijing Natural Science Foundation; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); UICC American Cancer Society Beginning Investigators Fellowship - American Cancer Society; Beijing Natural Science Foundation(Beijing Natural Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Natural Science Foundation of China (81101561) to Xuemei Ji; UICC American Cancer Society Beginning Investigators Fellowship funded by the American Cancer Society to Xuemei Ji.; Beijing Natural Science Foundation to Xuemei Ji. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Benowitz NL, 1996, ANNU REV PHARMACOL, V36, P597, DOI 10.1146/annurev.pa.36.040196.003121; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Boffetta P, 2008, SCAND J UROL NEPHROL, V42, P45, DOI 10.1080/03008880802283664; BURT RD, 1992, INT J CANCER, V52, P549, DOI 10.1002/ijc.2910520409; Carlsten C, 2006, JAMA-J AM MED ASSOC, V296, P2480, DOI 10.1001/jama.296.20.2480; Chen JY, 2011, PANCREAS, V40, P872, DOI 10.1097/MPA.0b013e318219dafe; Coker AL, 2009, GYNECOL ONCOL, V112, P365, DOI 10.1016/j.ygyno.2008.10.013; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; De Stefani E, 1998, ORAL ONCOL, V34, P340, DOI 10.1016/S1368-8375(98)00014-1; Doyle GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023373; Fehringer G, 2012, CANCER EPIDEM BIOMAR, V21, P1097, DOI 10.1158/1055-9965.EPI-11-1123-T; Hsu WL, 2009, CANCER EPIDEM BIOMAR, V18, P1218, DOI 10.1158/1055-9965.EPI-08-1175; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Ji XM, 2011, INT J CANCER, V129, P724, DOI 10.1002/ijc.25696; Levi F, 2001, ANN ONCOL, V12, P733, DOI 10.1023/A:1011124523984; Liang PS, 2009, INT J CANCER, V124, P2406, DOI 10.1002/ijc.24191; Lin J, 2006, CANCER-AM CANCER SOC, V107, P705, DOI 10.1002/cncr.22071; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Loh KS, 2006, ARCH OTOLARYNGOL, V132, P82, DOI 10.1001/archotol.132.1.82; Lynch SM, 2009, AM J EPIDEMIOL, V170, P403, DOI 10.1093/aje/kwp134; Merimsky O, 1998, CLIN DERMATOL, V16, P585, DOI 10.1016/S0738-081X(98)00043-1; Morabia A, 2002, ENVIRON MOL MUTAGEN, V39, P89, DOI 10.1002/em.10046; NAM JM, 1992, J NATL CANCER I, V84, P619, DOI 10.1093/jnci/84.8.619; OSANN KE, 1991, CANCER RES, V51, P4893; Oze I, 2012, JPN J CLIN ONCOL, V42, P63, DOI 10.1093/jjco/hyr170; Saccone NL, 2009, AM J MED GENET B, V150B, P453, DOI 10.1002/ajmg.b.30828; Sherva R, 2010, NEUROPSYCHOPHARMACOL, V35, P1921, DOI 10.1038/npp.2010.64; Takahashi I, 2008, PUBLIC HEALTH, V122, P891, DOI 10.1016/j.puhe.2007.10.004; Tavani A, 2000, CONTRIB NEPHROL, V130, P11, DOI 10.1159/000060038; Tekpli X, 2013, INT J CANCER, V132, P1811, DOI 10.1002/ijc.27870; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Wang JC, 2009, HUM MOL GENET, V18, P3125, DOI 10.1093/hmg/ddp231; Wei CJ, 2011, CANCER EPIDEM BIOMAR, V20, P2603, DOI 10.1158/1055-9965.EPI-11-0749; *WHO, 2006, FACTS SMOK HLTH; Zhang HP, 2010, NEUROPSYCHOPHARMACOL, V35, P2211, DOI 10.1038/npp.2010.95; Zheng X, 2011, CANCER-AM CANCER SOC, V117, P4714, DOI 10.1002/cncr.26017	41	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109036	10.1371/journal.pone.0109036	http://dx.doi.org/10.1371/journal.pone.0109036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329654	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100016
J	Costa-Malaquias, A; Almeida, MB; Monteiro, JRS; Macchi, BDM; do Nascimento, JLM; Crespo-Lopez, ME				Costa-Malaquias, Allan; Almeida, Mauro B.; Souza Monteiro, Jose R.; Macchi, Barbarella de Matos; do Nascimento, Jose Luiz M.; Crespo-Lopez, Maria Elena			Morphine Protects against Methylmercury Intoxication: A Role for Opioid Receptors in Oxidative Stress?	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INDUCED DEATH; CELL-DEATH; LOW-LEVEL; MERCURY; NEUROTOXICITY; GENOTOXICITY; GLUTATHIONE; GLUTAMATE; TOXICITY	Mercury is an extremely dangerous environmental contaminant responsible for episodes of human intoxication throughout the world. Methylmercury, the most toxic compound of this metal, mainly targets the central nervous system, accumulating preferentially in cells of glial origin and causing oxidative stress. Despite studies demonstrating the current exposure of human populations, the consequences of mercury intoxication and concomitant use of drugs targeting the central nervous system (especially drugs used in long-term treatments, such as analgesics) are completely unknown. Morphine is a major option for pain management; its global consumption more than quadrupled in the last decade. Controversially, morphine has been proposed to function in oxidative stress independent of the activation of the opioid receptors. In this work, a therapeutic concentration of morphine partially protected the cellular viability of cells from a C6 glioma cell line exposed to methylmercury. Morphine treatment also reduced lipid peroxidation and totally prevented increases in nitrite levels in those cells. A mechanistic study revealed no alteration in sulfhydryl groups or direct scavenging at this opioid concentration. Interestingly, the opioid antagonist naloxone completely eliminated the protective effect of morphine against methylmercury intoxication, pointing to opioid receptors as the major contributor to this action. Taken together, the experiments in the current study provide the first demonstration that a therapeutic concentration of morphine is able to reduce methylmercury-induced oxidative damage and cell death by activating the opioid receptors. Thus, these receptors may be a promising pharmacological target for modulating the deleterious effects of mercury intoxication. Although additional studies are necessary, our results support the clinical safety of using this opioid in methylmercury-intoxicated patients, suggesting that normal analgesic doses could confer an additional degree of protection against the cytotoxicity of this xenobiotic.	[Costa-Malaquias, Allan; Almeida, Mauro B.; Souza Monteiro, Jose R.; Crespo-Lopez, Maria Elena] Univ Fed Para UFPA, Inst Ciencias Biol, Lab Farmacol Mol, Belem, Para, Brazil; [Macchi, Barbarella de Matos; do Nascimento, Jose Luiz M.] Univ Fed Para UFPA, Inst Ciencias Biol, Lab Neuroquim Mol & Celular, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para	Crespo-Lopez, ME (corresponding author), Univ Fed Para UFPA, Inst Ciencias Biol, Lab Farmacol Mol, Belem, Para, Brazil.	maria.elena.crespo.lopez@gmail.com	Crespo-Lopez, Maria Elena/X-7912-2018; Macchi, Barbarella/ACM-9455-2022	Crespo-Lopez, Maria Elena/0000-0002-1335-6853; Macchi, Barbarella/0000-0002-8667-1942; do Nascimento, jose/0000-0003-3647-9124	Conselho Nacional de Ciencia e Tecnologia em Pesquisa [478580/2012-6]	Conselho Nacional de Ciencia e Tecnologia em Pesquisa	The work was supported by the following: CRISTALIA (www.2cristalia.com.br/) - donation of morphine; Conselho Nacional de Ciencia e Tecnologia em Pesquisa (www.cnpq.br) - grant number #478580/2012-6; Pro-Reitoria de Pesquisa/Universidade Federal do Para (www.propesp.ufpa.br) - revision and publication fee payments; and Fundacao Amazonia Paraense (www.fapespa.pa.gov.br/) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) - PhD fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Zaher AO, 2013, BEHAV BRAIN RES, V247, P17, DOI 10.1016/j.bbr.2013.02.034; Almeida MB, 2014, BRAZ J MED BIOL RES, V47, P398, DOI 10.1590/1414-431X20143697; Aschner M, 2007, BRAZ J MED BIOL RES, V40, P285, DOI 10.1590/S0100-879X2007000300001; Belletti S, 2002, J NEUROSCI RES, V70, P703, DOI 10.1002/jnr.10419; Nevado JJB, 2010, ENVIRON INT, V36, P593, DOI 10.1016/j.envint.2010.03.011; Nevado JJB, 2009, MICROCHEM J, V93, P12, DOI 10.1016/j.microc.2009.03.008; Bird R.P, 1984, METHODS ENZYMOL, V90, P105, DOI DOI 10.1016/S0076-6879(84)05038-2; Bohn LM, 1998, J NEUROCHEM, V70, P1819; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carta P, 2003, NEUROTOXICOLOGY, V24, P617, DOI 10.1016/S0161-813X(03)00080-9; Chang JY, 2008, NEUROTOXICOLOGY, V29, P1054, DOI 10.1016/j.neuro.2008.08.003; Cookson MR, 1996, TOXICOL IN VITRO, V10, P257, DOI 10.1016/0887-2333(96)00012-4; Crespo-Lopez ME, 2007, ENVIRON INT, V33, P141, DOI 10.1016/j.envint.2006.08.005; Crespo-Lopez ME, 2011, ENVIRON INT, V37, P136, DOI 10.1016/j.envint.2010.08.009; Crespo-Lopez ME, 2009, PHARMACOL RES, V60, P212, DOI 10.1016/j.phrs.2009.02.011; do Nascimento JLM, 2008, INDIAN J MED RES, V128, P373; Ekstrom EB, 2008, ENVIRON SCI TECHNOL, V42, P93, DOI 10.1021/es0705644; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; Farina M, 2011, TOXICOL APPL PHARM, V256, P405, DOI 10.1016/j.taap.2011.05.001; Feng Y, 2008, LIFE SCI, V82, P752, DOI 10.1016/j.lfs.2008.01.004; Gibb H., 2014, ENV HLTH PERSPECT; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gulcin I, 2004, PHARMACOL RES, V49, P59, DOI 10.1016/j.phrs.2003.07.012; Guzman DC, 2006, NEUROCHEM RES, V31, P549, DOI 10.1007/s11064-006-9053-7; Harris HH, 2003, SCIENCE, V301, P1203, DOI 10.1126/science.1085941; Herculano AM, 2006, BRAZ J MED BIOL RES, V39, P415, DOI 10.1590/S0100-879X2006000300013; ICBN, 2013, REP INT NARC CONTR B, P146; Kanesaki T, 1999, EUR J PHARMACOL, V372, P319, DOI 10.1016/S0014-2999(99)00206-X; Karagas MR, 2012, ENVIRON HEALTH PERSP, V120, P799, DOI 10.1289/ehp.1104494; Kaur P, 2008, TOXICOL IN VITRO, V22, P1392, DOI 10.1016/j.tiv.2008.01.017; Kaur P, 2010, TOXICOLOGY, V276, P73, DOI 10.1016/j.tox.2010.07.006; Lee J, 2004, IMMUNOPHARM IMMUNOT, V26, P17, DOI 10.1081/IPH-120029941; Linden A, 2008, TOXICOL IN VITRO, V22, P1371, DOI 10.1016/j.tiv.2008.02.003; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NEUMANN PB, 1982, PAIN, V13, P247, DOI 10.1016/0304-3959(82)90014-8; Ni MW, 2011, GLIA, V59, P810, DOI 10.1002/glia.21153; Ozmen I, 2007, NEUROCHEM RES, V32, P19, DOI 10.1007/s11064-006-9217-5; Qian L, 2007, J IMMUNOL, V179, P1198, DOI 10.4049/jimmunol.179.2.1198; Martin-Doimeadios RC, 2014, ENVIRON SCI POLLUT R, V21, P7466, DOI 10.1007/s11356-014-2680-7; Rozisky JR, 2013, NEUROCHEM RES, V38, P494, DOI 10.1007/s11064-012-0941-8; Safeliu C, 2001, NEUROTOXICOLOGY, V22, P317, DOI 10.1016/S0161-813X(01)00015-8; Sen CK, 1997, J NUTR BIOCHEM, V8, P660, DOI 10.1016/S0955-2863(97)00113-7; Trescot AM, 2008, PAIN PHYSICIAN, V11, pS5; Yamashita T, 1997, BBA-GEN SUBJECTS, V1334, P303, DOI 10.1016/S0304-4165(96)00108-0; Zhou JQ, 2011, NEUROTOX RES, V20, P334, DOI 10.1007/s12640-011-9247-x	46	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110815	10.1371/journal.pone.0110815	http://dx.doi.org/10.1371/journal.pone.0110815			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330195	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100108
J	Jacobs, C; Graham, ID; Makarski, J; Chasse, M; Fergusson, D; Hutton, B; Clemons, M				Jacobs, Carmel; Graham, Ian D.; Makarski, Julie; Chasse, Michael; Fergusson, Dean; Hutton, Brian; Clemons, Mark			Clinical Practice Guidelines and Consensus Statements in Oncology - An Assessment of Their Methodological Quality	PLOS ONE			English	Article							CANCER AMERICAN SOCIETY; CELL LUNG-CANCER; INDUCED FEBRILE NEUTROPENIA; ONTARIO PRACTICE GUIDELINE; COLONY-STIMULATING FACTOR; CONFLICTS-OF-INTEREST; SOFT-TISSUE SARCOMA; LYMPH-NODE BIOPSY; COLORECTAL-CANCER; GROWTH-FACTOR	Background: Consensus statements and clinical practice guidelines are widely available for enhancing the care of cancer patients. Despite subtle differences in their definition and purpose, these terms are often used interchangeably. We systematically assessed the methodological quality of consensus statements and clinical practice guidelines published in three commonly read, geographically diverse, cancer-specific journals. Methods Consensus statements and clinical practice guidelines published between January 2005 and September 2013 in Current Oncology, European Journal of Cancer and Journal of Clinical Oncology were evaluated. Each publication was assessed using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) rigour of development and editorial independence domains. For assessment of transparency of document development, 7 additional items were taken from the Institute of Medicine's standards for practice guidelines and the Journal of Clinical Oncology guidelines for authors of guidance documents. Methods: Consensus statements and clinical practice guidelines published between January 2005 and September 2013 in Current Oncology, European Journal of Cancer and Journal of Clinical Oncology were evaluated. Each publication was assessed using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) rigour of development and editorial independence domains. For assessment of transparency of document development, 7 additional items were taken from the Institute of Medicine's standards for practice guidelines and the Journal of Clinical Oncology guidelines for authors of guidance documents. Findings: Thirty-four consensus statements and 67 clinical practice guidelines were evaluated. The rigour of development score for consensus statements over the three journals was 32% lower than that of clinical practice guidelines. The editorial independence score was 15% lower for consensus statements than clinical practice guidelines. One journal scored consistently lower than the others over both domains. No journals adhered to all the items related to the transparency of document development. One journal's consensus statements endorsed a product made by the sponsoring pharmaceutical company in 64% of cases. Conclusion: Guidance documents are an essential part of oncology care and should be subjected to a rigorous and validated development process. Consensus statements had lower methodological quality than clinical practice guidelines using AGREE II. At a minimum, journals should ensure that that all consensus statements and clinical practice guidelines adhere to AGREE II criteria. Journals should consider explicitly requiring guidelines to declare pharmaceutical company sponsorship and to identify the sponsor's product to enhance transparency.	[Jacobs, Carmel; Clemons, Mark] Ottawa Hosp, Ctr Canc, Div Med Oncol, Ottawa, ON, Canada; [Jacobs, Carmel; Graham, Ian D.; Fergusson, Dean; Clemons, Mark] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Graham, Ian D.; Chasse, Michael; Fergusson, Dean; Hutton, Brian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Graham, Ian D.; Fergusson, Dean; Clemons, Mark] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Makarski, Julie] Independent Consultant, Hamilton, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Jacobs, C (corresponding author), Ottawa Hosp, Ctr Canc, Div Med Oncol, Ottawa, ON, Canada.	cjacobs@toh.on.ca	Chassé, Michaël/L-7906-2017; Chassé, Michaël/Y-7820-2019; Graham, Ian D./ABD-5259-2021	Chassé, Michaël/0000-0001-7075-1924; Graham, Ian D./0000-0002-3669-1216; Hutton, Brian/0000-0001-5662-8647; Jacobs, Carmel/0000-0001-5178-7307; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research (CHIR) [FRN: IOP 123548]	Canadian Institutes of Health Research (CHIR)(Canadian Institutes of Health Research (CIHR))	IG received funding from the Canadian Institutes of Health Research (CHIR) number; FRN: IOP 123548 (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro MS, 2006, EUR J CANCER, V42, P2433, DOI 10.1016/j.ejca.2006.05.002; Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; Amant F, 2010, EUR J CANCER, V46, P3158, DOI 10.1016/j.ejca.2010.09.010; American Society of Clinical Oncology, 2013, CONFL INT POL IMPL C; [Anonymous], 2009, MOSBYS MED DICT, V8th; Asmis T, 2010, CURR ONCOL, V17, P6; Aubin F, 2011, CURR ONCOL, V18, pE180; Azzoli CG, 2011, J CLIN ONCOL, V29, P3825, DOI 10.1200/JCO.2010.34.2774; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI [10.1200/JCO.2010.34.4614, 10.1200/JOP.2011.000397]; Basch EM, 2007, J CLIN ONCOL, V25, P5313, DOI 10.1200/JCO.2007.13.4536; Becker G, 2006, EUR J CANCER, V42, P589, DOI 10.1016/j.ejca.2005.11.018; Bokemeyer C, 2007, EUR J CANCER, V43, P258, DOI 10.1016/j.ejca.2006.10.014; Brock PR, 2012, J CLIN ONCOL, V30, P2408, DOI 10.1200/JCO.2011.39.1110; Brouwers, 2010, STAND GUID EV SAG DI; Brouwers MC, 2011, EXPERT REV PHARM OUT, V11, P151, DOI [10.1586/ERP.11.11, 10.1586/erp.11.11]; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Burgers JS, 2004, J CLIN ONCOL, V22, P2000, DOI 10.1200/JCO.2004.06.157; Burstein HJ, 2011, J CLIN ONCOL, V29, P3328, DOI 10.1200/JCO.2011.36.0354; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Cataliotti L, 2007, EUR J CANCER, V43, P660, DOI 10.1016/j.ejca.2006.12.008; Chen C, 2013, CURR ONCOL, V20, pE136, DOI 10.3747/co.20.1252; Collaboration TC, 2014, IND SEARCH TECHN INF; Colorectal Cancer Association of Canada, 2009, Curr Oncol, V16, P50; Cosgrove L, 2013, J EVAL CLIN PRACT, V19, P674, DOI 10.1111/jep.12016; Cripps C, 2010, CURR ONCOL, V17, P37; Czauderna P, 2005, EUR J CANCER, V41, P1031, DOI 10.1016/j.ejca.2005.02.004; Darling GE, 2011, CURR ONCOL, V18, pE304; Dawson AJ, 2011, CURR ONCOL, V18, pE250; De Haas E, 2007, J EUR ACAD DERMATOL, V21, P1193, DOI 10.1111/j.1468-3083.2007.02216.x; Desch CE, 2005, J CLIN ONCOL, V23, P8512, DOI 10.1200/JCO.2005.04.0063; Di Valentin T, 2013, CURR ONCOL, V20, pE455, DOI 10.3747/co.20.1638; Dimopoulos MA, 2010, J CLIN ONCOL, V28, P4976, DOI 10.1200/JCO.2010.30.8791; Dodge JE, 2012, CURR ONCOL, V19, pE244, DOI 10.3747/co.19.980; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; Elit L, 2010, CURR ONCOL, V17, P65; Ellis PM, 2009, CURR ONCOL, V16, P27; Fervers B, 2005, INT J QUAL HEALTH C, V17, P123, DOI 10.1093/intqhc/mzi011; Flowers CR, 2013, J CLIN ONCOL, V31, P794, DOI 10.1200/JCO.2012.45.8661; Fraser G SC, 2007, CURRENT ONCOLOGY, P14; Gallinger S, 2013, CURR ONCOL, V20, pE255, DOI 10.3747/co.20.1341; Garbe C, 2012, EUR J CANCER, V48, P2375, DOI 10.1016/j.ejca.2012.06.013; Garbe C, 2010, EUR J CANCER, V46, P270, DOI 10.1016/j.ejca.2009.10.032; Gilligan TD, 2010, J CLIN ONCOL, V28, P3388, DOI 10.1200/JCO.2009.26.4481; Glenny AM, EUROPEAN J CANC, V46, P1399; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Graham RMM, COMMITTEE STANDARDS; Gridelli C, 2011, EUR J CANCER, V47, pS248, DOI 10.1016/S0959-8049(11)70171-X; Griggs JJ, 2012, J CLIN ONCOL, V30, P1553, DOI 10.1200/JCO.2011.39.9436; Griggs JJ, 2011, J CLIN ONCOL, V29, P3939, DOI 10.1200/JCO.2011.36.4950; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Gupta AA, 2013, CURR ONCOL, V20, pE448, DOI 10.3747/co.20.1357; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hanna W, 2007, Curr Oncol, V14, P149, DOI 10.3747/co.2007.131; Hensley ML, 2009, J CLIN ONCOL, V27, P127, DOI 10.1200/JCO.2008.17.2627; Herkert JC, 2011, EUR J CANCER, V47, P965, DOI 10.1016/j.ejca.2011.01.013; Hogeveen SE, 2012, CURR ONCOL, V19, pE184, DOI 10.3747/co.19.930; Howell D, 2013, CURR ONCOL, V20, pE233, DOI 10.3747/co.20.1302; Howell D, 2011, CURR ONCOL, V18, pE265; Jonker D, 2006, Curr Oncol, V13, P173; Juweid ME, 2007, J CLIN ONCOL, V25, P571, DOI 10.1200/JCO.2006.08.2305; Kandel R, 2013, CURR ONCOL, V20, pE247, DOI 10.3747/co.20.1308; Khatcheressian JL, 2013, J CLIN ONCOL, V31, P961, DOI 10.1200/JCO.2012.45.9859; Khorana AA, 2009, J CLIN ONCOL, V27, P4919, DOI 10.1200/JCO.2009.22.3214; Kocha W, 2010, CURR ONCOL, V17, P49; Kramer BS, 2009, J CLIN ONCOL, V27, P1502, DOI 10.1200/JCO.2008.16.9599; Kris MG, 2006, J CLIN ONCOL, V24, P2932, DOI 10.1200/JCO.2006.06.9591; Kulke MH, 2011, J CLIN ONCOL, V29, P934, DOI 10.1200/JCO.2010.33.2056; Kyle RA, 2007, J CLIN ONCOL, V25, P2464, DOI 10.1200/JCO.2007.12.1269; Laneuville P, 2006, Curr Oncol, V13, P201; Langton JM, 2011, BRIT J CANCER, V105, P1166, DOI 10.1038/bjc.2011.378; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Loblaw DA, 2007, J CLIN ONCOL, V25, P1596, DOI 10.1200/JCO.2006.10.1949; Lokhorst H, 2010, J CLIN ONCOL, V28, P4521, DOI 10.1200/JCO.2010.29.7929; Lopez-Olivo MA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1625, DOI 10.1002/art.24207; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; Lutz MP, 2012, EUR J CANCER, V48, P2941, DOI 10.1016/j.ejca.2012.07.029; Lyman GH, 2007, J CLIN ONCOL, V25, P5490, DOI 10.1200/JCO.2007.14.1283; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; MacKenzie M, 2011, CURR ONCOL, V18, pE202; Maroun J, 2006, Curr Oncol, V13, P67; Maschmeyer G, 2009, EUR J CANCER, V45, P2462, DOI 10.1016/j.ejca.2009.05.001; Mason W P, 2007, Curr Oncol, V14, P110, DOI 10.3747/co.2007.119; McEwen S, 2013, CURR ONCOL, V20, P64, DOI 10.3747/co.20.1277; Mendelson TB, 2011, ARCH INTERN MED, V171, P577, DOI 10.1001/archinternmed.2011.96; Mintz A, 2007, Curr Oncol, V14, P131, DOI 10.3747/co.2007.129; Norris SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025153; Olsen EA, 2011, J CLIN ONCOL, V29, P2598, DOI 10.1200/JCO.2010.32.0630; Petrella T, 2007, Curr Oncol, V14, P21, DOI 10.3747/co.2007.97; Pfister DG, 2006, J CLIN ONCOL, V24, P3693, DOI 10.1200/JCO.2006.07.4559; Philip PA, 2009, J CLIN ONCOL, V27, P5660, DOI 10.1200/JCO.2009.21.9022; Pisters KMW, 2007, J CLIN ONCOL, V25, P5506, DOI 10.1200/JCO.2007.14.1226; Ponzoni M, 2007, J CLIN ONCOL, V25, P3168, DOI 10.1200/JCO.2006.08.2313; Pritchard KI, 2013, CURR ONCOL, V20, P48, DOI 10.3747/co.20.1316; Quinn B, 2008, EUR J CANCER, V44, P61, DOI 10.1016/j.ejca.2007.09.014; Quirt I, 2007, CURRENT ONCOLOGY, P14; Rayner L, 2011, EUR J CANCER, V47, P702, DOI 10.1016/j.ejca.2010.11.027; Reece D, 2006, Curr Oncol, V13, P160; Rizzo JD, 2010, J ONCOL PRACT, V6, P317, DOI 10.1200/JOP.2010.000132; Schiffer CA, 2013, J CLIN ONCOL, V31, P1357, DOI 10.1200/JCO.2012.45.5733; Sherman M, 2011, CURR ONCOL, V18, P228; Shimbo T, 2010, INT J CLIN ONCOL, V15, P227, DOI 10.1007/s10147-010-0060-y; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; Trautinger F, 2006, EUR J CANCER, V42, P1014, DOI 10.1016/j.ejca.2006.01.025; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Van Cutsem E, 2006, EUR J CANCER, V42, P2212, DOI 10.1016/j.ejca.2006.04.012; Verma S, 2008, CURR ONCOL, V15, P85; Verma S, 2008, CURR ONCOL, V15, P80; Verma S, 2007, Curr Oncol, V14, P144; Vickers M, 2010, CURR ONCOL, V17, P116; Vickers MM, 2012, CURR ONCOL, V19, pE468, DOI 10.3747/co.19.1167; Visvanathan K, 2013, J CLIN ONCOL, V31, P2942, DOI 10.1200/JCO.2013.49.3122; Visvanathan K, 2009, J CLIN ONCOL, V27, P3235, DOI 10.1200/JCO.2008.20.5179; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wong SL, 2012, J CLIN ONCOL, V30, P2912, DOI 10.1200/JCO.2011.40.3519; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; Yoo J, 2013, CURR ONCOL, V20, pE132, DOI 10.3747/co.20.1237; Zinzani PL, 2008, EUR J CANCER, V44, P366, DOI 10.1016/j.ejca.2007.12.008	120	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110469	10.1371/journal.pone.0110469	http://dx.doi.org/10.1371/journal.pone.0110469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329669	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100078
J	Ma, SY; Sung, J; Magis, AT; Wang, YL; Geman, D; Price, ND				Ma, Shuyi; Sung, Jaeyun; Magis, Andrew T.; Wang, Yuliang; Geman, Donald; Price, Nathan D.			Measuring the Effect of Inter-Study Variability on Estimating Prediction Error	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY DATA; LUNG-CANCER; RNA-SEQ; REPRODUCIBILITY; IDENTIFICATION; SENSITIVITY; SIGNATURES; GENOME; ROBUST	Background: The biomarker discovery field is replete with molecular signatures that have not translated into the clinic despite ostensibly promising performance in predicting disease phenotypes. One widely cited reason is lack of classification consistency, largely due to failure to maintain performance from study to study. This failure is widely attributed to variability in data collected for the same phenotype among disparate studies, due to technical factors unrelated to phenotypes (e. g., laboratory settings resulting in "batch-effects") and non-phenotype-associated biological variation in the underlying populations. These sources of variability persist in new data collection technologies. Methods: Here we quantify the impact of these combined "study-effects" on a disease signature's predictive performance by comparing two types of validation methods: ordinary randomized cross-validation (RCV), which extracts random subsets of samples for testing, and inter-study validation (ISV), which excludes an entire study for testing. Whereas RCV hardwires an assumption of training and testing on identically distributed data, this key property is lost in ISV, yielding systematic decreases in performance estimates relative to RCV. Measuring the RCV-ISV difference as a function of number of studies quantifies influence of study-effects on performance. Results: As a case study, we gathered publicly available gene expression data from 1,470 microarray samples of 6 lung phenotypes from 26 independent experimental studies and 769 RNA-seq samples of 2 lung phenotypes from 4 independent studies. We find that the RCV-ISV performance discrepancy is greater in phenotypes with few studies, and that the ISV performance converges toward RCV performance as data from additional studies are incorporated into classification. Conclusions: We show that by examining how fast ISV performance approaches RCV as the number of studies is increased, one can estimate when "sufficient" diversity has been achieved for learning a molecular signature likely to translate without significant loss of accuracy to new clinical settings.	[Ma, Shuyi; Sung, Jaeyun; Magis, Andrew T.; Wang, Yuliang; Price, Nathan D.] Inst Syst Biol, Seattle, WA 98103 USA; [Ma, Shuyi; Price, Nathan D.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Sung, Jaeyun] Asia Pacific Ctr Theoret Phys, Pohang, Gyeongbuk, South Korea; [Magis, Andrew T.; Price, Nathan D.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Wang, Yuliang] Sage Bionetworks, Seattle, WA USA; [Geman, Donald] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD USA; [Geman, Donald] Johns Hopkins Univ, Dept Appl Math & Stat, Baltimore, MD USA	Institute for Systems Biology (ISB); University of Illinois System; University of Illinois Urbana-Champaign; Asia Pacific Center for Theoretical Physics; University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University; Johns Hopkins University	Price, ND (corresponding author), Inst Syst Biol, Seattle, WA 98103 USA.	nprice@systemsbiology.org	Wang, Yuliang/H-9070-2012	Wang, Yuliang/0000-0002-3788-5477; Magis, Andrew/0000-0003-0576-677X; Ma, Shuyi/0000-0003-0783-1328; Price, Nathan/0000-0002-4157-0267; Sung, Jaeyun/0000-0002-3005-2798	National Institutes of Health-National Cancer Institute Howard Temin Pathway to Independence Award in Cancer Research [4R00CA126184]; Grand Duchy of Luxembourg-Institute for Systems Biology Consortium; Camille Dreyfus Teacher-Scholar program; National Science Foundation Graduate Research Fellowship [DGE-1144245]; National Research Foundation of Korea [NRF-2012R1A1A2008925]; NATIONAL CANCER INSTITUTE [R00CA126184] Funding Source: NIH RePORTER	National Institutes of Health-National Cancer Institute Howard Temin Pathway to Independence Award in Cancer Research; Grand Duchy of Luxembourg-Institute for Systems Biology Consortium; Camille Dreyfus Teacher-Scholar program; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors disclose the following funding sources: a National Institutes of Health-National Cancer Institute Howard Temin Pathway to Independence Award in Cancer Research (http://www.cancer.gov/researchandfunding/cancertraining/funding/K99, grant number 4R00CA126184), the Grand Duchy of Luxembourg-Institute for Systems Biology Consortium, the Camille Dreyfus Teacher-Scholar program (NDP, http://www.dreyfus.org/awards/camille_dreyfus_teacher_award.shtml), a National Science Foundation Graduate Research Fellowship (SM, http://www.nsfgrfp.org/, grant number DGE-1144245), and a Basic Science Research Program through the National Research Foundation of Korea (JS, NRF-2012R1A1A2008925). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2022, TABLES 84F0209X MORT; [Anonymous], 2004, COPD STAT INF; Baran-Gale J, 2013, MASSIVELY DIFFERENTI; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bhattacharya S, 2009, AM J RESP CELL MOL, V40, P359, DOI 10.1165/rcmb.2008-0114OC; Cahan P, 2007, GENE, V401, P12, DOI 10.1016/j.gene.2007.06.016; Cepelak I, 2007, CLIN CHEM LAB MED, V45, P945, DOI 10.1515/CCLM.2007.326; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; Chen JJ, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-412; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dudley JT, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.66; Geman Donald, 2004, Stat Appl Genet Mol Biol, V3, pArticle19; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kadota K, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-7; Kim JH, 2002, JAMA-J AM MED ASSOC, V287, P1671, DOI 10.1001/jama.287.13.1671; Kim JE, 2008, EXP MOL MED, V40, P709, DOI 10.3858/emm.2008.40.6.709; Kim SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055596; Lazar C, 2012, BRIEF BIOINFORM; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Leidinger P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-18; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Luo J, 2010, PHARMACOGENOMICS J, V10, P278, DOI 10.1038/tpj.2010.57; Ma SY, 2010, DISCOV MED, V10, P531; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Micheel C., 2012, EVOLUTION TRANSLATIO; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Pedotti P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-124; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; SCHERER A., 2009, BATCH EFFECTS NOISE; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shmulevich I, 2002, BIOINFORMATICS, V18, P555, DOI 10.1093/bioinformatics/18.4.555; Sung J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003148; Sung JY, 2012, BIOTECHNOL J, V7, P946, DOI 10.1002/biot.201100305; 't Hoen PAC, 2013, NAT BIOTECHNOL, V31, P1015, DOI 10.1038/nbt.2702; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang HX, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-71; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xu L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-275; Yang HN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003724; Zhou XB, 2003, MOL CANCER THER, V2, P679; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	52	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110840	10.1371/journal.pone.0110840	http://dx.doi.org/10.1371/journal.pone.0110840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330348	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100109
J	Matus, JT; Aquea, F; Espinoza, C; Vega, A; Cavallini, E; Dal Santo, S; Canon, P; de la Guardia, ARH; Serrano, J; Tornielli, GB; Arce-Johnson, P				Tomas Matus, Jose; Aquea, Felipe; Espinoza, Carmen; Vega, Andrea; Cavallini, Erika; Dal Santo, Silvia; Canon, Paola; Rodriguez-Hoces de la Guardia, Amparo; Serrano, Jennifer; Battista Tornielli, Giovanni; Arce-Johnson, Patricio			Inspection of the Grapevine BURP Superfamily Highlights an Expansion of RD22 Genes with Distinctive Expression Features in Berry Development and ABA-Mediated Stress Responses	PLOS ONE			English	Article							DOMAIN-CONTAINING GENES; ABSCISIC-ACID; TRANSCRIPTION FACTOR; BETA-SUBUNIT; ARABIDOPSIS-THALIANA; CABERNET-SAUVIGNON; PLANT; PROTEIN; IDENTIFICATION; DEHYDRATION	The RESPONSIVE TO DEHYDRATION 22 (RD22) gene is a molecular link between abscisic acid (ABA) signalling and abiotic stress responses. Its expression has been used as a reliable ABA early response marker. In Arabidopsis, the single copy RD22 gene possesses a BURP domain also located at the C-terminus of USP embryonic proteins and the beta subunit of polygalacturonases. In grapevine, a RD22 gene has been identified but putative paralogs are also found in the grape genome, possibly forming a large RD22 family in this species. In this work, we searched for annotations containing BURP domains in the Vitis vinifera genome. Nineteen proteins were defined by a comparative analysis between the two genome predictions and RNA-Seq data. These sequences were compared to other plant BURPs identified in previous genome surveys allowing us to reconceive group classifications based on phylogenetic relationships and protein motif occurrence. We observed a lineage-specific evolution of the RD22 family, with the biggest expansion in grapevine and poplar. In contrast, rice, sorghum and maize presented highly expanded monocot-specific groups. The Vitis RD22 group may have expanded from segmental duplications as most of its members are confined to a region in chromosome 4. The inspection of transcriptomic data revealed variable expression of BURP genes in vegetative and reproductive organs. Many genes were induced in specific tissues or by abiotic and biotic stresses. Three RD22 genes were further studied showing that they responded oppositely to ABA and to stress conditions. Our results show that the inclusion of RNA-Seq data is essential while describing gene families and improving gene annotations. Robust phylogenetic analyses including all BURP members from other sequenced species helped us redefine previous relationships that were erroneously established. This work provides additional evidence for RD22 genes serving as marker genes for different organs or stresses in grapevine.	[Tomas Matus, Jose] CSIC IRTA UAB UB, Ctr Res Agr Genom, Barcelona, Spain; [Tomas Matus, Jose; Aquea, Felipe; Espinoza, Carmen; Canon, Paola; Rodriguez-Hoces de la Guardia, Amparo; Serrano, Jennifer; Arce-Johnson, Patricio] Pontificia Univ Catolica Chile, Dept Microbiol & Mol Genet, Santiago, Chile; [Vega, Andrea] Pontificia Univ Catolica Chile, Fac Agron & Ingn Forestal, Dept Ciencias Vegetales, Santiago, Chile; [Cavallini, Erika; Dal Santo, Silvia; Battista Tornielli, Giovanni] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University of Verona	Arce-Johnson, P (corresponding author), Pontificia Univ Catolica Chile, Dept Microbiol & Mol Genet, Alameda 340, Santiago, Chile.	parce@bio.puc.cl	Vega, Andrea/Y-1874-2019; Matus, José Tomás/G-3195-2016; Tornielli, Giovanni Battista/AAG-1735-2019; Vega, Andrea/J-2961-2016; Montenegro, Gloria/D-9830-2013	Vega, Andrea/0000-0003-0841-5713; Matus, José Tomás/0000-0002-9196-1813; Tornielli, Giovanni Battista/0000-0001-5027-0269; Vega, Andrea/0000-0003-0841-5713; Montenegro, Gloria/0000-0003-3878-5686; Aquea, Felipe/0000-0002-1174-3139; Espinoza, Carmen/0000-0003-1469-9492; Dal Santo, Silvia/0000-0001-5012-1140	Chilean Wine Consortium [05CTE01-03]; Fruit Consortium [07Genoma01]; Millennium Nucleus for Plant Functional Genomics [P06-009-F]; Postdoctoral Project "Programa Bicentenario de Ciencia y Tecnologia/CONICYT-Banco Mundial'' [PSD74-2006]; CONICYT; Chilean National Council of Science and Technology; VRAID, Pontificia Universidad Catolica de Chile	Chilean Wine Consortium; Fruit Consortium; Millennium Nucleus for Plant Functional Genomics; Postdoctoral Project "Programa Bicentenario de Ciencia y Tecnologia/CONICYT-Banco Mundial''; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Chilean National Council of Science and Technology; VRAID, Pontificia Universidad Catolica de Chile	This work was supported by the Chilean Wine Consortium 05CTE01-03, the Fruit Consortium, 07Genoma01 and Millennium Nucleus for Plant Functional Genomics (P06-009-F). FA was supported by a Postdoctoral Project "Programa Bicentenario de Ciencia y Tecnologia/CONICYT-Banco Mundial'' (PSD74-2006). AV, PC and JS were supported by a PhD fellowship from CONICYT, Chilean National Council of Science and Technology and VRAID, Pontificia Universidad Catolica de Chile. This work also benefited from the networking activities within the European-funded COST ACTION FA1106 'An integrated systems approach to determine the developmental mechanisms controlling fleshy fruit quality in tomato and grapevine'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Alazem M, 2014, MOL PLANT MICROBE IN, V27, P177, DOI 10.1094/MPMI-08-13-0216-R; Albertazzi G, 2009, PLANT SCI, V176, P792, DOI 10.1016/j.plantsci.2009.03.001; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Banzai T, 2002, TREES-STRUCT FUNCT, V16, P87, DOI 10.1007/s00468-001-0144-4; BAUMLEIN H, 1991, Molecular and General Genetics, V225, P459, DOI 10.1007/BF00261688; BOUTILIER KA, 1994, PLANT MOL BIOL, V26, P1711, DOI 10.1007/BF00019486; Bray EA, 2002, ANN BOT-LONDON, V89, P803, DOI 10.1093/aob/mcf104; CAHILL DM, 1989, PHYSIOL MOL PLANT P, V35, P483, DOI 10.1016/0885-5765(89)90090-8; Carra A, 2009, PLANT J, V59, P750, DOI 10.1111/j.1365-313X.2009.03906.x; Cramer GR, 2007, FUNCT INTEGR GENOMIC, V7, P111, DOI 10.1007/s10142-006-0039-y; Cucurachi M, 2012, PLANT PHYSIOL BIOCH, V54, P123, DOI 10.1016/j.plaphy.2012.02.017; Dal Santo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062206; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Davies C, 1997, PLANT PHYSIOL, V115, P1155, DOI 10.1104/pp.115.3.1155; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Deluc LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-212; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Ding XP, 2009, PLANTA, V230, P149, DOI 10.1007/s00425-009-0929-z; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Espinoza C, 2007, FUNCT INTEGR GENOMIC, V7, P95, DOI 10.1007/s10142-006-0031-6; Fasoli M, 2012, PLANT CELL, V24, P3489, DOI 10.1105/tpc.112.100230; Fernandez L, 2007, PLANT MOL BIOL, V63, P307, DOI 10.1007/s11103-006-9090-2; Galbiati M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-142; Gamm M, 2011, MOL GENET GENOMICS, V285, P273, DOI 10.1007/s00438-011-0607-2; Gan DF, 2011, MOL BIOL REP, V38, P4553, DOI 10.1007/s11033-010-0587-z; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Granger C, 2002, GENOME, V45, P693, DOI [10.1139/g02-032, 10.1139/G02-032]; Hanana M, 2008, CR BIOL, V331, P569, DOI 10.1016/j.crvi.2008.05.002; Hattori J, 1998, MOL GEN GENET, V259, P424, DOI 10.1007/s004380050832; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; IWASAKI T, 1995, MOL GEN GENET, V247, P391, DOI 10.1007/BF00293139; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones R., 2000, BIOCH MOL BIOL PLANT, P1158, DOI DOI 10.12691/WJAR-2-2-2; Kim J, 2006, BBA-GENE STRUCT EXPR, V1759, P191, DOI 10.1016/j.bbaexp.2006.03.002; Kuhn N, 2013, J EXPT BOT; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Liu HH, 2014, PLANT CELL ENVIRON, V37, P1144, DOI 10.1111/pce.12223; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Miozzi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089951; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Orozco-Cardenas ML, 2003, PLANT PHYSIOL, V133, P693, DOI 10.1104/pp.103.023226; Peeters L, 2004, BIOTECHNOL BIOENG, V86, P543, DOI 10.1002/bit.20134; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; RYERSON E, 1993, PHYSIOL MOL PLANT P, V43, P265, DOI 10.1006/pmpp.1993.1056; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Shao YH, 2011, J INTEGR PLANT BIOL, V53, P743, DOI 10.1111/j.1744-7909.2011.01068.x; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Van Son L, 2009, PLANT MOL BIOL, V71, P319, DOI 10.1007/s11103-009-9526-6; Vega A, 2011, PLANT MOL BIOL, V77, P261, DOI 10.1007/s11103-011-9807-8; Venturini L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-41; Wang HM, 2012, PLANT CELL ENVIRON, V35, P1932, DOI 10.1111/j.1365-3040.2012.02526.x; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; WHENHAM RJ, 1986, PLANTA, V168, P592, DOI 10.1007/BF00392281; Xu B, 2013, MOL PLANT, V6, P945, DOI 10.1093/mp/sss112; Xu HL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-197; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V238, P17, DOI 10.1007/BF00279525; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang M, 2009, J PLANT PHYSIOL, V166, P1241, DOI 10.1016/j.jplph.2009.01.013	66	33	38	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110372	10.1371/journal.pone.0110372	http://dx.doi.org/10.1371/journal.pone.0110372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330210	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800079
J	Tresukosol, D; Suktitipat, B; Hunnangkul, S; Kamkaew, R; Poldee, S; Tassaneetrithep, B; Likidlilid, A				Tresukosol, Damrus; Suktitipat, Bhoom; Hunnangkul, Saowalak; Kamkaew, Ruttakarn; Poldee, Saiphon; Tassaneetrithep, Boonrat; Likidlilid, Atip			Effects of Cytochrome P450 2C19 and Paraoxonase 1 Polymorphisms on Antiplatelet Response to Clopidogrel Therapy in Patients with Coronary Artery Disease	PLOS ONE			English	Article							OF-FUNCTION POLYMORPHISM; PLATELET REACTIVITY; GENE POLYMORPHISMS; STENT THROMBOSIS; DENSITY-LIPOPROTEIN; MAJOR DETERMINANT; CLINICAL-OUTCOMES; VARIANTS; RISK; ASSOCIATION	Clopidogrel is an antiplatelet prodrug that is recommended to reduce the risk of recurrent thrombosis in coronary artery disease (CAD) patients. Paraoxonase 1 (PON1) is suggested to be a rate-limiting enzyme in the conversion of 2-oxo-clopidogrel to active thiol metabolite with inconsistent results. Here, we sought to determine the associations of CYP2C19 and PON1 gene polymorphisms with clopidogrel response and their role in ADP-induced platelet aggregation. Clopidogrel response and platelet aggregation were determined using Multiplate aggregometer in 211 patients with established CAD who received 75 mg clopidogrel and 75-325 mg aspirin daily for at least 14 days. Polymorphisms in CYP2C19 and PON1 were genotyped and tested for association with clopidogrel resistance. Linkage disequilibrium (LD) and their epistatic interaction effects on ADP-induced platelet aggregation were analysed. The prevalence of clopidogrel resistance in this population was approximately 33.2% (n = 70). The frequencies of CYP2C19*2 and *3 were significantly higher in non-responder than those in responders. After adjusting for established risk factors, CYP2C19*2 and *3 alleles independently increased the risk of clopidogrel resistance with adjusted ORs 2.94 (95%CI, 1.65-5.26; p < 0.001) and 11.26 (95%CI, 2.47-51.41; p = 0.002, respectively). Patients with *2 or *3 allele and combined with smoking, diabetes and increased platelet count had markedly increased risk of clopidogrel resistance. No association was observed between PON1 Q192R and clopidogrel resistance (adjusted OR = 1.13, 95%CI, 0.70-1.82; p = 0.622). Significantly higher platelet aggregation values were found in CYP2C19*2 and *3 patients when compared with *1/*1 allele carriers (p = 1.98 x 10(-6)). For PON1 Q192R genotypes, aggregation values were similar across all genotype groups (p = 0.359). There was no evidence of gene-gene interaction or LD between CYP2C19 and PON1 polymorphisms on ADP-induced platelet aggregation. Our findings indicated that only CYP2C19*2 and *3 alleles had an influence on clopidogrel resistance. The risk of clopidogrel resistance increased further with smoking, diabetes, and increased platelet count.	[Tresukosol, Damrus] Mahidol Univ, Siriraj Hosp, Div Cardiol, Dept Internal Med, Bangkok 10700, Thailand; [Suktitipat, Bhoom; Kamkaew, Ruttakarn; Poldee, Saiphon; Likidlilid, Atip] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Biochem, Bangkok 10700, Thailand; [Suktitipat, Bhoom] Mahidol Univ, Integrat Computat BioSci Ctr, Salaya, Nakhon Prathom, Thailand; [Hunnangkul, Saowalak; Tassaneetrithep, Boonrat] Mahidol Univ, Dept Hlth Res & Dev, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Likidlilid, A (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Dept Biochem, Bangkok 10700, Thailand.	atip.lik@mahidol.ac.th	Tassaneetrithep, Boonrat/ACF-0768-2022; Tassaneetrithep, Boonrat/AAF-5715-2022; Suktitipat, Bhoom/H-4239-2019	Suktitipat, Bhoom/0000-0001-8034-7757; Tassaneetrithep, Boonrat/0000-0001-9617-3659	Faculty of Medicine Siriraj Hospital, Mahidol University	Faculty of Medicine Siriraj Hospital, Mahidol University	This study was partly supported by Graduate Thesis Scholarship grant from Faculty of Medicine Siriraj Hospital, Mahidol University to RK. AL and BS were supported by "Chalermphrakiat'' grant, Faculty of Medicine Siriraj Hospital, Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo DJ, 2005, DIABETES, V54, P2430, DOI 10.2337/diabetes.54.8.2430; Angiolillo DJ, 2005, THROMB RES, V115, P101, DOI 10.1016/j.thromres.2004.07.007; Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Campo S, 2004, EXP GERONTOL, V39, P1089, DOI 10.1016/j.exger.2004.03.017; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Ferre N, 2002, CLIN BIOCHEM, V35, P197, DOI 10.1016/S0009-9120(02)00295-3; Fontana P, 2011, J THROMB HAEMOST, V9, P1664, DOI 10.1111/j.1538-7836.2011.04409.x; Gerotziafas GT, 2012, CLIN APPL THROMB-HEM, V18, P356, DOI 10.1177/1076029611429122; Goldstein JA, 2001, BRIT J CLIN PHARMACO, V52, P349, DOI 10.1046/j.0306-5251.2001.01499.x; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2006, NAT CLIN PRACT CARD, V3, P387, DOI 10.1038/ncpcardio0602; Harmsze AM, 2010, EUR HEART J, V31, P3046, DOI 10.1093/eurheartj/ehq321; Hochholzer W, 2010, J AM COLL CARDIOL, V55, P2427, DOI 10.1016/j.jacc.2010.02.031; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Imai Y, 2000, ATHEROSCLEROSIS, V149, P435, DOI 10.1016/S0021-9150(99)00340-8; Jaremo P, 2002, J INTERN MED, V252, P233, DOI 10.1046/j.1365-2796.2002.01027.x; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Ko YL, 1998, ATHEROSCLEROSIS, V141, P259, DOI 10.1016/S0021-9150(98)00179-8; Kreutz RP, 2012, CLIN PHARMACOL-ADV A, V4, P13, DOI 10.2147/CPAA.S27822; Lawlor DA, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-17; Lewis JP, 2011, CLIN PHARMACOL THER, V90, P568, DOI 10.1038/clpt.2011.194; Likidlilid A, 2010, ACTA CARDIOL, V65, P681, DOI 10.1080/AC.65.6.2059866; Mackness MI, 1997, LANCET, V349, P851, DOI 10.1016/S0140-6736(05)61755-2; Marsillach J, 2009, CLIN BIOCHEM, V42, P91, DOI 10.1016/j.clinbiochem.2008.09.120; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; Mega JL, 2010, LANCET, V376, P1312, DOI 10.1016/S0140-6736(10)61273-1; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mega JL, 2009, CIRCULATION, V119, P2553, DOI 10.1161/CIRCULATIONAHA.109.851949; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mobley JE, 2004, AM J CARDIOL, V93, P456, DOI 10.1016/j.amjcard.2003.10.042; Moleerergpoom Worachat, 2007, Journal of the Medical Association of Thailand, V90, P21; Muller I, 2003, THROMB HAEMOSTASIS, V89, P783, DOI 10.1055/s-0037-1613462; Pare G, 2012, CIRC-CARDIOVASC GENE, V5, P250, DOI 10.1161/CIRCGENETICS.111.961417; R Core Team, 2021, R LANGUAGE ENV STAT; Regieli JJ, 2009, J AM COLL CARDIOL, V54, P1238, DOI 10.1016/j.jacc.2009.05.061; Rideg O, 2011, PHARMACOGENOMICS, V12, P1269, DOI [10.2217/PGS.11.73, 10.2217/pgs.11.73]; Schwender H., 2013, scrime: Analysis of High-Dimensional Categorical Data such as SNP Data; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2010, J THROMB HAEMOST, V8, P1685, DOI 10.1111/j.1538-7836.2010.03921.x; Sibbing D, 2008, THROMB HAEMOSTASIS, V99, P121, DOI 10.1160/TH07-07-0478; Sibbing D, 2011, EUR HEART J, V32, P1605, DOI 10.1093/eurheartj/ehr155; Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Simon T, 2011, CLIN PHARMACOL THER, V90, P561, DOI 10.1038/clpt.2011.193; Smith SC, 2006, J AM COLL CARDIOL, V47, P216, DOI 10.1016/j.jacc.2005.11.025; Syed FA, 2011, CARDIOVASC HEMATOL D; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Trenk D, 2011, CIRC-CARDIOVASC GENE, V4, P429, DOI 10.1161/CIRCGENETICS.111.960112; Umemura K, 2008, J THROMB HAEMOST, V6, P1439, DOI 10.1111/j.1538-7836.2008.03050.x	56	17	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110188	10.1371/journal.pone.0110188	http://dx.doi.org/10.1371/journal.pone.0110188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329996	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800066
J	Xiu, YC; Liu, Z; Xia, SY; Jin, CJ; Yin, HF; Zhao, WM; Wu, Q				Xiu, Youcheng; Liu, Zan; Xia, Shunyao; Jin, Chengjun; Yin, Huaifu; Zhao, Weiming; Wu, Qiong			RETRACTED: MicroRNA-137 Upregulation Increases Bladder Cancer Cell Proliferation and Invasion by Targeting PAQR3 (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							TUMOR-SUPPRESSOR; MIR-137; METASTASIS; EXPRESSION; PLAYER; RAF	There is increasing evidence suggesting that dysregulation of some microRNAs (miRNAs) may contribute to tumor progression and metastasis and have been proposed to be key regulators of diverse biological processes such as transcriptional regulation, cell growth and tumorigenesis. Previous studies have shown that miR-137 is dysregulated in some malignancies, but its role in bladder cancer is still unknown. In our study, we find that miR-137 is up-regulated in human bladder cancer tissues and cell lines. Moreover, the higher level of miR-137 was associated with pM or pTNM stage in clinical bladder cancer patients. Enforced expression of miR-137 in bladder cancer cells significantly enhanced their proliferation, migration and invasion. Bioinformatics analysis identified the tumor suppressor gene PAQR3 as a potential miR-137 target gene. Further studies indicated that miR-137 suppressed the expression of PAQR3 by binding to its 3'-untranslated region. Silencing of PAQR3 by small interfering RNAs phenocopied the effects of miR-137 overexpression, whereas restoration of PAQR3 in bladder cancer cells bladder cancer cells overexpressing miR-137, partially reversed the suppressive effects of miR-137. These findings indicate that miR-137 could be a potential oncogene in bladder cancer.	[Xiu, Youcheng; Wu, Qiong] Harbin Inst Technol, Sch Life Sci & Biotechnol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China; [Xiu, Youcheng; Liu, Zan; Xia, Shunyao; Jin, Chengjun; Yin, Huaifu; Zhao, Weiming] Harbin Med Univ, Affiliated Hosp 1, Dept Urol, Harbin, Peoples R China	Harbin Institute of Technology; Harbin Medical University	Wu, Q (corresponding author), Harbin Inst Technol, Sch Life Sci & Biotechnol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China.	link375@163.com	wu, qiong/GRY-4672-2022		National Natural Science Foundation of China [81170534]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding from National Natural Science Foundation of China (81170534) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2013, UROL ONCOL-SEMIN ORI, V31, P1701, DOI 10.1016/j.urolonc.2012.06.010; Althoff K, 2013, INT J CANCER, V133, P1064, DOI 10.1002/ijc.28091; Amling CL, 2001, CURR PROB CANCER, V25, P219; Bier A, 2013, ONCOTARGET, V4, P665, DOI 10.18632/oncotarget.928; Brenner B, 2011, WORLD J GASTROENTERO, V17, P3976, DOI 10.3748/wjg.v17.i35.3976; Bulbul Muhammad A, 2005, J Med Liban, V53, P107; Chen QJ, 2011, DIGEST DIS SCI, V56, P2009, DOI 10.1007/s10620-010-1536-3; Fan FJ, 2008, CARCINOGENESIS, V29, P1157, DOI 10.1093/carcin/bgn119; Feng L, 2007, P NATL ACAD SCI USA, V104, P14348, DOI 10.1073/pnas.0701298104; Guancial EA, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.04.014; Guo JL, 2013, BIOCHEM BIOPH RES CO, V441, P357, DOI 10.1016/j.bbrc.2013.10.052; Han Y, 2013, FEBS LETT; Han YH, 2013, FEBS LETT, V587, P3875, DOI 10.1016/j.febslet.2013.10.023; Jiang QQ, 2013, ASIAN PAC J CANCER P, V14, P4127, DOI 10.7314/APJCP.2013.14.7.4127; Jiang YH, 2011, CANCER RES, V71, P2959, DOI 10.1158/0008-5472.CAN-10-4077; Khatri R, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00268; Li PP, 2014, BIOMED PHARMACOTHER, V68, P7, DOI 10.1016/j.biopha.2013.12.002; Li Z., 2014, GASTRIC CANC; Liang L, 2013, GASTROENTEROLOGY, V144, P624, DOI 10.1053/j.gastro.2012.11.033; Matsuyama H, 2011, BLOOD, V118, P6881, DOI 10.1182/blood-2011-05-354654; Miao J, 2013, TUMOUR BIOL; Pasin Erik, 2008, Rev Urol, V10, P31; Sanchez-Carbayo M, 2012, EXPERT REV MOL DIAGN, V12, P429, DOI [10.1586/ERM.12.42, 10.1586/erm.12.42]; Shimizu T, 2013, EUR UROL, V63, P1091, DOI 10.1016/j.eururo.2012.11.030; Tatarano S, 2012, INT J ONCOL, V40, P951, DOI 10.3892/ijo.2011.1294; Vinall RL, 2012, INT J CANCER, V130, P2526, DOI 10.1002/ijc.26256; Wang LD, 2013, ENDOCRINOLOGY, V154, P4525, DOI 10.1210/en.2013-1633; Wang X, 2012, CARCINOGENESIS, V33, P2228, DOI 10.1093/carcin/bgs245; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156; Yin JW, 2014, INT J MOL SCI, V15, P3262, DOI 10.3390/ijms15023262; Yongchun Z, 2014, CANC LETT; Yoon SO, 2011, HUM PATHOL, V42, P1391, DOI 10.1016/j.humpath.2010.12.010; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Yu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083080; Zhang Y, 2010, ONCOGENE, V29, P5404, DOI 10.1038/onc.2010.270; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhang ZP, 2010, INT J BIOCHEM CELL B, V42, P367, DOI 10.1016/j.biocel.2009.11.023; Zhao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039102; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714	40	64	66	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109734	10.1371/journal.pone.0109734	http://dx.doi.org/10.1371/journal.pone.0109734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330156	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210800034
J	Chuang, HY; Chang, YF; Liu, RS; Hwang, JJ				Chuang, Hui-Yen; Chang, Ya-Fang; Liu, Ren-Shyan; Hwang, Jeng-Jong			Serial Low Doses of Sorafenib Enhance Therapeutic Efficacy of Adoptive T Cell Therapy in a Murine Model by Improving Tumor Microenvironment	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; IN-VIVO; EFFECTOR FUNCTIONS; ANTITUMOR-ACTIVITY; SUPPRESSOR-CELLS; TRANSCRIPTION 3; FAS LIGAND; CANCER; IMMUNOTHERAPY; IMMUNITY	Requirements of large numbers of transferred T cells and various immunosuppressive factors and cells in the tumor microenvironment limit the applications of adoptive T cells therapy (ACT) in clinic. Accumulating evidences show that chemotherapeutic drugs could act as immune supportive instead of immunosuppressive agents when proper dosage is used, and combined with immunotherapy often results in better treatment outcomes than monotherapy. Controversial immunomodulation effects of sorafenib, a multi-kinases inhibitor, at high and low doses have been reported in several types of cancer. However, what is the range of the low-dose sorafenib will influence the host immunity and responses of ACT is still ambiguous. Here we used a well-established E.G7/OT-1 murine model to understand the effects of serial low doses of sorafenib on both tumor microenvironment and transferred CD8+ T cells and the underlying mechanisms. Sorafenib lowered the expressions of immunosuppressive factors, and enhanced functions and migrations of transferred CD8+ T cells through inhibition of STAT3 and other immunosuppressive factors. CD8+ T cells were transduced with granzyme B promoter for driving imaging reporters to visualize the activation and distribution of transferred CD8+ T cells prior to adoptive transfer. Better activations of CD8+ T cells and tumor inhibitions were found in the combinational group compared with CD8+ T cells or sorafenib alone groups. Not only immunosuppressive factors but myeloid derived suppressive cells (MDSCs) and regulatory T cells (Tregs) were decreased in sorafenib-treated group, indicating that augmentation of tumor inhibition and function of CD8+ T cells by serial low doses of sorafenib were via reversing the immunosuppressive microenvironment. These results revealed that the tumor inhibitions of sorafenib not only through eradicating tumor cells but modifying tumor microenvironment, which helps outcomes of ACT significantly.	[Chuang, Hui-Yen; Chang, Ya-Fang; Hwang, Jeng-Jong] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Liu, Ren-Shyan] Taipei Vet Gen Hosp, Natl PET Cyclotron Ctr, Taipei, Taiwan; [Liu, Ren-Shyan] Taipei Vet Gen Hosp, Dept Nucl Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Hwang, JJ (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	jjhwang@ym.edu.tw	CHUANG, HUI-YEN/GVW-2101-2022		National Science Council, Taiwan [NSC 100-2321-B-010-013, NSC 101-2321-B-010-006, NSC 102-2321-B-010-005]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan. NSC 100-2321-B-010-013, NSC 101-2321-B-010-006 and NSC 102-2321-B-010-005 (JJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Azad NS, 2009, CLIN CANCER RES, V15, P1411, DOI 10.1158/1078-0432.CCR-08-1141; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Brose MS, 2014, LANCET, V384, P319, DOI 10.1016/S0140-6736(14)60421-9; Busse A, 2011, EUR J CANCER, V47, P690, DOI 10.1016/j.ejca.2010.11.021; Cabrera R, 2013, CANCER IMMUNOL IMMUN, V62, P737, DOI 10.1007/s00262-012-1380-8; Cao MD, 2011, LAB INVEST, V91, P598, DOI 10.1038/labinvest.2010.205; Chang YF, 2012, CANCER PREV RES, V5, P444, DOI 10.1158/1940-6207.CAPR-11-0308; Charo J, 2005, CANCER RES, V65, P2001, DOI 10.1158/0008-5472.CAN-04-2006; Chen ML, 2014, INT J CANCER, V134, P319, DOI 10.1002/ijc.28362; Chen WJ, 2011, NAT IMMUNOL, V12, P809, DOI 10.1038/ni.2088; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Desar IME, 2011, INT J CANCER, V129, P507, DOI 10.1002/ijc.25674; El Tal AK, 2013, INT J DERMATOL, V52, P1538, DOI 10.1111/j.1365-4632.2012.05485.x; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Fridlender ZG, 2010, CANCER RES, V70, P109, DOI 10.1158/0008-5472.CAN-09-2326; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Ghiringhelli F, 2004, EUR J IMMUNOL, V34, P336, DOI 10.1002/eji.200324181; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; Gutzmer R, 2012, DTSCH ARZTEBL INT, V109, P133, DOI 10.3238/arztebl.2012.0133; Hawkins RE, 2010, HUM GENE THER, V21, P665, DOI 10.1089/hum.2010.086; Hipp MM, 2008, BLOOD, V111, P5610, DOI 10.1182/blood-2007-02-075945; Hosoi A, 2014, INT J CANCER, V134, P1810, DOI 10.1002/ijc.28506; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Kharaziha P, 2012, CANCER RES, V72, P5348, DOI 10.1158/0008-5472.CAN-12-0658; Knight DA, 2013, J CLIN INVEST, V123, P1371, DOI 10.1172/JCI66236; Krysko DV, 2006, APOPTOSIS, V11, P1709, DOI 10.1007/s10495-006-9527-8; Kudo-Saito C, 2013, CLIN EXP METASTAS, V30, P393, DOI 10.1007/s10585-012-9545-6; Kujawski M, 2010, CANCER RES, V70, P9599, DOI 10.1158/0008-5472.CAN-10-1293; Kuo YC, 2012, BIOMED PHARMACOTHER, V66, P12, DOI 10.1016/j.biopha.2011.09.011; Lacour S, 2001, CANCER RES, V61, P1645; Leen AM, 2007, ANNU REV IMMUNOL, V25, P243, DOI 10.1146/annurev.immunol.25.022106.141527; Liu CW, 2013, CLIN CANCER RES, V19, P393, DOI 10.1158/1078-0432.CCR-12-1626; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Menard C, 2008, CANCER IMMUNOL IMMUN, V57, P1579, DOI 10.1007/s00262-008-0505-6; Micheau O, 1997, J NATL CANCER I, V89, P783, DOI 10.1093/jnci/89.11.783; Mitchem JB, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3149; Molhoek KR, 2009, CANCER IMMUNOL IMMUN, V58, P867, DOI 10.1007/s00262-008-0602-6; Mondino A, 2010, HUM GENE THER, V21, P533, DOI 10.1089/hum.2010.033; OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Ramakrishnan R, 2008, CANCER IMMUNOL IMMUN, V57, P1523, DOI 10.1007/s00262-008-0531-4; Ramakrishnan R, 2010, J CLIN INVEST, V120, P1111, DOI 10.1172/JCI40269; RASMUSSEN L, 1982, ENVIRON HEALTH PERSP, V43, P21, DOI 10.2307/3429163; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ryan AE, 2005, CANCER RES, V65, P9817, DOI 10.1158/0008-5472.CAN-05-1462; Sprinzl MF, 2013, HEPATOLOGY, V57, P2358, DOI 10.1002/hep.26328; Tai WT, 2011, J HEPATOL, V55, P1041, DOI 10.1016/j.jhep.2011.06.005; Takahashi Y, 2013, ENDOSCOPY, V45, pE179, DOI 10.1055/s-0032-1326641; Tartour E, 2011, CANCER METAST REV, V30, P83, DOI 10.1007/s10555-011-9281-4; Toaldo MB, 2015, MOL IMAGING BIOL, V17, P29, DOI 10.1007/s11307-014-0764-x; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Yang F, 2010, MOL CANCER THER, V9, P953, DOI 10.1158/1535-7163.MCT-09-0947; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056	58	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109992	10.1371/journal.pone.0109992	http://dx.doi.org/10.1371/journal.pone.0109992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333973	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200072
J	Du, YP; Zhou, X; Huang, ZB; Qiu, TZ; Wang, J; Zhu, W; Wang, TS; Liu, P				Du, Yiping; Zhou, Xin; Huang, Zebo; Qiu, Tianzhu; Wang, Jian; Zhu, Wei; Wang, Tongshan; Liu, Ping			Meta-Analysis of the Prognostic Value of Smad4 Immunohistochemistry in Various Cancers	PLOS ONE			English	Article							PANCREATIC DUCTAL ADENOCARCINOMA; ENDOTHELIAL GROWTH-FACTOR; HUMAN GASTRIC CARCINOMAS; BETA SIGNALING PATHWAYS; COLORECTAL-CANCER; COLON-CANCER; CELL CARCINOMA; POOR SURVIVAL; MESSENGER-RNA; EXPRESSION	Background: Accumulating evidence indicates that Smad4 (DPC4) plays a fundamental role in the development and prognosis of several types of cancer. The objective of this study was to conduct a meta-analysis to evaluate whether the loss of Smad4 staining could serve as a prognostic marker. Methods: A comprehensive meta-analysis was conducted using major useful databases to determine the relationship between the immunohistochemical detection of Smad4 and the survival of patients with various cancers. We used hazard ratios (HRs) with 95% confidence interval (CIs) as the effect estimation to evaluate the association of Smad4 with overall survival (OS), cancer-specific survival (CSS) or recurrence-free survival (RFS). The relationship between the clinical characteristics of patients and Smad4 was also evaluated using the odds ratio (OR). Results: A total of 7570 patients from 26 studies were included in the analysis. The pooled results showed that loss of Smad4 staining was a negative predictor of OS with an HR of 1.97 (95% CI: 1.55-2.51; P-heterogeneity<0.001) and CSS/RFS (HR = 1.81; 95% CI: 1.30-2.54; P-heterogeneity<0.001). In addition, loss of Smad4 staining was more likely to be found in older (OR = 1.69, 95% CI: 1.09-2.61; P-heterogeneity = 0.648) colorectal cancer patients with a late tumor stage (OR = 2.31, 95% CI: 1.71-3.10; P-heterogeneity = 0.218) and in gastric cancer patients with lymph node metastasis (OR = 2.11, 95% CI: 1.03-4.34; P-heterogeneity = 0.038). Conclusion: Based on these results, our meta-analysis provided evidence that loss of Smad4 staining could act as an unfavorable biomarker in the prognosis of various cancers and should be used as a powerful tool in future clinical trials.	[Du, Yiping; Zhou, Xin; Huang, Zebo; Qiu, Tianzhu; Wang, Jian; Zhu, Wei; Wang, Tongshan; Liu, Ping] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Liu, Ping] Nanjing Med Univ, Ctr Canc, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, TS (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	kingtsh@163.com; liu-ping@csco.org.cn			National Natural Science foundation of China [81171908, 81201796]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science foundation of China (Grant number: 81171908 and 81201796) http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhopuro P, 2005, CLIN CANCER RES, V11, P6311, DOI 10.1158/1078-0432.CCR-05-0244; Bachet JB, 2012, ANN ONCOL, V23, P2327, DOI 10.1093/annonc/mdr617; Biankin AV, 2002, J CLIN ONCOL, V20, P4531, DOI 10.1200/JCO.2002.12.063; Dai JL, 1999, P NATL ACAD SCI USA, V96, P1427, DOI 10.1073/pnas.96.4.1427; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fu HL, 2013, TUMOR BIOL, V34, P3817, DOI 10.1007/s13277-013-0966-x; Handra-Luca A, 2013, J HEPATO-BIL-PAN SCI, V20, P294, DOI 10.1007/s00534-012-0518-6; Hiwatashi K, 2009, ANN SURG ONCOL, V16, P3176, DOI 10.1245/s10434-009-0614-2; Hong L, 2013, GENET TEST MOL BIOMA, V17, P348, DOI 10.1089/gtmb.2012.0421; Hua Z, 2003, WORLD J GASTROENTERO, V9, P2764; Isaksson-Mettavainio M, 2006, ANTICANCER RES, V26, P507; Isaksson-Mettavainio M, 2012, INT J CANCER, V131, P779, DOI 10.1002/ijc.26473; Javle M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085942; Ji YN, 2014, TUMOR BIOL, V35, P2787, DOI 10.1007/s13277-013-1371-1; Khorana AA, 2005, J GASTROINTEST SURG, V9, P903, DOI 10.1016/j.gassur.2005.06.021; Kim YH, 2004, ANN ONCOL, V15, P574, DOI 10.1093/annonc/mdh131; Kloth JN, 2008, MODERN PATHOL, V21, P866, DOI 10.1038/modpathol.2008.62; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lampropoulos P, 2012, TUMOR BIOL, V33, P1005, DOI 10.1007/s13277-012-0333-3; Li H, 2014, TUMOUR BIOL; Li XM, 2011, J GASTROINTEST SURG, V15, P2001, DOI 10.1007/s11605-011-1627-2; Malats W, 2005, LANCET ONCOL, V6, P678; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mesker WE, 2009, CELL ONCOL, V31, P169, DOI 10.3233/CLO-2009-0478; Natsugoe S, 2002, CLIN CANCER RES, V8, P1838; Noordhuis MG, 2011, CLIN CANCER RES, V17, P1317, DOI 10.1158/1078-0432.CCR-10-2320; Okano H, 2004, CLIN CANCER RES, V10, P6938, DOI 10.1158/1078-0432.CCR-0731-03; Oshima M, 2013, ANN SURG, V258, P336, DOI 10.1097/SLA.0b013e3182827a65; Ottenhof NA, 2012, CELL ONCOL, V35, P119, DOI 10.1007/s13402-012-0072-x; Papageorgis P, 2011, CANCER RES, V71, P998, DOI 10.1158/0008-5472.CAN-09-3269; Park JH, 2013, HUM PATHOL, V44, P2047, DOI 10.1016/j.humpath.2013.03.009; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Roth AD, 2012, JNCI-J NATL CANCER I, V104, P1635, DOI 10.1093/jnci/djs427; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh P, 2011, INDIAN J CANCER, V48, P170, DOI 10.4103/0019-509X.82876; Smith RA, 2011, BRIT J CANCER, V104, P1440, DOI 10.1038/bjc.2011.110; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Stuelten CH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-25; Toga T, 2004, ANTICANCER RES, V24, P1173; Villanueva A, 1998, ONCOGENE, V17, P1969, DOI 10.1038/sj.onc.1202118; Voorneveld PW, 2013, EUR J CANCER PREV, V22, P420, DOI 10.1097/CEJ.0b013e32835e88e2; Wang LH, 2007, CLIN CANCER RES, V13, P102, DOI 10.1158/1078-0432.CCR-06-1467; Won KY, 2010, PATHOLOGY, V42, P242, DOI 10.3109/00313021003631288; Xiangming C, 2001, CLIN CANCER RES, V7, P277; Yu Q, 2013, ASIAN PAC J CANCER P, V14, P5735, DOI 10.7314/APJCP.2013.14.10.5735; Zhou SB, 1998, P NATL ACAD SCI USA, V95, P2412, DOI 10.1073/pnas.95.5.2412	46	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110182	10.1371/journal.pone.0110182	http://dx.doi.org/10.1371/journal.pone.0110182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333693	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200098
J	Harshavardhan, VT; Son, LV; Seiler, C; Junker, A; Weigelt-Fischer, K; Klukas, C; Altmann, T; Sreenivasulu, N; Baumlein, H; Kuhlmann, M				Harshavardhan, Vokkaliga Thammegowda; Le Van Son; Seiler, Christiane; Junker, Astrid; Weigelt-Fischer, Kathleen; Klukas, Christian; Altmann, Thomas; Sreenivasulu, Nese; Baeumlein, Helmut; Kuhlmann, Markus			AtRD22 and AtUSPL1, Members of the Plant-Specific BURP Domain Family Involved in Arabidopsis thaliana Drought Tolerance	PLOS ONE			English	Article							OSMOTIC-STRESS RESPONSES; ABSCISIC-ACID; PROTEIN GENE; HYDROGEN-PEROXIDE; NITRIC-OXIDE; EXPRESSION; ABA; DEHYDRATION; CHLOROPHYLL; INDUCTION	Crop plants are regularly challenged by a range of environmental stresses which typically retard their growth and ultimately compromise economic yield. The stress response involves the reprogramming of approximately 4% of the transcriptome. Here, the behavior of AtRD22 and AtUSPL1, both members of the Arabidopsis thaliana BURP (BNM2, USP, RD22 and polygalacturonase isozyme) domain-containing gene family, has been characterized. Both genes are up-regulated as part of the abscisic acid (ABA) mediated moisture stress response. While AtRD22 transcript was largely restricted to the leaf, that of AtUSPL1 was more prevalent in the root. As the loss of function of either gene increased the plant's moisture stress tolerance, the implication was that their products act to suppress the drought stress response. In addition to the known involvement of AtUSPL1 in seed development, a further role in stress tolerance was demonstrated. Based on transcriptomic data and phenotype we concluded that the enhanced moisture stress tolerance of the two loss-of-function mutants is a consequence of an enhanced basal defense response.	[Harshavardhan, Vokkaliga Thammegowda; Seiler, Christiane; Sreenivasulu, Nese; Kuhlmann, Markus] Interdisciplinary Ctr Crop Plant Res IZN, Res Grp Abiot Stress Genom, Halle, Saale, Germany; [Harshavardhan, Vokkaliga Thammegowda; Seiler, Christiane; Sreenivasulu, Nese; Kuhlmann, Markus] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Stadt Seeland, Ot Gatersleben, Germany; [Le Van Son; Baeumlein, Helmut] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Res Grp Gene Regulat, Stadt Seeland, Ot Gatersleben, Germany; [Le Van Son] Acad Sci & Technol, Inst Biotechnol Vietnam, Natl Key Lab Gene Technol, Hanoi, Vietnam; [Junker, Astrid; Weigelt-Fischer, Kathleen; Altmann, Thomas] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Res Grp Heterosis, Stadt Seeland, Ot Gatersleben, Germany; [Klukas, Christian] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Res Grp Image Anal, Stadt Seeland, Ot Gatersleben, Germany; [Sreenivasulu, Nese] Int Rice Res Inst IRRI, Grain Qual & Nutr Ctr, Manila, Philippines	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Vietnam Academy of Science & Technology (VAST); Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; CGIAR; International Rice Research Institute (IRRI)	Kuhlmann, M (corresponding author), Interdisciplinary Ctr Crop Plant Res IZN, Res Grp Abiot Stress Genom, Halle, Saale, Germany.	kuhlmann@ipk-gatersleben.de	Sreenivasulu, Nese/E-8600-2011; V T, Harshavardhan/M-6018-2017	Sreenivasulu, Nese/0000-0002-3998-038X; V T, Harshavardhan/0000-0002-3453-2385; Junker, Astrid/0000-0002-4656-0308; Altmann, Thomas/0000-0002-3759-360X; Kuhlmann, Markus/0000-0003-3104-0825	junior Research Group Abiotic Stress Genomics; BMBF [FKZ 0315041A, FKZ 0315041C]; IB-BMBF [Ind09/526]	junior Research Group Abiotic Stress Genomics; BMBF(Federal Ministry of Education & Research (BMBF)); IB-BMBF	The work was funded by Vietnamese government. The junior Research Group Abiotic Stress Genomics (MK and NS) is funded by IZN (Interdisciplinary Center for Crop Plant Research, Halle (Saale), Germany. VTH and CS are funded by BMBF (GABI- GRAIN: Integrative genomics approach for exploring seed quality and yield under terminal drought; FKZ 0315041A and FKZ 0315041C) and IB-BMBF (Ind09/526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Barrero JM, 2006, PLANT CELL ENVIRON, V29, P2000, DOI 10.1111/j.1365-3040.2006.01576.x; Batchelor AK, 2002, PLANTA, V215, P523, DOI 10.1007/s00425-002-0798-1; BAUMLEIN H, 1991, Molecular and General Genetics, V225, P459, DOI 10.1007/BF00261688; Bechthold N, 1993, CR HEBD ACAD SCI, V316, P871; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOUTILIER KA, 1994, PLANT MOL BIOL, V26, P1711, DOI 10.1007/BF00019486; Catala R, 2007, PLANT CELL, V19, P2952, DOI 10.1105/tpc.106.049981; Chen LZ, 2005, J PLANT PHYSIOL, V162, P1141, DOI 10.1016/j.jplph.2005.02.010; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Coego A, 2005, PLANT CELL, V17, P2123, DOI 10.1105/tpc.105.032375; DATTA N, 1993, PLANT MOL BIOL, V21, P859, DOI 10.1007/BF00027117; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Desikan R, 2004, J EXP BOT, V55, P205, DOI 10.1093/jxb/erh033; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; Fujii H, 2011, P NATL ACAD SCI USA, V108, P1717, DOI 10.1073/pnas.1018367108; Gan DF, 2011, MOL BIOL REP, V38, P4553, DOI 10.1007/s11033-010-0587-z; Govind G, 2009, MOL GENET GENOMICS, V281, P591, DOI 10.1007/s00438-009-0432-z; Granger C, 2002, GENOME, V45, P693, DOI [10.1139/g02-032, 10.1139/G02-032]; Hancock JT, 2001, BIOCHEM SOC T, V29, P345, DOI 10.1042/BST0290345; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hattori J, 1998, MOL GEN GENET, V259, P424, DOI 10.1007/s004380050832; Held BM, 1997, PLANT MOL BIOL, V35, P367, DOI 10.1023/A:1005830313272; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Huang NC, 2012, PLANT J, V72, P175, DOI 10.1111/j.1365-313X.2012.05076.x; HWANG IW, 1995, PLANT J, V8, P37, DOI 10.1046/j.1365-313X.1995.08010037.x; Hynninen PH, 2010, BBA-BIOENERGETICS, V1797, P531, DOI 10.1016/j.bbabio.2010.01.017; IWASAKI T, 1995, MOL GEN GENET, V247, P391, DOI 10.1007/BF00293139; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jones R., 2000, BIOCH MOL BIOL PLANT, P1158, DOI DOI 10.12691/WJAR-2-2-2; KAR RK, 1987, PHYSIOL PLANTARUM, V70, P729, DOI 10.1111/j.1399-3054.1987.tb04331.x; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Klukas C, 2014, PLANT PHYSIOL; Klukas C, 2012, J INTEGR BIOINFORMAT, V9, DOI 10.2390/biecoll-jib-2012-191; Li CL, 2010, PLANT PHYSIOL, V154, P211, DOI 10.1104/pp.110.161182; Miao YC, 2006, PLANT CELL, V18, P2749, DOI 10.1105/tpc.106.044230; Mullineaux P, 2000, PHILOS T ROY SOC B, V355, P1531, DOI 10.1098/rstb.2000.0713; Munns R, 2010, J EXP BOT, V61, P3499, DOI 10.1093/jxb/erq199; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; ORKIN S, 1990, NATURE, V343, P604, DOI 10.1038/343604a0; Park MY, 2009, PHYSIOL PLANTARUM, V135, P426, DOI 10.1111/j.1399-3054.2008.01202.x; POORTER H, 1986, PHYSIOL PLANTARUM, V67, P223, DOI 10.1111/j.1399-3054.1986.tb02447.x; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Ramirez V, 2009, PLANT J, V58, P578, DOI 10.1111/j.1365-313X.2009.03804.x; Rosado A, 2006, PLANT PHYSIOL, V142, P1113, DOI 10.1104/pp.106.085191; Sanchez JP, 2001, PLANT CELL, V13, P1143, DOI 10.1105/tpc.13.5.1143; Santos CLV, 2001, J EXP BOT, V52, P351, DOI 10.1093/jexbot/52.355.351; Schallau A, 2008, PLANT J, V53, P414, DOI 10.1111/j.1365-313X.2007.03354.x; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Seiler C, 2014, PLANT PHYSIOL, V164, P1677, DOI 10.1104/pp.113.229062; Shao YH, 2011, J INTEGR PLANT BIOL, V53, P743, DOI 10.1111/j.1744-7909.2011.01068.x; Shinozaki K, 1992, Tanpakushitsu Kakusan Koso, V37, P1190; Song HM, 2009, PLANTA, V229, P955, DOI 10.1007/s00425-008-0886-y; Sreenivasulu N, 2007, GENE, V388, P1, DOI 10.1016/j.gene.2006.10.009; Sreenivasulu N, 2006, PLANT J, V47, P310, DOI 10.1111/j.1365-313X.2006.02789.x; Teerawanichpan P, 2009, PLANT MOL BIOL, V71, P331, DOI 10.1007/s11103-009-9541-7; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Treacy BK, 1997, PLANT MOL BIOL, V34, P603, DOI 10.1023/A:1005851801107; Van Son L, 2009, PLANT MOL BIOL, V71, P319, DOI 10.1007/s11103-009-9526-6; Wang AM, 2003, P NATL ACAD SCI USA, V100, P14487, DOI 10.1073/pnas.2231254100; Wang HM, 2012, PLANT CELL ENVIRON, V35, P1932, DOI 10.1111/j.1365-3040.2012.02526.x; Wang YN, 2007, PLANT MOL BIOL, V64, P633, DOI 10.1007/s11103-007-9182-7; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wohlfarth T, 1998, J PLANT PHYSIOL, V152, P600, DOI 10.1016/S0176-1617(98)80018-7; Xu B, 2013, MOL PLANT, V6, P945, DOI 10.1093/mp/sss112; Xu HL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-197; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1992, NUCLEIC ACIDS RES, V20, P6737, DOI 10.1093/nar/20.24.6737; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V238, P17, DOI 10.1007/BF00279525; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	72	52	58	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110065	10.1371/journal.pone.0110065	http://dx.doi.org/10.1371/journal.pone.0110065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333723	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200089
J	Smith, DP; Weber, MF; Soga, K; Korda, RJ; Tikellis, G; Patel, MI; Clements, MS; Dwyer, T; Latz, IK; Banks, E				Smith, David P.; Weber, Marianne F.; Soga, Kay; Korda, Rosemary J.; Tikellis, Gabriella; Patel, Manish I.; Clements, Mark S.; Dwyer, Terry; Latz, Isabel K.; Banks, Emily			Relationship between Lifestyle and Health Factors and Severe Lower Urinary Tract Symptoms (LUTS) in 106,435 Middle-Aged and Older Australian Men: Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; REPRODUCTIVE HEALTH; ALCOHOL-CONSUMPTION; RISK; PREVALENCE; OBESITY; SMOKING; COHORT; WOMEN	Background: Despite growing interest in prevention of lower urinary tract symptoms (LUTS) through better understanding of modifiable risk factors, large-scale population-based evidence is limited. Objective: To describe risk factors associated with severe LUTS in the 45 and Up Study, a large cohort study. Design, Setting, and Participants: A cross-sectional analysis of questionnaire data from 106,435 men aged >= 45 years, living in New South Wales, Australia. Outcome Measures and Statistical Analysis: LUTS were measured by a modified version of the International Prostate Symptom Score (m-IPSS). The strength of association between severe LUTS and socio-demographic, lifestyle and health-related factors was estimated, using logistic regression to calculate odds ratios, adjusted for a range of confounding factors. Results: Overall, 18.3% reported moderate, and 3.6% severe, LUTS. Severe LUTS were more common among men reporting previous prostate cancer (7.6%), total prostatectomy (4.9%) or having part of the prostate removed (8.2%). After excluding men with prostate cancer or prostate surgery, the prevalence of moderate-severe LUTS in the cohort (n = 95,089) ranged from 10.6% to 35.4% for ages 45-49 to >= 80; the age-related increase was steeper for storage than voiding symptoms. The adjusted odds of severe LUTS decreased with increasing education (tertiary qualification versus no school certificate, odds ratio (OR = 0.78 (0.68-0.89))) and increasing physical activity (high versus low, OR = 0.83 (0.76-0.91)). Odds were elevated among current smokers versus never-smokers (OR = 1.64 (1.43-1.88)), obese versus healthy-weight men (OR = 1.27 (1.14-1.41)) and for comorbid conditions (e.g., heart disease versus no heart disease, OR = 1.36 (1.24-1.49)), and particularly for severe versus no physical functional limitation (OR = 5.17 (4.51-5.93)). Conclusions: LUTS was associated with a number of factors, including modifiable risk factors, suggesting potential targets for prevention.	[Smith, David P.] NSW Canc Council, Canc Res Div, Sydney, NSW, Australia; [Smith, David P.; Weber, Marianne F.] Griffith Univ, Griffith Hlth Inst, Gold Coast, Qld, Australia; [Weber, Marianne F.; Patel, Manish I.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Soga, Kay; Korda, Rosemary J.; Banks, Emily] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Tikellis, Gabriella; Dwyer, Terry] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Clements, Mark S.] Karolinska Inst, Stockholm, Sweden; [Latz, Isabel K.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Banks, Emily] Sax Inst, Sydney, NSW, Australia	Cancer Council New South Wales; Griffith University; Menzies Health Institute Queensland; University of Sydney; Australian National University; Murdoch Children's Research Institute; Karolinska Institutet; University of California System; University of California Los Angeles; University of Sydney	Smith, DP (corresponding author), NSW Canc Council, Canc Res Div, Sydney, NSW, Australia.	dsmith@nswcc.org.au	lei, cao/ABA-7520-2021; Clements, Mark/W-5906-2018	Clements, Mark/0000-0003-4518-5670; Banks, Emily/0000-0002-4617-1302; Korda, Rosemary/0000-0002-9390-2171; Weber, Marianne/0000-0001-5731-9651; Smith, David/0000-0002-1474-3214	National Health and Medical Research Council of Australia [APP1016598, APP1042717, APP1024450]; Pharmaceutical Society of Western Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Pharmaceutical Society of Western Australia	DPS (APP1016598) and EB (APP1042717) are supported by the National Health and Medical Research Council of Australia, https://www.nhmrc.gov.au/. This project was supported in part by a JM O'Hara Grant from the Pharmaceutical Society of Western Australia, http://www.pswa.org.au/, and by a National Health and Medical Research Council of Australia project grant (APP1024450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlantis E, 2011, SOC PSYCH PSYCH EPID, V46, P1303, DOI 10.1007/s00127-010-0302-3; Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Banks E, 2010, MED J AUSTRALIA, V193, pS62; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Boyle P, 2003, BJU INT, V92, P409, DOI 10.1046/j.1464-410X.2003.04369.x; Coyne KS, 2009, BJU INT, V103, P24, DOI 10.1111/j.1464-410X.2009.08438.x; Coyne KS, 2009, BJU INT, V103, P4, DOI 10.1111/j.1464-410X.2009.08371.x; Coyne KS, 2009, BJU INT; Girman CJ, 1998, UROLOGY, V51, P428, DOI 10.1016/S0090-4295(97)00717-6; Hays RD, 2007, MED CARE, V45, pS32, DOI 10.1097/01.mlr.0000246649.43232.82; Holden CA, 2005, LANCET, V366, P218, DOI 10.1016/S0140-6736(05)66911-5; Holden CA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-96; Irwin DE, 2009, EUR UROL, V56, P14, DOI 10.1016/j.eururo.2009.02.026; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kirby M, 2013, INT J CLIN PRACT, V67, P606, DOI 10.1111/ijcp.12176; Latz I, 2012, WORLD J UROLOGY; Malmsten UGH, 2010, EUR UROL, V58, P149, DOI 10.1016/j.eururo.2010.03.014; Maserejian NN, 2012, J UROLOGY, V188, P490, DOI 10.1016/j.juro.2012.03.128; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Mondul AM, 2014, J UROLOGY, V191, P715, DOI 10.1016/j.juro.2013.08.110; Parsons JK, 2008, EUR UROL, V53, P1228, DOI 10.1016/j.eururo.2008.02.019; Parsons JK, 2011, EUR UROL, V60, P1173, DOI 10.1016/j.eururo.2011.07.040; Parsons JK, 2009, J UROLOGY, V182, pS27, DOI 10.1016/j.juro.2009.07.086; Parsons JK, 2009, J UROLOGY, V182, P1463, DOI 10.1016/j.juro.2009.06.038; Perchon LFG, 2011, NEUROUROL URODYNAM, V30, P515, DOI 10.1002/nau.21008; Platz EA, 1999, AM J EPIDEMIOL, V149, P106, DOI 10.1093/oxfordjournals.aje.a009775; Rohrmann S, 2004, AM J EPIDEMIOL, V159, P390, DOI 10.1093/aje/kwh060; Seim A, 2005, BJU INT, V96, P88, DOI 10.1111/j.1464-410X.2005.05573.x; Sexton CC, 2009, BJU INT, V103, P12, DOI 10.1111/j.1464-410X.2009.08369.x; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Stroup SP, 2012, BJU INT, V109, P84, DOI 10.1111/j.1464-410X.2011.10250.x; Suzuki S, 2002, AM J CLIN NUTR, V75, P689, DOI 10.1093/ajcn/75.4.689; Wennberg AL, 2011, EUR UROL, V59, P1032, DOI 10.1016/j.eururo.2011.03.007; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	35	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109278	10.1371/journal.pone.0109278	http://dx.doi.org/10.1371/journal.pone.0109278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333345	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200020
J	Yang, XY; Steukers, L; Forier, K; Xiong, RH; Braeckmans, K; Van Reeth, K; Nauwynck, H				Yang, Xiaoyun; Steukers, Lennert; Forier, Katrien; Xiong, Ranhua; Braeckmans, Kevin; Van Reeth, Kristien; Nauwynck, Hans			A Beneficiary Role for Neuraminidase in Influenza Virus Penetration through the Respiratory Mucus	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; SURFACTANT PROTEIN-D; A VIRUSES; SUBSTRATE-SPECIFICITY; RECEPTOR SPECIFICITY; AIRWAY EPITHELIUM; PROTECTIVE ROLE; VIRAL PROTEIN; SIALIC ACIDS; INFECTION	Swine influenza virus (SIV) has a strong tropism for pig respiratory mucosa, which consists of a mucus layer, epithelium, basement membrane and lamina propria. Sialic acids present on the epithelial surface have long been considered to be determinants of influenza virus tropism. However, mucus which is also rich in sialic acids may serve as the first barrier of selection. It was investigated how influenza virus interacts with the mucus to infect epithelial cells. Two techniques were applied to track SIV H1N1 in porcine mucus. The microscopic diffusion of SIV particles in the mucus was analyzed by single particle tracking (SPT), and the macroscopic penetration of SIV through mucus was studied by a virus in-capsule-mucus penetration system, followed by visualizing the translocation of the virions with time by immunofluorescence staining. Furthermore, the effects of neuraminidase on SIV getting through or binding to the mucus were studied by using zanamivir, a neuraminidase inhibitor (NAI), and Arthrobacter ureafaciens neuraminidase. The distribution of the diffusion coefficient shows that 70% of SIV particles were entrapped, while the rest diffused freely in the mucus. Additionally, SIV penetrated the porcine mucus with time, reaching a depth of 65 mm at 30 min post virus addition, 2 fold of that at 2 min. Both the microscopic diffusion and macroscopic penetration were largely diminished by NAI, while were clearly increased by the effect of exogenous neuraminidase. Moreover, the exogenous neuraminidase sufficiently prevented the binding of SIV to mucus which was reversely enhanced by effect of NAI. These findings clearly show that the neuraminidase helps SIV move through the mucus, which is important for the virus to reach and infect epithelial cells and eventually become shed into the lumen of the respiratory tract.	[Yang, Xiaoyun; Steukers, Lennert; Van Reeth, Kristien; Nauwynck, Hans] Univ Ghent, Fac Vet Med, Virol Lab, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Forier, Katrien; Xiong, Ranhua; Braeckmans, Kevin] Univ Ghent, Lab Gen Biochem & Phys Pharm, B-9000 Ghent, Belgium; [Forier, Katrien; Xiong, Ranhua; Braeckmans, Kevin] Univ Ghent, Ctr Nano & Biophoton, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Nauwynck, H (corresponding author), Univ Ghent, Fac Vet Med, Virol Lab, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	hans.nauwynck@ugent.be	xiong, ranhua/ABH-6408-2020; Braeckmans, Kevin/HCH-3119-2022	Braeckmans, Kevin/0000-0002-7993-6295; Forier, Katrien/0000-0002-7003-3612; Nauwynck, Hans/0000-0001-5470-0713	Research Council of Ghent University, Belgium [01G01311]; Belgian Science Policy (BELSPO)	Research Council of Ghent University, Belgium; Belgian Science Policy (BELSPO)(Belgian Federal Science Policy Office)	This research was supported by the Concerted Research Action 01G01311 of the Research Council of Ghent University, Belgium. HJN is a member of BELVIR consortium (IAP, phase VII) sponsored by Belgian Science Policy (BELSPO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 2009, J VIROL, V83, P4023, DOI 10.1128/JVI.02391-08; Bisaillon M, 1999, J MOL BIOL, V286, P759, DOI 10.1006/jmbi.1998.2495; Bradley KC, 2011, VIROLOGY, V413, P169, DOI 10.1016/j.virol.2011.01.027; Braeckmans K, 2010, NANO LETT, V10, P4435, DOI 10.1021/nl103264u; Braeckmans KVD, 2010, SCI TECH NEWS, V64, P92; Brooke CB, 2013, J VIROL, V87, P3155, DOI 10.1128/JVI.02284-12; Celli JP, 2009, P NATL ACAD SCI USA, V106, P14321, DOI 10.1073/pnas.0903438106; Chen LM, 2011, VIROLOGY, V412, P401, DOI 10.1016/j.virol.2011.01.015; Cohen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-321; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; COUCEIRO JNSS, 1994, MEM I OSWALDO CRUZ, V89, P587, DOI 10.1590/S0074-02761994000400015; Crisci E, 2013, MOL IMMUNOL, V55, P200, DOI 10.1016/j.molimm.2013.02.008; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; De Vleeschauwer A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006662; DESTGROTH SF, 1952, J HYG-CAMBRIDGE, V50, P471, DOI 10.1017/S0022172400019756; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Duerrwald R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061597; Ehre C, 2012, P NATL ACAD SCI USA, V109, P16528, DOI 10.1073/pnas.1206552109; Frederick JR, 2005, GLYCOBIOLOGY, V15, p53R, DOI 10.1093/glycob/cwj007; Gambaryan AS, 2005, VIRUS RES, V114, P15, DOI 10.1016/j.virusres.2005.05.005; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; Itamura S, 1997, Nihon Rinsho, V55, P2570; Kobasa D, 1999, J VIROL, V73, P6743, DOI 10.1128/JVI.73.8.6743-6751.1999; LEITCH GJ, 1988, AM J TROP MED HYG, V39, P282, DOI 10.4269/ajtmh.1988.39.282; Lillehoj EP, 2002, ARCH PHARM RES, V25, P770, DOI 10.1007/BF02976990; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Olmsted SS, 2003, SEX TRANSM DIS, V30, P257, DOI 10.1097/00007435-200303000-00016; Peltola VT, 2005, J INFECT DIS, V192, P249, DOI 10.1086/430954; Pittet LA, 2010, AM J RESP CELL MOL, V42, P450, DOI 10.1165/rcmb.2007-0417OC; Ramos I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00117; Roberts KL, 2011, J GEN VIROL, V92, P1822, DOI 10.1099/vir.0.031203-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schicht M, 2013, AM J RHINOL ALLERGY, V27, P24, DOI 10.2500/ajra.2013.27.3838; Schwegmann-Wessels C, 2006, GLYCOCONJUGATE J, V23, P51, DOI 10.1007/s10719-006-5437-9; SETO JT, 1969, J VIROL, V4, P58, DOI 10.1128/JVI.4.1.58-66.1969; Shtyrya YA, 2009, ACTA NATURAE, V1, P26, DOI 10.32607/20758251-2009-1-2-26-32; Silva AJ, 2003, MICROBIOL-SGM, V149, P1883, DOI 10.1099/mic.0.26086-0; Sorrell EM, 2011, CURR OPIN VIROL, V1, P635, DOI 10.1016/j.coviro.2011.07.003; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Thacker E, 2008, J INFECT DIS, V197, pS19, DOI 10.1086/524988; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Tjabringa GS, 2005, FEMS IMMUNOL MED MIC, V45, P151, DOI 10.1016/j.femsim.2005.03.004; Torremorell M., 2012, TRANSBOUND EMERG DIS; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051054; Yassine Hadi M., 2010, Animal Health Research Reviews, V11, P53, DOI 10.1017/S1466252310000137	52	60	63	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110026	10.1371/journal.pone.0110026	http://dx.doi.org/10.1371/journal.pone.0110026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333824	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200079
J	Chaki, M; Kovacs, I; Spannagl, M; Lindermayr, C				Chaki, Mounira; Kovacs, Izabella; Spannagl, Manuel; Lindermayr, Christian			Computational Prediction of Candidate Proteins for S-Nitrosylation in Arabidopsis thaliana	PLOS ONE			English	Article							NITRIC-OXIDE BIOACTIVITY; RIBOSOMAL-PROTEINS; PROTEOMIC ANALYSIS; CELL-DEATH; TYROSINE NITRATION; REACTIVE NITROGEN; REDOX REGULATION; PLANT IMMUNITY; ABIOTIC STRESS; IDENTIFICATION	Nitric oxide (NO) is an important signaling molecule that regulates many physiological processes in plants. One of the most important regulatory mechanisms of NO is S-nitrosylation-the covalent attachment of NO to cysteine residues. Although the involvement of cysteine S-nitrosylation in the regulation of protein functions is well established, its substrate specificity remains unknown. Identification of candidates for S-nitrosylation and their target cysteine residues is fundamental for studying the molecular mechanisms and regulatory roles of S-nitrosylation in plants. Several experimental methods that are based on the biotin switch have been developed to identify target proteins for S-nitrosylation. However, these methods have their limits. Thus, computational methods are attracting considerable attention for the identification of modification sites in proteins. Using GPS-SNO version 1.0, a recently developed S-nitrosylation site-prediction program, a set of 16,610 candidate proteins for S-nitrosylation containing 31,900 S-nitrosylation sites was isolated from the entire Arabidopsis proteome using the medium threshold. In the compartments "chloroplast,'' "CUL4-RING ubiquitin ligase complex,'' and "membrane'' more than 70% of the proteins were identified as candidates for S-nitrosylation. The high number of identified candidates in the proteome reflects the importance of redox signaling in these compartments. An analysis of the functional distribution of the predicted candidates showed that proteins involved in signaling processes exhibited the highest prediction rate. In a set of 46 proteins, where 53 putative S-nitrosylation sites were already experimentally determined, the GPS-SNO program predicted 60 S-nitrosylation sites, but only 11 overlap with the results of the experimental approach. In general, a computer-assisted method for the prediction of targets for S-nitrosylation is a very good tool; however, further development, such as including the three dimensional structure of proteins in such analyses, would improve the identification of S-nitrosylation sites.	[Chaki, Mounira; Kovacs, Izabella; Lindermayr, Christian] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Biochem Plant Pathol, Neuherberg, Germany; [Spannagl, Manuel] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Bioinformat & Syst Biol, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lindermayr, C (corresponding author), Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Biochem Plant Pathol, Neuherberg, Germany.	lindermayr@helmholtz-muenchen.de	Lindermayr, Christian/M-7338-2014; Chaki, Mounira/H-6785-2015	Lindermayr, Christian/0000-0002-9343-4996; Chaki, Mounira/0000-0002-8393-7012; Spannagl, Manuel/0000-0003-0701-7035	Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (Call: FP7-PEOPLE-IEF) [300176]; Bundesministerium fur Forschung und Bildung	Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (Call: FP7-PEOPLE-IEF); Bundesministerium fur Forschung und Bildung(Federal Ministry of Education & Research (BMBF))	This work was supported by Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (Call: FP7-PEOPLE-2011-IEF) under grant agreement no300176 and the Bundesministerium fur Forschung und Bildung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abat JK, 2008, FEBS J, V275, P2862, DOI 10.1111/j.1742-4658.2008.06425.x; Abat JK, 2009, PROTEOMICS, V9, P4368, DOI 10.1002/pmic.200800985; Allen JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026372; Astier J, 2012, BIOCHEM J, V447, P249, DOI 10.1042/BJ20120257; Astier J, 2012, FREE RADICAL BIO MED, V53, P1101, DOI 10.1016/j.freeradbiomed.2012.06.032; Baier M, 2005, J EXP BOT, V56, P1449, DOI 10.1093/jxb/eri161; Begara-Morales JC, 2013, J EXP BOT; Begara-Morales JC, 2013, J EXP BOT, V64, P1121, DOI 10.1093/jxb/ert006; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; Camejo D, 2013, J PROTEOMICS, V79, P87, DOI 10.1016/j.jprot.2012.12.003; Chaki M, 2009, PLANT CELL PHYSIOL, V50, P265, DOI 10.1093/pcp/pcn196; Chen YJ, 2010, J PROTEOME RES, V9, P6417, DOI 10.1021/pr100680a; Chen YY, 2008, J BIOL CHEM, V283, P35265, DOI 10.1074/jbc.M805287200; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Christian JO, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00207; Ckless K, 2004, NITRIC OXIDE-BIOL CH, V11, P216, DOI 10.1016/j.niox.2004.06.002; Corpas FJ, 2008, PLANT CELL PHYSIOL, V49, P1711, DOI 10.1093/pcp/pcn144; Lombardo MC, 2006, PLANT SIGNAL BEHAV, V1, P28, DOI 10.4161/psb.1.1.2398; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Doulias PT, 2010, P NATL ACAD SCI USA, V107, P16958, DOI 10.1073/pnas.1008036107; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Ferreyra MLF, 2010, PLANT PHYSIOL, V153, P1878, DOI 10.1104/pp.110.157057; Fares A, 2011, BIOCHEM BIOPH RES CO, V416, P331, DOI 10.1016/j.bbrc.2011.11.036; Ferl RJ, 2002, GENOME BIOL, V3; Frohlich A, 2012, PLANT PHYSIOL, V159, P902, DOI 10.1104/pp.112.198077; Fujikura U, 2009, PLANT J, V59, P499, DOI 10.1111/j.1365-313X.2009.03886.x; Galatro A, 2013, PLANT PHYSIOL BIOCH, V66, P26, DOI 10.1016/j.plaphy.2013.01.019; Garcia-Mata C, 2002, PLANT PHYSIOL, V128, P790, DOI 10.1104/pp.011020; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; Hao G, 2004, J BIOL CHEM, V279, P36192, DOI 10.1074/jbc.M404866200; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Holtgrefe S, 2008, PHYSIOL PLANTARUM, V133, P211, DOI 10.1111/j.1399-3054.2008.01066.x; Holzmeister C, 2011, PROTEOMICS, V11, P1664, DOI 10.1002/pmic.201000652; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kato H, 2013, PHYSIOL PLANTARUM, V148, P371, DOI 10.1111/j.1399-3054.2012.01684.x; Kohr MJ, 2014, J MOL CELL CARDIOL, V69, P67, DOI 10.1016/j.yjmcc.2014.01.010; Kovacs I, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00137; Kuncewicz T, 2003, MOL CELL PROTEOMICS, V2, P156, DOI 10.1074/mcp.M300003-MCP200; Kwon E, 2012, PLANTA, V236, P887, DOI 10.1007/s00425-012-1697-8; Lee TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021849; Lin AH, 2012, PLANT PHYSIOL, V158, P451, DOI 10.1104/pp.111.184531; Lindermayr C, 2006, J BIOL CHEM, V281, P4285, DOI 10.1074/jbc.M511635200; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Liu MA, 2010, ANAL CHEM, V82, P7160, DOI 10.1021/ac100569d; Liu ZX, 2011, MOL BIOSYST, V7, P1197, DOI 10.1039/c0mb00279h; Maldonado-Alconada AM, 2011, ACTA PHYSIOL PLANT, V33, P1493, DOI 10.1007/s11738-010-0688-2; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042; Misra AN, 2014, NITRIC OXIDE-BIOL CH, V39, P35, DOI 10.1016/j.niox.2014.04.003; Ng JY, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120148; Ortega-Galisteo AP, 2012, J EXP BOT, V63, P2089, DOI 10.1093/jxb/err414; Palmieri MC, 2010, PLANT PHYSIOL, V152, P1514, DOI 10.1104/pp.109.152579; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Perazzolli M, 2004, PLANT CELL, V16, P2785, DOI 10.1105/tpc.104.025379; Pinon V, 2008, DEVELOPMENT, V135, P1315, DOI 10.1242/dev.016469; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Romero-Puertas MC, 2008, PROTEOMICS, V8, P1459, DOI 10.1002/pmic.200700536; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; Rosado A, 2010, PLANT CELL, V22, P143, DOI 10.1105/tpc.109.068320; Schippers JHM, 2012, CELL MOL LIFE SCI, V69, P3245, DOI 10.1007/s00018-012-1092-4; Sehrawat A, 2014, J PROTEOME RES; Sirova J, 2011, PLANT SCI, V181, P560, DOI 10.1016/j.plantsci.2011.03.014; Song CX, 2012, MOL CELL PROTEOMICS, V11, P1070, DOI 10.1074/mcp.M111.012625; Spadaro D, 2010, PHYSIOL PLANTARUM, V138, P360, DOI 10.1111/j.1399-3054.2009.01307.x; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Su MG, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S16-S2; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Szakonyi D, 2011, PLANT J, V65, P269, DOI 10.1111/j.1365-313X.2010.04422.x; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Taldone FS, 2005, NITRIC OXIDE-BIOL CH, V13, P176, DOI 10.1016/j.niox.2005.06.004; Tanou G, 2012, PLANT J, V72, P585, DOI 10.1111/j.1365-313X.2012.05100.x; Tanou G, 2009, PLANT J, V60, P795, DOI 10.1111/j.1365-313X.2009.04000.x; Tavares CP, 2014, BBA-PROTEINS PROTEOM, V1844, P810, DOI 10.1016/j.bbapap.2014.02.015; Terrile MC, 2012, PLANT J, V70, P492, DOI 10.1111/j.1365-313X.2011.04885.x; Tewari RK, 2013, PLANT CELL REP, V32, P31, DOI 10.1007/s00299-012-1338-5; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; van der Linde K, 2011, PLANT PHYSIOL BIOCH, V49, P946, DOI 10.1016/j.plaphy.2011.06.009; Wang YQ, 2009, J BIOL CHEM, V284, P2131, DOI 10.1074/jbc.M806782200; Xu Y, 2013, PEERJ, V1, DOI 10.7717/peerj.171; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Xue Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011290; Yang Ning-Sun, 2011, COMPUTATIONAL PREDIC, P105; Yao Y, 2008, DEVELOPMENT, V135, P1325, DOI 10.1242/dev.017913; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427; Zaffagninia M, 2014, MOL PLANT, V7, P101, DOI 10.1093/mp/sst139; Zaman K, 2006, MOL PHARMACOL, V70, P1435, DOI 10.1124/mol.106.023242	92	25	26	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110232	10.1371/journal.pone.0110232	http://dx.doi.org/10.1371/journal.pone.0110232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333472	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200029
J	Collery, RF; Veth, KN; Dubis, AM; Carroll, J; Link, BA				Collery, Ross F.; Veth, Kerry N.; Dubis, Adam M.; Carroll, Joseph; Link, Brian A.			Rapid, Accurate, and Non-Invasive Measurement of Zebrafish Axial Length and Other Eye Dimensions Using SD-OCT Allows Longitudinal Analysis of Myopia and Emmetropization	PLOS ONE			English	Article							REFRACTIVE ERROR; OUTDOOR ACTIVITY; MOUSE MODEL; PROMOTER; PREVALENCE; EXPRESSION; GROWTH; LENS; PROTEIN; SCLERA	Refractive errors in vision can be caused by aberrant axial length of the eye, irregular corneal shape, or lens abnormalities. Causes of eye length overgrowth include multiple genetic loci, and visual parameters. We evaluate zebrafish as a potential animal model for studies of the genetic, cellular, and signaling basis of emmetropization and myopia. Axial length and other eye dimensions of zebrafish were measured using spectral domain-optical coherence tomography (SD-OCT). We used ocular lens and body metrics to normalize and compare eye size and relative refractive error (difference between observed retinal radial length and controls) in wild-type and lrp2 zebrafish. Zebrafish were dark-reared to assess effects of visual deprivation on eye size. Two relative measurements, ocular axial length to body length and axial length to lens diameter, were found to accurately normalize comparisons of eye sizes between different sized fish (R-2 = 0.9548, R-2 = 0.9921). Ray-traced focal lengths of wild-type zebrafish lenses were equal to their retinal radii, while lrp2 eyes had longer retinal radii than focal lengths. Both genetic mutation (lrp2) and environmental manipulation (dark-rearing) caused elongated eye axes. lrp2 mutants had relative refractive errors of -0.327 compared to wild-types, and dark-reared wild-type fish had relative refractive errors of -0.132 compared to light-reared siblings. Therefore, zebrafish eye anatomy (axial length, lens radius, retinal radius) can be rapidly and accurately measured by SD-OCT, facilitating longitudinal studies of regulated eye growth and emmetropization. Specifically, genes homologous to human myopia candidates may be modified, inactivated or overexpressed in zebrafish, and myopia-sensitizing conditions used to probe gene-environment interactions. Our studies provide foundation for such investigations into genetic contributions that control eye size and impact refractive errors.	[Collery, Ross F.; Veth, Kerry N.; Dubis, Adam M.; Carroll, Joseph; Link, Brian A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Carroll, Joseph] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [Carroll, Joseph] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Link, BA (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	blink@mcw.edu			Research Training Program in Vision Sciences Grants [T32EYE014537]; National Institutes of Health [R01EY16060]; National Eye Institute [P30EY001931]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY001931, R01EY016060] Funding Source: NIH RePORTER	Research Training Program in Vision Sciences Grants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by Research Training Program in Vision Sciences Grants T32EYE014537 (KNV; AMD)(https://www.nei.nih.gov/funding/neifm.asp); National Institutes of Health Grant R01EY16060 (BAL)(https://www.nei.nih.gov/funding/neifm.asp); and National Eye Institute Core Facilities Grant P30EY001931 (https://www.nei.nih.gov/funding/neifm.asp), and an unrestricted Departmental grant from Research to Prevent Blindness (JC)(https://www.rpbusa.org/rpb/grants/grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WT, 2004, VISUAL NEUROSCI, V21, P945, DOI 10.1017/S0952523804216145; Atchison DA, 2004, INVEST OPHTH VIS SCI, V45, P3380, DOI 10.1167/iovs.04-0292; Baird PN, 2010, PROG RETIN EYE RES, V29, P520, DOI 10.1016/j.preteyeres.2010.05.004; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Burton T C, 1989, Trans Am Ophthalmol Soc, V87, P143; CHARMAN WN, 1973, VISION RES, V13, P1, DOI 10.1016/0042-6989(73)90160-0; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Fleisch VC, 2006, ZEBRAFISH, V3, P191, DOI 10.1089/zeb.2006.3.191; Godinho L, 2005, DEVELOPMENT, V132, P5069, DOI 10.1242/dev.02075; Graham B, 1999, VISION RES, V39, P189, DOI 10.1016/S0042-6989(98)00189-8; Hawthorne FA, 2013, EXP EYE RES, V114, P141, DOI 10.1016/j.exer.2012.12.015; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; Ho J, 2010, INVEST OPHTH VIS SCI, V51, P3714, DOI 10.1167/iovs.09-4057; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; HOYT CS, 1981, AM J OPHTHALMOL, V91, P197, DOI 10.1016/0002-9394(81)90173-2; Hsi E, 2013, INVEST OPHTH VIS SCI, V54, P3265, DOI 10.1167/iovs.13-11814; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Kennedy BN, 2001, J BIOL CHEM, V276, P14037, DOI 10.1074/jbc.M010490200; Kennedy BN, 2007, INVEST OPHTH VIS SCI, V48, P522, DOI 10.1167/iovs.06-0975; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Makhankov YV, 2004, J NEUROSCI METH, V135, P205, DOI 10.1016/j.jneumeth.2003.12.015; Matsumura H, 1999, SURV OPHTHALMOL, V44, pS109, DOI 10.1016/S0039-6257(99)00094-6; Matthiessen L., 1882, ARCH GESAMTE PHYSIOL, V27, P510, DOI DOI 10.1007/BF01802978; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; Meyer C, 1999, SURV OPHTHALMOL, V44, pS93, DOI 10.1016/S0039-6257(99)00091-0; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Norton TT, 2006, INVEST OPHTH VIS SCI, V47, P4700, DOI 10.1167/iovs.05-1641; Pardue MT, 2008, INVEST OPHTH VIS SCI, V49, P706, DOI 10.1167/iovs.07-0643; Pardue MT, 2013, EXP EYE RES, V114, P96, DOI 10.1016/j.exer.2012.12.014; Park HN, 2012, OPTOMETRY VISION SCI, V89, P296, DOI 10.1097/OPX.0b013e31824529e5; Pizzarello L, 2004, ARCH OPHTHALMOL-CHIC, V122, P615, DOI 10.1001/archopht.122.4.615; Prashar A, 2009, EXP EYE RES, V89, P42, DOI 10.1016/j.exer.2009.02.008; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Ritchey ER, 2012, EXP EYE RES, V102, P59, DOI 10.1016/j.exer.2012.07.001; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P3174; Schippert R, 2007, INVEST OPHTH VIS SCI, V48, P11, DOI 10.1167/iovs.06-0851; Schroeter EH, 2006, VISUAL NEUROSCI, V23, P833, DOI 10.1017/S0952523806230219; Shand J, 1999, VISION RES, V39, P1071, DOI 10.1016/S0042-6989(98)00215-6; Shen W, 2005, INVEST OPHTH VIS SCI, V46, P1797, DOI 10.1167/iovs.04-1318; Shen W, 2007, INVEST OPHTH VIS SCI, V48, P4829, DOI 10.1167/iovs.06-1273; SHERMAN SM, 1977, BRAIN RES, V124, P154, DOI 10.1016/0006-8993(77)90872-1; Shields CR, 2007, J COMP NEUROL, V501, P765, DOI 10.1002/cne.21282; Siegwart JT, 2010, EXP EYE RES, V91, P660, DOI 10.1016/j.exer.2010.08.010; SMITH EL, 1994, VISION RES, V34, P293, DOI 10.1016/0042-6989(94)90088-4; Stujenske JM, 2011, INVEST OPHTH VIS SCI, V52, P4200, DOI 10.1167/iovs.10-6434; Tkatchenko TV, 2013, EXP EYE RES, V115, P87, DOI 10.1016/j.exer.2013.06.025; Verhoeven VJM, 2013, NAT GENET, V45, P712, DOI 10.1038/ng0613-712b; Veth KN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001310; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; WIESEL TN, 1977, NATURE, V266, P66, DOI 10.1038/266066a0; Yeh LK, 2010, J BIOL CHEM, V285, P28141, DOI 10.1074/jbc.M109.043679; Yin G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043172	60	37	38	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110699	10.1371/journal.pone.0110699	http://dx.doi.org/10.1371/journal.pone.0110699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25334040	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200067
J	Donnelly, NA; Holtzman, T; Rich, PD; Nevado-Holgado, AJ; Fernando, ABP; Van Dijck, G; Holzhammer, T; Paul, O; Ruther, P; Paulsen, O; Robbins, TW; Dalley, JW				Donnelly, Nicholas A.; Holtzman, Tahl; Rich, P. Dylan; Nevado-Holgado, Alejo J.; Fernando, Anushka B. P.; Van Dijck, Gert; Holzhammer, Tobias; Paul, Oliver; Ruther, Patrick; Paulsen, Ole; Robbins, Trevor W.; Dalley, Jeffrey W.			Oscillatory Activity in the Medial Prefrontal Cortex and Nucleus Accumbens Correlates with Impulsivity and Reward Outcome	PLOS ONE			English	Article							REACTION-TIME-TASK; LOCALLY EVOKED-POTENTIALS; VENTRAL STRIATUM; ATTENTIONAL PERFORMANCE; ANTERIOR CINGULATE; FRONTAL-CORTEX; PREPARATORY ATTENTION; ORBITOFRONTAL CORTEX; GAMMA OSCILLATIONS; FIELD POTENTIALS	Actions expressed prematurely without regard for their consequences are considered impulsive. Such behaviour is governed by a network of brain regions including the prefrontal cortex (PFC) and nucleus accumbens (NAcb) and is prevalent in disorders including attention deficit hyperactivity disorder (ADHD) and drug addiction. However, little is known of the relationship between neural activity in these regions and specific forms of impulsive behaviour. In the present study we investigated local field potential (LFP) oscillations in distinct sub-regions of the PFC and NAcb on a 5-choice serial reaction time task (5-CSRTT), which measures sustained, spatially-divided visual attention and action restraint. The main findings show that power in gamma frequency (50-60 Hz) LFP oscillations transiently increases in the PFC and NAcb during both the anticipation of a cue signalling the spatial location of a nose-poke response and again following correct responses. Gamma oscillations were coupled to low-frequency delta oscillations in both regions; this coupling strengthened specifically when an error response was made. Theta (7-9 Hz) LFP power in the PFC and NAcb increased during the waiting period and was also related to response outcome. Additionally, both gamma and theta power were significantly affected by upcoming premature responses as rats waited for the visual cue to respond. In a subgroup of rats showing persistently high levels of impulsivity we found that impulsivity was associated with increased error signals following a nose-poke response, as well as reduced signals of previous trial outcome during the waiting period. Collectively, these in-vivo neurophysiological findings further implicate the PFC and NAcb in anticipatory impulsive responses and provide evidence that abnormalities in the encoding of rewarding outcomes may underlie trait-like impulsive behaviour.	[Donnelly, Nicholas A.; Holtzman, Tahl; Rich, P. Dylan; Nevado-Holgado, Alejo J.; Fernando, Anushka B. P.; Van Dijck, Gert; Paulsen, Ole; Robbins, Trevor W.; Dalley, Jeffrey W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Donnelly, Nicholas A.; Holtzman, Tahl; Rich, P. Dylan; Nevado-Holgado, Alejo J.; Fernando, Anushka B. P.; Van Dijck, Gert; Robbins, Trevor W.; Dalley, Jeffrey W.] Univ Cambridge, Dept Psychol, Cambridge, England; [Rich, P. Dylan] Howard Hughes Med Inst, Ashburn, VA USA; [Nevado-Holgado, Alejo J.; Fernando, Anushka B. P.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Holzhammer, Tobias; Paul, Oliver; Ruther, Patrick] Univ Freiburg, Dept Microsyst Engn, Microsyst Mat Lab, D-79106 Freiburg, Germany; [Paulsen, Ole] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Dalley, Jeffrey W.] Univ Cambridge, Dept Psychiat, Cambridge, England	University of Cambridge; University of Cambridge; Howard Hughes Medical Institute; University of Oxford; University of Freiburg; University of Cambridge; University of Cambridge	Dalley, JW (corresponding author), Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England.	jwd20@cam.ac.uk	Robbins, Trevor W/A-7551-2008; Paulsen, Ole/ABB-4843-2020	Paulsen, Ole/0000-0002-2258-5455; Donnelly, Nicholas/0000-0003-2234-8545; Dalley, Jeffrey/0000-0002-2282-3660; Nevado-Holgado, Alejo/0000-0001-9276-2720; Robbins, Trevor/0000-0003-0642-5977	Information Society Technologies (IST) Integrated Project NeuroProbes of the 6th Framework Program of the European Commission [IST-027017]; Wellcome Trust [093875/Z/10/Z]; Medical Research Council in the United Kingdom [G1000183]; Howard Hughes Medical Institute Janelia Farm graduate programme; Cambridge University School of Clinical Medicine MB/PhD Programme; Isaac Newton Trust at Cambridge University; Wellcome Trust VIP Award; MRC [G1000183, G0701500] Funding Source: UKRI; Medical Research Council [G1000183, G0701500, G0001354, G1000183B, G0001354B] Funding Source: researchfish	Information Society Technologies (IST) Integrated Project NeuroProbes of the 6th Framework Program of the European Commission; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council in the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Howard Hughes Medical Institute Janelia Farm graduate programme; Cambridge University School of Clinical Medicine MB/PhD Programme; Isaac Newton Trust at Cambridge University; Wellcome Trust VIP Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Information Society Technologies (IST) Integrated Project NeuroProbes of the 6th Framework Program of the European Commission (IST-027017) and with assistance from the Howard Hughes Medical Institute Janelia Farm Research Campus, Washington DC, USA. The authors acknowledge funding support from the Wellcome Trust and Medical Research Council in the United Kingdom to the Behavioural and Clinical Neuroscience Institute at Cambridge University (MRC ref: G1000183; Wellcome Trust ref: 093875/Z/10/Z at Cambridge University). PDR was funded by the Howard Hughes Medical Institute Janelia Farm graduate programme. NAD was funded by the Cambridge University School of Clinical Medicine MB/PhD Programme. TH was supported by a grant from the Isaac Newton Trust at Cambridge University and a Wellcome Trust VIP Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; [Anonymous], P NATL ACAD SCI, V104, P5644; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Basar K, 2010, PROG NEUROBIOL, V92, P533, DOI 10.1016/j.pneurobio.2010.08.007; Bates D.M., 2010, LME4 MIXED EFFECTS M; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; BERENDSE HW, 1991, NEUROSCIENCE, V42, P73, DOI 10.1016/0306-4522(91)90151-D; Berke JD, 2009, EUR J NEUROSCI, V30, P848, DOI 10.1111/j.1460-9568.2009.06843.x; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Besson M, 2009, NEUROPSYCHOPHARMACOL; Besson M, 2013, NEUROPSYCHOPHARMACOL, V38, P1963, DOI 10.1038/npp.2013.95; Blondeau C, 2007, BIOL PSYCHIAT, V61, P1340, DOI 10.1016/j.biopsych.2006.06.030; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Bruns A, 2004, INT J PSYCHOPHYSIOL, V51, P97, DOI 10.1016/j.ijpsycho.2003.07.001; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Caprioli D, 2014, BIOL PSYCHIAT, V75, P115, DOI 10.1016/j.biopsych.2013.07.013; Caprioli D, 2013, NEUROPSYCHOPHARMACOL, V38, P1460, DOI 10.1038/npp.2013.44; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cardinal RN, 2010, BEHAV RES METHODS, V42, P1059, DOI 10.3758/BRM.42.4.1059; Christakou A, 2004, J NEUROSCI, V24, P773, DOI 10.1523/JNEUROSCI.0949-03.2004; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P875, DOI 10.1162/jocn.2009.21062; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dvorak D, 2014, J NEUROSCI METH, V225, P42, DOI 10.1016/j.jneumeth.2014.01.002; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Dzirasa K, 2010, J NEUROSCI, V30, P16314, DOI 10.1523/JNEUROSCI.4289-10.2010; Economidou D, 2012, NEUROPSYCHOPHARMACOL, V37, P2057, DOI 10.1038/npp.2012.53; Economidou D, 2009, BIOL PSYCHIAT, V65, P851, DOI 10.1016/j.biopsych.2008.12.008; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022033; Fernando ABP, 2012, PSYCHOPHARMACOLOGY, V219, P341, DOI 10.1007/s00213-011-2408-z; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; Goldstein BL, 2012, J NEUROSCI, V32, P2027, DOI 10.1523/JNEUROSCI.5349-11.2012; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Goto Y, 2001, J NEUROSCI, V21, P4498, DOI 10.1523/JNEUROSCI.21-12-04498.2001; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; GROENEWEGEN HJ, 1987, NEUROSCIENCE, V23, P103, DOI 10.1016/0306-4522(87)90275-2; Gruber AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005062; Herwik S, 2011, J MICROELECTROMECH S, V20, P791, DOI 10.1109/JMEMS.2011.2148159; Horst NK, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00056; Howe MW, 2011, P NATL ACAD SCI USA, V108, P16801, DOI 10.1073/pnas.1113158108; Humby T, 1999, EUR J NEUROSCI, V11, P2813, DOI 10.1046/j.1460-9568.1999.00701.x; Humphries MD, 2010, PROG NEUROBIOL, V90, P385, DOI 10.1016/j.pneurobio.2009.11.003; Hyman JM, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/neuro.07.002.2010; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Johansen EB, 2002, BEHAV BRAIN RES, V130, P37, DOI 10.1016/S0166-4328(01)00434-X; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jupp B, 2013, EUR J NEUROSCI, V37, P1519, DOI 10.1111/ejn.12146; Kalenscher T, 2010, J NEUROPHYSIOL, V103, P1658, DOI 10.1152/jn.00432.2009; Kay LM, 1998, BEHAV NEUROSCI, V112, P541, DOI 10.1037/0735-7044.112.3.541; Kim H, 2013, J NEUROSCI, V33, P52, DOI 10.1523/JNEUROSCI.2422-12.2013; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Lazic SE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-5; LEUNG LS, 1993, CAN J PHYSIOL PHARM, V71, P311, DOI 10.1139/y93-049; Mailly P, 2013, J NEUROSCI, V33, P5718, DOI 10.1523/JNEUROSCI.5248-12.2013; Masimore B, 2005, NEUROREPORT, V16, P2021, DOI 10.1097/00001756-200512190-00010; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; McGinty VB, 2013, NEURON, V78, P910, DOI 10.1016/j.neuron.2013.04.010; McKittrick CR, 2007, J NEUROCHEM, V100, P1247, DOI 10.1111/j.1471-4159.2006.04300.x; MISGELD U, 1979, EXP BRAIN RES, V34, P575; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Moreno M, 2013, PSYCHOPHARMACOLOGY, V228, P19, DOI 10.1007/s00213-013-3010-3; Muir JL, 1996, CEREB CORTEX, V6, P470, DOI 10.1093/cercor/6.3.470; Narayanan NS, 2008, J NEUROPHYSIOL, V100, P520, DOI 10.1152/jn.00035.2008; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; Narayanan NS, 2013, NAT NEUROSCI, V16, P1888, DOI 10.1038/nn.3549; Narayanan NS, 2009, J NEUROPHYSIOL, V101, P2859, DOI 10.1152/jn.90615.2008; Onslow ACE, 2011, PROG BIOPHYS MOL BIO, V105, P49, DOI 10.1016/j.pbiomolbio.2010.09.007; Passetti F, 2002, CEREB CORTEX, V12, P1254, DOI 10.1093/cercor/12.12.1254; Patel AX, 2014, NEUROIMAGE; Pattij T, 2007, PSYCHOPHARMACOLOGY, V191, P587, DOI 10.1007/s00213-006-0533-x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PENNARTZ CMA, 1990, BRAIN RES, V529, P30, DOI 10.1016/0006-8993(90)90808-O; Pezze MA, 2007, NEUROPSYCHOPHARMACOL, V32, P273, DOI 10.1038/sj.npp.1301073; Pothuizen HHJ, 2005, EUR J NEUROSCI, V22, P2605, DOI 10.1111/j.1460-9568.2005.04388.x; R Core Team, 2020, R LANG ENV STAT COMP; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Robinson ESJ, 2009, BEHAV BRAIN RES, V196, P310, DOI 10.1016/j.bbr.2008.09.021; Ruther P, 2011, IEEE ENG MED BIO, P2284, DOI 10.1109/IEMBS.2011.6090575; Ruther P, 2010, IEEJ T ELECTR ELECTR, V5, P505, DOI 10.1002/tee.20566; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Steiner AP, 2014, NAT NEUROSCI, V17, P995, DOI 10.1038/nn.3740; Steiner AP, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00131; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Totah NKB, 2013, J NEUROPHYSIOL, V110, P75, DOI 10.1152/jn.00784.2012; Totah NKB, 2013, CEREB CORTEX, V23, P729, DOI 10.1093/cercor/bhs057; Totah NKB, 2009, J NEUROSCI, V29, P6418, DOI 10.1523/JNEUROSCI.1142-09.2009; UCHIMURA N, 1989, J NEUROPHYSIOL, V61, P769, DOI 10.1152/jn.1989.61.4.769; van der Meer M.A.A., 2009, FRONT INTEGR NEUROSC, V3; van der Meer MAA, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00300; van der Meer MAA, 2010, NEURON, V67, P25, DOI 10.1016/j.neuron.2010.06.023; van der Meer MAA, 2009, FRONT INTEGR NEUROSC, V3, DOI [10.3389/neuro.07.009.2009, 10.3389/neuro.07.001.2009]; van der Meij R, 2012, J NEUROSCI, V32, P111, DOI 10.1523/JNEUROSCI.4816-11.2012; van Wingerden M, 2014, J NEUROSCI, V34, P493, DOI 10.1523/JNEUROSCI.2098-13.2014; Voon V, 2014, BIOL PSYCHIAT, V75, P148, DOI 10.1016/j.biopsych.2013.05.013; Voon V, 2011, NAT REV NEUROL, V7, P541, DOI 10.1038/nrneurol.2011.139; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wiltschko AB, 2010, NEUROPSYCHOPHARMACOL, V35, P1261, DOI 10.1038/npp.2009.226; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Womelsdorf T, 2010, P NATL ACAD SCI USA, V107, P5248, DOI 10.1073/pnas.0906194107; Yamada H, 2007, J NEUROPHYSIOL, V98, P3557, DOI 10.1152/jn.00779.2007; ZAHM DS, 1992, NEUROSCIENCE, V50, P751, DOI 10.1016/0306-4522(92)90202-D	115	46	46	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111300	10.1371/journal.pone.0111300	http://dx.doi.org/10.1371/journal.pone.0111300			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333512	Green Submitted, Green Published, gold			2022-12-27	WOS:000343731200112
J	Hsu, CH; Lin, CY; Chi, H; Chang, JH; Hung, HY; Kao, HA; Peng, CC; Jim, WT				Hsu, Chyong-Hsin; Lin, Chia-Ying; Chi, Hsin; Chang, Jui-Hsing; Hung, Han-Yang; Kao, Hsin-An; Peng, Chun-Chih; Jim, Wai-Tim			Prolonged Seasonality of Respiratory Syncytial Virus Infection among Preterm Infants in a Subtropical Climate	PLOS ONE			English	Article							PEDIATRIC INPATIENTS; HOSPITALIZATION; EPIDEMIOLOGY; DISEASE; REHOSPITALIZATION; CHILDREN; TAIWAN; RATES; BORN	Objective: There is limited epidemiological data on the seasonality of respiratory syncytial virus (RSV) infection in subtropical climates, such as in Taiwan. This study aimed to assess RSV seasonality among children <= 24 months of age in Taiwan. We also assessed factors (gestational age [GA], chronologic age [CA], and bronchopulmonary dysplasia [BPD]) associated with RSV-associated hospitalization in preterm infants to confirm the appropriateness of the novel Taiwanese RSV prophylactic policy. Study Design: From January 2000 to August 2010, 3572 children aged <= 24-months were admitted to Taipei Mackay Memorial Hospital due to RSV infection. The monthly RSV-associated hospitalization rate among children aged <= 24 months was retrospectively reviewed. Among these children, 378 were born preterm. The associations between GA, CA, and BPD and the incidence of RSV-associated hospitalization in the preterm infants were assessed. Results: In children aged <= 24 months, the monthly distribution of RSV-associated hospitalization rates revealed a prolonged RSV season with a duration of 10 months. Infants with GAs <= 32 weeks and those who had BPD had the highest rates of RSV hospitalization (P<0.001). Preterm infants were most vulnerable to RSV infection within CA 9 months. Conclusions: Given that Taiwan has a prolonged (10-month) RSV season, the American Academy of Pediatrics' recommendations for RSV prophylaxis are not directly applicable. The current Taiwanese guidelines for RSV prophylaxis, which specify palivizumab injection (a total six doses until CA 8-9 months) for preterm infants (those born before 28(6/7) weeks GA or before 35(6/7) weeks GA with BPD), are appropriate. This prophylaxis strategy may be applicable to other countries/regions with subtropical climates.	[Hsu, Chyong-Hsin; Lin, Chia-Ying; Chang, Jui-Hsing; Hung, Han-Yang; Kao, Hsin-An; Peng, Chun-Chih; Jim, Wai-Tim] Mackay Mem Hosp, Dept Pediat, Div Neonatol, Taipei, Taiwan; [Chi, Hsin] Mackay Mem Hosp, Dept Pediat, Div Infect Dis, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Memorial Hospital	Hsu, CH (corresponding author), Mackay Mem Hosp, Dept Pediat, Div Neonatol, Taipei, Taiwan.	t200441@mmh.org.tw						Bocchini JA, 2009, PEDIATRICS, V124, P1216, DOI [10.1542/peds.2009-1806, 10.1542/peds.2009-2345]; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Carbonell-Estrany X, 2001, PEDIATR INFECT DIS J, V20, P874, DOI 10.1097/00006454-200109000-00010; Carbonell-Estrany X, 2000, PEDIATR INFECT DIS J, V19, P592, DOI 10.1097/00006454-200007000-00002; Chan PKS, 1999, EPIDEMIOL INFECT, V123, P257, DOI 10.1017/S0950268899002824; Chi H, 2011, J FORMOS MED ASSOC, V110, P388, DOI 10.1016/S0929-6646(11)60057-0; Christine AG, 2012, AVERYS DIS NEWBORN; Chu SC, 2013, TAIWAN CDC TAIWAN EP, P29; Figueras-Aloy J, 2008, PEDIATR INFECT DIS J, V27, P788, DOI 10.1097/INF.0b013e3181710990; Fryzek JP, 2011, ADV THER, V28, P195, DOI 10.1007/s12325-010-0106-6; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Huang YC, 2001, EUR J PEDIATR, V160, P581, DOI 10.1007/s004310100803; Joffe S, 1999, PEDIATRICS, V104, P894, DOI 10.1542/peds.104.4.894; Kusuda S, 2011, PEDIATR INT, V53, P368, DOI 10.1111/j.1442-200X.2010.03249.x; Lee Jian-Te, 2007, Journal of Microbiology Immunology and Infection, V40, P293; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Tatochenko Vladimir, 2010, Clin Epidemiol, V2, P221, DOI 10.2147/CLEP.S12279; Tsai HP, 2001, J CLIN MICROBIOL, V39, P111, DOI 10.1128/JCM.39.1.111-118.2001; US CDC, 2013, OV INFL SURV US; Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321	23	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110166	10.1371/journal.pone.0110166	http://dx.doi.org/10.1371/journal.pone.0110166			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333346	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200027
J	Jenison, RL				Jenison, Rick L.			Directional Influence between the Human Amygdala and Orbitofrontal Cortex at the Time of Decision-Making	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; EMPIRICAL MODE DECOMPOSITION; BASOLATERAL AMYGDALA; VALUE COMPUTATIONS; NEURAL BASIS; LINEAR-DEPENDENCE; SUBJECTIVE VALUE; ECONOMIC CHOICE; SINGLE NEURONS; GOAL VALUES	There is a growing consensus that the brain makes simple choices, such as choosing between an apple and an orange, by assigning value to the options under consideration, and comparing those values to make a choice. There is also a consensus that value signals computed in orbitofrontal cortex (OFC) and amygdala play a critical role in the choice process. However, the nature of the flow of information between OFC and amygdala at the time of decision is still unknown. In order to study this question, simultaneous local field potentials were recorded from OFC and amygdala in human patients while they performed a simple food choice task. Although the interaction of these circuits has been studied in animals, this study examines the effective connectivity directly in the human brain on a moment-by-moment basis. A spectral conditional Granger causality analysis was performed in order to test if the modulation of activity goes mainly from OFC-to-amygdala, from amygdala-to-OFC, or if it is bi-directional. Influence from amygdala-to-OFC was dominant prior to the revealed choice, with a small but significant OFC influence on the amygdala earlier in the trial. Alpha oscillation amplitudes analyzed with the Hilbert-Huang transform revealed differences in choice valence coincident with temporally specific amygdala influence on the OFC.	Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Jenison, RL (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	rjenison@wisc.edu		Jenison, Rick/0000-0002-3712-300X	National Institutes of Health [RO1AA018736]; National Science Foundation [SES-0820316, MO1RR59]; Hoover Fund; Carver Trust; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Hoover Fund; Carver Trust; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health RO1AA018736 (RLJ), the National Science Foundation SES-0820316 (RLJ), MO1RR59 (General Clinical Research Centers Program), the Hoover Fund, and Carver Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Harris, 2011, PLOS ONE, V6; Akaishi R, 2014, NEURON, V81, P195, DOI 10.1016/j.neuron.2013.10.018; Barbas H, 1997, CEREB CORTEX, V7, P635, DOI 10.1093/cercor/7.7.635; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Baumgartner T, 2011, NAT NEUROSCI, V14, P1468, DOI 10.1038/nn.2933; Bechara A, 1999, J NEUROSCI, V19, P5473; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Bermudez MA, 2010, J NEUROPHYSIOL, V104, P3424, DOI 10.1152/jn.00540.2010; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Brovelli A, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/697610; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Camille N, 2011, J NEUROSCI, V31, P7527, DOI 10.1523/JNEUROSCI.6527-10.2011; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Carnevale F, 2012, P NATL ACAD SCI USA, V109, P18938, DOI 10.1073/pnas.1216799109; Chang JY, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00317; Chavez M, 2006, J NEUROSCI METH, V154, P149, DOI 10.1016/j.jneumeth.2005.12.009; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Chicharro D, 2011, BIOL CYBERN, V105, P331, DOI 10.1007/s00422-011-0469-z; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Dhamala M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018701; Ding M, 2009, HDB TIME SERIES ANAL, P437; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Dolan RJ, 2007, PHILOS T R SOC B, V362, P787, DOI 10.1098/rstb.2007.2088; Dutt V, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00177; Fecteau JH, 2003, NAT REV NEUROSCI, V4, P435, DOI 10.1038/nrn1114; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grabenhorst F, 2012, P NATL ACAD SCI USA, V109, P18950, DOI 10.1073/pnas.1212706109; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hampton AN, 2007, NEURON, V55, P545, DOI 10.1016/j.neuron.2007.07.022; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Izquierdo A, 2005, J NEUROSCI, V25, P8534, DOI 10.1523/JNEUROSCI.1232-05.2005; Izquierdo A, 2007, J NEUROSCI, V27, P1054, DOI 10.1523/JNEUROSCI.3616-06.2007; Jenison RL, 2011, J NEUROSCI, V31, P331, DOI 10.1523/JNEUROSCI.4461-10.2011; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lee D, 2012, ANNU REV NEUROSCI, V35, P287, DOI 10.1146/annurev-neuro-062111-150512; Levy I, 2010, J NEUROPHYSIOL, V103, P1036, DOI 10.1152/jn.00853.2009; Liang HL, 2005, BIOL CYBERN, V92, P380, DOI 10.1007/s00422-005-0566-y; Lim SL, 2011, J NEUROSCI, V31, P13214, DOI 10.1523/JNEUROSCI.1246-11.2011; LITT A, 2010, CEREB CORTEX; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; Machado CJ, 2007, EUR J NEUROSCI, V25, P2885, DOI 10.1111/j.1460-9568.2007.05525.x; Marinazzo D, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/303601; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Mormann F, 2008, J NEUROSCI, V28, P8865, DOI 10.1523/JNEUROSCI.1640-08.2008; Morrison SE, 2011, NEURON, V71, P1127, DOI 10.1016/j.neuron.2011.07.016; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Murray EA, 2007, ANN NY ACAD SCI, V1121, P273, DOI 10.1196/annals.1401.021; Murray EA, 2007, TRENDS COGN SCI, V11, P489, DOI 10.1016/j.tics.2007.08.013; Murray EA, 2010, CURR OPIN NEUROBIOL, V20, P212, DOI 10.1016/j.conb.2010.02.001; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Doherty JP, 2011, ANN NY ACAD SCI, V1239, P118, DOI 10.1111/j.1749-6632.2011.06290.x; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Oostenveld R., 2011, COMPUTATIONAL INTELL, V2011; Oya H, 2009, STEREOT FUNCT NEUROS, V87, P219, DOI 10.1159/000225975; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Padoa-Schioppa C, 2009, J NEUROSCI, V29, P14004, DOI 10.1523/JNEUROSCI.3751-09.2009; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Palva S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00204; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Peck CJ, 2013, NAT NEUROSCI, V16, P340, DOI 10.1038/nn.3328; Philiastides MG, 2010, P NATL ACAD SCI USA, V107, P9430, DOI 10.1073/pnas.1001732107; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; Rangel A, 2013, NEUROECONOMICS DECIS; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Rich EL, 2013, NEURON, V80, P1344, DOI 10.1016/j.neuron.2013.11.027; Rudebeck PH, 2013, NEURON, V80, P1519, DOI 10.1016/j.neuron.2013.09.036; Rutishauser U, 2006, NEURON, V49, P805, DOI 10.1016/j.neuron.2006.02.015; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; SLEPIAN D, 1961, BELL SYST TECH J, V40, P43, DOI 10.1002/j.1538-7305.1961.tb03976.x; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Sugase-Miyamoto Y, 2005, J NEUROSCI, V25, P11071, DOI 10.1523/JNEUROSCI.1796-05.2005; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Wallis JD, 2012, NAT NEUROSCI, V15, P13, DOI 10.1038/nn.2956; WILSON GT, 1972, SIAM J APPL MATH, V23, P420, DOI 10.1137/0123044; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107; Zhang WJ, 2013, J NEUROSCI, V33, P722, DOI 10.1523/JNEUROSCI.2970-12.2013	105	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e109689	10.1371/journal.pone.0109689	http://dx.doi.org/10.1371/journal.pone.0109689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR7AB	25333929	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200016
J	Laverde, D; Wobser, D; Romero-Saavedra, F; Hogendorf, W; van der Marel, G; Berthold, M; Kropec, A; Codee, J; Huebner, J				Laverde, Diana; Wobser, Dominique; Romero-Saavedra, Felipe; Hogendorf, Wouter; van der Marel, Gijsbert; Berthold, Martin; Kropec, Andrea; Codee, Jeroen; Huebner, Johannes			Synthetic Teichoic Acid Conjugate Vaccine against Nosocomial Gram-Positive Bacteria	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; LIPOTEICHOIC ACID; CAPSULAR POLYSACCHARIDE; CLOSTRIDIUM-DIFFICILE; STAPHYLOCOCCUS-AUREUS; ENTEROCOCCUS-FAECALIS; STREPTOCOCCUS-PNEUMONIAE; MONOCLONAL-ANTIBODY; FAECIUM; PROTECTION	Lipoteichoic acids (LTA) are amphiphilic polymers that are important constituents of the cell wall of many Gram-positive bacteria. The chemical structures of LTA vary among organisms, albeit in the majority of Gram-positive bacteria the LTAs feature a common poly-1,3-(glycerolphosphate) backbone. Previously, the specificity of opsonic antibodies for this backbone present in some Gram-positive bacteria has been demonstrated, suggesting that this minimal structure may be sufficient for vaccine development. In the present work, we studied a well-defined synthetic LTA-fragment, which is able to inhibit opsonic killing of polyclonal rabbit sera raised against native LTA from Enterococcus faecalis 12030. This promising compound was conjugated with BSA and used to raise rabbit polyclonal antibodies. Subsequently, the opsonic activity of this serum was tested in an opsonophagocytic assay and specificity was confirmed by an opsonophagocytic inhibition assay. The conjugated LTA-fragment was able to induce specific opsonic antibodies that mediate killing of the clinical strains E. faecalis 12030, Enterococcus faecium E1162, and community-acquired Staphylococcus aureus strain MW2 (USA400). Prophylactic immunization with the teichoic acid conjugate and with the rabbit serum raised against this compound was evaluated in active and passive immunization studies in mice, and in an enterococcal endocarditis rat model. In all animal models, a statistically significant reduction of colony counts was observed indicating that the novel synthetic LTA-fragment conjugate is a promising vaccine candidate for active or passive immunotherapy against E. faecalis and other Gram-positive bacteria.	[Laverde, Diana; Wobser, Dominique; Romero-Saavedra, Felipe; Berthold, Martin; Kropec, Andrea; Huebner, Johannes] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany; [Laverde, Diana; Romero-Saavedra, Felipe] Univ Caen Lower Normandy, Stress Virulence U2RM EA4655, Caen, France; [Hogendorf, Wouter; van der Marel, Gijsbert] Leiden Univ, Leiden Inst Chem, Fac Sci, Bioorgan Synth Unit, Leiden, Netherlands; [Huebner, Johannes] Univ Munich, Dr von Hauner Childrens Hosp, Div Pediat Infect Dis, Munich, Germany; [Huebner, Johannes] Partnersite Munich, German Ctr Infect Res DZIF, Munich, Germany	University of Freiburg; Universite de Caen Normandie; Leiden University; Leiden University - Excl LUMC; University of Munich; German Center for Infection Research	Codee, J (corresponding author), Leiden Univ, Leiden Inst Chem, Fac Sci, Bioorgan Synth Unit, Leiden, Netherlands.	jcodee@chem.leidenuniv.nl; johannes.huebner@med.uni-muenchen.de		Huebner, Johannes/0000-0003-1232-4646; Hogendorf, Wouter/0000-0003-3231-5325				[Anonymous], 2011, EP APPL EUROPEAN PAT, V1, P1; Chen QY, 2013, INFECT IMMUN, V81, P2554, DOI 10.1128/IAI.00271-13; Chen QY, 2008, J IMMUNOL, V181, P8258, DOI 10.4049/jimmunol.181.12.8258; Chu KC, 2012, FUTURE MED CHEM, V4, P1767, DOI [10.4155/fmc.12.102, 10.4155/FMC.12.102]; Cox AD, 2013, GLYCOCONJUGATE J, V30, P843, DOI 10.1007/s10719-013-9489-3; DRIJFHOUT JW, 1990, ANAL BIOCHEM, V187, P349, DOI 10.1016/0003-2697(90)90468-O; Fernandez-Santana V, 1998, GLYCOCONJUGATE J, V15, P549, DOI 10.1023/A:1006903524007; Finn A, 2004, BRIT MED BULL, V70, P1, DOI 10.1093/bmb/ldh021; Goldenberg HB, 2004, J INFECT DIS, V190, P1254, DOI 10.1086/424517; Graveline R, 2007, INT IMMUNOL, V19, P375, DOI 10.1093/intimm/dxm003; Haller C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091863; Heikens E, 2007, J BACTERIOL, V189, P8233, DOI 10.1128/JB.01205-07; Hogendorf WFJ, 2012, CARBOHYD RES, V356, P142, DOI 10.1016/j.carres.2012.02.023; Hogendorf WFJ, 2012, FLUOROUS LINKER FACI, DOI [10.1021/ol2033652, DOI 10.1021/0L2033652]; Hogendorf WFJ, 2011, CHEM COMMUN, V47, P8961, DOI 10.1039/c1cc13132j; Hogendorf WFJ, 2010, BIOORGAN MED CHEM, V18, P3668, DOI 10.1016/j.bmc.2010.03.071; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Hufnagel M, 2005, CLIN DIAGN LAB IMMUN, V12, P930, DOI 10.1128/CDLI.12.8.930-934.2005; Kelly-Quintos C, 2005, J INFECT DIS, V192, P2012, DOI 10.1086/497604; Kropec A, 2011, MICROBIOL-SGM, V157, P3429, DOI 10.1099/mic.0.053207-0; Leendertse M, 2010, J INFECT DIS, V201, P544, DOI 10.1086/650341; Martin CE, 2013, CHEM COMMUN, V49, P7159, DOI 10.1039/c3cc43545h; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Oberli MA, 2011, CHEM BIOL, V18, P580, DOI 10.1016/j.chembiol.2011.03.009; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; Phalipon A, 2009, J IMMUNOL, V182, P2241, DOI 10.4049/jimmunol.0803141; Romero-Steiner S, 1999, CLIN INFECT DIS, V29, P281, DOI 10.1086/520200; Theilacker C, 2004, VACCINE, V22, pS31, DOI 10.1016/j.vaccine.2004.08.014; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2012, J INFECT DIS, V205, P1076, DOI 10.1093/infdis/jis022; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; VANDERLEY P, 1991, INFECT IMMUN, V59, P2963, DOI 10.1128/IAI.59.9.2963-2971.1991; Verez-Bencomo V, 2004, SCIENCE, V305, P522, DOI 10.1126/science.1095209; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Weisman LE, 2009, PHASE 1 2 DOUBLE BLI, DOI [10.1128/AAC.01565-08, DOI 10.1128/AAC.01565-08]; Weisman LE, 2011, PEDIATRICS, V128, P271, DOI 10.1542/peds.2010-3081; Weisman LE, 2009, INT IMMUNOPHARMACOL, V9, P639, DOI 10.1016/j.intimp.2009.02.008; Yokoyama Y, 2002, INT J PEDIATR OTORHI, V63, P235, DOI 10.1016/S0165-5876(02)00021-6; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	44	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110953	10.1371/journal.pone.0110953	http://dx.doi.org/10.1371/journal.pone.0110953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333799	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200095
J	Nakazawa, Y; Ariyoshi, T; Noga, A; Kamiya, R; Hirono, M				Nakazawa, Yuki; Ariyoshi, Tetsuro; Noga, Akira; Kamiya, Ritsu; Hirono, Masafumi			Space-Dependent Formation of Central Pair Microtubules and Their Interactions with Radial Spokes	PLOS ONE			English	Article							DYNEIN REGULATORY COMPLEX; CENTRAL APPARATUS; FLAGELLAR DYNEIN; MOLECULAR ARCHITECTURE; STRUCTURAL BASIS; 9-FOLD SYMMETRY; CENTRAL TUBULES; GAMMA-TUBULIN; BASAL BODY; CHLAMYDOMONAS	Cilia and flagella contain nine outer doublet microtubules and a pair of central microtubules. The central pair of microtubules (CP) is important for cilia/flagella beating, as clearly shown by primary ciliary dyskinesia resulting from the loss of the CP. The CP is thought to regulate axonemal dyneins through interaction with radial spokes (RSs). However, the nature of the CP-RS interaction is poorly understood. Here we examine the appearance of CPs in the axonemes of a Chlamydomonas mutant, bld12, which produces axonemes with 8 to 11 outer-doublets. Most of its 8-doublet axonemes lack CPs. However, in the double mutant of bld12 and pf14, a mutant lacking the RS, most 8-doublet axonemes contain the CP. Thus formation of the CP apparently depends on the internal space limited by the outer doublets and RSs. In 10- or 11-doublet axonemes, only 3-5 RSs are attached to the CP and the doublet arrangement is distorted most likely because the RSs attached to the CP pull the outer doublets toward the axonemal center. The CP orientation in the axonemes varies in double mutants formed between bld12 and mutants lacking particular CP projections. The mutant bld12 thus provides the first direct and visual information about the CP-RS interaction, as well as about the mechanism of CP formation.	[Nakazawa, Yuki; Ariyoshi, Tetsuro; Noga, Akira; Kamiya, Ritsu; Hirono, Masafumi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Kamiya, Ritsu] Gakushuin Univ, Fac Sci, Dept Life Sci, Toshima Ku, Tokyo 171, Japan	University of Tokyo; Gakushuin University	Hirono, M (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	hirono@bs.s.u-tokyo.ac.jp	HIRONO, MASAFUMI/G-4948-2014	HIRONO, MASAFUMI/0000-0002-2497-4227	JSPS KAKENHI [23657046, 24370079, 25113503]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 23657046, 24370079, and 25113503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RD, 1969, J CELL BIOL, V40, P716, DOI 10.1083/jcb.40.3.716; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Brown JM, 2012, J CELL SCI, V125, P3904, DOI 10.1242/jcs.107151; Bui KH, 2012, J CELL BIOL, V198, P913, DOI 10.1083/jcb.201201120; Bui KH, 2008, J CELL BIOL, V183, P923, DOI 10.1083/jcb.200808050; Carbajal-Gonzalez BI, 2013, CYTOSKELETON, V70, P101, DOI 10.1002/cm.21094; CAVALIER.T, 1974, J CELL SCI, V16, P529; Dentler W L, 1982, Prog Clin Biol Res, V80, P13; DENTLER WL, 1977, J CELL BIOL, V74, P747, DOI 10.1083/jcb.74.3.747; DENTLER WL, 1980, J CELL SCI, V42, P207; DUTCHER SK, 1984, J CELL BIOL, V98, P229, DOI 10.1083/jcb.98.1.229; DUTCHER SK, 1995, METHOD CELL BIOL, V47, P531, DOI 10.1016/S0091-679X(08)60857-2; DUTE R, 1978, J CELL BIOL, V78, P451, DOI 10.1083/jcb.78.2.451; Feistel K, 2006, DEV DYNAM, V235, P3348, DOI 10.1002/dvdy.20986; Gadelha C, 2006, J CELL SCI, V119, P2405, DOI 10.1242/jcs.02969; GIBBONS IR, 1960, J BIOPHYS BIOCHEM CY, V7, P697, DOI 10.1083/jcb.7.4.697; GIBBONS IR, 1961, J BIOPHYS BIOCHEM CY, V11, P179, DOI 10.1083/jcb.11.1.179; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; HABERMACHER G, 1995, CELL MOTIL CYTOSKEL, V32, P106, DOI 10.1002/cm.970320207; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; JARVIK JW, 1991, J CELL SCI, V99, P731; Kamiya R., 1982, Progress in Clinical and Biological Research, V80, P169; Kamiya R, 2002, INT REV CYTOL, V219, P115; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lechtreck Karl-Ferdinand, 2013, Cilia, V2, P15, DOI 10.1186/2046-2530-2-15; LINDEMANN CB, 1995, CELL MOTIL CYTOSKEL, V31, P1, DOI 10.1002/cm.970310102; McKean PG, 2003, CURR BIOL, V13, P598, DOI 10.1016/S0960-9822(03)00174-X; Mitchell DR, 2004, J CELL BIOL, V166, P709, DOI 10.1083/jcb.200406148; Mitchell DR, 1999, J CELL BIOL, V144, P293, DOI 10.1083/jcb.144.2.293; Mitchell DR., 2009, CHLAMYDOMONAS SOURCE, V3, P235; Mizuno N, 2012, J MOL BIOL, V422, P163, DOI 10.1016/j.jmb.2012.05.040; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Oda T, 2014, J CELL BIOL, V204, P807, DOI 10.1083/jcb.201312014; OMOTO CK, 1979, NATURE, V279, P532, DOI 10.1038/279532a0; Onoufriadis A, 2014, HUM MOL GENET, V23, P3362, DOI 10.1093/hmg/ddu046; Pigino G, 2011, J CELL BIOL, V195, P673, DOI 10.1083/jcb.201106125; PIPERNO G, 1977, P NATL ACAD SCI USA, V74, P1600, DOI 10.1073/pnas.74.4.1600; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; RANDALL J, 1964, NATURE, V203, P912, DOI 10.1038/203912a0; Randall SJ, 1967, DEV BIOL S, V1, P43; Silflow CD, 1999, CELL MOTIL CYTOSKEL, V42, P285, DOI 10.1002/(SICI)1097-0169(1999)42:4<285::AID-CM3>3.0.CO;2-Z; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; Smith EF, 2002, MOL BIOL CELL, V13, P3303, DOI 10.1091/mbc.E02-04-0185; Smith EF, 2002, CELL MOTIL CYTOSKEL, V52, P33, DOI 10.1002/cm.10031; TAMM SL, 1981, J CELL BIOL, V89, P495, DOI 10.1083/jcb.89.3.495; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325; Wargo MJ, 2003, P NATL ACAD SCI USA, V100, P137, DOI 10.1073/pnas.0135800100; WARNER FD, 1974, J CELL BIOL, V63, P35, DOI 10.1083/jcb.63.1.35; WARR JR, 1966, GENET RES, V7, P335, DOI 10.1017/S0016672300009794; Wirschell M., 2009, CHLAMYDOMONAS SOURCE, V3, P253; WITMAN GB, 1978, J CELL BIOL, V76, P729, DOI 10.1083/jcb.76.3.729; WITMAN GB, 1986, METH ENZYMOLOGY, V134, P280; Yang P., 2009, CHLAMYDOMONAS SOURCE, P209; Yang PF, 2000, J BIOL CHEM, V275, P18905, DOI 10.1074/jbc.M002134200; Yoshimura M, 1999, CELL STRUCT FUNCT, V24, P43, DOI 10.1247/csf.24.43	58	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110513	10.1371/journal.pone.0110513	http://dx.doi.org/10.1371/journal.pone.0110513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333940	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200050
J	Seward, AM; Beale, CM; Gilbert, L; Jones, TH; Thomas, RJ				Seward, Adam M.; Beale, Colin M.; Gilbert, Lucy; Jones, T. Hefin; Thomas, Robert J.			The Impact of Increased Food Availability on Reproduction in a Long-Distance Migratory Songbird: Implications for Environmental Change?	PLOS ONE			English	Article							WHEATEAR OENANTHE-OENANTHE; GLOBAL CLIMATE-CHANGE; FEEDING EXPERIMENT; TERRITORY QUALITY; NORTHERN WHEATEAR; BREEDING SUCCESS; ARRIVAL DATE; CLUTCH-SIZE; GREAT TITS; EGG SIZE	Many populations of migratory songbirds are declining or shifting in distribution. This is likely due to environmental changes that alter factors such as food availability that may have an impact on survival and/or breeding success. We tested the impact of experimentally supplemented food on the breeding success over three years of northern wheatears (Oenanthe oenanthe), a species in decline over much of Europe. The number of offspring fledged over the season was higher for food-supplemented birds than for control birds. The mechanisms for this effect were that food supplementation advanced breeding date, which, together with increased resources, allowed further breeding attempts. While food supplementation did not increase the clutch size, hatching success or number of chicks fledged per breeding attempt, it did increase chick size in one year of the study. The increased breeding success was greater for males than females; males could attempt to rear simultaneous broods with multiple females as well as attempting second broods, whereas females could only increase their breeding effort via second broods. Multiple brooding is rare in the study population, but this study demonstrates the potential for changes in food availability to affect wheatear breeding productivity, primarily via phenotypic flexibility in the number of breeding attempts. Our results have implications for our understanding of how wheatears may respond to natural changes in food availability due to climate changes or changes in habitat management.	[Seward, Adam M.; Jones, T. Hefin; Thomas, Robert J.] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Seward, Adam M.; Beale, Colin M.; Gilbert, Lucy] James Hutton Inst, Aberdeen, Scotland	Cardiff University; James Hutton Institute	Seward, AM (corresponding author), Red Squirrels Northern England, Stocksfield, Northd, England.	adammichaelseward@gmail.com	Thomas, Robert J/A-6612-2010	Thomas, Robert J/0000-0001-5256-3313; Jones, T Hefin/0000-0002-7874-3627; Beale, Colin Michael/0000-0002-2960-5666	Natural Environment Research Council; James Hutton Institute; Fair Isle Bird Observatory Trust	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); James Hutton Institute; Fair Isle Bird Observatory Trust	This study was funded by the Natural Environment Research Council, James Hutton Institute, and Fair Isle Bird Observatory Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCESE P, 1988, J ANIM ECOL, V57, P119, DOI 10.2307/4768; Arlt D, 2007, ECOLOGY, V88, P792, DOI 10.1890/06-0574; Arlt D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003006; ARNOLD TW, 1992, CAN J ZOOL, V70, P1904, DOI 10.1139/z92-259; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Berthold P, 2001, AUK, V2nd; BOLTON M, 1992, J ANIM ECOL, V61, P521, DOI 10.2307/5607; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Both Christiaan, 2010, P129; Buchanan GM, 2006, IBIS, V148, P615, DOI 10.1111/j.1474-919X.2006.00578.x; BURFIELD IJ, 2004, BIRDS EUROPE POPULAT; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Christians JK, 2002, BIOL REV, V77, P1, DOI 10.1017/S1464793101005784; Coppack T, 2002, ARDEA, V90, P369; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Currie D, 2000, IBIS, V142, P389, DOI 10.1111/j.1474-919X.2000.tb04435.x; Dell D, 2005, EUR J ENTOMOL, V102, P161, DOI 10.14411/eje.2005.026; EWALD PW, 1982, J ANIM ECOL, V51, P429, DOI 10.2307/3975; GRUBB TC, 1975, CONDOR, V77, P175, DOI 10.2307/1365788; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; Illera JC, 2006, J AVIAN BIOL, V37, P447, DOI 10.1111/j.2006.0908-8857.03676.x; KALLANDER H, 1974, IBIS, V116, P365, DOI 10.1111/j.1474-919X.1974.tb00133.x; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Low M, 2010, J ANIM ECOL, V79, P214, DOI 10.1111/j.1365-2656.2009.01595.x; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; MAYFIELD HF, 1975, WILSON BULL, V87, P456; Mazerolle DF, 2014, PACKAGE AICCMODAVG; MORENO J, 1989, J ORNITHOL, V130, P321, DOI 10.1007/BF01644745; Nagy LR, 2005, ECOLOGY, V86, P675, DOI 10.1890/04-0155; Part T, 2001, ANIM BEHAV, V62, P379, DOI 10.1006/anbe.2001.1754; Part T, 2001, P ROY SOC B-BIOL SCI, V268, P2267, DOI 10.1098/rspb.2001.1803; Pearce-Higgins JW, 2010, GLOBAL CHANGE BIOL, V16, P12, DOI 10.1111/j.1365-2486.2009.01883.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Reed TE, 2013, J ANIM ECOL, V82, P131, DOI 10.1111/j.1365-2656.2012.02020.x; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Rockwell SM, 2012, AUK, V129, P744, DOI 10.1525/auk.2012.12003; RODENHOUSE NL, 1992, ECOLOGY, V73, P357, DOI 10.2307/1938747; Salvante KG, 2007, J EXP BIOL, V210, P1325, DOI 10.1242/jeb.02745; Schoech SJ, 2008, BIOL CONSERV, V141, P162, DOI 10.1016/j.biocon.2007.09.009; Seward AM, 2013, ECOLOGY, V94, P221, DOI 10.1890/12-0121.1; SIMONS LS, 1990, ECOLOGY, V71, P869, DOI 10.2307/1937358; SMITH JNM, 1980, OECOLOGIA, V47, P164, DOI 10.1007/BF00346815; Soler M, 1996, IBIS, V138, P377, DOI 10.1111/j.1474-919X.1996.tb08054.x; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Svensson L., 1992, IDENTIFICATION GUIDE; Thaxter CB, 2010, BIOL CONSERV, V143, P2006, DOI 10.1016/j.biocon.2010.05.004; TYE A, 1992, IBIS, V134, P273, DOI 10.1111/j.1474-919X.1992.tb03810.x; Van Buskirk J, 2009, GLOBAL CHANGE BIOL, V15, P760, DOI 10.1111/j.1365-2486.2008.01751.x; Visser ME, 2011, FUNCT ECOL, V25, P868, DOI 10.1111/j.1365-2435.2011.01844.x; Visser ME, 2009, P ROY SOC B-BIOL SCI, V276, P2323, DOI 10.1098/rspb.2009.0213; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; White TCR, 2008, BIOL REV, V83, P227, DOI 10.1111/j.1469-185X.2008.00041.x; Wingfield JC, 2008, PHILOS T R SOC B, V363, P425, DOI 10.1098/rstb.2007.2149; Wretenberg J, 2006, J APPL ECOL, V43, P1110, DOI 10.1111/j.1365-2664.2006.01216.x	55	9	10	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111180	10.1371/journal.pone.0111180	http://dx.doi.org/10.1371/journal.pone.0111180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333485	Green Published, gold, Green Accepted			2022-12-27	WOS:000343731200103
J	Song, HJ; Moulton, MJ; Whiting, MF				Song, Hojun; Moulton, Matthew J.; Whiting, Michael F.			Rampant Nuclear Insertion of mtDNA across Diverse Lineages within Orthoptera (Insecta)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCES; NUMT INSERTION; CYTOCHROME-B; HUMAN-GENOME; PSEUDOGENES; EVOLUTION; INTEGRATIONS; SYSTEMATICS; PHYLOGENY; UTILITY	Nuclear mitochondrial pseudogenes (numts) are non-functional fragments of mtDNA inserted into the nuclear genome. Numts are prevalent across eukaryotes and a positive correlation is known to exist between the number of numts and the genome size. Most numt surveys have relied on model organisms with fully sequenced nuclear genomes, but such analyses have limited utilities for making a generalization about the patterns of numt accumulation for any given clade. Among insects, the order Orthoptera is known to have the largest nuclear genome and it is also reported to include several species with a large number of numts. In this study, we use Orthoptera as a case study to document the diversity and abundance of numts by generating numts of three mitochondrial loci across 28 orthopteran families, representing the phylogenetic diversity of the order. We discover that numts are rampant in all lineages, but there is no discernable and consistent pattern of numt accumulation among different lineages. Likewise, we do not find any evidence that a certain mitochondrial gene is more prone to nuclear insertion than others. We also find that numt insertion must have occurred continuously and frequently throughout the diversification of Orthoptera. Although most numts are the result of recent nuclear insertion, we find evidence of very ancient numt insertion shared by highly divergent families dating back to the Jurassic period. Finally, we discuss several factors contributing to the extreme prevalence of numts in Orthoptera and highlight the importance of exploring the utility of numts in evolutionary studies.	[Song, Hojun] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Moulton, Matthew J.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Moulton, Matthew J.; Whiting, Michael F.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Moulton, Matthew J.; Whiting, Michael F.] Brigham Young Univ, ML Bean Museum, Provo, UT 84602 USA	State University System of Florida; University of Central Florida; Utah System of Higher Education; University of Utah; Brigham Young University; Brigham Young University	Song, HJ (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.	song@ucf.edu	Moulton, Matthew/S-1642-2019	Moulton, Matthew/0000-0003-0228-7669	National Science Foundation [DEB-0816962]; Division Of Integrative Organismal Systems [1210899] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (www.nsf.gov) grant number DEB-0816962 to H.S. and M.F.W. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh F, 2006, BIOINFORMATICS, V22, P1225, DOI 10.1093/bioinformatics/btl064; [Anonymous], 1968, T I PALEONTOL ACAD S; Anthony NM, 2007, MOL PHYLOGENET EVOL, V43, P553, DOI 10.1016/j.ympev.2006.09.013; Baldo L, 2011, MOL BIOL EVOL, V28, P195, DOI 10.1093/molbev/msq193; Behura SK, 2007, MOL BIOL EVOL, V24, P1492, DOI 10.1093/molbev/msm068; Benesh DP, 2006, INT J PARASITOL, V36, P247, DOI 10.1016/j.ijpara.2005.09.008; Bensasson D, 2000, MOL BIOL EVOL, V17, P406, DOI 10.1093/oxfordjournals.molbev.a026320; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bensasson D, 2003, J MOL EVOL, V57, P343, DOI 10.1007/s00239-003-2485-7; Bensasson D, 2001, MOL BIOL EVOL, V18, P246, DOI 10.1093/oxfordjournals.molbev.a003798; Bertheau C, 2011, MOL ECOL RESOUR, V11, P1056, DOI 10.1111/j.1755-0998.2011.03050.x; BLANCHARD JL, 1995, J MOL EVOL, V41, P397, DOI 10.1007/BF00160310; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; DENSMORE LD, 1985, GENETICS, V110, P689; DESCAMPS M, 1973, Acrida, V2, P161; DESCAMPS M., 1968, BULL SOC ENTOMOL FR, V73, P31; DeWoody JA, 1999, J MOL EVOL, V48, P380, DOI 10.1007/PL00013154; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; GELLISSEN G, 1983, NATURE, V301, P631, DOI 10.1038/301631a0; GELLISSEN G, 1987, ANN NY ACAD SCI, V503, P391, DOI 10.1111/j.1749-6632.1987.tb40625.x; Gorochov A.V., 1988, Paleontologicheskii Zhurnal, V1988, P54; Gregory T. R, 2014, ANIMAL GENOME SIZE D; Hanrahan SJ, 2011, CHROMOSOME RES, V19, P809, DOI 10.1007/s10577-011-9231-6; Hay JM, 2004, HEREDITY, V93, P468, DOI 10.1038/sj.hdy.6800525; Hazkani-Covo E, 2003, J MOL EVOL, V56, P169, DOI 10.1007/s00239-002-2390-5; Hazkani-Covo E, 2007, MOL BIOL EVOL, V24, P13, DOI 10.1093/molbev/msl149; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Hazkani-Covo E, 2009, MOL BIOL EVOL, V26, P2175, DOI 10.1093/molbev/msp131; Hazkani-Covo E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000237; Heads SW, 2008, PALAEONTOLOGY, V51, P499, DOI 10.1111/j.1475-4983.2008.00756.x; Heads Sam W., 2009, Denisia, P75; Henze K, 2001, TRENDS GENET, V17, P383, DOI 10.1016/S0168-9525(01)02312-5; Ho JWK, 2006, BIOINFORMATICS, V22, P2162, DOI 10.1093/bioinformatics/btl283; Hodgkinson A, 2014, SCIENCE, V344, P413, DOI 10.1126/science.1251110; HOEH WR, 1991, SCIENCE, V251, P1488, DOI 10.1126/science.1672472; Hugel Sylvain, 2005, Bulletin de la Societe Entomologique de France, V110, P153; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jensen-Seaman MI, 2009, J MOL EVOL, V68, P688, DOI 10.1007/s00239-009-9243-4; KONDO R, 1990, GENETICS, V126, P657; Kuck P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036593; Kvist L, 2003, MOL BIOL EVOL, V20, P243, DOI 10.1093/molbev/msg025; Leavitt JR, 2013, MOL PHYLOGENET EVOL, V67, P494, DOI 10.1016/j.ympev.2013.02.019; Leroux C, 1997, J VIROL, V71, P9627, DOI 10.1128/JVI.71.12.9627-9639.1997; Li MK, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks499; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Lopez JV, 1997, MOL BIOL EVOL, V14, P277, DOI 10.1093/oxfordjournals.molbev.a025763; Lunt DH, 1998, MOL ECOL, V7, P1441, DOI 10.1046/j.1365-294x.1998.00495.x; Miller M.A., 2011, CIPRES PORTALS; Miraldo A, 2012, MOL ECOL, V21, P1005, DOI 10.1111/j.1365-294X.2011.05422.x; Mirol PM, 2000, HEREDITY, V84, P538, DOI 10.1046/j.1365-2540.2000.00689.x; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Mourier T, 2001, MOL BIOL EVOL, V18, P1833, DOI 10.1093/oxfordjournals.molbev.a003971; Olson LE, 2002, MOL BIOL EVOL, V19, P93, DOI 10.1093/oxfordjournals.molbev.a003987; Perna NT, 1996, CURR BIOL, V6, P128, DOI 10.1016/S0960-9822(02)00441-4; Petrov DA, 2000, SCIENCE, V287, P1060, DOI 10.1126/science.287.5455.1060; Leite LAR, 2012, BIOTA NEOTROP, V12, P301, DOI 10.1590/S1676-06032012000300029; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; Ricchetti M, 2004, PLOS BIOL, V2, P1313, DOI 10.1371/journal.pbio.0020273; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Schmitz J, 2005, J MOL EVOL, V61, P1, DOI 10.1007/s00239-004-0293-3; Scudder SH, 1885, HDB PALAEONTOLOGIE 1, V2, P747; Sheffield NC, 2010, MITOCHONDR DNA, V21, P87, DOI 10.3109/19401736.2010.500812; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Song HJ, 2013, CLADISTICS, V29, P643, DOI 10.1111/cla.12013; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; Soto-Calderon ID, 2012, J MOL EVOL, V75, P102, DOI 10.1007/s00239-012-9519-y; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; Sword GA, 2007, SYST ENTOMOL, V32, P420, DOI 10.1111/j.1365-3113.2007.00385.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thalmann O, 2004, MOL ECOL, V13, P321, DOI 10.1046/j.1365-294X.2003.02070.x; Thalmann O, 2005, MOL ECOL, V14, P179, DOI 10.1111/j.1365-294X.2004.02382.x; Thorsness PE, 1996, INT REV CYTOL, V165, P207, DOI 10.1016/S0074-7696(08)62223-8; Triant DA, 2007, J MAMMAL, V88, P908, DOI 10.1644/06-MAMM-A-204R1.1; Triant DA, 2007, GENE, V401, P61, DOI 10.1016/j.gene.2007.07.003; Triant DA, 2009, J MAMMAL, V90, P561, DOI 10.1644/08-MAMM-A-149R1.1; Tsuji J, 2012, NUCLEIC ACIDS RES, V40, P9073, DOI 10.1093/nar/gks424; VANDERKUYL AC, 1995, J MOL EVOL, V40, P652, DOI 10.1007/BF00160513; Vaughan HE, 1999, GENOME, V42, P874, DOI 10.1139/gen-42-5-874; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; Wolff JN, 2013, HEREDITY, V110, P57, DOI 10.1038/hdy.2012.60; Wolff JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037142; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Zhang DX, 1996, MOL ECOL, V5, P295, DOI 10.1111/j.1365-294X.1996.tb00317.x; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8; Zhang HL, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-37; Zischler H, 2000, ELECTROPHORESIS, V21, P531, DOI 10.1002/(SICI)1522-2683(20000201)21:3<531::AID-ELPS531>3.3.CO;2-G; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	94	38	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110508	10.1371/journal.pone.0110508	http://dx.doi.org/10.1371/journal.pone.0110508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333882	Green Submitted, gold, Green Published			2022-12-27	WOS:000343731200049
J	Yu, WN; Liu, WN; Huang, HQ; Zheng, F; Wang, XY; Wu, YY; Li, KJ; Xie, XM; Jin, Y				Yu, Wangning; Liu, Weina; Huang, Huoqing; Zheng, Fei; Wang, Xiaoyu; Wu, Yuying; Li, Kangjia; Xie, Xiangming; Jin, Yi			Application of a Novel Alkali-Tolerant Thermostable DyP-Type Peroxidase from Saccharomonospora viridis DSM 43017 in Biobleaching of Eucalyptus Kraft Pulp	PLOS ONE			English	Article							PHANEROCHAETE SORDIDA YK-624; RHODOCOCCUS-JOSTII RHA1; CANDIDUM DEC 1; DECOLORIZING PEROXIDASE; MANGANESE PEROXIDASE; SWISS-MODEL; HETEROLOGOUS EXPRESSION; MALACHITE-GREEN; CRYSTAL VIOLET; HEME-BINDING	Saccharomonospora viridis is a thermophilic actinomycete that may have biotechnological applications because of its dye decolorizing activity, though the enzymatic oxidative system responsible for this activity remains elusive. Bioinformatic analysis revealed a DyP-type peroxidase gene in the genome of S. viridis DSM 43017 with sequence similarity to peroxidase from dye-decolorizing microbes. This gene, svidyp, consists of 1,215 bp encoding a polypeptide of 404 amino acids. The gene encoding SviDyP was cloned, heterologously expressed in Escherichia coli, and then purified. The recombinant protein could efficiently decolorize several triarylmethane dyes, anthraquinonic and azo dyes under neutral to alkaline conditions. The optimum pH and temperature for SviDyP was pH 7.0 and 70 degrees C, respectively. Compared with other DyP-type peroxidases, SviDyP was more active at high temperatures, retaining >63% of its maximum activity at 50-80 degrees C. It also showed broad pH adaptability (>35% activity at pH 4.0-9.0) and alkali-tolerance (>80% activity after incubation at pH 5-10 for 1 h at 37 degrees C), and was highly thermostable (>60% activity after incubation at 70 degrees C for 2 h at pH 7.0). SviDyP had an accelerated action during the biobleaching of eucalyptus kraft pulp, resulting in a 21.8% reduction in kappa number and an increase of 2.98% (ISO) in brightness. These favorable properties make SviDyP peroxidase a promising enzyme for use in the pulp and paper industries.	[Yu, Wangning; Liu, Weina; Zheng, Fei; Wang, Xiaoyu; Li, Kangjia; Xie, Xiangming; Jin, Yi] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Huang, Huoqing] Chinese Acad Agr Sci, Feed Res Inst, Beijing 100193, Peoples R China; [Wu, Yuying] Beijing Forestry Univ, Coll Mat Sci & Technol, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Beijing Forestry University	Xie, XM (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.	xxm1005@126.com; wizard.jin@163.com			Fundamental Research Funds for the Central University [TD2012-03]; National Natural Science Foundation of China [31070635, 30870028, J1103516]	Fundamental Research Funds for the Central University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central University (No. TD2012-03) and the National Natural Science Foundation of China (No. 31070635, No. 30870028, and No. J1103516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; An SY, 2002, BIOTECHNOL LETT, V24, P1037, DOI 10.1023/A:1015610018103; Antonopoulos VT, 2001, APPL MICROBIOL BIOT, V57, P92; ARCHIBALD FS, 1992, APPL ENVIRON MICROB, V58, P3110, DOI 10.1128/AEM.58.9.3110-3116.1992; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beg QK, 2000, ENZYME MICROB TECH, V27, P459, DOI 10.1016/S0141-0229(00)00231-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao P, 2005, PROTEIN EXPRES PURIF, V43, P157, DOI 10.1016/j.pep.2005.04.022; Colpa DI, 2014, J IND MICROBIOL BIOT, V41, P1, DOI 10.1007/s10295-013-1371-6; Coughlin MF, 2003, WATER RES, V37, P2757, DOI 10.1016/S0043-1354(03)00069-1; Daneshvar N, 2007, BIORESOURCE TECHNOL, V98, P1176, DOI 10.1016/j.biortech.2006.05.025; Du YL, 2013, BIORESOURCE TECHNOL, V130, P161, DOI 10.1016/j.biortech.2012.12.067; Dunford H. B., 1999, HEME PEROXIDASES; Fodil D, 2012, BIORESOURCE TECHNOL, V111, P383, DOI 10.1016/j.biortech.2012.01.153; Fodil D, 2011, INT BIODETER BIODEGR, V65, P470, DOI 10.1016/j.ibiod.2011.01.009; Georis J, 2000, ENZYME MICROB TECH, V26, P178, DOI 10.1016/S0141-0229(99)00141-6; Harazono K, 1996, APPL ENVIRON MICROB, V62, P913, DOI 10.1128/AEM.62.3.913-917.1996; Heck JX, 2006, BIORESOURCE TECHNOL, V97, P1902, DOI 10.1016/j.biortech.2005.08.013; Jones JJ, 2003, ANTIMICROB AGENTS CH, V47, P2323, DOI 10.1128/AAC.47.7.2323-2326.2003; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029; KONDO R, 1994, APPL ENVIRON MICROB, V60, P4359, DOI 10.1128/AEM.60.12.4359-4363.1994; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li J, 2012, APPL BIOCHEM BIOTECH, V166, P774, DOI 10.1007/s12010-011-9466-x; Liers C, 2013, APPL MICROBIOL BIOT, V97, P5839, DOI 10.1007/s00253-012-4521-2; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780; Ogola HJO, 2009, APPL ENVIRON MICROB, V75, P7509, DOI 10.1128/AEM.01121-09; Pati A, 2009, STAND GENOMIC SCI, V1, P141, DOI 10.4056/sigs.20263; Pogni R, 2005, BIOCHEMISTRY-US, V44, P4267, DOI 10.1021/bi047474l; Reid ID, 1998, APPL ENVIRON MICROB, V64, P2273; Ren SZ, 2006, APPL MICROBIOL BIOT, V72, P1316, DOI 10.1007/s00253-006-0418-2; ROBERTS JC, 1990, ENZYME MICROB TECH, V12, P210, DOI 10.1016/0141-0229(90)90040-W; Roberts JN, 2011, IDENTIFICATION CHAR; Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h; Salvachua D, 2013, APPL ENVIRON MICROB, V79, P4316, DOI 10.1128/AEM.00699-13; Sani RK, 1999, ENZYME MICROB TECH, V24, P433, DOI 10.1016/S0141-0229(98)00159-8; Santos A, 2014, APPL MICROBIOL BIOT, V98, P2053, DOI 10.1007/s00253-013-5041-4; Sato T, 2004, ACTA CRYSTALLOGR D, V60, P149, DOI 10.1107/S0907444903025472; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shimokawa T, 2009, J BIOSCI BIOENG, V107, P113, DOI 10.1016/j.jbiosc.2008.09.013; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Sugano Y, 2000, APPL ENVIRON MICROB, V66, P1754, DOI 10.1128/AEM.66.4.1754-1758.2000; Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8; Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIEN M, 1988, METHOD ENZYMOL, V161, P238; van Bloois E, 2010, APPL MICROBIOL BIOT, V86, P1419, DOI 10.1007/s00253-009-2369-x; Wang ZY, 2012, WORLD J MICROB BIOT, V28, P2741, DOI 10.1007/s11274-012-1085-3; WARIISHI H, 1992, J BIOL CHEM, V267, P23688; Webb MD, 2001, SOIL BIOL BIOCHEM, V33, P1903, DOI 10.1016/S0038-0717(01)00115-8; Welinder KG, 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [DOI 10.1016/0959-440X(92)90230-5, 10.1016/0959-440x(92)90230-5]; Wesenberg D, 2003, BIOTECHNOL ADV, V22, P161, DOI 10.1016/j.biotechadv.2003.08.011; YATOME C, 1993, APPL MICROBIOL BIOT, V38, P565; Zubieta C, 2007, PROTEINS, V69, P223, DOI 10.1002/prot.21550; Zubieta C, 2007, PROTEINS, V69, P234, DOI 10.1002/prot.21673	57	43	45	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110319	10.1371/journal.pone.0110319	http://dx.doi.org/10.1371/journal.pone.0110319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333297	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200032
J	Abou-Youssef, HS; Kamal, MM; Mehaney, DA				Abou-Youssef, Hazem S.; Kamal, Manal M.; Mehaney, Dina A.			Triple Test Screening for Down Syndrome: An Egyptian-Tailored Study	PLOS ONE			English	Article							SERUM ALPHA-FETOPROTEIN; NEURAL-TUBE DEFECTS; GESTATIONAL-AGE; RISK; ADJUSTMENT	Background: The incidence of Down syndrome (DS) in Egypt varies between 1:555 and 1:770 and its screening by triple test is becoming increasingly popular nowadays. Results, however, seem inaccurate due to the lack of Egyptian-specific information needed for risk calculation and a clear policy for programme implementation. Our study aimed at calculation and validation of the triple marker medians used in screening Egyptian females as well as to recommend programme conventions to unify screening in this country. Methods: The study was conducted on 668 Egyptian women, in weeks 15-20 of pregnancy as proven by sonar. Chorionic gonadotropin (CG), alpha-fetoprotein (AFP) and unconjugated oestriol (uE3) were measured on Siemens Immulite analyzer. Medians of the three parameters were calculated, regressed against gestational age (GA) and weighted by the number of participants/week. Equations were derived to adjust each parameter to the maternal weight and were centered on the median Egyptian weight. Prisca software was fed with the above data, multiples-of-median (MoM) and DS risks were calculated and the screening performance was evaluated at a mid-trimester risk cutoff of 1:270. Results: Log-linear [AFP/uE3 = 10((A+B*GA))] and exponential equations [CG = A*e ((B*GA))] were derived and the regressed medians were found to follow similar patterns to other Asian and Western medians. Oestriol was always lowest (even halved) while CG and AFP were intermediate. A linear reciprocal model best fitted weight distribution among Egyptians and successfully adjusted each parameter to a weight of 78.2 kg. Epidemiological monitoring of these recommendations revealed satisfactory performance in terms of 6.7% initial positive rate and 1.00 grand MoM. Conclusions: Adoption of the above recommendations is hoped to pave the way to a successful DS screening programme tailored to Egyptian peculiarities.	[Abou-Youssef, Hazem S.; Kamal, Manal M.; Mehaney, Dina A.] Cairo Univ, Fac Med, Clin & Chem Pathol Dept, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University	Abou-Youssef, HS (corresponding author), Cairo Univ, Fac Med, Clin & Chem Pathol Dept, Cairo, Egypt.	hazem2000@kasralainy.edu.eg		Abou-Youssef, Hazem/0000-0001-5088-5909	Cairo University Research Fund	Cairo University Research Fund(Cairo University)	This work was supported by the Cairo University Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; Ashwood ER, 2012, TIETZ TXB CLIN CHEM, P1991; Benn PA, 2002, CLIN CHIM ACTA, V323, P1, DOI 10.1016/S0009-8981(02)00186-9; Benn PA, 1997, AM J OBSTET GYNECOL, V176, P1056, DOI 10.1016/S0002-9378(97)70402-2; BISHOP J, 1995, ANN CLIN BIOCHEM, V32, P464, DOI 10.1177/000456329503200506; CUCKLE H, 1995, PRENATAL DIAG, V15, P1057, DOI 10.1002/pd.1970151111; CUCKLE HS, 1987, BRIT J OBSTET GYNAEC, V94, P387, DOI 10.1111/j.1471-0528.1987.tb03115.x; HAFEZ M, 1984, HUM BIOL, V56, P703; Knight GJ, 2003, CLIN LAB MED, V23, P531, DOI 10.1016/S0272-2712(03)00023-4; Kwon JY, 2011, J KOREAN MED SCI, V26, P1619, DOI 10.3346/jkms.2011.26.12.1619; Lambert-Messerlian GM, 2006, PRENATAL DIAG, V26, P17, DOI 10.1002/pd.1326; MacRae AR, 2003, CLIN CHEM, V49, P69, DOI 10.1373/49.1.69; Mazen I, 1998, E MEDITERR HEALTH J, V4, P252; Neveux LM, 1996, PRENATAL DIAG, V16, P1115, DOI 10.1002/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO;2-6; Nicholas SH, 1997, ARAB SOC CLASS GENDE, P6; OBrien JE, 1997, OBSTET GYNECOL, V89, P355, DOI 10.1016/S0029-7844(96)00524-8; Palomaki G E, 1996, J Med Screen, V3, P12; Palomaki GE, 2005, GENET MED, V7, P344, DOI 10.1097/01.GIM.0000167808.96439.F3; PALOMAKI GE, 1987, AM J OBSTET GYNECOL, V156, P460, DOI 10.1016/0002-9378(87)90309-7; Reynolds T, 2004, ANN CLIN BIOCHEM, V41, P464, DOI 10.1258/0004563042466901; Reynolds TM, 2006, J CLIN PATHOL, V59, P753, DOI 10.1136/jcp.2005.034280; Reynols TM, 1990, ANN CLIN BIOCHEM, V27, P425; Snijders RJM, 1999, ULTRASOUND OBST GYN, V13, P167, DOI 10.1046/j.1469-0705.1999.13030167.x; Vranken G, 2006, J CLIN PATHOL, V59, P639, DOI 10.1136/jcp.2005.034272; Wald NJ, 2000, J MED SCREEN, V7, P74, DOI 10.1136/jms.7.2.74; WALD NJ, 1992, BRIT J OBSTET GYNAEC, V99, P144, DOI 10.1111/j.1471-0528.1992.tb14474.x; Wang YY, 2006, INT J GYNECOL OBSTET, V94, P67, DOI 10.1016/j.ijgo.2006.04.030	27	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110370	10.1371/journal.pone.0110370	http://dx.doi.org/10.1371/journal.pone.0110370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330176	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100057
J	Duca, FA; Swartz, TD; Covasa, M				Duca, Frank A.; Swartz, Timothy D.; Covasa, Mihai			Effect of Diet on Preference and Intake of Sucrose in Obese Prone and Resistant Rats	PLOS ONE			English	Article							HIGH-FAT DIET; GLUCAGON-LIKE PEPTIDE-1; SWEET TASTE; REGULATE SECRETION; UMAMI TASTE; WEIGHT-LOSS; FOOD-INTAKE; MICE; RECEPTOR; T1R3	Increased orosensory stimulation from palatable diets and decreased feedback from gut signals have been proposed as contributing factors to obesity development. Whether altered taste functions associated with obesity are common traits or acquired deficits to environmental factors, such as a high-energy (HE)-diet, however, is not clear. To address this, we examined preference and sensitivity of increasing concentrations of sucrose solutions in rats prone (OP) and resistant (OR) to obesity during chow and HE feeding and measured lingual gene expression of the sweet taste receptor T1R3. When chow-fed, OP rats exhibited reduced preference and acceptance of dilute sucrose solutions, sham-fed less sucrose compared to OR rats, and had reduced lingual T1R3 gene expression. HE-feeding abrogated differences in sucrose preference and intake and lingual T1R3 expression between phenotypes. Despite similar sucrose intakes however, OP rats consumed significantly more total calories during 48-h two-bottle testing compared to OR rats. The results demonstrate that OP rats have an innate deficit for sweet taste detection, as illustrated by a reduction in sensitivity to sweets and reduced T1R3 gene expression; however their hyperphagia and subsequent obesity during HE-feeding is most likely not due to altered consumption of sweets.	[Duca, Frank A.; Swartz, Timothy D.; Covasa, Mihai] INRA, Ctr Rech, MICALIS, UMR 1319, Jouy En Josas, France; [Duca, Frank A.; Swartz, Timothy D.; Covasa, Mihai] AgroParisTech, Jouy En Josas, France; [Covasa, Mihai] Western Univ Hlth Sci, Coll Osteopath Med, Dept Basic Med Sci, Pomona, CA USA; [Covasa, Mihai] Univ Suceava, Dept Human Hlth & Dev, Suceava, Romania	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Western University of Health Sciences; Stefan cel Mare University of Suceava	Covasa, M (corresponding author), INRA, Ctr Rech, MICALIS, UMR 1319, Jouy En Josas, France.	mcovasa@jouy.inra.fr		Swartz, Timothy/0000-0002-9801-8756	Romanian National Program [PN-II-ID-PCE-2012-4-0608, 48/02.09.2013]	Romanian National Program	The study was supported by the Romanian National Program PN-II-ID-PCE-2012-4-0608 no. 48/02.09.2013, Analysis of novel risk factors influencing control of food intake and regulation of body weight. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKROFF K, 1991, PHYSIOL BEHAV, V49, P1047, DOI 10.1016/0031-9384(91)90330-Q; Bartoshuk LM, 2006, PHILOS T R SOC B, V361, P1137, DOI 10.1098/rstb.2006.1853; Berthoud HR, 2012, PHYSIOL BEHAV, V107, P527, DOI 10.1016/j.physbeh.2012.04.004; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Bray GA, 2004, PHYSIOL BEHAV, V83, P549, DOI 10.1016/j.physbeh.2004.08.039; Chen K, 2010, BRAIN RES, V1325, P53, DOI 10.1016/j.brainres.2010.02.026; Covasa M, 2010, AM J PHYSIOL-REG I, V299, pR1423, DOI 10.1152/ajpregu.00126.2010; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; De Jonghe BC, 2005, AM J PHYSIOL-REG I, V288, pR292, DOI 10.1152/ajpregu.00481.2004; Donaldson LF, 2009, AM J CLIN NUTR, V90, p800S, DOI 10.3945/ajcn.2009.27462Q; Duca F.A., 2013, DIABETES; Duca F.A., 2012, INT J OBES LOND; Duca FA, 2012, BR J NUTR, P1; Duca FA, 2013, HORM BEHAV, V64, P812, DOI 10.1016/j.yhbeh.2013.09.004; Eny KM, 2010, AM J CLIN NUTR, V92, P1501, DOI 10.3945/ajcn.2010.29836; Geiger BM, 2009, NEUROSCIENCE, V159, P1193, DOI 10.1016/j.neuroscience.2009.02.007; Geiger BM, 2008, FASEB J, V22, P2740, DOI 10.1096/fj.08-110759; Glendinning JI, 2010, AM J PHYSIOL-REG I, V299, pR1333, DOI 10.1152/ajpregu.00331.2010; Greenberg D, 1999, PHYSIOL BEHAV, V66, P621, DOI 10.1016/S0031-9384(98)00336-9; GRINKER J, 1978, AM J CLIN NUTR, V31, P1078, DOI 10.1093/ajcn/31.6.1078; Inoue M, 2007, PHYSIOL GENOMICS, V32, P82, DOI 10.1152/physiolgenomics.00161.2007; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Ji H, 2007, METABOLISM, V56, P1124, DOI 10.1016/j.metabol.2007.04.006; Johnson AW, 2012, APPETITE, V58, P215, DOI 10.1016/j.appet.2011.09.015; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Kokrashvili Z, 2009, ANN NY ACAD SCI, V1170, P91, DOI 10.1111/j.1749-6632.2009.04485.x; Lanfer A, 2012, INT J OBESITY, V36, P27, DOI 10.1038/ijo.2011.164; Levin BE, 2010, FRONT NEUROENDOCRIN, V31, P270, DOI 10.1016/j.yfrne.2010.02.005; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Overberg J, 2012, ARCH DIS CHILD, V97, P1048, DOI 10.1136/archdischild-2011-301189; Sartor F, 2011, APPETITE, V57, P237, DOI 10.1016/j.appet.2011.05.107; Sclafani A, 2005, AM J PHYSIOL-REG I, V289, pR712, DOI 10.1152/ajpregu.00176.2005; Sclafani A, 2006, PHYSIOL BEHAV, V89, P525, DOI 10.1016/j.physbeh.2006.03.021; Sclafani A, 2013, APPETITE, V71, P454, DOI 10.1016/j.appet.2012.05.024; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Shigemura N, 2004, ENDOCRINOLOGY, V145, P839, DOI 10.1210/en.2003-0602; Shin AC, 2011, INT J OBESITY, V35, pS40, DOI 10.1038/ijo.2011.147; Shin AC, 2010, NEUROSCIENCE, V170, P580, DOI 10.1016/j.neuroscience.2010.07.017; Shin AC, 2011, INT J OBES LOND; Shin AC, 2011, AM J PHYSIOL-REG I, V301, pR1267, DOI 10.1152/ajpregu.00314.2011; Swartz TD, 2010, PHYSIOL BEHAV, V99, P109, DOI 10.1016/j.physbeh.2009.10.016; Swartz T. D., 2011, BR J NUTR, P1; TORDOFF MG, 1991, APPETITE, V17, P97, DOI 10.1016/0195-6663(91)90065-Z; Zhang XJ, 2013, PEPTIDES, V47, P115, DOI 10.1016/j.peptides.2013.07.015; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zukerman S, 2009, AM J PHYSIOL-REG I, V296, pR866, DOI 10.1152/ajpregu.90870.2008	47	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e111232	10.1371/journal.pone.0111232	http://dx.doi.org/10.1371/journal.pone.0111232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329959	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100116
J	Ji, H; Chen, MS; Greening, DW; He, WF; Rai, A; Zhang, WW; Simpson, RJ				Ji, Hong; Chen, Maoshan; Greening, David W.; He, Weifeng; Rai, Alin; Zhang, Wenwei; Simpson, Richard J.			Deep Sequencing of RNA from Three Different Extracellular Vesicle (EV) Subtypes Released from the Human LIM1863 Colon Cancer Cell Line Uncovers Distinct Mirna-Enrichment Signatures	PLOS ONE			English	Article							COLORECTAL-CANCER; EXPRESSION PROFILES; SIGNALING PATHWAYS; EXOSOMAL PROTEINS; MICRORNA CLUSTER; TUMOR-SUPPRESSOR; UP-REGULATION; METASTASIS; PROLIFERATION; BIOMARKERS	Secreted microRNAs (miRNAs) enclosed within extracellular vesicles (EVs) play a pivotal role in intercellular communication by regulating recipient cell gene expression and affecting target cell function. Here, we report the isolation of three distinct EV subtypes from the human colon carcinoma cell line LIM1863-shed microvesicles (sMVs) and two exosome populations (immunoaffinity isolated A33-exosomes and EpCAM-exosomes). Deep sequencing of miRNA libraries prepared from parental LIM1863 cells/derived EV subtype RNA yielded 254 miRNA identifications, of which 63 are selectively enriched in the EVs-miR-19a/b-3p, miR-378a/c/d, and miR-577 and members of the let-7 and miR-8 families being the most prominent. Let-7a-3p*, let-7f-1-3p*, miR-451a, miR-574-5p*, miR-4454 and miR-7641 are common to all EV subtypes, and 6 miRNAs (miR-320a/b/c/d, miR-221-3p, and miR-200c-3p) discern LIM1863 exosomes from sMVs; miR-98-5p was selectively represented only in sMVs. Notably, A33-Exos contained the largest number (32) of exclusively-enriched miRNAs; 14 of these miRNAs have not been reported in the context of CRC tissue/biofluid analyses and warrant further examination as potential diagnostic markers of CRC. Surprisingly, miRNA passenger strands (star miRNAs) for miR-3613-3p*, -362-3p*, -625-3p*, -6842-3p* were the dominant strand in A33-Exos, the converse to that observed in parental cells. This finding suggests miRNA biogenesis may be interlinked with endosomal/exosomal processing.	[Ji, Hong; Chen, Maoshan; Greening, David W.; Rai, Alin; Simpson, Richard J.] La Trobe Univ, La Trobe Inst Mol Sci LIMS, Melbourne, Vic, Australia; [He, Weifeng] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, Chongqing Key Lab Dis Proteom, Chongqing, Peoples R China; [He, Weifeng] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China; [Zhang, Wenwei] BGI Shenzhen, Shenzhen, Peoples R China	La Trobe University; Army Medical University; Army Medical University; Beijing Genomics Institute (BGI)	Simpson, RJ (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci LIMS, Melbourne, Vic, Australia.	Richard.simpson@latrobe.edu.au	Rai, Alin/ABC-7474-2020; Greening, David/K-1369-2019; Greening, David/E-9138-2016	Greening, David/0000-0001-7516-485X; Rai, Alin/0000-0001-7994-5151; CHEN, MAOSHAN/0000-0002-3827-4969; Simpson, Richard/0000-0002-9834-0796	National Health and Medical Research Council of Australia (NHMRC) program [487922]; La Trobe University Research Scholarship	National Health and Medical Research Council of Australia (NHMRC) program; La Trobe University Research Scholarship	This work was supported by National Health and Medical Research Council of Australia (NHMRC) program grant #487922. MC and AR are supported by a La Trobe University Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bandres E, 2007, DNA CELL BIOL, V26, P273, DOI 10.1089/dna.2006.0544; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen HY, 2012, CANCER RES, V72, P3631, DOI 10.1158/0008-5472.CAN-12-0667; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Chen WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095240; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Corte H, 2012, DIGEST LIVER DIS, V44, P195, DOI 10.1016/j.dld.2011.10.010; Dong Y, 2011, BRIT J CANCER, V104, P893, DOI 10.1038/bjc.2011.57; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; EL Andaloussi S, 2013, ADV DRUG DELIVER REV, V65, P391, DOI 10.1016/j.addr.2012.08.008; Ell B, 2013, CANCER CELL, V24, P542, DOI 10.1016/j.ccr.2013.09.008; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Geng L, 2013, ONCOGENE IN PRESS; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hu MH, 2010, DIGEST DIS SCI, V55, P2365, DOI 10.1007/s10620-009-1008-9; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Ji H, 2013, PROTEOMICS, V13, P1672, DOI 10.1002/pmic.201200562; Kato M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003389; Kim DK, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20384; Kinet Virginie, 2013, Frontiers in Genetics, V4, P214, DOI 10.3389/fgene.2013.00214; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Luo XY, 2011, CANCER EPIDEM BIOMAR, V20, P1272, DOI 10.1158/1055-9965.EPI-11-0035; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; Mazeh H, 2013, J CANCER, V4, P281, DOI 10.7150/jca.5836; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Morello M, 2013, CELL CYCLE, V12, P3526, DOI 10.4161/cc.26539; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Nair R, 2014, STEM CELLS DEV, V23, P1625, DOI 10.1089/scd.2013.0633; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Plaisier CL, 2012, GENOME RES, V22, P2302, DOI 10.1101/gr.133991.111; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Rak J, 2012, BIOESSAYS, V34, P489, DOI 10.1002/bies.201100169; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Rossi S, 2012, FEBS LETT, V586, P3000, DOI 10.1016/j.febslet.2012.07.048; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2012, CANCER J, V18, P244, DOI 10.1097/PPO.0b013e318258b78f; Senanayake U, 2012, CARCINOGENESIS, V33, P1014, DOI 10.1093/carcin/bgs126; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stoorvogel W, 2012, BLOOD, V119, P646, DOI 10.1182/blood-2011-11-389478; Sun JY, 2012, BIOCHEM BIOPH RES CO, V420, P787, DOI 10.1016/j.bbrc.2012.03.075; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P2148, DOI 10.1074/mcp.M112.027086; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P587, DOI 10.1074/mcp.M112.021303; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tsai KW, 2009, EPIGENETICS-US, V4, P587, DOI 10.4161/epi.4.8.10230; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valencia K, 2014, MOL ONCOL, V8, P689, DOI 10.1016/j.molonc.2014.01.012; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044398; WHITEHEAD RH, 1987, CANCER RES, V47, P2683; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Xie BY, 2013, BIOINFORMATICS, V29, P638, DOI 10.1093/bioinformatics/btt014; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhang YJ, 2012, ONCOL REP, V27, P685, DOI 10.3892/or.2011.1561	100	138	144	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110314	10.1371/journal.pone.0110314	http://dx.doi.org/10.1371/journal.pone.0110314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330373	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100063
J	Kim, HK; Lee, JS; Park, MH; Cho, JS; Yoon, JH; Kim, SJ; Kang, HC				Kim, Hee Kyung; Lee, Ji Shin; Park, Min Ho; Cho, Jin Seong; Yoon, Jee Hee; Kim, Soo Jeong; Kang, Ho-Cheol			Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients with Acromegaly	PLOS ONE			English	Article							GROWTH-FACTOR-I; BRAF(V600E) MUTATION; IGF-I; INSULIN; EXPRESSION; RECEPTOR; ACTIVATION; MORTALITY; CARCINOMA; CRITERIA	Introduction: Several studies have reported a high frequency of papillary thyroid cancer (PTC) in patients with acromegaly. The aim of this study was to determine the prevalence and predictors of thyroid cancer in patients with acromegaly and to investigate the frequency of the BRAF(V600E) mutation in PTC patients with and without acromegaly. Materials and Methods: We conducted a retrospective study of 60 patients with acromegaly. Thyroid ultrasonography (US) and US-guided fine needle aspiration were performed on nodules with sonographic features of malignancy. We selected 16 patients with non-acromegalic PTC as a control group. The BRAF(V600E) mutation was analyzed in paraffin-embedded surgical specimens of PTC by real-time polymerase chain reaction, and tumor specimens from patients with PTC were stained immunohistochemically with an antibody against insulin-like growth factor-1 receptor beta (IGF-1R beta). Results: Thyroid cancer was found in 15 (25.0%) patients. No differences in age, sex, initial growth hormone (GH) and IGF-1 percentage of the upper limit of normal values or treatment modalities were observed between patients with and without PTC. Acromegaly was active in 12 of 15 patients at the time of PTC diagnosis; uncontrolled acromegaly had a significantly higher frequency in the PTC group (60%) than in the non-PTC group (28.9%) (p = 0.030). The BRAF(V600E) mutation was present in only 9.1% (1/11) of PTC patients with acromegaly, although 62.5% (10/16) of control patients with PTC had the mutation (p = 0.007). IGF-1Rb immunostaining showed moderate-to-strong staining in all malignant PTC cells in patients with and without acromegaly. Significantly less staining for IGF-1Rb was observed in normal adjacent thyroid tissues of PTC patients with acromegaly compared with those without (p = 0.014). Conclusion: The prevalence of PTC in acromegalic patients was high (25%). An uncontrolled hyperactive GH-IGF-1 axis may play a dominant role in the development of PTC rather than the BRAF(V600E) mutation in patients with acromegaly.	[Kim, Hee Kyung; Yoon, Jee Hee; Kim, Soo Jeong; Kang, Ho-Cheol] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Lee, Ji Shin] Chonnam Natl Univ, Sch Med, Dept Pathol, Kwangju, South Korea; [Park, Min Ho; Cho, Jin Seong] Chonnam Natl Univ, Sch Med, Dept Surg, Kwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Kang, HC (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea.	drkang@chonnam.ac.kr	Kang, Ho-Cheol/E-7969-2011	Kang, Ho-Cheol/0000-0002-0448-1345				Baris D, 2002, CANCER CAUSE CONTROL, V13, P395, DOI 10.1023/A:1015713732717; Caronia LM, 2011, CLIN CANCER RES, V17, P7511, DOI 10.1158/1078-0432.CCR-11-1155; dos Santos MCC, 2013, PITUITARY, V16, P109, DOI 10.1007/s11102-012-0383-y; Chung KW, 2006, CLIN ENDOCRINOL, V65, P660, DOI 10.1111/j.1365-2265.2006.02646.x; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Dagdelen S, 2013, PITUITARY; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giustina A, 2000, J CLIN ENDOCR METAB, V85, P526, DOI 10.1210/jc.85.2.526; Gullu BE, 2010, PITUITARY, V13, P242, DOI 10.1007/s11102-010-0224-9; Gydee H, 2004, PEDIATR RES, V55, P709, DOI 10.1203/01.PDR.0000111282.98401.93; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Holdaway IM, 2004, J CLIN ENDOCR METAB, V89, P667, DOI 10.1210/jc.2003-031199; Jenkins PJ, 2004, HORM RES, V62, P108, DOI 10.1159/000080768; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Kim EK, 2002, AM J ROENTGENOL, V178, P687, DOI 10.2214/ajr.178.3.1780687; Kim SK, 2008, DIAGN MOL PATHOL, V17, P118, DOI 10.1097/PDM.0b013e31815d059d; Kim TH, 2012, CANCER-AM CANCER SOC, V118, P1764, DOI 10.1002/cncr.26500; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Lim JY, 2013, THYROID, V23, P1423, DOI 10.1089/thy.2013.0036; Loeper S, 2008, REV ENDOCR METAB DIS, V9, P41, DOI 10.1007/s11154-007-9063-z; Maiorano E, 2000, APPL IMMUNOHISTO M M, V8, P110, DOI 10.1097/00022744-200006000-00005; Melmed S, 2002, J CLIN ENDOCR METAB, V87, P4054, DOI 10.1210/jc.2002-011841; MINUTO F, 1989, J CLIN ENDOCR METAB, V68, P621, DOI 10.1210/jcem-68-3-621; Mountzios G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054048; Murphy DA, 2006, AM J PATHOL, V169, P1875, DOI 10.2353/ajpath.2006.050711; MYERS MG, 1994, J BIOL CHEM, V269, P28783; Oh EY, 2010, J KOREAN THYROID ASS, V3, P142; ONODA N, 1992, EUR J CANCER, V28A, P1904, DOI 10.1016/0959-8049(92)90033-X; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; Ouban A, 2003, HUM PATHOL, V34, P803, DOI 10.1016/S0046-8177(03)00291-0; Rogozinski A, 2012, ARQ BRAS ENDOCRINOL, V56, P300, DOI 10.1590/S0004-27302012000500004; SAJI M, 1987, ENDOCRINOLOGY, V121, P749, DOI 10.1210/endo-121-2-749; Schoffski P, 2013, EUR J CANCER, V49, P3219, DOI 10.1016/j.ejca.2013.06.010; Siegel G, 2005, ENDOCR RES, V31, P51, DOI 10.1080/07435800500229177; TERZOLO M, 1994, ARCH INTERN MED, V154, P1272, DOI 10.1001/archinte.154.11.1272; TODE B, 1989, J CLIN ENDOCR METAB, V69, P639, DOI 10.1210/jcem-69-3-639; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wolinski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088787; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; YASHIRO T, 1989, ACTA ENDOCRINOL-COP, V121, P112, DOI 10.1530/acta.0.1210112	40	13	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110241	10.1371/journal.pone.0110241	http://dx.doi.org/10.1371/journal.pone.0110241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329702	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204100050
J	Diaz-Herrero, MM; del Campo, JA; Carbonero-Aguilar, P; Vega-Perez, JM; Iglesias-Guerra, F; Perinan, I; Minano, FJ; Bautista, J; Romero-Gomez, M				Mar Diaz-Herrero, M.; del Campo, Jose A.; Carbonero-Aguilar, Pilar; Vega-Perez, Jose M.; Iglesias-Guerra, Fernando; Perinan, Ignacio; Minano, Francisco J.; Bautista, Juan; Romero-Gomez, Manuel			THDP17 Decreases Ammonia Production through Glutaminase Inhibition. A New Drug for Hepatic Encephalopathy Therapy	PLOS ONE			English	Article							GERM-FREE; CYTOTOXICITY; LOCALIZATION; CIRRHOSIS; TOXICITY; THIOUREA	Ammonia production is implicated in the pathogenesis of hepatic encephalopathy (HE), being intestinal glutaminase activity the main source for ammonia. Management of ammonia formation can be effective in HE treatment by lowering intestinal ammonia production. The use of glutaminase inhibitors represents one way to achieve this goal. In this work, we have performed a search for specific inhibitors that could decrease glutaminase activity by screening two different groups of compounds: i) a group integrated by a diverse, highly pure small molecule compounds derived from thiourea ranging from 200 to 800 Daltons; and ii) a group integrated by commonly use compounds in the treatment of HE. Results shown that THDP-17 (10 mu M), a thiourea derivate product, could inhibit the intestinal glutaminase activity (57.4 +/- 6.7%). Inhibitory effect was tissue dependent, ranging from 40 +/- 5.5% to 80 +/- 7.8% in an uncompetitive manner, showing V-max and K-m values of 384.62 mu mol min(-1), 13.62 mM with THDP-17 10 mu M, respectively. This compound also decreased the glutaminase activity in Caco-2 cell cultures, showing a reduction of ammonia and glutamate production, compared to control cultures. Therefore, the THDP-17 compound could be a good candidate for HE management, by lowering ammonia production.	[Mar Diaz-Herrero, M.; Carbonero-Aguilar, Pilar; Bautista, Juan] Univ Seville, Fac Farm, Dept Bioquim & Biol Mol, Seville, Spain; [del Campo, Jose A.; Romero-Gomez, Manuel] Hosp Univ Valme, Unidad Gest Clin Enfermedades Digest, Seville, Spain; [del Campo, Jose A.; Romero-Gomez, Manuel] Hosp Univ Valme, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Seville, Spain; [Vega-Perez, Jose M.; Iglesias-Guerra, Fernando; Perinan, Ignacio] Univ Seville, Fac Farm, Dept Quim Organ & Quim Farmaceut, Seville, Spain; [Minano, Francisco J.] Univ Seville, Hosp Univ Valme, UFEC, Seville, Spain	University of Sevilla; Hospital Valme; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Valme; University of Sevilla; Hospital Valme; University of Sevilla	Bautista, J (corresponding author), Univ Seville, Fac Farm, Dept Bioquim & Biol Mol, Seville, Spain.	jdbaut@us.es; mromerogomez@us.es	Romero-Gomez, Manuel/L-8030-2014; Miñano, Francisco/F-2257-2015; IBIS, DIGESTIVAS/O-1913-2015; IBIS, NEUROFARMACOLOGIA/C-1788-2016; Miñano, Francisco/A-2004-2008; /AAA-4450-2019	Romero-Gomez, Manuel/0000-0001-8494-8947; Miñano, Francisco/0000-0002-8971-6966; /0000-0002-7203-5777	Junta de Andalucia (Spain) [P06-CTS-01887]; Ministerio de Sanidad y Consumo of Spain [PI070425]	Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); Ministerio de Sanidad y Consumo of Spain(Spanish Government)	Supported by research grants by Junta de Andalucia (Spain) P06-CTS-01887 and by Ministerio de Sanidad y Consumo of Spain PI070425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; Ampuero J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049279; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butterworth RF, 2009, LIVER INT, V29, P783, DOI 10.1111/j.1478-3231.2009.02034.x; Castell L, 2004, J BIOL CHEM, V279, P13305, DOI 10.1074/jbc.M309520200; Dam G, 2013, HEPATOLOGY, V57, P258, DOI 10.1002/hep.25995; Damink SWMO, 2002, HEPATOLOGY, V36, P1163, DOI 10.1053/jhep.2002.36497; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Furdik M., 1961, CHEM ZVESTI, V15, P173; HAWKINS RA, 1994, ADV EXP MED BIOL, V368, P125; HEINI HG, 1987, EUR J BIOCHEM, V162, P541, DOI 10.1111/j.1432-1033.1987.tb10673.x; Iliceto A, 1960, GAZZ CHIM ITAL, V90, P919; James LA, 1998, BRIT J NUTR, V79, P365, DOI 10.1079/BJN19980061; James LA, 1998, CLIN SCI, V94, P313, DOI 10.1042/cs0940313; Jover-Cobos M, 2014, J HEPATOL, V60, P545, DOI 10.1016/j.jhep.2013.10.012; Llansola M, 2013, METAB BRAIN DIS, V28, P151, DOI 10.1007/s11011-012-9337-3; Lund P, 1988, METHOD ENZYMAT AN, P57; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NANCE FC, 1971, ANN SURG, V174, P856, DOI 10.1097/00000658-197111000-00018; Olalla L, 2002, J BIOL CHEM, V277, P38939, DOI 10.1074/jbc.C200373200; Perez-Gomez C, 2005, BIOCHEM J, V386, P535, DOI 10.1042/BJ20040996; Roberg BA, 2010, NEUROCHEM RES, V35, P875, DOI 10.1007/s11064-009-0077-7; Romero Gomez M, 2004, Gastroenterol Hepatol, V27 Suppl 1, P40; Romero-Gomez M, 2004, J HEPATOL, V41, P49, DOI 10.1016/j.jhep.2004.03.021; Romero-Gomez M, 2010, ANN INTERN MED, V153, P281, DOI 10.7326/0003-4819-153-5-201009070-00002; SHAPIRO RA, 1985, ARCH BIOCHEM BIOPHYS, V243, P1, DOI 10.1016/0003-9861(85)90767-2; Smith PB, 2002, BIOCHEM PHARMACOL, V63, P1941, DOI 10.1016/S0006-2952(02)00978-4; Spielmann H, 1999, ATLA-ALTERN LAB ANIM, V27, P957, DOI 10.1177/026119299902700609; Vega-Perez JM, 2012, EUR J MED CHEM, V58, P591, DOI 10.1016/j.ejmech.2012.10.042; WARREN KS, 1959, AM J PHYSIOL, V197, P717, DOI 10.1152/ajplegacy.1959.197.3.717; WEBER FL, 1979, GASTROENTEROLOGY, V77, P235; Zemtsova I, 2011, HEPATOLOGY, V54, P204, DOI 10.1002/hep.24326; ZHANG SZ, 1990, CELL BIOL TOXICOL, V6, P219	33	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109787	10.1371/journal.pone.0109787	http://dx.doi.org/10.1371/journal.pone.0109787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329718	Green Published, gold			2022-12-27	WOS:000345204100029
J	Billard, V; Ourry, A; Maillard, A; Garnica, M; Coquet, L; Jouenne, T; Cruz, F; Garcia-Mina, JM; Yvin, JC; Etienne, P				Billard, Vincent; Ourry, Alain; Maillard, Anne; Garnica, Maria; Coquet, Laurent; Jouenne, Thierry; Cruz, Florence; Garcia-Mina, Jose-Maria; Yvin, Jean-Claude; Etienne, Philippe			Copper-Deficiency in Brassica napus Induces Copper Remobilization, Molybdenum Accumulation and Modification of the Expression of Chloroplastic Proteins	PLOS ONE			English	Article							PHOTOSYSTEM-II; ARABIDOPSIS-THALIANA; IRON HOMEOSTASIS; PLANT-PROTEINS; OILSEED RAPE; BINDING; ZINC; MOLYBDATE; METALS; GROWTH	During the last 40 years, crop breeding has strongly increased yields but has had adverse effects on the content of micronutrients, such as Fe, Mg, Zn and Cu, in edible products despite their sufficient supply in most soils. This suggests that micronutrient remobilization to edible tissues has been negatively selected. As a consequence, the aim of this work was to quantify the remobilization of Cu in leaves of Brassica napus L. during Cu deficiency and to identify the main metabolic processes that were affected so that improvements can be achieved in the future. While Cu deficiency reduced oilseed rape growth by less than 19% compared to control plants, Cu content in old leaves decreased by 61.4%, thus demonstrating a remobilization process between leaves. Cu deficiency also triggered an increase in Cu transporter expression in roots (COPT2) and leaves (HMA1), and more surprisingly, the induction of the MOT1 gene encoding a molybdenum transporter associated with a strong increase in molybdenum (Mo) uptake. Proteomic analysis of leaves revealed 33 proteins differentially regulated by Cu deficiency, among which more than half were located in chloroplasts. Eleven differentially expressed proteins are known to require Cu for their synthesis and/or activity. Enzymes that were located directly upstream or downstream of Cu-dependent enzymes were also differentially expressed. The overall results are then discussed in relation to remobilization of Cu, the interaction between Mo and Cu that occurs through the synthesis pathway of Mo cofactor, and finally their putative regulation within the Calvin cycle and the chloroplastic electron transport chain.	[Billard, Vincent; Ourry, Alain; Maillard, Anne; Etienne, Philippe] Normandie Univ, Caen, France; [Billard, Vincent; Ourry, Alain; Maillard, Anne; Etienne, Philippe] UNICAEN, UMR Ecophysiol Vegetale Agron & Nutr NCS 950, Caen, France; [Billard, Vincent; Ourry, Alain; Maillard, Anne; Etienne, Philippe] INRA, UMR Ecophysiol Vegetale Agron & Nutr NCS 950, Caen, France; [Garnica, Maria; Garcia-Mina, Jose-Maria] Timac Agro Spain, Poligono Arazuri Orcoyen, Orcoyen, Spain; [Coquet, Laurent; Jouenne, Thierry] Fac Sci Rouen, CNRS, UMR6270, Plateforme Prote PISSARO, Mont St Aignan, France; [Cruz, Florence; Yvin, Jean-Claude] Ctr Rech Int Agrosci, CRIAS TAI, Grp Roullier, Dinard, France	Universite de Caen Normandie; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Etienne, P (corresponding author), Normandie Univ, Caen, France.	philippe.etienne@unicaen.fr	ETIENNE, Philippe/AAS-2211-2021; OURRY, Alain/AFN-5444-2022; Garnica, Maria/F-2426-2016; García-Mina, José María/O-7577-2014	ETIENNE, Philippe/0000-0002-4531-3874; OURRY, Alain/0000-0002-3654-4195; Garnica, Maria/0000-0001-9646-6726; García-Mina, José María/0000-0001-6352-9612; COQUET, Laurent/0000-0001-7778-7321; jouenne, thierry/0000-0003-0994-9944	Regional Council of Basse-Normandie; Timac Agro International	Regional Council of Basse-Normandie(Region Normandie); Timac Agro International	VB's PhD grant was funded by the Regional Council of Basse-Normandie (http://www.region-basse-normandie.fr/) and Timac Agro International (http://www.timacagro.fr/). Regional Council of Basse-Normandie had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Timac Agro Internationnal had a role in study design and analysis.	Abdallah M, 2010, J EXP BOT, V61, P2635, DOI 10.1093/jxb/erq096; Allen L, 2006, GUIDELINES FOOD FORT; Andersen P, 2007, MT RES DEV, V27, P331, DOI 10.1659/mrd.0915; Andres-Colas N, 2013, METALLOMICS, V5, P1234, DOI 10.1039/c3mt00025g; [Anonymous], [No title captured]; ANSES, 2012, ANS TABL CIQ 2012 CO; Avice J-C, 2014, J EXP BOT IN PRESS; BAILEY E, 1968, BIOCHEM J, V108, P427, DOI 10.1042/bj1080427; BASAK A, 1982, PLANT SOIL, V68, P261, DOI 10.1007/BF02373712; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Bernal M, 2012, PLANT CELL, V24, P738, DOI 10.1105/tpc.111.090431; BERRY A, 1993, FEBS LETT, V318, P11, DOI 10.1016/0014-5793(93)81317-S; Bittner F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00028; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bouis I, 2012, BIOFORTIFICATION LEV, P83; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradova J, 2008, CHROMATOGRAPHIA, V67, pS83, DOI 10.1365/s10337-008-0545-2; Broadley M, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P191, DOI 10.1016/B978-0-12-384905-2.00007-8; Burda K, 2003, BIOCHEM J, V371, P597, DOI 10.1042/BJ20021265; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Cereda A, 2009, BIOCHEM J, V418, P135, DOI 10.1042/BJ20081218; Chavez A. L., 2000, Food and Nutrition Bulletin, V21, P410; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; Collins JF, 2011, ADV NUTR, V2, P520, DOI 10.3945/an.111.001222; del Pozo T, 2010, BIOCHEM BIOPH RES CO, V393, P248, DOI 10.1016/j.bbrc.2010.01.111; Deng FL, 2013, PLANT PHYSIOL, V163, P1353, DOI 10.1104/pp.113.226225; Desclos M, 2008, PLANT PHYSIOL, V147, P1830, DOI 10.1104/pp.108.116905; Dubousset L, 2010, J EXP BOT, V61, P4313, DOI 10.1093/jxb/erq233; Etienne P, 2007, FUNCT PLANT BIOL, V34, P895, DOI 10.1071/FP07088; Fan MS, 2008, J TRACE ELEM MED BIO, V22, P315, DOI 10.1016/j.jtemb.2008.07.002; Ferrer JL, 2004, J BIOL CHEM, V279, P44235, DOI 10.1074/jbc.C400325200; Garcia-Molina A, 2013, PLANT CELL PHYSIOL, V54, P1378, DOI 10.1093/pcp/pct088; Garvin DF, 2006, J SCI FOOD AGR, V86, P2213, DOI 10.1002/jsfa.2601; Giulia M, 2012, BIOCHEMISTRY; Grusak MA, 2005, BIOL SCI SER, P265; Hansch R, 2009, CURR OPIN PLANT BIOL, V12, P259, DOI 10.1016/j.pbi.2009.05.006; Hennig M, 1997, P NATL ACAD SCI USA, V94, P4866, DOI 10.1073/pnas.94.10.4866; Higashi Y, 2013, PLANT CELL PHYSIOL, V54, P1345, DOI 10.1093/pcp/pct084; Ide Y, 2011, J EXP BOT, V62, P1483, DOI 10.1093/jxb/erq345; IKEUCHI M, 1986, ARCH BIOCHEM BIOPHYS, V247, P97, DOI 10.1016/0003-9861(86)90538-2; Komenda J, 2010, BBA-BIOENERGETICS, V1797, P566, DOI 10.1016/j.bbabio.2010.02.006; Kung CCS, 2006, PROTEOMICS, V6, P2746, DOI 10.1002/pmic.200500108; Kuper J, 2004, NATURE, V430, P803, DOI 10.1038/nature02681; LIDON FC, 1993, J PLANT NUTR, V16, P1449, DOI 10.1080/01904169309364626; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAHMOUD YAG, 1995, ARCH BIOCHEM BIOPHYS, V322, P69, DOI 10.1006/abbi.1995.1437; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Matrix science, MASC SEARCH ENG PROT; Mechin V, 2003, PROTEOMICS, V3, P1299, DOI 10.1002/pmic.200300450; Mendel RR, 2013, J BIOL CHEM, V288, P13165, DOI 10.1074/jbc.R113.455311; Mooney S, 2010, PHYTOCHEMISTRY, V71, P495, DOI 10.1016/j.phytochem.2009.12.015; Mora V, 2010, J PLANT PHYSIOL, V167, P633, DOI 10.1016/j.jplph.2009.11.018; Munoz-Bertomeu J, 2009, PLANT PHYSIOL, V151, P541, DOI 10.1104/pp.109.143701; O'Sullivan JN, 2007, J PLANT NUTR SOIL SC, V170, P273, DOI 10.1002/jpln.200625049; Peverill K., 1999, SOIL ANAL INTERPRETA; Pilon Marinus, 2006, Genet Eng (N Y), V27, P101, DOI 10.1007/0-387-25856-6_7; Ravet K, 2011, PLANT PHYSIOL, V157, P1300, DOI 10.1104/pp.111.183350; Ruston D., 2004, NATL DIET NUTR SURVE, V4; Schwarz G, 2000, PLANT CELL, V12, P2455, DOI 10.1105/tpc.12.12.2455; SLOVACEK RE, 1983, ARCH BIOCHEM BIOPHYS, V224, P310, DOI 10.1016/0003-9861(83)90214-X; Steinnes E, 2009, ENVIRON GEOCHEM HLTH, V31, P523, DOI 10.1007/s10653-009-9257-2; TAINER JA, 1983, NATURE, V306, P284, DOI 10.1038/306284a0; Tan YF, 2010, PLANT PHYSIOL, V152, P747, DOI 10.1104/pp.109.147942; Tejada-Jimenez M, 2009, CURR OPIN PLANT BIOL, V12, P358, DOI 10.1016/j.pbi.2009.04.012; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Tomatsu H, 2007, P NATL ACAD SCI USA, V104, P18807, DOI 10.1073/pnas.0706373104; VOLINI M, 1978, ARCH BIOCHEM BIOPHYS, V191, P205, DOI 10.1016/0003-9861(78)90083-8; WALLACE A, 1977, COMMUN SOIL SCI PLAN, V8, P741, DOI 10.1080/00103627709366768; Wang W, 2003, ELECTROPHORESIS, V24, P2369, DOI 10.1002/elps.200305500; Waters BM, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26611; White PJ, 2005, TRENDS PLANT SCI, V10, P586, DOI 10.1016/j.tplants.2005.10.001; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yruela I, 2013, METALLOMICS, V5, P1090, DOI 10.1039/c3mt00086a; Yruela I, 2009, FUNCT PLANT BIOL, V36, P409, DOI 10.1071/FP08288; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	76	27	27	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109889	10.1371/journal.pone.0109889	http://dx.doi.org/10.1371/journal.pone.0109889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333918	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200063
J	Ko, JH; Gu, WJ; Lim, I; Zhou, T; Bang, H				Ko, Jae-Hong; Gu, Wanjun; Lim, Inja; Zhou, Tong; Bang, Hyoweon			Expression Profiling of Mitochondrial Voltage-Dependent Anion Channel-1 Associated Genes Predicts Recurrence-Free Survival in Human Carcinomas	PLOS ONE			English	Article							CANCER CELLS; BCL-XL; COLORECTAL-CANCER; PROSTATE-CANCER; DOWN-REGULATION; CYTOCHROME-C; VDAC; APOPTOSIS; DATABASE; INFORMATION	Background: Mitochondrial voltage-dependent anion channels (VDACs) play a key role in mitochondria-mediated apoptosis. Both in vivo and in vitro evidences indicate that VDACs are actively involved in tumor progression. Specifically, VDAC-1, one member of the VDAC family, was thought to be a potential anti-cancer therapeutic target. Our previous study demonstrated that the human gene VDAC1 (encoding the VDAC-1 isoform) was significantly up-regulated in lung tumor tissue compared with normal tissue. Also, we found a significant positive correlation between the gene expression of VDAC1 and histological grade in breast cancer. However, the prognostic power of VDAC1 and its associated genes in human cancers is largely unknown. Methods: We systematically analyzed the expression pattern of VDAC1 and its interacting genes in breast, colon, liver, lung, pancreatic, and thyroid cancers. The genes differentially expressed between normal and tumor tissues in human carcinomas were identified. Results: The expression level of VDAC1 was uniformly up-regulated in tumor tissue compared with normal tissue in breast, colon, liver, lung, pancreatic, and thyroid cancers. Forty-four VDAC1 interacting genes were identified as being commonly differentially expressed between normal and tumor tissues in human carcinomas. We designated VDAC1 and the 44 dysregulated interacting genes as the VDAC1 associated gene signature (VAG). We demonstrate that the VAG signature is a robust prognostic biomarker to predict recurrence-free survival in breast, colon, and lung cancers, and is independent of standard clinical and pathological prognostic factors. Conclusions: VAG represents a promising prognostic biomarker in human cancers, which may enhance prediction accuracy in identifying patients at higher risk for recurrence. Future therapies aimed specifically at VDAC1 associated genes may lead to novel agents in the treatment of cancer.	[Ko, Jae-Hong; Lim, Inja; Bang, Hyoweon] Chung Ang Univ, Coll Med, Dept Physiol, Seoul 156756, South Korea; [Gu, Wanjun] Southeast Univ, Res Ctr Learning Sci, Nanjing, Jiangsu, Peoples R China; [Zhou, Tong] Univ Arizona, Dept Med, Tucson, AZ 85721 USA	Chung Ang University; Chung Ang University Hospital; Southeast University - China; University of Arizona	Zhou, T (corresponding author), Univ Arizona, Dept Med, Tucson, AZ 85721 USA.	tongzhou@email.arizona.edu; haena@cau.ac.kr	Gu, Wanjun/P-5389-2019	Gu, Wanjun/0000-0003-4501-0539	Korea Research Foundation [KRF-2011-0016587]	Korea Research Foundation(National Research Foundation of Korea)	This work was supported by the Korea Research Foundation Grant (http://www.krf.or.kr/) funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) (KRF-2011-0016587 to JHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; Blachly-Dyson E, 2001, IUBMB LIFE, V52, P113; Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Castilla C, 2006, ENDOCRINOLOGY, V147, P4960, DOI 10.1210/en.2006-0502; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; DIHANICH M, 1990, EXPERIENTIA, V46, P146, DOI 10.1007/BF02027310; Ehrlichova M, 2005, ANTICANCER RES, V25, P4215; Fernald K, 2013, TRENDS CELL BIOL, V23, P620, DOI 10.1016/j.tcb.2013.07.006; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Grills C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014635; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Ko JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086569; Ko JH, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-106; Koren I, 2010, CANCER BIOL THER, V9, P1046, DOI 10.4161/cbt.9.12.11879; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Krasnov GS, 2013, EXPERT OPIN THER TAR, V17, P681, DOI 10.1517/14728222.2013.775253; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Leanza L., 2014, ONCOGENE; Leanza L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00227; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Mathupala SP, 2010, CANCER BIOL THER, V9, P1053, DOI 10.4161/cbt.9.12.12451; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mohammad RM, 2005, PANCREAS, V31, P317, DOI 10.1097/01.mpa.0000179731.46210.01; Ni IBP, 2010, PATHOL RES PRACT, V206, P223, DOI 10.1016/j.prp.2009.11.006; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Okada SF, 2004, J GEN PHYSIOL, V124, P513, DOI 10.1085/jgp.200409154; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Perevoshchikova IV, 2010, FEBS LETT, V584, P2397, DOI 10.1016/j.febslet.2010.04.033; Pitroda SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046104; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Sabatier R, 2011, BREAST CANCER RES TR, V126, P407, DOI 10.1007/s10549-010-0897-9; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Schmitt E, 2004, CANCER RES, V64, P2705, DOI 10.1158/0008-5472.CAN-03-2475; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Sillars-Hardebol AH, 2012, J PATHOL, V226, P442, DOI 10.1002/path.2983; Simamura E, 2008, J BIOENERG BIOMEMBR, V40, P213, DOI 10.1007/s10863-008-9158-6; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Tan WZ, 2012, BBA-BIOMEMBRANES, V1818, P1555, DOI 10.1016/j.bbamem.2011.12.032; Tsujimoto Y, 2002, BIOCHIMIE, V84, P187, DOI 10.1016/S0300-9084(02)01370-6; Uddin S, 2011, AM J PATHOL, V178, P537, DOI 10.1016/j.ajpath.2010.10.020; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Vilenchik M, 2002, CANCER RES, V62, P2175; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhu HB, 2007, INT J CANCER, V121, P1366, DOI 10.1002/ijc.22856	62	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e110094	10.1371/journal.pone.0110094	http://dx.doi.org/10.1371/journal.pone.0110094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333947	Green Submitted, gold, Green Published			2022-12-27	WOS:000346766200092
J	Liu, YY; Nacher, JC; Ochiai, T; Martino, M; Altshuler, Y				Liu, Yang-Yu; Nacher, Jose C.; Ochiai, Tomoshiro; Martino, Mauro; Altshuler, Yaniv			Prospect Theory for Online Financial Trading	PLOS ONE			English	Article							DISPOSITION; AVERSION; LONG	Prospect theory is widely viewed as the best available descriptive model of how people evaluate risk in experimental settings. According to prospect theory, people are typically risk-averse with respect to gains and risk-seeking with respect to losses, known as the "reflection effect". People are much more sensitive to losses than to gains of the same magnitude, a phenomenon called "loss aversion". Despite of the fact that prospect theory has been well developed in behavioral economics at the theoretical level, there exist very few large-scale empirical studies and most of the previous studies have been undertaken with micro-panel data. Here we analyze over 28.5 million trades made by 81.3 thousand traders of an online financial trading community over 28 months, aiming to explore the large-scale empirical aspect of prospect theory. By analyzing and comparing the behavior of winning and losing trades and traders, we find clear evidence of the reflection effect and the loss aversion phenomenon, which are essential in prospect theory. This work hence demonstrates an unprecedented large-scale empirical evidence of prospect theory, which has immediate implication in financial trading, e.g., developing new trading strategies by minimizing the impact of the reflection effect and the loss aversion phenomenon. Moreover, we introduce three novel behavioral metrics to differentiate winning and losing traders based on their historical trading behavior. This offers us potential opportunities to augment online social trading where traders are allowed to watch and follow the trading activities of others, by predicting potential winners based on their historical trading behavior.	[Liu, Yang-Yu] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Liu, Yang-Yu] Harvard Univ, Sch Med, Boston, MA USA; [Liu, Yang-Yu] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Liu, Yang-Yu] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Liu, Yang-Yu] Northeastern Univ, Dept Comp Sci, Boston, MA 02115 USA; [Liu, Yang-Yu] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Liu, Yang-Yu] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Nacher, Jose C.] Toho Univ, Fac Sci, Dept Informat Sci, Funabashi, Chiba 274, Japan; [Ochiai, Tomoshiro] Otsuma Womens Univ, Dept Social Informat Studies, Tama, Tokyo, Japan; [Martino, Mauro] IBM Corp, Ctr Innovat Visual Analyt, Watson Res Ctr, Cambridge, MA USA; [Altshuler, Yaniv] MIT, Media Lab, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Northeastern University; Northeastern University; Northeastern University; Northeastern University; Harvard University; Dana-Farber Cancer Institute; Toho University; International Business Machines (IBM); Massachusetts Institute of Technology (MIT)	Liu, YY (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	yyl@channing.harvard.edu	Liu, Yang-Yu/G-8885-2011; Chanelian, Serena/ABE-4873-2021	Liu, Yang-Yu/0000-0003-2728-4907; Chanelian, Serena/0000-0001-5727-6137	NS-CTA - US Army Research Laboratory [W911NF-09-2-0053]; DARPA [11645021]; DTRA [HDTRA1-10-1-0100/BRBAA08-Per4-C-2-0033]	NS-CTA - US Army Research Laboratory; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DTRA(United States Department of DefenseDefense Threat Reduction Agency)	This work was partially supported by NS-CTA sponsored by US Army Research Laboratory under Agreement No. W911NF-09-2-0053; DARPA under Agreement No. 11645021; DTRA under Agreement No. HDTRA1-10-1-0100/BRBAA08-Per4-C-2-0033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellaoui M, 2000, MANAGE SCI, V46, P1497, DOI 10.1287/mnsc.46.11.1497.12080; Abdellaoui M, 2011, THEORY, V74, P411; Abdellaoui M, 2007, MANAGE SCI, V53, P1659, DOI 10.1287/mnsc.1070.0711; Alanyali M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03578; Barber BM, 2000, J FINANC, V55, P773, DOI 10.1111/0022-1082.00226; Barberis N, 2009, J FINANC, V64, P751, DOI 10.1111/j.1540-6261.2009.01448.x; Barberis NC, 2013, J ECON PERSPECT, V27, P173, DOI 10.1257/jep.27.1.173; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Booij AS, 2010, THEOR DECIS, V68, P115, DOI 10.1007/s11238-009-9144-4; Brooks P, 2005, J RISK UNCERTAINTY, V31, P301, DOI 10.1007/s11166-005-5105-7; Camerer CF, 1998, WORKING PAPERS CALTE, V1037; Costa ND, 2013, J BANK FINANC, V37; Diamond P, 2007, BEHAV EC ITS APPL HA; Dietz PO, 2004, SPAULDING SERIES; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Krasny Y., 2013, SECURITY PRIVACY SOC, P85, DOI [10.1007/978-1-4614-4139-7_6, DOI 10.1007/978-1-4614-4139-7_6]; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Odean T, 1998, J FINANC, V53, P1775, DOI 10.1111/0022-1082.00072; Pan W, 2012, Proceedings of 2012 ASE/IEEE International Conference on Privacy, Security, Risk and Trust and 2012 ASE/IEEE International Conference on Social Computing (SocialCom/PASSAT 2012), P203, DOI 10.1109/SocialCom-PASSAT.2012.133; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Schmidt U, 2005, J RISK UNCERTAINTY, V30, P157, DOI 10.1007/s11166-005-6564-6; Schmidt U, 2002, ROYAL EC SOC ANN C 2; Schmidt U, 2008, J RISK UNCERTAINTY, V36, P203, DOI 10.1007/s11166-008-9040-2; Schmidt U, 2008, MANAGE SCI, V54, P208, DOI 10.1287/mnsc.1070.0762; SHEFRIN H, 1985, J FINANC, V40, P777, DOI 10.2307/2327802; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; WAKKER P, 1993, J RISK UNCERTAINTY, V7, P147, DOI 10.1007/BF01065812; Weber M, 1998, J ECON BEHAV ORGAN, V33, P167, DOI 10.1016/S0167-2681(97)00089-9; Wu G, 2005, J RISK UNCERTAINTY, V30, P107, DOI 10.1007/s11166-005-6561-9; Zhang WL, 2009, J ECON BEHAV ORGAN, V72, P835, DOI 10.1016/j.jebo.2009.08.003	34	18	18	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109458	10.1371/journal.pone.0109458	http://dx.doi.org/10.1371/journal.pone.0109458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IH	25330203	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200031
J	Costela, FM; Otero-Millan, J; McCamy, MB; Macknik, SL; Troncoso, XG; Jazi, AN; Crook, SM; Martinez-Conde, S				Costela, Francisco M.; Otero-Millan, Jorge; McCamy, Michael B.; Macknik, Stephen L.; Troncoso, Xoana G.; Jazi, Ali Najafian; Crook, Sharon M.; Martinez-Conde, Susana			Fixational Eye Movement Correction of Blink-Induced Gaze Position Errors	PLOS ONE			English	Article							SEARCH COIL; MICROSACCADES; SACCADE; ROTATION; DRIFTS; FOVEAL; MOTION; MONKEY	Our eyes move continuously. Even when we attempt to fix our gaze, we produce "fixational'' eye movements including microsaccades, drift and tremor. The potential role of microsaccades versus drifts in the control of eye position has been debated for decades and remains in question today. Here we set out to determine the corrective functions of microsaccades and drifts on gaze-position errors due to blinks in non-human primates (Macaca mulatta) and humans. Our results show that blinks contribute to the instability of gaze during fixation, and that microsaccades, but not drifts, correct fixation errors introduced by blinks. These findings provide new insights about eye position control during fixation, and indicate a more general role of microsaccades in fixation correction than thought previously.	[Costela, Francisco M.; Otero-Millan, Jorge; McCamy, Michael B.; Macknik, Stephen L.; Troncoso, Xoana G.; Jazi, Ali Najafian; Martinez-Conde, Susana] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Costela, Francisco M.] Arizona State Univ, Interdisciplinary Grad Program Neurosci, Phoenix, AZ USA; [Otero-Millan, Jorge] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Macknik, Stephen L.; Martinez-Conde, Susana] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Troncoso, Xoana G.] UNIC, UPR CNRS 3293, Unite Neurosci Informat & Complex, Gif Sur Yvette, France; [Crook, Sharon M.] Arizona State Univ, Sch Math & Stat Sci, Phoenix, AZ USA; [Crook, Sharon M.] Arizona State Univ, Sch Life Sci, Phoenix, AZ USA	Barrow Neurological Institute; Arizona State University; Arizona State University-Downtown Phoenix; Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Arizona State University; Arizona State University-Downtown Phoenix; Arizona State University; Arizona State University-Downtown Phoenix	Martinez-Conde, S (corresponding author), Barrow Neurol Inst, Phoenix, AZ 85013 USA.	smart@neuralcorrelate.com	Costela, Francisco M/ABG-7910-2020; Macknik, Stephen L./H-7704-2019; Otero-Millan, Jorge/A-4193-2014	Costela, Francisco M/0000-0002-3530-6224; Macknik, Stephen L./0000-0002-3143-9230; Otero-Millan, Jorge/0000-0002-9789-8392; Troncoso, Xoana/0000-0001-7343-1272	Barrow Neurological Foundation; National Science Foundations [0852636, 1153786, 0726113]	Barrow Neurological Foundation; National Science Foundations(National Science Foundation (NSF))	Barrow Neurological Foundation (http://www.thebarrow.org/) to SLM and SMC. National Science Foundations Awards 0852636 and 1153786 to SMC and Award 0726113 to SLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida H, 2010, J VIS, V10, P827; Betta E, 2006, NEUROREPORT, V17, P1001, DOI 10.1097/01.wnr.0000223392.82198.6d; BOYCE PR, 1967, PROC R SOC SER B-BIO, V167, P293, DOI 10.1098/rspb.1967.0028; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; COLLEWIJN H, 1985, J NEUROPHYSIOL, V54, P11, DOI 10.1152/jn.1985.54.1.11; Collewijn H, 2008, J VISION, V8, DOI 10.1167/8.14.20; CORNSWEET TN, 1956, J OPT SOC AM, V46, P987, DOI 10.1364/JOSA.46.000987; Costela FM, 2013, PEERJ, V1, DOI 10.7717/peerj.119; Donner K, 2007, VISION RES, V47, P1166, DOI 10.1016/j.visres.2006.11.024; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; Engbert R, 2006, PROG BRAIN RES, V154, P177, DOI 10.1016/S0079-6123(06)54009-9; EVINGER C, 1984, J NEUROPHYSIOL, V52, P323, DOI 10.1152/jn.1984.52.2.323; GINSBORG B L, 1959, Br J Ophthalmol, V43, P435, DOI 10.1136/bjo.43.7.435; Ginsborg BL, 1952, ROTATION EYES INVOLU, V169, P412, DOI [10.1038/169412b0, DOI 10.1038/169412B0]; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3411, DOI 10.1152/jn.2000.83.6.3411; Gori S, 2006, VISION RES, V46, P3267, DOI 10.1016/j.visres.2006.03.009; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; HADDAD GM, 1973, VISION RES, V13, P1075, DOI 10.1016/0042-6989(73)90145-4; Kleiner M, 2007, PERCEPTION, V36, P14; Kuriki I, 2008, J VISION, V8, DOI 10.1167/8.10.16; Laubrock J, 2005, VISION RES, V45, P721, DOI 10.1016/j.visres.2004.09.029; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2002, P NATL ACAD SCI USA, V99, P13920, DOI 10.1073/pnas.212500599; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Martinez-Conde S, 2013, NAT REV NEUROSCI, V14, P83, DOI 10.1038/nrn3405; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; McCamy MB, 2014, J PHYSL; McCamy MB, 2014, J NEUROSCI, V34, P2956, DOI 10.1523/JNEUROSCI.4448-13.2014; McCamy MB, 2013, PEERJ, V1, DOI 10.7717/peerj.9; McCamy MB, 2013, PEERJ, V1, DOI 10.7717/peerj.14; McCamy MB, 2012, J NEUROSCI, V32, P9194, DOI 10.1523/JNEUROSCI.0515-12.2012; NACHMIAS J, 1961, J OPT SOC AM, V51, P761, DOI 10.1364/JOSA.51.000761; Otero-Millan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058535; Otero-Millan J, 2013, P NATL ACAD SCI USA, V110, P6175, DOI 10.1073/pnas.1222715110; Otero-Millan J, 2012, J NEUROSCI, V32, P6043, DOI 10.1523/JNEUROSCI.5823-11.2012; Otero-Millan J, 2011, ANN NY ACAD SCI, V1233, P107, DOI 10.1111/j.1749-6632.2011.06177.x; Otero-Millan J, 2011, J NEUROSCI, V31, P4379, DOI 10.1523/JNEUROSCI.2600-10.2011; PASTOR AM, 1991, J NEUROPHYSIOL, V66, P2125, DOI 10.1152/jn.1991.66.6.2125; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PORTER JD, 1993, BRAIN RES, V609, P159, DOI 10.1016/0006-8993(93)90869-O; Putnam NM, 2005, J VISION, V5, P632, DOI 10.1167/5.7.3; RIGGS LA, 1987, INVEST OPHTH VIS SCI, V28, P334; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Rolfs M, 2006, EXP BRAIN RES, V169, P369, DOI 10.1007/s00221-005-0148-1; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Rucci M, 2007, NATURE, V447, P851, DOI 10.1038/nature05866; Ruzzoli M, 2011, NEUROPSYCHOLOGIA, V49, P3648, DOI 10.1016/j.neuropsychologia.2011.09.020; Siegenthaler E, 2014, EUR J NEUROSCI, V39, P287, DOI 10.1111/ejn.12395; STCYR GJ, 1969, VISION RES, V9, P245, DOI 10.1016/0042-6989(69)90004-2; TAKAGI M, 1992, DOC OPHTHALMOL, V80, P343, DOI 10.1007/BF00154383; Troncoso XG, 2008, P NATL ACAD SCI USA, V105, P16033, DOI 10.1073/pnas.0709389105; Troncoso XG, 2008, J VISION, V8, DOI 10.1167/8.14.15	55	28	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110889	10.1371/journal.pone.0110889	http://dx.doi.org/10.1371/journal.pone.0110889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333481	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200082
J	Fossum-Raunehaug, S; Helgesen, E; Stokke, C; Skarstad, K				Fossum-Raunehaug, Solveig; Helgesen, Emily; Stokke, Caroline; Skarstad, Kirsten			Escherichia coli SeqA Structures Relocalize Abruptly upon Termination of Origin Sequestration during Multifork DNA Replication	PLOS ONE			English	Article							SISTER CHROMOSOME COHESION; SEPARATE CELL HALVES; TOPOISOMERASE-IV; E. COLI; BIDIRECTIONAL MIGRATION; NUCLEOID ORGANIZATION; LIVING CELLS; PROTEIN; SEGREGATION; BACTERIAL	The Escherichia coli SeqA protein forms complexes with new, hemimethylated DNA behind replication forks and is important for successful replication during rapid growth. Here, E. coli cells with two simultaneously replicating chromosomes (multifork DNA replication) and YFP tagged SeqA protein was studied. Fluorescence microscopy showed that in the beginning of the cell cycle cells contained a single focus at midcell. The focus was found to remain relatively immobile at midcell for a period of time equivalent to the duration of origin sequestration. Then, two abrupt relocalization events occurred within 2-6 minutes and resulted in SeqA foci localized at each of the cell's quarter positions. Imaging of cells containing an additional fluorescent tag in the origin region showed that SeqA colocalizes with the origin region during sequestration. This indicates that the newly replicated DNA of first one chromosome, and then the other, is moved from midcell to the quarter positions. At the same time, origins are released from sequestration. Our results illustrate that newly replicated sister DNA is segregated pairwise to the new locations. This mode of segregation is in principle different from that of slowly growing bacteria where the newly replicated sister DNA is partitioned to separate cell halves and the decatenation of sisters a prerequisite for, and possibly a mechanistic part of, segregation.	[Fossum-Raunehaug, Solveig; Helgesen, Emily; Stokke, Caroline; Skarstad, Kirsten] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Cell Biol, Oslo, Norway; [Fossum-Raunehaug, Solveig; Skarstad, Kirsten] Univ Oslo, Fac Math & Nat Sci, Sch Pharm, Oslo, Norway	University of Oslo; University of Oslo	Skarstad, K (corresponding author), Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Cell Biol, Oslo, Norway.	Kirsten.Skarstad@rr-research.no	Helgesen, Emily/AAX-2584-2020		MLS (EMBIO) at the University of Oslo; Research Council of Norway	MLS (EMBIO) at the University of Oslo; Research Council of Norway(Research Council of Norway)	This work was supported by MLS (EMBIO) at the University of Oslo and the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adachi S, 2008, GENES CELLS, V13, P181, DOI 10.1111/j.1365-2443.2007.01157.x; Babic A, 2008, SCIENCE, V319, P1533, DOI 10.1126/science.1153498; Bach T, 2005, J MOL BIOL, V350, P7, DOI 10.1016/j.jmb.2005.04.055; Bach T, 2003, EMBO J, V22, P315, DOI 10.1093/emboj/cdg020; Badrinarayanan A, 2012, J BACTERIOL, V194, P4669, DOI 10.1128/JB.00957-12; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; BOYE E, 1991, RES MICROBIOL, V142, P131, DOI 10.1016/0923-2508(91)90020-B; Brendler T, 1999, EMBO J, V18, P2304, DOI 10.1093/emboj/18.8.2304; Cagliero C, 2013, NUCLEIC ACIDS RES, V41, P6058, DOI 10.1093/nar/gkt325; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; Chung YS, 2009, NUCLEIC ACIDS RES, V37, P3143, DOI 10.1093/nar/gkp151; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Espeli O, 2008, MOL MICROBIOL, V68, P1418, DOI 10.1111/j.1365-2958.2008.06239.x; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; Fossum S, 2007, EMBO J, V26, P4514, DOI 10.1038/sj.emboj.7601871; Hayama Ryo, 2010, Proc Natl Acad Sci U S A, V107, P18826, DOI 10.1073/pnas.1008140107; Hiraga S, 2000, GENES CELLS, V5, P327, DOI 10.1046/j.1365-2443.2000.00334.x; Hiraga S, 1998, MOL CELL, V1, P381, DOI 10.1016/S1097-2765(00)80038-6; Hiraga S, 2000, ANNU REV GENET, V34, P21, DOI 10.1146/annurev.genet.34.1.21; HOWARDFLANDERS P, 1964, GENETICS, V49, P237; Joshi MC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003673; Joshi MC, 2011, P NATL ACAD SCI USA, V108, P2765, DOI 10.1073/pnas.1019593108; Kang SH, 2003, J BIOL CHEM, V278, P48779, DOI 10.1074/jbc.M308843200; Kornberg A., 1992, DNA REPLICATION; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Le Chat L, 2012, MOL MICROBIOL, V86, P1285, DOI 10.1111/mmi.12073; Li YF, 2002, MOL MICROBIOL, V46, P985, DOI 10.1046/j.1365-2958.2002.03234.x; Li YY, 2010, P NATL ACAD SCI USA, V107, P18832, DOI 10.1073/pnas.1008678107; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Liu X, 2010, MOL MICROBIOL, V75, P1090, DOI 10.1111/j.1365-2958.2009.06791.x; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Mercier R, 2008, CELL, V135, P475, DOI 10.1016/j.cell.2008.08.031; Miller JH, 1992, SHORT COURSE BACTERI, P221; Molina F, 2004, MOL MICROBIOL, V52, P1597, DOI 10.1111/j.1365-2958.2004.04097.x; Morigen, 2009, GENES CELLS, V14, P643, DOI 10.1111/j.1365-2443.2009.01298.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nicolas E, 2014, MBIO, V5, DOI 10.1128/mBio.01001-13; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; Niki H, 2000, GENE DEV, V14, P212; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; OGDEN GB, 1988, CELL, V54, P127, DOI 10.1016/0092-8674(88)90186-9; Onogi T, 1999, MOL MICROBIOL, V31, P1775, DOI 10.1046/j.1365-2958.1999.01313.x; Ozaki S, 2013, CELL REP, V4, P985, DOI 10.1016/j.celrep.2013.07.040; Possoz C, 2006, EMBO J, V25, P2596, DOI 10.1038/sj.emboj.7601155; Possoz C, 2012, FRONT BIOSCI-LANDMRK, V17, P1020, DOI 10.2741/3971; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Reyes-Larnothe R, 2008, TRENDS MICROBIOL, V16, P238, DOI 10.1016/j.tim.2008.02.003; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Skarstad K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012922; SLATER S, 1995, CELL, V82, P927, DOI 10.1016/0092-8674(95)90272-4; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Stokke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030981; Sunako Y, 2001, MOL MICROBIOL, V42, P1233, DOI 10.1046/j.1365-2958.2001.02680.x; Torheim NK, 2000, MOL MICROBIOL, V37, P629, DOI 10.1046/j.1365-2958.2000.02031.x; VONFREIESLEBEN U, 1994, MOL MICROBIOL, V14, P763; Waldminghaus T, 2012, NUCLEIC ACIDS RES, V40, P5465, DOI 10.1093/nar/gks187; Wang XD, 2008, GENE DEV, V22, P2426, DOI 10.1101/gad.487508; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Wang XD, 2013, NAT REV GENET, V14, P191, DOI 10.1038/nrg3375; Yamaichi Y, 2004, EMBO J, V23, P221, DOI 10.1038/sj.emboj.7600028; Yamazoe M, 2005, MOL MICROBIOL, V55, P289, DOI 10.1111/j.1365-2958.2004.04389.x; Youngren B, 2014, GENE DEV, V28, P71, DOI 10.1101/gad.231050.113	63	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110575	10.1371/journal.pone.0110575	http://dx.doi.org/10.1371/journal.pone.0110575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333813	gold, Green Published, Green Submitted			2022-12-27	WOS:000343731200057
J	Howard, IS; Messum, P				Howard, Ian S.; Messum, Piers			Learning to Pronounce First Words in Three Languages: An Investigation of Caregiver and Infant Behavior Using a Computational Model of an Infant	PLOS ONE			English	Article							VOWEL ACQUISITION; IMITATION; REINFORCEMENT; MIND	Words are made up of speech sounds. Almost all accounts of child speech development assume that children learn the pronunciation of first language (L1) speech sounds by imitation, most claiming that the child performs some kind of auditory matching to the elements of ambient speech. However, there is evidence to support an alternative account and we investigate the non-imitative child behavior and well-attested caregiver behavior that this account posits using Elija, a computational model of an infant. Through unsupervised active learning, Elija began by discovering motor patterns, which produced sounds. In separate interaction experiments, native speakers of English, French and German then played the role of his caregiver. In their first interactions with Elija, they were allowed to respond to his sounds if they felt this was natural. We analyzed the interactions through phonemic transcriptions of the caregivers' utterances and found that they interpreted his output within the framework of their native languages. Their form of response was almost always a reformulation of Elija's utterance into well-formed sounds of L1. Elija retained those motor patterns to which a caregiver responded and formed associations between his motor pattern and the response it provoked. Thus in a second phase of interaction, he was able to parse input utterances in terms of the caregiver responses he had heard previously, and respond using his associated motor patterns. This capacity enabled the caregivers to teach Elija to pronounce some simple words in their native languages, by his serial imitation of the words' component speech sounds. Overall, our results demonstrate that the natural responses and behaviors of human subjects to infant-like vocalizations can take a computational model from a biologically plausible initial state through to word pronunciation. This provides support for an alternative to current auditory matching hypotheses for how children learn to pronounce.	[Howard, Ian S.] Univ Plymouth, Sch Comp & Math, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England; [Howard, Ian S.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England; [Messum, Piers] Pronunciat Sci Ltd, London, England	University of Plymouth; University of Cambridge	Howard, IS (corresponding author), Univ Plymouth, Sch Comp & Math, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England.	ian.howard@plymouth.ac.uk		Howard, Ian/0000-0002-6041-9669; Messum, Piers/0000-0001-5450-3189	Plymouth University	Plymouth University	This work was initially carried out by the authors in their own time, and later it was supported by Plymouth University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altvater-Mackensen N, 2010, LINGUA, V120, P1898, DOI 10.1016/j.lingua.2010.02.010; [Anonymous], 1989, FIRST LANG, DOI DOI 10.1177/014272378900900603; Bailly G, 1997, SPEECH COMMUN, V22, P251, DOI 10.1016/S0167-6393(97)00025-3; Baranes A, 2013, ROBOT AUTON SYST, V61, P49, DOI 10.1016/j.robot.2012.05.008; Chouinard MM, 2003, J CHILD LANG, V30, P637, DOI 10.1017/S0305000903005701; Ellis D., 2003, DYNAMIC TIME WARP DT; Ellis D.P.W., 2009, GAMMATONE LIKE SPECT; Fant G., 1985, STL QPSR, V4, P1, DOI DOI 10.1016/0167-6393(89)90001-0; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FRY DB, 1968, BRIT J DISORD COMMUN, V3, P13; Gattegno C, 1973, UNIVERSE BABIES BEGI; Goldstein M.H., 2010, OXFORD HDB DEV BEHAV, P708; GUENTHER FH, 1994, BIOL CYBERN, V72, P43, DOI 10.1007/BF00206237; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Gunnilstam O, 1974, J PHONETICS, V2, P91; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Howard IS, 2011, MOTOR CONTROL, V15, P85, DOI 10.1123/mcj.15.1.85; Howard IS., 2007, P 12 INT C SPEECH CO, P756; Ishihara H, 2009, IEEE T AUTON MENT DE, V1, P217, DOI 10.1109/TAMD.2009.2038988; Jonsson CO, 2001, SCAND J PSYCHOL, V42, P377, DOI 10.1111/1467-9450.00249; Kokkinaki T, 2000, J REPROD INFANT PSYC, V18, P173, DOI 10.1080/713683042; Kroger BJ, 2009, SPEECH COMMUN, V51, P793, DOI 10.1016/j.specom.2008.08.002; Kuhl PK, 2000, P NATL ACAD SCI USA, V97, P11850, DOI 10.1073/pnas.97.22.11850; Lametti DR, 2012, J NEUROSCI, V32, P9351, DOI 10.1523/JNEUROSCI.0404-12.2012; Locke J. L., 1979, CHILD LANGUAGE COMM, V12, P83; MacDonald EN, 2012, CURR BIOL, V22, P113, DOI 10.1016/j.cub.2011.11.052; MAEDA S, 1990, NATO ADV SCI I D-BEH, V55, P131; MAEDA S, 1979, J ACOUST SOC AM, V65, pS22, DOI 10.1121/1.2017158; MARKEY K, 1994, THESIS U COLORADO; McCune L., 1987, PAPERS REPORTS CHILD, V26, P72; Meltzoff AN, 1999, J COMMUN DISORD, V32, P251, DOI 10.1016/S0021-9924(99)00009-X; MENN L, 1993, NATO ADV SCI INST SE, V69, P421; Messum P, 2012, CURR BIOL, V22, pR160, DOI 10.1016/j.cub.2012.01.032; Messum PR, 2007, THESIS U LONDON; Miura K, 2007, ADV ROBOTICS, V21, P1583; Miura K, 2012, ADV ROBOTICS, V26, P23, DOI 10.1163/016918611X607347; MOSKOWITZ AI, 1970, LANGUAGE, V46, P426, DOI 10.2307/412287; Moulin-Frier C, 2012, P 2012 IEEE INT C DE, P1; Moulin-Frier C, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01006; Nehaniv CL, 2002, FROM ANIM ANIMAT, P41; NEWSON J, 1979, SPEECH BEGINNING INT, P207; Oller D.K, 2000, EMERGENCE SPEECH CAP, DOI [10.4324/9781410602565, DOI 10.4324/9781410602565]; Otomo K, 2001, J CHILD LANG, V28, P29, DOI 10.1017/S0305000900004578; Pawlby, 1977, THESIS U NOTTINGHAM; Pawlby S. J, 1977, STUDIES MOTHER INFAN, P203; Pelaez M, 2011, J APPL BEHAV ANAL, V44, P33, DOI 10.1901/jaba.2011.44-33; Rasanen O, 2012, SPEECH COMMUN, V54, P975, DOI 10.1016/j.specom.2012.05.001; Rolf M, 2010, IEEE T AUTON MENT DE, V2, P216, DOI 10.1109/TAMD.2010.2062511; Saltzman E., 1989, ECOL PSYCHOL, V1, P333, DOI [10.1207/s15326969eco0104_2, DOI 10.1207/S15326969EC00104_]; Serkhane J, 2005, INTERACTION STUDIES, V6, P253, DOI [10.1007/978-3-540-79007-5_14, DOI 10.1007/978-3-540-79007-5_14, DOI 10.1075/IS.6.2.06SER]; Singh S, 2010, IEEE T AUTON MENT DE, V2, P70, DOI 10.1109/TAMD.2010.2051031; Slaney M, 1993, EFFICIENT IMPLEMENTA, P8; Smith VA, 2000, ANIM BEHAV, V60, P599, DOI 10.1006/anbe.2000.1531; Stern D.N., 1985, INTERPERSONAL WORLD; Stetson R. H., 1951, MOTOR PHONETICS STUD; STEVENS KN, 1989, J PHONETICS, V17, P3, DOI 10.1016/S0095-4470(19)31520-7; Studdert-Kennedy Michael, 2002, MIRROR NEURONS EVOLU, P207, DOI [10.1075/aicr.42.17stu, DOI 10.1075/AICR.42.17STU]; Turetsky R. J., 2003, 4 INT S MUS INF RETR, P135; Veneziano E., 1988, EMERGENT LEXICON CHI, P109; VIHMAN MM, 1993, J PHONETICS, V21, P61, DOI 10.1016/S0095-4470(19)31321-X; Warlaumont Anne S., 2013, 2013 IEEE Third Joint International Conference on Development and Learning and Epigenetic Robotics (ICDL), DOI 10.1109/DevLrn.2013.6652547; Warlaumont AS, 2013, NEURAL NETWORKS, V38, P64, DOI 10.1016/j.neunet.2012.11.012; WEIZENBAUM J, 1966, COMMUN ACM, V9, P36, DOI 10.1145/357980.357991; Wells J. C., 1997, HDB STANDARDS RESOUR; Westermann G, 2004, BRAIN LANG, V89, P393, DOI 10.1016/S0093-934X(03)00345-6; Winnicott D.W., 1967, PLAYING REALITY, V1971, P111; Yoshikawa Y, 2003, CONNECT SCI, V15, P245, DOI 10.1080/09540090310001655075	67	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110334	10.1371/journal.pone.0110334	http://dx.doi.org/10.1371/journal.pone.0110334			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR7AB	25333740	gold, Green Submitted, Green Published			2022-12-27	WOS:000343731200033
J	Roth, MO; Wilkins, AG; Cooke, GM; Raftos, DA; Nair, SV				Roth, Mattias O.; Wilkins, Adam G.; Cooke, Georgina M.; Raftos, David A.; Nair, Sham V.			Characterization of the Highly Variable Immune Response Gene Family, He185/333, in the Sea Urchin, Heliocidaris erythrogramma	PLOS ONE			English	Article							STRONGYLOCENTROTUS-PURPURATUS; CLUSTAL-W; DIVERSITY; EXPRESSION; PROTEINS; PREDICTION; SEQUENCE; IDENTIFICATION; SPECIFICITY; PATTERNS	This study characterizes the highly variable He185/333 genes, transcripts and proteins in coelomocytes of the sea urchin, Heliocidaris erythrogramma. Originally discovered in the purple sea urchin, Strongylocentrotus purpuratus, the products of this gene family participate in the anti-pathogen defenses of the host animals. Full-length He185/333 genes and transcripts are identified. Complete open reading frames of He185/333 homologues are analyzed as to their element structure, single nucleotide polymorphisms, indels and sequence repeats and are subjected to diversification analyses. The sequence elements that compose He185/333 are different to those identified for Sp185/333. Differences between Sp185/333 and He185/333 genes are also evident in the complexity of the sequences of the introns. He185/333 proteins show a diverse range of molecular weights on Western blots. The observed sizes and pIs of the proteins differ from predicted values, suggesting post-translational modifications and oligomerization. Immunofluorescence microscopy shows that He185/333 proteins are mainly located on the surface of coelomocyte subpopulations. Our data demonstrate that He185/333 bears the same substantial characteristics as their S. purpuratus homologues. However, we also identify several unique characteristics of He185/333 (such as novel element patterns, sequence repeats, distribution of positively-selected codons and introns), suggesting species-specific adaptations. All sequences in this publication have been submitted to Genbank (accession numbers JQ780171-JQ780321) and are listed in table S1.	[Roth, Mattias O.; Wilkins, Adam G.; Cooke, Georgina M.; Raftos, David A.; Nair, Sham V.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	Nair, SV (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	sham.nair@mq.edu.au						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brockton V, 2008, J CELL SCI, V121, P339, DOI 10.1242/jcs.012096; Buckley KM, 2008, J MOL BIOL, V379, P912, DOI 10.1016/j.jmb.2008.04.037; Buckley KM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-68; Buckley KM, 2008, J IMMUNOL, V181, P8585, DOI 10.4049/jimmunol.181.12.8585; Cannon JP, 2002, NAT IMMUNOL, V3, P1200, DOI 10.1038/ni849; Caragea C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-438; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dheilly NM, 2011, IMMUNOL CELL BIOL, V89, P861, DOI 10.1038/icb.2011.3; Dheilly NM, 2009, J IMMUNOL, V182, P2203, DOI 10.4049/jimmunol.07012766; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Du Pasquier L, 2006, IMMUNOL LETT, V104, P2, DOI 10.1016/j.imlet.2005.11.022; Ghosh J, 2010, DEV COMP IMMUNOL, V34, P235, DOI 10.1016/j.dci.2009.10.008; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Kurtz J, 2006, TRENDS IMMUNOL, V27, P493, DOI 10.1016/j.it.2006.09.001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; Lessios HA, 2012, RAPIDLY EVOLVING GENES AND GENETIC SYSTEMS, P136; Miller C, 2010, KNIGHT IN POLITICS: A BIOGRAPHY OF SIR FREDERICK BORDEN, P11; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nair SV, 2005, PHYSIOL GENOMICS, V22, P33, DOI 10.1152/physiolgenomics.00052.2005; Palumbi SR, 2005, P NATL ACAD SCI USA, V102, P6566, DOI 10.1073/pnas.0501806102; Pancer Z, 2000, P NATL ACAD SCI USA, V97, P13156, DOI 10.1073/pnas.230096397; Pederson HG, 2008, ICES J MAR SCI, V65, P1, DOI 10.1093/icesjms/fsm168; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Roth O, 2009, DEV COMP IMMUNOL, V33, P1151, DOI 10.1016/j.dci.2009.04.005; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Smith LC, 2006, ISJ-INVERT SURVIV J, V3, P25; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Terwilliger DP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-16; Terwilliger DP, 2006, PHYSIOL GENOMICS, V26, P134, DOI 10.1152/physiolgenomics.00011.2006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Zhang SM, 2003, DEV COMP IMMUNOL, V27, P175, DOI 10.1016/S0145-305X(02)00091-5	47	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e62079	10.1371/journal.pone.0062079	http://dx.doi.org/10.1371/journal.pone.0062079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333281	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200001
J	Sze, MA; Tsuruta, M; Yang, SWJ; Oh, Y; Man, SFP; Hogg, JC; Sin, DD				Sze, Marc A.; Tsuruta, Masashi; Yang, Shun-Wei Julia; Oh, Yeni; Man, S. F. Paul; Hogg, James C.; Sin, Don D.			Changes in the Bacterial Microbiota in Gut, Blood, and Lungs following Acute LPS Instillation into Mice Lungs	PLOS ONE			English	Article							TRANSLOCATION; ANTIBIOTICS; INJURY	Introduction: Previous reports have shown that the gastrointestinal (GI) bacterial microbiota can have profound effects on the lungs, which has been described as the "gut-lung axis". However, whether a "lung-gut" axis exists wherein acute lung inflammation perturbs the gut and blood microbiota is unknown. Methods: Adult C57/Bl6 mice were exposed to one dose of LPS or PBS instillation (n = 3 for each group) directly into lungs. Bacterial microbiota of the bronchoalveolar lavage fluid, blood, and cecum were determined using 454 pyrotag sequencing and quantitative polymerase chain reaction (qPCR) at 4 through 168 hours post-instillation. We then investigated the effects of oral neomycin and streptomycin (n = 8) on the microbiota at 4 and 24 hours post LPS instillation versus control treatment (n = 5 at baseline and 4 hours, n = 7 at 24 hours). Results: At 24 hours post LPS instillation, the total bacterial count was significantly increased in the cecum (P < 0.05); whereas the total bacterial count in blood was increased at 4, 48, and 72 hours (P < 0.05). Antibiotic treatment reduced the total bacteria in blood but not in the cecum. The increase in total bacteria in the blood correlated with Phyllobacteriaceae OTU 40 and was significantly reduced in the blood for both antibiotic groups (P < 0.05). Conclusion: LPS instillation in lungs leads to acute changes in the bacterial microbiota in the blood and cecum, which can be modulated with antibiotics.	[Sze, Marc A.; Tsuruta, Masashi; Yang, Shun-Wei Julia; Oh, Yeni; Man, S. F. Paul; Hogg, James C.; Sin, Don D.] Univ British Columbia, St Pauls Hosp, Heart Lung Innovat Ctr, Vancouver, BC V5Z 1M9, Canada; [Man, S. F. Paul; Sin, Don D.] Univ British Columbia, Dept Med, Div Resp, Vancouver, BC V5Z 1M9, Canada; [Sze, Marc A.; Hogg, James C.] Univ British Columbia, Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; University of British Columbia	Sin, DD (corresponding author), Univ British Columbia, St Pauls Hosp, Heart Lung Innovat Ctr, Vancouver, BC V5Z 1M9, Canada.	Don.Sin@hli.ubc.ca	Sin, Don/AAC-2219-2021	Sze, Marc/0000-0002-3532-9653				Berrington JE, 2013, ARCH DIS CHILD-FETAL, V98, pF286, DOI 10.1136/archdischild-2012-302134; Butaye P, 2003, CLIN MICROBIOL REV, V16, P175, DOI 10.1128/CMR.16.2.175-188.2003; DEITCH EA, 1985, J TRAUMA, V25, P385, DOI 10.1097/00005373-198505000-00002; Dijkstra HM, 1996, BURNS, V22, P15, DOI 10.1016/0305-4179(95)00080-1; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Liu Qing-hua, 2008, Zhonghua Jiehe He Huxi Zazhi, V31, P509; Lo SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082673; Macfarlane GT, 1997, SCAND J GASTROENTERO, V32, P3, DOI 10.1080/00365521.1997.11720708; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Morris A, 2013, AM J RESP CRIT CARE, V187; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Souza DG, 2004, J IMMUNOL, V173, P4137, DOI 10.4049/jimmunol.173.6.4137; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; Suda K, 2011, AM J RESP CELL MOL, V45, P510, DOI 10.1165/rcmb.2010-0169OC; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3106	21	97	106	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111228	10.1371/journal.pone.0111228	http://dx.doi.org/10.1371/journal.pone.0111228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333938	Green Published, Green Submitted, gold			2022-12-27	WOS:000343731200108
J	Harris, JK; El Kasmi, KC; Anderson, AL; Devereaux, MW; Fillon, SA; Robertson, CE; Wagner, BD; Stevens, MJ; Pace, NR; Sokol, RJ				Harris, J. Kirk; El Kasmi, Karim C.; Anderson, Aimee L.; Devereaux, Michael W.; Fillon, Sophie A.; Robertson, Charles E.; Wagner, Brandie D.; Stevens, Mark J.; Pace, Norman R.; Sokol, Ronald J.			Specific Microbiome Changes in a Mouse Model of Parenteral Nutrition Associated Liver Injury and Intestinal Inflammation	PLOS ONE			English	Article							BARCODED PRIMERS; DISEASE; CHOLESTASIS; INFANTS; FAILURE; CHILDREN	Background: Parenteral nutrition (PN) has been a life-saving treatment in infants intolerant of enteral feedings. However, PN is associated with liver injury (PN Associated Liver Injury: PNALI) in a significant number of PN-dependent infants. We have previously reported a novel PNALI mouse model in which PN infusion combined with intestinal injury results in liver injury. In this model, lipopolysaccharide activation of toll-like receptor 4 signaling, soy oil-derived plant sterols, and proinflammatory activation of Kupffer cells (KCs) played key roles. The objective of this study was to explore changes in the intestinal microbiome associated with PNALI. Methodology and Principal Findings: Microbiome analysis in the PNALI mouse identified specific alterations within colonic microbiota associated with PNALI and further association of these communities with the lipid composition of the PN solution. Intestinal inflammation or soy oil-based PN infusion alone (in the absence of enteral feeds) caused shifts within the gut microbiota. However, the combination resulted in accumulation of a specific taxon, Erysipelotrichaceae (23.8% vs. 1.7% in saline infused controls), in PNALI mice. Moreover, PNALI was markedly attenuated by enteral antibiotic treatment, which also was associated with significant reduction of Erysipelotrichaceae (0.6%) and a Gram-negative constituent, the S24-7 lineage of Bacteroidetes (53.5% in PNALI vs. 0.8%). Importantly, removal of soy oil based-lipid emulsion from the PN solution resulted in significant reduction of Erysipelotrichaceae as well as attenuation of PNALI. Finally, addition of soy-derived plant sterol (stigmasterol) to fish oil-based PN restored Erysipelotrichaceae abundance and PNALI. Conclusions: Soy oil-derived plant sterols and the associated specific bacterial groups in the colonic microbiota are associated with PNALI. Products from these bacteria may directly trigger activation of KCs and promote PNALI. Furthermore, the results indicate that lipid modification of PN solutions may alter specific intestinal bacterial species associated with PNALI, and thus suggest strategies for management of PNALI.	[Harris, J. Kirk; Stevens, Mark J.] Univ Colorado, Sect Pulm Med, Dept Pediat, Aurora, CO 80045 USA; [El Kasmi, Karim C.; Anderson, Aimee L.; Devereaux, Michael W.; Fillon, Sophie A.; Sokol, Ronald J.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat,Sect Gastroenterol Hepatol & Nutr,Dig, Aurora, CO USA; [Robertson, Charles E.; Pace, Norman R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Wagner, Brandie D.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Harris, JK (corresponding author), Univ Colorado, Sect Pulm Med, Dept Pediat, Aurora, CO 80045 USA.	jonathan.harris@ucdenver.edu		ROBERTSON, CHARLES/0000-0002-4136-4121; Harris, Jonathan/0000-0002-2378-4202; Wagner, brandie/0000-0002-2745-0103	NIH [3P30DK048520]; NIH/NCATS Colorado CTSA [KL2 TR000156-05, UL1 TR000154-05]; Children's Hospital Colorado Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR000154, KL2TR001080, KL2TR000156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCATS Colorado CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Children's Hospital Colorado Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by NIH grant 3P30DK048520 and by NIH/NCATS Colorado CTSA Grants KL2 TR000156-05 (SAF) and UL1 TR000154-05 (RJS), and Children's Hospital Colorado Research Institute (KCE and RJS). Its contents are the authors' sole responsibility and do not necessarily represent official NIH views. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchinson EJ, 1986, STAT ANAL COMPOSITIO; BEALE EF, 1979, PEDIATRICS, V64, P342; Beath SV, 1996, J PEDIATR SURG, V31, P604, DOI 10.1016/S0022-3468(96)90507-2; BELL RL, 1986, JPEN-PARENTER ENTER, V10, P356, DOI 10.1177/0148607186010004356; BENJAMIN DR, 1981, AM J CLIN PATHOL, V76, P276; Botha JF, 2006, LIVER TRANSPLANT, V12, P1062, DOI 10.1002/lt.20763; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown EM, 2013, NAT IMMUNOL, V14, P660, DOI 10.1038/ni.2611; Btaiche IF, 2002, PHARMACOTHERAPY, V22, P188, DOI 10.1592/phco.22.3.188.33553; Buchman A, 2002, JPEN-PARENTER ENTER, V26, pS43, DOI 10.1177/014860710202600512; Buchman AL, 2006, HEPATOLOGY, V43, P9, DOI 10.1002/hep.20997; Carter BA, 2007, SEMIN LIVER DIS, V27, P251, DOI 10.1055/s-2007-985070; Carter BA, 2007, NAT CLIN PRACT GASTR, V4, P277, DOI 10.1038/ncpgasthep0796; COHEN C, 1981, ARCH PATHOL LAB MED, V105, P152; COLOMB V, 1994, TRANSPLANT P, V26, P1467; Conterno L, 2011, GENES NUTR, V6, P241, DOI 10.1007/s12263-011-0230-1; Duro D, 2008, J PEDIATR GASTR NUTR, V47, pS33, DOI 10.1097/MPG.0b013e3181819007; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; El Kasmi KC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006898; El Kasmi KC, 2012, HEPATOLOGY, V55, P1518, DOI 10.1002/hep.25500; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Filzmoser P, 2009, SCI TOTAL ENVIRON, V407, P6100, DOI 10.1016/j.scitotenv.2009.08.008; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gura KM, 2006, PEDIATRICS, V118, pE197, DOI 10.1542/peds.2005-2662; Haas BJ, 2011, GENOME RES; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris JK, 2012, J ALLERGY CLIN IMMUN, V129, P441, DOI 10.1016/j.jaci.2011.12.969; Harris JK, 2010, APPL ENVIRON MICROB, V76, P3863, DOI 10.1128/AEM.02585-09; HODES JE, 1982, J PEDIATR SURG, V17, P463, DOI 10.1016/S0022-3468(82)80090-0; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jeejeebhoy KN, 2001, AM J CLIN NUTR, V74, P160; Kaufman SS, 1997, J PEDIATR-US, V131, P356, DOI 10.1016/S0022-3476(97)80058-3; Kaufman Stuart S, 2003, Semin Neonatol, V8, P375, DOI 10.1016/S1084-2756(03)00094-0; Kelly DA, 2006, GASTROENTEROLOGY, V130, pS70, DOI 10.1053/j.gastro.2005.10.066; Martinez I, 2012, APPL ENV MICROBIOL; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Miyasaka EA, 2013, J IMMUNOL, V190, P6607, DOI 10.4049/jimmunol.1201746; MOSS RL, 1993, J PEDIATR SURG, V28, P1270, DOI 10.1016/S0022-3468(05)80311-2; MULLICK FG, 1994, MODERN PATHOL, V7, P190; Neil C, 2007, J AM COLL SURGEONS, V205, P755, DOI 10.1016/j.jamcollsurg.2007.06.299; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Robertson CE, 2013, BIOINFORMATICS; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sokol Ronald J., 1997, Acta Paediatrica Sinica, V38, P418; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; TAYLOR SF, 1991, J PEDIATR-US, V119, P24, DOI 10.1016/S0022-3476(05)81033-9; Teitelbaum D H, 2001, Semin Pediatr Surg, V10, P72, DOI 10.1053/spsu.2001.22386; Teitelbaum DH, 1997, CURR OPIN PEDIATR, V9, P270; Trauner M, 2003, CURR OPIN GASTROEN, V19, P216, DOI 10.1097/00001574-200305000-00005; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; WILMORE DW, 1968, J AMER MED ASSOC, V203, P860, DOI 10.1001/jama.203.10.860; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Zambrano E, 2004, PEDIATR DEVEL PATHOL, V7, P425, DOI 10.1007/s10024-001-0154-7	59	49	52	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110396	10.1371/journal.pone.0110396	http://dx.doi.org/10.1371/journal.pone.0110396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329595	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100060
J	Lechaftois, M; Dreano, E; Palmier, B; Margaill, I; Marchand-Leroux, C; Bachelot-Loza, C; Lerouet, D				Lechaftois, Marie; Dreano, Elise; Palmier, Bruno; Margaill, Isabelle; Marchand-Leroux, Catherine; Bachelot-Loza, Christilla; Lerouet, Dominique			Another "String to the Bow" of PJ34, a Potent Poly(ADP-Ribose)Polymerase Inhibitor: An Antiplatelet Effect through P2Y(12) Antagonism?	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; IN-VITRO; POLYMERASE INHIBITOR; ARTERIAL REOCCLUSION; STROKE; PARP; THERAPY; DAMAGE; RECANALIZATION; PREVENTION	Background: Neuro- and vasoprotective effects of poly(ADP-ribose) polymerase (PARP) inhibition have been largely documented in models of cerebral ischemia, particularly with the potent PARP inhibitor PJ34. Furthermore, after ischemic stroke, physicians are faced with incomplete tissue reperfusion and reocclusion, in which platelet activation/aggregation plays a key role. Data suggest that certain PARP inhibitors could act as antiplatelet agents. In that context, the present in vitro study investigated on human blood the potential antiplatelet effect of PJ34 and two structurally different PARP inhibitors, DPQ and INO-1001. Methods and results: ADP concentrations were chosen to induce a biphasic aggregation curve resulting from the successive activation of both its receptors P2Y(1) and P2Y(12). In these experimental conditions, PJ34 inhibited the second phase of aggregation; this effect was reduced by incremental ADP concentrations. In addition, in line with a P2Y12 pathway inhibitory effect, PJ34 inhibited the dephosphorylation of the vasodilator stimulated phosphoprotein (VASP) in a concentration- dependent manner. Besides, PJ34 had no effect on platelet aggregation induced by collagen or PAR1 activating peptide, used at concentrations inducing a strong activation independent on secreted ADP. By contrast, DPQ and INO-1001 were devoid of any effect whatever the platelet agonist used. Conclusions: We showed that, in addition to its already demonstrated beneficial effects in in vivo models of cerebral ischemia, the potent PARP inhibitor PJ34 exerts in vitro an antiplatelet effect. Moreover, this is the first study to report that PJ34 could act via a competitive P2Y12 antagonism. Thus, this antiplatelet effect could improve post-stroke reperfusion and/or prevent reocclusion, which reinforces the interest of this drug for stroke treatment.	[Lechaftois, Marie; Palmier, Bruno; Margaill, Isabelle; Marchand-Leroux, Catherine; Lerouet, Dominique] Univ Paris 05, Fac Sci Pharmaceut & Biol, Pharmacol Circulat Cerebrale EA4475, Comue Sorbonne Paris Cite, Paris, France; [Dreano, Elise; Bachelot-Loza, Christilla] INSERM, UMR S1140, Paris, France; [Dreano, Elise; Bachelot-Loza, Christilla] Univ Paris 05, Fac Sci Pharmaceut & Biol, Comue Sorbonne Paris Cite, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Lerouet, D (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, Pharmacol Circulat Cerebrale EA4475, Comue Sorbonne Paris Cite, Paris, France.	dominique.lerouet@parisdescartes.fr	LEROUET, Dominique/L-7288-2017; MARCHAND-LEROUX, Catherine/L-7453-2017; Margaill, Isabelle/ABA-4362-2020	LEROUET, Dominique/0000-0002-5656-8768; MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; Margaill, Isabelle/0000-0002-7941-6644; Bachelot-Loza, Christilla/0000-0002-6264-902X	Universite Paris Descartes; Groupe de Reflexion sur la Recherche Cardiovasculaire; Societe Francaise de Pharmacologie et de Therapeutique; Federation Francaise de Cardiologie; Societe Francaise de Cardiologie	Universite Paris Descartes; Groupe de Reflexion sur la Recherche Cardiovasculaire; Societe Francaise de Pharmacologie et de Therapeutique; Federation Francaise de Cardiologie; Societe Francaise de Cardiologie	This work was supported by "Universite Paris Descartes" and the following Societies: "Groupe de Reflexion sur la Recherche Cardiovasculaire," "Societe Francaise de Pharmacologie et de Therapeutique," "Federation Francaise de Cardiologie" and "Societe Francaise de Cardiologie." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkarim GE, 2001, INT J MOL MED, V7, P255; Aleil B, 2005, J THROMB HAEMOST, V3, P85, DOI 10.1111/j.1538-7836.2004.01063.x; Alexandrov AV, 2002, NEUROLOGY, V59, P862, DOI 10.1212/WNL.59.6.862; Alexy T, 2004, J CARDIOVASC PHARM, V43, P423, DOI 10.1097/00005344-200403000-00014; Antolin AA, 2012, ACS CHEM BIOL, V7, P1962, DOI 10.1021/cb300317y; Balami JS, 2013, CNS NEUROL DISORD-DR, V12, P155; Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; del Zoppo GJ, 1998, NEUROLOGY, V51, pS9, DOI 10.1212/WNL.51.3_Suppl_3.S9; Di Minno MND, 2011, CURR VASC PHARMACOL, V9, P723; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Fabre JE, 2010, MOL BIOSYST, V6, P305, DOI 10.1039/b914375k; Franks ZG, 2010, ANN NY ACAD SCI, V1207, P11, DOI 10.1111/j.1749-6632.2010.05733.x; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Giovannelli L, 2002, J CEREBR BLOOD F MET, V22, P697, DOI 10.1097/00004647-200206000-00008; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Haddad M, 2006, BRIT J PHARMACOL, V149, P23, DOI 10.1038/sj.bjp.0706837; Haddad M, 2008, EUR J PHARMACOL, V588, P52, DOI 10.1016/j.ejphar.2008.04.013; Haddad M, 2013, FUND CLIN PHARMACOL, V27, P393, DOI 10.1111/j.1472-8206.2012.01036.x; Iyu D, 2011, ARTERIOSCL THROM VAS, V31, P416, DOI 10.1161/ATVBAHA.110.219501; Kauppinen TM, 2009, J CEREBR BLOOD F MET, V29, P820, DOI 10.1038/jcbfm.2009.9; Kirshner HS, 2012, CURR PHARM DESIGN, V18, P5261; Komjati K, 2004, INT J MOL MED, V13, P373; Komjati K, 2005, CNS NEUROL DISORD-DR, V4, P179, DOI 10.2174/1568007053544138; Lenzser G, 2007, J CEREBR BLOOD F MET, V27, P1318, DOI 10.1038/sj.jcbfm.9600437; Madison DL, 2011, DNA REPAIR, V10, P1003, DOI 10.1016/j.dnarep.2011.07.006; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mathews MT, 2008, ARTERIOSCL THROM VAS, V28, P711, DOI 10.1161/ATVBAHA.107.156406; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Nasrabady SE, 2012, NEUROPHARMACOLOGY, V63, P415, DOI 10.1016/j.neuropharm.2012.04.014; Park EM, 2004, STROKE, V35, P2896, DOI 10.1161/01.STR.0000147042.53659.6c; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Rubiera M, 2005, STROKE, V36, P1452, DOI 10.1161/01.STR.0000170711.43405.81; Saqqur M, 2007, STROKE, V38, P69, DOI 10.1161/01.STR.0000251800.01964.f6; Stoll G, 2008, BLOOD, V112, P3555, DOI 10.1182/blood-2008-04-144758; Szepes M, 2013, INT J MOL MED, V31, P26, DOI 10.3892/ijmm.2012.1186; Takahashi K, 1999, BRAIN RES, V829, P46, DOI 10.1016/S0006-8993(99)01335-9; Teng F, 2013, EXP NEUROL, V248, P416, DOI 10.1016/j.expneurol.2013.07.007; Toth O, 2006, LIFE SCI, V79, P317, DOI 10.1016/j.lfs.2006.01.007; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; Weber Ralph, 2012, Handb Exp Pharmacol, P519, DOI 10.1007/978-3-642-29423-5_21; Xiang BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051037; Yip HK, 2005, CEREBROVASC DIS, V20, P120, DOI 10.1159/000086802	43	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110776	10.1371/journal.pone.0110776	http://dx.doi.org/10.1371/journal.pone.0110776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329809	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100095
J	Lim, S; Stember, KG; He, W; Bianca, PC; Yelibi, C; Marquis, A; Sturmer, T; Buse, JB; Meigs, JB				Lim, Soo; Stember, Katherine G.; He, Wei; Bianca, Porneala C.; Yelibi, Carine; Marquis, Alison; Stuermer, Til; Buse, John B.; Meigs, James B.			Electronic Medical Record Cancer Incidence over Six Years Comparing New Users of Glargine with New Users of NPH Insulin	PLOS ONE			English	Article							MALIGNANCIES; RISK; ANALOGS; COHORT	Background: Recent studies suggested that insulin glargine use could be associated with increased risk of cancer. We compared the incidence of cancer in new users of glargine versus new users of NPH in a longitudinal clinical cohort with diabetes for up to 6 years. Methods and Findings: From all patients who had been regularly followed at Massachusetts General Hospital from 1/01/2005 to 12/31/2010, 3,680 patients who had a medication record for glargine or NPH usage were obtained from the electronic medical record (EMR). From those we selected 539 new glargine users (age: 60.1 +/- 13.6 years, BMI: 32.7 +/- 7.5 kg/m(2)) and 343 new NPH users (61.5 +/- 14.1 years, 32.7 +/- 8.3 kg/m(2)) who had no prevalent cancer during 19 months prior to glargine or NPH initiation. All incident cancer cases were ascertained from the EMR requiring at least 2 ICD-9 codes within a 2 month period. Insulin exposure time and cumulative dose were validated. The statistical analysis compared the rates of cancer in new glargine vs. new NPH users while on treatment, adjusted for the propensity to receive one or the other insulin. There were 26 and 28 new cancer cases in new glargine and new NPH users for 1559 and 1126 person-years follow-up, respectively. There were no differences in the propensity-adjusted clinical characteristics between groups. The adjusted hazard ratio for the cancer incidence comparing glargine vs. NPH use was 0.65 (95% CI: 0.36-1.19). Conclusions: Insulin glargine is not associated with development of cancers when compared with NPH in this longitudinal and carefully retrieved EMR data.	[Lim, Soo; Stember, Katherine G.; He, Wei; Bianca, Porneala C.; Yelibi, Carine; Meigs, James B.] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA; [Lim, Soo; Stember, Katherine G.; He, Wei; Bianca, Porneala C.; Yelibi, Carine; Meigs, James B.] Harvard Univ, Sch Med, Boston, MA USA; [Lim, Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Songnam, South Korea; [Lim, Soo] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea; [Stember, Katherine G.] Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Stember, Katherine G.] Harvard Univ, Sch Med, Boston, MA USA; [Marquis, Alison; Buse, John B.] Univ N Carolina, Sch Med, Div Endocrinol, Chapel Hill, NC USA; [Stuermer, Til] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Seoul National University (SNU); Seoul National University (SNU); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Meigs, JB (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA.	jmeigs@partners.org	Meigs, James/P-3927-2019; Buse, John Bernard/J-9742-2019; Lim, Soo/AAU-8107-2020; Stürmer, Til/AAB-5459-2022	Meigs, James/0000-0002-2439-2657; Buse, John Bernard/0000-0002-9723-3876; Lim, Soo/0000-0002-4137-1671; 	Sanofi through University of North Carolina at Chapel Hill;  [K24 DK080140];  [R01 AG023178]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK080140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023178] Funding Source: NIH RePORTER	Sanofi through University of North Carolina at Chapel Hill; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded by Sanofi through a subcontract with the University of North Carolina at Chapel Hill. JBM is supported by K24 DK080140; TS is supported by R01 AG023178. The funders played no role in the study design; collection, analysis, or interpretation of data; the writing of the report; or the decision to submit the article for publication.	Atlas SJ, 2006, J GEN INTERN MED, V21, P973, DOI 10.1007/BF02743147; Blin P, 2012, DIABETOLOGIA, V55, P644, DOI 10.1007/s00125-011-2429-5; Bloomgarden Zachary T, 2011, Diabetes Care, V34, pe100, DOI 10.2337/dc11-0591; Buchs AE, 2011, METABOLISM, V60, P1379, DOI 10.1016/j.metabol.2011.05.002; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0021368]; Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Fagot JP, 2013, DIABETES CARE, V36, P294, DOI 10.2337/dc12-0506; Gough Stephen C L, 2011, Adv Ther, V28 Suppl 5, P1, DOI 10.1007/s12325-011-0047-8; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Mannucci E, 2010, DIABETES CARE, V33, P1997, DOI 10.2337/dc10-0476; Morden NE, 2011, DIABETES CARE, V34, P1965, DOI 10.2337/dc11-0699; Pocock SJ, 2009, LANCET, V374, P511, DOI 10.1016/S0140-6736(09)61307-6; Regan S, 2012, CARDIOVASCULAR DIS E; Rosenstock J, 2009, DIABETOLOGIA, V52, P1971, DOI 10.1007/s00125-009-1452-2; Ruiter R, 2012, DIABETOLOGIA, V55, P51, DOI 10.1007/s00125-011-2312-4; Setoguchi S, 2007, CANCER CAUSE CONTROL, V18, P561, DOI 10.1007/s10552-007-0131-1; Sturmer T, 2013, DIABETES CARE, V36, P3517, DOI 10.2337/dc13-0263; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Suissa S, 2011, DIABETOLOGIA, V54, P2254, DOI 10.1007/s00125-011-2190-9	21	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109433	10.1371/journal.pone.0109433	http://dx.doi.org/10.1371/journal.pone.0109433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329887	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100025
J	Schlaubitz, S; Derkaoui, SM; Marosa, L; Miraux, S; Renard, M; Catros, S; Le Visage, C; Letourneur, D; Amedee, J; Fricain, JC				Schlaubitz, Silke; Derkaoui, Sidi Mohammed; Marosa, Lydia; Miraux, Sylvain; Renard, Martine; Catros, Sylvain; Le Visage, Catherine; Letourneur, Didier; Amedee, Joelle; Fricain, Jean-Christophe			Pullulan/dextran/nHA Macroporous Composite Beads for Bone Repair in a Femoral Condyle Defect in Rats	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOINDUCTIVE BIOMATERIALS; ENDOTHELIAL-CELLS; DRUG-DELIVERY; GROWTH-FACTOR; IN-VITRO; SCAFFOLDS; CERAMICS; COLLAGEN; SUBSTITUTE	The repair of bone defects is of particular interest for orthopedic, oral, maxillofacial, and dental surgery. Bone loss requiring reconstruction is conventionally addressed through bone grafting. Depending on the size and the location of the defect, this method has limits and risks. Biomaterials can offer an alternative and have features supporting bone repair. Here, we propose to evaluate the cellular penetration and bone formation of new macroporous beads based on pullulan/dextran that has been supplemented with nanocrystalline hydroxyapatite in a rat model. Cross-linked beads of 300-500 mm diameters were used in a lateral femoral condyle defect and analyzed by magnetic resonance imaging, micro-computed tomography, and histology in comparison to the empty defects 15, 30, and 70 days after implantation. Inflammation was absent for both conditions. For empty defects, cellularisation and mineralization started from the periphery of the defect. For the defects containing beads, cellular structures filling out the spaces between the scaffolds with increasing interconnectivity and trabecular-like organization were observed over time. The analysis of calcified sections showed increased mineralization over time for both conditions, but was more pronounced for the samples containing beads. Bone Mineral Density and Bone Mineral Content were both significantly higher at day 70 for the beads in comparison to empty defects as well as compared with earlier time points. Analysis of newly formed tissue around the beads showed an increase of osteoid tissue, measured as percentage of the defect surface. This study suggests that the use of beads for the repair of small size defects in bone may be expanded on to meet the clinical need for a ready-to-use fill-up material that can favor bone formation and mineralization, as well as promote vessel ingrowth into the defect site.	[Schlaubitz, Silke; Renard, Martine] Univ Hosp Bordeaux, INSERM, CIC 1401, Bordeaux, France; [Derkaoui, Sidi Mohammed; Le Visage, Catherine; Letourneur, Didier] INSERM, LVTS, U1148, Paris, France; [Derkaoui, Sidi Mohammed; Le Visage, Catherine; Letourneur, Didier] Univ Paris 13, Pres Sorbonne Paris Cite, Paris, France; [Derkaoui, Sidi Mohammed; Le Visage, Catherine; Letourneur, Didier] Univ Paris 07, Paris, France; [Marosa, Lydia; Catros, Sylvain; Amedee, Joelle; Fricain, Jean-Christophe] Univ Bordeaux, INSERM, Tissue Bioengn U1026, Bordeaux, France; [Miraux, Sylvain] CNRS, RMSB Ctr, UMR 5536, Bordeaux, France; [Catros, Sylvain; Fricain, Jean-Christophe] Univ Bordeaux, Sch Dent, Bordeaux, France	CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Fricain, JC (corresponding author), Univ Bordeaux, INSERM, Tissue Bioengn U1026, Bordeaux, France.	jean-christophe.fricain@inserm.fr	AMEDEE, Joelle VILAMITJANA/F-3369-2013; jean-christophe, fricain/AGN-5552-2022; Miraux, Sylvain/AAF-1023-2019; Le Visage, Catherine/E-5460-2011; Didier, letourneur/H-5268-2012	Le Visage, Catherine/0000-0003-1816-1649; Didier, letourneur/0000-0003-2197-9468; fricain, jean christophe/0000-0001-7855-6437; Miraux, Sylvain/0000-0002-3642-2390; catros, sylvain/0000-0002-3419-3467	Agence National de la Recherche [ANR-07-TecSan-011-01 ITOV, ANR-10-EMMA-009-01 MATRI+]	Agence National de la Recherche(French National Research Agency (ANR))	This work is funded by ANR-07-TecSan-011-01 ITOV and ANR-10-EMMA-009-01 MATRI+ from Agence National de la Recherche: (http://www.agence-nationale-recherche.fr/) to JA and DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed A, 2011, J BIOMED MATER RES A, V96A, P535, DOI 10.1002/jbm.a.33007; Afshar A, 2003, MATER DESIGN, V24, P197, DOI 10.1016/S0261-3069(03)00003-7; Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; [Anonymous], 2007, TRENDS BIOMATER ARTI; Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x; Autissier A, 2007, J BIOMED MATER RES A, V82A, P336, DOI 10.1002/jbm.a.30998; Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4; Barbieri D, 2010, EUR CELLS MATER, V19, P252, DOI 10.22203/eCM.v019a24; Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499; Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31; Bongio M, 2015, J TISSUE ENG REGEN M, V9, P191, DOI 10.1002/term.1637; Borden M, 2004, J BONE JOINT SURG BR, V86B, P1200, DOI 10.1302/0301-620X.86B8.14267; Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017; Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031; Castellani C, 2009, CLIN ORAL IMPLAN RES, V20, P1367, DOI 10.1111/j.1600-0501.2009.01760.x; Catros S, 2010, IRBM, V31, P226, DOI 10.1016/j.irbm.2010.04.002; Catros S, 2012, TISSUE ENG PART C-ME, V18, P62, DOI [10.1089/ten.tec.2011.0382, 10.1089/ten.TEC.2011.0382]; Chen FM, 2005, ACTA PHARMACOL SIN, V26, P1093, DOI 10.1111/j.1745-7254.2005.00180.x; Chen Y, 2012, J NANOMATER, V2012, DOI 10.1155/2012/401084; Cho MH, 2008, TISSUE ENG PT A, V14, P1099, DOI [10.1089/ten.tea.2007.0305, 10.1089/tea.2007.0305]; Costa-Pinto AR, 2011, TISSUE ENG PART B-RE, V17, P331, DOI 10.1089/ten.teb.2010.0704; Daculsi G, 2010, J MATER SCI-MATER M, V21, P855, DOI 10.1007/s10856-009-3914-y; Degat MC, 2009, J BIOMED MATER RES A, V88A, P174, DOI 10.1002/jbm.a.31884; Dhandayuthapani B, 2011, INT J POLYM SCI, V2011, DOI 10.1155/2011/290602; Dragoo JL, 2003, J ORTHOP RES, V21, P622, DOI 10.1016/S0736-0266(02)00238-3; Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014; Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078; Fricain JC, 1998, J BIOMED MATER RES, V42, P96, DOI 10.1002/(SICI)1097-4636(199810)42:1<96::AID-JBM12>3.0.CO;2-M; Fricain JC, 2013, BIOMATERIALS, V34, P2947, DOI 10.1016/j.biomaterials.2013.01.049; Garg T, 2012, CRIT REV THER DRUG, V29, P1; Garrido CA, 2011, INT J BIOMATER, V2011, DOI 10.1155/2011/129727; Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033; Guerrero J, 2013, ACTA BIOMATER, V9, P8200, DOI 10.1016/j.actbio.2013.05.025; Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5; Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014; Ji W, 2011, PHARM RES-DORDR, V28, P1259, DOI 10.1007/s11095-010-0320-6; Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x; Kim SS, 2007, J BIOMED MATER RES A, V80A, P206, DOI 10.1002/jbm.a.30836; Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074; Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394; Lalande C, 2011, EUR CELLS MATER, V21, P341, DOI 10.22203/eCM.v021a25; Laquerriere P, 2004, BIOMATERIALS, V25, P2515, DOI 10.1016/j.biomaterials.2003.09.034; LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81; Letourneur D, 2012, CROSSLINKED POLYSACC; Liu JS, 2011, MED HYPOTHESES, V76, P173, DOI 10.1016/j.mehy.2010.09.009; Mallick Kajal K, 2013, Front Biosci (Elite Ed), V5, P341; Matsuno T, 2008, DENT MATER J, V27, P827, DOI 10.4012/dmj.27.827; Miraux S, 2008, J MAGN RESON IMAGING, V28, P497, DOI 10.1002/jmri.21449; Monfoulet L, 2010, CALCIFIED TISSUE INT, V86, P72, DOI 10.1007/s00223-009-9314-y; Oh SA, 2012, TISSUE ENG PT A, V18, P1087, DOI [10.1089/ten.tea.2011.0360, 10.1089/ten.TEA.2011.0360]; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Porporatto C, 2003, BIOCHEM BIOPH RES CO, V304, P266, DOI 10.1016/S0006-291X(03)00579-5; Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246; Seiler J G 3rd, 2000, J South Orthop Assoc, V9, P91; Shi L, 2011, J BIOMAT SCI-POLYM E, V22, P1459, DOI 10.1163/092050610X512108; Stodolak-Zych E, 2013, MATER SCI FORUM, V730-732, P38, DOI 10.4028/www.scientific.net/MSF.730-732.38; Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015; Thebaud NB, 2007, J MATER SCI-MATER M, V18, P339, DOI 10.1007/s10856-006-0698-1; Tsai CH, 2002, J BIOMED MATER RES, V63, P65, DOI 10.1002/jbm.10089; UCHIDA A, 1984, J BONE JOINT SURG BR, V66, P269, DOI 10.1302/0301-620X.66B2.6323483; UCHIDA A, 1985, J ORTHOP RES, V3, P65, DOI 10.1002/jor.1100030108; Van Tomme SR, 2007, EXPERT REV MED DEVIC, V4, P147, DOI 10.1586/17434440.4.2.147; Vasconcelos DP, 2013, BIOMATERIALS, V34, P9952, DOI 10.1016/j.biomaterials.2013.09.012; Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006; WINTER GD, 1969, NATURE, V223, P88, DOI 10.1038/223088a0; Wu Dong-jin, 2012, Zhonghua Yi Xue Za Zhi, V92, P1630; Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107; Zhao HG, 2009, MAT SCI ENG C-BIO S, V29, P836, DOI 10.1016/j.msec.2008.07.033; Zheng H, 2014, J BIOMED MATER RES B, V102, P376, DOI 10.1002/jbm.b.33016; Zhou HZ, 2011, BIOMATERIALS, V32, P7503, DOI 10.1016/j.biomaterials.2011.06.045	71	20	24	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110251	10.1371/journal.pone.0110251	http://dx.doi.org/10.1371/journal.pone.0110251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330002	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100047
J	Shoji, Y; Nishio, Y; Baba, T; Uchiyama, M; Yokoi, K; Ishioka, T; Hosokai, Y; Hirayama, K; Fukuda, H; Aoki, M; Hasegawa, T; Takeda, A; Mori, E				Shoji, Yumiko; Nishio, Yoshiyuki; Baba, Toru; Uchiyama, Makoto; Yokoi, Kayoko; Ishioka, Toshiyuki; Hosokai, Yoshiyuki; Hirayama, Kazumi; Fukuda, Hiroshi; Aoki, Masashi; Hasegawa, Takafumi; Takeda, Atsushi; Mori, Etsuro			Neural Substrates of Cognitive Subtypes in Parkinson's Disease: A 3-Year Longitudinal Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; LEWY BODIES; OLFACTORY DYSFUNCTION; CEREBRAL ATROPHY; DEMENTIA; IMPAIRMENT; DONEPEZIL; COHORT; TRIAL; NEUROPATHOLOGY	Background: The neuropsychological features and neuropathological progression patterns associated with rapidly evolving cognitive decline or dementia in Parkinson's disease (PD) remain to be elucidated. Methods: Fifty-three PD patients without dementia were recruited to participate in a 3-year longitudinal cohort study. The patients were grouped according to the Clinical Dementia Rating (CDR). Group-wise comparisons were made with regard to demographic characteristics, motor symptoms, neuropsychological performances and 18F-fluorodeoxyglucose positron emission tomography. Results: Patients who had memory-plus cognitive impairment (patients whose CDR was 0 at baseline and 0.5 in memory and other domains at follow-up, and those whose baseline CDR was 0.5 in memory and other domains) exhibited higher age at onset, visuoperceptual impairment, non-tremor-dominant motor disturbance, rapid symptomatic progression and posterior neocortical hypometabolism. In patients who were cognitively unimpaired and those who had memory-dominant cognitive impairment (patients whose CDR was 0 at baseline and 0.5 only in memory domain at follow-up, and those whose baseline CDR was 0.5 only in memory domain), the posterior neocortex was relatively unaffected until a later stage of the disease. Conclusions: These results suggest that visuoperceptual impairment and the early involvement of the posterior neocortex may be risk factors for rapid symptomatic progression and dementia in PD.	[Shoji, Yumiko; Nishio, Yoshiyuki; Baba, Toru; Uchiyama, Makoto; Yokoi, Kayoko; Hirayama, Kazumi; Mori, Etsuro] Tohoku Univ, Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi 980, Japan; [Uchiyama, Makoto] Niigata Univ Hlth & Welf, Dept Speech Language & Hearing Sci, Niigata, Japan; [Ishioka, Toshiyuki] Saitama Prefectural Univ, Dept Occupat Therapy, Koshigaya, Japan; [Hosokai, Yoshiyuki] Tohoku Univ, Sch Med, Dept Diagnost Image Anal, Sendai, Miyagi 980, Japan; [Hirayama, Kazumi] Yamagata Prefectural Univ Hlth Sci, Dept Occupat Therapy, Yamagata, Japan; [Fukuda, Hiroshi] Tohoku Univ, Inst Dev Aging & Canc, Dept Radiol & Nucl Med, Sendai, Miyagi 980, Japan; [Aoki, Masashi; Hasegawa, Takafumi] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Takeda, Atsushi] Sendai Nishitaga Hosp, Dept Neurol, Sendai, Miyagi, Japan	Tohoku University; Niigata University; Tohoku University; Tohoku University; Tohoku University	Nishio, Y (corresponding author), Tohoku Univ, Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi 980, Japan.	nishiou@med.tohoku.ac.jp	Perry, George/A-8611-2009; Hasegawa, Takafumi/I-6668-2017	Perry, George/0000-0002-6547-0172; Nishio, Yoshiyuki/0000-0002-6857-1200; Hosokai, Yoshiyuki/0000-0001-5320-1074; Baba, Toru/0000-0003-0936-2510; Ishioka, Toshiyuki/0000-0002-3987-0383	 [24390278];  [90451591]; Grants-in-Aid for Scientific Research [26461263, 24390278] Funding Source: KAKEN	; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B) (24390278 to EM) and a Grant-in-Aid for Scientific Research for Young Scientists (90451591 to YN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2005, ANN NEUROL, V58, P773, DOI 10.1002/ana.20635; Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Aarsland D, 2011, CURR NEUROL NEUROSCI, V11, P371, DOI 10.1007/s11910-011-0203-1; Abe N, 2009, BRAIN, V132, P1386, DOI 10.1093/brain/awp052; Abner EL, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-217; Amrerical Psychiatric Association, 1987, DIAGN STAT MAN MENT; Baba T, 2012, BRAIN, V135, P161, DOI 10.1093/brain/awr321; Bohnen NI, 2013, J NEURAL TRANSM, V120, P571, DOI 10.1007/s00702-012-0956-y; Bohnen NI, 2011, J NUCL MED, V52, P848, DOI 10.2967/jnumed.111.089946; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Burn DJ, 2006, J NEUROL NEUROSUR PS, V77, P585, DOI 10.1136/jnnp.2005.081711; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Doody RS, 2009, NEUROLOGY, V72, P1555, DOI 10.1212/01.wnl.0000344650.95823.03; Dubois B, 2012, MOVEMENT DISORD, V27, P1230, DOI 10.1002/mds.25098; Duff K, 2007, ARCH CLIN NEUROPSYCH, V22, P15, DOI 10.1016/j.acn.2006.08.013; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Goldman JG, 2012, MOVEMENT DISORD, V27, P1129, DOI 10.1002/mds.25062; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Hanna-Pladdy B, 2013, DEMENT GER COGN D EX, V3, P168, DOI 10.1159/000351421; Hosokai Y, 2009, MOVEMENT DISORD, V24, P854, DOI 10.1002/mds.22444; Huang CR, 2007, NEUROIMAGE, V34, P714, DOI 10.1016/j.neuroimage.2006.09.003; Ishioka T, 2011, MOVEMENT DISORD, V26, P837, DOI 10.1002/mds.23576; Janvin CC, 2006, MOVEMENT DISORD, V21, P1343, DOI 10.1002/mds.20974; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Levy G, 2002, MOVEMENT DISORD, V17, P1221, DOI 10.1002/mds.10280; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823; Machulda MM, 2013, CLIN NEUROPSYCHOL, V27, P1247, DOI 10.1080/13854046.2013.836567; Mahieux F, 1998, J NEUROL NEUROSUR PS, V64, P178, DOI 10.1136/jnnp.64.2.178; Mathews M, 2014, ALZHEIMERS DEMENT, V10, P675, DOI 10.1016/j.jalz.2013.11.007; Mathews M, 2013, INT PSYCHOGERIATR, V25, P1115, DOI 10.1017/S1041610213000367; MOHS RC, 1983, PSYCHOPHARMACOL BULL, V19, P448; Mori E, 2012, ANN NEUROL, V72, P41, DOI 10.1002/ana.23557; Morris JC, 1997, ALZ DIS ASSOC DIS, V11, P1, DOI 10.1097/00002093-199706001-00001; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Nishio Y, 2010, EUR J NEUROL, V17, P1090, DOI 10.1111/j.1468-1331.2010.02980.x; Rabbitt P, 2008, J GERONTOL B-PSYCHOL, V63, pP235, DOI 10.1093/geronb/63.4.P235; Rabbitt P, 2009, Q J EXP PSYCHOL, V62, P1859, DOI 10.1080/17470210802633461; Reijnders JSAM, 2009, PARKINSONISM RELAT D, V15, P379, DOI 10.1016/j.parkreldis.2008.09.003; Rogers SL, 1998, DEMENT GERIATR COGN, V9, P29, DOI 10.1159/000051201; Schrag A, 2007, MOVEMENT DISORD, V22, P938, DOI 10.1002/mds.21429; Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234; Summerfield C, 2005, ARCH NEUROL-CHICAGO, V62, P281, DOI 10.1001/archneur.62.2.281; van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Zaccai J, 2008, NEUROLOGY, V70, P1042, DOI 10.1212/01.wnl.0000306697.48738.b6	49	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110547	10.1371/journal.pone.0110547	http://dx.doi.org/10.1371/journal.pone.0110547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25330390	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100071
J	Taruffi, L; Koelsch, S				Taruffi, Liila; Koelsch, Stefan			The Paradox of Music-Evoked Sadness: An Online Survey	PLOS ONE			English	Article							EMOTIONAL RESPONSES; INDIVIDUAL-DIFFERENCES; NEGATIVE EMOTION; CIRCUMPLEX MODEL; SAD MUSIC; EXPERIENCE; EXPRESSION; PERSONALITY; NOSTALGIA; HAPPINESS	This study explores listeners' experience of music-evoked sadness. Sadness is typically assumed to be undesirable and is therefore usually avoided in everyday life. Yet the question remains: Why do people seek and appreciate sadness in music? We present findings from an online survey with both Western and Eastern participants (N = 772). The survey investigates the rewarding aspects of music-evoked sadness, as well as the relative contribution of listener characteristics and situational factors to the appreciation of sad music. The survey also examines the different principles through which sadness is evoked by music, and their interaction with personality traits. Results show 4 different rewards of music-evoked sadness: reward of imagination, emotion regulation, empathy, and no "real-life'' implications. Moreover, appreciation of sad music follows a mood-congruent fashion and is greater among individuals with high empathy and low emotional stability. Surprisingly, nostalgia rather than sadness is the most frequent emotion evoked by sad music. Correspondingly, memory was rated as the most important principle through which sadness is evoked. Finally, the trait empathy contributes to the evocation of sadness via contagion, appraisal, and by engaging social functions. The present findings indicate that emotional responses to sad music are multifaceted, are modulated by empathy, and are linked with a multidimensional experience of pleasure. These results were corroborated by a follow-up survey on happy music, which indicated differences between the emotional experiences resulting from listening to sad versus happy music. This is the first comprehensive survey of music-evoked sadness, revealing that listening to sad music can lead to beneficial emotional effects such as regulation of negative emotion and mood as well as consolation. Such beneficial emotional effects constitute the prime motivations for engaging with sad music in everyday life.	[Taruffi, Liila; Koelsch, Stefan] Free Univ Berlin, Dept Educ Sci & Psychol & Cluster Excellence Lang, Berlin, Germany	Free University of Berlin	Taruffi, L (corresponding author), Free Univ Berlin, Dept Educ Sci & Psychol & Cluster Excellence Lang, Berlin, Germany.	liilataruffi@zedat.fu-berlin.de	Koelsch, Stefan/AAV-1556-2020	Taruffi, Liila/0000-0002-6580-9164; Koelsch, Stefan/0000-0002-8714-3404	Cluster of Excellence "Languages of Emotion" of the Freie Universitat Berlin	Cluster of Excellence "Languages of Emotion" of the Freie Universitat Berlin	The study was funded by the Cluster of Excellence "Languages of Emotion" of the Freie Universitat Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R, 2010, MUSIC PERCEPT, V27, P251, DOI 10.1525/MP.2010.27.4.251; [Anonymous], 2004, BBC RADIO 4, V4; [Anonymous], 1973, LANGUAGES ART APPROA; [Anonymous], 2008, PSYCHOL AESTHETICS C, P115, DOI [10.1037/1931-3896.2.2.115, DOI 10.1037/1931-3896.2.2.115]; Aristotle, 1986, ARISTOTLES POETICS; Barrett FS, 2010, EMOTION, V10, P390, DOI 10.1037/a0019006; Batcho KI, 2007, AM J PSYCHOL, V120, P361, DOI 10.2307/20445410; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Brattico E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00308; Chamorro-Premuzic T, 2007, BRIT J PSYCHOL, V98, P175, DOI 10.1348/000712606X111177; Chamorro-Premuzic T, 2010, PSYCHOL AESTHET CREA, V4, P205, DOI 10.1037/a0019210; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Chin TC, 2012, MUSIC PERCEPT, V29, P429, DOI 10.1525/MP.2012.29.4.429; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; CSIKSZENTMIHALYI M, 1989, J PERS SOC PSYCHOL, V56, P815, DOI 10.1037/0022-3514.56.5.815; Davies JB, 1978, PSYCHOL MUSIC; DAVIES S., 1997, MUSIC MEANING PP, P242; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; Eerola T, 2011, PSYCHOL MUSIC, V39, P18, DOI 10.1177/0305735610362821; Egermann H, 2011, MUSIC SCI, V15, P307, DOI 10.1177/1029864911399497; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; ELLSWORTH PC, 1988, MOTIV EMOTION, V12, P271, DOI 10.1007/BF00993115; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fischer A.H., 2001, APPRAISAL PROCESSES, P221; Gabrielsson A, 1993, MUSIKPSYCHOLOGIE JB, V10, P118; Garrido S, 2011, EMPIR MUSICOL REV, V6, P214, DOI 10.18061/1811/52950; Garrido S, 2011, MUSIC PERCEPT, V28, P279, DOI 10.1525/MP.2011.28.3.279; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Hatfield E, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P19; Hunter PG, 2011, EMOTION, V11, P1068, DOI 10.1037/a0023749; Hunter PG, 2010, PSYCHOL AESTHET CREA, V4, P47, DOI 10.1037/a0016873; Huron D., 2009, OXFORD HDB MUSIC PSY, P151; Huron D, 2011, MUSIC SCI, V15, P146, DOI 10.1177/1029864911401171; Izard C. E., 2000, ENCY PSYCHOL, P137; Janata P, 2007, MEMORY, V15, P845, DOI 10.1080/09658210701734593; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2008, EMOTION, V8, P668, DOI 10.1037/a0013505; Juslin PN, 2014, PSYCHOL MUSIC, V42, P599, DOI 10.1177/0305735613484548; Juslin PN, 2013, PHYS LIFE REV, V10, P235, DOI 10.1016/j.plrev.2013.05.008; Juslin PN, 2012, EMOT REV, V4, P283, DOI 10.1177/1754073912439773; Juslin PN, 2004, J NEW MUSIC RES, V33, P217, DOI 10.1080/0929821042000317813; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kawakami A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00311; KELTNER D, 1993, J PERS SOC PSYCHOL, V64, P740, DOI 10.1037/0022-3514.64.5.740; Kitayama S, 1997, J PERS SOC PSYCHOL, V72, P1245, DOI 10.1037/0022-3514.72.6.1245; Kivy Peter, 1989, SOUND SENTIMENT; Koelsch S., 2012, BRAIN MUSIC; Kringelbach ML, 2009, TRENDS COGN SCI, V13, P479, DOI 10.1016/j.tics.2009.08.006; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Ladinig O, 2012, PSYCHOL AESTHET CREA, V6, P146, DOI 10.1037/a0024671; Larsen JT, 2011, EMOTION, V11, P1469, DOI 10.1037/a0024081; Larsen RJ, 2000, PSYCHOL INQ, V11, P129, DOI 10.1207/S15327965PLI1103_01; Laukka P., 2007, J HAPPINESS STUD, V8, P215, DOI [DOI 10.1007/S10902-006-9024-3, 10.1007/s10902-006-9024-3]; Lazarus R.S., 1991, EMOTION ADAPTATION; Levinson Jerrold, 1997, MUSIC MEANING, P215; Liljestrom S, 2013, PSYCHOL MUSIC, V41, P579, DOI 10.1177/0305735612440615; Lundqvist LO, 2009, PSYCHOL MUSIC, V37, P61, DOI 10.1177/0305735607086048; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Mas-Herrero E, 2013, MUSIC PERCEPT, V31, P118, DOI 10.1525/MP.2013.31.2.118; McKinney CH, 1997, HEALTH PSYCHOL, V16, P390, DOI 10.1037/0278-6133.16.4.390; McKinney CH, 1997, J BEHAV MED, V20, P85, DOI 10.1023/A:1025543330939; MESQUITA B, 1992, PSYCHOL BULL, V112, P179, DOI 10.1037/0033-2909.112.2.179; Murata A, 2013, SOC COGN AFFECT NEUR, V8, P595, DOI 10.1093/scan/nss036; Nemiah J.C., 1976, MODERN TRENDS PSYCHO, P430, DOI DOI 10.1016/J.IJNURSTU.2009.03.014; Noy P, 1993, PSYCHOANALYTIC EXPLO, P125; Panksepp J, 1995, MUSIC PERCEPT, V13, P171; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; Randall WM, 2013, MUSIC PERCEPT, V31, P157, DOI 10.1525/MP.2013.31.2.157; Rivers SE., 2007, J HAPPINESS STUD, V8, P393, DOI [10.1007/s10902-006-9017-2, DOI 10.1007/S10902-006-9017-2]; ROBINSON J, 1994, J AESTHET ART CRITIC, V52, P13, DOI 10.2307/431581; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Saarikallio S., 2007, PSYCHOL MUSIC, V35, P88, DOI DOI 10.1177/0305735607068889; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Schafer T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00511; Schellenberg EG, 2008, COGNITION EMOTION, V22, P218, DOI 10.1080/02699930701350753; Scherer KR, 2004, J NEW MUSIC RES, V33, P239, DOI 10.1080/0929821042000317822; SCHWARTZ GE, 1981, PSYCHOSOM MED, V43, P343, DOI 10.1097/00006842-198108000-00007; Sedikides C, 2008, CURR DIR PSYCHOL SCI, V17, P304, DOI 10.1111/j.1467-8721.2008.00595.x; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; SHIELDS SA, 1984, MOTIV EMOTION, V8, P1, DOI 10.1007/BF00992989; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sloboda, 2001, MUSIC EMOTION THEORY, P413; SLOBODA J. A., 2001, MUSIC SCI, V5, P9, DOI [10.1177/102986490100500102, DOI 10.1177/102986490100500102]; Sobin C, 1999, J PSYCHOLINGUIST RES, V28, P347, DOI 10.1023/A:1023237014909; Stone AA, 1998, J PERS SOC PSYCHOL, V74, P1670, DOI 10.1037/0022-3514.74.6.1670; STRATTON VN, 1984, J MUSIC THER, V21, P16, DOI 10.1093/jmt/21.1.16; Trost W, 2012, CEREB CORTEX, V22, P2769, DOI 10.1093/cercor/bhr353; van Dijk-de Vries AN, 2011, PATIENT, V4, P115, DOI 10.2165/11538390-000000000-00000; van Goethem A, 2011, MUSIC SCI, V15, P208, DOI 10.1177/1029864911401174; Vuoskoski JK, 2012, PSYCHOL AESTHET CREA, V6, P204, DOI 10.1037/a0026937; Vuoskoski JK, 2012, MUSIC PERCEPT, V29, P311, DOI 10.1525/MP.2012.29.3.311; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494	95	124	126	3	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110490	10.1371/journal.pone.0110490	http://dx.doi.org/10.1371/journal.pone.0110490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AS0AY	25330315	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100065
J	Akhtar, MN; Southey, BR; Andren, PE; Sweedler, JV; Rodriguez-Zas, SL				Akhtar, Malik N.; Southey, Bruce R.; Andren, Per E.; Sweedler, Jonathan V.; Rodriguez-Zas, Sandra L.			Accurate Assignment of Significance to Neuropeptide Identifications Using Monte Carlo K-Permuted Decoy Databases	PLOS ONE			English	Article							PROTEIN IDENTIFICATION; ENDOGENOUS NEUROPEPTIDES; SEQUENCE DATABASES; PEPTIDE; TANDEM; DISCOVERY; STRATEGY	In support of accurate neuropeptide identification in mass spectrometry experiments, novel Monte Carlo permutation testing was used to compute significance values. Testing was based on k-permuted decoy databases, where k denotes the number of permutations. These databases were integrated with a range of peptide identification indicators from three popular open-source database search software (OMSSA, Crux, and X! Tandem) to assess the statistical significance of neuropeptide spectra matches. Significance p-values were computed as the fraction of the sequences in the database with match indicator value better than or equal to the true target spectra. When applied to a test-bed of all known manually annotated mouse neuropeptides, permutation tests with k-permuted decoy databases identified up to 100% of the neuropeptides at p-value < 10(-5). The permutation test p-values using hyperscore (X! Tandem), E-value (OMSSA) and Sp score (Crux) match indicators outperformed all other match indicators. The robust performance to detect peptides of the intuitive indicator "number of matched ions between the experimental and theoretical spectra" highlights the importance of considering this indicator when the p-value was borderline significant. Our findings suggest permutation decoy databases of size 1x10(5) are adequate to accurately detect neuropeptides and this can be exploited to increase the speed of the search. The straightforward Monte Carlo permutation testing (comparable to a zero order Markov model) can be easily combined with existing peptide identification software to enable accurate and effective neuropeptide detection. The source code is available at http://stagbeetle.animal.uiuc.edu/pepshop/MSMSpermutationtesting.	[Akhtar, Malik N.; Southey, Bruce R.; Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Andren, Per E.] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Stat, Urbana, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; Uppsala University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.	rodrgzzs@illinois.edu	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Southey, Bruce/0000-0002-8959-7709; Andren, Per/0000-0002-4062-7743	NIH [R21 DA027548, P30 DA 018310]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027548, P30DA018310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH R21 DA027548 and P30 DA 018310. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MN, 2012, J PROTEOME RES, V11, P6044, DOI 10.1021/pr3007123; Alves G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015438; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Falth M, 2006, MOL CELL PROTEOMICS, V5, P998, DOI 10.1074/mcp.M500401-MCP200; Frank AM, 2007, J PROTEOME RES, V6, P114, DOI 10.1021/pr060271u; Frese CK, 2013, ANAL CHEM, V85, P4594, DOI 10.1021/ac400232y; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Higdon R, 2005, OMICS, V9, P364, DOI 10.1089/omi.2005.9.364; Hook V, 2008, ANNU REV PHARMACOL, V48, P393, DOI 10.1146/annurev.pharmtox.48.113006.094812; Hummon AB, 2006, MASS SPECTROM REV, V25, P77, DOI 10.1002/mas.20055; Jia CX, 2013, J PROTEOMICS, V91, P1, DOI 10.1016/j.jprot.2013.06.021; Kapp EA, 2005, PROTEOMICS, V5, P3475, DOI 10.1002/pmic.200500126; Kim S, 2010, MOL CELL PROTEOMICS, V9, P2840, DOI 10.1074/mcp.M110.003731; Klammer AA, 2009, J PROTEOME RES, V8, P2106, DOI 10.1021/pr8011107; Knijnenburg TA, 2009, BIOINFORMATICS, V25, pI161, DOI 10.1093/bioinformatics/btp211; Nesvizhskii AI, 2010, J PROTEOMICS, V73, P2092, DOI 10.1016/j.jprot.2010.08.009; Park CY, 2008, J PROTEOME RES, V7, P3022, DOI 10.1021/pr800127y; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Sadygov RG, 2003, ANAL CHEM, V75, P3792, DOI 10.1021/ac034157w; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; Southey BR, 2014, ANAL CHEM, V86, P443, DOI 10.1021/ac4023378; Svensson M, 2003, J PROTEOME RES, V2, P213, DOI 10.1021/pr020010u; Xie F, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-28; Yin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028679; Zamdborg L, 2007, NUCLEIC ACIDS RES, V35, pW701, DOI 10.1093/nar/gkm371; Zhang XZ, 2012, J PROTEOME RES, V11, P2819, DOI 10.1021/pr3001699	30	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e111112	10.1371/journal.pone.0111112	http://dx.doi.org/10.1371/journal.pone.0111112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329667	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100115
J	Buratto, LG; Pottage, CL; Brown, C; Morrison, CM; Schaefer, A				Buratto, Luciano G.; Pottage, Claire L.; Brown, Charity; Morrison, Catriona M.; Schaefer, Alexandre			The Effects of a Distracting N-Back Task on Recognition Memory Are Reduced by Negative Emotional Intensity	PLOS ONE			English	Article							WORKING-MEMORY; DIVIDED ATTENTION; RECOLLECTIVE EXPERIENCE; DECLARATIVE MEMORY; SUBSEQUENT MEMORY; NEURAL MECHANISMS; ENHANCED MEMORY; AROUSAL; CONSOLIDATION; PERCEPTION	Memory performance is usually impaired when participants have to encode information while performing a concurrent task. Recent studies using recall tasks have found that emotional items are more resistant to such cognitive depletion effects than non-emotional items. However, when recognition tasks are used, the same effect is more elusive as recent recognition studies have obtained contradictory results. In two experiments, we provide evidence that negative emotional content can reliably reduce the effects of cognitive depletion on recognition memory only if stimuli with high levels of emotional intensity are used. In particular, we found that recognition performance for realistic pictures was impaired by a secondary 3-back working memory task during encoding if stimuli were emotionally neutral or had moderate levels of negative emotionality. In contrast, when negative pictures with high levels of emotional intensity were used, the detrimental effects of the secondary task were significantly attenuated.	[Buratto, Luciano G.; Schaefer, Alexandre] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Pottage, Claire L.; Brown, Charity] Univ Leeds, Dept Psychol, Leeds LS2 9JT, W Yorkshire, England; [Schaefer, Alexandre] Monash Univ Malaysia, Sch Business, Bandar Sunway, Malaysia; [Morrison, Catriona M.] Heriot Watt Univ, Dept Psychol, Edinburgh, Midlothian, Scotland	Durham University; University of Leeds; Monash University; Monash University Sunway; Heriot Watt University	Schaefer, A (corresponding author), Univ Durham, Dept Psychol, Durham DH1 3LE, England.	alexandre.schaefer@monash.edu		Schaefer, Alexandre/0000-0003-0864-9384; Brown, Charity/0000-0001-9697-4878	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H001476/1, BB/H001476/2]; BBSRC [BB/H001476/2, BB/H001476/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001476/1, BB/H001476/2] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the UK Biotechnology and Biological Sciences Research Council (BBSRC, reference: BB/H001476/1, and BB/H001476/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; Andreano JM, 2006, PSYCHOL SCI, V17, P466, DOI 10.1111/j.1467-9280.2006.01729.x; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; CHRISTIANSON SA, 1991, J EXP PSYCHOL LEARN, V17, P693, DOI 10.1037/0278-7393.17.4.693; CHRISTIANSON SA, 1992, PSYCHOL BULL, V112, P284, DOI 10.1037/0033-2909.112.2.284; Clark-Foos A, 2008, MEMORY, V16, P530, DOI 10.1080/09658210802007493; D'Argembeau A, 2007, EMOTION, V7, P507, DOI 10.1037/1528-3542.7.3.507; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; Fales CL, 2008, COGN AFFECT BEHAV NE, V8, P239, DOI 10.3758/CABN.8.3.239; GARDINER JM, 1993, EUR J COGN PSYCHOL, V5, P337, DOI 10.1080/09541449308520122; Gasbarri A, 2006, BEHAV BRAIN RES, V168, P177, DOI 10.1016/j.bbr.2005.07.034; Gray JR, 2005, COGN AFFECT BEHAV NE, V5, P182, DOI 10.3758/CABN.5.2.182; Hicks JL, 2000, J EXP PSYCHOL LEARN, V26, P1483, DOI 10.1037//0278-7393.26.6.1483; Huang YM, 2008, J EXP PSYCHOL HUMAN, V34, P328, DOI 10.1037/0096-1523.34.2.328; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; Kensinger EA, 2003, BRAIN COGNITION, V51, P223; Kensinger EA, 2003, EMOTION, V3, P378, DOI 10.1037/1528-3542.3.4.378; Kensinger EA, 2009, EMOT REV, V1, P99, DOI 10.1177/1754073908100432; Kern RP, 2005, EMOTION, V5, P408, DOI 10.1037/1528-3542.5.4.408; Lang PJ., 2001, INT AFFECTIVE PICTUR; LOFTUS EF, 1987, LAW HUMAN BEHAV, V11, P55, DOI 10.1007/BF01044839; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Lupien SJ, 2002, PSYCHONEUROENDOCRINO, V27, P401, DOI 10.1016/S0306-4530(01)00061-0; Maddox GB, 2012, PSYCHON B REV, V19, P1128, DOI 10.3758/s13423-012-0315-x; Mather M, 2005, PSYCHOL AGING, V20, P554, DOI 10.1037/0882-7974.20.4.554; Mather M, 2008, J MEM LANG, V58, P449, DOI 10.1016/j.jml.2007.01.004; Mather M, 2011, PERSPECT PSYCHOL SCI, V6, P114, DOI 10.1177/1745691611400234; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mermillod M, 2010, PSYCHOL SCI, V21, P1429, DOI 10.1177/0956797610381503; Naveh-Benjamin M, 2000, J EXP PSYCHOL LEARN, V26, P1461, DOI 10.1037/0278-7393.26.6.1461; Nyhus E, 2009, BRAIN RES, V1283, P102, DOI 10.1016/j.brainres.2009.05.091; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Park H, 2008, LEARN MEMORY, V15, P417, DOI 10.1101/lm.878908; Payne JD, 2010, CURR DIR PSYCHOL SCI, V19, P290, DOI 10.1177/0963721410383978; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Pottage CL, 2012, EMOTION, V12, P33, DOI 10.1037/a0024574; RAJARAM S, 1993, MEM COGNITION, V21, P89, DOI 10.3758/BF03211168; Rugg MD, 2003, TRENDS COGN SCI, V7, P313, DOI 10.1016/S1364-6613(03)00131-1; Schaefer A, 2005, MEMORY, V13, P148, DOI 10.1080/09658210344000648; Schaefer A, 2006, J NEUROSCI, V26, P10120, DOI 10.1523/JNEUROSCI.2567-06.2006; Schaefer A, 2011, NEUROIMAGE, V54, P714, DOI 10.1016/j.neuroimage.2010.07.030; Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322; Schaefer A, 2009, NEUROREPORT, V20, P319, DOI 10.1097/WNR.0b013e3283229b52; Schmidt SR, 2007, MEM COGNITION, V35, P1905, DOI 10.3758/BF03192924; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; Sharot T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001068; Sharot T, 2008, COGNITION, V106, P538, DOI 10.1016/j.cognition.2007.03.002; Sharot T, 2004, COGN AFFECT BEHAV NE, V4, P294, DOI 10.3758/CABN.4.3.294; Song Z, 2011, P NATL ACAD SCI USA, V108, P9655, DOI 10.1073/pnas.1107247108; SONNEMANS J, 1995, COGNITION EMOTION, V9, P483, DOI 10.1080/02699939508408977; Steinmetz KRM, 2009, PSYCHOPHYSIOLOGY, V46, P1190, DOI 10.1111/j.1469-8986.2009.00868.x; Talmi D, 2007, EMOTION, V7, P89, DOI 10.1037/1528-3542.7.1.89; Talmi D, 2013, CURR DIR PSYCHOL SCI, V22, P430, DOI 10.1177/0963721413498893; Talmi D, 2012, J MEM LANG, V66, P93, DOI 10.1016/j.jml.2011.07.009; Todd RM, 2012, J NEUROSCI, V32, P11201, DOI 10.1523/JNEUROSCI.0155-12.2012; van Stegeren AH, 2005, NEUROIMAGE, V24, P898, DOI 10.1016/j.neuroimage.2004.09.011; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2009, CURR DIR PSYCHOL SCI, V18, P148, DOI 10.1111/j.1467-8721.2009.01626.x; Watts S, 2014, PSYCHOPHYSIOLOGY, V51, P673, DOI 10.1111/psyp.12211; Yonelinas AP, 2001, J EXP PSYCHOL GEN, V130, P361, DOI 10.1037//0096-3445.130.3.361	67	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110211	10.1371/journal.pone.0110211	http://dx.doi.org/10.1371/journal.pone.0110211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9XC	25330251	Green Accepted, Green Published, gold			2022-12-27	WOS:000343210800069
J	Yan, B; Xie, SB; Liu, Z; Ran, J; Li, YY; Wang, J; Yang, Y; Zhou, J; Li, DW; Liu, M				Yan, Bing; Xie, Songbo; Liu, Zhu; Ran, Jie; Li, Yuanyuan; Wang, Jian; Yang, Yang; Zhou, Jun; Li, Dengwen; Liu, Min			HDAC6 Deacetylase Activity Is Critical for Lipopolysaccharide-Induced Activation of Macrophages	PLOS ONE			English	Article							HISTONE DEACETYLASE; ACETYLATION; INHIBITOR; DYNAMICS; MODULATION; PHENOTYPE; MOTILITY; KINASE	Activated macrophages play an important role in both innate and adaptive immune responses, and aberrant activation of macrophages often leads to inflammatory and immune disorders. However, the molecular mechanisms of how macrophages are activated are not fully understood. In this study, we identify a novel role for histone deacetylse 6 (HDAC6) in lipopolysaccharide (LPS)-induced macrophage activation. Our data show that suppression of HDAC6 activity significantly restrains LPS-induced activation of macrophages and production of pro-inflammatory cytokines. Further study reveals that the regulation of macrophage activation by HDAC6 is independent of F-actin polymerization and filopodium formation; instead, it is mediated by the effects of HDAC6 on cell adhesion and microtubule acetylation. These data thus suggest that HDAC6 is an important regulator of LPS-induced macrophage activation and might be a potential target for the management of inflammatory disorders.	[Yan, Bing; Xie, Songbo; Ran, Jie; Li, Yuanyuan; Wang, Jian; Yang, Yang; Zhou, Jun; Li, Dengwen] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Liu, Zhu; Liu, Min] Tianjin Med Univ, Sch Basic Med Sci, Minist Educ, Key Lab Immune Microenvironm & Dis, Tianjin, Peoples R China	Nankai University; Tianjin Medical University	Liu, M (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Minist Educ, Key Lab Immune Microenvironm & Dis, Tianjin, Peoples R China.	minliu@tijmu.edu.cn	Xie, Songbo/AAD-9850-2020; Zhou, Jun/D-4654-2017; li, yuanyuan/GZA-4435-2022	Zhou, Jun/0000-0001-7858-8260; 	National Natural Science Foundation of China [31171334, 31170820]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants (31171334 to DL and 31170820 to ML) from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON SL, 1990, J IMMUNOL, V144, P625; Alford PW, 2011, INTEGR BIOL-UK, V3, P1063, DOI 10.1039/c1ib00061f; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Cruz-Leal Y, 2014, IMMUNOBIOLOGY, V219, P403, DOI 10.1016/j.imbio.2014.01.006; Cui SN, 2014, INT IMMUNOPHARMACOL, V18, P142, DOI 10.1016/j.intimp.2013.11.016; Gabhann JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085834; Gallo P, 2008, CARDIOVASC RES, V80, P416, DOI 10.1093/cvr/cvn215; Gao JM, 2010, BLOOD, V115, P4130, DOI 10.1182/blood-2009-10-248526; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hancock WW, 2012, ANN RHEUM DIS, V71, P46, DOI 10.1136/annrheumdis-2011-200593; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huo LH, 2011, J BIOL CHEM, V286, P9280, DOI 10.1074/jbc.M110.208884; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kozyreva VK, 2014, MOL CANCER RES, V12, P681, DOI 10.1158/1541-7786.MCR-13-0654; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Li DW, 2014, PROTEIN CELL, V5, P214, DOI 10.1007/s13238-013-0010-3; Li DW, 2014, CELL CYCLE, V13, P974, DOI 10.4161/cc.27838; Li DW, 2011, PROTEIN CELL, V2, P150, DOI 10.1007/s13238-011-1015-4; Liu M, 2014, J PATHOL, V233, P138, DOI 10.1002/path.4333; Liu QP, 1999, J IMMUNOL, V163, P6606; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ray M, 2010, J IMMUNOL, V185, P7309, DOI 10.4049/jimmunol.1000095; Slingerland M, 2014, ANTI-CANCER DRUG, V25, P140, DOI 10.1097/CAD.0000000000000040; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Tala, 2014, THERANOSTICS, V4, P1052, DOI 10.7150/thno.9727; Tala A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100825; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Tripathi S, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-1; Venter G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096786; Vishwakarma S, 2013, INT IMMUNOPHARMACOL, V16, P72, DOI 10.1016/j.intimp.2013.03.016; Wang B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4479; WEINSTEIN SL, 1991, P NATL ACAD SCI USA, V88, P4148, DOI 10.1073/pnas.88.10.4148; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xie SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094496; Yang YF, 2014, P NATL ACAD SCI USA, V111, P2158, DOI 10.1073/pnas.1319341111; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhou J, 2009, J BIOL CHEM, V284, P9648, DOI 10.1074/jbc.M808708200	44	37	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110718	10.1371/journal.pone.0110718	http://dx.doi.org/10.1371/journal.pone.0110718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25330030	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800107
J	Dai, Y; Guo, YL; Wang, C; Liu, Q; Yang, Y; Li, SY; Guo, XL; Lian, RL; Yu, RJ; Liu, HW; Chen, JS				Dai, Ying; Guo, Yonglong; Wang, Chan; Liu, Qing; Yang, Yan; Li, Shanyi; Guo, Xiaoling; Lian, Ruiling; Yu, Rongjie; Liu, Hongwei; Chen, Jiansu			Non-Genetic Direct Reprogramming and Biomimetic Platforms in a Preliminary Study for Adipose-Derived Stem Cells into Corneal Endothelia-Like Cells	PLOS ONE			English	Article							MOUSE SOMATIC-CELLS; DIRECT CONVERSION; HUMAN FIBROBLASTS; DOPAMINE NEURONS; DIFFERENTIATION; PURMORPHAMINE; COMBINATION; ACTIVATION; GENERATION; DERIVATION	Cell fate and function can be regulated and reprogrammed by intrinsic genetic program, extrinsic factors and niche microenvironment. Direct reprogramming has shown many advantages in the field of cellular reprogramming. Here we tried the possibility to generate corneal endothelia (CE) -like cells from human adipose-derived stem cells (ADSCs) by the non-genetic direct reprogramming of recombinant cell-penetrating proteins Oct4/Klf4/Sox2 (PTD-OKS) and small molecules (purmorphamine, RG108 and other reprogramming chemical reagents), as well as biomimetic platforms of simulate microgravity (SMG) bioreactor. Co-cultured with corneal cells and decellularized corneal ECM, Reprogrammed ADSCs revealed spherical growth and positively expressing Nanog for RT-PCR analysis and CD34 for immunofluorescence staining after 7 days-treatment of both purmorphamine and PTD-OKS (P-OKS) and in SMG culture. ADSCs changed to CEC polygonal morphology from spindle shape after the sequential non-genetic direct reprogramming and biomimetic platforms. At the same time, induced cells converted to weakly express CD31, AQP-1 and ZO-1. These findings demonstrated that the treatments were able to promote the stem-cell reprogramming for human ADSCs. Our study also indicates for the first time that SMG rotary cell culture system can be used as a non-genetic means to promote direct reprogramming. Our methods of reprogramming provide an alternative strategy for engineering patient-specific multipotent cells for cellular plasticity research and future autologous CEC replacement therapy that avoids complications associated with the use of human pluripotent stem cells.	[Dai, Ying; Guo, Yonglong; Wang, Chan; Li, Shanyi; Guo, Xiaoling; Liu, Hongwei; Chen, Jiansu] Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Liu, Qing; Yang, Yan; Lian, Ruiling; Chen, Jiansu] Jinan Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Liu, Qing; Yang, Yan; Lian, Ruiling; Chen, Jiansu] Jinan Univ, Coll Med, Inst Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjie] Jinan Univ, Bioengn Inst, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University; Jinan University	Chen, JS (corresponding author), Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China.	chenjiansu2000@163.com	Guo, Xiaoling/AAJ-2958-2020; Li, Shanyi/W-5833-2019	Li, Shanyi/0000-0003-0208-0481; Chen, Jiansu/0000-0001-6703-9573; Yu, Rongjie/0000-0001-9285-5783	National Natural Science Foundation of China [81371689]; Ministry of Science and Technology [2012DFH30060]; Natural Science Foundation of Guangdong Province [S2013010013391]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (81371689), collaborated grant for HK-Macao-TW of Ministry of Science and Technology (2012DFH30060) and the Natural Science Foundation of Guangdong Province (S2013010013391). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AF, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.25; Alexanian AR, 2013, INT J BIOCHEM CELL B, V45, P1633, DOI 10.1016/j.biocel.2013.04.022; Azarin SM, 2010, BIOCHEM ENG J, V48, P378, DOI 10.1016/j.bej.2009.10.020; Baer PC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/812693; Bekhite MM, 2014, STEM CELLS DEV, V23, P333, DOI 10.1089/scd.2013.0268; Campioni D, 2006, HAEMATOLOGICA, V91, P364; Chen JS, 2007, ARTIF ORGANS, V31, P722, DOI 10.1111/j.1525-1594.2007.00440.x; Dai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050114; Dong FL, 2012, GENET MOL RES, V11, P4179, DOI 10.4238/2012.December.6.1; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Gaafar TM, 2014, CLIN EXP MED, V14, P177, DOI 10.1007/s10238-013-0238-5; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; Hatou S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0286; Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605; Ho JHC, 2011, TISSUE ENG PT A, V17, P255, DOI 10.1089/ten.TEA.2010.0106; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Inagawa K, 2013, J CARDIOVASC TRANSL, V6, P37, DOI 10.1007/s12265-012-9412-5; Ju CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042378; Kang PJ, 2014, BIOMATERIALS, V35, P7336, DOI 10.1016/j.biomaterials.2014.05.015; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; [李红阳 LI Hongyang], 2011, [中国病理生理杂志, Chinese Journal of Pathophysiology], V27, P1790; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; [刘晓飞 LIU Xiaofei], 2011, [生物技术, Biotechnology], V21, P23; Mitsuhara T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt184; Moon JH, 2011, CELL RES, V21, P1305, DOI 10.1038/cr.2011.107; Morris SA, 2013, CELL RES, V23, P33, DOI 10.1038/cr.2013.1; Nemes C, 2014, TISSUE ENG PART C-ME, V20, P383, DOI [10.1089/ten.TEC.2013.0026, 10.1089/ten.tec.2013.0026]; Oliveira FS, 2012, J CELL BIOCHEM, V113, P204, DOI 10.1002/jcb.23345; Orza AI, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/6/065102; Pereira TS, 2009, BONE, V44, pS314, DOI 10.1016/j.bone.2009.03.589; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Plaisant M, 2009, STEM CELLS, V27, P703, DOI 10.1634/stemcells.2008-0888; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Sancho-Martinez I, 2012, NAT CELL BIOL, V14, P892, DOI 10.1038/ncb2567; Sowa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084206; [苏航 SU Hang], 2011, [中国生物工程杂志, Journal of Chinese Biotechnology], V31, P48; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Suzuki H, 2009, JPN J OPHTHALMOL, V53, P151, DOI 10.1007/s10384-008-0629-4; Szablowska-Gadomska I, 2012, ACTA NEUROBIOL EXP, V72, P337; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; [谭美华 Tan Meihua], 2012, [中国病理生理杂志, Chinese Journal of Pathophysiology], V28, P1488; Thier M, 2010, INT J DEV BIOL, V54, P1713, DOI 10.1387/ijdb.103193mt; Vunjak-Novakovic G, 2011, CELL STEM CELL, V8, P252, DOI 10.1016/j.stem.2011.02.014; Wagner DE, 2013, RESPIROLOGY, V18, P895, DOI 10.1111/resp.12102; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Yoshida S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028856; Yuge L, 2011, STEM CELLS DEV, V20, P893, DOI 10.1089/scd.2010.0294; Zhang H, 2012, BIOMATERIALS, V33, P5047, DOI 10.1016/j.biomaterials.2012.03.061; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Yi-ye, 2013, Genomics Proteomics & Bioinformatics, V11, P284, DOI 10.1016/j.gpb.2013.09.008	56	31	31	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109856	10.1371/journal.pone.0109856	http://dx.doi.org/10.1371/journal.pone.0109856			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25333522	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200060
J	Gong, ZY; Kidoya, H; Mohri, T; Han, YL; Takakura, N				Gong, Zhi-Yuan; Kidoya, Hiroyasu; Mohri, Tomomi; Han, Yinglu; Takakura, Nobuyuki			DNA Damage Enhanced by the Attenuation of SLD5 Delays Cell Cycle Restoration in Normal Cells but Not in Cancer Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MULTIPROTEIN COMPLEX; CRYSTAL-STRUCTURE; UP-REGULATION; GINS COMPLEX; REPLICATION; PSF1; EXPRESSION; PROTEIN; STEM	SLD5 is a member of the GINS complex composed of PSF1, PSF2, PSF3 and SLD5, playing a critical role in the formation of the DNA replication fork with CDC45 in yeast. Previously, we had isolated a PSF1 orthologue from a murine hematopoietic stem cell DNA library and were then able to identify orthologues of all the other GINS members by the yeast two hybrid approach using PSF1 as the bait. These GINS orthologues may also function in DNA replication in mammalian cells because they form tetrameric complexes as observed in yeast, and gene deletion mutants of both PSF1 and SLD5 result in a lack of epiblast proliferation and early embryonic lethality. However, we found that PSF1 is also involved in chromosomal segregation in M phase, consistent with recent suggestions that homologues of genes associated with DNA replication in lower organisms also regulate cellular events other than DNA replication in mammalian cells. Here we analyzed the function of SLD5 other than DNA replication and found that it is active in DNA damage and repair. Attenuation of SLD5 expression results in marked DNA damage in both normal cells and cancer cells, suggesting that it protects against DNA damage. Attenuation of SLD5 delays the DNA repair response and cell cycle restoration in normal cells but not in cancer cells. These findings suggest that SLD5 might represent a therapeutic target molecule acting at the level of tumor stromal cells rather than the cancerous cells themselves, because development of the tumor microenvironment could be delayed or disrupted by the suppression of its expression in the normal cell types within the tumor.	[Gong, Zhi-Yuan; Kidoya, Hiroyasu; Mohri, Tomomi; Han, Yinglu; Takakura, Nobuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka, Japan; [Takakura, Nobuyuki] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan	Osaka University; Japan Science & Technology Agency (JST)	Takakura, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka, Japan.	ntakaku@biken.osaka-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology and Grants-in-Aid for Scientific Research (KAKENHI) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akala OO, 2006, CURR OPIN GENET DEV, V16, P496, DOI 10.1016/j.gde.2006.08.011; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Chang YP, 2007, P NATL ACAD SCI USA, V104, P12685, DOI 10.1073/pnas.0705558104; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Cho SG, 2009, CANCER RES, V69, P7062, DOI 10.1158/0008-5472.CAN-09-0476; Choi JM, 2007, GENE DEV, V21, P1316, DOI 10.1101/gad.1548107; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gouge CA, 2010, BIOCHEM BIOPH RES CO, V400, P145, DOI 10.1016/j.bbrc.2010.08.033; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashi Reiko, 2006, Genomics Proteomics & Bioinformatics, V4, P156, DOI 10.1016/S1672-0229(06)60028-4; Huang HK, 2005, MOL CELL BIOL, V25, P9000, DOI 10.1128/MCB.25.20.9000-9015.2005; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kong LY, 2006, BIOCHEM BIOPH RES CO, V339, P1204, DOI 10.1016/j.bbrc.2005.11.136; Lambert JF, 2003, J EXP MED, V197, P1563, DOI 10.1084/jem.20030031; LJUNGMAN M, 1992, MOL CARCINOGEN, V5, P264, DOI 10.1002/mc.2940050406; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; MacNeill SA, 2010, BIOCHEM J, V425, P489, DOI 10.1042/BJ20091531; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Mohri T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078961; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nagahama Y, 2010, CANCER RES, V70, P1215, DOI 10.1158/0008-5472.CAN-09-3662; Nakahara I, 2010, GENES CELLS, V15, P1015, DOI 10.1111/j.1365-2443.2010.01442.x; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Obama K, 2005, ONCOL REP, V14, P701; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Ueno M, 2005, MOL CELL BIOL, V25, P10528, DOI 10.1128/MCB.25.23.10528-10532.2005; Ueno M, 2009, BLOOD, V113, P555, DOI 10.1182/blood-2008-01-136879; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Walker JV, 2002, CANCER INVEST, V20, P570, DOI 10.1081/CNV-120002156; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271	41	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e110483	10.1371/journal.pone.0110483	http://dx.doi.org/10.1371/journal.pone.0110483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25334017	Green Submitted, gold, Green Published			2022-12-27	WOS:000343731200044
J	Roux, PF; Boutin, M; Desert, C; Djari, A; Esquerre, D; Klopp, C; Lagarrigue, S; Demeure, O				Roux, Pierre-Francois; Boutin, Morgane; Desert, Colette; Djari, Anis; Esquerre, Diane; Klopp, Christophe; Lagarrigue, Sandrine; Demeure, Olivier			Re-Sequencing Data for Refining Candidate Genes and Polymorphisms in QTL Regions Affecting Adiposity in Chicken	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PHOSPHOLIPASE A(2) RECEPTOR; BODY-COMPOSITION; AFFECTING FATNESS; METABOLIC TRAITS; F-2 INTERCROSS; ABDOMINAL FAT; GENOME; GROWTH; LINES	In this study, we propose an approach aiming at fine-mapping adiposity QTL in chicken, integrating whole genome resequencing data. First, two QTL regions for adiposity were identified by performing a classical linkage analysis on 1362 offspring in 11 sire families obtained by crossing two meat-type chicken lines divergently selected for abdominal fat weight. Those regions, located on chromosome 7 and 19, contained a total of 77 and 84 genes, respectively. Then, SNPs and indels in these regions were identified by re-sequencing sires. Considering issues related to polymorphism annotations for regulatory regions, we focused on the 120 and 104 polymorphisms having an impact on protein sequence, and located in coding regions of 35 and 42 genes situated in the two QTL regions. Subsequently, a filter was applied on SNPs considering their potential impact on the protein function based on conservation criteria. For the two regions, we identified 42 and 34 functional polymorphisms carried by 18 and 24 genes, and likely to deeply impact protein, including 3 coding indels and 4 nonsense SNPs. Finally, using gene functional annotation, a short list of 17 and 4 polymorphisms in 6 and 4 functional genes has been defined. Even if we cannot exclude that the causal polymorphisms may be located in regulatory regions, this strategy gives a complete overview of the candidate polymorphisms in coding regions and prioritize them on conservation-and functional-based arguments.	[Roux, Pierre-Francois; Boutin, Morgane; Desert, Colette; Lagarrigue, Sandrine; Demeure, Olivier] INRA, PEGASE, UMR1348, St Gilles, France; [Roux, Pierre-Francois; Boutin, Morgane; Desert, Colette; Lagarrigue, Sandrine; Demeure, Olivier] Agrocampus Ouest, PEGASE, UMR1348, Rennes, France; [Roux, Pierre-Francois; Boutin, Morgane; Desert, Colette; Lagarrigue, Sandrine] Univ Europeenne Bretagne, Rennes, France; [Klopp, Christophe] INRA, SIGENAE, F-31326 Castanet Tolosan, France; [Esquerre, Diane] INRA, GenPhySE, GeT PlaGe, UMR1388, F-31326 Castanet Tolosan, France	INRAE; Institut Agro; Agrocampus Ouest; Universite de Bretagne Occidentale; INRAE; INRAE	Demeure, O (corresponding author), INRA, PEGASE, UMR1348, St Gilles, France.	olivier.demeure@rennes.inra.fr	Klopp, Christophe/J-3164-2019; Roux, Pierre-François/J-8875-2019	Klopp, Christophe/0000-0001-7126-5477; Roux, Pierre-François/0000-0002-0695-4206; Lagarrigue, Sandrine/0000-0002-4887-7245	INRA; Region Bretagne	INRA; Region Bretagne(Region Bretagne)	This work was founded by INRA, in the scope of program ChickSeq (2010). Pierre-Francois Roux's thesis grant was co-funded by INRA and Region Bretagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Ankra-Badu GA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-107; Baud A, 2013, NAT GENET, V45, P767, DOI 10.1038/ng.2644; Carneiro MO, 2013, CURRENT PROTOCOLS BI, V11; Chang CT, 2012, SCI WORLD J, DOI 10.1100/2012/365104; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Demeure O, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-36; Demeure Olivier, 2008, BMC Res Notes, V1, P9, DOI 10.1186/1756-0500-1-9; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Filangi O, 2012, QTLMAP SOFTWARE QTL; Georges M, 2007, ANNU REV GENOM HUM G, V8, P131, DOI 10.1146/annurev.genom.8.080706.092408; Givry S, 2005, BIOINFORMATICS, V21, P1703, DOI DOI 10.1093/BI0INF0RMATICS/BTI222; Goenaga D, 2009, MOL ENDOCRINOL, V23, P1043, DOI 10.1210/me.2008-0360; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Grant JR, 2011, BIOINFORMATICS, V27, P2300, DOI 10.1093/bioinformatics/btr372; Greenawalt DM, 2012, AM J EPIDEMIOL, V176, P423, DOI 10.1093/aje/kws123; Grisart B., 2004, GENETIC FUNCTIONAL C; Groenen MAM, GENOME RES, V19, P510; Hanasaki K, 1999, ARCH BIOCHEM BIOPHYS, V372, P215, DOI 10.1006/abbi.1999.1511; HARRELL FE, 1982, BIOMETRIKA, V69, P635; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Ikeobi CON, 2002, ANIM GENET, V33, P428, DOI 10.1046/j.1365-2052.2002.00911.x; Jacobsson L, 2005, GENET RES, V86, P115, DOI 10.1017/S0016672305007767; Jennen DGJ, 2004, POULTRY SCI, V83, P295, DOI 10.1093/ps/83.3.295; Karlberg N, 2005, DIABETES, V54, P3577, DOI 10.2337/diabetes.54.12.3577; Kasus-Jacobi A, 1998, J BIOL CHEM, V273, P26026, DOI 10.1074/jbc.273.40.26026; Kubitz R, 2012, CLIN RES HEPATOL GAS, V36, P536, DOI 10.1016/j.clinre.2012.06.006; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lagarrigue S, 2006, GENET SEL EVOL, V38, P85, DOI 10.1051/gse:2005028; Laulederkind SJF, 2013, BRIEF BIOINFORM, V14, P520, DOI 10.1093/bib/bbt007; Le Bihan-Duval E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014825; Lecerf F, 2011, NUCLEIC ACIDS RES, V39, pW328, DOI 10.1093/nar/gkr361; LECLERCQ B, 1980, BRIT POULTRY SCI, V21, P107, DOI 10.1080/00071668008416644; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2014, DIABETOLOGIA, V57, P2173, DOI 10.1007/s00125-014-3312-y; McElroy JP, 2006, POULTRY SCI, V85, P593, DOI 10.1093/ps/85.4.593; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Murakami Y, 2003, MOL BIOL CELL, V14, P4285, DOI 10.1091/mbc.E03-03-0193; Nadaf J, 2009, PHYSIOL GENOMICS, V38, P241, DOI 10.1152/physiolgenomics.90384.2008; Napolioni V, 2011, MOL NEUROBIOL, V44, P83, DOI 10.1007/s12035-011-8192-2; Ott J., 1999, ANAL HUMAN GENETIC L; Page G, 1999, FEBS LETT, V462, P187, DOI 10.1016/S0014-5793(99)01529-X; Park HB, 2006, PHYSIOL GENOMICS, V25, P216, DOI 10.1152/physiolgenomics.00113.2005; Paul DS, 2014, BIOESSAYS, V36, P191, DOI 10.1002/bies.201300126; Pieper-Furst U, 2013, BBA-MOL CELL BIOL L, V1831, P1191, DOI 10.1016/j.bbalip.2013.03.013; Ramalingam L, 2014, DIABETOLOGIA, V57, P1476, DOI 10.1007/s00125-014-3227-7; Ramalingam L, 2012, DIABETES, V61, P2424, DOI 10.2337/db11-1525; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Staines K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051799; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Tamaru S, 2013, J IMMUNOL, V191, P1021, DOI 10.4049/jimmunol.1300738; Tatsuda Ken, 2001, Journal of Poultry Science, V38, P266, DOI 10.2141/jpsa.38.266; Tian JW, 2010, ANIM BIOTECHNOL, V21, P42, DOI 10.1080/10495390903347009; Wang SZ, 2012, GENET MOL RES, V11, P956, DOI 10.4238/2012.April.19.1; Zhou H, 2006, POULTRY SCI, V85, P1712, DOI 10.1093/ps/85.10.1712	61	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e111299	10.1371/journal.pone.0111299	http://dx.doi.org/10.1371/journal.pone.0111299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333370	Green Submitted, gold, Green Published			2022-12-27	WOS:000343731200111
J	Teves, ME; Sears, PR; Li, W; Zhang, ZG; Tang, WX; van Reesema, L; Costanzo, RM; Davis, CW; Knowles, MR; Strauss, JF; Zhang, ZB				Teves, Maria E.; Sears, Patrick R.; Li, Wei; Zhang, Zhengang; Tang, Waixing; van Reesema, Lauren; Costanzo, Richard M.; Davis, C. William; Knowles, Michael R.; Strauss, Jerome F., III; Zhang, Zhibing			Sperm-Associated Antigen 6 (SPAG6) Deficiency and Defects in Ciliogenesis and Cilia Function: Polarity, Density, and Beat	PLOS ONE			English	Article							PLANAR-CELL-POLARITY; CENTRAL APPARATUS; MOTILE CILIA; MALE-INFERTILITY; BASAL BODIES; PROTEIN; HYDROCEPHALUS; POLARIZATION; MICROTUBULE; MOUSE	SPAG6, an axoneme central apparatus protein, is essential for function of ependymal cell cilia and sperm flagella. A significant number of Spag6-deficient mice die with hydrocephalus, and surviving males are sterile because of sperm motility defects. In further exploring the ciliary dysfunction in Spag6-null mice, we discovered that cilia beat frequency was significantly reduced in tracheal epithelial cells, and that the beat was not synchronized. There was also a significant reduction in cilia density in both brain ependymal and trachea epithelial cells, and cilia arrays were disorganized. The orientation of basal feet, which determines the direction of axoneme orientation, was apparently random in Spag6-deficient mice, and there were reduced numbers of basal feet, consistent with reduced cilia density. The polarized epithelial cell morphology and distribution of intracellular mucin, alpha-tubulin, and the planar cell polarity protein, Vangl2, were lost in Spag6-deficient tracheal epithelial cells. Polarized epithelial cell morphology and polarized distribution of alpha-tubulin in tracheal epithelial cells was observed in one-week old wild-type mice, but not in the Spag6-deficient mice of the same age. Thus, the cilia and polarity defects appear prior to 7 days post-partum. These findings suggest that SPAG6 not only regulates cilia/flagellar motility, but that in its absence, ciliogenesis, axoneme orientation, and tracheal epithelial cell polarity are altered.	[Teves, Maria E.; Li, Wei; Zhang, Zhengang; van Reesema, Lauren; Strauss, Jerome F., III; Zhang, Zhibing] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23298 USA; [Strauss, Jerome F., III; Zhang, Zhibing] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Sears, Patrick R.] Univ N Carolina, Cyst Fibrosis Ctr, Chapel Hill, NC USA; [Zhang, Zhengang] Huazhong Univ Sci & Technol, Dept Infect Dis, Tongji Med Coll, Wuhan, Hunan, Peoples R China; [Tang, Waixing] Univ Penn, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA; [Costanzo, Richard M.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA; [Davis, C. William; Knowles, Michael R.] Univ N Carolina, Dept Cell Mol Physiol Med, Chapel Hill, NC USA	Virginia Commonwealth University; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill; Huazhong University of Science & Technology; University of Pennsylvania; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill	Zhang, ZB (corresponding author), Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23298 USA.	zzhang4@vcu.edu	Teves, Maria/AAJ-9523-2020	Teves, Maria/0000-0001-7035-2202; Costanzo, Richard/0000-0002-6839-3520	NIH [HD076257, HD37416, HL071798]; Virginia Commonwealth University Presidential Research Incentive Program (PRIP); Massey Cancer Award; NIH-NCI Cancer Center Core Grant [5P30CA016059]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076257] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037416] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071798, U54HL096458] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University Presidential Research Incentive Program (PRIP); Massey Cancer Award; NIH-NCI Cancer Center Core Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by NIH grant HD076257, Virginia Commonwealth University Presidential Research Incentive Program (PRIP) and Massey Cancer Award (to ZZ), NIH grants HD37416 (JFS), and HL071798 (MRK). The authors also thank Pamela J. Gigliotti for technical support with the tissue processing at the VCU Biological Macromolecule Core Facility, supported, in part, with the funding from NIH-NCI Cancer Center Core Grant 5P30CA016059. The authors declare no competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbe OK, 2013, DEV BIOL, V382, P172, DOI 10.1016/j.ydbio.2013.07.003; BOISVIEUXULRICH E, 1990, CELL TISSUE RES, V259, P443, DOI 10.1007/BF01740770; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; CHAILLEY B, 1989, BIOL CELL, V67, P81, DOI 10.1111/j.1768-322X.1989.tb03012.x; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Dworkin S, 2011, ORGANOGENESIS, V7, P202, DOI 10.4161/org.7.3.18431; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Hannus M, 2002, DEVELOPMENT, V129, P3493; House SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002167; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Kunimoto K, 2012, CELL, V148, P189, DOI 10.1016/j.cell.2011.10.052; Lee L, 2008, MOL CELL BIOL, V28, P949, DOI 10.1128/MCB.00354-07; Matsuo M, 2013, AM J PHYSIOL-LUNG C, V304, pL736, DOI 10.1152/ajplung.00425.2012; Mirzadeh Z, 2010, J NEUROSCI, V30, P2600, DOI 10.1523/JNEUROSCI.3744-09.2010; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Mitchell B, 2009, CURR BIOL, V19, P924, DOI 10.1016/j.cub.2009.04.018; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Pearson CG, 2009, MOL BIOL CELL, V20, P904, DOI 10.1091/mbc.E08-08-0835; Qiu H, 2013, J MOL EVOL, V77, P119, DOI 10.1007/s00239-013-9585-9; SANDOZ D, 1988, BIOL CELL, V63, P183, DOI 10.1016/0248-4900(88)90057-3; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Sapiro R, 2000, BIOL REPROD, V62, P511, DOI 10.1095/biolreprod62.3.511; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Sironen A, 2011, BIOL REPROD, V85, P690, DOI 10.1095/biolreprod.111.091132; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Smith EF, 1996, J CELL BIOL, V132, P359, DOI 10.1083/jcb.132.3.359; SOROKIN SP, 1968, J CELL SCI, V3, P207; Straschil U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012901; Teves ME, 2013, AM J RESP CELL MOL, V48, P765, DOI 10.1165/rcmb.2012-0362OC; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Tsuneoka M, 2006, INT J ANDROL, V29, P323, DOI 10.1111/j.1365-2605.2005.00572.x; Turner CM, 1998, MECH DEVELOP, V70, P181, DOI 10.1016/S0925-4773(97)00194-9; Vladar EK, 2012, CURR BIOL, V22, P2203, DOI 10.1016/j.cub.2012.09.046; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; Wallingford JB, 2010, CURR OPIN CELL BIOL, V22, P597, DOI 10.1016/j.ceb.2010.07.011; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Zhang ZB, 2006, BIOL REPROD, V74, P751, DOI 10.1095/biolreprod.105.049254; Zhang ZB, 2007, CELL MOTIL CYTOSKEL, V64, P360, DOI 10.1002/cm.20189	42	29	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2014	9	10							e107271	10.1371/journal.pone.0107271	http://dx.doi.org/10.1371/journal.pone.0107271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7AB	25333478	Green Published, gold, Green Submitted			2022-12-27	WOS:000343731200003
J	Colleter, J; Penman, DJ; Lallement, S; Fauvel, C; Hanebrekke, T; Osvik, RD; Eilertsen, HC; D'Cotta, H; Chatain, B; Peruzzi, S				Colleter, Julie; Penman, David J.; Lallement, Stephane; Fauvel, Christian; Hanebrekke, Tanja; Osvik, Renate D.; Eilertsen, Hans C.; D'Cotta, Helena; Chatain, Beatrice; Peruzzi, Stefano			Genetic Inactivation of European Sea Bass (Dicentrarchus labrax L.) Eggs Using UV-Irradiation: Observations and Perspectives	PLOS ONE			English	Article							RAINBOW-TROUT; COMMON CARP; MICROSATELLITE MARKERS; NILE TILAPIA; 1ST CLEAVAGE; AMINO-ACIDS; DNA-DAMAGE; ANDROGENESIS; SPERM; GYNOGENESIS	Androgenesis is a form of uniparental reproduction leading to progenies inheriting only the paternal set of chromosomes. It has been achieved with variable success in a number of freshwater species and can be attained by artificial fertilization of genetically inactivated eggs following exposure to gamma (gamma), X-ray or UV irradiation (haploid androgenesis) and by restoration of diploidy by suppression of mitosis using a pressure or thermal shock. The conditions for the genetic inactivation of the maternal genome in the European sea bass (Dicentrarchus labrax L.) were explored using different combinations of UV irradiation levels and durations. UV treatments significantly affected embryo survival and generated a wide range of developmental abnormalities. Despite the wide range of UV doses tested (from 7.2 to 720 mJ.cm(-2)), only one dose (60 mJ.cm(-2).min(-1) with 1 min irradiation) resulted in a small percentage (14%) of haploid larvae at hatching in the initial trials as verified by flow cytometry. Microsatellite marker analyses of three further batches of larvae produced by using this UV treatment showed a majority of larvae with variable levels of paternal and maternal contributions and only one larva displaying pure paternal inheritance. The results are discussed also in the context of an assessment of the UV-absorbance characteristics of egg extracts in this species that revealed the presence of gadusol, a compound structurally related to mycosporine-like amino acids (MAAs) with known UV-screening properties.	[Colleter, Julie; D'Cotta, Helena] Cirad, Persyst, UMR Intrepid, Montpellier, France; [Colleter, Julie; Lallement, Stephane; Fauvel, Christian; Chatain, Beatrice] IFREMER, Lab Rech Piscicole Mediterranee, Stn Expt Aquaculture, Palavas Les Flots, France; [Penman, David J.] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Hanebrekke, Tanja; Osvik, Renate D.; Eilertsen, Hans C.; Peruzzi, Stefano] Univ Tromso, Fac Biosci Fisheries & Econ, Dept Arctic & Marine Biol, Tromso, Norway	CIRAD; Ifremer; University of Stirling; UiT The Arctic University of Tromso	Peruzzi, S (corresponding author), Univ Tromso, Fac Biosci Fisheries & Econ, Dept Arctic & Marine Biol, Tromso, Norway.	spe002@uit.no	Peruzzi, Stefano/O-5009-2019; peruzzi, Stefano/A-2634-2008	Peruzzi, Stefano/0000-0002-9043-7438; peruzzi, Stefano/0000-0002-9043-7438; Osvik, Renate/0000-0001-8893-9394	EU Seventh Framework Programme by the AQUAEXCEL project [262336]; (Unite Mixte de recherche - Intensification raisonnee) UMR Intrepid (Cirad-Ifremer); Department of Arctic and Marine Biology (University of Tromso)	EU Seventh Framework Programme by the AQUAEXCEL project; (Unite Mixte de recherche - Intensification raisonnee) UMR Intrepid (Cirad-Ifremer); Department of Arctic and Marine Biology (University of Tromso)	Julie Colleter's doctoral study was partly funded under the EU Seventh Framework Programme by the AQUAEXCEL project No 262336: AQUAculture infrastructures for EXCELlence in European fish research. The views expressed in this work are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. Additional financial support was provided by the (Unite Mixte de recherche - Intensification raisonnee) UMR Intrepid (Cirad-Ifremer) and the Department of Arctic and Marine Biology (University of Tromso). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 1995, AQUACULTURE, V137, P131, DOI 10.1016/0044-8486(95)01106-4; Arai K, 2001, AQUACULTURE, V197, P205, DOI 10.1016/S0044-8486(01)00588-9; ARAI K, 1992, NIPPON SUISAN GAKK, V58, P1197, DOI 10.2331/suisan.58.1197; Arbeloa EM, 2010, FOOD CHEM, V119, P586, DOI 10.1016/j.foodchem.2009.06.061; Babiak I, 2002, THERIOGENOLOGY, V57, P1229, DOI 10.1016/S0093-691X(02)00631-3; Babiak I, 2002, J FISH BIOL, V61, P432, DOI [10.1006/jfbi.2002.2049, 10.1111/j.1095-8649.2002.tb01575.x]; Bercsenyi M, 1998, GENOME, V41, P573, DOI 10.1139/gen-41-4-573; BONGERS ABJ, 1994, AQUACULTURE, V122, P119, DOI 10.1016/0044-8486(94)90504-5; Bongers ABJ, 1998, LAB ANIM-UK, V32, P349, DOI 10.1258/002367798780599749; Browman HI, 2003, PHOTOCHEM PHOTOBIOL, V77, P397, DOI 10.1562/0031-8655(2003)077<0397:UNDDIT>2.0.CO;2; Brown KH, 2006, COMP BIOCHEM PHYS B, V143, P415, DOI 10.1016/j.cbpb.2005.12.015; Brown KH, 2002, AQUACULTURE, V204, P323, DOI 10.1016/S0044-8486(01)00844-4; Brown KH, 2008, P NATL ACAD SCI USA, V105, P19786, DOI 10.1073/pnas.0808333105; CARTER RE, 1991, AQUACULTURE, V95, P41, DOI 10.1016/0044-8486(91)90071-E; CHIOCCARA F, 1980, B SOC CHIM BELG, V89, P1101; Chistiakov DA, 2005, GENETICS, V170, P1821, DOI 10.1534/genetics.104.039719; Chistiakov DA, 2004, ANIM GENET, V35, P53, DOI 10.1046/j.1365-2052.2003.01076.x; CHOURROUT D, 1984, AQUACULTURE, V36, P111, DOI 10.1016/0044-8486(84)90058-9; Christopher Johnsamuel Godwin, 2012, International Aquatic Research, V4, P4; Ciftci Y, 2002, MOL ECOL NOTES, V2, P575, DOI 10.1046/j.1471-8286.2002.00327.x; Cockell CS, 1999, BIOL REV, V74, P311, DOI 10.1017/S0006323199005356; CorleySmith GE, 1996, GENETICS, V142, P1265; David CJ, 2006, J EXP ZOOL PART A, V305A, P83, DOI 10.1002/jez.a.247; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; DISNEY JE, 1987, J EXP ZOOL, V244, P151, DOI 10.1002/jez.1402440118; Ezaz MT, 2004, AQUACULTURE, V232, P205, DOI 10.1016/j.aquaculture.2003.08.001; Fauvel C., 1988, PISCIC FR, V134, P5; Felip A, 2006, AQUACULTURE, V256, P570, DOI 10.1016/j.aquaculture.2006.02.014; Fujimoto T, 2007, J EXP ZOOL PART A, V307A, P449, DOI 10.1002/jez.398; Garcia DL, 1995, MOL MARINE BIOL BIOT, V4, P62; Gomelsky B, 2003, AQUAT LIVING RESOUR, V16, P408, DOI 10.1016/S0990-7440(03)00085-8; Grimholt U, 2009, LAB ANIM-UK, V43, P121, DOI 10.1258/la.2008.008013; Grunina A, 2005, RUSSIAN J DEV BIOL, V36, P208; Grunina AS, 2011, RUSS J DEV BIOL+, V42, P108, DOI 10.1134/S1062360411020056; GRUNINA AS, 1990, GENETIKA+, V26, P2037; Hou JL, 2014, AQUACULTURE, V420, pS57, DOI 10.1016/j.aquaculture.2013.05.021; Karayucel S, 2002, ISR J AQUACULT-BAMID, V54, P145; Kirankumar S, 2003, AQUACULTURE, V228, P37, DOI 10.1016/S0044-8486(03)00132-7; Komen H, 2007, AQUACULTURE, V269, P150, DOI 10.1016/j.aquaculture.2007.05.009; Kucharczyk D, 2001, CYTOBIOS, V104, P189; Kucharczyk D, 2014, ITAL J ANIM SCI, V13, DOI 10.4081/ijas.2014.2890; Kucharczyk Dariusz, 2008, Archiwum Rybactwa Polskiego, V16, P437, DOI 10.2478/s10086-008-0030-4; Kuhl H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-68; Lin F, 1998, MOL REPROD DEV, V49, P10, DOI 10.1002/(SICI)1098-2795(199801)49:1&lt;10::AID-MRD2&gt;3.0.CO;2-R; Lucas MD, 2004, BEHAV GENET, V34, P355, DOI 10.1023/B:BEGE.0000017879.68818.21; Arbeloa EM, 2011, PHOTOCH PHOTOBIO SCI, V10, P133, DOI 10.1039/c0pp00250j; Michalik O, 2014, REPROD DOMEST ANIM, V49, P191, DOI 10.1111/rda.12248; Morishima K, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-116; Muller-Belecke A, 2000, AQUACULTURE, V184, P67, DOI 10.1016/S0044-8486(99)00318-X; MYERS JM, 1995, THEOR APPL GENET, V90, P205, DOI 10.1007/BF00222203; Pandian TJ, 1998, HYDROBIOLOGIA, V384, P167, DOI 10.1023/A:1003332526659; Pandian TJ, 2003, CURR SCI INDIA, V85, P917; Peruzzi S, 2000, AQUACULTURE, V189, P23, DOI 10.1016/S0044-8486(00)00355-0; PLACK PA, 1981, BIOCHEM J, V199, P741, DOI 10.1042/bj1990741; Recoubratsky A, 2001, RUSSIAN J DEV BIOL, V32, P298; SCHEERER PD, 1986, AQUACULTURE, V57, P289, DOI 10.1016/0044-8486(86)90207-3; Sinha RP, 2007, J PHOTOCH PHOTOBIO B, V89, P29, DOI 10.1016/j.jphotobiol.2007.07.006; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; SUWA M, 1994, FISHERIES SCI, V60, P673, DOI 10.2331/fishsci.60.673; Tanck MWT, 2001, GENOME, V44, P743, DOI 10.1139/gen-44-5-743; THORGAARD GH, 1983, FISH PHYSIOL, V9, P405; THORGAARD GH, 1990, AQUACULTURE, V85, P215, DOI 10.1016/0044-8486(90)90021-E; THORGAARD GH, 1985, THEOR APPL GENET, V71, P119, DOI 10.1007/BF00278262; TIERSCH TR, 1989, COMP BIOCHEM PHYS B, V94, P465, DOI 10.1016/0305-0491(89)90182-X; Tsigenopoulos CS, 2003, MOL ECOL NOTES, V3, P352, DOI 10.1046/j.1471-8286.2003.00447.x; Ungar AR, 1998, MOL MAR BIOL BIOTECH, V7, P320; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vandeputte M, 2009, CAH AGRIC, V18, P262, DOI 10.1684/agr.2009.0291	68	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109572	10.1371/journal.pone.0109572	http://dx.doi.org/10.1371/journal.pone.0109572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329931	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100030
J	DiGiandomenico, A; Veach, RA; Zienkiewicz, J; Moore, DJ; Wylezinski, LS; Hutchens, MA; Hawiger, J				DiGiandomenico, Antonio; Veach, Ruth Ann; Zienkiewicz, Jozef; Moore, Daniel J.; Wylezinski, Lukasz S.; Hutchens, Martha A.; Hawiger, Jacek			The "Genomic Storm" Induced by Bacterial Endotoxin Is Calmed by a Nuclear Transport Modifier That Attenuates Localized and Systemic Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; CARE-ASSOCIATED INFECTIONS; RHEUMATOID-ARTHRITIS; NOSOCOMIAL PNEUMONIA; INNATE IMMUNITY; MORTALITY; THERAPY; IMPORT; SEPSIS; HYDROCORTISONE	Lipopolysaccharide (LPS) is a potent microbial virulence factor that can trigger production of proinflammatory mediators involved in the pathogenesis of localized and systemic inflammation. Importantly, the role of nuclear transport of stress responsive transcription factors in this LPS-generated "genomic storm" remains largely undefined. We developed a new nuclear transport modifier (NTM) peptide, cell-penetrating cSN50.1, which targets nuclear transport shuttles importin alpha 5 and importin beta 1, to analyze its effect in LPS-induced localized (acute lung injury) and systemic (lethal endotoxic shock) murine inflammation models. We analyzed a human genome database to match 46 genes that encode cytokines, chemokines and their receptors with transcription factors whose nuclear transport is known to be modulated by NTM. We then tested the effect of cSN50.1 peptide on proinflammatory gene expression in murine bone marrow-derived macrophages stimulated with LPS. This NTM suppressed a proinflammatory transcriptome of 37 out of 84 genes analyzed, without altering expression of housekeeping genes or being cytotoxic. Consistent with gene expression analysis in primary macrophages, plasma levels of 23 out of 26 LPS-induced proinflammatory cytokines, chemokines, and growth factors were significantly attenuated in a murine model of LPS-induced systemic inflammation (lethal endotoxic shock) while the anti-inflammatory cytokine, interleukin 10, was enhanced. This anti-inflammatory reprogramming of the endotoxin-induced genomic response was accompanied by complete protection against lethal endotoxic shock with prophylactic NTM treatment, and 75% protection when NTM was first administered after LPS exposure. In a murine model of localized lung inflammation caused by direct airway exposure to LPS, expression of cytokines and chemokines in the bronchoalveolar space was suppressed with a concomitant reduction of neutrophil trafficking. Thus, calming the LPS-triggered "genomic storm" by modulating nuclear transport with cSN50.1 peptide attenuates the systemic inflammatory response associated with lethal shock as well as localized lung inflammation.	[DiGiandomenico, Antonio; Hutchens, Martha A.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA; [Veach, Ruth Ann; Zienkiewicz, Jozef; Moore, Daniel J.; Wylezinski, Lukasz S.; Hutchens, Martha A.; Hawiger, Jacek] Vanderbilt Univ, Sch Med, Immunotherapy Program, Nashville, TN 37212 USA; [Veach, Ruth Ann; Zienkiewicz, Jozef; Hawiger, Jacek] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; [Moore, Daniel J.] Vanderbilt Univ, Sch Med, Dept Pediat, Ian Burr Div Endocrinol & Diabet, Nashville, TN 37212 USA; [Moore, Daniel J.] Vanderbilt Univ, Sch Med, Dept Microbiol Pathol & Immunol, Nashville, TN 37212 USA; [Wylezinski, Lukasz S.; Hawiger, Jacek] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hawiger, J (corresponding author), Vanderbilt Univ, Sch Med, Immunotherapy Program, Nashville, TN 37212 USA.	jacek.hawiger@vanderbilt.edu	Moore, Daniel/V-6145-2019; Moore, Daniel J/A-4924-2008	Moore, Daniel/0000-0002-6889-9345; Moore, Daniel J/0000-0002-6889-9345; DiGiandomenico, Antonio/0000-0003-1745-647X; Veach, Ruth Ann/0000-0003-0038-8802; Wylezinski, Lukasz/0000-0001-6481-8379	National Institutes of Health [R01HL087531, R01HL069452, T32HL069765, 5K08DK090146, F32HL087531]; Vanderbilt University Medical Center's Digestive Disease Research Center - NIH [P30DK058404]; Vanderbilt Ingram Cancer Center - NIH [2P30CA68485]; Vanderbilt University Medical Center Immunotherapy Program; Vanderbilt Clinical and Translational Science Award (CTSA); NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL087531, T32HL069765, R01HL069452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090146, P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Medical Center's Digestive Disease Research Center - NIH; Vanderbilt Ingram Cancer Center - NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Medical Center Immunotherapy Program; Vanderbilt Clinical and Translational Science Award (CTSA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grants R01HL087531, R01HL069452, T32HL069765 (JH), 5K08DK090146 (DJM) and F32HL087531 (AD). Scholarships for core services were provided by Vanderbilt University Medical Center's Digestive Disease Research Center supported by NIH grant P30DK058404 and the Vanderbilt Ingram Cancer Center supported by NIH grant 2P30CA68485. Additional support was provided through the Vanderbilt University Medical Center Immunotherapy Program and the Vanderbilt Clinical and Translational Science Award (CTSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Andaluz-Ojeda D, 2012, CYTOKINE, V57, P332, DOI 10.1016/j.cyto.2011.12.002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Bannerman DD, 2003, AM J PHYSIOL-LUNG C, V284, pL899, DOI 10.1152/ajplung.00338.2002; Barcia AM, 2005, CLIN INFECT DIS, V41, pS498, DOI 10.1086/432005; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; Boyer A, 2011, CRIT CARE, V15, DOI 10.1186/cc10026; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Chopra I, 2008, LANCET INFECT DIS, V8, P133, DOI 10.1016/S1473-3099(08)70018-5; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Duffy JY, 2009, CRIT CARE MED, V37, P577, DOI 10.1097/CCM.0b013e318194ab65; FAGON JY, 1993, AM J MED, V94, P281, DOI 10.1016/0002-9343(93)90060-3; Frank KM, 2012, INFECT IMMUN, V80, P3161, DOI 10.1128/IAI.00191-12; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Hawiger J, 2001, IMMUNOL RES, V23, P99, DOI 10.1385/IR:23:2-3:099; Hawiger J, 2011, CRIT CARE, V15, DOI 10.1186/cc10482; Hoffken G, 2002, CHEST, V122, P2183, DOI 10.1378/chest.122.6.2183; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Jarvis WR, 2007, J HOSP INFECT, V65, P3, DOI 10.1016/S0195-6701(07)60005-X; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Lehr HA, 2001, CIRCULATION, V104, P914, DOI 10.1161/hc3401.093153; Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001; LEVIN J, 1972, ANN INTERN MED, V76, P1, DOI 10.7326/0003-4819-76-1-1; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu DY, 2009, MOL THER, V17, P796, DOI 10.1038/mt.2009.18; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu XY, 2000, J BIOL CHEM, V275, P16774; Liu Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000093; Lorente JA, 2005, SHOCK, V24, P107, DOI 10.1097/01.shk.0000191343.21228.78; Lorenz HM, 1996, J IMMUNOL, V156, P1646; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Moore DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013235; Nakahara H, 2003, ARTHRITIS RHEUM-US, V48, P1521, DOI 10.1002/art.11143; O'Sullivan AW, 2009, J SURG RES, V152, P46, DOI 10.1016/j.jss.2008.04.030; Opal SM, 2010, INT J ANTIMICROB AG, V36, pS70, DOI 10.1016/j.ijantimicag.2010.11.008; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Raghavendran K, 2005, AM J PHYSIOL-LUNG C, V289, pL134, DOI 10.1152/ajplung.00390.2004; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Rose WE, 2012, J INFECT DIS, V206, P1604, DOI 10.1093/infdis/jis552; ROSENBERG HF, 2003, FUNDAMENTAL IMMUNOLO, P1151; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sjovall F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097673; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Stanbury RM, 1998, BRIT J OPHTHALMOL, V82, P704, DOI 10.1136/bjo.82.6.704; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Torgerson TR, 1998, J IMMUNOL, V161, P6084; Tweedell A, 2011, METABOLISM, V60, P92, DOI 10.1016/j.metabol.2009.12.022; Veach RA, 2004, J BIOL CHEM, V279, P11425, DOI 10.1074/jbc.M311089200; Veach RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030527; VIAL T, 1995, DRUG SAFETY, V13, P371, DOI 10.2165/00002018-199513060-00006; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Wang JC, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-19; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WENDLING D, 1993, J RHEUMATOL, V20, P259; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zienkiewicz J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000386	63	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110183	10.1371/journal.pone.0110183	http://dx.doi.org/10.1371/journal.pone.0110183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329889	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100042
J	Golokhvast, KS; Shvedova, AA				Golokhvast, Kirill S.; Shvedova, Anna A.			Galvanic Manufacturing in the Cities of Russia: Potential Source of Ambient Nanoparticles	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; AMERICAN-HEART-ASSOCIATION; AIR-POLLUTION; PARTICULATE MATTER; HEAVY-METALS; CARDIOVASCULAR-DISEASE; RISK-ASSESSMENT; IN-VITRO; HEALTH; SLUDGE	Galvanic manufacturing is widely employed and can be found in nearly every average city in Russia. The release and accumulation of different metals (Me), depending on the technology used can be found in the vicinities of galvanic plants. Under the environmental protection act in Russia, the regulations for galvanic manufacturing do not include the regulations and safety standards for ambient ultrafine and nanosized particulate matter (PM). To assess whether Me nanoparticles (NP) are among environmental pollutants caused by galvanic manufacturing, the level of Me NP were tested in urban snow samples collected around galvanic enterprises in two cities. Employing transmission electronic microscopy, energy-dispersive X-ray spectroscopy, and a laser diffraction particle size analyzer, we found that the size distribution of tested Me NP was within 10-120 nm range. This is the first study to report that Me NP of Fe, Cr, Pb, Al, Ni, Cu, and Zn were detected around galvanic shop settings.	[Golokhvast, Kirill S.] Far Eastern Fed Univ, Sci Educ Ctr Nanotechnol, Vladivostok, Russia; [Shvedova, Anna A.] CDC, NIOSH, Pathol & Physiol Res Branch, Morgantown, WV USA; [Shvedova, Anna A.] W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Morgantown, VA USA	Far Eastern Federal University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); West Virginia University	Golokhvast, KS (corresponding author), Far Eastern Fed Univ, Sci Educ Ctr Nanotechnol, Vladivostok, Russia.	droopy@mail.ru	Golokhvast, Kirill Sergeevich/E-5051-2014	Golokhvast, Kirill Sergeevich/0000-0002-4873-2281	Far Eastern Federal University [13-06-0318-m_a]; Presidential Grant for supporting young scientists [MK-1547.2013.5]; Ministry of Education and Science of the Russian Federation [14.594.21.0006]	Far Eastern Federal University; Presidential Grant for supporting young scientists; Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	The work is financially supported by the Scientific Fund of the Far Eastern Federal University (No. 13-06-0318-m_a), the Presidential Grant for supporting young scientists (MK-1547.2013.5) and the Grant of the Ministry of Education and Science of the Russian Federation (No. 14.594.21.0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ZJ, 2008, OCCUP ENVIRON MED, V65, P458, DOI 10.1136/oem.2007.033290; Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1; Andrus ME, 2000, MET FINISH, V11, P20, DOI [10.1016/S0026-0576(00)83532-1, DOI 10.1016/S0026-0576(00)83532-1]; BABICH H, 1985, ENVIRON RES, V36, P111, DOI 10.1016/0013-9351(85)90011-8; BATES DV, 1995, ENVIRON HEALTH PERSP, V103, P49, DOI 10.2307/3432345; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; BURKIN AR, 1969, POWDER METALL, V12, P243, DOI 10.1179/pom.1969.12.23.012; Cakmak S, 2014, ENVIRON POLLUT, V189, P208, DOI 10.1016/j.envpol.2014.03.004; Campen MJ, 2001, TOXICOL SCI, V64, P243, DOI 10.1093/toxsci/64.2.243; CANDELONE JP, 1995, J GEOPHYS RES-ATMOS, V100, P16605, DOI 10.1029/95JD00989; Chen LC, 2009, INHAL TOXICOL, V21, P1, DOI [10.1080/08958370802105405, 10.1080/08958370802105405 ]; Erdem M, 2011, HYDROMETALLURGY, V105, P270, DOI 10.1016/j.hydromet.2010.10.014; Fadeel B, 2012, ADVERSE EFFECTS OF ENGINEERED NANOMATERIALS: EXPOSURE, TOXICOLOGY, AND IMPACT ON HUMAN HEALTH, pIX; GUILIZZONI P, 1991, AQUAT BOT, V41, P87, DOI 10.1016/0304-3770(91)90040-C; Horie M, 2013, ENVIRON TOXICOL, V28, P61, DOI 10.1002/tox.20695; Kreyling WG, 2006, J NANOPART RES, V8, P543, DOI 10.1007/s11051-005-9068-z; Moulin JJ, 1998, AM J EPIDEMIOL, V148, P241; Murray AR, 2013, CELL BIOCHEM BIOPHYS, V67, P461, DOI 10.1007/s12013-012-9367-9; Ozdemir OD, 2012, J CHEM SOC PAKISTAN, V34, P1032; Ozverdl A, 2010, HYDROMETALLURGY, V100, P103, DOI 10.1016/j.hydromet.2009.10.011; Raza A, 2014, EUR HEART J, V35, P861, DOI 10.1093/eurheartj/eht489; Rossini G, 2006, J HAZARD MATER, V131, P210, DOI 10.1016/j.jhazmat.2005.09.035; Ryabukhin AG, 2002, REPORTS CHELYABINSK, V4, P111; Silva JE, 2005, J HAZARD MATER, V120, P113, DOI 10.1016/j.jhazmat.2004.12.008; Soenen SJ, 2012, METHOD ENZYMOL, V509, P195, DOI 10.1016/B978-0-12-391858-1.00011-3; Szalay B, 2012, J APPL TOXICOL, V32, P446, DOI 10.1002/jat.1779; U.S. Imports Exports and Tariff Data, 1989, 9387 NBER; VALLI J, 1986, J VAC SCI TECHNOL A, V4, P3007, DOI 10.1116/1.573616; Vinogradov S.S., 2002, ECOLOGICALLY SAFE GA; Voutsa D, 2002, ATMOS ENVIRON, V36, P3583, DOI 10.1016/S1352-2310(02)00282-0; Yanamala N, 2013, ADV DRUG DELIVER REV, V65, P2070, DOI 10.1016/j.addr.2013.05.005; Zhang ZH, 2009, INT J ENVIRON HEAL R, V19, P175, DOI 10.1080/09603120802460392; Zhu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046286	34	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110573	10.1371/journal.pone.0110573	http://dx.doi.org/10.1371/journal.pone.0110573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329582	gold, Green Submitted, Green Published			2022-12-27	WOS:000343942100075
J	Kuck, LR; Sorensen, M; Matthews, E; Srivastava, I; Cox, MMJ; Rowlen, KL				Kuck, Laura R.; Sorensen, Michelle; Matthews, Erin; Srivastava, Indresh; Cox, Manon M. J.; Rowlen, Kathy L.			Titer on Chip: New Analytical Tool for Influenza Vaccine Potency Determination	PLOS ONE			English	Article							SINGLE-RADIAL-IMMUNODIFFUSION; MASS-SPECTROMETRY; QUANTIFICATION; HEMAGGLUTININ; QUANTITATION; CHALLENGES; ANTIBODIES; ASSAY	Titer on Chip (Flu-ToC) is a new technique for quantification of influenza hemagglutinin (HA) concentration. In order to evaluate the potential of this new technique, a comparison of Flu-ToC to more conventional methods was conducted using recombinant HA produced in a baculovirus expression system as a test case. Samples from current vaccine strains were collected from four different steps in the manufacturing process. A total of 19 samples were analysed by Flu-ToC (blinded), single radial immunodiffusion (SRID), an enzyme-linked immunosorbent assay (ELISA), and the purity adjusted bicinchoninic acid assay (paBCA). The results indicated reasonable linear correlation between Flu-ToC and SRID, ELISA, and paBCA, with regression slopes of log-log plots being 0.91, 1.03, and 0.91, respectively. The average ratio for HA content measured by FluToC relative to SRID, ELISA, and paBCA was 83%, 147%, and 81%, respectively; indicating nearly equivalent potency determination for Flu-ToC relative to SRID and paBCA. These results, combined with demonstrated multiplexed analysis of all components within a quadrivalent formulation and robust response to HA strains over a wide time period, support the conclusion that Flu-ToC can be used as a reliable and time-saving alternative potency assay for influenza vaccines.	[Kuck, Laura R.; Rowlen, Kathy L.] InDevR Inc, Boulder, CO USA; [Sorensen, Michelle; Matthews, Erin; Srivastava, Indresh; Cox, Manon M. J.] Prot Sci Corp, Meriden, CT USA		Srivastava, I (corresponding author), Prot Sci Corp, Meriden, CT USA.	isrivastava@proteinsciences.com; rowlen@indevr.com			National Institute of Allergy and Infectious Diseases as part of the inter-agency Influenza Vaccine Improvement Initiative [R43 AI102318]; Biomedical Advanced Research and Development Authority [HHSO100200900106C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI102318, R43AI102318] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases as part of the inter-agency Influenza Vaccine Improvement Initiative; Biomedical Advanced Research and Development Authority; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	InDevR's contribution to this study was funded by National Institute of Allergy and Infectious Diseases R43 AI102318 as part of the inter-agency Influenza Vaccine Improvement Initiative. Protein Sciences Corporation contributions were funded by a contract (HHSO100200900106C) with the Biomedical Advanced Research and Development Authority. Coauthors Laura R. Kuck and Kathy L. Rowlen are employed by InDevR Inc. InDevR Inc. provided support in the form of salaries for authors LRK and KLR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. Coauthors Michelle Sorensen, Erin Matthews, Indresh Srivastava, and Manon M. J. Cox are employed by Protein Sciences Corporation. Protein Sciences Corporation provided support in the form of salaries for authors MS, EM, IS, and MMJC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Bodle J, 2013, INFLUENZA OTHER RESP, V7, P191, DOI 10.1111/j.1750-2659.2012.00375.x; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; CMC Working Group, 2012, A VAX APPL QUAL DES; Donabedian A, 2009, USP 2 BIOASS WORKSH; EMA/EDQM, 2011, JOINT EMA EDQM WORKS; FDA, 2014, FDA APPR PROD FLUBL; FDA, 2011, STRAT PLAN ADV REG S; FDA, 2006, GUID IND QUAL SYST A; Hashem AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055428; Kapteyn JC, 2009, VACCINE, V27, P1468, DOI 10.1016/j.vaccine.2008.11.113; Kapteyn JC, 2006, VACCINE, V24, P3137, DOI 10.1016/j.vaccine.2006.01.046; Legastelois I, 2011, J VIROL METHODS, V178, P129, DOI 10.1016/j.jviromet.2011.08.027; Nilsson CE, 2010, VACCINE, V28, P759, DOI 10.1016/j.vaccine.2009.10.070; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Pierce CL, 2011, ANAL CHEM, V83, P4729, DOI 10.1021/ac2006526; Thompson CM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-141; WILLIAMS MS, 1993, VET MICROBIOL, V37, P253, DOI 10.1016/0378-1135(93)90027-5; Williams TL, 2012, VACCINE, V30, P2475, DOI 10.1016/j.vaccine.2011.12.056	18	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109616	10.1371/journal.pone.0109616	http://dx.doi.org/10.1371/journal.pone.0109616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330238	Green Published, gold			2022-12-27	WOS:000343942100032
J	Le, QH; Cui, XH; Xiang, J; Ge, L; Gong, L; Xu, JJ				Le, Qihua; Cui, Xinhan; Xiang, Jun; Ge, Ling; Gong, Lan; Xu, Jianjiang			Impact of Conjunctivochalasis on Visual Quality of Life: A Community Population Survey	PLOS ONE			English	Article							DRY EYE SYNDROME; OPTICAL COHERENCE TOMOGRAPHY; OCULAR SURFACE; GENERAL-POPULATION; INFLAMMATION; MENISCUS; TESTS	Conjunctivochalasis (Cch) is a very common ocular disorder, which can cause an unstable tear film and ocular discomfort. The study of vision-related quality of life (VR-QoL) in a community population with Cch can provide a better understanding of the impact of Cch on common people than objective clinical examinations alone. This cross-sectional comparative study enrolled 360 participants >= 40 years old living in Sanle Community, Shanghai. In the study, 198 subjects were diagnosed with Cch and 86 with dry eye syndrome (DES) without Cch. The remaining 76 subjects were normal controls. Socio-demographical data were collected, and Cch and related ocular symptoms and signs were evaluated. In addition, all participants were required to complete the Chinese version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) and Ocular Surface Disease Index Questionnaire (OSDI). Main outcome measures include the comparison on the OSDI score and VFQ-25 score among the subgroups, and the correlation of these scores with the socio-demographical and clinical data. The results revealed that subjects with Cch had significantly decreased tear film stability even compared with those with DES (P = 0.001). The participants with either Cch or DES reported significantly higher OSDI scores and lower VFQ-25 composite scores than the normal controls (P<0.001 and 0.007 respectively). Further comparisons among the subgroups of Cch revealed that the following factors were associated with higher OSDI scores and lower VFQ-25 composite scores: nasal-side Cch, chalasis folds higher than tear meniscus height, punctal occlusion, or increased extent of chalasis on digital pressure. In conclusion, Cch was associated with an adverse impact on VR-QoL in a community population, and the impairment in VR-QoL had a significant correlation with disease severity and tear film abnormalities.	[Le, Qihua; Cui, Xinhan; Xiang, Jun; Gong, Lan; Xu, Jianjiang] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Le, Qihua] Fudan Univ, Eye & ENT Hosp, Res Ctr, Shanghai 200433, Peoples R China; [Le, Qihua; Gong, Lan; Xu, Jianjiang] Fudan Univ, Eye & ENT Hosp, Myopia Key Lab Minist Hlth, Shanghai 200433, Peoples R China; [Ge, Ling] Shanghai Eye Dis Prevent & Treatment Ctr, Dept Ocular Surface Dis, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Xu, JJ (corresponding author), Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China.	jianjiang-xu@163.com		Gong, Lan/0000-0002-3422-0752	National Natural Science Grant [81020108017, 81270014]; Shanghai Technology Phospherus Program [11QA1401000]	National Natural Science Grant; Shanghai Technology Phospherus Program	The study is supported by National Natural Science Grant (81020108017, 81270014) and Shanghai Technology Phospherus Program (11QA1401000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Chan CWS, 2009, BRIT J OPHTHALMOL, V93, P1431, DOI 10.1136/bjo.2009.158428; Chen Q, 2011, INVEST OPHTH VIS SCI, V52, P9373, DOI 10.1167/iovs.11-7431; DOANE MG, 1981, OPHTHALMOLOGY, V88, P844; Fodor E, 2012, CURR EYE RES, V37, P80, DOI 10.3109/02713683.2011.623810; Fodor E, 2010, CURR EYE RES, V35, P665, DOI 10.3109/02713681003770738; Gumus K, 2010, AM J OPHTHALMOL, V150, P798, DOI 10.1016/j.ajo.2010.06.014; Hara S, 2011, OPTOMETRY VISION SCI, V88, P1112, DOI 10.1097/OPX.0b013e3182223573; Hoh H, 1995, Ophthalmologe, V92, P802; Huang YK, 2013, OPHTHALMOLOGY, V120, P1681, DOI 10.1016/j.ophtha.2013.01.007; Hughes WL, 1942, AM J OPHTHALMOL, V25, P48; Kashima T, 2011, CLIN OPHTHALMOL, V5, P1391, DOI 10.2147/OPTH.S24475; Le QH, 2014, ACTA OPHTHALMOL, V92, pE124, DOI 10.1111/aos.12204; Le QH, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-22; Le QH, 2011, INVEST OPHTH VIS SCI, V52, P8951, DOI 10.1167/iovs.11-8355; Li MY, 2012, INVEST OPHTH VIS SCI, V53, P5722, DOI 10.1167/iovs.11-9094; MCDONALD JE, 1971, AM J OPHTHALMOL, V72, P139, DOI 10.1016/0002-9394(71)91604-7; Meller D, 1998, SURV OPHTHALMOL, V43, P225, DOI 10.1016/S0039-6257(98)00037-X; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Mimura T, 2011, EYE CONTACT LENS, V37, P71, DOI 10.1097/ICL.0b013e31820ca377; Mimura T, 2009, AM J OPHTHALMOL, V147, P171, DOI 10.1016/j.ajo.2008.07.010; Mimura T, 2009, AM J OPHTHALMOL, V148, P20, DOI 10.1016/j.ajo.2009.02.018; Mizuno Y, 2010, JPN J OPHTHALMOL, V54, P259, DOI 10.1007/s10384-010-0812-2; Murube J, 2005, OCUL SURF, V3, P7, DOI 10.1016/S1542-0124(12)70118-0; Nichols KK, 2002, CORNEA, V21, P578, DOI 10.1097/00003226-200208000-00009; Tong L, 2013, MED HYPOTHESES, V81, P927, DOI 10.1016/j.mehy.2013.08.017; Wang CW, 2008, OPTOMETRY VISION SCI, V85, P1091, DOI 10.1097/OPX.0b013e31818b9f23; Wang Y, 2007, AM J OPHTHALMOL, V144, P930, DOI 10.1016/j.ajo.2007.07.037; Ward SK, 2010, INVEST OPHTH VIS SCI, V51, P1994, DOI 10.1167/iovs.09-4130; Yokoi N, 2005, CORNEA, V24, pS24, DOI 10.1097/01.ico.0000178740.14212.1a; Zhang XB, 2011, OPHTHALMOLOGY, V118, P902, DOI 10.1016/j.ophtha.2010.08.033; Zhang XR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-198; Zheng XD, 2014, ACTA OPHTHALMOL, V92, pE105, DOI 10.1111/aos.12260	33	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110821	10.1371/journal.pone.0110821	http://dx.doi.org/10.1371/journal.pone.0110821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25330252	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100099
J	Lehr, NA; Wang, Z; Li, N; Hewitt, DA; Lopez-Giraldez, F; Trail, F; Townsend, JP				Lehr, Nina A.; Wang, Zheng; Li, Ning; Hewitt, David A.; Lopez-Giraldez, Francesc; Trail, Frances; Townsend, Jeffrey P.			Gene Expression Differences among Three Neurospora Species Reveal Genes Required for Sexual Reproduction in Neurospora crassa	PLOS ONE			English	Article							FRUITING BODY DEVELOPMENT; MATING-TYPE GENES; ASPERGILLUS-NIDULANS; SORDARIA-MACROSPORA; GENOME SEQUENCE; PROTEINS; GELASINOSPORA; ANCESTORS; PHYLOGENY; PODOSPORA	Many fungi form complex three-dimensional fruiting bodies, within which the meiotic machinery for sexual spore production has been considered to be largely conserved over evolutionary time. Indeed, much of what we know about meiosis in plant and animal taxa has been deeply informed by studies of meiosis in Saccharomyces and Neurospora. Nevertheless, the genetic basis of fruiting body development and its regulation in relation to meiosis in fungi is barely known, even within the best studied multicellular fungal model Neurospora crassa. We characterized morphological development and genome-wide transcriptomics in the closely related species Neurospora crassa, Neurospora tetrasperma, and Neurospora discreta, across eight stages of sexual development. Despite diverse life histories within the genus, all three species produce vase-shaped perithecia. Transcriptome sequencing provided gene expression levels of orthologous genes among all three species. Expression of key meiosis genes and sporulation genes corresponded to known phenotypic and developmental differences among these Neurospora species during sexual development. We assembled a list of genes putatively relevant to the recent evolution of fruiting body development by sorting genes whose relative expression across developmental stages increased more in N. crassa relative to the other species. Then, in N. crassa, we characterized the phenotypes of fruiting bodies arising from crosses of homozygous knockout strains of the top genes. Eight N. crassa genes were found to be critical for the successful formation of perithecia. The absence of these genes in these crosses resulted in either no perithecium formation or in arrested development at an early stage. Our results provide insight into the genetic basis of Neurospora sexual reproduction, which is also of great importance with regard to other multicellular ascomycetes, including perithecium-forming pathogens, such as Claviceps purpurea, Ophiostoma ulmi, and Glomerella graminicola.	[Lehr, Nina A.; Wang, Zheng; Li, Ning; Lopez-Giraldez, Francesc; Townsend, Jeffrey P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Wang, Zheng; Townsend, Jeffrey P.] Yale Univ, Dept Biostat, New Haven, CT USA; [Hewitt, David A.] Acad Nat Sci, Dept Bot, Philadelphia, PA USA; [Hewitt, David A.] Wagner Free Inst Sci, Philadelphia, PA USA; [Trail, Frances] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Trail, Frances] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Townsend, Jeffrey P.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Townsend, Jeffrey P.] Yale Univ, Program Microbiol, New Haven, CT USA	Yale University; Yale University; Michigan State University; Michigan State University; Yale University; Yale University	Townsend, JP (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	Jeffrey.Townsend@Yale.edu	Hewitt, David/AAA-9160-2021; Wang, Zheng/A-2318-2011; López-Giráldez, Francesc/A-5251-2011; Townsend, Jeffrey/H-2747-2019	Hewitt, David/0000-0003-3789-9534; Wang, Zheng/0000-0002-8849-8549; López-Giráldez, Francesc/0000-0001-7476-9822; Townsend, Jeffrey/0000-0002-9890-3907	Yale Institute of Biospheric studies; National Science Foundation (NSF) [MCB 0923797]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	Yale Institute of Biospheric studies; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by a Gaylord Donnelley Environmental Fellowship of the Yale Institute of Biospheric studies to NL, and National Science Foundation (NSF) Grant MCB 0923797 to FT and JPT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499; BEATTY NP, 1994, MYCOL RES, V98, P1309, DOI 10.1016/S0953-7562(09)80304-3; Benkhali JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003642; BISTIS GN, 1981, MYCOLOGIA, V73, P959, DOI 10.2307/3759806; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; Busch S, 2007, MOL MICROBIOL, V64, P873, DOI 10.1111/j.1365-2958.2007.05711.x; Casselton LA, 2008, BIOESSAYS, V30, P711, DOI 10.1002/bies.20782; Clark TA., 2008, FUNGAL GENET REP, V55, P6, DOI [DOI 10.4148/1941-4765.1086, 10.4148/1941-4765.1086]; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; Coppin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037488; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; DELANGE AM, 1980, GENETICS, V96, P367; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Dodge BO, 1927, J AGRIC RES, V35, P0289; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; Eckert SE, 1999, ARCH MICROBIOL, V172, P157, DOI 10.1007/s002030050755; Eckert SE, 2000, MOL GEN GENET, V263, P867, DOI 10.1007/s004380000250; Fischer R., 2003, DEV PROCESSES FILAME, P41; Fu C, 2011, EUKARYOT CELL, V10, P1100, DOI 10.1128/EC.05003-11; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Hallen HE, 2007, FUNGAL GENET BIOL, V44, P1146, DOI 10.1016/j.fgb.2007.04.007; HARRIS JL, 1975, J BACTERIOL, V122, P1239, DOI 10.1128/JB.122.3.1239-1246.1975; Harting R, 2013, MOL MICROBIOL, V90, P1125, DOI 10.1111/mmi.12421; Jamet-Vierny C, 2007, FUNGAL GENET BIOL, V44, P1219, DOI 10.1016/j.fgb.2007.04.005; JOHNSON TE, 1979, GENETICS, V92, P1107; Kim H, 2012, GENETICS, V190, P1389, DOI 10.1534/genetics.111.136358; Klix V, 2010, EUKARYOT CELL, V9, P894, DOI 10.1128/EC.00019-10; Kronstad JW, 1997, ANNU REV GENET, V31, P245, DOI 10.1146/annurev.genet.31.1.245; LESLIE JF, 1985, GENETICS, V111, P759; Lumbsch HT, 2000, NATURWISSENSCHAFTEN, V87, P335, DOI 10.1007/s001140050736; MaoDraayer Y, 1996, GENETICS, V144, P71; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; Nowrousian M, 2005, MOL GENET GENOMICS, V273, P137, DOI 10.1007/s00438-005-1118-9; Nygren K, 2011, MOL PHYLOGENET EVOL, V59, P649, DOI 10.1016/j.ympev.2011.03.023; Palma-Guerrero J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003669; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; PERKINS DD, 1986, EXP MYCOL, V10, P323, DOI 10.1016/0147-5975(86)90019-8; Poggeler S., 2018, PHYSL GENETICS, V15, P325, DOI [10.1007/978-3-319-71740-1_1, DOI 10.1007/978-3-319-71740-1_1, DOI 10.1007/3-540-28135-5_16]; Poptsova MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-120; RAJU NB, 1980, EUR J CELL BIOL, V23, P208; RAJU NB, 1992, MYCOL RES, V96, P241, DOI 10.1016/S0953-7562(09)80934-9; RAJU NB, 1994, DEV GENET, V15, P104, DOI 10.1002/dvg.1020150111; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Samils N, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0862; Seo J, 2002, COMPUTER, V35, P80; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Strandberg R, 2010, FUNGAL GENET BIOL, V47, P869, DOI 10.1016/j.fgb.2010.06.008; Trail F, 2014, MYCOTA COMPREHENSIVE, P267; Trail F, 2013, FUSARIUM GENOMICS MO; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner E, 2010, J EVOLUTION BIOL, V23, P1642, DOI 10.1111/j.1420-9101.2010.02030.x; Wang Z, 2014, EUKARYOT CELL, V13, P154, DOI 10.1128/EC.00248-13; Wang Z, 2012, FUNGAL GENET BIOL, V49, P533, DOI 10.1016/j.fgb.2012.05.004; Wang Z, 2012, FUNGAL GENET BIOL, V49, P405, DOI 10.1016/j.fgb.2012.03.004; Whittle CA, 2011, FUNGAL GENET BIOL, V48, P661, DOI 10.1016/j.fgb.2011.02.005; Yun SH, 1999, P NATL ACAD SCI USA, V96, P5592, DOI 10.1073/pnas.96.10.5592; Zhang Z, 2010, BIOINFORMATICS, V26, P1918, DOI 10.1093/bioinformatics/btq303; Zhang Z, 2010, FUNGAL GENET BIOL, V47, P199, DOI 10.1016/j.fgb.2009.12.001	65	26	26	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110398	10.1371/journal.pone.0110398	http://dx.doi.org/10.1371/journal.pone.0110398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329823	Green Submitted, gold, Green Published			2022-12-27	WOS:000343942100061
J	Pauciullo, A; Perucatti, A; Cosenza, G; Iannuzzi, A; Incarnato, D; Genualdo, V; Di Berardino, D; Iannuzzi, L				Pauciullo, Alfredo; Perucatti, Angela; Cosenza, Gianfranco; Iannuzzi, Alessandra; Incarnato, Domenico; Genualdo, Viviana; Di Berardino, Dino; Iannuzzi, Leopoldo			Sequential Cross-Species Chromosome Painting among River Buffalo, Cattle, Sheep and Goat: A Useful Tool for Chromosome Abnormalities Diagnosis within the Family Bovidae	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; BOS-TAURUS BREEDS; BUBALUS-BUBALIS; CENTRIC FUSION; IDENTIFICATION; MICRODISSECTION; STANDARDIZATION; REARRANGEMENTS; ANEUPLOIDY; KARYOTYPE	The main goal of this study was to develop a comparative multi-colour Zoo-FISH on domestic ruminants metaphases using a combination of whole chromosome and sub-chromosomal painting probes obtained from the river buffalo species (Bubalus bubalis, 2n = 50, XY). A total of 13 DNA probes were obtained through chromosome microdissection and DOP-PCR amplification, labelled with two fluorochromes and sequentially hybridized on river buffalo, cattle (Bos taurus, 2n = 60, XY), sheep (Ovis aries, 2n = 54, XY) and goat (Capra hircus, 2n = 60, XY) metaphases. The same set of paintings were then hybridized on bovine secondary oocytes to test their potential use for aneuploidy detection during in vitro maturation. FISH showed excellent specificity on metaphases and interphase nuclei of all the investigated species. Eight pairs of chromosomes were simultaneously identified in buffalo, whereas the same set of probes covered 13 out 30 chromosome pairs in the bovine and goat karyotypes and 40% of the sheep karyotype (11 out of 27 chromosome pairs). This result allowed development of the first comparative M-FISH karyotype within the domestic ruminants. The molecular resolution of complex karyotypes by FISH is particularly useful for the small chromosomes, whose similarity in the banding patterns makes their identification very difficult. The M-FISH karyotype also represents a practical tool for structural and numerical chromosome abnormalities diagnosis. In this regard, the successful hybridization on bovine secondary oocytes confirmed the potential use of this set of probes for the simultaneous identification on the same germ cell of 12 chromosome aneuploidies. This is a fundamental result for monitoring the reproductive health of the domestic animals in relation to management errors and/or environmental hazards.	[Pauciullo, Alfredo; Perucatti, Angela; Iannuzzi, Alessandra; Incarnato, Domenico; Genualdo, Viviana; Iannuzzi, Leopoldo] CNR, Inst Anim Prod Syst Mediterranean Environm, Naples, Italy; [Cosenza, Gianfranco; Di Berardino, Dino] Univ Naples Federico II, Dept Agr, Portici, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); University of Naples Federico II	Pauciullo, A (corresponding author), CNR, Inst Anim Prod Syst Mediterranean Environm, Naples, Italy.	alfredo.pauciullo@cnr.it	Iannuzzi, Alessandra/B-8085-2015; Pauciullo, Alfredo/AAF-7713-2020; Perucatti, Angela/B-7743-2015; Cosenza, Gianfranco/Q-3131-2017	Perucatti, Angela/0000-0003-4642-9921; Cosenza, Gianfranco/0000-0001-6006-4987; IANNUZZI, Alessandra/0000-0002-2693-3111; Pauciullo, Alfredo/0000-0002-3140-9373; INCARNATO, Domenico/0000-0003-4945-986X; Iannuzzi, Leopoldo/0000-0002-5445-883X	CISIA-VARIGEAV project, National Research Council (CNR) of Italy	CISIA-VARIGEAV project, National Research Council (CNR) of Italy	This research was financially supported by CISIA-VARIGEAV project, National Research Council (CNR) of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmus G, 2007, CHROMOSOME RES, V15, P499, DOI 10.1007/s10577-007-1154-x; Brown J, 2001, NAT MED, V7, P497, DOI 10.1038/86581; Chudoba I, 1999, CYTOGENET CELL GENET, V84, P156, DOI 10.1159/000015245; Claussen U, 2002, CYTOGENET GENOME RES, V98, P136, DOI 10.1159/000069817; De Lorenzi L, 2008, ANIM GENET, V39, P454, DOI 10.1111/j.1365-2052.2008.01731.x; De Lorenzi L, 2008, CYTOGENET GENOME RES, V120, P144, DOI 10.1159/000118754; Di Berardino D, 2001, CYTOGENET CELL GENET, V92, P284; Di Meo GP, 2011, CYTOGENET GENOME RES, V133, P16, DOI 10.1159/000323796; Di Meo GP, 2000, CARYOLOGIA, V53, P213, DOI 10.1080/00087114.2000.10589198; DIBERARDINO D, 1990, CYTOGENET CELL GENET, V53, P65, DOI 10.1159/000132898; EVANS HJ, 1973, CHROMOSOMA, V42, P383, DOI 10.1007/BF00399407; Fauth C, 2001, HUM GENET, V109, P576, DOI 10.1007/s00439-001-0629-7; Ferguson-Smith Malcolm A., 1998, ILAR J, V39, P68; Gianaroli L, 2010, HUM REPROD, V25, P2374, DOI 10.1093/humrep/deq123; GUSTAVSSON I, 1964, NATURE, V203, P990, DOI 10.1038/203990a0; Handyside AH, 2010, J MED GENET, V47, P651, DOI 10.1136/jmg.2009.069971; Henegariu O, 2001, LAB INVEST, V81, P475, DOI 10.1038/labinvest.3780255; Hornak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018892; IANNUZZI L, 1994, CYTOGENET CELL GENET, V67, P102; Iannuzzi L, 2008, J APPL GENET, V49, P357, DOI 10.1007/BF03195634; Karhu R, 2001, GENE CHROMOSOME CANC, V30, P105, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1068>3.0.CO;2-9; Kubickova S, 2002, CHROMOSOME RES, V10, P571, DOI 10.1023/A:1020914702767; Muller S, 1998, CYTOMETRY, V33, P445; Nicodemo D, 2010, THERIOGENOLOGY, V73, P523, DOI 10.1016/j.theriogenology.2009.10.007; Nicodemo D, 2009, CYTOGENET GENOME RES, V126, P217, DOI 10.1159/000245923; Pauciullo A, 2012, THERIOGENOLOGY, V77, P675, DOI 10.1016/j.theriogenology.2011.09.016; Pauciullo A, 2014, J APPL GENET, V55, P397, DOI 10.1007/s13353-014-0207-z; Pinton A, 2003, GENET SEL EVOL, V35, P685, DOI 10.1051/gse:2003047; Rubes J, 2009, CYTOGENET GENOME RES, V126, P34, DOI 10.1159/000245905; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Solinas-Toldo S, 1995, GENOMICS, V33, P214; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; STANYON R, 1995, CYTOGENET CELL GENET, V68, P74, DOI 10.1159/000133894; Switonski M, 2008, CYTOGENET GENOME RES, V121, P245, DOI 10.1159/000138891; Tanke HJ, 1999, EUR J HUM GENET, V7, P2, DOI 10.1038/sj.ejhg.5200265	35	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110297	10.1371/journal.pone.0110297	http://dx.doi.org/10.1371/journal.pone.0110297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25330006	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100061
J	Qiao, S; Li, XM; Zhang, C; Zhou, YJ; Shen, ZY; Tang, ZZ; Stanton, B				Qiao, Shan; Li, Xiaoming; Zhang, Chen; Zhou, Yuejiao; Shen, Zhiyong; Tang, Zhenzhu; Stanton, Bonita			Psychological Fears among Low-Paid Female Sex Workers in Southwest China and Their Implications for HIV Prevention	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; RISK BEHAVIORS; PARTNER VIOLENCE; YUNNAN PROVINCE; SUBSTANCE-ABUSE; KAIYUAN CITY; CONDOM USE; LOW-INCOME; HEALTH; PREVALENCE	Commercial sex plays a critical role in rapidly increasing heterosexual transmission of HIV in China. Low-paid female sex workers (FSWs) are especially vulnerable to HIV/AIDS. Because of the illegality and stigma associated with sex work, FSWs may constantly live with fears in their daily life. Based on cross-sectional study of 794 low-paid FSWs in China we described their psychological fears related to commercial sex and examined the associations between fears and HIV-related behaviors. Fear of HIV infection was significantly associated with consistent use of condoms with clients. However, fear of breaching sex worker identity significantly prevented the FSWs from consistently using condoms with clients and taking HIV tests. Fear of being arrested by the police was positively associated with consistent use of condoms but negatively associated with accessing HIV prevention services. Our findings underlined the importance of examining the triadic interaction of behavioral, psychological and environmental factors in HIV prevention interventions among low-paid FSWs.	[Qiao, Shan; Li, Xiaoming; Stanton, Bonita] Wayne State Univ, Prevent Res Ctr, Carman & Ann Adams Dept Pediat, Sch Med, Detroit, MI 48202 USA; [Zhang, Chen] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37235 USA; [Zhou, Yuejiao; Shen, Zhiyong; Tang, Zhenzhu] Guangxi Ctr Dis Control & Prevent, Guangxi, Peoples R China	Wayne State University; Vanderbilt University	Qiao, S (corresponding author), Wayne State Univ, Prevent Res Ctr, Carman & Ann Adams Dept Pediat, Sch Med, Detroit, MI 48202 USA.	sqiao@med.wayne.edu	Li, Xiaoming/AAF-1362-2019	Li, Xiaoming/0000-0002-5555-9034; Zhang, Chen/0000-0002-8771-561X	National Institute for Alcohol Abuse and Alcoholism (NIAAA) [R01AA018090]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018090] Funding Source: NIH RePORTER	National Institute for Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was supported by the National Research Grant R01AA018090 by the National Institute for Alcohol Abuse and Alcoholism (NIAAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, DORLANDS MED DICT HL; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beck A.T., 1967, DEPRESSION CLIN EXPT; Boster F.J., 1984, COMMUNICATION YB, V8, P330, DOI [10.1080/23808985.1984.11678581, DOI 10.1080/23808985.1984.11678581]; Chang H, 2010, SYSTEMATIC REV METAA; Chen XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060626; Chinese Ministry of Health, 2012, 2012 CHIN AIDS RESP; El-Bassel N, 2001, AIDS PATIENT CARE ST, V15, P41, DOI 10.1089/108729101460092; Fang XY, 2008, HEALTH CARE WOMEN IN, V29, P316, DOI 10.1080/07399330701738382; Fornasa CV, 2005, ACTA DERMATOVEN ALP, V14, P107; Gerrard M, 1996, PSYCHOL BULL, V119, P390, DOI 10.1037/0033-2909.119.3.390; Green EC, 2006, J HEALTH COMMUN, V11, P245, DOI 10.1080/10810730600613807; Gu J, 2010, WOMEN HEALTH, V50, P20, DOI 10.1080/03630241003601137; Guangxi Center for Disease Control and Prevention, 2009, WORKSH NIAAA VEN BAS; Hagan JE, 2007, SEX TRANSM DIS, V34, P83, DOI 10.1097/01.olq.0000237670.59140.0f; Harcourt C, 2001, AUST NZ J PUBL HEAL, V25, P84, DOI 10.1111/j.1467-842X.2001.tb00556.x; Hong Y, 2008, AIDS BEHAV, V12, P623, DOI 10.1007/s10461-007-9287-7; Hong Y, 2007, SEX HEALTH, V4, P99, DOI 10.1071/SH06063; Hong Y, 2012, AIDS BEHAV, V16, P44, DOI 10.1007/s10461-011-9960-8; Kutner M. H., 2004, APPL LINEAR REGRESSI; Lautz TB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040816; Leith KP, 1996, J PERS SOC PSYCHOL, V71, P1250, DOI 10.1037/0022-3514.71.6.1250; Li J, 2012, SEX TRANSM DIS, V39, P195, DOI 10.1097/OLQ.0b013e31823d2e2a; Ling DC, 2007, J SEX MARITAL THER, V33, P281, DOI 10.1080/00926230701385498; Lu F, 2009, SE ASIAN J TROP MED, V40, P263; Mondal NI, 2008, BRAZ J INFECT DIS, V12, P287, DOI 10.1590/S1413-86702008000400006; Panchanadeswaran S, 2008, INT J DRUG POLICY, V19, P106, DOI 10.1016/j.drugpo.2007.11.013; Paone D, 1999, AIDS CARE, V11, P269, DOI 10.1080/09540129947910; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; Preiss R.W., 1998, PERSUASION ADV METAA, P53; Rahman M, 2000, J CLIN MICROBIOL, V38, P1244, DOI 10.1128/JCM.38.3.1244-1246.2000; Roxburgh A, 2008, SUBST USE MISUSE, V43, P1202, DOI 10.1080/10826080801914410; Roxburgh A, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-24; Ruan YH, 2006, SEX TRANSM DIS, V33, P719, DOI 10.1097/01.olq.0000218881.01437.99; SILBERT MH, 1982, J PSYCHOACTIVE DRUGS, V14, P193, DOI 10.1080/02791072.1982.10471928; Tucker JD, 2011, INT J EPIDEMIOL, V40, P1421, DOI 10.1093/ije/dyr021; Ullah AA, 2005, J INT WOMENS STUDIES, V7, P111; Wang H, 2009, SEX TRANSM INFECT, V85, P290, DOI 10.1136/sti.2008.033100; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Wang L., 2014, CLIN INFECT DIS; Wang Y, 2011, AIDS BEHAV, V15, P702, DOI 10.1007/s10461-010-9703-2; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; Wilson D, 2004, BRIT MED J, V328, P848, DOI 10.1136/bmj.328.7444.848; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; Witte K, 2001, EFFECTIVE HLTH RISK; Wong WCW, 2006, J WOMENS HEALTH, V15, P390, DOI 10.1089/jwh.2006.15.390; Zhang C, 2013, AIDS CARE, V25, P503, DOI 10.1080/09540121.2012.726345; Zhou YJ, 2013, AIDS CARE, V25, P1433, DOI 10.1080/09540121.2013.772282	49	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e111012	10.1371/journal.pone.0111012	http://dx.doi.org/10.1371/journal.pone.0111012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TF	25330242	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100113
J	Faiq, MA; Ali, M; Dada, T; Dada, R; Saluja, D				Faiq, Muneeb A.; Ali, Mashook; Dada, Tanuj; Dada, Rima; Saluja, Daman			A Novel Methodology for Enhanced and Consistent Heterologous Expression of Unmodified Human Cytochrome P450 1B1 (CYP1B1)	PLOS ONE			English	Article							PRIMARY CONGENITAL GLAUCOMA; ESCHERICHIA-COLI; P4501B1 CYP1B1; TRANSLATION INITIATION; PROTEIN EXPRESSION; GENE-EXPRESSION; BREAST-CANCER; CODON BIAS; MUTATIONS; P450CYP1B1	Cytochrome P450 1B1 (CYP1B1) is a universal cancer marker and is implicated in many other disorders. Mutations in CYP1B1 are also associated with childhood blindness due to primary congenital glaucoma (PCG). To understand the CYP1B1 mediated etiopathology of PCG and pathomechanism of various cancers, it is important to carry out its functional studies. Heterologous expression of CYP1B1 in prokaryotes is imperative because bacteria yield a higher amount of heterologous proteins in lesser time and so the expressed protein is ideal for functional studies. In such expression system there is no interference by other eukaryotic proteins. But the story is not that simple as expression of heterologous CYP1B1 poses many technical difficulties. Investigators have employed various modifications/deletions of CYP N-terminus to improve CYP1B1 expression. However, the drawback of these studies is that it changes the original protein and, as a result, invalidates functional studies. The present study examines the role of various conditions and reagents in successful and consistent expression of sufficient quantities of unmodified/native human CYP1B1 in E. coli. We aimed at expressing CYP1B1 in various strains of E. coli and in the course developed a protocol that results in high expression of unmodified protein sufficient for functional/biophysical studies. We examined CYP1B1 expression with respect to different expression vectors, bacterial strains, types of culture media, time, Isopropyl beta-D-1-thiogalactopyranoside concentrations, temperatures, rotations per minute, conditioning reagents and the efficacy of a newly described technique called double colony selection. We report a protocol that is simple, easy and can be carried out in any laboratory without the requirement of a fermentor. Though employed for CYP1B1 expression, this protocol can ideally be used to express any eukaryotic membrane protein.	[Faiq, Muneeb A.; Dada, Tanuj] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India; [Faiq, Muneeb A.; Ali, Mashook; Saluja, Daman] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Med Biotechnol Lab, Delhi 110007, India; [Faiq, Muneeb A.; Dada, Rima] All India Inst Med Sci, Dept Anat, Lab Mol Reprod & Genet, Ansari Nagar, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; University of Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Dada, R (corresponding author), All India Inst Med Sci, Dept Anat, Lab Mol Reprod & Genet, Ansari Nagar, India.	dsalujach59@gmail.com; rima_dada@rediffmail.com		Faiq, Muneeb/0000-0002-1430-3139	Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi; Indian Council of Medical Research, New Delhi	Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi; Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	The author(s) received no specific funding for this work but the institutional grant by Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi to DS and funding by Indian Council of Medical Research, New Delhi to RD is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allert M, 2010, J MOL BIOL, V402, P905, DOI 10.1016/j.jmb.2010.08.010; ARDITTI RR, 1968, J MOL BIOL, V38, P421, DOI 10.1016/0022-2836(68)90396-3; Bejjani BA, 2002, EXP EYE RES, V75, P249, DOI 10.1006/exer.2002.2025; Bejjani BA, 1998, AM J HUM GENET, V62, P325, DOI 10.1086/301725; Bejjani BA, 2000, HUM MOL GENET, V9, P367, DOI 10.1093/hmg/9.3.367; Carnell DM, 2004, INT J RADIAT ONCOL, V58, P500, DOI 10.1016/j.ijrobp.2003.09.064; Caspeta L, 2009, BIOTECHNOL BIOENG, V102, P468, DOI 10.1002/bit.22084; Chavarria-Soley G, 2008, HUM MUTAT, V29, P1147, DOI 10.1002/humu.20786; CHEN GFT, 1994, GENE DEV, V8, P2641, DOI 10.1101/gad.8.21.2641; Corisdeo S, 2004, PROTEIN EXPRES PURIF, V34, P270, DOI 10.1016/j.pep.2003.11.020; de Valdivia EIG, 2004, NUCLEIC ACIDS RES, V32, P5198, DOI 10.1093/nar/gkh857; Doshi M, 2006, EXP EYE RES, V82, P24, DOI 10.1016/j.exer.2005.04.016; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Faiq Muneeb, 2013, J Curr Glaucoma Pract, V7, P25, DOI 10.5005/jp-journals-10008-1133; Faiq Muneeb, 2013, J Curr Glaucoma Pract, V7, P66, DOI 10.5005/jp-journals-10008-1140; Freigassner M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-69; Gibson P, 2003, MOL CANCER THER, V2, P527; GILLAM EMJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P540, DOI 10.1006/abbi.1995.1329; Jansson I, 2000, TOXICOLOGY, V144, P211, DOI 10.1016/S0300-483X(99)00209-7; Kaur K, 2011, MIDDLE EAST AFR J OP, V18, P7, DOI 10.4103/0974-9233.75878; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Li N, 2011, EXP EYE RES, V93, P572, DOI 10.1016/j.exer.2011.07.009; Low C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038244; Ma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076913; Maecker B, 2003, BLOOD, V102, P3287, DOI 10.1182/blood-2003-05-1374; McFadyen MCE, 1999, J HISTOCHEM CYTOCHEM, V47, P1457, DOI 10.1177/002215549904701111; McFadyen MCE, 2001, BRIT J CANCER, V85, P242, DOI 10.1054/bjoc.2001.1907; McFadyen Morag C E, 2005, Future Oncol, V1, P259, DOI 10.1517/14796694.1.2.259; Murray GI, 1997, CANCER RES, V57, P3026; Murray GI, 2001, ANNU REV PHARMACOL, V41, P297, DOI 10.1146/annurev.pharmtox.41.1.297; Orawan K., 2012, ASIAN PACIFIC J TROP, P159; Oyama T, 2005, FRONT BIOSCI, V10, P1156, DOI 10.2741/1608; Panicker SG, 2002, INVEST OPHTH VIS SCI, V43, P1358; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Rai M, 2001, CURR SCI INDIA, V80, P1121; Sahdev S, 2008, MOL CELL BIOCHEM, V307, P249, DOI 10.1007/s11010-007-9603-6; Saida F, 2007, CURRENT PROTOC PROTE; SANDHU P, 1994, ARCH BIOCHEM BIOPHYS, V309, P168, DOI 10.1006/abbi.1994.1099; Sarfarazi M, 2000, EYE, V14, P422, DOI 10.1038/eye.2000.126; Schenkman John B., 1998, V107, P25; Schlegel S, 2010, MICROB BIOTECHNOL, V3, P403, DOI 10.1111/j.1751-7915.2009.00148.x; Shimada T, 1998, ARCH BIOCHEM BIOPHYS, V357, P111, DOI 10.1006/abbi.1998.0808; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Stenstrom CM, 2002, GENE, V288, P1, DOI 10.1016/S0378-1119(02)00501-2; Stenstrom CM, 2001, GENE, V263, P273, DOI 10.1016/S0378-1119(00)00550-3; Stenstrom CM, 2001, GENE, V273, P259, DOI 10.1016/S0378-1119(01)00584-4; Stoilov I, 2004, MOL VIS, V10, P629; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; SUTTER TR, 1994, J BIOL CHEM, V269, P13092; Tang WM, 1996, J BIOL CHEM, V271, P28324, DOI 10.1074/jbc.271.45.28324; Tanwar M, 2009, MOL VIS, V15, P2926; Tanwar M, 2009, MOL VIS, V15, P1200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Welch M, 2011, METHOD ENZYMOL, V498, P43, DOI 10.1016/B978-0-12-385120-8.00003-6	56	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110473	10.1371/journal.pone.0110473	http://dx.doi.org/10.1371/journal.pone.0110473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329831	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800089
J	Kamada, M; Hase, S; Sato, K; Toyoda, A; Fujiyama, A; Sakakibara, Y				Kamada, Mayumi; Hase, Sumitaka; Sato, Kengo; Toyoda, Atsushi; Fujiyama, Asao; Sakakibara, Yasubumi			Whole Genome Complete Resequencing of Bacillus subtilis Natto by Combining Long Reads with High-Quality Short Reads	PLOS ONE			English	Article							MOLECULE SEQUENCING READS; RNA GENES; DNA; ASSEMBLIES; ALIGNMENT; STRAIN; VISUALIZATION; OUTBREAK	De novo microbial genome sequencing reached a turning point with third-generation sequencing (TGS) platforms, and several microbial genomes have been improved by TGS long reads. Bacillus subtilis natto is closely related to the laboratory standard strain B. subtilis Marburg 168, and it has a function in the production of the traditional Japanese fermented food "natto.'' The B. subtilis natto BEST195 genome was previously sequenced with short reads, but it included some incomplete regions. We resequenced the BEST195 genome using a PacBio RS sequencer, and we successfully obtained a complete genome sequence from one scaffold without any gaps, and we also applied Illumina MiSeq short reads to enhance quality. Compared with the previous BEST195 draft genome and Marburg 168 genome, we found that incomplete regions in the previous genome sequence were attributed to GC-bias and repetitive sequences, and we also identified some novel genes that are found only in the new genome.	[Kamada, Mayumi; Hase, Sumitaka; Sato, Kengo; Sakakibara, Yasubumi] Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 223, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Fujiyama, Asao] Natl Inst Informat, Principles Informat Res Div, Chiyoda Ku, Tokyo, Japan	Keio University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Sakakibara, Y (corresponding author), Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 223, Japan.	yasu@bio.keio.ac.jp	Sato, Kengo/D-6043-2012	Sato, Kengo/0000-0001-6744-7390	Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002, 23241066]; Transdisciplinary Research Integration Center (TRIC) of Research Organization of Information and Systems; Grants-in-Aid for Scientific Research [23241066] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Transdisciplinary Research Integration Center (TRIC) of Research Organization of Information and Systems; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for KAKENHI (Grant-in-Aid for Scientific Research) on Innovative Areas No. 221S0002, and Scientific Research (A) No. 23241066 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Also the work was partly supported by the Transdisciplinary Research Integration Center (TRIC) of Research Organization of Information and Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au KF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046679; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carneiro MO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-375; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deshpande V, 2013, 13 WORKSH ALG BIOINF; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Glenn T. C., 2014, 2014 NGS FIELD GUIDE; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Itaya M, 1999, BIOSCI BIOTECH BIOCH, V63, P2034, DOI 10.1271/bbb.63.2034; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nishito Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-243; Popendorf K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012651; Qiu DR, 2004, APPL ENVIRON MICROB, V70, P6247, DOI 10.1128/AEM.70.10.6247-6256.2004; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Zhang XJ, 2012, BIOTECHNIQUES, V53, P61, DOI 10.2144/0000113891; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	41	30	41	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109999	10.1371/journal.pone.0109999	http://dx.doi.org/10.1371/journal.pone.0109999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329997	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800049
J	Kuang, CY; Yang, TH; Zhang, Y; Zhang, L; Wu, Q				Kuang, Chun-yan; Yang, Tian-he; Zhang, Yang; Zhang, Lu; Wu, Qiang			Schlafen 1 Inhibits the Proliferation and Tube Formation of Endothelial Progenitor Cells	PLOS ONE			English	Article							CYCLIN D1; FAMILY; GENE; ARREST; GROWTH; LOCALIZATION; ACTIVATION; EXPRESSION; MIGRATION	Endothelial progenitor cells (EPCs) are the major source of cells that restore the endothelium during reendothelialization. This study was designed to investigate whether Schlafen 1 (Slfn1) has an effect on the proliferation and tube formation of EPCs in vivo. Slfn1 was expressed in rat EPCs. The overexpression of Slfn1 suppressed the proliferation and tube formation of EPCs; conversely, the knockdown of Slfn1 by shRNA promoted the proliferation and tube formation of EPCs. Furthermore, when Slfn1 was overexpressed, the EPCs were arrested in the G1 phase of the cell cycle. In contrast, when Slfn1 was knocked down, the EPCs progressed into the S phase of the cell cycle. Additionally, the overexpression of Slfn1 decreased the expression of Cyclin D1, whereas the knockdown of Slfn1 increased the expression of Cyclin D1; these findings suggest that Cyclin D1 is downstream of Slfn1 in Slfn1-mediated EPC proliferation. Taken together, these results indicate a key role for Slfn1 in the regulation of EPC biological behavior, which may provide a new target for the use of EPCs during reendothelialization.	[Kuang, Chun-yan; Yang, Tian-he; Zhang, Yang; Wu, Qiang] Peoples Hosp Guizhou Prov, Dept Cardiovasc Dis, Guiyang, Peoples R China; [Zhang, Lu] Peoples Hosp Guizhou Prov, Med Examinat Ctr, Guiyang, Peoples R China		Zhang, L (corresponding author), Peoples Hosp Guizhou Prov, Med Examinat Ctr, Guiyang, Peoples R China.	121981890@qq.com; 413972183@qq.com			Guizhou Science and Technology Department National Natural Science Foundation of China [024, 81360034]	Guizhou Science and Technology Department National Natural Science Foundation of China	This work was supported by Guizhou Science and Technology Department (Grant Qian-Ke-He LS [2011] No. 024) National Natural Science Foundation of China (Grant 81360034). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell TA, 2006, GENETICS, V172, P411, DOI 10.1534/genetics.105.047118; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Cubbon RM, 2009, CLIN SCI, V117, P173, DOI 10.1042/CS20080263; Du ZY, 2013, J BIOL CHEM, V288, P26678, DOI 10.1074/jbc.M113.466433; Ferguson DA, 2005, GENE EXPR PATTERNS, V5, P619, DOI 10.1016/j.modgep.2005.03.003; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Hanai J, 2002, J BIOL CHEM, V277, P16464, DOI 10.1074/jbc.M112274200; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Kuang CY, 2012, STEM CELLS DEV, V21, P487, DOI 10.1089/scd.2011.0027; Kuang CY, 2010, BIOCHEM BIOPH RES CO, V398, P315, DOI 10.1016/j.bbrc.2010.06.088; Michinaga S, 2013, NEUROCHEM INT, V63, P25, DOI 10.1016/j.neuint.2013.04.004; Neumann B, 2008, BIOCHEM BIOPH RES CO, V370, P62, DOI 10.1016/j.bbrc.2008.03.032; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Sethi R, 2012, J INTERV CARDIOL, V25, P493, DOI 10.1111/j.1540-8183.2012.00740.x; Sohn WJ, 2007, MOL IMMUNOL, V44, P3273, DOI 10.1016/j.molimm.2007.03.001; van den Oever IAM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/792393; Wang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031195; Yasui M, 2006, CLIN CANCER RES, V12, P4720, DOI 10.1158/1078-0432.CCR-05-1213; Zhang YF, 2008, BIOCHEM J, V413, P239, DOI 10.1042/BJ20071510	22	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109711	10.1371/journal.pone.0109711	http://dx.doi.org/10.1371/journal.pone.0109711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329797	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800033
J	Liu, YR; Fang, JX; Joo, KI; Wong, MK; Wang, P				Liu, Yarong; Fang, Jinxu; Joo, Kye-Il; Wong, Michael K.; Wang, Pin			Codelivery of Chemotherapeutics via Crosslinked Multilamellar Liposomal Vesicles to Overcome Multidrug Resistance in Tumor	PLOS ONE			English	Article							SMALL INTERFERING RNA; BREAST-CANCER; PACLITAXEL; DOXORUBICIN; DELIVERY; NANOPARTICLES; COMBINATIONS; AGENTS	Multidrug resistance (MDR) is a significant challenge to effective cancer chemotherapy treatment. However, the development of a drug delivery system that allows for the sustained release of combined drugs with improved vesicle stability could overcome MDR in cancer cells. To achieve this, we have demonstrated codelivery of doxorubicin (Dox) and paclitaxel (PTX) via a crosslinked multilamellar vesicle (cMLV). This combinatorial delivery system achieves enhanced drug accumulation and retention, in turn resulting in improved cytotoxicity against tumor cells, including drug-resistant cells. Moreover, this delivery approach significantly overcomes MDR by reducing the expression of P-glycoprotein (P-gp) in cancer cells, thus improving antitumor activity in vivo. Thus, by enhancing drug delivery to tumors and lowering the apoptotic threshold of individual drugs, this combinatorial delivery system represents a potentially promising multimodal therapeutic strategy to overcome MDR in cancer therapy.	[Liu, Yarong; Fang, Jinxu; Joo, Kye-Il; Wang, Pin] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Wong, Michael K.] Univ So Calif, Keck Sch Med, Div Med Oncol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Wang, Pin] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Wang, Pin] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Wang, P (corresponding author), Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA.	pinwang@usc.edu	Liu, Yarong/B-4952-2015; zhang, guoshi/GSD-3017-2022	Joo, Kye Il/0000-0001-8834-5561	National Institutes of Health [R01AI068978, R01CA170820, P01CA132681]; Joint Center for Translational Medicine; National Cancer Institute [P30CA014089]; Ming Hsieh Institute for Research on Engineering Medicine for Cancer; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA170820, P01CA132681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Center for Translational Medicine; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ming Hsieh Institute for Research on Engineering Medicine for Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants (R01AI068978, R01CA170820 and P01CA132681), a translational acceleration grant from the Joint Center for Translational Medicine, the National Cancer Institute (P30CA014089), and a grant from the Ming Hsieh Institute for Research on Engineering Medicine for Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012; Bird BRJH, 2008, CLIN CANCER RES, V14, P14, DOI 10.1158/1078-0432.CCR-07-1033; Calabro F, 2009, CANCER-AM CANCER SOC, V115, P2652, DOI 10.1002/cncr.24313; Chen YC, 2010, J BIOL CHEM, V285, P22639, DOI 10.1074/jbc.M110.125906; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; De Laurentiis M, 2008, J CLIN ONCOL, V26, P44, DOI 10.1200/JCO.2007.11.3787; Dean-Colomb W, 2008, SEMIN ONCOL, V35, pS31, DOI 10.1053/j.seminoncol.2008.02.008; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gao HL, 2014, CURR PHARM BIOTECHNO, V15, P210, DOI 10.2174/1389201015666140617092552; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Grasselli G, 2001, J CLIN ONCOL, V19, P2222, DOI 10.1200/JCO.2001.19.8.2222; Gustafson DL, 2005, CANCER LETT, V220, P161, DOI 10.1016/j.canlet.2004.09.007; Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z; Hubensack M, 2008, J CANCER RES CLIN, V134, P597, DOI 10.1007/s00432-007-0323-9; Joo KI, 2013, BIOMATERIALS, V34, P3098, DOI 10.1016/j.biomaterials.2013.01.039; Kataja V, 2008, ANN ONCOL, V19, P11, DOI 10.1093/annonc/mdn072; Lee BD, 2003, ONCOL RES, V14, P49, DOI 10.3727/000000003108748603; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lespine A, 2012, INT J PARASITOL-DRUG, V2, P230; Liu YR, 2014, NANO LIFE, V4, DOI 10.1142/S1793984414410074; Liu YR, 2014, MOL PHARMACEUT, V11, P1651, DOI 10.1021/mp5000373; Liu Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/378380; Mamounas EP, 2001, SEMIN ONCOL, V28, P24, DOI 10.1053/sonc.2001.26432; Rahman AM, 2007, INT J NANOMED, V2, P567; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Schondorf T, 2002, ANTICANCER RES, V22, P2199; Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Teicher BA, 2009, BIOCHEM PHARMACOL, V77, P1665, DOI 10.1016/j.bcp.2009.01.006; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Wang H, 2011, BIOMATERIALS, V32, P8281, DOI 10.1016/j.biomaterials.2011.07.032; Xu D, 2005, MOL THER, V11, P523, DOI 10.1016/j.ymthe.2004.12.019; Yu ZQ, 2013, J AM CHEM SOC, V135, P2883, DOI 10.1021/ja311090e	37	32	38	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110611	10.1371/journal.pone.0110611	http://dx.doi.org/10.1371/journal.pone.0110611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	24489844	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204100095
J	Liu, Y; Wang, J; Liu, DB; Li, ZG; Zhang, GS; Tao, Y; Xie, J; Pan, JF; Chen, F				Liu, Yi; Wang, Jing; Liu, Dongbi; Li, Zhiguo; Zhang, Guoshi; Tao, Yong; Xie, Juan; Pan, Junfeng; Chen, Fang			Straw Mulching Reduces the Harmful Effects of Extreme Hydrological and Temperature Conditions in Citrus Orchards	PLOS ONE			English	Article							WATER-USE EFFICIENCY; ZEA-MAYS L.; SOIL-TEMPERATURE; LOESS PLATEAU; MANAGEMENT-PRACTICES; GRASS COVER; YIELD; RUNOFF; MOISTURE; MAIZE	Extreme weather conditions with negative impacts can strongly affect agricultural production. In the Danjiangkou reservoir area, citrus yields were greatly influenced by cold weather conditions and drought stress in 2011. Soil straw mulching (SM) practices have a major effect on soil water and thermal regimes. A two-year field experiment was conducted to evaluate whether the SM practices can help achieve favorable citrus fruit yields. Results showed that the annual total runoff was significantly (P<0.05) reduced with SM as compared to the control (CK). Correspondingly, mean soil water storage in the top 100 cm of the soil profile was increased in the SM as compared to the CK treatment. However, this result was significant only in the dry season (Jan to Mar), and not in the wet season (Jul to Sep) for both years. Interestingly, the SM treatment did not significantly increase citrus fruit yield in 2010 but did so in 2011, when the citrus crop was completely destroyed (zero fruit yield) in the CK treatment plot due to extremely low temperatures during the citrus overwintering stage. The mulch probably acted as an insulator, resulting in smaller fluctuations in soil temperature in the SM than in the CK treatment. The results suggested that the small effects on soil water and temperature changes created by surface mulch had limited impact on citrus fruit yield in a normal year (e. g., in 2010). However, SM practices can positively impact citrus fruit yield in extreme weather conditions.	[Liu, Yi; Wang, Jing; Li, Zhiguo; Zhang, Guoshi; Tao, Yong; Xie, Juan; Pan, Junfeng; Chen, Fang] Chinese Acad Sci China, Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Peoples R China; [Liu, Dongbi] Hubei Acad Agr Sci, Inst Plant Protect & Soil Fertilizer, Wuhan, Peoples R China; [Zhang, Guoshi; Chen, Fang] IPNI, China Program, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Hubei Academy of Agricultural Sciences	Chen, F (corresponding author), Chinese Acad Sci China, Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Peoples R China.	fchenipni@126.com	Liu, Yarong/B-4952-2015; zhang, guoshi/GSD-3017-2022	Joo, Kye Il/0000-0001-8834-5561	National Key Technology RD Program [2012BAD15B01]; NSFC [31100386]; Key Laboratory of Aquatic Botany and Watershed Ecology, Chinese Academy of Sciences [Y152741s04]; International Plant Nutrition Institute [IPNI-HB-33]; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA170820, P01CA132681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068978] Funding Source: NIH RePORTER	National Key Technology RD Program(National Key Technology R&D Program); NSFC(National Natural Science Foundation of China (NSFC)); Key Laboratory of Aquatic Botany and Watershed Ecology, Chinese Academy of Sciences; International Plant Nutrition Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was financially supported by the National Key Technology R&D Program (2012BAD15B01), the NSFC (31100386), the Open Funding Project (Y152741s04) of the Key Laboratory of Aquatic Botany and Watershed Ecology, Chinese Academy of Sciences and the Cooperated Program with the International Plant Nutrition Institute (IPNI-HB-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekalu KO, 2007, BIORESOURCE TECHNOL, V98, P912, DOI 10.1016/j.biortech.2006.02.044; Balwinder-Singh, 2011, FIELD CROP RES, V121, P209, DOI 10.1016/j.fcr.2010.12.005; Bao S., 2000, SOIL AGROCHEMICAL AN; Carrer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050755; Chen SY, 2007, ANN APPL BIOL, V150, P261, DOI 10.1111/j.1744-7348.2007.00144.x; Doring TF, 2005, FIELD CROP RES, V94, P238, DOI 10.1016/j.fcr.2005.01.006; Edwards L, 2000, AGR ECOSYST ENVIRON, V81, P217, DOI 10.1016/S0167-8809(00)00162-6; Fang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047369; Farkas C, 2009, BIOLOGIA, V64, P624, DOI 10.2478/s11756-009-0079-6; Ghosh PK, 2006, FIELD CROP RES, V99, P76, DOI 10.1016/j.fcr.2006.03.004; Gutierrez J, 1996, J ARID ENVIRON, V34, P287, DOI 10.1006/jare.1996.0110; Huang YL, 2005, AGR WATER MANAGE, V72, P209, DOI 10.1016/j.agwat.2004.09.012; Kar G, 2007, AGR WATER MANAGE, V94, P109, DOI 10.1016/j.agwat.2007.08.004; LAL R, 1976, GEODERMA, V16, P377, DOI 10.1016/0016-7061(76)90002-1; Li R, 2012, SOIL RES, V50, P105, DOI 10.1071/SR11331; Li XH, 2011, PEDOSPHERE, V21, P238, DOI 10.1016/S1002-0160(11)60123-9; Liu WZ, 2011, CLEAN-SOIL AIR WATER, V39, P109, DOI 10.1002/clen.200900212; Liu Y, 2012, AGR WATER MANAGE, V110, P34, DOI 10.1016/j.agwat.2012.03.011; Liu Y, 2010, AGR FOREST METEOROL, V150, P606, DOI 10.1016/j.agrformet.2010.02.003; Liu Y, 2010, AGR WATER MANAGE, V97, P769, DOI 10.1016/j.agwat.2010.01.010; Lou YL, 2011, CATENA, V86, P117, DOI 10.1016/j.catena.2011.03.006; National Soil Survey Office, 1992, SOIL SURV TECHN CHIN; Novak MD, 2000, AGR FOREST METEOROL, V102, P155, DOI 10.1016/S0168-1923(00)00097-6; Olasantan FO, 1999, SOIL TILL RES, V50, P215, DOI 10.1016/S0167-1987(98)00192-5; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; Ramakrishna A, 2006, FIELD CROP RES, V95, P115, DOI 10.1016/j.fcr.2005.01.030; Sarkar S, 2007, SOIL TILL RES, V93, P94, DOI 10.1016/j.still.2006.03.015; She DL, 2009, PESQUI AGROPECU BRAS, V44, P189, DOI 10.1590/S0100-204X2009000200011; Silvente S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038554; van der Velde M, 2012, CLIMATIC CHANGE, V113, P751, DOI 10.1007/s10584-011-0368-2; Wakindiki IIC, 2011, AFR J AGR RES, V6, P725; Wang YJ, 2011, AGR WATER MANAGE, V101, P88, DOI 10.1016/j.agwat.2011.09.006; Zhang QF, 2009, J AM WATER RESOUR AS, V45, P1238, DOI 10.1111/j.1752-1688.2009.00357.x; Zhang SL, 2009, SOIL TILL RES, V102, P78, DOI 10.1016/j.still.2008.07.019; Zhao H, 2012, PLASTIC FILM MULCH H	35	32	38	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87094	10.1371/journal.pone.0087094	http://dx.doi.org/10.1371/journal.pone.0087094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489844	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000107
J	Mao, M; Varadarajan, S; Fukai, T; Bakhshi, FR; Chernaya, O; Dudley, SC; Minshall, RD; Bonini, MG				Mao, Mao; Varadarajan, Sudhahar; Fukai, Tohru; Bakhshi, Farnaz R.; Chernaya, Olga; Dudley, Samuel C., Jr.; Minshall, Richard D.; Bonini, Marcelo G.			Nitroglycerin Tolerance in Caveolin-1 Deficient Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; MICROVASCULAR PERMEABILITY; ENOS ACTIVATION; IN-VIVO; SUPEROXIDE; PEROXYNITRITE; TETRAHYDROBIOPTERIN; PROTEIN; HYPERPERMEABILITY	Nitrate tolerance developed after persistent nitroglycerin (GTN) exposure limits its clinical utility. Previously, we have shown that the vasodilatory action of GTN is dependent on endothelial nitric oxide synthase (eNOS/NOS3) activity. Caveolin-1 (Cav-1) is known to interact with NOS3 on the cytoplasmic side of cholesterol-enriched plasma membrane microdomains (caveolae) and to inhibit NOS3 activity. Loss of Cav-1 expression results in NOS3 hyperactivation and uncoupling, converting NOS3 into a source of superoxide radicals, peroxynitrite, and oxidative stress. Therefore, we hypothesized that nitrate tolerance induced by persistent GTN treatment results from NOS3 dysfunction and vascular toxicity. Exposure to GTN for 48-72 h resulted in nitrosation and depletion (>50%) of Cav-1, NOS3 uncoupling as measured by an increase in peroxynitrite production (>100%), and endothelial toxicity in cultured cells. In the Cav-1 deficient mice, NOS3 dysfunction was accompanied by GTN tolerance (>50% dilation inhibition at low GTN concentrations). In conclusion, GTN tolerance results from Cav-1 modification and depletion by GTN that causes persistent NOS3 activation and uncoupling, preventing it from participating in GTN-medicated vasodilation.	[Mao, Mao; Varadarajan, Sudhahar; Fukai, Tohru; Dudley, Samuel C., Jr.; Bonini, Marcelo G.] Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL 60607 USA; [Mao, Mao; Varadarajan, Sudhahar; Fukai, Tohru; Bakhshi, Farnaz R.; Chernaya, Olga; Minshall, Richard D.; Bonini, Marcelo G.] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Minshall, Richard D.] Univ Illinois, Dept Anesthesiol, Chicago, IL USA; [Mao, Mao] Univ Illinois, Dept Pathol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bonini, MG (corresponding author), Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL 60607 USA.	mbonini@uic.edu	Mao, Mao/E-3783-2013; Dudley, Samuel C/A-7085-2009; Dudley, Samuel/AAR-7950-2021; Varadarajan, Sudhahar/AAJ-6910-2021	Mao, Mao/0000-0003-1524-8853; Dudley, Samuel/0000-0001-5843-5961; Varadarajan, Sudhahar/0000-0002-9675-0097	American Heart Association [09SDG2250933, 13GRNT16400010]; National Institutes of Health NHLBI [PO1-HL060678]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070187, P01HL060678] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association, grants 09SDG2250933 and 13GRNT16400010 (to M.G.B.) and National Institutes of Health NHLBI grant PO1-HL060678 (to R.D.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablikim M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.172002; Bakhshi FR, 2013, PULM CIRC, V3, P816, DOI 10.1086/674753; Bauersachs J, 2005, CARDIOVASC RES, V65, P768, DOI 10.1016/j.cardiores.2004.12.011; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bendall JK, 2005, CIRC RES, V97, P864, DOI 10.1161/01.RES.0000187447.03525.72; Boden WE, 2012, CLIN CARDIOL, V35, P263, DOI 10.1002/clc.21993; Bonini MG, 2008, P NATL ACAD SCI USA, V105, P8569, DOI 10.1073/pnas.0708615105; Bonini MG, 2002, CHEM RES TOXICOL, V15, P506, DOI 10.1021/tx015571z; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; Crabtree MJ, 2013, J BIOL CHEM, V288, P561, DOI 10.1074/jbc.M112.415992; Daiber A, 2004, MOL PHARMACOL, V66, P1372, DOI 10.1124/mol.104.002600; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; Karuppiah K, 2011, AM J PHYSIOL-HEART C, V301, pH903, DOI 10.1152/ajpheart.00936.2010; Kollau A, 2005, BIOCHEM J, V385, P769, DOI 10.1042/BJ20041354; KRISHNA MC, 1992, P NATL ACAD SCI USA, V89, P5537, DOI 10.1073/pnas.89.12.5537; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Lin MI, 2007, CANCER RES, V67, P2849, DOI 10.1158/0008-5472.CAN-06-4082; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Mao M, 2012, FREE RADICAL BIO MED, V52, P427, DOI 10.1016/j.freeradbiomed.2011.09.020; Mirza MK, 2010, AM J PATHOL, V176, P2344, DOI 10.2353/ajpath.2010.091088; Morais C, 2012, AM J PATHOL, V180, P1702, DOI 10.1016/j.ajpath.2011.12.018; Munzel T, 1996, Am J Cardiol, V77, p24C, DOI 10.1016/S0002-9149(96)00185-3; Place AT, 2011, MOL PHARMACOL, V80, P665, DOI 10.1124/mol.111.073957; Sanchez FA, 2009, P NATL ACAD SCI USA, V106, P6849, DOI 10.1073/pnas.0812694106; Sato M, 2012, J BIOL CHEM, V287, P20674, DOI 10.1074/jbc.M111.280651; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Schnorbus B, 2010, CLIN RES CARDIOL, V99, P115, DOI 10.1007/s00392-009-0096-z; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Schuhmacher S, 2011, DIABETES, V60, P2608, DOI 10.2337/db10-1395; Scotland RS, 2005, CIRCULATION, V111, P796, DOI 10.1161/01.CIR.0000155238.70797.4E; Siddiqui MR, 2011, J CELL BIOL, V193, P841, DOI 10.1083/jcb.201012129; Sikora A, 2011, CHEM RES TOXICOL, V24, P687, DOI 10.1021/tx100439a; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Sydow K, 2004, J CLIN INVEST, V113, P482, DOI 10.1172/JCI200419267; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080	41	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104101	10.1371/journal.pone.0104101	http://dx.doi.org/10.1371/journal.pone.0104101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25329888	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200009
J	Xu, XY; Li, F; Zhang, X; Li, PC; Zhang, X; Wu, ZX; Li, DP				Xu, Xiaoyan; Li, Feng; Zhang, Xin; Li, Pengcheng; Zhang, Xing; Wu, Zhaoxi; Li, Dapeng			In Vitro Synergistic Antioxidant Activity and Identification of Antioxidant Components from Astragalus membranaceus and Paeonia lactiflora	PLOS ONE			English	Article							RADIX-ASTRAGALI; HPLC; MECHANISMS; CONSTITUENTS; PERSPECTIVE; ANTICANCER; FLAVONOIDS; APOPTOSIS; EXTRACT; ASSAY	Many traditionally used herbs demonstrate significantly better pharmacological effects when used in combination than when used alone. However, the mechanism underlying this synergism is still poorly understood. This study aimed to investigate the synergistic antioxidant activity of Astragalus membranaceus (AME) and Paeonia Lactiflora (PL), and identify the potential antioxidant components by 1,1-diphenyl-2-picrylhydrazine (DPPH) radical spiking test followed by a high performance liquid chromatography separation combined with diode array detection and tandem mass spectrometry analysis (DPPH-HPLC-DAD-MS/MS). Eight AME-PL combined extracts (E-1-E-8) were prepared based on bioactivity-guided fractionation. Among them, E-1 exhibited the strongest synergistic effect in scavenging DPPH radicals and reducing ferric ions (P<0.05). Moreover, E-1 presented strong cytoprotection against H2O2-induced oxidative damage in MRC-5 cells by suppressing the decrease of the superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT) activities. A strong correlation between the increment of total phenolic/flavonoid and synergistic antioxidant activity, especially between the increment of total flavonoid and the increase in ferric reducing power was observed. Finally, seven antioxidant substances were identified in E-1 as oxypaeoniflora, catechin, calycosin-7-O-beta-D-glucopyranoside, fomononetin-7-O-beta-D-glucopyranoside, 9,10-dimethoxy-pterocarpan-3-O-beta-D-glucopyranoside, quercetin and 2'-dihydroxy-3',4'-dimethyl-isoflavan- 7-O-beta-D-glucopyranoside.	[Xu, Xiaoyan; Li, Feng; Zhang, Xin; Zhang, Xing; Wu, Zhaoxi; Li, Dapeng] Shandong Agr Univ, Dept Food Sci, Tai An, Shandong, Peoples R China; [Li, Pengcheng] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Li, Dapeng] Natl Res Ctr Apple Engn & Technol, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Li, DP (corresponding author), Shandong Agr Univ, Dept Food Sci, Tai An, Shandong, Peoples R China.	dpli73@sdau.edu.cn	DaPeng, Li/G-4164-2010; li, dapeng/G-4166-2010	DaPeng, Li/0000-0002-1816-3217; li, dapeng/0000-0002-1816-3217; Ross, Kathryn/0000-0002-3628-766X; Demos, Kathryn/0000-0002-8578-4312; Xu, Xiaomeng/0000-0003-3695-4845	National Key Technology R&D Program of China [2012BAK17B05]; Shandong Provincial Natural Science Foundation of China [ZR2009DM046]; Foundation of National Natural Science Foundation of China [31201417]	National Key Technology R&D Program of China(National Key Technology R&D Program); Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province); Foundation of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Technology R&D Program of China (2012BAK17B05), Shandong Provincial Natural Science Foundation of China (ZR2009DM046), and the Foundation of National Natural Science Foundation of China (31201417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atangwho IJ, 2012, J ETHNOPHARMACOL, V141, P878, DOI 10.1016/j.jep.2012.03.041; Bandoniene D, 2002, J BIOCHEM BIOPH METH, V53, P45, DOI 10.1016/S0165-022X(02)00091-X; Barbouti A, 2002, FREE RADICAL BIO MED, V33, P691, DOI 10.1016/S0891-5849(02)00967-X; Bendaoud H, 2010, J FOOD SCI, V75, pC466, DOI 10.1111/j.1750-3841.2010.01711.x; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; Chu C, 2010, J SEP SCI, V33, P570, DOI 10.1002/jssc.200900687; Fattahi M, 2013, FOOD CHEM, V141, P139, DOI 10.1016/j.foodchem.2013.03.019; GRECO WR, 1995, PHARMACOL REV, V47, P331; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kim SH, 2009, J ENZYM INHIB MED CH, V24, P1138, DOI 10.1080/14756360802667977; Leung HWC, 2006, EUR J PHARMACOL, V534, P12, DOI 10.1016/j.ejphar.2006.01.021; Ma XH, 2009, DRUG DISCOV TODAY, V14, P579, DOI 10.1016/j.drudis.2009.03.012; MAK IT, 1983, J BIOL CHEM, V258, P3733; Misbah H, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-118; Nagata Hidetaka, 1999, Tokai Journal of Experimental and Clinical Medicine, V24, P1; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Rathee JS, 2006, J AGR FOOD CHEM, V54, P9046, DOI 10.1021/jf061679e; Rodea-Palomares I, 2010, WATER RES, V44, P427, DOI 10.1016/j.watres.2009.07.026; SIMIC MG, 1988, MUTAT RES, V202, P377, DOI 10.1016/0027-5107(88)90199-6; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Stermitz FR, 2000, P NATL ACAD SCI USA, V97, P1433, DOI 10.1073/pnas.030540597; Tang D, 2008, J SEP SCI, V31, P3519, DOI 10.1002/jssc.200800173; Verma AR, 2010, FOOD CHEM TOXICOL, V48, P704, DOI 10.1016/j.fct.2009.11.052; Wang L.S., 2012, NUTR WELL BEING HLTH, V7, P201, DOI DOI 10.5772/25862; Wang PC, 2003, MECH AGEING DEV, V124, P1025, DOI 10.1016/j.mad.2003.08.005; Wijesekara I, 2011, FOOD RES INT, V44, P703, DOI 10.1016/j.foodres.2010.12.022; Xiao HB, 2004, J CHROMATOGR A, V1032, P117, DOI 10.1016/j.chroma.2003.09.032; Yang WJ, 2009, BIOL PHARM BULL, V32, P1021, DOI 10.1248/bpb.32.1021; Yao H, 2012, FOOD CHEM, V135, P2802, DOI 10.1016/j.foodchem.2012.07.076; Zhu YZ, 2004, NAT PROD REP, V21, P478, DOI 10.1039/b304821g	33	85	91	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96780	10.1371/journal.pone.0096780	http://dx.doi.org/10.1371/journal.pone.0096780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24816851	Green Published, gold, Green Submitted			2022-12-27	WOS:000336838000064
J	Santos, J; Gouveia, MJ; Vale, N; Delgado, MD; Goncalves, A; da Silva, JMT; Oliveira, C; Xavier, P; Gomes, P; Santos, LL; Lopes, C; Barros, A; Rinaldi, G; Brindley, PJ; da Costa, JMC; Sousa, M; Botelho, MC				Santos, Julio; Gouveia, Maria Joao; Vale, Nuno; Delgado, Maria de Lurdes; Goncalves, Ana; Teixeira da Silva, Jose M.; Oliveira, Cristiano; Xavier, Pedro; Gomes, Paula; Santos, Lucio L.; Lopes, Carlos; Barros, Alberto; Rinaldi, Gabriel; Brindley, Paul J.; Correia da Costa, Jose M.; Sousa, Mario; Botelho, Monica C.			Urinary Estrogen Metabolites and Self-Reported Infertility in Women Infected with Schistosoma haematobium	PLOS ONE			English	Article							HUMAN CANCERS; HEALTH; BREAST; QUANTIFICATION; BIOMARKERS; QUINONES; PROSTATE; MANSONI; DISEASE; EGGS	Background: Schistosomiasis is a neglected tropical disease, endemic in 76 countries, that afflicts more than 240 million people. The impact of schistosomiasis on infertility may be underestimated according to recent literature. Extracts of Schistosoma haematobium include estrogen-like metabolites termed catechol-estrogens that down regulate estrogen receptors alpha and beta in estrogen responsive cells. In addition, schistosome derived catechol-estrogens induce genotoxicity that result in estrogen-DNA adducts. These catechol estrogens and the catechol-estrogen-DNA adducts can be isolated from sera of people infected with S. haematobium. The aim of this study was to study infertility in females infected with S. haematobium and its association with the presence of schistosome-derived catechol-estrogens. Methodology/Principal Findings: A cross-sectional study was undertaken of female residents of a region in Bengo province, Angola, endemic for schistosomiasis haematobia. Ninety-three women and girls, aged from two (parents interviewed) to 94 years were interviewed on present and previous urinary, urogenital and gynecological symptoms and complaints. Urine was collected from the participants for egg-based parasitological assessment of schistosome infection, and for liquid chromatography diode array detection electron spray ionization mass spectrometry (LC/UV-DAD/ESI-MSn) to investigate estrogen metabolites in the urine. Novel estrogen-like metabolites, potentially of schistosome origin, were detected in the urine of participants who were positive for eggs of S. haematobium, but not detected in urines negative for S. haematobium eggs. The catechol-estrogens/DNA adducts were significantly associated with schistosomiasis (OR 3.35; 95% CI 2.32-4.84; P <= 0.001). In addition, presence of these metabolites was positively associated with infertility (OR 4.33; 95% CI 1.13-16.70; P <= 0.05). Conclusions/Significance: Estrogen metabolites occur widely in diverse metabolic pathways. In view of the statistically significant association between catechol-estrogens/DNA adducts and self-reported infertility, we propose that an estrogen-DNA adduct mediated pathway in S. haematobium-induced ovarian hormonal deregulation could be involved. In addition, the catechol-estrogens/DNA adducts described here represent potential biomarkers for schistosomiasis haematobia.	[Santos, Julio; Santos, Lucio L.; Lopes, Carlos] Clin Sagrada Esperanca, Luanda, Angola; [Gouveia, Maria Joao; Vale, Nuno; Gomes, Paula] Univ Porto, Fac Sci, Dept Chem & Biochem, CIQUP, P-4100 Oporto, Portugal; [Delgado, Maria de Lurdes; Correia da Costa, Jose M.; Botelho, Monica C.] INSA, Natl Inst Hlth, Oporto, Portugal; [Goncalves, Ana; Teixeira da Silva, Jose M.; Oliveira, Cristiano; Xavier, Pedro; Barros, Alberto] Ctr Reprod Genet Prof Alberto Barros, Oporto, Portugal; [Santos, Lucio L.] Portuguese Inst Oncol, Expt Therapeut & Pathol Res Grp, Oporto, Portugal; [Lopes, Carlos] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Dept Pathol & Mol Immunol, P-4100 Oporto, Portugal; [Barros, Alberto] Univ Porto, Fac Med, Dept Genet, P-4100 Oporto, Portugal; [Rinaldi, Gabriel; Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Rinaldi, Gabriel; Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Res Ctr Neglected Dis Poverty, Washington, DC 20052 USA; [Rinaldi, Gabriel] Univ Republica, Fac Med, Dept Genet, UDELAR, Montevideo, Uruguay; [Correia da Costa, Jose M.; Botelho, Monica C.] Univ Porto, Ctr Study Anim Sci, CECA ICETA, P-4100 Oporto, Portugal; [Sousa, Mario] Univ Porto, Multidisciplinary Unit Biomed Res UMIB, Inst Biomed Sci Abel Salazar ICBAS, Dept Microscopy,Lab Cell Biol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade de Coimbra; Universidade do Porto; Universidade do Porto; George Washington University; George Washington University; Universidad de la Republica, Uruguay; Universidade do Porto; Universidade do Porto	Botelho, MC (corresponding author), INSA, Natl Inst Hlth, Oporto, Portugal.	monicabotelho@hotmail.com	Sousa, Mário/A-7340-2019; Gouveia, Maria/AAV-9144-2020; Botelho, Monica C/E-7170-2014; Santos, Lúcio Lara/AAE-2822-2021; Santos, Magda/J-4509-2015; Gomes, Paula/C-6698-2008; Barros, Alberto/L-3094-2013	Sousa, Mário/0000-0002-3009-3290; Botelho, Monica C/0000-0003-0466-8465; Santos, Lúcio Lara/0000-0002-0521-5655; Santos, Magda/0000-0003-0626-3015; Xavier, Pedro/0000-0002-3871-5568; Rinaldi, Gabriel/0000-0002-7767-4922; Gomes, Paula/0000-0002-6018-4724; Barros, Alberto/0000-0002-8700-3698; Brindley, Paul J./0000-0003-1765-0002; Gouveia, Maria/0000-0003-3747-5520; Vale, Nuno/0000-0002-1283-1042	National Funds through FCT-Foundation for Science and Technology [PEst-OE/AGR/UI0211/2011, Fcomp-01-0124-FEDER-015893]	National Funds through FCT-Foundation for Science and Technology	Centre for the Study of Animal Science (CECA) is funded by National Funds through FCT-Foundation for Science and Technology, under the "PEst-OE/AGR/UI0211/2011" project. Multidisciplinary Unit of Biomedical Research (UMIB) is funded by National Funds through FCT-Foundation for Science and Technology, under the "Fcomp-01-0124-FEDER-015893" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisa J, 2012, AFR HEALTH SCI, V12, P563, DOI 10.4314/ahs.v12i4.26; Bailey SL, 2011, J TRAVEL MED, V18, P61, DOI 10.1111/j.1708-8305.2010.00476.x; BALASCH J, 1995, HUM REPROD, V10, P1725, DOI 10.1093/oxfordjournals.humrep.a136163; Bindseil E, 1991, In Vivo, V5, P175; Botelho MC, 2009, EXP PARASITOL, V122, P250, DOI 10.1016/j.exppara.2009.04.001; Botelho MC, 2013, INT J PARASITOL, V43, P17, DOI 10.1016/j.ijpara.2012.10.023; Botelho MC, 2011, VIRULENCE, V2, P267, DOI 10.4161/viru.2.4.16734; Botelho MC, 2010, EXP PARASITOL, V126, P526, DOI 10.1016/j.exppara.2010.06.012; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brindley PJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001961; BULLOUGH CHW, 1976, BRIT J OBSTET GYNAEC, V83, P819, DOI 10.1111/j.1471-0528.1976.tb00751.x; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; Cavalieri E, 2006, ANN NY ACAD SCI, V1089, P286, DOI 10.1196/annals.1386.042; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Cavalieri EL, 2011, J STEROID BIOCHEM, V125, P169, DOI 10.1016/j.jsbmb.2011.03.008; Dzeing-Ella A, 2009, AM J TROP MED HYG, V81, P549, DOI 10.4269/ajtmh.2009.08-0498; ELMAHGOUB S, 1982, INT J GYNECOL OBSTET, V20, P201, DOI 10.1016/0020-7292(82)90072-8; FELDMEIER H, 1979, TROPENMED PARASITOL, V30, P417; Goverde AJ, 1996, HUM REPROD, V11, P531, DOI 10.1093/HUMREP/11.3.531; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000559; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Pharmaceuticals, 2012, IARC MONOGR EVAL CAR, V100, P1; Jourdan PM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001170; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Kini Suresh, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.01.2009.1481; Kjetland EF, 2012, TRENDS PARASITOL, V28, P58, DOI 10.1016/j.pt.2011.10.008; Kjetland EF, 2010, FERTIL STERIL, V94, P1551, DOI 10.1016/j.fertnstert.2009.12.050; Layman LC, 2002, J MED GENET, V39, P153, DOI 10.1136/jmg.39.3.153; Leutscher P, 1998, TROP MED INT HEALTH, V3, P327, DOI 10.1046/j.1365-3156.1998.00230.x; Lopes LV, 2012, PAN AFR MED J, V12; Lu Weiqin, 2007, Drug Discov Today Dis Models, V4, P67, DOI 10.1016/j.ddmod.2007.10.005; Markushin Y, 2006, PROSTATE, V66, P1565, DOI 10.1002/pros.20484; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Poggensee G, 1999, PARASITOL TODAY, V15, P378, DOI 10.1016/S0169-4758(99)01497-0; Ramarakoto CE, 2008, T ROY SOC TROP MED H, V102, P767, DOI 10.1016/j.trstmh.2008.03.007; Rinaldi G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001348; Schanz A, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.05.043; Shiff C, 2006, T ROY SOC TROP MED H, V100, P847, DOI 10.1016/j.trstmh.2005.10.010; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Takougang Innocent, 2004, Afr J Health Sci, V11, P111; The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO), 2009, REV GLOSS ART TERM; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Young ND, 2012, NAT GENET, V44, P221, DOI 10.1038/ng.1065; Zahid M, 2013, INT J CANCER, V133, P2642, DOI 10.1002/ijc.28275	45	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e96774	10.1371/journal.pone.0096774	http://dx.doi.org/10.1371/journal.pone.0096774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	25334008	Green Published, gold, Green Submitted			2022-12-27	WOS:000336730600015
J	Wang, LL; Sun, XY; Li, SY; Zhang, T; Zhang, W; Zhai, PH				Wang, Linlin; Sun, Xiangyang; Li, Suyan; Zhang, Tao; Zhang, Wei; Zhai, Penghui			Application of Organic Amendments to a Coastal Saline Soil in North China: Effects on Soil Physical and Chemical Properties and Tree Growth	PLOS ONE			English	Article							BIOLOGICAL-PROPERTIES; MICROBIAL COMMUNITIES; CATION-EXCHANGE; SEWAGE-SLUDGE; BEET VINASSE; SODIC SOILS; NITROGEN; RECLAMATION; PHOSPHORUS; POTASSIUM	The ability of the following four organic amendments to ameliorate saline soil in coastal northern China was investigated from April 2010 to October 2012 in a field experiment: green waste compost (GWC), sedge peat (SP), furfural residue (FR), and a mixture of GWC, SP and FR (1: 1: 1 by volume) (GSF). Compared to a non-amended control (CK), the amendments, which were applied at 4.5 kg organic matter m(-3), dramatically promoted plant growth; improved soil structure; increased the cation exchange capacity (CEC), organic carbon, and available nutrients; and reduced the salt content, electrical conductivity (EC), and exchangeable sodium percentage (ESP). At the end of the experiment in soil amended with GSF, bulk density, EC, and ESP had decreased by 11, 87, and 71%, respectively, and total porosity and organic carbon had increased by 25 and 96% respectively, relative to the CK. The GSF treatment resulted in a significantly lower Na++K+ content than the other treatments. CEC and the contents of available N, P, and K were significantly higher in the GSF-treated soil than in the CK and were the highest in all treatments. The FR treatment resulted in the lowest pH value and Ca2+ concentration, which decreased by 8% and 39%, respectively, relative to the CK. Overall, the results indicate that a combination of green waste compost, sedge peat and furfural residue (GSF treatment) has substantial potential for ameliorating saline soils in the coastal areas of northern China, and it works better than each amendment alone. Utilization of GWC and FR can be an alternative organic amendment to substitute the nonrenewable SP in saline soil amelioration.	[Wang, Linlin; Sun, Xiangyang; Li, Suyan; Zhang, Tao; Zhang, Wei; Zhai, Penghui] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Wang, Linlin] Forestry Res Inst Hulun Buir, Hulun Buir, Inner Mongolia, Peoples R China	Beijing Forestry University	Sun, XY (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	sunxy1965@126.com; lisuyan@bjfu.edu.cn	; Williams, Robert W./H-8789-2016	Deng, Hong-Wen/0000-0002-0387-8818; Williams, Robert W./0000-0001-8924-4447; Farber, Charles/0000-0002-6748-4711; Wang, Cong-Yi/0000-0001-7914-168X; Habibovic, Pamela/0000-0001-8249-5155	Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs [2009BADB2B0504]; Fundamental Research Funds for the Central Universities; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051190, R01AR050496, R01AR064825, R01AR057049, P50AR055081, R01AR050066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, P01AG018397, R03AG020321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662] Funding Source: NIH RePORTER	Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs (No. 2009BADB2B0504), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi MK, 2007, COMMUN SOIL SCI PLAN, V38, P1691, DOI 10.1080/00103620701435464; Amezketa E, 2005, AGRON J, V97, P983, DOI 10.2134/agronj2004.0236; Antil Rajinder Singh, 2007, Archives of Agronomy and Soil Science, V53, P519, DOI 10.1080/03650340701571033; BAO SD, 2005, ANAL SOIL AGROCHEMIS; BARKHAM JP, 1993, BIODIVERS CONSERV, V2, P556, DOI 10.1007/BF00056749; Barzegar AR, 1997, SOIL SCI SOC AM J, V61, P1131, DOI 10.2136/sssaj1997.03615995006100040020x; Bhattacharyya P, 2007, CHEMOSPHERE, V66, P1789, DOI 10.1016/j.chemosphere.2006.07.062; Brady AC, 2002, NATURE PROPERTIES SO; Clark GJ, 2007, SOIL BIOL BIOCHEM, V39, P2806, DOI 10.1016/j.soilbio.2007.06.003; Cooperband L., 2002, BUILDING SOIL ORGANI; David R, 2002, GEODERMA, V107, P271, DOI 10.1016/S0016-7061(01)00152-5; Feng YJ, 2006, PEDOSPHERE, V16, P668, DOI 10.1016/S1002-0160(06)60101-X; Hahn AS, 2013, PLANT SOIL, V363, P331, DOI 10.1007/s11104-012-1306-4; Hanay A, 2004, COMPOST SCI UTIL, V12, P175, DOI 10.1080/1065657x.2004.10702177; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Jackson M. L., 1958, Soil Chemical Analysis.; Kahlown MA, 2003, AGR WATER MANAGE, V62, P127, DOI 10.1016/S0378-3774(03)00096-9; Kaya C, 2001, J PLANT NUTR, V24, P357, DOI 10.1081/PLN-100001394; Larney FJ, 2012, CAN J SOIL SCI, V92, P19, DOI [10.4141/cjss2010-064, 10.4141/CJSS2010-064]; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Liang YC, 2003, GEODERMA, V115, P149, DOI 10.1016/S0016-7061(03)00084-3; Liu GQ, 2009, BIORESOURCE TECHNOL, V100, P5103, DOI 10.1016/j.biortech.2009.03.081; Mamedov AI, 2002, SOIL TILL RES, V68, P121, DOI 10.1016/S0167-1987(02)00115-0; Melero S, 2007, EUR J AGRON, V26, P327, DOI 10.1016/j.eja.2006.11.004; Oo AN, 2013, LAND DEGRAD DEV, DOI 101002/ldr2208; Page A.L., 1982, AGRONOMY SERIES, V9, DOI DOI 10.1002/JP1N.19851480319; Pocknee S, 1997, SOIL SCI SOC AM J, V61, P86, DOI 10.2136/sssaj1997.03615995006100010014x; Qadir M, 2007, ADV AGRON, V96, P197, DOI 10.1016/S0065-2113(07)96006-X; Qadir M, 2004, SCI TOTAL ENVIRON, V323, P1, DOI 10.1016/j.scitotenv.2003.10.012; Qadir M, 1998, SOIL TILL RES, V45, P119, DOI 10.1016/S0933-3630(96)00130-4; Qadir M, 2000, LAND DEGRAD DEV, V11, P501, DOI 10.1002/1099-145X(200011/12)11:6<501::AID-LDR405>3.0.CO;2-S; RICHARDS LA, 1954, AGR HDB, V60, P98; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Roca-Perez L, 2009, CHEMOSPHERE, V75, P781, DOI 10.1016/j.chemosphere.2008.12.058; Ros M, 2003, SOIL BIOL BIOCHEM, V35, P463, DOI 10.1016/S0038-0717(02)00298-5; Sumner M.E., 2000, HDB SOIL SCI; Sun R, 2011, BIORESOURCES, V6, P317; Tejada M, 2008, BIORESOURCE TECHNOL, V99, P1758, DOI 10.1016/j.biortech.2007.03.052; Tejada M, 2006, SOIL BIOL BIOCHEM, V38, P1413, DOI 10.1016/j.soilbio.2005.10.017; Tejada M, 2006, SOIL SCI SOC AM J, V70, P900, DOI 10.2136/sssaj2005.0271; Tejada M, 2005, EUR J AGRON, V23, P336, DOI 10.1016/j.eja.2005.02.005; TUCKER BM, 1954, AUST J AGR RES, V5, P706, DOI 10.1071/AR9540706; Wang Z.Q., 1993, SALINE SOIL IN CHINA; Warman PR, 2005, BIORESOURCE TECHNOL, V96, P955, DOI 10.1016/j.biortech.2004.08.003; Wichern J, 2006, GEODERMA, V137, P100, DOI 10.1016/j.geoderma.2006.08.001; Withers PJA, 2003, SOIL USE MANAGE, V19, P28, DOI 10.1111/j.1475-2743.2003.tb00276.x; Wong VNL, 2009, APPL SOIL ECOL, V41, P29, DOI 10.1016/j.apsoil.2008.08.006; Xing Y, 2012, CELL CHEM TECHNOL, V46, P249; Yazdanpanah N, 2013, AGR WATER MANAGE, V120, P39, DOI 10.1016/j.agwat.2012.08.017; Zhang L, 2013, BIORESOURCE TECHNOL, V131, P68, DOI 10.1016/j.biortech.2012.10.059; Zhang XC, 2002, J HYDROL, V260, P194, DOI 10.1016/S0022-1694(01)00612-6	51	125	145	9	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89185	10.1371/journal.pone.0089185	http://dx.doi.org/10.1371/journal.pone.0089185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	25330365	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700132
J	Wang, LS; Lu, WL; Zhang, L; Huang, Y; Scheib, R; Liu, XY; Myers, L; Lu, L; Farber, CR; Liu, GF; Wang, CY; Deng, HW; Williams, RW; Wang, YJ; Gu, WK; Jiao, Y				Wang, Lishi; Lu, Wenli; Zhang, Lei; Huang, Yue; Scheib, Rachel; Liu, Xiaoyun; Myers, Linda; Lu, Lu; Farber, Charles R.; Liu, Gaifen; Wang, Cong-Yi; Deng, Hongwen; Williams, Robert W.; Wang, Yongjun; Gu, Weikuan; Jiao, Yan			Trps1 Differentially Modulates the Bone Mineral Density between Male and Female Mice and Its Polymorphism Associates with BMD Differently between Women and Men	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TRICHORHINOPHALANGEAL-SYNDROME; MISSENSE MUTATION; GENE-EXPRESSION; POPULATION; IDENTIFICATION; METAANALYSIS; NETWORKS; LINKAGE; GROWTH	The objective of our study was to identify genetic factors that regulate bone mineral density (BMD) in mice using well defined recombinant inbred strains. For this purpose we chose the BXD recombinant inbred (RI) strains derived from progeny of the C57BL/6J (B6) and DBA/2J (D2) progenitor strains. We sampled both male and female mice (similar to 4 each) of 46 strains at 3 months-of-age, measured their BMD, and conducted QTL mapping. The data were analyzed to identify candidates genes contained within the most significant quantitative trait locus (QTL). Evaluation of candidate genes included functional assessment, single nucleotide polymorphism (SNP) genotyping and direct sequencing. We established that there was a QTL for BMD in males on chromosome 15 that has the impact larger than QTLs on all other chromosomes. The QTL on chromosome 15 was narrowed to a genomic region between 38 Mbp and 52 Mbp. By examining transcripts within this region, we found an important candidate gene: trichorhinophalangeal syndrome, type I (Trps1). SNP analysis identified a nonsynonymous SNP (rs32398060) in Trps1 that co-segregated with bone mineral density. Analysis of association between this SNP within TRPS1 and BMD in a human population confirmed its significance.	[Wang, Lishi; Lu, Wenli; Huang, Yue; Scheib, Rachel; Liu, Xiaoyun; Gu, Weikuan; Jiao, Yan] Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg & BioMed Engn, Memphis, TN 38163 USA; [Wang, Lishi] Inner Mongolia Med Univ, Dept Basic Med, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Lei; Deng, Hongwen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA USA; [Myers, Linda] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN USA; [Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Farber, Charles R.] Univ Virginia, Dept Med, Div Cardiol, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Farber, Charles R.] Univ Virginia, Dept Biochem & Mol Genet, Div Cardiol, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Liu, Gaifen; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Cong-Yi] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Ctr Biomed Res, Wuhan 430074, Hubei, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; Inner Mongolia Medical University; Tulane University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Virginia; University of Virginia; Capital Medical University; Huazhong University of Science & Technology	Gu, WK (corresponding author), Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg & BioMed Engn, Memphis, TN 38163 USA.	wgu@uthsc.edu; yjiao2@utusc.edu	; Williams, Robert W./H-8789-2016	Deng, Hong-Wen/0000-0002-0387-8818; Williams, Robert W./0000-0001-8924-4447; Farber, Charles/0000-0002-6748-4711; Wang, Cong-Yi/0000-0001-7914-168X; Habibovic, Pamela/0000-0001-8249-5155	National Institute of Arthritis (NIA); Musculoskeletal and Skin Diseases, National Institutes of Health (NIH) [R01 AR51190]; Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, Tennessee; NIH [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221, R01 AR/AG 41398, R01 AR050066, R03 AG20321]; Franklin D. Dickson/Missouri Endowment; Edward G. Schlieder Endowment; National Natural Science Foundation of China [31100902]; National Heart, Lung, and Blood Institute (NHLBI); Boston University [N01-HC-25195]; NHLBI [N02-HL-64278]; NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility [P01-AG018397]; NIH NIA; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051190, R01AR050496, R01AR064825, R01AR057049, P50AR055081, R01AR050066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, P01AG018397, R03AG020321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662] Funding Source: NIH RePORTER	National Institute of Arthritis (NIA); Musculoskeletal and Skin Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, Tennessee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin D. Dickson/Missouri Endowment; Edward G. Schlieder Endowment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility; NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was partially supported by grants from the National Institute of Arthritis (NIA) and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH)(R01 AR51190 to W.G.), Genediscovery Core at UTHSC, and the Veterans Administration Medical Center in Memphis, Tennessee. H. W. D. was partially supported by grants from NIH (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221), the Franklin D. Dickson/Missouri Endowment and the Edward G. Schlieder Endowment. L.Z. was partially supported by National Natural Science Foundation of China (project 31100902). The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. Funding support for the Framingham Bone Mineral Density datasets was provided by NIH grants R01 AR/AG 41398, R01 AR050066 and R03 AG20321. Funding support for the Genetic Determinants of Bone Fragility (the Indiana fragility study) was provided through the NIA Division of Geriatrics and Clinical Gerontology. Genetic Determinants of Bone Fragility is a genome-wide association studies funded as part of the NIA Division of Geriatrics and Clinical Gerontology. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the NIA Division of Geriatrics and Clinical Gerontology and the NIA Division of Aging Biology. Support for the collection of datasets and samples were provided by the parent grant, Genetic Determinants of Bone Fragility (P01-AG018397). Funding support for the genotyping which was performed at the Johns Hopkins University Center for Inherited Diseases Research was provided by the NIH NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell CL, 2012, BONE; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Beamer WG, 1999, MAMM GENOME, V10, P1043, DOI 10.1007/s003359901159; BONJOUR JP, 1994, OSTEOPOROSIS INT, V4, P7; Calabrese G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003150; CARRINGTON PR, 1994, J AM ACAD DERMATOL, V31, P331, DOI 10.1016/S0190-9622(94)70166-0; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Garnero P., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P50; Geisert EE, 2009, MOL VIS, V15, P1730; Grubb SC, 2004, BIOINFORMATICS, V20, P2857, DOI 10.1093/bioinformatics/bth299; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ishimori N, 2008, J BONE MINER RES, V23, P1529, DOI 10.1359/JBMR.080414; Jiao Y, 2008, GENOMICS, V91, P407, DOI 10.1016/j.ygeno.2007.12.010; Klein RF, 1998, J BONE MINER RES, V13, P1648, DOI 10.1359/jbmr.1998.13.11.1648; Kolta S, 2003, J CLIN DENSITOM, V6, P251, DOI 10.1385/JCD:6:3:251; Li GHY, 2011, HUM GENET, V130, P539, DOI 10.1007/s00439-011-0972-2; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; Lynch RM, 2010, PHYSIOL GENOMICS, V41, P244, DOI 10.1152/physiolgenomics.00020.2010; Milner LC, 2010, INT REV NEUROBIOL, V91, P173, DOI 10.1016/S0074-7742(10)91006-4; NOLTORP S, 1986, ANN RHEUM DIS, V45, P31, DOI 10.1136/ard.45.1.31; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Pei YF, 2013, HUM MOL GENET; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rossi A, 2007, BRIT J DERMATOL, V157, P1021, DOI 10.1111/j.1365-2133.2007.08158.x; Sarafoglou K, 2010, CLIN GENET, V78, P591, DOI 10.1111/j.1399-0004.2010.01434.x; SCHNITZLER CM, 1993, CALCIFIED TISSUE INT, V53, pS27, DOI 10.1007/BF01673398; Soon G, 2006, CALCIFIED TISSUE INT, V78, P186, DOI 10.1007/s00223-005-0191-8; Suwanwela J, 2011, J BONE MINER RES, V26, P747, DOI 10.1002/jbmr.271; Tariq M, 2008, BRIT J DERMATOL, V159, P476, DOI 10.1111/j.1365-2133.2008.08658.x; Tremollieres F, 2010, MATURITAS, V65, P348, DOI 10.1016/j.maturitas.2009.12.023; Vaccaro M, 2009, PEDIATR DERMATOL, V26, P171, DOI 10.1111/j.1525-1470.2009.00905.x; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xiong Q, 2008, BIOINFORMATICS, V24, P1011, DOI 10.1093/bioinformatics/btn002; Xiong Q, 2009, GENOMICS, V93, P401, DOI 10.1016/j.ygeno.2008.12.008; Yu H, 2007, CALCIFIED TISSUE INT, V80, P103, DOI 10.1007/s00223-006-0187-z; Zhang L, 2009, ANN HUM GENET, V73, P601, DOI 10.1111/j.1469-1809.2009.00539.x	42	125	145	9	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84485	10.1371/journal.pone.0084485	http://dx.doi.org/10.1371/journal.pone.0084485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	25330365	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500131
J	Li, X; Wu, LH; Liu, W; Jin, YC; Chen, Q; Wang, LL; Fan, XH; Li, Z; Cheng, YY				Li, Xiang; Wu, Leihong; Liu, Wei; Jin, Yecheng; Chen, Qian; Wang, Linli; Fan, Xiaohui; Li, Zheng; Cheng, Yiyu			A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action	PLOS ONE			English	Article							PPAR-GAMMA AGONISTS; SIGNALING PATHWAYS; HEME OXYGENASE-1; RAW264.7; EXPRESSION; MECHANISMS; PROTEIN; LIPOPOLYSACCHARIDE; INFLAMMATION; THERAPEUTICS	Chinese medicine is a complex system guided by traditional Chinese medicine (TCM) theories, which has proven to be especially effective in treating chronic and complex diseases. However, the underlying modes of action (MOA) are not always systematically investigated. Herein, a systematic study was designed to elucidate the multi-compound, multi-target and multi-pathway MOA of a Chinese medicine, QiShenYiQi (QSYQ), on myocardial infarction. QSYQ is composed of Astragalus membranaceus (Huangqi), Salvia miltiorrhiza (Danshen), Panax notoginseng (Sanqi), and Dalbergia odorifera (Jiangxiang). Male Sprague Dawley rat model of myocardial infarction were administered QSYQ intragastrically for 7 days while the control group was not treated. The differentially expressed genes (DEGs) were identified from myocardial infarction rat model treated with QSYQ, followed by constructing a cardiovascular disease (CVD)-related multilevel compound-target-pathway network connecting main compounds to those DEGs supported by literature evidences and the pathways that are functionally enriched in ArrayTrack. 55 potential targets of QSYQ were identified, of which 14 were confirmed in CVD-related literatures with experimental supporting evidences. Furthermore, three sesquiterpene components of QSYQ, Trans-nerolidol, (3S, 6S, 7R)-3,7,11-trimethyl-3,6-epoxy-1,10-dodecadien-7-ol and (3S, 6R, 7R)-3,7,11-trimethyl- 3,6-epoxy-1,10-dodecadien-7-ol from Dalbergia odorifera T. Chen, were validated experimentally in this study. Their anti-inflammatory effects and potential targets including extracellular signal-regulated kinase-1/2, peroxisome proliferator-activated receptor-gamma and heme oxygenase-1 were identified. Finally, through a three-level compound-target-pathway network with experimental analysis, our study depicts a complex MOA of QSYQ on myocardial infarction.	[Li, Xiang; Wu, Leihong; Liu, Wei; Jin, Yecheng; Chen, Qian; Wang, Linli; Fan, Xiaohui; Cheng, Yiyu] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Zheng] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China	Zhejiang University; Tianjin University of Traditional Chinese Medicine	Fan, XH (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	fanxh@zju.edu.cn; lizheng1@gmail.com	Wu, Leihong/AAM-9483-2020; FAN, Xiaohui/F-6458-2010; Bligh, S W Annie/AAI-9786-2020	Wu, Leihong/0000-0002-4093-3708; FAN, Xiaohui/0000-0002-6336-3007; Bligh, S W Annie/0000-0002-4757-2159; LI, Xiaojun/0000-0003-0336-8081	National Basic Research Program of China [2012CB518405]; National Natural Science Foundation of China [81373893]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program of China (no. 2012CB518405) and the National Natural Science Foundation of China (no. 81373893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Microarray test was performed by National Engineering Center for Biochip at Shanghai by Dr. Huasheng Xiao's team.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Aramoto H, 2004, AM J PHYSIOL-HEART C, V287, pH1590, DOI 10.1152/ajpheart.00767.2003; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Campbell IW, 2005, CURR MOL MED, V5, P349, DOI 10.2174/1566524053766068; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen T, 2011, JIANGXI MED J, V46, P3; Cheung F, 2011, NATURE, V480, pS82, DOI 10.1038/480S82a; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Diez D, 2010, MOL BIOSYST, V6, P289, DOI 10.1039/b912078e; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hirota SA, 2009, RECENT PATENTS INFLA, V3, P1, DOI 10.2174/187221309787158434; Hong SeChul, 2012, Journal of Medicinal Plants Research, V6, P4494; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Jeong JB, 2013, FOOD CHEM TOXICOL, V55, P229, DOI 10.1016/j.fct.2012.12.062; Ji HY, 2010, INFLAMM RES, V59, P921, DOI 10.1007/s00011-010-0203-7; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang WY, 2005, TRENDS PHARMACOL SCI, V26, P558, DOI 10.1016/j.tips.2005.09.006; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kim BC, 2006, J ETHNOPHARMACOL, V106, P364, DOI 10.1016/j.jep.2006.01.009; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kronke G, 2007, ARTERIOSCL THROM VAS, V27, P1276, DOI 10.1161/ATVBAHA.107.142638; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee M, 2012, STRAD, V123, P7; Li YF, 2008, J PHARMACEUT BIOMED, V47, P407, DOI 10.1016/j.jpba.2007.12.037; Li YF, 2008, CHROMATOGRAPHIA, V67, P293, DOI 10.1365/s10337-007-0479-0; Lin HY, 2003, BIOCHEM PHARMACOL, V66, P1821, DOI 10.1016/S0006-2952(03)00422-2; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Martin H, 2009, MUTAT RES-FUND MOL M, V669, P1, DOI 10.1016/j.mrfmmm.2009.06.009; Miksa M, 2007, J IMMUNOL, V179, P6263, DOI 10.4049/jimmunol.179.9.6263; Murphy GJ, 2000, TRENDS PHARMACOL SCI, V21, P469, DOI 10.1016/S0165-6147(00)01559-5; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726, DOI 10.1152/ajpheart.2001.280.6.H2726; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Robinson ES, 2010, SEMIN NEPHROL, V30, P591, DOI 10.1016/j.semnephrol.2010.09.007; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Suefuji H, 1997, AM HEART J, V134, P253, DOI 10.1016/S0002-8703(97)70132-7; Suh SJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P136, DOI 10.1016/j.abb.2006.01.016; Tang S, 2011, INFLAMMATION, V34, P111, DOI 10.1007/s10753-010-9214-3; Tao Y, 2010, FITOTERAPIA, V81, P393, DOI 10.1016/j.fitote.2009.11.012; Terzic A, 2011, CTS-CLIN TRANSL SCI, V4, P225, DOI 10.1111/j.1752-8062.2011.00295.x; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; von Knethen A, 2011, FREE RADICAL BIO MED, V51, P396, DOI 10.1016/j.freeradbiomed.2011.04.033; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Waldman SA, 2011, CLIN PHARMACOL THER, V90, P483, DOI 10.1038/clpt.2011.213; Wang Linli, 2013, Evid Based Complement Alternat Med, V2013, P652373, DOI 10.1155/2013/652373; [魏万林 WEI Wan-lin], 2009, [中国循环杂志, Chinese Circulation Journal], V24, P182; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu Leihong, 2013, Database (Oxford), V2013, pbat047, DOI 10.1093/database/bat047; Xing B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-4; Yamaguchi F, 1997, J MOL CELL CARDIOL, V29, P753, DOI 10.1006/jmcc.1996.0319; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yan F. F., 2007, SHANGHAI J TRADITION, V41, P59; Yaoita H, 2000, CARDIOVASC RES, V45, P630, DOI 10.1016/S0008-6363(99)00349-1; Zaytseva YY, 2011, ANTICANCER RES, V31, P813; Zhang L, 2010, INT J CARDIOL, V143, P105, DOI 10.1016/j.ijcard.2008.11.210; Zhang YF, 2012, CURR DRUG METAB, V13, P510, DOI 10.2174/1389200211209050510; Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520; Zheng XH, 2007, AM J CHINESE MED, V35, P831, DOI 10.1142/S0192415X07005302; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; 朱明丹, 2013, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V24, P22; 刘梅, 2009, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V20, P829	80	220	235	12	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e95004	10.1371/journal.pone.0095004	http://dx.doi.org/10.1371/journal.pone.0095004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24587076	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000010
